Citrus Sinensis ID: 048439

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610---
Protein Sequence
MDDPYLTDARPSALPVNQSIHLTWIRNYSAPDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDNTGNLGGPNPEPRTIPPNLDASPTIEPTKKNNVTGMVAGAISGSSVLSLLLLLIFWRGRKVKDSSSGTGTSLLGTFLWSKTIKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSIAIAKEIDENEEEEKLLDNYETDGSGPVFSSVGEHVLSDSKTISTVTISTTTATDDQSLSTGSSDKYTGAVFSEILNPKGR
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccHHHHHHHHHccccccccccccEEEEEEEcccccEEEEEEEEcccccccccccEEEEEEEccccccccccHHHHHccccEEEEEEEEEEcccccccccccccEEEEEEEcccccccccccccccEEEEEEEcccccccccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHEEEEEEccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEEccccEEEEEEEccccccccHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEEEccccccccccccccccccccccccccccccccccccHHHHHccccccccccccHHHHHHHHHccccccccccccccccHHHHHHHHHHcccccccccccccHHccccccccccccHHHHHHHHHHHHHcccHHHHHHccccHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccEEccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccEEcccccccccccHHHHHHHHHHccccccccccEEEEEEEcccccEEEEEEEEEEEEEcccccccEEEEEEEcccEEcccccHHHHccccccEEEEEEEEEEccccccccccEEEEEEEccccccccccccEEEccEEEEEEccccccccccccccccccccccccccccccccccHEHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHccEEEccccccEEEEEEccccEEEEEEEcccccHccHHHHHHHHHHHHHHHHHcHHHEEEcccccccEEEEEHHHccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHccccccEEEcccccHHHEEEcccccEEEcccccccccccccccccccHHHHHHHHccccccHHHHHHEEHHHHcccccccccccHHHHHHHHHHHHHHHcccHHHHccHHHHHHHHHHccccccccHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccEccccccccccccccccHHHHHHHHcccccc
Coil and Loop (DISEMBL)
mddpyltdarpsalpvnqsiHLTWIrnysapdlVYETARTmgqdreinekynltwefevdsGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWtgangvtvYRDYAVMigskpneenIKQNlsiqlhpaprwrtkYSDAILNGLeifkvdntgnlggpnpeprtippnldasptieptkknnvtgMVAGAISGSSVLSLLLLLIFWRgrkvkdsssgtgtslLGTFLWSktikatkssrgsflpsdlctqfSLSEIQAAtnnfdndlvigvggfgdvykgfingsttpvaikrlepesqqgALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMargtlpdhlyhsdnpplpwnqrLEICIGAARglhylhtganhAVIIHRDVKTTNILLDEKWVAKVsdfglskfgptsvskthldpeyyrlqqlteksdvySFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCyqngtidqIVDPFLKAMSClndegirrpsmsdVVWGLEFSLQLQESSIAIAKEIDENEEEEKLldnyetdgsgpvfssvgehvlsdsktISTVTIstttatddqslstgssdkytGAVFSeilnpkgr
Flexible Loop (DISEMBL)
mddpyltdarpsalpvnqsihlTWIRNYSAPDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQNLsiqlhpaprwRTKYSDAILNGLEIFKVDNTGNLGGPNPEPRTIPPNLDASPTIEPTKKNNVTGMVAGAISGSSVLSLLLLLIFWRGRkvkdsssgtgtsllgtfLWSKTIKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFglskfgptsvskthldPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSIAIAKEIDENEEEEKLLDNYETDGSGPVFSSVGEHVLSDSKTISTVtistttatddqslstgssdkytgavfseilnpkgr
Low Complexity Region (SEG)
MDDPYLTDARPSALPVNQSIHLTWIRNYSAPDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDNTGNLGGPNPEPRTIPPNLDASPTIEPTKKNNVTGMvagaisgssvlsllllliFWRGRKVKDsssgtgtsllgtflwsKTIKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSIaiakeideneeeeklldnYETDGSGPVFSSVGEHVLsdsktistvtistttatddqsLSTGSSDKYTGAVFSEILNPKGR
Disordered region (IsUnstruct)
**************PVNQSIHLTWIRNYSAPDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYAVMIGSK****NIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDN********************************TGMVAGAISGSSVLSLLLLLIFWRGRKVKD***GTGTSLLGTFLWSKTIKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL******GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSIAI******************************************************************************
Disordered Region (DISOPRED)
MDDPYLTDARPSALPVNQSIHLTWIRNYSAPDLVYETARTM*****INEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDNTGNLGGP***************************MVAGAISGSSVLSLLLLLIFWR*****************************************TQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAI*R***********FQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSL********************************************************************************ILNP***
Disordered Region (DISEMBL)
********ARPSALPVNQSIHLTWIRNYSAPDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDNTGNLGGPNPEPRTIPPNLDASPTIEPTKKNNVTGMVAGAISGSSVLSLLLLLIFWRGRK********GTSLLGTFLWSKTIKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSIAIAKEIDENEEEEKLLDNYETDGSGPVFSSVGEHVLSDSKTISTVTISTT************SDKYTGAVFSEILNPKGR
Disordered Region (DISPRO)
***PYLTDARPSALPVNQSIHLTWIRNYSAPDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDNTGNLGGPNPEPRTIPPNLD**********NNVTGMVAGAISGSSVLSLLLLLIFWRGRKVK******************************L*SDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSI********************************************************************************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDDPYLTDARPSALPVNQSIHLTWIRNYSAPDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDNTGNLGGPNPEPRTIPPNLDASPTIEPTKKNNVTGMVAGAISGSSVLSLLLLLIFWRGRKVKDSSSGTGTSLLGTFLWSKTIKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSIAxxxxxxxxxxxxxxxxxxxxxGSGPVFSSVGEHVLSDSKTISTVTISTTTATDDQSLSTGSSDKYTGAVFSEILNPKGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	613	2.2.26 [Sep-21-2011]
Q9SCZ4	895	Receptor-like protein kin	yes	no	0.975	0.668	0.511	1e-164
Q9FID8	873	Putative receptor-like pr	no	no	0.908	0.638	0.473	1e-145
Q3E8W4	858	Receptor-like protein kin	no	no	0.902	0.644	0.468	1e-143
Q9FID9	880	Probable receptor-like pr	no	no	0.962	0.670	0.449	1e-140
Q9SR05	850	Receptor-like protein kin	no	no	0.884	0.637	0.454	1e-139
Q9SA72	849	Probable receptor-like pr	no	no	0.786	0.567	0.450	1e-113
Q9FLJ8	842	Probable receptor-like pr	no	no	0.807	0.587	0.429	1e-110
Q9LK35	855	Receptor-like protein kin	no	no	0.926	0.664	0.387	1e-108
Q9T020	878	Probable receptor-like pr	no	no	0.892	0.623	0.405	1e-105
Q9SJT0	871	Probable receptor-like pr	no	no	0.796	0.560	0.432	1e-105

>sp|Q9SCZ4|FERON_ARATH Receptor-like protein kinase FERONIA OS=Arabidopsis thaliana GN=FER PE=1 SV=1

 Score =  580 bits (1494), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 337/659 (51%), Positives = 422/659 (64%), Gaps = 61/659 (9%)

Query: 2   DDPYLTDAR---PSALPVNQSI-HLTWIRNYSAPDLVYETARTMGQDREINEKYNLTWEF 57
           D PY+  A    P     N +I + T    Y AP  VY TAR+MG   +IN  YNLTW F
Sbjct: 251 DQPYIFGAGLGIPETADPNMTIKYPTGTPTYVAPVDVYSTARSMGPTAQINLNYNLTWIF 310

Query: 58  EVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYA 117
            +DSGFTY +RLHFCE    +T+   RVF I++ N TAE +ADVIAWT +NGV  ++DY 
Sbjct: 311 SIDSGFTYLVRLHFCEVSSNITKINQRVFTIYLNNQTAEPEADVIAWTSSNGVPFHKDYV 370

Query: 118 VMIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDNT-GNLGGPNPEPRTI 176
           V     P E N +Q+L + LHP P  + +Y D++LNG+EIFK++ + GNL G NP P   
Sbjct: 371 V----NPPEGNGQQDLWLALHPNPVNKPEYYDSLLNGVEIFKMNTSDGNLAGTNPIPG-- 424

Query: 177 PPNLDASPT--IEPTKKNNVTGMVAGAISGSSVLSLLLLLIF-----WRGRK------VK 223
            P + A P+  + PT + + +     A + S  + L L++ F     +R RK        
Sbjct: 425 -PQVTADPSKVLRPTTRKSKSNTAIIAGAASGAVVLALIIGFCVFGAYRRRKRGDYQPAS 483

Query: 224 DSSSG-TGTSLLGTFLWSKTIKA-TKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIG 281
           D++SG    SL G    + + K  T  S  S LPS+LC  FS +EI+AAT NFD   V+G
Sbjct: 484 DATSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFDESRVLG 543

Query: 282 VGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD 341
           VGGFG VY+G I+G TT VAIKR  P S+QG  EFQTEI MLS+LRH HLVSLIG+C ++
Sbjct: 544 VGGFGKVYRGEIDGGTTKVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN 603

Query: 342 REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDV 401
            EMILVYD+MA GT+ +HLY + NP LPW QRLEICIGAARGLHYLHTGA H  IIHRDV
Sbjct: 604 CEMILVYDYMAHGTMREHLYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKH-TIIHRDV 662

Query: 402 KTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH-----------LDPEYYRLQQLTEKSDV 450
           KTTNILLDEKWVAKVSDFGLSK GPT +  TH           LDPEY+R QQLTEKSDV
Sbjct: 663 KTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 721

Query: 451 YSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK---------- 500
           YSFGVVLFE LCARP++  T AK+QVSLA WA  CY+ G +DQIVDP+LK          
Sbjct: 722 YSFGVVLFEALCARPALNPTLAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFKK 781

Query: 501 ----AMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSIAIAKEI-DENEEEEKLLDNYETD 555
               AM C+ D+GI RPSM DV+W LEF+LQLQES+    K +  + + +E   D+    
Sbjct: 782 FAETAMKCVLDQGIERPSMGDVLWNLEFALQLQESAEENGKGVCGDMDMDEIKYDDGNCK 841

Query: 556 GSGPVFSSVGEHVLSDSKTISTVTISTTTATDDQSLSTGSSDKYT-GAVFSEILNPKGR 613
           G     S V E  ++DS++ S + +S       +SL++  SD  T  AVFS+I+NPKGR
Sbjct: 842 GKNDKSSDVYEGNVTDSRS-SGIDMS----IGGRSLASEDSDGLTPSAVFSQIMNPKGR 895

Receptor-like protein kinase that mediates the female control of male gamete delivery during fertilization, including growth cessation of compatible pollen tubes ensuring a reproductive isolation barriers. Required for cell elongation during vegetative growth, mostly in a brassinosteroids- (BR-) independent manner.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FID8|Y5900_ARATH Putative receptor-like protein kinase At5g39000 OS=Arabidopsis thaliana GN=At5g39000 PE=3 SV=1

 Score =  514 bits (1323), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 299/631 (47%), Positives = 384/631 (60%), Gaps = 74/631 (11%)

Query: 27  NYSAPDLVYETARTMGQ--DREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDR 84
           +Y APD VY T+R+MG     E N  +NLTW F VD+GF+Y +RLHFCE   EV ++G R
Sbjct: 273 SYVAPDDVYATSRSMGNADHPEQNLNFNLTWLFTVDAGFSYLVRLHFCETLSEVNKEGQR 332

Query: 85  VFQIFIANLTAEVQADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWR 144
           VF IFI N TA ++ DV   +G + + +Y DY V+ GS       + +L + LHP     
Sbjct: 333 VFSIFIENQTATLEMDVFRMSGGSWIPMYLDYTVIAGSGSGR---RHDLRLDLHPLVSIN 389

Query: 145 TKYSDAILNGLEIFKV-DNTGNLGGPNPEPRTIP---PNLDASPTIEPTKKNNVTGMVAG 200
            KY DAILNG+EI K+ D  GNL GPNP+P   P   PN  A+P I   K + +      
Sbjct: 390 PKYYDAILNGVEILKMNDPDGNLAGPNPDPLVSPDLIPN-RATPRIRKNKSHIL------ 442

Query: 201 AISGSSVLSLLLLLIFWRGRKVKDSSSGTGTSLLGTFLWSKTIKATKSSR---GSFLPSD 257
            I+ + V SL++L +F  G  V        +       W      T S+       LP+D
Sbjct: 443 PITLAVVGSLVVLAMFVVGVLVI-MKKKKKSKPSTNSSWCPLPHGTDSTNTKPAKSLPAD 501

Query: 258 LCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ 317
           LC +FS+ EI++ATN+F++ L+IGVGGFG VYKG I+G  T VA+KRLE  S QGA EF+
Sbjct: 502 LCRRFSIFEIKSATNDFEDKLIIGVGGFGSVYKGQIDGGATLVAVKRLEITSNQGAKEFE 561

Query: 318 TEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSD---NPPLPWNQRL 374
           TE+ MLS+LRH+HLVSLIG+C++D EM+LVY++M  GTL DHL+  D   +PPL W +RL
Sbjct: 562 TELEMLSKLRHVHLVSLIGYCDEDNEMVLVYEYMPHGTLKDHLFRRDKTSDPPLSWKRRL 621

Query: 375 EICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH- 433
           EICIGAARGL YLHTGA +  IIHRD+KTTNILLDE +V KVSDFGLS+ GPTS S+TH 
Sbjct: 622 EICIGAARGLQYLHTGAKYT-IIHRDIKTTNILLDENFVTKVSDFGLSRVGPTSASQTHV 680

Query: 434 ----------LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQ 483
                     LDPEYYR Q LTEKSDVYSFGVVL EVLC RP  +++   +Q  L  W +
Sbjct: 681 STVVKGTFGYLDPEYYRRQVLTEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWVK 740

Query: 484 QCYQNGTIDQIVDPFLK--------------AMSCLNDEGIRRPSMSDVVWGLEFSLQLQ 529
             Y+ GT+DQI+D  L               A+ C+ D G+ RP M+DVVW LEF+LQL 
Sbjct: 741 SNYRRGTVDQIIDSDLSADITSTSLEKFCEIAVRCVQDRGMERPPMNDVVWALEFALQLH 800

Query: 530 ESSIAIAKEIDENEEEEKLLDNYE----TDGSGPVFSSVGEHVLSDSKTISTVTISTTTA 585
           E+    AK+ ++N E   L+ + E    TDG   +FS    HV              +T 
Sbjct: 801 ET----AKKKNDNVESLDLMPSGEVGTTTDGEDDLFSRTTGHV------------GKSTT 844

Query: 586 TDDQSLSTGSSDKYTGA---VFSEILNPKGR 613
           TDD  L  G  D+ +G+   VFSEI  PK R
Sbjct: 845 TDDSVLVVG--DERSGSSWGVFSEINEPKAR 873

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q3E8W4|ANX2_ARATH Receptor-like protein kinase ANXUR2 OS=Arabidopsis thaliana GN=ANX2 PE=2 SV=1

 Score =  508 bits (1308), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 291/621 (46%), Positives = 377/621 (60%), Gaps = 68/621 (10%)

Query: 29  SAPDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQI 88
           +AP  VY+TAR+ G + +IN K NLTW F+VD+ FTY +RLHFCEFQ+   +   +VF I
Sbjct: 270 TAPADVYKTARSQGPNGDINMKSNLTWMFQVDTNFTYIMRLHFCEFQL--AKINQKVFNI 327

Query: 89  FIANLTAEVQ---ADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRT 145
           FI N TA+     AD++ WTG  G+  Y+DYA+ + +  N     + +S+Q+ P+   + 
Sbjct: 328 FINNRTAQGDTNPADILGWTGGKGIPTYKDYAIYVDA--NTGGGGEEISLQMTPSTFGQP 385

Query: 146 KYSDAILNGLEIFKVDNTGNLGGPNPEPRTIPPNLDASPTIEPTKKNNVTGMVAGAISGS 205
           +Y D+ LNGLEIFK+D   NL GPNP+P  +  N D     +  K+  +T  V G+  G 
Sbjct: 386 EYYDSQLNGLEIFKIDTMKNLAGPNPKPSPMQANEDVKKDFQGDKR--ITAFVIGSAGGV 443

Query: 206 SVLSLLLLLIFWRGRKVKDSSSGTGTSLLGTFLWSKTIKATKS---------SRGSFLPS 256
           + +    L      RK K S S + TS       +    ATKS         S  S L +
Sbjct: 444 AAVLFCALCFTMYQRKRKFSGSDSHTSSWLPIYGNSHTSATKSTISGKSNNGSHLSNLAA 503

Query: 257 DLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEF 316
            LC +FSLSEI+  T+NFD   VIGVGGFG VYKG I+G T  VAIK+  P S+QG  EF
Sbjct: 504 GLCRRFSLSEIKHGTHNFDESNVIGVGGFGKVYKGVIDGGTK-VAIKKSNPNSEQGLNEF 562

Query: 317 QTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEI 376
           +TEI +LS+LRH HLVSLIG+C++  EM L+YD+M+ GTL +HLY++  P L W +RLEI
Sbjct: 563 ETEIELLSRLRHKHLVSLIGYCDEGGEMCLIYDYMSLGTLREHLYNTKRPQLTWKRRLEI 622

Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-------TSV 429
            IGAARGLHYLHTGA +  IIHRDVKTTNILLDE WVAKVSDFGLSK GP       T+V
Sbjct: 623 AIGAARGLHYLHTGAKY-TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMNGGHVTTV 681

Query: 430 SK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCY 486
            K    +LDPEY+R QQLTEKSDVYSFGVVLFEVLCARP++  + +K+QVSL  WA  C 
Sbjct: 682 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNPSLSKEQVSLGDWAMNCK 741

Query: 487 QNGTIDQIVDPFLK--------------AMSCLNDEGIRRPSMSDVVWGLEFSLQLQESS 532
           + GT++ I+DP LK              A  CL+D G+ RP+M DV+W LEF+LQLQE++
Sbjct: 742 RKGTLEDIIDPNLKGKINPECLKKFADTAEKCLSDSGLDRPTMGDVLWNLEFALQLQETA 801

Query: 533 IAIAKEIDENEEEEKLLDNYETDGSGPVFSSVGEHVLSDSKTISTVTISTTTATDDQSLS 592
                                 DGS     S G   +        VT++ +    D  L 
Sbjct: 802 ----------------------DGSRHRTPSNGGGSVDLGGGGGGVTVNISAGESD--LG 837

Query: 593 TGSSDKYTGAVFSEILNPKGR 613
              S +    +FS+I+NPKGR
Sbjct: 838 DDLSSEENSGIFSQIVNPKGR 858

Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FID9|Y5389_ARATH Probable receptor-like protein kinase At5g38990 OS=Arabidopsis thaliana GN=At5g38990 PE=2 SV=1

 Score =  498 bits (1281), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 297/661 (44%), Positives = 388/661 (58%), Gaps = 71/661 (10%)

Query: 2   DDPYLTDARPSALPVNQSIHLTWIRN---YSAPDLVYETARTMGQDR--EINEKYNLTWE 56
           D+ +L      A+P    + + +      Y AP+ VY T R MG     E+N  +NLTW 
Sbjct: 242 DEGFLLGINSGAIPNITGVKINYTDKTPAYVAPEDVYTTCRLMGNKDSPELNLNFNLTWL 301

Query: 57  FEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDY 116
           FEVD+GF Y +RLHFCE Q EV + GDRVF IF     A  + DV   +G   + +Y D+
Sbjct: 302 FEVDAGFAYIVRLHFCETQPEVNKTGDRVFSIFFGYQLAMREMDVFRLSGGFRLPMYLDF 361

Query: 117 AVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDNT-GNLGGPNPEPRT 175
            V++ +    +  + +L + L P       Y DAIL+G+EI K+ N+ GNL G NP P+ 
Sbjct: 362 KVLVDADGTSQ--RPSLRVDLTPYKEDYPTYYDAILSGVEILKLSNSDGNLAGLNPIPQL 419

Query: 176 IPPNLDASPTIEPTKKNNVTGMVAGAISGSSVLSLLLLLI-----FWRGRKVKDSSSGTG 230
            PP    +P     K ++V  ++  A+ GS+V     +L+       R +K  +SS  T 
Sbjct: 420 SPPPQSITPLKGKGKSSHVLPIII-AVVGSAVALAFFVLVVVLVVMKRKKKSNESSVDTT 478

Query: 231 TSLLGTFLWSKTIKATKSSR---GSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGD 287
                   W   +  T S+     S LPSDLC +FS+ EI++ATN+F+  L+IGVGGFG 
Sbjct: 479 NKPSTNSSWGPLLHGTGSTNTKSASSLPSDLCRRFSIYEIKSATNDFEEKLIIGVGGFGS 538

Query: 288 VYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV 347
           VYKG I+G  T VA+KRLE  S QGA EF TE+ MLS+LRH+HLVSLIG+C+DD EM+LV
Sbjct: 539 VYKGRIDGGATLVAVKRLEITSNQGAKEFDTELEMLSKLRHVHLVSLIGYCDDDNEMVLV 598

Query: 348 YDFMARGTLPDHLYHSD---NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTT 404
           Y++M  GTL DHL+  D   +PPL W +RLEICIGAARGL YLHTGA +  IIHRD+KTT
Sbjct: 599 YEYMPHGTLKDHLFRRDKASDPPLSWKRRLEICIGAARGLQYLHTGAKYT-IIHRDIKTT 657

Query: 405 NILLDEKWVAKVSDFGLSKFGPTSVSKTH-----------LDPEYYRLQQLTEKSDVYSF 453
           NILLDE +VAKVSDFGLS+ GPTS S+TH           LDPEYYR Q LTEKSDVYSF
Sbjct: 658 NILLDENFVAKVSDFGLSRVGPTSASQTHVSTVVKGTFGYLDPEYYRRQILTEKSDVYSF 717

Query: 454 GVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK------------- 500
           GVVL EVLC RP  +++   +Q  L  W +  +   T+DQI+D  L              
Sbjct: 718 GVVLLEVLCCRPIRMQSVPPEQADLIRWVKSNFNKRTVDQIIDSDLTADITSTSMEKFCE 777

Query: 501 -AMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSIAIAKEIDENEEEEKLLDNYE----TD 555
            A+ C+ D G+ RP M+DVVW LEF+LQL E+    AK+ ++N E   L+ + E    TD
Sbjct: 778 IAIRCVQDRGMERPPMNDVVWALEFALQLHET----AKKKNDNVESLDLMPSGEVGTTTD 833

Query: 556 GSGPVFSSVGEHVLSDSKTISTVTISTTTATDDQSLSTGSSDKYTGA---VFSEILNPKG 612
           G   +FS    HV              +T TDD  L  G  D+ +G+   VFSEI  PK 
Sbjct: 834 GEDDLFSRTTGHV------------GKSTTTDDSVLVVG--DERSGSSWGVFSEINEPKA 879

Query: 613 R 613
           R
Sbjct: 880 R 880

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SR05|ANX1_ARATH Receptor-like protein kinase ANXUR1 OS=Arabidopsis thaliana GN=ANX1 PE=2 SV=1

 Score =  494 bits (1273), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 283/623 (45%), Positives = 379/623 (60%), Gaps = 81/623 (13%)

Query: 30  APDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIF 89
           AP  +Y+TAR+ G + +IN K NLTW F++D  FTY LRLHFCEFQ+  ++   +VF I+
Sbjct: 270 APADIYKTARSQGPNGDINLKSNLTWMFQIDKNFTYILRLHFCEFQL--SKINQKVFNIY 327

Query: 90  IANLTAEVQ---ADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRTK 146
           I N TA+     AD+I WTG  G+ +Y+DYA+ +    +  N  + +++Q+ P+   + +
Sbjct: 328 INNRTAQADTTPADIIGWTGEKGIPMYKDYAIYV----DANNGGEEITLQMTPSTFGQPE 383

Query: 147 YSDAILNGLEIFKVDNTGNLGGPNPEPRTIPPNLDASPTIEPTKKNNVTGMVAGAISGSS 206
           Y D+ LNGLEIFK+D   NL GPNPEP  +    +     +  K++     + G+  G  
Sbjct: 384 YYDSSLNGLEIFKMDTMKNLAGPNPEPSPMQAEEEVKKEFKNEKRH---AFIIGSAGG-- 438

Query: 207 VLSLLLLLIFWRGRKVKDSSSGTGTSLLGTFL---------WSKTIKATKSSRGSFL--- 254
           VL++L+  + +   K K    G G S   ++L          +K+  + KS+ GS L   
Sbjct: 439 VLAVLIGALCFTAYKKKQGYQG-GDSHTSSWLPIYGNSTTSGTKSTISGKSNNGSHLSNL 497

Query: 255 PSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL 314
            + LC +FSL EI+  T NFD+  VIGVGGFG VYKG I+G TT VA+K+  P S+QG  
Sbjct: 498 AAGLCRRFSLPEIKHGTQNFDDSNVIGVGGFGKVYKGVIDG-TTKVAVKKSNPNSEQGLN 556

Query: 315 EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL 374
           EF+TEI +LS+LRH HLVSLIG+C++  EM LVYD+MA GTL +HLY++  P L W +RL
Sbjct: 557 EFETEIELLSRLRHKHLVSLIGYCDEGGEMCLVYDYMAFGTLREHLYNTKKPQLTWKRRL 616

Query: 375 EICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-------T 427
           EI IGAARGLHYLHTGA +  IIHRDVKTTNIL+DE WVAKVSDFGLSK GP       T
Sbjct: 617 EIAIGAARGLHYLHTGAKY-TIIHRDVKTTNILVDENWVAKVSDFGLSKTGPNMNGGHVT 675

Query: 428 SVSK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQ 484
           +V K    +LDPEY+R QQLTEKSDVYSFGVVLFE+LCARP++  +  K+QVSL  WA  
Sbjct: 676 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPSLPKEQVSLGDWAMN 735

Query: 485 CYQNGTIDQIVDPFLK--------------AMSCLNDEGIRRPSMSDVVWGLEFSLQLQE 530
           C + G ++ I+DP LK              A  CLND G+ RP+M DV+W LEF+LQLQE
Sbjct: 736 CKRKGNLEDIIDPNLKGKINAECLKKFADTAEKCLNDSGLERPTMGDVLWNLEFALQLQE 795

Query: 531 SSIAIAKEIDENEEEEKLLDNYETDGSGPVFSSVGEHVLSDSKTISTVTISTTTATDDQS 590
           ++         N    + L        G   +  G   +SD        +S+   T+   
Sbjct: 796 TADGTRHRTPNNGGSSEDLGR-----GGMAVNVAGRDDVSD--------LSSEDNTE--- 839

Query: 591 LSTGSSDKYTGAVFSEILNPKGR 613
                       +FS+I+NPKGR
Sbjct: 840 ------------IFSQIVNPKGR 850

Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1

 Score =  410 bits (1055), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 242/537 (45%), Positives = 310/537 (57%), Gaps = 55/537 (10%)

Query: 30  APDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIF 89
           AP LVYETAR M     + +++N++W+FEVD  F Y +RLHFCE  ++  +   R+F+I+
Sbjct: 283 APLLVYETARMMSNTEVLEKRFNISWKFEVDPNFDYLVRLHFCELLVD--KQNQRIFRIY 340

Query: 90  IANLTAEVQADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSD 149
           I N TA    D+ A  G     +Y+DY   + SK +       L IQL P         D
Sbjct: 341 INNQTAAGNFDIFAHAGGKNKGIYQDYLDPVSSKNDV------LWIQLGPDSSVGAS-GD 393

Query: 150 AILNGLEIFKVDNTGNLGGPNPEPRTIPPNLDASPTIEPTKKNNVTGMVAGA----ISGS 205
           A+L+GLEIFK+   GNL              D++       K  +  +  GA    I   
Sbjct: 394 ALLSGLEIFKLSKNGNLAHL--------IRFDSTGHSVSDSKMRIIWISVGAGIAIIIFF 445

Query: 206 SVLSLLLLLIFWRGRKVKDSSSGTGTSLLGTFLWSKTIKATKSSRGSFL------PSDLC 259
             L +L++ +  + R   D S          FL      A   + G  L       S + 
Sbjct: 446 VFLGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVNNSTANAKATGGSLRLNTLAASTMG 505

Query: 260 TQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTE 319
            +F+L+EI+AAT NFD+ L IGVGGFG VY+G +   T  +AIKR  P SQQG  EF+TE
Sbjct: 506 RKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTL-IAIKRATPHSQQGLAEFETE 564

Query: 320 IGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG 379
           I MLS+LRH HLVSLIGFC++  EMILVY++MA GTL  HL+ S+ PPL W QRLE CIG
Sbjct: 565 IVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSWKQRLEACIG 624

Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH------ 433
           +ARGLHYLHTG+    IIHRDVKTTNILLDE +VAK+SDFGLSK GP S+  TH      
Sbjct: 625 SARGLHYLHTGSERG-IIHRDVKTTNILLDENFVAKMSDFGLSKAGP-SMDHTHVSTAVK 682

Query: 434 -----LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN 488
                LDPEY+R QQLTEKSDVYSFGVVLFE +CAR  I  T  K Q++LA WA    + 
Sbjct: 683 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQKQ 742

Query: 489 GTIDQIVDPFLK--------------AMSCLNDEGIRRPSMSDVVWGLEFSLQLQES 531
             ++ I+D  L+              A  CL DEG  RP M +V+W LE+ LQ+ E+
Sbjct: 743 RNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEYVLQIHEA 799

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FLJ8|Y5613_ARATH Probable receptor-like protein kinase At5g61350 OS=Arabidopsis thaliana GN=At5g61350 PE=2 SV=1

 Score =  400 bits (1027), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 252/587 (42%), Positives = 335/587 (57%), Gaps = 92/587 (15%)

Query: 30  APDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIF 89
           AP+ VY TA  M   +     +NL+W   VD G  YF+RLHFC+  I      D +F +F
Sbjct: 272 APNPVYATAEEMADAQTSQPNFNLSWRMSVDFGHDYFIRLHFCD--IVSKSLNDLIFNVF 329

Query: 90  IANLTAEVQADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSD 149
           I  L+A    D+ + T A G   Y D+ +   +  N      ++ +Q+ P P  ++   +
Sbjct: 330 INKLSAISALDLSSLTSALGTAYYADFVLNASTITN-----GSILVQVGPTPNLQSGKPN 384

Query: 150 AILNGLEIFKVDNTGNLGGPNPEPRTIPPNLDASPTIEPTKKNNVTGMVAG--AISG--- 204
           AILNGLEI K++N                +LD    ++   K  + GM +   AI+G   
Sbjct: 385 AILNGLEIMKLNNAAG-------------SLDGLFGVDGKYKGPIGGMSSKKLAIAGIGF 431

Query: 205 ----SSVLSLLLLLIFWRGRKVKD----------------------SSSGTGTSLLGTFL 238
               ++ L +++LL+ W+ R+ KD                      SS G  TS   +  
Sbjct: 432 VMALTAFLGVVVLLVRWQ-RRPKDWQKQNSFSSWLLPLHASHSSYISSKGGSTSRRMSIF 490

Query: 239 WSKTIKATKSSRGSFLPSD-LCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGST 297
            SK  K+   S  SF  +  L   F  +E+Q AT NFD + V GVGGFG VY G I+G T
Sbjct: 491 GSKKSKSNGFS--SFFSNQGLGRYFPFTELQTATQNFDENAVCGVGGFGKVYIGEIDGGT 548

Query: 298 TPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLP 357
             VAIKR    S+QG  EFQTEI MLS+LRH HLVSLIGFC++++EMILVY++M+ G L 
Sbjct: 549 Q-VAIKRGSQSSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYEYMSNGPLR 607

Query: 358 DHLYHSDN------PPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK 411
           DHLY S        P L W QRLEICIG+ARGLHYLHTGA    IIHRDVKTTNILLDE 
Sbjct: 608 DHLYGSKENDPNPIPTLSWKQRLEICIGSARGLHYLHTGAAQG-IIHRDVKTTNILLDEN 666

Query: 412 WVAKVSDFGLSKFGP-------TSVSKT--HLDPEYYRLQQLTEKSDVYSFGVVLFEVLC 462
            VAKVSDFGLSK  P       T+V  +  +LDPEY+R QQLT+KSDVYSFGVVLFEVLC
Sbjct: 667 LVAKVSDFGLSKDAPMDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 726

Query: 463 ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP-------------FLKAM-SCLNDE 508
           ARP I     ++QV+LA +A   ++ G +++I+DP             F++A   CL + 
Sbjct: 727 ARPVINPQLPREQVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRKFVEAAEKCLAEY 786

Query: 509 GIRRPSMSDVVWGLEFSLQLQESSIAIAKEIDENEEEEKLLDNYETD 555
           G+ RP M DV+W LE++LQLQE+S     ++D +E++  +  N E D
Sbjct: 787 GVDRPGMGDVLWNLEYALQLQEAS----AQVDLSEDKTTM--NIEMD 827

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1

 Score =  394 bits (1011), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 249/643 (38%), Positives = 353/643 (54%), Gaps = 75/643 (11%)

Query: 9   ARPSALPVNQSIHLTWIRNYSAPDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLR 68
           A PS++  + S+        +AP++VY TA TMG     +  +N+TW   VD  F YF+R
Sbjct: 250 ANPSSIKYSPSV-----TQETAPNMVYATADTMGDANVASPSFNVTWVLPVDPDFRYFVR 304

Query: 69  LHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYAVMIGSKPNEEN 128
           +HFC+   +       VF +++ +  A    D+   T    V  ++D+        +  +
Sbjct: 305 VHFCDIVSQALNT--LVFNLYVNDDLALGSLDLSTLTNGLKVPYFKDFI-------SNGS 355

Query: 129 IKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDNTG-NLGGPNPEPRTIPPNLDASPTIE 187
           ++ +  + +   P  +   ++A +NGLE+ K+ N   +L G +     +P    +    +
Sbjct: 356 VESSGVLTVSVGPDSQADITNATMNGLEVLKISNEAKSLSGVSSVKSLLPGGSGSKSKKK 415

Query: 188 PTKKNNVTGMVAGAISGSSVLSLLLLLIFWRGRKVKDSS---SGTGTSLLGTFLWSKTIK 244
                 + G + GA++   ++++         RK + +S    G G   L   L+  +  
Sbjct: 416 AV----IIGSLVGAVTLILLIAVCCYCCLVASRKQRSTSPQEGGNGHPWLPLPLYGLSQT 471

Query: 245 ATKSSRG---------SFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFING 295
            TKS+           S   + L   F   EI  ATN FD   ++GVGGFG VYKG +  
Sbjct: 472 LTKSTASHKSATASCISLASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLED 531

Query: 296 STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGT 355
            T  VA+KR  P S+QG  EF+TEI MLS+LRH HLVSLIG+C++  EMILVY++MA G 
Sbjct: 532 GTK-VAVKRGNPRSEQGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGP 590

Query: 356 LPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAK 415
           L  HLY +D PPL W QRLEICIGAARGLHYLHTGA+ + IIHRDVKTTNILLDE  VAK
Sbjct: 591 LRSHLYGADLPPLSWKQRLEICIGAARGLHYLHTGASQS-IIHRDVKTTNILLDENLVAK 649

Query: 416 VSDFGLSKFGPTSVSKTH-----------LDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           V+DFGLSK GP S+ +TH           LDPEY+R QQLTEKSDVYSFGVVL EVLC R
Sbjct: 650 VADFGLSKTGP-SLDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCR 708

Query: 465 PSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL--------------KAMSCLNDEGI 510
           P++     ++QV++A WA    + G +DQI+D  L               A  CL + G+
Sbjct: 709 PALNPVLPREQVNIAEWAMAWQKKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGV 768

Query: 511 RRPSMSDVVWGLEFSLQLQESSIAIAKEIDENEEEEKLLDNYETDGSGPVFSSVGEHVLS 570
            RPSM DV+W LE++LQL+E+S A+  E D+N           T+    +  +  E   +
Sbjct: 769 DRPSMGDVLWNLEYALQLEETSSALM-EPDDN----------STNHIPGIPMAPMEPFDN 817

Query: 571 DSKTISTVTISTTTATDDQSLSTGSSDKYTGAVFSEILNPKGR 613
               I    +++ T TDD      + D  T AVFS++++P+GR
Sbjct: 818 SMSIIDRGGVNSGTGTDDD-----AEDATTSAVFSQLVHPRGR 855

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1

 Score =  384 bits (986), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 252/621 (40%), Positives = 338/621 (54%), Gaps = 74/621 (11%)

Query: 30  APDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIF 89
           AP  VY TA  M     I+  +N++W F  +  F Y +RLHFC+  I      D  F ++
Sbjct: 295 APQTVYATAVEMANSLTIDPNFNVSWNFPSNPSFNYLIRLHFCD--IVSKSLNDLYFNVY 352

Query: 90  IANLTAEVQADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSD 149
           I   TA    D+    G      Y+D  V      N   +   L +Q+ P     T   +
Sbjct: 353 INGKTAISGLDLSTVAGNLAAPYYKDIVV------NATLMGPELQVQIGPMGE-DTGTKN 405

Query: 150 AILNGLEIFKVDNTGNLGGPNPEPRTIPPNLDASPTIE-PTKKNNVTGMVAGA---ISGS 205
           AILNG+E+ K+ N+ N             +LD    ++  T      GMVA A   +   
Sbjct: 406 AILNGVEVLKMSNSVN-------------SLDGEFGVDGRTTGMGKHGMVATAGFVMMFG 452

Query: 206 SVLSLLLLLIFWRGRKVKDSSSGTGTSLL-------GTFLWSKTIKATKSSRGSFLPS-- 256
           + + L  ++  W+ R        + +S L        TF+ SK      S + +F  S  
Sbjct: 453 AFIGLGAMVYKWKKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKG----GSQKSNFYNSTL 508

Query: 257 DLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEF 316
            L   FSLSE+Q AT NF+   +IGVGGFG+VY G ++  T  VA+KR  P+S+QG  EF
Sbjct: 509 GLGRYFSLSELQEATKNFEASQIIGVGGFGNVYIGTLDDGTK-VAVKRGNPQSEQGITEF 567

Query: 317 QTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEI 376
           QTEI MLS+LRH HLVSLIG+C+++ EMILVY+FM+ G   DHLY  +  PL W QRLEI
Sbjct: 568 QTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEI 627

Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK---FGPTSVSKT- 432
           CIG+ARGLHYLHTG     IIHRDVK+TNILLDE  VAKV+DFGLSK   FG   VS   
Sbjct: 628 CIGSARGLHYLHTGTAQG-IIHRDVKSTNILLDEALVAKVADFGLSKDVAFGQNHVSTAV 686

Query: 433 -----HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ 487
                +LDPEY+R QQLT+KSDVYSFGVVL E LCARP+I     ++QV+LA WA Q  +
Sbjct: 687 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMQWKR 746

Query: 488 NGTIDQIVDPFL--------------KAMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSI 533
            G +++I+DP L               A  CL D G+ RP+M DV+W LE++LQLQE+  
Sbjct: 747 KGLLEKIIDPHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLEYALQLQEAFT 806

Query: 534 AIAKEIDENEEEEKLLDNYETDGSGPVFSSVGEHVLSDSKTISTVTISTTTATDDQSLST 593
               E  EN + + +     T GS PV  S    +     T    T+      ++ S + 
Sbjct: 807 QGKAEETENAKPDVV-----TPGSVPV--SDPSPITPSVTTNEAATVPVPAKVEENSGT- 858

Query: 594 GSSDKYTG-AVFSEILNPKGR 613
            + D+++G A+F++  N  GR
Sbjct: 859 -AVDEHSGTAMFTQFANLNGR 878

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SJT0|Y2214_ARATH Probable receptor-like protein kinase At2g21480 OS=Arabidopsis thaliana GN=At2g21480 PE=3 SV=1

 Score =  382 bits (981), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 237/548 (43%), Positives = 306/548 (55%), Gaps = 60/548 (10%)

Query: 30  APDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIF 89
           AP  VY T   M   + I+  +N+TW F  +  F YF+RLHFC+  I      D  F ++
Sbjct: 294 APQTVYATGAEMADSQTIDPNFNVTWNFPSNPSFHYFIRLHFCD--IISKSLNDLYFNVY 351

Query: 90  IANLTAEVQADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSD 149
           I   TA    D+    G      Y+D  V      N   +   L +Q+ P     T   +
Sbjct: 352 INGKTAISGLDLSTVAGDLSAPYYKDIVV------NSTLMTSELQVQIGPMGE-DTGKKN 404

Query: 150 AILNGLEIFKVDNTGNLGGPNPEPRTIPPNLDASPTIEPTKKN-NVTGMVAGA---ISGS 205
           AILNG+E+ K+ N+ N             +LD    ++  + +    GMVA A   +   
Sbjct: 405 AILNGVEVLKMSNSVN-------------SLDGEFGVDGQRASMGKQGMVATAGFVMMFG 451

Query: 206 SVLSLLLLLIFWRGRKVKDSSSGTGTSLL-------GTFLWSKTIKATKSSRGSFLPSDL 258
           + + L  ++  W+ R        + +S L        TF+ SKT     +   S L   L
Sbjct: 452 AFVGLGAMVYKWKKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKTGSHKSNLYNSAL--GL 509

Query: 259 CTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT 318
              FSLSE+Q  T NFD   +IGVGGFG+VY G I+  T  VAIKR  P+S+QG  EF T
Sbjct: 510 GRYFSLSELQEVTKNFDASEIIGVGGFGNVYIGTIDDGTQ-VAIKRGNPQSEQGITEFHT 568

Query: 319 EIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICI 378
           EI MLS+LRH HLVSLIG+C+++ EMILVY++M+ G   DHLY  +  PL W QRLEICI
Sbjct: 569 EIQMLSKLRHRHLVSLIGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRLEICI 628

Query: 379 GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK---FGPTSVSKT--- 432
           GAARGLHYLHTG     IIHRDVK+TNILLDE  VAKV+DFGLSK   FG   VS     
Sbjct: 629 GAARGLHYLHTGTAQG-IIHRDVKSTNILLDEALVAKVADFGLSKDVAFGQNHVSTAVKG 687

Query: 433 ---HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG 489
              +LDPEY+R QQLT+KSDVYSFGVVL E LCARP+I     ++QV+LA WA    Q G
Sbjct: 688 SFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMLWKQKG 747

Query: 490 TIDQIVDPFL--------------KAMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSIAI 535
            +++I+DP L               A  CL D G+ RP+M DV+W LE++LQLQE+    
Sbjct: 748 LLEKIIDPHLVGAVNPESMKKFAEAAEKCLADYGVDRPTMGDVLWNLEYALQLQEAFSQG 807

Query: 536 AKEIDENE 543
             E +E E
Sbjct: 808 KAEAEEVE 815

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	613
359488520	894	PREDICTED: receptor-like protein kinase	0.972	0.666	0.579	0.0
359488516	1393	PREDICTED: receptor-like protein kinase	0.978	0.430	0.574	0.0
296082193	932	unnamed protein product [Vitis vinifera]	0.879	0.578	0.600	0.0
255580328	904	kinase, putative [Ricinus communis] gi|2	0.973	0.660	0.540	0.0
356551038	894	PREDICTED: receptor-like protein kinase	0.955	0.655	0.530	1e-170
351724969	708	FERONIA receptor-like kinase [Glycine ma	0.942	0.816	0.542	1e-170
297819852	891	hypothetical protein ARALYDRAFT_485507 [	0.977	0.672	0.524	1e-168
155242187	898	FERONIA receptor-like kinase [Cardamine	0.970	0.662	0.515	1e-167
449438963	892	PREDICTED: receptor-like protein kinase	0.959	0.659	0.506	1e-167
449476518	892	PREDICTED: receptor-like protein kinase	0.959	0.659	0.506	1e-167

>gi|359488520|ref|XP_003633771.1| PREDICTED: receptor-like protein kinase FERONIA-like [Vitis vinifera]

 Score =  689 bits (1778), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 379/654 (57%), Positives = 454/654 (69%), Gaps = 58/654 (8%)

Query: 1   MDDPYLTDARPSALPVNQSIHL--TWIRNYSAPDLVYETARTMGQDREINEKYNLTWEFE 58
           MDD Y    + + +P N SI+L  T I NY+AP  VY TARTMG ++  N  YNLTW   
Sbjct: 258 MDDDYCM--KLAFVPANTSINLKFTKIPNYTAPHDVYRTARTMGNNKTENMGYNLTWVLP 315

Query: 59  VDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYAV 118
           VDSGF Y +RLHFCEFQ E+ +  DR F IFIAN TAE  ADVI W+G NGV +YRDY V
Sbjct: 316 VDSGFYYLIRLHFCEFQPEIQQQHDREFTIFIANQTAENHADVITWSGGNGVPIYRDYGV 375

Query: 119 MIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDN-TGNLGGPNPEPRTIP 177
           M+ S+ +  N KQNL IQLHP P + T Y+DAILNG+E+FK+ N   +L GPNP+P   P
Sbjct: 376 MMPSQGS--NKKQNLYIQLHPNPDYETVYNDAILNGIELFKLSNPEKSLAGPNPDPSEAP 433

Query: 178 PNLDASPTIEPTKKNNVTGMVAGA---ISGSSVLSLLLLLIFWRGRKVKDSSSGTGTSLL 234
                  +  P  K+N T ++A A   ++G   LS++ L I WRGR+V+DS    G S  
Sbjct: 434 APPPPVQSTSP--KSNKTKLIAIAGSVVAGLIALSVIALFIVWRGRRVRDSEPSDGGSWW 491

Query: 235 GTFLWSKTIKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFIN 294
           G F ++ ++K+TK+SR S LPSDLC  F+L EI+ ATNNFDN  +IGVGGFG+VYKG+IN
Sbjct: 492 GQFSYT-SVKSTKTSRSS-LPSDLCRLFTLQEIKVATNNFDNVFIIGVGGFGNVYKGYIN 549

Query: 295 GSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARG 354
           G TTPVAIKRL PESQQGA EFQTEI MLSQLRHLHLVSLIG+CNDDREMILVYD+MA G
Sbjct: 550 GGTTPVAIKRLNPESQQGAQEFQTEIEMLSQLRHLHLVSLIGYCNDDREMILVYDYMAHG 609

Query: 355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVA 414
           TL DHLY +DNPPL W QRLEICIGAARGLHYLHTG  H  IIHRDVKTTNILLDEKWVA
Sbjct: 610 TLRDHLYKTDNPPLSWKQRLEICIGAARGLHYLHTGVKH-TIIHRDVKTTNILLDEKWVA 668

Query: 415 KVSDFGLSKFGPTSVSKTH-----------LDPEYYRLQQLTEKSDVYSFGVVLFEVLCA 463
           KVSDFGLSK GPTS+S  H           LDPEYYR QQLTEKSDVYSFGVVLFEVLCA
Sbjct: 669 KVSDFGLSKMGPTSMSNAHVSTVVKGSFGYLDPEYYRRQQLTEKSDVYSFGVVLFEVLCA 728

Query: 464 RPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--------------AMSCLNDEG 509
           RP + +T  K++VSLA WA  CY++G ++QIVDPFLK              A+SCL D+G
Sbjct: 729 RPPLNQTVEKERVSLAQWAPSCYRDGKLEQIVDPFLKGKIAPDCLQKFGEIAVSCLQDQG 788

Query: 510 IRRPSMSDVVWGLEFSLQLQESSIAIAKEIDENEEEEKLLDNYETDGSGPVFSSVGE--- 566
           I RPSM+DVVWGL+F++QLQES+        E E E+        D   P+ +S+ +   
Sbjct: 789 IERPSMTDVVWGLQFAMQLQESA--------EQETEKSGSWRKVKDEEAPLKTSITDDSD 840

Query: 567 --HVL-SDS----KTISTVTISTTTATDDQSLSTGSSDKYTGAVFSEILNPKGR 613
             +VL SDS     + S+  +  ++  +  S S  S    +GAVFSEILNPKGR
Sbjct: 841 DAYVLTSDSGGTWDSQSSGIMIPSSGEEKSSTSRESDALMSGAVFSEILNPKGR 894

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488516|ref|XP_003633769.1| PREDICTED: receptor-like protein kinase FERONIA-like [Vitis vinifera]

 Score =  682 bits (1759), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 372/648 (57%), Positives = 448/648 (69%), Gaps = 48/648 (7%)

Query: 2    DDPYLTDARPSALPVNQSIHL--TWIRNYSAPDLVYETARTMGQDREINEKYNLTWEFEV 59
            DD Y    + + +P N SI+L  T I NY+AP  VY TARTMG ++  N  YNLTW   V
Sbjct: 758  DDEYC--VKLAFVPANTSINLKFTQIPNYTAPLDVYRTARTMGNNKTENMGYNLTWFLPV 815

Query: 60   DSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYAVM 119
            DSGF+Y LRLHFCEFQ E+ E  DR F I IAN TAE  ADVI W+  NGV +Y+DY VM
Sbjct: 816  DSGFSYLLRLHFCEFQPEIQEQHDREFAIIIANQTAENHADVITWSTGNGVPIYKDYGVM 875

Query: 120  IGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDN-TGNLGGPNPEPRTIPP 178
            + S+ +  N KQNL IQLHP P   T Y+DAILNG+E+FK+ N   +L GPNP+P   P 
Sbjct: 876  MPSQGS--NKKQNLYIQLHPNPDSETVYNDAILNGIELFKLSNPEKSLAGPNPDPSEAPA 933

Query: 179  NLDASPTIEPTK-KNNVTGMVAGAISGSSVLSLLLLLIFWRGRKVKDSSSGTGTSLLGTF 237
                  +  P + K  +  +    ++G   LS+++L I WRGR+V+DS    G S  G F
Sbjct: 934  PPPPVQSTSPKRNKTKLIAIAGSVVAGLIALSVIVLFIVWRGRRVRDSEPSDGGSWWGQF 993

Query: 238  LWSKTIKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGST 297
             ++ ++K+TK+SR S LPSDLC  F+L E++ ATNNFD   +IGVGGFG+VYKG+ING T
Sbjct: 994  SYT-SVKSTKTSRSS-LPSDLCRHFTLQEVKVATNNFDQVFIIGVGGFGNVYKGYINGGT 1051

Query: 298  TPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLP 357
            TPVAIKRL PESQQGA EFQTEI MLSQLRHLHLVSLIG+CNDDREMILVYD+MA GTL 
Sbjct: 1052 TPVAIKRLNPESQQGAQEFQTEIEMLSQLRHLHLVSLIGYCNDDREMILVYDYMAHGTLR 1111

Query: 358  DHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVS 417
            DHLY +DNPPL W QRLEICIGAARGLHYLHTG  H  IIHRDVKTTNILLDEKWVAKVS
Sbjct: 1112 DHLYKTDNPPLSWKQRLEICIGAARGLHYLHTGVKH-TIIHRDVKTTNILLDEKWVAKVS 1170

Query: 418  DFGLSKFGPTSVSKTH-----------LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPS 466
            DFGLSK GPTS+S  H           LDPEYYR QQLTEKSDVYSFGVVLFEVLCARP 
Sbjct: 1171 DFGLSKMGPTSMSNAHVSTVVKGSFGYLDPEYYRRQQLTEKSDVYSFGVVLFEVLCARPP 1230

Query: 467  ILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--------------AMSCLNDEGIRR 512
            + +T  K++VSLA WA  CY++G ++QIVDPFLK              A+SCL D+GI R
Sbjct: 1231 LNQTVEKERVSLAQWAPACYRDGKLEQIVDPFLKGKIAPDCLQKFGEIAVSCLQDQGIER 1290

Query: 513  PSMSDVVWGLEFSLQLQESSIAIAKEIDENEEEEKLLDNYETDGSGPVFSSVGEHVLS-- 570
            PSMSDVVWGL+F++QLQES+    +E++++    K+ D      +     S   +VL+  
Sbjct: 1291 PSMSDVVWGLQFAMQLQESA---EQEMEKSGSWRKVKDEEAPLKASITDDSDDAYVLTSD 1347

Query: 571  -----DSKTISTVTISTTTATDDQSLSTGSSDKYTGAVFSEILNPKGR 613
                 DSK+ S V I  ++  +  S S  S    +GAVFSEILNPKGR
Sbjct: 1348 SGGTWDSKS-SGVMIQ-SSGEEKSSTSCESDALMSGAVFSEILNPKGR 1393

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296082193|emb|CBI21198.3| unnamed protein product [Vitis vinifera]

 Score =  663 bits (1711), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 347/578 (60%), Positives = 415/578 (71%), Gaps = 39/578 (6%)

Query: 2   DDPYLTDARPSALPVNQSIHL--TWIRNYSAPDLVYETARTMGQDREINEKYNLTWEFEV 59
           DD Y    + + +P N SI+L  T I NY+AP  VY TARTMG ++  N  YNLTW   V
Sbjct: 288 DDEYC--VKLAFVPANTSINLKFTQIPNYTAPLDVYRTARTMGNNKTENMGYNLTWFLPV 345

Query: 60  DSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYAVM 119
           DSGF+Y LRLHFCEFQ E+ E  DR F I IAN TAE  ADVI W+  NGV +Y+DY VM
Sbjct: 346 DSGFSYLLRLHFCEFQPEIQEQHDREFAIIIANQTAENHADVITWSTGNGVPIYKDYGVM 405

Query: 120 IGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDN-TGNLGGPNPEPRTIPP 178
           + S+ +  N KQNL IQLHP P   T Y+DAILNG+E+FK+ N   +L GPNP+P   P 
Sbjct: 406 MPSQGS--NKKQNLYIQLHPNPDSETVYNDAILNGIELFKLSNPEKSLAGPNPDPSEAPA 463

Query: 179 NLDASPTIEPTK-KNNVTGMVAGAISGSSVLSLLLLLIFWRGRKVKDSSSGTGTSLLGTF 237
                 +  P + K  +  +    ++G   LS+++L I WRGR+V+DS    G S  G F
Sbjct: 464 PPPPVQSTSPKRNKTKLIAIAGSVVAGLIALSVIVLFIVWRGRRVRDSEPSDGGSWWGQF 523

Query: 238 LWSKTIKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGST 297
            ++ ++K+TK+SR S LPSDLC  F+L E++ ATNNFD   +IGVGGFG+VYKG+ING T
Sbjct: 524 SYT-SVKSTKTSRSS-LPSDLCRHFTLQEVKVATNNFDQVFIIGVGGFGNVYKGYINGGT 581

Query: 298 TPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLP 357
           TPVAIKRL PESQQGA EFQTEI MLSQLRHLHLVSLIG+CNDDREMILVYD+MA GTL 
Sbjct: 582 TPVAIKRLNPESQQGAQEFQTEIEMLSQLRHLHLVSLIGYCNDDREMILVYDYMAHGTLR 641

Query: 358 DHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVS 417
           DHLY +DNPPL W QRLEICIGAARGLHYLHTG  H  IIHRDVKTTNILLDEKWVAKVS
Sbjct: 642 DHLYKTDNPPLSWKQRLEICIGAARGLHYLHTGVKH-TIIHRDVKTTNILLDEKWVAKVS 700

Query: 418 DFGLSKFGPTSVSKTH-----------LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPS 466
           DFGLSK GPTS+S  H           LDPEYYR QQLTEKSDVYSFGVVLFEVLCARP 
Sbjct: 701 DFGLSKMGPTSMSNAHVSTVVKGSFGYLDPEYYRRQQLTEKSDVYSFGVVLFEVLCARPP 760

Query: 467 ILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--------------AMSCLNDEGIRR 512
           + +T  K++VSLA WA  CY++G ++QIVDPFLK              A+SCL D+GI R
Sbjct: 761 LNQTVEKERVSLAQWAPACYRDGKLEQIVDPFLKGKIAPDCLQKFGEIAVSCLQDQGIER 820

Query: 513 PSMSDVVWGLEFSLQLQESSIAIAKEIDENEEEEKLLD 550
           PSMSDVVWGL+F++QLQES+    +E++++    K+ D
Sbjct: 821 PSMSDVVWGLQFAMQLQESA---EQEMEKSGSWRKVKD 855

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255580328|ref|XP_002530992.1| kinase, putative [Ricinus communis] gi|223529419|gb|EEF31380.1| kinase, putative [Ricinus communis]

 Score =  644 bits (1661), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/649 (54%), Positives = 438/649 (67%), Gaps = 52/649 (8%)

Query: 2   DDPYLTDARPSALPVNQSIHLTW---IRNYSAPDLVYETARTMGQDREINEKYNLTWEFE 58
           D  Y+     SAL  N    L +   I  YSAPD VY T+R MG +  INEK+NLTW+F+
Sbjct: 271 DTDYIILESQSALAHNNVTQLKYRDNITRYSAPDEVYNTSRMMGLNATINEKHNLTWQFQ 330

Query: 59  VDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYAV 118
           VDS F Y +R +FCEF   +T+ GDRVF I++AN TAE  ADVI W+G NG+ VY+DYAV
Sbjct: 331 VDSDFIYLVRFYFCEFYPPITQKGDRVFLIYMANQTAEDYADVIEWSGGNGIPVYKDYAV 390

Query: 119 MIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDNTGNLGGPNPE-PRTIP 177
            +  K +E+   Q L+I LHP P  RT+ + AILNGLEIFK+  + NL  PNP+ P +  
Sbjct: 391 KMEPKGSEK--FQKLAIALHPKPEDRTRAASAILNGLEIFKLSVSDNLASPNPDIPLSNT 448

Query: 178 PNLDASPTIEPTKKNNVTGMVAGAISGSSVLSLLLLLIFWRGRKVKDSSSGTGTSLLGTF 237
           P+  A+  I  + K+N++ ++ GA++G   LSLLL  I+WR  K K S    G S L  F
Sbjct: 449 PS--AATPIPKSSKSNISAIIGGAVAGFVALSLLLFFIYWRRSKSKQSGFNDGASRLDQF 506

Query: 238 LWSKTIKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGST 297
             + T  A   ++GS LPSDLC +FSL EI+ ATNNFD+  +IGVGGFG+VY+G IN   
Sbjct: 507 STASTKSA--KTQGSTLPSDLCRRFSLPEIKEATNNFDSVFIIGVGGFGNVYRGLINDGA 564

Query: 298 TPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLP 357
             VAIKRL P S+QGA EF+TEI MLSQLR+LHLVSLIG+C +D EMILVYD+MARGTL 
Sbjct: 565 VTVAIKRLNPGSEQGAHEFKTEIEMLSQLRYLHLVSLIGYCYEDNEMILVYDYMARGTLR 624

Query: 358 DHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVS 417
           DHLY +DNPPL W QRLEICIGAARGL YLH+GA +  IIHRDVKTTNILLDEKW AKVS
Sbjct: 625 DHLYKTDNPPLTWIQRLEICIGAARGLQYLHSGAKN-TIIHRDVKTTNILLDEKWAAKVS 683

Query: 418 DFGLSKFGPTSVSKTH-----------LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPS 466
           DFGLSK GP+S+SK H           LDPEYYRLQ+LTEKSDVYSFGVVLFEVL ARP 
Sbjct: 684 DFGLSKVGPSSMSKPHISTVVKGSFGYLDPEYYRLQRLTEKSDVYSFGVVLFEVLSARPP 743

Query: 467 ILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--------------AMSCLNDEGIRR 512
           + +++  K VSLA WA+QCY+ GT+D IVDP LK              A+SCL D G+ R
Sbjct: 744 VSKSSFNKPVSLAEWARQCYRKGTLDDIVDPHLKGKIAPDCLKKFFELAVSCLLDNGMDR 803

Query: 513 PSMSDVVWGLEFSLQLQESSIAIAKEIDENEEEEKLLDNYETDGSGPVFSSVGEHV---- 568
           PSMSDVVWGLEF+LQLQE++I    + D N+ E  +  + ET   G       + +    
Sbjct: 804 PSMSDVVWGLEFALQLQETAI----KQDRNQTEMDI--DMETPIKGSSIDDSSDDLFSSG 857

Query: 569 --LSDSKTISTVTISTTTATDDQSLSTGSSDK--YTGAVFSEILNPKGR 613
             L     +S +T+  T+++DDQS  +  SD+   +  VFS+I+NP GR
Sbjct: 858 SGLVIGSRLSGMTL--TSSSDDQSFLSNVSDQIMLSNVVFSQIMNPDGR 904

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356551038|ref|XP_003543886.1| PREDICTED: receptor-like protein kinase FERONIA-like [Glycine max]

 Score =  605 bits (1560), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 350/660 (53%), Positives = 440/660 (66%), Gaps = 74/660 (11%)

Query: 2   DDPYLTDARPSALPVNQSIHLTWIRNYSAPDLVYETARTMGQDREINEKYNLTWEFEVDS 61
           D P +TD +         +++T   +Y AP  +Y   R+MG +  +N+  NLTWEF VDS
Sbjct: 261 DLPAITDGK---------MNITVNPDYVAPKELYRAGRSMGTNATLNKISNLTWEFPVDS 311

Query: 62  GFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWT-GANGVTVYRDYAVMI 120
           GFTY LRLHFCE   ++ +DG+RVF I+IA+  AE  ADV+ W+    G+ V R+YA++I
Sbjct: 312 GFTYVLRLHFCELDPDINKDGNRVFFIYIASQLAENHADVMQWSHNQKGLAVQRNYAILI 371

Query: 121 GSKPNEENIKQ-NLSIQLHP-APRWRTKYSDAILNGLEIFKVDNTG--NLGGPNPEPRTI 176
              PN+   K+ NLS+Q+HP A    T YSDA LNGLEIFK+   G  NL GPNP+P   
Sbjct: 372 ---PNDNTQKKVNLSLQMHPYATNDETTYSDAFLNGLEIFKISEAGSNNLAGPNPDPVQT 428

Query: 177 PPNLDASPTIEPTKKN--NVTGMVAGAISG--SSVLSLLLLLIFWRGRKVK-----DSSS 227
           P N   +P    + K+  ++ G+VAG +SG     L +L L++F+R + +      + S 
Sbjct: 429 PHNNIPAPKGNRSSKSGTSIIGIVAGVVSGVVLISLIILFLIVFFRRKTITTPKDYNKSK 488

Query: 228 GTGTSLLGTFLWSKTIKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGD 287
            + TS  G    S T   + ++  S LPSDLC  FSL EI++ATNNFD+  ++GVGGFG 
Sbjct: 489 SSATSKWGPL--SFTTTKSTTTTKSSLPSDLCRHFSLPEIKSATNNFDDVFIVGVGGFGH 546

Query: 288 VYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV 347
           VYKG+I+  +TPVAIKRL+P SQQGA EF  EI MLSQLRHLHLVSLIG+CN++ EMILV
Sbjct: 547 VYKGYIDNGSTPVAIKRLKPGSQQGAHEFMNEIEMLSQLRHLHLVSLIGYCNENNEMILV 606

Query: 348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNIL 407
           YDFMARGTL DHLY++DNPPL W QRL+ICIGAARGLHYLHTGA H  IIHRDVKTTNIL
Sbjct: 607 YDFMARGTLRDHLYNTDNPPLTWKQRLQICIGAARGLHYLHTGAKH-TIIHRDVKTTNIL 665

Query: 408 LDEKWVAKVSDFGLSKFGPTSVSKTH-----------LDPEYYRLQQLTEKSDVYSFGVV 456
           LD+KWVAKVSDFGLS+ GPT  +K H           LDPEYY+ Q+LTEKSDVYSFGVV
Sbjct: 666 LDDKWVAKVSDFGLSRIGPTGNAKAHVSTVVKGSIGYLDPEYYKRQRLTEKSDVYSFGVV 725

Query: 457 LFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--------------AM 502
           LFE+LCARP ++RTA KKQVSLA WA+ C QNGTI QIVDP LK              A+
Sbjct: 726 LFELLCARPPLIRTAEKKQVSLADWARHCCQNGTIGQIVDPTLKGRMAPECLRKFCEVAV 785

Query: 503 SCLNDEGIRRPSMSDVVWGLEFSLQLQESSIAIAKEIDENEEEEKLLD-----NYETDGS 557
           SCL D+G  RPSM+DVVW LEF+LQLQES+        E  E   ++D       E + S
Sbjct: 786 SCLLDDGTLRPSMNDVVWMLEFALQLQESA--------EQRENTNIVDNEINERREEEAS 837

Query: 558 GPVFS---SVGEHVLSDSKTISTVTISTTTATDDQSLSTGSSDK-YTGAVFSEILNPKGR 613
             +FS   SVG+  +SD    S V +S +T +++ S S   SDK  +G VFSEI++PK R
Sbjct: 838 DDLFSTGTSVGQ--VSDFNKSSGV-VSVSTDSEELSSSYKESDKLMSGTVFSEIVDPKPR 894

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351724969|ref|NP_001237588.1| FERONIA receptor-like kinase [Glycine max] gi|223452286|gb|ACM89471.1| FERONIA receptor-like kinase [Glycine max]

 Score =  603 bits (1556), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 348/641 (54%), Positives = 433/641 (67%), Gaps = 63/641 (9%)

Query: 20  IHLTWIRNYSAPDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVT 79
           +++T   +Y AP  +Y TAR MG +  +N+  NLTWEF VDSGFTY LRLHFCE    + 
Sbjct: 84  MNITVNPDYVAPKELYRTARNMGTNATLNKISNLTWEFPVDSGFTYVLRLHFCELDPNIN 143

Query: 80  EDGDRVFQIFIANLTAEVQADVIAWT-GANGVTVYRDYAVMIGSKPNEENIKQNLSIQLH 138
           +DGDRVF I+IA+  AE  ADV+ W+    G+ V R+YAV+I  K N +  K NLS+++ 
Sbjct: 144 KDGDRVFFIYIASQLAENHADVMQWSHNQKGLAVQRNYAVLI-PKDNTQK-KVNLSLRMD 201

Query: 139 P-APRWRTKYSDAILNGLEIFKVDNTG--NLGGPNPEPRTIPPNLDASPTIEPTKKN--N 193
           P A   +T YSDA LNGLEIFK+   G  NL GPNP+P   P N   +P    + K+  +
Sbjct: 202 PYATNDKTTYSDAFLNGLEIFKISEAGSNNLAGPNPDPVQTPHNNIPAPKGNRSSKSGTS 261

Query: 194 VTGMVAGAISG--SSVLSLLLLLIFWRGRKVK-----DSSSGTGTSLLGTFLWSKTIKAT 246
           + G+VAG +SG     L +L L++F+R + +      + S  + TS  G    S T   +
Sbjct: 262 IIGIVAGVVSGVVLISLIILFLIVFFRRKTITTPKDYNKSKSSATSKWGPL--SFTTTKS 319

Query: 247 KSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLE 306
            ++  S LPSDLC  FSL EI++ATNNFD+  ++GVGGFG VYKG+I+  +TPVAIKRL+
Sbjct: 320 TTTTKSSLPSDLCRHFSLPEIKSATNNFDDVFIVGVGGFGHVYKGYIDNGSTPVAIKRLK 379

Query: 307 PESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNP 366
           P SQQGA EF  EI MLSQLRHLHLVSLIG+CN++ EMILVYDFMARGTL DHLY++DNP
Sbjct: 380 PGSQQGAHEFMNEIEMLSQLRHLHLVSLIGYCNENNEMILVYDFMARGTLRDHLYNTDNP 439

Query: 367 PLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP 426
           PL W QRL+ICIGAARGLHYLHTGA H  IIHRDVKTTNILLD+KWVAKVSDFGLS+ GP
Sbjct: 440 PLTWKQRLQICIGAARGLHYLHTGAKH-TIIHRDVKTTNILLDDKWVAKVSDFGLSRIGP 498

Query: 427 TSVSKTH-----------LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQ 475
           T  +K H           LDPEYY+ Q+LTEKSDVYSFGVVLFE+LCARP ++RTA KKQ
Sbjct: 499 TGNAKAHVSTVVKGSIGYLDPEYYKRQRLTEKSDVYSFGVVLFELLCARPPLIRTAEKKQ 558

Query: 476 VSLAVWAQQCYQNGTIDQIVDPFLK--------------AMSCLNDEGIRRPSMSDVVWG 521
           VSLA WA+ C QNGTI QIVDP LK              A+SCL D+G  RPSM+DVVW 
Sbjct: 559 VSLADWARHCCQNGTIGQIVDPTLKGRMAPECLRKFCEVAVSCLLDDGTLRPSMNDVVWM 618

Query: 522 LEFSLQLQESSIAIAKEIDENEEEEKLLD-----NYETDGSGPVFS---SVGEHVLSDSK 573
           LEF+LQLQES+        E  E   ++D       E + S  +FS   SVG+  +SD  
Sbjct: 619 LEFALQLQESA--------EQRENTNIVDNEINERREEEASDDLFSTGTSVGQ--VSDFN 668

Query: 574 TISTVTISTTTATDDQSLSTGSSDK-YTGAVFSEILNPKGR 613
             S V +S +T +++ S S   SDK  +G VFSEI++PK R
Sbjct: 669 KSSGV-VSVSTDSEELSSSYKESDKLMSGTVFSEIVDPKPR 708

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297819852|ref|XP_002877809.1| hypothetical protein ARALYDRAFT_485507 [Arabidopsis lyrata subsp. lyrata] gi|155242124|gb|ABT18096.1| FERONIA receptor-like kinase [Arabidopsis lyrata] gi|297323647|gb|EFH54068.1| hypothetical protein ARALYDRAFT_485507 [Arabidopsis lyrata subsp. lyrata]

 Score =  597 bits (1540), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 345/658 (52%), Positives = 429/658 (65%), Gaps = 59/658 (8%)

Query: 2   DDPYLTDAR---PSALPVNQSI-HLTWIRNYSAPDLVYETARTMGQDREINEKYNLTWEF 57
           D PY+  A    P     N +I + T    Y AP  VY TAR+MG   +IN  YNLTW F
Sbjct: 247 DQPYIFGAGLGIPETADPNMTIKYPTGTPTYVAPVDVYSTARSMGPTAQINLNYNLTWIF 306

Query: 58  EVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYA 117
            +DSGFTY +RLHFCE    +T+   RVF I++ N TAE +AD+IAWT +NGV  ++DY 
Sbjct: 307 SIDSGFTYLVRLHFCEVSSNITKINQRVFTIYLNNQTAEPEADIIAWTSSNGVPFHKDYV 366

Query: 118 VMIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDNT-GNLGGPNPEPR-- 174
           V     P E N +Q++ + LHP P  + +Y D+ILNG+EIFK++ + GNL GPNP P   
Sbjct: 367 V----NPPEGNGQQDMWLALHPNPINKPEYYDSILNGVEIFKMNTSDGNLAGPNPIPGPQ 422

Query: 175 -TIPPNLDASPTIEPTKKNNVTGMVAGAISGSSVLSLLL-LLIF--WRGRK------VKD 224
            T  P+   SPT   +K N  T +VAGA SG+ VL+L++   +F  +R RK        D
Sbjct: 423 VTADPSKVLSPTSGKSKSN--TAIVAGAASGAVVLALIIGFCVFGAYRRRKRGDYQPASD 480

Query: 225 SSSG-TGTSLLGTFLWSKTIKA-TKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGV 282
           ++SG    SL G    + + K  T  S  S LPS+LC  FS +EI+AAT NFD   V+GV
Sbjct: 481 ATSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGV 540

Query: 283 GGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR 342
           GGFG VY+G I+G TT VAIKR  P S+QG  EFQTEI MLS+LRH HLVSLIG+C ++ 
Sbjct: 541 GGFGKVYRGEIDGGTTKVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC 600

Query: 343 EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVK 402
           EMILVYD+MA GT+ +HLY + NP LPW QRLEICIGAARGLHYLHTGA H  IIHRDVK
Sbjct: 601 EMILVYDYMAHGTMREHLYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKH-TIIHRDVK 659

Query: 403 TTNILLDEKWVAKVSDFGLSKFGPTSVSKTH-----------LDPEYYRLQQLTEKSDVY 451
           TTNILLDEKWVAKVSDFGLSK GPT +  TH           LDPEY+R QQLTEKSDVY
Sbjct: 660 TTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVY 718

Query: 452 SFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK----------- 500
           SFGVVLFE LCARP++  T AK+QVSLA WA  CY+ G +DQIVDP+LK           
Sbjct: 719 SFGVVLFEALCARPALNPTLAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKF 778

Query: 501 ---AMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSIAIAKEI-DENEEEEKLLDNYETDG 556
              AM C+ D+GI RPSM DV+W LEF+LQLQES+    K +  + + +E   D+    G
Sbjct: 779 AETAMKCVLDQGIERPSMGDVLWNLEFALQLQESAEESGKGVCGDMDMDEIKYDDGNCKG 838

Query: 557 SGPVFSSVGEHVLSDSKTISTVTISTTTATDDQSLSTGSSDKYT-GAVFSEILNPKGR 613
                S V E  ++DS++ S + +S       +SL++  SD  T  AVFS+I+NPKGR
Sbjct: 839 KNDKSSDVYEGNVTDSRS-SGIDMS----IGGRSLASEDSDGLTPSAVFSQIMNPKGR 891

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|155242187|gb|ABT18099.1| FERONIA receptor-like kinase [Cardamine flexuosa]

 Score =  594 bits (1532), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 342/664 (51%), Positives = 430/664 (64%), Gaps = 69/664 (10%)

Query: 2   DDPYLTDARPS-ALPVNQSIHLTW---IRNYSAPDLVYETARTMGQDREINEKYNLTWEF 57
           D PYL  A      P + ++++T+      Y AP  VY TARTMG +  IN  YNLTW F
Sbjct: 252 DQPYLFGAAIGIPYPADPTMNITYPTGTPTYVAPKDVYSTARTMGPNARININYNLTWVF 311

Query: 58  EVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTG--ANGVTVYRD 115
            +DSGF+Y +RLHFCE     T+   RVF I++ N TAE +ADVIAWTG   NG+  ++D
Sbjct: 312 SIDSGFSYLVRLHFCEVSTNTTKSNQRVFAIYLNNQTAEPEADVIAWTGNQGNGIAFHKD 371

Query: 116 YAVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDNT-GNLGGPNPEPR 174
           Y V     P +   +Q+L + L P  R + +Y D+ILNG+EIFKV+ + GNL GPNP P 
Sbjct: 372 YVV----NPPDGKGQQDLWLALTPNQRTKPQYYDSILNGVEIFKVNTSDGNLAGPNPIPG 427

Query: 175 TIPPNLDASPT--IEP--TKKNNVTGMVAGAISGSSVLSL---LLLLIFWRGRK------ 221
              P + A P+  + P  ++  N T +VAGA SG+ VL+L   L +L+ +R R       
Sbjct: 428 ---PKVTADPSKVLRPRTSQSRNHTAIVAGAASGAIVLALIIGLCVLVAYRRRNRVNYQP 484

Query: 222 VKDSSSG-TGTSLLGTFLWSKTIKA-TKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLV 279
             D++SG    SL G    + + K  T  S  S LPS+LC  FS +EI+AAT NFD   V
Sbjct: 485 ASDATSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFDESRV 544

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +GVGGFG VY+G I+G TT VAIKR  P S+QG  EFQTEI MLS+LRH HLVSLIG+C 
Sbjct: 545 LGVGGFGKVYRGEIDGGTTKVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 604

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
           ++ EMILVYD+MA GT+ +HLY + N PLPW QRLEICIGAARGLHYLHTGA H  IIHR
Sbjct: 605 ENCEMILVYDYMAYGTMREHLYKTQNSPLPWKQRLEICIGAARGLHYLHTGAKH-TIIHR 663

Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH-----------LDPEYYRLQQLTEKS 448
           DVKTTNILLDEKWVAKVSDFGLSK GPT +  TH           LDPEY+R QQLTEKS
Sbjct: 664 DVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 722

Query: 449 DVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-------- 500
           DVYSFGVVLFE LCARP++  T AK+QVSLA WA  CY+ G +DQIVDP+LK        
Sbjct: 723 DVYSFGVVLFEALCARPALNPTLAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECF 782

Query: 501 ------AMSCLNDEGIRRPSMSDVVWGLEFSLQLQESS----IAIAKEIDENEEEEKLLD 550
                 AM C+ D+GI RPSM DV+W LEF+LQLQES+      +  ++D NE +    D
Sbjct: 783 KKFSETAMKCVLDQGIERPSMGDVLWNLEFALQLQESAEENGKGVGGDMDMNEIK---YD 839

Query: 551 NYETDGSGPVFSSVGEHVLSDSKTISTVTISTTTATDDQSLSTGSSDKYT-GAVFSEILN 609
           +    G   + S V E  ++DS++ S + +S       +SL++  S+  T  AVFS+I+N
Sbjct: 840 DGNCKGKNDMSSDVYEGNVTDSRS-SGIDMS----IGGRSLASEDSEGLTPSAVFSQIMN 894

Query: 610 PKGR 613
           PKGR
Sbjct: 895 PKGR 898

Source: Cardamine flexuosa

Species: Cardamine flexuosa

Genus: Cardamine

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449438963|ref|XP_004137257.1| PREDICTED: receptor-like protein kinase FERONIA-like [Cucumis sativus]

 Score =  594 bits (1532), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 330/651 (50%), Positives = 420/651 (64%), Gaps = 63/651 (9%)

Query: 5   YLTDARPSALPVNQSIHLTWIRN--YSAPDLVYETARTMGQDREINEKYNLTWEFEVDSG 62
           Y+ D    A P N SI L +I    Y+AP+ VY TARTMG +  +N+ YNLTWE+ VD G
Sbjct: 263 YMNDYVADARPANLSIQLNYIERQPYTAPENVYRTARTMGPNSTLNKNYNLTWEYPVDPG 322

Query: 63  FTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYAVMIGS 122
           F Y +RLHFCEFQ E+T  GDRVF I+I + TAE   DV          +Y DY V + +
Sbjct: 323 FYYMIRLHFCEFQAEITAAGDRVFLIYIKDATAEESFDVFQKARGKYNPIYEDYGVFV-T 381

Query: 123 KPNEENIKQNLSIQLHPAPRWR-TKYSDAILNGLEIFKVDNT-GNLGGPNPEP---RTIP 177
           K N++ +  NLS++L P P    T++S+ ILNG+EIFK+++T GNLGG NP+P   +++P
Sbjct: 382 KSNQKKV--NLSVKLRPNPNDDLTRFSNVILNGVEIFKLNDTNGNLGGQNPDPPPTQSLP 439

Query: 178 PNLDASPTIEPTKKNNVTGMVAGAISGSSVLSLLLLLIFWRGRKVKDSSSGTGTSLLGTF 237
           P+           K     +        ++L+L LL  F R R + D +S  GTS    F
Sbjct: 440 PSTPQMNNDSSNTKIVAIVIPVVIGVVVAILALGLLF-FRRRRTLTDQASSDGTSWWAPF 498

Query: 238 LWSKTIKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGST 297
             S +   T  +R S LPSDLC  FSL EI+AAT NFD+  +IGVGGFG+VYKG+I+   
Sbjct: 499 --STSTNKTSKTRNSNLPSDLCRYFSLGEIKAATKNFDDVFIIGVGGFGNVYKGYIDDGA 556

Query: 298 TPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLP 357
           T VAIKRL+P S+QGA EF+TEI MLSQLRHLHLVSLIG+CND  EMILVY++M+ GTL 
Sbjct: 557 TQVAIKRLKPGSKQGAHEFKTEIEMLSQLRHLHLVSLIGYCNDGNEMILVYEYMSHGTLR 616

Query: 358 DHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVS 417
            HLY +D  PL WNQRL+IC+GAA+GLHYLHTGANH  IIHRDVKTTNILLDEKW+AKVS
Sbjct: 617 SHLYGNDEQPLTWNQRLQICVGAAKGLHYLHTGANH-TIIHRDVKTTNILLDEKWIAKVS 675

Query: 418 DFGLSKFGPTSVSKT------------HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           DFGLSK GP ++S              +LDPEYYR QQLTEKSDVYSFGVVL EVLCARP
Sbjct: 676 DFGLSKVGPANMSNNTHISTVVKGSFGYLDPEYYRRQQLTEKSDVYSFGVVLCEVLCARP 735

Query: 466 SILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--------------AMSCLNDEGIR 511
            ++R+A KK+V LA W +QC++  T+ Q +D  +K              A+SC+ D+G++
Sbjct: 736 PLVRSAEKKEVYLAEWVRQCHRKNTVAQTIDKNVKNEISPECLRKFIEIAVSCVEDDGVK 795

Query: 512 RPSMSDVVWGLEFSLQLQESSIAIAKEIDENE---------EEEKLLDNYETDGSGPVFS 562
           RP M DVVWGLEF+LQLQE+S    K++DE+E         EE   LD  ET     +FS
Sbjct: 796 RPPMKDVVWGLEFALQLQEAS---KKKVDEDEVGSGKRDSSEERWCLD--ET-----LFS 845

Query: 563 SVGEHVLSDSKTISTVTISTTTATDDQSLSTGSSDKYTGAVFSEILNPKGR 613
           S G+        +S+    TT+ +DD S +       +G VFSEI +  GR
Sbjct: 846 STGDRRRDSELGVSSYV--TTSNSDDSSYTHNKG--MSGTVFSEIKDAAGR 892

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449476518|ref|XP_004154759.1| PREDICTED: receptor-like protein kinase FERONIA-like [Cucumis sativus]

 Score =  594 bits (1531), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 330/651 (50%), Positives = 420/651 (64%), Gaps = 63/651 (9%)

Query: 5   YLTDARPSALPVNQSIHLTWIRN--YSAPDLVYETARTMGQDREINEKYNLTWEFEVDSG 62
           Y+ D    A P N SI L +I    Y+AP+ VY TARTMG +  +N+ YNLTWE+ VD G
Sbjct: 263 YMNDYVADARPANLSIQLNYIERQPYTAPENVYRTARTMGPNSTLNKNYNLTWEYPVDPG 322

Query: 63  FTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYAVMIGS 122
           F Y +RLHFCEFQ E+T  GDRVF I+I + TAE   DV          +Y DY V + +
Sbjct: 323 FYYMIRLHFCEFQAEITAAGDRVFLIYIKDATAEESFDVFQKARGKYNPIYEDYGVFV-T 381

Query: 123 KPNEENIKQNLSIQLHPAPRWR-TKYSDAILNGLEIFKVDNT-GNLGGPNPEP---RTIP 177
           K N++ +  NLS++L P P    T++S+ ILNG+EIFK+++T GNLGG NP+P   +++P
Sbjct: 382 KSNQKKV--NLSVKLRPNPNDDLTRFSNVILNGVEIFKLNDTNGNLGGQNPDPPPTQSLP 439

Query: 178 PNLDASPTIEPTKKNNVTGMVAGAISGSSVLSLLLLLIFWRGRKVKDSSSGTGTSLLGTF 237
           P+           K     +        ++L+L LL  F R R + D +S  GTS    F
Sbjct: 440 PSTPQMNNDSSNTKIVAIVIPVVIGVVVAILALGLLF-FRRRRTLTDQASSDGTSWWAPF 498

Query: 238 LWSKTIKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGST 297
             S +   T  +R S LPSDLC  FSL EI+AAT NFD+  +IGVGGFG+VYKG+I+   
Sbjct: 499 --STSTNKTSKTRNSNLPSDLCRYFSLGEIKAATKNFDDVFIIGVGGFGNVYKGYIDDGA 556

Query: 298 TPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLP 357
           T VAIKRL+P S+QGA EF+TEI MLSQLRHLHLVSLIG+CND  EMILVY++M+ GTL 
Sbjct: 557 TQVAIKRLKPGSKQGAHEFKTEIEMLSQLRHLHLVSLIGYCNDGNEMILVYEYMSHGTLR 616

Query: 358 DHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVS 417
            HLY +D  PL WNQRL+IC+GAA+GLHYLHTGANH  IIHRDVKTTNILLDEKW+AKVS
Sbjct: 617 SHLYGNDEQPLTWNQRLQICVGAAKGLHYLHTGANH-TIIHRDVKTTNILLDEKWIAKVS 675

Query: 418 DFGLSKFGPTSVSKT------------HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           DFGLSK GP ++S              +LDPEYYR QQLTEKSDVYSFGVVL EVLCARP
Sbjct: 676 DFGLSKVGPANMSNNTHISTVVKGSFGYLDPEYYRRQQLTEKSDVYSFGVVLCEVLCARP 735

Query: 466 SILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--------------AMSCLNDEGIR 511
            ++R+A KK+V LA W +QC++  T+ Q +D  +K              A+SC+ D+G++
Sbjct: 736 PLVRSAEKKEVYLAEWVRQCHRKNTVAQTIDENVKNEISPECLRKFIEIAVSCVEDDGVK 795

Query: 512 RPSMSDVVWGLEFSLQLQESSIAIAKEIDENE---------EEEKLLDNYETDGSGPVFS 562
           RP M DVVWGLEF+LQLQE+S    K++DE+E         EE   LD  ET     +FS
Sbjct: 796 RPPMKDVVWGLEFALQLQEAS---KKKVDEDEVGSGKRDSSEERWCLD--ET-----LFS 845

Query: 563 SVGEHVLSDSKTISTVTISTTTATDDQSLSTGSSDKYTGAVFSEILNPKGR 613
           S G+        +S+    TT+ +DD S +       +G VFSEI +  GR
Sbjct: 846 STGDRRRDSELGVSSYV--TTSNSDDSSYTHNKG--MSGTVFSEIKDAAGR 892

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	613
TAIR|locus:2081895	895	FER "FERONIA" [Arabidopsis tha	0.694	0.475	0.512	6.3e-146
TAIR|locus:2148830	858	ANX2 "ANXUR2" [Arabidopsis tha	0.776	0.554	0.488	8.4e-121
TAIR|locus:2084953	850	ANX1 "ANXUR1" [Arabidopsis tha	0.769	0.555	0.485	1.6e-117
TAIR|locus:2177202	873	AT5G39000 [Arabidopsis thalian	0.797	0.560	0.483	1e-116
TAIR|locus:2204564	849	HERK2 "hercules receptor kinas	0.414	0.299	0.588	7.6e-99
TAIR|locus:2152312	880	AT5G38990 [Arabidopsis thalian	0.701	0.488	0.456	6.1e-94
TAIR|locus:2151349	855	THE1 "THESEUS1" [Arabidopsis t	0.407	0.292	0.590	3.3e-93
TAIR|locus:2163158	842	AT5G61350 [Arabidopsis thalian	0.432	0.314	0.569	2.7e-92
TAIR|locus:2050080	871	AT2G21480 [Arabidopsis thalian	0.402	0.283	0.592	6.3e-89
TAIR|locus:2136338	878	AT4G39110 [Arabidopsis thalian	0.425	0.297	0.568	2.7e-88

TAIR|locus:2081895 FER "FERONIA" [Arabidopsis thaliana (taxid:3702)]

 Score = 1047 (373.6 bits), Expect = 6.3e-146, Sum P(3) = 6.3e-146
 Identities = 231/451 (51%), Positives = 279/451 (61%)

Query:     2 DDPYLTDAR---PSALPVNQSI-HLTWIRNYSAPDLVYETARTMGQDREINEKYNLTWEF 57
             D PY+  A    P     N +I + T    Y AP  VY TAR+MG   +IN  YNLTW F
Sbjct:   251 DQPYIFGAGLGIPETADPNMTIKYPTGTPTYVAPVDVYSTARSMGPTAQINLNYNLTWIF 310

Query:    58 EVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYA 117
              +DSGFTY +RLHFCE    +T+   RVF I++ N TAE +ADVIAWT +NGV  ++DY 
Sbjct:   311 SIDSGFTYLVRLHFCEVSSNITKINQRVFTIYLNNQTAEPEADVIAWTSSNGVPFHKDYV 370

Query:   118 VMIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDNT-GNLGGPNPEPR-- 174
             V     P E N +Q+L + LHP P  + +Y D++LNG+EIFK++ + GNL G NP P   
Sbjct:   371 V----NPPEGNGQQDLWLALHPNPVNKPEYYDSLLNGVEIFKMNTSDGNLAGTNPIPGPQ 426

Query:   175 -TIPPNLDASPTIEPTKKNN--VTGMXXXXXXXXXXXXXXXXXXFWRGRKVKDXXXXXXX 231
              T  P+    PT   +K N   + G                   + R RK  D       
Sbjct:   427 VTADPSKVLRPTTRKSKSNTAIIAGAASGAVVLALIIGFCVFGAY-RRRKRGDYQPASDA 485

Query:   232 XXX-------XXXXXXKTIKA-TKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVG 283
                              + K  T  S  S LPS+LC  FS +EI+AAT NFD   V+GVG
Sbjct:   486 TSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVG 545

Query:   284 GFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDRE 343
             GFG VY+G I+G TT VAIKR  P S+QG  EFQTEI MLS+LRH HLVSLIG+C ++ E
Sbjct:   546 GFGKVYRGEIDGGTTKVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCE 605

Query:   344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKT 403
             MILVYD+MA GT+ +HLY + NP LPW QRLEICIGAARGLHYLHTGA H  IIHRDVKT
Sbjct:   606 MILVYDYMAHGTMREHLYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHT-IIHRDVKT 664

Query:   404 TNILLDEKWVAKVSDFGLSKFGPTSVSKTHL 434
             TNILLDEKWVAKVSDFGLSK GPT +  TH+
Sbjct:   665 TNILLDEKWVAKVSDFGLSKTGPT-LDHTHV 694

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0016020 "membrane" evidence=IDA

GO:0010483 "pollen tube reception" evidence=IMP

GO:0043680 "filiform apparatus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009791 "post-embryonic development" evidence=IMP

GO:0050832 "defense response to fungus" evidence=IMP

GO:0009506 "plasmodesma" evidence=IDA

GO:0000902 "cell morphogenesis" evidence=RCA

GO:0006007 "glucose catabolic process" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0010193 "response to ozone" evidence=RCA

GO:0016049 "cell growth" evidence=RCA

GO:0030244 "cellulose biosynthetic process" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048193 "Golgi vesicle transport" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2148830 ANX2 "ANXUR2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1153 (410.9 bits), Expect = 8.4e-121, Sum P(2) = 8.4e-121
 Identities = 246/504 (48%), Positives = 320/504 (63%)

Query:    29 SAPDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQI 88
             +AP  VY+TAR+ G + +IN K NLTW F+VD+ FTY +RLHFCEFQ+   +   +VF I
Sbjct:   270 TAPADVYKTARSQGPNGDINMKSNLTWMFQVDTNFTYIMRLHFCEFQL--AKINQKVFNI 327

Query:    89 FIANLTAEVQ---ADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRT 145
             FI N TA+     AD++ WTG  G+  Y+DYA+ + +  N     + +S+Q+ P+   + 
Sbjct:   328 FINNRTAQGDTNPADILGWTGGKGIPTYKDYAIYVDA--NTGGGGEEISLQMTPSTFGQP 385

Query:   146 KYSDAILNGLEIFKVDNTGNLGGPNPEPRTIPPNLDASPTIEPTKKNNVTGMXXXXXXXX 205
             +Y D+ LNGLEIFK+D   NL GPNP+P  +  N D     +  K+     +        
Sbjct:   386 EYYDSQLNGLEIFKIDTMKNLAGPNPKPSPMQANEDVKKDFQGDKRITAFVIGSAGGVAA 445

Query:   206 XXXXXXXXXXFWRGRKVKDXXXXXXX----XXXXXXXXXKTIKATKSSRGSFLPS---DL 258
                       + R RK                       K+  + KS+ GS L +    L
Sbjct:   446 VLFCALCFTMYQRKRKFSGSDSHTSSWLPIYGNSHTSATKSTISGKSNNGSHLSNLAAGL 505

Query:   259 CTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT 318
             C +FSLSEI+  T+NFD   VIGVGGFG VYKG I+G T  VAIK+  P S+QG  EF+T
Sbjct:   506 CRRFSLSEIKHGTHNFDESNVIGVGGFGKVYKGVIDGGTK-VAIKKSNPNSEQGLNEFET 564

Query:   319 EIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICI 378
             EI +LS+LRH HLVSLIG+C++  EM L+YD+M+ GTL +HLY++  P L W +RLEI I
Sbjct:   565 EIELLSRLRHKHLVSLIGYCDEGGEMCLIYDYMSLGTLREHLYNTKRPQLTWKRRLEIAI 624

Query:   379 GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-------TSVSK 431
             GAARGLHYLHTGA +  IIHRDVKTTNILLDE WVAKVSDFGLSK GP       T+V K
Sbjct:   625 GAARGLHYLHTGAKYT-IIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMNGGHVTTVVK 683

Query:   432 T---HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN 488
                 +LDPEY+R QQLTEKSDVYSFGVVLFEVLCARP++  + +K+QVSL  WA  C + 
Sbjct:   684 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNPSLSKEQVSLGDWAMNCKRK 743

Query:   489 GTIDQIVDPFLKAMSCLNDEGIRR 512
             GT++ I+DP LK    +N E +++
Sbjct:   744 GTLEDIIDPNLKGK--INPECLKK 765

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009860 "pollen tube growth" evidence=IGI

GO:0016324 "apical plasma membrane" evidence=IDA

GO:0090404 "pollen tube tip" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2084953 ANX1 "ANXUR1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1127 (401.8 bits), Expect = 1.6e-117, Sum P(2) = 1.6e-117
 Identities = 244/503 (48%), Positives = 319/503 (63%)

Query:    30 APDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIF 89
             AP  +Y+TAR+ G + +IN K NLTW F++D  FTY LRLHFCEFQ+  ++   +VF I+
Sbjct:   270 APADIYKTARSQGPNGDINLKSNLTWMFQIDKNFTYILRLHFCEFQL--SKINQKVFNIY 327

Query:    90 IANLTAEVQ---ADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRTK 146
             I N TA+     AD+I WTG  G+ +Y+DYA+ + +    E I    ++Q+ P+   + +
Sbjct:   328 INNRTAQADTTPADIIGWTGEKGIPMYKDYAIYVDANNGGEEI----TLQMTPSTFGQPE 383

Query:   147 YSDAILNGLEIFKVDNTGNLGGPNPEPRTIPPNLDASPTIEPTKKNN-VTGMXXXXXXXX 205
             Y D+ LNGLEIFK+D   NL GPNPEP  +    +     +  K++  + G         
Sbjct:   384 YYDSSLNGLEIFKMDTMKNLAGPNPEPSPMQAEEEVKKEFKNEKRHAFIIGSAGGVLAVL 443

Query:   206 XXXXXXXXXXFWRGRKVKDXXXXXXXXXXXXXXXXKTIKAT---KSSRGSFLPS---DLC 259
                         +G +  D                 T K+T   KS+ GS L +    LC
Sbjct:   444 IGALCFTAYKKKQGYQGGDSHTSSWLPIYGNSTTSGT-KSTISGKSNNGSHLSNLAAGLC 502

Query:   260 TQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTE 319
              +FSL EI+  T NFD+  VIGVGGFG VYKG I+G TT VA+K+  P S+QG  EF+TE
Sbjct:   503 RRFSLPEIKHGTQNFDDSNVIGVGGFGKVYKGVIDG-TTKVAVKKSNPNSEQGLNEFETE 561

Query:   320 IGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG 379
             I +LS+LRH HLVSLIG+C++  EM LVYD+MA GTL +HLY++  P L W +RLEI IG
Sbjct:   562 IELLSRLRHKHLVSLIGYCDEGGEMCLVYDYMAFGTLREHLYNTKKPQLTWKRRLEIAIG 621

Query:   380 AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-------TSVSKT 432
             AARGLHYLHTGA +  IIHRDVKTTNIL+DE WVAKVSDFGLSK GP       T+V K 
Sbjct:   622 AARGLHYLHTGAKYT-IIHRDVKTTNILVDENWVAKVSDFGLSKTGPNMNGGHVTTVVKG 680

Query:   433 ---HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG 489
                +LDPEY+R QQLTEKSDVYSFGVVLFE+LCARP++  +  K+QVSL  WA  C + G
Sbjct:   681 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPSLPKEQVSLGDWAMNCKRKG 740

Query:   490 TIDQIVDPFLKAMSCLNDEGIRR 512
              ++ I+DP LK    +N E +++
Sbjct:   741 NLEDIIDPNLKGK--INAECLKK 761

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009860 "pollen tube growth" evidence=IGI;RCA

GO:0016324 "apical plasma membrane" evidence=IDA

GO:0090404 "pollen tube tip" evidence=IDA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2177202 AT5G39000 [Arabidopsis thaliana (taxid:3702)]

 Score = 1150 (409.9 bits), Expect = 1.0e-116, P = 1.0e-116
 Identities = 254/525 (48%), Positives = 322/525 (61%)

Query:     2 DDPYLTDARPSALPVNQSIHLTWIR---NYSAPDLVYETARTMGQ-DR-EINEKYNLTWE 56
             DD  +        P+   I + +     +Y APD VY T+R+MG  D  E N  +NLTW 
Sbjct:   245 DDEIILSESSGISPIVPDIKINYTEKTPSYVAPDDVYATSRSMGNADHPEQNLNFNLTWL 304

Query:    57 FEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDY 116
             F VD+GF+Y +RLHFCE   EV ++G RVF IFI N TA ++ DV   +G + + +Y DY
Sbjct:   305 FTVDAGFSYLVRLHFCETLSEVNKEGQRVFSIFIENQTATLEMDVFRMSGGSWIPMYLDY 364

Query:   117 AVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKV-DNTGNLGGPNPEPRT 175
              V+ GS       + +L + LHP      KY DAILNG+EI K+ D  GNL GPNP+P  
Sbjct:   365 TVIAGSGSGR---RHDLRLDLHPLVSINPKYYDAILNGVEILKMNDPDGNLAGPNPDPLV 421

Query:   176 IP---PNLDASPTIEPTKKN--NVTGMXXXXXXXXXXXXXXXXXXFWRGRKVKDXXXXXX 230
              P   PN  A+P I   K +   +T                      + +K K       
Sbjct:   422 SPDLIPNR-ATPRIRKNKSHILPITLAVVGSLVVLAMFVVGVLVIMKKKKKSKPSTNSSW 480

Query:   231 XXXXXXXXXXKTIKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYK 290
                        T K  KS     LP+DLC +FS+ EI++ATN+F++ L+IGVGGFG VYK
Sbjct:   481 CPLPHGTDSTNT-KPAKS-----LPADLCRRFSIFEIKSATNDFEDKLIIGVGGFGSVYK 534

Query:   291 GFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF 350
             G I+G  T VA+KRLE  S QGA EF+TE+ MLS+LRH+HLVSLIG+C++D EM+LVY++
Sbjct:   535 GQIDGGATLVAVKRLEITSNQGAKEFETELEMLSKLRHVHLVSLIGYCDEDNEMVLVYEY 594

Query:   351 MARGTLPDHLYHSD---NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNIL 407
             M  GTL DHL+  D   +PPL W +RLEICIGAARGL YLHTGA +  IIHRD+KTTNIL
Sbjct:   595 MPHGTLKDHLFRRDKTSDPPLSWKRRLEICIGAARGLQYLHTGAKYT-IIHRDIKTTNIL 653

Query:   408 LDEKWVAKVSDFGLSKFGPTSVSKTH-----------LDPEYYRLQQLTEKSDVYSFGVV 456
             LDE +V KVSDFGLS+ GPTS S+TH           LDPEYYR Q LTEKSDVYSFGVV
Sbjct:   654 LDENFVTKVSDFGLSRVGPTSASQTHVSTVVKGTFGYLDPEYYRRQVLTEKSDVYSFGVV 713

Query:   457 LFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKA 501
             L EVLC RP  +++   +Q  L  W +  Y+ GT+DQI+D  L A
Sbjct:   714 LLEVLCCRPIRMQSVPPEQADLIRWVKSNYRRGTVDQIIDSDLSA 758

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2204564 HERK2 "hercules receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 748 (268.4 bits), Expect = 7.6e-99, Sum P(2) = 7.6e-99
 Identities = 159/270 (58%), Positives = 191/270 (70%)

Query:   244 KATKSSR--GSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVA 301
             KAT  S    +   S +  +F+L+EI+AAT NFD+ L IGVGGFG VY+G +   T  +A
Sbjct:   488 KATGGSLRLNTLAASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTL-IA 546

Query:   302 IKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY 361
             IKR  P SQQG  EF+TEI MLS+LRH HLVSLIGFC++  EMILVY++MA GTL  HL+
Sbjct:   547 IKRATPHSQQGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLF 606

Query:   362 HSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL 421
              S+ PPL W QRLE CIG+ARGLHYLHTG+    IIHRDVKTTNILLDE +VAK+SDFGL
Sbjct:   607 GSNLPPLSWKQRLEACIGSARGLHYLHTGSERG-IIHRDVKTTNILLDENFVAKMSDFGL 665

Query:   422 SKFGPTSVSKTH-----------LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRT 470
             SK GP S+  TH           LDPEY+R QQLTEKSDVYSFGVVLFE +CAR  I  T
Sbjct:   666 SKAGP-SMDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPT 724

Query:   471 AAKKQVSLAVWAQQCYQNGTIDQIVDPFLK 500
               K Q++LA WA    +   ++ I+D  L+
Sbjct:   725 LPKDQINLAEWALSWQKQRNLESIIDSNLR 754

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IGI

GO:0009826 "unidimensional cell growth" evidence=IGI

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2152312 AT5G38990 [Arabidopsis thaliana (taxid:3702)]

 Score = 935 (334.2 bits), Expect = 6.1e-94, P = 6.1e-94
 Identities = 205/449 (45%), Positives = 269/449 (59%)

Query:     2 DDPYLTDARPSALPVNQSIHLTWIRN---YSAPDLVYETARTMG-QDR-EINEKYNLTWE 56
             D+ +L      A+P    + + +      Y AP+ VY T R MG +D  E+N  +NLTW 
Sbjct:   242 DEGFLLGINSGAIPNITGVKINYTDKTPAYVAPEDVYTTCRLMGNKDSPELNLNFNLTWL 301

Query:    57 FEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDY 116
             FEVD+GF Y +RLHFCE Q EV + GDRVF IF     A  + DV   +G   + +Y D+
Sbjct:   302 FEVDAGFAYIVRLHFCETQPEVNKTGDRVFSIFFGYQLAMREMDVFRLSGGFRLPMYLDF 361

Query:   117 AVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDNT-GNLGGPNPEPRT 175
              V++ +    +  + +L + L P       Y DAIL+G+EI K+ N+ GNL G NP P+ 
Sbjct:   362 KVLVDADGTSQ--RPSLRVDLTPYKEDYPTYYDAILSGVEILKLSNSDGNLAGLNPIPQL 419

Query:   176 IPPNLDASPTIEPTKKNNVT----GMXXXXXXXXXXXXXXXXXXFWRGRKVKDXXXXXXX 231
              PP    +P     K ++V      +                    R +K  +       
Sbjct:   420 SPPPQSITPLKGKGKSSHVLPIIIAVVGSAVALAFFVLVVVLVVMKRKKKSNESSVDTTN 479

Query:   232 XXXXXXXXXKTIKATKSSR---GSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDV 288
                        +  T S+     S LPSDLC +FS+ EI++ATN+F+  L+IGVGGFG V
Sbjct:   480 KPSTNSSWGPLLHGTGSTNTKSASSLPSDLCRRFSIYEIKSATNDFEEKLIIGVGGFGSV 539

Query:   289 YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY 348
             YKG I+G  T VA+KRLE  S QGA EF TE+ MLS+LRH+HLVSLIG+C+DD EM+LVY
Sbjct:   540 YKGRIDGGATLVAVKRLEITSNQGAKEFDTELEMLSKLRHVHLVSLIGYCDDDNEMVLVY 599

Query:   349 DFMARGTLPDHLYHSD---NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTN 405
             ++M  GTL DHL+  D   +PPL W +RLEICIGAARGL YLHTGA +  IIHRD+KTTN
Sbjct:   600 EYMPHGTLKDHLFRRDKASDPPLSWKRRLEICIGAARGLQYLHTGAKYT-IIHRDIKTTN 658

Query:   406 ILLDEKWVAKVSDFGLSKFGPTSVSKTHL 434
             ILLDE +VAKVSDFGLS+ GPTS S+TH+
Sbjct:   659 ILLDENFVAKVSDFGLSRVGPTSASQTHV 687

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2151349 THE1 "THESEUS1" [Arabidopsis thaliana (taxid:3702)]

 Score = 742 (266.3 bits), Expect = 3.3e-93, Sum P(3) = 3.3e-93
 Identities = 156/264 (59%), Positives = 187/264 (70%)

Query:   244 KATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK 303
             K+  +S  S   + L   F   EI  ATN FD   ++GVGGFG VYKG +   T  VA+K
Sbjct:   480 KSATASCISLASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTK-VAVK 538

Query:   304 RLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHS 363
             R  P S+QG  EF+TEI MLS+LRH HLVSLIG+C++  EMILVY++MA G L  HLY +
Sbjct:   539 RGNPRSEQGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGA 598

Query:   364 DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
             D PPL W QRLEICIGAARGLHYLHTGA+ + IIHRDVKTTNILLDE  VAKV+DFGLSK
Sbjct:   599 DLPPLSWKQRLEICIGAARGLHYLHTGASQS-IIHRDVKTTNILLDENLVAKVADFGLSK 657

Query:   424 FGPTSVSKTH-----------LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAA 472
              GP S+ +TH           LDPEY+R QQLTEKSDVYSFGVVL EVLC RP++     
Sbjct:   658 TGP-SLDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLP 716

Query:   473 KKQVSLAVWAQQCYQNGTIDQIVD 496
             ++QV++A WA    + G +DQI+D
Sbjct:   717 REQVNIAEWAMAWQKKGLLDQIMD 740

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0009791 "post-embryonic development" evidence=IGI

GO:0051510 "regulation of unidimensional cell growth" evidence=IGI;RCA

GO:0009741 "response to brassinosteroid stimulus" evidence=IGI

GO:0009826 "unidimensional cell growth" evidence=IGI

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2163158 AT5G61350 [Arabidopsis thaliana (taxid:3702)]

 Score = 729 (261.7 bits), Expect = 2.7e-92, Sum P(2) = 2.7e-92
 Identities = 163/286 (56%), Positives = 201/286 (70%)

Query:   244 KATKSSR-GSFLPSD-LCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVA 301
             K +KS+   SF  +  L   F  +E+Q AT NFD + V GVGGFG VY G I+G T  VA
Sbjct:   493 KKSKSNGFSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVGGFGKVYIGEIDGGTQ-VA 551

Query:   302 IKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY 361
             IKR    S+QG  EFQTEI MLS+LRH HLVSLIGFC++++EMILVY++M+ G L DHLY
Sbjct:   552 IKRGSQSSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYEYMSNGPLRDHLY 611

Query:   362 HS-DNPPLP-----WNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAK 415
              S +N P P     W QRLEICIG+ARGLHYLHTGA    IIHRDVKTTNILLDE  VAK
Sbjct:   612 GSKENDPNPIPTLSWKQRLEICIGSARGLHYLHTGAAQG-IIHRDVKTTNILLDENLVAK 670

Query:   416 VSDFGLSKFGP-------TSVSKT--HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPS 466
             VSDFGLSK  P       T+V  +  +LDPEY+R QQLT+KSDVYSFGVVLFEVLCARP 
Sbjct:   671 VSDFGLSKDAPMDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPV 730

Query:   467 ILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRR 512
             I     ++QV+LA +A   ++ G +++I+DP  K +  ++   +R+
Sbjct:   731 INPQLPREQVNLAEYAMNLHRKGMLEKIIDP--KIVGTISKGSLRK 774

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2050080 AT2G21480 [Arabidopsis thaliana (taxid:3702)]

 Score = 736 (264.1 bits), Expect = 6.3e-89, Sum P(2) = 6.3e-89
 Identities = 154/260 (59%), Positives = 187/260 (71%)

Query:   262 FSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIG 321
             FSLSE+Q  T NFD   +IGVGGFG+VY G I+  T  VAIKR  P+S+QG  EF TEI 
Sbjct:   513 FSLSELQEVTKNFDASEIIGVGGFGNVYIGTIDDGTQ-VAIKRGNPQSEQGITEFHTEIQ 571

Query:   322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
             MLS+LRH HLVSLIG+C+++ EMILVY++M+ G   DHLY  +  PL W QRLEICIGAA
Sbjct:   572 MLSKLRHRHLVSLIGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRLEICIGAA 631

Query:   382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK---FGPTSVSKT------ 432
             RGLHYLHTG     IIHRDVK+TNILLDE  VAKV+DFGLSK   FG   VS        
Sbjct:   632 RGLHYLHTGTAQG-IIHRDVKSTNILLDEALVAKVADFGLSKDVAFGQNHVSTAVKGSFG 690

Query:   433 HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID 492
             +LDPEY+R QQLT+KSDVYSFGVVL E LCARP+I     ++QV+LA WA    Q G ++
Sbjct:   691 YLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMLWKQKGLLE 750

Query:   493 QIVDPFLKAMSCLNDEGIRR 512
             +I+DP L  +  +N E +++
Sbjct:   751 KIIDPHL--VGAVNPESMKK 768

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2136338 AT4G39110 [Arabidopsis thaliana (taxid:3702)]

 Score = 741 (265.9 bits), Expect = 2.7e-88, Sum P(2) = 2.7e-88
 Identities = 157/276 (56%), Positives = 195/276 (70%)

Query:   248 SSRGSFLPSDLCT--QFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL 305
             S + +F  S L     FSLSE+Q AT NF+   +IGVGGFG+VY G ++  T  VA+KR 
Sbjct:   498 SQKSNFYNSTLGLGRYFSLSELQEATKNFEASQIIGVGGFGNVYIGTLDDGTK-VAVKRG 556

Query:   306 EPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDN 365
              P+S+QG  EFQTEI MLS+LRH HLVSLIG+C+++ EMILVY+FM+ G   DHLY  + 
Sbjct:   557 NPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNL 616

Query:   366 PPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-- 423
              PL W QRLEICIG+ARGLHYLHTG     IIHRDVK+TNILLDE  VAKV+DFGLSK  
Sbjct:   617 APLTWKQRLEICIGSARGLHYLHTGTAQG-IIHRDVKSTNILLDEALVAKVADFGLSKDV 675

Query:   424 -FGPTSVSKT------HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV 476
              FG   VS        +LDPEY+R QQLT+KSDVYSFGVVL E LCARP+I     ++QV
Sbjct:   676 AFGQNHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQV 735

Query:   477 SLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRR 512
             +LA WA Q  + G +++I+DP L     +N E +++
Sbjct:   736 NLAEWAMQWKRKGLLEKIIDPHLAGT--INPESMKK 769

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

GO:0030048 "actin filament-based movement" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9SCZ4	FERON_ARATH	2, ., 7, ., 1, 1, ., 1	0.5113	0.9755	0.6681	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00038043001 SubName- Full=Chromosome chr14 scaffold_9, whole genome shotgun sequence; (695 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	613
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-47
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-47
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-46
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-46
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-44
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-37
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-36
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-32
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-32
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-31
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-28
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-27
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-27
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-26
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-24
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-24
pfam12819	335	pfam12819, Malectin_like, Carbohydrate-binding pro	8e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-23
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-22
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-22
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-21
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-21
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-21
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-20
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-19
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-19
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	8e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-18
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-17
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-17
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-17
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-16
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-15
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-15
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-15
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-14
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-14
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-14
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-14
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-13
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-12
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-12
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-12
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	7e-12
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-12
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	7e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	9e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-10
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-10
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-09
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	8e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-08
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-07
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	8e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-06
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-05
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-04
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	8e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	0.001
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	0.002
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	0.003

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  167 bits (425), Expect = 1e-47
 Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 27/210 (12%)

Query: 279 VIGVGGFGDVYKGF---INGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVSL 334
            +G G FG+VYKG     +G TT VA+K L E  S++   +F  E  ++ +L H ++V L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 335 IGFCNDDREMILVYDFMARGTLPDHL-------YHSDNPPLPWNQRLEICIGAARGLHYL 387
           +G C ++  + LV ++M  G L D+L          +   L     L   I  A+G+ YL
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD----------PE 437
              +     +HRD+   N L+ E  V K+SDFGLS+                      PE
Sbjct: 122 A--SKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 438 YYRLQQLTEKSDVYSFGVVLFEV--LCARP 465
             +    T KSDV+SFGV+L+E+  L A P
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  164 bits (419), Expect = 7e-47
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 36/207 (17%)

Query: 279 VIGVGGFGDVYKGFINGS----TTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVS 333
            +G G FG+VYKG + G      T VA+K L+   S++   EF  E  ++ +L H ++V 
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L+G C     + +V ++M  G L D L       L     L++ +  A+G+ YL   + +
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLE--SKN 122

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ---------- 443
              +HRD+   N L+ E  V K+SDFGL        S+   + +YYR +           
Sbjct: 123 --FVHRDLAARNCLVTENLVVKISDFGL--------SRDIYEDDYYRKRGGGKLPIKWMA 172

Query: 444 --------LTEKSDVYSFGVVLFEVLC 462
                    T KSDV+SFGV+L+E+  
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFT 199

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  163 bits (416), Expect = 2e-46
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 20/203 (9%)

Query: 279 VIGVGGFGDVYKGFING----STTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
            +G G FG+VYKG + G        VA+K L E  S+Q   EF  E  ++ +L H ++V 
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L+G C ++  +++V ++M  G L D+L  +    L  +  L   +  ARG+ YL   + +
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--SKN 123

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQL 444
              IHRD+   N L+ E  V K+SDFGLS+                     PE  +  + 
Sbjct: 124 --FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181

Query: 445 TEKSDVYSFGVVLFEV--LCARP 465
           T KSDV+SFGV+L+E+  L   P
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEP 204

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  162 bits (412), Expect = 7e-46
 Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 21/203 (10%)

Query: 279 VIGVGGFGDVYKGFINGS----TTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVS 333
            +G G FG+VYKG + G        VA+K L+ ++ +  + EF  E  ++ +L H ++V 
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L+G C ++  + +V ++M  G L  +L   + P L  +  L   +  ARG+ YL   + +
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE--SKN 122

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQL 444
              IHRD+   N L+ E  V K+SDFGLS+                     PE  +  + 
Sbjct: 123 --FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180

Query: 445 TEKSDVYSFGVVLFEV--LCARP 465
           T KSDV+SFGV+L+E+  L  +P
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQP 203

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  157 bits (398), Expect = 2e-44
 Identities = 68/191 (35%), Positives = 95/191 (49%), Gaps = 16/191 (8%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSLIGFC 338
           +G GGFG VY      +   VAIK ++ E     LE    EI +L +L H ++V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
            D+  + LV ++   G+L D L   +   L  ++ L I +    GL YLH  +N   IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL-KENEGKLSEDEILRILLQILEGLEYLH--SNG--IIH 115

Query: 399 RDVKTTNILLDEK-WVAKVSDFGLSKFGPTSVSKTHLD--------PEYYR-LQQLTEKS 448
           RD+K  NILLD      K++DFGLSK   +  S             PE        +EKS
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 449 DVYSFGVVLFE 459
           D++S GV+L+E
Sbjct: 176 DIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  137 bits (348), Expect = 7e-37
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 16/196 (8%)

Query: 279 VIGVGGFGDVYKGFINGST-TPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSLIG 336
            +G G FG VY    +  T   VAIK ++ +  +   E    EI +L +L+H ++V L  
Sbjct: 6   KLGEGSFGKVYLA-RDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
              D+ ++ LV ++   G L D L       L  ++           L YLH  +    I
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLH--SKG--I 118

Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD-------PEYYRLQQLTEKSD 449
           +HRD+K  NILLDE    K++DFGL++        T          PE    +   +  D
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVD 178

Query: 450 VYSFGVVLFEVLCARP 465
           ++S GV+L+E+L  +P
Sbjct: 179 IWSLGVILYELLTGKP 194

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  135 bits (341), Expect = 8e-36
 Identities = 72/198 (36%), Positives = 102/198 (51%), Gaps = 17/198 (8%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ--QGALEFQTEIGMLSQLRHLHLVSLIG 336
            +G G FG VYK    G+   VA+K L+  S+  +     + EI +L +L H ++V LI 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
              D   + LV ++   G L D+L  S   PL  ++  +I +   RGL YLH  +N   I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLH--SNG--I 119

Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQL-TEK 447
           IHRD+K  NILLDE  V K++DFGL+K    S S           + PE          K
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 448 SDVYSFGVVLFEVLCARP 465
            DV+S GV+L+E+L  +P
Sbjct: 180 VDVWSLGVILYELLTGKP 197

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  123 bits (312), Expect = 7e-32
 Identities = 62/195 (31%), Positives = 97/195 (49%), Gaps = 16/195 (8%)

Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
           F+    IG GGFG+VYK     +   VAIK ++ ES++   +   EI +L + +H ++V 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 334 LIG--FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
             G     D+  +++  +F + G+L D L  S N  L  +Q   +C    +GL YLH  +
Sbjct: 62  YYGSYLKKDELWIVM--EFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLH--S 116

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH-------LDPEYYRLQQL 444
           N   IIHRD+K  NILL      K+ DFGLS     + ++         + PE    +  
Sbjct: 117 NG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY 174

Query: 445 TEKSDVYSFGVVLFE 459
             K+D++S G+   E
Sbjct: 175 DYKADIWSLGITAIE 189

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  123 bits (311), Expect = 7e-32
 Identities = 65/190 (34%), Positives = 98/190 (51%), Gaps = 20/190 (10%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FGDV  G   G    VA+K L+ +S   A  F  E  +++ LRH +LV L+G   
Sbjct: 14  IGKGEFGDVMLGDYRGQK--VAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
               + +V ++MA+G+L D+L       +   Q+L   +    G+ YL         +HR
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN----FVHR 126

Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------LDPEYYRLQQLTEKSDV 450
           D+   N+L+ E  VAKVSDFGL+K      S+             PE  R ++ + KSDV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182

Query: 451 YSFGVVLFEV 460
           +SFG++L+E+
Sbjct: 183 WSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  121 bits (306), Expect = 4e-31
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 24/203 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++G G FG VY      +   +A+K   L  +S++     + EI +LS L+H ++V   G
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 337 FC-NDDREMILVY-DFMARGTLPDHLYHSDNPPLPWN--QRLEICIGAARGLHYLHTGAN 392
              ++++  + ++ ++++ G+L   L       LP    ++    I    GL YLH  +N
Sbjct: 67  SERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQI--LEGLAYLH--SN 120

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD----------PEYYRLQ 442
              I+HRD+K  NIL+D   V K++DFG +K      +               PE  R +
Sbjct: 121 G--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178

Query: 443 QLTEKSDVYSFGVVLFEVLCARP 465
           +    +D++S G  + E+   +P
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  114 bits (288), Expect = 1e-28
 Identities = 60/189 (31%), Positives = 95/189 (50%), Gaps = 13/189 (6%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG+V++G        VAIK L+ +      +FQ E+  L +LRH HL+SL   C+
Sbjct: 14  LGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
               + ++ + M +G+L   L   +   LP    +++    A G+ YL     +   IHR
Sbjct: 73  VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE--EQN--SIHR 128

Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLTEKSDVY 451
           D+   NIL+ E  V KV+DFGL++     V  +           PE       + KSDV+
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVW 188

Query: 452 SFGVVLFEV 460
           SFG++L+E+
Sbjct: 189 SFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 2e-27
 Identities = 59/191 (30%), Positives = 99/191 (51%), Gaps = 15/191 (7%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG+V++G  N  TTPVA+K L+P +     +F  E  ++ +LRH  L+ L   C 
Sbjct: 14  LGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +  + +V + M  G+L ++L       L   Q +++    A G+ YL    N+   IHR
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA-QNY---IHR 127

Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N+L+ E  + KV+DFGL++     + +             PE     + + KSDV
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187

Query: 451 YSFGVVLFEVL 461
           +SFG++L E++
Sbjct: 188 WSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 4e-27
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 23/199 (11%)

Query: 279 VIGVGGFGDVYKGFINGS---TTPVAIKRLEPESQQGA-LEFQTEIGMLSQLRHLHLVSL 334
           VIG G FG+V +G +         VAIK L+  S     L+F TE  ++ Q  H +++ L
Sbjct: 11  VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
            G     R ++++ ++M  G+L   L  +D       Q + +  G A G+ YL   +   
Sbjct: 71  EGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYL---SEM- 125

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTHLDPEYYRLQ 442
             +HRD+   NIL++   V KVSDFGLS+             G   +  T   PE    +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTA--PEAIAYR 183

Query: 443 QLTEKSDVYSFGVVLFEVL 461
           + T  SDV+SFG+V++EV+
Sbjct: 184 KFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  110 bits (277), Expect = 4e-27
 Identities = 64/264 (24%), Positives = 109/264 (41%), Gaps = 42/264 (15%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKR-----LEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            IG G FG VY            +K      +  + ++ AL    E+ +L +L H +++ 
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN---EVKILKKLNHPNIIK 63

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHL--YHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
                 +  ++ +V ++   G L   +     +  P P  Q L+  +     L YLH+  
Sbjct: 64  YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-- 121

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSVSKT------HLDPEYYRLQQ 443
               I+HRD+K  NI L    + K+ DFG+SK       ++KT      +L PE  + + 
Sbjct: 122 RK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP 179

Query: 444 LTEKSDVYSFGVVLFEVLCARPSILRTA--AKKQVSLAVWAQQCYQ--NGTIDQI---VD 496
              KSD++S G VL+E LC     L+     +  + L        +   G    I     
Sbjct: 180 YNYKSDIWSLGCVLYE-LCT----LKHPFEGENLLEL------ALKILKGQYPPIPSQYS 228

Query: 497 PFLKAM--SCLNDEGIRRPSMSDV 518
             L+ +  S L  +   RPS++ +
Sbjct: 229 SELRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  110 bits (277), Expect = 5e-27
 Identities = 73/222 (32%), Positives = 111/222 (50%), Gaps = 56/222 (25%)

Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRL----EPESQQGALEFQTEIGMLSQLRHLH 330
           +G G FG VYKG + G     S T VAIK L    EP+ QQ   EF+ E  ++S L+H +
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ---EFRQEAELMSDLQHPN 69

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLY----HSD----------NPPLPWNQRLEI 376
           +V L+G C  ++   ++++++A G L + L     HSD             L  +  L I
Sbjct: 70  IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDP 436
            I  A G+ YL   ++H   +HRD+   N L+ E    K+SDFGLS+   ++        
Sbjct: 130 AIQIAAGMEYL--SSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA-------- 177

Query: 437 EYYRLQ------------------QLTEKSDVYSFGVVLFEV 460
           +YYR+Q                  + T +SD++SFGVVL+E+
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  109 bits (275), Expect = 9e-27
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 25/201 (12%)

Query: 280 IGVGGFGDVYKG---FINGSTTP-VAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           +G G FG V       +  +T   VA+K L    ++    +F+ EI +L  L H ++V  
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 335 IGFCNDD--REMILVYDFMARGTLPDHL-YHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
            G C     R + L+ +++  G+L D+L  H D   L   + L       +G+ YL +  
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--RLLLFSSQICKGMDYLGSQR 129

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTHLD-------PEYYR 440
                IHRD+   NIL++ + + K+SDFGL+K  P        K   +       PE  R
Sbjct: 130 ----YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 441 LQQLTEKSDVYSFGVVLFEVL 461
             + +  SDV+SFGV L+E+ 
Sbjct: 186 TSKFSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 2e-26
 Identities = 64/190 (33%), Positives = 104/190 (54%), Gaps = 15/190 (7%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG+V+ G  NG TT VA+K L+P +      F  E  ++ +LRH  LV L   C+
Sbjct: 14  LGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
           ++  + +V ++M++G+L D L   +   L   Q +++    A G+ YL +  N+   IHR
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES-RNY---IHR 127

Query: 400 DVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEKSDV 450
           D+   NIL+ E  V K++DFGL++      +     +K  +    PE     + T KSDV
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDV 187

Query: 451 YSFGVVLFEV 460
           +SFG++L E+
Sbjct: 188 WSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 2e-26
 Identities = 74/258 (28%), Positives = 121/258 (46%), Gaps = 34/258 (13%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKR----LEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           IG G FGDVYKG + G+T  VA+K     L P+ ++   +F  E  +L Q  H ++V LI
Sbjct: 3   IGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKR---KFLQEAEILKQYDHPNIVKLI 58

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
           G C   + + +V + +  G+L   L    N  L   + L++ + AA G+ YL +      
Sbjct: 59  GVCVQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKN---- 113

Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSK---FGPTSVSK-------THLDPEYYRLQQLT 445
            IHRD+   N L+ E  V K+SDFG+S+    G  +VS            PE     + T
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173

Query: 446 EKSDVYSFGVVLFEVL----CARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKA 501
            +SDV+S+G++L+E         P +     ++++      +  Y+        +   + 
Sbjct: 174 SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI------ESGYRMPAPQLCPEEIYRL 227

Query: 502 M-SCLNDEGIRRPSMSDV 518
           M  C   +   RPS S++
Sbjct: 228 MLQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 5e-25
 Identities = 65/205 (31%), Positives = 94/205 (45%), Gaps = 38/205 (18%)

Query: 280 IGVGGFGDVYKGFI---NGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V KG     +G    VA+K L+ E    G  EF  E  +++QL H  +V LI
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
           G C  +  ++LV +    G L  +L       +P +   E+    A G+ YL +   H V
Sbjct: 63  GVCKGE-PLMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYLES--KHFV 117

Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTHLDPEYYRLQQ----------- 443
             HRD+   N+LL  +  AK+SDFG+S+  G  S        +YYR              
Sbjct: 118 --HRDLAARNVLLVNRHQAKISDFGMSRALGAGS--------DYYRATTAGRWPLKWYAP 167

Query: 444 -------LTEKSDVYSFGVVLFEVL 461
                   + KSDV+S+GV L+E  
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  101 bits (254), Expect = 3e-24
 Identities = 71/242 (29%), Positives = 117/242 (48%), Gaps = 17/242 (7%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           +IG G FG V +G   G    V   + +  +Q     F  E  ++++L H +LV L+G  
Sbjct: 13  IIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRLLGVI 68

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
             +  + +V + M++G L + L       +   Q L+  +  A G+ YL +      ++H
Sbjct: 69  LHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK----LVH 123

Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD-----PEYYRLQQLTEKSDVYSF 453
           RD+   NIL+ E  VAKVSDFGL++ G   V  + L      PE  + ++ + KSDV+S+
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSY 183

Query: 454 GVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAM-SCLNDEGIRR 512
           GV+L+EV     +     + K+V   V  ++ Y+    +         M SC   E  +R
Sbjct: 184 GVLLWEVFSYGRAPYPKMSLKEVKECV--EKGYRMEPPEGCPADVYVLMTSCWETEPKKR 241

Query: 513 PS 514
           PS
Sbjct: 242 PS 243

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 4e-24
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 32/205 (15%)

Query: 279 VIGVGGFGDVYKGFINGST-TPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +IG G FG VYKG +N  T   VAIK++  E   ++       EI +L  L+H ++V  I
Sbjct: 7   LIGRGAFGVVYKG-LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA---RGLHYLHTGAN 392
           G       + ++ ++   G+L   +      P P +    + +      +GL YLH    
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFG--PFPES---LVAVYVYQVLQGLAYLHEQG- 119

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD------------PEYYR 440
              +IHRD+K  NIL  +  V K++DFG++    T ++    D            PE   
Sbjct: 120 ---VIHRDIKAANILTTKDGVVKLADFGVA----TKLNDVSKDDASVVGTPYWMAPEVIE 172

Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
           +   +  SD++S G  + E+L   P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNP 197

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  101 bits (254), Expect = 6e-24
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 32/210 (15%)

Query: 279 VIGVGGFGDVYKG-----FINGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLV 332
            +G G FG V+ G             VA+K L E  S     +F+ E  +L+  +H ++V
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71

Query: 333 SLIGFCNDDREMILVYDFMARGTL--------PD--HLYHSDNPPLPWN--QRLEICIGA 380
              G C +    I+V+++M  G L        PD   L   D+P       Q L+I +  
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVS 430
           A G+ YL   + H V  HRD+ T N L+    V K+ DFG+S+           G T + 
Sbjct: 132 ASGMVYL--ASQHFV--HRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEV 460
              + PE    ++ T +SDV+SFGVVL+E+
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  100 bits (251), Expect = 7e-24
 Identities = 65/193 (33%), Positives = 100/193 (51%), Gaps = 22/193 (11%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL---EFQTEIGMLSQLRHLHLVSLIG 336
           IG G FG V+ G+       VAIK +    ++GA+   +F  E  ++ +L H  LV L G
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
            C +   + LV++FM  G L D+L  +          L +C+    G+ YL +    + +
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEGMAYLES----SNV 121

Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKF----GPTSVSKTHL-----DPEYYRLQQLTEK 447
           IHRD+   N L+ E  V KVSDFG+++F      TS + T        PE +   + + K
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181

Query: 448 SDVYSFGVVLFEV 460
           SDV+SFGV+++EV
Sbjct: 182 SDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER

 Score =  102 bits (256), Expect = 8e-24
 Identities = 43/159 (27%), Positives = 64/159 (40%), Gaps = 20/159 (12%)

Query: 3   DPYLTDARPSALPVNQSIHLTWIRN-YSAPDLVYETARTMGQDREINEKYNLTWEFEVDS 61
           +P+ +    S +  + S+ ++     Y  P  V +TA T       +   N TW+  VD 
Sbjct: 196 EPFFSSPGWSQISTSLSVDISSNNAPYIPPSAVLQTAVTPTNA---SAPLNFTWDL-VDP 251

Query: 62  GFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYAVMIG 121
            F Y++ LHF E Q   T    R F I+I   T         + G +   +Y D+ V + 
Sbjct: 252 NFEYYVYLHFAEIQSLET----REFDIYINGKTVYGDVS-PKYLGTDTGALYLDFPVNVS 306

Query: 122 SKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKV 160
                      L+I L P           +LN LEIFKV
Sbjct: 307 G-------GGLLNISLVPTSGSTL---PPLLNALEIFKV 335

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  100 bits (249), Expect = 1e-23
 Identities = 65/188 (34%), Positives = 105/188 (55%), Gaps = 14/188 (7%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            IG G FGDV  G   G    VA+K ++ ++   A  F  E  +++QLRH +LV L+G  
Sbjct: 13  TIGKGEFGDVMLGDYRG--NKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQLLGVI 68

Query: 339 NDDR-EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
            +++  + +V ++MA+G+L D+L       L  +  L+  +     + YL   AN+   +
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--ANN--FV 124

Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHL-----DPEYYRLQQLTEKSDVYS 452
           HRD+   N+L+ E  VAKVSDFGL+K   ++     L      PE  R ++ + KSDV+S
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 184

Query: 453 FGVVLFEV 460
           FG++L+E+
Sbjct: 185 FGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 97.8 bits (244), Expect = 9e-23
 Identities = 56/196 (28%), Positives = 87/196 (44%), Gaps = 20/196 (10%)

Query: 280 IGVGGFGDVYKG---FINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V +G      G   PVA+K L+ +     + +F  E  ++  L H +L+ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
           G       +++V +    G+L D L          +   +  +  A G+ YL +      
Sbjct: 63  GVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---- 117

Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTHLD-------PEYYRLQQL 444
            IHRD+   NILL      K+ DFGL +  P +    V + HL        PE  R +  
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177

Query: 445 TEKSDVYSFGVVLFEV 460
           +  SDV+ FGV L+E+
Sbjct: 178 SHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 42/213 (19%)

Query: 278 LVIGVGGFGDVYKGFINGST-----TPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHL 331
             +G G FG+V+     G       T V +K L+    +    EF+ E+ M  +L H ++
Sbjct: 11  TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70

Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHL-------YHSDNPPLPWNQRLEICIGAARGL 384
           V L+G C +     ++ ++   G L   L            PPL   Q++ +C   A G+
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 385 HYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL 444
            +L      A  +HRD+   N L+  +   KVS   LSK           + EYY+L+  
Sbjct: 131 DHLSN----ARFVHRDLAARNCLVSSQREVKVSLLSLSK--------DVYNSEYYKLRNA 178

Query: 445 -----------------TEKSDVYSFGVVLFEV 460
                            + KSDV+SFGV+++EV
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 95.9 bits (239), Expect = 5e-22
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 25/205 (12%)

Query: 279 VIGVGGFGDVYKGF----INGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVS 333
           V+G G FG VYKG           PVAIK L  E+  +   E   E  +++ + H H+V 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           L+G C   + + L+   M  G L D++  H DN  +     L  C+  A+G+ YL     
Sbjct: 74  LLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEKR- 129

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH----------LDPEYYRLQ 442
              ++HRD+   N+L+      K++DFGL+K       + H          +  E    +
Sbjct: 130 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR 186

Query: 443 QLTEKSDVYSFGVVLFEVLC--ARP 465
             T KSDV+S+GV ++E++   A+P
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 96.1 bits (240), Expect = 6e-22
 Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 14/197 (7%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH 330
              + N   IG G  G+VYK     +   VAIK++    Q   L    EI ++   +H +
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPN 76

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           +V          E+ +V ++M  G+L D +  +    +   Q   +C    +GL YLH  
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH-- 133

Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQ 442
           + +  +IHRD+K+ NILL +    K++DFG +       SK +        + PE  + +
Sbjct: 134 SQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK 191

Query: 443 QLTEKSDVYSFGVVLFE 459
               K D++S G++  E
Sbjct: 192 DYGPKVDIWSLGIMCIE 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 97.5 bits (241), Expect = 8e-22
 Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 30/210 (14%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---FQTEIGMLSQLRHL-HLVSL 334
            +G G FG+VY          VA+K L  + +  + E   F  EI +L+ L H  ++V L
Sbjct: 7   KLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 335 IGFCNDDREMILVYDFMARGTLPDHL-YHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
             F  D+  + LV +++  G+L D L       PL  ++ L I       L YLH+    
Sbjct: 64  YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG-- 121

Query: 394 AVIIHRDVKTTNILLDEK-WVAKVSDFGLSKFGPTSVSKTH--------------LDPEY 438
             IIHRD+K  NILLD    V K+ DFGL+K  P   S +               + PE 
Sbjct: 122 --IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179

Query: 439 YRLQQL---TEKSDVYSFGVVLFEVLCARP 465
                L   +  SD++S G+ L+E+L   P
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLP 209

Length = 384

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 95.0 bits (236), Expect = 1e-21
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 20/198 (10%)

Query: 279 VIGVGGFGDVYKGFIN---GSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSL 334
           VIG G FG+V++G +         VAIK L+P  +++   +F +E  ++ Q  H +++ L
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
            G     +  +++ ++M  G L  +L   D     + Q + +  G A G+ YL +  N+ 
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY-QLVGMLRGIAAGMKYL-SDMNY- 128

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD-----------PEYYRLQQ 443
             +HRD+   NIL++     KVSDFGLS+        T+             PE    ++
Sbjct: 129 --VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186

Query: 444 LTEKSDVYSFGVVLFEVL 461
            T  SDV+SFG+V++EV+
Sbjct: 187 FTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 95.1 bits (236), Expect = 1e-21
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 34/211 (16%)

Query: 280 IGVGGFGDVYKG-----FINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           +G G FG V+               VA+K L+  S+    +FQ E  +L+ L+H H+V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNP--------------PLPWNQRLEICIGA 380
            G C + R +++V+++M  G L +    S  P               L   Q L I    
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVS 430
           A G+ YL   + H   +HRD+ T N L+ +  V K+ DFG+S+           G T + 
Sbjct: 132 ASGMVYL--ASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187

Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              + PE    ++ T +SD++SFGVVL+E+ 
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 54/190 (28%), Positives = 94/190 (49%), Gaps = 14/190 (7%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL     +   IHR
Sbjct: 73  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN--FIHR 128

Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 188

Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 189 WAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 56/225 (24%)

Query: 280 IGVGGFGDVYK----GFINGST-TPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVS 333
           IG G FG V++    G +     T VA+K L+ E S     +FQ E  ++++  H ++V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYH------------------SDNPPLPWNQRLE 375
           L+G C   + M L++++MA G L + L H                      PLP +   +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 376 ICIGA--ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH 433
           +CI    A G+ YL         +HRD+ T N L+ E  V K++DFGLS+         +
Sbjct: 133 LCIAKQVAAGMAYL--SERK--FVHRDLATRNCLVGENMVVKIADFGLSR-------NIY 181

Query: 434 LDPEYYRLQQ------------------LTEKSDVYSFGVVLFEV 460
              +YY+  +                   T +SDV+++GVVL+E+
Sbjct: 182 S-ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 65/206 (31%), Positives = 96/206 (46%), Gaps = 28/206 (13%)

Query: 279 VIGVGGFGDVYKGFING-----STTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLV 332
            +G G FG+VY+G   G         VA+K L E  S+Q   +F  E  ++S+  H ++V
Sbjct: 13  ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHS----DNP-PLPWNQRLEICIGAARGLHYL 387
            LIG   +     ++ + MA G L   L  +    + P  L     L      A+G  YL
Sbjct: 73  RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132

Query: 388 HTGANHAVIIHRDVKTTNILLDEKW---VAKVSDFGLS----------KFGPTSVSKTHL 434
               NH   IHRD+   N LL  K    VAK++DFG++          K G   +    +
Sbjct: 133 EE--NH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188

Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEV 460
            PE +     T K+DV+SFGV+L+E+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 91.7 bits (228), Expect = 9e-21
 Identities = 64/193 (33%), Positives = 97/193 (50%), Gaps = 22/193 (11%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL---EFQTEIGMLSQLRHLHLVSLIG 336
           +G G FG V+ G   G    VAIK +    ++GA+   +F  E  ++ +L H +LV L G
Sbjct: 12  LGSGQFGVVHLGKWRGKID-VAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
            C   R + +V ++MA G L ++L       L     L++C      + YL +       
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCEAMEYLES----NGF 121

Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKF----GPTSVSKTHL-----DPEYYRLQQLTEK 447
           IHRD+   N L+ E  V KVSDFGL+++      TS   T        PE +   + + K
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181

Query: 448 SDVYSFGVVLFEV 460
           SDV+SFGV+++EV
Sbjct: 182 SDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 91.2 bits (226), Expect = 3e-20
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 33/211 (15%)

Query: 280 IGVGGFGDVYKG-FINGSTTP----VAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           +G G FG V+     N S T     VA+K L+  +     +FQ E  +L+ L+H H+V  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 335 IGFCNDDREMILVYDFMARGTL--------PDHLYHSDNPPLPWN------QRLEICIGA 380
            G C D   +I+V+++M  G L        PD +   D  P          Q L I    
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVS 430
           A G+ YL   + H   +HRD+ T N L+    + K+ DFG+S+           G T + 
Sbjct: 133 ASGMVYL--ASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188

Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              + PE    ++ T +SDV+SFGV+L+E+ 
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIF 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 90.1 bits (223), Expect = 4e-20
 Identities = 70/255 (27%), Positives = 122/255 (47%), Gaps = 27/255 (10%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           ++G G FG+V+KG +    TPVA+K  + +  Q+  ++F +E  +L Q  H ++V LIG 
Sbjct: 2   LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
           C   + + +V + +  G     L    +  L   Q ++  + AA G+ YL +       I
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYLESKN----CI 115

Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSK---------FGPTSVSKTHLDPEYYRLQQLTEKS 448
           HRD+   N L+ E  V K+SDFG+S+          G   +      PE     + + +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 449 DVYSFGVVLFEV----LCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS- 503
           DV+S+G++L+E     +C  P +    A++QV      ++ Y+     +  D   K M  
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQV------EKGYRMSCPQKCPDDVYKVMQR 229

Query: 504 CLNDEGIRRPSMSDV 518
           C + +   RP  S++
Sbjct: 230 CWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 90.3 bits (224), Expect = 4e-20
 Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 22/200 (11%)

Query: 279 VIGVGGFGDVYKG---FINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSL 334
           VIG G FG+V +G           VAIK L+   +++   +F +E  ++ Q  H +++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
            G     R ++++ +FM  G L   L  +D       Q + +  G A G+ YL    +  
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQ-FTVIQLVGMLRGIAAGMKYL----SEM 125

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKF------GPTSVSKTH-------LDPEYYRL 441
             +HRD+   NIL++   V KVSDFGLS+F       PT  S            PE    
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 442 QQLTEKSDVYSFGVVLFEVL 461
           ++ T  SDV+S+G+V++EV+
Sbjct: 186 RKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 89.7 bits (223), Expect = 9e-20
 Identities = 59/232 (25%), Positives = 102/232 (43%), Gaps = 58/232 (25%)

Query: 280 IGVGGFGDVY----------------KGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGM 322
           +G G FG+V+                +     +   VA+K L P++   A  +F  E+ +
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 323 LSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHS---------DNPPLPWNQR 373
           LS+L   ++  L+G C  D  + ++ ++M  G L   L            ++  L ++  
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 374 LEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH 433
           L +    A G+ YL +  N    +HRD+ T N L+ + +  K++DFG+S+   +S     
Sbjct: 133 LYMATQIASGMRYLES-LN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD---- 184

Query: 434 LDPEYYRLQ------------------QLTEKSDVYSFGVVLFEV--LCARP 465
               YYR+Q                  + T KSDV++FGV L+E+  LC   
Sbjct: 185 ----YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 89.7 bits (222), Expect = 9e-20
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 30/208 (14%)

Query: 280 IGVGGFGDV-----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           +G G FG V     Y          VA+K L+  S     +F  E  +L+ L+H H+V  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 335 IGFCNDDREMILVYDFMARGTL--------PDHLYHSD-NPP--LPWNQRLEICIGAARG 383
            G C +   +I+V+++M  G L        PD +  ++ N P  L  +Q L I    A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTH 433
           + YL   + H   +HRD+ T N L+ E  + K+ DFG+S+           G T +    
Sbjct: 133 MVYL--ASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188

Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           + PE    ++ T +SDV+S GVVL+E+ 
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 72/254 (28%), Positives = 117/254 (46%), Gaps = 25/254 (9%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKR----LEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           IG G FG+V+ G +    TPVA+K     L P+ +    +F  E  +L Q  H ++V LI
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA---KFLQEARILKQYSHPNIVRLI 59

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
           G C   + + +V + +  G     L  ++ P L   + +++   AA G+ YL +   H  
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLES--KHC- 115

Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRLQQLT 445
            IHRD+   N L+ EK V K+SDFG+S+           G   +      PE     + +
Sbjct: 116 -IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174

Query: 446 EKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAM-SC 504
            +SDV+SFG++L+E            + +Q   A+  +Q  +    +   D   + M  C
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI--EQGVRLPCPELCPDAVYRLMERC 232

Query: 505 LNDEGIRRPSMSDV 518
              +  +RPS S V
Sbjct: 233 WEYDPGQRPSFSTV 246

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 88.4 bits (219), Expect = 1e-19
 Identities = 64/190 (33%), Positives = 95/190 (50%), Gaps = 16/190 (8%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG V  G   G    VAIK ++ E      EF  E  ++ +L H  LV L G C 
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-VAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
             R + +V ++M+ G L ++L        P +Q LE+C     G+ YL +       IHR
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQP-SQLLEMCKDVCEGMAYLESKQ----FIHR 124

Query: 400 DVKTTNILLDEKWVAKVSDFGLSKF----GPTSVSKTHLD-----PEYYRLQQLTEKSDV 450
           D+   N L+D++   KVSDFGLS++      TS   +        PE     + + KSDV
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184

Query: 451 YSFGVVLFEV 460
           ++FGV+++EV
Sbjct: 185 WAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 88.8 bits (220), Expect = 1e-19
 Identities = 61/192 (31%), Positives = 99/192 (51%), Gaps = 18/192 (9%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG+V+ G+ NG  T VAIK L+  S      F  E  ++ QL+H  LV L     
Sbjct: 14  LGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 340 DDREMI-LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
             +E I ++ ++M  G+L D L   +   L  N+ +++    A G+ ++    N+   IH
Sbjct: 72  --QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER-KNY---IH 125

Query: 399 RDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEKSD 449
           RD++  NIL+ E    K++DFGL++      +     +K  +    PE       T KSD
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185

Query: 450 VYSFGVVLFEVL 461
           V+SFG++L E++
Sbjct: 186 VWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 65/194 (33%), Positives = 105/194 (54%), Gaps = 16/194 (8%)

Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           D+ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L  
Sbjct: 11  DVKLGQGCFGEVWMGTWNG-TTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYA 68

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V +FM +G+L D L   D   L   Q +++    A G+ Y+    N+   
Sbjct: 69  VVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER-MNY--- 123

Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           IHRD++  NIL+ +  V K++DFGL++      +     +K  +    PE     + T K
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 448 SDVYSFGVVLFEVL 461
           SDV+SFG++L E++
Sbjct: 184 SDVWSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 56/191 (29%), Positives = 100/191 (52%), Gaps = 15/191 (7%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG+V+ G+ N ST  VA+K L+P +      F  E  ++  L+H  LV L     
Sbjct: 14  LGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +  + ++ ++MA+G+L D L   +   +   + ++     A G+ Y+    N+   IHR
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER-KNY---IHR 127

Query: 400 DVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEKSDV 450
           D++  N+L+ E  + K++DFGL++      +     +K  +    PE       T KSDV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187

Query: 451 YSFGVVLFEVL 461
           +SFG++L+E++
Sbjct: 188 WSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 87.6 bits (217), Expect = 3e-19
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 15/200 (7%)

Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL--EFQTEIGMLSQLRHLH 330
           +F+    IG G FG V+K          A+K+++          E   E  +L++L   +
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           ++       D  ++ +V ++   G L   L      PLP +Q     I    GL +LH+ 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV-SKTHLDPEYYRLQQL---- 444
                I+HRD+K+ N+ LD     K+ D G++K     +  + T +   YY   +L    
Sbjct: 121 K----ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176

Query: 445 --TEKSDVYSFGVVLFEVLC 462
              EKSDV++ GVVL+E  C
Sbjct: 177 PYNEKSDVWALGVVLYE-CC 195

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 16/196 (8%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEF-QTEIGMLSQLRHLHLVSLIGF 337
            IG G FG+VYK     +   VAIK ++ E  +  +E  Q EI  LSQ R  ++    G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
                ++ ++ ++   G+  D L       L       I      GL YLH        I
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGK----I 120

Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLTEKSD 449
           HRD+K  NILL E+   K++DFG+S    +++SK +        + PE  +     EK+D
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKAD 180

Query: 450 VYSFGVVLFEVLCARP 465
           ++S G+   E+    P
Sbjct: 181 IWSLGITAIELAKGEP 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 25/201 (12%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHLHLVSLIGF 337
           IG G +G VYK     +   VAIK+++   +   +      EI +L +L H +++ L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 338 CNDDREMILVYDFMARGTLPDH-LYH---SDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
                ++ LV++FM      D  LY         LP +          +GL + H+    
Sbjct: 67  FRHKGDLYLVFEFM------DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---- 116

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQL------- 444
             I+HRD+K  N+L++ + V K++DFGL++ FG      TH +   +YR  +L       
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY 176

Query: 445 TEKSDVYSFGVVLFEVLCARP 465
           +   D++S G +  E+L  RP
Sbjct: 177 STPVDIWSVGCIFAELLSRRP 197

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 87.4 bits (216), Expect = 6e-19
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 29/208 (13%)

Query: 279 VIGVGGFGDVYKGFI--NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL-RHLHLVSL 334
           VIG G FG V +  I  +G     AIK L E  S+    +F  E+ +L +L  H ++++L
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLY--------------HSDNPPLPWNQRLEICIGA 380
           +G C +   + +  ++   G L D L               H     L   Q L+     
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--HLDPEY 438
           A G+ YL    +    IHRD+   N+L+ E   +K++DFGLS+     V KT   L   +
Sbjct: 129 ATGMQYL----SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRW 184

Query: 439 YRLQQL-----TEKSDVYSFGVVLFEVL 461
             ++ L     T KSDV+SFGV+L+E++
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 7e-19
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 30/212 (14%)

Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G   G       T VAIK + E  S +  +EF  E  ++ +    H+V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHL-------YHSDNPPLPWNQR-LEICIGAARGLH 385
           L+G  +  +  ++V + MA+G L  +L        ++     P  Q+ +++    A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL   A     +HRD+   N ++ E    K+ DFG++          K G   +    + 
Sbjct: 134 YLA--AKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEV--LCARP 465
           PE  +    T KSDV+SFGVVL+E+  L  +P
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 86.2 bits (214), Expect = 8e-19
 Identities = 62/263 (23%), Positives = 102/263 (38%), Gaps = 38/263 (14%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G FG VY      +   +A+K  R++    +   E   E+ +L  L+H +LV   G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-----ARGLHYLHTGAN 392
                ++ +  ++ + GTL + L H            E  I         GL YLH+   
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLEHGRILD-------EHVIRVYTLQLLEGLAYLHS--- 117

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSK------------FGPTSVSKTHLDPEYYR 440
              I+HRD+K  NI LD   V K+ DFG +                 + +  ++ PE   
Sbjct: 118 -HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 441 LQQLTEK---SDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVD- 496
             +       +D++S G V+ E+   +        + Q+   V A          Q+   
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPE 236

Query: 497 --PFLKAMSCLNDEGIRRPSMSD 517
              FL    CL  +  +RP+ S+
Sbjct: 237 GKDFLD--RCLESDPKKRPTASE 257

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 86.0 bits (213), Expect = 8e-19
 Identities = 69/260 (26%), Positives = 121/260 (46%), Gaps = 34/260 (13%)

Query: 279 VIGVGGFGD--VYKGFINGSTT---PVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
           V+G G FG+  +Y+   + S      V + RL  + ++ AL    EI +LS L+H ++++
Sbjct: 7   VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL---NEIVILSLLQHPNIIA 63

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
                 DD  +++  ++   GTL D +             L         + Y+H     
Sbjct: 64  YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---- 119

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSVSKT------HLDPEYYRLQQLT 445
           A I+HRD+KT NI L +  + K+ DFG+SK      S+++T      ++ PE  +  +  
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYN 179

Query: 446 EKSDVYSFGVVLFEVLCARPSILRT-AAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAM-- 502
            KSD+++ G VL+E+L  +    RT  A   ++L V   Q   N T   +V  +   +  
Sbjct: 180 FKSDIWALGCVLYELLTLK----RTFDATNPLNLVVKIVQG--NYTP--VVSVYSSELIS 231

Query: 503 ---SCLNDEGIRRPSMSDVV 519
              S L  +  +RP+  +V+
Sbjct: 232 LVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 68/208 (32%), Positives = 101/208 (48%), Gaps = 29/208 (13%)

Query: 279 VIGVGGFGDVYKGFI--NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL-RHLHLVSL 334
           VIG G FG V K  I  +G     AIKR+ E  S+    +F  E+ +L +L  H ++++L
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLY--------------HSDNPPLPWNQRLEICIGA 380
           +G C     + L  ++   G L D L               +S    L   Q L      
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--HLDPEY 438
           ARG+ YL    +    IHRD+   NIL+ E +VAK++DFGLS+     V KT   L   +
Sbjct: 134 ARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 189

Query: 439 YRLQQL-----TEKSDVYSFGVVLFEVL 461
             ++ L     T  SDV+S+GV+L+E++
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 86.1 bits (213), Expect = 1e-18
 Identities = 70/213 (32%), Positives = 104/213 (48%), Gaps = 49/213 (23%)

Query: 279 VIGVGGFGDV----YKGFINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVS 333
           V+G G FG V    Y    +G+   VA+K L+ E  QQ    ++ EI +L  L H ++V 
Sbjct: 11  VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 334 LIGFCND--DREMILVYDFMARGTLPDHL-YHSDNPPLPWNQRL----EICIGAARGLHY 386
             G C++   + + L+ +++  G+L D+L  H     L   Q L    +IC     G+ Y
Sbjct: 71  YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQIC----EGMAY 122

Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ--- 443
           LH  + H   IHRD+   N+LLD   + K+ DFGL+K  P          EYYR+++   
Sbjct: 123 LH--SQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG-------HEYYRVREDGD 171

Query: 444 ----------LTE-----KSDVYSFGVVLFEVL 461
                     L E      SDV+SFGV L+E+L
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 46/210 (21%)

Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+  + +   +F+ EI +L  L+H ++V   
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 336 GFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL-----EICIGAARGLHYLH 388
           G C     R + LV +++  G+L D+L    +     +++L     +IC    +G+ YL 
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQIC----KGMEYLG 125

Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ----- 443
           +       +HRD+ T NIL++ +   K+ DFGL+K  P        D EYY++++     
Sbjct: 126 SKR----YVHRDLATRNILVESENRVKIGDFGLTKVLP-------QDKEYYKVREPGESP 174

Query: 444 --------LTE-----KSDVYSFGVVLFEV 460
                   LTE      SDV+SFGVVL+E+
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 61/193 (31%), Positives = 94/193 (48%), Gaps = 22/193 (11%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL---EFQTEIGMLSQLRHLHLVSLIG 336
           +G G FG V+ G    +   VAIK +     +GA+   +F  E  ++ +L H  LV L G
Sbjct: 12  LGSGQFGVVHLGKWR-AQIKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
            C   + + +V +FM  G L ++L       L  +  L +C     G+ YL   +     
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLERNS----F 121

Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKF----GPTSVSKTHL-----DPEYYRLQQLTEK 447
           IHRD+   N L+    V KVSDFG++++      TS S          PE +   + + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181

Query: 448 SDVYSFGVVLFEV 460
           SDV+SFGV+++EV
Sbjct: 182 SDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 59/191 (30%), Positives = 102/191 (53%), Gaps = 16/191 (8%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG+V+ G  NG  T VA+K L+P +      F  E  ++ +LRH  LV L    +
Sbjct: 14  LGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
           +   + +V ++M++G+L D L   +   L     +++    A G+ Y+    N+   IHR
Sbjct: 72  E-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER-MNY---IHR 126

Query: 400 DVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEKSDV 450
           D+++ NIL+ +  V K++DFGL++      +     +K  +    PE     + T KSDV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 451 YSFGVVLFEVL 461
           +SFG++L E++
Sbjct: 187 WSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 52/152 (34%), Positives = 76/152 (50%), Gaps = 5/152 (3%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G +GDVYK     +   VAIK ++ E        Q EI ML + RH ++V+  G   
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              ++ +V ++   G+L D +Y     PL   Q   +C    +GL YLH        IHR
Sbjct: 71  RRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLH----ETGKIHR 125

Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSK 431
           D+K  NILL E    K++DFG+S     +++K
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAK 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 18/198 (9%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHLHLVSLIGF 337
           IG G  G V+K     +   VA+K++     +G +  Q   EI  L   +H ++V L+  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
                  +LV ++M    L + L   + P LP  Q         +G+ Y+H       I+
Sbjct: 68  FPHGSGFVLVMEYMPS-DLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMH-ANG---IM 121

Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSK--FGPTSVSKTH-------LDPE-YYRLQQLTEK 447
           HRD+K  N+L+    V K++DFGL++          +H         PE  Y  ++    
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181

Query: 448 SDVYSFGVVLFEVLCARP 465
            D+++ G +  E+L   P
Sbjct: 182 VDLWAVGCIFAELLNGSP 199

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 15/200 (7%)

Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
           FD    +G G +G VYK     +   VAIK +  E      E   EI +L Q    ++V 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
             G    + ++ +V ++   G++ D +    N  L   +   I     +GL YLH  +N 
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEEEIAAILYQTLKGLEYLH--SNK 119

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLT 445
              IHRD+K  NILL+E+  AK++DFG+S     +++K +        + PE  +     
Sbjct: 120 --KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177

Query: 446 EKSDVYSFGVVLFEVLCARP 465
            K+D++S G+   E+   +P
Sbjct: 178 NKADIWSLGITAIEMAEGKP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 83.4 bits (206), Expect = 7e-18
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 14/199 (7%)

Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLH 330
            ++   V+G G FG V+          V IK++  E  ++   L  Q E  +L  L H +
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           ++       +D+ +++V ++   GTL +++    N  L  +  L   +     LH++HT 
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT- 119

Query: 391 ANHAVIIHRDVKTTNILLDE-KWVAKVSDFGLSK-FGPTSVSKT------HLDPEYYRLQ 442
               +I+HRD+KT NILLD+ K V K+ DFG+SK     S + T      ++ PE    +
Sbjct: 120 ---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGK 176

Query: 443 QLTEKSDVYSFGVVLFEVL 461
              +KSD+++ G VL+E+ 
Sbjct: 177 PYNQKSDIWALGCVLYELA 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 83.6 bits (206), Expect = 8e-18
 Identities = 63/190 (33%), Positives = 102/190 (53%), Gaps = 16/190 (8%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L    +
Sbjct: 14  LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
           ++  + +V ++M++G+L D L       L   Q +++    A G+ Y+    N+   +HR
Sbjct: 72  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-MNY---VHR 126

Query: 400 DVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEKSDV 450
           D++  NIL+ E  V KV+DFGL++      +     +K  +    PE     + T KSDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 451 YSFGVVLFEV 460
           +SFG++L E+
Sbjct: 187 WSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 83.0 bits (206), Expect = 1e-17
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 30/201 (14%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRL---EPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           V+G G  G VYK     +    A+K++     E  +  L    E+  L      ++V   
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL--RELKTLRSCESPYVVKCY 65

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
           G    + E+ +V ++M  G+L D L       +P      I     +GL YLHT  +   
Sbjct: 66  GAFYKEGEISIVLEYMDGGSLADLLK--KVGKIPEPVLAYIARQILKGLDYLHTKRH--- 120

Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH-------------LDPEYYRLQ 442
           IIHRD+K +N+L++ K   K++DFG+SK    ++ + +             +  E Y   
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY--- 177

Query: 443 QLTEKSDVYSFGVVLFEVLCA 463
             +  +D++S G+ L E  CA
Sbjct: 178 --SYAADIWSLGLTLLE--CA 194

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 83.6 bits (206), Expect = 1e-17
 Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 27/201 (13%)

Query: 279 VIGVGGFGDVYKGFI--NGSTT--PVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           V+G G FG VYKG     G T   PVAIK L E    +  +EF  E  +++ + H HLV 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           L+G C     + LV   M  G L D+++ H DN  +     L  C+  A+G+ YL     
Sbjct: 74  LLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIAKGMMYLE---- 126

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTHLDPEYYR 440
              ++HRD+   N+L+      K++DFGL++             G   +    L+  +YR
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186

Query: 441 LQQLTEKSDVYSFGVVLFEVL 461
             + T +SDV+S+GV ++E++
Sbjct: 187 --KFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 82.2 bits (204), Expect = 2e-17
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 23/200 (11%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEF-QTEIGMLSQLRHLHLVSLI- 335
           +G G FG V       +    A+K L+ +   ++  +E   TE  +LS++ H  +V L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL--EICIGAARGLHYLHTGANH 393
            F   + ++ LV ++   G L  HL           +    EI +     L YLH   + 
Sbjct: 61  AF-QTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----LEYLH---SL 112

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLT 445
             II+RD+K  NILLD     K++DFGL+K   +  S+T+        L PE    +   
Sbjct: 113 G-IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYG 171

Query: 446 EKSDVYSFGVVLFEVLCARP 465
           +  D +S GV+L+E+L  +P
Sbjct: 172 KAVDWWSLGVLLYEMLTGKP 191

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 46/212 (21%)

Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G +   +G     A+K L   +    +E F  E  ++    H +++SL
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 335 IGFCNDDREMILV-YDFMARGTLPDHLYHSDNPPLPWNQRLEICIG----AARGLHYLHT 389
           +G C       LV   +M  G L + +    + P      ++  IG     A+G+ YL  
Sbjct: 62  LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP-----TVKDLIGFGLQVAKGMEYL-- 114

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRL-------- 441
            A+    +HRD+   N +LDE +  KV+DFGL        ++   D EYY +        
Sbjct: 115 -ASKK-FVHRDLAARNCMLDESFTVKVADFGL--------ARDIYDKEYYSVHNHTGAKL 164

Query: 442 ------------QQLTEKSDVYSFGVVLFEVL 461
                       Q+ T KSDV+SFGV+L+E++
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 31/214 (14%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLE------PESQQGALEFQTEIGMLS 324
             NF  +  IG G F  VYK         VA+K+++       +++Q  L+   EI +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLK 57

Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYH--SDNPPLP----WNQRLEICI 378
           QL H +++  +    ++ E+ +V +    G L   + H       +P    W   +++C 
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC- 116

Query: 379 GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH----- 433
                L ++H+      I+HRD+K  N+ +    V K+ D GL +F  +  +  H     
Sbjct: 117 ---SALEHMHSKR----IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 169

Query: 434 ---LDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
              + PE         KSD++S G +L+E+   +
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 81.7 bits (201), Expect = 4e-17
 Identities = 68/249 (27%), Positives = 114/249 (45%), Gaps = 18/249 (7%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSLIGFC 338
           IG G FG+V+KG  N +   VAIK ++ E  +  +E  Q EI +LSQ    ++    G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
             D ++ ++ +++  G+  D L   +  PL   Q   I     +GL YLH+       IH
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK----IH 124

Query: 399 RDVKTTNILLDEKWVAKVSDFGLS-KFGPTSVSKTH-------LDPEYYRLQQLTEKSDV 450
           RD+K  N+LL E    K++DFG++ +   T + +         + PE  +      K+D+
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 184

Query: 451 YSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGI 510
           +S G+   E+    P        K + L          G   + +  F++A  CLN E  
Sbjct: 185 WSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA--CLNKEPS 242

Query: 511 RRPSMSDVV 519
            RP+  +++
Sbjct: 243 FRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 73/243 (30%), Positives = 102/243 (41%), Gaps = 32/243 (13%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKR------LEPESQQGALEFQTEIGMLSQLRHLHLV 332
           VIG G FG V       +    A+K       +E  S +  L    E  +L +L H  LV
Sbjct: 7   VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN---ERRILQELNHPFLV 63

Query: 333 SL-IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ-RLEIC-IGAARGLHYLHT 389
           +L   F  D+  M LV D +  G L  HL  S        Q +  IC I  A  L YLH+
Sbjct: 64  NLWYSFQ-DEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICEIVLA--LEYLHS 118

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS-KFGP----TSVSKT--HLDPEYYRLQ 442
                 IIHRD+K  NILLDE+    ++DF ++ K  P    TS S T  ++ PE    Q
Sbjct: 119 KG----IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQ 174

Query: 443 QLTEKSDVYSFGVVLFEVLCAR---PSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL 499
             +   D +S GV  +E L  +       RT   +  +    A   Y      + +D  +
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAID-AI 233

Query: 500 KAM 502
             +
Sbjct: 234 NKL 236

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 81.4 bits (202), Expect = 4e-17
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 27/202 (13%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHLHLVSLIGF 337
           +G G +G VYK     +   VA+K++  ++++  +      EI +L +L+H ++V L+  
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 338 CNDDREMILVYDFMARGTLPD--HLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
            + +R++ LV+++       D          PL  N    I     RGL Y H  ++   
Sbjct: 67  IHTERKLYLVFEYCDM----DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH--SHR-- 118

Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH----LDPEYYR----LQQLTE 446
           I+HRD+K  NIL++   V K++DFGL++ FG    + TH    L   +YR    L     
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTL---WYRAPEILLGSKH 175

Query: 447 KS---DVYSFGVVLFEVLCARP 465
            S   D++S G +  E++  +P
Sbjct: 176 YSTAVDIWSVGCIFAEMITGKP 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 81.1 bits (201), Expect = 5e-17
 Identities = 66/276 (23%), Positives = 111/276 (40%), Gaps = 61/276 (22%)

Query: 279 VIGVGGFGDVYK------GFINGSTTPVAIKRL------EPESQQGALEFQTEIGMLSQL 326
            IG G FG V K      G I      +  K +      E E QQ      +E+ +L +L
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKI------LVWKEIDYGNMTEKEKQQ----LVSEVNILREL 56

Query: 327 RHLHLVSLIGFCNDDRE-------MILVYDFMARGTLPDHL--YHSDNPPLPWNQRLEIC 377
           +H ++V        DR        + +V ++   G L   +     +   +       I 
Sbjct: 57  KHPNIVRYY-----DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL 111

Query: 378 IGAARGLHYLHTGANHA-VIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSVSKTHL 434
                 L+  H  ++    ++HRD+K  NI LD     K+ DFGL+K     +S +KT++
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV 171

Query: 435 DPEYY------RLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN 488
              YY            EKSD++S G +++E LCA        A+ Q+ L        + 
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYE-LCALSPPFT--ARNQLQL----ASKIKE 224

Query: 489 GTIDQIVDPF-------LKAMSCLNDEGIRRPSMSD 517
           G   +I   +       +K+M  ++ +  +RPS  +
Sbjct: 225 GKFRRIPYRYSSELNEVIKSMLNVDPD--KRPSTEE 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 55/196 (28%), Positives = 84/196 (42%), Gaps = 19/196 (9%)

Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSL 334
            IG G FGDVY+G           VA+K  +  +     E F  E  ++ Q  H H+V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           IG   ++  + +V +    G L  +L  +    L     +      +  L YL       
Sbjct: 73  IGVITEN-PVWIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALAYLE-SKR-- 127

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTHL-----DPEYYRLQQLT 445
             +HRD+   N+L+      K+ DFGLS++         SK  L      PE    ++ T
Sbjct: 128 -FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186

Query: 446 EKSDVYSFGVVLFEVL 461
             SDV+ FGV ++E+L
Sbjct: 187 SASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 80.8 bits (199), Expect = 6e-17
 Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 46/240 (19%)

Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G   G       T VAIK + E  S +  +EF  E  ++ +    H+V 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYH-----SDNP---PLPWNQRLEICIGAARGLH 385
           L+G  +  +  +++ + M RG L  +L        +NP   P    + +++    A G+ 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HRD+   N ++ E +  K+ DFG++          K G   +    + 
Sbjct: 134 YL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189

Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV 495
           PE  +    T  SDV+SFGVVL+E+                  A  A+Q YQ  + +Q++
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEI------------------ATLAEQPYQGMSNEQVL 231

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 80.7 bits (199), Expect = 7e-17
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 31/211 (14%)

Query: 278 LVIGVGGFGDVYKGF---INGSTT---PVAIKRLEPES-QQGALEFQTEIGMLSQLRHLH 330
             +G G FG+VY+G    I G  +    VA+K L   +  Q   EF  E  ++S   H +
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSD-----NPPLPWNQRLEICIGAARGLH 385
           +V L+G C  +    ++ + M  G L  +L  +       P L   + L+IC+  A+G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKW-----VAKVSDFGLS----------KFGPTSVS 430
           YL         IHRD+   N L+ EK      V K+ DFGL+          K G   + 
Sbjct: 121 YLE----QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              + PE     + T +SDV+SFGV+++E+L
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 20/200 (10%)

Query: 277 DLVIGVGGFGDVYKGFI---NGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLV 332
           + VIG G FG+V  G +        PVAIK L+   +++   +F +E  ++ Q  H +++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            L G     + +++V ++M  G+L   L   D       Q + +  G A G+ YL     
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-FTVIQLVGMLRGIASGMKYLSDMG- 126

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTH--------LDPEYYRL 441
               +HRD+   NIL++   V KVSDFGLS+     P +   T           PE    
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 442 QQLTEKSDVYSFGVVLFEVL 461
           ++ T  SDV+S+G+V++EV+
Sbjct: 184 RKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 50/220 (22%)

Query: 280 IGVGGFGDVYKG--FING--STTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSL 334
           +G   FG +YKG  ++ G      VAIK L+   + Q   EFQ E  ++++L H ++V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLY----HSD-----------NPPLPWNQRLEICIG 379
           +G    ++ + ++++++ +G L + L     HSD              L     L I I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYY 439
            A G+ YL   ++H   +H+D+   NIL+ E+   K+SD GLS+   ++        +YY
Sbjct: 133 IAAGMEYL---SSH-FFVHKDLAARNILIGEQLHVKISDLGLSREIYSA--------DYY 180

Query: 440 RLQ------------------QLTEKSDVYSFGVVLFEVL 461
           R+Q                  + +  SD++SFGVVL+E+ 
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 68/208 (32%), Positives = 101/208 (48%), Gaps = 29/208 (13%)

Query: 279 VIGVGGFGDVYKGFI--NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL-RHLHLVSL 334
           VIG G FG V K  I  +G     AIKR+ E  S+    +F  E+ +L +L  H ++++L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLY--------------HSDNPPLPWNQRLEICIGA 380
           +G C     + L  ++   G L D L               +S    L   Q L      
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--HLDPEY 438
           ARG+ YL    +    IHRD+   NIL+ E +VAK++DFGLS+     V KT   L   +
Sbjct: 122 ARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177

Query: 439 YRLQQL-----TEKSDVYSFGVVLFEVL 461
             ++ L     T  SDV+S+GV+L+E++
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 45/216 (20%)

Query: 279 VIGVGGFGDVYKGFIN---GSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
           ++G G FG V +G ++   GS   VA+K  +L+  +     EF +E   +    H +++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 334 LIGFCNDDREM------ILVYDFMARGTLPDHLYHS---DNPP-LPWNQRLEICIGAARG 383
           LIG C +   +      +++  FM  G L   L +S     P  LP    L+  +  A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYR--- 440
           + YL         IHRD+   N +L E     V+DFGL        SK     +YYR   
Sbjct: 126 MEYLSNRN----FIHRDLAARNCMLREDMTVCVADFGL--------SKKIYSGDYYRQGR 173

Query: 441 ----------LQQL-----TEKSDVYSFGVVLFEVL 461
                     ++ L     T KSDV++FGV ++E+ 
Sbjct: 174 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 209

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKR-LEPESQQGALEFQT-EIGMLSQLRHL 329
             ++N  ++G G +G V K     +   VAIK+ LE E  +   +    EI ML QLRH 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           +LV+LI      + + LV++F+   T+ D L    N  L  ++  +      RG+ + H 
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCH- 117

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSVSKTHLDPEYYRLQQLTEK 447
             +H  IIHRD+K  NIL+ +  V K+ DFG ++    P  V   ++   +YR  +L   
Sbjct: 118 --SHN-IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG 174

Query: 448 S-------DVYSFGVVLFEVLCARP 465
                   D+++ G ++ E+L   P
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGEP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 79.3 bits (195), Expect = 4e-16
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 23/204 (11%)

Query: 274 FDNDLVIGVGGFGDVYKGFIN----GSTTPVAIKRL-EPESQQGALEFQTEIGMLSQLRH 328
           F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYL 387
            H+  L+G C     + L+   M  G L D++  H DN    +   L  C+  A+G++YL
Sbjct: 69  PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYL 125

Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDP-----EYYRLQ 442
                   ++HRD+   N+L+      K++DFGL+K       + H +      ++  L+
Sbjct: 126 E----ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181

Query: 443 QL-----TEKSDVYSFGVVLFEVL 461
            +     T +SDV+S+GV ++E++
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 61/195 (31%), Positives = 93/195 (47%), Gaps = 22/195 (11%)

Query: 280 IGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGAL--EFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V KG   +  S   VA+K L+ ++   AL  E   E  ++ QL + ++V +I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
           G C  +  M LV +    G  P + +   N  +      E+    + G+ YL        
Sbjct: 63  GICEAESWM-LVMELAELG--PLNKFLQKNKHVTEKNITELVHQVSMGMKYLE----ETN 115

Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTH-------LDPEYYRLQQL 444
            +HRD+   N+LL  +  AK+SDFGLSK          +KTH         PE     + 
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175

Query: 445 TEKSDVYSFGVVLFE 459
           + KSDV+SFGV+++E
Sbjct: 176 SSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 78.5 bits (193), Expect = 6e-16
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 42/223 (18%)

Query: 277 DLVIGVGGFGDVYKGF---ING--STTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLH 330
              +G G FG V K     + G    T VA+K L+  +    L +  +E  +L Q+ H H
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64

Query: 331 LVSLIGFCNDDREMILVYDFMARGTL----------------------PDHLYHSDNPPL 368
           ++ L G C+ D  ++L+ ++   G+L                        +L + D   L
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 369 PWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK--FGP 426
                +      +RG+ YL        ++HRD+   N+L+ E    K+SDFGLS+  +  
Sbjct: 125 TMGDLISFAWQISRGMQYL----AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 427 TSVSKTHLD--------PEYYRLQQLTEKSDVYSFGVVLFEVL 461
            S  K             E       T +SDV+SFGV+L+E++
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.5 bits (191), Expect = 7e-16
 Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 26/212 (12%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLE--PESQQGALEFQT---EIGMLSQL 326
            N+    ++G G FG VY  +   +   +A+K++   P+S +   E      EI +L  L
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL--YHSDNPPLPWNQRLEICIGAARGL 384
           +H  +V   G   DD  + +  ++M  G++ D L  Y +    +      +I      G+
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGV 117

Query: 385 HYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK---------FGPTSVSKT--H 433
            YLH+  N   I+HRD+K  NIL D     K+ DFG SK          G  SV+ T   
Sbjct: 118 EYLHS--NM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173

Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           + PE    +    K+DV+S G  + E+L  +P
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 21/194 (10%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGM-LSQLRHLHLVSLI 335
            +G G  G V K     +   +A+K  RLE          Q +I   L  L   +   ++
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-----AIQKQILRELDILHKCNSPYIV 62

Query: 336 GF---CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           GF     ++ ++ +  ++M  G+L D +       +P     +I +   +GL YLH    
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYY----RLQ--QLTE 446
              IIHRDVK +NIL++ +   K+ DFG+S     S++KT +    Y    R+Q    + 
Sbjct: 122 ---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSV 178

Query: 447 KSDVYSFGVVLFEV 460
           KSD++S G+ L E+
Sbjct: 179 KSDIWSLGLSLIEL 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 15/151 (9%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKR--LEPESQQGAL---EFQTEIGMLSQLRHLHLVSL 334
           +G G FG VY+G         A+K   L  + Q G     + + EI +LS+L+H ++V  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 335 IGFCNDDREMILVYDFMARGTLPDHL--YHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           +G   ++  + +  + +  G+L   L  Y S   P+      +I +G    L YLH    
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLH--DR 121

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
           +   +HRD+K  NIL+D   V K++DFG++K
Sbjct: 122 N--TVHRDIKGANILVDTNGVVKLADFGMAK 150

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 79.9 bits (197), Expect = 2e-15
 Identities = 63/238 (26%), Positives = 114/238 (47%), Gaps = 36/238 (15%)

Query: 318 TEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEIC 377
           +EI  + +L+H ++V LIG C  ++   L+++++    L + L +     L W +R +I 
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIA 786

Query: 378 IGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP------TSVSK 431
           IG A+ L +LH   + AV++  ++    I++D K    +    LS  G         +S 
Sbjct: 787 IGIAKALRFLHCRCSPAVVVG-NLSPEKIIIDGKDEPHLR---LSLPGLLCTDTKCFISS 842

Query: 432 THLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV--SLAVWAQQCYQNG 489
            ++ PE    + +TEKSD+Y FG++L E+L  +       A+  V  S+  WA+ CY + 
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSP---ADAEFGVHGSIVEWARYCYSDC 899

Query: 490 TIDQIVDPFLK----------------AMSCLNDEGIRRPSMSDVVWGLEFSLQLQES 531
            +D  +DP ++                A+ C   +   RP  +DV+  LE + +   S
Sbjct: 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957

Length = 968

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 49/221 (22%)

Query: 280 IGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGALEFQT---EIGMLSQLRHLHLVSL 334
           IG G +G VYK            AIK+ + + +Q     Q+   EI +L +L+H ++VSL
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 335 IGFC--NDDREMILVYDFMARGTLPDHL--YHSDN-----PP-----LPWNQRLEICIGA 380
           +     + D+ + L++D+         +  +H        PP     L W Q L      
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLW--QIIKFHRQAKRVSIPPSMVKSLLW-QILN----- 119

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILL----DEKWVAKVSDFGLS-KFGPTSVSKTHLD 435
             G+HYLH  +N   ++HRD+K  NIL+     E+ V K+ D GL+  F         LD
Sbjct: 120 --GVHYLH--SNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173

Query: 436 PE----YYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
           P     +YR  +L       T+  D+++ G +  E+L   P
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEP 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 29/202 (14%)

Query: 279 VIGVGGFGDVYKGFI--NGSTT--PVAIKRLEPESQQGALEFQTEIGMLS--QLRHLHLV 332
           ++G G FG V+KG     G +   PVAIK ++  S +   +  T+  ML+   L H ++V
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITD-HMLAMGSLDHAYIV 72

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHL-YHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
            L+G C     + LV      G+L DH+  H D+  L   + L  C+  A+G++YL    
Sbjct: 73  RLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLEEHR 129

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP------------TSVSKTHLDPEYY 439
               ++HR++   NILL    + +++DFG++                T +    L+   +
Sbjct: 130 ----MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185

Query: 440 RLQQLTEKSDVYSFGVVLFEVL 461
              + T +SDV+S+GV ++E++
Sbjct: 186 G--RYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 65/247 (26%), Positives = 109/247 (44%), Gaps = 58/247 (23%)

Query: 254 LPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRL-EP 307
           LP D   +     +            +G G FG V K    G      T+ VA+K L + 
Sbjct: 1   LPLDPEWELPRDRLTL-------GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD 53

Query: 308 ESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL------ 360
            +++   +  +E+ M+  + +H ++++L+G C  +  + +V ++ A G L D L      
Sbjct: 54  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPP 113

Query: 361 --YHSDNPPLPWNQRL------EICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW 412
             Y S + P P  + L            ARG+ +L +       IHRD+   N+L+ E  
Sbjct: 114 GEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK----CIHRDLAARNVLVTEDH 169

Query: 413 VAKVSDFGLSKFGPTSVSKTHLDPEYYR-------------LQQL-----TEKSDVYSFG 454
           V K++DFGL++         H+D  YYR              + L     T +SDV+SFG
Sbjct: 170 VMKIADFGLAR------DIHHID--YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 221

Query: 455 VVLFEVL 461
           V+L+E+ 
Sbjct: 222 VLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 76.0 bits (188), Expect = 3e-15
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 22/206 (10%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT--EIGMLSQLR 327
           ++F+    +G G FG V      GS    A+K L      +   +E     E  +L  +R
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVE-HVLNEKRILQSIR 59

Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR---GL 384
           H  LV+L G   DD  + LV +++  G L  HL  S   P P          AA+    L
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV-----ARFYAAQVVLAL 114

Query: 385 HYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT---SVSKTH--LDPEYY 439
            YLH       I++RD+K  N+LLD     K++DFG +K       ++  T   L PE  
Sbjct: 115 EYLH----SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEII 170

Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARP 465
             +   +  D ++ G++++E+L   P
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAGYP 196

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.8 bits (190), Expect = 3e-15
 Identities = 60/227 (26%), Positives = 91/227 (40%), Gaps = 68/227 (29%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT---------EIGMLSQLRHL 329
            IG G +G V       +   VAIK++          F           EI +L  LRH 
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLLRHLRHE 59

Query: 330 HLVSLIGF-----CNDDREMILVYDFM---------ARGTL-PDH----LYHSDNPPLPW 370
           +++ L+         D  ++ +V + M         +   L  DH    LY         
Sbjct: 60  NIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLY--------- 110

Query: 371 NQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV 429
            Q L       RGL YLH+ AN   +IHRD+K +NIL++     K+ DFGL++   P   
Sbjct: 111 -QIL-------RGLKYLHS-AN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158

Query: 430 SKTHLDPE----YYR-------LQQLTEKSDVYSFGVVLFEVLCARP 465
            K  L       +YR         + T+  D++S G +  E+L  +P
Sbjct: 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 31/202 (15%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEF-QTEIGMLSQLRHLHLVSLIGF 337
           VIGVG    VY      +   VAIKR++ E  Q +++  + E+  +SQ  H ++V     
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA-----RGLHYLHTGAN 392
                E+ LV  +++ G+L D +  S     P     E  I        +GL YLH+   
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSS----YPRGGLDEAIIATVLKEVLKGLEYLHSNGQ 123

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH------------LDPEYYR 440
               IHRD+K  NILL E    K++DFG+S        +T             + PE   
Sbjct: 124 ----IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV-- 177

Query: 441 LQQL---TEKSDVYSFGVVLFE 459
           ++Q+     K+D++SFG+   E
Sbjct: 178 MEQVHGYDFKADIWSFGITAIE 199

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 66/227 (29%), Positives = 110/227 (48%), Gaps = 38/227 (16%)

Query: 266 EIQAATNNFDNDLVIGVGGFGDVYKGFINGS-----TTPVAIKRLEPESQQGAL--EFQT 318
           EI  +T  F  +L  G   FG VYKG + G+     T  VAIK L+ +  +G L  EF+ 
Sbjct: 1   EINLSTVRFMEEL--GEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKH 57

Query: 319 EIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY----HSD---------- 364
           E  M S+L+H ++V L+G    ++ + +++ + +   L + L     HSD          
Sbjct: 58  EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117

Query: 365 NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK- 423
              L     + I    A G+ +L   ++H V +H+D+ T N+L+ +K   K+SD GL + 
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFL---SSHHV-VHKDLATRNVLVFDKLNVKISDLGLFRE 173

Query: 424 ---------FGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
                     G + +    + PE     + +  SD++S+GVVL+EV 
Sbjct: 174 VYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 23/200 (11%)

Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           +G G FG V    Y    + +   VA+K L+PES    + + + EI +L  L H ++V  
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 335 IGFCNDD--REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            G C +D    + L+ +F+  G+L ++L  + N  +   Q+L+  +   +G+ YL  G+ 
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYL--GSR 128

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTHLD-------PEYYRL 441
             V  HRD+   N+L++ +   K+ DFGL+K   T       K  LD       PE    
Sbjct: 129 QYV--HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 442 QQLTEKSDVYSFGVVLFEVL 461
            +    SDV+SFGV L+E+L
Sbjct: 187 SKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 74.9 bits (184), Expect = 6e-15
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 28/216 (12%)

Query: 279 VIGVGGFGDVYKGFIN-GSTTPVAIKRLEPESQQGA----LEFQTEIGMLSQLRHLHLVS 333
           V+G G +G VY G  N G    V    L+  +   A     + Q E+ +L  L+H+++V 
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
            +G C DD  + +  +F+  G++   L      P P   +    I    G+ YLH     
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYLHNNC-- 122

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLS-KFGPTSVSKTHLD-------------PEYY 439
             ++HRD+K  N++L    + K+ DFG + +     +  TH +             PE  
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARP---SILRTAA 472
                  KSD++S G  +FE+   +P   S+ R AA
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA 216

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 75.0 bits (184), Expect = 7e-15
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 33/210 (15%)

Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVS 333
           ++G G FG V +  +   +GS   VA+K L+ +  S     EF  E   + +  H +++ 
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 334 LIGFCNDDREM------ILVYDFMARGTLPDHLYHS---DNP-PLPWNQRLEICIGAARG 383
           LIG     R        +++  FM  G L   L  S   + P  LP    +   I  A G
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSVSKTHLDP 436
           + YL +       IHRD+   N +L+E     V+DFGLSK       +     SK  L  
Sbjct: 126 MEYLSSKN----FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK--LPV 179

Query: 437 EYYRLQQL-----TEKSDVYSFGVVLFEVL 461
           ++  L+ L     T  SDV++FGV ++E++
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIM 209

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 75.0 bits (184), Expect = 7e-15
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 43/194 (22%)

Query: 300 VAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPD 358
           VA+K L  +  + A  +F  EI ++S+L++ +++ L+G C  D  + ++ ++M  G L  
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 359 HL---------YHSDN-PPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL 408
            L          H++N P +     L + +  A G+ YL +       +HRD+ T N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS----LNFVHRDLATRNCLV 162

Query: 409 DEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQ------------------QLTEKSDV 450
              +  K++DFG+        S+     +YYR+Q                  + T  SDV
Sbjct: 163 GNHYTIKIADFGM--------SRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDV 214

Query: 451 YSFGVVLFEV--LC 462
           ++FGV L+E+  LC
Sbjct: 215 WAFGVTLWEMFTLC 228

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 74.9 bits (185), Expect = 8e-15
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 40/210 (19%)

Query: 280 IGVGGFGDVYKGFINGST-TPVAIKRLEPESQQGALEFQT--EIGMLSQLRHLHLVSLIG 336
           IG G +G VYK   N  T   VA+K++  E+++         EI +L +LRH ++V L  
Sbjct: 7   IGEGTYGQVYKA-RNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 337 FC--NDDREMILVYDFMARGTLPDH----LYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
                    + +V+++M      DH    L  S       +Q          GL YLH  
Sbjct: 66  IVTSKGKGSIYMVFEYM------DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH-- 117

Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY--------YRLQ 442
                I+HRD+K +NIL++   V K++DFGL++      +K +   +Y        YR  
Sbjct: 118 --SNGILHRDIKGSNILINNDGVLKLADFGLARP----YTKRN-SADYTNRVITLWYRPP 170

Query: 443 QL-------TEKSDVYSFGVVLFEVLCARP 465
           +L         + D++S G +L E+   +P
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 20/196 (10%)

Query: 280 IGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSLIG 336
           +G G FG V KG   +      VAIK L+ E+++    E   E  ++ QL + ++V +IG
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
            C  +  M+++   MA G   +         +  +  +E+    + G+ YL  G N    
Sbjct: 63  VCEAEALMLVME--MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE-GKN---F 116

Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK--------FGPTSVSKTHLD---PEYYRLQQLT 445
           +HRD+   N+LL  +  AK+SDFGLSK        +   S  K  L    PE    ++ +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 446 EKSDVYSFGVVLFEVL 461
            +SDV+S+G+ ++E  
Sbjct: 177 SRSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 48/198 (24%)

Query: 300 VAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPD 358
           VA+K L P++ + A  +F  E+ +LS+L+  +++ L+G C D+  + ++ ++M  G L  
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 359 HLYH------------SDNP--PLP---WNQRLEICIGAARGLHYLHTGANHAVIIHRDV 401
            L              +  P   LP   ++  L + +  A G+ YL +       +HRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS----LNFVHRDL 164

Query: 402 KTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQ------------------Q 443
            T N L+ E    K++DFG+        S+     +YYR+Q                  +
Sbjct: 165 ATRNCLVGENLTIKIADFGM--------SRNLYAGDYYRIQGRAVLPIRWMAWECILMGK 216

Query: 444 LTEKSDVYSFGVVLFEVL 461
            T  SDV++FGV L+E+L
Sbjct: 217 FTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 33/208 (15%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES--------QQGALE-FQTEIGMLSQLRHL 329
           +IG G FG VY G    S   +A+K++E  S        ++  L+    EI +L +L+H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHL--YHSDNPPLPWNQRLEICIGAARGLHYL 387
           ++V  +G   D   + +  +++  G++   L  Y +    L  N   +I     +GL+YL
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYL 122

Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD------------ 435
           H       IIHRD+K  NIL+D K   K+SDFG+SK    +   T  +            
Sbjct: 123 HNRG----IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 436 --PEYYRLQQLTEKSDVYSFGVVLFEVL 461
             PE  +    T K+D++S G ++ E+L
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEML 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 32/209 (15%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLE-----PESQQGALEFQTEIGMLSQLRHLHLVS 333
           ++G G FG VY  +   +   +A+K+++     PE+ +     + EI +L  L H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 334 LIGFCND--DREMILVYDFMARGTLPDHLYH----SDNPPLPWNQRLEICIGAARGLHYL 387
             G   D  +R + +  + M  G++ D L      ++N    + +++        G+ YL
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI------LEGVSYL 122

Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK---------FGPTSVSKTH--LDP 436
           H+     +I+HRD+K  NIL D     K+ DFG SK          G  SV+ T   + P
Sbjct: 123 HSN----MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +    K+D++S G  + E+L  +P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 50/229 (21%), Positives = 94/229 (41%), Gaps = 44/229 (19%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEF-QTEIGMLSQL-R 327
           ++F    +IG G F  V       +    AIK L+     ++  +++ + E  +L++L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ--RLEICIGAARGLH 385
           H  ++ L     D+  +  V ++   G L  ++    +      +    EI +     L 
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLA----LE 116

Query: 386 YLHT-GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH----------- 433
           YLH+ G     IIHRD+K  NILLD+    K++DFG +K    + S              
Sbjct: 117 YLHSKG-----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 434 -----------------LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
                            + PE    +   + SD+++ G +++++L  +P
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 16/209 (7%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGA-LEFQTEIGMLSQLRHLHLVSLIGFC 338
           +G G +  V+KG    +   VA+K +  E ++GA      E+ +L  L+H ++V+L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
           + +R + LV++++    L  +L +  N     N ++       RGL Y H       I+H
Sbjct: 73  HTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCH----KRKILH 126

Query: 399 RDVKTTNILLDEKWVAKVSDFGL--SKFGPTSVSKTHLDPEYYR----LQQLTEKS---D 449
           RD+K  N+L++EK   K++DFGL  +K  PT      +   +YR    L   TE S   D
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186

Query: 450 VYSFGVVLFEVLCARPSILRTAAKKQVSL 478
           ++  G +L+E+   RP    +  K+++ L
Sbjct: 187 MWGVGCILYEMATGRPMFPGSTVKEELHL 215

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 20/206 (9%)

Query: 266 EIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQ 325
           EI   +   +  L  G G FG+V+    N   T VA+K ++P S      F  E  ++  
Sbjct: 2   EIPRESLKLEKKL--GAGQFGEVWMATYN-KHTKVAVKTMKPGSMS-VEAFLAEANVMKT 57

Query: 326 LRHLHLVSLIGFCNDDREMI-LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGL 384
           L+H  LV L       +E I ++ +FMA+G+L D L   +    P  + ++     A G+
Sbjct: 58  LQHDKLVKLHAVVT--KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 115

Query: 385 HYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD--- 435
            ++    N+   IHRD++  NIL+    V K++DFGL++      +     +K  +    
Sbjct: 116 AFIEQ-RNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 171

Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVL 461
           PE       T KSDV+SFG++L E++
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIV 197

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 22/200 (11%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKR--LEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G VYK          A+K   L   SQ+   +   EI +L+ + H +++S    
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNP--PLP----WNQRLEICIGAARGLHYLHTGA 391
             D  ++ +V ++   G L   +         +P    W   +++     RGL  LH   
Sbjct: 68  FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGLQALHEQK 123

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPEYYRLQQLT 445
               I+HRD+K+ NILL    + K+ D G+SK    +++KT      ++ PE ++ +  +
Sbjct: 124 ----ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYS 179

Query: 446 EKSDVYSFGVVLFEVLCARP 465
            KSD++S G +L+E+    P
Sbjct: 180 YKSDIWSLGCLLYEMATFAP 199

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.2 bits (179), Expect = 3e-14
 Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 16/195 (8%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSLIGFC 338
           IG G FG+VYKG  N +   VAIK ++ E  +  +E  Q EI +LSQ    ++    G  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
               ++ ++ +++  G+  D L      PL       I     +GL YLH+       IH
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERK----IH 124

Query: 399 RDVKTTNILLDEKWVAKVSDFGLS-KFGPTSVSKTH-------LDPEYYRLQQLTEKSDV 450
           RD+K  N+LL E+   K++DFG++ +   T + +         + PE  +      K+D+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184

Query: 451 YSFGVVLFEVLCARP 465
           +S G+   E+    P
Sbjct: 185 WSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 25/206 (12%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALE-FQTEIGMLSQLRHLHLV 332
            +G G F   Y+     + T +A+K     R     Q+  +E  + EI ++++L H H++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            ++G   +D    L  ++MA G++   L  S          +       RGL YLH    
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLL--SKYGAFKEAVIINYTEQLLRGLSYLHENQ- 123

Query: 393 HAVIIHRDVKTTNILLDEK-WVAKVSDFGLSKFGPTSVSKT------------HLDPEYY 439
              IIHRDVK  N+L+D      +++DFG +       +               + PE  
Sbjct: 124 ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180

Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARP 465
           R +Q     DV+S G V+ E+  A+P
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 70/270 (25%), Positives = 111/270 (41%), Gaps = 47/270 (17%)

Query: 280 IGVGGFGDVYKG-FINGST---------TPVAIKRLEPESQQGALEFQTEIGMLSQLRHL 329
           +G G F ++YKG     S            V +K L     + +L F     ++SQL H 
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHK 61

Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           HLV L G C  D E I+V +++  G L D   H +   +  + +L++    A  LHYL  
Sbjct: 62  HLVKLYGVCVRD-ENIMVEEYVKFGPL-DVFLHREKNNVSLHWKLDVAKQLASALHYLED 119

Query: 390 GANHAVIIHRDVKTTNILL-----DEKWV--AKVSDFGLSKFGPTSVSKTH--------L 434
                 ++H +V   NIL+     +E +V   K+SD G+    P +V            +
Sbjct: 120 KK----LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI----PITVLSREERVERIPWI 171

Query: 435 DPEYYRLQQ--LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID 492
            PE  R  Q  LT  +D +SFG  L E+       L T +  +       ++ YQ+    
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE------KERFYQDQHRL 225

Query: 493 QIVDP---FLKAMSCLNDEGIRRPSMSDVV 519
            + D          C   +  +RPS   ++
Sbjct: 226 PMPDCAELANLINQCWTYDPTKRPSFRAIL 255

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 63/276 (22%), Positives = 117/276 (42%), Gaps = 31/276 (11%)

Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQLRHL 329
           NF  +  IG G F +VY+        PVA+K+++      A   Q    EI +L QL H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP--LP----WNQRLEICIGAARG 383
           +++  +    +D E+ +V +    G L   + +       +P    W   +++C      
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SA 118

Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LD 435
           + ++H+      ++HRD+K  N+ +    V K+ D GL +F  +  +  H        + 
Sbjct: 119 VEHMHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174

Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC-YQNGTIDQI 494
           PE         KSD++S G +L+E + A  S          SL    +QC Y     +  
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYE-MAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHY 233

Query: 495 VDPFLKAMS-CLNDEGIRRPSMSDVVWGLEFSLQLQ 529
            +   + +S C+  +  +RP   D+ +  + + Q+ 
Sbjct: 234 SEKLRELVSMCIYPDPDQRP---DIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 72.8 bits (179), Expect = 5e-14
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 49/214 (22%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHLHLVSL--- 334
           IG G +G VY+     S   VA+K++  ++++  +   +  EI +L  LRH ++V L   
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 335 ------------IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR 382
                       + +C  D   +L  D M               P   +Q   + +   R
Sbjct: 75  VVGKHLDSIFLVMEYCEQDLASLL--DNMPT-------------PFSESQVKCLMLQLLR 119

Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE----Y 438
           GL YLH       IIHRD+K +N+LL +K   K++DFGL++     +    + P+    +
Sbjct: 120 GLQYLH----ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLW 173

Query: 439 YRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
           YR  +L       T   D+++ G +L E+L  +P
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 38/216 (17%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-----EPESQQGALEFQTEIGMLSQL 326
           N ++   V+G G +G V K     +   VAIK+      + + ++ AL    E+ +L QL
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR---EVKVLRQL 57

Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDN--PP-----LPWNQRLEICIG 379
           RH ++V+L         + LV++++ R TL + L  S    PP       W Q L     
Sbjct: 58  RHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIW-QLL----- 110

Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTHLDP 436
             + + Y H+      IIHRD+K  NIL+ E  V K+ DFG ++     P S    ++  
Sbjct: 111 --QAIAYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVAT 164

Query: 437 EYYRLQQLTEKS-------DVYSFGVVLFEVLCARP 465
            +YR  +L           DV++ G ++ E+L   P
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 32/209 (15%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRL--EPESQQGALE---FQTEIGMLSQLRHLHLVS 333
           ++G G FG+VY  +   +   +A+K++  +P+SQ+ + E    + EI +L  LRH  +V 
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 334 LIGFCND--DREMILVYDFMARGTLPDHLYH----SDNPPLPWNQRLEICIGAARGLHYL 387
             G   D  ++++ +  ++M  G++ D L      ++N    + +++       +G+ YL
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI------LQGVSYL 122

Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK---------FGPTSVSKTH--LDP 436
           H+     +I+HRD+K  NIL D     K+ DFG SK          G  SV+ T   + P
Sbjct: 123 HSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +    K+DV+S    + E+L  +P
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 7e-14
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 20/200 (10%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI-GFC 338
           +G G FG VYK     +    A K ++ ES++   +F  EI +LS+ +H ++V L   + 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
            +++  IL+ +F   G L D +       L   Q   +C      L++LH   +H VI H
Sbjct: 73  YENKLWILI-EFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVI-H 126

Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEY-----YRLQQLT 445
           RD+K  NILL      K++DFG+S    +++ K          + PE      ++     
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD 186

Query: 446 EKSDVYSFGVVLFEVLCARP 465
            K+D++S G+ L E+    P
Sbjct: 187 YKADIWSLGITLIELAQMEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 71.4 bits (175), Expect = 9e-14
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 40/214 (18%)

Query: 279 VIGVGGFGDVYKGFINGSTTPV-AIKRLE---------PESQQGALE-FQTEIGMLSQLR 327
           +IG G +G VY   +N +T  + A+K++E            Q+  ++  ++EI  L  L 
Sbjct: 8   LIGKGTYGRVYLA-LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHL--YHSDNPPLP---WNQRLEICIGAAR 382
           HL++V  +GF   +  + +  +++  G++   L  Y      L      Q LE       
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE------- 119

Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK--------FGPTSVSKT-- 432
           GL YLH+      I+HRD+K  N+L+D   + K+SDFG+SK            S+  +  
Sbjct: 120 GLAYLHSKG----ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF 175

Query: 433 HLDPEYYRLQQ--LTEKSDVYSFGVVLFEVLCAR 464
            + PE         + K D++S G V+ E+   R
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 16/195 (8%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSLIGFC 338
           IG G FG+V+KG  N +   VAIK ++ E  +  +E  Q EI +LSQ    ++    G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
               ++ ++ +++  G+  D L      P    Q   +     +GL YLH+       IH
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKK----IH 124

Query: 399 RDVKTTNILLDEKWVAKVSDFGLS-KFGPTSVSKTH-------LDPEYYRLQQLTEKSDV 450
           RD+K  N+LL E+   K++DFG++ +   T + +         + PE  +      K+D+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 184

Query: 451 YSFGVVLFEVLCARP 465
           +S G+   E+    P
Sbjct: 185 WSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 28/205 (13%)

Query: 280 IGVGGFGDVYKG----FINGST-TPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G     I G   T VA+K + E  S +  +EF  E  ++      H+V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 334 LIGFCNDDREMILVYDFMARGTL--------PDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           L+G  +  +  ++V + MA G L        P+   +   PP    + +++    A G+ 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HRD+   N ++   +  K+ DFG++          K G   +    + 
Sbjct: 134 YL----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEV 460
           PE  +    T  SD++SFGVVL+E+
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 21/206 (10%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALE-FQTEIGMLSQ 325
           NN      +G G FG V +    G     +   VA+K L+P +     E   +E+ ++S 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 326 L-RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGL 384
           L  H ++V+L+G C     ++++ ++   G L + L       L     L      A+G+
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154

Query: 385 HYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHL 434
            +L +       IHRD+   N+LL    + K+ DFGL++           G   +    +
Sbjct: 155 AFLASKN----CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210

Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEV 460
            PE       T +SDV+S+G++L+E+
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 70.1 bits (171), Expect = 3e-13
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 28/207 (13%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLE-----PESQQGALEFQTEIGMLSQLRHLHLVS 333
           ++G G FG VY  +   +   +A K+++     PE+ +     + EI +L  L+H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 334 LIGFCND--DREMILVYDFMARGTLPDHL--YHSDNPPLPWNQRLEICIGAARGLHYLHT 389
             G   D  ++ + +  ++M  G++ D L  Y +    +      +I      G+ YLH+
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLHS 124

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK---------FGPTSVSKTH--LDPEY 438
                +I+HRD+K  NIL D     K+ DFG SK          G  SV+ T   + PE 
Sbjct: 125 N----MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +    K+DV+S G  + E+L  +P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 56/215 (26%), Positives = 104/215 (48%), Gaps = 37/215 (17%)

Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G         T VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHL-----------YHSDNPP---LPWNQRLEI 376
           +++L+G C  D  + ++ ++ ++G L ++L           Y+    P   L +   +  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV 429
               ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+ 
Sbjct: 146 AYQVARGMEYLASKK----CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 430 SK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            +     + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 44/213 (20%)

Query: 280 IGVGGFGDVYKGFIN--GSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V +G +N   S   VA+K ++    ++    +F +E   + +  H +++ LI
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 336 GFC--NDDREM----ILVYDFMARGTLPDHLYHS---DNPP-LPWNQRLEICIGAARGLH 385
           G C    + E     +++  FM  G L   L +S   D P  LP    ++     A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL- 444
           YL + +     IHRD+   N +L+E     V+DFGLSK       K + + +YYR  ++ 
Sbjct: 127 YLSSKS----FIHRDLAARNCMLNENMNVCVADFGLSK-------KIY-NGDYYRQGRIA 174

Query: 445 -----------------TEKSDVYSFGVVLFEV 460
                            T KSDV+SFGV ++E+
Sbjct: 175 KMPVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 69.5 bits (171), Expect = 6e-13
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 56/218 (25%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---FQT--EIGMLSQLRHLHLVSL 334
           +G G +  VYK     +   VAIK+++   ++ A +   F    EI +L +L+H +++ L
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 335 IG-FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA------------ 381
           +  F +    + LV++FM           +D         LE  I               
Sbjct: 68  LDVFGHKSN-INLVFEFM----------ETD---------LEKVIKDKSIVLTPADIKSY 107

Query: 382 -----RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHL 434
                RGL YLH  +N   I+HRD+K  N+L+    V K++DFGL++ FG P       +
Sbjct: 108 MLMTLRGLEYLH--SNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQV 163

Query: 435 DPEYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
              +YR  +L           D++S G +  E+L   P
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 68.9 bits (168), Expect = 7e-13
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 12/161 (7%)

Query: 266 EIQAATNNFDNDLV--IGVGGFGDVYKG--FINGSTTPVAIKRLEPESQQGALEFQTEIG 321
           +I       D +L+  +G G +GDVYK      G    V I +LEP      +  Q EI 
Sbjct: 1   DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLI--QQEIF 58

Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           M+ + +H ++V+  G      ++ +  ++   G+L D +YH   P L   Q   +C    
Sbjct: 59  MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGP-LSELQIAYVCRETL 116

Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS 422
           +GL YLH+       +HRD+K  NILL +    K++DFG++
Sbjct: 117 QGLAYLHSKGK----MHRDIKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 69.5 bits (170), Expect = 9e-13
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 19/205 (9%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRH 328
           TN + +   +G+G FG V       +   VAIK++        L  +T  E+ +L  LRH
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 329 LHLVSLIG-FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
            +++SL   F +   ++  V + +  GT    L  S      + Q     I   RGL Y+
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQI--LRGLKYV 124

Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRL------ 441
           H+    A ++HRD+K +NIL++E    K+ DFGL++     ++  ++   YYR       
Sbjct: 125 HS----AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG-YVSTRYYRAPEIMLT 179

Query: 442 -QQLTEKSDVYSFGVVLFEVLCARP 465
            Q+   + D++S G +  E+L  +P
Sbjct: 180 WQKYDVEVDIWSAGCIFAEMLEGKP 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 63/268 (23%), Positives = 116/268 (43%), Gaps = 34/268 (12%)

Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKR------LEPESQQGALEFQTEIGMLSQL 326
           NF  +  IG G F +VY+        PVA+K+      ++ +++   ++   EI +L QL
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQL 59

Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYH--SDNPPLP----WNQRLEICIGA 380
            H +++       +D E+ +V +    G L   + H       +P    W   +++C   
Sbjct: 60  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC--- 116

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH------- 433
              L ++H+      ++HRD+K  N+ +    V K+ D GL +F  +  +  H       
Sbjct: 117 -SALEHMHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171

Query: 434 -LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC-YQNGTI 491
            + PE         KSD++S G +L+E + A  S          SL    +QC Y     
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYE-MAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS 230

Query: 492 DQIVDPFLKAMS-CLNDEGIRRPSMSDV 518
           D   +   + ++ C+N +  +RP ++ V
Sbjct: 231 DHYSEELRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 46/143 (32%), Positives = 73/143 (51%), Gaps = 6/143 (4%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G +GDVYK     +    AIK ++ E  +     Q EI M+   +H ++V+  G   
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              ++ +  +F   G+L D +YH    PL  +Q   +     +GL+YLH+       +HR
Sbjct: 77  RRDKLWICMEFCGGGSLQD-IYHVTG-PLSESQIAYVSRETLQGLYYLHSKGK----MHR 130

Query: 400 DVKTTNILLDEKWVAKVSDFGLS 422
           D+K  NILL +    K++DFG+S
Sbjct: 131 DIKGANILLTDNGHVKLADFGVS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 31/204 (15%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRL-----EPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           IG G +G V+K     +   VAIK+      +P  ++ AL    EI ML QL+H +LV+L
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR---EIRMLKQLKHPNLVNL 65

Query: 335 IGFCNDDREMILVYDFMARGTLPDH--LYHSDNPP--LPWNQRLEICIGAARGLHYLHTG 390
           I      R++ LV+++       DH  L   +  P  +P +   +I     + +++ H  
Sbjct: 66  IEVFRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK- 118

Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSVSKTHLDPEYYRLQQL---- 444
             H  I HRDVK  NIL+ ++   K+ DFG ++   GP      ++   +YR  +L    
Sbjct: 119 --HNCI-HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175

Query: 445 TEKS---DVYSFGVVLFEVLCARP 465
           T+     DV++ G V  E+L  +P
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLE-PESQQGALEFQT--EIGMLSQLR---HLHLVS 333
           IG G +G VYK     +   VA+K++  P S++G +   T  EI +L QL    H ++V 
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG-IPLSTLREIALLKQLESFEHPNIVR 65

Query: 334 LIGFC---NDDREMI--LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
           L+  C     DRE+   LV++ + +  L  +L     P LP     ++     RG+ +LH
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH 124

Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-----FGPTSVSKTHLDPEYYR--- 440
           +   H  I+HRD+K  NIL+      K++DFGL++        TSV  T     +YR   
Sbjct: 125 S---HR-IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVT----LWYRAPE 176

Query: 441 -LQQLTEKS--DVYSFGVVLFEVLCARP 465
            L Q +  +  D++S G +  E+   RP
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAELFRRRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 28/202 (13%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPE------SQQGALEFQTEIGMLSQLRHLHLVS 333
           +G GGFG+V    +  +    A K+L+ +       +Q AL    E  +L ++    +VS
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMAL---NEKKILEKVSSRFIVS 57

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL----EICIGAARGLHYLHT 389
           L        ++ LV   M  G L  H+Y+   P  P  + +    +I  G    L +LH 
Sbjct: 58  LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLH- 112

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS-----KFGPTSVSKTH--LDPEYYRLQ 442
                 I++RD+K  N+LLD+    ++SD GL+            + T   + PE  + +
Sbjct: 113 ---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE 169

Query: 443 QLTEKSDVYSFGVVLFEVLCAR 464
                 D ++ G  L+E++  R
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 16/196 (8%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGA-LEFQTEIGMLSQLRHLHLVSLIGFC 338
           +G G +  VYKG    +   VA+K +  E ++GA      E+ +L  L+H ++V+L    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
           + ++ + LV++++ +  L  +L    N     N +L       RGL+Y H       ++H
Sbjct: 74  HTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKL-FLFQLLRGLNYCH----RRKVLH 127

Query: 399 RDVKTTNILLDEKWVAKVSDFGL--SKFGPTSVSKTHLDPEYYR----LQQLTEKS---D 449
           RD+K  N+L++E+   K++DFGL  +K  PT      +   +YR    L   T+ S   D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQID 187

Query: 450 VYSFGVVLFEVLCARP 465
           ++  G + +E+   RP
Sbjct: 188 MWGVGCIFYEMSTGRP 203

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 60/198 (30%), Positives = 89/198 (44%), Gaps = 20/198 (10%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQLRHLHLVSLIG 336
           IG G FG VY      +   VAIK++    +Q   ++Q    E+  L QLRH + +   G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +    LV ++   G+  D +      PL   +   IC GA +GL YLH   +H  I
Sbjct: 83  CYLREHTAWLVMEYCL-GSASD-ILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERI 137

Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQ---------QLTEK 447
            HRD+K  NILL E    K++DFG +     S + + +   Y+            Q   K
Sbjct: 138 -HRDIKAGNILLTEPGTVKLADFGSASL--VSPANSFVGTPYWMAPEVILAMDEGQYDGK 194

Query: 448 SDVYSFGVVLFEVLCARP 465
            DV+S G+   E+   +P
Sbjct: 195 VDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 33/88 (37%), Positives = 48/88 (54%), Gaps = 10/88 (11%)

Query: 379 GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------ 432
              +GL YLH+      IIHRD+K +NILL  K   K+ DFG+S     S++ T      
Sbjct: 113 SVLKGLSYLHSRK----IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF 168

Query: 433 HLDPEYYRLQQLTEKSDVYSFGVVLFEV 460
           ++ PE  + +  +  SDV+S G+ L EV
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 42/219 (19%)

Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHL 331
            + N   IG G +G V       +   VAIK++ P E Q        EI +L + +H ++
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65

Query: 332 VSL------IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---G 379
           + +        F +   ++ +V + M        LY      L   Q L    I      
Sbjct: 66  IGILDIIRPPSFESF-NDVYIVQELM-----ETDLYK-----LIKTQHLSNDHIQYFLYQ 114

Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-PTSVSKTHLDPEY 438
             RGL Y+H  AN   ++HRD+K +N+LL+     K+ DFGL++   P       L  EY
Sbjct: 115 ILRGLKYIH-SAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL-TEY 169

Query: 439 -----YR-------LQQLTEKSDVYSFGVVLFEVLCARP 465
                YR        +  T+  D++S G +L E+L  RP
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 19/156 (12%)

Query: 319 EIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEIC- 377
           E+ ++ + R  ++VS  G   ++  + +  +FM  G+L D +Y    P       +EI  
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGP-----IPVEILG 106

Query: 378 ---IGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-- 432
              +    GL YL+   N   I+HRD+K +NIL++ +   K+ DFG+S     S++ T  
Sbjct: 107 KIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV 163

Query: 433 ----HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
               ++ PE  +  + T KSDV+S G+ + E+   +
Sbjct: 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 51/196 (26%), Positives = 96/196 (48%), Gaps = 16/196 (8%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGA-LEFQTEIGMLSQLRHLHLVSLIGFC 338
           +G G +  V+KG    +   VA+K +  E ++GA      E+ +L  L+H ++V+L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
           + D+ + LV++++ +  L  ++    N     N ++       RGL Y H       ++H
Sbjct: 74  HTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKI-FLYQILRGLAYCHRRK----VLH 127

Query: 399 RDVKTTNILLDEKWVAKVSDFGL--SKFGPTSVSKTHLDPEYYR-------LQQLTEKSD 449
           RD+K  N+L++E+   K++DFGL  +K  PT      +   +YR         + + + D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQID 187

Query: 450 VYSFGVVLFEVLCARP 465
           ++  G + FE+   RP
Sbjct: 188 MWGVGCIFFEMASGRP 203

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 21/198 (10%)

Query: 279 VIGVGGFGDVYKGFI--NGSTT--PVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           V+G G FG VYKG    +G     PVAIK L E  S +   E   E  +++ +   ++  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L+G C     + LV   M  G L D++   +   +     L  C+  A+G+ YL      
Sbjct: 74  LLGICLTS-TVQLVTQLMPYGCLLDYV-RENKDRIGSQDLLNWCVQIAKGMSYLE----E 127

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDP----------EYYRLQQ 443
             ++HRD+   N+L+      K++DFGL++      ++ H D           E    ++
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187

Query: 444 LTEKSDVYSFGVVLFEVL 461
            T +SDV+S+GV ++E++
Sbjct: 188 FTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 46/190 (24%), Positives = 89/190 (46%), Gaps = 40/190 (21%)

Query: 300 VAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTL-- 356
           VA+K L  ++ + A  +F  EI ++S+L+  +++ L+  C     + ++ ++M  G L  
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 357 -------PDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD 409
                   +    +D   + ++  + +    A G+ YL +  N    +HRD+ T N L+ 
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL-SSLN---FVHRDLATRNCLVG 164

Query: 410 EKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQ------------------QLTEKSDVY 451
           + +  K++DFG+        S+     +YYR+Q                  + T  SDV+
Sbjct: 165 KNYTIKIADFGM--------SRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVW 216

Query: 452 SFGVVLFEVL 461
           +FGV L+E+L
Sbjct: 217 AFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 5e-12
 Identities = 67/286 (23%), Positives = 111/286 (38%), Gaps = 55/286 (19%)

Query: 270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL 329
            T  F+   VIG G +G VYK     +   VAIK ++    +   E + E  +L +  + 
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-EIKEEYNILRKYSNH 62

Query: 330 HLVSLIGF---------CNDDREMILVYDFMARGTLPDHL--YHSDNPPLPWNQRLEICI 378
              ++  F           +D ++ LV +    G++ D +         L       I  
Sbjct: 63  P--NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120

Query: 379 GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH----- 433
              RGL YLH   N   +IHRD+K  NILL +    K+ DFG+S    +++ + +     
Sbjct: 121 ETLRGLAYLH--ENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGT 176

Query: 434 ---LDPE-----YYRLQQLTEKSDVYSFGVVLFEV------LC------ARPSILRTAAK 473
              + PE              +SDV+S G+   E+      LC      A   I R    
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP 236

Query: 474 KQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVV 519
              S   W+++ + +         F+    CL     +RP M +++
Sbjct: 237 TLKSPENWSKK-FND---------FIS--ECLIKNYEQRPFMEELL 270

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.1 bits (169), Expect = 5e-12
 Identities = 47/191 (24%), Positives = 87/191 (45%), Gaps = 30/191 (15%)

Query: 300 VAIKRLE---PESQQGALEFQTEIGMLSQLRHLHLVSLI--GFCNDDREMILVYDFMARG 354
           VAIK L    PE +     F+ E  + ++L H ++V+L+  G       +  V++++   
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPGR 64

Query: 355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL---DEK 411
           TL + L  + +  LP  +   + +     L   H    +  I+HRD+K  NI++     +
Sbjct: 65  TLREVL--AADGALPAGETGRLMLQVLDALACAH----NQGIVHRDLKPQNIMVSQTGVR 118

Query: 412 WVAKVSDFGLSKFGP-------TSVSKTH--------LDPEYYRLQQLTEKSDVYSFGVV 456
             AKV DFG+    P        ++++T           PE  R + +T  SD+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178

Query: 457 LFEVLCARPSI 467
             E L  +  +
Sbjct: 179 FLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 53/215 (24%), Positives = 103/215 (47%), Gaps = 37/215 (17%)

Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G           VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHL---------YHSD-----NPPLPWNQRLEI 376
           +++L+G C  D  + ++ ++ ++G L ++L         Y  D     +  + +   +  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV 429
               ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+ 
Sbjct: 143 TYQVARGMEYLASQK----CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198

Query: 430 SK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            +     + PE    +  T +SDV+SFGV+++E+ 
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 233

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 22/203 (10%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHL---HLVSL 334
           IGVG +G VYK     S   VA+K +  ++ +  L   T  E+ +L +L      ++V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 335 IGFC---NDDRE--MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           +  C     DRE  + LV++ + +  L  +L     P LP     ++     RGL +LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSVSKTHLDPEYYRLQ 442
                 I+HRD+K  NIL+      K++DFGL++         P  V+  +  PE     
Sbjct: 127 NC----IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS 182

Query: 443 QLTEKSDVYSFGVVLFEVLCARP 465
                 D++S G +  E+   +P
Sbjct: 183 TYATPVDMWSVGCIFAEMFRRKP 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 66.0 bits (161), Expect = 6e-12
 Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 34/212 (16%)

Query: 280 IGVGGFGDVYK-GFINGSTTPVAIKRL---EPESQQGALEFQTEIGML--------SQLR 327
           +G G FG VYK    N     +A+K +    P   +   E    IG +         QLR
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 328 HLHLVSLI-GFCNDDREMILVYDFMARGTLPDHL------YHSDNPPLPWNQRLEICIGA 380
           H ++V     F  +DR  I V D +    L +H                WN  +++ +  
Sbjct: 68  HPNIVRYYKTFLENDRLYI-VMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGP----TSVSKTHLD 435
              L YLH       I+HRD+   NI+L E     ++DFGL+K   P    TSV  T L 
Sbjct: 126 ---LRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179

Query: 436 --PEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
             PE  + +   EK+DV++FG +L+++   +P
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQP 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 65.9 bits (161), Expect = 7e-12
 Identities = 61/292 (20%), Positives = 126/292 (43%), Gaps = 41/292 (14%)

Query: 257 DLCTQFSLSEIQ-AATNNFDND--LVIGVGGFGDVYKGFINGSTTPVAIKRLE-PESQQG 312
           ++ T+  +++I+   +++ D    ++I       +YKG  N     V I+  +       
Sbjct: 2   NIITRSYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIFNN--KEVIIRTFKKFHKGHK 59

Query: 313 AL--EFQTEIGMLSQLRHLHLVSLIGF----CNDDREMILVYDFMARGTLPDHLYHSDNP 366
            L    + EI  L ++   +++ + GF     +D   + L+ ++  RG L + L    + 
Sbjct: 60  VLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD- 118

Query: 367 PLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP 426
            L +  +L++ I   +GL+ L+   N     ++++ + + L+ E +  K+   GL K   
Sbjct: 119 -LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILS 174

Query: 427 TSVSKTHLDPEY--YRL-----QQLTEKSDVYSFGVVLFEVLCAR--------PSILRTA 471
           +   K      Y  Y++      + T K D+YS GVVL+E+   +          I    
Sbjct: 175 SPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI 234

Query: 472 AKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLE 523
             K  SL +    C     I  IV+      +C + + I+RP++ ++++ L 
Sbjct: 235 INKNNSLKL-PLDCPL--EIKCIVE------ACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 65.6 bits (160), Expect = 7e-12
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 18/213 (8%)

Query: 266 EIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQ 325
           E +   +     +V+G G +G VY      +   +AIK +     +       EI + S 
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61

Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA--RG 383
           L+H ++V  +G  +++    +  + +  G+L   L  S   PL  N++  I        G
Sbjct: 62  LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIIFYTKQILEG 120

Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDE-KWVAKVSDFGLSK--FGPTSVSKTHLDPEYYR 440
           L YLH       I+HRD+K  N+L++    V K+SDFG SK   G    ++T      Y 
Sbjct: 121 LKYLHDNQ----IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYM 176

Query: 441 LQQLTEK--------SDVYSFGVVLFEVLCARP 465
             ++ +K        +D++S G  + E+   +P
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKP 209

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 66.5 bits (162), Expect = 8e-12
 Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 37/215 (17%)

Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V +    G        T  VA+K L+  +    L +  +E+ ++  + +H +
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHL---------YHSDNPPLPWNQ----RLEIC 377
           +++L+G C  +  + ++ ++ A+G L + L         Y  D   +P  Q     L  C
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 378 I-GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV 429
               ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  TS 
Sbjct: 140 AYQVARGMEYLESRR----CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 430 SK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            +     + PE    +  T +SDV+SFG++++E+ 
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 66.3 bits (162), Expect = 8e-12
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 38/219 (17%)

Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHLHL 331
           FD    IG G +G VYK     +   VA+K  RL+ E +   +    EI +L QL H ++
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 332 VSL----------IGFCNDDREMILVYDFMAR---GTLPDHLYH--SDNPPLPWNQRLEI 376
           V+L          + F  D     LV+++M     G L   L H   D+      Q LE 
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE- 127

Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDP 436
                 GL+Y H        +HRD+K +NILL+ K   K++DFGL++   +  S+ + + 
Sbjct: 128 ------GLNYCHKKN----FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177

Query: 437 E---YYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
               +YR  +L           DV+S G +L E+   +P
Sbjct: 178 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 62/246 (25%), Positives = 111/246 (45%), Gaps = 44/246 (17%)

Query: 254 LPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFING-------STTPVAIKRLE 306
           LP+D   + S + +            +G G FG V      G           VA+K L+
Sbjct: 1   LPADPKWELSRTRLTLGKP-------LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK 53

Query: 307 PESQQGAL-EFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL---- 360
            ++    L +  +E+ M+  + +H ++++L+G C  D  + ++ ++ ++G L ++L    
Sbjct: 54  DDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARR 113

Query: 361 -----YHSDNPPLPWNQR-----LEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE 410
                Y  D   LP  Q      +      ARG+ YL +       IHRD+   N+L+ E
Sbjct: 114 PPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK----CIHRDLAARNVLVTE 169

Query: 411 KWVAKVSDFGLSK-------FGPTSVSK---THLDPEYYRLQQLTEKSDVYSFGVVLFEV 460
             V K++DFGL++       +  T+  +     + PE    +  T +SDV+SFGV+L+E+
Sbjct: 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Query: 461 LCARPS 466
                S
Sbjct: 230 FTLGGS 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 22/198 (11%)

Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLE---PESQQGALEFQTEIGMLSQLRHLHLV 332
           ++G G FG++ +G +   +    PVAI  L     + Q+    F  E   L Q  H ++V
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR--RGFLAEALTLGQFDHSNIV 69

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            L G       M++V ++M+ G L D         L   Q + +  G A G+ YL    +
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYL----S 124

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQ 443
               +H+ +    +L++   V K+S F   +   +    T +          PE  +   
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184

Query: 444 LTEKSDVYSFGVVLFEVL 461
            +  SDV+SFG+V++EV+
Sbjct: 185 FSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 18/199 (9%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG VYK     +    A K +E +S++   ++  EI +L+   H ++V L+G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            D ++ ++ +F   G +   +   D   L   Q   IC      L YLH+      IIHR
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVICRQMLEALQYLHSMK----IIHR 134

Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLTE----- 446
           D+K  N+LL      K++DFG+S     ++ +          + PE    + + +     
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194

Query: 447 KSDVYSFGVVLFEVLCARP 465
           K+D++S G+ L E+    P
Sbjct: 195 KADIWSLGITLIEMAQIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 64/205 (31%), Positives = 93/205 (45%), Gaps = 20/205 (9%)

Query: 280 IGVGGFGDVYKGFINGSTTP--VAIKRLEPESQQGALEFQ---TEIGMLSQLRHLHLVSL 334
           IG G FG VY  F   S T   VA+K++    +Q   ++Q    E+  L QL+H + +  
Sbjct: 29  IGHGSFGAVY--FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
            G    +    LV ++   G+  D L      PL   +   I  GA +GL YLH+     
Sbjct: 87  KGCYLKEHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFG-LSKFGPTSV---SKTHLDPEYYRLQ---QLTEK 447
            +IHRD+K  NILL E    K++DFG  SK  P +    +   + PE        Q   K
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGK 200

Query: 448 SDVYSFGVVLFEVLCARPSILRTAA 472
            DV+S G+   E+   +P +    A
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNA 225

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 20/200 (10%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEF-QTEIGMLSQL-RHLHLVSL 334
           V+G G FG V    + G+    A+K L+ +   Q   +E   TE  +L+   +H  L  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 335 IG-FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
              F   DR +  V +++  G L  H+  S     P  +     I    GL +LH     
Sbjct: 62  HSCFQTKDR-LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI--VLGLQFLHERG-- 116

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------HLDPEYYRLQQLT 445
             II+RD+K  N+LLD +   K++DFG+ K G      T        ++ PE    Q   
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYG 174

Query: 446 EKSDVYSFGVVLFEVLCARP 465
              D ++ GV+L+E+L  + 
Sbjct: 175 PAVDWWALGVLLYEMLAGQS 194

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 34/177 (19%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKR--LEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G FG+V+K     +   VA+K+  +E E +   +    EI +L  L+H ++V+LI  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 338 C-------NDDREMI-LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR------- 382
           C       N  +    LV++F       +H    D   L  N+ ++  +   +       
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFC------EH----DLAGLLSNKNVKFTLSEIKKVMKMLL 129

Query: 383 -GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY 438
            GL+Y+H       I+HRD+K  NIL+ +  + K++DFGL++    S+SK      Y
Sbjct: 130 NGLYYIHRNK----ILHRDMKAANILITKDGILKLADFGLAR--AFSLSKNSKPNRY 180

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 28/202 (13%)

Query: 280 IGVGGFGDVY----KGFINGSTTPV----AIKRLEP-ESQQGALEFQTEIGMLSQLRHLH 330
           +G G FG VY    K  +      V     +  L P E+ Q   E Q    +LS+L H  
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQ----LLSKLDHPA 63

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHL--YHSDNPPLPWNQRLEICIGAARGLHYLH 388
           +V       +     ++ ++     L   L         L  NQ  E  I    G+HY+H
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSVSKT------HLDPEYYR 440
                  I+HRD+K  NI L +  + K+ DFG+S+   G   ++ T      ++ PE  +
Sbjct: 124 QRR----ILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK 178

Query: 441 LQQLTEKSDVYSFGVVLFEVLC 462
            Q    KSD++S G +L+E+ C
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 27/203 (13%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G +G VYKG    +   VA+K  RLE E +        EI +L +L+H ++V L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV-- 395
              +  + L+++F++     D   + D+  LP  Q ++    A     YL+      +  
Sbjct: 68  LMQESRLYLIFEFLSM----DLKKYLDS--LPKGQYMD----AELVKSYLYQILQGILFC 117

Query: 396 ----IIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQLTEKS- 448
               ++HRD+K  N+L+D K V K++DFGL++ FG P  V    +   +YR  ++   S 
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP 177

Query: 449 ------DVYSFGVVLFEVLCARP 465
                 D++S G +  E+   +P
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 33/91 (36%), Positives = 45/91 (49%), Gaps = 17/91 (18%)

Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH-------- 433
           + L+YL        IIHRDVK +NILLD     K+ DFG+S     S++KT         
Sbjct: 118 KALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYM 174

Query: 434 ----LDPEYYRLQQLTEKSDVYSFGVVLFEV 460
               +DP          +SDV+S G+ L+EV
Sbjct: 175 APERIDPS--ARDGYDVRSDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 9/194 (4%)

Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHLH 330
           NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L H +
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           +V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + H+ 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS- 118

Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQLTEKS 448
             H V+ HRD+K  N+L++ +   K++DFGL++ FG    + TH +   +YR  ++    
Sbjct: 119 --HRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 175

Query: 449 DVYSFGVVLFEVLC 462
             YS  V ++ + C
Sbjct: 176 KYYSTAVDIWSLGC 189

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 21/285 (7%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQLRHLHLVSLIG 336
           IG G FG VY      ++  VAIK++    +Q   ++Q    E+  L +LRH + +   G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +    LV ++   G+  D L      PL   +   +  GA +GL YLH   +H  +
Sbjct: 83  CYLREHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHN-M 136

Query: 397 IHRDVKTTNILLDEKWVAKVSDFG-LSKFGPTSV---SKTHLDPEYYRLQ---QLTEKSD 449
           IHRDVK  NILL E  + K+ DFG  S   P +    +   + PE        Q   K D
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVD 196

Query: 450 VYSFGVVLFEVLCARPSILRTAAKKQV-SLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDE 508
           V+S G+   E+   +P +    A   +  +A       Q+G   +    F+   SCL   
Sbjct: 197 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD--SCLQKI 254

Query: 509 GIRRPSMSDVVWGLEFSLQLQESSIAIAKEIDENEEEEKLLDNYE 553
              RP+ S+V+    F +  +     I   I   ++  + LDN +
Sbjct: 255 PQDRPT-SEVLLKHRF-VLRERPPTVIMDLIQRTKDAVRELDNLQ 297

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 63.0 bits (154), Expect = 6e-11
 Identities = 57/219 (26%), Positives = 85/219 (38%), Gaps = 53/219 (24%)

Query: 280 IGVGGFGDVYKGFINGST-TPVAIKRLEPESQQGALEFQ---TEIGMLSQLRHLHLVSLI 335
           I  G +G V+      ST    AIK ++        +     TE  +LSQ +  ++V L 
Sbjct: 1   ISKGAYGRVFLA-KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-----AR-------- 382
                 + + LV +++  G L   L  +              +G+     AR        
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLA-SLLEN--------------VGSLDEDVARIYIAEIVL 104

Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD------- 435
            L YLH   ++  IIHRD+K  NIL+D     K++DFGLSK G         D       
Sbjct: 105 ALEYLH---SNG-IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160

Query: 436 ---------PEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
                    PE    Q  ++  D +S G +L+E L   P
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 48/202 (23%), Positives = 92/202 (45%), Gaps = 16/202 (7%)

Query: 273 NFDNDLVIGVGGFGDVY--KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH 330
            ++    IG G FG +Y  K   +     +    L     +     + E+ +L++++H +
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           +V+      ++  + +V ++   G L   +          +Q L   +  + GL ++H  
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120

Query: 391 ANHAVIIHRDVKTTNILLDEK-WVAKVSDFGLSK-------FGPTSV-SKTHLDPEYYRL 441
                I+HRD+K+ NI L +   VAK+ DFG+++          T V +  +L PE  + 
Sbjct: 121 K----ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176

Query: 442 QQLTEKSDVYSFGVVLFEVLCA 463
           +    K+D++S G VL+E LC 
Sbjct: 177 RPYNNKTDIWSLGCVLYE-LCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 62.9 bits (153), Expect = 7e-11
 Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 36/223 (16%)

Query: 280 IGVGGFGDVYKG-------FINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           +G G F  ++KG       +     T V +K L+   +  +  F     M+SQL H HLV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNP-PLPWNQRLEICIGAARGLHYLHTGA 391
              G C    E I+V +++  G+L  +L  + N   + W  +LE+    A  LH+L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120

Query: 392 NHAVIIHRDVKTTNILL----DEKW----VAKVSDFGLSKFGPTSVSKTHL-------DP 436
               + H +V   N+LL    D K       K+SD G+S    T + K  L        P
Sbjct: 121 ----LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS---ITVLPKEILLERIPWVPP 173

Query: 437 EYYR-LQQLTEKSDVYSFGVVLFEVLCA--RP-SILRTAAKKQ 475
           E     Q L+  +D +SFG  L+E+     +P S L +  K Q
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ 216

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 63.2 bits (154), Expect = 7e-11
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 17/202 (8%)

Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
             DN + IG G  G V       +   VA+K+++   QQ       E+ ++   +H ++V
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            +        E+ +V +F+  G L D + H+    +   Q   +C+   + L +LH    
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSFLHAQG- 135

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFG----LSKFGPTSVSKTH----LDPEYY-RLQQ 443
              +IHRD+K+ +ILL      K+SDFG    +SK  P   S       + PE   RL  
Sbjct: 136 ---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192

Query: 444 LTEKSDVYSFGVVLFEVLCARP 465
            TE  D++S G+++ E++   P
Sbjct: 193 GTE-VDIWSLGIMVIEMVDGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 18/199 (9%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG VYK     +    A K ++ +S++   ++  EI +L+   H ++V L+    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +  + ++ +F A G + D +      PL   Q   +C      L+YLH       IIHR
Sbjct: 73  YENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENK----IIHR 127

Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLTE----- 446
           D+K  NIL       K++DFG+S     ++ +          + PE    +   +     
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 187

Query: 447 KSDVYSFGVVLFEVLCARP 465
           K+DV+S G+ L E+    P
Sbjct: 188 KADVWSLGITLIEMAQIEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 62.9 bits (153), Expect = 9e-11
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 23/201 (11%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G +G VYK     +   +A+K  RLE E +        EI +L +++H ++V L   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDN-PPLPWNQRL--EICIGAARGLHYLHTGANHA 394
            + ++ + LV++++      D   H D+ P    N RL         RG+ Y H+   H 
Sbjct: 70  VHSEKRLYLVFEYLDL----DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HR 122

Query: 395 VIIHRDVKTTNILLDEKWVA-KVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQLTEKS--- 448
           V +HRD+K  N+L+D +  A K++DFGL++ FG    + TH +   +YR  ++   S   
Sbjct: 123 V-LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHY 181

Query: 449 ----DVYSFGVVLFEVLCARP 465
               D++S G +  E++  +P
Sbjct: 182 STPVDIWSVGCIFAEMVNQKP 202

Length = 294

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 62.6 bits (152), Expect = 9e-11
 Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 17/198 (8%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           +G GGFG+V    +  +    A K+L  +    ++G      E  +L+++    +VSL  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSD--NPPLPWNQRLEICIGAARGLHYLHTGANHA 394
                 ++ LV   M  G L  H+Y+ D  NP  P  +          GL +LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH----QR 116

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLTE 446
            II+RD+K  N+LLD     ++SD GL+       SKT         + PE  + ++   
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176

Query: 447 KSDVYSFGVVLFEVLCAR 464
             D ++ GV L+E++ AR
Sbjct: 177 SVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 17/201 (8%)

Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            D+ + IG G  G V       +   VA+K+++   QQ       E+ ++    H ++V 
Sbjct: 24  LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +        E+ +V +F+  G L D + H+    +   Q   +C+   R L YLH     
Sbjct: 84  MYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQG-- 138

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYY-RLQQL 444
             +IHRD+K+ +ILL      K+SDFG        V K          + PE   RL   
Sbjct: 139 --VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196

Query: 445 TEKSDVYSFGVVLFEVLCARP 465
           TE  D++S G+++ E++   P
Sbjct: 197 TE-VDIWSLGIMVIEMIDGEP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 16/98 (16%)

Query: 375 EICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-- 432
           +I +   + L YLH+  +   +IHRDVK +N+L++     K+ DFG+S +   SV+KT  
Sbjct: 107 KIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID 163

Query: 433 ----------HLDPEYYRLQQLTEKSDVYSFGVVLFEV 460
                      ++PE    +    KSDV+S G+ + E+
Sbjct: 164 AGCKPYMAPERINPE-LNQKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 54/193 (27%), Positives = 90/193 (46%), Gaps = 15/193 (7%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRL--EPESQQGALEFQTEIGMLSQLRHLHLVSLI- 335
           V+G G +G+V             IK+L     S++     + E  +LSQL+H ++V+   
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
            +  +D  + +V  F   G L   L       LP NQ +E  +  A  L YLH    H  
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE--KH-- 122

Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV-SKTHLDPEYYRLQQLTEK 447
           I+HRD+KT N+ L    + KV D G+++          T + +  ++ PE +  +    K
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYK 182

Query: 448 SDVYSFGVVLFEV 460
           SDV++ G  ++E+
Sbjct: 183 SDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 48/198 (24%), Positives = 93/198 (46%), Gaps = 26/198 (13%)

Query: 280 IGVGGFGDVYKGFINGSTT--------PVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL 331
           IG G FG   K  +  S           + I ++ P+ ++   E + E+ +LS ++H ++
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNI 61

Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V       ++  + +V D+   G L   +        P +Q L+  +     L ++H   
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV--SKTHLDPEYYRLQQLTE--- 446
               I+HRD+K+ NI L +    K+ DFG+++   ++V  ++T +   YY   ++ E   
Sbjct: 122 ----ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP 177

Query: 447 ---KSDVYSFGVVLFEVL 461
              KSD+++ G VL+E+ 
Sbjct: 178 YNNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 55/263 (20%), Positives = 107/263 (40%), Gaps = 41/263 (15%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSLI-- 335
           +IG G +G VY+G    +   VA+K +  ++    + + Q E+ +LSQLR     ++   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 336 -GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA-----RGLHYLHT 389
            G       + ++ ++   G++   +      P+      E  I          L Y+H 
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIA-----EKYISVIIREVLVALKYIH- 118

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYR- 440
                 +IHRD+K  NIL+      K+ DFG++     + SK          + PE    
Sbjct: 119 ---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE 175

Query: 441 LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK 500
            +    K+D++S G+ ++E+    P      A + + L   ++            + + K
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLED------NGYSK 229

Query: 501 AM-----SCLNDEGIRRPSMSDV 518
            +     +CL++E   R S  ++
Sbjct: 230 LLREFVAACLDEEPKERLSAEEL 252

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 59/201 (29%), Positives = 87/201 (43%), Gaps = 29/201 (14%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE----------FQTEIGMLSQLRH 328
           V+G G FG V       +    AIK L+        E          F+T     +  RH
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFET----ANSERH 61

Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
             LV+L      +  +  V ++ A G L  H+ H+D    P       C+    GL YLH
Sbjct: 62  PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACV--VLGLQYLH 118

Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK--FGPTSVSKTHL-DPEYYRLQQLT 445
                  I++RD+K  N+LLD +   K++DFGL K   G    + T    PE+   + LT
Sbjct: 119 ENK----IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT 174

Query: 446 EKS-----DVYSFGVVLFEVL 461
           E S     D +  GV+++E+L
Sbjct: 175 ETSYTRAVDWWGLGVLIYEML 195

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 22/197 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLI 335
           V+G GGFG+V    +  +    A K+LE +    ++G      E  +L ++    +VSL 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL----EICIGAARGLHYLHTGA 391
                   + LV   M  G L  H+YH         + +    EIC G    L  LH   
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLH--- 119

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-------HLDPEYYRLQQL 444
               I++RD+K  NILLD+    ++SD GL+   P   +         ++ PE  + ++ 
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 178

Query: 445 TEKSDVYSFGVVLFEVL 461
           T   D ++ G +L+E++
Sbjct: 179 TFSPDWWALGCLLYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 27/196 (13%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIK--RLEPESQ---QGALEFQTEIGMLSQLRHLHLVSL 334
           IG G +G VYK     +   VA+K  RLE E +     A+    EI +L +L H ++V L
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---EISLLKELNHPNIVRL 63

Query: 335 IGFCNDDREMILVYDF--MARGTLPDHLYHSDNPPLPWNQRL-EICIGAARGLHYLHTGA 391
           +   + + ++ LV++F  +      D    +   P      L ++     +G+ Y H+  
Sbjct: 64  LDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL----QGIAYCHS-- 117

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTHLDPE----YYRLQQLTE 446
            H  ++HRD+K  N+L+D +   K++DFGL++ FG    + TH   E    +YR  ++  
Sbjct: 118 -HR-VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVVTLWYRAPEILL 172

Query: 447 KSDVYSFGVVLFEVLC 462
            S  YS  V ++ + C
Sbjct: 173 GSRQYSTPVDIWSIGC 188

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 48/197 (24%), Positives = 98/197 (49%), Gaps = 16/197 (8%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT-EIGMLSQLRHLHLVSLIGFC 338
           +G G +  VYKG    +   VA+K +  ++++G       EI ++ +L+H ++V L    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 339 NDDREMILVYDFMARGTLPDHL-YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
           + + +++LV+++M    L  ++  H     L  N          +G+ + H       ++
Sbjct: 68  HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR----VL 122

Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQLTEKS------- 448
           HRD+K  N+L++++   K++DFGL++ FG P +     +   +YR   +   S       
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSI 182

Query: 449 DVYSFGVVLFEVLCARP 465
           D++S G ++ E++  RP
Sbjct: 183 DIWSVGCIMAEMITGRP 199

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 15/200 (7%)

Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            DN + IG G  G V    +  S   VA+K+++   QQ       E+ ++   +H ++V 
Sbjct: 22  LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +        E+ +V +F+  G L D + H+    +   Q   +C+   + L  LH     
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLHAQG-- 136

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS--KTHLDPEYYRLQQLTEK---- 447
             +IHRD+K+ +ILL      K+SDFG        V   K+ +   Y+   +L  +    
Sbjct: 137 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194

Query: 448 --SDVYSFGVVLFEVLCARP 465
              D++S G+++ E++   P
Sbjct: 195 PEVDIWSLGIMVIEMVDGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 57/230 (24%), Positives = 93/230 (40%), Gaps = 64/230 (27%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEF--QTEIGMLSQLRHLHLVSLIGF 337
           +G G FG+VYK     +   VA+K++   +++         EI +L +L+H ++V LI  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLI-- 73

Query: 338 CNDDREMILVYDFMARGTLP---------DH----LYHSDNPPLPWN---------QRLE 375
                +M +     ++             DH    L    NP +            Q LE
Sbjct: 74  -----DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE--NPSVKLTESQIKCYMLQLLE 126

Query: 376 ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---------GP 426
                  G++YLH   NH  I+HRD+K  NIL+D + + K++DFGL++          G 
Sbjct: 127 -------GINYLH--ENH--ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 427 TSVSKTHLDP----EYYR-------LQQLTEKSDVYSFGVVLFEVLCARP 465
                          +YR        ++ T   D++  G V  E+   RP
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 50/197 (25%), Positives = 92/197 (46%), Gaps = 15/197 (7%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G  G VY      +   VAIK++  + Q        EI ++ + +H ++V+ +    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              E+ +V +++A G+L D +  +    +   Q   +C    + L +LH  +N   +IHR
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQ--VIHR 139

Query: 400 DVKTTNILLDEKWVAKVSDFGL-SKFGPTSVSKTH-------LDPEYYRLQQLTEKSDVY 451
           D+K+ NILL      K++DFG  ++  P    ++        + PE    +    K D++
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 452 SFGVVLFEVLCARPSIL 468
           S G++  E++   P  L
Sbjct: 200 SLGIMAIEMVEGEPPYL 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 61.9 bits (151), Expect = 3e-10
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 38/208 (18%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRL-EP-ESQQGALEFQTEIGMLSQLRHLHLVSLIG- 336
           +G G +G V   F   +   VAIK+L  P +S   A     E+ +L  + H +++ L+  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 337 FC-----NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICIGA---ARGLH 385
           F       D +++ LV   M        L +     +   Q+L    I        RGL 
Sbjct: 83  FTPASSLEDFQDVYLVTHLMGA-----DLNN-----IVKCQKLSDDHIQFLVYQILRGLK 132

Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-HLDPEYYRLQQL 444
           Y+H+    A IIHRD+K +NI ++E    K+ DFGL++   T    T ++   +YR  ++
Sbjct: 133 YIHS----AGIIHRDLKPSNIAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEI 186

Query: 445 -------TEKSDVYSFGVVLFEVLCARP 465
                   +  D++S G ++ E+L  + 
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKT 214

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 21/205 (10%)

Query: 273 NFDNDLVIGVGGFGDVYKG-FINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRH 328
           +F+    +G G FG V    + N    PVAIKR E      Q+      +E  +L+ + H
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90

Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGL---H 385
              V+L G   D+  + LV +F+  G     L  +   P         C  AA+ +    
Sbjct: 91  PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG-----CFYAAQIVLIFE 145

Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLT 445
           YL +      I++RD+K  N+LLD+    K++DFG +K   T        PEY   + L 
Sbjct: 146 YLQS----LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILL 201

Query: 446 -----EKSDVYSFGVVLFEVLCARP 465
                + +D ++ G+ ++E+L   P
Sbjct: 202 NVGHGKAADWWTLGIFIYEILVGCP 226

Length = 340

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 61.0 bits (148), Expect = 8e-10
 Identities = 32/91 (35%), Positives = 56/91 (61%), Gaps = 14/91 (15%)

Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS----KT------H 433
           +H++H+   H  +IHRD+K+ NILL    + K+ DFG SK    +VS    +T      +
Sbjct: 156 VHHVHS--KH--MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           + PE +R +  ++K+D++S GV+L+E+L  +
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242

Length = 496

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 60.0 bits (145), Expect = 8e-10
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)

Query: 280 IGVGGFGDVYKG--FINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLR---HLHLV 332
           IG G +G V+K     NG    VA+KR+  ++ +  +   T  E+ +L  L    H ++V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRF-VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 333 SLIGFCN---DDRE--MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
            L   C     DRE  + LV++ + +  L  +L     P +P     ++     RGL +L
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126

Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF-----GPTSVSKT--HLDPEYYR 440
           H+   H V+ HRD+K  NIL+      K++DFGL++        TSV  T  +  PE   
Sbjct: 127 HS---HRVV-HRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 182

Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
                   D++S G +  E+   +P
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 8e-10
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 22/200 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQT--EIGMLSQLRHLHLVSL 334
            +G G +  VYKG    +   VA+K  RLE E  +GA  F    E  +L  L+H ++V+L
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGA-PFTAIREASLLKDLKHANIVTL 68

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
               +  + + LV++++    L  ++          N RL       RGL Y H      
Sbjct: 69  HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRL-FLFQLLRGLAYCH----QR 122

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGL--SKFGPTSVSKTHLDPEYYR----LQQLTEKS 448
            ++HRD+K  N+L+ E+   K++DFGL  +K  P+      +   +YR    L   TE S
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 449 ---DVYSFGVVLFEVLCARP 465
              D++  G + +E+   RP
Sbjct: 183 TSLDMWGVGCIFYEMATGRP 202

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 53/198 (26%), Positives = 81/198 (40%), Gaps = 20/198 (10%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEI----GMLSQLRHLHLVSLI 335
           +GVGGFG V    +       A+K +  +        Q  I     +L +  H  +V L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCV-KKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
               D + + ++ ++   G L   L           +    C+  A    YLH       
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLA--FEYLH--NRG-- 113

Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHL---DPEYYRLQQLTEK----- 447
           II+RD+K  N+LLD     K+ DFG +K    S  KT      PEY   + +  K     
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKK-LKSGQKTWTFCGTPEYVAPEIILNKGYDFS 172

Query: 448 SDVYSFGVVLFEVLCARP 465
            D +S G++L+E+L  RP
Sbjct: 173 VDYWSLGILLYELLTGRP 190

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 59.9 bits (146), Expect = 8e-10
 Identities = 50/209 (23%), Positives = 100/209 (47%), Gaps = 45/209 (21%)

Query: 283 GGFGDVYKGFINGSTTPVAIKRL--EPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCND 340
           G +G VY+     +   VA+K+L  E E +   +    EI +L +L+H ++V++      
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTV------ 69

Query: 341 DREMI---------LVYDFMARG--TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
            +E++         +V +++     +L + +      P   ++   + +    G+ +LH 
Sbjct: 70  -KEVVVGSNLDKIYMVMEYVEHDLKSLMETM----KQPFLQSEVKCLMLQLLSGVAHLH- 123

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS-KFG-P----TSVSKTHLDPEYYRLQQ 443
                 I+HRD+KT+N+LL+ + + K+ DFGL+ ++G P    T +  T     +YR  +
Sbjct: 124 ---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL----WYRAPE 176

Query: 444 L-------TEKSDVYSFGVVLFEVLCARP 465
           L       +   D++S G +  E+L  +P
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTKKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 60.2 bits (146), Expect = 8e-10
 Identities = 63/201 (31%), Positives = 89/201 (44%), Gaps = 22/201 (10%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIG-----MLSQLRHLHLVS 333
           VIG G FG V            A+K L+ ++     E Q  I      +L  ++H  LV 
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLVG 60

Query: 334 L-IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           L   F   D+ +  V D++  G L  HL    + P P  +     I +A G  YLH+   
Sbjct: 61  LHYSFQTADK-LYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS--- 114

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--PTSVSKT------HLDPEYYRLQQL 444
              II+RD+K  NILLD +    ++DFGL K G   +  + T      +L PE  R Q  
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173

Query: 445 TEKSDVYSFGVVLFEVLCARP 465
               D +  G VL+E+L   P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 59.6 bits (144), Expect = 9e-10
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 25/209 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGF 337
           V+G G +G VYKG    +    AIK ++    +   E + EI ML +   H ++ +  G 
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE-EIKLEINMLKKYSHHRNIATYYGA 81

Query: 338 ------CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
                    D ++ LV +F   G++ D + ++    L  +    IC    RGL +LH  A
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH--A 139

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSK--THLDPEYYRLQQLTE--- 446
           +   +IHRD+K  N+LL E    K+ DFG+S     +V +  T +   Y+   ++     
Sbjct: 140 HK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 197

Query: 447 --------KSDVYSFGVVLFEVLCARPSI 467
                   +SD++S G+   E+    P +
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 54/197 (27%), Positives = 86/197 (43%), Gaps = 22/197 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLI 335
           V+G GGFG+V    +  +    A KRLE +    ++G      E  +L ++    +V+L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL----EICIGAARGLHYLHTGA 391
                   + LV   M  G L  H+Y+  NP     + L    EI  G    L  LH   
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----LEDLHREN 122

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-------HLDPEYYRLQQL 444
                ++RD+K  NILLD+    ++SD GL+   P   S         ++ PE    Q+ 
Sbjct: 123 ----TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY 178

Query: 445 TEKSDVYSFGVVLFEVL 461
           T   D +  G +++E++
Sbjct: 179 TLSPDYWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 25/209 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI--G 336
           ++G G +G VYKG    +    AIK ++    +   E + EI ML +  H   ++     
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKKYSHHRNIATYYGA 71

Query: 337 FCND-----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           F        D ++ LV +F   G++ D + ++    L       IC    RGL +LH   
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 128

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSK--THLDPEYYRLQQLTE--- 446
            H VI HRD+K  N+LL E    K+ DFG+S     +V +  T +   Y+   ++     
Sbjct: 129 QHKVI-HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 187

Query: 447 --------KSDVYSFGVVLFEVLCARPSI 467
                   KSD++S G+   E+    P +
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 22/215 (10%)

Query: 280 IGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHLHLVSLI 335
           +G G +  VYKG   ING    VA+K +  ++++G + F    E  +L  L+H ++V L 
Sbjct: 13  LGEGSYATVYKGISRINGQL--VALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLH 69

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
              +    +  V+++M    L  ++        P+N RL       RGL Y+H       
Sbjct: 70  DIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH----GQH 123

Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGL--SKFGPTSVSKTHLDPEYYR----LQQLTEKS- 448
           I+HRD+K  N+L+      K++DFGL  +K  P+    + +   +YR    L   T+ S 
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183

Query: 449 --DVYSFGVVLFEVLCARPSILRTAAKKQVSLAVW 481
             D++  G +  E+L  +P+    +   +    +W
Sbjct: 184 ALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 36/106 (33%), Positives = 52/106 (49%), Gaps = 18/106 (16%)

Query: 367 PLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP 426
           P+P +   ++ +   + LHYL     H VI HRDVK +NILLD     K+ DFG+S    
Sbjct: 110 PIPEDILGKMTVAIVKALHYLKE--KHGVI-HRDVKPSNILLDASGNVKLCDFGISGRLV 166

Query: 427 TSVSKT-------HLDPEYYRLQQLTEK------SDVYSFGVVLFE 459
            S +KT       ++ PE  R+            +DV+S G+ L E
Sbjct: 167 DSKAKTRSAGCAAYMAPE--RIDPPDPNPKYDIRADVWSLGISLVE 210

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 34/89 (38%), Positives = 50/89 (56%), Gaps = 12/89 (13%)

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-------- 432
           A  L +LH+      II+RD+K  NILLDE+   K++DFGLSK       K         
Sbjct: 108 ALALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 163

Query: 433 HLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           ++ PE    +  T+ +D +SFGV++FE+L
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEML 192

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 20/205 (9%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQLRHLHLVSLIG 336
           IG G FG VY      +   VAIK++    +Q   ++Q    E+  L +++H + +   G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +    LV ++   G+  D L      PL   +   I  GA +GL YLH+      +
Sbjct: 93  CYLREHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYLHSHN----M 146

Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQ---------QLTEK 447
           IHRD+K  NILL E    K++DFG +     S + + +   Y+            Q   K
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASI--ASPANSFVGTPYWMAPEVILAMDEGQYDGK 204

Query: 448 SDVYSFGVVLFEVLCARPSILRTAA 472
            DV+S G+   E+   +P +    A
Sbjct: 205 VDVWSLGITCIELAERKPPLFNMNA 229

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 58.6 bits (141), Expect = 2e-09
 Identities = 49/197 (24%), Positives = 93/197 (47%), Gaps = 15/197 (7%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G  G V+      +   VAIK++  + Q        EI ++ +L++ ++V+ +    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              E+ +V +++A G+L D +  +    +   Q   +C    + L +LH  AN   +IHR
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLH--ANQ--VIHR 139

Query: 400 DVKTTNILLDEKWVAKVSDFGL-SKFGPTSVSKTH-------LDPEYYRLQQLTEKSDVY 451
           D+K+ N+LL      K++DFG  ++  P    ++        + PE    +    K D++
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 452 SFGVVLFEVLCARPSIL 468
           S G++  E++   P  L
Sbjct: 200 SLGIMAIEMVEGEPPYL 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 22/197 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLI 335
           V+G GGFG+V    +  +    A K+LE +    ++G      E  +L ++    +VSL 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL----EICIGAARGLHYLHTGA 391
                   + LV   M  G L  H+Y+  NP     + +    EI  G    L  LH   
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG----LEDLHR-- 120

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLS---KFGPTSVSKT----HLDPEYYRLQQL 444
               I++RD+K  NILLD+    ++SD GL+     G T   +     ++ PE  + ++ 
Sbjct: 121 --ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY 178

Query: 445 TEKSDVYSFGVVLFEVL 461
           T   D +  G +++E++
Sbjct: 179 TFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 33/202 (16%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHLH------L 331
           +G G +G VYK     +   +A+K  RLE       L+      ++ +L  LH      +
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLE-------LDESKFNQIIMELDILHKAVSPYI 61

Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLY--HSDNPPLPWNQRLEICIGAARGLHYLHT 389
           V   G    +  + +  ++M  G+L D LY        +P +    I     +GL +L  
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYY----RLQQL- 444
             N   IIHRDVK TN+L++     K+ DFG+S     S++KT++  + Y    R++   
Sbjct: 121 EHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGG 177

Query: 445 -------TEKSDVYSFGVVLFE 459
                  T +SDV+S G+ + E
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILE 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 58.2 bits (140), Expect = 3e-09
 Identities = 47/197 (23%), Positives = 91/197 (46%), Gaps = 15/197 (7%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G  G VY      +   VAI+++  + Q        EI ++ + ++ ++V+ +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              E+ +V +++A G+L D +  +    +   Q   +C    + L +LH+      +IHR
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ----VIHR 140

Query: 400 DVKTTNILLDEKWVAKVSDFGL-SKFGPTSVSKTH-------LDPEYYRLQQLTEKSDVY 451
           D+K+ NILL      K++DFG  ++  P    ++        + PE    +    K D++
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200

Query: 452 SFGVVLFEVLCARPSIL 468
           S G++  E++   P  L
Sbjct: 201 SLGIMAIEMIEGEPPYL 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 58.5 bits (142), Expect = 4e-09
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 40/213 (18%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHLHLVSLIG 336
            IG G +G V       S   VAIK++        L  +T  E+ +L   +H +++++  
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71

Query: 337 FC----NDDREMILVYDFMARGTLPDHLYHSDNPPLPWN------QRLEICIGAARGLHY 386
                  D +++ +V D M   +   H+ HSD P    +      Q L       RGL Y
Sbjct: 72  ILRPPGADFKDVYVVMDLM--ESDLHHIIHSDQPLTEEHIRYFLYQLL-------RGLKY 122

Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS--VSKTHLDPEY-----Y 439
           +H+    A +IHRD+K +N+L++E    ++ DFG+++   +S    K  +  EY     Y
Sbjct: 123 IHS----ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT-EYVATRWY 177

Query: 440 R-------LQQLTEKSDVYSFGVVLFEVLCARP 465
           R       L + T   D++S G +  E+L  R 
Sbjct: 178 RAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 57.8 bits (139), Expect = 4e-09
 Identities = 48/197 (24%), Positives = 91/197 (46%), Gaps = 15/197 (7%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G  G VY      +   VAIK++  + Q        EI ++ + ++ ++V+ +    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              E+ +V +++A G+L D +  +    +   Q   +C    + L +LH+      +IHR
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQ----VIHR 139

Query: 400 DVKTTNILLDEKWVAKVSDFGL-SKFGPTSVSKTH-------LDPEYYRLQQLTEKSDVY 451
           D+K+ NILL      K++DFG  ++  P    ++        + PE    +    K D++
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 452 SFGVVLFEVLCARPSIL 468
           S G++  E++   P  L
Sbjct: 200 SLGIMAIEMVEGEPPYL 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 59/200 (29%), Positives = 86/200 (43%), Gaps = 20/200 (10%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE-----SQQGALEFQTEIGMLSQLRHLHLVS 333
           VIG G FG V            A+K L+ +      +Q  +  +  + +L  ++H  LV 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVG 60

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L        ++  V DF+  G L  HL    + P P  +     I +A G  YLH+    
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS---- 114

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------HLDPEYYRLQQLT 445
             I++RD+K  NILLD +    ++DFGL K G      T        +L PE  R Q   
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174

Query: 446 EKSDVYSFGVVLFEVLCARP 465
              D +  G VL+E+L   P
Sbjct: 175 NTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 56.8 bits (137), Expect = 8e-09
 Identities = 50/196 (25%), Positives = 93/196 (47%), Gaps = 23/196 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK----RLEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           ++G G  G VYK +   +   +A+K     +  E Q+   +  +E+ +L +    +++  
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK---QIMSELEILYKCDSPYIIGF 64

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
            G    +  + +  +FM  G+L   +Y      +P +    I +   +GL YL +     
Sbjct: 65  YGAFFVENRISICTEFMDGGSL--DVYRK----IPEHVLGRIAVAVVKGLTYLWS----L 114

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPEYYRLQQLTEKS 448
            I+HRDVK +N+L++ +   K+ DFG+S     S++KT      ++ PE    +Q    S
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 449 DVYSFGVVLFEVLCAR 464
           DV+S G+   E+   R
Sbjct: 175 DVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 57.1 bits (138), Expect = 8e-09
 Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 55/221 (24%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           VIG G +G V       +   VAIK++    E    A     EI +L  LRH  +V +  
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 337 FC-----NDDREMILVYDFM---------ARGTL-PDH----LYHSDNPPLPWNQRLEIC 377
                   + +++ +V++ M         A   L P+H    LY          Q L   
Sbjct: 67  IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLY----------QLL--- 113

Query: 378 IGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF----GPTSVSKT- 432
               R L Y+HT    A + HRD+K  NIL +     K+ DFGL++      PT++  T 
Sbjct: 114 ----RALKYIHT----ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165

Query: 433 HLDPEYYRLQQL--------TEKSDVYSFGVVLFEVLCARP 465
           ++   +YR  +L        T   D++S G +  EVL  +P
Sbjct: 166 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 57.6 bits (139), Expect = 8e-09
 Identities = 40/110 (36%), Positives = 56/110 (50%), Gaps = 14/110 (12%)

Query: 367 PLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF-- 424
           PLP +Q L I      GL YLH       IIHRDVKT NI +++     + D G ++F  
Sbjct: 153 PLPIDQALIIEKQILEGLRYLHAQR----IIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208

Query: 425 ------GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSIL 468
                 G     +T+  PE     +   K+D++S G+VLFE+L A PS +
Sbjct: 209 VAPAFLGLAGTVETN-APEVLARDKYNSKADIWSAGIVLFEML-AYPSTI 256

Length = 357

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 57.0 bits (138), Expect = 8e-09
 Identities = 57/197 (28%), Positives = 87/197 (44%), Gaps = 20/197 (10%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQLRHLHLVSLIG 336
           +G GG+G V+      +   VA+KR++        E +   TE  +L+  +   LV L+ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ-RLEIC--IGAARGLHYLHTGANH 393
              DD  + L  +++  G     L  ++   L  +  R  +     A   LH L      
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDALHELG----- 121

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT---SV--SKTHLDPEYYRLQQLTEKS 448
              IHRD+K  N L+D     K++DFGLSK   T   SV  S  ++ PE  R +      
Sbjct: 122 --YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTV 179

Query: 449 DVYSFGVVLFEVLCARP 465
           D +S G +L+E LC  P
Sbjct: 180 DYWSLGCMLYEFLCGFP 196

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 60/200 (30%), Positives = 89/200 (44%), Gaps = 23/200 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSL- 334
           ++G G FG V       S    A+K L+ E   ++       TE  +L   RH  L SL 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA--ARGLHYLHTGAN 392
             F   DR +  V +++  G L    +H     +    R     GA     L YLH+G  
Sbjct: 62  YSFQTKDR-LCFVMEYVNGGEL---FFHLSRERVFSEDRTRF-YGAEIVSALDYLHSGK- 115

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS--KT------HLDPEYYRLQQL 444
              I++RD+K  N++LD+    K++DFGL K G T  +  KT      +L PE       
Sbjct: 116 ---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY 172

Query: 445 TEKSDVYSFGVVLFEVLCAR 464
               D +  GVV++E++C R
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 43/146 (29%), Positives = 64/146 (43%), Gaps = 25/146 (17%)

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG----AARGLHY 386
           LV+L      D ++ L+ D++  G L  HLY  ++        + + I     A   LH 
Sbjct: 67  LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE---SEVRVYIAEIVLALDHLHQ 123

Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH--------LDPE 437
           L        II+RD+K  NILLD +    ++DFGLSK F      + +        + PE
Sbjct: 124 LG-------IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176

Query: 438 YYRLQQLTEKS--DVYSFGVVLFEVL 461
             R          D +S GV+ FE+L
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 22/198 (11%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ------TEIGMLSQLRHLHLVS 333
           +G G FG V      G+    AIK L+   ++  L+ +       E  +L +L H  +V+
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLK---KREILKMKQVQHVAQEKSILMELSHPFIVN 82

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEI-CIGAARGLHYLHTGAN 392
           ++    D+  +  + +F+  G L  HL  +   P   N   +           YLH+   
Sbjct: 83  MMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFP---NDVAKFYHAELVLAFEYLHS--- 136

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTEKS---- 448
              II+RD+K  N+LLD K   KV+DFG +K  P         PEY   + +  K     
Sbjct: 137 -KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKA 195

Query: 449 -DVYSFGVVLFEVLCARP 465
            D ++ GV+L+E +   P
Sbjct: 196 VDWWTMGVLLYEFIAGYP 213

Length = 329

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 20/200 (10%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES-----QQGALEFQTEIGMLSQLRHLHLVS 333
           VIG G FG V         +  A+K L+ ++     +Q  +  +  + +L  L+H  LV 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVG 60

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L        ++  V D++  G L  HL        P  +     + +A G  YLH+    
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIG--YLHS---- 114

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--PTSVSKT------HLDPEYYRLQQLT 445
             II+RD+K  NILLD +    ++DFGL K G  P   + T      +L PE  R +   
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174

Query: 446 EKSDVYSFGVVLFEVLCARP 465
              D +  G VL+E+L   P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 54/237 (22%), Positives = 101/237 (42%), Gaps = 50/237 (21%)

Query: 260 TQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLE--------PESQQ 311
             FS+SE             +G G +G V K +   +   VAIK+++         + +Q
Sbjct: 2   MSFSISERYIQKGAH-----LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQ 56

Query: 312 G----ALEFQT--EIGMLSQLRHLHLVSLIG-FCNDDREMILVYDFMA---RGTLPDHLY 361
                 + F T  E+ ++++++H +++ L+  +   D  + LV D MA   +  +   + 
Sbjct: 57  LVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF-INLVMDIMASDLKKVVDRKIR 115

Query: 362 HSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL 421
            +++      Q   I +    GL+ LH        +HRD+   NI ++ K + K++DFGL
Sbjct: 116 LTES------QVKCILLQILNGLNVLHK----WYFMHRDLSPANIFINSKGICKIADFGL 165

Query: 422 S-KFGPTSVSKTHLDPEY---------------YRLQQLTEKSDVYSFGVVLFEVLC 462
           + ++G    S T    E                YR  +L   ++ Y F V ++ V C
Sbjct: 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGC 222

Length = 335

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 15/218 (6%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           V+G G FG         S    A+K +  P+S     + + E  +L++++H ++V+    
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
              D  + +V ++   G L   +        P +  L+  +    G+ ++H       ++
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR----VL 122

Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSVSKTHLDPEYYRLQQLTE------KSD 449
           HRD+K+ NI L +    K+ DFG ++    P + + T++   YY   ++ E      KSD
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSD 182

Query: 450 VYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ 487
           ++S G +L+E LC      +  + K + L V  Q  Y+
Sbjct: 183 IWSLGCILYE-LCTLKHPFQANSWKNLILKV-CQGSYK 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 15/157 (9%)

Query: 319 EIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICI 378
           E+ +L +    ++V   G    D E+ +  + M  G+L   L  +   P     ++ I +
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108

Query: 379 GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV------SKT 432
              RGL YL     H  I+HRDVK +NIL++ +   K+ DFG+S     S+      +++
Sbjct: 109 --LRGLTYLRE--KHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 163

Query: 433 HLDPEYYRLQ--QLTEKSDVYSFGVVLFEVLCARPSI 467
           ++ PE  RLQ    T +SD++S G+ L E+   R  I
Sbjct: 164 YMSPE--RLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 32/87 (36%), Positives = 44/87 (50%), Gaps = 8/87 (9%)

Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--PTSVSKT--HLDPEY 438
           G+  LH       IIHRD+K  N+L+D+    K++DFGLS+ G        T  +L PE 
Sbjct: 109 GVEDLHQRG----IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPET 164

Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
                  + SD +S G V+FE L   P
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 55.2 bits (134), Expect = 2e-08
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 29/203 (14%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRL--EPESQQGALEFQTEIGMLSQL-RHLHLVSLIG 336
           +G G FG VY      +   VAIK++  +  S +  +  + E+  L +L  H ++V L  
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKLNEHPNIVKLKE 65

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
              ++ E+  V+++M  G L   +      P   +    I     +GL ++H    H   
Sbjct: 66  VFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHG-F 120

Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDP--EY-----YRLQQLTEKSD 449
            HRD+K  N+L+    V K++DFGL++      S+    P  +Y     YR  ++  +S 
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAR---EIRSR---PPYTDYVSTRWYRAPEILLRST 174

Query: 450 VYS-------FGVVLFEVLCARP 465
            YS        G ++ E+   RP
Sbjct: 175 SYSSPVDIWALGCIMAELYTLRP 197

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 42/207 (20%)

Query: 283 GGFGDVYKGFIN----GSTTPVAIKRLEPESQQGALEFQ-----TEIGMLSQLRHLHLVS 333
           G FG ++ G +     G    V +K +    +  A E Q      E  +L  L H +++ 
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTV----KDHASEIQVTLLLQESCLLYGLSHQNILP 72

Query: 334 LIGFCNDDREMILV-YDFMARGTLPDHL----YHSDNPPLPWNQR--LEICIGAARGLHY 386
           ++  C +D E   V Y +M  G L   L        N P   + +  + + I  A G+ Y
Sbjct: 73  ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132

Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK--FGPTSVSKTH----------- 433
           LH      VI H+D+   N ++DE+   K++D  LS+  F P      H           
Sbjct: 133 LH---KRGVI-HKDIAARNCVIDEELQVKITDNALSRDLF-P---MDYHCLGDNENRPVK 184

Query: 434 -LDPEYYRLQQLTEKSDVYSFGVVLFE 459
            +  E    ++ +  SDV+SFGV+L+E
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWE 211

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 39/112 (34%), Positives = 53/112 (47%), Gaps = 16/112 (14%)

Query: 367 PLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS---- 422
           PLP  Q + I       L YLH       IIHRDVKT NI LDE   A + DFG +    
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGRG----IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236

Query: 423 -------KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSI 467
                   +G +   +T+  PE   L     K+D++S G+VLFE+     ++
Sbjct: 237 AHPDTPQCYGWSGTLETN-SPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 28/203 (13%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRL-EP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V       +   VAIK+L  P +S+  A     E+ +L  ++H +++ L+  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 338 CNDD------REMILVYDFMAR--GTLPDHLYHSDNPPLPWNQRLEICI-GAARGLHYLH 388
              D       +  LV  FM    G L  H   S++       R++  +    +GL Y+H
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSED-------RIQFLVYQMLKGLKYIH 135

Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS-----VSKTHLDPEY-YRLQ 442
                A IIHRD+K  N+ ++E    K+ DFGL++   +      V++ +  PE      
Sbjct: 136 A----AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWM 191

Query: 443 QLTEKSDVYSFGVVLFEVLCARP 465
             T+  D++S G ++ E+L  +P
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGKP 214

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 54.8 bits (132), Expect = 5e-08
 Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 12/87 (13%)

Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------HL 434
           GL +LH       II+RD+K  N+LLD+    K++DFG+ K       K         ++
Sbjct: 108 GLQFLHKKG----IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYI 163

Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            PE  + Q+  E  D +SFGV+L+E+L
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 24/198 (12%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLI 335
           V+G GGFG+V    +  +    A K+LE +    ++G      E  +L ++    +VSL 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL-----EICIGAARGLHYLHTG 390
                   + LV   M  G L  H+Y+  NP     QR      E+C G    L  L   
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD-EQRAIFYAAELCCG----LEDLQ-- 119

Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV-------SKTHLDPEYYRLQQ 443
                I++RD+K  NILLD++   ++SD GL+   P          +  ++ PE    ++
Sbjct: 120 --RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEK 177

Query: 444 LTEKSDVYSFGVVLFEVL 461
            T   D +  G +++E++
Sbjct: 178 YTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 54.4 bits (131), Expect = 6e-08
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRH-LHLVSLIG 336
           IG G +G VYK     +   VA+K+   E  +  +      EI +L  L   +++V L+ 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 337 FCNDDRE-----MILVYDFMARG--TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
             + + +     + LV++++        D        PLP            +G+ + H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH- 127

Query: 390 GANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQLTE 446
              H V+ HRD+K  N+L+D +K + K++D GL + F     S TH +   +YR  ++  
Sbjct: 128 --KHGVM-HRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLL 184

Query: 447 KSDVYSFGVVLFEVLCARPSILRTAA 472
            S  YS  V ++ V C    + R   
Sbjct: 185 GSTHYSTPVDIWSVGCIFAEMSRKQP 210

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 54.7 bits (132), Expect = 6e-08
 Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 16/94 (17%)

Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE---- 437
           RGL YLH+    A I+HRD+K  N+L++   V K+ DFGL++      SK H+  E    
Sbjct: 114 RGLKYLHS----AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-HMTQEVVTQ 168

Query: 438 YYRLQQL-------TEKSDVYSFGVVLFEVLCAR 464
           YYR  ++       T   D++S G +  E+L  R
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 54.4 bits (131), Expect = 7e-08
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 14/94 (14%)

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK---FGPTSVSKT----- 432
           A GL +LH+      II+RD+K  N++LD +   K++DFG+ K   FG  + ++T     
Sbjct: 111 AIGLFFLHSKG----IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT-TRTFCGTP 165

Query: 433 -HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
            ++ PE    Q   +  D ++FGV+L+E+L  +P
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 54.3 bits (130), Expect = 7e-08
 Identities = 49/200 (24%), Positives = 85/200 (42%), Gaps = 15/200 (7%)

Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            +N + IG G  G V       S   VA+K ++   QQ       E+ ++   +H ++V 
Sbjct: 23  LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVE 82

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +        E+ ++ +F+  G L D +  +    L   Q   +C    + L YLH+    
Sbjct: 83  MYKSYLVGEELWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLHSQG-- 137

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLT 445
             +IHRD+K+ +ILL      K+SDFG        V K          + PE        
Sbjct: 138 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195

Query: 446 EKSDVYSFGVVLFEVLCARP 465
            + D++S G+++ E++   P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 55.0 bits (132), Expect = 7e-08
 Identities = 49/197 (24%), Positives = 93/197 (47%), Gaps = 26/197 (13%)

Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS----------KTHLDPEYYRLQQLT 445
           ++HRD+K+ NI L    + K+ DFG SK    SVS            +L PE +  ++ +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249

Query: 446 EKSDVYSFGVVLFEVLCA-RPSILRTAAKKQVSLAVWAQQ-----CYQNGTIDQIVDPFL 499
           +K+D++S GV+L+E+L   RP   +  +++++   V   +     C  +  +  ++DP L
Sbjct: 250 KKADMWSLGVILYELLTLHRP--FKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLL 307

Query: 500 KAMSCLNDEGIRRPSMSDVVWG--LEFSLQLQESSIAIAKEIDENEEEEKLLDNYETDGS 557
                L      RP+   ++    L++   L +  +  ++ I  ++ EE L    E+   
Sbjct: 308 SKNPAL------RPTTQQLLHTEFLKYVANLFQDIVRHSETISPHDREEILRQLQESGER 361

Query: 558 GPVFSSVGEHVLSDSKT 574
            P  SS+   V++   T
Sbjct: 362 APPPSSIRYGVVTSDVT 378

Length = 478

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.1 bits (130), Expect = 8e-08
 Identities = 37/104 (35%), Positives = 53/104 (50%), Gaps = 30/104 (28%)

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYR 440
           ARG+ +L +       IHRD+   NILL E  V K+ DFGL++         + DP+Y R
Sbjct: 183 ARGMEFLASRK----CIHRDLAARNILLSENNVVKICDFGLAR-------DIYKDPDYVR 231

Query: 441 -------LQQL----------TEKSDVYSFGVVLFEV--LCARP 465
                  L+ +          T +SDV+SFGV+L+E+  L A P
Sbjct: 232 KGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 35/162 (21%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQ-----QGALEFQTEIGMLSQLRHLHLVSL 334
           IG G +G V+K     +   VA+KR+  +         AL    EI +L +L+H ++V L
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKHKNIVRL 64

Query: 335 IGFCNDDREMILVYDFM----------ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGL 384
               + D+++ LV+++             G +   +  S        Q L       +GL
Sbjct: 65  YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKS-----FMFQLL-------KGL 112

Query: 385 HYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG 425
            + H+   H V +HRD+K  N+L+++    K++DFGL++ FG
Sbjct: 113 AFCHS---HNV-LHRDLKPQNLLINKNGELKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 28/200 (14%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQ------LRHLHLV 332
           ++G G FG V+   + G+    AIK L+ +     ++   E  M+ +        H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHL---YHSDNPPLPWNQRLEICIGAARGLHYLHT 389
            L         +  V +++  G L  H+   +  D P   +     IC     GL +LH+
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC-----GLQFLHS 114

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------HLDPEYYRL 441
                 I++RD+K  NILLD     K++DFG+ K      +KT        ++ PE    
Sbjct: 115 KG----IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 442 QQLTEKSDVYSFGVVLFEVL 461
           Q+     D +SFGV+L+E+L
Sbjct: 171 QKYNTSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 1e-07
 Identities = 42/153 (27%), Positives = 64/153 (41%), Gaps = 19/153 (12%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE----SQQGALEFQTEIGMLSQLRHLHLVSL 334
           VIG G FG+V+      +    A+K L         Q A   + E  +L+      +V L
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADADSPWIVKL 66

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ----RLEICIGAARGLHYLHTG 390
                D+  + LV ++M  G L + L   D  P    +     L + + +   L +    
Sbjct: 67  YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF---- 122

Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
                 IHRD+K  NIL+D     K++DFGL K
Sbjct: 123 ------IHRDIKPDNILIDADGHIKLADFGLCK 149

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 44/162 (27%), Positives = 78/162 (48%), Gaps = 11/162 (6%)

Query: 319 EIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICI 378
           E+ +L +    ++V   G    D E+ +  + M  G+L   L  +    +P     ++ I
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSI 110

Query: 379 GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV------SKT 432
              RGL YL        I+HRDVK +NIL++ +   K+ DFG+S     S+      +++
Sbjct: 111 AVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 167

Query: 433 HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK 474
           ++ PE  +    + +SD++S G+ L E+   R  I    AK+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 53.7 bits (130), Expect = 1e-07
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 26/102 (25%)

Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDP----- 436
           + L Y+H+G     +IHRD+K +NILL+     K++DFGL++    S+S+   +P     
Sbjct: 118 KALKYIHSGN----VIHRDLKPSNILLNSDCRVKLADFGLAR----SLSELEENPENPVL 169

Query: 437 -EY-----YRLQQLTEKSDVYSFGV-------VLFEVLCARP 465
            +Y     YR  ++   S  Y+ GV       +L E+L  +P
Sbjct: 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 63/222 (28%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G +G V     + +   VAIK++    +++  A     EI +L  L H +++++   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 338 C--------NDDREMILVYDFM-------ARGTLP---DH----LYHSDNPPLPWNQRLE 375
                    ND   + +VY+ M        R +     DH    LY          Q L 
Sbjct: 73  MPPPHREAFND---VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLY----------QLL- 118

Query: 376 ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD 435
                 RGL Y+H+ AN   ++HRD+K +N+LL+     K+ DFGL++   T+  K    
Sbjct: 119 ------RGLKYIHS-AN---VLHRDLKPSNLLLNANCDLKICDFGLAR---TTSEKGDFM 165

Query: 436 PEY-----YRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            EY     YR  +L       T   DV+S G +  E+L  +P
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 51/195 (26%), Positives = 73/195 (37%), Gaps = 31/195 (15%)

Query: 283 GGFGDVYKGFINGSTTPVAIKR--LEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCND 340
                + K     + T VA+K+  L+  S++     Q EI    QL+H +++  +     
Sbjct: 13  LMIVHLAKH--KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV 70

Query: 341 DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICI---GAARGLHYLHTGANHAVII 397
           D E+ +V   MA G+  D L       LP    L I          L Y+H        I
Sbjct: 71  DSELYVVSPLMAYGSCEDLLKTHFPEGLP---ELAIAFILKDVLNALDYIH----SKGFI 123

Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSK------------FGPTSVSKTHLD---PE--YYR 440
           HR VK ++ILL       +S    S                   S  +L    PE     
Sbjct: 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQN 183

Query: 441 LQQLTEKSDVYSFGV 455
           LQ   EKSD+YS G+
Sbjct: 184 LQGYNEKSDIYSVGI 198

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 46/195 (23%), Positives = 88/195 (45%), Gaps = 14/195 (7%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           +G GGFG+V    +  +    A K+L+ +    + G      E  +L ++    +V+L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
                  + LV   M  G L  H+Y+     L   + +        G+ +LH+      I
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD----I 116

Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLS---KFGPTSVSKT----HLDPEYYRLQQLTEKSD 449
           ++RD+K  N+LLD++   ++SD GL+   K G T   +     ++ PE  + +  +   D
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVD 176

Query: 450 VYSFGVVLFEVLCAR 464
            ++ G  ++E++  R
Sbjct: 177 WFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 51/182 (28%), Positives = 81/182 (44%), Gaps = 23/182 (12%)

Query: 294 NGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMAR 353
           NG    V +K L+P  +  AL F     ++SQ+ H+HL  + G C    E I+V +F+  
Sbjct: 41  NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100

Query: 354 GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV 413
           G L D     +   +P   ++ +    A  L YL        ++H +V   NILL    +
Sbjct: 101 GPL-DVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN----LVHGNVCAKNILLARLGL 155

Query: 414 A-------KVSDFGLSKFGPTSVSKTH-------LDPEYYR-LQQLTEKSDVYSFGVVLF 458
           A       K+SD G+S    T++S+         + PE       L+  +D +SFG  L 
Sbjct: 156 AEGTSPFIKLSDPGVSF---TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLL 212

Query: 459 EV 460
           E+
Sbjct: 213 EI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 28/210 (13%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSL--IGF 337
           +G G +G VYK               + E    ++    EI +L +L+H ++++L  +  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 338 CNDDREMILVYDFMARGTLPDHLYH----SDNPP--LPWNQRLEICIGAARGLHYLHTGA 391
            + DR++ L++D+          +H    ++  P  LP +    +      G+HYLH  A
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH--A 126

Query: 392 NHAVIIHRDVKTTNILL----DEKWVAKVSDFGLSK-FGPTSVSKTHLDPE----YYRLQ 442
           N   ++HRD+K  NIL+     E+   K++D G ++ F         LDP     +YR  
Sbjct: 127 NW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 443 QL-------TEKSDVYSFGVVLFEVLCARP 465
           +L       T+  D+++ G +  E+L + P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 52/179 (29%), Positives = 81/179 (45%), Gaps = 29/179 (16%)

Query: 300 VAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDH 359
           V +K L+P  +  +L F     M+ Q+ H H+V L G C  D E I+V +F+  G L D 
Sbjct: 35  VILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL-DL 93

Query: 360 LYHSDNPPL--PWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV---- 413
             H  +  L  PW  + ++    A  L YL        ++H +V T NILL  + +    
Sbjct: 94  FMHRKSDVLTTPW--KFKVAKQLASALSYLEDKD----LVHGNVCTKNILLAREGIDGEC 147

Query: 414 ---AKVSDFGLSKFGPTSVSKTH--------LDPEYYR-LQQLTEKSDVYSFGVVLFEV 460
               K+SD G+    P +V            + PE     + L+  +D +SFG  L+E+
Sbjct: 148 GPFIKLSDPGI----PITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 28/210 (13%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSL--IGF 337
           +G G +G VYK               + E    ++    EI +L +L+H +++SL  +  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 338 CNDDREMILVYDFMARGTLPDHLYH----SDNPP--LPWNQRLEICIGAARGLHYLHTGA 391
            + DR++ L++D+          +H    ++  P  LP      +      G+HYLH  A
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--A 126

Query: 392 NHAVIIHRDVKTTNILL----DEKWVAKVSDFGLSK-FGPTSVSKTHLDPE----YYRLQ 442
           N   ++HRD+K  NIL+     E+   K++D G ++ F         LDP     +YR  
Sbjct: 127 NW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 443 QL-------TEKSDVYSFGVVLFEVLCARP 465
           +L       T+  D+++ G +  E+L + P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 85  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 138

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 139 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-YVATRWYRAPEIMLNWMHY 195

Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 196 NQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 23/193 (11%)

Query: 280 IGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +  VYKG   +NG    + + RL+ E +        E  +L  L+H ++V L   
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQ-EEEGTPFTAIREASLLKGLKHANIVLLHDI 71

Query: 338 CNDDREMILVYDFMARGTL------PDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
            +    + LV++++           P  L H +N  L   Q L       RGL Y+H   
Sbjct: 72  IHTKETLTLVFEYVHTDLCQYMDKHPGGL-HPENVKLFLFQLL-------RGLSYIH--- 120

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGL--SKFGPTSVSKTHLDPEYYRLQQLTEKSD 449
               I+HRD+K  N+L+ +    K++DFGL  +K  P+      +   +YR   +   S 
Sbjct: 121 -QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGST 179

Query: 450 VYSFGVVLFEVLC 462
            YS  + ++ V C
Sbjct: 180 EYSTCLDMWGVGC 192

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 19/198 (9%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSL- 334
           ++G G FG V       +    A+K L+ E   ++       TE  +L   RH  L +L 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
             F   DR +  V ++   G L  HL           +     I +A  L YLH+     
Sbjct: 62  YSFQTHDR-LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LGYLHSCD--- 115

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHL---DPEYYRLQQLTEKS--- 448
            +++RD+K  N++LD+    K++DFGL K G +  +        PEY   + L +     
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 449 --DVYSFGVVLFEVLCAR 464
             D +  GVV++E++C R
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 37/97 (38%), Positives = 51/97 (52%), Gaps = 16/97 (16%)

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK---FGPTSVSKTH---- 433
           ARG+ +L +       IHRD+   NILL E  V K+ DFGL++     P  V K      
Sbjct: 184 ARGMEFLASRK----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 434 ---LDPEYYRLQQLTEKSDVYSFGVVLFEV--LCARP 465
              + PE    +  T +SDV+SFGV+L+E+  L A P
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 58/199 (29%), Positives = 82/199 (41%), Gaps = 23/199 (11%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL------HLVS 333
           IG G FG VY+     +    A+K L  +      E    IG  + L          +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARGLHYLHTGAN 392
           L      D ++ LV D+M+ G L  HL            R +  I      L +LH    
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALEHLHKYD- 116

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------HLDPEYYRLQQ- 443
              I++RD+K  NILLD      + DFGLSK   T    T        +L PE    ++ 
Sbjct: 117 ---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173

Query: 444 LTEKSDVYSFGVVLFEVLC 462
            T+  D +S GV++FE+ C
Sbjct: 174 YTKHVDFWSLGVLVFEMCC 192

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 51/215 (23%), Positives = 82/215 (38%), Gaps = 37/215 (17%)

Query: 280 IGVGGFGDVYKGFING--STTPVAIKRLEPESQ-QGALEFQTEIGMLSQLRHLHLVSLIG 336
           IG G FG V  G  +   S   V +K L   +     L F  E+    +L H +++  +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 337 FCNDDREMILVYDFMARGTLPDHLY----HSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            C +    +LV +F   G L ++L                +   C  A+ GL +LH    
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS-GLLWLH---- 117

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGL--SKF------------------GPTSVSKT 432
            A  IH D+   N  L      K+ D+GL   ++                   P  V   
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 433 HLDPEYYRLQQLTEKSDVYSFGVVLFEV--LCARP 465
             D      +  T+KS+++S GV ++E+     +P
Sbjct: 178 GQD---LLPKDQTKKSNIWSLGVTMWELFTAADQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 16/212 (7%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHL 329
           ++F+    +G G  G V+K     S   +A K +  E +  A+  Q   E+ +L +    
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP-AIRNQIIRELQVLHECNSP 63

Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL-EICIGAARGLHYLH 388
           ++V   G    D E+ +  + M  G+L   L  +   P    Q L ++ I   +GL YL 
Sbjct: 64  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVSIAVIKGLTYLR 120

Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV------SKTHLDPEYYRLQ 442
               H  I+HRDVK +NIL++ +   K+ DFG+S     S+      +++++ PE  +  
Sbjct: 121 E--KHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177

Query: 443 QLTEKSDVYSFGVVLFEVLCARPSILRTAAKK 474
             + +SD++S G+ L E+   R  I    AK+
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 31/87 (35%), Positives = 48/87 (55%), Gaps = 12/87 (13%)

Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK---FGPTSVSK-----THL 434
           GL +LH+      II+RD+K  N++LD     K++DFG+ K   FG    S       ++
Sbjct: 108 GLQFLHSKG----IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYI 163

Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            PE  +  + T   D +SFGV+L+E+L
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 28/208 (13%)

Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLE-PE--SQQGALEFQTEIGMLSQLRHL 329
           + +    +G G FG V+      S    A+K +  PE    +       E  +L ++ H 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYH----SDNPPLPWNQRLEICIGAARGLH 385
            ++ L    +D R + ++ +++  G L  +L +    S++  L +   + +C      L 
Sbjct: 62  FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI-VC-----ALE 115

Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHL---DPEYYRLQ 442
           YLH+      I++RD+K  NILLD++   K++DFG +K       +T      PEY   +
Sbjct: 116 YLHSKE----IVYRDLKPENILLDKEGHIKLTDFGFAK---KLRDRTWTLCGTPEYLAPE 168

Query: 443 QLTEKS-----DVYSFGVVLFEVLCARP 465
            +  K      D ++ G++++E+L   P
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGYP 196

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 23/198 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQG---ALEFQTEIGMLSQLRHLHLV 332
           +IG GGFG+VY      +    A+K L+ +    +QG   AL  +  + ++S      +V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            +    +   ++  + D M  G L  HL  S +      +          GL ++H    
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLEHMH---- 114

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGL----SKFGPTSVSKTH--LDPEYYRLQQLT- 445
           +  +++RD+K  NILLDE    ++SD GL    SK  P +   TH  + PE   LQ+ T 
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV--LQKGTA 172

Query: 446 --EKSDVYSFGVVLFEVL 461
               +D +S G +LF++L
Sbjct: 173 YDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 50.8 bits (121), Expect = 8e-07
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 34/222 (15%)

Query: 264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGML 323
           L  +   T+ ++    IG G +G VYK       +  A+K L+P S     E + E  +L
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIEAEYNIL 72

Query: 324 SQL-RHLHLVSLIG-FCNDDR----EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE-- 375
             L  H ++V   G F   D+    ++ LV +    G++ + +       L   QRL+  
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV----KGLLICGQRLDEA 128

Query: 376 ----ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS-KFGPTSVS 430
               I  GA  GL +LH       IIHRDVK  NILL  +   K+ DFG+S +   T + 
Sbjct: 129 MISYILYGALLGLQHLHNNR----IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184

Query: 431 KTH-------LDPEYYRLQQLTEKS-----DVYSFGVVLFEV 460
           +         + PE    +Q  + S     DV+S G+   E+
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 36/104 (34%), Positives = 53/104 (50%), Gaps = 30/104 (28%)

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYR 440
           A+G+ +L +       IHRD+   NILL E  V K+ DFGL++         + DP+Y R
Sbjct: 189 AKGMEFLASRK----CIHRDLAARNILLSENNVVKICDFGLAR-------DIYKDPDYVR 237

Query: 441 -------LQQL----------TEKSDVYSFGVVLFEV--LCARP 465
                  L+ +          T +SDV+SFGV+L+E+  L A P
Sbjct: 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 26/203 (12%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQ-------LRHLHL 331
           VIG G FG V            A+K L+   ++  L+ + E  ++S+       ++H  L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQ---KKAILKKKEEKHIMSERNVLLKNVKHPFL 58

Query: 332 VSL-IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           V L   F   D+ +  V D++  G L  HL        P  +     I +A G  YLH+ 
Sbjct: 59  VGLHFSFQTADK-LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG--YLHS- 114

Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK--FGPTSVSKT------HLDPEYYRLQ 442
                I++RD+K  NILLD +    ++DFGL K        + T      +L PE    Q
Sbjct: 115 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQ 171

Query: 443 QLTEKSDVYSFGVVLFEVLCARP 465
                 D +  G VL+E+L   P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 37/146 (25%), Positives = 67/146 (45%), Gaps = 13/146 (8%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G  G VYK     +    A+K +    +     +   EI +L  + H ++V      
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141

Query: 339 NDDREMILVYDFMARGTLPD-HLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
           + + E+ ++ +FM  G+L   H+              ++      G+ YLH    H  I+
Sbjct: 142 DHNGEIQVLLEFMDGGSLEGTHIADE-------QFLADVARQILSGIAYLHR--RH--IV 190

Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSK 423
           HRD+K +N+L++     K++DFG+S+
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSR 216

Length = 353

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 18/144 (12%)

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ--RLEICIGAARGLHYLH 388
           LV L         + LV +++  G L  H+      P    +    EICI     L++LH
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA----LNFLH 113

Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK--FGPTSVSKT------HLDPEYYR 440
                  II+RD+K  N+LLD     K++D+G+ K   GP   + T      ++ PE  R
Sbjct: 114 ERG----IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR 169

Query: 441 LQQLTEKSDVYSFGVVLFEVLCAR 464
            ++     D ++ GV++FE++  R
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 16/98 (16%)

Query: 375 EICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--PTSVSKT 432
           EI +     L++LH       II+RD+K  N+LLD +   K++D+G+ K G  P   + T
Sbjct: 104 EISLA----LNFLHERG----IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST 155

Query: 433 ------HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
                 ++ PE  R +      D ++ GV++FE++  R
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 30/210 (14%)

Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTP-----VAIKRLEP----ESQQGALEFQTEIGML 323
           NF+   V+G G +G V+   +   T        A+K L+     +  +     +TE  +L
Sbjct: 1   NFELLKVLGTGAYGKVF--LVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVL 58

Query: 324 SQLRHL-HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA- 381
             +R    LV+L      + ++ L+ D+++ G +  HLY  DN        +    G   
Sbjct: 59  EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEII 115

Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKT-------- 432
             L +LH       I++RD+K  NILLD +    ++DFGLSK F      +T        
Sbjct: 116 LALEHLHKLG----IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE 171

Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVL 461
           ++ PE  R +    K+ D +S G+++FE+L
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 32/130 (24%), Positives = 60/130 (46%), Gaps = 18/130 (13%)

Query: 31  PDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFI 90
           P+ +Y++A         + + +L++  +VD    Y + LHF E    +T +G RVF + I
Sbjct: 251 PESLYQSALV-----STDTQPDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLI 305

Query: 91  ANLTAEVQADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSDA 150
              TA    D++  +G     +  +  V +  +         L+I L P      K + A
Sbjct: 306 NGDTAFKDVDIVKMSGERYTALVLNKTVAVSGR--------TLTIVLQP-----KKGTHA 352

Query: 151 ILNGLEIFKV 160
           I+N +E+F++
Sbjct: 353 IINAIEVFEI 362

Length = 623

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 12/93 (12%)

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF----GPTSV----SKT 432
           A GL +LH+      II+RD+K  N++LD +   K++DFG+ K     G T+     +  
Sbjct: 111 AIGLFFLHSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD 166

Query: 433 HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           ++ PE    Q   +  D ++FGV+L+E+L  + 
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 60/197 (30%), Positives = 90/197 (45%), Gaps = 20/197 (10%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALE-FQTEIGMLSQLR-HLHLVSL 334
           V+G G FG V    +  S    A+K L+ +   Q   +E   TE  +LS  R H  L  L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 335 I-GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
              F   DR +  V +F+  G L  H+  S        +     I +A  L +LH     
Sbjct: 62  YCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA--LMFLHDKG-- 116

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-----PTSV---SKTHLDPEYYRLQQLT 445
             II+RD+K  N+LLD +   K++DFG+ K G      TS    +  ++ PE  +     
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174

Query: 446 EKSDVYSFGVVLFEVLC 462
              D ++ GV+L+E+LC
Sbjct: 175 PSVDWWAMGVLLYEMLC 191

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 48.9 bits (116), Expect = 4e-06
 Identities = 50/197 (25%), Positives = 90/197 (45%), Gaps = 24/197 (12%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRL-EP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G  G V   F       VA+K+L  P ++Q  A     E+ +L  + H +++SL+  
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 338 CNDDR------EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
               +      ++ LV + M            D+  + +     +C     G+ +LH+  
Sbjct: 89  FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHS-- 141

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-HLDPEYYRLQQL------ 444
             A IIHRD+K +NI++      K+ DFGL++   T+   T ++   YYR  ++      
Sbjct: 142 --AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGY 199

Query: 445 TEKSDVYSFGVVLFEVL 461
            E  D++S G ++ E++
Sbjct: 200 KENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 48.9 bits (116), Expect = 4e-06
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 11/90 (12%)

Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--PTSVSKT------HL 434
            L YLH+  N   +++RD+K  N++LD+    K++DFGL K G    +  KT      +L
Sbjct: 107 ALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYL 163

Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
            PE           D +  GVV++E++C R
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 48.9 bits (117), Expect = 4e-06
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 11/89 (12%)

Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-HLDPEYYRL 441
           G+ +LH+    A IIHRD+K +NI++      K+ DFGL++   TS   T ++   YYR 
Sbjct: 130 GIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 185

Query: 442 QQL------TEKSDVYSFGVVLFEVLCAR 464
            ++       E  D++S G ++ E++   
Sbjct: 186 PEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 29/89 (32%), Positives = 47/89 (52%), Gaps = 12/89 (13%)

Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT--SVSKT------HLD 435
           L YLH+      +++RD+K  N++LD+    K++DFGL K G +  +  KT      +L 
Sbjct: 108 LEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 163

Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           PE           D +  GVV++E++C R
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 17/205 (8%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHL 329
           N F+   V+G G +G V K     +   VAIK+ +   +   ++  T  E+ ML  L+  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           ++V L        ++ LV++++ +  L + L    N   P   R  I     + +H+ H 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHK 118

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTHLDPEYYRLQQLT- 445
                 I+HRD+K  N+L+    V K+ DFG ++    G  +    ++   +YR  +L  
Sbjct: 119 ND----IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174

Query: 446 -----EKSDVYSFGVVLFEVLCARP 465
                +  D++S G +L E+   +P
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 48.9 bits (116), Expect = 5e-06
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 32/208 (15%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI--- 335
           +IG G FG VY+     ++  VAIK++  + Q        E+ ++  L H++++ L    
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK----NRELLIMKNLNHINIIFLKDYY 128

Query: 336 ---GFCNDDREMIL--VYDFMARGTLPDHL--YHSDNPPLPWNQRLEICIGAARGLHYLH 388
               F  +++ + L  V +F+ + T+  ++  Y  +N  LP            R L Y+H
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187

Query: 389 TGANHAVIIHRDVKTTNILLDEK-WVAKVSDFGLSK---FGPTSVSKTHLDPEYYRLQQL 444
           +      I HRD+K  N+L+D      K+ DFG +K    G  SVS  ++   +YR  +L
Sbjct: 188 S----KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS--YICSRFYRAPEL 241

Query: 445 -------TEKSDVYSFGVVLFEVLCARP 465
                  T   D++S G ++ E++   P
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILGYP 269

Length = 440

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.5 bits (116), Expect = 5e-06
 Identities = 24/57 (42%), Positives = 32/57 (56%), Gaps = 5/57 (8%)

Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTEKSDVYSF 453
           IHRD+K  N+LLD K   K+SDFGL     T + K+H   E+YR+      S+   F
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLC----TGLKKSH-RTEFYRILSHALPSNFLDF 174

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 46/151 (30%), Positives = 64/151 (42%), Gaps = 14/151 (9%)

Query: 280 IGVGGFGDVYKGFING--STTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           IG G FG V  G +N   +   V +K L    S Q  ++F  E      L+H +L+  +G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 337 FCNDDREMILVYDFMARGTLPDHLY-----HSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
            C +    +LV +F   G L  +L          P     QR+   I  A GL +LH   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI--ALGLLHLHKNN 120

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLS 422
                IH D+   N LL      K+ D+GLS
Sbjct: 121 ----FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 31/106 (29%), Positives = 51/106 (48%), Gaps = 35/106 (33%)

Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSVSKTHLDPEY-- 438
           RGL Y+H+ AN   ++HRD+K  N+ ++ E  V K+ DFGL++          +DP Y  
Sbjct: 125 RGLKYIHS-AN---VLHRDLKPANVFINTEDLVLKIGDFGLARI---------VDPHYSH 171

Query: 439 ------------YRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
                       YR  +L       T+  D+++ G +  E+L  +P
Sbjct: 172 KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 48.5 bits (115), Expect = 6e-06
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 23/211 (10%)

Query: 267 IQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK---RLEPESQQGALEFQTEIGML 323
           +Q    ++D   VIG G FG+V       S    A+K   + E   +  +  F  E  ++
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 324 SQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARG 383
           +      +V L     DD+ + +V ++M  G L + + + D P   W +     +  A  
Sbjct: 98  AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAKFYTAEVVLA-- 154

Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS-KFGPTSV--------SKTHL 434
           L  +H+      +IHRDVK  N+LLD+    K++DFG   K   T +        +  ++
Sbjct: 155 LDAIHSMG----LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYI 210

Query: 435 DPEYYRLQ----QLTEKSDVYSFGVVLFEVL 461
            PE  + Q        + D +S GV LFE+L
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 48.1 bits (114), Expect = 7e-06
 Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 28/222 (12%)

Query: 260 TQFSLSEIQAAT----NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGA 313
             F   EI  +T      + N   IG G  G V   +       VAIK+L    ++Q  A
Sbjct: 8   NNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA 67

Query: 314 LEFQTEIGMLSQLRHLHLVSLIGFCNDDR------EMILVYDFMARGTLPDHLYHSDNPP 367
                E+ ++  + H +++ L+      +      ++ +V + M            D+  
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER 127

Query: 368 LPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT 427
           + +     +C     G+ +LH+    A IIHRD+K +NI++      K+ DFGL++   T
Sbjct: 128 MSYLLYQMLC-----GIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178

Query: 428 SVSKT-HLDPEYYRLQQL------TEKSDVYSFGVVLFEVLC 462
           S   T ++   YYR  ++       E  D++S G ++ E++ 
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 15/157 (9%)

Query: 317 QTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE 375
           QTE  +  Q   H  LV L      +  +  V +++  G L  H+      P    +   
Sbjct: 43  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 102

Query: 376 ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-----PTSV- 429
             I  A  L+YLH       II+RD+K  N+LLD +   K++D+G+ K G      TS  
Sbjct: 103 AEISLA--LNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF 156

Query: 430 --SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
             +  ++ PE  R +      D ++ GV++FE++  R
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 37/205 (18%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSL- 334
           +IG GGFG+VY      +    A+K L+ +    +QG      E  MLS      LVS  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTG 54

Query: 335 ---------IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
                      F   D+ +  + D M  G L  HL  S +      +          GL 
Sbjct: 55  DCPFIVCMSYAFHTPDK-LSFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLE 111

Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL----SKFGPTSVSKTH--LDPEYY 439
           ++H    +  +++RD+K  NILLDE    ++SD GL    SK  P +   TH  + PE  
Sbjct: 112 HMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV- 166

Query: 440 RLQQLT---EKSDVYSFGVVLFEVL 461
            LQ+       +D +S G +LF++L
Sbjct: 167 -LQKGVAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 26/70 (37%), Positives = 32/70 (45%), Gaps = 11/70 (15%)

Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDP 436
           C+ A   +H L         IHRD+K  NIL+D     K+SDFGLS    T   K H   
Sbjct: 110 CVLAIEAVHKLG-------FIHRDIKPDNILIDRGGHIKLSDFGLS----TGFHKQHDSA 158

Query: 437 EYYRLQQLTE 446
            Y +L Q   
Sbjct: 159 YYQKLLQGKS 168

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 31/97 (31%), Positives = 47/97 (48%), Gaps = 17/97 (17%)

Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTHLDPEY-- 438
            GL Y+H+    A ++HRD+K  N+L++     K+ DFGL++ F            EY  
Sbjct: 116 CGLKYIHS----ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171

Query: 439 ---YR-------LQQLTEKSDVYSFGVVLFEVLCARP 465
              YR        Q  T+  DV+S G +L E+L  +P
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 54/220 (24%), Positives = 97/220 (44%), Gaps = 28/220 (12%)

Query: 261 QFSLSEIQAAT----NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGAL 314
           QF   E+  +T      + N   IG G  G V   +       VAIK+L    ++Q  A 
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61

Query: 315 EFQTEIGMLSQLRHLHLVSLIGFCNDDR------EMILVYDFMARGTLPDHLYHSDNPPL 368
               E+ ++  + H +++SL+      +      ++ LV + M            D+  +
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERM 121

Query: 369 PWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS 428
            +     +C     G+ +LH+    A IIHRD+K +NI++      K+ DFGL++   TS
Sbjct: 122 SYLLYQMLC-----GIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172

Query: 429 VSKT-HLDPEYYRLQQL------TEKSDVYSFGVVLFEVL 461
              T ++   YYR  ++       E  D++S G ++ E++
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 34/213 (15%)

Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES------------QQGALEFQTEI 320
           +F+  +V+G G FG V      G+    AIK L+ +             ++  L  Q + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 321 GMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA 380
             L+QL          F   DR +  V +++  G L  H+        P  Q +      
Sbjct: 61  PFLTQLHSC-------FQTVDR-LYFVMEYVNGGDLMYHIQQVGKFKEP--QAVFYAAEI 110

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF----GPTSV----SKT 432
           + GL +LH       II+RD+K  N++LD +   K++DFG+ K     G T+     +  
Sbjct: 111 SVGLFFLHRRG----IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD 166

Query: 433 HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           ++ PE    Q   +  D +++GV+L+E+L  +P
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 38/161 (23%), Positives = 62/161 (38%), Gaps = 18/161 (11%)

Query: 318 TEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEIC 377
           TE  +L  + H  ++ L G    ++   L+   + R     + Y +    +     L I 
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIE 188

Query: 378 IGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHL--- 434
               R + YLH       IIHRD+K  NI ++      + DFG + F P  ++       
Sbjct: 189 RSVLRAIQYLHENR----IIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYYGW 243

Query: 435 -------DPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSIL 468
                   PE           D++S G+VLFE+     S+ 
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284

Length = 391

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.0 bits (110), Expect = 3e-05
 Identities = 37/140 (26%), Positives = 58/140 (41%), Gaps = 11/140 (7%)

Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
           + + + L       +  +L+ D++  G L D L       L   +  +I       L+ L
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDL 125

Query: 388 HTGANHAVIIHRDVKTTNILLDE-KWVAKVSDFGLSK-FGPTSVSKTHLD---PEYYRLQ 442
           H    H  IIH D+K  N+L D  K    + D+GL K  G  S     LD   PE  +  
Sbjct: 126 H---KHN-IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKIKGH 181

Query: 443 QLTEKSDVYSFGVVLFEVLC 462
                 D ++ GV+ +E+L 
Sbjct: 182 NYDVSFDWWAVGVLTYELLT 201

Length = 267

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 28/90 (31%), Positives = 48/90 (53%), Gaps = 12/90 (13%)

Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------HLD 435
           L +LH    H VI +RD+K  NILLD +   K++DFG+ K G  +   T        ++ 
Sbjct: 109 LMFLHR---HGVI-YRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIA 164

Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           PE  +  +     D ++ GV+++E++  +P
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQP 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 27/217 (12%)

Query: 263 SLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL---EPESQQGALEFQTE 319
            +++++    +FD   VIG G FG+V       S    A+K L   E   +  +  F  E
Sbjct: 34  KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 320 IGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ--RLEIC 377
             +++      +V L     DD+ + +V ++M  G L + + + D P   W +    E+ 
Sbjct: 94  RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-KWARFYTAEVV 152

Query: 378 IGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG----LSKFG----PTSV 429
           + A   +H +         IHRDVK  N+LLD+    K++DFG    +   G     T+V
Sbjct: 153 L-ALDAIHSMG-------FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV 204

Query: 430 SKT-HLDPEYYRLQ----QLTEKSDVYSFGVVLFEVL 461
               ++ PE  + Q        + D +S GV L+E+L
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 45.3 bits (108), Expect = 4e-05
 Identities = 28/96 (29%), Positives = 45/96 (46%), Gaps = 21/96 (21%)

Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY--- 438
           + L ++H       I HRD+K  NIL+ +  + K++DFG  +     +       EY   
Sbjct: 111 KSLDHMH----RNGIFHRDIKPENILIKDD-ILKLADFGSCR----GIYSKPPYTEYIST 161

Query: 439 --YRLQQ--LTE-----KSDVYSFGVVLFEVLCARP 465
             YR  +  LT+     K D+++ G V FE+L   P
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 45.6 bits (108), Expect = 5e-05
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 31/207 (14%)

Query: 279 VIGVGGFGDVYK-GFINGSTTP--VAIKRLEP----ESQQGALEFQTEIGMLSQLRHLHL 331
           V+G GG+G V++   + G+ T    A+K L+      +Q+     + E  +L  ++H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHL-----YHSDNPPLPWNQRLEICIGAARGLHY 386
           V LI       ++ L+ ++++ G L  HL     +  D      +   EI +     L +
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS---EISLA----LEH 115

Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEY 438
           LH       II+RD+K  NILLD +   K++DFGL K      + TH        + PE 
Sbjct: 116 LHQQG----IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171

Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
                  +  D +S G +++++L   P
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAP 198

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 27/201 (13%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK---RLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           VIG G FG+V       +    A+K   + E   +  +  F  E  +++      +V L 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ--RLEICIGAARGLHYLHTGANH 393
               DDR + +V ++M  G L + + + D P   W +    E+ + A   +H +      
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVL-ALDAIHSMG----- 162

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFG----LSKFGPTSVSKTHLDPEYYRLQQLTEKS- 448
              IHRDVK  N+LLD+    K++DFG    ++K G          P+Y   + L  +  
Sbjct: 163 --FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 449 --------DVYSFGVVLFEVL 461
                   D +S GV L+E+L
Sbjct: 221 DGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 34/107 (31%), Positives = 53/107 (49%), Gaps = 14/107 (13%)

Query: 364 DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
           D+ PL  +  L      A+G+ +L    N    IHRDV   N+LL +  VAK+ DFGL++
Sbjct: 205 DSWPLDLDDLLRFSSQVAQGMDFL-ASKN---CIHRDVAARNVLLTDGRVAKICDFGLAR 260

Query: 424 ----------FGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEV 460
                      G   +    + PE       T +SDV+S+G++L+E+
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 45.0 bits (106), Expect = 6e-05
 Identities = 46/203 (22%), Positives = 91/203 (44%), Gaps = 36/203 (17%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHLHLVSLIGF 337
           +G G +G V   +       VA+K+L    Q      +T  E+ +L  ++H +++ L+  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 338 ------CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLH 385
                   +  E+ LV + M           +D   +   Q+L       +     RGL 
Sbjct: 83  FTPATSIENFNEVYLVTNLMG----------ADLNNIVKCQKLSDEHVQFLIYQLLRGLK 132

Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL- 444
           Y+H+    A IIHRD+K +N+ ++E    ++ DFGL++     ++  ++   +YR  ++ 
Sbjct: 133 YIHS----AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTG-YVATRWYRAPEIM 187

Query: 445 ------TEKSDVYSFGVVLFEVL 461
                  +  D++S G ++ E+L
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 70/266 (26%), Positives = 113/266 (42%), Gaps = 37/266 (13%)

Query: 273 NFDNDLVIGVGGFGDVY---KGFINGSTTPVAIKRLEP----ESQQGALEFQTEIGMLSQ 325
           NF+   V+G G +G V+   K   + S    A+K L+     +  +     +TE  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 326 LRHL-HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
           +R    LV+L      D ++ L+ D++  G L  HL   +       Q ++I  G     
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLA 117

Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKT--------HL 434
           L +LH       II+RD+K  NILLD      ++DFGLSK F    V +         ++
Sbjct: 118 LEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 435 DPEYYRLQQLTEKS--DVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTI 491
            P+  R          D +S GV+++E+L  A P  +      Q  ++           I
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS---------RRI 224

Query: 492 DQIVDPFLKAMSCLNDEGIRRPSMSD 517
            +   P+ + MS L  + I+R  M D
Sbjct: 225 LKSEPPYPQEMSALAKDIIQRLLMKD 250

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 29/109 (26%), Positives = 52/109 (47%), Gaps = 14/109 (12%)

Query: 363 SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS 422
           +++P L +   +      A G+ +L +       +HRD+   N+L+ E  + K+ DFGL+
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLASKN----CVHRDLAARNVLICEGKLVKICDFGLA 286

Query: 423 K----------FGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           +           G T +    + PE       T  SDV+SFG++L+E+ 
Sbjct: 287 RDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIF 335

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 54/187 (28%), Positives = 81/187 (43%), Gaps = 19/187 (10%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP----ESQQGALEFQTEIGMLSQLR 327
           ++F++  VIG G FG+V       +    A+K L      E +Q A   + E  +L +  
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVA-HIRAERDILVEAD 59

Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ-RLEICIGAARGLHY 386
              +V +     D R + L+ +F+  G +   L   D       Q  +   + A   +H 
Sbjct: 60  GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ 119

Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTE 446
           L         IHRD+K  N+LLD K   K+SDFGL     T + K H   E+YR      
Sbjct: 120 LG-------FIHRDIKPDNLLLDAKGHVKLSDFGLC----TGLKKAH-RTEFYRNLTHNP 167

Query: 447 KSDVYSF 453
            SD +SF
Sbjct: 168 PSD-FSF 173

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 27/101 (26%)

Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----PTSVSKTHLD---- 435
           L YLH       I+HRD+K  N+L+      K++DFGLSK G     T++ + H++    
Sbjct: 114 LEYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 436 ----------PEYYR----LQQLTEKS-DVYSFGVVLFEVL 461
                     PEY      L+Q   K  D ++ G++L+E L
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 46/220 (20%), Positives = 87/220 (39%), Gaps = 42/220 (19%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL---EFQTEIGMLSQLRHLHLVSLIG 336
           IG GG G+VY  +    +  VA+K++  +  +  L    F  E  + + L H  +V +  
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 337 FCNDDREMILVYDFMARGTLPDHL---YHSDNPPLPWNQR------LEICIGAARGLHYL 387
            C+D   +     ++   TL   L   +  ++      ++      L I       + Y+
Sbjct: 70  ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV 129

Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--------GPTSVSKT------- 432
           H+      ++HRD+K  NILL       + D+G + F            V +        
Sbjct: 130 HSKG----VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185

Query: 433 -----------HLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
                      ++ PE       +E +D+Y+ GV+L+++L
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 41/149 (27%), Positives = 66/149 (44%), Gaps = 13/149 (8%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIK---RLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           I  G FG VY G    ++   A+K   + +  ++    + Q E   L+  +   +V L  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 337 FCNDDREMILVYDFMARGTLPD--HLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
                  + LV +++  G +    H+Y   +  +      E     A  L YLH    H 
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE----VALALDYLH---RHG 124

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
            IIHRD+K  N+L+  +   K++DFGLSK
Sbjct: 125 -IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 14/91 (15%)

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVS 430
           ARG+ +L +       +HRD+   N+LL +  + K+ DFGL++           G T + 
Sbjct: 247 ARGMEFLASKN----CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              + PE       T  SDV+S+G++L+E+ 
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIF 333

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 41/205 (20%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRL-EP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V       +   VAIK+L  P +S+  A     E+ +L  ++H +++ L+  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 338 ------CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
                  ++ ++  LV  +M +  L   + H    PL  ++   +      GL Y+H+  
Sbjct: 83  FTSAVSGDEFQDFYLVMPYM-QTDLQKIMGH----PLSEDKVQYLVYQMLCGLKYIHS-- 135

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE--------YYRLQQ 443
             A IIHRD+K  N+ ++E    K+ DFGL++         H D E        +YR  +
Sbjct: 136 --AGIIHRDLKPGNLAVNEDCELKILDFGLAR---------HADAEMTGYVVTRWYRAPE 184

Query: 444 L-------TEKSDVYSFGVVLFEVL 461
           +        +  D++S G ++ E+L
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEML 209

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 52/175 (29%), Positives = 77/175 (44%), Gaps = 22/175 (12%)

Query: 273 NFDNDLVIGVGGFGDV--YKGFINGSTTPVAIKR----LEPESQQGALEFQTEIGMLSQL 326
           +F++  VIG G FG+V   +    G    + I R    LE E Q G +  + +I  L + 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE-QVGHIRAERDI--LVEA 58

Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ-RLEICIGAARGLH 385
             L +V +     D   + L+ +F+  G +   L   D       Q  +   + A   +H
Sbjct: 59  DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH 118

Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYR 440
            L         IHRD+K  N+LLD K   K+SDFGL     T + K H   E+YR
Sbjct: 119 QLG-------FIHRDIKPDNLLLDSKGHVKLSDFGLC----TGLKKAH-RTEFYR 161

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 42.2 bits (99), Expect = 4e-04
 Identities = 27/78 (34%), Positives = 39/78 (50%), Gaps = 8/78 (10%)

Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------HLDPEYYRLQQLTEK 447
           +I+RD+K  NILLD +    + DFGL K       KT        +L PE       T+ 
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173

Query: 448 SDVYSFGVVLFEVLCARP 465
            D ++ GV+L+E+L   P
Sbjct: 174 VDWWTLGVLLYEMLTGLP 191

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 43.2 bits (101), Expect = 5e-04
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 27/105 (25%)

Query: 385 HYLHTGANHAVIIHRDVKTTNIL-----------------LDEKWVAKVSDFGLSK-FGP 426
           H L  G N   ++HRD+K  NI                  L+ + +AK+ DFGLSK  G 
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194

Query: 427 TSVSKTHLDPEYYRLQQL--------TEKSDVYSFGVVLFEVLCA 463
            S++ + +   YY   +L         +KSD+++ G +++E LC+
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE-LCS 238

Length = 1021

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.8 bits (98), Expect = 7e-04
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 14/91 (15%)

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVS 430
           A+G+ +L    N    IHRD+   NILL    + K+ DFGL++           G   + 
Sbjct: 224 AKGMSFL-ASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              + PE       T +SDV+S+G++L+E+ 
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIF 310

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.5 bits (97), Expect = 8e-04
 Identities = 51/191 (26%), Positives = 80/191 (41%), Gaps = 29/191 (15%)

Query: 295 GSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARG 354
           G+   V I  LE  +++     Q E+ +    RH ++++          + ++  FMA G
Sbjct: 25  GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84

Query: 355 TLPDHLYHSDNPPLPWNQRL--EICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW 412
           +  + L  +  P    ++ L   I  GA RGL+YLH        IHR++K ++IL+    
Sbjct: 85  S-ANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQNG----YIHRNIKASHILISGDG 138

Query: 413 VAKVSDFGLSK----------------FGPTSVS-KTHLDPEYYR--LQQLTEKSDVYSF 453
           +  +S  GLS                 F   S S    L PE  R  L     KSD+YS 
Sbjct: 139 LVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSV 196

Query: 454 GVVLFEVLCAR 464
           G+   E+   R
Sbjct: 197 GITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 46/219 (21%), Positives = 89/219 (40%), Gaps = 39/219 (17%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRH 328
            +FD   ++G G FG+V       +    A+K ++     +Q+    F+ E  +LS    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL------EICIGAAR 382
             +  L     D   + LV ++   G L   L   ++    +++ +      E+ +    
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ---FDEDMAQFYLAELVLA--- 114

Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD------P 436
            +H +H        +HRD+K  N+L+D     K++DFG +     + +K          P
Sbjct: 115 -IHSVHQMG----YVHRDIKPENVLIDRTGHIKLADFGSA--ARLTANKMVNSKLPVGTP 167

Query: 437 EYYRLQQLTEKS-----------DVYSFGVVLFEVLCAR 464
           +Y   + LT  +           D +S GV+ +E++  R
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 34/206 (16%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---FQTEIGMLSQLRHLHLVSLI 335
           VIG G FG+V    +  +    A+K L         E   F+ E  +L    +  + +L 
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ------RLEICIGAARGLHYLHT 389
               D+  + LV D+   G L   L   ++  LP +        + I I +   LHY   
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQLHY--- 123

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFG----LSKFGPTSVSKTHLDPEYYR---LQ 442
                  +HRD+K  NIL+D     +++DFG    L + G    S     P+Y     LQ
Sbjct: 124 -------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176

Query: 443 QLTE-------KSDVYSFGVVLFEVL 461
            + +       + D +S GV ++E+L
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 34/206 (16%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIG-F 337
           IG G +G V+K     + +  A+K L+P       E + E  +L  L  H ++V   G +
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE-EIEAEYNILKALSDHPNVVKFYGMY 84

Query: 338 CNDDR----EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYL 387
              D     ++ LV +    G++ D +       L   +R+E      I   A  GL +L
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLV----KGFLKRGERMEEPIIAYILHEALMGLQHL 140

Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS-KFGPTSVSKTH-------LDPEYY 439
           H        IHRDVK  NILL  +   K+ DFG+S +   T + +         + PE  
Sbjct: 141 HVNKT----IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196

Query: 440 RLQQ-----LTEKSDVYSFGVVLFEV 460
             +Q        + DV+S G+   E+
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	613
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.98
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.98
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.98
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.98
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.93
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
PF12819	347	Malectin_like: Carbohydrate-binding protein of the	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
PLN03150	623	hypothetical protein; Provisional	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.82
PRK10345	210	hypothetical protein; Provisional	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.77
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.76
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.76
PRK14879	211	serine/threonine protein kinase; Provisional	99.75
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.75
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.73
smart00090	237	RIO RIO-like kinase.	99.72
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.71
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.62
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.6
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.6
PF11721	174	Malectin: Di-glucose binding within endoplasmic re	99.49
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.45
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.43
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.42
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.31
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.26
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.23
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.2
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.18
KOG1243	690	consensus Protein kinase [General function predict	99.11
KOG3087	229	consensus Serine/threonine protein kinase [General	99.08
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.06
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.05
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.92
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.88
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.88
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.71
PRK09902	216	hypothetical protein; Provisional	98.52
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.46
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.43
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.35
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.33
COG4248	637	Uncharacterized protein with protein kinase and he	98.25
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.21
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.18
PF01636	239	APH: Phosphotransferase enzyme family This family	98.15
PLN02876	822	acyl-CoA dehydrogenase	98.09
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.04
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.0
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.93
PLN03150	623	hypothetical protein; Provisional	97.89
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.87
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.85
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.81
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.8
PRK10593	297	hypothetical protein; Provisional	97.77
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.65
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.63
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.61
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.6
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.6
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.48
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.28
PF12819	347	Malectin_like: Carbohydrate-binding protein of the	97.21
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.1
PRK05231	319	homoserine kinase; Provisional	96.96
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.89
PLN02236	344	choline kinase	96.67
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.64
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.62
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.47
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.36
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.27
PLN02756	418	S-methyl-5-thioribose kinase	96.26
PRK12396	409	5-methylribose kinase; Reviewed	95.76
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.58
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.55
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.51
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.49
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.4
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.38
KOG2270	520	consensus Serine/threonine protein kinase involved	95.36
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.35
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.31
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.27

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-58  Score=488.16  Aligned_cols=266  Identities=49%  Similarity=0.817  Sum_probs=239.1

Q ss_pred             cccccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEE
Q 048439          258 LCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF  337 (613)
Q Consensus       258 ~~~~f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~  337 (613)
                      ..+.|++.||..||++|+..++||+|+||.||+|.+.++ ..||||++...+.+...+|.+|+.+|++++|||||+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            456799999999999999999999999999999999887 7799999887654425569999999999999999999999


Q ss_pred             eecCCc-eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEE
Q 048439          338 CNDDRE-MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKV  416 (613)
Q Consensus       338 ~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl  416 (613)
                      |.+.+. .+||||||++|+|.++|+.....+|+|.+|++||.++|+||+|||+...++ ||||||||+|||||+++++||
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~-iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPP-IIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCC-EecCCCCHHHeeECCCCCEEc
Confidence            999994 999999999999999998754438999999999999999999999987655 999999999999999999999


Q ss_pred             EecCCCccCCC---------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc
Q 048439          417 SDFGLSKFGPT---------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ  487 (613)
Q Consensus       417 ~DFGls~~~~~---------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~  487 (613)
                      +|||||+..+.         .++.+|+||||+..+.+|+|+|||||||+|+||+||+++.+...+.....+..|+.....
T Consensus       219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            99999998876         788899999999999999999999999999999999999887665666679999988888


Q ss_pred             cCCccccccHHHH----------------HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          488 NGTIDQIVDPFLK----------------AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       488 ~~~~~~~~d~~~~----------------~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ++.+.+++|+.+.                |+.|++.+|.+||+|.+|++.|+..
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            8777777775531                5599999999999999999999543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-47  Score=397.02  Aligned_cols=242  Identities=36%  Similarity=0.542  Sum_probs=200.3

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh--hcHHHHHHHHHHHhccCccceeeEEEEeecCC-ceEEEEEcCCCCC
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ--QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR-EMILVYDFMARGT  355 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~~gs  355 (613)
                      .||+|+||+||+|.+.+. ..||||++.....  ...++|.+|+.+|++++|||||+++|+|.+.. .+++|||||++|+
T Consensus        48 ~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs  126 (362)
T KOG0192|consen   48 VLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS  126 (362)
T ss_pred             hcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence            599999999999999875 4499999986532  22668999999999999999999999999987 7999999999999


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC-cEEEEecCCCccCC--------
Q 048439          356 LPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW-VAKVSDFGLSKFGP--------  426 (613)
Q Consensus       356 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGls~~~~--------  426 (613)
                      |.++|+......|+|..++.|+.+||+||.|||+++.   ||||||||+|||++.++ ++||+|||+++...        
T Consensus       127 L~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~---iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~  203 (362)
T KOG0192|consen  127 LSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP---IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTS  203 (362)
T ss_pred             HHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC---eeecccChhhEEEcCCCCEEEECCCccceeeccccccccC
Confidence            9999977557889999999999999999999999873   89999999999999998 99999999997532        


Q ss_pred             CCCCcccCChhhhh--cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHHH--h
Q 048439          427 TSVSKTHLDPEYYR--LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKA--M  502 (613)
Q Consensus       427 ~~~~~~~~aPE~~~--~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~--~  502 (613)
                      ..+|..|||||+++  ...+++|+|||||||+||||+||+.||..... .+.  +...........+.....+.+..  .
T Consensus       204 ~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~--~~~v~~~~~Rp~~p~~~~~~l~~l~~  280 (362)
T KOG0192|consen  204 VAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQV--ASAVVVGGLRPPIPKECPPHLSSLME  280 (362)
T ss_pred             CCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHH--HHHHHhcCCCCCCCccCCHHHHHHHH
Confidence            45678899999999  66999999999999999999999999976654 222  22222112222222223333332  2


Q ss_pred             cccccCCCCCCCHHHHHHHHHHhhh
Q 048439          503 SCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       503 ~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      +||+.||.+||++.+++..|+....
T Consensus       281 ~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  281 RCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             HhCCCCCCcCCCHHHHHHHHHHHHH
Confidence            7999999999999999999996554

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=368.37  Aligned_cols=253  Identities=24%  Similarity=0.315  Sum_probs=205.9

Q ss_pred             ccccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEE
Q 048439          259 CTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGF  337 (613)
Q Consensus       259 ~~~f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~  337 (613)
                      +..++++||+...       +||+|..|+|||++++.++..+|+|.+... .....+++.+|++++++.+||+||.++|.
T Consensus        73 ~~~i~~~dle~~~-------~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~yga  145 (364)
T KOG0581|consen   73 DNGISLSDLERLG-------VLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGA  145 (364)
T ss_pred             ccccCHHHhhhhh-------hcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEE
Confidence            3457777776544       899999999999999999999999999655 34456778999999999999999999999


Q ss_pred             eecCC-ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEeccCCCCceeeCCCCcEE
Q 048439          338 CNDDR-EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT-GANHAVIIHRDVKTTNILLDEKWVAK  415 (613)
Q Consensus       338 ~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~iiHrDlk~~NILl~~~~~~k  415 (613)
                      |..+. ++.++||||++|+|++++..  ..++++...-+|+.+|++||.|||. .+    ||||||||+|||++..|.+|
T Consensus       146 F~~~~~~isI~mEYMDgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~~~----IIHRDIKPsNlLvNskGeVK  219 (364)
T KOG0581|consen  146 FYSNGEEISICMEYMDGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEERK----IIHRDIKPSNLLVNSKGEVK  219 (364)
T ss_pred             EEeCCceEEeehhhcCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhccC----eeeccCCHHHeeeccCCCEE
Confidence            99988 59999999999999999843  3679999999999999999999996 55    99999999999999999999


Q ss_pred             EEecCCCcc------CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchh--hhhhhhHHHHHHHhhc
Q 048439          416 VSDFGLSKF------GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTA--AKKQVSLAVWAQQCYQ  487 (613)
Q Consensus       416 l~DFGls~~------~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~--~~~~~~l~~~~~~~~~  487 (613)
                      |||||.|+.      ....||..||+||.+++..|+.++||||||++|+|+.+|+.|+....  ......+..+.-....
T Consensus       220 icDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp  299 (364)
T KOG0581|consen  220 ICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP  299 (364)
T ss_pred             eccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC
Confidence            999999864      23457888999999999999999999999999999999999986641  1222233332222122


Q ss_pred             cCCccccccHHHHHh--cccccCCCCCCCHHHHHHHHHH
Q 048439          488 NGTIDQIVDPFLKAM--SCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       488 ~~~~~~~~d~~~~~~--~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .........+....+  .||++||.+||++.+++++...
T Consensus       300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi  338 (364)
T KOG0581|consen  300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFI  338 (364)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHH
Confidence            222222233333322  7999999999999999987763

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=386.75  Aligned_cols=239  Identities=31%  Similarity=0.487  Sum_probs=201.7

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCChh
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLP  357 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~  357 (613)
                      +.||+|-||.||.|.+++. ..||||.++... ...+.|.+|+++|.+|+|+|||+|+|+|..++.++||||||++|+|.
T Consensus       212 ~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl  289 (468)
T KOG0197|consen  212 RELGSGQFGEVWLGKWNGS-TKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL  289 (468)
T ss_pred             HHhcCCccceEEEEEEcCC-CcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence            3799999999999999886 569999998763 34568999999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC---------C
Q 048439          358 DHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT---------S  428 (613)
Q Consensus       358 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~---------~  428 (613)
                      ++|.......+.-.+.+.+|.|||+||+||++++    +|||||.++||||+++..+||+||||||....         .
T Consensus       290 ~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~----~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~k  365 (468)
T KOG0197|consen  290 DYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN----YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGK  365 (468)
T ss_pred             HHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC----ccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCC
Confidence            9998766788999999999999999999999999    99999999999999999999999999995221         1


Q ss_pred             CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHHHh-cccc
Q 048439          429 VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAM-SCLN  506 (613)
Q Consensus       429 ~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~-~Cl~  506 (613)
                      ....|.|||.+..++++.|||||||||+||||+| |+.|+......+.....+...   +.+..+...+..-..| .||+
T Consensus       366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy---Rlp~P~~CP~~vY~lM~~CW~  442 (468)
T KOG0197|consen  366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY---RLPRPEGCPDEVYELMKSCWH  442 (468)
T ss_pred             CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC---cCCCCCCCCHHHHHHHHHHhh
Confidence            1345899999999999999999999999999998 677776665555444444333   3333444444444443 7999


Q ss_pred             cCCCCCCCHHHHHHHHHHh
Q 048439          507 DEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       507 ~~p~~RPs~~evl~~Le~~  525 (613)
                      .+|++|||+..+.+.|+..
T Consensus       443 ~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  443 EDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             CCcccCCCHHHHHHHHHHh
Confidence            9999999999888887743

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.2e-45  Score=401.62  Aligned_cols=245  Identities=29%  Similarity=0.492  Sum_probs=202.3

Q ss_pred             CcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCCChh-cHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          276 NDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPESQQ-GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       276 ~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ....||+|.||+||+|+..+     ..+.||||.++..... ..++|++|+++|+.|+|||||+|+|+|.+++.++||+|
T Consensus       490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFE  569 (774)
T KOG1026|consen  490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFE  569 (774)
T ss_pred             ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEE
Confidence            34479999999999998743     3477999999887544 78899999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEE
Q 048439          350 FMARGTLPDHLYHSD------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVS  417 (613)
Q Consensus       350 y~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~  417 (613)
                      ||.+|||.++|....            ..+|+..+.+.||.|||.||.||-++.    ++||||.++|+|+.++..+||+
T Consensus       570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~----FVHRDLATRNCLVge~l~VKIs  645 (774)
T KOG1026|consen  570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH----FVHRDLATRNCLVGENLVVKIS  645 (774)
T ss_pred             ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc----ccccchhhhhceeccceEEEec
Confidence            999999999996321            234999999999999999999999988    9999999999999999999999


Q ss_pred             ecCCCccC----------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhh
Q 048439          418 DFGLSKFG----------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCY  486 (613)
Q Consensus       418 DFGls~~~----------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~  486 (613)
                      ||||+|..          ......+||+||.+..+++|++||||||||||||+++ |+.|+.+....+.+..+.-..-  
T Consensus       646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l--  723 (774)
T KOG1026|consen  646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL--  723 (774)
T ss_pred             ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc--
Confidence            99999741          2233567999999999999999999999999999996 8899987766654444332211  


Q ss_pred             ccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          487 QNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       487 ~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                       -...+...+.... .+.||+.+|++||+++||-..|+...+
T Consensus       724 -L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  724 -LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             -ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence             1112222333322 236999999999999999999986554

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=366.14  Aligned_cols=199  Identities=32%  Similarity=0.477  Sum_probs=179.8

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ..+|.....||+|+||+||+|+++.++..||||++...  .....+-...||.+|+.++|||||.|+.++..++.++|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            35677777899999999999999988899999999876  5556667899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC------CcEEEEecCCC
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK------WVAKVSDFGLS  422 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~------~~~kl~DFGls  422 (613)
                      |||.+|+|.++|+.  ...+++.....+..|+|.||++||+++    ||||||||.||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~~~----IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHENN----IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999954  447999999999999999999999999    9999999999999865      56899999999


Q ss_pred             ccCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhh
Q 048439          423 KFGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQ  475 (613)
Q Consensus       423 ~~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~  475 (613)
                      |...       .+|++-|||||+++.++|+.|+|+||.|++||+|++|++||......+-
T Consensus       163 R~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL  222 (429)
T KOG0595|consen  163 RFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL  222 (429)
T ss_pred             hhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence            8643       3578889999999999999999999999999999999999986655543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-44  Score=377.92  Aligned_cols=243  Identities=23%  Similarity=0.363  Sum_probs=206.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ..|...++||+|||+.||+++...++..||+|++.+.   .....+...+||++.++|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688888999999999999999788899999999764   3344567899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      |+|++|+|..++.  .+.+|++.+.+.+..||+.||.|||+.+    |||||||..|+||+++.++||+|||||...   
T Consensus        98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~----IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLG----IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcC----ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999884  5678999999999999999999999999    999999999999999999999999999643   


Q ss_pred             -----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          426 -----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       426 -----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                           ..+||+.|+|||++.....+..+||||+|||||-||+|+|||....-.+....+.......+.    .+..+...
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~d  247 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKD  247 (592)
T ss_pred             ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHH
Confidence                 356899999999999999999999999999999999999999876555544433322222222    22222111


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHHH
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                       ..+.|+.+|.+|||+.+|+.+-.+
T Consensus       248 LI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  248 LIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             HHHHHhcCCcccCCCHHHHhcCHhh
Confidence             126999999999999999977665

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-44  Score=362.43  Aligned_cols=249  Identities=24%  Similarity=0.345  Sum_probs=199.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh-------cHHHHHHHHHHHhccCccceeeEEEEeecCCce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ-------GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~-------~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~  344 (613)
                      ..|...+.||+|+||.|-+|..+.+++.||||+++.....       .....++|+++|++|+|||||++++++...+..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            3456677999999999999999999999999999764211       122347999999999999999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC---CcEEEEecCC
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK---WVAKVSDFGL  421 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGl  421 (613)
                      |||||||++|+|.+.+..  +..+.+..-..++.|++.|+.|||+.|    |+||||||+|||+..+   ..+||+||||
T Consensus       252 YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~G----I~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQG----IIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             EEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHcC----cccccCCcceEEeccCCcceEEEecccch
Confidence            999999999999999954  456777788899999999999999999    9999999999999765   8899999999


Q ss_pred             CccC-------CCCCCcccCChhhhhcCCC---CchhHHHHHHHHHHHHHhCCCCccchhhhh-hhhHHHHHHHhhccCC
Q 048439          422 SKFG-------PTSVSKTHLDPEYYRLQQL---TEKSDVYSFGVVLFEVLCARPSILRTAAKK-QVSLAVWAQQCYQNGT  490 (613)
Q Consensus       422 s~~~-------~~~~~~~~~aPE~~~~~~~---t~ksDV~SfGvvL~elltg~~p~~~~~~~~-~~~l~~~~~~~~~~~~  490 (613)
                      |+..       ..+||+.|.|||++..+..   ..|.|+||+|||||-+|||.+||....... ....+......+....
T Consensus       326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~  405 (475)
T KOG0615|consen  326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ  405 (475)
T ss_pred             hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence            9863       4578999999999987654   348899999999999999999997654332 2222222222222223


Q ss_pred             ccccccHHHHHh-cccccCCCCCCCHHHHHHHHHHhh
Q 048439          491 IDQIVDPFLKAM-SCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       491 ~~~~~d~~~~~~-~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ..++-+..+..+ ++|..||++||++.|++++.++..
T Consensus       406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~  442 (475)
T KOG0615|consen  406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD  442 (475)
T ss_pred             hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence            333333333222 899999999999999999988754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-44  Score=346.10  Aligned_cols=249  Identities=24%  Similarity=0.340  Sum_probs=200.2

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEE-EeecCCc-eEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIG-FCNDDRE-MILVY  348 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g-~~~~~~~-~~lV~  348 (613)
                      +|...++||+|.||.|||+.+..++..||.|.++-.  +.+..+....|+.+|++|+|||||++++ -+.++++ ++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            355566899999999999999888899999998754  4566778999999999999999999999 4556666 89999


Q ss_pred             EcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          349 DFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      |||..|+|...+.+  +....++++.+|+++.|+++||.++|..-....|+||||||.||+|+.+|++||+||||++...
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            99999999998843  4567899999999999999999999995433349999999999999999999999999998633


Q ss_pred             --------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          427 --------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       427 --------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                              -.||+.||+||.+....|+.||||||+||++|||+.-++||.+..-   ..+.....++-..+-.++.....
T Consensus       180 s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~---~~L~~KI~qgd~~~~p~~~YS~~  256 (375)
T KOG0591|consen  180 SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL---LSLCKKIEQGDYPPLPDEHYSTD  256 (375)
T ss_pred             chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH---HHHHHHHHcCCCCCCcHHHhhhH
Confidence                    3468899999999999999999999999999999999999987632   22333333221111222333322


Q ss_pred             HH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          499 LK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       499 ~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      +.  +-.|+..||+.||+.-.++..+..
T Consensus       257 l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  257 LRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            32  237999999999996666555544

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=352.53  Aligned_cols=241  Identities=28%  Similarity=0.475  Sum_probs=195.3

Q ss_pred             CCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh-cHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCC
Q 048439          275 DNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ-GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMAR  353 (613)
Q Consensus       275 ~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  353 (613)
                      ...+.||+|-||.|..+...+. ..||||.+++.... ...+|.+||++|.+|+|||||+|+|+|..++.+++|+|||++
T Consensus       541 ~~~ekiGeGqFGEVhLCeveg~-lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn  619 (807)
T KOG1094|consen  541 RFKEKIGEGQFGEVHLCEVEGP-LKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN  619 (807)
T ss_pred             ehhhhhcCcccceeEEEEecCc-eEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence            3455899999999999999874 78999999987544 458999999999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-------
Q 048439          354 GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-------  426 (613)
Q Consensus       354 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-------  426 (613)
                      |+|.++|.....+.+.-..-+.||.|||.||+||.+.+    ++||||.++|||+|+++++||+|||++|..-       
T Consensus       620 GDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n----fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  620 GDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN----FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             CcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc----hhhccccccceeecCcccEEecCcccccccccCCceee
Confidence            99999997655455566777889999999999999988    9999999999999999999999999998321       


Q ss_pred             ---CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHH--hCCCCccchhhhhhhhHHHHHHHhhccCC-------cccc
Q 048439          427 ---TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL--CARPSILRTAAKKQVSLAVWAQQCYQNGT-------IDQI  494 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ell--tg~~p~~~~~~~~~~~l~~~~~~~~~~~~-------~~~~  494 (613)
                         .....+|||+|.+..+++|++||||+|||+|||++  |...|+.....+..   .+-.......+.       ..-.
T Consensus       696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~~l~~P~~c  772 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQVVLSRPPAC  772 (807)
T ss_pred             ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCcceeccCCCcC
Confidence               12246799999999999999999999999999975  67788754433222   222222222111       1112


Q ss_pred             ccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          495 VDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       495 ~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .+.+.+ .+.||..+-++||+++++...|.
T Consensus       773 p~~lyelml~Cw~~es~~RPsFe~lh~~lq  802 (807)
T KOG1094|consen  773 PQGLYELMLRCWRRESEQRPSFEQLHLFLQ  802 (807)
T ss_pred             cHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence            222222 44899999999999999987776

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=348.57  Aligned_cols=233  Identities=25%  Similarity=0.349  Sum_probs=196.1

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ..+|+..++||+|+||+||.++.+++++.+|+|.+++..   .........|..+|.+++||.||+++-.|++.+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            457889999999999999999999999999999998763   33456678999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--  425 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--  425 (613)
                      +||+.||.|..+|.  +...+++.....++..|+.||.|||+.+    ||||||||+|||||++|+++|+|||||+..  
T Consensus       104 ld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~g----IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSKG----IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhCC----eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999994  4567999999999999999999999999    999999999999999999999999999742  


Q ss_pred             ------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH
Q 048439          426 ------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       426 ------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                            ..+||..|||||++.+..++..+|+||+||+||||++|.+||...........+.....    ...+...+...
T Consensus       178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~----~~~p~~ls~~a  253 (357)
T KOG0598|consen  178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL----PLPPGYLSEEA  253 (357)
T ss_pred             CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC----CCCCccCCHHH
Confidence                  23678889999999999999999999999999999999999987654443333222221    11223233332


Q ss_pred             HHh--cccccCCCCCC
Q 048439          500 KAM--SCLNDEGIRRP  513 (613)
Q Consensus       500 ~~~--~Cl~~~p~~RP  513 (613)
                      +.+  +.|..+|++|-
T Consensus       254 rdll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  254 RDLLKKLLKRDPRQRL  269 (357)
T ss_pred             HHHHHHHhccCHHHhc
Confidence            222  68899999995

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=369.53  Aligned_cols=244  Identities=30%  Similarity=0.476  Sum_probs=198.1

Q ss_pred             ceeeeeCcEEEEEEEEcCCc----eeEEEEEeCC---CChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          278 LVIGVGGFGDVYKGFINGST----TPVAIKRLEP---ESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~----~~vAVK~~~~---~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +.||+|+||.||+|++...+    ..||||..+.   .......+|++|+++|++++|||||+++|++..+..++||||+
T Consensus       163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl  242 (474)
T KOG0194|consen  163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL  242 (474)
T ss_pred             ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence            58999999999999985431    2389999885   3466778999999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC---
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT---  427 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~---  427 (613)
                      |.||+|.++|.+.. ..++..+++.+|.++|+||+|||+++    +|||||.++|||++.++.+||+|||||+.+..   
T Consensus       243 ~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~----~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~  317 (474)
T KOG0194|consen  243 CNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKN----CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM  317 (474)
T ss_pred             cCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCC----CcchhHhHHHheecCCCeEEeCccccccCCcceee
Confidence            99999999996533 36999999999999999999999998    99999999999999999999999999987641   


Q ss_pred             -----CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHH-HHhhccCCccccccHHHH
Q 048439          428 -----SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWA-QQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       428 -----~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~d~~~~  500 (613)
                           .....|+|||.+....++.|+|||||||++||+++ |..|+.+....+   ...+. ...+..............
T Consensus       318 ~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI~~~~~r~~~~~~~p~~~~~  394 (474)
T KOG0194|consen  318 KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKIVKNGYRMPIPSKTPKELAK  394 (474)
T ss_pred             ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHHHhcCccCCCCCCCHHHHHH
Confidence                 12357999999999999999999999999999998 777886654433   22222 111222111111111111


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHHHhhhhh
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLEFSLQLQ  529 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le~~l~~~  529 (613)
                       ..+||..+|++||+|.++.+.|+...+..
T Consensus       395 ~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  395 VMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             HHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence             22899999999999999999998655443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-43  Score=373.51  Aligned_cols=262  Identities=25%  Similarity=0.435  Sum_probs=212.6

Q ss_pred             ccCHHHHHHHhcCC---------CCcceeeeeCcEEEEEEEEcCCc---eeEEEEEeCCC-ChhcHHHHHHHHHHHhccC
Q 048439          261 QFSLSEIQAATNNF---------DNDLVIGVGGFGDVYKGFINGST---TPVAIKRLEPE-SQQGALEFQTEIGMLSQLR  327 (613)
Q Consensus       261 ~f~~~el~~at~~f---------~~~~~iG~G~fG~Vy~g~~~~~~---~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~  327 (613)
                      .++++|--.|...|         .+.++||.|-||.|++|+++-.+   ..||||.++.. .+..+.+|+.|+.+|.+..
T Consensus       609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd  688 (996)
T KOG0196|consen  609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD  688 (996)
T ss_pred             CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence            45666555554444         35678999999999999996433   56999999877 4556778999999999999


Q ss_pred             ccceeeEEEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCcee
Q 048439          328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNIL  407 (613)
Q Consensus       328 H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NIL  407 (613)
                      ||||++|.|+.......++|.|||+||+|+.+|+.++ ..+++.+...+.++||.||.||-+.+    ++||||.++|||
T Consensus       689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~----YVHRDLAARNIL  763 (996)
T KOG0196|consen  689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMN----YVHRDLAARNIL  763 (996)
T ss_pred             CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcC----chhhhhhhhhee
Confidence            9999999999999999999999999999999997655 45999999999999999999999998    999999999999


Q ss_pred             eCCCCcEEEEecCCCccCCCCC-----------CcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhh
Q 048439          408 LDEKWVAKVSDFGLSKFGPTSV-----------SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQ  475 (613)
Q Consensus       408 l~~~~~~kl~DFGls~~~~~~~-----------~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~  475 (613)
                      ++.+..+||+||||+|......           ..+|.|||.+...++|.+||||||||||||+++ |..|+......+.
T Consensus       764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV  843 (996)
T KOG0196|consen  764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV  843 (996)
T ss_pred             eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH
Confidence            9999999999999998642111           246999999999999999999999999999875 8888766655554


Q ss_pred             hhHHHHHHHhhccCCccccccHHHHHhcccccCCCCCCCHHHHHHHHHHhhhhh
Q 048439          476 VSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQLQ  529 (613)
Q Consensus       476 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~Cl~~~p~~RPs~~evl~~Le~~l~~~  529 (613)
                      +..++...+.  ...+++-.-....++.||++|-.+||.+.+|+..|.......
T Consensus       844 IkaIe~gyRL--PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  844 IKAIEQGYRL--PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             HHHHHhccCC--CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            4444322222  122233222333456899999999999999999999665433

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-40  Score=351.01  Aligned_cols=250  Identities=26%  Similarity=0.413  Sum_probs=194.4

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEc-----CCceeEEEEEeCCCC-hhcHHHHHHHHHHHhcc-CccceeeEEEEeecC-C
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFIN-----GSTTPVAIKRLEPES-QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDD-R  342 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~-----~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~-~  342 (613)
                      .++|...++||+|+||.||+|...     ..+..||||+++... ......+.+|+.++.++ +||||++++|+|... +
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            457888889999999999999752     233579999997543 33456789999999999 899999999998764 4


Q ss_pred             ceEEEEEcCCCCChhHHhhcCC----------------------------------------------------------
Q 048439          343 EMILVYDFMARGTLPDHLYHSD----------------------------------------------------------  364 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------  364 (613)
                      .+++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            5899999999999999985421                                                          


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----------CCCCcc
Q 048439          365 --NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----------TSVSKT  432 (613)
Q Consensus       365 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----------~~~~~~  432 (613)
                        ..++++.+++.++.|+++||+|||+.+    |+||||||+|||+++++.+||+|||+++...          ..++..
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~----ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC----EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence              135889999999999999999999988    9999999999999999999999999986421          122356


Q ss_pred             cCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--HhcccccCC
Q 048439          433 HLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSCLNDEG  509 (613)
Q Consensus       433 ~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~Cl~~~p  509 (613)
                      |+|||++....++.++|||||||+||||++ |++||......+...  ..... ...........+.+.  ..+||+.+|
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp  318 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC--QRLKD-GTRMRAPENATPEIYRIMLACWQGDP  318 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH--HHHhc-CCCCCCCCCCCHHHHHHHHHHccCCh
Confidence            999999999999999999999999999997 999986543222111  10000 000111122222222  338999999


Q ss_pred             CCCCCHHHHHHHHHHhhh
Q 048439          510 IRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       510 ~~RPs~~evl~~Le~~l~  527 (613)
                      .+||++.||++.|+..++
T Consensus       319 ~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         319 KERPTFSALVEILGDLLQ  336 (338)
T ss_pred             hhCcCHHHHHHHHHHHHh
Confidence            999999999999996553

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=343.09  Aligned_cols=247  Identities=24%  Similarity=0.370  Sum_probs=195.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCC--ceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR--EMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~E  349 (613)
                      .++...+.||+|+||.||++....++...|||.....+....+.+.+|+.+|++++|||||+++|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            34556679999999999999998877889999987664333667899999999999999999999855544  6899999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC-CCcEEEEecCCCccC---
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE-KWVAKVSDFGLSKFG---  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGls~~~---  425 (613)
                      |+++|+|.+++.+... .|++..+..+..|+++||+|||+++    |+||||||+||||+. ++.+||+|||+++..   
T Consensus        97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g----~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG----IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC----EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999966554 7999999999999999999999998    999999999999999 799999999988632   


Q ss_pred             --------CCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccccc
Q 048439          426 --------PTSVSKTHLDPEYYRLQQL-TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVD  496 (613)
Q Consensus       426 --------~~~~~~~~~aPE~~~~~~~-t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  496 (613)
                              ...+++.|||||++..+.. ..++|||||||++.||+||++||....  +......+.......+.+...+.
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~--~~~~~~~~ig~~~~~P~ip~~ls  249 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF--EEAEALLLIGREDSLPEIPDSLS  249 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc--chHHHHHHHhccCCCCCCCcccC
Confidence                    2346788999999996433 359999999999999999999996531  11111111111111122222232


Q ss_pred             HHHH--HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          497 PFLK--AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       497 ~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ....  ..+|+..+|++|||+.+++.+....
T Consensus       250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~  280 (313)
T KOG0198|consen  250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLK  280 (313)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence            2222  2279999999999999999887743

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-41  Score=379.41  Aligned_cols=246  Identities=29%  Similarity=0.454  Sum_probs=201.5

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCc-----eeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGST-----TPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~-----~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ......||+|.||.||+|.+.+-.     ..||||.++.. +.+...+|++|..+|++++|||||+++|+|.+....+++
T Consensus       694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~  773 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL  773 (1025)
T ss_pred             eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence            345568999999999999985432     34999999876 566778999999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCC
Q 048439          348 YDFMARGTLPDHLYHSD-----NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS  422 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls  422 (613)
                      +|||++|+|..+|.+.+     ...|+..+.+.+|.+||+|+.||++++    +|||||.++||||++...+||+|||||
T Consensus       774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~----fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH----FVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC----CcCcchhhhheeecccCcEEEcccchh
Confidence            99999999999997642     457999999999999999999999998    999999999999999999999999999


Q ss_pred             cc----------CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCc
Q 048439          423 KF----------GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTI  491 (613)
Q Consensus       423 ~~----------~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~  491 (613)
                      |.          +.......|||||.+..+.+|.|||||||||+|||++| |..|+......+.  +..+...- +.+..
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v--~~~~~~gg-RL~~P  926 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV--LLDVLEGG-RLDPP  926 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH--HHHHHhCC-ccCCC
Confidence            82          11122357999999999999999999999999999998 5566643332222  22222222 33444


Q ss_pred             cccccHHHHHh-cccccCCCCCCCHHHHHHHHHHhh
Q 048439          492 DQIVDPFLKAM-SCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       492 ~~~~d~~~~~~-~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ....+++...| .||+.+|++||++.++++.++...
T Consensus       927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence            55566655544 799999999999999998666544

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.1e-40  Score=338.64  Aligned_cols=248  Identities=20%  Similarity=0.325  Sum_probs=194.2

Q ss_pred             ccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhc---HHHHHHHHHHHhccCccceeeEEEE
Q 048439          261 QFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQG---ALEFQTEIGMLSQLRHLHLVSLIGF  337 (613)
Q Consensus       261 ~f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~---~~~f~~Ei~~l~~l~H~niv~l~g~  337 (613)
                      .++.++|     +......||+|++|.||+|.+.  +..||||+++......   .+.|.+|+.+|.+++|||||+++|+
T Consensus        14 ~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~   86 (283)
T PHA02988         14 CIESDDI-----DKYTSVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF   86 (283)
T ss_pred             ecCHHHc-----CCCCCeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence            3455555     3333458999999999999985  3679999997653332   4678899999999999999999999


Q ss_pred             eec----CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcEEeccCCCCceeeCCCC
Q 048439          338 CND----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG-ANHAVIIHRDVKTTNILLDEKW  412 (613)
Q Consensus       338 ~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~iiHrDlk~~NILl~~~~  412 (613)
                      +.+    ...+++||||+++|+|.+++..  ...++|...+.++.+++.||.|||+. +    ++||||||+|||+++++
T Consensus        87 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~----~~Hrdlkp~nill~~~~  160 (283)
T PHA02988         87 IIDIVDDLPRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTN----KPYKNLTSVSFLVTENY  160 (283)
T ss_pred             EEecccCCCceEEEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCC----CCCCcCChhhEEECCCC
Confidence            876    4578999999999999999954  45789999999999999999999974 5    78999999999999999


Q ss_pred             cEEEEecCCCccC-----CCCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHh
Q 048439          413 VAKVSDFGLSKFG-----PTSVSKTHLDPEYYRL--QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC  485 (613)
Q Consensus       413 ~~kl~DFGls~~~-----~~~~~~~~~aPE~~~~--~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~  485 (613)
                      .+||+|||+++..     ...++..|+|||++..  ..++.++|||||||++|||++|+.||......+.....  ....
T Consensus       161 ~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i--~~~~  238 (283)
T PHA02988        161 KLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI--INKN  238 (283)
T ss_pred             cEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH--HhcC
Confidence            9999999998742     2234567999999976  68999999999999999999999999765433321111  1111


Q ss_pred             hccCCccccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          486 YQNGTIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       486 ~~~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                       .....+....+.+.  ..+||+.||.+||++.||++.|+.
T Consensus       239 -~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        239 -NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             -CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence             11111111122222  227999999999999999999884

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.3e-40  Score=339.37  Aligned_cols=244  Identities=23%  Similarity=0.293  Sum_probs=195.6

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      |...+.||+|+||.||+|....++..||||.+....   ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            666779999999999999998888899999987542   23344678999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      |++|+|.+++.......+++.+++.++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+++...    
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER----IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC----EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence            99999998886555567999999999999999999999998    9999999999999999999999999986421    


Q ss_pred             ---CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhh-HHHHHHHhhccCCccccccHHHH--
Q 048439          427 ---TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVS-LAVWAQQCYQNGTIDQIVDPFLK--  500 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~~~--  500 (613)
                         ..++..|+|||++.+..++.++|||||||+||||++|+.||.......... ...... ..... ....++....  
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~-~~~~~s~~~~~l  235 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK-EDQEE-YSEKFSEDAKSI  235 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh-ccccc-CCccCCHHHHHH
Confidence               235678999999999999999999999999999999999997543322111 111111 01111 1111222222  


Q ss_pred             HhcccccCCCCCCC-----HHHHHHHHH
Q 048439          501 AMSCLNDEGIRRPS-----MSDVVWGLE  523 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs-----~~evl~~Le  523 (613)
                      ..+||+.+|.+||+     +.+++++..
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~  263 (285)
T cd05631         236 CRMLLTKNPKERLGCRGNGAAGVKQHPI  263 (285)
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence            22799999999997     888886654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.3e-40  Score=334.64  Aligned_cols=239  Identities=34%  Similarity=0.546  Sum_probs=187.2

Q ss_pred             cceeeeeCcEEEEEEEEc----CCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          277 DLVIGVGGFGDVYKGFIN----GSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       277 ~~~iG~G~fG~Vy~g~~~----~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      .+.||.|.||.||+|.+.    ..+..|+||.++.. .....++|.+|++.+++++||||++++|+|...+..++||||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            458999999999999998    34577999999764 3445788999999999999999999999999888899999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++|+|.++|.......+++.+++.|+.|+|+||.|||+.+    ++|+||+++|||+++++.+||+|||+++...     
T Consensus        84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~----iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN----IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT----EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccc
Confidence            9999999998765678999999999999999999999988    9999999999999999999999999986541     


Q ss_pred             -----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          427 -----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                           ......|+|||++....++.++||||||+++|||++ |+.|+......+   ..................+....
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  236 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEKLKQGQRLPIPDNCPKDIYS  236 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHHHHTTEETTSBTTSBHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccceeccchhHHHHH
Confidence                 123456899999999999999999999999999999 678875543222   22222222221112222222222


Q ss_pred             -HhcccccCCCCCCCHHHHHHHH
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                       ...||+.+|++||++.++++.|
T Consensus       237 li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  237 LIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHHHHT-SSGGGS--HHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHhcC
Confidence             3379999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.1e-41  Score=326.81  Aligned_cols=246  Identities=24%  Similarity=0.304  Sum_probs=197.2

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      .|+...++|+|+||.|||++.+++++.||||++....  +.-.+--++||++|++|+|+|+|.|+.+|.....++||+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            3556668999999999999999999999999986542  22334468999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCCCC-
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV-  429 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~-  429 (613)
                      |+.--| +-|.+ ....++.....+++.|+++|++|+|+++    ||||||||+|||++.++.+||||||+||.....+ 
T Consensus        83 ~dhTvL-~eLe~-~p~G~~~~~vk~~l~Q~l~ai~~cHk~n----~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd  156 (396)
T KOG0593|consen   83 CDHTVL-HELER-YPNGVPSELVKKYLYQLLKAIHFCHKNN----CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD  156 (396)
T ss_pred             cchHHH-HHHHh-ccCCCCHHHHHHHHHHHHHHhhhhhhcC----eecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence            998444 44432 3456889999999999999999999999    9999999999999999999999999998755322 


Q ss_pred             -------CcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc---------cCC--
Q 048439          430 -------SKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ---------NGT--  490 (613)
Q Consensus       430 -------~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~---------~~~--  490 (613)
                             |.-|.|||.+-+ -+|....||||.||++.||++|.|-|.+...-+|..++........         .+.  
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence                   456899999987 7899999999999999999999999988877777666554332111         110  


Q ss_pred             ---cccc-------------ccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          491 ---IDQI-------------VDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       491 ---~~~~-------------~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                         +++.             ....+. +..||+.||.+|++-++++.+--+
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF  287 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF  287 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence               1111             111111 228999999999999999966443

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-41  Score=354.51  Aligned_cols=251  Identities=27%  Similarity=0.464  Sum_probs=198.9

Q ss_pred             HHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCC
Q 048439          265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR  342 (613)
Q Consensus       265 ~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~  342 (613)
                      ++-....+++.....||+|.||+||+|++-++   ||||.++..  +.+..++|.+|+.++++-||.||+-++|||....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            34444444555666899999999999999875   999999876  4556788999999999999999999999999887


Q ss_pred             ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCC
Q 048439          343 EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS  422 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls  422 (613)
                      . .+|.-+|++-+|..+|+.. ...|+..+.+.|+.|||+||.|||.++    |||||||+.||+|.+++++||+||||+
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK~----IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAKN----IIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             e-eeeehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhhh----hhhhhccccceEEccCCcEEEecccce
Confidence            6 9999999999999999764 366999999999999999999999999    999999999999999999999999998


Q ss_pred             cc----------CCCCCCcccCChhhhhcC---CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccC
Q 048439          423 KF----------GPTSVSKTHLDPEYYRLQ---QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG  489 (613)
Q Consensus       423 ~~----------~~~~~~~~~~aPE~~~~~---~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~  489 (613)
                      ..          ....+...|||||+++.+   +|+..|||||||+|+|||+||..|+. ....++.-...  .+-+...
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmV--GrG~l~p  612 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMV--GRGYLMP  612 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEe--cccccCc
Confidence            53          233456679999999764   68999999999999999999999997 33333321111  1111111


Q ss_pred             Cccc----cccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          490 TIDQ----IVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       490 ~~~~----~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      .+..    ....+.+ ...||..++++||.+.+|+..|+..+.
T Consensus       613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            1111    1111111 237999999999999999998886543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=335.61  Aligned_cols=248  Identities=25%  Similarity=0.314  Sum_probs=199.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh-cHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ-GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ++|....+||.|.-+.||+|++...+..||||+++.+... ..+++++|+..|+.++||||++++..|..+.++|+||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            5678888999999999999999888899999999876433 358899999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc------
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------  424 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~------  424 (613)
                      |.+|++.+++...-...|++..+..|..++++||.|||.++    .||||||+.||||+++|.+||+|||.+..      
T Consensus       106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G----~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG----HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC----ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            99999999997655566999999999999999999999999    99999999999999999999999997631      


Q ss_pred             ------CCCCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccC--Cccc-
Q 048439          425 ------GPTSVSKTHLDPEYYRL--QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG--TIDQ-  493 (613)
Q Consensus       425 ------~~~~~~~~~~aPE~~~~--~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~~-  493 (613)
                            ....+++.|||||+++.  ..|+.|+||||||++.+||.+|..||....+.....+.. ....+...  .++. 
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~t~~~~~d  260 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLLTSGLDKD  260 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCcccccCChH
Confidence                  23356788999999654  468999999999999999999999997655433221111 11110000  0000 


Q ss_pred             ---cccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          494 ---IVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       494 ---~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                         ..+...+  .-.||+.||.+|||+++++++-.+
T Consensus       261 ~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FF  296 (516)
T KOG0582|consen  261 EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFF  296 (516)
T ss_pred             HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHH
Confidence               0011111  127999999999999999976554

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-41  Score=347.79  Aligned_cols=238  Identities=29%  Similarity=0.482  Sum_probs=196.4

Q ss_pred             ccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeec
Q 048439          261 QFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCND  340 (613)
Q Consensus       261 ~f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~  340 (613)
                      .+++++|...       .-||.|+.|-||+|++.+  ..||||+++.-.       .++|+-|++|+|+||+.+.|+|..
T Consensus       120 eiPFe~IsEL-------eWlGSGaQGAVF~Grl~n--etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq  183 (904)
T KOG4721|consen  120 EIPFEEISEL-------EWLGSGAQGAVFLGRLHN--ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ  183 (904)
T ss_pred             cCCHHHhhhh-------hhhccCcccceeeeeccC--ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC
Confidence            4666666433       389999999999999987  559999876432       468899999999999999999999


Q ss_pred             CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecC
Q 048439          341 DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG  420 (613)
Q Consensus       341 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG  420 (613)
                      ...+|+|||||+.|.|.+.|.  ....+.......+..+||.||+|||.+.    |||||||+-||||..+-.+||+|||
T Consensus       184 sPcyCIiMEfCa~GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~hK----IIHRDLKSPNiLIs~~d~VKIsDFG  257 (904)
T KOG4721|consen  184 SPCYCIIMEFCAQGQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLHK----IIHRDLKSPNILISYDDVVKISDFG  257 (904)
T ss_pred             CceeEEeeeccccccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHhh----HhhhccCCCceEeeccceEEecccc
Confidence            999999999999999999994  4567888899999999999999999998    9999999999999999999999999


Q ss_pred             CCcc-------CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHH--hhccCCc
Q 048439          421 LSKF-------GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQ--CYQNGTI  491 (613)
Q Consensus       421 ls~~-------~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~--~~~~~~~  491 (613)
                      -++.       ....+|..|||||+++..+.++|.|||||||||||||||.-|+..-..    ..+.|.-.  .+.....
T Consensus       258 TS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwGVGsNsL~LpvP  333 (904)
T KOG4721|consen  258 TSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWGVGSNSLHLPVP  333 (904)
T ss_pred             chHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEeccCCcccccCc
Confidence            8864       345677889999999999999999999999999999999999854322    12233221  1222233


Q ss_pred             cccccHHHHH-hcccccCCCCCCCHHHHHHHHHH
Q 048439          492 DQIVDPFLKA-MSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       492 ~~~~d~~~~~-~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ....|-+... ..||+..|..||++.+++.+|+.
T Consensus       334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            4444444333 38999999999999999999874

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=348.32  Aligned_cols=243  Identities=25%  Similarity=0.361  Sum_probs=203.1

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCC
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMA  352 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  352 (613)
                      .|.....||+|+-|.||.++...++..||||++........+-..+|+.+|+.++|+|||.++..+...+++++|||||+
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~  353 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME  353 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence            46666789999999999999988889999999988766666678999999999999999999999998999999999999


Q ss_pred             CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc--------
Q 048439          353 RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--------  424 (613)
Q Consensus       353 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~--------  424 (613)
                      +|+|.|.+.   ...+++.++..||.+++.||+|||.++    |+|||||.+||||+.+|.+||+|||++..        
T Consensus       354 ggsLTDvVt---~~~~~E~qIA~Icre~l~aL~fLH~~g----IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR  426 (550)
T KOG0578|consen  354 GGSLTDVVT---KTRMTEGQIAAICREILQGLKFLHARG----IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR  426 (550)
T ss_pred             CCchhhhhh---cccccHHHHHHHHHHHHHHHHHHHhcc----eeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence            999999984   345999999999999999999999999    99999999999999999999999999853        


Q ss_pred             CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHHHh--
Q 048439          425 GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAM--  502 (613)
Q Consensus       425 ~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~--  502 (613)
                      ..-.||+.|||||++....|.+|.||||||++++||+-|.|||....+-....++.-..  ..+-...+.+.+.++.+  
T Consensus       427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng--~P~lk~~~klS~~~kdFL~  504 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG--TPKLKNPEKLSPELKDFLD  504 (550)
T ss_pred             ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC--CCCcCCccccCHHHHHHHH
Confidence            23356889999999999999999999999999999999999997544433333322111  11111222233333221  


Q ss_pred             cccccCCCCCCCHHHHHHHHHH
Q 048439          503 SCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       503 ~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      +||..|+++||++.|+|++...
T Consensus       505 ~cL~~dv~~RasA~eLL~HpFl  526 (550)
T KOG0578|consen  505 RCLVVDVEQRASAKELLEHPFL  526 (550)
T ss_pred             HHhhcchhcCCCHHHHhcChhh
Confidence            7999999999999999988765

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-40  Score=340.33  Aligned_cols=247  Identities=23%  Similarity=0.311  Sum_probs=196.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecC--CceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD--REMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV  347 (613)
                      ..|.....||+|.||.||||+...++..||+|++..+.  ........+||.+|++|+||||++|.+...+.  ..+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            34555568999999999999999999999999987764  34445568999999999999999999988776  789999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT  427 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~  427 (613)
                      +|||++ +|.-++.. ....|+..++..++.|++.||+|||+.+    |+|||||.+|||||.+|++||+|||||++...
T Consensus       197 FeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~g----vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRG----VLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             Eecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcC----eeeccccccceEEcCCCCEEeccccceeeccC
Confidence            999998 88888743 3457999999999999999999999999    99999999999999999999999999985332


Q ss_pred             C---------CCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcc-----
Q 048439          428 S---------VSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID-----  492 (613)
Q Consensus       428 ~---------~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-----  492 (613)
                      .         .|.-|.+||.+.+ ..|+.+.|+||.||||.||+.|+|.+.+..+.+|...+-..-....+....     
T Consensus       271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence            2         2455899999987 479999999999999999999999999888877765543221111111000     


Q ss_pred             ------------ccc-------c-HHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          493 ------------QIV-------D-PFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       493 ------------~~~-------d-~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                                  ..+       + ..+. .-.+|..||.+|.|+.+++..-.+
T Consensus       351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence                        000       0 0111 115677899999999999965444

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-40  Score=341.59  Aligned_cols=248  Identities=22%  Similarity=0.281  Sum_probs=205.6

Q ss_pred             HHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCc
Q 048439          268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDRE  343 (613)
Q Consensus       268 ~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~  343 (613)
                      ....++|...+.||+|+|.+|++|+...++..+|||++.+.   .+...+-...|-.+|.+| .||.|++|+.-|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            34456788888999999999999999999999999999765   233344466788899999 89999999999999999


Q ss_pred             eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCc
Q 048439          344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK  423 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~  423 (613)
                      +|+|+||+++|+|.++|.+  -+.|++.....++.+|+.||+|||+.+    ||||||||+|||||+||++||.|||-|+
T Consensus       149 LYFvLe~A~nGdll~~i~K--~Gsfde~caR~YAAeIldAleylH~~G----IIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKK--YGSFDETCARFYAAEILDALEYLHSNG----IIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             eEEEEEecCCCcHHHHHHH--hCcchHHHHHHHHHHHHHHHHHHHhcC----ceeccCChhheeEcCCCcEEEeeccccc
Confidence            9999999999999999954  467999999999999999999999999    9999999999999999999999999886


Q ss_pred             cCC---------------------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHH
Q 048439          424 FGP---------------------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWA  482 (613)
Q Consensus       424 ~~~---------------------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~  482 (613)
                      ...                     ..||..|.+||++..+..+..+|+|+|||+||.|+.|.|||....+-.....+...
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l  302 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL  302 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence            411                     12456799999999999999999999999999999999999776554433333333


Q ss_pred             HHhhccCCccccccHHHHHhcccccCCCCCCCHHHHHHHHHH
Q 048439          483 QQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       483 ~~~~~~~~~~~~~d~~~~~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ...+.++..+.+.|...   +.|..||.+|++..+|.++..+
T Consensus       303 ~y~fp~~fp~~a~dLv~---KLLv~dp~~Rlt~~qIk~HpFF  341 (604)
T KOG0592|consen  303 DYEFPEGFPEDARDLIK---KLLVRDPSDRLTSQQIKAHPFF  341 (604)
T ss_pred             cccCCCCCCHHHHHHHH---HHHccCccccccHHHHhhCccc
Confidence            33344444433333333   5888999999999999887754

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.9e-39  Score=328.69  Aligned_cols=245  Identities=22%  Similarity=0.376  Sum_probs=195.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEc---CCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFIN---GSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~---~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|...+.||+|+||.||+|.+.   .....||+|.++... ......|.+|+.++.+++||||++++|++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            56778889999999999999874   345689999988653 33445789999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-  426 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-  426 (613)
                      |||+++|+|.+++... ...++|.+++.++.|++.||+|||+.+    ++||||||+|||++.++.+|++|||++.... 
T Consensus        85 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~----iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          85 TEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMG----YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC----EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            9999999999998543 356899999999999999999999988    9999999999999999999999999875321 


Q ss_pred             --------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccH
Q 048439          427 --------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP  497 (613)
Q Consensus       427 --------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  497 (613)
                              ...+..|+|||++....++.++|||||||++||+++ |++||......+.   ...................
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  236 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKAVEDGFRLPAPRNCPNL  236 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHHHCCCCCCCCCCCCHH
Confidence                    112346999999999999999999999999999775 9999965543322   1111111111111222222


Q ss_pred             HHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          498 FLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       498 ~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ... ...||+.+|.+||++.++++.|..
T Consensus       237 ~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         237 LHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             HHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence            222 337999999999999999988864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.6e-39  Score=346.06  Aligned_cols=247  Identities=23%  Similarity=0.406  Sum_probs=193.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEE-----cCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFI-----NGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~-----~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~  344 (613)
                      ++|...+.||+|+||.||+|+.     .+++..||||+++... ......+.+|+.+|..+ +||||++++|+|.+.+..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4577778999999999999974     3345679999997543 33456788999999999 899999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCC------------------------------------------------------------
Q 048439          345 ILVYDFMARGTLPDHLYHSD------------------------------------------------------------  364 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------------  364 (613)
                      ++|||||++|+|.+++....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999999885321                                                            


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC----
Q 048439          365 -------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT----  427 (613)
Q Consensus       365 -------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~----  427 (613)
                                   ...++|..++.++.|+++||.|||+.+    |+||||||+|||+++++.+||+|||+++....    
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~----ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN----CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                         125889999999999999999999988    99999999999999999999999999864211    


Q ss_pred             ------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          428 ------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       428 ------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                            ..+..|+|||++....++.++|||||||+||||++ |.+||........  ...+........ .....+..+.
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~l~  347 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYKMIKEGYRML-SPECAPSEMY  347 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHHHHHhCccCC-CCCCCCHHHH
Confidence                  12345999999999999999999999999999998 8888854332221  111111111111 1111222221


Q ss_pred             --HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          501 --AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       501 --~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                        ..+||+.+|++||++.||++.|+..
T Consensus       348 ~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         348 DIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHHHHccCChhHCcCHHHHHHHHHhh
Confidence              3379999999999999999999853

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1e-38  Score=381.26  Aligned_cols=252  Identities=26%  Similarity=0.477  Sum_probs=197.7

Q ss_pred             ccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeec
Q 048439          261 QFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCND  340 (613)
Q Consensus       261 ~f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~  340 (613)
                      .++++++.   ..|....+||+|+||.||+|+...++..||||+++.....    ...|++.+++++|||||+++|+|.+
T Consensus       682 ~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~  754 (968)
T PLN00113        682 SITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS  754 (968)
T ss_pred             hhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc
Confidence            35555554   4577788999999999999999777788999998754322    2356889999999999999999999


Q ss_pred             CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecC
Q 048439          341 DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG  420 (613)
Q Consensus       341 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG  420 (613)
                      .+..++|||||++|+|.+++.     .++|.++.+|+.|+|+||+|||....+. |+||||||+||+++.++.+++. ||
T Consensus       755 ~~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~-iiH~dlkp~Nil~~~~~~~~~~-~~  827 (968)
T PLN00113        755 EKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPA-VVVGNLSPEKIIIDGKDEPHLR-LS  827 (968)
T ss_pred             CCCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCC-eecCCCCHHhEEECCCCceEEE-ec
Confidence            999999999999999999994     3899999999999999999999653333 9999999999999999988876 66


Q ss_pred             CCccC----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccccc
Q 048439          421 LSKFG----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVD  496 (613)
Q Consensus       421 ls~~~----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  496 (613)
                      ++...    ...++..|+|||++....++.|+|||||||++|||++|+.|++.... .......|.............+|
T Consensus       828 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  906 (968)
T PLN00113        828 LPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWID  906 (968)
T ss_pred             cccccccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeC
Confidence            65421    22345789999999999999999999999999999999999854322 22345555554332221111111


Q ss_pred             ----------------HHHHHhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          497 ----------------PFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       497 ----------------~~~~~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                                      ....+.+||+.+|++||+|.||++.|+...+
T Consensus       907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence                            1112458999999999999999999986543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.6e-40  Score=345.41  Aligned_cols=241  Identities=24%  Similarity=0.366  Sum_probs=199.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|..-..||+|.||.||||+.+.+.+.||+|.+.+.  .....+...+|++++++|+|||||.++.+|+...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            4566677899999999999999999999999999765  34456678999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----  425 (613)
                      |+.+ +|+.+|  .....|++.+...|+.+++.||+|||+.+    |+|||+||.||||+.++++|+||||+||..    
T Consensus        82 ~a~g-~L~~il--~~d~~lpEe~v~~~a~~LVsaL~yLhs~r----ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTIL--EQDGKLPEEQVRAIAYDLVSALYYLHSNR----ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHhcC----cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9987 999999  44567999999999999999999999998    999999999999999999999999999853    


Q ss_pred             ----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHHH
Q 048439          426 ----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKA  501 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  501 (613)
                          ...|++-|||||.+.++.|+..+|.||+||+|||+.+|+|||.......-...+......+    ...+...+...
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~----p~~~S~~f~nf  230 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP----PSTASSSFVNF  230 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC----cccccHHHHHH
Confidence                2357888999999999999999999999999999999999997654433222222111111    11221112111


Q ss_pred             h-cccccCCCCCCCHHHHHHHHH
Q 048439          502 M-SCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       502 ~-~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      + ..|.+||.+|.+-.+++.+..
T Consensus       231 l~gLL~kdP~~RltW~~Ll~HpF  253 (808)
T KOG0597|consen  231 LQGLLIKDPAQRLTWTDLLGHPF  253 (808)
T ss_pred             HHHHhhcChhhcccHHHHhcChH
Confidence            1 578999999999999996653

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-40  Score=337.66  Aligned_cols=242  Identities=21%  Similarity=0.265  Sum_probs=197.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|....+++.||+|++....   ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36778889999999999999998878899999986532   233456889999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+++|+|.+++..  ...+++...+.++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+++...  
T Consensus        81 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKE----IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            99999999999854  456899999999999999999999998    9999999999999999999999999987432  


Q ss_pred             ---CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--H
Q 048439          427 ---TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--A  501 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~  501 (613)
                         ..++..|+|||++.+..++.++|||||||+||||++|+.||......+.......     ....+....++.+.  .
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~-----~~~~~~~~~~~~~~~li  229 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA-----GKLEFPRHLDLYAKDLI  229 (291)
T ss_pred             cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----CCcCCCccCCHHHHHHH
Confidence               2356789999999999999999999999999999999999976543322111110     11112222233322  2


Q ss_pred             hcccccCCCCCCC-----HHHHHHHHHH
Q 048439          502 MSCLNDEGIRRPS-----MSDVVWGLEF  524 (613)
Q Consensus       502 ~~Cl~~~p~~RPs-----~~evl~~Le~  524 (613)
                      .+||+.||.+||+     +.|++.+.++
T Consensus       230 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~  257 (291)
T cd05612         230 KKLLVVDRTRRLGNMKNGADDVKNHRWF  257 (291)
T ss_pred             HHHcCCCHHHccCCccCCHHHHhcCccc
Confidence            2799999999995     8888877654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.4e-39  Score=332.19  Aligned_cols=248  Identities=24%  Similarity=0.399  Sum_probs=191.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcC----------------CceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFING----------------STTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSL  334 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~----------------~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l  334 (613)
                      ++|...+.||+|+||.||+|.+..                ++..||+|.+.... .....+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467778899999999999998643                23469999997653 3445679999999999999999999


Q ss_pred             EEEeecCCceEEEEEcCCCCChhHHhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEE
Q 048439          335 IGFCNDDREMILVYDFMARGTLPDHLYHSD-----------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVII  397 (613)
Q Consensus       335 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ii  397 (613)
                      +++|.+.+..++||||+++|+|.+++....                 ...++|.+++.++.|++.||.|||+.+    |+
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~----iv  160 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN----FV  160 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC----cc
Confidence            999999999999999999999999885321                 135789999999999999999999988    99


Q ss_pred             eccCCCCceeeCCCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh--CCC
Q 048439          398 HRDVKTTNILLDEKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC--ARP  465 (613)
Q Consensus       398 HrDlk~~NILl~~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt--g~~  465 (613)
                      ||||||+|||+++++.+||+|||+++...          ..++..|+|||++..+.++.++|||||||++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            99999999999999999999999986421          122456999999999999999999999999999986  456


Q ss_pred             CccchhhhhhhhHH-HHHHHhhc---cCCccccccHHH-HHhcccccCCCCCCCHHHHHHHHH
Q 048439          466 SILRTAAKKQVSLA-VWAQQCYQ---NGTIDQIVDPFL-KAMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       466 p~~~~~~~~~~~l~-~~~~~~~~---~~~~~~~~d~~~-~~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      |+............ .+......   ............ ...+||+.+|++||++.+|.+.|+
T Consensus       241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            66543322211111 11010000   000111111111 133799999999999999988875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=341.04  Aligned_cols=249  Identities=21%  Similarity=0.273  Sum_probs=203.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHH--HHHHHHHHhccC-ccceeeEEEEeecCC-ceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE--FQTEIGMLSQLR-HLHLVSLIGFCNDDR-EMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~--f~~Ei~~l~~l~-H~niv~l~g~~~~~~-~~~lV  347 (613)
                      ++|...+.||.|.||.||+|+-..++..||||+++..-.. .++  =++|+..|++|. |||||+|..++.+.+ .+++|
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            4566667899999999999999888899999999765221 333  368999999998 999999999998887 99999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT  427 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~  427 (613)
                      ||||+. +|.+++.++ +..|++..+..|+.||++||+|+|.+|    +.||||||+|||+.....+||+||||||....
T Consensus        89 fE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G----fFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG----FFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             HHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC----cccccCChhheEecccceeEeccccccccccc
Confidence            999987 999999766 788999999999999999999999999    99999999999999999999999999985322


Q ss_pred             -------CCCcccCChhhh-hcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccc------
Q 048439          428 -------SVSKTHLDPEYY-RLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ------  493 (613)
Q Consensus       428 -------~~~~~~~aPE~~-~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~------  493 (613)
                             ..|+-|.|||++ +.+-|+.+.||||+|||++|+.+-+|-|.+..+.++...+.-+..........+      
T Consensus       163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~  242 (538)
T KOG0661|consen  163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS  242 (538)
T ss_pred             CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence                   225568999997 456789999999999999999999999998888887766554443222221111      


Q ss_pred             ----------------ccc----HHH-HHhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          494 ----------------IVD----PFL-KAMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       494 ----------------~~d----~~~-~~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                                      ++.    ... ....||+.||.+|||+.+.+++.-+...
T Consensus       243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence                            100    001 1227999999999999999988766543

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9.6e-39  Score=335.80  Aligned_cols=194  Identities=26%  Similarity=0.331  Sum_probs=172.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ++|.....||+|+||.||+++...++..+|+|.+.... ......|.+|+++|++++|+||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            57888889999999999999998888899999987653 33456799999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      +++|+|.+++..  ...+++..+..++.|++.||.|||+.+.   |+||||||+|||+++++.+||+|||+++...    
T Consensus        85 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  159 (331)
T cd06649          85 MDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  159 (331)
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCccccccccccc
Confidence            999999999854  3468999999999999999999998532   9999999999999999999999999986421    


Q ss_pred             --CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          427 --TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       427 --~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                        ..++..|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus       160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence              23567899999999999999999999999999999999999643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.7e-40  Score=342.21  Aligned_cols=235  Identities=23%  Similarity=0.316  Sum_probs=191.8

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCC
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGT  355 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs  355 (613)
                      +||+|+||.||+++...++..||||+++...   ......+.+|+.++.+++||||+++++++.+.+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            7999999999999998888999999987542   3344567899999999999999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--------CC
Q 048439          356 LPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--------PT  427 (613)
Q Consensus       356 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--------~~  427 (613)
                      |.+++..  ...+++.+...++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++..        ..
T Consensus        82 L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~----ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  155 (323)
T cd05571          82 LFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCD----VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             HHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence            9999853  457899999999999999999999998    999999999999999999999999998642        12


Q ss_pred             CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhccc
Q 048439          428 SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSCL  505 (613)
Q Consensus       428 ~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~Cl  505 (613)
                      .++..|+|||++.+..++.++|||||||+||||++|+.||.............     .....+...+.+.+.  ..+||
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~-----~~~~~~p~~~~~~~~~li~~~L  230 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-----MEEIRFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCHHHHHHHHHHc
Confidence            35678999999999999999999999999999999999996543322111111     111112222222222  22799


Q ss_pred             ccCCCCCC-----CHHHHHHHHHH
Q 048439          506 NDEGIRRP-----SMSDVVWGLEF  524 (613)
Q Consensus       506 ~~~p~~RP-----s~~evl~~Le~  524 (613)
                      +.||++||     ++.+++++-.+
T Consensus       231 ~~dP~~R~~~~~~~~~~ll~h~~f  254 (323)
T cd05571         231 KKDPKQRLGGGPEDAKEIMEHRFF  254 (323)
T ss_pred             cCCHHHcCCCCCCCHHHHHcCCCc
Confidence            99999999     89999866543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=340.99  Aligned_cols=247  Identities=23%  Similarity=0.317  Sum_probs=202.3

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC----Ch-hcHHHHHHHHHHHhccC-ccceeeEEEEeecCC
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE----SQ-QGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDR  342 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~----~~-~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~  342 (613)
                      ...++|...+.||+|+||+|++|....++..||||.++..    .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3456788889999999999999999888899999987664    11 22344668999999999 999999999999999


Q ss_pred             ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC-CcEEEEecCC
Q 048439          343 EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK-WVAKVSDFGL  421 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGl  421 (613)
                      .+++||||+.+|+|.+++..  ..++.+....+++.|++.|++|||+.+    |+||||||+|||||.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g----i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG----IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC----EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999955  567899999999999999999999999    9999999999999999 9999999999


Q ss_pred             CccC--------CCCCCcccCChhhhhcCC-CC-chhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCc
Q 048439          422 SKFG--------PTSVSKTHLDPEYYRLQQ-LT-EKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTI  491 (613)
Q Consensus       422 s~~~--------~~~~~~~~~aPE~~~~~~-~t-~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~  491 (613)
                      +...        ..+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||...........     .....-.+
T Consensus       168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-----i~~~~~~~  242 (370)
T KOG0583|consen  168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-----IRKGEFKI  242 (370)
T ss_pred             ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-----HhcCCccC
Confidence            9754        235688899999999977 85 789999999999999999999986332221111     11111223


Q ss_pred             cccc-cHHHH--HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          492 DQIV-DPFLK--AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       492 ~~~~-d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ...+ .+...  ..+||..+|.+|+++.+|+.+-++..
T Consensus       243 p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  243 PSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            3333 33222  23799999999999999997777554

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=341.32  Aligned_cols=246  Identities=25%  Similarity=0.332  Sum_probs=200.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|.....||+|+||.||+|+...++..||||++....   ......+.+|+.++.+++|+||+++++++.+.+..+|||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36788889999999999999998888899999987542   234456889999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+++|+|.+++..  ...+++.+...++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++..   
T Consensus        81 e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~----ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~  154 (333)
T cd05600          81 EYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELG----YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY  154 (333)
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ccccCCCHHHEEECCCCCEEEEeCcCCcccccc
Confidence            99999999999843  456899999999999999999999998    999999999999999999999999998743   


Q ss_pred             --CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhh-HHHHHHHhhccCCcc----ccccHH
Q 048439          426 --PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVS-LAVWAQQCYQNGTID----QIVDPF  498 (613)
Q Consensus       426 --~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~----~~~d~~  498 (613)
                        ...++..|+|||++.+..++.++|||||||+||||++|++||......+... +..|... .......    .+.+..
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~s~~~  233 (333)
T cd05600         155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET-LQRPVYDDPRFNLSDEA  233 (333)
T ss_pred             cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-ccCCCCCccccccCHHH
Confidence              2345778999999999999999999999999999999999997654433222 2222211 1111111    112222


Q ss_pred             HHH-hcccccCCCCCCCHHHHHHHHHH
Q 048439          499 LKA-MSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       499 ~~~-~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ... .+||..+|.+||++.+++.+..+
T Consensus       234 ~~li~~~l~~~~~rr~s~~~ll~h~~~  260 (333)
T cd05600         234 WDLITKLINDPSRRFGSLEDIKNHPFF  260 (333)
T ss_pred             HHHHHHHhhChhhhcCCHHHHHhCccc
Confidence            222 26999999999999999987654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.3e-39  Score=325.40  Aligned_cols=245  Identities=24%  Similarity=0.423  Sum_probs=198.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      .+|...+.||+|+||.||+|.....+..||+|.+... .....++.+|++++.+++|+||++++++|..++..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            3466777999999999999999887788999998754 334567999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT----  427 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~----  427 (613)
                      ++|+|.+++.......+++..++.++.|++.||+|||+.+    ++||||||+|||+++++.+||+|||+++....    
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~----i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999999996655567999999999999999999999988    99999999999999999999999999864321    


Q ss_pred             -----CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          428 -----SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       428 -----~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                           ..+..|++||++....++.++|||||||++|||++ |..|+......+....   ................... 
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l  237 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEKGYRMERPEGCPPKVYEL  237 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HHCCCCCCCCCCCCHHHHHH
Confidence                 11346999999999999999999999999999998 8888865433221111   1111111111111111111 


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ..+||..+|++||++.++++.|+.
T Consensus       238 i~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         238 MRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             HHHHccCCcccCCCHHHHHHHHHh
Confidence            338999999999999999999874

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.6e-39  Score=343.25  Aligned_cols=248  Identities=26%  Similarity=0.429  Sum_probs=194.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCCC-hhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPES-QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~  344 (613)
                      ++|...+.||+|+||.||+|+...     +...||||+++... ......+.+|+.+++.+ +|+|||+++++|.+.+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            467788899999999999998532     23579999997643 33455688999999999 899999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCC------------------------------------------------------------
Q 048439          345 ILVYDFMARGTLPDHLYHSD------------------------------------------------------------  364 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------------  364 (613)
                      ++|||||++|+|.+++....                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999999885321                                                            


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC---------
Q 048439          365 --------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT---------  427 (613)
Q Consensus       365 --------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~---------  427 (613)
                              ..++++.++++|+.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++....         
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g----iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN----CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC----EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    135889999999999999999999988    99999999999999999999999999864211         


Q ss_pred             -CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhc
Q 048439          428 -SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMS  503 (613)
Q Consensus       428 -~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~  503 (613)
                       ..+..|+|||++....++.++|||||||+||||++ |+.||..........  ........ ........+.+.  ..+
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~l~~li~~  350 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY--KMVKRGYQ-MSRPDFAPPEIYSIMKM  350 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHH--HHHHcccC-ccCCCCCCHHHHHHHHH
Confidence             12345999999999999999999999999999997 999986543322111  11111111 111112222222  237


Q ss_pred             ccccCCCCCCCHHHHHHHHHHhh
Q 048439          504 CLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       504 Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ||+.+|.+||++.+|++.|+.++
T Consensus       351 cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         351 CWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HcCCChhhCcCHHHHHHHHHHHh
Confidence            99999999999999999998654

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7.5e-39  Score=328.01  Aligned_cols=246  Identities=28%  Similarity=0.473  Sum_probs=195.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCc-----eeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGST-----TPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~-----~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  345 (613)
                      ++|...+.||+|+||.||+|......     ..||+|.++... .....+|.+|+.++.+++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            35667779999999999999986543     679999987543 334567899999999999999999999999999999


Q ss_pred             EEEEcCCCCChhHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC
Q 048439          346 LVYDFMARGTLPDHLYHSD--------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK  411 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~  411 (613)
                      ++|||+++|+|.+++....              ...+++.+++.++.|++.||.|||+.+    ++||||||+|||++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~----i~H~dlkp~Nil~~~~  160 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH----FVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC----eeccccccceEEEcCC
Confidence            9999999999999985421              156889999999999999999999988    9999999999999999


Q ss_pred             CcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHH
Q 048439          412 WVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAV  480 (613)
Q Consensus       412 ~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~  480 (613)
                      +.+||+|||+++...          ...+..|+|||++....++.++|||||||+||||++ |+.||......+..   .
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~---~  237 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI---E  237 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H
Confidence            999999999986421          122456999999999999999999999999999998 99998765443321   1


Q ss_pred             HHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          481 WAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       481 ~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ...............+.+.. ..+||+.+|.+||++.||+++|+.
T Consensus       238 ~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            11111111111112222221 237999999999999999999873

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-39  Score=341.51  Aligned_cols=242  Identities=24%  Similarity=0.336  Sum_probs=197.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|+...+++.||||.+....   ......+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46777889999999999999998888899999986532   234557889999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+++|+|.+++..  ...+++.....++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++...  
T Consensus        98 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~----ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKD----IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999999854  456889999999999999999999998    9999999999999999999999999987432  


Q ss_pred             ---CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--H
Q 048439          427 ---TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--A  501 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~  501 (613)
                         ..++..|+|||++....++.++|||||||+||||++|++||............   .  .....+...++..+.  .
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i---~--~~~~~~p~~~~~~~~~li  246 (329)
T PTZ00263        172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI---L--AGRLKFPNWFDGRARDLV  246 (329)
T ss_pred             cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH---h--cCCcCCCCCCCHHHHHHH
Confidence               23567799999999999999999999999999999999999654332211111   1  011112223333332  2


Q ss_pred             hcccccCCCCCCC-----HHHHHHHHHH
Q 048439          502 MSCLNDEGIRRPS-----MSDVVWGLEF  524 (613)
Q Consensus       502 ~~Cl~~~p~~RPs-----~~evl~~Le~  524 (613)
                      .+||+.||.+||+     +.|++.+..+
T Consensus       247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f  274 (329)
T PTZ00263        247 KGLLQTDHTKRLGTLKGGVADVKNHPYF  274 (329)
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCCcc
Confidence            2799999999996     7888766553

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=6.6e-39  Score=341.40  Aligned_cols=246  Identities=22%  Similarity=0.326  Sum_probs=194.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||+||++....++..||||+++...   ......+..|+.++.+++|+||+++++++.+...++|||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888889999999999999998888899999997542   233456789999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      |||++|+|.+++..  ...+++.+...++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++...  
T Consensus        81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~g----ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLG----FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999999854  457999999999999999999999998    9999999999999999999999999986321  


Q ss_pred             -----------------------------------------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCC
Q 048439          427 -----------------------------------------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP  465 (613)
Q Consensus       427 -----------------------------------------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~  465 (613)
                                                               ..++..|+|||++.+..++.++|||||||+||||++|++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence                                                     235678999999999999999999999999999999999


Q ss_pred             Cccchhhhhhhh-HHHHHHHhhccC--CccccccHHHHHhcccccCCCCCCCHHHHHHHHH
Q 048439          466 SILRTAAKKQVS-LAVWAQQCYQNG--TIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       466 p~~~~~~~~~~~-l~~~~~~~~~~~--~~~~~~d~~~~~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ||......+... ...|........  .+......++..+.|...++..||++.||+++..
T Consensus       235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~  295 (363)
T cd05628         235 PFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPF  295 (363)
T ss_pred             CCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCC
Confidence            997654333221 111111111111  1111111222233354455567899999987654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.4e-39  Score=339.22  Aligned_cols=235  Identities=23%  Similarity=0.309  Sum_probs=191.5

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      ++||+|+||.||+++...++..||+|.++..   .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3799999999999999888889999998754   2334456789999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--------C
Q 048439          355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--------P  426 (613)
Q Consensus       355 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--------~  426 (613)
                      +|.+++..  ...+++..++.++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++..        .
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~----ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  154 (323)
T cd05595          81 ELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence            99988843  456899999999999999999999998    999999999999999999999999998642        1


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhcc
Q 048439          427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSC  504 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~C  504 (613)
                      ..++..|+|||++.++.++.++|||||||+||||++|+.||.............     .....+...+++.+.  ..+|
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~-----~~~~~~p~~~~~~~~~li~~~  229 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-----MEEIRFPRTLSPEAKSLLAGL  229 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh-----cCCCCCCCCCCHHHHHHHHHH
Confidence            235678999999999999999999999999999999999996554332221111     111112222222222  2279


Q ss_pred             cccCCCCCC-----CHHHHHHHHH
Q 048439          505 LNDEGIRRP-----SMSDVVWGLE  523 (613)
Q Consensus       505 l~~~p~~RP-----s~~evl~~Le  523 (613)
                      |+.+|.+||     ++.+++++-.
T Consensus       230 L~~dP~~R~~~~~~~~~~~l~h~~  253 (323)
T cd05595         230 LKKDPKQRLGGGPSDAKEVMEHRF  253 (323)
T ss_pred             ccCCHHHhCCCCCCCHHHHHcCCC
Confidence            999999998     8999886654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=339.44  Aligned_cols=249  Identities=24%  Similarity=0.411  Sum_probs=206.9

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCC
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMA  352 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  352 (613)
                      +..-.+.||-|.||.||.|.++.-...||||.++.+. ....+|+.|+.+|+.++|||+|+|+|+|..+..+|||.|||.
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC  346 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence            3445568999999999999998887889999998654 557899999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCCC----
Q 048439          353 RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----  428 (613)
Q Consensus       353 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~----  428 (613)
                      .|+|.++|+..++..++-...+.++.||+.||.||..++    +|||||.++|||+.++..+||+||||+|+....    
T Consensus       347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn----FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA  422 (1157)
T KOG4278|consen  347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA  422 (1157)
T ss_pred             CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh----hhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence            999999999888888999999999999999999999988    999999999999999999999999999864321    


Q ss_pred             -----CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHHH-
Q 048439          429 -----VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKA-  501 (613)
Q Consensus       429 -----~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~-  501 (613)
                           ....|.|||-+....++.|||||+|||+|||+.| |..|+.+-.......+.+...+   ....+.......+. 
T Consensus       423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR---M~~PeGCPpkVYeLM  499 (1157)
T KOG4278|consen  423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR---MDGPEGCPPKVYELM  499 (1157)
T ss_pred             ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc---ccCCCCCCHHHHHHH
Confidence                 1345899999999999999999999999999986 6677755444333334333222   22223333322222 


Q ss_pred             hcccccCCCCCCCHHHHHHHHHHhhhhh
Q 048439          502 MSCLNDEGIRRPSMSDVVWGLEFSLQLQ  529 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~Le~~l~~~  529 (613)
                      ..||+.+|.+||++.|+-+.+|...+-.
T Consensus       500 raCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  500 RACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             HHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            2699999999999999999999776543

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.6e-39  Score=338.70  Aligned_cols=234  Identities=24%  Similarity=0.322  Sum_probs=191.7

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCC
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGT  355 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs  355 (613)
                      +||+|+||.||+++...++..||||++...   .......+.+|+.+++.++||||+++++++.+.+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            699999999999999888899999999754   23345678899999999999999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--------CC
Q 048439          356 LPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--------PT  427 (613)
Q Consensus       356 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--------~~  427 (613)
                      |.+++..  ...+++.++..++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+++..        ..
T Consensus        82 L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~----ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  155 (328)
T cd05593          82 LFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGK----IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF  155 (328)
T ss_pred             HHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence            9988843  456899999999999999999999998    999999999999999999999999998642        12


Q ss_pred             CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhccc
Q 048439          428 SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSCL  505 (613)
Q Consensus       428 ~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~Cl  505 (613)
                      .++..|+|||++....++.++|||||||+||||++|+.||......+.......     ....+...+.+.+.  ..+||
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-----~~~~~p~~~~~~~~~li~~~L  230 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----EDIKFPRTLSADAKSLLSGLL  230 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-----CCccCCCCCCHHHHHHHHHHc
Confidence            356789999999999999999999999999999999999965443322211111     11112222222222  22799


Q ss_pred             ccCCCCCC-----CHHHHHHHHH
Q 048439          506 NDEGIRRP-----SMSDVVWGLE  523 (613)
Q Consensus       506 ~~~p~~RP-----s~~evl~~Le  523 (613)
                      +.+|.+||     ++.+++++..
T Consensus       231 ~~dP~~R~~~~~~~~~~il~h~~  253 (328)
T cd05593         231 IKDPNKRLGGGPDDAKEIMRHSF  253 (328)
T ss_pred             CCCHHHcCCCCCCCHHHHhcCCC
Confidence            99999997     8999987654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.6e-38  Score=348.72  Aligned_cols=241  Identities=17%  Similarity=0.271  Sum_probs=194.5

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCC-ceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCC
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGS-TTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMA  352 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~-~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  352 (613)
                      |...++||+|+||.||+|....+ +..||+|.+..........+.+|+.+|+.++|||||+++++|...+..+|||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            77788999999999999987655 67799998766655555678899999999999999999999999999999999999


Q ss_pred             CCChhHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          353 RGTLPDHLYHS--DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       353 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      +|+|.++|...  ...++++..+..++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++...    
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~----ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK----MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC----EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99999988542  3457899999999999999999999988    9999999999999999999999999986421    


Q ss_pred             ------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          427 ------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       427 ------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                            ..++..|+|||++....++.++|||||||++|||++|+.||......+........   ........+.+....
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~s~~~~~  301 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG---KYDPFPCPVSSGMKA  301 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCCccCCHHHHH
Confidence                  12577799999999999999999999999999999999999654332221111111   001111111111111


Q ss_pred             -HhcccccCCCCCCCHHHHHHH
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~  521 (613)
                       ..+||+.+|++||++.+++.+
T Consensus       302 li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        302 LLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             HHHHHhccChhhCcCHHHHHhC
Confidence             237999999999999999854

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.4e-38  Score=332.19  Aligned_cols=245  Identities=24%  Similarity=0.403  Sum_probs=193.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCce----eEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTT----PVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~----~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ++|...+.||+|+||.||+|++..++.    .||||.++... ....++|.+|+.+++.++|+||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            468888899999999999998754433    48999987553 34566799999999999999999999999875 5789


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      |+||+++|+|.+++... ...+++..++.++.|+++||+|||+.+    |+||||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~----iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcC----eeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999998643 346899999999999999999999988    9999999999999999999999999997432


Q ss_pred             C----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccc-c
Q 048439          427 T----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ-I  494 (613)
Q Consensus       427 ~----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-~  494 (613)
                      .          ..+..|++||++....++.++|||||||+||||++ |++|+......+..   .............. .
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~  237 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGERLPQPPICT  237 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHhCCCCCCCCCCCC
Confidence            1          11346999999999999999999999999999997 99998654332211   11111111111111 1


Q ss_pred             ccHHHHHhcccccCCCCCCCHHHHHHHHHHh
Q 048439          495 VDPFLKAMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       495 ~d~~~~~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      .+......+||..+|.+||++.+++..|...
T Consensus       238 ~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         238 IDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1222234489999999999999999887744

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-39  Score=307.85  Aligned_cols=246  Identities=24%  Similarity=0.319  Sum_probs=207.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|+..+.||+|-||.||.|+.+.+.-.||+|++.+..   .+...++.+|+++-+.|+||||++++||+.+....||++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            46888999999999999999999988999999986542   233457899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||.+.|.|...|.......+++.....+..|+|.||.|+|..+    +|||||||+|+|++.++..||+|||.+...   
T Consensus       102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~----VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~  177 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSN  177 (281)
T ss_pred             EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC----cccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence            9999999999998667778999999999999999999999988    999999999999999999999999998543   


Q ss_pred             ---CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHHHh
Q 048439          426 ---PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAM  502 (613)
Q Consensus       426 ---~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  502 (613)
                         .-++|..|++||...+...+.+.|+|++||+.||++.|.+||......+....+.............+..|.   .+
T Consensus       178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dl---I~  254 (281)
T KOG0580|consen  178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADL---IS  254 (281)
T ss_pred             CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHH---HH
Confidence               335677899999999999999999999999999999999999776644433333322222222222222222   23


Q ss_pred             cccccCCCCCCCHHHHHHHHHH
Q 048439          503 SCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       503 ~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .|+..+|.+|.+..||+.+.+.
T Consensus       255 ~ll~~~p~~r~~l~~v~~hpwI  276 (281)
T KOG0580|consen  255 RLLVKNPIERLALTEVMDHPWI  276 (281)
T ss_pred             HHhccCccccccHHHHhhhHHH
Confidence            6999999999999999987663

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-39  Score=313.21  Aligned_cols=195  Identities=25%  Similarity=0.362  Sum_probs=178.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      .+|.....||.|+||.|.+++.+.++..+|+|.++...   ....+...+|..+|+.+.||.+++|++.|.+.+.++|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            35677779999999999999999989999999998753   233456789999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc----
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF----  424 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~----  424 (613)
                      ||.++|.|..+|+  +..++++.....++.+|+.||+|||+.+    |++|||||+|||||.+|.+||.|||.|+.    
T Consensus       124 eyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~~----iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSLD----IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhcC----eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            9999999999994  4567999999999999999999999999    99999999999999999999999999974    


Q ss_pred             -CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhh
Q 048439          425 -GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAA  472 (613)
Q Consensus       425 -~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~  472 (613)
                       ...+||+.|+|||.++...+..++|.|||||++|||++|.+||....+
T Consensus       198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~  246 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP  246 (355)
T ss_pred             EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence             345789999999999999999999999999999999999999987665

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.8e-39  Score=332.68  Aligned_cols=247  Identities=21%  Similarity=0.282  Sum_probs=202.6

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ..++|+...+||+|+||.||+|+-++++..+|+|++++..   .......+.|-.+|....+++||+|+-.|++.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            5578899999999999999999999999999999998763   3445667899999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc--
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--  424 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~--  424 (613)
                      ||||++||++..+|..  ...|++.....++.+++.|+.-||+.|    +|||||||+|+|||..|++||+|||||.-  
T Consensus       219 iMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~g----yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQLG----YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHcC----cccccCChhheeecCCCCEeeccccccchhh
Confidence            9999999999999954  567888889999999999999999999    99999999999999999999999999831  


Q ss_pred             -----------------------------------------------------CCCCCCcccCChhhhhcCCCCchhHHH
Q 048439          425 -----------------------------------------------------GPTSVSKTHLDPEYYRLQQLTEKSDVY  451 (613)
Q Consensus       425 -----------------------------------------------------~~~~~~~~~~aPE~~~~~~~t~ksDV~  451 (613)
                                                                           ....||+.|+|||++.+..|+..+|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence                                                                 011235669999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCccchhhhhhh-hHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCC---CHHHHHHHHHH
Q 048439          452 SFGVVLFEVLCARPSILRTAAKKQV-SLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRP---SMSDVVWGLEF  524 (613)
Q Consensus       452 SfGvvL~elltg~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RP---s~~evl~~Le~  524 (613)
                      |+|||+||||.|.|||....+.+.. .+..|............ -+.... ..+||. ||++|-   .+.||-++..+
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~-s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF  448 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDL-SDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFF  448 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcc-cHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcc
Confidence            9999999999999999887776554 45566654433222211 121111 124555 898986   47777766554

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-39  Score=336.10  Aligned_cols=233  Identities=23%  Similarity=0.251  Sum_probs=188.8

Q ss_pred             eeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCCh
Q 048439          280 IGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTL  356 (613)
Q Consensus       280 iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  356 (613)
                      ||+|+||.||+|+...++..||+|+++..   .......+..|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999999888889999998653   234456788999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--------CC
Q 048439          357 PDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--------TS  428 (613)
Q Consensus       357 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--------~~  428 (613)
                      .+++..  ...+++..+..++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++...        ..
T Consensus        81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          81 FHHLQR--EGRFDLSRARFYTAELLCALENLHKFN----VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence            999854  456899999999999999999999998    9999999999999999999999999987421        23


Q ss_pred             CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhcccc
Q 048439          429 VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSCLN  506 (613)
Q Consensus       429 ~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~Cl~  506 (613)
                      ++..|+|||++.+..++.++|||||||++|||++|++||......+.....     ......+....++.+.  ..+||+
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~  229 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI-----LQEPLRFPDGFDRDAKDLLIGLLS  229 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH-----HcCCCCCCCcCCHHHHHHHHHHcC
Confidence            567899999999999999999999999999999999999654332211111     1111112222222222  227999


Q ss_pred             cCCCCCCC---HHHHHHHHH
Q 048439          507 DEGIRRPS---MSDVVWGLE  523 (613)
Q Consensus       507 ~~p~~RPs---~~evl~~Le  523 (613)
                      .||.+||+   +.|++.+..
T Consensus       230 ~dp~~R~~~~~~~e~l~hp~  249 (312)
T cd05585         230 RDPTRRLGYNGAQEIKNHPF  249 (312)
T ss_pred             CCHHHcCCCCCHHHHHcCCC
Confidence            99999985   566665544

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=326.66  Aligned_cols=247  Identities=23%  Similarity=0.289  Sum_probs=196.9

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      +|...++||+|+||.||++....++..||||.+....   ......+.+|+.++++++|+||+++++++.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4667789999999999999998777899999987542   2233457889999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---  426 (613)
                      |+++|+|.+++.......+++..+..++.|++.||.|||+.+    |+||||||+||++++++.++|+|||+++...   
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER----IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC----cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            999999999886655567999999999999999999999998    9999999999999999999999999986432   


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--  500 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--  500 (613)
                          ..++..|++||++....++.++|||||||++|||++|+.||.................... ......++..+.  
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l  235 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ-EEYSEKFSEAARSI  235 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc-cccCcccCHHHHHH
Confidence                2346679999999999999999999999999999999999975433222111111111111 111112222222  


Q ss_pred             HhcccccCCCCCC-----CHHHHHHHHHH
Q 048439          501 AMSCLNDEGIRRP-----SMSDVVWGLEF  524 (613)
Q Consensus       501 ~~~Cl~~~p~~RP-----s~~evl~~Le~  524 (613)
                      ..+||+.||.+||     ++.+++.+...
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~  264 (285)
T cd05605         236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFF  264 (285)
T ss_pred             HHHHccCCHHHhcCCCCCCHHHHhcCcCc
Confidence            2379999999999     88898766543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.1e-38  Score=320.10  Aligned_cols=240  Identities=25%  Similarity=0.451  Sum_probs=191.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||.||++...++ ..+|+|.+.... .....|.+|+.++++++||||++++++|.+.+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~-~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQ-IKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccC-ceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            4567777899999999999998765 569999886442 33467899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT----  427 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~----  427 (613)
                      ++|+|.+++... ...++|..++.++.+++.||.|||+.+    |+||||||+||++++++.+||+|||+++....    
T Consensus        82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          82 ENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNS----FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             CCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC----ccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            999999998643 246899999999999999999999988    99999999999999999999999999864211    


Q ss_pred             -----CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          428 -----SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       428 -----~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                           ..+..|+|||++....++.++||||||++||||++ |++||......+.   .......... .........+. 
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i~~~~~~-~~~~~~~~~~~~  232 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMISRGFRL-YRPKLASMTVYE  232 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHCCCCC-CCCCCCCHHHHH
Confidence                 12346999999998899999999999999999999 8999865433221   1111111111 11111222111 


Q ss_pred             -HhcccccCCCCCCCHHHHHHHH
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                       +.+||+.+|.+||++.++++.|
T Consensus       233 li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         233 VMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HHHHHccCCcccCcCHHHHHHhh
Confidence             3379999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.1e-39  Score=339.17  Aligned_cols=242  Identities=23%  Similarity=0.298  Sum_probs=195.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCc-eeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGST-TPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~-~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|.....||+|+||.||+|.+..++ ..||+|++...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            46888889999999999999876543 67999998643   233455788999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-  426 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-  426 (613)
                      |||+++|+|.+++..  ...+++..+..++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++... 
T Consensus       110 ~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~----ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLN----IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            999999999999854  456899999999999999999999998    9999999999999999999999999987432 


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--  500 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--  500 (613)
                          ..++..|+|||++.+..++.++|||||||+||||++|++||.............     .....+....+....  
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~-----~~~~~~p~~~~~~~~~l  258 (340)
T PTZ00426        184 RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL-----EGIIYFPKFLDNNCKHL  258 (340)
T ss_pred             CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh-----cCCCCCCCCCCHHHHHH
Confidence                235677999999999899999999999999999999999997544322111111     111111222222222  


Q ss_pred             HhcccccCCCCCC-----CHHHHHHHHHH
Q 048439          501 AMSCLNDEGIRRP-----SMSDVVWGLEF  524 (613)
Q Consensus       501 ~~~Cl~~~p~~RP-----s~~evl~~Le~  524 (613)
                      ..+||+.+|++|+     ++.+++++..+
T Consensus       259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f  287 (340)
T PTZ00426        259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWF  287 (340)
T ss_pred             HHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence            2279999999995     89999877553

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.5e-38  Score=321.65  Aligned_cols=248  Identities=27%  Similarity=0.464  Sum_probs=202.9

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++..+|...+.||.|+||.||+|...+ +..+|+|.+.........++..|+.+++.++|+||+++++++.+.+..++||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence            345667888899999999999999988 5789999998776656778999999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC-
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-  427 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~-  427 (613)
                      ||+++|+|.+++.......+++.+++.++.+++.||.|||+.+    |+||||||+|||+++++.+||+|||++..... 
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~----i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN----SIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            9999999999997655667999999999999999999999988    99999999999999999999999999864321 


Q ss_pred             -------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH
Q 048439          428 -------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       428 -------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                             ..+..|++||.+....++.++|||||||++|||++ |+.||......+....   ..............+...
T Consensus       158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  234 (261)
T cd05148         158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ---ITAGYRMPCPAKCPQEIY  234 (261)
T ss_pred             cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH---HHhCCcCCCCCCCCHHHH
Confidence                   12346999999998899999999999999999998 8999865443222211   111111111122222222


Q ss_pred             H-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          500 K-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       500 ~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      . +.+||+.+|.+||++.++++.|+.
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         235 KIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             HHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            2 338999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.6e-38  Score=323.37  Aligned_cols=247  Identities=25%  Similarity=0.431  Sum_probs=195.2

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCc
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDRE  343 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~  343 (613)
                      ++++|...+.||+|+||.||+|...+     .+..||||.+... ......+|.+|+.+++.++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            56788899999999999999998643     2466999998654 33445678999999999999999999999999999


Q ss_pred             eEEEEEcCCCCChhHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEE
Q 048439          344 MILVYDFMARGTLPDHLYHSD--------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAK  415 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~k  415 (613)
                      .++||||+++|+|.+++....        ...++|.+++.++.|++.||.|||+.+    ++||||||+|||+++++.+|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~----~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK----FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCcchheEEEcCCCCEE
Confidence            999999999999999985421        235789999999999999999999988    99999999999999999999


Q ss_pred             EEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHH
Q 048439          416 VSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQ  484 (613)
Q Consensus       416 l~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~  484 (613)
                      |+|||+++...          ...+..|+|||++..+.++.++|||||||++|||++ |.+||...........   ...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~---~~~  236 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF---VME  236 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HHc
Confidence            99999986321          122446999999999999999999999999999999 6888865433322111   111


Q ss_pred             hhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          485 CYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       485 ~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ...........+.+.. ..+||+.+|++||++.|++++|+
T Consensus       237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            1111111222222222 33899999999999999998876

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-38  Score=333.65  Aligned_cols=244  Identities=24%  Similarity=0.348  Sum_probs=188.7

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecC-----CceE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD-----REMI  345 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~  345 (613)
                      +|...++||+|+||.||+|+...++..||||++...  .......+.+|+.++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            366778999999999999999888889999998753  233445688999999999999999999988543     3479


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +|||||. ++|.+++..  ...+++..+..++.|+++||.|||+.+    |+||||||+|||+++++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTAN----VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999996 689888843  456999999999999999999999998    999999999999999999999999998642


Q ss_pred             -----------CCCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHH-----------
Q 048439          426 -----------PTSVSKTHLDPEYYRL--QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVW-----------  481 (613)
Q Consensus       426 -----------~~~~~~~~~aPE~~~~--~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~-----------  481 (613)
                                 ...++..|+|||++..  ..++.++|||||||++|||++|++||.......+......           
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence                       1235667999999876  6789999999999999999999999965433222111000           


Q ss_pred             ----------HHHhhccC------CccccccHHH--HHhcccccCCCCCCCHHHHHHHHHH
Q 048439          482 ----------AQQCYQNG------TIDQIVDPFL--KAMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       482 ----------~~~~~~~~------~~~~~~d~~~--~~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                                ........      .... .++.+  ...+||+.+|++||++.|++.+..+
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f  293 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPN-ADPLALRLLERLLAFDPKDRPTAEEALADPYF  293 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCC-CChHHHHHHHHHcCcCcccCCCHHHHhcCchh
Confidence                      00000000      0001 11111  1237999999999999999977654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4e-38  Score=324.12  Aligned_cols=247  Identities=26%  Similarity=0.406  Sum_probs=197.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEc-----CCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFIN-----GSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~-----~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      .+|...+.||+|+||+||++...     .+...+|+|.+..........+.+|++++.+++|+||++++++|...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46778889999999999999862     3346699999987766667789999999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEE
Q 048439          347 VYDFMARGTLPDHLYHS-----------DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAK  415 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~k  415 (613)
                      ||||+++|+|.+++...           ....+++.+++.++.|++.||.|||+.+    ++||||||+|||+++++.+|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~----i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH----FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----eeecccCcceEEEccCCcEE
Confidence            99999999999998532           1235999999999999999999999988    99999999999999999999


Q ss_pred             EEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHH
Q 048439          416 VSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQ  484 (613)
Q Consensus       416 l~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~  484 (613)
                      |+|||+++...          ..++..|+|||++....++.++|||||||++|||++ |.+||......+....   ...
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~---i~~  237 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC---ITQ  237 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHc
Confidence            99999986321          112346999999999999999999999999999998 8999865443221111   111


Q ss_pred             hhccCCccccccHHHH--HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          485 CYQNGTIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       485 ~~~~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      .... ......+..+.  ..+||+.+|.+||++.+|++.|+...
T Consensus       238 ~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         238 GRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             CCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            1100 11111222222  23799999999999999998888544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.4e-38  Score=325.14  Aligned_cols=194  Identities=23%  Similarity=0.314  Sum_probs=170.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|...+.||+|+||.||+|+...++..||||++....  ......+.+|+.++++++|+||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46888889999999999999998888899999987542  3345568899999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---  426 (613)
                      |++++.|..+..  ....+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++...   
T Consensus        81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~----i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKND----IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999987765442  2456899999999999999999999988    9999999999999999999999999986422   


Q ss_pred             ------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          427 ------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       427 ------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                            ..++..|+|||++.+..++.++|||||||+||||++|++||....
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~  205 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES  205 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence                  124567999999999899999999999999999999999996543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.1e-38  Score=322.95  Aligned_cols=247  Identities=25%  Similarity=0.405  Sum_probs=195.8

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCc
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDRE  343 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~  343 (613)
                      ++++|...+.||+|+||.||+|.+..     ....||+|.+.... ......|..|+.++++++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            45678888999999999999999976     56789999887543 3345679999999999999999999999999999


Q ss_pred             eEEEEEcCCCCChhHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC---cEE
Q 048439          344 MILVYDFMARGTLPDHLYHSD-----NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW---VAK  415 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~---~~k  415 (613)
                      .++||||+++|+|.+++....     ...++|.+++.++.|++.||+|||+.+    ++||||||+|||++.++   .+|
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~----ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH----FIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC----EeecccchheEEEeccCCCcceE
Confidence            999999999999999986432     236999999999999999999999998    99999999999998754   699


Q ss_pred             EEecCCCccCCC----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHH
Q 048439          416 VSDFGLSKFGPT----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQ  484 (613)
Q Consensus       416 l~DFGls~~~~~----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~  484 (613)
                      |+|||+++....          ..+..|+|||++....++.++|||||||++|||++ |+.||......+.....   ..
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~---~~  236 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV---TG  236 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---Hc
Confidence            999999874311          11235999999999999999999999999999997 99998654433221111   11


Q ss_pred             hhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          485 CYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       485 ~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .........+...... ..+||+.+|++||++.+|+++|+
T Consensus       237 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         237 GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1111111112222222 23799999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3e-38  Score=325.28  Aligned_cols=244  Identities=23%  Similarity=0.317  Sum_probs=191.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      .+|...++||+|+||.||+|+...++..||+|.++... ......+.+|+.++++++|+||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            45778889999999999999998888999999987543 23345678999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-----  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-----  425 (613)
                      +++ +|.+++... ...+++..+..++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+++..     
T Consensus        85 ~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~----ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRK----ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            985 999888543 345889999999999999999999988    999999999999999999999999998642     


Q ss_pred             ---CCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHH-----------------
Q 048439          426 ---PTSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQ-----------------  484 (613)
Q Consensus       426 ---~~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~-----------------  484 (613)
                         ...++..|+|||.+.+ ..++.++|||||||++|||++|++||......+..........                 
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence               1234567999999865 5689999999999999999999999976544433222111100                 


Q ss_pred             --hhccCC------ccccccHHHH--HhcccccCCCCCCCHHHHHHH
Q 048439          485 --CYQNGT------IDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       485 --~~~~~~------~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~  521 (613)
                        ......      ....++....  ..+||..||.+|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence              000000      0001111111  227999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.6e-38  Score=340.59  Aligned_cols=245  Identities=22%  Similarity=0.333  Sum_probs=196.3

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      .|...+.||+|+||+||+|+...++..||||++....   ......+.+|+.++.+++|+||+++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5777889999999999999998888999999997542   3345678999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----  425 (613)
                      |+++|+|.+++..  ...+++.....++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..    
T Consensus        82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~g----ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKMG----FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999999854  346889999999999999999999988    999999999999999999999999987421    


Q ss_pred             ---------------------------------------------------CCCCCcccCChhhhhcCCCCchhHHHHHH
Q 048439          426 ---------------------------------------------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFG  454 (613)
Q Consensus       426 ---------------------------------------------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfG  454 (613)
                                                                         ...++..|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence                                                               11356789999999999999999999999


Q ss_pred             HHHHHHHhCCCCccchhhhhh-hhHHHHHHHhhccC--Cc-cccccHHHHHhcccccCCCCCCCHHHHHHHHHH
Q 048439          455 VVLFEVLCARPSILRTAAKKQ-VSLAVWAQQCYQNG--TI-DQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       455 vvL~elltg~~p~~~~~~~~~-~~l~~~~~~~~~~~--~~-~~~~d~~~~~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      |+||||++|++||......+. .....|........  .+ .+..| ++..+.|+..++..||++.|++.+..+
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d-li~~ll~~~~~~~~R~~~~~~l~hp~f  308 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVD-LITKLCCSAEERLGRNGADDIKAHPFF  308 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHH-HHHHHccCcccccCCCCHHHHhcCccc
Confidence            999999999999976543322 11222221111111  11 11112 222345778888889999999977654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.8e-38  Score=319.85  Aligned_cols=244  Identities=25%  Similarity=0.466  Sum_probs=197.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||.||+|...++ ..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNS-TKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCC-ceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            4677778999999999999997665 569999987543 33567899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT----  427 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~----  427 (613)
                      ++|+|.+++.......+++.+++.++.|++.||+|||+.+    ++||||||+||++++++.+||+|||+++....    
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~----i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN----YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            9999999997655567899999999999999999999988    99999999999999999999999999864321    


Q ss_pred             -----CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          428 -----SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       428 -----~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                           ..+..|+|||++....++.++|||||||++|||++ |+.||.......   ...+............+.+.... 
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQRGYRMPRMENCPDELYDI  236 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHcCCCCCCCCCCCHHHHHH
Confidence                 12345999999999999999999999999999998 999986433222   11111111111112222222222 


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ..+||..+|++||++.++++.|+.
T Consensus       237 i~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         237 MKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             HHHHccCCcccCcCHHHHHHHHhc
Confidence            338999999999999999998873

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7e-38  Score=329.60  Aligned_cols=194  Identities=26%  Similarity=0.347  Sum_probs=172.4

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      .++|...+.||+|+||.||++....++..+|+|.+... .......+.+|++++++++|+||++++++|.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            36788888999999999999999888888999998765 33345678999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG-ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      |+++|+|.+++..  ...+++.....++.+++.||.|||+. +    |+||||||+|||+++++.+||+|||++...   
T Consensus        84 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~----ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          84 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCC----EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            9999999999854  34689999999999999999999974 5    999999999999999999999999998642   


Q ss_pred             ---CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          426 ---PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       426 ---~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                         ...++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence               123566899999999989999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-38  Score=319.94  Aligned_cols=247  Identities=27%  Similarity=0.460  Sum_probs=197.1

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCC---ceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGS---TTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~---~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      .++|...+.||+|+||.||+|++...   ...||||.++... .....+|.+|+.++++++|+||+++++++.+.+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            35688888999999999999998532   4579999987653 3345679999999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ||||+++|+|.+++... ...+++.+++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++...
T Consensus        83 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~----i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEMN----YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            99999999999998543 347899999999999999999999988    9999999999999999999999999987532


Q ss_pred             ----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          427 ----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       427 ----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                                ...+..|++||++....++.++||||||+++|||++ |..||......+   ..................
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~  234 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAVEDGYRLPPPMDCP  234 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHHHcCCCCCCCCCCC
Confidence                      112346999999999999999999999999999998 999985443222   112111111111111111


Q ss_pred             cHHHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          496 DPFLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       496 d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      +.... ..+||+.+|++||++.+|+++|+..
T Consensus       235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         235 SALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11211 3379999999999999999998853

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.4e-38  Score=323.69  Aligned_cols=245  Identities=23%  Similarity=0.364  Sum_probs=187.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEc-CCceeEEEEEeCCCC--hhcHHHHHHHHHHHhcc---CccceeeEEEEee-----c
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFIN-GSTTPVAIKRLEPES--QQGALEFQTEIGMLSQL---RHLHLVSLIGFCN-----D  340 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~-~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l---~H~niv~l~g~~~-----~  340 (613)
                      ++|...+.||+|+||.||+|+.. .++..||||+++...  ......+.+|+.+++++   +||||++++++|.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36778889999999999999974 345789999986542  22234566777777665   6999999999985     3


Q ss_pred             CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecC
Q 048439          341 DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG  420 (613)
Q Consensus       341 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG  420 (613)
                      ...+++||||++ ++|.+++.......+++.+++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~----iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            456899999997 59999986655567999999999999999999999998    9999999999999999999999999


Q ss_pred             CCccCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc-----
Q 048439          421 LSKFGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN-----  488 (613)
Q Consensus       421 ls~~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-----  488 (613)
                      +++...       ..++..|+|||.+....++.++|||||||+||||++|++||......+..............     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            986422       23466799999999999999999999999999999999999765443322211110000000     


Q ss_pred             ------C--------Ccc---ccccHHHH--HhcccccCCCCCCCHHHHHHH
Q 048439          489 ------G--------TID---QIVDPFLK--AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       489 ------~--------~~~---~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~  521 (613)
                            .        .+.   .-++....  ..+||+.+|++||++.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence                  0        000   01122222  238999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-39  Score=340.84  Aligned_cols=245  Identities=21%  Similarity=0.297  Sum_probs=195.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...++||+|+||.||+|+...+++.||||++....   ......+.+|+.+|..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888899999999999999998888899999997532   233456789999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+++|+|.+++..  ...+++..+..++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++...  
T Consensus        81 E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~----ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLG----YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999999854  346999999999999999999999998    9999999999999999999999999985311  


Q ss_pred             --------------------------------------------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh
Q 048439          427 --------------------------------------------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC  462 (613)
Q Consensus       427 --------------------------------------------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt  462 (613)
                                                                  ..++..|+|||++....++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence                                                        136778999999999999999999999999999999


Q ss_pred             CCCCccchhhhhhhh-HHHHHHHhhccCCccccccHHHHHh-cccccCCCCCCC---HHHHHHHHHH
Q 048439          463 ARPSILRTAAKKQVS-LAVWAQQCYQNGTIDQIVDPFLKAM-SCLNDEGIRRPS---MSDVVWGLEF  524 (613)
Q Consensus       463 g~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~~~~~-~Cl~~~p~~RPs---~~evl~~Le~  524 (613)
                      |++||......+... ...|...... .....+.+.....+ +|+. +|.+|++   +.|++.+..+
T Consensus       235 G~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~  299 (364)
T cd05599         235 GYPPFCSDNPQETYRKIINWKETLQF-PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF  299 (364)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCccCC-CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCc
Confidence            999997654332211 1112111110 00011112222222 4554 8999998   9999876653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.3e-38  Score=337.98  Aligned_cols=250  Identities=24%  Similarity=0.394  Sum_probs=194.8

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCC-----ceeEEEEEeCCCC-hhcHHHHHHHHHHHhccC-ccceeeEEEEeecCCc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGS-----TTPVAIKRLEPES-QQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDRE  343 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~-----~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~  343 (613)
                      .++|...++||+|+||.||+|+....     ...||||+++... ....+.|.+|+.+|+++. ||||++++|+|.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            45777888999999999999987432     2469999997653 334567999999999996 9999999999999999


Q ss_pred             eEEEEEcCCCCChhHHhhcCC-----------------------------------------------------------
Q 048439          344 MILVYDFMARGTLPDHLYHSD-----------------------------------------------------------  364 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~-----------------------------------------------------------  364 (613)
                      .+||||||++|+|.++|....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999999885421                                                           


Q ss_pred             -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC
Q 048439          365 -----------------------------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD  409 (613)
Q Consensus       365 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~  409 (613)
                                                         ...+++.+++.++.|+++||.|||+.+    |+||||||+|||++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~----ivH~dikp~Nill~  271 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN----CVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC----eeCCCCChHhEEEe
Confidence                                               134889999999999999999999988    99999999999999


Q ss_pred             CCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhH
Q 048439          410 EKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSL  478 (613)
Q Consensus       410 ~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l  478 (613)
                      +++.+||+|||+++...          ..++..|+|||.+.+..++.++|||||||+||||++ |+.||.......... 
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~-  350 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY-  350 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH-
Confidence            99999999999986421          112346999999999999999999999999999997 888886543222111 


Q ss_pred             HHHHHHhhccCCccccccHHH-HHhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          479 AVWAQQCYQNGTIDQIVDPFL-KAMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       479 ~~~~~~~~~~~~~~~~~d~~~-~~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                       ..............+..... ...+||+.+|++||++.+|++.|+..+
T Consensus       351 -~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         351 -NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             -HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence             11111111111112222222 233799999999999999999998544

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.3e-38  Score=323.70  Aligned_cols=249  Identities=25%  Similarity=0.410  Sum_probs=197.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ++|.....||+|+||.||+|+..+     ....+++|.+..........|.+|++++++++|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            356677799999999999998632     335699999887766666789999999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC
Q 048439          347 VYDFMARGTLPDHLYHSD--------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW  412 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~  412 (613)
                      ||||+++++|.+++....              ...++|..++.++.|++.||.|||+.+    |+||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~----i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH----FVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC----eeecccCcceEEEccCC
Confidence            999999999999985421              235899999999999999999999998    99999999999999999


Q ss_pred             cEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHH
Q 048439          413 VAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVW  481 (613)
Q Consensus       413 ~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~  481 (613)
                      .+||+|||+++...          ..++..|+|||++....++.++|||||||++|||++ |++||......+...   .
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~---~  237 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE---C  237 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---H
Confidence            99999999986421          112446999999999999999999999999999998 999986544333211   1


Q ss_pred             HHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          482 AQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       482 ~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      ................+.. ..+||+.+|++||++.+|++.|+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         238 ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            1111111111111111211 337999999999999999999986543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.9e-39  Score=335.99  Aligned_cols=235  Identities=23%  Similarity=0.316  Sum_probs=191.0

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCC
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGT  355 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs  355 (613)
                      +||+|+||.||++....++..||+|.+...   .......+..|++++..++|+||+++++++.+.+..++||||+++|+
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence            699999999999999888889999998754   23344567899999999999999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--------
Q 048439          356 LPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT-GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--------  426 (613)
Q Consensus       356 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--------  426 (613)
                      |.+++..  ...+++.++..++.|++.||.|||+ .+    |+||||||+|||+++++.+||+|||+++...        
T Consensus        82 L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~----ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          82 LFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKN----VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             HHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCC----EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            9988843  4568999999999999999999997 56    9999999999999999999999999986421        


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhcc
Q 048439          427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSC  504 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~C  504 (613)
                      ..++..|+|||++.+..++.++|||||||+||||++|+.||..............     ....+....++.+.  ..+|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-----~~~~~p~~~~~~~~~li~~~  230 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----EEIRFPRTLSPEAKSLLSGL  230 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc-----CCCCCCCCCCHHHHHHHHHH
Confidence            2356789999999999999999999999999999999999965543322222111     11112222222222  2279


Q ss_pred             cccCCCCCC-----CHHHHHHHHHH
Q 048439          505 LNDEGIRRP-----SMSDVVWGLEF  524 (613)
Q Consensus       505 l~~~p~~RP-----s~~evl~~Le~  524 (613)
                      |+.||.+|+     ++.+++++..+
T Consensus       231 L~~dP~~R~~~~~~~~~~il~h~~~  255 (325)
T cd05594         231 LKKDPKQRLGGGPDDAKEIMQHKFF  255 (325)
T ss_pred             hhcCHHHhCCCCCCCHHHHhcCCCc
Confidence            999999996     89999877543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.6e-38  Score=322.25  Aligned_cols=245  Identities=25%  Similarity=0.423  Sum_probs=195.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCCChh-cHHHHHHHHHHHhccCccceeeEEEEeecCCceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPESQQ-GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  345 (613)
                      ++|...+.||+|+||.||+|...+     ....||||.++..... ....|.+|+++|++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            456677799999999999998743     2467999999765444 4578999999999999999999999999999999


Q ss_pred             EEEEcCCCCChhHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc
Q 048439          346 LVYDFMARGTLPDHLYHSD------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV  413 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~  413 (613)
                      +||||+++|+|.+++....            ...+++.++..++.|++.||.|||+.+    ++||||||+|||++.++.
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~----i~h~dlkp~nili~~~~~  160 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH----FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC----eeccccccceEEEcCCCe
Confidence            9999999999999986421            245899999999999999999999998    999999999999999999


Q ss_pred             EEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHH
Q 048439          414 AKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWA  482 (613)
Q Consensus       414 ~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~  482 (613)
                      +||+|||+++...          ...+..|+|||++....++.++|||||||++|||++ |..||......+..   ...
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~---~~~  237 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI---ECI  237 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHH
Confidence            9999999986421          112346999999999999999999999999999998 99998654433221   111


Q ss_pred             HHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          483 QQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       483 ~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .................. ..+||+.+|.+||++.||++.|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         238 TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            111111111111122222 23799999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.5e-38  Score=318.50  Aligned_cols=247  Identities=26%  Similarity=0.464  Sum_probs=196.8

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCc---eeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGST---TPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~---~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      +++|+..+.||+|+||.||+|++..++   ..+|+|.+... .....++|..|++++.+++|+||+++++++.+.+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            457788889999999999999986433   36999998765 34445679999999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ||||+++++|.+++... ...+++.+++.++.|++.||+|||+.+    ++||||||+||++++++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~----i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMN----YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC----eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            99999999999998543 356899999999999999999999988    9999999999999999999999999986432


Q ss_pred             CC-----------CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCcccc
Q 048439          427 TS-----------VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQI  494 (613)
Q Consensus       427 ~~-----------~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  494 (613)
                      ..           .+..|++||++..+.++.++|||||||++|||++ |+.||......+.....   ............
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i---~~~~~~~~~~~~  235 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI---NDGFRLPAPMDC  235 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH---hcCCCCCCCCCC
Confidence            11           1235999999999999999999999999999997 99998654332211111   111111111122


Q ss_pred             ccHHHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          495 VDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       495 ~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ...... ..+||+.+|.+||++.+|++.|+..
T Consensus       236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            222222 3379999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-40  Score=334.68  Aligned_cols=242  Identities=25%  Similarity=0.370  Sum_probs=202.3

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      .|....+||+|.||.||||.+..+++.||+|.+..+ ......+.+.|+.+|++++|+||.+++|.+..+..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            355556899999999999999999999999999876 4455678899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc-------
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF-------  424 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~-------  424 (613)
                      .+|++.+.|.  ....+.+....-|.+++..||.|||.++    .+|||||+.|||+..+|.+||+|||.+..       
T Consensus        94 ~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~~----kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   94 GGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSEK----KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             cCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhcc----eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            9999999993  3455688888899999999999999998    99999999999999999999999998742       


Q ss_pred             -CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHHHhc
Q 048439          425 -GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS  503 (613)
Q Consensus       425 -~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  503 (613)
                       ....+|+.|||||++....|+.|+||||||++.+||.+|.||+....+.....++.........+....-+..+..  .
T Consensus       168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~--~  245 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVE--A  245 (467)
T ss_pred             cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHH--H
Confidence             3445788899999999889999999999999999999999999776664444443322222222322222223333  6


Q ss_pred             ccccCCCCCCCHHHHHHHH
Q 048439          504 CLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       504 Cl~~~p~~RPs~~evl~~L  522 (613)
                      ||+.+|+.||++.+++++-
T Consensus       246 CL~k~P~~RpsA~~LLKh~  264 (467)
T KOG0201|consen  246 CLDKNPEFRPSAKELLKHK  264 (467)
T ss_pred             HhhcCcccCcCHHHHhhhH
Confidence            9999999999999999663

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5e-38  Score=316.36  Aligned_cols=236  Identities=28%  Similarity=0.451  Sum_probs=189.5

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCChh
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLP  357 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~  357 (613)
                      .||+|+||.||+|+...++..||+|.+... .......|.+|++++++++|+||++++++|...+..++||||+++++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            689999999999999877788999987654 3344567999999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC----------
Q 048439          358 DHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT----------  427 (613)
Q Consensus       358 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~----------  427 (613)
                      +++... ...++|.+++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++....          
T Consensus        82 ~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~----i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          82 TFLRTE-GPRLKVKELIQMVENAAAGMEYLESKH----CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC----ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            998542 356899999999999999999999988    99999999999999999999999999864221          


Q ss_pred             CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhcc
Q 048439          428 SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSC  504 (613)
Q Consensus       428 ~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~C  504 (613)
                      ..+..|+|||++..+.++.++|||||||++|||++ |.+|+.............   .... ..........+.  ..+|
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~li~~~  232 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE---QGVR-LPCPELCPDAVYRLMERC  232 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH---cCCC-CCCcccCCHHHHHHHHHH
Confidence            11235999999999999999999999999999998 888885443322111111   1111 111112222221  2379


Q ss_pred             cccCCCCCCCHHHHHHHHH
Q 048439          505 LNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       505 l~~~p~~RPs~~evl~~Le  523 (613)
                      |+.+|++||++.+|++.|+
T Consensus       233 l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         233 WEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCChhhCcCHHHHHHHHh
Confidence            9999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-38  Score=318.15  Aligned_cols=245  Identities=27%  Similarity=0.469  Sum_probs=197.4

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      .++|...+.||+|+||.||+|...++ ..||||.++... ....+|.+|+.++++++|+||+++++++...+..++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCC-eEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            45677888999999999999997665 679999987653 3456789999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC---
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT---  427 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~---  427 (613)
                      +++++|.+++.......++|.++..++.+++.||.|||+.+    |+||||||+||++++++.+||+|||+++....   
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN----YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC----eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            99999999996544557999999999999999999999988    99999999999999999999999999864221   


Q ss_pred             ---CC---CcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          428 ---SV---SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       428 ---~~---~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                         .+   ...|++||++....++.++|||||||++|||++ |+.||.........   ................+....
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  235 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL---QQVDQGYRMPCPPGCPKELYD  235 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHHcCCCCCCCCcCCHHHHH
Confidence               11   235999999999999999999999999999999 99998654322211   111111111111222222222


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHHH
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                       +.+||+.+|.+||++.++++.|+.
T Consensus       236 li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         236 IMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             HHHHHhhcCcccCCCHHHHHHHHhc
Confidence             338999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.2e-38  Score=322.17  Aligned_cols=239  Identities=25%  Similarity=0.333  Sum_probs=188.9

Q ss_pred             eeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCCh
Q 048439          280 IGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTL  356 (613)
Q Consensus       280 iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  356 (613)
                      ||+|+||+||++....++..||||.+....   ......+..|++++++++|+||+++.+++..++..++|||||++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999998888899999986542   22345678999999999999999999999999999999999999999


Q ss_pred             hHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--------
Q 048439          357 PDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--------  426 (613)
Q Consensus       357 ~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--------  426 (613)
                      .+++..  .....+++..++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++...        
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~----i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR----IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence            988754  23457999999999999999999999998    9999999999999999999999999986421        


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc-CCccccccHHHH--Hhc
Q 048439          427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN-GTIDQIVDPFLK--AMS  503 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~d~~~~--~~~  503 (613)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||.........  .......... ........+.+.  ..+
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRILNDSVTYPDKFSPASKSFCEA  234 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHhhcccCCCCcccCCHHHHHHHHH
Confidence            23466799999999999999999999999999999999999654322111  1111111111 111111222221  227


Q ss_pred             ccccCCCCCC-----CHHHHHHHHHH
Q 048439          504 CLNDEGIRRP-----SMSDVVWGLEF  524 (613)
Q Consensus       504 Cl~~~p~~RP-----s~~evl~~Le~  524 (613)
                      ||+.+|++||     ++.+++.+..+
T Consensus       235 ~l~~~P~~R~~~~~~~~~~~l~h~~~  260 (280)
T cd05608         235 LLAKDPEKRLGFRDGNCDGLRTHPLF  260 (280)
T ss_pred             HhcCCHHHhcCCCCCCHHHHhcChhh
Confidence            9999999999     77888876553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.7e-38  Score=303.20  Aligned_cols=246  Identities=24%  Similarity=0.331  Sum_probs=201.1

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh-c-HHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ-G-ALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~-~-~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +|...++||+|.||.||+|+...+++.||||+++..... + .....+||..|+.++|+||+.|++++...+.+-||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            466667999999999999999999999999999876432 2 23568999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC---
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT---  427 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~---  427 (613)
                      |+. +|...+.+ +...|+..++..++.++++||+|||.+.    |+||||||.|+|++++|.+||+|||||+....   
T Consensus        83 m~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~----IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   83 MPT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKW----ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             ccc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhh----hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            987 99888854 4567999999999999999999999998    99999999999999999999999999986432   


Q ss_pred             -----CCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccc---cc--
Q 048439          428 -----SVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQI---VD--  496 (613)
Q Consensus       428 -----~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~---~d--  496 (613)
                           ..+.-|.|||.+.+ ++|+...||||.||++.||+-|.|-|.+...-+|...+-.+.....+....++   .|  
T Consensus       157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence                 23556899998876 57899999999999999999999999888777776665544433332222111   11  


Q ss_pred             -------------------HHHHHh-cccccCCCCCCCHHHHHHHHHH
Q 048439          497 -------------------PFLKAM-SCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       497 -------------------~~~~~~-~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                                         ..+..+ +++..||.+|+++.|++++--+
T Consensus       237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf  284 (318)
T KOG0659|consen  237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYF  284 (318)
T ss_pred             HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhh
Confidence                               111112 6899999999999999866553

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.5e-38  Score=340.94  Aligned_cols=244  Identities=20%  Similarity=0.253  Sum_probs=191.6

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      +|...++||+|+||.||+|+...++..||||++....   ......+.+|+.++++++|+|||++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5777889999999999999998888899999987542   2334568899999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----  425 (613)
                      ||++|+|.+++..  ...+++.....++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++..    
T Consensus        82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~~----ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKMG----FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999999854  346889999999999999999999998    999999999999999999999999996411    


Q ss_pred             ---------------------------------------------------CCCCCcccCChhhhhcCCCCchhHHHHHH
Q 048439          426 ---------------------------------------------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFG  454 (613)
Q Consensus       426 ---------------------------------------------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfG  454 (613)
                                                                         ...++..|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                               01356779999999999999999999999


Q ss_pred             HHHHHHHhCCCCccchhhhhhh-hHHHHHHHhhccCCccccccHHHHHhcccccCCCCCCC---HHHHHHHHH
Q 048439          455 VVLFEVLCARPSILRTAAKKQV-SLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPS---MSDVVWGLE  523 (613)
Q Consensus       455 vvL~elltg~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~~~~~~Cl~~~p~~RPs---~~evl~~Le  523 (613)
                      |+||||++|++||......+.. ....|.... .......+.+.....+.++..+|.+|++   +.+++.+..
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~  307 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSL-HIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPF  307 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc-CCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCC
Confidence            9999999999999765433221 112221111 1111111222222222223358999987   888876543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.9e-38  Score=334.15  Aligned_cols=240  Identities=21%  Similarity=0.259  Sum_probs=185.0

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCC
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMA  352 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  352 (613)
                      |...+.||+|+||.||+|+...+++.||||.+.... ......+.+|++++++++|+||+++++++.+.+.+++||||++
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  155 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD  155 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence            344568999999999999998878899999986543 3345678999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC------
Q 048439          353 RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP------  426 (613)
Q Consensus       353 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~------  426 (613)
                      +|+|.+..      .+.+..+..++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++...      
T Consensus       156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~----ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  225 (353)
T PLN00034        156 GGSLEGTH------IADEQFLADVARQILSGIAYLHRRH----IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC  225 (353)
T ss_pred             CCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC----EeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence            99986532      3567788899999999999999998    9999999999999999999999999986422      


Q ss_pred             --CCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH
Q 048439          427 --TSVSKTHLDPEYYRL-----QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       427 --~~~~~~~~aPE~~~~-----~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                        ..++..|+|||++..     ...+.++|||||||+||||++|+.||......+...+...............+...+.
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  305 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR  305 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHH
Confidence              235678999998853     2335689999999999999999999963322221111111111111111111111222


Q ss_pred             H-HhcccccCCCCCCCHHHHHHHHH
Q 048439          500 K-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       500 ~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      . ..+||+.+|++||++.|++++..
T Consensus       306 ~li~~~l~~~P~~Rpt~~ell~hp~  330 (353)
T PLN00034        306 HFISCCLQREPAKRWSAMQLLQHPF  330 (353)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcc
Confidence            2 22799999999999999997755

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.8e-38  Score=316.79  Aligned_cols=240  Identities=29%  Similarity=0.453  Sum_probs=191.2

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCC
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMA  352 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  352 (613)
                      +|.....||+|+||.||+|...+. ..+|||.+.... ....+|.+|+.++.+++||||++++++|.+.+..++||||++
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~-~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCC-CcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            466667899999999999988764 459999987543 334679999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC-----
Q 048439          353 RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-----  427 (613)
Q Consensus       353 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~-----  427 (613)
                      +|+|.+++... ...++|.+++.++.|++.||+|||+.+    ++|+||||+|||+++++.+||+|||+++....     
T Consensus        83 ~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          83 NGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLESKQ----FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC----eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            99999998543 236899999999999999999999988    99999999999999999999999999864211     


Q ss_pred             ----CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHH-HH-
Q 048439          428 ----SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF-LK-  500 (613)
Q Consensus       428 ----~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~-~~-  500 (613)
                          .++..|++||++....++.++|||||||++|||++ |+.||......+...   ......... ........ .. 
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~l  233 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE---KVSQGLRLY-RPHLASEKVYAI  233 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH---HHhcCCCCC-CCCCCCHHHHHH
Confidence                12345999999998899999999999999999998 999986543322111   111111111 11112222 21 


Q ss_pred             HhcccccCCCCCCCHHHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ..+||+.+|.+||++.++++.|+
T Consensus       234 i~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         234 MYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHHHcCCCcccCCCHHHHHHhhC
Confidence            33799999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.5e-38  Score=316.17  Aligned_cols=241  Identities=25%  Similarity=0.347  Sum_probs=196.8

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +|...+.||+|+||.||+|....++..|++|.+...  ......++.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            466778999999999999999888889999998643  344567799999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC---
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT---  427 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~---  427 (613)
                      +++++|.+++.......+++.+++.++.+++.||.|||+.+    ++||||||+||++++++.+||+|||+++....   
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~----i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK----ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999999997654567999999999999999999999988    99999999999999999999999999864221   


Q ss_pred             -----CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--
Q 048439          428 -----SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--  500 (613)
Q Consensus       428 -----~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--  500 (613)
                           .++..|+|||++....++.++|||||||++|||++|+.||.......   .......... .......+..+.  
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~~~  232 (256)
T cd08529         157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILKIIRGVF-PPVSQMYSQQLAQL  232 (256)
T ss_pred             hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHcCCC-CCCccccCHHHHHH
Confidence                 23456999999999999999999999999999999999996544222   1111111111 112212222222  


Q ss_pred             HhcccccCCCCCCCHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      ..+||+.+|++||++.+++++
T Consensus       233 i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         233 IDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             HHHHccCCcccCcCHHHHhhC
Confidence            238999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7e-38  Score=323.91  Aligned_cols=250  Identities=27%  Similarity=0.430  Sum_probs=197.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCce--eEEEEEeCCC-ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTT--PVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~--~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|....+||+|+||.||+|....++.  .+++|.++.. .....+.|.+|+.++.++ +||||+++++++.+.+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            467788899999999999999866543  4788888753 344556789999999999 799999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc
Q 048439          348 YDFMARGTLPDHLYHSD--------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV  413 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~  413 (613)
                      +||+++|+|.+++....              ...+++..++.++.|++.||+|||+.+    |+||||||+|||+++++.
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~----ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ----FIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCcCCcceEEECCCCe
Confidence            99999999999985421              135899999999999999999999988    999999999999999999


Q ss_pred             EEEEecCCCccCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHh
Q 048439          414 AKVSDFGLSKFGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQC  485 (613)
Q Consensus       414 ~kl~DFGls~~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~  485 (613)
                      +||+|||++....       ...+..|++||++....++.++|||||||++|||++ |+.||......+....   ....
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~---~~~~  234 (297)
T cd05089         158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK---LPQG  234 (297)
T ss_pred             EEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HhcC
Confidence            9999999986321       111335999999999899999999999999999997 9999965543332111   1111


Q ss_pred             hccCCccccccHHHH--HhcccccCCCCCCCHHHHHHHHHHhhhhh
Q 048439          486 YQNGTIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEFSLQLQ  529 (613)
Q Consensus       486 ~~~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~l~~~  529 (613)
                      .... .....+..+.  ..+||+.+|.+||++.++++.|+..++..
T Consensus       235 ~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         235 YRME-KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             CCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            1111 1112222222  33799999999999999999998776544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.8e-38  Score=332.20  Aligned_cols=235  Identities=20%  Similarity=0.274  Sum_probs=189.5

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      +||+|+||.||+|+...++..||||++...   .......+..|.+++..+ +||||+++++++.+.+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            699999999999999888889999998754   233445678899999866 7999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--------C
Q 048439          355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--------P  426 (613)
Q Consensus       355 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--------~  426 (613)
                      +|.+.+..  ...+++..+..++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++..        .
T Consensus        82 ~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~----ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          82 DLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence            99988853  356899999999999999999999998    999999999999999999999999998642        1


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhcc
Q 048439          427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSC  504 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~C  504 (613)
                      ..++..|+|||++....++.++|||||||++|||++|++||.............     ..........+....  ..+|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~-----~~~~~~p~~~~~~~~~ll~~~  230 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL-----HDDVLYPVWLSKEAVSILKAF  230 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCHHHHHHHHHH
Confidence            235678999999999999999999999999999999999997654333211111     111111111222221  2279


Q ss_pred             cccCCCCCC-------CHHHHHHHHHH
Q 048439          505 LNDEGIRRP-------SMSDVVWGLEF  524 (613)
Q Consensus       505 l~~~p~~RP-------s~~evl~~Le~  524 (613)
                      |+.+|++||       ++.+++++..+
T Consensus       231 L~~dp~~R~~~~~~~~~~~~~~~hp~~  257 (321)
T cd05591         231 MTKNPNKRLGCVASQGGEDAIKQHPFF  257 (321)
T ss_pred             hccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence            999999999       88888866543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9.9e-38  Score=319.58  Aligned_cols=238  Identities=20%  Similarity=0.270  Sum_probs=187.7

Q ss_pred             eeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCCh
Q 048439          280 IGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTL  356 (613)
Q Consensus       280 iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  356 (613)
                      ||+|+||.||+++...++..||+|++....   ......+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999998888999999986432   12233456799999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-------CCCC
Q 048439          357 PDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-------PTSV  429 (613)
Q Consensus       357 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-------~~~~  429 (613)
                      .+++.......+++..++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||++...       ...+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~----ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD----IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC----EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCC
Confidence            99886655667999999999999999999999988    999999999999999999999999998642       2345


Q ss_pred             CcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccC--CccccccHHHH--Hhccc
Q 048439          430 SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG--TIDQIVDPFLK--AMSCL  505 (613)
Q Consensus       430 ~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~d~~~~--~~~Cl  505 (613)
                      +..|+|||++....++.++|||||||++|||++|+.||........  ............  ......+....  ..+||
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  234 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLEDEVKFEHQNFTEESKDICRLFL  234 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhccccccccccCCHHHHHHHHHHh
Confidence            6789999999999999999999999999999999999865332111  111111111100  00111122222  22799


Q ss_pred             ccCCCCCCCHHHHHHHHH
Q 048439          506 NDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       506 ~~~p~~RPs~~evl~~Le  523 (613)
                      +.+|++||++.|+++.+.
T Consensus       235 ~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         235 AKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             ccCHhhCCCCccchhhhh
Confidence            999999999977664433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.2e-38  Score=329.77  Aligned_cols=232  Identities=24%  Similarity=0.316  Sum_probs=186.2

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhc-cCccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQ-LRHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      .||+|+||.||+|+...++..||||.++...   ......+..|..++.. ++||||+++++++.+.+.+++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            6999999999999998888899999987542   2334456778888876 48999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--------C
Q 048439          355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--------P  426 (613)
Q Consensus       355 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--------~  426 (613)
                      +|.+++..  ...+++.+...++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+++..        .
T Consensus        82 ~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~----ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          82 DLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKG----IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence            99999843  356899999999999999999999988    999999999999999999999999998632        1


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhcc
Q 048439          427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSC  504 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~C  504 (613)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||......+........     ........+....  ..+|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-----~~~~~~~~~~~~~~li~~~  230 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-----NPCYPRWLTREAKDILVKL  230 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----CCCCCccCCHHHHHHHHHH
Confidence            23567899999999999999999999999999999999999765433222211111     1111122222211  2379


Q ss_pred             cccCCCCCCCHH-HHHHH
Q 048439          505 LNDEGIRRPSMS-DVVWG  521 (613)
Q Consensus       505 l~~~p~~RPs~~-evl~~  521 (613)
                      |+.+|.+||++. +++++
T Consensus       231 l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         231 FVREPERRLGVKGDIRQH  248 (316)
T ss_pred             hccCHhhcCCChHHHHcC
Confidence            999999999997 66544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-38  Score=339.07  Aligned_cols=245  Identities=22%  Similarity=0.274  Sum_probs=192.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||++....++..||||++...   .......+.+|++++.+++||||+++++++.+.+..+|||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4678888999999999999999888899999998653   2334566889999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+++|+|.+++..  ...+++.....++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++..   
T Consensus        81 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~g----ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLG----FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999999853  456899999999999999999999998    999999999999999999999999998521   


Q ss_pred             ----------------------------------------------------CCCCCcccCChhhhhcCCCCchhHHHHH
Q 048439          426 ----------------------------------------------------PTSVSKTHLDPEYYRLQQLTEKSDVYSF  453 (613)
Q Consensus       426 ----------------------------------------------------~~~~~~~~~aPE~~~~~~~t~ksDV~Sf  453 (613)
                                                                          ...++..|+|||++....++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence                                                                0235677999999999999999999999


Q ss_pred             HHHHHHHHhCCCCccchhhhhhhh-HHHHHHHhhccCCccccccHHHHH-hcccccCCCC---CCCHHHHHHHHHH
Q 048439          454 GVVLFEVLCARPSILRTAAKKQVS-LAVWAQQCYQNGTIDQIVDPFLKA-MSCLNDEGIR---RPSMSDVVWGLEF  524 (613)
Q Consensus       454 GvvL~elltg~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~~~~-~~Cl~~~p~~---RPs~~evl~~Le~  524 (613)
                      ||+||||++|++||......+... ...|........ ...+....... .+||. +|.+   |+++.|++++...
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~  308 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFF  308 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCc
Confidence            999999999999997654433221 111211111111 00111111111 15775 5655   5699999987654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.1e-38  Score=337.75  Aligned_cols=243  Identities=20%  Similarity=0.237  Sum_probs=193.0

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      +|...+.||+|+||.||+++...++..||||++....   ......+.+|+++|.+++|+||+++++.+.+++.+++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6788889999999999999998888999999986532   2234568899999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----  425 (613)
                      |+++|+|.+++..  ...+++.....++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||++...    
T Consensus        82 ~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~----ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          82 YIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMG----FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            9999999999854  456889999999999999999999998    999999999999999999999999997311    


Q ss_pred             -----------------------------------------------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHH
Q 048439          426 -----------------------------------------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLF  458 (613)
Q Consensus       426 -----------------------------------------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~  458 (613)
                                                                     ...++..|+|||++.+..++.++|||||||+||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                           113567899999999999999999999999999


Q ss_pred             HHHhCCCCccchhhhhhhh-HHHHHHHhhccCCccccccHHHHHh-cccccCCCCCC---CHHHHHHHHH
Q 048439          459 EVLCARPSILRTAAKKQVS-LAVWAQQCYQNGTIDQIVDPFLKAM-SCLNDEGIRRP---SMSDVVWGLE  523 (613)
Q Consensus       459 elltg~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~~~~~-~Cl~~~p~~RP---s~~evl~~Le  523 (613)
                      ||++|++||......+... ...|..... ......+.......+ +|+ .+|.+|+   ++.+++.+..
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~  303 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVINWETTLH-IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF  303 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHhccCcccc-CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence            9999999997654433211 122211111 111111212222222 333 5999999   8999987755

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.3e-37  Score=316.73  Aligned_cols=244  Identities=26%  Similarity=0.370  Sum_probs=189.3

Q ss_pred             CCcceeeeeCcEEEEEEEEcCCce--eEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecC------Cce
Q 048439          275 DNDLVIGVGGFGDVYKGFINGSTT--PVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD------REM  344 (613)
Q Consensus       275 ~~~~~iG~G~fG~Vy~g~~~~~~~--~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~------~~~  344 (613)
                      ...++||+|+||.||+|.+...+.  .||+|.++..  +......|..|+.++++++|+||++++++|...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            455689999999999999876543  5999988654  344567789999999999999999999988542      356


Q ss_pred             EEEEEcCCCCChhHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecC
Q 048439          345 ILVYDFMARGTLPDHLYHS----DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG  420 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG  420 (613)
                      ++||||+++|+|.+++...    ....++|...+.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS----FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC----eeccccchhheEEcCCCCEEECCCC
Confidence            8999999999999987421    2345899999999999999999999988    9999999999999999999999999


Q ss_pred             CCccCCC----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccC
Q 048439          421 LSKFGPT----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNG  489 (613)
Q Consensus       421 ls~~~~~----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~  489 (613)
                      +++....          ..+..|++||++....++.++|||||||++|||++ |++||........   ...........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~~~~~~~~  234 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI---YDYLRQGNRLK  234 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHcCCCCC
Confidence            9874221          12346999999999999999999999999999999 7888864332221   11111111101


Q ss_pred             CccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          490 TIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       490 ~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ......+.... ..+||+.+|++||++.++++.|+.+
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11222222222 3389999999999999999998853

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.3e-37  Score=319.06  Aligned_cols=245  Identities=24%  Similarity=0.403  Sum_probs=191.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCce----eEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTT----PVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~----~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      .+|...+.||+|+||.||+|....++.    .+++|.+.... .....++..|+.++++++|+||++++|++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            356667799999999999999865443    47888876443 3344678889999999999999999999864 45788


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ++||+++|+|.+++... ...++|..++.|+.|++.||.|||+.+    ++||||||+|||+++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~----iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHR----MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC----EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            99999999999999643 356899999999999999999999988    9999999999999999999999999986421


Q ss_pred             ----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCcccc-
Q 048439          427 ----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQI-  494 (613)
Q Consensus       427 ----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~-  494 (613)
                                ..++..|++||++..+.++.++|||||||++|||++ |+.||..........+.   ..... ...... 
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~---~~~~~-~~~~~~~  236 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL---EKGER-LAQPQIC  236 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HCCCc-CCCCCCC
Confidence                      112346999999999999999999999999999998 99998665433322221   11110 011111 


Q ss_pred             -ccHHHHHhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          495 -VDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       495 -~d~~~~~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                       .+......+||..+|.+||++.|+++.|+...
T Consensus       237 ~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         237 TIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence             12222344899999999999999998887544

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.7e-38  Score=331.46  Aligned_cols=250  Identities=26%  Similarity=0.411  Sum_probs=193.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCCC-hhcHHHHHHHHHHHhcc-CccceeeEEEEeec-CCc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPES-QQGALEFQTEIGMLSQL-RHLHLVSLIGFCND-DRE  343 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~-~~~  343 (613)
                      ++|...++||+|+||.||+|...+     +++.||+|+++... ......+..|+.++.++ +|+||++++++|.. +..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            467788899999999999997543     23679999987543 33445688999999999 89999999998865 456


Q ss_pred             eEEEEEcCCCCChhHHhhcCC-----------------------------------------------------------
Q 048439          344 MILVYDFMARGTLPDHLYHSD-----------------------------------------------------------  364 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~-----------------------------------------------------------  364 (613)
                      ++++|||+++|+|.+++....                                                           
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            889999999999999885321                                                           


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----------CCCCcccC
Q 048439          365 NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----------TSVSKTHL  434 (613)
Q Consensus       365 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----------~~~~~~~~  434 (613)
                      ..+++|..+..++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++...          ..++..|+
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~----ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRK----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence            136899999999999999999999988    9999999999999999999999999987421          11234699


Q ss_pred             ChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHH-HHHhcccccCCCCC
Q 048439          435 DPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF-LKAMSCLNDEGIRR  512 (613)
Q Consensus       435 aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~-~~~~~Cl~~~p~~R  512 (613)
                      |||++....++.++|||||||+||||++ |.+||......+.  +.................... ..+.+||+.+|++|
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R  320 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR  320 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence            9999999999999999999999999998 9999865332221  111111101111111111111 12347999999999


Q ss_pred             CCHHHHHHHHHHhhh
Q 048439          513 PSMSDVVWGLEFSLQ  527 (613)
Q Consensus       513 Ps~~evl~~Le~~l~  527 (613)
                      |++.||+++|+..++
T Consensus       321 Ps~~ell~~l~~~~~  335 (337)
T cd05054         321 PTFSELVEILGDLLQ  335 (337)
T ss_pred             cCHHHHHHHHHHHHh
Confidence            999999999997664

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.4e-38  Score=324.86  Aligned_cols=250  Identities=29%  Similarity=0.446  Sum_probs=195.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCc--eeEEEEEeCCC-ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGST--TPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~--~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|.....||+|+||.||+|.+..++  ..+|+|.+... .......|.+|++++.++ +|+||+++++++.+++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            56778889999999999999986544  34688887653 344556789999999999 899999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc
Q 048439          348 YDFMARGTLPDHLYHSD--------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV  413 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~  413 (613)
                      |||+++|+|.+++....              ...+++.+++.++.|++.||.|||+.+    |+||||||+|||+++++.
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g----i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ----FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC----ccccccchheEEecCCCc
Confidence            99999999999986432              236899999999999999999999988    999999999999999999


Q ss_pred             EEEEecCCCccCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHh
Q 048439          414 AKVSDFGLSKFGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQC  485 (613)
Q Consensus       414 ~kl~DFGls~~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~  485 (613)
                      +||+|||+++...       ...+..|++||++....++.++|||||||+||||++ |.+||......+..   ......
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~~~~  239 (303)
T cd05088         163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---EKLPQG  239 (303)
T ss_pred             EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH---HHHhcC
Confidence            9999999986321       112346999999988889999999999999999998 99998654332211   111111


Q ss_pred             hccCCccccccHHH-HHhcccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          486 YQNGTIDQIVDPFL-KAMSCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       486 ~~~~~~~~~~d~~~-~~~~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                      .............. ...+||+.+|++||++.++++.|+..++-
T Consensus       240 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         240 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            11111111111111 13389999999999999999999865543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.8e-38  Score=330.21  Aligned_cols=237  Identities=24%  Similarity=0.306  Sum_probs=187.0

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHH---hccCccceeeEEEEeecCCceEEE
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGML---SQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      |...+.||+|+||.||+|....++..||||+++...   ....+.+..|++++   ++++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            455678999999999999998888899999997542   22344566666554   567899999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--  425 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--  425 (613)
                      |||+++|+|..++..   ..+++..++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++..  
T Consensus        81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~----ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC----eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            999999999988743   46999999999999999999999988    999999999999999999999999998642  


Q ss_pred             ------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH
Q 048439          426 ------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       426 ------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                            ...++..|+|||++.+..++.++|||||||+||||++|+.||......+........     .......+...+
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-----~~~~p~~~~~~~  228 (324)
T cd05589         154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND-----EVRYPRFLSREA  228 (324)
T ss_pred             CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----CCCCCCCCCHHH
Confidence                  123567899999999999999999999999999999999999765433322111111     111111222222


Q ss_pred             H--HhcccccCCCCCC-----CHHHHHHHH
Q 048439          500 K--AMSCLNDEGIRRP-----SMSDVVWGL  522 (613)
Q Consensus       500 ~--~~~Cl~~~p~~RP-----s~~evl~~L  522 (613)
                      .  ..+||+.+|.+||     ++.+++++.
T Consensus       229 ~~li~~~L~~dP~~R~~~~~~~~~~l~~~~  258 (324)
T cd05589         229 ISIMRRLLRRNPERRLGSGEKDAEDVKKQP  258 (324)
T ss_pred             HHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence            2  2279999999999     466666544

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.5e-37  Score=320.00  Aligned_cols=247  Identities=26%  Similarity=0.425  Sum_probs=194.9

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      +|.....||+|+||.||+|+...     +...+++|.+.... ......+.+|+.+++.++||||+++++.|...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            35667799999999999998743     22569999887553 3345678999999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcC----------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCC
Q 048439          347 VYDFMARGTLPDHLYHS----------------------DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTT  404 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~----------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~  404 (613)
                      |+||+++|+|.+++...                      ....+++.+++.++.|++.||+|||+.+    |+||||||+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----ivH~dikp~  156 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK----LVHRDLAAR  156 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC----eehhhhhhh
Confidence            99999999999987532                      1235889999999999999999999988    999999999


Q ss_pred             ceeeCCCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhh
Q 048439          405 NILLDEKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAK  473 (613)
Q Consensus       405 NILl~~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~  473 (613)
                      |||+++++.+||+|||+++...          ...+..|++||++....++.++||||||+++|||++ |+.||......
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  236 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE  236 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            9999999999999999986421          122346999999998899999999999999999998 99998654433


Q ss_pred             hhhhHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          474 KQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       474 ~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ..   ..+................+.. +.+||+.+|++||++.++++.|+..+
T Consensus       237 ~~---~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         237 RL---FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HH---HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            21   1222211111111122222222 33799999999999999999998654

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=336.08  Aligned_cols=244  Identities=24%  Similarity=0.306  Sum_probs=196.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|+...++..||||+++...   ......+..|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888889999999999999998878899999987542   234557899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++...  
T Consensus        81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g----iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG----FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC----eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999999543  67899999999999999999999988    9999999999999999999999999986421  


Q ss_pred             -----------------------------------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          427 -----------------------------------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       427 -----------------------------------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                                                         ..++..|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence                                               124667999999999999999999999999999999999997654


Q ss_pred             hhhhhh-HHHHHHHhhccCCccccccHHHH--HhcccccCCCCCCC-HHHHHHHHHH
Q 048439          472 AKKQVS-LAVWAQQCYQNGTIDQIVDPFLK--AMSCLNDEGIRRPS-MSDVVWGLEF  524 (613)
Q Consensus       472 ~~~~~~-l~~~~~~~~~~~~~~~~~d~~~~--~~~Cl~~~p~~RPs-~~evl~~Le~  524 (613)
                      ...... +..|...... ..... .++.+.  ..+|+. +|.+||+ +.+++++...
T Consensus       235 ~~~~~~~i~~~~~~~~~-p~~~~-~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~  288 (350)
T cd05573         235 LQETYNKIINWKESLRF-PPDPP-VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF  288 (350)
T ss_pred             HHHHHHHHhccCCcccC-CCCCC-CCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence            332211 1111111111 11111 122222  126886 9999999 9999977653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.2e-38  Score=330.33  Aligned_cols=227  Identities=25%  Similarity=0.311  Sum_probs=179.4

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHH-HHhccCccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIG-MLSQLRHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      +||+|+||.||+|+...++..||+|++....   ......+..|.. +++.++|+||+++++++.+.+..++||||+++|
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            7999999999999998888899999986542   222344555554 678899999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--------
Q 048439          355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--------  426 (613)
Q Consensus       355 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--------  426 (613)
                      +|.+++..  ...+++.+...++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++...        
T Consensus        82 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~----ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05603          82 ELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLN----IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST  155 (321)
T ss_pred             CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence            99988843  456889999999999999999999988    9999999999999999999999999986421        


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcc-ccccHHHH-Hhcc
Q 048439          427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID-QIVDPFLK-AMSC  504 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~d~~~~-~~~C  504 (613)
                      ..++..|+|||.+....++.++|||||||+||||++|++||...........   ...  ....+. ...+.... ..+|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~--~~~~~~~~~~~~~~~li~~~  230 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDN---ILH--KPLQLPGGKTVAACDLLVGL  230 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHH---Hhc--CCCCCCCCCCHHHHHHHHHH
Confidence            1246679999999999999999999999999999999999976543221111   111  111111 11111111 2379


Q ss_pred             cccCCCCCCCHH
Q 048439          505 LNDEGIRRPSMS  516 (613)
Q Consensus       505 l~~~p~~RPs~~  516 (613)
                      |+.+|.+||+..
T Consensus       231 l~~~p~~R~~~~  242 (321)
T cd05603         231 LHKDQRRRLGAK  242 (321)
T ss_pred             ccCCHhhcCCCC
Confidence            999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.1e-37  Score=314.34  Aligned_cols=248  Identities=21%  Similarity=0.343  Sum_probs=197.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|+...++..||||.++..   .......|.+|+++++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4688888999999999999999877789999987642   2334456899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          349 DFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ||+++|+|.+++..  .....+++..++.++.|+++||.|||+.+    ++||||||+|||++.++.++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~----i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC----eeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            99999999988843  23456899999999999999999999988    9999999999999999999999999986422


Q ss_pred             --------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcc-ccccH
Q 048439          427 --------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID-QIVDP  497 (613)
Q Consensus       427 --------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~d~  497 (613)
                              ..++..|+|||++.+..++.++||||||+++|||++|+.|+....... ................. ...+.
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKIEQCDYPPLPTEHYSEK  236 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHHhcCCCCCCChhhcCHH
Confidence                    234557999999999899999999999999999999999985432211 11111111111111111 11111


Q ss_pred             HHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          498 FLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       498 ~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ... ..+||..+|++||++.+|++.|+.
T Consensus       237 ~~~li~~cl~~~p~~Rp~~~~vl~~~~~  264 (267)
T cd08228         237 LRELVSMCIYPDPDQRPDIGYVHQIAKQ  264 (267)
T ss_pred             HHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence            111 227999999999999999988874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.5e-38  Score=330.48  Aligned_cols=238  Identities=22%  Similarity=0.292  Sum_probs=190.6

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCcc-ceeeEEEEeecCCceEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHL-HLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~  348 (613)
                      +|...+.||+|+||.||+|+..+++..||||++...   .......+..|++++..++|+ +|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            467778999999999999999888889999998754   233456788999999999764 5888999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+++|+|.+++..  ...+++.+++.++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+++..   
T Consensus        81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~----ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSKG----IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999998843  456899999999999999999999988    999999999999999999999999998632   


Q ss_pred             -----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          426 -----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       426 -----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                           ...++..|+|||++.+..++.++|||||||+||||++|++||......+.....   .  .........++....
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i---~--~~~~~~~~~~~~~~~  229 (324)
T cd05587         155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI---M--EHNVSYPKSLSKEAV  229 (324)
T ss_pred             CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---H--cCCCCCCCCCCHHHH
Confidence                 123567899999999999999999999999999999999999765433222111   1  111112222332222


Q ss_pred             --HhcccccCCCCCCCH-----HHHHHH
Q 048439          501 --AMSCLNDEGIRRPSM-----SDVVWG  521 (613)
Q Consensus       501 --~~~Cl~~~p~~RPs~-----~evl~~  521 (613)
                        ..+||..+|.+|++.     .+++++
T Consensus       230 ~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         230 SICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             HHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              227999999999986     555544

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-37  Score=319.88  Aligned_cols=244  Identities=25%  Similarity=0.425  Sum_probs=192.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEc----CCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFIN----GSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~----~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      .+|+..+.||+|+||.||+|...    ..+..||+|.+... ..+...+|.+|+.++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            34666779999999999999852    24467999999754 34445678999999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC
Q 048439          347 VYDFMARGTLPDHLYHSD---------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK  411 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~  411 (613)
                      ||||+++|+|.+++....               ...+++.+.+.++.+++.||.|||+.+    |+||||||+|||++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~----i~H~dlkp~nili~~~  160 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF----FVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC----eehhccccceEEEcCC
Confidence            999999999999985321               235889999999999999999999988    9999999999999999


Q ss_pred             CcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHH
Q 048439          412 WVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAV  480 (613)
Q Consensus       412 ~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~  480 (613)
                      +.+||+|||+++...          ...+..|++||++.+..++.++|||||||+||||++ |.+||......+.   ..
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~---~~  237 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV---IE  237 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HH
Confidence            999999999986421          112345999999998899999999999999999998 9889865433221   11


Q ss_pred             HHHHhhccCCccccccHHHH--HhcccccCCCCCCCHHHHHHHHH
Q 048439          481 WAQQCYQNGTIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       481 ~~~~~~~~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ......... .....++.+.  ..+||+.+|.+||++.+|++.|.
T Consensus       238 ~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         238 MVRKRQLLP-CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             HHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence            111111111 1122222222  23799999999999999998876

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.4e-38  Score=329.59  Aligned_cols=238  Identities=21%  Similarity=0.279  Sum_probs=189.8

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      +|.....||+|+||.||+|+...++..||||.+....   ......+..|..++..+ +|++|+++++++.+.+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4677789999999999999998888899999987542   23344567788888877 5899999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+++|+|.+++..  ...+++.+++.++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+++..   
T Consensus        81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~----ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999998843  356899999999999999999999988    999999999999999999999999998642   


Q ss_pred             -----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          426 -----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       426 -----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                           ...++..|+|||++....++.++|||||||+||||++|++||.............  .   .........+....
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~--~---~~~~~p~~~s~~~~  229 (323)
T cd05616         155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--E---HNVAYPKSMSKEAV  229 (323)
T ss_pred             CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH--h---CCCCCCCcCCHHHH
Confidence                 1235678999999999999999999999999999999999997654333221111  1   11111111222222


Q ss_pred             --HhcccccCCCCCCCH-----HHHHHH
Q 048439          501 --AMSCLNDEGIRRPSM-----SDVVWG  521 (613)
Q Consensus       501 --~~~Cl~~~p~~RPs~-----~evl~~  521 (613)
                        ..+||+.+|.+|++.     .++..+
T Consensus       230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         230 AICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             HHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence              237999999999984     565543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=338.32  Aligned_cols=245  Identities=24%  Similarity=0.324  Sum_probs=204.1

Q ss_pred             HHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCc
Q 048439          268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDRE  343 (613)
Q Consensus       268 ~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~  343 (613)
                      ....++|....+||+|.||+|+++.+++++..+|||.+++.   .....+..+.|.+++... +||.|+.|+++++..++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            34556899999999999999999999999999999999886   345566778898888877 59999999999999999


Q ss_pred             eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCc
Q 048439          344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK  423 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~  423 (613)
                      +++||||+.||++..+.   ....+++.....++..|+.||.|||+++    ||+||||.+|||||.+|.+||+||||++
T Consensus       444 l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~----IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENG----IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcC----ceeeecchhheEEcccCcEEeccccccc
Confidence            99999999999954443   3467999999999999999999999999    9999999999999999999999999997


Q ss_pred             c--------CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          424 F--------GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       424 ~--------~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                      .        ...+||+.|||||++..+.|+.+.|+|||||+|||||.|.+||.+..+++..+-+......++.....+.+
T Consensus       517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~  596 (694)
T KOG0694|consen  517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAI  596 (694)
T ss_pred             ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHH
Confidence            5        33567889999999999999999999999999999999999998877776554444333333333333333


Q ss_pred             cHHHHHhcccccCCCCCCCH-----HHHHHHH
Q 048439          496 DPFLKAMSCLNDEGIRRPSM-----SDVVWGL  522 (613)
Q Consensus       496 d~~~~~~~Cl~~~p~~RPs~-----~evl~~L  522 (613)
                      +.+.   +.|..+|++|.-+     .+|..+.
T Consensus       597 ~il~---~ll~k~p~kRLG~~e~d~~~i~~hp  625 (694)
T KOG0694|consen  597 AIMR---RLLRKNPEKRLGSGERDAEDIKKHP  625 (694)
T ss_pred             HHHH---HHhccCcccccCCCCCCchhhhhCC
Confidence            3322   5889999999865     4555443

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.1e-38  Score=330.47  Aligned_cols=234  Identities=21%  Similarity=0.271  Sum_probs=187.9

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      +||+|+||.||+|+...++..||||++...   .......+..|+.++..+ +||||+++++++.+.+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            799999999999999888889999998753   233455678899888876 6999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--------C
Q 048439          355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--------P  426 (613)
Q Consensus       355 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--------~  426 (613)
                      +|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++..        .
T Consensus        82 ~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~~----ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          82 DLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKG----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             hHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence            99998854  356899999999999999999999998    999999999999999999999999998642        1


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhcc
Q 048439          427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSC  504 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~C  504 (613)
                      ..++..|+|||++....++.++|||||||++|||++|+.||......+.....   .  ..........+....  ..+|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i---~--~~~~~~~~~~~~~~~~li~~~  230 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI---L--NDEVVYPTWLSQDAVDILKAF  230 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH---h--cCCCCCCCCCCHHHHHHHHHH
Confidence            23567899999999999999999999999999999999999755433221111   1  111111222222222  2279


Q ss_pred             cccCCCCCCCH------HHHHHHHH
Q 048439          505 LNDEGIRRPSM------SDVVWGLE  523 (613)
Q Consensus       505 l~~~p~~RPs~------~evl~~Le  523 (613)
                      |+.||.+||++      .+++++..
T Consensus       231 L~~dP~~R~~~~~~~~~~~~~~h~~  255 (320)
T cd05590         231 MTKNPTMRLGSLTLGGEEAILRHPF  255 (320)
T ss_pred             cccCHHHCCCCCCCCCHHHHHcCCC
Confidence            99999999998      56654433

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.8e-38  Score=345.20  Aligned_cols=248  Identities=23%  Similarity=0.316  Sum_probs=196.9

Q ss_pred             HHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCC--
Q 048439          267 IQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR--  342 (613)
Q Consensus       267 l~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~--  342 (613)
                      +....++|...++||+|+||.||+|+...++..||||++...  +......+.+|+..+..++|+||++++..+...+  
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            344557899999999999999999999877889999998654  3445567889999999999999999988765432  


Q ss_pred             ------ceEEEEEcCCCCChhHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcE
Q 048439          343 ------EMILVYDFMARGTLPDHLYHS--DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVA  414 (613)
Q Consensus       343 ------~~~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~  414 (613)
                            .+++||||+++|+|.+++...  ....+++..+..++.|++.||+|||+.+    |+||||||+|||+++++.+
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~----IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH----MIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC----EecCCCCHHHEEEeCCCCE
Confidence                  368999999999999998542  3457899999999999999999999988    9999999999999999999


Q ss_pred             EEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHH
Q 048439          415 KVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQ  484 (613)
Q Consensus       415 kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~  484 (613)
                      ||+|||+++...          ..++..|+|||++....++.++|||||||+||||++|+.||......+......   .
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~---~  259 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL---A  259 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh---c
Confidence            999999986421          235677999999999999999999999999999999999997544322211111   0


Q ss_pred             hhccCCccccccHHHH--HhcccccCCCCCCCHHHHHHHH
Q 048439          485 CYQNGTIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       485 ~~~~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                      ..... +.....+.+.  ..+||+.+|.+||++.+++.+.
T Consensus       260 ~~~~~-~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p  298 (496)
T PTZ00283        260 GRYDP-LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP  298 (496)
T ss_pred             CCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence            01111 1111222222  2279999999999999998753

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-38  Score=337.50  Aligned_cols=238  Identities=24%  Similarity=0.314  Sum_probs=198.9

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      |..++.||.|+-|.|-.|++..+|+.+|||++....   ......+.+||-+|+-+.|||+++|+.++.+..++|||.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            566678999999999999999999999999997652   22344578999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc------
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------  424 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~------  424 (613)
                      +++|-|.++|..  .++|++.+..+++.||+.|+.|+|..+    |+||||||+|+|||.++++||+|||+|..      
T Consensus        94 v~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~~----icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl  167 (786)
T KOG0588|consen   94 VPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAFN----ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL  167 (786)
T ss_pred             cCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhhc----ceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence            999999999954  567999999999999999999999998    99999999999999999999999999964      


Q ss_pred             -CCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccc---cHHH
Q 048439          425 -GPTSVSKTHLDPEYYRLQQL-TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV---DPFL  499 (613)
Q Consensus       425 -~~~~~~~~~~aPE~~~~~~~-t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---d~~~  499 (613)
                       ...+|++.|.+||++++.+| ..++||||.|||||-||+|+.||++.....   +...+..-.- .+...+.   +.++
T Consensus       168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~---LLlKV~~G~f-~MPs~Is~eaQdLL  243 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV---LLLKVQRGVF-EMPSNISSEAQDLL  243 (786)
T ss_pred             ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH---HHHHHHcCcc-cCCCcCCHHHHHHH
Confidence             34578889999999999998 579999999999999999999998554433   2222221110 1112222   1222


Q ss_pred             HHhcccccCCCCCCCHHHHHHHHH
Q 048439          500 KAMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       500 ~~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .  +++..||++|.|+.||+++..
T Consensus       244 r--~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  244 R--RMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             H--HHhccCccccccHHHHhhCch
Confidence            2  699999999999999998865

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.7e-38  Score=328.47  Aligned_cols=232  Identities=23%  Similarity=0.327  Sum_probs=184.9

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhc-cCccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQ-LRHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      +||+|+||.||+|+..+++..||||.++...   ......+..|..++.. .+||||+++++++...+.+++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            7999999999999998888899999987542   2334456677777765 48999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--------C
Q 048439          355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--------P  426 (613)
Q Consensus       355 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--------~  426 (613)
                      +|.+++..  ...+++.+...++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..        .
T Consensus        82 ~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~----ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          82 DLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKG----IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence            99998843  356899999999999999999999988    999999999999999999999999998642        1


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhcc
Q 048439          427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSC  504 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~C  504 (613)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||......+......     ..........+....  ..+|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~ll~~~  230 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL-----NDRPHFPRWISKEAKDCLSKL  230 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCHHHHHHHHHH
Confidence            235778999999999999999999999999999999999997654332211111     111122222332222  2279


Q ss_pred             cccCCCCCCCHH-HHHHH
Q 048439          505 LNDEGIRRPSMS-DVVWG  521 (613)
Q Consensus       505 l~~~p~~RPs~~-evl~~  521 (613)
                      |+.+|.+||++. +++.+
T Consensus       231 l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         231 FERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             ccCCHHHcCCChHHHHcC
Confidence            999999999875 55443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.9e-37  Score=315.22  Aligned_cols=248  Identities=23%  Similarity=0.354  Sum_probs=198.6

Q ss_pred             HHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceE
Q 048439          266 EIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       266 el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  345 (613)
                      |++.+++++.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.++++++|+||+++++++..++..+
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            45667888888889999999999999988888889999988776667778999999999999999999999999999999


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC-CCcEEEEecCCC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPL--PWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE-KWVAKVSDFGLS  422 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGls  422 (613)
                      +|+||+++++|.+++... ...+  ++..++.++.|++.||.|||+.+    |+||||||+||+++. ++.+||+|||++
T Consensus        82 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~----i~h~dl~p~nil~~~~~~~~~l~dfg~~  156 (268)
T cd06624          82 IFMEQVPGGSLSALLRSK-WGPLKDNEQTIIFYTKQILEGLKYLHDNQ----IVHRDIKGDNVLVNTYSGVVKISDFGTS  156 (268)
T ss_pred             EEEecCCCCCHHHHHHHh-cccCCCcHHHHHHHHHHHHHHHHHHHHCC----EeecCCCHHHEEEcCCCCeEEEecchhh
Confidence            999999999999998643 2335  88899999999999999999988    999999999999986 679999999988


Q ss_pred             ccCC--------CCCCcccCChhhhhcCC--CCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhh-ccCCc
Q 048439          423 KFGP--------TSVSKTHLDPEYYRLQQ--LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCY-QNGTI  491 (613)
Q Consensus       423 ~~~~--------~~~~~~~~aPE~~~~~~--~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~-~~~~~  491 (613)
                      ....        ..++..|++||++....  ++.++|||||||++|||++|++|+........   ..+..... ....+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~  233 (268)
T cd06624         157 KRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFKIHPEI  233 (268)
T ss_pred             eecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhccCCCC
Confidence            5321        23456799999987654  78999999999999999999999864322111   11111111 11112


Q ss_pred             cccccHHHH--HhcccccCCCCCCCHHHHHHH
Q 048439          492 DQIVDPFLK--AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       492 ~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      ....++.+.  ..+||+.+|.+||++.|++.+
T Consensus       234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            222222222  237999999999999999865

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.5e-37  Score=318.58  Aligned_cols=245  Identities=27%  Similarity=0.435  Sum_probs=195.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEc-----CCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFIN-----GSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~-----~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ++|....+||+|+||.||++...     ..+..+|+|.+..........|.+|++++++++|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            35666779999999999999753     2346799999887776777789999999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc
Q 048439          347 VYDFMARGTLPDHLYHSD-------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV  413 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~  413 (613)
                      ||||+++|+|.+++....             ...+++.+++.++.|++.||.|||+.+    ++||||||+|||+++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~----i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH----FVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC----eecccccHhhEEEcCCCC
Confidence            999999999999986432             135899999999999999999999988    999999999999999999


Q ss_pred             EEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHH
Q 048439          414 AKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWA  482 (613)
Q Consensus       414 ~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~  482 (613)
                      +||+|||+++...          ...+..|++||++....++.++|||||||++|||++ |++||......+......  
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--  238 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT--  238 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH--
Confidence            9999999986321          112356999999999999999999999999999998 899986543333221111  


Q ss_pred             HHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          483 QQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       483 ~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                       ..........+.+.... ..+||+.+|.+||++.||+..|+
T Consensus       239 -~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         239 -QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence             11111111122222222 23799999999999999998876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.4e-37  Score=320.88  Aligned_cols=194  Identities=21%  Similarity=0.337  Sum_probs=168.1

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh-hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ-QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      .++|...+.||+|+||.||+|+...++..||||.++.... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            3678888999999999999999987778899999875432 233467899999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----  425 (613)
                      |++ ++|.+++.. ....+++..+..++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++..    
T Consensus        84 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQRY----ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 588887754 3456899999999999999999999998    999999999999999999999999998632    


Q ss_pred             ----CCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          426 ----PTSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                          ...++..|+|||.+.+ ..++.++|||||||+||||++|++||...
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                1234567999999865 45789999999999999999999999653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.4e-38  Score=328.46  Aligned_cols=240  Identities=23%  Similarity=0.295  Sum_probs=188.3

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEEEcCCC
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYDFMAR  353 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~  353 (613)
                      ++||+|+||.||+|+...++..||+|.++..   .......+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            3799999999999999888889999998754   233445678899988876 799999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--------
Q 048439          354 GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--------  425 (613)
Q Consensus       354 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--------  425 (613)
                      |+|.+++..  ...+++..+..++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++..        
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~----ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~  154 (329)
T cd05618          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS  154 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence            999988843  456999999999999999999999998    999999999999999999999999998642        


Q ss_pred             CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhh--hhhHHHHHHHhh--ccCCccccccHHHH-
Q 048439          426 PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK--QVSLAVWAQQCY--QNGTIDQIVDPFLK-  500 (613)
Q Consensus       426 ~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~--~~~l~~~~~~~~--~~~~~~~~~d~~~~-  500 (613)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||.......  ......+.....  ....+....+.... 
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  234 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS  234 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence            1235678999999999999999999999999999999999995311110  011111111111  11112222222221 


Q ss_pred             -HhcccccCCCCCCC------HHHHHHHHH
Q 048439          501 -AMSCLNDEGIRRPS------MSDVVWGLE  523 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs------~~evl~~Le  523 (613)
                       ..+||+.||.+||+      +.+++.+..
T Consensus       235 ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~  264 (329)
T cd05618         235 VLKSFLNKDPKERLGCHPQTGFADIQGHPF  264 (329)
T ss_pred             HHHHHhcCCHHHcCCCCCCCCHHHHhcCCC
Confidence             22799999999998      567765544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.5e-37  Score=315.35  Aligned_cols=248  Identities=23%  Similarity=0.353  Sum_probs=197.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|....++..+|||.+...   ......+|.+|+.+++.++|+||+++++++.+++..++||
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4577778999999999999998777788999987643   2334567899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          349 DFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ||+++++|.+++..  .....++|.+++.++.+++.||.|||+.+    ++|+||||+||+++.++.+||+|||++....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~----i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            99999999998853  23456899999999999999999999988    9999999999999999999999999876421


Q ss_pred             --------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          427 --------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       427 --------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                              ..++..|+|||++....++.++||||||+++|||++|..||........ ...................+..
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKKIEQCDYPPLPSDHYSEE  236 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHhhhhhcCCCCCCCcccccHH
Confidence                    2345579999999999999999999999999999999999864432211 1111111111111111122222


Q ss_pred             HH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          499 LK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       499 ~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      +.  ..+||+.+|.+||+|.+|++.++.
T Consensus       237 ~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         237 LRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            22  227999999999999999988874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.4e-37  Score=319.83  Aligned_cols=247  Identities=22%  Similarity=0.399  Sum_probs=196.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEE-----cCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFI-----NGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~-----~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~  344 (613)
                      ++|...+.||+|+||.||+|..     ......||||+++... ......+.+|+.+++++ +|+||++++++|...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            5688888999999999999975     2334579999987653 33456789999999999 799999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++||||+++|+|.+++.......+++.+++.++.+++.||.|||+.+    |+|+||||+|||+++++.+||+|||+++.
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~----ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN----CIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC----eehhhhccceEEEcCCCeEEECCCccccc
Confidence            99999999999999996544455899999999999999999999988    99999999999999999999999999874


Q ss_pred             CCC----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccc
Q 048439          425 GPT----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ  493 (613)
Q Consensus       425 ~~~----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  493 (613)
                      ...          .++..|+|||.+....++.++|||||||++|||++ |.+||......+..  ........... ...
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~~~~~~~~~~-~~~  267 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YKLIKEGYRMA-QPE  267 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HHHHHcCCcCC-CCC
Confidence            221          12346999999999999999999999999999998 99998654332211  11111111111 111


Q ss_pred             cccHHHH--HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          494 IVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       494 ~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ..++.+.  ..+||+.+|++||++.||++.|+.+
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            1222222  2379999999999999999998853

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=9.3e-38  Score=328.10  Aligned_cols=241  Identities=23%  Similarity=0.291  Sum_probs=190.2

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEEEcCCC
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYDFMAR  353 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~  353 (613)
                      ++||+|+||.||+|+...++..||||.++..   .......+..|+.++.++ +||||+++++++.+.+.+++|||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3799999999999999888889999999754   223445688999999998 799999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--------
Q 048439          354 GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--------  425 (613)
Q Consensus       354 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--------  425 (613)
                      |+|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++..        
T Consensus        81 g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~----ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (329)
T cd05588          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERG----IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS  154 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence            999988843  356999999999999999999999998    999999999999999999999999998642        


Q ss_pred             CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhh--hhhHHHHHHHhhcc--CCccccccHHHH-
Q 048439          426 PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK--QVSLAVWAQQCYQN--GTIDQIVDPFLK-  500 (613)
Q Consensus       426 ~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~--~~~l~~~~~~~~~~--~~~~~~~d~~~~-  500 (613)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||......+  ......+.......  ..+...++..+. 
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  234 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS  234 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            1235677999999999999999999999999999999999996322111  11111111111111  112222222222 


Q ss_pred             -HhcccccCCCCCCC------HHHHHHHHHH
Q 048439          501 -AMSCLNDEGIRRPS------MSDVVWGLEF  524 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs------~~evl~~Le~  524 (613)
                       ..+||+.||.+||+      +.+++.+..+
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~  265 (329)
T cd05588         235 VLKGFLNKDPKERLGCHPQTGFRDIKSHPFF  265 (329)
T ss_pred             HHHHHhccCHHHcCCCCCCCCHHHHhcCCCC
Confidence             22799999999997      6788766543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-37  Score=315.22  Aligned_cols=244  Identities=25%  Similarity=0.404  Sum_probs=191.3

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCC---ceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCc-----
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGS---TTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDRE-----  343 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~---~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~-----  343 (613)
                      |...+.||+|+||.||+|.+..+   ...||||+++..  .......+.+|+..++.++|+||+++++++.+...     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            45667899999999999998543   367999998754  33445679999999999999999999999876554     


Q ss_pred             -eEEEEEcCCCCChhHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEe
Q 048439          344 -MILVYDFMARGTLPDHLYHS----DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSD  418 (613)
Q Consensus       344 -~~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~D  418 (613)
                       .++|+||+++|+|.+++...    ....+++...+.++.|++.||.|||+.+    ++||||||+||++++++.+||+|
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~----i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN----FIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC----eeccccchheEEECCCCeEEECC
Confidence             79999999999999988542    2346899999999999999999999988    99999999999999999999999


Q ss_pred             cCCCccCCC----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhc
Q 048439          419 FGLSKFGPT----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQ  487 (613)
Q Consensus       419 FGls~~~~~----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~  487 (613)
                      ||+++....          ..+..|++||++....++.++|||||||++|||++ |.+||......+   ...+......
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~~~~~  233 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLRHGNR  233 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCC
Confidence            999874221          12346899999998899999999999999999999 888885543222   1222211111


Q ss_pred             cCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          488 NGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       488 ~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ........+.... ..+||+.+|.+||++.||++.|+.
T Consensus       234 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         234 LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            1111222222222 237999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.8e-37  Score=319.05  Aligned_cols=246  Identities=24%  Similarity=0.310  Sum_probs=195.8

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      |...++||+|+||.||++....+++.||||.+....   ......+..|+.++++++|+||+++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            566679999999999999999888999999986542   22234578899999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      +++|+|.+++.......+++.+++.++.|++.||.|||+.+    |+||||||+||++++++.++|+|||++....    
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~----iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC----EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            99999999986655567999999999999999999999988    9999999999999999999999999986422    


Q ss_pred             ---CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--H
Q 048439          427 ---TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--A  501 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~  501 (613)
                         ..++..|+|||++....++.++|||||||++|||++|++||...................... .....++...  .
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li  236 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE-YSEKFSPDARSLC  236 (285)
T ss_pred             ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhh-cCccCCHHHHHHH
Confidence               235668999999999999999999999999999999999997543211100000000000111 1112222222  2


Q ss_pred             hcccccCCCCCCC-----HHHHHHHHHH
Q 048439          502 MSCLNDEGIRRPS-----MSDVVWGLEF  524 (613)
Q Consensus       502 ~~Cl~~~p~~RPs-----~~evl~~Le~  524 (613)
                      .+||+.+|++||+     +.|++.+..+
T Consensus       237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~  264 (285)
T cd05630         237 KMLLCKDPKERLGCQGGGAREVKEHPLF  264 (285)
T ss_pred             HHHhhcCHHHccCCCCCchHHHHcChhh
Confidence            2799999999999     8899877664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.9e-37  Score=317.49  Aligned_cols=246  Identities=23%  Similarity=0.272  Sum_probs=193.8

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      |...++||+|+||+||+|....+++.||+|.+....   ......+.+|+++|++++|+||+++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            555678999999999999998888899999986542   22334578899999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      +++|+|.+++.......+++..+..++.|++.||.|||+.+    |+||||||+||++++++.+||+|||++....    
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~----iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN----TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            99999999987655567999999999999999999999988    9999999999999999999999999985421    


Q ss_pred             ---CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-Hh
Q 048439          427 ---TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AM  502 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~  502 (613)
                         ..++..|+|||++.+..++.++|||||||++|||++|+.||..........................+...... ..
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK  237 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence               23467899999999999999999999999999999999999754332221111111111111111112111111 23


Q ss_pred             cccccCCCCCCC-----HHHHHHHHH
Q 048439          503 SCLNDEGIRRPS-----MSDVVWGLE  523 (613)
Q Consensus       503 ~Cl~~~p~~RPs-----~~evl~~Le  523 (613)
                      .||+.+|++||+     +.+++.+-.
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~~~~  263 (285)
T cd05632         238 MLLTKDPKQRLGCQEEGAGEVKRHPF  263 (285)
T ss_pred             HHccCCHhHcCCCcccChHHHHcChh
Confidence            799999999999     666665433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.6e-38  Score=321.64  Aligned_cols=251  Identities=25%  Similarity=0.444  Sum_probs=197.3

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCC-----ceeEEEEEeCCC-ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecC
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGS-----TTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDD  341 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~-----~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~  341 (613)
                      ...++|...+.||+|+||.||++...+.     ...+|+|.+... ..+...++.+|+.++.++ +|+||++++++|.++
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            3445677888999999999999987543     367999998754 334456789999999999 899999999999999


Q ss_pred             CceEEEEEcCCCCChhHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCcee
Q 048439          342 REMILVYDFMARGTLPDHLYHS--------------DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNIL  407 (613)
Q Consensus       342 ~~~~lV~Ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NIL  407 (613)
                      +..++||||+++|+|.+++...              ....+++..++.++.|++.||.|||+.+    |+||||||+|||
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~----ivH~dlkp~Nil  164 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK----CIHRDLAARNVL  164 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC----ccccccceeeEE
Confidence            9999999999999999998532              2356899999999999999999999988    999999999999


Q ss_pred             eCCCCcEEEEecCCCccCCC----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhh
Q 048439          408 LDEKWVAKVSDFGLSKFGPT----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQV  476 (613)
Q Consensus       408 l~~~~~~kl~DFGls~~~~~----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~  476 (613)
                      +++++.+||+|||+++....          ..+..|++||++....++.++|||||||++|||++ |..|+......+..
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  244 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  244 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence            99999999999999864221          12346999999999999999999999999999998 88888654332221


Q ss_pred             hHHHHHHHhhccCCccccccHHH-HHhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          477 SLAVWAQQCYQNGTIDQIVDPFL-KAMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       477 ~l~~~~~~~~~~~~~~~~~d~~~-~~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ...   ................. ...+||..+|.+|||+.|+++.|+..+
T Consensus       245 ~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 KLL---KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHH---HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            111   11111111111112222 233799999999999999999998643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.1e-38  Score=337.14  Aligned_cols=249  Identities=23%  Similarity=0.259  Sum_probs=194.3

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceE
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  345 (613)
                      ...++|...+.||+|+||.||+++...++..||+|++...   .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            3456788889999999999999999888889999998643   2233445789999999999999999999999999999


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +||||+++|+|.+++..   ..+++.....++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+++..
T Consensus       120 lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~----ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMG----FIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC----eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            99999999999998843   35788889999999999999999998    999999999999999999999999998642


Q ss_pred             C---------CCCCcccCChhhhhcC----CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcc
Q 048439          426 P---------TSVSKTHLDPEYYRLQ----QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID  492 (613)
Q Consensus       426 ~---------~~~~~~~~aPE~~~~~----~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  492 (613)
                      .         ..++..|+|||++...    .++.++|||||||+||||++|++||....................-....
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  272 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI  272 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence            1         2356789999998754    47899999999999999999999997654322211111000000000000


Q ss_pred             ccccHHHH-HhcccccCCCC--CCCHHHHHHHHHH
Q 048439          493 QIVDPFLK-AMSCLNDEGIR--RPSMSDVVWGLEF  524 (613)
Q Consensus       493 ~~~d~~~~-~~~Cl~~~p~~--RPs~~evl~~Le~  524 (613)
                      .+...... ..+||..+|.+  ||++.|++.+...
T Consensus       273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~  307 (370)
T cd05596         273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF  307 (370)
T ss_pred             CCCHHHHHHHHHHccChhhccCCCCHHHHhcCccc
Confidence            11111111 22689888887  9999999977654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.2e-38  Score=328.13  Aligned_cols=235  Identities=21%  Similarity=0.280  Sum_probs=187.0

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEEEcCCC
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYDFMAR  353 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~  353 (613)
                      ++||+|+||.||+|+...++..||||.++...   ......+..|..++..+ +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            37999999999999998888899999987542   23345567788888754 899999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--------
Q 048439          354 GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--------  425 (613)
Q Consensus       354 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--------  425 (613)
                      |+|.+++..  ...+++.+...++.|+++||+|||+.+    |+||||||+|||+++++.+||+|||+++..        
T Consensus        81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05620          81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKG----IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS  154 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence            999998843  456899999999999999999999998    999999999999999999999999998631        


Q ss_pred             CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhc
Q 048439          426 PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMS  503 (613)
Q Consensus       426 ~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~  503 (613)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||............   .  .............+.  ..+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~---~--~~~~~~~~~~~~~~~~li~~  229 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI---R--VDTPHYPRWITKESKDILEK  229 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---H--hCCCCCCCCCCHHHHHHHHH
Confidence            123567899999999999999999999999999999999999654432211111   1  111112222222222  227


Q ss_pred             ccccCCCCCCCHH-HHHHHHH
Q 048439          504 CLNDEGIRRPSMS-DVVWGLE  523 (613)
Q Consensus       504 Cl~~~p~~RPs~~-evl~~Le  523 (613)
                      ||+.||.+||++. +++.+..
T Consensus       230 ~l~~dP~~R~~~~~~~~~h~~  250 (316)
T cd05620         230 LFERDPTRRLGVVGNIRGHPF  250 (316)
T ss_pred             HccCCHHHcCCChHHHHcCCC
Confidence            9999999999984 5654433

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-37  Score=313.08  Aligned_cols=239  Identities=28%  Similarity=0.453  Sum_probs=190.5

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCC
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMA  352 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  352 (613)
                      +|...+.||+|+||.||+|....+ ..+|+|.+.... .....|.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~-~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGK-IDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCC-ccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            466777999999999999988654 579999986432 234578899999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC-----
Q 048439          353 RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-----  427 (613)
Q Consensus       353 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~-----  427 (613)
                      +++|.+++... ...++|..++.++.|++.||+|||+.+    ++||||||+||++++++.+||+|||+++....     
T Consensus        83 ~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          83 NGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESNG----FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC----cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            99999998643 346899999999999999999999998    99999999999999999999999999864211     


Q ss_pred             ----CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--
Q 048439          428 ----SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--  500 (613)
Q Consensus       428 ----~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--  500 (613)
                          ..+..|++||++....++.++|||||||+||||++ |++||......+..   ........... ....+..+.  
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~l  233 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---ESVSAGYRLYR-PKLAPTEVYTI  233 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---HHHHcCCcCCC-CCCCCHHHHHH
Confidence                11235999999999999999999999999999999 78888654332211   11111111111 111222222  


Q ss_pred             HhcccccCCCCCCCHHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                      ..+||..+|++||++.|+++.|
T Consensus       234 i~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         234 MYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHHHh
Confidence            2379999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=317.95  Aligned_cols=238  Identities=26%  Similarity=0.385  Sum_probs=178.4

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHh--ccCccceeeEEEEeecCC----ceEEEEEcCC
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLS--QLRHLHLVSLIGFCNDDR----EMILVYDFMA  352 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~--~l~H~niv~l~g~~~~~~----~~~lV~Ey~~  352 (613)
                      +||+|+||.||||.+.+  +.||||++...   ..+.|++|-++.+  .++|+||++++++-....    +++||+||.+
T Consensus       217 li~~Grfg~V~KaqL~~--~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~  291 (534)
T KOG3653|consen  217 LIGRGRFGCVWKAQLDN--RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP  291 (534)
T ss_pred             HhhcCccceeehhhccC--ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence            89999999999999987  67999998754   4556777777666  468999999999976655    8999999999


Q ss_pred             CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--
Q 048439          353 RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA-----NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--  425 (613)
Q Consensus       353 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--  425 (613)
                      +|+|.++|.   ...++|....+|+..+++||+|||+..     .+++|+|||||++||||..|+++.|+|||||...  
T Consensus       292 kGsL~dyL~---~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p  368 (534)
T KOG3653|consen  292 KGSLCDYLK---ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP  368 (534)
T ss_pred             CCcHHHHHH---hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence            999999994   456999999999999999999999753     3466999999999999999999999999999532  


Q ss_pred             --------CCCCCcccCChhhhhcCC-CC-----chhHHHHHHHHHHHHHhCCCCccc--------hhh---hhhhhHHH
Q 048439          426 --------PTSVSKTHLDPEYYRLQQ-LT-----EKSDVYSFGVVLFEVLCARPSILR--------TAA---KKQVSLAV  480 (613)
Q Consensus       426 --------~~~~~~~~~aPE~~~~~~-~t-----~ksDV~SfGvvL~elltg~~p~~~--------~~~---~~~~~l~~  480 (613)
                              ...||.+|||||++.+.. +.     .+.||||+|.|||||++....++.        ..+   ...-.+.+
T Consensus       369 ~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~  448 (534)
T KOG3653|consen  369 GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEE  448 (534)
T ss_pred             CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHH
Confidence                    234688999999997632 22     268999999999999987543321        000   00001111


Q ss_pred             HHHHhhccCCccccccHHHH----------HhcccccCCCCCCCHHHHHHHHHH
Q 048439          481 WAQQCYQNGTIDQIVDPFLK----------AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       481 ~~~~~~~~~~~~~~~d~~~~----------~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .......+..-+.+.+....          ...||+.||+.|.|+.=|.+.+..
T Consensus       449 mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~  502 (534)
T KOG3653|consen  449 MQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAE  502 (534)
T ss_pred             HHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence            11111222222233332221          227999999999999888766653

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.4e-38  Score=328.99  Aligned_cols=235  Identities=23%  Similarity=0.293  Sum_probs=187.9

Q ss_pred             ceeeeeCcEEEEEEEEc---CCceeEEEEEeCCC----ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          278 LVIGVGGFGDVYKGFIN---GSTTPVAIKRLEPE----SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~---~~~~~vAVK~~~~~----~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +.||+|+||.||+++..   ..++.||||.++..    .......+..|+.+|++++||||+++++++.+++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            47999999999999863   34578999998753    223345678999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-----  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-----  425 (613)
                      +++|+|.+++..  ...+.+..+..++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++..     
T Consensus        82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQG----IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            999999999843  456888999999999999999999998    999999999999999999999999998631     


Q ss_pred             ---CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--
Q 048439          426 ---PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--  500 (613)
Q Consensus       426 ---~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--  500 (613)
                         ...++..|+|||++.+..++.++|||||||+||||++|++||.............     .....+....++.+.  
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l  230 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL-----KGKLNLPPYLTPEARDL  230 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCHHHHHH
Confidence               1235677999999999899999999999999999999999997654332211111     111112222222222  


Q ss_pred             HhcccccCCCCCC-----CHHHHHHHHH
Q 048439          501 AMSCLNDEGIRRP-----SMSDVVWGLE  523 (613)
Q Consensus       501 ~~~Cl~~~p~~RP-----s~~evl~~Le  523 (613)
                      ..+||+.+|++||     ++.+++.+..
T Consensus       231 i~~~l~~~p~~R~~~~~~~~~~l~~h~~  258 (323)
T cd05584         231 LKKLLKRNPSSRLGAGPGDAAEVQSHPF  258 (323)
T ss_pred             HHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence            2279999999999     8888876654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-37  Score=314.67  Aligned_cols=241  Identities=29%  Similarity=0.466  Sum_probs=189.3

Q ss_pred             eeeeeCcEEEEEEEEcCCce--eEEEEEeCCC-ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          279 VIGVGGFGDVYKGFINGSTT--PVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~--~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      +||+|+||.||+|.+.+++.  .+++|.++.. .......+.+|++++.++ +||||++++++|...+..++||||+++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            68999999999999876543  4788988754 344556789999999999 7999999999999999999999999999


Q ss_pred             ChhHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecC
Q 048439          355 TLPDHLYHSD--------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG  420 (613)
Q Consensus       355 sL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG  420 (613)
                      +|.+++....              ...+++.+++.++.|++.||+|||+.+    ++||||||+|||+++++.+||+|||
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~----i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ----FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC----EeecccccceEEEcCCCeEEECCCC
Confidence            9999985422              235899999999999999999999988    9999999999999999999999999


Q ss_pred             CCccCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCcc
Q 048439          421 LSKFGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTID  492 (613)
Q Consensus       421 ls~~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  492 (613)
                      +++...       ...+..|+|||++....++.++|||||||++|||++ |+.||......+....   ...........
T Consensus       158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~  234 (270)
T cd05047         158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---LPQGYRLEKPL  234 (270)
T ss_pred             CccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH---HhCCCCCCCCC
Confidence            985221       112345999999998899999999999999999997 9999865433221111   11111111111


Q ss_pred             ccccHHH-HHhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          493 QIVDPFL-KAMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       493 ~~~d~~~-~~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      .+..... ...+||..+|.+||++.++++.|+..+
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         235 NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            1111111 233899999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.9e-38  Score=327.98  Aligned_cols=234  Identities=23%  Similarity=0.302  Sum_probs=188.4

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      +||+|+||.||+|+...++..||||+++..   .......+..|++++..+ +||||+++++++.+.+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            699999999999999888889999998754   233455678899999888 7999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--------C
Q 048439          355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--------P  426 (613)
Q Consensus       355 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--------~  426 (613)
                      +|.+++..  ...+++.++..++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++..        .
T Consensus        82 ~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          82 DLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence            99988843  356999999999999999999999998    999999999999999999999999998642        1


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhcc
Q 048439          427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSC  504 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~C  504 (613)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||............   ..  .........+....  ..+|
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i---~~--~~~~~~~~~~~~~~~li~~~  230 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI---LE--DEVRYPRWLSKEAKSILKSF  230 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH---Hc--CCCCCCCcCCHHHHHHHHHH
Confidence            12466799999999999999999999999999999999999654432211111   10  11111122222222  2279


Q ss_pred             cccCCCCCCCH-----HHHHHHHH
Q 048439          505 LNDEGIRRPSM-----SDVVWGLE  523 (613)
Q Consensus       505 l~~~p~~RPs~-----~evl~~Le  523 (613)
                      |+.+|.+||++     .+++.+-.
T Consensus       231 l~~dP~~R~s~~~~~~~~ll~~~~  254 (318)
T cd05570         231 LTKNPEKRLGCLPTGEQDIKGHPF  254 (318)
T ss_pred             ccCCHHHcCCCCCCCHHHHhcCCC
Confidence            99999999999     88775543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.3e-37  Score=312.87  Aligned_cols=235  Identities=27%  Similarity=0.383  Sum_probs=186.6

Q ss_pred             eeeeeCcEEEEEEEE--cCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          279 VIGVGGFGDVYKGFI--NGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~--~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      .||+|+||.||+|.+  ..++..+|+|+++...  ....++|..|+.++++++|+||++++|++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999975  3455789999987543  3345679999999999999999999999864 5678999999999


Q ss_pred             ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC-------
Q 048439          355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-------  427 (613)
Q Consensus       355 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~-------  427 (613)
                      +|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++....       
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~----i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETN----FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            99999843  346899999999999999999999988    99999999999999999999999999864221       


Q ss_pred             ----CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--
Q 048439          428 ----SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--  500 (613)
Q Consensus       428 ----~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--  500 (613)
                          ..+..|+|||.+....++.++|||||||++|||++ |++||......+......   ... .........+.+.  
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~---~~~-~~~~~~~~~~~l~~l  230 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE---SGE-RMECPQRCPPEMYDL  230 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---CCC-CCCCCCCCCHHHHHH
Confidence                11246999999988889999999999999999998 999996543332222211   111 1111122222222  


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ..+||+.+|++||++.+|.+.|+.
T Consensus       231 i~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         231 MKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             HHHHhccCchhCcCHHHHHHHHhc
Confidence            227999999999999999998874

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.1e-37  Score=316.70  Aligned_cols=243  Identities=21%  Similarity=0.330  Sum_probs=192.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||.||+|+...++..||+|++..........+.+|+.++.+++|+||+++++++..++..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            46888889999999999999998778899999997665455567889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++|+|.+++..  ...+++.++..++.|++.||.|||+.+    |+||||||+||++++++.+||+|||+++...     
T Consensus        89 ~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06646          89 GGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKG----KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK  162 (267)
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence            99999998853  456899999999999999999999988    9999999999999999999999999986321     


Q ss_pred             ---CCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcc--ccccHH
Q 048439          427 ---TSVSKTHLDPEYYR---LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID--QIVDPF  498 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~---~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--~~~d~~  498 (613)
                         ..++..|++||.+.   ...++.++|||||||++|||++|++|+......+...  .+...........  .-.+..
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMSKSNFQPPKLKDKTKWSST  240 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--eeecCCCCCCCCccccccCHH
Confidence               12455799999984   3457889999999999999999999985443222111  1111111111110  011111


Q ss_pred             HH--HhcccccCCCCCCCHHHHHHHH
Q 048439          499 LK--AMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       499 ~~--~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                      +.  ..+||..+|++||++.+++++|
T Consensus       241 ~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         241 FHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            11  2279999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.3e-37  Score=318.24  Aligned_cols=246  Identities=29%  Similarity=0.460  Sum_probs=194.4

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCce
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~  344 (613)
                      .++|.....||+|+||.||+|...+     ++..||+|.+.... .....+|.+|+.++++++|+||++++++|.+++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            4678888899999999999998743     45789999987653 34456799999999999999999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCC
Q 048439          345 ILVYDFMARGTLPDHLYHS--------------------DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTT  404 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~  404 (613)
                      ++||||+++|+|.+++...                    ....+++.+++.++.|++.||.|||+.+    ++||||||+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~----i~H~dl~p~  159 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK----FVHRDLATR  159 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC----eecccccHh
Confidence            9999999999999998532                    1235889999999999999999999988    999999999


Q ss_pred             ceeeCCCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhh
Q 048439          405 NILLDEKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAK  473 (613)
Q Consensus       405 NILl~~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~  473 (613)
                      |||+++++.+||+|||+++...          ...+..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999986321          112335999999999999999999999999999997 88888654333


Q ss_pred             hhhhHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          474 KQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       474 ~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      +......   ............+.+.. ..+||+.+|.+||++.|+++.|+
T Consensus       240 ~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         240 EVIYYVR---DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             HHHHHHh---cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            2211111   10000001111122221 33899999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.4e-37  Score=318.81  Aligned_cols=243  Identities=25%  Similarity=0.378  Sum_probs=190.9

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCC-----ceeEEEEEeCCCChh-cHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGS-----TTPVAIKRLEPESQQ-GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~-----~~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      |...+.||+|+||.||+|...++     +..||||+++..... ....|..|+.++.+++|+||+++++++.+.+..+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            44556899999999999987542     467999999765433 345688999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc
Q 048439          348 YDFMARGTLPDHLYHS--------------DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV  413 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~  413 (613)
                      +||+++++|.+++...              ....+++..++.++.|++.||.|||+.+    |+||||||+|||+++++.
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g----i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH----VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC----ccccccchhheEecCCCc
Confidence            9999999999998521              1245899999999999999999999988    999999999999999999


Q ss_pred             EEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHH
Q 048439          414 AKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWA  482 (613)
Q Consensus       414 ~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~  482 (613)
                      +||+|||+++...          ...+..|+|||++..+.++.++|||||||++|||++ |.+|+......+.   ....
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~~i  239 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---IEMI  239 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH
Confidence            9999999976421          112346999999998999999999999999999998 8888865433221   1111


Q ss_pred             HHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          483 QQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       483 ~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .............+.... ...||+.+|.+||++.+|+..|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         240 RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            111111111222222221 23799999999999999999886

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.8e-37  Score=315.81  Aligned_cols=246  Identities=25%  Similarity=0.341  Sum_probs=193.0

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEeecC------
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDD------  341 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~------  341 (613)
                      .+++.|...+.||+|+||.||+|....+++.||+|++.... ....++..|+.++.++ +|+||++++++|...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            46677888889999999999999998888999999986543 3456788999999998 799999999998753      


Q ss_pred             CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCC
Q 048439          342 REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL  421 (613)
Q Consensus       342 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl  421 (613)
                      ..+++||||+++|+|.+++.......++|..+..++.|++.||+|||+.+    |+||||||+||++++++.+||+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~----ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK----VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC----CccCCCCHHHEEECCCCCEEEccCCC
Confidence            45899999999999999987655567999999999999999999999988    99999999999999999999999999


Q ss_pred             CccCC--------CCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc
Q 048439          422 SKFGP--------TSVSKTHLDPEYYR-----LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN  488 (613)
Q Consensus       422 s~~~~--------~~~~~~~~aPE~~~-----~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~  488 (613)
                      ++...        ..++..|+|||++.     ...++.++|||||||++|||++|+.||............. . .....
T Consensus       158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~-~-~~~~~  235 (272)
T cd06637         158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-R-NPAPR  235 (272)
T ss_pred             ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh-c-CCCCC
Confidence            86422        22455699999986     3457889999999999999999999996543322211110 0 00000


Q ss_pred             CCccccccHHHH-HhcccccCCCCCCCHHHHHHH
Q 048439          489 GTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       489 ~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      .....+.+.... ..+||..+|.+||++.+++.+
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            001111112221 227999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.4e-38  Score=334.55  Aligned_cols=252  Identities=23%  Similarity=0.269  Sum_probs=193.8

Q ss_pred             HHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCC
Q 048439          266 EIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR  342 (613)
Q Consensus       266 el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~  342 (613)
                      ++....++|...+.||+|+||.||+++...++..+|+|.+...   .......+.+|+.+++.++||||+++++++.+++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            3344557899999999999999999999888889999998642   2233456889999999999999999999999999


Q ss_pred             ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCC
Q 048439          343 EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS  422 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls  422 (613)
                      ..++|||||++|+|.+++..   ..+++.....++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~----IvHrDLKp~NILl~~~~~~kL~DFG~a  189 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMG----LIHRDVKPDNMLLDKHGHLKLADFGTC  189 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC----eEecCCCHHHEEECCCCCEEEEecccc
Confidence            99999999999999999843   35889999999999999999999998    999999999999999999999999998


Q ss_pred             ccC---------CCCCCcccCChhhhhcCC----CCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccC
Q 048439          423 KFG---------PTSVSKTHLDPEYYRLQQ----LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG  489 (613)
Q Consensus       423 ~~~---------~~~~~~~~~aPE~~~~~~----~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~  489 (613)
                      +..         ...++..|+|||++....    ++.++|||||||+||||++|++||......................
T Consensus       190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p  269 (370)
T cd05621         190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP  269 (370)
T ss_pred             eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCC
Confidence            642         223677899999997643    7889999999999999999999997654332211111000001101


Q ss_pred             CccccccHHHHHh-cccccCCC--CCCCHHHHHHHHHH
Q 048439          490 TIDQIVDPFLKAM-SCLNDEGI--RRPSMSDVVWGLEF  524 (613)
Q Consensus       490 ~~~~~~d~~~~~~-~Cl~~~p~--~RPs~~evl~~Le~  524 (613)
                      ....+.+.....+ .||..++.  .||++.|++++.++
T Consensus       270 ~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~  307 (370)
T cd05621         270 EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF  307 (370)
T ss_pred             CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence            1111122222222 46654443  38899999987654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.5e-37  Score=321.25  Aligned_cols=250  Identities=24%  Similarity=0.421  Sum_probs=197.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcC-------CceeEEEEEeCCC-ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFING-------STTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDR  342 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~-------~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~  342 (613)
                      ++|...+.||+|+||.||+++..+       ....+|+|.++.. ......++..|+.++.++ +|+||++++++|.+.+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            468888899999999999998643       2246999999865 334556788999999999 7999999999999999


Q ss_pred             ceEEEEEcCCCCChhHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee
Q 048439          343 EMILVYDFMARGTLPDHLYHSD--------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL  408 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl  408 (613)
                      ..++||||+++|+|.+++....              ...++|.+++.++.|++.||+|||+.+    ++||||||+|||+
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g----i~H~dlkp~Nill  173 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK----CIHRDLAARNVLV  173 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC----cccccccHHheEE
Confidence            9999999999999999996432              135899999999999999999999988    9999999999999


Q ss_pred             CCCCcEEEEecCCCccCCC----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhh
Q 048439          409 DEKWVAKVSDFGLSKFGPT----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVS  477 (613)
Q Consensus       409 ~~~~~~kl~DFGls~~~~~----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~  477 (613)
                      ++++.+||+|||+++....          ..+..|+|||++.+..++.++|||||||++|||++ |.+||......+...
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~  253 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  253 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            9999999999999864221          12246999999999999999999999999999998 888886543322211


Q ss_pred             HHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          478 LAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       478 l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                      ...   ................. ..+||..+|.+||+|.+|++.|+..++.
T Consensus       254 ~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         254 LLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HHH---cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            111   11111111122222212 3379999999999999999999976654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-38  Score=321.19  Aligned_cols=250  Identities=24%  Similarity=0.308  Sum_probs=197.4

Q ss_pred             HHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh--------------hcHHHHHHHHHHHhccCccceee
Q 048439          268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ--------------QGALEFQTEIGMLSQLRHLHLVS  333 (613)
Q Consensus       268 ~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~--------------~~~~~f~~Ei~~l~~l~H~niv~  333 (613)
                      ....|+|.....||+|.||+|-+|+...+++.||||++.+...              ...+...+||.+|++|+|+|||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            3456889999999999999999999998889999999975311              11246789999999999999999


Q ss_pred             EEEEeec--CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC
Q 048439          334 LIGFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK  411 (613)
Q Consensus       334 l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~  411 (613)
                      |+.+..+  .+.+|||+|||..|.+...=  .....|+..+.++++.++..||+|||.++    ||||||||+|+||+++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Qg----iiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQG----IIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcC----eeccccchhheEEcCC
Confidence            9999876  46799999999998875432  23344999999999999999999999999    9999999999999999


Q ss_pred             CcEEEEecCCCccC-------------CCCCCcccCChhhhhcCC----CCchhHHHHHHHHHHHHHhCCCCccchhhhh
Q 048439          412 WVAKVSDFGLSKFG-------------PTSVSKTHLDPEYYRLQQ----LTEKSDVYSFGVVLFEVLCARPSILRTAAKK  474 (613)
Q Consensus       412 ~~~kl~DFGls~~~-------------~~~~~~~~~aPE~~~~~~----~t~ksDV~SfGvvL~elltg~~p~~~~~~~~  474 (613)
                      |++||+|||.+...             ...||+.|+|||.+.++.    .+.+.||||+||+||.|+.|+.||......+
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~  326 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE  326 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence            99999999988532             245788999999998743    3568999999999999999999997765544


Q ss_pred             hhhHHHHHHHhhccC-CccccccHHHHHhcccccCCCCCCCHHHHHHHHHHh
Q 048439          475 QVSLAVWAQQCYQNG-TIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       475 ~~~l~~~~~~~~~~~-~~~~~~d~~~~~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ....+.-..-.+... .+.+..+.+  .+++|.+||++|.+..||..+++..
T Consensus       327 l~~KIvn~pL~fP~~pe~~e~~kDl--i~~lL~KdP~~Ri~l~~ik~Hpwvt  376 (576)
T KOG0585|consen  327 LFDKIVNDPLEFPENPEINEDLKDL--IKRLLEKDPEQRITLPDIKLHPWVT  376 (576)
T ss_pred             HHHHHhcCcccCCCcccccHHHHHH--HHHHhhcChhheeehhhheecceec
Confidence            332222111111111 122222222  2368999999999999999887744

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.3e-37  Score=314.75  Aligned_cols=245  Identities=27%  Similarity=0.448  Sum_probs=195.3

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCc---eeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGST---TPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~---~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      +|...+.||+|+||.||+|.+..++   ..||||.+... ......+|..|+.++++++||||+++++++.+++..++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            4667789999999999999986543   36999998765 3445678999999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCCC
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS  428 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~  428 (613)
                      ||+++|+|.+++... ...+++.+++.++.|++.||.|||+.+    ++||||||+|||++.++.+||+|||+++.....
T Consensus        85 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g----~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          85 EFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMN----YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             ecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC----EeecccChheEEEcCCCcEEECCCccccccccC
Confidence            999999999998543 356899999999999999999999988    999999999999999999999999998642110


Q ss_pred             -------------CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCcccc
Q 048439          429 -------------VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQI  494 (613)
Q Consensus       429 -------------~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  494 (613)
                                   .+..|++||++....++.++|||||||++|||++ |..||......+   ...+...........+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~~~~~~~~~~~~  236 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIEQDYRLPPPMDC  236 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHHcCCcCCCcccC
Confidence                         0235999999999999999999999999999886 999986544332   22222211111111121


Q ss_pred             ccHHH-HHhcccccCCCCCCCHHHHHHHHHHh
Q 048439          495 VDPFL-KAMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       495 ~d~~~-~~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ..... ...+||+.+|.+||++.+|+..|+..
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         237 PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11111 13379999999999999999988753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.3e-37  Score=314.69  Aligned_cols=248  Identities=26%  Similarity=0.395  Sum_probs=191.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEc----CCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeec--CCceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFIN----GSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCND--DREMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~----~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~  345 (613)
                      ++|.....||+|+||.||+|...    ..+..||||++..........|.+|++++++++|+||+++++++..  ...++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46777789999999999999853    3457899999987776667789999999999999999999998754  45689


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +||||+++|+|.+++... ...++|..++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++..
T Consensus        84 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~----i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKR----YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC----ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999998543 346899999999999999999999988    999999999999999999999999998753


Q ss_pred             CCC-----------CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhh-------------hhHHHH
Q 048439          426 PTS-----------VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQ-------------VSLAVW  481 (613)
Q Consensus       426 ~~~-----------~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~-------------~~l~~~  481 (613)
                      ...           ....|++||++.+..++.++|||||||++|||++|..++........             ..+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            221           12248999999998999999999999999999998766432211000             001111


Q ss_pred             HHHhhccCCccccccHHH-HHhcccccCCCCCCCHHHHHHHHHH
Q 048439          482 AQQCYQNGTIDQIVDPFL-KAMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       482 ~~~~~~~~~~~~~~d~~~-~~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ............+.+... ...+||+.+|++|||+.||+..|+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            111100011111111222 1337999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.7e-37  Score=310.21  Aligned_cols=248  Identities=23%  Similarity=0.350  Sum_probs=197.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|....++..||+|.++..   .......+.+|++++++++|+||+++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            5788888999999999999999877788999988642   2333567899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          349 DFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ||+++|+|.+++..  .....+++.+++.++.+++.||.|||+.+    |+||||||+||+++.++.+||+|||+++...
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~----i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR----IMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC----EecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            99999999998854  23456899999999999999999999988    9999999999999999999999999986422


Q ss_pred             --------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcc-ccccH
Q 048439          427 --------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID-QIVDP  497 (613)
Q Consensus       427 --------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~d~  497 (613)
                              ..++..|++||++.+..++.++|||||||++|||++|+.|+......- ................. ...+.
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEKCDYPPLPADHYSEE  236 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH-HHHHhhhhcCCCCCCChhhcCHH
Confidence                    124556999999999899999999999999999999999985432111 11111111111111111 11112


Q ss_pred             HHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          498 FLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       498 ~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ... ..+||..+|.+||++.+|++.|+.
T Consensus       237 ~~~~i~~cl~~~p~~Rp~~~~il~~~~~  264 (267)
T cd08224         237 LRDLVSRCINPDPEKRPDISYVLQVAKE  264 (267)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence            221 237999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-37  Score=311.18  Aligned_cols=242  Identities=24%  Similarity=0.381  Sum_probs=195.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-----hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-----QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ++|...+.||+|+||.||+|....++..||+|.+....     ......+.+|++++++++|+||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57888999999999999999988778899999886432     2234568899999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      |+||+++++|.+++..  ...+++..+..++.+++.||.|||+.+    |+||||+|+||++++++.+||+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~----i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSNM----IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999998853  356899999999999999999999998    9999999999999999999999999986321


Q ss_pred             -----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          427 -----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       427 -----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                                 ..++..|+|||++.+..++.++|||||||++|||++|++||.........   ................
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~  232 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FKIATQPTNPQLPSHV  232 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HHHhccCCCCCCCccC
Confidence                       12345799999999999999999999999999999999998654322211   1111111112222233


Q ss_pred             cHHHH--HhcccccCCCCCCCHHHHHHHH
Q 048439          496 DPFLK--AMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       496 d~~~~--~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                      +..+.  ..+||..+|.+||++.|++.+.
T Consensus       233 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         233 SPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             CHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence            32222  2279999999999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.6e-38  Score=309.30  Aligned_cols=247  Identities=22%  Similarity=0.285  Sum_probs=196.2

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhc--HHHHHHHHHHHhccCccceeeEEEEeec--CCceEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQG--ALEFQTEIGMLSQLRHLHLVSLIGFCND--DREMILVY  348 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~--~~~f~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~  348 (613)
                      +|...+.|++|.||.||+|+++.++..||+|+++.+....  -..-++||.+|.+++|||||.+-.+...  -+.+||||
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM  156 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM  156 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence            4566668999999999999999999999999998664221  2245899999999999999999877643  46799999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC-
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-  427 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~-  427 (613)
                      |||++ +|..++.. -..++...+...+..|+++||+|||...    |+|||||++|+|+...|.+||+||||||.... 
T Consensus       157 e~~Eh-DLksl~d~-m~q~F~~~evK~L~~QlL~glk~lH~~w----ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  157 EYVEH-DLKSLMET-MKQPFLPGEVKTLMLQLLRGLKHLHDNW----ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             HHHHh-hHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHhhce----eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            99998 99998854 3467999999999999999999999998    99999999999999999999999999985332 


Q ss_pred             -------CCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccc----
Q 048439          428 -------SVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV----  495 (613)
Q Consensus       428 -------~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~----  495 (613)
                             ..|.-|.|||.+.+ ..|++..|+||+|||+.||++++|-|.+..+.+|.+.+-.......+..++.+.    
T Consensus       231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~  310 (419)
T KOG0663|consen  231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA  310 (419)
T ss_pred             cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence                   23556999999877 468999999999999999999999998888877776654433222221111110    


Q ss_pred             ------------------------cHHHHHh-cccccCCCCCCCHHHHHHHHHHh
Q 048439          496 ------------------------DPFLKAM-SCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       496 ------------------------d~~~~~~-~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                                              +.-...+ ..|..||.+|.|+.|.+++-.+.
T Consensus       311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~  365 (419)
T KOG0663|consen  311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFR  365 (419)
T ss_pred             hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccc
Confidence                                    1001111 46778999999999998766543

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=342.60  Aligned_cols=253  Identities=21%  Similarity=0.271  Sum_probs=201.6

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC-ccceeeEEEEe-e---c---CC
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGFC-N---D---DR  342 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~-~---~---~~  342 (613)
                      ..+....++|.+|||+.||.+....++..+|+|++-..++...+...+||++|++|+ |+|||.+++.+ .   .   .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            345667779999999999999998877889999998888888999999999999997 99999999932 1   1   24


Q ss_pred             ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCC
Q 048439          343 EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS  422 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls  422 (613)
                      +.+|.||||++|.|-|++..+....|++.++++|+.++++|+.+||...  ++|||||||-+||||+.+++.||||||-+
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~--pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK--PPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC--CccchhhhhhhheEEcCCCCEEeCccccc
Confidence            7899999999999999997666667999999999999999999999865  44999999999999999999999999988


Q ss_pred             ccCC-----------------CCCCcccCChhhh---hcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHH
Q 048439          423 KFGP-----------------TSVSKTHLDPEYY---RLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWA  482 (613)
Q Consensus       423 ~~~~-----------------~~~~~~~~aPE~~---~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~  482 (613)
                      ...-                 ...|+.|.+||.+   ++..+++|+|||+|||+||-|+....||+......   + .-+
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la---I-lng  269 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA---I-LNG  269 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---E-Eec
Confidence            5311                 1236789999975   56789999999999999999999999996542111   0 001


Q ss_pred             HHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhhhhhh
Q 048439          483 QQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQLQES  531 (613)
Q Consensus       483 ~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~~~~  531 (613)
                      .  +.-+..+...+.+.. ...||+.||.+||++.+|+..+..+...+..
T Consensus       270 ~--Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~  317 (738)
T KOG1989|consen  270 N--YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP  317 (738)
T ss_pred             c--ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence            1  111112222222222 1269999999999999999888776654443

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.3e-37  Score=326.05  Aligned_cols=232  Identities=22%  Similarity=0.296  Sum_probs=185.7

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccC-ccceeeEEEEeecCCceEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~  348 (613)
                      +|...++||+|+||.||+|....++..||+|++...   .......+..|+.++..+. |++|+++++++.+.+.+++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            366778999999999999999888889999998754   2234456788999998885 577888999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+++|+|.+++..  ...+++.+++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++...  
T Consensus        81 Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~----ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRRG----IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999998843  456999999999999999999999988    9999999999999999999999999986421  


Q ss_pred             ------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          427 ------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       427 ------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                            ..++..|+|||++.+..++.++|||||||+||||++|++||.............   .  .........+....
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~---~--~~~~~p~~~~~~~~  229 (323)
T cd05615         155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM---E--HNVSYPKSLSKEAV  229 (323)
T ss_pred             CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH---h--CCCCCCccCCHHHH
Confidence                  235678999999999999999999999999999999999997654332211111   1  11111111222111


Q ss_pred             --HhcccccCCCCCCCH
Q 048439          501 --AMSCLNDEGIRRPSM  515 (613)
Q Consensus       501 --~~~Cl~~~p~~RPs~  515 (613)
                        ..+||+.+|.+|++.
T Consensus       230 ~li~~~l~~~p~~R~~~  246 (323)
T cd05615         230 SICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HHHHHHcccCHhhCCCC
Confidence              237999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-37  Score=315.96  Aligned_cols=245  Identities=25%  Similarity=0.423  Sum_probs=195.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCC-----ceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGS-----TTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~-----~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  345 (613)
                      ++|.....||+|+||.||+|...+.     ...||+|.+.... ......|.+|+.++..++|+||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            5677788999999999999988643     3679999987553 344567899999999999999999999999999999


Q ss_pred             EEEEcCCCCChhHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEE
Q 048439          346 LVYDFMARGTLPDHLYHSD--------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVS  417 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~  417 (613)
                      +||||+++|+|.+++....        ...++|..++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK----FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC----ccccccChheEEEcCCCCEEEC
Confidence            9999999999999985421        234789999999999999999999988    9999999999999999999999


Q ss_pred             ecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhh
Q 048439          418 DFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCY  486 (613)
Q Consensus       418 DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~  486 (613)
                      |||+++...          ..++..|+|||.+..+.++.++|||||||++|||++ |++||......+......   ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~---~~~  238 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI---DGG  238 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh---cCC
Confidence            999986321          122456999999998899999999999999999998 899986544333222111   111


Q ss_pred             ccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          487 QNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       487 ~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .............. ..+||+.+|++|||+.+++..|+
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            11111222222222 23799999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.1e-37  Score=319.08  Aligned_cols=243  Identities=21%  Similarity=0.328  Sum_probs=197.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      .+|...+.||+|+||.||+|+...++..||+|.+..........+.+|+.+++.++|+||+++++++......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            46777789999999999999988777889999998765555677899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++|+|.+++..   ..+++.+++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++...     
T Consensus       100 ~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~g----i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654         100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             CCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            99999999843   45899999999999999999999998    9999999999999999999999999876421     


Q ss_pred             ---CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc-CCccccccHHHH-H
Q 048439          427 ---TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN-GTIDQIVDPFLK-A  501 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~d~~~~-~  501 (613)
                         ..++..|++||++....++.++|||||||++|||++|++||.........  ..+....... .....+...... .
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li  250 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIATNGTPELQNPEKLSAIFRDFL  250 (296)
T ss_pred             cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHHhcCCCCCCCCccccCHHHHHHH
Confidence               23456799999999988999999999999999999999999655432221  1111111111 111122222222 2


Q ss_pred             hcccccCCCCCCCHHHHHHHHH
Q 048439          502 MSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .+||..+|++||++.|++.+-.
T Consensus       251 ~~~l~~~p~~Rpt~~eil~~~~  272 (296)
T cd06654         251 NRCLDMDVEKRGSAKELLQHQF  272 (296)
T ss_pred             HHHCcCCcccCcCHHHHhhChh
Confidence            3799999999999999997544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.3e-37  Score=317.34  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=194.0

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCc
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDRE  343 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~  343 (613)
                      .+++|...++||+|+||.||+|...+     .+..||+|.++... ......+.+|+.++++++|+||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45678888999999999999997642     23579999886543 2334568899999999999999999999999999


Q ss_pred             eEEEEEcCCCCChhHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEE
Q 048439          344 MILVYDFMARGTLPDHLYHSD--------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAK  415 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~k  415 (613)
                      .++||||+++|+|.+++....        ...+++..++.++.|++.||.|||+.+    |+||||||+|||+++++.+|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~----i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK----FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----CcCCCCChheEEEcCCCcEE
Confidence            999999999999999995421        245678889999999999999999988    99999999999999999999


Q ss_pred             EEecCCCccCCC----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHH
Q 048439          416 VSDFGLSKFGPT----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQ  484 (613)
Q Consensus       416 l~DFGls~~~~~----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~  484 (613)
                      |+|||+++....          ..+..|++||++..+.++.++|||||||++|||++ |.+||......+...   ....
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~---~~~~  236 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK---FVMD  236 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHc
Confidence            999999864211          12346999999999999999999999999999998 788886543322111   1110


Q ss_pred             hhccCCccccccHHHH--HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          485 CYQNGTIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       485 ~~~~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      . ..........+.+.  ..+||+.+|++||++.++++.|+..
T Consensus       237 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         237 G-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             C-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            0 00011111122222  2389999999999999999888754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-37  Score=309.61  Aligned_cols=242  Identities=30%  Similarity=0.498  Sum_probs=196.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|.....||.|+||.||+|...+  +.||||.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~~--~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYRG--QKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhccceeeeecCCCceEEEEEecC--cEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            467778899999999999998763  6799999976654 5678999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT----  427 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~----  427 (613)
                      ++++|.+++.......++|..++.++.|++.||.|||+.+    ++||||||+||+++.++.+||+|||+++....    
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~----i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~  158 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN----FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS  158 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----ccchhcccceEEEeCCCCEEEccccccccccccccc
Confidence            9999999996555457999999999999999999999998    99999999999999999999999999875321    


Q ss_pred             -CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-Hhcc
Q 048439          428 -SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSC  504 (613)
Q Consensus       428 -~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~C  504 (613)
                       .....|++||++..+.++.++||||||+++|||++ |+.||......+.   .................+.... ..+|
T Consensus       159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (256)
T cd05039         159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPHVEKGYRMEAPEGCPPEVYKVMKDC  235 (256)
T ss_pred             CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHhcCCCCCCccCCCHHHHHHHHHH
Confidence             12345999999998899999999999999999997 9999865433221   1111111111111111121211 2379


Q ss_pred             cccCCCCCCCHHHHHHHHH
Q 048439          505 LNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       505 l~~~p~~RPs~~evl~~Le  523 (613)
                      |..+|++||++.|++..|+
T Consensus       236 l~~~p~~Rp~~~~l~~~l~  254 (256)
T cd05039         236 WELDPAKRPTFKQLREQLA  254 (256)
T ss_pred             hccChhhCcCHHHHHHHHh
Confidence            9999999999999999886

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.3e-37  Score=316.41  Aligned_cols=246  Identities=24%  Similarity=0.409  Sum_probs=193.2

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCC----------------ceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceee
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGS----------------TTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVS  333 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~----------------~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~  333 (613)
                      .++|.....||+|+||.||+|.....                ...||+|.+.... .....+|.+|++++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            35678888999999999999987543                2558999987653 345667999999999999999999


Q ss_pred             EEEEeecCCceEEEEEcCCCCChhHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCC
Q 048439          334 LIGFCNDDREMILVYDFMARGTLPDHLYHSD---------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTT  404 (613)
Q Consensus       334 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~  404 (613)
                      ++++|..++..++||||+++++|.+++....         ...+++..++.++.|++.||.|||+.+    |+||||||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~----i~H~dlkp~  159 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN----FVHRDLATR  159 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC----ccccccchh
Confidence            9999999999999999999999999985432         236899999999999999999999988    999999999


Q ss_pred             ceeeCCCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh--CCCCccchhh
Q 048439          405 NILLDEKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC--ARPSILRTAA  472 (613)
Q Consensus       405 NILl~~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt--g~~p~~~~~~  472 (613)
                      ||++++++.+||+|||+++...          ...+..|+|||++....++.++|||||||++|||++  +..|+.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            9999999999999999987421          122446999999999899999999999999999998  6677754322


Q ss_pred             hhhhhHHHHHHHhhc-------cCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          473 KKQVSLAVWAQQCYQ-------NGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       473 ~~~~~l~~~~~~~~~-------~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ...   .........       ..........+.. +.+||+.+|.+||++.+|++.|+
T Consensus       240 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 QQV---IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHH---HHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            221   111111100       0011111112222 33799999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.2e-37  Score=311.26  Aligned_cols=241  Identities=27%  Similarity=0.450  Sum_probs=191.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||.||+|...++ ..+|+|.+..... ....|.+|+.++++++|+|++++++++.+ ...++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM   82 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCC-ceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence            3567778999999999999988755 5699999876433 34579999999999999999999998854 5688999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT----  427 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~----  427 (613)
                      ++++|.+++.......+++.+++.++.+++.||.|||+.+    |+||||||+||++++++.+||+|||++.....    
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~----i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN----YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            9999999997655567899999999999999999999988    99999999999999999999999999864221    


Q ss_pred             -----CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          428 -----SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       428 -----~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                           .++..|+|||++....++.++|||||||++|||++ |++||......+..   ......... ......+..+. 
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~  234 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL---EQVERGYRM-PCPQDCPISLHE  234 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHHcCCCC-CCCCcCCHHHHH
Confidence                 12235999999998999999999999999999999 88888654332211   111111111 11111112221 


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHH
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                       ..+||..+|.+|||+.++.+.|+
T Consensus       235 li~~~l~~~p~~Rpt~~~l~~~l~  258 (260)
T cd05070         235 LMLQCWKKDPEERPTFEYLQSFLE  258 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHHHHh
Confidence             23899999999999999998886

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.8e-37  Score=310.82  Aligned_cols=240  Identities=27%  Similarity=0.450  Sum_probs=185.1

Q ss_pred             eeeeeCcEEEEEEEEcC---CceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeec-CCceEEEEEcCCC
Q 048439          279 VIGVGGFGDVYKGFING---STTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND-DREMILVYDFMAR  353 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~---~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~~~  353 (613)
                      +||+|+||.||+|.+.+   ....||+|++... .......|..|+.+++.++||||++++++|.. ++..++|+||+.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   81 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH   81 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence            68999999999998743   3467999998643 33446678999999999999999999998764 5568999999999


Q ss_pred             CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-------
Q 048439          354 GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-------  426 (613)
Q Consensus       354 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-------  426 (613)
                      |+|.+++... ...+++..++.++.|++.||.|||+.+    ++||||||+|||+++++.+||+|||+++...       
T Consensus        82 ~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          82 GDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKK----FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC----ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            9999998543 345788889999999999999999988    9999999999999999999999999986321       


Q ss_pred             -----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhC-CCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          427 -----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCA-RPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                           ...+..|+|||++....++.++|||||||++|||++| .+|+......+   +...............+.+....
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  233 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYLLQGRRLLQPEYCPDPLYE  233 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHhcCCCCCCCCcCCHHHHH
Confidence                 1123469999999999999999999999999999995 55664332222   11111111111111112222222


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                       ..+||+.+|++||++.||+..|+...
T Consensus       234 li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         234 VMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             HHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence             33799999999999999999998643

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.9e-37  Score=312.31  Aligned_cols=244  Identities=28%  Similarity=0.426  Sum_probs=192.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||.||+|++.++ ..||+|++.... .....|.+|++++++++|+||+++++++.+ ...++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            4577888999999999999998766 459999987543 234578999999999999999999998754 5679999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT----  427 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~----  427 (613)
                      ++|+|.+++.......++|..++.++.+++.||.|||+.+    ++||||||+||++++++.+||+|||+++....    
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~----i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC----ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            9999999996544556899999999999999999999988    99999999999999999999999999864211    


Q ss_pred             -----CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          428 -----SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       428 -----~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                           .++..|++||+.....++.++|||||||++|||++ |++||......+.......   .........+...+.. 
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~l  235 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPESLHDL  235 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc---CCCCCCccccCHHHHHH
Confidence                 12345999999998999999999999999999999 8888865433222111110   0001111111121222 


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ..+|++.+|++||++.++++.|+..
T Consensus       236 i~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         236 MCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             HHHHccCCcccCCCHHHHHHHHHHh
Confidence            3389999999999999999998854

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.9e-37  Score=325.81  Aligned_cols=243  Identities=22%  Similarity=0.267  Sum_probs=190.0

Q ss_pred             CCCCcceeeeeCcEEEEEEEEc---CCceeEEEEEeCCCC----hhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCce
Q 048439          273 NFDNDLVIGVGGFGDVYKGFIN---GSTTPVAIKRLEPES----QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~---~~~~~vAVK~~~~~~----~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~  344 (613)
                      +|...+.||+|+||.||+++..   .++..||+|++....    ......+..|+.++.++ +|+||+++++++.+.+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4677789999999999999863   356789999986532    22345678999999999 599999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++||||+++|+|.+++..  ...+++.++..++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLG----IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999999854  356899999999999999999999988    99999999999999999999999999864


Q ss_pred             C---------CCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhh-hHHHHHHHhhccCCccc
Q 048439          425 G---------PTSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV-SLAVWAQQCYQNGTIDQ  493 (613)
Q Consensus       425 ~---------~~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~  493 (613)
                      .         ...++..|+|||++.+. .++.++|||||||+||||++|+.||......... .......  .....+..
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~  232 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL--KCDPPFPS  232 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh--cCCCCCCC
Confidence            2         12356789999999865 4789999999999999999999999643222111 1111111  11112222


Q ss_pred             cccHHHH--HhcccccCCCCCC-----CHHHHHHHHH
Q 048439          494 IVDPFLK--AMSCLNDEGIRRP-----SMSDVVWGLE  523 (613)
Q Consensus       494 ~~d~~~~--~~~Cl~~~p~~RP-----s~~evl~~Le  523 (613)
                      .+++...  ..+||+.||++||     ++.+++++..
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~  269 (332)
T cd05614         233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF  269 (332)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence            2333222  2279999999999     7778876654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.6e-37  Score=309.65  Aligned_cols=241  Identities=30%  Similarity=0.485  Sum_probs=191.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEee-cCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN-DDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~Ey  350 (613)
                      .+|...+.||+|+||.||+|...+  ..||+|.++...  ..+.|.+|+.++++++|+|++++++++. +.+..++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~--~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEcC--CcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            467777899999999999998764  569999986543  3457899999999999999999999764 45678999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC---
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT---  427 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~---  427 (613)
                      +++|+|.+++.......++|..++.++.+++.||+|||+.+    ++||||||+||++++++.+||+|||+++....   
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  157 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD  157 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----EeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence            99999999997655566999999999999999999999988    99999999999999999999999999874321   


Q ss_pred             --CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hh
Q 048439          428 --SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AM  502 (613)
Q Consensus       428 --~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~  502 (613)
                        ..+..|+|||++....++.++|||||||++|||++ |+.|+......+   +..+........ ......+.+.  ..
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~li~  233 (256)
T cd05082         158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGYKMD-APDGCPPVVYDVMK  233 (256)
T ss_pred             CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcCCCCC-CCCCCCHHHHHHHH
Confidence              22346999999999999999999999999999997 999885433222   111111111111 1111222222  23


Q ss_pred             cccccCCCCCCCHHHHHHHHHH
Q 048439          503 SCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       503 ~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      +||+.+|++||++.++++.|+.
T Consensus       234 ~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         234 QCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             HHhcCChhhCcCHHHHHHHHhc
Confidence            7999999999999999988863

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.2e-37  Score=310.08  Aligned_cols=237  Identities=24%  Similarity=0.391  Sum_probs=186.0

Q ss_pred             eeeeeCcEEEEEEEEc--CCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCC
Q 048439          279 VIGVGGFGDVYKGFIN--GSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGT  355 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~--~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs  355 (613)
                      .||+|+||.||+|.+.  +++..||+|.+.... ....++|.+|+.++++++|+||++++++|.. ...++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999874  344569999987654 3344679999999999999999999999864 57899999999999


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC--------
Q 048439          356 LPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT--------  427 (613)
Q Consensus       356 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~--------  427 (613)
                      |.+++.. ....+++.++++++.|++.||.|||+.+    ++||||||+|||++.++.+||+|||+++....        
T Consensus        81 L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGKN----FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhcC----eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9999854 2457999999999999999999999988    99999999999999999999999999863211        


Q ss_pred             ---CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-Hh
Q 048439          428 ---SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AM  502 (613)
Q Consensus       428 ---~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~  502 (613)
                         ..+..|+|||++..+.++.++|||||||++|||++ |.+||......+..   ................+.+.. ..
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~  232 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM---SFIEQGKRLDCPAECPPEMYALMK  232 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH---HHHHCCCCCCCCCCCCHHHHHHHH
Confidence               11246999999998899999999999999999996 99998654433221   111111111111111112212 23


Q ss_pred             cccccCCCCCCCHHHHHHHHHH
Q 048439          503 SCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       503 ~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      +||..+|++||++.+|.+.|+.
T Consensus       233 ~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         233 DCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             HHcCCChhhCcCHHHHHHHHhh
Confidence            7999999999999999988874

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.4e-37  Score=312.94  Aligned_cols=249  Identities=22%  Similarity=0.347  Sum_probs=197.6

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcC----CceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeec-CCce
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFING----STTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND-DREM  344 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~----~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~-~~~~  344 (613)
                      .++|...++||+|+||.||+|....    +...|++|++... .......+.+|+.++++++|+||+++++++.+ ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678888899999999999999865    2477999998754 33445678999999999999999999999876 5778


Q ss_pred             EEEEEcCCCCChhHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEe
Q 048439          345 ILVYDFMARGTLPDHLYHSDN------PPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSD  418 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~D  418 (613)
                      ++++||+++|+|.+++.....      ..+++.+++.++.|++.||+|||+.+    ++||||||+|||+++++.+||+|
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG----VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC----EeecccCHhhEEEcCCCcEEECC
Confidence            999999999999999854321      56999999999999999999999988    99999999999999999999999


Q ss_pred             cCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhc
Q 048439          419 FGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQ  487 (613)
Q Consensus       419 FGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~  487 (613)
                      ||+++...          ..++..|+|||++....++.++|||||||++||+++ |++||......+   +..+......
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~  237 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLKDGYR  237 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHHcCCC
Confidence            99997421          122345999999999899999999999999999998 999986543322   2222222211


Q ss_pred             cCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          488 NGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       488 ~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ........+.... ..+||..+|++||++.+|+..|+...
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         238 LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            1111111222222 33799999999999999999998654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.3e-38  Score=332.17  Aligned_cols=196  Identities=24%  Similarity=0.364  Sum_probs=173.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||++....++..||||+++...   ......+..|+.++.+++|+||+++++++.+.+.++|||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36778889999999999999998888999999987532   233456889999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+++|+|.+++..  ...+++.....++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++..   
T Consensus        81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~g----ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLG----FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999999853  456899999999999999999999998    999999999999999999999999997532   


Q ss_pred             ----------------------------------------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCC
Q 048439          426 ----------------------------------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP  465 (613)
Q Consensus       426 ----------------------------------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~  465 (613)
                                                              ...++..|+|||++.+..++.++|||||||+||||++|++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence                                                    1235678999999999999999999999999999999999


Q ss_pred             Cccchhhh
Q 048439          466 SILRTAAK  473 (613)
Q Consensus       466 p~~~~~~~  473 (613)
                      ||......
T Consensus       235 Pf~~~~~~  242 (360)
T cd05627         235 PFCSETPQ  242 (360)
T ss_pred             CCCCCCHH
Confidence            99765443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.1e-38  Score=327.20  Aligned_cols=227  Identities=26%  Similarity=0.339  Sum_probs=180.5

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHH-HHhccCccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIG-MLSQLRHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      +||+|+||.||+|+...++..||||++....   .....++..|.. +++.++||||+++++++.+.+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            7999999999999998888999999987542   223344555554 567899999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--------C
Q 048439          355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--------P  426 (613)
Q Consensus       355 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--------~  426 (613)
                      +|.+++..  ...+++..+..++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++..        .
T Consensus        82 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g----ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          82 ELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLN----IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence            99998853  456899999999999999999999998    999999999999999999999999998642        1


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhcc
Q 048439          427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSC  504 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~C  504 (613)
                      ..++..|+|||++.+..++.++|||||||+||||++|++||......+......  .   ....+....+....  ..+|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--~---~~~~~~~~~~~~~~~li~~~  230 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL--N---KPLRLKPNISVSARHLLEGL  230 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH--c---CCCCCCCCCCHHHHHHHHHH
Confidence            235667999999999999999999999999999999999997543322111111  0   01111111122222  2279


Q ss_pred             cccCCCCCCCHH
Q 048439          505 LNDEGIRRPSMS  516 (613)
Q Consensus       505 l~~~p~~RPs~~  516 (613)
                      |+.+|.+||++.
T Consensus       231 l~~~p~~R~~~~  242 (323)
T cd05575         231 LQKDRTKRLGAK  242 (323)
T ss_pred             hhcCHHhCCCCC
Confidence            999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.1e-37  Score=318.41  Aligned_cols=251  Identities=23%  Similarity=0.420  Sum_probs=195.7

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcC-------CceeEEEEEeCCC-ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecC
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFING-------STTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDD  341 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~-------~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~  341 (613)
                      -.+|.....||+|+||.||+|+...       ....||+|.+... ......++.+|+.++..+ +|+||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            3567777899999999999997521       2346999998754 334556789999999999 899999999999999


Q ss_pred             CceEEEEEcCCCCChhHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCcee
Q 048439          342 REMILVYDFMARGTLPDHLYHSD--------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNIL  407 (613)
Q Consensus       342 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NIL  407 (613)
                      ...++||||+++|+|.+++....              ...++|.+++.++.|++.||.|||+.+    |+||||||+|||
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g----ivH~dlkp~Nil  169 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK----CIHRDLAARNVL  169 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC----eeecccccceEE
Confidence            99999999999999999986431              235889999999999999999999998    999999999999


Q ss_pred             eCCCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhh
Q 048439          408 LDEKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQV  476 (613)
Q Consensus       408 l~~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~  476 (613)
                      +++++.+||+|||+++...          ...+..|+|||++....++.++|||||||+||||++ |..|+......+..
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  249 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  249 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence            9999999999999986422          112346999999999899999999999999999998 77887544332221


Q ss_pred             hHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          477 SLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       477 ~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                      ...   .................. ..+||+.+|.+||++.||++.|+..+.+
T Consensus       250 ~~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         250 KLL---KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             HHH---HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            111   111111111111112211 3379999999999999999999866544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.1e-37  Score=312.05  Aligned_cols=245  Identities=26%  Similarity=0.441  Sum_probs=194.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCC---ceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGS---TTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~---~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      .+|...+.||+|+||.||+|+...+   ...+|+|.++... ......|.+|+.++.+++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            4677788999999999999987422   3479999987643 33456789999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT  427 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~  427 (613)
                      |||+++|+|.+++... ...+++.+++.++.|++.||.|||+.+    ++||||||+|||++.++.+||+|||+++....
T Consensus        84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~----i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMG----YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC----EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999998543 356899999999999999999999988    99999999999999999999999999864221


Q ss_pred             C-----------CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          428 S-----------VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       428 ~-----------~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                      .           .+..|++||++..+.++.++|||||||++||+++ |+.||......+.   .................
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~  235 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIEEGYRLPAPMDCP  235 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHhCCCcCCCCCCCC
Confidence            1           1235899999999999999999999999999886 9999865443321   11111111111111111


Q ss_pred             cHHH-HHhcccccCCCCCCCHHHHHHHHHH
Q 048439          496 DPFL-KAMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       496 d~~~-~~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .... ...+|++.+|.+||+|.++++.|+.
T Consensus       236 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         236 AALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             HHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence            1111 1337999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.9e-37  Score=328.85  Aligned_cols=245  Identities=23%  Similarity=0.310  Sum_probs=191.2

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCC-----ceE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR-----EMI  345 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~  345 (613)
                      +|+..+.||+|+||.||++....++..||||++...  .......+.+|+++++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477788999999999999999877789999998653  2334567889999999999999999999998776     789


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +|+||+. ++|.+.+.  ....+++..+..++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~----ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSAG----ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC----eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 58888774  3457999999999999999999999998    999999999999999999999999998642


Q ss_pred             C---------CCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHH--------------
Q 048439          426 P---------TSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVW--------------  481 (613)
Q Consensus       426 ~---------~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~--------------  481 (613)
                      .         ..++..|+|||++.+. .++.++|||||||++|||++|++||.......+......              
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            1         2235679999999874 479999999999999999999999976544333221111              


Q ss_pred             --HHHhh-c----cCC------ccccccHHH--HHhcccccCCCCCCCHHHHHHHHHH
Q 048439          482 --AQQCY-Q----NGT------IDQIVDPFL--KAMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       482 --~~~~~-~----~~~------~~~~~d~~~--~~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                        ..... .    ...      .....++..  ...+||+.||.+||++.|++.+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  291 (372)
T cd07853         234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL  291 (372)
T ss_pred             HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhh
Confidence              00000 0    000      000011111  1237999999999999999977653

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6e-38  Score=329.44  Aligned_cols=247  Identities=20%  Similarity=0.239  Sum_probs=194.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|.....||+|+||.||+++...++..||||+++...   ......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888889999999999999998888899999997542   234556889999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+++|+|.+++... ...+++..+..++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++...  
T Consensus        81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~----i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG----YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999998543 356999999999999999999999998    9999999999999999999999999986421  


Q ss_pred             -------CCCCcccCChhhhh------cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccc
Q 048439          427 -------TSVSKTHLDPEYYR------LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ  493 (613)
Q Consensus       427 -------~~~~~~~~aPE~~~------~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  493 (613)
                             ..++..|+|||++.      ...++.++|||||||+||||++|+.||..........................
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK  235 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCC
Confidence                   23567799999987      45678999999999999999999999965443322111110000000011111


Q ss_pred             cccHHHHHh-cccccCCCCCCCHHHHHHHHHH
Q 048439          494 IVDPFLKAM-SCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       494 ~~d~~~~~~-~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      +.+.....+ .||. +|.+||++.+++.+..+
T Consensus       236 ~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~  266 (330)
T cd05601         236 VSSDFLDLIQSLLC-GQKERLGYEGLCCHPFF  266 (330)
T ss_pred             CCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCc
Confidence            122222222 5776 99999999999866553

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-37  Score=315.59  Aligned_cols=248  Identities=24%  Similarity=0.407  Sum_probs=191.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCC--------------ceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGS--------------TTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIG  336 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~--------------~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g  336 (613)
                      ++|...+.||+|+||.||+++..+.              ...||||.++.. .......|.+|++++.+++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            4677888999999999999987532              235899998765 3344567999999999999999999999


Q ss_pred             EeecCCceEEEEEcCCCCChhHHhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCce
Q 048439          337 FCNDDREMILVYDFMARGTLPDHLYHSD----------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNI  406 (613)
Q Consensus       337 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NI  406 (613)
                      ++...+..++||||+++++|.+++....          ...++|..++.++.++++||.|||+.+    ++||||||+||
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~----i~H~dlkp~Ni  160 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN----FVHRDLATRNC  160 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC----eeccccChhhE
Confidence            9999999999999999999999985421          135789999999999999999999988    99999999999


Q ss_pred             eeCCCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh--CCCCccchhhhh
Q 048439          407 LLDEKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC--ARPSILRTAAKK  474 (613)
Q Consensus       407 Ll~~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt--g~~p~~~~~~~~  474 (613)
                      |+++++.+||+|||+++...          ...+..|+|||++..+.++.++|||||||++|||++  +..||.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            99999999999999986421          112346999999999999999999999999999998  556775433222


Q ss_pred             hhhHHH--HHHHhh--ccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          475 QVSLAV--WAQQCY--QNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       475 ~~~l~~--~~~~~~--~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ......  +.....  ...........+.. +.+||+.+|++||+|.+|++.|+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            111111  000000  00001111122222 33799999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.1e-37  Score=315.55  Aligned_cols=233  Identities=24%  Similarity=0.373  Sum_probs=182.6

Q ss_pred             eeeeeCcEEEEEEEEcC------------------------CceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeE
Q 048439          279 VIGVGGFGDVYKGFING------------------------STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSL  334 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~------------------------~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l  334 (613)
                      .||+|+||.||+|.+..                        ....|++|.+.........+|.+|+.++++++|+||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998632                        124589999877655556678999999999999999999


Q ss_pred             EEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC--
Q 048439          335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW--  412 (613)
Q Consensus       335 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~--  412 (613)
                      +|+|.+....++||||+++|+|.+++.. ....+++..++.++.|+++||+|||+.+    |+||||||+|||+++.+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~----iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDKN----LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCC----ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999988854 3456899999999999999999999988    99999999999997654  


Q ss_pred             -----cEEEEecCCCccC----CCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHH-hCCCCccchhhhhhhhHHHH
Q 048439          413 -----VAKVSDFGLSKFG----PTSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVL-CARPSILRTAAKKQVSLAVW  481 (613)
Q Consensus       413 -----~~kl~DFGls~~~----~~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~ell-tg~~p~~~~~~~~~~~l~~~  481 (613)
                           .+|++|||++...    ...++..|++||++.. ..++.++|||||||++|||+ +|+.|+......+....   
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~---  233 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF---  233 (274)
T ss_pred             cCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH---
Confidence                 4899999987532    1234567999999876 56899999999999999995 78998865433222111   


Q ss_pred             HHHhhccCCcccccc-HHH-HHhcccccCCCCCCCHHHHHHHH
Q 048439          482 AQQCYQNGTIDQIVD-PFL-KAMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       482 ~~~~~~~~~~~~~~d-~~~-~~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                      ....   ....+... .+. .+.+||+.+|++||++.+|++.|
T Consensus       234 ~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         234 YEKK---HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHhc---cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            1111   11111111 111 13379999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.3e-37  Score=332.49  Aligned_cols=254  Identities=22%  Similarity=0.281  Sum_probs=195.5

Q ss_pred             HHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeec
Q 048439          264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND  340 (613)
Q Consensus       264 ~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~  340 (613)
                      +.++....++|...+.||+|+||.||+++...++..+|+|++...   .......+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            445566678999999999999999999999988899999998642   22334557899999999999999999999999


Q ss_pred             CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecC
Q 048439          341 DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG  420 (613)
Q Consensus       341 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG  420 (613)
                      ++..++||||+++|+|.+++..   ..++...+..++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~----ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG----FIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC----EEeCCCCHHHEEECCCCCEEEEeCC
Confidence            9999999999999999998843   34888899999999999999999998    9999999999999999999999999


Q ss_pred             CCccCC---------CCCCcccCChhhhhcCC----CCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc
Q 048439          421 LSKFGP---------TSVSKTHLDPEYYRLQQ----LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ  487 (613)
Q Consensus       421 ls~~~~---------~~~~~~~~aPE~~~~~~----~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~  487 (613)
                      +++...         ..++..|+|||++....    ++.++|||||||+||||++|++||....................
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~  267 (371)
T cd05622         188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT  267 (371)
T ss_pred             ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc
Confidence            986421         23577899999997643    78999999999999999999999976543222111110000000


Q ss_pred             cCCccccccHHHHH-hcccccCCCC--CCCHHHHHHHHHH
Q 048439          488 NGTIDQIVDPFLKA-MSCLNDEGIR--RPSMSDVVWGLEF  524 (613)
Q Consensus       488 ~~~~~~~~d~~~~~-~~Cl~~~p~~--RPs~~evl~~Le~  524 (613)
                      ......+....... .+||..++.+  ||++.|++++..+
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~  307 (371)
T cd05622         268 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  307 (371)
T ss_pred             CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence            00111122222222 2577643433  7899999987754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-37  Score=309.38  Aligned_cols=236  Identities=27%  Similarity=0.426  Sum_probs=187.7

Q ss_pred             eeeeeCcEEEEEEEEcCCc---eeEEEEEeCCCCh-hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          279 VIGVGGFGDVYKGFINGST---TPVAIKRLEPESQ-QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~---~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      +||+|+||.||+|++....   ..+|+|.+..... ....++.+|+.+++++.|+||+++++++. .+..++||||+++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~   80 (257)
T cd05060           2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG   80 (257)
T ss_pred             ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence            6999999999999875443   6799999876543 34567899999999999999999999886 45689999999999


Q ss_pred             ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCCC------
Q 048439          355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS------  428 (613)
Q Consensus       355 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~------  428 (613)
                      +|.+++...  ..+++..++.++.|++.||.|||..+    ++||||||+|||++.++.+||+|||+++.....      
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~----i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          81 PLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKH----FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcC----eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            999999543  37899999999999999999999988    999999999999999999999999998642111      


Q ss_pred             -----CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-H
Q 048439          429 -----VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-A  501 (613)
Q Consensus       429 -----~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~  501 (613)
                           .+..|++||.+....++.++|||||||++|||++ |++||......+   ...+................... .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li  231 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLESGERLPRPEECPQEIYSIM  231 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHcCCcCCCCCCCCHHHHHHH
Confidence                 1235999999999999999999999999999998 999986543322   22222211111111112122211 3


Q ss_pred             hcccccCCCCCCCHHHHHHHHHH
Q 048439          502 MSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .+||..+|.+||++.+|++.|+.
T Consensus       232 ~~cl~~~p~~Rp~~~~l~~~l~~  254 (257)
T cd05060         232 LSCWKYRPEDRPTFSELESTFRR  254 (257)
T ss_pred             HHHhcCChhhCcCHHHHHHHHHh
Confidence            37999999999999999999885

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.4e-37  Score=306.88  Aligned_cols=236  Identities=26%  Similarity=0.466  Sum_probs=188.0

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh-hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCChh
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ-QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLP  357 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~  357 (613)
                      +||+|+||.||+|...+ +..+|+|.++.... .....|.+|++++++++|+||++++++|.+.+..++||||+++|+|.
T Consensus         2 ~ig~g~~g~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           2 LLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             ccCCCCCceEEEEEecC-CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            68999999999999765 47799999876543 33456899999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---------CC
Q 048439          358 DHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---------TS  428 (613)
Q Consensus       358 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---------~~  428 (613)
                      +++... ...++|..++.++.+++.||.|||+.+    ++||||||+||++++++.+||+|||+++...         ..
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~----~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          81 SFLRKK-KDELKTKQLVKFALDAAAGMAYLESKN----CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC----eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            988543 356899999999999999999999988    9999999999999999999999999986421         11


Q ss_pred             CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH-HHhcccc
Q 048439          429 VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL-KAMSCLN  506 (613)
Q Consensus       429 ~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~-~~~~Cl~  506 (613)
                      ....|++||++..+.++.++|||||||++|||++ |..||.........   ..............+..... ...+||+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~  232 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR---EQVEKGYRMSCPQKCPDDVYKVMQRCWD  232 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH---HHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            2345999999999999999999999999999998 99998654322211   11111111111111111111 2348999


Q ss_pred             cCCCCCCCHHHHHHHHH
Q 048439          507 DEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       507 ~~p~~RPs~~evl~~Le  523 (613)
                      .+|++||++.|+++.|.
T Consensus       233 ~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         233 YKPENRPKFSELQKELA  249 (250)
T ss_pred             cCcccCCCHHHHHHHhc
Confidence            99999999999998764

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=8.7e-37  Score=308.06  Aligned_cols=238  Identities=24%  Similarity=0.369  Sum_probs=190.3

Q ss_pred             eeeeeCcEEEEEEEEcC-C--ceeEEEEEeCCCCh-hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          279 VIGVGGFGDVYKGFING-S--TTPVAIKRLEPESQ-QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~-~--~~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      +||+|+||.||+|.+.. +  ...||||.+..... ...+.|.+|+.++++++|+||+++++++.+ ...++||||+++|
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~   80 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG   80 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence            68999999999999854 2  23699999987765 566789999999999999999999999988 8899999999999


Q ss_pred             ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC-------
Q 048439          355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-------  427 (613)
Q Consensus       355 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~-------  427 (613)
                      +|.+++.......++|...+.++.|++.||+|||+.+    ++||||||+||+++.++.+||+|||+++....       
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~----i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR----FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC----ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            9999996543357899999999999999999999988    99999999999999999999999999864322       


Q ss_pred             ----CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-H
Q 048439          428 ----SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-A  501 (613)
Q Consensus       428 ----~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~  501 (613)
                          .++..|++||++....++.++|||||||++|||++ |+.|+......+......  .................. .
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li  234 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID--KEGERLERPEACPQDIYNVM  234 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--hcCCcCCCCccCCHHHHHHH
Confidence                23456999999999999999999999999999998 999986443332111111  111111111111122211 2


Q ss_pred             hcccccCCCCCCCHHHHHHHHH
Q 048439          502 MSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .+||+.+|.+||++.||+..|.
T Consensus       235 ~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         235 LQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HHHCCCCcccCCCHHHHHHHhc
Confidence            3799999999999999998774

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.7e-37  Score=313.25  Aligned_cols=246  Identities=24%  Similarity=0.366  Sum_probs=192.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCce----eEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTT----PVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~----~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ++|...++||+|+||.||+|....++.    .||+|.++.. ......++.+|+.++..++|+||++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            467777899999999999998754443    4899998754 334456789999999999999999999999764 5789


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ++||+++|+|.+++... ...+++..++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++...
T Consensus        86 ~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~----iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          86 VTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVR----LVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeccccccceEEEcCCCcEEECCCCceeecc
Confidence            99999999999998542 356999999999999999999999988    9999999999999999999999999986432


Q ss_pred             ----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          427 ----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       427 ----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                                ...+..|++||......++.++|||||||++|||++ |.+||.......   +..+..............
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~  237 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEKGERLPQPPICT  237 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCCCcCCCCccCC
Confidence                      112346999999999999999999999999999998 889886543222   222222111111111111


Q ss_pred             cHH-HHHhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          496 DPF-LKAMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       496 d~~-~~~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      +.. ....+||+.+|++||++.+++..|+...
T Consensus       238 ~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         238 IDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            111 1233799999999999999998877543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.2e-37  Score=323.73  Aligned_cols=238  Identities=23%  Similarity=0.287  Sum_probs=188.2

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      +||+|+||.||+|+...++..||||++....   ......+..|+.++.++ +|+||+++++++.+.+.+++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            7999999999999998888899999997642   23455688999999888 6999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--------C
Q 048439          355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--------P  426 (613)
Q Consensus       355 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--------~  426 (613)
                      +|.+++..  ...+++..+..++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+++..        .
T Consensus        82 ~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~----ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          82 DLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERG----IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence            99988843  356999999999999999999999998    999999999999999999999999998642        1


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHh--hccCCccccccHHHH--Hh
Q 048439          427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC--YQNGTIDQIVDPFLK--AM  502 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~d~~~~--~~  502 (613)
                      ..++..|+|||++.+..++.++|||||||+||||++|++||.............+....  .....+...++....  ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~  235 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLK  235 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            23567899999999999999999999999999999999999643221111111111111  111122222322222  23


Q ss_pred             cccccCCCCCCCH------HHHHHHH
Q 048439          503 SCLNDEGIRRPSM------SDVVWGL  522 (613)
Q Consensus       503 ~Cl~~~p~~RPs~------~evl~~L  522 (613)
                      +||+.||.+||++      .+++.+.
T Consensus       236 ~~L~~dP~~R~~~~~~~~~~~i~~h~  261 (327)
T cd05617         236 GFLNKDPKERLGCQPQTGFSDIKSHT  261 (327)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHHcCC
Confidence            7999999999984      5665443

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8.8e-37  Score=328.45  Aligned_cols=249  Identities=25%  Similarity=0.401  Sum_probs=193.7

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCCC-hhcHHHHHHHHHHHhccC-ccceeeEEEEeecCCc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPES-QQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDRE  343 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~  343 (613)
                      .++|...+.||+|+||.||+|++.+     .+..||||+++... ....+.+.+|+.+|.++. |||||+++|+|...+.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            3456677799999999999998643     34679999997653 333457899999999997 9999999999999999


Q ss_pred             eEEEEEcCCCCChhHHhhcCC-----------------------------------------------------------
Q 048439          344 MILVYDFMARGTLPDHLYHSD-----------------------------------------------------------  364 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~-----------------------------------------------------------  364 (613)
                      .++||||+++|+|.++++...                                                           
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            999999999999999986421                                                           


Q ss_pred             -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCcee
Q 048439          365 -------------------------------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNIL  407 (613)
Q Consensus       365 -------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NIL  407 (613)
                                                           ...++|.+++.|+.|++.||.|||+.+    |+||||||+|||
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~----ivHrdlkp~NiL  271 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN----CVHRDLAARNVL  271 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC----cCcccCCcceEE
Confidence                                                 134788899999999999999999988    999999999999


Q ss_pred             eCCCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhh
Q 048439          408 LDEKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQV  476 (613)
Q Consensus       408 l~~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~  476 (613)
                      +++++.+||+|||+++...          ..++..|++||++....++.++|||||||+||||++ |+.||......+..
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence            9999999999999986421          122356999999999899999999999999999998 88888543322211


Q ss_pred             hHHHHHHHhhccCCccccccHHHH--HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          477 SLAVWAQQCYQNGTIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       477 ~l~~~~~~~~~~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ...  ........ ........+.  +.+||..+|.+||++.||+..|+..+
T Consensus       352 ~~~--~~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         352 YNA--IKRGYRMA-KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHH--HHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            111  11110111 1111222222  23799999999999999999998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=8.6e-38  Score=327.69  Aligned_cols=230  Identities=26%  Similarity=0.302  Sum_probs=181.2

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHH-HHhccCccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIG-MLSQLRHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      +||+|+||.||+|+...++..||||++...   ......++..|.. +++.++||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG   81 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence            699999999999999888889999998654   2233445566655 567799999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--------
Q 048439          355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--------  426 (613)
Q Consensus       355 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--------  426 (613)
                      +|.+++..  ...+++.+...++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+++...        
T Consensus        82 ~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~g----ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (325)
T cd05604          82 ELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSIN----IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT  155 (325)
T ss_pred             CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence            99988843  457899999999999999999999998    9999999999999999999999999986421        


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-Hhccc
Q 048439          427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCL  505 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl  505 (613)
                      ..++..|+|||++.+..++.++|||||||+||||++|++||......+......  ....  ............ ..+||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~ll~~ll  231 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL--HKPL--VLRPGASLTAWSILEELL  231 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH--cCCc--cCCCCCCHHHHHHHHHHh
Confidence            235667999999999999999999999999999999999997554332211111  0000  001111111111 22799


Q ss_pred             ccCCCCCCCHHHH
Q 048439          506 NDEGIRRPSMSDV  518 (613)
Q Consensus       506 ~~~p~~RPs~~ev  518 (613)
                      +.+|.+||++.+.
T Consensus       232 ~~~p~~R~~~~~~  244 (325)
T cd05604         232 EKDRQRRLGAKED  244 (325)
T ss_pred             ccCHHhcCCCCCC
Confidence            9999999988643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8e-37  Score=322.88  Aligned_cols=249  Identities=25%  Similarity=0.405  Sum_probs=192.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEc-----CCceeEEEEEeCCCC-hhcHHHHHHHHHHHhcc-CccceeeEEEEeecC-Cc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFIN-----GSTTPVAIKRLEPES-QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDD-RE  343 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~-----~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~-~~  343 (613)
                      ++|...+.||+|+||.||+|...     .+++.||||+++... ......+.+|+.++.++ +|+||++++++|... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            46888889999999999999852     345789999997643 33456788999999999 689999999988654 56


Q ss_pred             eEEEEEcCCCCChhHHhhcCC-----------------------------------------------------------
Q 048439          344 MILVYDFMARGTLPDHLYHSD-----------------------------------------------------------  364 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~-----------------------------------------------------------  364 (613)
                      .++||||+++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            789999999999999985421                                                           


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----------CC
Q 048439          365 ------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----------TS  428 (613)
Q Consensus       365 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----------~~  428 (613)
                            ...++|.++..++.|+++||.|||+.+    |+||||||+|||+++++++||+|||+++...          ..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~----i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                  124789999999999999999999988    9999999999999999999999999986421          11


Q ss_pred             CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH--HHhccc
Q 048439          429 VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL--KAMSCL  505 (613)
Q Consensus       429 ~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~--~~~~Cl  505 (613)
                      ++..|++||++....++.++|||||||++|||++ |..|+.........  ....... .........++.+  ....||
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~cl  319 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKEG-TRMRAPDYTTPEMYQTMLDCW  319 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH--HHHHhcc-CCCCCCCCCCHHHHHHHHHHc
Confidence            2345999999999999999999999999999997 88888543222111  1101000 0111122223222  234799


Q ss_pred             ccCCCCCCCHHHHHHHHHHhhh
Q 048439          506 NDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       506 ~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      +.+|++||++.||+++|+..++
T Consensus       320 ~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         320 HGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             cCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999997765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.4e-37  Score=310.04  Aligned_cols=241  Identities=20%  Similarity=0.301  Sum_probs=195.0

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      +|...+.||+|+||.||++....++..+|+|.++.. .....+.+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            466778999999999999999888889999998643 3445567889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++|+|.+++.......+++...+.++.+++.||.|||+.+    |+|+||||+||++++++.++|+|||+++...     
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~----i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR----VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC----cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            9999999886545567899999999999999999999988    9999999999999999999999999986432     


Q ss_pred             ---CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--H
Q 048439          427 ---TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--A  501 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~  501 (613)
                         ..++..|+|||++.+..++.++||||||+++|+|++|++||............   ... .........+..+.  .
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~li  232 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV---CQG-SYKPLPSHYSYELRSLI  232 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH---hcC-CCCCCCcccCHHHHHHH
Confidence               22455699999999999999999999999999999999999754332211111   000 01111122222222  2


Q ss_pred             hcccccCCCCCCCHHHHHHH
Q 048439          502 MSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~  521 (613)
                      .+||+.+|++||++.+++..
T Consensus       233 ~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         233 KQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHhCCcccCCCHHHHhhc
Confidence            37999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.4e-37  Score=309.48  Aligned_cols=242  Identities=27%  Similarity=0.457  Sum_probs=193.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...++||+|+||.||+|...++ ..||+|.+.... .....|.+|+.++++++|+||+++++++. .+..++||||+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~-~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCC-ceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            4677788999999999999997665 679999987543 33567899999999999999999999874 55789999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++|+|.+++.......+++.+++.++.|++.||+|||+.+    ++||||||+||++++++.++|+|||++....     
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~----i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN----YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC----eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            9999999987655667999999999999999999999988    9999999999999999999999999986432     


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                          ...+..|++||++....++.++|||||||++|||++ |++||......+....   ................... 
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN---LERGYRMPRPDNCPEELYEL  235 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH---HHcCCCCCCCCCCCHHHHHH
Confidence                112346999999999999999999999999999999 9999965433221111   1111111111111112222 


Q ss_pred             HhcccccCCCCCCCHHHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ..+||+.+|++||++.+++..|+
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~~l~  258 (260)
T cd05067         236 MRLCWKEKPEERPTFEYLRSVLE  258 (260)
T ss_pred             HHHHccCChhhCCCHHHHHHHhh
Confidence            22799999999999999998887

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.8e-37  Score=318.82  Aligned_cols=247  Identities=21%  Similarity=0.331  Sum_probs=192.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh-hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ-QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ++|...+.||+|+||.||+|+...++..||+|+++.... .....+.+|+.++++++|+||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            467778899999999999999988888899999875532 2334678999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      +++ +|.+++... ...+++..+..++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++...    
T Consensus        86 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRK----VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            985 888887543 345899999999999999999999988    9999999999999999999999999986421    


Q ss_pred             ----CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHH------------------
Q 048439          427 ----TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQ------------------  483 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~------------------  483 (613)
                          ..++..|+|||.+.+ ..++.++|||||||++|||++|++||......+.........                  
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence                224567999999865 468999999999999999999999996654333222211100                  


Q ss_pred             -HhhccCCc------cccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          484 -QCYQNGTI------DQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       484 -~~~~~~~~------~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                       ........      ...+++...  ..+||+.||.+|||+.|++.+..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~  289 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF  289 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence             00000000      001122111  237999999999999999977664

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=9.3e-37  Score=309.99  Aligned_cols=242  Identities=24%  Similarity=0.377  Sum_probs=193.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-----hhcHHHHHHHHHHHhccCccceeeEEEEeec--CCce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-----QQGALEFQTEIGMLSQLRHLHLVSLIGFCND--DREM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~--~~~~  344 (613)
                      .+|...++||+|+||.||+|....++..||+|++....     .+....+.+|+.++++++|+||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47888899999999999999998878899999886432     2334568899999999999999999998875  3567


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++++||+++++|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~----i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSNM----IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999999854  345899999999999999999999988    99999999999999999999999999863


Q ss_pred             CC-----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccc
Q 048439          425 GP-----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ  493 (613)
Q Consensus       425 ~~-----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  493 (613)
                      ..           ..++..|+|||++.+..++.++|||||||++|||++|++||..........  . .........+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~--~-~~~~~~~~~~~~  232 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF--K-IATQPTNPQLPS  232 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH--H-HhcCCCCCCCch
Confidence            21           124556999999999899999999999999999999999996543222111  1 111111122222


Q ss_pred             cccHH-HHHhcccccCCCCCCCHHHHHHHH
Q 048439          494 IVDPF-LKAMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       494 ~~d~~-~~~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                      ..++. ...++||..+|++||+++||+.+-
T Consensus       233 ~~~~~~~~li~~~~~~p~~Rp~~~eil~hp  262 (266)
T cd06651         233 HISEHARDFLGCIFVEARHRPSAEELLRHP  262 (266)
T ss_pred             hcCHHHHHHHHHhcCChhhCcCHHHHhcCc
Confidence            23332 334579999999999999998654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-37  Score=314.56  Aligned_cols=234  Identities=25%  Similarity=0.345  Sum_probs=183.4

Q ss_pred             eeeeeCcEEEEEEEEcCCc-------eeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          279 VIGVGGFGDVYKGFINGST-------TPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~-------~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      .||+|+||.||+|.....+       ..+|+|.+........++|.+|+.+++.++|+||+++++++..++..++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            6899999999999875432       348899887665555678899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc--------EEEEecCCCc
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV--------AKVSDFGLSK  423 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~--------~kl~DFGls~  423 (613)
                      ++|+|.+++... ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.        +|++|||++.
T Consensus        82 ~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~----iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          82 KFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKG----LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999998643 346899999999999999999999988    999999999999987765        6999999986


Q ss_pred             cCC----CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCC-CCccchhhhhhhhHHHHHHHhhccCCccccccH
Q 048439          424 FGP----TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCAR-PSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP  497 (613)
Q Consensus       424 ~~~----~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  497 (613)
                      ...    ..++..|++||++.. ..++.++|||||||++|||++|. +|+.............      ....+......
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~  230 (258)
T cd05078         157 TVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE------DRHQLPAPKWT  230 (258)
T ss_pred             ccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH------ccccCCCCCcH
Confidence            422    234567999999987 45799999999999999999995 5554332222111111      11111111111


Q ss_pred             -HH-HHhcccccCCCCCCCHHHHHHHHH
Q 048439          498 -FL-KAMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       498 -~~-~~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                       .. ...+||+.+|++||++.++++.|+
T Consensus       231 ~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         231 ELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             11 122799999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.5e-37  Score=318.07  Aligned_cols=193  Identities=28%  Similarity=0.347  Sum_probs=171.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ++|...+.||+|+||.||++....++..+|+|.+... ......++.+|++++.+++||||++++++|.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            4688888999999999999999888888999998755 333445688999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG-ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---  426 (613)
                      +++|+|.+++..  ...+++..+..++.|+++||.|||+. +    ++||||||+|||+++++.+||+|||++....   
T Consensus        81 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (308)
T cd06615          81 MDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  154 (308)
T ss_pred             cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC----EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence            999999999854  35689999999999999999999974 5    9999999999999999999999999986422   


Q ss_pred             ---CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          427 ---TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                         ..++..|++||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~  201 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP  201 (308)
T ss_pred             cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence               23456799999998888999999999999999999999998543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9.4e-37  Score=310.49  Aligned_cols=240  Identities=25%  Similarity=0.335  Sum_probs=182.8

Q ss_pred             eeeeeCcEEEEEEEEcC--CceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCC
Q 048439          279 VIGVGGFGDVYKGFING--STTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGT  355 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~--~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs  355 (613)
                      .||+|+||.||+|...+  +...+|+|.++... ......|.+|+.++++++|+||++++|+|.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            68999999999998753  33569999987653 3344578999999999999999999999999999999999999999


Q ss_pred             hhHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC------
Q 048439          356 LPDHLYHSD---NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP------  426 (613)
Q Consensus       356 L~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~------  426 (613)
                      |.+++....   ...+++..++.++.|+++||+|||+.+    ++||||||+||++++++++||+|||+++...      
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~----i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN----FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC----EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            999986422   235678888999999999999999988    9999999999999999999999999986421      


Q ss_pred             ----CCCCcccCChhhhhcC-------CCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHH-HHHHHhhccCCccc
Q 048439          427 ----TSVSKTHLDPEYYRLQ-------QLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLA-VWAQQCYQNGTIDQ  493 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~-------~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~-~~~~~~~~~~~~~~  493 (613)
                          ..++..|+|||++...       .++.++|||||||++|||++ |++||......+..... .........+.+..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL  237 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence                1224569999998642       35789999999999999996 99998654332221111 11111111111111


Q ss_pred             cc-cHHHHHh-cccccCCCCCCCHHHHHHHHH
Q 048439          494 IV-DPFLKAM-SCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       494 ~~-d~~~~~~-~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .. +.....+ .|+ .+|++||++.||++.|+
T Consensus       238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11 2222222 687 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-36  Score=307.55  Aligned_cols=244  Identities=28%  Similarity=0.496  Sum_probs=197.1

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      .++|...+.||+|+||.||+|...++ ..||||.+.... ....++.+|+.++++++|+||+++++++.+....++||||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~-~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCC-ceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            45788888999999999999998765 679999987543 3456799999999999999999999999998999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC---
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT---  427 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~---  427 (613)
                      +++++|.+++.......+++.+++.++.+++.||.|||+.+    ++|+||||+||++++++.+||+|||+++....   
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~----i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN----YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            99999999997655567999999999999999999999988    99999999999999999999999999864321   


Q ss_pred             ------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          428 ------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       428 ------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                            ..+..|++||.+.+..++.++|||||||++|||++ |+.||..........  . ...................
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~  235 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLE--Q-VERGYRMPRPPNCPEELYD  235 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--H-HHcCCCCCCCCCCCHHHHH
Confidence                  12346999999999999999999999999999998 999986543322111  1 1111111111111122222


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHH
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                       ..+||..+|++||+++++.+.|+
T Consensus       236 ~i~~~l~~~p~~Rp~~~~l~~~l~  259 (261)
T cd05034         236 LMLQCWDKDPEERPTFEYLQSFLE  259 (261)
T ss_pred             HHHHHcccCcccCCCHHHHHHHHh
Confidence             33799999999999999998876

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7.3e-37  Score=348.43  Aligned_cols=252  Identities=23%  Similarity=0.285  Sum_probs=198.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...++||+|+||.||+|+...+++.||||+++...   ....+.|.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            46888889999999999999998888899999997542   233457999999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcC---------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEec
Q 048439          349 DFMARGTLPDHLYHS---------DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDF  419 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DF  419 (613)
                      ||+++|+|.+++...         ....+++..++.++.|+++||+|||+.+    |+||||||+|||++.++.+||+||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G----IIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG----VLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC----ccccCCchheEEEcCCCCEEEEec
Confidence            999999999988531         1235678889999999999999999988    999999999999999999999999


Q ss_pred             CCCccC--------------------------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhh
Q 048439          420 GLSKFG--------------------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAK  473 (613)
Q Consensus       420 Gls~~~--------------------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~  473 (613)
                      |+++..                          ...++..|+|||++.+..++.++|||||||+||||++|++||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            998643                          113577899999999999999999999999999999999999653322


Q ss_pred             hhhhHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCC-CHHHHHHHHHHhhhh
Q 048439          474 KQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRP-SMSDVVWGLEFSLQL  528 (613)
Q Consensus       474 ~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RP-s~~evl~~Le~~l~~  528 (613)
                      ..... ..............+.+.+.. +.+||+.+|++|| ++.+++..|+..++.
T Consensus       238 ki~~~-~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        238 KISYR-DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhhhh-hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            21111 000000000011122222211 3379999999996 577777888776653

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.4e-38  Score=327.57  Aligned_cols=229  Identities=25%  Similarity=0.307  Sum_probs=184.0

Q ss_pred             ceeeeeCcEEEEEEEE---cCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCC
Q 048439          278 LVIGVGGFGDVYKGFI---NGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMA  352 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~---~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  352 (613)
                      +.||+|+||.||+++.   ..++..||+|++....  ......+..|+++|++++||||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4799999999999876   3456789999987542  2234457889999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC------
Q 048439          353 RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP------  426 (613)
Q Consensus       353 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~------  426 (613)
                      +|+|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++...      
T Consensus        82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~  155 (318)
T cd05582          82 GGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA  155 (318)
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence            9999999843  456899999999999999999999998    9999999999999999999999999986422      


Q ss_pred             --CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hh
Q 048439          427 --TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AM  502 (613)
Q Consensus       427 --~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~  502 (613)
                        ..++..|++||.+....++.++|||||||++|||++|+.||......+.....   .  .....+...+++.+.  ..
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i---~--~~~~~~p~~~~~~~~~li~  230 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI---L--KAKLGMPQFLSPEAQSLLR  230 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH---H--cCCCCCCCCCCHHHHHHHH
Confidence              23466799999999989999999999999999999999999754432221111   1  111112222332222  22


Q ss_pred             cccccCCCCCCCHHH
Q 048439          503 SCLNDEGIRRPSMSD  517 (613)
Q Consensus       503 ~Cl~~~p~~RPs~~e  517 (613)
                      +||+.||++||++.+
T Consensus       231 ~~l~~~P~~R~~a~~  245 (318)
T cd05582         231 ALFKRNPANRLGAGP  245 (318)
T ss_pred             HHhhcCHhHcCCCCC
Confidence            799999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.2e-36  Score=308.15  Aligned_cols=242  Identities=29%  Similarity=0.457  Sum_probs=191.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|.....||+|+||.||+|...++ ..+|+|.+.... ...+.|.+|+.++++++|+|++++++++. .+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            3466777999999999999998776 459999886543 23467899999999999999999999885 45688999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT----  427 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~----  427 (613)
                      ++|+|.+++.......++|..+..++.+++.||.|||+.+    ++||||||+||++++++.+||+|||+++....    
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~----i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN----YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999999997655556899999999999999999999988    99999999999999999999999999864211    


Q ss_pred             -----CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          428 -----SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       428 -----~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                           ..+..|++||+.....++.++|||||||++|||++ |+.||......+..   .+................+.. 
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL---EQVERGYRMPCPQGCPESLHEL  235 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCCCCCCCcccCHHHHHH
Confidence                 12345999999998999999999999999999999 89998654332211   111111111111111111111 


Q ss_pred             HhcccccCCCCCCCHHHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ..+||+.+|.+||++.+|++.|+
T Consensus       236 i~~~l~~~p~~Rp~~~~i~~~l~  258 (260)
T cd05069         236 MKLCWKKDPDERPTFEYIQSFLE  258 (260)
T ss_pred             HHHHccCCcccCcCHHHHHHHHh
Confidence            22799999999999999998887

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7e-37  Score=308.53  Aligned_cols=242  Identities=24%  Similarity=0.336  Sum_probs=196.8

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +|+..++||.|+||.||.++...++..+++|.+...  +.....++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            467778999999999999999888888999987654  345566789999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      +++|+|.+++.......+++.++..++.|++.||.|||+.+    ++||||||+||++++++.+||+|||+++...    
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~----i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG----ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC----ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999996544567899999999999999999999988    9999999999999999999999999986432    


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--  500 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--  500 (613)
                          ..++..|++||++.+...+.++||||||+++|||++|+.||......+......  ......  .....+..+.  
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~~  232 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV--QGNYTP--VVSVYSSELISL  232 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--cCCCCC--CccccCHHHHHH
Confidence                224567999999998889999999999999999999999986544332211111  111111  1111111222  


Q ss_pred             HhcccccCCCCCCCHHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                      ..+||..+|.+||++.|+++++
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCc
Confidence            2379999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=306.81  Aligned_cols=238  Identities=32%  Similarity=0.544  Sum_probs=192.5

Q ss_pred             eeeeeCcEEEEEEEEcCC---ceeEEEEEeCCCChh-cHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          279 VIGVGGFGDVYKGFINGS---TTPVAIKRLEPESQQ-GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~---~~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      .||+|+||.||+|.....   +..|++|.+...... ....+.+|++++..++|+||+++++++.+....++||||+++|
T Consensus         2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (262)
T cd00192           2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG   81 (262)
T ss_pred             ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence            699999999999999764   688999999876433 3678999999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC
Q 048439          355 TLPDHLYHSD-------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT  427 (613)
Q Consensus       355 sL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~  427 (613)
                      +|.+++....       ...+++.+++.++.|++.||+|||+.+    ++||||||+||++++++.+||+|||+++....
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~----i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK----FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC----cccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999986531       367999999999999999999999988    99999999999999999999999999875332


Q ss_pred             ----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCcccccc
Q 048439          428 ----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVD  496 (613)
Q Consensus       428 ----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  496 (613)
                                ..+..|+|||.+....++.++|||||||++|||++ |+.||......+..   ..............+..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~  234 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL---EYLRKGYRLPKPEYCPD  234 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHHcCCCCCCCccCCh
Confidence                      23456999999998899999999999999999999 58998665332211   11111111111111111


Q ss_pred             HHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          497 PFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       497 ~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .... ..+||..+|.+||++.|++.+|+
T Consensus       235 ~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         235 ELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            1111 33799999999999999998774

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.8e-37  Score=308.76  Aligned_cols=234  Identities=25%  Similarity=0.396  Sum_probs=183.4

Q ss_pred             eeeeeCcEEEEEEEEcCCc----------eeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          279 VIGVGGFGDVYKGFINGST----------TPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~----------~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      .||+|+||.||+|.+...+          ..|++|.+...... ...|.+|+.++++++|+||++++|+|.. ...++||
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            6899999999999997654          35888887655433 6789999999999999999999999988 7889999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC-------cEEEEecCC
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW-------VAKVSDFGL  421 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~-------~~kl~DFGl  421 (613)
                      ||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+    |+||||||+|||++.++       .+||+|||+
T Consensus        80 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~----i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          80 EYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKK----LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC----eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            9999999999986432 36899999999999999999999988    99999999999999888       899999999


Q ss_pred             CccCC----CCCCcccCChhhhhcC--CCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCcccc
Q 048439          422 SKFGP----TSVSKTHLDPEYYRLQ--QLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQI  494 (613)
Q Consensus       422 s~~~~----~~~~~~~~aPE~~~~~--~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  494 (613)
                      ++...    ..+...|++||++...  .++.++|||||||++|||++ |..|+......+....  +.. .... .....
T Consensus       155 a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~--~~~-~~~~-~~~~~  230 (259)
T cd05037         155 PITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF--YQD-QHRL-PMPDC  230 (259)
T ss_pred             ccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH--Hhc-CCCC-CCCCc
Confidence            87532    2234579999999877  78999999999999999999 5777754432221111  111 0000 01111


Q ss_pred             ccHHHHHhcccccCCCCCCCHHHHHHHHH
Q 048439          495 VDPFLKAMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       495 ~d~~~~~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .+......+||..+|.+||++.||++.|+
T Consensus       231 ~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         231 AELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            11111123799999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-36  Score=311.66  Aligned_cols=244  Identities=27%  Similarity=0.405  Sum_probs=187.5

Q ss_pred             CCcceeeeeCcEEEEEEEE----cCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecC--CceEEE
Q 048439          275 DNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD--REMILV  347 (613)
Q Consensus       275 ~~~~~iG~G~fG~Vy~g~~----~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV  347 (613)
                      ...+.||+|+||+||++..    ...+..||+|.+.... ......|.+|+++|++++|+||++++++|...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            6677999999999988764    2345779999987653 34456789999999999999999999998764  457899


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT  427 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~  427 (613)
                      |||+++|+|.+++..   ..++|.+++.++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+++....
T Consensus        87 ~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~----i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          87 MEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQH----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCC----eeccccChheEEEcCCCcEEEeecccccccCC
Confidence            999999999999853   35999999999999999999999988    99999999999999999999999999874321


Q ss_pred             -----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhh---------hhHHHHHHHh--
Q 048439          428 -----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQ---------VSLAVWAQQC--  485 (613)
Q Consensus       428 -----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~---------~~l~~~~~~~--  485 (613)
                                 ..+..|++||++....++.++|||||||++|||++|+.|+......-.         .....+....  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence                       123358999999988999999999999999999999988753221100         0000000000  


Q ss_pred             -hccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          486 -YQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       486 -~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                       ............... ...||+.+|++||++.+|++.|+..
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence             000001111122211 3379999999999999999998854

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.4e-37  Score=324.29  Aligned_cols=231  Identities=24%  Similarity=0.287  Sum_probs=181.3

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHH-HHHhccCccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEI-GMLSQLRHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei-~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      .||+|+||.||+|+...++..||+|++....   .....++..|. .+++.++|+||+++++++.+.+..++||||+++|
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            6999999999999998888889999987532   22233444454 4567899999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--------C
Q 048439          355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--------P  426 (613)
Q Consensus       355 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--------~  426 (613)
                      +|.+++..  ...+.+.....++.|+++||.|||+.+    |+||||||+|||++.++.+||+|||+++..        .
T Consensus        82 ~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~g----iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          82 ELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLN----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence            99998854  456788888999999999999999998    999999999999999999999999998632        1


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-Hhccc
Q 048439          427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCL  505 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl  505 (613)
                      ..++..|+|||++.+..++.++|||||||++|||++|++||......+....   .... .......+.+.... ..+||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~-~~~~~~~~~~~~~~li~~~l  231 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN---ILNK-PLQLKPNITNSARHLLEGLL  231 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHH---HHhC-CcCCCCCCCHHHHHHHHHHc
Confidence            2356789999999999999999999999999999999999975443322111   1111 00111112221111 22799


Q ss_pred             ccCCCCCCCHHHHH
Q 048439          506 NDEGIRRPSMSDVV  519 (613)
Q Consensus       506 ~~~p~~RPs~~evl  519 (613)
                      +.+|.+||++.+.+
T Consensus       232 ~~~p~~R~~~~~~~  245 (325)
T cd05602         232 QKDRTKRLGAKDDF  245 (325)
T ss_pred             ccCHHHCCCCCCCH
Confidence            99999999987544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.2e-38  Score=313.75  Aligned_cols=241  Identities=23%  Similarity=0.352  Sum_probs=202.0

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      +|...+.||+|.||+|-+++....++.||||.+++.   ++++.-.+.+||++|+.|+||||+.++.+|+..+.+.||||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME  133 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME  133 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence            455555899999999999998777799999999875   45666678999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc-----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF-----  424 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~-----  424 (613)
                      |..+|.|.|++.  ....|++.+...+++||..|++|+|.++    ++|||||.+|||||.++++||+||||+.+     
T Consensus       134 YaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHknr----VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  134 YASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKNR----VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             ecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhcc----ceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            999999999994  4677999999999999999999999998    99999999999999999999999999964     


Q ss_pred             --CCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHHH
Q 048439          425 --GPTSVSKTHLDPEYYRLQQL-TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKA  501 (613)
Q Consensus       425 --~~~~~~~~~~aPE~~~~~~~-t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  501 (613)
                        ...++++-|.+||.+.+.+| .+..|-||+||+||.|+.|.-||++.+-...+..+.  ...+.++  ..-.|.....
T Consensus       208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs--~GaYrEP--~~PSdA~gLI  283 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS--RGAYREP--ETPSDASGLI  283 (668)
T ss_pred             HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh--cccccCC--CCCchHHHHH
Confidence              23567888999999999888 578999999999999999999998765443222211  1122221  2223444444


Q ss_pred             hcccccCCCCCCCHHHHHHHHH
Q 048439          502 MSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      -|+|..||++|.|+.||..+.+
T Consensus       284 RwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  284 RWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             HHHHhcCcccchhHHHHhhhhe
Confidence            5899999999999999996654

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.7e-36  Score=316.18  Aligned_cols=247  Identities=22%  Similarity=0.418  Sum_probs=193.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEc-------CCceeEEEEEeCCC-ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFIN-------GSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDR  342 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~-------~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~  342 (613)
                      .+|...+.||+|+||.||+++..       .....+|+|.++.. ......++..|+.++.++ +|+||++++++|.+.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            46777789999999999999753       22356999998754 334456789999999999 6999999999999999


Q ss_pred             ceEEEEEcCCCCChhHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee
Q 048439          343 EMILVYDFMARGTLPDHLYHSD--------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL  408 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl  408 (613)
                      ..++||||+++|+|.+++....              ...++|.+++.++.|++.||.|||+.+    |+||||||+|||+
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g----i~H~dlkp~Nill  167 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR----CIHRDLAARNVLV  167 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC----eeeccccceeEEE
Confidence            9999999999999999985421              245899999999999999999999988    9999999999999


Q ss_pred             CCCCcEEEEecCCCccCCC----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhh
Q 048439          409 DEKWVAKVSDFGLSKFGPT----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVS  477 (613)
Q Consensus       409 ~~~~~~kl~DFGls~~~~~----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~  477 (613)
                      ++++.+||+|||+++....          ..+..|++||++..+.++.++|||||||++|||++ |..||......+...
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~  247 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK  247 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999964321          11235999999999999999999999999999999 888886543322211


Q ss_pred             HHHHHHHhhccCCccccccHHH-HHhcccccCCCCCCCHHHHHHHHHHh
Q 048439          478 LAVWAQQCYQNGTIDQIVDPFL-KAMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       478 l~~~~~~~~~~~~~~~~~d~~~-~~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      .   ............+..... ...+||..+|++||++.|+++.|+..
T Consensus       248 ~---~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         248 L---LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             H---HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            1   111111111111112222 23379999999999999999888743

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7.5e-37  Score=308.38  Aligned_cols=243  Identities=28%  Similarity=0.430  Sum_probs=193.5

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHH--HHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL--EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~--~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      |...+.||+|+||+||+++...++..+|+|++.........  ....|+.++.+++|+||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            34567899999999999999998889999999876543332  3456999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc-------
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF-------  424 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~-------  424 (613)
                      ++++|.+++.  ....+++..++.++.|+++||+|||+.+    |+||||||+|||+++++.++|+|||++..       
T Consensus        81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~----i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKG----IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN  154 (260)
T ss_dssp             TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTT----EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred             cccccccccc--cccccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccc
Confidence            9999999996  3466899999999999999999999998    99999999999999999999999999853       


Q ss_pred             -CCCCCCcccCChhhhh-cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHh---hccCCccccccHHH
Q 048439          425 -GPTSVSKTHLDPEYYR-LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC---YQNGTIDQIVDPFL  499 (613)
Q Consensus       425 -~~~~~~~~~~aPE~~~-~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~---~~~~~~~~~~d~~~  499 (613)
                       ....++..|+|||++. ....+.++||||+|+++|+|++|+.|+......+...........   ............+.
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELR  234 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHH
Confidence             1234566799999998 888999999999999999999999999765222222222211111   11111100011111


Q ss_pred             H-HhcccccCCCCCCCHHHHHHHH
Q 048439          500 K-AMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       500 ~-~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                      . ..+||+.+|++||++.+++++.
T Consensus       235 ~li~~~l~~~p~~R~~~~~l~~~~  258 (260)
T PF00069_consen  235 DLIKKMLSKDPEQRPSAEELLKHP  258 (260)
T ss_dssp             HHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred             HHHHHHccCChhHCcCHHHHhcCC
Confidence            1 2279999999999999998653

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.3e-36  Score=306.49  Aligned_cols=241  Identities=24%  Similarity=0.336  Sum_probs=193.5

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeec-CCceEEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND-DREMILVYD  349 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~E  349 (613)
                      +|...+.||+|+||.||++....++..||+|++...  .....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            467778999999999999999887788999998654  23445678999999999999999999998764 445789999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---  426 (613)
                      |+++++|.+++.......+++.+++.++.+++.||+|||+.+    |+||||||+||+++.++.+||+|||++....   
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~----i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH----ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            999999999997655567999999999999999999999998    9999999999999999999999999986422   


Q ss_pred             -----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          427 -----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                           ..++..|+|||++.+..++.++|||||||++|||++|+.||...........  ......  .......++... 
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~~~  232 (257)
T cd08223         157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR--IIEGKL--PPMPKDYSPELGE  232 (257)
T ss_pred             CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH--HHhcCC--CCCccccCHHHHH
Confidence                 2345679999999999999999999999999999999999865443222111  111111  011122222222 


Q ss_pred             -HhcccccCCCCCCCHHHHHHH
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~  521 (613)
                       ..+||+.+|++||++.+++.+
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcC
Confidence             237999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.4e-36  Score=309.17  Aligned_cols=246  Identities=23%  Similarity=0.363  Sum_probs=193.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCC---ceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGS---TTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~---~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|....+||+|+||.||+|...+.   ...||||...... ....+.|.+|+.++++++|+||++++++|.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4567778999999999999987543   3569999987654 4556689999999999999999999999875 457899


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT  427 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~  427 (613)
                      |||+++|+|.+++... ...+++.+++.++.+++.||.|||+.+    ++||||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~----~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKR----FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC----eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999999543 346899999999999999999999988    99999999999999999999999999864211


Q ss_pred             ---------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccH
Q 048439          428 ---------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP  497 (613)
Q Consensus       428 ---------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  497 (613)
                               .....|+|||.+....++.++|||||||++|||++ |++||......+....   ............+...
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~  236 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR---IENGERLPMPPNCPPT  236 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HHcCCcCCCCCCCCHH
Confidence                     11246999999988899999999999999999996 9999966543332211   1111111111222122


Q ss_pred             HHH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          498 FLK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       498 ~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ... ..+|+..+|.+||++.+++..|+...
T Consensus       237 ~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         237 LYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            222 23799999999999999999998644

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.8e-36  Score=310.35  Aligned_cols=243  Identities=20%  Similarity=0.253  Sum_probs=192.4

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      +|....+||+|+||.||+|+...++..||+|.+... ......+|.+|+.++.+++||||++++++|...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            566777999999999999999888889999998654 3344567999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++|+|..+.      .+++.....++.|++.||.|||+.+    |+|+||||+|||++.++.+||+|||++....     
T Consensus        82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~  151 (279)
T cd06619          82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK----ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK  151 (279)
T ss_pred             CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC----EeeCCCCHHHEEECCCCCEEEeeCCcceeccccccc
Confidence            999996542      4688899999999999999999988    9999999999999999999999999986421     


Q ss_pred             -CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhh-hHHHHHHHhh---ccCCccccccHHHH-
Q 048439          427 -TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV-SLAVWAQQCY---QNGTIDQIVDPFLK-  500 (613)
Q Consensus       427 -~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~-~l~~~~~~~~---~~~~~~~~~d~~~~-  500 (613)
                       ..++..|+|||++....++.++|||||||++|||++|+.||......... ....+.....   .........++.+. 
T Consensus       152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (279)
T cd06619         152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH  231 (279)
T ss_pred             CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence             23456799999999999999999999999999999999998653221111 1111111111   11111111222222 


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                       ..+||+.+|++||++.|++.+....
T Consensus       232 li~~~l~~~P~~Rp~~~eil~~~~~~  257 (279)
T cd06619         232 FITQCMRKQPKERPAPENLMDHPFIV  257 (279)
T ss_pred             HHHHHhhCChhhCCCHHHHhcCcccc
Confidence             2379999999999999999876653

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.7e-36  Score=311.43  Aligned_cols=195  Identities=27%  Similarity=0.442  Sum_probs=164.6

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhcc---CccceeeEEEEeec-----CC
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQL---RHLHLVSLIGFCND-----DR  342 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l---~H~niv~l~g~~~~-----~~  342 (613)
                      +|...+.||+|+||.||+|+...+++.||+|.++...  ......+.+|+.++.++   +|+||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            3667789999999999999998888999999987542  22233456777777665   69999999998864     34


Q ss_pred             ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCC
Q 048439          343 EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS  422 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls  422 (613)
                      ..++||||+++ +|.+++.......+++..+..++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~----ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC----IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57999999985 8988886555566999999999999999999999998    999999999999999999999999998


Q ss_pred             ccCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhh
Q 048439          423 KFGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAA  472 (613)
Q Consensus       423 ~~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~  472 (613)
                      +...       ..++..|+|||++.+..++.++|||||||++|||++|++||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~  212 (288)
T cd07863         156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE  212 (288)
T ss_pred             ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH
Confidence            6422       2345679999999999999999999999999999999999965433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.3e-37  Score=311.05  Aligned_cols=242  Identities=23%  Similarity=0.330  Sum_probs=192.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||.||+|+...++..||+|.++.........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            45666678999999999999998888899999987765555567889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC------
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG------  425 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~------  425 (613)
                      ++++|.+++..  ...+++.+.+.++.|++.||.|||+.+    |+|+||||+||+++.++.+||+|||++...      
T Consensus        89 ~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06645          89 GGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKG----KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK  162 (267)
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence            99999998843  456899999999999999999999998    999999999999999999999999997532      


Q ss_pred             --CCCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccc--ccHH
Q 048439          426 --PTSVSKTHLDPEYYR---LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQI--VDPF  498 (613)
Q Consensus       426 --~~~~~~~~~aPE~~~---~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~d~~  498 (613)
                        ...++..|+|||++.   ...++.++|||||||++|||++|++|+............  .............  .+..
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--TKSNFQPPKLKDKMKWSNS  240 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh--hccCCCCCcccccCCCCHH
Confidence              123456799999984   456889999999999999999999998654332221111  1111111111110  1111


Q ss_pred             H--HHhcccccCCCCCCCHHHHHHH
Q 048439          499 L--KAMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       499 ~--~~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      +  ...+||+.+|++||++.+|+.+
T Consensus       241 ~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         241 FHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             HHHHHHHHccCCchhCcCHHHHhcC
Confidence            1  1237999999999999999754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.2e-36  Score=331.87  Aligned_cols=247  Identities=22%  Similarity=0.319  Sum_probs=186.5

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecC--------
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD--------  341 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~--------  341 (613)
                      ..++|...++||+|+||.||+|....++..||||++....    ....+|+.+|++++|+|||++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3467888999999999999999998888899999885432    2345799999999999999999876432        


Q ss_pred             CceEEEEEcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC-cEEEEe
Q 048439          342 REMILVYDFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW-VAKVSD  418 (613)
Q Consensus       342 ~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~-~~kl~D  418 (613)
                      ..+++||||+++ +|.+++..  .....+++.....++.|++.||+|||+.+    |+||||||+|||++.++ .+||+|
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~----IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF----ICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC----EecCCcCHHHEEEcCCCCceeeec
Confidence            236789999985 77776642  34567999999999999999999999998    99999999999999664 799999


Q ss_pred             cCCCccCC-------CCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHH------
Q 048439          419 FGLSKFGP-------TSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQ------  484 (613)
Q Consensus       419 FGls~~~~-------~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~------  484 (613)
                      ||+|+...       ..++..|+|||++.+. .++.++|||||||+||||++|++||......+..........      
T Consensus       215 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~  294 (440)
T PTZ00036        215 FGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ  294 (440)
T ss_pred             cccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            99997421       2346679999998764 689999999999999999999999976543332221111000      


Q ss_pred             ------hhccCCccc-------------cccHHHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          485 ------CYQNGTIDQ-------------IVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       485 ------~~~~~~~~~-------------~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                            .+....+..             ..+.... ..+||..+|.+||++.|++.+..+.
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~  355 (440)
T PTZ00036        295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD  355 (440)
T ss_pred             HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence                  000000000             0111111 2279999999999999999887653

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.3e-37  Score=310.75  Aligned_cols=238  Identities=27%  Similarity=0.447  Sum_probs=187.2

Q ss_pred             eeeeeCcEEEEEEEEcCCc------eeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          279 VIGVGGFGDVYKGFINGST------TPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~------~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      .||+|+||.||+|+..+..      ..+|||.+.... .....+|.+|+.+++.++|+||++++++|...+..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            6899999999999885432      679999886543 344567899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC-----cEEEEecCC
Q 048439          352 ARGTLPDHLYHS-----DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW-----VAKVSDFGL  421 (613)
Q Consensus       352 ~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~-----~~kl~DFGl  421 (613)
                      ++|+|.+++...     ....++|.+++.++.|++.||.|||+.+    ++|+||||+|||++.+.     .+||+|||+
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~----i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC----cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999642     2345899999999999999999999988    99999999999999877     899999999


Q ss_pred             CccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCC
Q 048439          422 SKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGT  490 (613)
Q Consensus       422 s~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~  490 (613)
                      ++...          ...+..|++||++..+.++.++|||||||++|||++ |+.||......+.   ............
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~~~~~~~~~~  234 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQHVTAGGRLQK  234 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHHHhcCCccCC
Confidence            86321          122456999999999999999999999999999998 9999854332221   111111000011


Q ss_pred             ccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          491 IDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       491 ~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ...+...... ..+||..+|.+||++.+|++.|+
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1111111111 22899999999999999998886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.3e-36  Score=307.38  Aligned_cols=240  Identities=24%  Similarity=0.351  Sum_probs=180.4

Q ss_pred             eeeeeCcEEEEEEEEcC--CceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCC
Q 048439          279 VIGVGGFGDVYKGFING--STTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGT  355 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~--~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs  355 (613)
                      .||+|+||.||+|....  ....+|+|.+.... ......|.+|+.+++.++|+||++++++|.+....++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997643  23568999876543 3345678999999999999999999999999999999999999999


Q ss_pred             hhHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC------
Q 048439          356 LPDHLYHSD---NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP------  426 (613)
Q Consensus       356 L~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~------  426 (613)
                      |.+++....   ....++...+.++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+++...      
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD----FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC----EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            999986532   234578888999999999999999998    9999999999999999999999999986421      


Q ss_pred             ----CCCCcccCChhhhhc-------CCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHH-HHHHhhccCCccc
Q 048439          427 ----TSVSKTHLDPEYYRL-------QQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAV-WAQQCYQNGTIDQ  493 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~-------~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~-~~~~~~~~~~~~~  493 (613)
                          ...+..|+|||++..       ..++.++|||||||++|||++ |++||......+...... .............
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL  237 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence                112345999999853       356889999999999999999 777875443222111110 0000111111222


Q ss_pred             cccH-HHHHh-cccccCCCCCCCHHHHHHHHH
Q 048439          494 IVDP-FLKAM-SCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       494 ~~d~-~~~~~-~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .... ....+ .|+ .+|++||++++|++.|.
T Consensus       238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         238 KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            2222 22222 466 59999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.5e-36  Score=308.05  Aligned_cols=238  Identities=25%  Similarity=0.366  Sum_probs=189.9

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh---------cHHHHHHHHHHHhccCccceeeEEEEeecCCce
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ---------GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~---------~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~  344 (613)
                      |.....||+|+||.||+|....++..+|+|.+......         ....+.+|+.++++++|+||+++++++.+.+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            55667999999999999998777788999988654221         224688999999999999999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++||||+++++|.+++..  ...+++..+..++.|++.||.|||+.+    ++||||+|+||++++++.+||+|||+++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~----ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          82 NIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNRG----IIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             EEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhcC----cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            999999999999999943  356899999999999999999999988    99999999999999999999999998864


Q ss_pred             CC--------------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCC
Q 048439          425 GP--------------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT  490 (613)
Q Consensus       425 ~~--------------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~  490 (613)
                      ..              ..++..|++||++....++.++|||||||++|||++|+.||..........  . ... .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~-~~~-~~~~~  231 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF--K-IGE-NASPE  231 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH--H-Hhc-cCCCc
Confidence            32              123456999999999899999999999999999999999996543222111  1 111 11111


Q ss_pred             ccccccHHHH--HhcccccCCCCCCCHHHHHHH
Q 048439          491 IDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       491 ~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      +....+..+.  ..+||+.+|.+||++.+|+++
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         232 IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            1111222111  227999999999999999854

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.2e-36  Score=311.79  Aligned_cols=245  Identities=23%  Similarity=0.310  Sum_probs=194.8

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCC
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMAR  353 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  353 (613)
                      |.....||+|+||.||+|....++..+++|.+..........|.+|+++++.++|+||++++++|..++..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            34456799999999999999888888999999876666677899999999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-------
Q 048439          354 GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-------  426 (613)
Q Consensus       354 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-------  426 (613)
                      |+|.+++.. ...++++..+..++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||++....       
T Consensus        87 ~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~----i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~  161 (282)
T cd06643          87 GAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENK----IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  161 (282)
T ss_pred             CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence            999988754 3457999999999999999999999988    9999999999999999999999999985421       


Q ss_pred             -CCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc-CCccccccHHH
Q 048439          427 -TSVSKTHLDPEYYR-----LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN-GTIDQIVDPFL  499 (613)
Q Consensus       427 -~~~~~~~~aPE~~~-----~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~d~~~  499 (613)
                       ..++..|++||++.     ...++.++|||||||++|||++|++||.........  .......... .....+.....
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  239 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LKIAKSEPPTLAQPSRWSSEFK  239 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HHHhhcCCCCCCCccccCHHHH
Confidence             23456799999984     345788999999999999999999998654332211  1111111111 00111111222


Q ss_pred             H-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          500 K-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       500 ~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      . ..+||+.+|.+||++.+++++....
T Consensus       240 ~li~~~l~~~p~~Rp~~~~il~~~~~~  266 (282)
T cd06643         240 DFLKKCLEKNVDARWTTTQLLQHPFVT  266 (282)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCCCEe
Confidence            2 2379999999999999998776643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=7.4e-37  Score=312.62  Aligned_cols=240  Identities=26%  Similarity=0.378  Sum_probs=192.9

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCC
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMA  352 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  352 (613)
                      |...+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.++++++|+||+++++++..++..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            444557999999999999998777899999987543 3445678999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC-----
Q 048439          353 RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-----  427 (613)
Q Consensus       353 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~-----  427 (613)
                      +++|.+++.   ...+++..+..++.|+++||.|||+.+    ++|+||+|+||++++++.+||+|||+++....     
T Consensus        86 ~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~----ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06642          86 GGSALDLLK---PGPLEETYIATILREILKGLDYLHSER----KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             CCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC----eeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence            999999884   346899999999999999999999988    99999999999999999999999999864221     


Q ss_pred             ---CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccc-cHHHH-Hh
Q 048439          428 ---SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV-DPFLK-AM  502 (613)
Q Consensus       428 ---~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-d~~~~-~~  502 (613)
                         .++..|++||++....++.++|||||||++|||++|++|+..........   +..... ........ ..... ..
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~li~  234 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---LIPKNS-PPTLEGQYSKPFKEFVE  234 (277)
T ss_pred             hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---hhhcCC-CCCCCcccCHHHHHHHH
Confidence               23556999999999999999999999999999999999986443322111   111110 11111111 11211 23


Q ss_pred             cccccCCCCCCCHHHHHHHHHH
Q 048439          503 SCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       503 ~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      +||+.+|.+||+|.+|+.+...
T Consensus       235 ~~l~~~p~~Rp~~~~il~~~~~  256 (277)
T cd06642         235 ACLNKDPRFRPTAKELLKHKFI  256 (277)
T ss_pred             HHccCCcccCcCHHHHHHhHHH
Confidence            7999999999999999987653

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-36  Score=308.75  Aligned_cols=234  Identities=24%  Similarity=0.395  Sum_probs=182.7

Q ss_pred             eeeeeCcEEEEEEEEcCC------------ceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          279 VIGVGGFGDVYKGFINGS------------TTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~------------~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      .||+|+||.||+|+....            ...|++|.+..........|.+|+.++++++||||++++++|.++...++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            689999999999986422            23589999877655556678999999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc-------EEEEec
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV-------AKVSDF  419 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~-------~kl~DF  419 (613)
                      ||||+++|+|..++.. ....+++..++.++.|+++||+|||+.+    |+||||||+|||++.++.       +|++||
T Consensus        82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~----ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          82 VEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKD----LVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCC----eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            9999999999888754 3456899999999999999999999988    999999999999987664       899999


Q ss_pred             CCCccCC----CCCCcccCChhhhh-cCCCCchhHHHHHHHHHHHHH-hCCCCccchhhhhhhhHHHHHHHhhccCCccc
Q 048439          420 GLSKFGP----TSVSKTHLDPEYYR-LQQLTEKSDVYSFGVVLFEVL-CARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ  493 (613)
Q Consensus       420 Gls~~~~----~~~~~~~~aPE~~~-~~~~t~ksDV~SfGvvL~ell-tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  493 (613)
                      |++....    ..++..|+|||++. ...++.++|||||||+||||+ .|+.|+......+....  +.....   ....
T Consensus       157 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~--~~~~~~---~~~~  231 (262)
T cd05077         157 GIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF--YEGQCM---LVTP  231 (262)
T ss_pred             CCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH--HhcCcc---CCCC
Confidence            9986432    22455799999987 466899999999999999998 58888754433222111  111000   0111


Q ss_pred             cccHHHH-HhcccccCCCCCCCHHHHHHHH
Q 048439          494 IVDPFLK-AMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       494 ~~d~~~~-~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                      ..+.... ..+||+.+|.+||++.+|++.+
T Consensus       232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         232 SCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            1111111 2379999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-36  Score=309.07  Aligned_cols=246  Identities=26%  Similarity=0.421  Sum_probs=195.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCc----eeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGST----TPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~----~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      .+|...+.||+|+||.||+|....++    ..+|+|.+.... .....++.+|+.++++++|+||++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            45666779999999999999976543    358999887654 3445678999999999999999999999987 78899


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~----i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC----EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999998643 345999999999999999999999988    9999999999999999999999999986432


Q ss_pred             CC----------CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          427 TS----------VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       427 ~~----------~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                      ..          .+..|++||.+....++.++|||||||++||+++ |++||......+...   ....... .......
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~~~~~-~~~~~~~  236 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD---LLEKGER-LPQPPIC  236 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH---HHhCCCC-CCCCCCC
Confidence            11          1346999999988899999999999999999998 999987654332211   1111111 1111112


Q ss_pred             --cHHHHHhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          496 --DPFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       496 --d~~~~~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                        +......+||..+|.+||++.+++..|+..++
T Consensus       237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         237 TIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence              22222348999999999999999999986544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.5e-37  Score=328.03  Aligned_cols=186  Identities=24%  Similarity=0.275  Sum_probs=165.9

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      .++|...+.||+|+||.||++....+++.||+|....      ..+.+|+++|++|+|||||++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            3679999999999999999999988889999997542      3468899999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-----  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-----  425 (613)
                      +. ++|.+++..  ...+++..++.|+.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..     
T Consensus       165 ~~-~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~~----IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        165 YK-TDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHENR----IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             CC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            96 688888743  356899999999999999999999998    999999999999999999999999998631     


Q ss_pred             ----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccc
Q 048439          426 ----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILR  469 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~  469 (613)
                          ...++..|+|||++....++.++|||||||+||||++|+.|+..
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence                12357789999999999999999999999999999999987653

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.5e-36  Score=310.94  Aligned_cols=248  Identities=23%  Similarity=0.390  Sum_probs=191.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcC----------------CceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFING----------------STTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSL  334 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~----------------~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l  334 (613)
                      ++|...+.||+|+||.||++...+                +...||+|.+... ......+|.+|+.++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            467888899999999999986432                2346999998765 34455689999999999999999999


Q ss_pred             EEEeecCCceEEEEEcCCCCChhHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCc
Q 048439          335 IGFCNDDREMILVYDFMARGTLPDHLYHSD---------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTN  405 (613)
Q Consensus       335 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~N  405 (613)
                      ++++...+..++||||+++|+|.+++....         ...+++.+++.++.|++.||.|||+.+    |+||||||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~----i~H~dlkp~N  160 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN----FVHRDLATRN  160 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC----eecccCChhe
Confidence            999999999999999999999999986432         134788999999999999999999998    9999999999


Q ss_pred             eeeCCCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh--CCCCccchhhh
Q 048439          406 ILLDEKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC--ARPSILRTAAK  473 (613)
Q Consensus       406 ILl~~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt--g~~p~~~~~~~  473 (613)
                      ||+++++.+||+|||+++...          ...+..|++||+...+.++.++|||||||++|||++  |..|+......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            999999999999999986421          111346899999988999999999999999999998  66777543332


Q ss_pred             hhhhH-HHHHHHhhc---cCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          474 KQVSL-AVWAQQCYQ---NGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       474 ~~~~l-~~~~~~~~~---~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      +.... ..+......   ........+.+.. ..+||+.+|.+||++.+|++.|+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            21111 111100000   0011111122222 33899999999999999998876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.6e-36  Score=305.93  Aligned_cols=241  Identities=22%  Similarity=0.322  Sum_probs=195.1

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +|...+.||+|+||.||++....++..||+|++...  ......++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            467778999999999999999887889999998643  334456789999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC---
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT---  427 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~---  427 (613)
                      +++++|.+++.......+++.+++.++.|++.||.|||+.+    ++|+||+|+|||++.++.+||+|||++.....   
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~----i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK----ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC----EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            99999999986544556899999999999999999999988    99999999999999999999999999864321   


Q ss_pred             -----CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--
Q 048439          428 -----SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--  500 (613)
Q Consensus       428 -----~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--  500 (613)
                           .++..|++||++.++..+.++|||||||+++||++|+.|+......+...  .......  .......+..+.  
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~~~~~~l  232 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL--KIIRGSY--PPVSSHYSYDLRNL  232 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHH--HHhcCCC--CCCcccCCHHHHHH
Confidence                 24557999999999999999999999999999999999986543332211  1111111  011111121111  


Q ss_pred             HhcccccCCCCCCCHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      ..+||+.+|.+||+|.||+++
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhC
Confidence            237999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.1e-36  Score=309.50  Aligned_cols=247  Identities=26%  Similarity=0.404  Sum_probs=193.1

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcC----CceeEEEEEeCCCChh-cHHHHHHHHHHHhccCccceeeEEEEeec--CCceE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFING----STTPVAIKRLEPESQQ-GALEFQTEIGMLSQLRHLHLVSLIGFCND--DREMI  345 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~----~~~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~  345 (613)
                      +|...+.||+|+||.||+|++..    .+..+|||.+...... ....|.+|+.++++++|+||+++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            45566789999999999999753    3578999999866543 46689999999999999999999999987  56789


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +||||+++++|.+++... ...++|..++.++.|++.||+|||+.+    ++||||||+||+++.++.+||+|||++...
T Consensus        85 lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQR----YIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            999999999999999543 336999999999999999999999988    999999999999999999999999998753


Q ss_pred             CC-----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhh------------hhhHHHHH
Q 048439          426 PT-----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK------------QVSLAVWA  482 (613)
Q Consensus       426 ~~-----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~------------~~~l~~~~  482 (613)
                      ..           .....|++||++....++.++||||||+++|||++|+.|+.......            ...+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            31           12335899999998899999999999999999999998875432211            01111111


Q ss_pred             HHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          483 QQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       483 ~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .................. ..+||+.+|.+||+|.||+++|+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence            111111111111111211 338999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=309.47  Aligned_cols=243  Identities=26%  Similarity=0.344  Sum_probs=196.4

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      +|.....||.|+||.||+|+...++..||+|.+.... ......+.+|++++++++|+||+++++++.++...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            5677779999999999999998888999999987553 444567899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++++|.+++...   .+++..++.++.|++.||.|||+.+    ++||||+|+||++++++.++|+|||+++...     
T Consensus        82 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  154 (274)
T cd06609          82 GGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG----KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK  154 (274)
T ss_pred             CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence            999999998532   7899999999999999999999988    9999999999999999999999999986432     


Q ss_pred             ---CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccc-ccHHHH--
Q 048439          427 ---TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQI-VDPFLK--  500 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~d~~~~--  500 (613)
                         ..++..|++||++.+..++.++|||||||++|||++|++||............   ... ....+.+. .+..+.  
T Consensus       155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~  230 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI---PKN-NPPSLEGNKFSKPFKDF  230 (274)
T ss_pred             cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh---hhc-CCCCCcccccCHHHHHH
Confidence               12345699999999989999999999999999999999999654322211111   111 11111111 121111  


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ..+||..+|++||++++++.+-...-
T Consensus       231 l~~~l~~~p~~Rpt~~~il~~~~~~~  256 (274)
T cd06609         231 VSLCLNKDPKERPSAKELLKHKFIKK  256 (274)
T ss_pred             HHHHhhCChhhCcCHHHHhhChhhcC
Confidence            23799999999999999998766433

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-37  Score=324.79  Aligned_cols=243  Identities=22%  Similarity=0.341  Sum_probs=202.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCc-eEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDRE-MILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lV~  348 (613)
                      ++|...++||+|+||.++..+.+.....+++|.++..  +.........|+.++++++|||||.+.+.+.+++. ++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            4566777999999999999999888889999998765  34445567899999999999999999999999888 99999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      +||+||+|.+.|...+...+++++++.++.|++.|+.|||+..    |+|||||+.||+++.+..+||+|||+|+...  
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~----iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR----VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh----hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999997766678999999999999999999999877    9999999999999999999999999998532  


Q ss_pred             ------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          427 ------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       427 ------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                            ..+++.|+.||.+.+.+|..|+|||||||++|||++-+++|.......   ++....+..... +.......++
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki~~~~~~P-lp~~ys~el~  235 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKINRGLYSP-LPSMYSSELR  235 (426)
T ss_pred             hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHHhhccCCC-CCccccHHHH
Confidence                  246888999999999999999999999999999999999997654433   222222222111 2222222222


Q ss_pred             --HhcccccCCCCCCCHHHHHHHH
Q 048439          501 --AMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       501 --~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                        ...||..+|+.||++.+++.+.
T Consensus       236 ~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  236 SLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             HHHHHHhhcCCccCCCHHHHhhCh
Confidence              2379999999999999999773

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2e-36  Score=313.18  Aligned_cols=246  Identities=21%  Similarity=0.327  Sum_probs=198.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      .+|...+.||.|+||.||+|....++..|++|.+..........+.+|+.+++.++|+||+++++++.+.+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            35777789999999999999988778899999987665555677899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++++|.+++..   ..+++.+++.++.+++.||+|||+.+    ++||||||+||+++.++.+||+|||++....     
T Consensus        99 ~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~----i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          99 AGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQ----VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             CCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            99999998843   35899999999999999999999998    9999999999999999999999999876321     


Q ss_pred             ---CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-Hh
Q 048439          427 ---TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AM  502 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~  502 (613)
                         ..++..|++||.+....++.++|||||||++|||++|++||............ +............+.+.... ..
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~  250 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPELQNPEKLSPIFRDFLN  250 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcCCcccCCcccCCHHHHHHHH
Confidence               23455799999999989999999999999999999999999765443322111 11100000111112222222 23


Q ss_pred             cccccCCCCCCCHHHHHHHHHHh
Q 048439          503 SCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       503 ~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      +||..+|.+||++.+++.+-...
T Consensus       251 ~~l~~dp~~Rpt~~~il~~~~~~  273 (296)
T cd06655         251 RCLEMDVEKRGSAKELLQHPFLK  273 (296)
T ss_pred             HHhhcChhhCCCHHHHhhChHhh
Confidence            79999999999999999776653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.8e-38  Score=312.73  Aligned_cols=243  Identities=26%  Similarity=0.339  Sum_probs=190.6

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCC-----ceEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR-----EMILV  347 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~lV  347 (613)
                      .|...+++|.|+||.||+|.+..+...||||+.-.+...    -.+|+++|++++|||||+|+-++....     ...||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            355667999999999999999888889999998665432    246899999999999999999876432     34589


Q ss_pred             EEcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC-CcEEEEecCCCcc
Q 048439          348 YDFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK-WVAKVSDFGLSKF  424 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGls~~  424 (613)
                      ||||+. +|.+.+..  ..+..++...+.-+..|+.+||.|||+.+    |+||||||.|+|+|.+ |.+||||||.|+.
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~----IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG----ICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC----cccCCCChheEEEcCCCCeEEeccCCccee
Confidence            999998 99998853  24567888888899999999999999988    9999999999999976 9999999999986


Q ss_pred             CCCC-------CCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccC-------
Q 048439          425 GPTS-------VSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG-------  489 (613)
Q Consensus       425 ~~~~-------~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-------  489 (613)
                      ....       .+..|.|||.+.+ ..||.+.||||.|||+.||+-|++-|.+....+|..++..........       
T Consensus       176 L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~  255 (364)
T KOG0658|consen  176 LVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP  255 (364)
T ss_pred             eccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence            3322       2456899999876 579999999999999999999999998877777665554433221111       


Q ss_pred             -----Cccc------------cccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          490 -----TIDQ------------IVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       490 -----~~~~------------~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                           ...+            ..++...  ..++|..+|.+|.++.|++.+--+
T Consensus       256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fF  309 (364)
T KOG0658|consen  256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFF  309 (364)
T ss_pred             ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhh
Confidence                 0011            1111111  237999999999999999977654

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=333.73  Aligned_cols=243  Identities=27%  Similarity=0.424  Sum_probs=205.2

Q ss_pred             CCcceeeeeCcEEEEEEEEcCC----ceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          275 DNDLVIGVGGFGDVYKGFINGS----TTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       275 ~~~~~iG~G~fG~Vy~g~~~~~----~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ...++||+|+||+||||.+-..    +.+||+|.+... +.+...+|+.|+.+|++|+||||++|+|+|.... +.||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            3455999999999999988332    367999998765 5566789999999999999999999999998776 889999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCCCC
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV  429 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~  429 (613)
                      ||+.|+|.|+++. .+..+.-+..+.|+.|||+||.|||.+.    ++||||.++|||+.+-..+||.|||+++.....+
T Consensus       778 ~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~qr----lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  778 LMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQR----LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             hcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhcc----hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            9999999999965 4566888999999999999999999888    9999999999999999999999999998654332


Q ss_pred             ----------CcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          430 ----------SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       430 ----------~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                                ...|||-|.++...+|.+||||||||++||++| |..|+++...++..++.+...+.  ....-.-+|..
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRL--sqPpiCtiDVy  930 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERL--SQPPICTIDVY  930 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccC--CCCCCccHHHH
Confidence                      234788899999999999999999999999997 88888887777766666655542  22334556777


Q ss_pred             HHHhcccccCCCCCCCHHHHHHHHHHh
Q 048439          499 LKAMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       499 ~~~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ...++||..|+..||+++++.......
T Consensus       931 ~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  931 MVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             HHHHHHhccCcccCccHHHHHHHHHHH
Confidence            777899999999999999998766543

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.7e-36  Score=305.39  Aligned_cols=241  Identities=25%  Similarity=0.358  Sum_probs=194.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|.....||+|+||.||+|+...++..+++|.+.....  ..++.+|++++++++|+||+++++++.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578888899999999999999988778899999876533  678999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT----  427 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~----  427 (613)
                      ++++|.+++.. ....++|..++.++.|++.||.|||+.+    ++||||+|+||++++++.+||+|||++.....    
T Consensus        81 ~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~~----i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          81 GAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSNK----KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             CCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence            99999999854 3457899999999999999999999988    99999999999999999999999999864221    


Q ss_pred             ----CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--H
Q 048439          428 ----SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--A  501 (613)
Q Consensus       428 ----~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~  501 (613)
                          .++..|++||++.+..++.++|||||||++|||++|++|+...........  ...............+..+.  .
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i  233 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM--IPNKPPPTLSDPEKWSPEFNDFV  233 (256)
T ss_pred             cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh--hccCCCCCCCchhhcCHHHHHHH
Confidence                234579999999999999999999999999999999999865433221111  00000000001111111111  2


Q ss_pred             hcccccCCCCCCCHHHHHHH
Q 048439          502 MSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~  521 (613)
                      .+||+.+|++||++.||+.+
T Consensus       234 ~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         234 KKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             HHHHhcChhhCcCHHHHhcC
Confidence            27999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=319.47  Aligned_cols=248  Identities=20%  Similarity=0.270  Sum_probs=192.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+++...++..||||.++..   .......|.+|+.++..++|+||+++++++.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4678888999999999999999888889999998642   2233456889999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||++....  
T Consensus        81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQLG----YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC----eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999853 2456899999999999999999999998    9999999999999999999999999985321  


Q ss_pred             -------CCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc-cC---C
Q 048439          427 -------TSVSKTHLDPEYYRL-----QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ-NG---T  490 (613)
Q Consensus       427 -------~~~~~~~~aPE~~~~-----~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~-~~---~  490 (613)
                             ..++..|+|||++..     +.++.++|||||||+||||++|+.||......+............. ..   .
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  235 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD  235 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCC
Confidence                   235678999999973     4578899999999999999999999965433222111110000000 01   1


Q ss_pred             ccccccHHHHHhcccccCCCCCCCHHHHHHHHHH
Q 048439          491 IDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       491 ~~~~~d~~~~~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ..+....++..+.|...++..||++.+++.+..+
T Consensus       236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~  269 (331)
T cd05597         236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF  269 (331)
T ss_pred             CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence            1111222333344666666668999999977653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-36  Score=305.84  Aligned_cols=242  Identities=26%  Similarity=0.411  Sum_probs=195.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|.....||.|+||.||+|....++..+++|.+........+.+.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            56778889999999999999998777889999998766556778999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++++|.+++... ...+++.++..++.|++.||.|||+.+    |+|+||||+||++++++.+||+|||++....     
T Consensus        83 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          83 GGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG----KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             CCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC----ceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence            999999988542 356999999999999999999999988    9999999999999999999999999886422     


Q ss_pred             ---CCCCcccCChhhhhcC---CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCc--cccccHH
Q 048439          427 ---TSVSKTHLDPEYYRLQ---QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTI--DQIVDPF  498 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~---~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~--~~~~d~~  498 (613)
                         ..++..|++||.+...   .++.++|||||||++|||++|++|+...........  ...........  ....+..
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  235 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL--ISKSNFPPPKLKDKEKWSPV  235 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhccCCCccccchhhhhHH
Confidence               1234569999999777   889999999999999999999999975443322211  11110011000  0011111


Q ss_pred             HH--HhcccccCCCCCCCHHHHHH
Q 048439          499 LK--AMSCLNDEGIRRPSMSDVVW  520 (613)
Q Consensus       499 ~~--~~~Cl~~~p~~RPs~~evl~  520 (613)
                      +.  ..+||..+|.+||++.+|+.
T Consensus       236 ~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         236 FHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhc
Confidence            11  23799999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=295.98  Aligned_cols=251  Identities=23%  Similarity=0.328  Sum_probs=202.0

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecC-----Cce
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD-----REM  344 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~  344 (613)
                      ..++|.+.+.||+|||..||.++.-.++..+|+|++...+.++.+..++|++..++++|||++++++++..+     .+.
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            346788889999999999999998777788999999988888888899999999999999999999987654     458


Q ss_pred             EEEEEcCCCCChhHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCC
Q 048439          345 ILVYDFMARGTLPDHLYHS--DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS  422 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls  422 (613)
                      ||++.|...|+|.+.+...  ++..+++.+.+.|+.|+++||.+||+...  +++||||||.|||+.+.+.++|.|||.+
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~--~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP--PYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC--cccccCCCcceeEecCCCceEEEeccCc
Confidence            9999999999999998643  34579999999999999999999999763  4999999999999999999999999987


Q ss_pred             ccCC-----------------CCCCcccCChhhhhcC---CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHH
Q 048439          423 KFGP-----------------TSVSKTHLDPEYYRLQ---QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWA  482 (613)
Q Consensus       423 ~~~~-----------------~~~~~~~~aPE~~~~~---~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~  482 (613)
                      +..+                 ...+..|.|||.+.-+   .+++++|||||||+||+|+.|..||+.... ....++.-.
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSlaLAv  255 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLALAV  255 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEEEee
Confidence            6422                 2235679999999654   568999999999999999999999975543 222221111


Q ss_pred             H----HhhccCCccccccHHHHHhcccccCCCCCCCHHHHHHHHHHh
Q 048439          483 Q----QCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       483 ~----~~~~~~~~~~~~d~~~~~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      .    ..+......+..-.+++  +|++.||.+||++.+++..++..
T Consensus       256 ~n~q~s~P~~~~yse~l~~lik--~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  256 QNAQISIPNSSRYSEALHQLIK--SMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             eccccccCCCCCccHHHHHHHH--HHhcCCcccCCCHHHHHHHHHhh
Confidence            1    11222222222222222  89999999999999999888743

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.6e-36  Score=320.82  Aligned_cols=193  Identities=25%  Similarity=0.341  Sum_probs=166.8

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCC-----
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR-----  342 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~-----  342 (613)
                      ..++|...+.||+|+||.||++....++..||||++...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            347888889999999999999999888889999998653  3344567889999999999999999999986543     


Q ss_pred             -ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCC
Q 048439          343 -EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL  421 (613)
Q Consensus       343 -~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl  421 (613)
                       ..++||||+++ +|.+.+.    ..+++..+..++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~----ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCCHHHEEECCCCCEEEecCCC
Confidence             47999999976 6666663    24888999999999999999999998    99999999999999999999999999


Q ss_pred             CccC-------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          422 SKFG-------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       422 s~~~-------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                      ++..       ...++..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~  226 (359)
T cd07876         170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD  226 (359)
T ss_pred             ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            8642       1234667999999999999999999999999999999999996543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-36  Score=302.26  Aligned_cols=235  Identities=29%  Similarity=0.487  Sum_probs=188.8

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh-hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCChh
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ-QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLP  357 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~  357 (613)
                      +||+|+||.||++...+ +..||+|.+..... .....|.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus         2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             ccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            69999999999999877 68899999876543 35668999999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----------C
Q 048439          358 DHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----------T  427 (613)
Q Consensus       358 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----------~  427 (613)
                      +++... ...+++..++.++.+++.||+|||+.+    ++||||||+|||++.++.+||+|||+++...          .
T Consensus        81 ~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~----i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKN----CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC----EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            998543 346899999999999999999999988    9999999999999999999999999986422          1


Q ss_pred             CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhcc
Q 048439          428 SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSC  504 (613)
Q Consensus       428 ~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~C  504 (613)
                      ..+..|++||.+.++.++.++|||||||++|||++ |..||...........   ...... ..........+.  ..+|
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~li~~~  231 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER---IESGYR-MPAPQLCPEEIYRLMLQC  231 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH---HhcCCC-CCCCccCCHHHHHHHHHH
Confidence            11335999999998999999999999999999999 7888855432221111   111111 111111112221  2379


Q ss_pred             cccCCCCCCCHHHHHHHHH
Q 048439          505 LNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       505 l~~~p~~RPs~~evl~~Le  523 (613)
                      |..+|.+||++.||++.|+
T Consensus       232 l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         232 WAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             hccChhhCcCHHHHHHHhh
Confidence            9999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.4e-36  Score=314.27  Aligned_cols=244  Identities=22%  Similarity=0.320  Sum_probs=197.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      .+|...+.||+|+||.||+|....++..||+|.+..........+.+|+.+++.++|+||++++++|...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            56788889999999999999987777889999997665555667899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++++|.+++..   ..+++.+++.++.+++.||.|||+.+    |+||||||+|||++.++.+||+|||++....     
T Consensus        99 ~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~----i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             CCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            99999999843   45899999999999999999999988    9999999999999999999999999986421     


Q ss_pred             ---CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--H
Q 048439          427 ---TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--A  501 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~  501 (613)
                         ..++..|++||++.+..++.++|||||||++|+|++|++||........... .+........ .....+..+.  .
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~li  249 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATNGTPELQ-NPERLSAVFRDFL  249 (297)
T ss_pred             cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-eccCCCCCCC-CccccCHHHHHHH
Confidence               2345579999999999999999999999999999999999965433222111 1111000000 1111222221  2


Q ss_pred             hcccccCCCCCCCHHHHHHHHHH
Q 048439          502 MSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .+||..+|.+||++.+++.+-..
T Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~  272 (297)
T cd06656         250 NRCLEMDVDRRGSAKELLQHPFL  272 (297)
T ss_pred             HHHccCChhhCcCHHHHhcCchh
Confidence            37999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.5e-36  Score=308.83  Aligned_cols=242  Identities=25%  Similarity=0.345  Sum_probs=195.0

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      .|+..+.||.|+||.||+|....++..||||.+... .......+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            455666899999999999999877789999998754 3445667999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++|+|.+++..   ..+++.+...++.+++.||.|||+.+    ++|+||+|+||+++.++.++|+|||++....     
T Consensus        85 ~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~----ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06640          85 GGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK----KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC----ccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence            99999999843   45899999999999999999999988    9999999999999999999999999985422     


Q ss_pred             ---CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--H
Q 048439          427 ---TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--A  501 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~  501 (613)
                         ..++..|++||++.+...+.++|||||||++|||++|.+|+.............    ...........+..+.  .
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li  233 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP----KNNPPTLTGEFSKPFKEFI  233 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh----cCCCCCCchhhhHHHHHHH
Confidence               123456899999999899999999999999999999999986544332211110    0011111111111111  2


Q ss_pred             hcccccCCCCCCCHHHHHHHHHHh
Q 048439          502 MSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      .+||+.+|++||++.|++.+....
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~~~~~  257 (277)
T cd06640         234 DACLNKDPSFRPTAKELLKHKFIV  257 (277)
T ss_pred             HHHcccCcccCcCHHHHHhChHhh
Confidence            279999999999999999876643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.7e-36  Score=312.18  Aligned_cols=255  Identities=25%  Similarity=0.320  Sum_probs=198.8

Q ss_pred             ccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEee
Q 048439          261 QFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCN  339 (613)
Q Consensus       261 ~f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~  339 (613)
                      .+++.++..++++|.....||+|+||.||++....++..+|+|.+.... .....+.+|+.++.++ +|+|+++++++|.
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            3667788888999999999999999999999998888899999986543 2235678899999999 7999999999987


Q ss_pred             cC-----CceEEEEEcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC
Q 048439          340 DD-----REMILVYDFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW  412 (613)
Q Consensus       340 ~~-----~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~  412 (613)
                      ..     +..++||||+++|+|.+++..  .....+++..++.++.|++.||+|||+.+    ++||||||+||++++++
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~----ivH~dlkp~nili~~~~  165 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR----IIHRDVKGNNILLTTEG  165 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----eeccCCCHHHEEEcCCC
Confidence            53     358999999999999998853  23456899999999999999999999988    99999999999999999


Q ss_pred             cEEEEecCCCccCC--------CCCCcccCChhhhhcCC-----CCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHH
Q 048439          413 VAKVSDFGLSKFGP--------TSVSKTHLDPEYYRLQQ-----LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLA  479 (613)
Q Consensus       413 ~~kl~DFGls~~~~--------~~~~~~~~aPE~~~~~~-----~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~  479 (613)
                      .+||+|||+++...        ..++..|++||++....     ++.++|||||||++|||++|++|+........  +.
T Consensus       166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~  243 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF  243 (291)
T ss_pred             CEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence            99999999986421        22355799999986543     68899999999999999999999865433221  11


Q ss_pred             HHHHHhhcc-CCccccccHHH-HHhcccccCCCCCCCHHHHHHHH
Q 048439          480 VWAQQCYQN-GTIDQIVDPFL-KAMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       480 ~~~~~~~~~-~~~~~~~d~~~-~~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                      .+....... .........+. ...+||+.+|++||++.|++++-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~  288 (291)
T cd06639         244 KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP  288 (291)
T ss_pred             HHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence            111111100 00111111111 12379999999999999998653

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-36  Score=312.22  Aligned_cols=255  Identities=22%  Similarity=0.304  Sum_probs=198.2

Q ss_pred             cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEee-
Q 048439          262 FSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCN-  339 (613)
Q Consensus       262 f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~-  339 (613)
                      +.++.+..++++|.....||+|+||.||++....++..+|+|.+.... ....++.+|+.++.++ +|+||++++++|. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            455677788899999999999999999999998888899999986533 2235688899999999 6999999999884 


Q ss_pred             ----cCCceEEEEEcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc
Q 048439          340 ----DDREMILVYDFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV  413 (613)
Q Consensus       340 ----~~~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~  413 (613)
                          .++..++||||+++|+|.+++..  .....+++..+..++.|++.||.|||+.+    |+||||||+||++++++.
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dlkp~nili~~~~~  162 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK----TIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC----ccccCCCHHhEEECCCCC
Confidence                34568999999999999998753  23456899999999999999999999988    999999999999999999


Q ss_pred             EEEEecCCCccCC--------CCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHH
Q 048439          414 AKVSDFGLSKFGP--------TSVSKTHLDPEYYRL-----QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAV  480 (613)
Q Consensus       414 ~kl~DFGls~~~~--------~~~~~~~~aPE~~~~-----~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~  480 (613)
                      +||+|||+++...        ..++..|+|||++..     ..++.++|||||||++|||++|+.|+.........  ..
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~~  240 (286)
T cd06638         163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--FK  240 (286)
T ss_pred             EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--hh
Confidence            9999999986421        234567999999853     44788999999999999999999998654332211  11


Q ss_pred             HHHHhhccCCccccccHHHH--HhcccccCCCCCCCHHHHHHHHH
Q 048439          481 WAQQCYQNGTIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       481 ~~~~~~~~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ...............+..+.  ..+||+.+|++||++.||++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         241 IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             ccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence            11111000001111111121  33799999999999999997653

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.4e-36  Score=308.19  Aligned_cols=249  Identities=24%  Similarity=0.388  Sum_probs=190.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEc----CCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecC--Cce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFIN----GSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD--REM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~----~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~--~~~  344 (613)
                      +.|...+.||+|+||.||++.+.    .++..||+|.++... ......|.+|+.++++++|+||++++++|.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            34667779999999999999853    345779999987653 34456799999999999999999999999875  568


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++||||+++++|.+++... ...++|..++.++.|++.||+|||+.+    ++||||||+|||++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~g----i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQ----YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeecccchheEEEcCCCCEEECCCccccc
Confidence            9999999999999998543 346899999999999999999999998    99999999999999999999999999864


Q ss_pred             CC-----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhh---------hhhhHHHHHHH
Q 048439          425 GP-----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAK---------KQVSLAVWAQQ  484 (613)
Q Consensus       425 ~~-----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~---------~~~~l~~~~~~  484 (613)
                      ..           ..++..|+|||++.+..++.++|||||||++|||++++.|.......         .+.....+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            21           12234589999999889999999999999999999987664321110         00111111111


Q ss_pred             hhc---cCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          485 CYQ---NGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       485 ~~~---~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ...   ........+.... ..+||+.+|.+||++.++++.|+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            110   0111111122222 3379999999999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.3e-36  Score=307.70  Aligned_cols=194  Identities=25%  Similarity=0.370  Sum_probs=167.3

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +|...+.||+|+||.||+|+...++..||||.+....  ......+.+|+.++.+++|+||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4667779999999999999998878899999986542  22345788999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---
Q 048439          351 MARGTLPDHLYHSD-NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---  426 (613)
                      ++ ++|.+++.... ...+++.+++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++...   
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR----VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC----eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 68988875432 367999999999999999999999988    9999999999999999999999999986321   


Q ss_pred             -----CCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          427 -----TSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                           ..++..|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~  206 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS  206 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence                 1235679999998654 57899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.6e-36  Score=303.92  Aligned_cols=241  Identities=27%  Similarity=0.386  Sum_probs=194.5

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +|...+.||+|+||.||++....++..+|||.+...  +......+.+|++++++++|+||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            467778999999999999999888899999998754  334456789999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC-CcEEEEecCCCccCC---
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK-WVAKVSDFGLSKFGP---  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGls~~~~---  426 (613)
                      +++++|.+++.......+++..++.++.+++.||.|||+.+    ++||||||+||+++++ +.+||+|||++....   
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~----i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL----ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999997655567899999999999999999999988    9999999999999854 568999999986432   


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--  500 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--  500 (613)
                          ..++..|++||.+....++.++||||||+++|||++|+.||........   .......... .+.....+.+.  
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~l~~l  232 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKIMSGTFA-PISDRYSPDLRQL  232 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHHHhcCCC-CCCCCcCHHHHHH
Confidence                2245579999999988899999999999999999999999865433221   1111111111 11111222121  


Q ss_pred             HhcccccCCCCCCCHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      ..+||+.+|.+||++.|++.+
T Consensus       233 i~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         233 ILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             HHHHccCChhhCCCHHHHhhC
Confidence            237999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.1e-36  Score=335.06  Aligned_cols=202  Identities=19%  Similarity=0.296  Sum_probs=167.1

Q ss_pred             HHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCc------cceeeEEEE
Q 048439          264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRH------LHLVSLIGF  337 (613)
Q Consensus       264 ~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H------~niv~l~g~  337 (613)
                      .+++...+++|...++||+|+||+||+|.....+..||||+++... ....++..|+.++..++|      .++++++++
T Consensus       121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            3455566789999999999999999999998888899999996532 223455667777777654      458899998


Q ss_pred             eecC-CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcEEeccCCCCceeeCCCC---
Q 048439          338 CNDD-REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG-ANHAVIIHRDVKTTNILLDEKW---  412 (613)
Q Consensus       338 ~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~iiHrDlk~~NILl~~~~---  412 (613)
                      +... ..+++|||++ +++|.+++..  ...+++..+..|+.||+.||.|||++ +    ||||||||+|||++.++   
T Consensus       200 ~~~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~g----IiHrDlKP~NILl~~~~~~~  272 (467)
T PTZ00284        200 FQNETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELH----LMHTDLKPENILMETSDTVV  272 (467)
T ss_pred             EEcCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCC----eecCCCCHHHEEEecCCccc
Confidence            8764 5788999988 6789888854  35699999999999999999999974 6    99999999999998765   


Q ss_pred             -------------cEEEEecCCCccC-----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhh
Q 048439          413 -------------VAKVSDFGLSKFG-----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAK  473 (613)
Q Consensus       413 -------------~~kl~DFGls~~~-----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~  473 (613)
                                   .+||+|||++...     ...++..|+|||++.+..++.++|||||||+||||++|++||......
T Consensus       273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        273 DPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             ccccccccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                         4999999987542     234577899999999999999999999999999999999999765443

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.2e-36  Score=312.50  Aligned_cols=245  Identities=25%  Similarity=0.439  Sum_probs=191.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCce----eEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTT----PVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~----~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ++|...+.||+|+||.||+|....++.    .||+|.+.... .....++.+|+.++++++|+||++++|+|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            456777799999999999998854443    47999887653 23345789999999999999999999999764 4679


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ++||+++|+|.+++... ...+++..++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~----ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERR----LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcC----eeccccccceeeecCCCceEEcccccccccc
Confidence            99999999999998543 346899999999999999999999988    9999999999999999999999999986421


Q ss_pred             ----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCcc-cc
Q 048439          427 ----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTID-QI  494 (613)
Q Consensus       427 ----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-~~  494 (613)
                                ...+..|++||++.+..++.++|||||||++|||++ |+.||..........+   ........... ..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~  237 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL---LEKGERLPQPPICT  237 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHCCCCCCCCCCCC
Confidence                      112346999999999999999999999999999997 8888865432222111   11111111011 11


Q ss_pred             ccHHHHHhcccccCCCCCCCHHHHHHHHHHh
Q 048439          495 VDPFLKAMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       495 ~d~~~~~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      .+.......||..+|++||++.++++.|+..
T Consensus       238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         238 IDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2222234589999999999999999988753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.4e-36  Score=315.82  Aligned_cols=189  Identities=23%  Similarity=0.242  Sum_probs=163.1

Q ss_pred             cceeeee--CcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCC
Q 048439          277 DLVIGVG--GFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMA  352 (613)
Q Consensus       277 ~~~iG~G--~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  352 (613)
                      ..+||+|  +||+||++....++..||||+++...  ......+.+|+++++.++||||++++++|..++..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            3589999  78999999999888999999997642  2334567789999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-------
Q 048439          353 RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-------  425 (613)
Q Consensus       353 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-------  425 (613)
                      +|+|.+++.......+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.++++||+.....       
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG----YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC----EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999986544456999999999999999999999988    999999999999999999999999854211       


Q ss_pred             --------CCCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCccc
Q 048439          426 --------PTSVSKTHLDPEYYRL--QQLTEKSDVYSFGVVLFEVLCARPSILR  469 (613)
Q Consensus       426 --------~~~~~~~~~aPE~~~~--~~~t~ksDV~SfGvvL~elltg~~p~~~  469 (613)
                              ...++..|+|||++..  ..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence                    0112345899999976  4689999999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.6e-36  Score=302.79  Aligned_cols=241  Identities=29%  Similarity=0.523  Sum_probs=192.3

Q ss_pred             CCcceeeeeCcEEEEEEEEcCCc----eeEEEEEeCCCChh-cHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          275 DNDLVIGVGGFGDVYKGFINGST----TPVAIKRLEPESQQ-GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       275 ~~~~~iG~G~fG~Vy~g~~~~~~----~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      .....||.|+||.||+++....+    ..||+|.+...... ....+..|++++..++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            44568999999999999997654    78999999766543 56789999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC--
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT--  427 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~--  427 (613)
                      |+++++|.+++.......+++.++..++.|++.||+|||+.+    ++||||||+||++++++.+||+|||+++....  
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~----~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN----FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC----eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999986533333899999999999999999999998    99999999999999999999999999864321  


Q ss_pred             -------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH
Q 048439          428 -------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       428 -------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                             .++..|++||.+....++.++|||||||+++||++ |++|+........   ...................+.
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  234 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LEYLKKGYRLPKPENCPPEIY  234 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHhcCCCCCCCCcCCHHHH
Confidence                   23457999999988889999999999999999998 7888865332221   111111111111111112222


Q ss_pred             H-HhcccccCCCCCCCHHHHHHHH
Q 048439          500 K-AMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       500 ~-~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                      . ..+||..+|++||++.|+++.|
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      235 KLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHHHHHCcCChhhCcCHHHHHhhC
Confidence            2 2379999999999999998653

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.4e-36  Score=304.70  Aligned_cols=240  Identities=30%  Similarity=0.498  Sum_probs=190.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||.||+|...+  ..||+|.++...  ....|.+|+.++++++|+||+++++++... ..++||||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~--~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYTG--QKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEecccCC--CceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            457777899999999999997643  569999986543  345789999999999999999999998765 479999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT----  427 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~----  427 (613)
                      ++|+|.+++.......+++..++.++.|++.||.|||+.+    ++||||||+|||++.++.+||+|||+++....    
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~----~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~  156 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK----LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN  156 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC----eeccccCcceEEEcCCCcEEECCCccceeccccCCC
Confidence            9999999997655567899999999999999999999988    99999999999999999999999999864321    


Q ss_pred             -CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-Hhcc
Q 048439          428 -SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSC  504 (613)
Q Consensus       428 -~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~C  504 (613)
                       .....|++||++..+.++.++|||||||++|||++ |++||......+.....   ...........+.+.... ..+|
T Consensus       157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~  233 (254)
T cd05083         157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV---EKGYRMEPPEGCPADVYVLMTSC  233 (254)
T ss_pred             CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH---hCCCCCCCCCcCCHHHHHHHHHH
Confidence             12346999999998999999999999999999997 99998655433221111   111111111111111111 2389


Q ss_pred             cccCCCCCCCHHHHHHHHH
Q 048439          505 LNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       505 l~~~p~~RPs~~evl~~Le  523 (613)
                      |+.+|.+||++.+++..|+
T Consensus       234 l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         234 WETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             cCCChhhCcCHHHHHHHHc
Confidence            9999999999999998876

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.6e-36  Score=316.50  Aligned_cols=248  Identities=23%  Similarity=0.418  Sum_probs=193.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcC-------CceeEEEEEeCCC-ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFING-------STTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDR  342 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~-------~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~  342 (613)
                      .+|...+.||+|+||.||+++..+       ....||+|.++.. ......++.+|+.++.++ +|+||++++++|.+.+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            357777899999999999998632       2236899988754 334567899999999999 7999999999999999


Q ss_pred             ceEEEEEcCCCCChhHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee
Q 048439          343 EMILVYDFMARGTLPDHLYHSD--------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL  408 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl  408 (613)
                      ..++||||+++|+|.+++....              ...++|.+++.++.|++.||.|||+.+    |+||||||+|||+
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g----ivH~dlkp~Nill  167 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK----CIHRDLAARNVLV  167 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC----eeccccccceEEE
Confidence            9999999999999999986421              235899999999999999999999988    9999999999999


Q ss_pred             CCCCcEEEEecCCCccCCC----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhh
Q 048439          409 DEKWVAKVSDFGLSKFGPT----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVS  477 (613)
Q Consensus       409 ~~~~~~kl~DFGls~~~~~----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~  477 (613)
                      ++++.+||+|||+++....          ..+..|+|||.+....++.++|||||||+||||++ |..||......+...
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  247 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  247 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            9999999999999864211          11235999999999999999999999999999998 888886543322111


Q ss_pred             HHHHHHHhhccCCccccccHHH-HHhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          478 LAVWAQQCYQNGTIDQIVDPFL-KAMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       478 l~~~~~~~~~~~~~~~~~d~~~-~~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ..   ...............+. ...+||+.+|.+||++.|++..|+...
T Consensus       248 ~~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         248 LL---KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             HH---HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            11   11111111111122222 133799999999999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.3e-36  Score=302.81  Aligned_cols=240  Identities=28%  Similarity=0.489  Sum_probs=190.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      .+|...+.||+|+||.||+|....+ ..+|+|.+.... ....+|.+|++++++++|+|++++++++......++||||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~-~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEK-RKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCC-CeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            3566677999999999999988654 569999886543 23457899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++|+|.+++... ...+++..++.++.+++.||+|||+.+    ++||||||+||+++.++.+||+|||+++...     
T Consensus        82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          82 EHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN----VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             CCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC----ccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            999999998543 346899999999999999999999988    9999999999999999999999999986321     


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH--
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL--  499 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~--  499 (613)
                          ...+..|++||++..+.++.++|||||||++|||++ |+.||..........   ......... ........+  
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~  232 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE---TINAGFRLY-KPRLASQSVYE  232 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH---HHhCCCCCC-CCCCCCHHHHH
Confidence                112346999999999999999999999999999998 899986543322111   111100100 111111111  


Q ss_pred             HHhcccccCCCCCCCHHHHHHHH
Q 048439          500 KAMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       500 ~~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                      .+.+||+.+|++||++.|+++.|
T Consensus       233 l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         233 LMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             HHHHHcccChhhCCCHHHHHHhh
Confidence            13389999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.3e-36  Score=301.27  Aligned_cols=240  Identities=23%  Similarity=0.378  Sum_probs=193.4

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-----hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-----QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      +|...+.||+|+||.||+|....++..|++|.+....     .+..+.+.+|+.++++++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3666779999999999999998667889999886532     33456789999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-  426 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-  426 (613)
                      +||+++++|.+++..  ...+++..++.++.|++.||.|||+.+    |+|+||+|+||+++.++.+||+|||++.... 
T Consensus        81 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRN----TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999854  346899999999999999999999988    9999999999999999999999999986421 


Q ss_pred             ------CCCCcccCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH
Q 048439          427 ------TSVSKTHLDPEYYRLQQ-LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       427 ------~~~~~~~~aPE~~~~~~-~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                            ..++..|++||++.... ++.++|+|||||++|||++|++||........  ...+.. ......+...+++.+
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~  231 (258)
T cd06632         155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKIGR-SKELPPIPDHLSDEA  231 (258)
T ss_pred             cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHHHHh-cccCCCcCCCcCHHH
Confidence                  22455699999998776 89999999999999999999999965542221  111111 011122223333332


Q ss_pred             H--HhcccccCCCCCCCHHHHHHH
Q 048439          500 K--AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       500 ~--~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      .  ..+||+.+|.+||++.+++.+
T Consensus       232 ~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         232 KDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhcC
Confidence            2  237999999999999999854

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.5e-36  Score=310.12  Aligned_cols=245  Identities=24%  Similarity=0.287  Sum_probs=194.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      +.|...+.||+|+||.||+|+...++..+++|.+..........+.+|+.++++++|+||+++++++..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            34667779999999999999998888899999998777777788999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++++|..++... ...+++..++.++.|++.||.|||+.+    ++||||||+||+++.++.+||+|||++....     
T Consensus        92 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~----i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          92 PGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMK----IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             CCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCC----eeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence            999998877543 356999999999999999999999988    9999999999999999999999999875421     


Q ss_pred             ---CCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCC-ccccccH
Q 048439          427 ---TSVSKTHLDPEYYR-----LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT-IDQIVDP  497 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~-----~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~d~  497 (613)
                         ..++..|++||++.     ...++.++|||||||++|||++|++|+........  ............. ...+...
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  244 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSEPPTLSQPSKWSME  244 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHHhcCCCccCCCCcccCHH
Confidence               12345799999985     34568899999999999999999999865432211  1111111110000 1111111


Q ss_pred             HH-HHhcccccCCCCCCCHHHHHHHHH
Q 048439          498 FL-KAMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       498 ~~-~~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .. ...+||..+|++||++.+++++..
T Consensus       245 ~~~li~~~l~~~p~~Rp~~~~il~~~~  271 (292)
T cd06644         245 FRDFLKTALDKHPETRPSAAQLLEHPF  271 (292)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            11 123799999999999999987644

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.7e-36  Score=311.47  Aligned_cols=247  Identities=21%  Similarity=0.351  Sum_probs=192.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ++|.....||+|+||.||+|+...++..||+|.+.... ......+.+|+.++++++|+||+++++++.+++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            45777789999999999999998888899999987543 23344678999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      ++ ++|.+++... ...+++..+..++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++...    
T Consensus        86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~----i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRK----VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC----eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 5898888543 446899999999999999999999988    9999999999999999999999999986421    


Q ss_pred             ----CCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHH----------HHHHhh----c
Q 048439          427 ----TSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAV----------WAQQCY----Q  487 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~----------~~~~~~----~  487 (613)
                          ..++..|++||.+.+. .++.++|||||||++|||++|++||......++.....          |.....    .
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence                2235579999998754 57889999999999999999999997654433221111          100000    0


Q ss_pred             cCCc-----------cccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          488 NGTI-----------DQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       488 ~~~~-----------~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ....           ...+++.+.  ..+||..||.+|||+.|++.+..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f  289 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF  289 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            0000           011122222  238999999999999999976654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.2e-36  Score=311.76  Aligned_cols=245  Identities=20%  Similarity=0.281  Sum_probs=193.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||++.....+..|++|.+....   ......+.+|+++++.++|+||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46788889999999999999998888899999987653   234557889999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+++|+|.+++..  ...+++..+..++.+++.||.|||+.+    ++||||||+||+++.++.+||+|||+++...  
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999944  356899999999999999999999988    9999999999999999999999999986310  


Q ss_pred             ---------------------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHh
Q 048439          427 ---------------------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC  485 (613)
Q Consensus       427 ---------------------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~  485 (613)
                                           ..++..|+|||++....++.++|||||||+||||++|+.||......+.....  ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~--~~~~  232 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV--ISDD  232 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--Hhcc
Confidence                                 12345699999999889999999999999999999999999654332211111  1111


Q ss_pred             hccCCccccccH-HHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          486 YQNGTIDQIVDP-FLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       486 ~~~~~~~~~~d~-~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ............ ... ..+||+.+|++||+..++.+.|+.
T Consensus       233 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         233 IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            111111111222 222 238999999999996555555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4e-36  Score=304.96  Aligned_cols=243  Identities=24%  Similarity=0.378  Sum_probs=193.6

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC------hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES------QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~------~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      +|+....||+|+||.||+|....++..||+|.+....      ......+..|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4777889999999999999988778899999986532      1234678999999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC-cEEEEecCCCccC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW-VAKVSDFGLSKFG  425 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGls~~~  425 (613)
                      ||||+++++|.+++..  ..++++..++.++.|++.||.|||+.+    ++||||||+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~----i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQ----IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999853  456899999999999999999999998    99999999999998776 6999999998542


Q ss_pred             C------------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccc
Q 048439          426 P------------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ  493 (613)
Q Consensus       426 ~------------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  493 (613)
                      .            ..++..|++||.+....++.++||||+||++|||++|+.||..........................
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE  234 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCch
Confidence            2            1234579999999988899999999999999999999999864432222222111111111222222


Q ss_pred             cccHHHH--HhcccccCCCCCCCHHHHHHH
Q 048439          494 IVDPFLK--AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       494 ~~d~~~~--~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      ..++.+.  ..+||..+|.+||++.+++.+
T Consensus       235 ~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         235 HLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             hhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            3333222  237999999999999999854

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-37  Score=325.31  Aligned_cols=237  Identities=24%  Similarity=0.382  Sum_probs=194.9

Q ss_pred             eeeeeCcEEEEEEEEcC---CceeEEEEEeCCCChh-cHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          279 VIGVGGFGDVYKGFING---STTPVAIKRLEPESQQ-GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~---~~~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      +||+|.||.|++|.+..   +...||||+++..... ...+|++|+.+|.+|+|+|+++|||+..+ ..+.||+|+++.|
T Consensus       117 ~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplG  195 (1039)
T KOG0199|consen  117 LLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLG  195 (1039)
T ss_pred             HhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccc
Confidence            79999999999999853   3466999999887544 67889999999999999999999999987 7889999999999


Q ss_pred             ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCCC------
Q 048439          355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS------  428 (613)
Q Consensus       355 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~------  428 (613)
                      +|.+.|++..+..|-......+|.|||.||.||..++    +|||||.++|+||-..-.+|||||||.|.....      
T Consensus       196 SLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr----lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm  271 (1039)
T KOG0199|consen  196 SLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR----LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVM  271 (1039)
T ss_pred             hHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh----hhhhhhhhhhheecccceeeeecccceeccCCCCcceEe
Confidence            9999998766778888999999999999999999998    999999999999999999999999999853321      


Q ss_pred             -----CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhcc-CCccccccHHHHH
Q 048439          429 -----VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQN-GTIDQIVDPFLKA  501 (613)
Q Consensus       429 -----~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~d~~~~~  501 (613)
                           ....|+|||.++..+++.+||||+|||+||||++ |..||.+.........++......+. .-.++|.+   .+
T Consensus       272 ~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~---im  348 (1039)
T KOG0199|consen  272 APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQ---IM  348 (1039)
T ss_pred             cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHH---HH
Confidence                 2345899999999999999999999999999997 56788766555444444422221111 11223333   34


Q ss_pred             hcccccCCCCCCCHHHHHHHHH
Q 048439          502 MSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ..||..+|.+||++.+|.+.+-
T Consensus       349 k~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  349 KNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             HHhccCCccccccHHHHHHhHH
Confidence            4699999999999999985543

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.9e-36  Score=303.63  Aligned_cols=242  Identities=25%  Similarity=0.451  Sum_probs=192.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||.||++...++ ..+|+|.+.... .....|.+|+.++++++|+||+++++++.+ ...+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~-~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKH-TKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCC-ccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            4677788999999999999987655 569999887543 345678999999999999999999999887 7789999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT----  427 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~----  427 (613)
                      ++|+|.+++.......+++.+++.++.+++.||.|||+.+    ++||||||+||+++.++.+||+|||++.....    
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~----i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC----ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            9999999997655567899999999999999999999988    99999999999999999999999998864221    


Q ss_pred             -----CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          428 -----SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       428 -----~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                           ..+..|++||++..+.++.++|||||||++||+++ |++||.........   .+................... 
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  235 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RALERGYRMPRPENCPEELYNI  235 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHhCCCCCCCcccCCHHHHHH
Confidence                 11235999999999899999999999999999998 89998654322211   111111111111111112211 


Q ss_pred             HhcccccCCCCCCCHHHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ..+||+.+|++||++.+++..|+
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~~L~  258 (260)
T cd05073         236 MMRCWKNRPEERPTFEYIQSVLD  258 (260)
T ss_pred             HHHHcccCcccCcCHHHHHHHHh
Confidence            23799999999999999998886

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.3e-36  Score=306.47  Aligned_cols=195  Identities=26%  Similarity=0.352  Sum_probs=168.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|.....||+|+||.||+|+...++..||+|++....  ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            35777789999999999999998777899999886432  2234568899999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC--
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT--  427 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~--  427 (613)
                      |+++++|..++..  ...++|.+++.++.|++.||.|||+.+    |+||||||+||+++.++.+||+|||++.....  
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHN----CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC----ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            9999988877632  346899999999999999999999988    99999999999999999999999999864322  


Q ss_pred             ------CCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhh
Q 048439          428 ------SVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAA  472 (613)
Q Consensus       428 ------~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~  472 (613)
                            .++..|++||++.+ ..++.++|||||||++|||++|++||.....
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~  206 (286)
T cd07847         155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD  206 (286)
T ss_pred             ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                  23456899999876 5578999999999999999999999965443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-37  Score=306.68  Aligned_cols=247  Identities=23%  Similarity=0.327  Sum_probs=197.7

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCC--CChhcHHHHHHHHHHHhccCccceeeEEEEeec-----CC
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGFCND-----DR  342 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~--~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~-----~~  342 (613)
                      ....|...+.||+|+||.|..+....++..||||++..  .+....+.-.+|+.+|+.++|+||+.+...+..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            34455556689999999999999999889999999973  355566778999999999999999999998754     46


Q ss_pred             ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCC
Q 048439          343 EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS  422 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls  422 (613)
                      ..|+|+|+|+. +|...+.  .+..|+......+..|+++||.|+|+.+    |+||||||+|+|++.+...||||||||
T Consensus       100 DvYiV~elMet-DL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHSAn----ViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  100 DVYLVFELMET-DLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHSAN----VIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eeEEehhHHhh-HHHHHHH--cCccccHHHHHHHHHHHHHhcchhhccc----ccccccchhheeeccCCCEEeccccce
Confidence            78999999954 8888883  4556999999999999999999999998    999999999999999999999999999


Q ss_pred             ccCCC---C-------CCcccCChhhhh-cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCc
Q 048439          423 KFGPT---S-------VSKTHLDPEYYR-LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTI  491 (613)
Q Consensus       423 ~~~~~---~-------~~~~~~aPE~~~-~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~  491 (613)
                      |....   .       .|.-|.|||.+. ...||.+.||||.||+|.||++|++-|.+....+|..++........+..+
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            97632   1       245589999874 468999999999999999999999999887776666555433322221111


Q ss_pred             cccc--------------------------cHHHH--HhcccccCCCCCCCHHHHHHHHH
Q 048439          492 DQIV--------------------------DPFLK--AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       492 ~~~~--------------------------d~~~~--~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ..+-                          ++...  ..++|..||.+|+|++|.+++.-
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPY  312 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPY  312 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence            1111                          11111  12799999999999999997764

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-37  Score=323.19  Aligned_cols=246  Identities=26%  Similarity=0.454  Sum_probs=199.3

Q ss_pred             CCCcceeeeeCcEEEEEEEEc----CCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          274 FDNDLVIGVGGFGDVYKGFIN----GSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~----~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ....++||+|.||.||+|.+.    +...-||||..+.+ .....+.|+.|..+|++++|||||+|+|+|.+. .+++||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence            345568999999999999984    33456999998874 455677899999999999999999999999864 799999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCCC
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS  428 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~  428 (613)
                      |.++-|.|+.+|.. +...|+......+|.|++.||.|||+..    ++||||.++|||+...-.+||+||||||.....
T Consensus       470 EL~~~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSkr----fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  470 ELAPLGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESKR----FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             ecccchhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhhc----hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            99999999999964 4567899999999999999999999998    999999999999999999999999999864322


Q ss_pred             ---------CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          429 ---------VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       429 ---------~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                               ....||+||.+.-.++|.+||||-|||++||++. |..||.+-...+.....+...+...   .+.....+
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~---P~nCPp~L  621 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC---PPNCPPAL  621 (974)
T ss_pred             chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC---CCCCChHH
Confidence                     1345999999999999999999999999999885 8899976554443333332222211   12222222


Q ss_pred             HHHh-cccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          499 LKAM-SCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       499 ~~~~-~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                      ...| +||+.+|.+||.+.++...|...++.
T Consensus       622 YslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  622 YSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             HHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence            2222 89999999999999999999877753

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.3e-36  Score=342.61  Aligned_cols=252  Identities=19%  Similarity=0.270  Sum_probs=191.9

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeec--CCce
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND--DREM  344 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~--~~~~  344 (613)
                      ...++|.....||+|+||.||+|....++..||+|.+...  .......|..|+.+|.+|+|||||++++++.+  ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            3456888889999999999999999888889999998754  33445678999999999999999999998854  4568


Q ss_pred             EEEEEcCCCCChhHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCC---CCcEEeccCCCCceeeCC---------
Q 048439          345 ILVYDFMARGTLPDHLYHS--DNPPLPWNQRLEICIGAARGLHYLHTGAN---HAVIIHRDVKTTNILLDE---------  410 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~---~~~iiHrDlk~~NILl~~---------  410 (613)
                      +|||||+++|+|.++|...  ....+++..++.|+.||+.||.|||+.+.   ...|+||||||+||||+.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999998542  23579999999999999999999998431   012999999999999964         


Q ss_pred             --------CCcEEEEecCCCccCC-------CCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCccchhhh
Q 048439          411 --------KWVAKVSDFGLSKFGP-------TSVSKTHLDPEYYRL--QQLTEKSDVYSFGVVLFEVLCARPSILRTAAK  473 (613)
Q Consensus       411 --------~~~~kl~DFGls~~~~-------~~~~~~~~aPE~~~~--~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~  473 (613)
                              .+.+||+|||+++...       ..++..|+|||++..  ..++.++||||||||||||++|+.||......
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~  249 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF  249 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence                    3459999999986421       235778999999864  45899999999999999999999999654322


Q ss_pred             hhhhHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          474 KQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       474 ~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ...  ........ ...+......+.. ...||..+|.+||++.+++....
T Consensus       250 ~ql--i~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~  297 (1021)
T PTZ00266        250 SQL--ISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQI  297 (1021)
T ss_pred             HHH--HHHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence            211  11111111 1111111111111 22799999999999999985433

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-37  Score=323.02  Aligned_cols=234  Identities=24%  Similarity=0.264  Sum_probs=181.8

Q ss_pred             eeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhcc---CccceeeEEEEeecCCceEEEEEcCCC
Q 048439          280 IGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQL---RHLHLVSLIGFCNDDREMILVYDFMAR  353 (613)
Q Consensus       280 iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~  353 (613)
                      ||+|+||.||+|+...++..||||++....   ......+..|..++.++   +||||+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999998888899999986432   22233456677777665   699999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--------
Q 048439          354 GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--------  425 (613)
Q Consensus       354 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--------  425 (613)
                      |+|.+++..  ...+++..+..++.|+++||+|||+.+    |+||||||+|||+++++.+||+|||+++..        
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~----ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~  154 (330)
T cd05586          81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN  154 (330)
T ss_pred             ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence            999998853  456899999999999999999999998    999999999999999999999999998642        


Q ss_pred             CCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hh
Q 048439          426 PTSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AM  502 (613)
Q Consensus       426 ~~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~  502 (613)
                      ...++..|+|||++.+. .++.++|||||||+||||++|+.||......+........    ........++....  ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~~li~  230 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG----KVRFPKNVLSDEGRQFVK  230 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC----CCCCCCccCCHHHHHHHH
Confidence            12356789999999765 4799999999999999999999999754432211111100    00111112222222  22


Q ss_pred             cccccCCCCCC----CHHHHHHHHH
Q 048439          503 SCLNDEGIRRP----SMSDVVWGLE  523 (613)
Q Consensus       503 ~Cl~~~p~~RP----s~~evl~~Le  523 (613)
                      +||+.+|.+||    ++.+++++..
T Consensus       231 ~~L~~~P~~R~~~~~~~~~ll~h~~  255 (330)
T cd05586         231 GLLNRNPQHRLGAHRDAVELKEHPF  255 (330)
T ss_pred             HHcCCCHHHCCCCCCCHHHHhcCcc
Confidence            79999999998    5677765544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-36  Score=308.14  Aligned_cols=247  Identities=23%  Similarity=0.300  Sum_probs=196.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ++|...+.||+|+||.||++....++..||+|.+.... ......|.+|+++++.++|+||+++++++...+..+|||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            45666679999999999999998777889999886543 34456789999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT-GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----  425 (613)
                      +++|+|.+++..  ...+++.....++.+++.||.|||+ .+    ++||||||+||++++++.++|+|||++...    
T Consensus        85 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~----i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          85 MDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHR----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             CCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcC----eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence            999999998843  3568999999999999999999997 45    999999999999999999999999998642    


Q ss_pred             --CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhh-----hhhhHHHHHHHhhcc--CCcc-ccc
Q 048439          426 --PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAK-----KQVSLAVWAQQCYQN--GTID-QIV  495 (613)
Q Consensus       426 --~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~-----~~~~l~~~~~~~~~~--~~~~-~~~  495 (613)
                        ...++..|++||++....++.++|||||||++|||++|+.||......     .......+.......  ..+. ...
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF  238 (284)
T ss_pred             cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhc
Confidence              123566899999998889999999999999999999999999754332     111111222221111  1111 101


Q ss_pred             cHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          496 DPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       496 d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ...+.  ..+||+.+|.+||++.||++++..
T Consensus       239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~  269 (284)
T cd06620         239 PEDLRDFVDACLLKDPTERPTPQQLCAMPPF  269 (284)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            11111  237999999999999999987654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=8.9e-36  Score=302.94  Aligned_cols=244  Identities=22%  Similarity=0.369  Sum_probs=191.4

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcC-CceeEEEEEeCCC----------ChhcHHHHHHHHHHHhc-cCccceeeEEEEeec
Q 048439          273 NFDNDLVIGVGGFGDVYKGFING-STTPVAIKRLEPE----------SQQGALEFQTEIGMLSQ-LRHLHLVSLIGFCND  340 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~-~~~~vAVK~~~~~----------~~~~~~~f~~Ei~~l~~-l~H~niv~l~g~~~~  340 (613)
                      +|.....||+|+||.||+|.... ++..+|||.+...          ......++..|+.++.+ ++|+||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            46677799999999999999977 5678999987532          22234567889988875 799999999999999


Q ss_pred             CCceEEEEEcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEeccCCCCceeeCCCCcEEEE
Q 048439          341 DREMILVYDFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHT-GANHAVIIHRDVKTTNILLDEKWVAKVS  417 (613)
Q Consensus       341 ~~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~iiHrDlk~~NILl~~~~~~kl~  417 (613)
                      .+..++||||+++++|.+++..  .....+++..++.++.|++.||.|||+ .+    ++||||||+|||+++++.+||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~----i~H~dl~~~nil~~~~~~~~l~  156 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR----IVHRDLTPNNIMLGEDDKVTIT  156 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc----eeecCCCHHHEEECCCCcEEEe
Confidence            9999999999999999998743  234569999999999999999999996 55    9999999999999999999999


Q ss_pred             ecCCCccCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCC
Q 048439          418 DFGLSKFGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT  490 (613)
Q Consensus       418 DFGls~~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~  490 (613)
                      |||++....       ..++..|++||++....++.++||||||+++|||++|++||............  ...... ..
T Consensus       157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~--~~~~~~-~~  233 (269)
T cd08528         157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI--VEAVYE-PL  233 (269)
T ss_pred             cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH--hhccCC-cC
Confidence            999986422       23456799999999988999999999999999999999998654332211111  111111 11


Q ss_pred             ccccccHHHH--HhcccccCCCCCCCHHHHHHHHH
Q 048439          491 IDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       491 ~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ......+.+.  ..+||+.||++||++.||..+++
T Consensus       234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            1111222222  22799999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.4e-36  Score=317.72  Aligned_cols=247  Identities=19%  Similarity=0.261  Sum_probs=191.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...++||+|+||.||+++...++..+|+|.+...   .......|..|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            3677888999999999999999888889999998643   2223445889999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+++|+|.+++... ...+++..+..++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..   
T Consensus        81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~----iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999999542 346899999999999999999999988    999999999999999999999999998531   


Q ss_pred             ------CCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc-cC---C
Q 048439          426 ------PTSVSKTHLDPEYYR-----LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ-NG---T  490 (613)
Q Consensus       426 ------~~~~~~~~~aPE~~~-----~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~-~~---~  490 (613)
                            ...++..|+|||++.     .+.++.++|||||||+||||++|+.||......+......-...... ..   .
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  235 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD  235 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcccc
Confidence                  123577899999986     34678999999999999999999999975443222111110000000 00   0


Q ss_pred             ccccccHHHHHhcccccCCCCCCCHHHHHHHHH
Q 048439          491 IDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       491 ~~~~~d~~~~~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .......++..+.|...++..|+++.|++++..
T Consensus       236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~  268 (332)
T cd05623         236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF  268 (332)
T ss_pred             CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence            111112233333455556666899999987754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8e-36  Score=302.78  Aligned_cols=241  Identities=25%  Similarity=0.357  Sum_probs=188.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-----hhcHHHHHHHHHHHhccCccceeeEEEEeecC--Cce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-----QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD--REM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~--~~~  344 (613)
                      ++|...++||+|+||.||+|....++..||||.+....     ......+.+|+.++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47888889999999999999998888899999875321     22345788999999999999999999998763  467


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++||||+++|+|.+++..  ...+++...+.++.|++.||.|||+.+    |+|+||||+|||++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~----i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSNM----IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC----EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            899999999999999853  345889999999999999999999988    99999999999999999999999998863


Q ss_pred             CC-----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccc
Q 048439          425 GP-----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ  493 (613)
Q Consensus       425 ~~-----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  493 (613)
                      ..           ..++..|+|||.+....++.++|||||||++|||++|++||..........  . ............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~--~-~~~~~~~~~~~~  232 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF--K-IATQPTNPVLPP  232 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH--H-HhcCCCCCCCch
Confidence            21           124556999999998889999999999999999999999996543222211  1 111111111121


Q ss_pred             cc-cHHHHHh-cccccCCCCCCCHHHHHHHH
Q 048439          494 IV-DPFLKAM-SCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       494 ~~-d~~~~~~-~Cl~~~p~~RPs~~evl~~L  522 (613)
                      .. +.....+ +|+ .+|.+||+++||+++.
T Consensus       233 ~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~  262 (265)
T cd06652         233 HVSDHCRDFLKRIF-VEAKLRPSADELLRHT  262 (265)
T ss_pred             hhCHHHHHHHHHHh-cChhhCCCHHHHhcCc
Confidence            12 2221222 466 4899999999998653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=306.90  Aligned_cols=247  Identities=25%  Similarity=0.370  Sum_probs=179.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHH--HhccCccceeeEEEEeecC----CceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGM--LSQLRHLHLVSLIGFCNDD----REMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~--l~~l~H~niv~l~g~~~~~----~~~~  345 (613)
                      ++....+.||+|.||.||+|.+++.  .||||++....+.   .+.+|.++  -..|||+||+.+++.-..+    .+++
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wrGe--~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWRGE--DVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             heeEEEEEecCccccceeeccccCC--ceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            4555666899999999999999985  4999999765433   34445444  4567999999999986544    3689


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC----CCCCcEEeccCCCCceeeCCCCcEEEEecCC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG----ANHAVIIHRDVKTTNILLDEKWVAKVSDFGL  421 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl  421 (613)
                      ||.+|.++|+|.|+|.   ...++....++++..+|.||+|||..    .+++.|.|||||+.|||+..++.+.|+|+||
T Consensus       286 LvTdYHe~GSL~DyL~---r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLN---RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             EeeecccCCcHHHHHh---hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            9999999999999993   36799999999999999999999953    2344499999999999999999999999999


Q ss_pred             Ccc------------CCCCCCcccCChhhhhcCC----C--CchhHHHHHHHHHHHHHhC----------CCCccchhhh
Q 048439          422 SKF------------GPTSVSKTHLDPEYYRLQQ----L--TEKSDVYSFGVVLFEVLCA----------RPSILRTAAK  473 (613)
Q Consensus       422 s~~------------~~~~~~~~~~aPE~~~~~~----~--t~ksDV~SfGvvL~elltg----------~~p~~~~~~~  473 (613)
                      |..            .+..||.+|||||++...-    +  -..+||||||.||||+...          ++||++-.+.
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            842            3456788999999996532    1  1358999999999999853          3666543332


Q ss_pred             hhhhHHHH----HHHhhccCCccccccHHHH----Hh-cccccCCCCCCCHHHHHHHHHHhh
Q 048439          474 KQVSLAVW----AQQCYQNGTIDQIVDPFLK----AM-SCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       474 ~~~~l~~~----~~~~~~~~~~~~~~d~~~~----~~-~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      +...-...    .++..+.....---++.+.    .| .||..+|..|-|+--+-+.|....
T Consensus       443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            22111111    1111111111111223332    22 799999999999888877766443

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.4e-36  Score=311.96  Aligned_cols=239  Identities=22%  Similarity=0.315  Sum_probs=192.3

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCChh
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLP  357 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~  357 (613)
                      ..||+|+||.||++....++..||||.+..........+.+|+.++++++|+||+++++.+...+..++||||+++++|.
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT  107 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence            47999999999999998777899999987666566677899999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--------CCC
Q 048439          358 DHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--------TSV  429 (613)
Q Consensus       358 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--------~~~  429 (613)
                      +++..   ..+++.+++.++.|++.||.|||+.+    |+||||||+||++++++.+||+|||++....        ..+
T Consensus       108 ~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~----ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~  180 (292)
T cd06658         108 DIVTH---TRMNEEQIATVCLSVLRALSYLHNQG----VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVG  180 (292)
T ss_pred             HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC----EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeec
Confidence            98743   35899999999999999999999988    9999999999999999999999999985321        124


Q ss_pred             CcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhccccc
Q 048439          430 SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSCLND  507 (613)
Q Consensus       430 ~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~Cl~~  507 (613)
                      +..|+|||++....++.++|||||||++|||++|+.||.............  .............+..+.  ..+||..
T Consensus       181 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~  258 (292)
T cd06658         181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR--DNLPPRVKDSHKVSSVLRGFLDLMLVR  258 (292)
T ss_pred             CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcCCCccccccccCHHHHHHHHHHccC
Confidence            557999999998899999999999999999999999986543322211111  110000001111222222  1279999


Q ss_pred             CCCCCCCHHHHHHHHHHh
Q 048439          508 EGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       508 ~p~~RPs~~evl~~Le~~  525 (613)
                      +|.+||++.+++++..+.
T Consensus       259 ~P~~Rpt~~~il~~~~~~  276 (292)
T cd06658         259 EPSQRATAQELLQHPFLK  276 (292)
T ss_pred             ChhHCcCHHHHhhChhhh
Confidence            999999999999775543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=308.24  Aligned_cols=246  Identities=24%  Similarity=0.302  Sum_probs=196.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||.|+||.||+|....++..+|+|.+..........|..|+.++++++|+||+++++++.++...++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            46777788999999999999998777899999998776666778999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++|+|.+++... ...+++.....++.|++.||.|||+.+    |+||||||+||+++.++.+||+|||++....     
T Consensus        85 ~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~----i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          85 DGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHK----VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             CCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence            999999988543 346999999999999999999999998    9999999999999999999999999875422     


Q ss_pred             ---CCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccccc-H
Q 048439          427 ---TSVSKTHLDPEYYRL-----QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVD-P  497 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~-----~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-~  497 (613)
                         ..++..|++||++..     ..++.++|||||||++|||++|++||.......  ....+.......-....... .
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  237 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLKILKSEPPTLDQPSKWSSS  237 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHHHhcCCCCCcCCcccCCHH
Confidence               124557999999853     446789999999999999999999996543222  11111111110000111111 1


Q ss_pred             HHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          498 FLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       498 ~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ... ..+||+.+|.+||++.+|+++...
T Consensus       238 ~~~li~~~l~~~p~~Rps~~~il~~~~~  265 (280)
T cd06611         238 FNDFLKSCLVKDPDDRPTAAELLKHPFV  265 (280)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhcChhh
Confidence            111 227999999999999999877553

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.6e-36  Score=303.72  Aligned_cols=245  Identities=27%  Similarity=0.432  Sum_probs=192.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCCChh-cHHHHHHHHHHHhccCccceeeEEEEeecCCceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPESQQ-GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  345 (613)
                      .+|.....||+|+||.||+|+...     ....|++|.+...... ...+|.+|++++++++|+||++++++|.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            467788899999999999999743     3467999988765443 4567999999999999999999999999999999


Q ss_pred             EEEEcCCCCChhHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEe
Q 048439          346 LVYDFMARGTLPDHLYHSD-------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSD  418 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~D  418 (613)
                      +||||+++|+|.+++....       ...+++..++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~----i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR----FVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC----cccCcCccceEEEeCCCcEEEcc
Confidence            9999999999999986433       126999999999999999999999988    99999999999999999999999


Q ss_pred             cCCCccCC---------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhh-c
Q 048439          419 FGLSKFGP---------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCY-Q  487 (613)
Q Consensus       419 FGls~~~~---------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~-~  487 (613)
                      ||+++...         ...+..|++||.+.....+.++|||||||++|||++ |..||.......   ......... .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~~~~~~~  237 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRLQAGKLE  237 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHHHcCCcC
Confidence            99986321         112345999999988889999999999999999999 778885432222   111111111 1


Q ss_pred             cCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          488 NGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       488 ~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ............. ..+||+.+|.+||++.|++..|.
T Consensus       238 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         238 LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1111112122222 23799999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-36  Score=318.74  Aligned_cols=249  Identities=21%  Similarity=0.311  Sum_probs=190.7

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecC-----
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD-----  341 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~-----  341 (613)
                      ...++|.....||+|+||.||+|....++..||||++....  ......+.+|+.+|++++|+||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34577888899999999999999998888899999987542  23345678999999999999999999987543     


Q ss_pred             -CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecC
Q 048439          342 -REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG  420 (613)
Q Consensus       342 -~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG  420 (613)
                       ...++++|++ +++|.+++.   ...+++..+..++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~----ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAG----IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC----eecccCChhhEEECCCCCEEEcCCc
Confidence             4578999988 679988773   346999999999999999999999998    9999999999999999999999999


Q ss_pred             CCccCC-----CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHH-HH-----------
Q 048439          421 LSKFGP-----TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAV-WA-----------  482 (613)
Q Consensus       421 ls~~~~-----~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~-~~-----------  482 (613)
                      +++...     ..++..|+|||++.+ ..++.++|||||||+||||++|+.||......+...... ..           
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         164 LARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             cceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            987532     234667999999877 568999999999999999999999996543222111000 00           


Q ss_pred             -----HHhhc------cCCcc---ccccHHHH--HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          483 -----QQCYQ------NGTID---QIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       483 -----~~~~~------~~~~~---~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                           .....      ...+.   .-.++...  ..+||..||.+|||+.|++.+..+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~  302 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS  302 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence                 00000      00000   00111111  2279999999999999999776543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.1e-35  Score=300.52  Aligned_cols=245  Identities=24%  Similarity=0.337  Sum_probs=198.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh-hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ-QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ++|...+.||+|++|.||+|+...++..|+||++..... .....+.+|+.++.+++|+||+++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            467788899999999999999988788999999877644 4567899999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT-GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---  426 (613)
                      +++++|.+++..  ...+++..++.++.|+++||.|||+ .+    ++||||+|+||+++.++.++|+|||++....   
T Consensus        81 ~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~~----~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKRH----IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhccCC----CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            999999999954  3678999999999999999999999 88    9999999999999999999999999986422   


Q ss_pred             -----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          427 -----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                           ..++..|++||.+....++.++||||||+++|||++|++|+..........+..+..............+..+. 
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  234 (264)
T cd06623         155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD  234 (264)
T ss_pred             CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence                 12345799999999999999999999999999999999998655321222222222211111111110122222 


Q ss_pred             -HhcccccCCCCCCCHHHHHHHH
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                       ..+||..+|++||++.+++++-
T Consensus       235 li~~~l~~~p~~R~~~~~ll~~~  257 (264)
T cd06623         235 FISACLQKDPKKRPSAAELLQHP  257 (264)
T ss_pred             HHHHHccCChhhCCCHHHHHhCH
Confidence             2279999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.5e-36  Score=319.32  Aligned_cols=193  Identities=24%  Similarity=0.322  Sum_probs=166.9

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecC------
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD------  341 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~------  341 (613)
                      ..++|...+.||+|+||.||++.....+..||||++...  .......+.+|+.+++.++|+||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            457898899999999999999998877788999998754  233456788999999999999999999988643      


Q ss_pred             CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCC
Q 048439          342 REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL  421 (613)
Q Consensus       342 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl  421 (613)
                      ...++||||+++ +|.+.+.    ..+++..+..++.|+++||.|||+.+    |+||||||+|||+++++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g----ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCChHHEEECCCCCEEEeeCcc
Confidence            357999999975 6766663    34889999999999999999999998    99999999999999999999999999


Q ss_pred             CccCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          422 SKFGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       422 s~~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                      ++...       ..++..|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  222 (355)
T cd07874         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_pred             cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            87422       235677999999999999999999999999999999999996543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.4e-36  Score=302.10  Aligned_cols=240  Identities=24%  Similarity=0.418  Sum_probs=189.1

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC------hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES------QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~------~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      +|.....||+|+||.||+|.... +..+|||.+....      ......+.+|++++++++|+||++++++|.+.+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~-~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcC-CCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            36677799999999999998754 4679999886432      2223468899999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ||||+++++|.+++..  ...+++..+..++.|++.||.|||+.+    |+|+||+|+||++++++.+||+|||+++...
T Consensus        80 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          80 FMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNC----VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            9999999999999843  346899999999999999999999988    9999999999999999999999999876321


Q ss_pred             --------------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcc
Q 048439          427 --------------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID  492 (613)
Q Consensus       427 --------------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  492 (613)
                                    ..++..|++||++.+..++.++|||||||++|||++|+.||..........  ...........+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~  231 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF--YIGAHRGLMPRLP  231 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH--HhhhccCCCCCCC
Confidence                          123456999999999999999999999999999999999996533222111  1111101111122


Q ss_pred             ccccHHHH--HhcccccCCCCCCCHHHHHHH
Q 048439          493 QIVDPFLK--AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       493 ~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      ...+..+.  ..+||+.+|.+||++.+++.+
T Consensus       232 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         232 DSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            22222222  227999999999999999753

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=326.21  Aligned_cols=238  Identities=24%  Similarity=0.373  Sum_probs=194.6

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCChhH
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPD  358 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~  358 (613)
                      +||+|.||+||-|++..+...+|||.+.....+..+-+..||.+.++|+|+|||+++|.|.+++.+-+.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            79999999999999999999999999988777777888999999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC-CCcEEEEecCCCccC--------CC
Q 048439          359 HLYHSDNPPL--PWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE-KWVAKVSDFGLSKFG--------PT  427 (613)
Q Consensus       359 ~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGls~~~--------~~  427 (613)
                      +|.. .-.+|  .+.+.-.+..||++||.|||+..    |+|||||-+|||++. .|.+||+|||-++..        ..
T Consensus       662 LLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen~----IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF  736 (1226)
T KOG4279|consen  662 LLRS-KWGPLKDNESTMNFYTKQILEGLKYLHENK----IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF  736 (1226)
T ss_pred             HHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhcc----eeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence            9954 34566  78888999999999999999998    999999999999974 689999999987632        23


Q ss_pred             CCCcccCChhhhhcCC--CCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhc
Q 048439          428 SVSKTHLDPEYYRLQQ--LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMS  503 (613)
Q Consensus       428 ~~~~~~~aPE~~~~~~--~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~  503 (613)
                      .||..|||||++..++  |..++|||||||++.||.||+|||............  +......+.+++.+....+  .++
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk--VGmyKvHP~iPeelsaeak~Filr  814 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK--VGMYKVHPPIPEELSAEAKNFILR  814 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh--hcceecCCCCcHHHHHHHHHHHHH
Confidence            4677899999997754  788999999999999999999999654332211111  1111112223333332222  348


Q ss_pred             ccccCCCCCCCHHHHHHHHH
Q 048439          504 CLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       504 Cl~~~p~~RPs~~evl~~Le  523 (613)
                      |+.++|.+||++.++++...
T Consensus       815 cFepd~~~R~sA~~LL~DpF  834 (1226)
T KOG4279|consen  815 CFEPDPCDRPSAKDLLQDPF  834 (1226)
T ss_pred             HcCCCcccCccHHHhccCcc
Confidence            99999999999999986554

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.7e-36  Score=301.93  Aligned_cols=240  Identities=24%  Similarity=0.356  Sum_probs=192.4

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh--hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ--QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +|...+.||+|+||.||+|....++..|++|.++....  .....+..|+.++++++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            46677899999999999999987778899999876543  3567899999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      +++++|.+++..  ...+++..+..|+.+++.||.|||+.+    |+|+||+|+||++++++.+||+|||++....    
T Consensus        81 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~----i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHG----IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999999854  345899999999999999999999988    9999999999999999999999999886421    


Q ss_pred             --------CCCCcccCChhhhhcCC---CCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          427 --------TSVSKTHLDPEYYRLQQ---LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       427 --------~~~~~~~~aPE~~~~~~---~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                              ..++..|++||++....   .+.++||||||+++|||++|+.||..........  ..... .....+....
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~--~~~~~-~~~~~~~~~~  231 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM--FHVGA-GHKPPIPDSL  231 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH--HHHhc-CCCCCCCccc
Confidence                    12355799999998776   8899999999999999999999996443221111  11111 1111111111


Q ss_pred             --cHHHH--HhcccccCCCCCCCHHHHHHH
Q 048439          496 --DPFLK--AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       496 --d~~~~--~~~Cl~~~p~~RPs~~evl~~  521 (613)
                        ++.+.  ..+||+.+|.+||++.|++.+
T Consensus       232 ~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         232 QLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence              22222  237999999999999999753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.1e-36  Score=308.93  Aligned_cols=194  Identities=27%  Similarity=0.381  Sum_probs=167.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|...+.||+|+||.||+|....++..||+|++....  ......+.+|+++++.++|+||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36777789999999999999998777899999876542  2234568899999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC--
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT--  427 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~--  427 (613)
                      |+++++|.++...  ...++|.+++.++.|++.||.|||+.+    |+||||+|+||++++++.+||+|||++.....  
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~----i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999999887643  345899999999999999999999988    99999999999999999999999999864221  


Q ss_pred             ------CCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          428 ------SVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       428 ------~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                            .++..|++||++.+ ..++.++|||||||++|||++|++||....
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~  205 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS  205 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence                  23456899999875 457889999999999999999999986443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.5e-36  Score=318.97  Aligned_cols=193  Identities=23%  Similarity=0.318  Sum_probs=167.1

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecC------
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD------  341 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~------  341 (613)
                      ..++|...+.||+|+||.||++.....+..||||++...  .......+.+|+.+++.++|+||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            346888889999999999999999877788999998754  233456788999999999999999999987543      


Q ss_pred             CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCC
Q 048439          342 REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL  421 (613)
Q Consensus       342 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl  421 (613)
                      ...++||||+++ +|.+.+.    ..+++..+..++.|+++||.|||+.+    |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~----ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhCC----eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999975 7777763    34889999999999999999999988    99999999999999999999999999


Q ss_pred             CccCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          422 SKFGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       422 s~~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                      ++...       ..++..|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus       173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  229 (364)
T cd07875         173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD  229 (364)
T ss_pred             ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence            97432       235677999999999999999999999999999999999996544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-37  Score=321.23  Aligned_cols=242  Identities=27%  Similarity=0.361  Sum_probs=194.9

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      |...+.||.|+||-||.+++..+...||||++.-..   ...+++++.|+..|.+|+|||+|.+-||+..+...+|||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            555568999999999999998888999999997654   34566789999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----C
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----P  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----~  426 (613)
                      |-| +-.|+|.- ...+|.+..+..||.|++.||+|||+.+    .||||||+.||||++.|.+||+|||.+...    .
T Consensus       108 ClG-SAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~~----~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns  181 (948)
T KOG0577|consen  108 CLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN----RIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS  181 (948)
T ss_pred             Hhc-cHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHhh----HHhhhccccceEecCCCeeeeccccchhhcCchhc
Confidence            964 77777632 3567999999999999999999999998    899999999999999999999999987653    3


Q ss_pred             CCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHH-HHHhhccCCccccccHHHHHh
Q 048439          427 TSVSKTHLDPEYYR---LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVW-AQQCYQNGTIDQIVDPFLKAM  502 (613)
Q Consensus       427 ~~~~~~~~aPE~~~---~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~d~~~~~~  502 (613)
                      ..||+.|||||++.   .++|+-|+||||+|++..||...+||...........-+.- ..+.+..+.+.+.+..+..  
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd--  259 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD--  259 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHH--
Confidence            45788999999974   58999999999999999999999999876544332221111 1111122222222222222  


Q ss_pred             cccccCCCCCCCHHHHHHHHH
Q 048439          503 SCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       503 ~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .||++-|.+|||..+++.+..
T Consensus       260 ~CLqKipqeRptse~ll~H~f  280 (948)
T KOG0577|consen  260 SCLQKIPQERPTSEELLKHRF  280 (948)
T ss_pred             HHHhhCcccCCcHHHHhhcch
Confidence            799999999999999987643

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.5e-35  Score=303.08  Aligned_cols=239  Identities=28%  Similarity=0.384  Sum_probs=193.0

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCC
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMA  352 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  352 (613)
                      |...+.||+|+||.||+|....++..||||.+.... ......|.+|+.++++++|+||+++++++.+++..++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            556668999999999999988777899999986543 3345678999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC-----
Q 048439          353 RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-----  427 (613)
Q Consensus       353 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~-----  427 (613)
                      +|+|.+++.   ...+++..+..++.+++.||.|||+.+    ++|+||||+||+++.++.++|+|||++.....     
T Consensus        86 ~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh~~~----i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06641          86 GGSALDLLE---PGPLDETQIATILREILKGLDYLHSEK----KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             CCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHccCC----eecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence            999999884   346899999999999999999999988    99999999999999999999999999864221     


Q ss_pred             ---CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hh
Q 048439          428 ---SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AM  502 (613)
Q Consensus       428 ---~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~  502 (613)
                         .++..|++||++.....+.++|||||||++|||++|..|+............   . ......+....+..+.  ..
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~i~  234 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI---P-KNNPPTLEGNYSKPLKEFVE  234 (277)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH---h-cCCCCCCCcccCHHHHHHHH
Confidence               2455689999999888999999999999999999999998654332211111   1 0111112222222222  33


Q ss_pred             cccccCCCCCCCHHHHHHHHH
Q 048439          503 SCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       503 ~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      +||+.+|.+||++.+++.+..
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~~~  255 (277)
T cd06641         235 ACLNKEPSFRPTAKELLKHKF  255 (277)
T ss_pred             HHccCChhhCcCHHHHHhCHH
Confidence            799999999999999998644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.8e-36  Score=325.88  Aligned_cols=185  Identities=23%  Similarity=0.251  Sum_probs=163.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      .+|.....||+|+||.||+|.....++.||||....      ..+.+|+++|++|+|+|||++++++...+..+||||++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            358888899999999999999988888999996432      24578999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      . ++|.+++... ...++|.+++.|+.|+++||.|||+.+    |+||||||+|||++.++.+||+|||+++...     
T Consensus       243 ~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g----IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        243 R-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             C-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC----EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            5 6898888542 346999999999999999999999998    9999999999999999999999999986421     


Q ss_pred             -----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCcc
Q 048439          427 -----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSIL  468 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~  468 (613)
                           ..++..|++||++.+..++.++|||||||+||||++|..++.
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence                 235778999999999999999999999999999999876553

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.6e-36  Score=306.02  Aligned_cols=247  Identities=21%  Similarity=0.277  Sum_probs=192.5

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      +|...+.||+|+||.||++.....+..||+|.+... .......+.+|+.++.+++|+||+++++++...+..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            566777999999999999999877789999988654 3344567899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---
Q 048439          352 ARGTLPDHLYHSD-NPPLPWNQRLEICIGAARGLHYLHTG-ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---  426 (613)
                      ++++|.+++.... ...+++..+..++.+++.||.|||+. +    |+||||||+||+++.++.+||+|||++....   
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN----IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC----EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            9999998885421 34799999999999999999999964 5    9999999999999999999999999986421   


Q ss_pred             ---CCCCcccCChhhhhcCC------CCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccH
Q 048439          427 ---TSVSKTHLDPEYYRLQQ------LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP  497 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~~------~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  497 (613)
                         ..++..|++||++....      ++.++|||||||++|||++|+.||.................. .........+.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  236 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG-DPPTLPSGYSD  236 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhc-CCCCCCcccCH
Confidence               22455799999986543      488999999999999999999999654322211111101111 11111111222


Q ss_pred             HHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          498 FLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       498 ~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ...  ..+||+.+|.+||++.+++.+...
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~l~~~~~~  265 (286)
T cd06622         237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWL  265 (286)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHhcChhh
Confidence            222  237999999999999999976553

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.5e-36  Score=305.83  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=198.3

Q ss_pred             cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEeec
Q 048439          262 FSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCND  340 (613)
Q Consensus       262 f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~  340 (613)
                      .++.++..+.+.|.....||.|+||.||+|.....+..+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            466777778889999999999999999999998888899999986543 3345688999999998 69999999999853


Q ss_pred             ------CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcE
Q 048439          341 ------DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVA  414 (613)
Q Consensus       341 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~  414 (613)
                            .+..++||||+++|+|.+++.......+++..++.++.|++.||.|||+.+    |+||||||+||++++++.+
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~----ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK----VIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEECCCCCE
Confidence                  457899999999999999986555566889999999999999999999988    9999999999999999999


Q ss_pred             EEEecCCCccCC--------CCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHH
Q 048439          415 KVSDFGLSKFGP--------TSVSKTHLDPEYYR-----LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVW  481 (613)
Q Consensus       415 kl~DFGls~~~~--------~~~~~~~~aPE~~~-----~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~  481 (613)
                      ||+|||++....        ..++..|+|||.+.     ...++.++|||||||++|||++|++||............. 
T Consensus       161 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~-  239 (282)
T cd06636         161 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP-  239 (282)
T ss_pred             EEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh-
Confidence            999999986321        22455799999986     3467889999999999999999999996543322221111 


Q ss_pred             HHHhhccCCcccccc-HHHH-HhcccccCCCCCCCHHHHHHH
Q 048439          482 AQQCYQNGTIDQIVD-PFLK-AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       482 ~~~~~~~~~~~~~~d-~~~~-~~~Cl~~~p~~RPs~~evl~~  521 (613)
                        ............+ .+.. ..+||..+|.+||++.|++.+
T Consensus       240 --~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         240 --RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             --hCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence              1111111111111 1122 227999999999999999754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4e-36  Score=311.04  Aligned_cols=239  Identities=21%  Similarity=0.282  Sum_probs=191.5

Q ss_pred             cceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCCh
Q 048439          277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTL  356 (613)
Q Consensus       277 ~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  356 (613)
                      ...||+|+||.||++....++..||+|.+..........+.+|+.++..++||||+++++++..++..++|+||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            34799999999999999877788999999765555566788999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--------CC
Q 048439          357 PDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--------TS  428 (613)
Q Consensus       357 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--------~~  428 (613)
                      .+++..   ..+++.+++.++.|++.||.|||+.+    ++||||||+|||++.++.+||+|||++....        ..
T Consensus       106 ~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~----ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~  178 (297)
T cd06659         106 TDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG----VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV  178 (297)
T ss_pred             HHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence            987732   45899999999999999999999988    9999999999999999999999999985321        22


Q ss_pred             CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc-CCccccccHHHH-Hhcccc
Q 048439          429 VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN-GTIDQIVDPFLK-AMSCLN  506 (613)
Q Consensus       429 ~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~d~~~~-~~~Cl~  506 (613)
                      ++..|+|||++.+..++.++|||||||++|||++|++||......+.....  ....... .....+.+.... ..+||+
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~i~~~l~  256 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--RDSPPPKLKNAHKISPVLRDFLERMLT  256 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--hccCCCCccccCCCCHHHHHHHHHHhc
Confidence            456799999999989999999999999999999999998654333222111  1110000 001111111111 227999


Q ss_pred             cCCCCCCCHHHHHHHHHH
Q 048439          507 DEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       507 ~~p~~RPs~~evl~~Le~  524 (613)
                      .+|.+||++.+++++...
T Consensus       257 ~~P~~Rps~~~ll~~~~~  274 (297)
T cd06659         257 REPQERATAQELLDHPFL  274 (297)
T ss_pred             CCcccCcCHHHHhhChhh
Confidence            999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.1e-35  Score=300.73  Aligned_cols=240  Identities=21%  Similarity=0.297  Sum_probs=179.2

Q ss_pred             eeeeeCcEEEEEEEEcCC--ceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCC
Q 048439          279 VIGVGGFGDVYKGFINGS--TTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGT  355 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~--~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs  355 (613)
                      .||+|+||.||+|....+  ...+++|.+.... ......|.+|+.+++.++||||++++++|.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            699999999999976433  2346777776543 3455689999999999999999999999999999999999999999


Q ss_pred             hhHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--------
Q 048439          356 LPDHLYHSD--NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--------  425 (613)
Q Consensus       356 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--------  425 (613)
                      |.+++....  ...+++...+.++.|+++||+|||+.+    ++||||||+|||++.++.+||+|||++...        
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~----i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN----FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC----eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            999996532  345677788899999999999999988    999999999999999999999999997531        


Q ss_pred             --CCCCCcccCChhhhhc-------CCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHH-hhccCCcccc
Q 048439          426 --PTSVSKTHLDPEYYRL-------QQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQ-CYQNGTIDQI  494 (613)
Q Consensus       426 --~~~~~~~~~aPE~~~~-------~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~-~~~~~~~~~~  494 (613)
                        ...++..|++||++..       ..++.++|||||||++|||++ |.+|+......+.......... ......+...
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP  237 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence              1123457999999853       245789999999999999997 4667754333222111111100 0111111212


Q ss_pred             ccHH-HHHh-cccccCCCCCCCHHHHHHHHH
Q 048439          495 VDPF-LKAM-SCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       495 ~d~~-~~~~-~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .++. ...+ .|| .+|++||++.+|++.|.
T Consensus       238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         238 YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2222 2222 588 67999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.6e-36  Score=300.57  Aligned_cols=245  Identities=23%  Similarity=0.310  Sum_probs=193.5

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh-hc-HHHHHHHHHHHhccCccc-eeeEEEEeecCC------ce
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ-QG-ALEFQTEIGMLSQLRHLH-LVSLIGFCNDDR------EM  344 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~-~~-~~~f~~Ei~~l~~l~H~n-iv~l~g~~~~~~------~~  344 (613)
                      |.....||+|+||+||+|+...++..||+|+++.... ++ -..-.+|+.+|++|+|+| ||+|++++...+      .+
T Consensus        13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l   92 (323)
T KOG0594|consen   13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL   92 (323)
T ss_pred             HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence            4444579999999999999998889999999987654 23 234589999999999999 999999998877      78


Q ss_pred             EEEEEcCCCCChhHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCC
Q 048439          345 ILVYDFMARGTLPDHLYHSDN--PPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS  422 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls  422 (613)
                      +||+||++. +|.+++.....  ..++...+..+..|+++||+|||+++    |+||||||.|||++++|.+||+|||+|
T Consensus        93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~----IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG----ILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC----eecccCCcceEEECCCCcEeeeccchH
Confidence            999999987 99999865332  35777889999999999999999999    999999999999999999999999999


Q ss_pred             ccCC--------CCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccc
Q 048439          423 KFGP--------TSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ  493 (613)
Q Consensus       423 ~~~~--------~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  493 (613)
                      +...        .-.|.-|.|||++.+. .|+...||||+||++.||+++++-|.+..+.++...+-.......+...+.
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            7432        2235568999999886 789999999999999999999999987776555444333222211111111


Q ss_pred             cc---------------------------cHHHHHhcccccCCCCCCCHHHHHHHHH
Q 048439          494 IV---------------------------DPFLKAMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       494 ~~---------------------------d~~~~~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      +.                           +-.-...+||+.+|.+|.|++.++.+--
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~y  304 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPY  304 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChh
Confidence            00                           1111134789999999999999886643

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-35  Score=302.40  Aligned_cols=241  Identities=23%  Similarity=0.354  Sum_probs=189.1

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh----------hcHHHHHHHHHHHhccCccceeeEEEEeecCC
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ----------QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR  342 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~----------~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~  342 (613)
                      +|...+.||+|+||.||+|....++..||||.++....          ...+.+..|+.++++++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            35667799999999999999887778899998754211          11345788999999999999999999999999


Q ss_pred             ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCC
Q 048439          343 EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS  422 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls  422 (613)
                      ..++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+    ++||||+|+||++++++.+||+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~----i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG----ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC----eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998543  57899999999999999999999988    999999999999999999999999998


Q ss_pred             ccCC----------CCCCcccCChhhhhcCC--CCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc---
Q 048439          423 KFGP----------TSVSKTHLDPEYYRLQQ--LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ---  487 (613)
Q Consensus       423 ~~~~----------~~~~~~~~aPE~~~~~~--~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~---  487 (613)
                      +...          ..++..|++||++....  ++.++||||||+++|||++|..|+.........  .........   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~  233 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM--FKLGNKRSAPPI  233 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH--HHhhccccCCcC
Confidence            6432          12455799999987755  789999999999999999999998543322111  111111101   


Q ss_pred             -cCCccccccHHHHH-hcccccCCCCCCCHHHHHHH
Q 048439          488 -NGTIDQIVDPFLKA-MSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       488 -~~~~~~~~d~~~~~-~~Cl~~~p~~RPs~~evl~~  521 (613)
                       ......+....... .+||..+|.+||++.+|+++
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         234 PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence             11111122222222 27999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.8e-36  Score=316.16  Aligned_cols=195  Identities=23%  Similarity=0.300  Sum_probs=171.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+++...++..||+|.+...   .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4678888999999999999999888889999998653   2223445888999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+++|+|.+++... ...+++..+..++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++...  
T Consensus        81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~----iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLH----YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999542 346899999999999999999999988    9999999999999999999999999985321  


Q ss_pred             -------CCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          427 -------TSVSKTHLDPEYYRL-----QQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       427 -------~~~~~~~~aPE~~~~-----~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                             ..++..|+|||++..     +.++.++|||||||+||||++|+.||....
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~  212 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence                   235778999999976     567899999999999999999999996543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=8.5e-36  Score=305.54  Aligned_cols=194  Identities=24%  Similarity=0.382  Sum_probs=168.7

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +|+..+.||.|+||.||+|+...++..||||++....  ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4777889999999999999998777899999987542  22345789999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      +. ++|.+++.......+++..++.++.|++.||+|||+.+    ++||||+|+||++++++.+||+|||+++...    
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~----i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 68999886655677999999999999999999999988    9999999999999999999999999986421    


Q ss_pred             ----CCCCcccCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          427 ----TSVSKTHLDPEYYRLQQ-LTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~-~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                          ..++..|++||++.+.. ++.++|||||||++|||++|+.||....
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  205 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS  205 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence                12345699999887644 5889999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=310.19  Aligned_cols=244  Identities=21%  Similarity=0.241  Sum_probs=194.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh---hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ---QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|...+++..||+|.+.....   .....+..|++++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            367788899999999999999988778999999876532   24567899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC-
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-  427 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~-  427 (613)
                      ||+.+++|.+++.......+++..+..++.|++.||.|||+.+    ++||||||+||+++.++.++|+|||++..... 
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~----i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC----eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            9999999999986554567999999999999999999999988    99999999999999999999999998753211 


Q ss_pred             ------------------------------------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          428 ------------------------------------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       428 ------------------------------------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                                                          .++..|++||++.+..++.++|||||||++|||++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence                                                23456999999999999999999999999999999999996544


Q ss_pred             hhhhhhHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCC----HHHHHHH
Q 048439          472 AKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPS----MSDVVWG  521 (613)
Q Consensus       472 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs----~~evl~~  521 (613)
                      .....  ...............+.+.... ..+||+.+|++||+    +.|++.+
T Consensus       237 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         237 RDETF--SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             hHHHH--HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            33221  1111111111111111122222 22799999999999    6666654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6.5e-36  Score=301.22  Aligned_cols=242  Identities=20%  Similarity=0.341  Sum_probs=192.6

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +|...+.||+|+||.||+|....++..+|+|.+....  ......+.+|+.++++++|+||+++++.+.+.+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4677789999999999999998887889999986542  23455788999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC-cEEEEecCCCccCC---
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW-VAKVSDFGLSKFGP---  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGls~~~~---  426 (613)
                      +++++|.+++.......++|..++.++.|++.||.|||+.+    ++|+||||+||++++++ .+||+|||++....   
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~----i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK----ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC----cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999999986655556899999999999999999999988    99999999999999885 56999999886422   


Q ss_pred             -----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          427 -----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                           ..++..|+|||++....++.++|||||||++|||++|+.|+..........  ....... ............. 
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~  233 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL--KICQGYF-APISPNFSRDLRSL  233 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH--HHhcccC-CCCCCCCCHHHHHH
Confidence                 124556999999988889999999999999999999999986543322111  1111000 0111111111221 


Q ss_pred             HhcccccCCCCCCCHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      ..+||..+|++||++.|++.+
T Consensus       234 i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         234 ISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             HHHHhccChhhCcCHHHHhhC
Confidence            237999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=304.55  Aligned_cols=194  Identities=23%  Similarity=0.408  Sum_probs=167.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh-cHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ-GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ++|.....||+|+||.||+|....++..||||.+...... ....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            5678888999999999999999877789999998754322 234577899999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      +++ +|.+++... ...+++.....++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++...    
T Consensus        85 ~~~-~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~----i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQRR----VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC----eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 999988543 346899999999999999999999988    9999999999999999999999999986421    


Q ss_pred             ----CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          427 ----TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                          ...+..|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence                123456999999875 457999999999999999999999986443

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-36  Score=315.73  Aligned_cols=245  Identities=22%  Similarity=0.300  Sum_probs=204.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh---cHHHHHHHHHHHhccC-ccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ---GALEFQTEIGMLSQLR-HLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~---~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV  347 (613)
                      ..|...+.||+|.||.||+++...++..+|+|.+.+....   ......+|+.+|+++. |||||.+.+.+++...+++|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            4566667999999999999999998899999999765433   3457899999999998 99999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC----CcEEEEecCCCc
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK----WVAKVSDFGLSK  423 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~----~~~kl~DFGls~  423 (613)
                      ||++.+|.|.+.+...   .+++.....++.|++.+++|||+.+    |+||||||+|+|+...    +.+|++|||+|.
T Consensus       115 mEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g----vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG----VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC----ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            9999999999999665   3999999999999999999999998    9999999999999543    579999999997


Q ss_pred             cCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccccc
Q 048439          424 FGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVD  496 (613)
Q Consensus       424 ~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  496 (613)
                      ...       ..+++.|+|||++....++..+||||+||++|.|+||.+||...........+......+..+.++.+.+
T Consensus       188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence            533       3568899999999999999999999999999999999999987665443332222222334444444433


Q ss_pred             HHHHH-hcccccCCCCCCCHHHHHHHHH
Q 048439          497 PFLKA-MSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       497 ~~~~~-~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ..... ..|+..||.+|+++.+++++.+
T Consensus       268 ~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             HHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence            33222 2799999999999999999865

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.6e-37  Score=293.10  Aligned_cols=250  Identities=22%  Similarity=0.313  Sum_probs=203.2

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC----hhc----HHHHHHHHHHHhcc-CccceeeEEEEeec
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES----QQG----ALEFQTEIGMLSQL-RHLHLVSLIGFCND  340 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~----~~~----~~~f~~Ei~~l~~l-~H~niv~l~g~~~~  340 (613)
                      .-+.|....+||+|..+.|-++..+.++...|+|++....    ...    .++-..|+.+|+++ -||+|+.+.++++.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            3456778889999999999999999888999999986431    111    23356899999998 59999999999999


Q ss_pred             CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecC
Q 048439          341 DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG  420 (613)
Q Consensus       341 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG  420 (613)
                      +..+++|+|.|+.|.|.|+|  .....++++...+|..|+..|++|||..+    |+||||||+|||+|++.++||+|||
T Consensus        95 ~sF~FlVFdl~prGELFDyL--ts~VtlSEK~tR~iMrqlfegVeylHa~~----IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYL--TSKVTLSEKETRRIMRQLFEGVEYLHARN----IVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             cchhhhhhhhcccchHHHHh--hhheeecHHHHHHHHHHHHHHHHHHHHhh----hhhcccChhheeeccccceEEeccc
Confidence            99999999999999999999  44677999999999999999999999998    9999999999999999999999999


Q ss_pred             CCccC-------CCCCCcccCChhhhhcC------CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc
Q 048439          421 LSKFG-------PTSVSKTHLDPEYYRLQ------QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ  487 (613)
Q Consensus       421 ls~~~-------~~~~~~~~~aPE~~~~~------~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~  487 (613)
                      +|+..       ..++|++|+|||.+...      .|+...|+|++||+||.||.|.+||......-...++.-....+.
T Consensus       169 Fa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~  248 (411)
T KOG0599|consen  169 FACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR  248 (411)
T ss_pred             eeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC
Confidence            99753       34689999999988653      567889999999999999999999976543332223322222333


Q ss_pred             cCCccccccHHHHH-hcccccCCCCCCCHHHHHHHHHHh
Q 048439          488 NGTIDQIVDPFLKA-MSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       488 ~~~~~~~~d~~~~~-~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      .+...++.+..... -+||+.||.+|.|++|++.+..+.
T Consensus       249 speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~  287 (411)
T KOG0599|consen  249 SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI  287 (411)
T ss_pred             CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence            33444444433322 279999999999999999887763

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.5e-35  Score=306.01  Aligned_cols=245  Identities=22%  Similarity=0.314  Sum_probs=188.7

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh-----cHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ-----GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~-----~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      +|...+.||+|+||.||+|....++..||||.+......     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            366677999999999999999877789999999765322     234577899999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT  427 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~  427 (613)
                      |||+ +|+|.+++.... ..+++..++.++.|+++||.|||+.+    |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~----i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW----ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC----eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999985432 47999999999999999999999998    99999999999999999999999999864321


Q ss_pred             --------CCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHH----------HHHHhhc-
Q 048439          428 --------SVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAV----------WAQQCYQ-  487 (613)
Q Consensus       428 --------~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~----------~~~~~~~-  487 (613)
                              ..+..|+|||.+.+ ..++.++|||||||++|||++|.++|......+......          |...... 
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence                    12345899999865 457899999999999999999988876443222111110          0000000 


Q ss_pred             c---------C----CccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          488 N---------G----TIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       488 ~---------~----~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .         .    ........... ..+||+.+|.+||++.||+.+-.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~  284 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY  284 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcc
Confidence            0         0    00011111111 23799999999999999987544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.1e-36  Score=316.56  Aligned_cols=187  Identities=27%  Similarity=0.362  Sum_probs=164.2

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ....+|...+.||+|+||.||+|+...++..||+|.....      ....|+.++++++|+||+++++++.+.+..++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            3456799999999999999999999888888999985433      2356999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+. |+|.+++.. ....++|..++.|+.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..   
T Consensus       137 e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHYS-SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQR----IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EccC-CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            9995 588888854 3457999999999999999999999998    999999999999999999999999998642   


Q ss_pred             ----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCc
Q 048439          426 ----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSI  467 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~  467 (613)
                          ...++..|+|||++.+..++.++|||||||+||||+++..++
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence                123567799999999999999999999999999999865554

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.7e-35  Score=299.62  Aligned_cols=242  Identities=27%  Similarity=0.373  Sum_probs=194.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ++|...+.||.|+||.||+|....++..+|+|++.... ......+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888889999999999999988777889999987543 33567799999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC--
Q 048439          351 MARGTLPDHLYHSDN-PPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT--  427 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~--  427 (613)
                      +++++|.+++..... ..+++.....++.|++.||.|||+.+    ++||||||+||++++++.+||+|||++.....  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~----i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG----QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999865332 56899999999999999999999988    99999999999999999999999998753211  


Q ss_pred             ----------CCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcc----
Q 048439          428 ----------SVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID----  492 (613)
Q Consensus       428 ----------~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~----  492 (613)
                                .++..|++||++... ..+.++|||||||++|||++|+.||.......  ........  ......    
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~--~~~~~~~~~~  232 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQN--DPPSLETGAD  232 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhcC--CCCCcCCccc
Confidence                      234569999999877 78999999999999999999999996543321  11111111  111111    


Q ss_pred             --ccccHHHH-HhcccccCCCCCCCHHHHHHH
Q 048439          493 --QIVDPFLK-AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       493 --~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~  521 (613)
                        .+...... ..+||..+|++||++.+++.+
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             cccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              11111112 227999999999999999865

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.9e-35  Score=302.63  Aligned_cols=248  Identities=22%  Similarity=0.262  Sum_probs=195.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecC--CceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD--REMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~  348 (613)
                      ++|...+.||.|++|.||+|....++..+|+|.+.... ......+.+|++++++++|+||++++++|.+.  +.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36777889999999999999998888999999987543 34456789999999999999999999998653  4689999


Q ss_pred             EcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          349 DFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ||+++++|.+++..  .....+++.....++.|++.||.|||+.+    ++|+||+|+||++++++.+||+|||++....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~----i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK----IIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            99999999988743  23456899999999999999999999988    9999999999999999999999999986321


Q ss_pred             ------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhh--hhhhhHHHHHHHhhccCCcccc----
Q 048439          427 ------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAA--KKQVSLAVWAQQCYQNGTIDQI----  494 (613)
Q Consensus       427 ------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~~----  494 (613)
                            ..++..|++||.+....++.++|||||||++|||++|+.||.....  .....+..+....... .+...    
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  235 (287)
T cd06621         157 NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP-ELKDEPGNG  235 (287)
T ss_pred             ccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch-hhccCCCCC
Confidence                  2345579999999999999999999999999999999999865421  1112223332221111 11110    


Q ss_pred             --ccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          495 --VDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       495 --~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                        .++.+.  ..+||..+|.+||++.||+++...
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~  269 (287)
T cd06621         236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI  269 (287)
T ss_pred             CchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence              111111  237999999999999999987764

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.9e-35  Score=299.50  Aligned_cols=245  Identities=22%  Similarity=0.298  Sum_probs=195.8

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      +|+..+.||+|+||.||++....++..+|+|++.... .....++.+|++++++++|+||+++++++...+..++|+||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5667779999999999999998877899999987653 345567899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT-GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-----  425 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-----  425 (613)
                      ++++|.+++.... ..+++.....++.|++.||+|||+ .+    ++||||||+||++++++.+||+|||++...     
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~----i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK----IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC----eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            9999999985432 678999999999999999999999 77    999999999999999999999999998532     


Q ss_pred             -CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc---CCccccccHHHH-
Q 048439          426 -PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN---GTIDQIVDPFLK-  500 (613)
Q Consensus       426 -~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~d~~~~-  500 (613)
                       ...++..|++||++.+..++.++|||||||++|||++|+.|+........ ............   .......+..+. 
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06605         157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNEPPPRLPSGKFSPDFQD  235 (265)
T ss_pred             hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence             13345679999999999999999999999999999999999865421111 111111111111   111111222222 


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHH
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                       ..+||..+|++||++.+++.+..
T Consensus       236 li~~~l~~~p~~Rpt~~~ll~~~~  259 (265)
T cd06605         236 FVNLCLIKDPRERPSYKELLEHPF  259 (265)
T ss_pred             HHHHHcCCCchhCcCHHHHhhCch
Confidence             22799999999999999987654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.3e-35  Score=300.41  Aligned_cols=244  Identities=26%  Similarity=0.399  Sum_probs=187.9

Q ss_pred             CCCcceeeeeCcEEEEEEEEcC---CceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCC------
Q 048439          274 FDNDLVIGVGGFGDVYKGFING---STTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR------  342 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~---~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~------  342 (613)
                      |...++||+|+||.||+|.+..   .+..||||++...  .....+++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            4556789999999999998643   3578999998754  3445667899999999999999999999886532      


Q ss_pred             ceEEEEEcCCCCChhHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEe
Q 048439          343 EMILVYDFMARGTLPDHLYHS----DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSD  418 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~D  418 (613)
                      ..++++||+++|+|.+++...    ....+++...+.++.|++.||+|||+.+    |+||||||+|||+++++.+||+|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~----i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN----FIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----EeecccchhhEEEcCCCCEEECc
Confidence            247899999999999887432    2235899999999999999999999988    99999999999999999999999


Q ss_pred             cCCCccCCC----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhc
Q 048439          419 FGLSKFGPT----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQ  487 (613)
Q Consensus       419 FGls~~~~~----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~  487 (613)
                      ||+++....          ..+..|++||.+....++.++|||||||++|||++ |++|+......+   +..+......
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~~~~  233 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLIKGNR  233 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHHcCCc
Confidence            999874321          11246899999998899999999999999999999 888886543322   1111111111


Q ss_pred             cCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          488 NGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       488 ~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ........+.... ..+||+.+|++||++.++++.|+.
T Consensus       234 ~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         234 LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            1111112222222 337999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.5e-35  Score=301.76  Aligned_cols=249  Identities=21%  Similarity=0.304  Sum_probs=188.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHH-HhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGM-LSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|.....||+|+||.||+|+...++..||+|+++... .....++..|+.. ++.++|+||+++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46788889999999999999998888999999987642 2233455566665 566789999999999999999999999


Q ss_pred             cCCCCChhHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          350 FMARGTLPDHLYHS--DNPPLPWNQRLEICIGAARGLHYLHTG-ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       350 y~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      |++ |+|.+++...  ....+++..++.++.|++.||+|||++ +    ++||||||+|||+++++.+||+|||+++...
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~----i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS----VIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC----eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            997 6888877542  345799999999999999999999986 6    9999999999999999999999999986422


Q ss_pred             -------CCCCcccCChhhhhc----CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          427 -------TSVSKTHLDPEYYRL----QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       427 -------~~~~~~~~aPE~~~~----~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                             ..++..|++||.+.+    ..++.++|||||||++|||++|+.||....... ..+..........-....+.
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLKQVVEEPSPQLPAEKFS  234 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHHHHHhcCCCCCCccccC
Confidence                   234556999999865    456889999999999999999999985422111 11111111111100011111


Q ss_pred             cHHHH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          496 DPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       496 d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ..+.. ..+||..+|.+||++.+++.+-....
T Consensus       235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  266 (283)
T cd06617         235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFEL  266 (283)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence            12222 22799999999999999997665443

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.3e-35  Score=304.38  Aligned_cols=245  Identities=26%  Similarity=0.355  Sum_probs=192.8

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      |...+.||+|+||.||+|+...++..||+|++....   ......+.+|++++++++|+|+++++++|.+++..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            566678999999999999998777899999986432   23345788999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC---
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT---  427 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~---  427 (613)
                      ++ |+|.+.+.. ...+++|.++..++.+++.||.|||+.+    |+||||+|+||+++.++.+||+|||++.....   
T Consensus       107 ~~-g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~----i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (317)
T cd06635         107 CL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN----MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS  180 (317)
T ss_pred             CC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCcccEEECCCCCEEEecCCCccccCCccc
Confidence            97 588777643 2456999999999999999999999988    99999999999999999999999999864332   


Q ss_pred             -CCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--H
Q 048439          428 -SVSKTHLDPEYYR---LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--A  501 (613)
Q Consensus       428 -~~~~~~~aPE~~~---~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~  501 (613)
                       .++..|++||++.   .+.++.++|||||||++|||++|++||.........  ..+........ ........+.  .
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~l~~li  257 (317)
T cd06635         181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQNESPTL-QSNEWSDYFRNFV  257 (317)
T ss_pred             ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH--HHHHhccCCCC-CCccccHHHHHHH
Confidence             3456799999984   467899999999999999999999998654322211  11111111111 1111222222  2


Q ss_pred             hcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          502 MSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      .+||+.+|.+||++.+|+.++.....
T Consensus       258 ~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         258 DSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             HHHccCCcccCcCHHHHHhChhhhcc
Confidence            27999999999999999988775443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.3e-35  Score=303.37  Aligned_cols=238  Identities=22%  Similarity=0.349  Sum_probs=192.2

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCC
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMAR  353 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  353 (613)
                      |.....||+|++|.||++....++..+++|+++.......+.+.+|+.++++++|+||+++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            44445999999999999998777788999998766555566789999999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-------
Q 048439          354 GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-------  426 (613)
Q Consensus       354 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-------  426 (613)
                      ++|.+++..   ..+++..+..++.|++.||.|||+.+    |+||||+|+||++++++.+||+|||++....       
T Consensus       101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~  173 (285)
T cd06648         101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG----VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK  173 (285)
T ss_pred             CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence            999999854   46899999999999999999999998    9999999999999999999999999875321       


Q ss_pred             -CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccc--ccHHHH--H
Q 048439          427 -TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQI--VDPFLK--A  501 (613)
Q Consensus       427 -~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~d~~~~--~  501 (613)
                       ..++..|++||.+.+..++.++|||||||++|||++|+.||.............   .. ........  .+..+.  .
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~l~~li  249 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR---DN-LPPKLKNLHKVSPRLRSFL  249 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH---hc-CCCCCcccccCCHHHHHHH
Confidence             124567999999998889999999999999999999999986543322211111   11 11111111  122222  2


Q ss_pred             hcccccCCCCCCCHHHHHHHH
Q 048439          502 MSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~L  522 (613)
                      .+||+.+|++||++.+++++-
T Consensus       250 ~~~l~~~p~~Rpt~~~il~~~  270 (285)
T cd06648         250 DRMLVRDPAQRATAAELLNHP  270 (285)
T ss_pred             HHHcccChhhCcCHHHHccCc
Confidence            279999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=302.38  Aligned_cols=246  Identities=25%  Similarity=0.320  Sum_probs=192.0

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCC-----
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDR-----  342 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~-----  342 (613)
                      .++++|...+.||+|+||.||+|....++..+++|.+..... ....|.+|+.+++++ .|+||+++++++.+..     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            457889999999999999999999987778899999876543 346789999999999 6999999999997654     


Q ss_pred             -ceEEEEEcCCCCChhHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEec
Q 048439          343 -EMILVYDFMARGTLPDHLYHSD--NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDF  419 (613)
Q Consensus       343 -~~~lV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DF  419 (613)
                       ..++||||+++++|.+++....  ...+++..+..++.|++.||.|||+.+    ++|+||+|+||++++++.+||+||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~----i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK----VIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC----cccCCCCHHHEEEccCCeEEECCC
Confidence             4899999999999999885432  467999999999999999999999988    999999999999999999999999


Q ss_pred             CCCccCC--------CCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhh
Q 048439          420 GLSKFGP--------TSVSKTHLDPEYYRL-----QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCY  486 (613)
Q Consensus       420 Gls~~~~--------~~~~~~~~aPE~~~~-----~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~  486 (613)
                      |++....        ..++..|+|||++..     ..++.++|||||||+||||++|++||........  +........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~  235 (275)
T cd06608         158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFKIPRNPP  235 (275)
T ss_pred             ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHHhhccCC
Confidence            9875321        224556999999864     3467899999999999999999999964332221  111111111


Q ss_pred             ccCCccc-cccHHHH-HhcccccCCCCCCCHHHHHHH
Q 048439          487 QNGTIDQ-IVDPFLK-AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       487 ~~~~~~~-~~d~~~~-~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      ....... ..+.+.. ..+||..||++||++.|++++
T Consensus       236 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         236 PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            0000001 1111111 227999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.4e-35  Score=301.64  Aligned_cols=196  Identities=23%  Similarity=0.353  Sum_probs=167.9

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh-hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ-QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++++|...+.||+|+||.||+|....++..||+|++..... .....+.+|+.++++++|+||+++++++.+++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            45788888999999999999999987778899999865432 23346789999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+. ++|.+.+... ...+++.++..++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++...  
T Consensus        83 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~----i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQH----ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 6777776432 356889999999999999999999988    9999999999999999999999999986421  


Q ss_pred             ------CCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          427 ------TSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       427 ------~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                            ..++..|+|||++.+. .++.++|||||||+||||++|++||....
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence                  1235679999998764 57889999999999999999999996543

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.1e-35  Score=298.15  Aligned_cols=242  Identities=21%  Similarity=0.297  Sum_probs=191.4

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeec--CCceEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND--DREMILVY  348 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~  348 (613)
                      +|...+.||.|+||.||++....++..+|+|.+...  .....+.+..|+.++++++|+||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            366778999999999999999888788999998653  34445678899999999999999999998754  45678999


Q ss_pred             EcCCCCChhHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCcEEeccCCCCceeeCCCCcEEEEecCC
Q 048439          349 DFMARGTLPDHLYHS--DNPPLPWNQRLEICIGAARGLHYLH-----TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL  421 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH-----~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl  421 (613)
                      ||+++++|.+++...  ....+++..++.++.+++.||.|||     +.+    ++|+||||+||++++++.+||+|||+
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~----i~h~dl~p~nili~~~~~~kl~d~g~  156 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT----VLHRDLKPANIFLDANNNVKLGDFGL  156 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc----ceecCCCHHHEEEecCCCEEEecccc
Confidence            999999999998542  2467999999999999999999999     666    99999999999999999999999999


Q ss_pred             CccCC--------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccc
Q 048439          422 SKFGP--------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ  493 (613)
Q Consensus       422 s~~~~--------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  493 (613)
                      +....        ..++..|++||++....++.++||||||+++|+|++|+.|+.......   +...............
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~  233 (265)
T cd08217         157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASKIKEGKFRRIPYR  233 (265)
T ss_pred             cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHHHhcCCCCCCccc
Confidence            86432        234567999999999899999999999999999999999997554221   1111111111111111


Q ss_pred             cccHHHH-HhcccccCCCCCCCHHHHHHH
Q 048439          494 IVDPFLK-AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       494 ~~d~~~~-~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      ..+.... ..+||+.+|.+||++.+|+++
T Consensus       234 ~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         234 YSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            1122211 237999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.3e-35  Score=302.24  Aligned_cols=244  Identities=22%  Similarity=0.321  Sum_probs=190.7

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +|...+.||+|+||.||+|....++..||||++....  ......+.+|+.++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            3667779999999999999998777899999987653  33356789999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      + +++|.+++... ...+++.+++.++.|+++||.|||+.+    ++|+||||+||++++++.++|+|||++....    
T Consensus        81 ~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHANG----IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 99999998543 366999999999999999999999988    9999999999999999999999999986432    


Q ss_pred             -----CCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHH----------HH--------
Q 048439          427 -----TSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAV----------WA--------  482 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~----------~~--------  482 (613)
                           ..++..|+|||++... .++.++|||||||++|||++|+++|.............          |.        
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence                 2235579999998654 46899999999999999999988875543322111110          00        


Q ss_pred             -HHhhccC-------CccccccHHHH-HhcccccCCCCCCCHHHHHHHH
Q 048439          483 -QQCYQNG-------TIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       483 -~~~~~~~-------~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                       .......       ......+.... ..+||..+|.+||++++++.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~  283 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP  283 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence             0000000       00111111111 2379999999999999998764

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.8e-35  Score=301.09  Aligned_cols=239  Identities=23%  Similarity=0.299  Sum_probs=187.7

Q ss_pred             eeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCCh
Q 048439          280 IGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTL  356 (613)
Q Consensus       280 iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  356 (613)
                      ||+|+||+||++....++..||+|.+....   ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999988878899999986532   22344578899999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-------CCC
Q 048439          357 PDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-------TSV  429 (613)
Q Consensus       357 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-------~~~  429 (613)
                      .+++.......+++.+++.++.|++.||.|||+.+    ++||||+|+||++++++.+||+|||++....       ..+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~----i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR----IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccC
Confidence            99997655557999999999999999999999988    9999999999999999999999999886422       223


Q ss_pred             CcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhccccc
Q 048439          430 SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSCLND  507 (613)
Q Consensus       430 ~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~Cl~~  507 (613)
                      +..|++||++.++.++.++|||||||++|||++|+.||............... ............++.+.  ..+||+.
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~  235 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR-TLEMAVEYPDKFSPEAKDLCEALLQK  235 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc-cccccccCCccCCHHHHHHHHHHccC
Confidence            45799999999888999999999999999999999999654331111111100 00011111111222222  2279999


Q ss_pred             CCCCCC-----CHHHHHHHHH
Q 048439          508 EGIRRP-----SMSDVVWGLE  523 (613)
Q Consensus       508 ~p~~RP-----s~~evl~~Le  523 (613)
                      +|.+||     ++.+++.+..
T Consensus       236 ~p~~R~~~~~~~~~~ll~h~~  256 (277)
T cd05577         236 DPEKRLGCRGGSADEVREHPL  256 (277)
T ss_pred             ChhHccCCCcccHHHHHhChh
Confidence            999999     6777765544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.4e-35  Score=304.43  Aligned_cols=247  Identities=28%  Similarity=0.350  Sum_probs=192.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      +.|...+.||+|+||.||+|+...++..||+|.+....   .....++.+|+++++.++||||++++++|.+.+..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45777789999999999999998777899999986432   334457889999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC-
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-  427 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~-  427 (613)
                      ||++ |+|.+++... ...+++..+..++.|++.||.|||+.+    |+||||+|+||++++++.+||+|||++..... 
T Consensus        95 e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~----i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHE----RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCC----ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9997 5777776432 346999999999999999999999988    99999999999999999999999999875432 


Q ss_pred             ---CCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          428 ---SVSKTHLDPEYYR---LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       428 ---~~~~~~~aPE~~~---~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                         .++..|+|||++.   .+.++.++|||||||++|||++|++|+.............+.  ................ 
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l  246 (307)
T cd06607         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPTLSSNDWSDYFRNF  246 (307)
T ss_pred             CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCCCCCchhhCHHHHHH
Confidence               2455799999874   456889999999999999999999998654332211111100  0000000111111111 


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ..+||+.+|++||++.+|+.+.....
T Consensus       247 i~~~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         247 VDSCLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             HHHHhcCChhhCcCHHHHhcChhhcc
Confidence            22799999999999999998766543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-35  Score=317.31  Aligned_cols=188  Identities=28%  Similarity=0.345  Sum_probs=164.8

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcC--CceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFING--STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~--~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ..+|.....||+|+||.||++...+  .+..||||.+....     .+.+|+++|++++|+|||++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            3578888999999999999998643  34679999886432     3568999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      |++. ++|.+++  .....++|.+++.|+.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++...  
T Consensus       166 e~~~-~~l~~~l--~~~~~l~~~~~~~i~~ql~~aL~~LH~~g----ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYV--DRSGPLPLEQAITIQRRLLEALAYLHGRG----IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHCC----ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9996 5888888  33567999999999999999999999998    9999999999999999999999999985321  


Q ss_pred             --------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          427 --------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       427 --------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                              ..++..|+|||++....++.++|||||||+||||++|+.||...
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence                    23567899999999999999999999999999999999998654

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-35  Score=300.68  Aligned_cols=242  Identities=21%  Similarity=0.340  Sum_probs=191.4

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccC---ccceeeEEEEeecCCceEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLR---HLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~  348 (613)
                      .|+..+.||+|+||.||+|....++..||+|.++.. ......++.+|+.++++++   |+|+++++++|.+....++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            466677899999999999999877789999998754 3344567889999999997   999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+++++|.+++..   ..+++...+.++.+++.||.|||+.+    |+||||+|+||++++++.++|+|||++....  
T Consensus        82 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~----i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVG----VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999998843   36899999999999999999999988    9999999999999999999999999886422  


Q ss_pred             ------CCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccc-cccHH
Q 048439          427 ------TSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ-IVDPF  498 (613)
Q Consensus       427 ------~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~d~~  498 (613)
                            ..++..|+|||++..+ .++.++|||||||++|||++|++||...........   ............ .....
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  231 (277)
T cd06917         155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML---IPKSKPPRLEDNGYSKLL  231 (277)
T ss_pred             ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc---cccCCCCCCCcccCCHHH
Confidence                  1244569999998764 468999999999999999999999965433221111   110000010111 11112


Q ss_pred             HH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          499 LK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       499 ~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .. ..+||+.+|++||++.|++.+...
T Consensus       232 ~~~i~~~l~~~p~~R~~~~~il~~~~~  258 (277)
T cd06917         232 REFVAACLDEEPKERLSAEELLKSKWI  258 (277)
T ss_pred             HHHHHHHcCCCcccCcCHHHHhhChHh
Confidence            11 237999999999999999876553

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.3e-35  Score=303.97  Aligned_cols=241  Identities=24%  Similarity=0.314  Sum_probs=195.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|.....||+|+||.||++....++..||+|.+....   ......+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46777889999999999999998878899999986532   233556889999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+++|+|.+++..  ...+++..+..++.|++.||.|||+.+    |+||||+|+|||+++++.+||+|||+++...  
T Consensus        81 e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~----i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSLD----IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            99999999999854  357899999999999999999999988    9999999999999999999999999987532  


Q ss_pred             ---CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--H
Q 048439          427 ---TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--A  501 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~  501 (613)
                         ..++..|++||.+.....+.++||||||+++|||++|+.||............     ......+....+..+.  .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li  229 (290)
T cd05580         155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI-----LEGKVRFPSFFSPDAKDLI  229 (290)
T ss_pred             CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----hcCCccCCccCCHHHHHHH
Confidence               23456799999998888999999999999999999999998654422111111     1111112222333332  2


Q ss_pred             hcccccCCCCCC-----CHHHHHHHHH
Q 048439          502 MSCLNDEGIRRP-----SMSDVVWGLE  523 (613)
Q Consensus       502 ~~Cl~~~p~~RP-----s~~evl~~Le  523 (613)
                      .+||..+|.+||     ++.|++++..
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~l~~~~~  256 (290)
T cd05580         230 RNLLQVDLTKRLGNLKNGVNDIKNHPW  256 (290)
T ss_pred             HHHccCCHHHccCcccCCHHHHHcCcc
Confidence            279999999999     7888876544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-35  Score=301.65  Aligned_cols=194  Identities=26%  Similarity=0.350  Sum_probs=168.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|+..+.||+|+||.||+|....++..||||+++..  .......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            3677888999999999999999888889999998754  23345678999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC--
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT--  427 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~--  427 (613)
                      |++++.|..++.  ....+++.++..++.+++.||.|||+.+    ++||||+|+||++++++.+||+|||++.....  
T Consensus        81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~----i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999877766553  3455899999999999999999999988    99999999999999999999999999864322  


Q ss_pred             -------CCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          428 -------SVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       428 -------~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                             .++..|++||++... .++.++||||||++||||++|++||....
T Consensus       155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~  206 (288)
T cd07833         155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS  206 (288)
T ss_pred             cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                   124569999999888 88999999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=318.62  Aligned_cols=241  Identities=23%  Similarity=0.314  Sum_probs=198.6

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCC
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMAR  353 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  353 (613)
                      |.+...||.|+||+||++..+.++...|-|.+...+.....+|+-||++|+.+.||+||+|++.|..++.++++.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            34445799999999999999988888899999888888999999999999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc--------C
Q 048439          354 GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--------G  425 (613)
Q Consensus       354 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~--------~  425 (613)
                      |-++..+.. -...|.+.++.-+|.+++.||.|||++.    |||||||+.|||+.-+|.++|+|||.+..        .
T Consensus       114 GAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~~----iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD  188 (1187)
T KOG0579|consen  114 GAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQN----IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD  188 (1187)
T ss_pred             chHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhcc----hhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence            999887754 3567999999999999999999999998    99999999999999999999999999742        3


Q ss_pred             CCCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhh-----ccCCccccc
Q 048439          426 PTSVSKTHLDPEYYRL-----QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCY-----QNGTIDQIV  495 (613)
Q Consensus       426 ~~~~~~~~~aPE~~~~-----~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~-----~~~~~~~~~  495 (613)
                      ...|++.|||||+...     .+|..++||||||++|.||..+.||...-.+...  +...+....     ...+...+-
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--llKiaKSePPTLlqPS~Ws~~F~  266 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSEPPTLLQPSHWSRSFS  266 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--HHHHhhcCCCcccCcchhhhHHH
Confidence            4467889999998754     6789999999999999999999999754433221  111111110     011112222


Q ss_pred             cHHHHHhcccccCCCCCCCHHHHHHHHHH
Q 048439          496 DPFLKAMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       496 d~~~~~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      |.+.   .||..||..||++.+++++...
T Consensus       267 DfLk---~cL~Knp~~Rp~aaqll~Hpfv  292 (1187)
T KOG0579|consen  267 DFLK---RCLVKNPRNRPPAAQLLKHPFV  292 (1187)
T ss_pred             HHHH---HHHhcCCccCCCHHHHhhCccc
Confidence            3222   5999999999999999988764

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.3e-35  Score=291.31  Aligned_cols=242  Identities=29%  Similarity=0.403  Sum_probs=195.4

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCC
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMA  352 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  352 (613)
                      +|...+.||+|++|.||++....++..+++|++..........+.+|++++++++|+|++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            36667799999999999999987778899999987765566789999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC-----
Q 048439          353 RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-----  427 (613)
Q Consensus       353 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~-----  427 (613)
                      +++|.+++... ...+++..+..++.+++.||.|||..+    ++||||+|+||++++++.+||+|||++.....     
T Consensus        81 ~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~----i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  155 (253)
T cd05122          81 GGSLKDLLKST-NQTLTESQIAYVCKELLKGLEYLHSNG----IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN  155 (253)
T ss_pred             CCcHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCC----EecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence            99999998543 257999999999999999999999988    99999999999999999999999999865332     


Q ss_pred             --CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccc-ccHHHH-Hhc
Q 048439          428 --SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQI-VDPFLK-AMS  503 (613)
Q Consensus       428 --~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~d~~~~-~~~  503 (613)
                        .++..|++||++.....+.++||||||++++||++|+.|+.............  ............ ...+.. ..+
T Consensus       156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~  233 (253)
T cd05122         156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA--TNGPPGLRNPEKWSDEFKDFLKK  233 (253)
T ss_pred             ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH--hcCCCCcCcccccCHHHHHHHHH
Confidence              23567999999998889999999999999999999999986543222211111  111111000110 111111 227


Q ss_pred             ccccCCCCCCCHHHHHHH
Q 048439          504 CLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       504 Cl~~~p~~RPs~~evl~~  521 (613)
                      ||+.+|++||++.|++++
T Consensus       234 ~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         234 CLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             HccCChhhCCCHHHHhcC
Confidence            999999999999999854

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.8e-35  Score=301.42  Aligned_cols=248  Identities=24%  Similarity=0.350  Sum_probs=198.8

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ..+++|.....||+|+||.||+|.....+..+++|.+..... ....+.+|++++++++|+|++++++++...+..++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            455677777899999999999999987678899999976554 5667899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+++++|.+++.... ..+++..++.++.+++.||.|||+.+    |+|+||+|+||+++.++.+||+|||++....  
T Consensus        95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g----i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN----VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC----eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999996532 47999999999999999999999988    9999999999999999999999999875322  


Q ss_pred             ------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          427 ------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       427 ------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                            ..++..|++||++....++.++|||||||++|||++|+.|+..........  ................+..+.
T Consensus       170 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~  247 (286)
T cd06614         170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--LITTKGIPPLKNPEKWSPEFK  247 (286)
T ss_pred             hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhcCCCCCcchhhCCHHHH
Confidence                  123457999999998889999999999999999999999986543322111  111111111001111222222


Q ss_pred             --HhcccccCCCCCCCHHHHHHHHHH
Q 048439          501 --AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       501 --~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                        ..+||+.+|.+||++.+|+.+...
T Consensus       248 ~li~~~l~~~p~~Rpt~~~il~~~~~  273 (286)
T cd06614         248 DFLNKCLVKDPEKRPSAEELLQHPFL  273 (286)
T ss_pred             HHHHHHhccChhhCcCHHHHhhChHh
Confidence              237999999999999999876654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.6e-35  Score=304.25  Aligned_cols=244  Identities=22%  Similarity=0.323  Sum_probs=196.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||.||+|....++..||+|.+........+.+.+|+.++++++||||++++++|...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57778889999999999999987777889999987655555677899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++|+|.+++..   ..+++.++..++.+++.||.|||+.+    ++||||||+||+++.++.+||+|||++....     
T Consensus        99 ~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~g----i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             CCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC----EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            99999999843   35889999999999999999999998    9999999999999999999999999875321     


Q ss_pred             ---CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--H
Q 048439          427 ---TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--A  501 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~  501 (613)
                         ..++..|++||++..+.++.++|||||||++|||++|++||............ +........ ....++..+.  .
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~l~~li  249 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPELQ-NPEKLSAIFRDFL  249 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-hcCCCCCCC-CccccCHHHHHHH
Confidence               12345699999999888999999999999999999999999654332221111 000000000 1111122222  2


Q ss_pred             hcccccCCCCCCCHHHHHHHHHH
Q 048439          502 MSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .+||+.+|.+||++.+++.+-.+
T Consensus       250 ~~~l~~~p~~Rp~~~~il~h~~~  272 (293)
T cd06647         250 NRCLEMDVEKRGSAKELLQHPFL  272 (293)
T ss_pred             HHHccCChhhCcCHHHHhcCHHH
Confidence            37999999999999999977654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.8e-35  Score=301.77  Aligned_cols=191  Identities=23%  Similarity=0.356  Sum_probs=164.0

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +|...+.||+|+||.||+|+...++..||+|++....  ......+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            3667778999999999999998888899999986542  22235678899999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      ++ ++|.+++... ...+++..++.++.|+++||.|||+.+    |+||||||+||+++.++.+||+|||+++...    
T Consensus        81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~----i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHN----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC----EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            97 4888877542 456999999999999999999999988    9999999999999999999999999986421    


Q ss_pred             ----CCCCcccCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCccc
Q 048439          427 ----TSVSKTHLDPEYYRLQQ-LTEKSDVYSFGVVLFEVLCARPSILR  469 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~-~t~ksDV~SfGvvL~elltg~~p~~~  469 (613)
                          ..++..|+|||++.+.. ++.++|||||||++|||++|+.|+..
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~  202 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  202 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence                22356799999987754 68999999999999999999888643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.2e-35  Score=304.19  Aligned_cols=186  Identities=25%  Similarity=0.417  Sum_probs=154.6

Q ss_pred             cceeeeeCcEEEEEEEEcC--CceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeec--CCceEEEEEcCC
Q 048439          277 DLVIGVGGFGDVYKGFING--STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCND--DREMILVYDFMA  352 (613)
Q Consensus       277 ~~~iG~G~fG~Vy~g~~~~--~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~  352 (613)
                      ...||+|+||.||+|+..+  ....||+|.+....  ....+.+|+.++++++||||+++++++..  +...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            3589999999999999754  34679999987543  23467899999999999999999998853  567899999987


Q ss_pred             CCChhHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee----CCCCcEEEEecCC
Q 048439          353 RGTLPDHLYHS-------DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL----DEKWVAKVSDFGL  421 (613)
Q Consensus       353 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGl  421 (613)
                      + +|.+++...       ....+++..+..++.|++.||.|||+.+    |+||||||+|||+    ++++.+||+|||+
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~----ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC----EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            5 777776321       2235899999999999999999999988    9999999999999    5678999999999


Q ss_pred             CccCC-----------CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccc
Q 048439          422 SKFGP-----------TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILR  469 (613)
Q Consensus       422 s~~~~-----------~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~  469 (613)
                      ++...           ..++..|+|||++.+ ..++.++|||||||++|||++|++||..
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            86421           123566999999976 4579999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.9e-35  Score=305.21  Aligned_cols=186  Identities=26%  Similarity=0.419  Sum_probs=154.8

Q ss_pred             cceeeeeCcEEEEEEEEcC--CceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeec--CCceEEEEEcCC
Q 048439          277 DLVIGVGGFGDVYKGFING--STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCND--DREMILVYDFMA  352 (613)
Q Consensus       277 ~~~iG~G~fG~Vy~g~~~~--~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~  352 (613)
                      ...||+|+||.||+|+..+  .+..||+|.+....  ....+.+|+.+|++++||||+++++++..  +...++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            3589999999999999753  45779999986542  23457889999999999999999998854  456889999997


Q ss_pred             CCChhHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee----CCCCcEEEEecCC
Q 048439          353 RGTLPDHLYHS-------DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL----DEKWVAKVSDFGL  421 (613)
Q Consensus       353 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGl  421 (613)
                      + +|.+++...       ....+++..+..++.|++.||.|||+.+    |+||||||+|||+    +.++.+||+|||+
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~----ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC----EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            5 888876421       1235899999999999999999999998    9999999999999    5668999999999


Q ss_pred             CccCC-----------CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccc
Q 048439          422 SKFGP-----------TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILR  469 (613)
Q Consensus       422 s~~~~-----------~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~  469 (613)
                      ++...           ..++..|+|||++.+ ..++.++|||||||++|||++|++||..
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            86421           234567999999977 4589999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8.2e-35  Score=294.67  Aligned_cols=237  Identities=21%  Similarity=0.245  Sum_probs=189.1

Q ss_pred             eeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCCh
Q 048439          280 IGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTL  356 (613)
Q Consensus       280 iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  356 (613)
                      ||.|+||.||+++...++..+|+|.+....   ....+.+.+|+.++++++|+||+++++++.+++..++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999998777889999986542   23446789999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC-------CC
Q 048439          357 PDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-------SV  429 (613)
Q Consensus       357 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~-------~~  429 (613)
                      .+++..  ...+++..+..++.|++.||+|||+.+    ++|+||+|+||+++.++.+||+|||+++....       .+
T Consensus        81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~----~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~  154 (262)
T cd05572          81 WTILRD--RGLFDEYTARFYIACVVLAFEYLHNRG----IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCG  154 (262)
T ss_pred             HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCC----cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccC
Confidence            999954  345899999999999999999999988    99999999999999999999999999875332       23


Q ss_pred             CcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhccccc
Q 048439          430 SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSCLND  507 (613)
Q Consensus       430 ~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~Cl~~  507 (613)
                      +..|++||.+....++.++|+||||+++|||++|..|+................ ...........+..+.  ..+||+.
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~  233 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK-GNGKLEFPNYIDKAAKDLIKQLLRR  233 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc-cCCCCCCCcccCHHHHHHHHHHccC
Confidence            567999999988889999999999999999999999996554211111111110 0111112222222222  2279999


Q ss_pred             CCCCCCC-----HHHHHHHHH
Q 048439          508 EGIRRPS-----MSDVVWGLE  523 (613)
Q Consensus       508 ~p~~RPs-----~~evl~~Le  523 (613)
                      +|.+||+     ++|++++..
T Consensus       234 ~p~~R~~~~~~~~~~l~~~~~  254 (262)
T cd05572         234 NPEERLGNLKGGIKDIKKHKW  254 (262)
T ss_pred             ChhhCcCCcccCHHHHhcChh
Confidence            9999999     788876554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2e-35  Score=298.50  Aligned_cols=240  Identities=25%  Similarity=0.282  Sum_probs=193.3

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      +|...+.||.|+||.||+|....++..||+|.+....   ....+.+.+|++++++++||||+++++++.+.+..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4677789999999999999998777889999987542   2446789999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---  426 (613)
                      |+++++|.+++..  ...+++.....++.++++||.|||+.+    ++|+||+|+||++++++.+||+|||++....   
T Consensus        81 ~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~----i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQ--KVKFSEEQVKFWICEIVLALEYLHSKG----IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHhCC----eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            9999999999854  357999999999999999999999988    9999999999999999999999999986432   


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccccc-HHHH-
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVD-PFLK-  500 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-~~~~-  500 (613)
                          ..++..|++||++....++.++||||||+++|+|++|+.|+.................  .......... .... 
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  232 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDA  232 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHH
Confidence                2345579999999998899999999999999999999999975543211111111110  1111111222 2222 


Q ss_pred             HhcccccCCCCCCCH--HHHHH
Q 048439          501 AMSCLNDEGIRRPSM--SDVVW  520 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~--~evl~  520 (613)
                      ..+||..+|.+||++  .|++.
T Consensus       233 i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         233 INKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             HHHHccCChhHcCCccHHHHhc
Confidence            227999999999999  77653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.1e-34  Score=299.05  Aligned_cols=194  Identities=23%  Similarity=0.361  Sum_probs=164.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccC-ccceeeEEEEeecCCc-----
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDRE-----  343 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~-----  343 (613)
                      ++|+..+.||+|+||.||+|....++..||||.+....  ......+.+|+.++++++ |+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888889999999999999998888899999876543  223457889999999995 6999999999887665     


Q ss_pred             eEEEEEcCCCCChhHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC-CCcEEEEec
Q 048439          344 MILVYDFMARGTLPDHLYHSD---NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE-KWVAKVSDF  419 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~-~~~~kl~DF  419 (613)
                      .++||||+++ +|.+++....   ...+++..++.++.||+.||.|||+.+    |+||||||+||+++. ++.+||+||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~----i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG----VMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeecCCChHHEEEecCCCeEEEeec
Confidence            8999999986 8988875432   346899999999999999999999988    999999999999998 899999999


Q ss_pred             CCCccCC--------CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          420 GLSKFGP--------TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       420 Gls~~~~--------~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                      |+++...        ...+..|+|||++.+ ..++.++|||||||++|||++|.+||...
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  215 (295)
T cd07837         156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD  215 (295)
T ss_pred             ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence            9986421        123456999999865 45799999999999999999999998654

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.4e-34  Score=296.41  Aligned_cols=195  Identities=23%  Similarity=0.402  Sum_probs=168.4

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh-cHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ-GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      +|+..+.||.|++|.||+|+...++..||||.++..... ....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            477788999999999999999888889999998765432 3456788999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-----
Q 048439          352 ARGTLPDHLYHSD-NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-----  425 (613)
Q Consensus       352 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-----  425 (613)
                      ++ +|.+++.... ...+++.++..++.|++.||.|||+.+    ++||||||+||++++++.+||+|||+++..     
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR----VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC----eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            85 8888875432 356999999999999999999999988    999999999999999999999999998632     


Q ss_pred             ---CCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhh
Q 048439          426 ---PTSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAA  472 (613)
Q Consensus       426 ---~~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~  472 (613)
                         ...++..|++||++.+. .++.++|||||||++|||++|++||.....
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~  206 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN  206 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence               12235569999998664 468899999999999999999999865443

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.8e-34  Score=297.49  Aligned_cols=195  Identities=23%  Similarity=0.372  Sum_probs=165.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|.....||+|+||.||+|....+++.||+|.+....  ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46788889999999999999998778899999986543  2334568899999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC-CCcEEEEecCCCccCC--
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE-KWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGls~~~~--  426 (613)
                      |++ ++|.+++.......+++.....++.|++.||+|||+.+    ++||||||+||++++ ++.+||+|||++....  
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~----i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR----VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC----eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 58888875544445788889999999999999999988    999999999999985 5679999999986421  


Q ss_pred             ------CCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          427 ------TSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       427 ------~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                            ..++..|++||++.+. .++.++|||||||++|||++|++||....
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~  208 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS  208 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                  1224569999998764 57899999999999999999999996543

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.6e-35  Score=298.24  Aligned_cols=238  Identities=24%  Similarity=0.295  Sum_probs=182.2

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHh---ccCccceeeEEEEeecCCceEEEEEcCC
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLS---QLRHLHLVSLIGFCNDDREMILVYDFMA  352 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~---~l~H~niv~l~g~~~~~~~~~lV~Ey~~  352 (613)
                      +||+|+||.||++....++..+|+|.+....   ......+.+|..++.   ..+|+||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999998878899999886542   122233445544443   4479999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC------C
Q 048439          353 RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG------P  426 (613)
Q Consensus       353 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~------~  426 (613)
                      +|+|.+++..  ...++|.++..++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||++...      .
T Consensus        81 ~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~----ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  154 (279)
T cd05633          81 GGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA  154 (279)
T ss_pred             CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----cCCCCCCHHHEEECCCCCEEEccCCcceeccccCccC
Confidence            9999998853  456999999999999999999999998    999999999999999999999999998532      1


Q ss_pred             CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhc
Q 048439          427 TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMS  503 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~  503 (613)
                      ..++..|+|||.+.. ..++.++|||||||++|||++|+.||..........+..... . ....+.......+.  ..+
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~li~~  232 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-T-VNVELPDSFSPELKSLLEG  232 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-c-CCcCCccccCHHHHHHHHH
Confidence            235678999999864 557999999999999999999999996543322221111111 1 11111112222222  227


Q ss_pred             ccccCCCCCC-----CHHHHHHHHHH
Q 048439          504 CLNDEGIRRP-----SMSDVVWGLEF  524 (613)
Q Consensus       504 Cl~~~p~~RP-----s~~evl~~Le~  524 (613)
                      ||..||.+||     ++.+++++..+
T Consensus       233 ~l~~~p~~R~~~~~~~~~~~~~h~~~  258 (279)
T cd05633         233 LLQRDVSKRLGCLGRGAQEVKEHVFF  258 (279)
T ss_pred             HhcCCHHHhcCCCCCCHHHHHhCccc
Confidence            9999999999     69999877654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2e-34  Score=289.35  Aligned_cols=240  Identities=24%  Similarity=0.394  Sum_probs=194.1

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecC--CceEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD--REMILVY  348 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~  348 (613)
                      +|...+.||+|++|.||+|....++..|++|.+....  ....+.+.+|+.++++++|+||+++++.+.+.  +..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4667789999999999999998777889999987654  24567899999999999999999999999988  8899999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+++++|.+++...  ..++|.+++.++.++++||.|||+.+    ++|+||+|+||+++.++.+||+|||.+....  
T Consensus        81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~----~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC----ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999998543  38999999999999999999999988    9999999999999999999999999876422  


Q ss_pred             --------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHh-hccCCccccccH
Q 048439          427 --------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC-YQNGTIDQIVDP  497 (613)
Q Consensus       427 --------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~d~  497 (613)
                              ..++..|++||.+.....+.++||||||++++||++|+.||........   ..+.... .....+....+.
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  231 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA---ALYKIGSSGEPPEIPEHLSE  231 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHhccccCCCcCCCcccCH
Confidence                    2245579999999988899999999999999999999999965541111   1111110 011111122222


Q ss_pred             HHH--HhcccccCCCCCCCHHHHHHH
Q 048439          498 FLK--AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       498 ~~~--~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      .+.  ..+|++.+|.+||++.|++.+
T Consensus       232 ~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         232 EAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             HHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            222  238999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-35  Score=298.36  Aligned_cols=193  Identities=25%  Similarity=0.366  Sum_probs=166.2

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      |...+.||.|++|.||+|....++..||+|++....  ......+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            456678999999999999998777899999987543  223456889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      + ++|.+++.......+++..++.++.|+++||.|||+.+    ++||||+|+||++++++.+||+|||+++...     
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~----~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR----VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 69999886544457999999999999999999999988    9999999999999999999999999986421     


Q ss_pred             ---CCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          427 ---TSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                         ..++..|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  204 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS  204 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence               1224569999988664 56899999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.5e-34  Score=298.94  Aligned_cols=197  Identities=27%  Similarity=0.393  Sum_probs=167.5

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCC----
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR----  342 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~----  342 (613)
                      .+.++|+....||+|+||.||+|....++..||||+++...  ......+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678889999999999999999998877889999987543  233456788999999999999999999987655    


Q ss_pred             ------ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEE
Q 048439          343 ------EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKV  416 (613)
Q Consensus       343 ------~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl  416 (613)
                            .+++|+||+++ +|.+.+... ...+++.+++.++.|++.||+|||+.+    |+||||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~----i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN----FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 777776433 457999999999999999999999998    999999999999999999999


Q ss_pred             EecCCCccCCC---------CCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          417 SDFGLSKFGPT---------SVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       417 ~DFGls~~~~~---------~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                      +|||++.....         ..+..|++||.+.. ..++.++|||||||++|||++|++||....
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~  222 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ  222 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999874321         12446999998865 356899999999999999999999996543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.3e-36  Score=316.82  Aligned_cols=240  Identities=23%  Similarity=0.386  Sum_probs=196.2

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCC----CChhcHHHHHHHHHHHhccCccceeeEEEEeecCCc--eEEEEEcCC
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEP----ESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDRE--MILVYDFMA  352 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~----~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~--~~lV~Ey~~  352 (613)
                      +||+|+|-+||||.+..++..||--.++.    .+....+.|..|+.+|+.|+|+|||+++.++.+...  +.+|+|.|.
T Consensus        47 vLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~T  126 (632)
T KOG0584|consen   47 VLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFT  126 (632)
T ss_pred             hcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeeccc
Confidence            89999999999999988887776543322    245556789999999999999999999999987655  789999999


Q ss_pred             CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC-CcEEEEecCCCccC------
Q 048439          353 RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK-WVAKVSDFGLSKFG------  425 (613)
Q Consensus       353 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGls~~~------  425 (613)
                      .|+|+.++.  +-..++.+....||+||++||+|||++.  +||||||||.+||+|+.+ |.+||+|+|||...      
T Consensus       127 SGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs~~--PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ak  202 (632)
T KOG0584|consen  127 SGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHSQD--PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAK  202 (632)
T ss_pred             CCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhcCC--CCccccccccceEEEcCCcCceeecchhHHHHhhccccc
Confidence            999999984  3456888999999999999999999976  459999999999999865 89999999998642      


Q ss_pred             CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHHH--hc
Q 048439          426 PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKA--MS  503 (613)
Q Consensus       426 ~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~--~~  503 (613)
                      .--||+.|||||.+. ..|++..||||||++|+||+|+..|+.......++.  ..+..-.....+..+-||..+.  .+
T Consensus       203 svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY--KKV~SGiKP~sl~kV~dPevr~fIek  279 (632)
T KOG0584|consen  203 SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY--KKVTSGIKPAALSKVKDPEVREFIEK  279 (632)
T ss_pred             eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH--HHHHcCCCHHHhhccCCHHHHHHHHH
Confidence            235789999999998 789999999999999999999999996655444332  2233333444566667776663  38


Q ss_pred             ccccCCCCCCCHHHHHHHHHHhh
Q 048439          504 CLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       504 Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      |+.. .++||++.|+|..-.+..
T Consensus       280 Cl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  280 CLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             HhcC-chhccCHHHHhhChhhcc
Confidence            9998 999999999997765443

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.9e-35  Score=300.09  Aligned_cols=244  Identities=23%  Similarity=0.322  Sum_probs=186.9

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccC-ccceeeEEEEeecCCceEEEEEc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +|.....||+|+||.||++....++..||+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            3444558999999999999998888999999987543 334567899999999996 99999999999999999999999


Q ss_pred             CCCCChhHH---hhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-
Q 048439          351 MARGTLPDH---LYHSDNPPLPWNQRLEICIGAARGLHYLHTG-ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-  425 (613)
Q Consensus       351 ~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-  425 (613)
                      +.. +|.++   +.......+++.....++.+++.||+|||+. +    |+||||||+|||++.++.+||+|||+++.. 
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~----i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK----IIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC----eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            874 55443   3333446799999999999999999999975 6    999999999999999999999999998532 


Q ss_pred             ------CCCCCcccCChhhhhcC---CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcc----
Q 048439          426 ------PTSVSKTHLDPEYYRLQ---QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID----  492 (613)
Q Consensus       426 ------~~~~~~~~~aPE~~~~~---~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~----  492 (613)
                            ...++..|++||++...   .++.++|||||||++|||++|++||....... ..+.....  .....+.    
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~--~~~~~~~~~~~  236 (288)
T cd06616         160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF-DQLTQVVK--GDPPILSNSEE  236 (288)
T ss_pred             cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH-HHHhhhcC--CCCCcCCCcCC
Confidence                  12345679999999876   68999999999999999999999986432110 01111000  0000110    


Q ss_pred             -ccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          493 -QIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       493 -~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                       .+...+.. ..+||+.+|++||++.+|+.+..+
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~  270 (288)
T cd06616         237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFI  270 (288)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence             11112222 227999999999999999977654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=296.15  Aligned_cols=193  Identities=26%  Similarity=0.417  Sum_probs=166.1

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecC--CceEEEEE
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD--REMILVYD  349 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E  349 (613)
                      |...+.||+|+||.||+|+...++..+|+|++....  ......+.+|++++++++|+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            455678999999999999998877899999998653  33445788999999999999999999999888  89999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC--
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT--  427 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~--  427 (613)
                      |+++ +|.+++... ...+++.+++.++.|++.||+|||+.+    ++|+||||+|||+++++.+||+|||++.....  
T Consensus        81 ~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~----~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNG----ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC----ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9985 898888543 257999999999999999999999988    99999999999999999999999999864321  


Q ss_pred             -------CCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhh
Q 048439          428 -------SVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAA  472 (613)
Q Consensus       428 -------~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~  472 (613)
                             ..+..|++||.+.+ ..++.++||||||+++|||++|++||.....
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~  207 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE  207 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                   22456999998765 4578999999999999999999999865443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.2e-34  Score=298.76  Aligned_cols=194  Identities=23%  Similarity=0.364  Sum_probs=166.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh--hcHHHHHHHHHHHhccCccceeeEEEEeecC--CceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ--QGALEFQTEIGMLSQLRHLHLVSLIGFCNDD--REMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV  347 (613)
                      ++|...+.||+|+||.||+|....++..+|+|.++....  .....+.+|+.++.+++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            467778899999999999999988788999999875432  2234577899999999999999999998877  899999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT  427 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~  427 (613)
                      |||+++ +|.+++... ...+++..++.++.|++.||.|||+.+    ++||||||+|||+++++.+||+|||+++....
T Consensus        85 ~e~~~~-~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~----i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDNW----ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999984 999888543 346999999999999999999999988    99999999999999999999999999864221


Q ss_pred             --------CCCcccCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          428 --------SVSKTHLDPEYYRLQQ-LTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       428 --------~~~~~~~aPE~~~~~~-~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                              .++..|+|||++.+.. ++.++|||||||++|||++|++||....
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~  211 (293)
T cd07843         159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS  211 (293)
T ss_pred             CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                    2345699999987644 6899999999999999999999986543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=290.31  Aligned_cols=238  Identities=26%  Similarity=0.430  Sum_probs=194.4

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh--hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ--QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +|.....||+|++|.||+++...++..|++|.+.....  .....+.+|++++++++|+|++++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            36677899999999999999987778899999977643  4566799999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      +++++|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+||+++.++.+||+|||++....    
T Consensus        81 ~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~----i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLHEQG----VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHhhCC----cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            999999999854  367999999999999999999999988    9999999999999999999999999986422    


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--  500 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--  500 (613)
                          ..++..|++||++.....+.++||||||+++|||++|+.|+.......    ..+.........+...++..+.  
T Consensus       155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  230 (254)
T cd06627         155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALFRIVQDDHPPLPEGISPELKDF  230 (254)
T ss_pred             cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHhccCCCCCCCCCCHHHHHH
Confidence                233556999999988888999999999999999999999986443211    1111111112222222232222  


Q ss_pred             HhcccccCCCCCCCHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVW  520 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~  520 (613)
                      ..+||..+|++||++.+++.
T Consensus       231 i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         231 LMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             HHHHHhCChhhCcCHHHHhc
Confidence            23799999999999999974

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.4e-35  Score=316.90  Aligned_cols=202  Identities=25%  Similarity=0.343  Sum_probs=177.0

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC-c-----cceeeEEEEeecCCceEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-H-----LHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H-----~niv~l~g~~~~~~~~~l  346 (613)
                      +|....+||+|.||.|-||....+++.||||+++... .-..+-+.|+.+|..|+ |     -|+|++++|+...+++||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            6778889999999999999999999999999998654 33345578999999997 3     599999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC--CcEEEEecCCCcc
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK--WVAKVSDFGLSKF  424 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~--~~~kl~DFGls~~  424 (613)
                      |+|.+.. +|.++|...+-..|+......|+.||+.||.+||+.+    |||+||||+||||.+-  ..+||+|||.|+.
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~----IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG----IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----eeeccCChhheeeccCCcCceeEEecccccc
Confidence            9999976 9999998777788999999999999999999999988    9999999999999653  3799999999986


Q ss_pred             CCCC-----CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHH
Q 048439          425 GPTS-----VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAV  480 (613)
Q Consensus       425 ~~~~-----~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~  480 (613)
                      ....     .+..|.|||++.+.+|+.+.||||||||+.||++|.|-|.+..+.+|...+.
T Consensus       341 ~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~  401 (586)
T KOG0667|consen  341 ESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARII  401 (586)
T ss_pred             cCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHH
Confidence            4432     2456899999999999999999999999999999999888777777655443

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.7e-34  Score=292.63  Aligned_cols=247  Identities=19%  Similarity=0.186  Sum_probs=189.2

Q ss_pred             CHHHHHHHhcCCCCccee--eeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEee
Q 048439          263 SLSEIQAATNNFDNDLVI--GVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCN  339 (613)
Q Consensus       263 ~~~el~~at~~f~~~~~i--G~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~  339 (613)
                      +..++....++|...+.+  |+|+||.||++....++..+|+|.+.......     .|+.....+ +|+||+++++++.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEe
Confidence            344555556777776666  99999999999998888889999986542211     122222222 6999999999999


Q ss_pred             cCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC-cEEEEe
Q 048439          340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW-VAKVSD  418 (613)
Q Consensus       340 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~-~~kl~D  418 (613)
                      ..+..++||||+++|+|.+++...  ..++|.+++.++.|+++||.|||+.+    ++||||||+||+++.++ .++|+|
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~----i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHN----IIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC----eeeCCCCHHHEEEeCCCCeEEEec
Confidence            999999999999999999998543  47999999999999999999999998    99999999999999998 999999


Q ss_pred             cCCCccCC----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccc
Q 048439          419 FGLSKFGP----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQI  494 (613)
Q Consensus       419 FGls~~~~----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  494 (613)
                      ||+++...    ..++..|+|||++....++.++|||||||++|||++|+.||...... ......+.............
T Consensus       154 fg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~  232 (267)
T PHA03390        154 YGLCKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQQKKLPFIKN  232 (267)
T ss_pred             CccceecCCCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhhcccCCcccc
Confidence            99986432    23466799999999999999999999999999999999999743222 12222232222111112222


Q ss_pred             ccHHHH--HhcccccCCCCCCC-HHHHHHH
Q 048439          495 VDPFLK--AMSCLNDEGIRRPS-MSDVVWG  521 (613)
Q Consensus       495 ~d~~~~--~~~Cl~~~p~~RPs-~~evl~~  521 (613)
                      .++.+.  ..+||+.+|.+||+ +++++++
T Consensus       233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        233 VSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             cCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            333332  22799999999996 6998754

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.9e-35  Score=297.03  Aligned_cols=245  Identities=23%  Similarity=0.238  Sum_probs=196.8

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      +|...+.||.|.-|+||++++.++....|+|++.+..   .......+.|-+||+.++||.++.|++.++.++..|||||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            3445558999999999999999998999999998763   3344557789999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----  425 (613)
                      ||+||+|..++++.....+++.....++..|+.||+|||-.|    ||.|||||+||||.++|++-|+||.||...    
T Consensus       158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG----ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG----IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc----eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            999999999998877889999999999999999999999999    999999999999999999999999986210    


Q ss_pred             ---------------------------------C---------------------------CCCCcccCChhhhhcCCCC
Q 048439          426 ---------------------------------P---------------------------TSVSKTHLDPEYYRLQQLT  445 (613)
Q Consensus       426 ---------------------------------~---------------------------~~~~~~~~aPE~~~~~~~t  445 (613)
                                                       .                           -.||..|+|||++++...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                             0                           0013348999999999999


Q ss_pred             chhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHH-HHHhcccccCCCCCCC----HHHHHH
Q 048439          446 EKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF-LKAMSCLNDEGIRRPS----MSDVVW  520 (613)
Q Consensus       446 ~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~-~~~~~Cl~~~p~~RPs----~~evl~  520 (613)
                      .+.|+|+|||+||||+.|..||.+...++...-+.  .+...-.....+.... -...+.|.+||.+|.-    +.||-+
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv--~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV--GQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh--cCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence            99999999999999999999998776554332222  2111111111111111 1122688999999998    777765


Q ss_pred             HHH
Q 048439          521 GLE  523 (613)
Q Consensus       521 ~Le  523 (613)
                      +..
T Consensus       392 HpF  394 (459)
T KOG0610|consen  392 HPF  394 (459)
T ss_pred             Ccc
Confidence            543

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.6e-35  Score=295.06  Aligned_cols=236  Identities=23%  Similarity=0.272  Sum_probs=186.5

Q ss_pred             eeeeCcEEEEEEEEcCCceeEEEEEeCCCCh---hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCCh
Q 048439          280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQ---QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTL  356 (613)
Q Consensus       280 iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  356 (613)
                      ||+|+||.||+++...++..+++|.+.....   .....+.+|++++++++|+||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999988778999999876533   4556789999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC---------
Q 048439          357 PDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT---------  427 (613)
Q Consensus       357 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~---------  427 (613)
                      .+++...  ..+++..++.++.|++.||.|||+.+    ++||||+|+||++++++.+||+|||++.....         
T Consensus        81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~----i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSNG----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcC----eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            9998543  37899999999999999999999988    99999999999999999999999999864321         


Q ss_pred             -------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          428 -------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       428 -------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                             .++..|++||+......+.++||||||+++|||++|+.||......+.......  ..........+.+....
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  232 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIEWPEDVEVSDEAID  232 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcCCCccccCCHHHHH
Confidence                   234468999999988899999999999999999999999965543322111111  01111111111122222


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHH
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                       ..+||+.+|.+||++.++.+.|+
T Consensus       233 ~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         233 LISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             HHHHHhcCCHhhcCCCccHHHHhc
Confidence             22799999999999955444333

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.9e-34  Score=299.85  Aligned_cols=248  Identities=25%  Similarity=0.323  Sum_probs=190.4

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh--hcHHHHHHHHHHHhccCccceeeEEEEeecC--CceEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ--QGALEFQTEIGMLSQLRHLHLVSLIGFCNDD--REMIL  346 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l  346 (613)
                      .++|...+.||+|+||.||+|....++..||+|.++....  .....+.+|+.++.+++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            4578888899999999999999988888999999865422  2233567899999999999999999998764  56899


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ||||+.+ +|.+++... ...+++.+++.++.|++.||+|||+.+    ++||||||+||++++++.+||+|||+++...
T Consensus        86 v~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~----i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENF----IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 888887543 356999999999999999999999998    9999999999999999999999999986432


Q ss_pred             C--------CCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHH-------------
Q 048439          427 T--------SVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQ-------------  484 (613)
Q Consensus       427 ~--------~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~-------------  484 (613)
                      .        ..+..|+|||.+.+ ..++.++|||||||++|||++|++||......+......-...             
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            1        12445999999865 4578999999999999999999999975544332221111000             


Q ss_pred             ------hhccCCcc------ccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          485 ------CYQNGTID------QIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       485 ------~~~~~~~~------~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                            ........      ....+...  ..+||+.||++||++.|++.+..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f  293 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF  293 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence                  00000000      00111111  237999999999999999977664

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=287.41  Aligned_cols=247  Identities=19%  Similarity=0.263  Sum_probs=196.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|+...+||+|.|+.||++....+++.+|+|.++..  +..+.+++.+|+++-+.|+|||||+|.....+....+||+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            3455556899999999999999888899999988654  45577889999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC---CCcEEEEecCCCcc--
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE---KWVAKVSDFGLSKF--  424 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGls~~--  424 (613)
                      +|.||+|..-+..+  .-+++...-....||+.+|.|+|.++    |+|||+||.|+||..   .--+||+|||++..  
T Consensus        91 ~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~----IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   91 LVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG----IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             cccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC----ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            99999998777432  45677888889999999999999999    999999999999954   34689999999864  


Q ss_pred             -----CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH
Q 048439          425 -----GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       425 -----~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                           ....+++.||+||+++..+++..+|||+.||+||-||.|++||.+.........+...........++.+.....
T Consensus       165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak  244 (355)
T KOG0033|consen  165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK  244 (355)
T ss_pred             CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence                 234568899999999999999999999999999999999999976433221111111111111112222222211


Q ss_pred             H-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          500 K-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       500 ~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      . .-++|..||.+|.|+.|.+.+.+.
T Consensus       245 ~LvrrML~~dP~kRIta~EAL~HpWi  270 (355)
T KOG0033|consen  245 SLIRRMLTVNPKKRITADEALKHPWI  270 (355)
T ss_pred             HHHHHHhccChhhhccHHHHhCCchh
Confidence            1 127999999999999999987764

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-34  Score=291.66  Aligned_cols=234  Identities=22%  Similarity=0.247  Sum_probs=180.2

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh---hcHHHHHHHHHH-HhccCccceeeEEEEeecCCceEEEEEcCCC
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ---QGALEFQTEIGM-LSQLRHLHLVSLIGFCNDDREMILVYDFMAR  353 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~---~~~~~f~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  353 (613)
                      +.||+|+||.||+|.....+..||||.+.....   .....+..|..+ ...++|+|++++++++.+.+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            368999999999999987778999999875432   222334455444 4456899999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----CCC
Q 048439          354 GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----TSV  429 (613)
Q Consensus       354 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----~~~  429 (613)
                      ++|.+++..  ...+++..+..++.|++.||.|||+.+    ++||||+|+||++++++.+||+|||+++...    ..+
T Consensus        82 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  155 (260)
T cd05611          82 GDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQRG----IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVG  155 (260)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHeEECCCCcEEEeecccceeccccccCCC
Confidence            999999843  346899999999999999999999988    9999999999999999999999999986432    234


Q ss_pred             CcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhh-ccCCccccccHHHH--Hhcccc
Q 048439          430 SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCY-QNGTIDQIVDPFLK--AMSCLN  506 (613)
Q Consensus       430 ~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~d~~~~--~~~Cl~  506 (613)
                      +..|++||.+.+..++.++||||||++||||++|.+||............  ..... .........+..+.  ..+||+
T Consensus       156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~l~  233 (260)
T cd05611         156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI--LSRRINWPEEVKEFCSPEAVDLINRLLC  233 (260)
T ss_pred             CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--HhcccCCCCcccccCCHHHHHHHHHHcc
Confidence            56799999999888999999999999999999999999654432211111  11111 01111112222222  238999


Q ss_pred             cCCCCCCCHHHHH
Q 048439          507 DEGIRRPSMSDVV  519 (613)
Q Consensus       507 ~~p~~RPs~~evl  519 (613)
                      .+|++||++.++.
T Consensus       234 ~~p~~R~~~~~~~  246 (260)
T cd05611         234 MDPAKRLGANGYQ  246 (260)
T ss_pred             CCHHHccCCCcHH
Confidence            9999999765443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.6e-34  Score=293.87  Aligned_cols=191  Identities=26%  Similarity=0.327  Sum_probs=160.7

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccC-ccceeeEEEEeecC--CceEEEEE
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDD--REMILVYD  349 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E  349 (613)
                      |...+.||+|+||.||+|....++..||+|+++... ........+|+.++.++. |+||+++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            445668999999999999998877899999987542 222334567999999985 99999999999987  88999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---  426 (613)
                      |++ |+|.+.+... ...++|.+++.++.|++.||.|||+.+    ++||||||+||+++. +.+||+|||+++...   
T Consensus        81 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~----i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNG----IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC----ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 5888887542 357899999999999999999999988    999999999999999 999999999986421   


Q ss_pred             ----CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          427 ----TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                          ..++..|++||++.. +.++.++|||||||++|||++|.+||....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~  203 (282)
T cd07831         154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN  203 (282)
T ss_pred             CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence                123556999998754 557899999999999999999999996543

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.6e-34  Score=296.96  Aligned_cols=246  Identities=22%  Similarity=0.324  Sum_probs=187.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccC-ccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|.....||+|+||.||+|....++..||||.++... .....++..|+.++.++. |+||++++++|.+....++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            45677789999999999999998877899999987543 334456777888777775 9999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT-GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      |+.+ +|.+++... ...+++..+..++.++++||+|||+ .+    |+||||+|+||++++++.+||+|||++....  
T Consensus        95 ~~~~-~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~----i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          95 LMST-CLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             ccCc-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCC----EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            9864 777766432 3479999999999999999999997 46    9999999999999999999999999986421  


Q ss_pred             -----CCCCcccCChhhhhcCC----CCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccc-ccc
Q 048439          427 -----TSVSKTHLDPEYYRLQQ----LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ-IVD  496 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~~~----~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~d  496 (613)
                           ..++..|+|||++....    ++.++||||||+++|||++|+.||....... ..+............... ..+
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06618         169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLTKILQEEPPSLPPNEGFSP  247 (296)
T ss_pred             CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHHHHhcCCCCCCCCCCCCCH
Confidence                 12345799999997654    7899999999999999999999986432211 111111111100000111 111


Q ss_pred             HHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          497 PFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       497 ~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .+.. ..+||+.+|.+||++.+++.+...
T Consensus       248 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~  276 (296)
T cd06618         248 DFCSFVDLCLTKDHRKRPKYRELLQHPFI  276 (296)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence            2222 237999999999999999977664

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2e-34  Score=289.50  Aligned_cols=241  Identities=23%  Similarity=0.373  Sum_probs=195.3

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +|...+.||.|+||.||++....++..+++|++....  .....++.+|++++++++|+|++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4667789999999999999998777899999987653  35566789999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC-
Q 048439          351 MARGTLPDHLYHSD--NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-  427 (613)
Q Consensus       351 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~-  427 (613)
                      +++++|.+++....  ...+++.+++.++.+++.||.|||+.+    ++|+||+|+||++++++.+||+|||++..... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~----~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC----EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            99999999986532  477999999999999999999999998    99999999999999999999999999864222 


Q ss_pred             -------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcc-ccccHHH
Q 048439          428 -------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID-QIVDPFL  499 (613)
Q Consensus       428 -------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~d~~~  499 (613)
                             .++..|++||.+....++.++||||||+++|+|++|+.|+........   ........ ...+. ...+...
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~  232 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL---ALKILKGQ-YPPIPSQYSSELR  232 (258)
T ss_pred             cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH---HHHHhcCC-CCCCCCCCCHHHH
Confidence                   235569999999999999999999999999999999999865432221   11111111 11111 1112222


Q ss_pred             H-HhcccccCCCCCCCHHHHHHH
Q 048439          500 K-AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       500 ~-~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      . ..+||..+|++||++.+++.+
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcC
Confidence            1 237999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=305.06  Aligned_cols=192  Identities=25%  Similarity=0.407  Sum_probs=164.3

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecC-----Cce
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD-----REM  344 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~  344 (613)
                      +++|...++||+|+||.||+|+...++..||||.+.... ......+.+|+.++++++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            467888899999999999999998888899999987543 33445688999999999999999999987654     357


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++|+||+.+ +|.+++.   ...+++..+..++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~-~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~----ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSAN----VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC----eeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999975 8887773   346999999999999999999999998    99999999999999999999999999864


Q ss_pred             CC-----------CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          425 GP-----------TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       425 ~~-----------~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                      ..           ..++..|+|||.+.. ..++.++|||||||++|||++|++||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~  213 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK  213 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            21           123556999998755 56899999999999999999999999654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-34  Score=298.67  Aligned_cols=192  Identities=25%  Similarity=0.406  Sum_probs=163.4

Q ss_pred             CCCcceeeeeCcEEEEEEEEcC--CceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecC--CceEE
Q 048439          274 FDNDLVIGVGGFGDVYKGFING--STTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD--REMIL  346 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~--~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l  346 (613)
                      |.....||+|+||.||+|....  .+..||+|.+....   ......+.+|+.++++++||||+++++++.+.  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            6667789999999999999977  67889999997642   33445678999999999999999999999988  88999


Q ss_pred             EEEcCCCCChhHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC----CCcEEEEec
Q 048439          347 VYDFMARGTLPDHLYHS---DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE----KWVAKVSDF  419 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~----~~~~kl~DF  419 (613)
                      ||||+++ +|.+++...   ....+++..++.++.|++.||+|||+.+    |+||||||+|||++.    ++.+||+||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW----VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC----EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            9999985 676666321   2247899999999999999999999998    999999999999999    999999999


Q ss_pred             CCCccCCC-----------CCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          420 GLSKFGPT-----------SVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       420 Gls~~~~~-----------~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                      |+++....           .++..|+|||++.+. .++.++|||||||+||||++|++||...
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  219 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR  219 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence            99874221           224569999998764 5789999999999999999999998644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.9e-34  Score=297.64  Aligned_cols=196  Identities=26%  Similarity=0.413  Sum_probs=164.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCC-------
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR-------  342 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~-------  342 (613)
                      ++|.....||+|+||.||+|....++..||||.+....  ......+.+|+.++++++||||++++++|....       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            46888889999999999999998888999999886432  222345678999999999999999999987654       


Q ss_pred             -ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCC
Q 048439          343 -EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL  421 (613)
Q Consensus       343 -~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl  421 (613)
                       ..++||||+.+ +|.+.+... ...+++.+.+.++.|++.||.|||+.+    ++|+||||+|||++.++.+||+|||+
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~----i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNK----ILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC----eeccCCCHHHEEECCCCcEEECcCCC
Confidence             35999999975 888877432 346899999999999999999999988    99999999999999999999999999


Q ss_pred             CccCCC------------CCCcccCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCccchhhh
Q 048439          422 SKFGPT------------SVSKTHLDPEYYRLQQ-LTEKSDVYSFGVVLFEVLCARPSILRTAAK  473 (613)
Q Consensus       422 s~~~~~------------~~~~~~~aPE~~~~~~-~t~ksDV~SfGvvL~elltg~~p~~~~~~~  473 (613)
                      +.....            .++..|+|||++.+.. ++.++||||||+++|||++|++||......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~  230 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ  230 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence            864211            1244699999987654 688999999999999999999998665443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.2e-34  Score=297.34  Aligned_cols=237  Identities=22%  Similarity=0.342  Sum_probs=190.6

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCChh
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLP  357 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~  357 (613)
                      ..||+|+||.||++....++..||||.+..........+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            37999999999999998888899999987655555667899999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--------CCC
Q 048439          358 DHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--------TSV  429 (613)
Q Consensus       358 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--------~~~  429 (613)
                      +++.   ...+++.....++.|++.||+|||+.+    ++||||+|+||++++++.++|+|||++....        ..+
T Consensus       106 ~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~g----ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  178 (292)
T cd06657         106 DIVT---HTRMNEEQIAAVCLAVLKALSVLHAQG----VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG  178 (292)
T ss_pred             HHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence            9873   245899999999999999999999988    9999999999999999999999999875321        123


Q ss_pred             CcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc-CCccccccHHHH--Hhcccc
Q 048439          430 SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN-GTIDQIVDPFLK--AMSCLN  506 (613)
Q Consensus       430 ~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~d~~~~--~~~Cl~  506 (613)
                      +..|++||++....++.++|||||||++|||++|.+||.............  ...... ..... .++.+.  ..+||.
T Consensus       179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~l~~li~~~l~  255 (292)
T cd06657         179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR--DNLPPKLKNLHK-VSPSLKGFLDRLLV  255 (292)
T ss_pred             CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hhCCcccCCccc-CCHHHHHHHHHHHh
Confidence            456999999988889999999999999999999999986543322211111  111110 01111 122221  227999


Q ss_pred             cCCCCCCCHHHHHHHHHH
Q 048439          507 DEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       507 ~~p~~RPs~~evl~~Le~  524 (613)
                      .+|.+||++.+++.+-..
T Consensus       256 ~~P~~R~~~~~ll~~~~~  273 (292)
T cd06657         256 RDPAQRATAAELLKHPFL  273 (292)
T ss_pred             CCcccCcCHHHHhcChHH
Confidence            999999999999876443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-34  Score=289.13  Aligned_cols=240  Identities=25%  Similarity=0.354  Sum_probs=188.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC-----ChhcHHHHHHHHHHHhccCccceeeEEEEeecC--Cce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE-----SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD--REM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~--~~~  344 (613)
                      .+|...++||+|+||.||+|....++..||+|.+...     ..+....|.+|++++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688888999999999999999887889999987532     233445788999999999999999999998764  458


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++|+||+++++|.+++..  ...+++...+.++.|++.||.|||+.+    ++|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~----i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSNM----IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC----EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999999853  345889999999999999999999988    99999999999999999999999999864


Q ss_pred             CC-----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccc
Q 048439          425 GP-----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ  493 (613)
Q Consensus       425 ~~-----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  493 (613)
                      ..           ..++..|++||++.+...+.++|||||||++|||++|++||..........  ... .......+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~-~~~~~~~~p~  232 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF--KIA-TQPTKPMLPD  232 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH--HHH-cCCCCCCCCc
Confidence            21           124556999999999889999999999999999999999996543222211  111 1111122222


Q ss_pred             cc-cHHHHH-hcccccCCCCCCCHHHHHHH
Q 048439          494 IV-DPFLKA-MSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       494 ~~-d~~~~~-~~Cl~~~p~~RPs~~evl~~  521 (613)
                      .+ +..... .+||. +|..||+..+++.+
T Consensus       233 ~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         233 GVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             ccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            22 222222 26887 57999999988754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.5e-34  Score=290.86  Aligned_cols=241  Identities=25%  Similarity=0.343  Sum_probs=194.4

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +|...+.||+|+||.||++....++..+|+|.+...  ......++.+|++++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            466778999999999999998877788999998754  334456788999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          351 MARGTLPDHLYHS--DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      +++++|.+++...  ....+++..++.++.+++.||.|||+.+    ++|+||+|+||++++++.+||+|||+++...  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~----i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK----ILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC----cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            9999999988542  2457899999999999999999999998    9999999999999999999999999986432  


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--  500 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--  500 (613)
                          ..++..|++||++....++.++|+||||+++|||++|+.||......+...   ..... .........+..+.  
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~l  232 (256)
T cd08530         157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY---KVQRG-KYPPIPPIYSQDLQNF  232 (256)
T ss_pred             CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHhcC-CCCCCchhhCHHHHHH
Confidence                234567999999999999999999999999999999999996554322111   11111 11111111222222  


Q ss_pred             HhcccccCCCCCCCHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      ..+||..+|.+||++.+++++
T Consensus       233 i~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         233 IRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             HHHHcCCCcccCCCHHHHhcC
Confidence            237999999999999999865

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-34  Score=292.11  Aligned_cols=194  Identities=28%  Similarity=0.449  Sum_probs=164.5

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh--hcHHHHHHHHHHHhcc---CccceeeEEEEeecCCc-----
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ--QGALEFQTEIGMLSQL---RHLHLVSLIGFCNDDRE-----  343 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l---~H~niv~l~g~~~~~~~-----  343 (613)
                      |+..+.||+|+||.||+|+...++..||+|+++....  .....+.+|+.++.++   +|+||+++++++.+.+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            4566789999999999999987778899999975422  2234566788777666   59999999999988776     


Q ss_pred             eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCc
Q 048439          344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK  423 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~  423 (613)
                      .+++|||+.+ +|.+++.......+++.+++.++.|++.||.|||+.+    ++|+||+|+||++++++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~----i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR----IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeeccCChhhEEEccCCCEEEeccCcce
Confidence            9999999975 8998886544456999999999999999999999988    9999999999999999999999999986


Q ss_pred             cCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhh
Q 048439          424 FGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAA  472 (613)
Q Consensus       424 ~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~  472 (613)
                      ...       ..++..|++||++....++.++|||||||++|||++|++||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~  211 (287)
T cd07838         156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE  211 (287)
T ss_pred             eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh
Confidence            432       1234569999999999999999999999999999999999875443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.2e-34  Score=293.76  Aligned_cols=238  Identities=23%  Similarity=0.268  Sum_probs=181.7

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh---hcHHHHHHHHH---HHhccCccceeeEEEEeecCCceEEEEEcCC
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ---QGALEFQTEIG---MLSQLRHLHLVSLIGFCNDDREMILVYDFMA  352 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~---~~~~~f~~Ei~---~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  352 (613)
                      +||+|+||.||++....+++.||+|.+.....   .....+..|..   .++...|+||+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999988778999999865421   22223444444   3444579999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC------C
Q 048439          353 RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG------P  426 (613)
Q Consensus       353 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~------~  426 (613)
                      +|+|.+++..  ...++|..+..++.|+++||.|||+.+    |+||||||+||++++++.+||+|||+++..      .
T Consensus        81 g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~----i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~  154 (278)
T cd05606          81 GGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA  154 (278)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----EEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcC
Confidence            9999998843  457999999999999999999999988    999999999999999999999999998632      1


Q ss_pred             CCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--Hhc
Q 048439          427 TSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMS  503 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~  503 (613)
                      ..++..|++||++..+ .++.++|||||||++|||++|+.||............. .... ....+.........  ..+
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~-~~~~~~~~~s~~~~~li~~  232 (278)
T cd05606         155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLT-MAVELPDSFSPELRSLLEG  232 (278)
T ss_pred             cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-Hhhc-cCCCCCCcCCHHHHHHHHH
Confidence            2356679999999754 68999999999999999999999996543222111111 1111 11111111222221  227


Q ss_pred             ccccCCCCCC-----CHHHHHHHHHH
Q 048439          504 CLNDEGIRRP-----SMSDVVWGLEF  524 (613)
Q Consensus       504 Cl~~~p~~RP-----s~~evl~~Le~  524 (613)
                      ||..+|.+||     ++.+++++.+.
T Consensus       233 ~l~~~p~~R~~~~~~~~~~ll~~~~~  258 (278)
T cd05606         233 LLQRDVNRRLGCLGRGAQEVKEHPFF  258 (278)
T ss_pred             HhhcCHHhccCCCCCCHHHHHhCccc
Confidence            9999999999     99999865543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-37  Score=296.06  Aligned_cols=242  Identities=23%  Similarity=0.319  Sum_probs=197.8

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCC
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMAR  353 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  353 (613)
                      |+....||+|+||.|||+.++.+++.||||.+..++  ..+++..||.++.+++.+++|+++|.+.....+++|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            444558999999999999999999999999986653  577899999999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc--------C
Q 048439          354 GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--------G  425 (613)
Q Consensus       354 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~--------~  425 (613)
                      |++.|.++. ++.+|++.++..++...++||+|||...    -||||||+.||||+.+|.+||+|||.+..        .
T Consensus       113 GSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~----KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN  187 (502)
T KOG0574|consen  113 GSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLK----KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN  187 (502)
T ss_pred             CcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHH----HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence            999999864 4678999999999999999999999877    69999999999999999999999998742        3


Q ss_pred             CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-Hhcc
Q 048439          426 PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSC  504 (613)
Q Consensus       426 ~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~C  504 (613)
                      ..-+++.|||||++..-.|..++||||+|++..||..|+||+..-.+......+--... ..-...+...+.+.. ..+|
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PP-PTF~KPE~WS~~F~DFi~~C  266 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPP-PTFKKPEEWSSEFNDFIRSC  266 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCC-CCCCChHhhhhHHHHHHHHH
Confidence            44578899999999999999999999999999999999999976544332222110000 000011111121111 1269


Q ss_pred             cccCCCCCCCHHHHHHHHH
Q 048439          505 LNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       505 l~~~p~~RPs~~evl~~Le  523 (613)
                      |-++|++|-|+.+++++..
T Consensus       267 LiK~PE~R~TA~~L~~H~F  285 (502)
T KOG0574|consen  267 LIKKPEERKTALRLCEHTF  285 (502)
T ss_pred             hcCCHHHHHHHHHHhhhhh
Confidence            9999999999999997754

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=9.3e-34  Score=292.89  Aligned_cols=244  Identities=14%  Similarity=0.140  Sum_probs=175.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCC---ceeEEEEEeCCCChhcH-----------HHHHHHHHHHhccCccceeeEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGS---TTPVAIKRLEPESQQGA-----------LEFQTEIGMLSQLRHLHLVSLIGF  337 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~---~~~vAVK~~~~~~~~~~-----------~~f~~Ei~~l~~l~H~niv~l~g~  337 (613)
                      ++|...++||+|+||.||+|...++   ...+|+|..........           .....+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5788888999999999999998776   55677776443322111           112334455667789999999998


Q ss_pred             eecCC----ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc
Q 048439          338 CNDDR----EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV  413 (613)
Q Consensus       338 ~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~  413 (613)
                      +....    ..++++|++.. ++.+.+..  ....++..++.|+.|++.||.|||+.+    |+||||||+|||++.++.
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~----iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEHG----ISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEEcCCCc
Confidence            76543    33677887654 66666532  234678889999999999999999988    999999999999999999


Q ss_pred             EEEEecCCCccCC---------------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhh-hhhh
Q 048439          414 AKVSDFGLSKFGP---------------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAK-KQVS  477 (613)
Q Consensus       414 ~kl~DFGls~~~~---------------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~-~~~~  477 (613)
                      +||+|||+|+...               ..++..|+|||++.+..++.++|||||||+||||++|++||...... +...
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            9999999986321               23567899999999999999999999999999999999999655221 1111


Q ss_pred             H--HHHHHHhhc-cCCccccccHHHHHh-cccccCCCCCCCHHHHHHHH
Q 048439          478 L--AVWAQQCYQ-NGTIDQIVDPFLKAM-SCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       478 l--~~~~~~~~~-~~~~~~~~d~~~~~~-~Cl~~~p~~RPs~~evl~~L  522 (613)
                      .  ..+...... ........+.....+ .|+..+|++||++.++++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        245 AAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1  111111111 111222222222222 69999999999999998765

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.4e-34  Score=301.10  Aligned_cols=201  Identities=24%  Similarity=0.408  Sum_probs=168.8

Q ss_pred             cCHHHHHHHh----cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEE
Q 048439          262 FSLSEIQAAT----NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLI  335 (613)
Q Consensus       262 f~~~el~~at----~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~  335 (613)
                      |+.+|+..++    ++|.....||+|+||.||+|+...++..||||++...  .......+.+|+.++++++|+||++++
T Consensus         1 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~   80 (342)
T cd07879           1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL   80 (342)
T ss_pred             CchhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchh
Confidence            4455666554    7888889999999999999998877789999998653  223345688999999999999999999


Q ss_pred             EEeecC------CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC
Q 048439          336 GFCNDD------REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD  409 (613)
Q Consensus       336 g~~~~~------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~  409 (613)
                      +++...      ...++|+||+.. +|.+++    ...+++..+..++.|+++||.|||+.+    |+||||||+|||++
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~----i~H~dlkp~NIll~  151 (342)
T cd07879          81 DVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAG----IIHRDLKPGNLAVN  151 (342)
T ss_pred             heecccccCCCCceEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEEC
Confidence            998654      346999999975 777665    235899999999999999999999988    99999999999999


Q ss_pred             CCCcEEEEecCCCccCCC-----CCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          410 EKWVAKVSDFGLSKFGPT-----SVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       410 ~~~~~kl~DFGls~~~~~-----~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                      .++.+||+|||+++....     .++..|+|||.+.. ..++.++|||||||++|||++|+.||....
T Consensus       152 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~  219 (342)
T cd07879         152 EDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  219 (342)
T ss_pred             CCCCEEEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999875322     23456899999876 468999999999999999999999997543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.8e-35  Score=308.75  Aligned_cols=247  Identities=21%  Similarity=0.257  Sum_probs=201.2

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ....|.....||+|.|++|..|+...++..||||.+++..  ....+.+.+|+++|..|+|||||+|+.+...+..+++|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            4567888889999999999999999888999999998763  33445689999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc---
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---  424 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~---  424 (613)
                      |||+.+|.++++|.+  ...+.......++.|+.+|++|||+++    |+|||||++||||+.+.++||+|||++..   
T Consensus       134 ~eya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~k~----ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHSKN----IVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhhcc----eeccccchhhcccccccceeeeccccceeecc
Confidence            999999999999954  345666888889999999999999999    99999999999999999999999999864   


Q ss_pred             ----CCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH
Q 048439          425 ----GPTSVSKTHLDPEYYRLQQL-TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       425 ----~~~~~~~~~~aPE~~~~~~~-t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                          ...++++.|.|||++.+.++ .+.+|+||+||+||-|++|..||++....+-..........+......+.-+.+.
T Consensus       208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLr  287 (596)
T KOG0586|consen  208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLR  287 (596)
T ss_pred             cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHH
Confidence                34567888999999999887 6799999999999999999999987655442222221111111111122222222


Q ss_pred             HHhcccccCCCCCCCHHHHHHHHHHh
Q 048439          500 KAMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       500 ~~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                         +.|-.+|.+|+++.++.+.-+..
T Consensus       288 ---k~lvl~Pskr~~~dqim~~~W~n  310 (596)
T KOG0586|consen  288 ---KFLVLNPSKRGPCDQIMKDRWRN  310 (596)
T ss_pred             ---HhhccCccccCCHHHhhhhcccc
Confidence               46789999999999999775543

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.4e-34  Score=300.96  Aligned_cols=257  Identities=22%  Similarity=0.298  Sum_probs=196.9

Q ss_pred             cccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEE
Q 048439          260 TQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGF  337 (613)
Q Consensus       260 ~~f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~  337 (613)
                      +.....++...+++|.....||+|+||.||+|....++..||+|++....  ......+.+|+.++.+++|+||++++++
T Consensus         5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~   84 (345)
T cd07877           5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV   84 (345)
T ss_pred             hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence            45667788889999999999999999999999988777899999987542  2334568899999999999999999998


Q ss_pred             eecC------CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC
Q 048439          338 CNDD------REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK  411 (613)
Q Consensus       338 ~~~~------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~  411 (613)
                      +...      ...+++++++ +++|.+++..   ..+++..+..++.|+++||+|||+.+    |+||||||+||+++++
T Consensus        85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~----ivH~dlkp~NIll~~~  156 (345)
T cd07877          85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNED  156 (345)
T ss_pred             eeecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC----eeecCCChHHEEEcCC
Confidence            8543      3467888877 7799887742   35899999999999999999999998    9999999999999999


Q ss_pred             CcEEEEecCCCccCC-----CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHH---
Q 048439          412 WVAKVSDFGLSKFGP-----TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWA---  482 (613)
Q Consensus       412 ~~~kl~DFGls~~~~-----~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~---  482 (613)
                      +.+||+|||+++...     ..++..|+|||.+.. ..++.++|||||||++|||++|++||...............   
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (345)
T cd07877         157 CELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  236 (345)
T ss_pred             CCEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999999999987532     223556999999866 56889999999999999999999998643322211111000   


Q ss_pred             ------------------HHhhc--cCCccc---cccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          483 ------------------QQCYQ--NGTIDQ---IVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       483 ------------------~~~~~--~~~~~~---~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                                        .....  ......   ..++.+.  ..+||+.+|.+||++.+++.+-.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f  303 (345)
T cd07877         237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF  303 (345)
T ss_pred             CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhh
Confidence                              00000  000000   0112222  227999999999999999977654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3e-34  Score=302.38  Aligned_cols=247  Identities=21%  Similarity=0.301  Sum_probs=190.0

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecC-----Cc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD-----RE  343 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~-----~~  343 (613)
                      .++|.....||+|+||.||+|+...++..||||.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45788888999999999999999888899999998753  233445678899999999999999999988654     35


Q ss_pred             eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCc
Q 048439          344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK  423 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~  423 (613)
                      .++||||+. ++|.+++..  ...+++.....++.|++.||.|||+.+    ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~----i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSAN----VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC----EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 689888843  456999999999999999999999988    9999999999999999999999999987


Q ss_pred             cCCC--------CCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHH--------------
Q 048439          424 FGPT--------SVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAV--------------  480 (613)
Q Consensus       424 ~~~~--------~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~--------------  480 (613)
                      ....        .++..|+|||.+.. ..++.++|||||||++|||++|++||.............              
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            5322        23556999998865 468899999999999999999999986543221111100              


Q ss_pred             -------HHHHhhcc------CCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          481 -------WAQQCYQN------GTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       481 -------~~~~~~~~------~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                             +.......      .....+...... ..+||+.+|++||++.+++++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~  294 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL  294 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcch
Confidence                   00000000      000111111111 237999999999999999988553

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1e-33  Score=294.47  Aligned_cols=246  Identities=27%  Similarity=0.344  Sum_probs=192.2

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      .|+..+.||+|+||.||+|+...++..+|+|.+...   ......++.+|+++++.++|+|++++++++.+.+..++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            355566899999999999999877788999998643   23344578899999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC--
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT--  427 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~--  427 (613)
                      |+. |+|.+.+... ...+++.+++.++.+++.||.|||+.+    ++||||||+|||++.++.+||+|||++.....  
T Consensus        96 ~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~----i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  169 (308)
T cd06634          96 YCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN  169 (308)
T ss_pred             ccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCCHHhEEECCCCcEEECCcccceeecCcc
Confidence            997 6888777433 356899999999999999999999988    99999999999999999999999999864322  


Q ss_pred             --CCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--
Q 048439          428 --SVSKTHLDPEYYR---LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--  500 (613)
Q Consensus       428 --~~~~~~~aPE~~~---~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--  500 (613)
                        .++..|+|||++.   .+.++.++|||||||++|||++|+.|+......+...  .+...... .......+..+.  
T Consensus       170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~l  246 (308)
T cd06634         170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQNESP-ALQSGHWSEYFRNF  246 (308)
T ss_pred             cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--HHhhcCCC-CcCcccccHHHHHH
Confidence              3456799999985   3567889999999999999999999986543222111  11111111 101112222222  


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      ..+||+.+|.+||++.+|+.+......
T Consensus       247 i~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         247 VDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             HHHHhhCCcccCCCHHHHhhCcccccc
Confidence            227999999999999999988775544

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.4e-34  Score=299.23  Aligned_cols=188  Identities=24%  Similarity=0.305  Sum_probs=160.7

Q ss_pred             eeeee--CcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          279 VIGVG--GFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       279 ~iG~G--~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      .||+|  +||+||++.....++.||||.+....  ....+.+.+|+.+++.++|+||++++++|..++..++|+||+.+|
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  99999999998778999999987542  334567889999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--------
Q 048439          355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--------  426 (613)
Q Consensus       355 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--------  426 (613)
                      +|.+++.......+++..+..++.|++.||.|||+.+    |+||||||+|||++.++.+|++||+.+....        
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~----ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG----YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999986544456899999999999999999999988    9999999999999999999999997532100        


Q ss_pred             -------CCCCcccCChhhhhcC--CCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          427 -------TSVSKTHLDPEYYRLQ--QLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       427 -------~~~~~~~~aPE~~~~~--~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                             ......|++||++.+.  .++.++|||||||++|||++|++||...
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence                   0123359999999764  4789999999999999999999999654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.6e-34  Score=302.46  Aligned_cols=246  Identities=20%  Similarity=0.287  Sum_probs=189.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeec----CCceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCND----DREMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~  345 (613)
                      .+|...+.||+|+||.||+|....++..||+|++....  ......+.+|+.+|++++|+||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            67888889999999999999998888899999987542  2345567889999999999999999998753    35689


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +||||+. |+|.+++..  ...+++..+..++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++..
T Consensus        85 lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          85 VVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSAN----VIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHEEEcCCCcEEecccccceee
Confidence            9999996 689888843  345999999999999999999999988    999999999999999999999999998532


Q ss_pred             C------------CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHH-----------
Q 048439          426 P------------TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVW-----------  481 (613)
Q Consensus       426 ~------------~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~-----------  481 (613)
                      .            ..++..|++||.+.. ..++.++|||||||++|||++|++||.......+......           
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            1            134556899999865 5689999999999999999999999965433222111100           


Q ss_pred             ------HHHh---hc-cCCc------cccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          482 ------AQQC---YQ-NGTI------DQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       482 ------~~~~---~~-~~~~------~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                            ....   .. ....      ....+.... ..+||+.+|.+||++.+++.+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~  297 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL  297 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence                  0000   00 0000      011111111 237999999999999999987664

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.9e-34  Score=294.12  Aligned_cols=239  Identities=21%  Similarity=0.291  Sum_probs=192.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccC-ccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|.....||+|+||.||+|....++..||+|++...   .......+.+|+.++.+++ |+||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4677788999999999999999888889999998753   2334467889999999998 99999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT  427 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~  427 (613)
                      |||+++++|.+++..  ...+++..++.|+.|++.||.|||+.+    ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~~----~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKG----IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999999854  347999999999999999999999988    99999999999999999999999999764211


Q ss_pred             ----------------------------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHH
Q 048439          428 ----------------------------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLA  479 (613)
Q Consensus       428 ----------------------------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~  479 (613)
                                                  .++..|++||.+....++.++||||||++++|+++|+.|+........  + 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~-  231 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--F-  231 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH--H-
Confidence                                        124568999999988899999999999999999999999975442111  1 


Q ss_pred             HHHHHhhccCCccccccHHHH--HhcccccCCCCCCCH----HHHHHH
Q 048439          480 VWAQQCYQNGTIDQIVDPFLK--AMSCLNDEGIRRPSM----SDVVWG  521 (613)
Q Consensus       480 ~~~~~~~~~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~----~evl~~  521 (613)
                      ....  .....+....++...  ..+||+.+|.+||++    .+++.+
T Consensus       232 ~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         232 QKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            1111  111112122222222  227999999999999    887754

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.6e-34  Score=301.72  Aligned_cols=192  Identities=23%  Similarity=0.328  Sum_probs=166.1

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecC------
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD------  341 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~------  341 (613)
                      ..++|...+.||+|+||.||+|+...++..||||++...  ......++.+|+.++++++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            347888889999999999999999888889999998643  333445678899999999999999999988643      


Q ss_pred             CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCC
Q 048439          342 REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL  421 (613)
Q Consensus       342 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl  421 (613)
                      ...++||||+.+ +|.+.+..    .+++.++..++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g----i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC----eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            357999999964 88887742    2899999999999999999999998    99999999999999999999999999


Q ss_pred             CccCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          422 SKFGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       422 s~~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                      ++...       ..++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  220 (353)
T cd07850         165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT  220 (353)
T ss_pred             ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence            87432       22455799999999999999999999999999999999998644

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-35  Score=296.74  Aligned_cols=201  Identities=26%  Similarity=0.363  Sum_probs=181.3

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ..+.|..-++||+||||.||-++...++..+|.|++.+.   ..++..--++|-.+|.+++.+.||.|--.+...+.+||
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            345678888999999999999999999999999998654   23445556899999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-  425 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-  425 (613)
                      |+..|.||+|.-||++-.++.+++...+.++.+|+.||++||...    |+.|||||+|||||+.|+++|+|.|||... 
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~----iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR----IVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc----eeeccCChhheeeccCCCeEeeccceEEecC
Confidence            999999999999999888889999999999999999999999998    999999999999999999999999999632 


Q ss_pred             ------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhh
Q 048439          426 ------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK  474 (613)
Q Consensus       426 ------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~  474 (613)
                            ...+|.+|||||++..+.|+...|+||+||+||||+.|+.||.......
T Consensus       339 ~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv  393 (591)
T KOG0986|consen  339 EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV  393 (591)
T ss_pred             CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh
Confidence                  2357889999999999999999999999999999999999997654443

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.9e-34  Score=300.63  Aligned_cols=245  Identities=23%  Similarity=0.322  Sum_probs=187.0

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecC--Cce
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDD--REM  344 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~--~~~  344 (613)
                      ..++|...+.||+|+||.||+|....++..+|||++...  .......+.+|+.+++++ +|+||++++++|...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            346777788999999999999999877788999988542  233445678899999999 999999999998653  468


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++||||++ ++|.+++...   .++|..++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~----i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN----VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 5998888432   7899999999999999999999988    99999999999999999999999999864


Q ss_pred             CCC-------------CCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHH-------
Q 048439          425 GPT-------------SVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQ-------  483 (613)
Q Consensus       425 ~~~-------------~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~-------  483 (613)
                      ...             .++..|++||++.. ..++.++|||||||++|||++|++||......+.........       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            221             13446999998755 457889999999999999999999986543322211111000       


Q ss_pred             ----------Hhh---c---c----CCccccccHHHH-HhcccccCCCCCCCHHHHHHHH
Q 048439          484 ----------QCY---Q---N----GTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       484 ----------~~~---~---~----~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                                ...   .   .    .....+.+.+.. ..+||+.+|.+||++.+++.+-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~  296 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP  296 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence                      000   0   0    000111111222 3379999999999999999764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-34  Score=292.72  Aligned_cols=193  Identities=23%  Similarity=0.365  Sum_probs=165.4

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh-hcHHHHHHHHHHHhccC-ccceeeEEEEeecCCceEEEEEcC
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ-QGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      |...+.||+|+||.||+|+..+++..|+||++..... .......+|+..+.+++ |+||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            4556789999999999999988778899999875432 22334567999999999 999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT----  427 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~----  427 (613)
                       +|+|.+++.......++|.+++.++.|++++|.|||+.+    ++|+||+|+||++++++.+||+|||+++....    
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~----i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG----FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence             889999886554467899999999999999999999988    99999999999999999999999999864321    


Q ss_pred             ---CCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          428 ---SVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       428 ---~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                         .++..|+|||++.. ..++.++||||||+++|||++|++||....
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~  203 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS  203 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence               23456899998854 457899999999999999999999986543

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-34  Score=289.71  Aligned_cols=193  Identities=26%  Similarity=0.383  Sum_probs=166.8

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh--hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ--QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      |.....||+|++|.||+|....++..+++|++.....  .....+..|+.++++++|+||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            4455689999999999999987788999999876532  24567889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT----  427 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~----  427 (613)
                      ++ +|.+++... ...+++.+++.++.+++.||.|||+.+    |+|+||||+||++++++.+||+|||.+.....    
T Consensus        81 ~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~----i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~  154 (283)
T cd05118          81 DT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHG----ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP  154 (283)
T ss_pred             CC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHCC----eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence            75 888887543 357999999999999999999999988    99999999999999999999999998854322    


Q ss_pred             ----CCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhh
Q 048439          428 ----SVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAA  472 (613)
Q Consensus       428 ----~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~  472 (613)
                          .++..|++||.+... .++.++||||||+++|+|++|++||.....
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~  204 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE  204 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Confidence                234468999999876 789999999999999999999999865443

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=288.10  Aligned_cols=243  Identities=25%  Similarity=0.319  Sum_probs=199.9

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ..++|+..++||+|.||+|-+++-+.+++.+|+|+++++   .......-+.|-++|...+||.+..|--.++..+.+|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            346788889999999999999999999999999999876   34445556899999999999999999888999999999


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc--
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--  424 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~--  424 (613)
                      ||||..+|.|.-+|.  +...+++.....+-..|+.||.|||+++    |+.||||.+|.|||.+|++||+||||++.  
T Consensus       246 VMeyanGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs~~----ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHSRN----IVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEEccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhhCC----eeeeechhhhheeccCCceEeeecccchhcc
Confidence            999999999998884  4567888888899999999999999988    99999999999999999999999999964  


Q ss_pred             ------CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          425 ------GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       425 ------~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                            ...++++.|+|||++....|..+.|+|.+|||+|||+|||.||+...-.....++....-     .++.-+.+.
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~-----kFPr~ls~e  394 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL-----KFPRTLSPE  394 (516)
T ss_pred             cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc-----cCCccCCHH
Confidence                  345678899999999999999999999999999999999999986654443333332222     222222222


Q ss_pred             HHH-h-cccccCCCCCC-----CHHHHHHHHH
Q 048439          499 LKA-M-SCLNDEGIRRP-----SMSDVVWGLE  523 (613)
Q Consensus       499 ~~~-~-~Cl~~~p~~RP-----s~~evl~~Le  523 (613)
                      .+. + ..|..||.+|.     .++||.++-.
T Consensus       395 AktLLsGLL~kdP~kRLGgGpdDakEi~~h~F  426 (516)
T KOG0690|consen  395 AKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRF  426 (516)
T ss_pred             HHHHHHHHhhcChHhhcCCCchhHHHHHhhhh
Confidence            221 1 57889999996     4566665543

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1e-33  Score=297.82  Aligned_cols=245  Identities=21%  Similarity=0.266  Sum_probs=187.1

Q ss_pred             CCC-CcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhc--------------HHHHHHHHHHHhccCccceeeEEEE
Q 048439          273 NFD-NDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQG--------------ALEFQTEIGMLSQLRHLHLVSLIGF  337 (613)
Q Consensus       273 ~f~-~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~--------------~~~f~~Ei~~l~~l~H~niv~l~g~  337 (613)
                      +|. ..+.||+|+||.||+|.....++.||||.+.......              ...+.+|++++++++|+||++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            443 3457999999999999998777899999986542211              1247799999999999999999999


Q ss_pred             eecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEE
Q 048439          338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVS  417 (613)
Q Consensus       338 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~  417 (613)
                      +..++..++||||+. |+|.+++..  ...+++.....++.|++.||+|||+.+    |+||||||+|||++.++.+||+
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~----i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         89 YVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWY----FMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eecccccHHHeEECCCCCEEEC
Confidence            999999999999997 699998843  456899999999999999999999988    9999999999999999999999


Q ss_pred             ecCCCccCC----------------------CCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhh
Q 048439          418 DFGLSKFGP----------------------TSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKK  474 (613)
Q Consensus       418 DFGls~~~~----------------------~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~  474 (613)
                      |||+++...                      ..++..|++||++.+. .++.++|||||||++|||++|++||......+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999886422                      1124469999998764 46899999999999999999999996554332


Q ss_pred             hhhHHHHHHHhhcc--------------------CCc----cccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          475 QVSLAVWAQQCYQN--------------------GTI----DQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       475 ~~~l~~~~~~~~~~--------------------~~~----~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ..............                    ...    ....+.... ..+||+.+|++||++.|++.+..+
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~  316 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF  316 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence            22111100000000                    000    001111111 237999999999999999976664

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8.5e-34  Score=295.35  Aligned_cols=183  Identities=26%  Similarity=0.259  Sum_probs=156.0

Q ss_pred             CcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCChhHHhh
Q 048439          284 GFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY  361 (613)
Q Consensus       284 ~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~  361 (613)
                      ++|.||.++...++..||||+++..  .......+.+|+.++++++|+||+++++++.+.+..+++|||+++|+|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            4455555555556688999998754  34456789999999999999999999999999999999999999999999997


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---------------
Q 048439          362 HSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---------------  426 (613)
Q Consensus       362 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---------------  426 (613)
                      ......+++.....++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||.+....               
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~----ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~  167 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHSKG----FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS  167 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCcceEEEecCCceEEecCccceeecccccccccccccccc
Confidence            554556899999999999999999999988    9999999999999999999999999875221               


Q ss_pred             CCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          427 TSVSKTHLDPEYYRL--QQLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~--~~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                      ...+..|+|||++..  ..++.++|||||||++|||++|+.||...
T Consensus       168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~  213 (314)
T cd08216         168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM  213 (314)
T ss_pred             ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            122346999999976  35789999999999999999999999654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.9e-33  Score=290.90  Aligned_cols=244  Identities=26%  Similarity=0.351  Sum_probs=189.6

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      |.....||+|+||.||+|+...++..|++|++....   ......+.+|++++++++|+|++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            444557999999999999998888899999986542   23345688999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      +. |+|.+++.. ...+++|.+++.++.|++.||.|||+.+    ++||||+|+||++++++.+||+|||++....    
T Consensus       103 ~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~g----i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~  176 (313)
T cd06633         103 CL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN----MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS  176 (313)
T ss_pred             CC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCChhhEEECCCCCEEEeecCCCcccCCCCC
Confidence            96 578777743 3456999999999999999999999988    9999999999999999999999999986432    


Q ss_pred             CCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-Hh
Q 048439          427 TSVSKTHLDPEYYR---LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AM  502 (613)
Q Consensus       427 ~~~~~~~~aPE~~~---~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~  502 (613)
                      ..++..|++||++.   .+.++.++|||||||++|||++|++|+.............  .............+.... ..
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~  254 (313)
T cd06633         177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA--QNDSPTLQSNEWTDSFRGFVD  254 (313)
T ss_pred             ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--hcCCCCCCccccCHHHHHHHH
Confidence            23455799999984   4668899999999999999999999986543322221111  000111111111122222 22


Q ss_pred             cccccCCCCCCCHHHHHHHHHHh
Q 048439          503 SCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       503 ~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      +||+.+|.+||++.+++.+....
T Consensus       255 ~~l~~~P~~Rp~~~~~l~~~~~~  277 (313)
T cd06633         255 YCLQKIPQERPASAELLRHDFVR  277 (313)
T ss_pred             HHccCChhhCcCHHHHhcCcccC
Confidence            79999999999999999775543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=318.49  Aligned_cols=249  Identities=26%  Similarity=0.445  Sum_probs=197.0

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcC-------CceeEEEEEeCCC-ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecC
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFING-------STTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDD  341 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~-------~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~  341 (613)
                      .++....+.||+|.||.|++|...+       ....||||.++.. .....+.+..|+.+|+.+ +|+||+.++|+|.++
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            3444455599999999999998631       1467999999865 345677899999999998 699999999999999


Q ss_pred             CceEEEEEcCCCCChhHHhhcCC------------C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCcee
Q 048439          342 REMILVYDFMARGTLPDHLYHSD------------N--PPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNIL  407 (613)
Q Consensus       342 ~~~~lV~Ey~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NIL  407 (613)
                      +..++|+||+..|+|.++|+.++            .  ..|+..+.+.++.|||.||+||++..    ++||||.++|||
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~----~vHRDLAaRNVL  450 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP----CVHRDLAARNVL  450 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC----ccchhhhhhhEE
Confidence            99999999999999999997644            0  23899999999999999999999988    999999999999


Q ss_pred             eCCCCcEEEEecCCCccCCC---------C--CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhC-CCCccchhhhhh
Q 048439          408 LDEKWVAKVSDFGLSKFGPT---------S--VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCA-RPSILRTAAKKQ  475 (613)
Q Consensus       408 l~~~~~~kl~DFGls~~~~~---------~--~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg-~~p~~~~~~~~~  475 (613)
                      +.++..+||+|||||+....         .  ....|||||.+....++.|||||||||+||||++. ..|+.+-.... 
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~-  529 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE-  529 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH-
Confidence            99999999999999984211         1  13459999999999999999999999999999985 55554321111 


Q ss_pred             hhHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          476 VSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       476 ~~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                       .+..+...-.+........+.... ...||+.+|++||++.++++.++..
T Consensus       530 -~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  530 -ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             -HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence             223334333333333333333322 2379999999999999999999974

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-33  Score=297.24  Aligned_cols=195  Identities=25%  Similarity=0.393  Sum_probs=166.9

Q ss_pred             HHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCC---
Q 048439          268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR---  342 (613)
Q Consensus       268 ~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~---  342 (613)
                      ....++|...+.||+|+||.||+|....++..||||++...  .......+.+|+.++++++|+||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            34567888889999999999999999887889999998643  2333456889999999999999999999987643   


Q ss_pred             ---ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEec
Q 048439          343 ---EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDF  419 (613)
Q Consensus       343 ---~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DF  419 (613)
                         ..++||||+ +++|.+++.   ...+++..++.++.|+++||.|||+.+    |+||||||+||+++.++.+||+||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~g----i~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAAG----IIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEEcCCCCEEEeec
Confidence               458999999 679988874   346899999999999999999999988    999999999999999999999999


Q ss_pred             CCCccCC-----CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          420 GLSKFGP-----TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       420 Gls~~~~-----~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                      |+++...     ..++..|++||.+.. ..++.++|||||||++|+|++|++||...
T Consensus       163 g~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  219 (343)
T cd07880         163 GLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH  219 (343)
T ss_pred             ccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9987532     234567899999876 45889999999999999999999999654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.1e-34  Score=298.18  Aligned_cols=245  Identities=23%  Similarity=0.306  Sum_probs=191.8

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCC-----ceE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR-----EMI  345 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~  345 (613)
                      +|.....||+|+||.||+|+...++..||||++....  ....+.+.+|+.++++++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4677789999999999999998777889999987653  344567899999999999999999999998775     789


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +||||+++ +|.+++..  ...+++..++.++.+++.||.|||+.+    |+||||||+|||++.++.+||+|||++...
T Consensus        81 lv~e~~~~-~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~g----i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELMET-DLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSAN----VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchhh-hHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            99999984 89888843  347999999999999999999999998    999999999999999999999999998643


Q ss_pred             CC-----------CCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHh--------
Q 048439          426 PT-----------SVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC--------  485 (613)
Q Consensus       426 ~~-----------~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~--------  485 (613)
                      ..           .++..|++||++.+. .++.++||||||+++|+|++|++||......+......-....        
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            21           124458999999887 7899999999999999999999999655433221111100000        


Q ss_pred             -------------hcc--CC----ccccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          486 -------------YQN--GT----IDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       486 -------------~~~--~~----~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                                   ...  ..    ...+...... ..+||+.+|.+||++.+++.+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~  292 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL  292 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence                         000  00    0011111111 237999999999999999977654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.3e-33  Score=288.68  Aligned_cols=243  Identities=24%  Similarity=0.259  Sum_probs=187.0

Q ss_pred             CCCCcceeeeeCcEEEEEEEEc---CCceeEEEEEeCCCC----hhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCce
Q 048439          273 NFDNDLVIGVGGFGDVYKGFIN---GSTTPVAIKRLEPES----QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~---~~~~~vAVK~~~~~~----~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~  344 (613)
                      +|.....||+|+||.||+++..   .++..||+|++....    ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4666779999999999999874   245789999987542    22345688999999999 599999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++||||+++++|.+++..  ...+++.....++.|++.||.|||+.+    ++||||||+|||+++++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~----i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999999854  356889999999999999999999988    99999999999999999999999999864


Q ss_pred             CC---------CCCCcccCChhhhhcC--CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc-cCCcc
Q 048439          425 GP---------TSVSKTHLDPEYYRLQ--QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ-NGTID  492 (613)
Q Consensus       425 ~~---------~~~~~~~~aPE~~~~~--~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~-~~~~~  492 (613)
                      ..         ..++..|++||++...  .++.++||||||+++|||++|+.|+.......  ........... .....
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~  232 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSEPPYP  232 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccCCCCC
Confidence            21         1245679999998753  46889999999999999999999985322111  11111111111 11122


Q ss_pred             ccccHHHH--HhcccccCCCCCC-----CHHHHHHHHH
Q 048439          493 QIVDPFLK--AMSCLNDEGIRRP-----SMSDVVWGLE  523 (613)
Q Consensus       493 ~~~d~~~~--~~~Cl~~~p~~RP-----s~~evl~~Le  523 (613)
                      ...++.+.  ..+||+.+|.+||     ++.+++.+-.
T Consensus       233 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~  270 (290)
T cd05613         233 QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF  270 (290)
T ss_pred             ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcc
Confidence            22333332  2279999999997     6777765433

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=287.93  Aligned_cols=192  Identities=27%  Similarity=0.415  Sum_probs=167.1

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      |.....||+|+||.||+|+...++..+|+|.+....  ......+..|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            345568999999999999998878899999987653  333467889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT----  427 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~----  427 (613)
                      + ++|.+++.... ..+++..++.++.+++.||.|||+.+    |+||||+|+||++++++.+||+|||+++....    
T Consensus        81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~----i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR----ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence            8 59999985432 46999999999999999999999988    99999999999999999999999999864321    


Q ss_pred             ----CCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          428 ----SVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       428 ----~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                          ..+..|+|||++... .++.++|||||||++|||++|++||....
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  203 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS  203 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence                124468999999776 78999999999999999999999986544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2e-33  Score=295.07  Aligned_cols=197  Identities=26%  Similarity=0.377  Sum_probs=168.7

Q ss_pred             HHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeec-CC
Q 048439          266 EIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND-DR  342 (613)
Q Consensus       266 el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~-~~  342 (613)
                      ++...+++|...+.||+|+||.||++....++..||||++...  .......+..|++++.+++||||++++++|.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            4456788999999999999999999999888889999988643  22345668899999999999999999998865 56


Q ss_pred             ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCC
Q 048439          343 EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS  422 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls  422 (613)
                      ..++|+||+ +++|.+++.   ...+++.....++.|+++||.|||+.+    |+||||||+|||+++++.+||+|||++
T Consensus        84 ~~~lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~----iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSAG----VVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             cEEEEeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCCHHHEeECCCCCEEeCccccc
Confidence            789999999 468988873   345888899999999999999999998    999999999999999999999999998


Q ss_pred             ccCCC-----CCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          423 KFGPT-----SVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       423 ~~~~~-----~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                      +....     .++..|++||++.. ..++.++|||||||++|||++|++||...
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~  209 (328)
T cd07856         156 RIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK  209 (328)
T ss_pred             cccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            64322     23456999998766 56899999999999999999999998654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.4e-33  Score=288.31  Aligned_cols=244  Identities=23%  Similarity=0.255  Sum_probs=188.5

Q ss_pred             CCCCcceeeeeCcEEEEEEEEc---CCceeEEEEEeCCCC----hhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCce
Q 048439          273 NFDNDLVIGVGGFGDVYKGFIN---GSTTPVAIKRLEPES----QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~---~~~~~vAVK~~~~~~----~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~  344 (613)
                      +|...+.||+|+||.||+++..   ..+..||||.++...    ......+.+|+.++.++ +|+||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3666779999999999999863   245779999987532    22345688999999999 599999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++||||+++|+|.+++..  ...+++.....++.|+++||.|||+.+    ++||||||+||+++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~----~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLG----IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCC----eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999999853  356899999999999999999999988    99999999999999999999999999864


Q ss_pred             CC---------CCCCcccCChhhhhcCC--CCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHh-hccCCcc
Q 048439          425 GP---------TSVSKTHLDPEYYRLQQ--LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC-YQNGTID  492 (613)
Q Consensus       425 ~~---------~~~~~~~~aPE~~~~~~--~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~-~~~~~~~  492 (613)
                      ..         ..++..|++||.+.+..  .+.++||||||+++|||++|..||........  ........ .......
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~  232 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKSKPPFP  232 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHccCCCCC
Confidence            21         12456799999987765  78899999999999999999999853221110  11111111 1112222


Q ss_pred             ccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          493 QIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       493 ~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ...+..+.  ..+||+.+|++|||+.++...|+.
T Consensus       233 ~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         233 KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            22333322  237999999999999888766653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7.9e-34  Score=287.12  Aligned_cols=240  Identities=23%  Similarity=0.345  Sum_probs=185.8

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC-----ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE-----SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      +|...+.||+|+||.||+++.......+++|.++..     .......+..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            366777999999999999998766555666666532     223344577899999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          348 YDFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      |||+++++|.+++..  .....+++.+++.++.|++.||.|||+.+    ++|+||||+||++++ +.+||+|||+++..
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~----i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR----ILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC----ccccCCChhheEeec-CCEeecccCceeec
Confidence            999999999988853  23467999999999999999999999988    999999999999985 56999999988642


Q ss_pred             --------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccH
Q 048439          426 --------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP  497 (613)
Q Consensus       426 --------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  497 (613)
                              ...++..|++||++....++.++||||||+++|+|++|+.|+.......   ........ .........+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~  231 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---VVLRIVEG-PTPSLPETYSR  231 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHcC-CCCCCcchhcH
Confidence                    1234557999999988889999999999999999999999986432211   11111111 11111122222


Q ss_pred             HH-H-HhcccccCCCCCCCHHHHHHH
Q 048439          498 FL-K-AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       498 ~~-~-~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      .+ . ..+||..+|++||++.|++++
T Consensus       232 ~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         232 QLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            22 1 227999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-33  Score=311.87  Aligned_cols=192  Identities=20%  Similarity=0.274  Sum_probs=154.8

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCc-eeEEEE------------------EeCCCChhcHHHHHHHHHHHhccCccc
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGST-TPVAIK------------------RLEPESQQGALEFQTEIGMLSQLRHLH  330 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~-~~vAVK------------------~~~~~~~~~~~~f~~Ei~~l~~l~H~n  330 (613)
                      ..++|.....||+|+||+||+|.++... ...++|                  .+. ........+.+|+.+|++++|+|
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            4578999999999999999998764321 112222                  111 11223456889999999999999


Q ss_pred             eeeEEEEeecCCceEEEEEcCCCCChhHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCcee
Q 048439          331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSD---NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNIL  407 (613)
Q Consensus       331 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NIL  407 (613)
                      ||++++++.+.+..++|+|++. ++|.+++....   .......+...|+.|++.||.|||+.+    |+||||||+|||
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g----IiHrDLKP~NIL  299 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK----LIHRDIKLENIF  299 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEE
Confidence            9999999999999999999986 47777775422   122345667789999999999999998    999999999999


Q ss_pred             eCCCCcEEEEecCCCccCC---------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCc
Q 048439          408 LDEKWVAKVSDFGLSKFGP---------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSI  467 (613)
Q Consensus       408 l~~~~~~kl~DFGls~~~~---------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~  467 (613)
                      ++.++.+||+|||+++...         ..++..|++||++.+..++.++|||||||+||||++|..++
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            9999999999999996421         23577899999999999999999999999999999987543

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2e-33  Score=291.43  Aligned_cols=196  Identities=27%  Similarity=0.406  Sum_probs=163.6

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCC------
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR------  342 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~------  342 (613)
                      .++|...+.||+|+||.||+|....++..+|||++....  ......+.+|++++++++|+||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468888899999999999999998877889999886542  222345788999999999999999999875433      


Q ss_pred             --ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecC
Q 048439          343 --EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG  420 (613)
Q Consensus       343 --~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG  420 (613)
                        .+++|+||+.+ +|.+.+.. ....+++.++..++.|+++||.|||+.+    |+||||||+|||+++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~----i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENH----ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEECCCCCEEECcCc
Confidence              46999999975 67776643 3457999999999999999999999998    9999999999999999999999999


Q ss_pred             CCccCCC-------------------CCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhh
Q 048439          421 LSKFGPT-------------------SVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAA  472 (613)
Q Consensus       421 ls~~~~~-------------------~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~  472 (613)
                      +++....                   .++..|+|||++.+. .++.++|||||||++|||++|++||.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~  232 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD  232 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence            9864211                   113459999988654 579999999999999999999999975443

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.7e-33  Score=297.37  Aligned_cols=245  Identities=21%  Similarity=0.321  Sum_probs=187.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecC----------
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD----------  341 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~----------  341 (613)
                      .+|...+.||.|+||.||+|....++..||+|.+........+.+.+|++++++++|+||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            5788888999999999999999888889999998776656667789999999999999999999776543          


Q ss_pred             ----CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC-CCCcEEE
Q 048439          342 ----REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKV  416 (613)
Q Consensus       342 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~-~~~~~kl  416 (613)
                          ...++||||++ ++|.+++.   ...+++.....++.|++.||.|||+.+    |+||||||+||+++ +++.+||
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g----ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSAN----VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCCHHHEEEcCCCceEEE
Confidence                35789999997 58988873   235899999999999999999999988    99999999999997 4568899


Q ss_pred             EecCCCccCC-----------CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHH--
Q 048439          417 SDFGLSKFGP-----------TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWA--  482 (613)
Q Consensus       417 ~DFGls~~~~-----------~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~--  482 (613)
                      +|||+++...           ..++..|+|||.+.. ..++.++|||||||++|||++|+.||......+........  
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999986321           123456999998754 56788999999999999999999999654332221111100  


Q ss_pred             ---------------HHhh-ccCC--------ccccccHHH-HHhcccccCCCCCCCHHHHHHHHHH
Q 048439          483 ---------------QQCY-QNGT--------IDQIVDPFL-KAMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       483 ---------------~~~~-~~~~--------~~~~~d~~~-~~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                                     .... ....        ...+..... ...+||..+|.+||++.|++.+-..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~  303 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM  303 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence                           0000 0000        001111111 1237999999999999999966543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.6e-33  Score=292.72  Aligned_cols=192  Identities=24%  Similarity=0.325  Sum_probs=160.9

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCC--ceeEEEEEeCCC--ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecC----Cc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGS--TTPVAIKRLEPE--SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDD----RE  343 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~--~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~----~~  343 (613)
                      +|...+.||+|+||.||++.....  +..||+|++...  .....+.+.+|+.++.++ .|+||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            466777999999999999999776  788999998653  222355688999999999 599999999975432    45


Q ss_pred             eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCc
Q 048439          344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK  423 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~  423 (613)
                      .++++||+. ++|.+.+.  ....+++..++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~g----ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSAN----VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            788899986 58988884  3456899999999999999999999998    9999999999999999999999999986


Q ss_pred             cCC------------CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          424 FGP------------TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       424 ~~~------------~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                      ...            ..++..|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~  214 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD  214 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence            321            124567999998866 468999999999999999999999986543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-33  Score=277.81  Aligned_cols=254  Identities=22%  Similarity=0.274  Sum_probs=204.9

Q ss_pred             CHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCc-----eeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEE
Q 048439          263 SLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGST-----TPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIG  336 (613)
Q Consensus       263 ~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~-----~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g  336 (613)
                      ..+||.....++....++.+|.||.||+|.+.+..     +.|-||.++.. ++-....|+.|..++..+.|||+.++.|
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            35667777778888889999999999999775432     44777776543 5566778999999999999999999999


Q ss_pred             EeecC-CceEEEEEcCCCCChhHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC
Q 048439          337 FCNDD-REMILVYDFMARGTLPDHLYH------SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD  409 (613)
Q Consensus       337 ~~~~~-~~~~lV~Ey~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~  409 (613)
                      +|.++ ...+++|.++.-|+|..+|..      +....++-.+...++.|++.||+|||.++    +||.||.++|+++|
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~----ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG----VIHKDIAARNCVID  430 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC----cccchhhhhcceeh
Confidence            99775 456888999999999999962      22356888899999999999999999999    99999999999999


Q ss_pred             CCCcEEEEecCCCccCCC----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhH
Q 048439          410 EKWVAKVSDFGLSKFGPT----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSL  478 (613)
Q Consensus       410 ~~~~~kl~DFGls~~~~~----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l  478 (613)
                      +...+||+|=.|||...+          .....||+||.+....++.++|||||||+||||+| |+.|+..-++.+....
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y  510 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY  510 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence            999999999999985322          22456999999999999999999999999999997 7888877666654433


Q ss_pred             HHHHHHhhccCCccccccHHHHHh-cccccCCCCCCCHHHHHHHHH
Q 048439          479 AVWAQQCYQNGTIDQIVDPFLKAM-SCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       479 ~~~~~~~~~~~~~~~~~d~~~~~~-~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .....+   -...-...|.+...| -||+..|++||+..+++.-|.
T Consensus       511 lkdGyR---laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs  553 (563)
T KOG1024|consen  511 LKDGYR---LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLS  553 (563)
T ss_pred             Hhccce---ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence            332222   222344556555544 699999999999999998775

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=276.66  Aligned_cols=239  Identities=19%  Similarity=0.325  Sum_probs=184.0

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccC-ccceeeEEEEeecCCceEEEEEcCCCCC
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDREMILVYDFMARGT  355 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gs  355 (613)
                      ..||.|..|.|++++.+.++...|||.+... +.+..+.++..++++.+-+ +|.||+.+|||..+...++-||.|.. .
T Consensus        98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C  176 (391)
T KOG0983|consen   98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-C  176 (391)
T ss_pred             HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-H
Confidence            3799999999999999999999999999765 4556677888888887765 89999999999999999999999853 3


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc-------CCCC
Q 048439          356 LPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF-------GPTS  428 (613)
Q Consensus       356 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~-------~~~~  428 (613)
                      + +.|..+...++++...=++...+.+||.||.++..   |||||+||+|||+|+.|++||||||+|..       ....
T Consensus       177 ~-ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~---viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsA  252 (391)
T KOG0983|consen  177 A-EKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSA  252 (391)
T ss_pred             H-HHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcc---eeecccCccceEEccCCCEEeecccccceeeccccccccc
Confidence            3 44434456678888888999999999999987653   99999999999999999999999999853       2234


Q ss_pred             CCcccCChhhhhcC---CCCchhHHHHHHHHHHHHHhCCCCccchhhh-hhhhHHHHHHH-hhccCC-ccccccHHHHHh
Q 048439          429 VSKTHLDPEYYRLQ---QLTEKSDVYSFGVVLFEVLCARPSILRTAAK-KQVSLAVWAQQ-CYQNGT-IDQIVDPFLKAM  502 (613)
Q Consensus       429 ~~~~~~aPE~~~~~---~~t~ksDV~SfGvvL~elltg~~p~~~~~~~-~~~~l~~~~~~-~~~~~~-~~~~~d~~~~~~  502 (613)
                      +...|||||.+...   +|..++||||||+.|+||.||+.||.....+ +....+.-... ++..+. +...+..+  ..
T Consensus       253 GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~f--v~  330 (391)
T KOG0983|consen  253 GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSF--VK  330 (391)
T ss_pred             CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHH--HH
Confidence            56679999998654   6788999999999999999999999764322 21111111111 111111 11111112  22


Q ss_pred             cccccCCCCCCCHHHHHHHHH
Q 048439          503 SCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       503 ~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .||..|+.+||...+++++-.
T Consensus       331 ~CL~kd~r~RP~Y~~Ll~h~F  351 (391)
T KOG0983|consen  331 DCLTKDHRKRPKYNKLLEHPF  351 (391)
T ss_pred             HHhhcCcccCcchHHHhcCcc
Confidence            799999999999999987654

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-33  Score=281.04  Aligned_cols=230  Identities=24%  Similarity=0.301  Sum_probs=185.5

Q ss_pred             eeeeCcEEEEEEEEcCCceeEEEEEeCCCCh---hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCCh
Q 048439          280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQ---QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTL  356 (613)
Q Consensus       280 iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  356 (613)
                      ||+|+||.||++.....+..+|+|.+.....   .....+..|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6999999999999987778899999876532   2455789999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC--------C
Q 048439          357 PDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT--------S  428 (613)
Q Consensus       357 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~--------~  428 (613)
                      .+++..  ...+++.....++.|++.||.|||+.+    ++|+||+|+||+++.++.++|+|||++.....        .
T Consensus        81 ~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~~~----~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          81 FSHLSK--EGRFSEERARFYAAEIVLALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence            999853  346899999999999999999999988    99999999999999999999999999864322        2


Q ss_pred             CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccccc-HHHH-Hhcccc
Q 048439          429 VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVD-PFLK-AMSCLN  506 (613)
Q Consensus       429 ~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-~~~~-~~~Cl~  506 (613)
                      ++..|++||...+...+.++|+||||+++|||++|+.||.......   .......  ....+....+ .... ..+||.
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~  229 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEKILK--DPLRFPEFLSPEARDLISGLLQ  229 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHhc--CCCCCCCCCCHHHHHHHHHHhc
Confidence            4557999999998889999999999999999999999996543311   1111111  1112222222 2222 227999


Q ss_pred             cCCCCCCCH---HHHHH
Q 048439          507 DEGIRRPSM---SDVVW  520 (613)
Q Consensus       507 ~~p~~RPs~---~evl~  520 (613)
                      .+|++||++   .+++.
T Consensus       230 ~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         230 KDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             CCHhhCCCcccHHHHHh
Confidence            999999999   55543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-34  Score=292.71  Aligned_cols=242  Identities=19%  Similarity=0.277  Sum_probs=194.6

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh--cHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      -|+..+.||+|-|..|-++++--++..||||++.+..-.  ....+..|++.|+.++|||||+||.+......+|||+|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            355666899999999999998877889999999876433  344688999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC-CCCcEEEEecCCCcc-----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKF-----  424 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGls~~-----  424 (613)
                      -.+|+|.|+|.+. ...|.+....+++.||+.|+.|+|+..    ++||||||+||.+- +-|-+||.|||++..     
T Consensus        99 GD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLH----VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   99 GDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLH----VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             cCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhh----hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            9999999999754 456899999999999999999999988    99999999999775 457899999999843     


Q ss_pred             --CCCCCCcccCChhhhhcCCCC-chhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHHH
Q 048439          425 --GPTSVSKTHLDPEYYRLQQLT-EKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKA  501 (613)
Q Consensus       425 --~~~~~~~~~~aPE~~~~~~~t-~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  501 (613)
                        ...+++..|-|||.+.+..|. ++.||||+||+||-|+||++||......+....+.--..........+.-|.   .
T Consensus       174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdL---I  250 (864)
T KOG4717|consen  174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDL---I  250 (864)
T ss_pred             hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHH---H
Confidence              334667789999999999885 6899999999999999999999766554433322211111111111222221   1


Q ss_pred             hcccccCCCCCCCHHHHHHHH
Q 048439          502 MSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~L  522 (613)
                      -.+|..||.+|.+.++|+..-
T Consensus       251 ~sMLvRdPkkRAslEeI~s~~  271 (864)
T KOG4717|consen  251 QSMLVRDPKKRASLEEIVSTS  271 (864)
T ss_pred             HHHHhcCchhhccHHHHhccc
Confidence            268999999999999998543

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.9e-33  Score=294.66  Aligned_cols=194  Identities=25%  Similarity=0.393  Sum_probs=166.5

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCc----
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDRE----  343 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~----  343 (613)
                      ..++|.....||+|+||.||+|+...++..||||++...  .......+.+|+.++++++|+||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            457788889999999999999999888889999998653  23344567889999999999999999998776554    


Q ss_pred             --eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCC
Q 048439          344 --MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL  421 (613)
Q Consensus       344 --~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl  421 (613)
                        .++|+||+ +++|.+++..   ..+++..++.++.|+++||.|||+.+    |+||||||+||++++++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g----i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG----IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999999 5699998843   46999999999999999999999988    99999999999999999999999999


Q ss_pred             CccCC-----CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          422 SKFGP-----TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       422 s~~~~-----~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                      +....     ..++..|++||.+.. ..++.++|||||||++|||++|++||....
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~  220 (343)
T cd07851         165 ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD  220 (343)
T ss_pred             cccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            86432     123556999999865 367899999999999999999999986543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-33  Score=292.58  Aligned_cols=238  Identities=20%  Similarity=0.290  Sum_probs=186.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCC--CChhcHHHHHHHHHHHhccC-ccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~--~~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ..|...+.||+||..+||++...+. +.+|+|++..  .+.+...-|.+||..|.+|+ |.+||.|++|-..++.+||||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            3477778999999999999988766 5688887643  35667788999999999995 999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||-+. +|...|.........| .+..+..|++.++.++|.++    |||.||||.|+|+- .|.+||+|||+|...   
T Consensus       440 E~Gd~-DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g----IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  440 ECGDI-DLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG----IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             ecccc-cHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc----eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence            98654 9999997655555556 67788999999999999999    99999999999998 579999999999642   


Q ss_pred             -------CCCCCcccCChhhhhcCC-----------CCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHh-h
Q 048439          426 -------PTSVSKTHLDPEYYRLQQ-----------LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC-Y  486 (613)
Q Consensus       426 -------~~~~~~~~~aPE~~~~~~-----------~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~-~  486 (613)
                             ...||..||+||.+....           .+.+|||||+||+||+|+.|++||.....       .|+... +
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~aKl~aI  585 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIAKLHAI  585 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHHHHHhh
Confidence                   345788899999986532           46799999999999999999999953221       111111 1


Q ss_pred             ccC----CccccccH--HHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          487 QNG----TIDQIVDP--FLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       487 ~~~----~~~~~~d~--~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ..+    .+.++...  +.. +..||+.||.+||+..++|++..-
T Consensus       586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl  630 (677)
T KOG0596|consen  586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFL  630 (677)
T ss_pred             cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccc
Confidence            111    12222221  222 226999999999999999977653

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.5e-33  Score=316.07  Aligned_cols=237  Identities=25%  Similarity=0.383  Sum_probs=179.8

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecC------
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD------  341 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~------  341 (613)
                      +-.++|.+..+||+||||.|||++.+-+++.+|||++... +........+|+.+|++|+|||||+++..+.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            4557788888999999999999999888899999998765 444556688999999999999999998321000      


Q ss_pred             --------------------------------------------------------------------------------
Q 048439          342 --------------------------------------------------------------------------------  341 (613)
Q Consensus       342 --------------------------------------------------------------------------------  341 (613)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CceEEEEEcCCCCChhHHhhcCCCCCC-CHHHHHHHHHHHHHHHHHH
Q 048439          342 ---------------------------------REMILVYDFMARGTLPDHLYHSDNPPL-PWNQRLEICIGAARGLHYL  387 (613)
Q Consensus       342 ---------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~l-~~~~~~~i~~~ia~gL~yL  387 (613)
                                                       ..+|+-||||+.-+|++++..+  ... .....++++.+|++||.|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N--~~~~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN--HFNSQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc--ccchhhHHHHHHHHHHHHHHHHH
Confidence                                             1257889999998888877443  222 4567789999999999999


Q ss_pred             hcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc-------------------C-------CCCCCcccCChhhhhc
Q 048439          388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF-------------------G-------PTSVSKTHLDPEYYRL  441 (613)
Q Consensus       388 H~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~-------------------~-------~~~~~~~~~aPE~~~~  441 (613)
                      |+++    ||||||||.||+||++..+||+|||+|+.                   +       ...||..|+|||.+..
T Consensus       714 H~~g----iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  714 HDQG----IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HhCc----eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            9999    99999999999999999999999999863                   0       1124567999999976


Q ss_pred             C---CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccc---ccH-----HHHHhcccccCCC
Q 048439          442 Q---QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQI---VDP-----FLKAMSCLNDEGI  510 (613)
Q Consensus       442 ~---~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~---~d~-----~~~~~~Cl~~~p~  510 (613)
                      .   +|+.|+|+||+||||+||+.   ||....+..  ....    ..+.+.++.-   .++     .....++++.||.
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa--~iL~----~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~  860 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA--SILT----NLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPS  860 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchHHHH--HHHH----hcccCCCCCCcccccccchHHHHHHHHHhcCCCc
Confidence            5   49999999999999999984   353332221  1111    1223333222   222     2223378899999


Q ss_pred             CCCCHHHHHH
Q 048439          511 RRPSMSDVVW  520 (613)
Q Consensus       511 ~RPs~~evl~  520 (613)
                      +|||+.|++.
T Consensus       861 kRPtA~eLL~  870 (1351)
T KOG1035|consen  861 KRPTATELLN  870 (1351)
T ss_pred             cCCCHHHHhh
Confidence            9999999984

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=302.23  Aligned_cols=194  Identities=28%  Similarity=0.435  Sum_probs=168.1

Q ss_pred             CcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCC------ceEEEE
Q 048439          276 NDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR------EMILVY  348 (613)
Q Consensus       276 ~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~lV~  348 (613)
                      ....||+|+||.||+|+.+.+|..||||.++..+ ....+...+|+++|++|+|+|||++++.-.+..      ...+||
T Consensus        17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm   96 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM   96 (732)
T ss_pred             ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence            3447999999999999999999999999998763 455667899999999999999999999866543      568999


Q ss_pred             EcCCCCChhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC--CCC--cEEEEecCCCc
Q 048439          349 DFMARGTLPDHLYHS-DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD--EKW--VAKVSDFGLSK  423 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~--~~~--~~kl~DFGls~  423 (613)
                      |||.+|+|+..|... +...|++.+.+.+...++.||.|||+++    |+||||||.||++-  ++|  ..||+|||.||
T Consensus        97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~----IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG----IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC----ceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            999999999999653 3567999999999999999999999988    99999999999983  333  57999999998


Q ss_pred             cCC-------CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhh
Q 048439          424 FGP-------TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAK  473 (613)
Q Consensus       424 ~~~-------~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~  473 (613)
                      ..+       ..||..|++||.+.. +.++..+|.|||||++||++||..||.+....
T Consensus       173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             cCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            543       346888999999995 78899999999999999999999999765443

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.1e-32  Score=312.52  Aligned_cols=146  Identities=27%  Similarity=0.350  Sum_probs=131.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|.....+..||||+++...   ......+..|+.++..++|+||+++++++...+..+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888889999999999999998778899999987542   333467889999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCc
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK  423 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~  423 (613)
                      ||+.+|+|.+++..  ...+++...+.|+.||+.||.|||..+    |+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~g----IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHG----IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999854  345889999999999999999999988    9999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=275.10  Aligned_cols=246  Identities=20%  Similarity=0.300  Sum_probs=196.0

Q ss_pred             HhcCCCCc-ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEeec----CCc
Q 048439          270 ATNNFDND-LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCND----DRE  343 (613)
Q Consensus       270 at~~f~~~-~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~----~~~  343 (613)
                      .|++|... .+||-|-.|+|-.+..+.+++.+|+|.+...     ..-.+|+++.-+. .|+|||++++++..    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            34555433 4899999999999999999999999998643     2347788887776 59999999998754    567


Q ss_pred             eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC---CCcEEEEecC
Q 048439          344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE---KWVAKVSDFG  420 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFG  420 (613)
                      +++|||+|+||.|...+..+....+++.+...|..||+.|+.|||+.+    |.||||||+|+|...   |..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n----IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN----IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc----hhhccCChhheeeecCCCCcceEecccc
Confidence            889999999999999998877888999999999999999999999998    999999999999964   5679999999


Q ss_pred             CCccCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhh----hhhHHHHHHHhhccC
Q 048439          421 LSKFGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK----QVSLAVWAQQCYQNG  489 (613)
Q Consensus       421 ls~~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~----~~~l~~~~~~~~~~~  489 (613)
                      +|+...       ++.|+.|.|||++...+|...+|+||+||++|-||||.|||+......    ....+......+.++
T Consensus       210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p  289 (400)
T KOG0604|consen  210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP  289 (400)
T ss_pred             cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence            998533       445777999999999999999999999999999999999998654321    112222222233344


Q ss_pred             CccccccHHHHHh-cccccCCCCCCCHHHHHHHHHH
Q 048439          490 TIDQIVDPFLKAM-SCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       490 ~~~~~~d~~~~~~-~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ..+++.......+ ..|..+|.+|.|+.+++.+.+.
T Consensus       290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi  325 (400)
T KOG0604|consen  290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI  325 (400)
T ss_pred             hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence            4444443333333 4577899999999999977654

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=3.2e-32  Score=272.29  Aligned_cols=215  Identities=20%  Similarity=0.198  Sum_probs=171.0

Q ss_pred             eCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCChhHHhhc
Q 048439          283 GGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYH  362 (613)
Q Consensus       283 G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~  362 (613)
                      |.||+||+++...+++.+|+|++...+     .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999998888999999997653     334556666667899999999999999999999999999999999854


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----CCCCcccCChh
Q 048439          363 SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----TSVSKTHLDPE  437 (613)
Q Consensus       363 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----~~~~~~~~aPE  437 (613)
                        ...+++..+..++.|++.||.|||+.+    |+||||||+||++++++.++++|||++....     ...+..|++||
T Consensus        79 --~~~l~~~~~~~~~~ql~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE  152 (237)
T cd05576          79 --FLNIPEECVKRWAAEMVVALDALHREG----IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPE  152 (237)
T ss_pred             --hcCCCHHHHHHHHHHHHHHHHHHHhCC----eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCc
Confidence              345999999999999999999999988    9999999999999999999999999875322     22344699999


Q ss_pred             hhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--HhcccccCCCCCCCH
Q 048439          438 YYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSCLNDEGIRRPSM  515 (613)
Q Consensus       438 ~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~  515 (613)
                      .+....++.++||||+||++|||++|+.|+.........         .....+...+++.+.  ..+||+.||.+||++
T Consensus       153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT---------HTTLNIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc---------ccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence            998888999999999999999999999887432211000         000011122222222  227999999999997


Q ss_pred             HH
Q 048439          516 SD  517 (613)
Q Consensus       516 ~e  517 (613)
                      .+
T Consensus       224 ~~  225 (237)
T cd05576         224 GV  225 (237)
T ss_pred             Cc
Confidence            43

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=5.5e-33  Score=309.16  Aligned_cols=252  Identities=22%  Similarity=0.287  Sum_probs=201.7

Q ss_pred             HHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeec
Q 048439          264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND  340 (613)
Q Consensus       264 ~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~  340 (613)
                      ..+++....+|.+.++||+|+||.|..++++.++..+|.|++++.   ......-|..|-.+|..-+.+-|+.|.-.|++
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            455666678899999999999999999999999999999999874   23344568999999999999999999999999


Q ss_pred             CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecC
Q 048439          341 DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG  420 (613)
Q Consensus       341 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG  420 (613)
                      ++.+|||||||+||+|-.++.+-.  ++++.....++..|+.||.-||+.|    +|||||||+|||||..|++||+|||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg----yVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG----YVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc----ceeccCCcceeEecccCcEeeccch
Confidence            999999999999999999995433  6899999999999999999999999    9999999999999999999999999


Q ss_pred             CCcc---------CCCCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhh
Q 048439          421 LSKF---------GPTSVSKTHLDPEYYRL-----QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCY  486 (613)
Q Consensus       421 ls~~---------~~~~~~~~~~aPE~~~~-----~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~  486 (613)
                      -+-.         ....||+.|++||+++.     +.|...+|+||+||++|||++|..||+.....+....+.-....+
T Consensus       221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l  300 (1317)
T KOG0612|consen  221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESL  300 (1317)
T ss_pred             hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhc
Confidence            7632         23457899999999964     578899999999999999999999998665444333332222222


Q ss_pred             ccC---CccccccHHHHHhcccccCCCCCCC---HHHHHHHHHH
Q 048439          487 QNG---TIDQIVDPFLKAMSCLNDEGIRRPS---MSDVVWGLEF  524 (613)
Q Consensus       487 ~~~---~~~~~~d~~~~~~~Cl~~~p~~RPs---~~evl~~Le~  524 (613)
                      .-+   .+.+-...++.++-|   +|+.|-.   +.|+-.+..+
T Consensus       301 ~FP~~~~VSeeakdLI~~ll~---~~e~RLgrngiedik~HpFF  341 (1317)
T KOG0612|consen  301 SFPDETDVSEEAKDLIEALLC---DREVRLGRNGIEDIKNHPFF  341 (1317)
T ss_pred             CCCcccccCHHHHHHHHHHhc---ChhhhcccccHHHHHhCccc
Confidence            211   111112223333334   6667776   9999877765

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.8e-32  Score=291.78  Aligned_cols=237  Identities=22%  Similarity=0.295  Sum_probs=191.6

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      +..|.....+|.|+|+.|-++....+.+..+||++.....    +-.+|+.++... +|+||+++.+.|.+..+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            5567777789999999999999998889999999976522    234577666665 69999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee-CCCCcEEEEecCCCccCC--
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL-DEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl-~~~~~~kl~DFGls~~~~--  426 (613)
                      ++.+|-|.+.+...  +.+. ..+..|+.+++.|+.|||.++    ++||||||+|||+ ++.++++|+|||.++...  
T Consensus       397 ~l~g~ell~ri~~~--~~~~-~e~~~w~~~lv~Av~~LH~~g----vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSK--PEFC-SEASQWAAELVSAVDYLHEQG----VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHhc--chhH-HHHHHHHHHHHHHHHHHHhcC----eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            99999988887432  3333 777889999999999999998    9999999999999 689999999999987533  


Q ss_pred             ---CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHHHh-
Q 048439          427 ---TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAM-  502 (613)
Q Consensus       427 ---~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~-  502 (613)
                         +..+..|.|||++....+|+++|+||||++|||||||+.||......      .-.......+.+.+.+....+.+ 
T Consensus       470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s~~vS~~AKdLl  543 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFSECVSDEAKDLL  543 (612)
T ss_pred             hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCccccccCHHHHHHH
Confidence               24466799999999999999999999999999999999999755443      11222333443334433333322 


Q ss_pred             -cccccCCCCCCCHHHHHHHHHH
Q 048439          503 -SCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       503 -~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                       +||+.||.+||+|.++..+-+.
T Consensus       544 ~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  544 QQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHhccCChhhCcChhhhccCcch
Confidence             7999999999999999877665

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=8.6e-34  Score=319.22  Aligned_cols=244  Identities=22%  Similarity=0.274  Sum_probs=191.5

Q ss_pred             HHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceE
Q 048439          268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       268 ~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  345 (613)
                      ...+-++.....||.|.||+||-|...+++...|+|-++-.  .........+|+.+|..|+|||+|+++|+-.+.+.++
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            34455677778999999999999999999999999977543  3444556789999999999999999999999999999


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      |.||||++|+|.+.+.+  ...+++.....+..|++.|+.|||+++    ||||||||.||||+.+|.+|++|||.|...
T Consensus      1311 IFMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~g----IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHG----IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcC----ceecCCCccceeeecCCcEEeecccceeEe
Confidence            99999999999999954  344666666778899999999999999    999999999999999999999999998642


Q ss_pred             ------------CCCCCcccCChhhhhcCC---CCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCC
Q 048439          426 ------------PTSVSKTHLDPEYYRLQQ---LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT  490 (613)
Q Consensus       426 ------------~~~~~~~~~aPE~~~~~~---~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~  490 (613)
                                  ...||+.|||||++.+..   -.-+.||||+|||.+||+||+.||...+..-+.....-+.   ..+.
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g---h~Pq 1461 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG---HKPQ 1461 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc---CCCC
Confidence                        234688899999997643   3568999999999999999999996554333322222121   1122


Q ss_pred             ccccccHHHHH--hcccccCCCCCCCHHHHHH
Q 048439          491 IDQIVDPFLKA--MSCLNDEGIRRPSMSDVVW  520 (613)
Q Consensus       491 ~~~~~d~~~~~--~~Cl~~~p~~RPs~~evl~  520 (613)
                      +++-+...-..  ..||..||++|-++.++++
T Consensus      1462 ~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1462 IPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             CchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            22222222221  2799999999977776653

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.98  E-value=1.4e-32  Score=268.60  Aligned_cols=194  Identities=27%  Similarity=0.418  Sum_probs=162.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCc----eeEEEEEeCCCChh--cHHHHHHHHHHHhccCccceeeEEEEeec-CCce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGST----TPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGFCND-DREM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~----~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l~H~niv~l~g~~~~-~~~~  344 (613)
                      ..|.....||+|.||.||+|+-.++.    ..+|+|+++.....  -...-.+|+.+++.|+|+||++|..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46777789999999999999764432    36899999766332  12346799999999999999999999877 7889


Q ss_pred             EEEEEcCCCCChhHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC----CcEEEE
Q 048439          345 ILVYDFMARGTLPDHLYH---SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK----WVAKVS  417 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~----~~~kl~  417 (613)
                      +|++||.++ +|.+.++.   .....++......|..||+.|++|||+.-    |+||||||.|||+..+    |.+||+
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW----vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW----VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh----eeeccCCcceEEEeccCCccCeeEee
Confidence            999999998 88888853   23457888999999999999999999998    9999999999999877    899999


Q ss_pred             ecCCCccCCC-----------CCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          418 DFGLSKFGPT-----------SVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       418 DFGls~~~~~-----------~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                      |||++|....           ..|.-|.|||.+.+ ..||.+.|||+.||+..||++..|-|.+.
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            9999985221           12456899999987 56899999999999999999988877543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.98  E-value=2.3e-31  Score=263.90  Aligned_cols=229  Identities=26%  Similarity=0.323  Sum_probs=184.9

Q ss_pred             CcEEEEEEEEcCCceeEEEEEeCCCChhc-HHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCChhHHhhc
Q 048439          284 GFGDVYKGFINGSTTPVAIKRLEPESQQG-ALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYH  362 (613)
Q Consensus       284 ~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~-~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~  362 (613)
                      +||.||+|+..+++..+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            68999999998877889999998765544 67899999999999999999999999999999999999999999999854


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-------CCCCcccCC
Q 048439          363 SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-------TSVSKTHLD  435 (613)
Q Consensus       363 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-------~~~~~~~~a  435 (613)
                      .  ..+++..++.++.+++++|.|||+.+    ++|+||+|+||++++++.++|+|||++....       ..+...|++
T Consensus        81 ~--~~~~~~~~~~~~~~l~~~l~~lh~~~----i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  154 (244)
T smart00220       81 R--GRLSEDEARFYARQILSALEYLHSNG----IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA  154 (244)
T ss_pred             c--cCCCHHHHHHHHHHHHHHHHHHHHcC----eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence            2  33899999999999999999999988    9999999999999999999999999986432       234567999


Q ss_pred             hhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccc--cccHHHH-HhcccccCCCCC
Q 048439          436 PEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ--IVDPFLK-AMSCLNDEGIRR  512 (613)
Q Consensus       436 PE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~d~~~~-~~~Cl~~~p~~R  512 (613)
                      ||.+....++.++||||||+++|||++|..|+.......  ....+............  +...+.. ..+||..+|.+|
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R  232 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR  232 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence            999998899999999999999999999999986522111  12222221111111110  2222222 337999999999


Q ss_pred             CCHHHHHH
Q 048439          513 PSMSDVVW  520 (613)
Q Consensus       513 Ps~~evl~  520 (613)
                      |++.++++
T Consensus       233 p~~~~~~~  240 (244)
T smart00220      233 LTAEEALQ  240 (244)
T ss_pred             cCHHHHhh
Confidence            99999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-32  Score=269.15  Aligned_cols=253  Identities=21%  Similarity=0.312  Sum_probs=196.4

Q ss_pred             CHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC-ccceeeEEEEeecC
Q 048439          263 SLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDD  341 (613)
Q Consensus       263 ~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~  341 (613)
                      +++|+.+.|.+     +||+|+|+.|--++...++..+|||++.+..........+|++++.+.+ |+||+.|+.||+++
T Consensus        74 ~F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            36777777776     8999999999999987788899999998876667778899999999996 99999999999999


Q ss_pred             CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC---cEEEEe
Q 048439          342 REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW---VAKVSD  418 (613)
Q Consensus       342 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~---~~kl~D  418 (613)
                      ..+|||||-|.+|.|..+|..  ...+++.+..++..+||.||.+||.++    |.||||||+|||..+-.   -+||||
T Consensus       149 ~~FYLVfEKm~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~kg----IAHRDlKPENiLC~~pn~vsPvKiCD  222 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLHTKG----IAHRDLKPENILCESPNKVSPVKICD  222 (463)
T ss_pred             ceEEEEEecccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhcC----cccccCCccceeecCCCCcCceeeec
Confidence            999999999999999999954  456899999999999999999999999    99999999999996543   589999


Q ss_pred             cCCCc---------------cCCCCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhh---
Q 048439          419 FGLSK---------------FGPTSVSKTHLDPEYYRL-----QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQ---  475 (613)
Q Consensus       419 FGls~---------------~~~~~~~~~~~aPE~~~~-----~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~---  475 (613)
                      |.|..               +..+.++..|||||+..-     ..|..++|.||+|||||-||+|.+||.+....+.   
T Consensus       223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd  302 (463)
T KOG0607|consen  223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD  302 (463)
T ss_pred             cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence            98853               123445667999998642     4578899999999999999999999976443211   


Q ss_pred             -----hhHHHHHHHhhccCCc-------cccccHHHHHh-cccccCCCCCCCHHHHHHHHHHhh
Q 048439          476 -----VSLAVWAQQCYQNGTI-------DQIVDPFLKAM-SCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       476 -----~~l~~~~~~~~~~~~~-------~~~~d~~~~~~-~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                           ..-.......++++..       ..+.+.....+ ..|..++.+|-++..++.+.+...
T Consensus       303 rGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~  366 (463)
T KOG0607|consen  303 RGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR  366 (463)
T ss_pred             CCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence                 0011111112233322       11211111111 456689999999999997665433

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=5.2e-32  Score=245.75  Aligned_cols=211  Identities=24%  Similarity=0.339  Sum_probs=177.0

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh-h-cHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ-Q-GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~-~-~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +|+.-+.||+|.||+||||+..++...||+|+.+.+.. + --..-.+||.+|+.|+|+|||+++.....++.+-||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            45555689999999999999999999999999876532 2 234578999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-----  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-----  425 (613)
                      |.. +|..+.. +-+..++......+..|+++||.++|+++    +.||||||.|.|++.+|+.|++|||+++..     
T Consensus        83 cdq-dlkkyfd-slng~~d~~~~rsfmlqllrgl~fchshn----vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFD-SLNGDLDPEIVRSFMLQLLRGLGFCHSHN----VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hhH-HHHHHHH-hcCCcCCHHHHHHHHHHHHhhhhhhhhhh----hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            976 7877763 45677999999999999999999999998    999999999999999999999999999742     


Q ss_pred             ---CCCCCcccCChhhhhcCC-CCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccC
Q 048439          426 ---PTSVSKTHLDPEYYRLQQ-LTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNG  489 (613)
Q Consensus       426 ---~~~~~~~~~aPE~~~~~~-~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~  489 (613)
                         ....+.-|.+|+++.+.+ |++..|+||-||++.|+.. |+|-|.+....+|...+-|......+.
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed  225 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTED  225 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccc
Confidence               223355689999987754 6889999999999999985 677777777777777777766554443

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-33  Score=268.22  Aligned_cols=243  Identities=23%  Similarity=0.301  Sum_probs=185.4

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh-hcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEEEcCCCCCh
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ-QGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYDFMARGTL  356 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  356 (613)
                      .||.|+||+|+|-.++..++..|||+++.... ...++|+.|.+...+- +.||||+++|.+..++..++-||.|.- +|
T Consensus        71 ~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-Sl  149 (361)
T KOG1006|consen   71 EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SL  149 (361)
T ss_pred             HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hH
Confidence            79999999999999999999999999987643 5667788888876554 799999999999999999999999965 66


Q ss_pred             hHH---hhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc-------CC
Q 048439          357 PDH---LYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF-------GP  426 (613)
Q Consensus       357 ~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~-------~~  426 (613)
                      ..+   ++...+..+++...-.|....++||.||.+.-.   ||||||||+|||||..|.+||||||++..       ..
T Consensus       150 DklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk---iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~  226 (361)
T KOG1006|consen  150 DKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK---IIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTV  226 (361)
T ss_pred             HHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh---hhhccCChhheEEecCCCEeeecccchHhHHHHHHhhh
Confidence            443   334456779999888999999999999987653   99999999999999999999999999853       22


Q ss_pred             CCCCcccCChhhhhcC--CCCchhHHHHHHHHHHHHHhCCCCccchhh-hhhhhHHHHHHHhhccCCcc--ccccHHHHH
Q 048439          427 TSVSKTHLDPEYYRLQ--QLTEKSDVYSFGVVLFEVLCARPSILRTAA-KKQVSLAVWAQQCYQNGTID--QIVDPFLKA  501 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~~--~~t~ksDV~SfGvvL~elltg~~p~~~~~~-~~~~~l~~~~~~~~~~~~~~--~~~d~~~~~  501 (613)
                      ..+...|||||.+...  .+.-+|||||+|++|+|+.||+.|+..... .+|...+............+  +...++..-
T Consensus       227 daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~f  306 (361)
T KOG1006|consen  227 DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRF  306 (361)
T ss_pred             ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHH
Confidence            3456789999998553  478899999999999999999999865432 22222221111111100000  111222221


Q ss_pred             -hcccccCCCCCCCHHHHHHHHHHh
Q 048439          502 -MSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       502 -~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                       -.||.+|-..||...++.++-.+.
T Consensus       307 intCl~Kd~~~Rpky~~Lk~~~fyr  331 (361)
T KOG1006|consen  307 INTCLIKDRSDRPKYDDLKKFPFYR  331 (361)
T ss_pred             HHHHhhcccccCcchhhhhcCchhh
Confidence             269999999999999998765543

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-32  Score=275.55  Aligned_cols=198  Identities=25%  Similarity=0.358  Sum_probs=173.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  347 (613)
                      .+|....+||+|+||+|.+|..+++...+|||+++++-   ....+--+.|-++|+.. +-|.++.|..+++..+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            36777889999999999999999999999999998752   22233346777888766 688999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc---
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---  424 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~---  424 (613)
                      |||+.+|+|--++.  +-..+.+.....+|..||-||-+||+++    ||.||||..|||||.+|.+||+|||+++.   
T Consensus       429 MEyvnGGDLMyhiQ--Q~GkFKEp~AvFYAaEiaigLFFLh~kg----IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQ--QVGKFKEPVAVFYAAEIAIGLFFLHSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             EEEecCchhhhHHH--HhcccCCchhhhhhHHHHHHhhhhhcCC----eeeeeccccceEeccCCceEeeeccccccccc
Confidence            99999999988874  3456778889999999999999999999    99999999999999999999999999974   


Q ss_pred             -----CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhh
Q 048439          425 -----GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQ  475 (613)
Q Consensus       425 -----~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~  475 (613)
                           ...++++.|+|||.+..++|....|+|||||+||||+.|++||++..+.+.
T Consensus       503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el  558 (683)
T KOG0696|consen  503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL  558 (683)
T ss_pred             CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence                 234678889999999999999999999999999999999999988776654

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=7.2e-31  Score=293.17  Aligned_cols=247  Identities=19%  Similarity=0.215  Sum_probs=165.5

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCC----ceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEE------ee
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGS----TTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF------CN  339 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~----~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~------~~  339 (613)
                      ..++|...+.||+|+||.||+|++..+    +..||||++......  +.+..|  .+....+.+++.++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            567899999999999999999999877    788999998653321  111121  1122222222222211      35


Q ss_pred             cCCceEEEEEcCCCCChhHHhhcCCC------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccC
Q 048439          340 DDREMILVYDFMARGTLPDHLYHSDN------------------PPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDV  401 (613)
Q Consensus       340 ~~~~~~lV~Ey~~~gsL~~~l~~~~~------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDl  401 (613)
                      +....+|||||+++++|.+++.....                  ....+..+..|+.|++.||+|||+.+    |+||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g----IiHRDL  281 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG----IVHRDV  281 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC----EEeCcC
Confidence            66789999999999999998854321                  01123345679999999999999988    999999


Q ss_pred             CCCceeeCC-CCcEEEEecCCCccCC---------CCCCcccCChhhhhcC----------------------CCCchhH
Q 048439          402 KTTNILLDE-KWVAKVSDFGLSKFGP---------TSVSKTHLDPEYYRLQ----------------------QLTEKSD  449 (613)
Q Consensus       402 k~~NILl~~-~~~~kl~DFGls~~~~---------~~~~~~~~aPE~~~~~----------------------~~t~ksD  449 (613)
                      ||+|||+++ ++.+||+|||+|+...         ..+++.|+|||.+...                      .++.++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999986 6899999999997421         2345689999966422                      2345679


Q ss_pred             HHHHHHHHHHHHhCCCCccchhhh-------hhhhHHHHHHHhhccCC-----ccccccHH-----HHHhcccccCCCCC
Q 048439          450 VYSFGVVLFEVLCARPSILRTAAK-------KQVSLAVWAQQCYQNGT-----IDQIVDPF-----LKAMSCLNDEGIRR  512 (613)
Q Consensus       450 V~SfGvvL~elltg~~p~~~~~~~-------~~~~l~~~~~~~~~~~~-----~~~~~d~~-----~~~~~Cl~~~p~~R  512 (613)
                      ||||||+||||+++..+.......       ....+..|.........     .-++.|..     -...+||+.||++|
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            999999999999977665432111       01122333322111100     00111110     11227999999999


Q ss_pred             CCHHHHHHHHHH
Q 048439          513 PSMSDVVWGLEF  524 (613)
Q Consensus       513 Ps~~evl~~Le~  524 (613)
                      ||+.+++++..+
T Consensus       442 ~ta~e~L~Hpff  453 (566)
T PLN03225        442 ISAKAALAHPYF  453 (566)
T ss_pred             CCHHHHhCCcCc
Confidence            999999988654

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=291.65  Aligned_cols=253  Identities=25%  Similarity=0.340  Sum_probs=201.5

Q ss_pred             HHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEeec--
Q 048439          264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCND--  340 (613)
Q Consensus       264 ~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~--  340 (613)
                      ++.+-..+.-|.+..+||.|.+|+||+++....++.+|||++...... .++...|.++|..+ .|||++.++|++..  
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            333444556678888999999999999999888899999999876433 44677888999887 69999999999753  


Q ss_pred             ---CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEE
Q 048439          341 ---DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVS  417 (613)
Q Consensus       341 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~  417 (613)
                         +++++||||||.+|+..|++.+.....+.|..+..|++.+++||.+||...    ++|||||-.||||++++.+||+
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk----viHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK----VIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc----eeeecccCceEEEeccCcEEEe
Confidence               678999999999999999997766788999999999999999999999988    9999999999999999999999


Q ss_pred             ecCCCcc--------CCCCCCcccCChhhhhcC-----CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHH
Q 048439          418 DFGLSKF--------GPTSVSKTHLDPEYYRLQ-----QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQ  484 (613)
Q Consensus       418 DFGls~~--------~~~~~~~~~~aPE~~~~~-----~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~  484 (613)
                      |||++..        ...-+++.|||||++...     .|+..+|+||+|++..||--|.||+.+..+.....++....+
T Consensus       166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP  245 (953)
T KOG0587|consen  166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP  245 (953)
T ss_pred             eeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC
Confidence            9999853        334578899999998664     356789999999999999999999976655433222211111


Q ss_pred             hh---ccCCccccccHHHHHhcccccCCCCCCCHHHHHHHHHH
Q 048439          485 CY---QNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       485 ~~---~~~~~~~~~d~~~~~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ..   .+.+..++.|...   .||.+|-++||++.+++++...
T Consensus       246 PkLkrp~kWs~~FndFIs---~cL~Kd~e~RP~~~~ll~hpFi  285 (953)
T KOG0587|consen  246 PKLKRPKKWSKKFNDFIS---TCLVKDYEQRPSTEELLKHPFI  285 (953)
T ss_pred             ccccchhhHHHHHHHHHH---HHHhhccccCcchhhhccCCcc
Confidence            10   0111122223222   6999999999999999977543

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=276.44  Aligned_cols=239  Identities=23%  Similarity=0.315  Sum_probs=193.8

Q ss_pred             cceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       277 ~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      .++||.|.||+||-|+.+.+++.||||.+.+.  .......+.+|+.+|.+++||.||.|...|+..+..++|||-+. |
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence            35899999999999999999999999999764  33444678999999999999999999999999999999999995 5


Q ss_pred             ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC---CcEEEEecCCCccCC-----
Q 048439          355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK---WVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       355 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGls~~~~-----  426 (613)
                      ++.+.+......+|++..-..++.||+.||.|||.++    |+|+||||+||||.+.   -.+||||||.||...     
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn----IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN----IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc----eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            7777777777888999999999999999999999999    9999999999999654   479999999998643     


Q ss_pred             --CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhh-hhhhhHHHHHHHhhccCCccccccHHHHHh-
Q 048439          427 --TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAA-KKQVSLAVWAQQCYQNGTIDQIVDPFLKAM-  502 (613)
Q Consensus       427 --~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~-  502 (613)
                        ..+|+.|+|||+++.+.|...-|+||.||++|--|+|..||..... .+|   +.-+...+......++....+..+ 
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ---IQNAaFMyPp~PW~eis~~AidlIn  800 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ---IQNAAFMYPPNPWSEISPEAIDLIN  800 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH---hhccccccCCCchhhcCHHHHHHHH
Confidence              3468899999999999999999999999999999999999965432 222   222333344444444443333222 


Q ss_pred             cccccCCCCCCCHHHHHHHHH
Q 048439          503 SCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       503 ~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ..|+..=.+|-+...-+.+.+
T Consensus       801 ~LLqVkm~kRysvdk~lsh~W  821 (888)
T KOG4236|consen  801 NLLQVKMRKRYSVDKSLSHPW  821 (888)
T ss_pred             HHHHHHHHHhcchHhhccchh
Confidence            456666667877777765554

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=2e-30  Score=283.12  Aligned_cols=251  Identities=22%  Similarity=0.254  Sum_probs=175.5

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEc----------------CCceeEEEEEeCCCChhcHHHH--------------HHH
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFIN----------------GSTTPVAIKRLEPESQQGALEF--------------QTE  319 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~----------------~~~~~vAVK~~~~~~~~~~~~f--------------~~E  319 (613)
                      ..++|...++||+|+||.||+|.+.                ..++.||||+++.......++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            3678999999999999999999752                2235699999976543333333              447


Q ss_pred             HHHHhccCccce-----eeEEEEeec--------CCceEEEEEcCCCCChhHHhhcCC----------------------
Q 048439          320 IGMLSQLRHLHL-----VSLIGFCND--------DREMILVYDFMARGTLPDHLYHSD----------------------  364 (613)
Q Consensus       320 i~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~----------------------  364 (613)
                      +.++.+++|.++     ++++|+|..        ++..+|||||+++|+|.++|+...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            778888877655     678888753        457899999999999999986421                      


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC---------CCCcccCC
Q 048439          365 NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT---------SVSKTHLD  435 (613)
Q Consensus       365 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~---------~~~~~~~a  435 (613)
                      ...++|..+..++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++....         ..++.|++
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~----ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG----IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence            123578889999999999999999988    99999999999999999999999999864211         12567999


Q ss_pred             hhhhhcCCC----------------------CchhHHHHHHHHHHHHHhCCC-Cccchhhh------hhhhHHHHHHHhh
Q 048439          436 PEYYRLQQL----------------------TEKSDVYSFGVVLFEVLCARP-SILRTAAK------KQVSLAVWAQQCY  486 (613)
Q Consensus       436 PE~~~~~~~----------------------t~ksDV~SfGvvL~elltg~~-p~~~~~~~------~~~~l~~~~~~~~  486 (613)
                      ||.+.....                      ..+.||||+||+|+||+++.. |+......      ....+..|.....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            998864321                      235799999999999999975 55321111      1112233332211


Q ss_pred             ccCCc---cccccHHHH-HhcccccCC---CCCCCHHHHHHHHHH
Q 048439          487 QNGTI---DQIVDPFLK-AMSCLNDEG---IRRPSMSDVVWGLEF  524 (613)
Q Consensus       487 ~~~~~---~~~~d~~~~-~~~Cl~~~p---~~RPs~~evl~~Le~  524 (613)
                      ....+   +.+-+.... +.++|..+|   .+|+|+.|++.+..+
T Consensus       459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f  503 (507)
T PLN03224        459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF  503 (507)
T ss_pred             cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence            11111   111111111 224666544   789999999987654

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.1e-31  Score=255.54  Aligned_cols=243  Identities=23%  Similarity=0.344  Sum_probs=187.2

Q ss_pred             CcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeec--------CCceE
Q 048439          276 NDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND--------DREMI  345 (613)
Q Consensus       276 ~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~--------~~~~~  345 (613)
                      ...+||+|.||.||+|+...+++.||+|+.--+  ...--..-++|+++|..|+|+|++.++..|..        ...++
T Consensus        21 k~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~y  100 (376)
T KOG0669|consen   21 KLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFY  100 (376)
T ss_pred             HHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceee
Confidence            344799999999999999988888999875332  22223456899999999999999999998854        24589


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      |||++|++ +|..+|.. ....++...+.++..++..||.|+|...    |+|||+|+.|+|++.++.+||+|||+++..
T Consensus       101 lVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k----ilHRDmKaaNvLIt~dgilklADFGlar~f  174 (376)
T KOG0669|consen  101 LVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNK----ILHRDMKAANVLITKDGILKLADFGLARAF  174 (376)
T ss_pred             eeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhh----HHhhcccHhhEEEcCCceEEeeccccccce
Confidence            99999998 88888843 3467899999999999999999999988    999999999999999999999999999642


Q ss_pred             C------C------CCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcc
Q 048439          426 P------T------SVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID  492 (613)
Q Consensus       426 ~------~------~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  492 (613)
                      .      .      ..+..|.+||.+.+ ..++++.|||.-||||.||.++.+-+.+..+..+..++...-........+
T Consensus       175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP  254 (376)
T KOG0669|consen  175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP  254 (376)
T ss_pred             ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence            1      1      12556899999877 568999999999999999999999988777666554443221111111110


Q ss_pred             ----------------------cc---cc-----H-HHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          493 ----------------------QI---VD-----P-FLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       493 ----------------------~~---~d-----~-~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                                            .+   ..     + .+. ....+..||.+|+.+.+++.+-.+
T Consensus       255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F  318 (376)
T KOG0669|consen  255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF  318 (376)
T ss_pred             CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence                                  00   00     0 000 126889999999999999977654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-30  Score=241.81  Aligned_cols=199  Identities=23%  Similarity=0.332  Sum_probs=165.7

Q ss_pred             HHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC-ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceE
Q 048439          268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       268 ~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~  345 (613)
                      +...+.......||+|++|.|-+-++..+++..|||++... ..+..+..+.|+.+..+. .+|.+|+++|...+....+
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw  121 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW  121 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence            33334444455799999999999999888899999999765 455666788888887665 7999999999999999999


Q ss_pred             EEEEcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCc
Q 048439          346 LVYDFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK  423 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~  423 (613)
                      +-||.|.- +|..+-.+  .....+++...=+|+..+.+||.|||++-.   +||||+||+|||++.+|.+|+||||+|.
T Consensus       122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~---vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS---VIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh---hhhccCCcceEEEccCCcEEEcccccce
Confidence            99999975 77665432  346678999999999999999999998754   9999999999999999999999999986


Q ss_pred             cCC-------CCCCcccCChhhhhc----CCCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          424 FGP-------TSVSKTHLDPEYYRL----QQLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       424 ~~~-------~~~~~~~~aPE~~~~----~~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                      ...       ..+...|+|||.+..    ..|+-||||||+|+.+.||.++|.|+...
T Consensus       198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            432       235567999998754    36889999999999999999999998643

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.3e-30  Score=271.09  Aligned_cols=206  Identities=24%  Similarity=0.329  Sum_probs=177.7

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      |...+.||-|+||+|-+++-.++...+|.|.+++.+   .........|-.||+....+-||+|+-.|++++.+|+||||
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            667778999999999999998888999999998764   33345578899999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc------
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------  424 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~------  424 (613)
                      ++||++-.+|.+  ..-|.+.....++..+.+|+++.|..|    +|||||||+|||||.+|.+||.||||+.-      
T Consensus       711 IPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkmG----FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  711 IPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKMG----FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             cCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhcc----ceecccCccceEEccCCceeeeeccccccceeccc
Confidence            999999999854  456888888889999999999999999    99999999999999999999999999831      


Q ss_pred             --------------------------------------------CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHH
Q 048439          425 --------------------------------------------GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEV  460 (613)
Q Consensus       425 --------------------------------------------~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~el  460 (613)
                                                                  -...++..|+|||++....++.-+|+||.|||||||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence                                                        001235569999999999999999999999999999


Q ss_pred             HhCCCCccchhh-hhhhhHHHHHHHh
Q 048439          461 LCARPSILRTAA-KKQVSLAVWAQQC  485 (613)
Q Consensus       461 ltg~~p~~~~~~-~~~~~l~~~~~~~  485 (613)
                      +.|++||....+ +.+...+.|....
T Consensus       865 ~~g~~pf~~~tp~~tq~kv~nw~~~l  890 (1034)
T KOG0608|consen  865 LVGQPPFLADTPGETQYKVINWRNFL  890 (1034)
T ss_pred             hhCCCCccCCCCCcceeeeeehhhcc
Confidence            999999976554 4455667776654

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-30  Score=260.88  Aligned_cols=198  Identities=21%  Similarity=0.306  Sum_probs=168.2

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCc--c----ceeeEEEEeecCCce
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRH--L----HLVSLIGFCNDDREM  344 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H--~----niv~l~g~~~~~~~~  344 (613)
                      +++|.....+|+|.||+|-.+.+...+..||||+++.-... .+.-+-|+++|.++.+  |    -+|.+.+|+.-.+.+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            67888888999999999999999888899999999765432 3345789999999942  1    367788889999999


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC--------------
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE--------------  410 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~--------------  410 (613)
                      |+|+|.| +-++.++|..++-.+++..++..|+.|++++++|||+.+    ++|-||||+|||+-+              
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k----l~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK----LTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc----eeecCCChheEEEeccceEEEeccCCccc
Confidence            9999988 349999997777788999999999999999999999998    999999999999831              


Q ss_pred             ------CCcEEEEecCCCccCCC-----CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhh
Q 048439          411 ------KWVAKVSDFGLSKFGPT-----SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK  474 (613)
Q Consensus       411 ------~~~~kl~DFGls~~~~~-----~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~  474 (613)
                            +..+||+|||-|+....     ..|..|.|||++.+-..+..+||||+||||+|+.+|..-|......+
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                  34689999999986432     34677999999999999999999999999999999998886555333

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-30  Score=262.96  Aligned_cols=238  Identities=24%  Similarity=0.309  Sum_probs=178.0

Q ss_pred             CcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--Chhc-----HHHHHHHHHHHhccCccceeeEEEEee-cCCceEEE
Q 048439          276 NDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQG-----ALEFQTEIGMLSQLRHLHLVSLIGFCN-DDREMILV  347 (613)
Q Consensus       276 ~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~-----~~~f~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV  347 (613)
                      ..++||+|||..|||+.+....+.||||+-...  ....     .+...+|.++.+.|.||.||++++|+. +.+.+|-|
T Consensus       467 lLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTV  546 (775)
T KOG1151|consen  467 LLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTV  546 (775)
T ss_pred             HHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceee
Confidence            345799999999999998877899999985432  2221     223578999999999999999999985 56788999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC---CCcEEEEecCCCcc
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE---KWVAKVSDFGLSKF  424 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGls~~  424 (613)
                      +|||++.+|+-+|  +....+++++...|+.||+.||.||....  ++|||-||||.||||-.   -|.+||.||||++.
T Consensus       547 LEYceGNDLDFYL--KQhklmSEKEARSIiMQiVnAL~YLNEik--pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  547 LEYCEGNDLDFYL--KQHKLMSEKEARSIIMQIVNALKYLNEIK--PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             eeecCCCchhHHH--HhhhhhhHHHHHHHHHHHHHHHHHHhccC--CCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            9999999998888  45667999999999999999999999865  44999999999999953   47899999999975


Q ss_pred             CC---------------CCCCcccCChhhhhc----CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHh
Q 048439          425 GP---------------TSVSKTHLDPEYYRL----QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC  485 (613)
Q Consensus       425 ~~---------------~~~~~~~~aPE~~~~----~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~  485 (613)
                      ..               ..++..|++||+|--    .+++.|.||||.||++|..+.|+.||.......  .+.......
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dILqeNTIl  700 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DILQENTIL  700 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HHHhhhchh
Confidence            22               234556899999854    367999999999999999999999996543221  111111100


Q ss_pred             h-c--cCCccccccHHHHHh--cccccCCCCCCCHHHHH
Q 048439          486 Y-Q--NGTIDQIVDPFLKAM--SCLNDEGIRRPSMSDVV  519 (613)
Q Consensus       486 ~-~--~~~~~~~~d~~~~~~--~Cl~~~p~~RPs~~evl  519 (613)
                      . .  .-.....+.....++  +||+..-++|...-++.
T Consensus       701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            0 0  001122233322222  79988888886655553

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.8e-30  Score=265.21  Aligned_cols=241  Identities=21%  Similarity=0.254  Sum_probs=194.4

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +.....||.||||.|=++........+|+|++++..   ....+....|-.+|..++.+.||+||--+.+....|++||-
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa  501 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA  501 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence            334446999999999999987765568999987652   33345578899999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc------
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------  424 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~------  424 (613)
                      |-||.|+..|.  .+..++......++..+.+|++|||+++    ||.|||||+|++||.+|-+||.|||+|+.      
T Consensus       502 ClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k~----iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  502 CLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRKG----IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             hcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhcC----ceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence            99999999994  4667899999999999999999999999    99999999999999999999999999964      


Q ss_pred             -CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccC-Cc-cccccHHHHH
Q 048439          425 -GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG-TI-DQIVDPFLKA  501 (613)
Q Consensus       425 -~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-~~-~~~~d~~~~~  501 (613)
                       ...++|+.|.|||.+..+....++|.||+|+++|||++|.|||...++....+++......+.-+ .+ ....+..   
T Consensus       576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li---  652 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI---  652 (732)
T ss_pred             eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH---
Confidence             34577889999999999999999999999999999999999998877766555544333222111 11 1111111   


Q ss_pred             hcccccCCCCCCC-----HHHHHHHHH
Q 048439          502 MSCLNDEGIRRPS-----MSDVVWGLE  523 (613)
Q Consensus       502 ~~Cl~~~p~~RPs-----~~evl~~Le  523 (613)
                      .+.+..+|.+|.-     +.||-++-+
T Consensus       653 k~LCr~~P~ERLG~~~~gI~DIkkH~W  679 (732)
T KOG0614|consen  653 KKLCRDNPTERLGYQKGGINDIKKHRW  679 (732)
T ss_pred             HHHHhcCcHhhhccccCChHHHHhhhh
Confidence            1456788988864     666665554

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-29  Score=248.33  Aligned_cols=193  Identities=25%  Similarity=0.361  Sum_probs=172.6

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l  346 (613)
                      .++|+...+||+|+|.+|..+++..+.+.+|+|+++++   ..+..+-.++|-.+..+. +||.+|.|..+++.+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            36788999999999999999999999999999998765   334455567888888776 69999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-  425 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-  425 (613)
                      |.||+++|+|--++  .++..|++.....+...|..||.|||+.+    ||.||||..|||||..|.+||.|+|+++.+ 
T Consensus       329 vieyv~ggdlmfhm--qrqrklpeeharfys~ei~lal~flh~rg----iiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEICLALNFLHERG----IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeeh--hhhhcCcHHHhhhhhHHHHHHHHHHhhcC----eeeeeccccceEEccCCceeecccchhhcCC
Confidence            99999999997666  34567999999999999999999999999    999999999999999999999999999742 


Q ss_pred             -------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccc
Q 048439          426 -------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILR  469 (613)
Q Consensus       426 -------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~  469 (613)
                             ..++++.|+|||.+++..|....|+|++||+++||+.||.||+-
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence                   34568889999999999999999999999999999999999963

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=4.4e-28  Score=234.04  Aligned_cols=203  Identities=34%  Similarity=0.539  Sum_probs=174.8

Q ss_pred             eeeeCcEEEEEEEEcCCceeEEEEEeCCCChh-cHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCChhH
Q 048439          280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ-GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPD  358 (613)
Q Consensus       280 iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~  358 (613)
                      ||+|++|.||++...+++..+++|++...... ....+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999876788999999876443 35678999999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC-CCcEEEEecCCCccCCC--------CC
Q 048439          359 HLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE-KWVAKVSDFGLSKFGPT--------SV  429 (613)
Q Consensus       359 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGls~~~~~--------~~  429 (613)
                      ++.... ..+++..++.++.+++++|.+||+.+    ++|+||+|.||+++. ++.++|+|||.+.....        ..
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~----~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNG----IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG  155 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC----eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence            985432 46899999999999999999999998    999999999999999 89999999999864332        24


Q ss_pred             CcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHHHhcccccC
Q 048439          430 SKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDE  508 (613)
Q Consensus       430 ~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~Cl~~~  508 (613)
                      ...|++||.+... ..+.++|+|++|+++++|                               ..+.+.   ...|++.+
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~---l~~~l~~~  201 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDL---IRKMLQKD  201 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHH---HHHHhhCC
Confidence            5578999999887 888999999999999999                               111111   22699999


Q ss_pred             CCCCCCHHHHHHH
Q 048439          509 GIRRPSMSDVVWG  521 (613)
Q Consensus       509 p~~RPs~~evl~~  521 (613)
                      |.+||++.+++..
T Consensus       202 p~~R~~~~~l~~~  214 (215)
T cd00180         202 PEKRPSAKEILEH  214 (215)
T ss_pred             cccCcCHHHHhhC
Confidence            9999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-29  Score=274.90  Aligned_cols=236  Identities=28%  Similarity=0.333  Sum_probs=177.7

Q ss_pred             CCCcceeeeeCcEE-EEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEEEcC
Q 048439          274 FDNDLVIGVGGFGD-VYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       274 f~~~~~iG~G~fG~-Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      |...+++|.|+-|+ ||+|.+.+  +.||||++-...   ..-.++||..|+.- .|||||+++|.-.++...|+..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye~--R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYEG--REVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeCC--ceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            45556889999876 89999976  689999986543   22347899999987 5999999999999999999999999


Q ss_pred             CCCChhHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC---C--CcEEEEecCCCcc
Q 048439          352 ARGTLPDHLYHS--DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE---K--WVAKVSDFGLSKF  424 (613)
Q Consensus       352 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~---~--~~~kl~DFGls~~  424 (613)
                      .. +|.+++...  ......-...+.+..|+++||++||+-+    |+||||||.||||+.   +  ..++|+|||+|+.
T Consensus       586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~----iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK----IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc----cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            76 999999653  1111111345678899999999999988    999999999999975   2  5799999999964


Q ss_pred             -----------CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhC-CCCccchhhhhhhhHHHHHHHhhccCCcc
Q 048439          425 -----------GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCA-RPSILRTAAKKQVSLAVWAQQCYQNGTID  492 (613)
Q Consensus       425 -----------~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  492 (613)
                                 ....|+.+|+|||.++...-+.+.||||+|||+|++++| ..||...... +.++..-......-....
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~NIl~~~~~L~~L~~~~  739 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QANILTGNYTLVHLEPLP  739 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhhhhcCccceeeeccCc
Confidence                       234567789999999999889999999999999999998 7888544332 222222111111111111


Q ss_pred             -ccccHHHHHhcccccCCCCCCCHHHHHHHH
Q 048439          493 -QIVDPFLKAMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       493 -~~~d~~~~~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                       +....+  .-++++.+|..||++.+|+.+.
T Consensus       740 d~eA~dL--I~~ml~~dP~~RPsa~~VL~HP  768 (903)
T KOG1027|consen  740 DCEAKDL--ISRMLNPDPQLRPSATDVLNHP  768 (903)
T ss_pred             hHHHHHH--HHHhcCCCcccCCCHHHHhCCC
Confidence             111111  2279999999999999999543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1.5e-27  Score=234.53  Aligned_cols=191  Identities=31%  Similarity=0.465  Sum_probs=168.0

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh-cHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCC
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ-GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMA  352 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  352 (613)
                      |.....||+|++|.||++...+++..+++|.+...... ....+.+|++.+.+++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            45567899999999999999886788999999876544 56789999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC-----
Q 048439          353 RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-----  427 (613)
Q Consensus       353 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~-----  427 (613)
                      +++|.+++..... .+++.....++.+++.+|.+||+.+    ++|+||+++||+++.++.++|+|||++.....     
T Consensus        81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~----i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~  155 (225)
T smart00221       81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG----IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL  155 (225)
T ss_pred             CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence            9999999854321 2899999999999999999999987    99999999999999999999999998864332     


Q ss_pred             ----CCCcccCChhhh-hcCCCCchhHHHHHHHHHHHHHhCCCCccc
Q 048439          428 ----SVSKTHLDPEYY-RLQQLTEKSDVYSFGVVLFEVLCARPSILR  469 (613)
Q Consensus       428 ----~~~~~~~aPE~~-~~~~~t~ksDV~SfGvvL~elltg~~p~~~  469 (613)
                          .+...|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence                234458999999 667788899999999999999999999955

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.4e-30  Score=246.85  Aligned_cols=197  Identities=26%  Similarity=0.390  Sum_probs=163.4

Q ss_pred             CCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecC-----CceEEE
Q 048439          275 DNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD-----REMILV  347 (613)
Q Consensus       275 ~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~lV  347 (613)
                      ...+-||-|+||.||..++..+++.||+|++...  +-...+.+.+|+.+|.-.+|.|++..++..+-.     .++|+|
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            4456899999999999999888899999998643  233456788999999999999999998876543     367889


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT  427 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~  427 (613)
                      .|.|.. +|...+.  ....|+-....-+..||++||.|||+.+    |.||||||.|.|++.+...|||||||+|....
T Consensus       136 TELmQS-DLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~----ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  136 TELMQS-DLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTAN----ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHh-hhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcc----hhhccCCCccEEeccCceEEecccccccccch
Confidence            999965 8877773  4567888888889999999999999998    99999999999999999999999999986543


Q ss_pred             CC---------CcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhH
Q 048439          428 SV---------SKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSL  478 (613)
Q Consensus       428 ~~---------~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l  478 (613)
                      ..         +..|.|||.+++ ..|+.+.||||.||+..||+..|--|....+-++..+
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~l  269 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQM  269 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHH
Confidence            22         445899999987 4689999999999999999988877765555555444

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.7e-28  Score=231.98  Aligned_cols=237  Identities=20%  Similarity=0.340  Sum_probs=176.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEE-eecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGF-CNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~-~~~~~~~~lV~E  349 (613)
                      +.|.+.+.||+|.||++-+++++++++.+++|.+... .-...+|.+|...--.| .|.||+.-+.. ++..+.+++++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            4577788999999999999999999999999988644 23467899998766666 59999987764 667788899999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC--CCCcEEEEecCCCccCCC
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD--EKWVAKVSDFGLSKFGPT  427 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~--~~~~~kl~DFGls~~~~~  427 (613)
                      |++.|+|.+-+.   ...+.+..-.+++.|+++||.|+|+++    ++|||||.+|||+-  +...+||||||+++....
T Consensus       103 ~aP~gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMHskn----lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  103 FAPRGDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMHSKN----LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             cCccchhhhhcC---cccccHHHHHHHHHHHHHHHHHhhccc----hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            999999998773   355888888999999999999999999    99999999999993  345899999999875322


Q ss_pred             -----CCCcccCChhhhhcC-----CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCC---cccc
Q 048439          428 -----SVSKTHLDPEYYRLQ-----QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT---IDQI  494 (613)
Q Consensus       428 -----~~~~~~~aPE~~~~~-----~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~  494 (613)
                           .....|.+||.....     ...+.+|||.||+++|.+++|++||......++ ...+|..  +..+.   ++..
T Consensus       176 tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-~Y~~~~~--w~~rk~~~~P~~  252 (378)
T KOG1345|consen  176 TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-PYWEWEQ--WLKRKNPALPKK  252 (378)
T ss_pred             eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-hHHHHHH--HhcccCccCchh
Confidence                 224468899987543     236789999999999999999999974433332 2223322  22222   2222


Q ss_pred             ccHH-HHHhcc----cccCCCCCCCHHHHH
Q 048439          495 VDPF-LKAMSC----LNDEGIRRPSMSDVV  519 (613)
Q Consensus       495 ~d~~-~~~~~C----l~~~p~~RPs~~evl  519 (613)
                      +.++ .++++|    |.+++++|--..++.
T Consensus       253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~k  282 (378)
T KOG1345|consen  253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAK  282 (378)
T ss_pred             hcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence            2222 124444    677888885444443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=2.4e-28  Score=259.38  Aligned_cols=240  Identities=25%  Similarity=0.400  Sum_probs=199.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      .+|.....+|.|.||.|||+++..++...|||.++........-.+.|+.+++..+|+|||.++|.+...+.+++.||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            56777789999999999999999988999999998877677777889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCc--------
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK--------  423 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~--------  423 (613)
                      .+|+|.+.-+  ...+|++.++...|+...+||+|||+.+    -+|||||-.|||+++.|.+|++|||.+.        
T Consensus        95 gggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~g----k~hRdiKGanilltd~gDvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   95 GGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQG----KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK  168 (829)
T ss_pred             CCCcccceee--ecccchhHHHHHHHhhhhccchhhhcCC----cccccccccceeecccCceeecccCchhhhhhhhhh
Confidence            9999988763  3578999999999999999999999998    6999999999999999999999999863        


Q ss_pred             cCCCCCCcccCChhhh---hcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccC------Ccccc
Q 048439          424 FGPTSVSKTHLDPEYY---RLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG------TIDQI  494 (613)
Q Consensus       424 ~~~~~~~~~~~aPE~~---~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~------~~~~~  494 (613)
                      ....-+++.|||||+.   +.+.|..++|||+.|+...|+---++|.....+.....+.  ....++..      ...+.
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm--TkS~~qpp~lkDk~kws~~  246 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM--TKSGFQPPTLKDKTKWSEF  246 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh--hccCCCCCcccCCccchHH
Confidence            2345678899999986   4567899999999999999999888887654443322222  22222222      22333


Q ss_pred             ccHHHHHhcccccCCCCCCCHHHHHHH
Q 048439          495 VDPFLKAMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       495 ~d~~~~~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      +..+.+  .|+-++|++||++..++.+
T Consensus       247 fh~fvK--~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  247 FHNFVK--GALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             HHHHHH--HHhcCCCccCCChhhheec
Confidence            334444  6999999999999998854

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=3.1e-27  Score=247.25  Aligned_cols=190  Identities=23%  Similarity=0.373  Sum_probs=164.4

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh--------hcHHHHHHHHHHHhccC---ccceeeEEEEeecC
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ--------QGALEFQTEIGMLSQLR---HLHLVSLIGFCNDD  341 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~--------~~~~~f~~Ei~~l~~l~---H~niv~l~g~~~~~  341 (613)
                      +|.....+|+|+||.|+.|.++.....|+||.+.++.-        ...-..-.||.+|+.|+   |+||++++.+|+++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            46777889999999999999998888999999876421        11112457999999997   99999999999999


Q ss_pred             CceEEEEEcC-CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecC
Q 048439          342 REMILVYDFM-ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG  420 (613)
Q Consensus       342 ~~~~lV~Ey~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG  420 (613)
                      +.+||+||-. ++-+|.+++  ...+.+++.....|+.||+.|+++||+++    |||||||-+||.++.+|-+||+|||
T Consensus       642 d~yyl~te~hg~gIDLFd~I--E~kp~m~E~eAk~IFkQV~agi~hlh~~~----ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFI--EFKPRMDEPEAKLIFKQVVAGIKHLHDQG----IVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             CeeEEEecCCCCCcchhhhh--hccCccchHHHHHHHHHHHhccccccccC----ceecccccccEEEecCCeEEEeecc
Confidence            9999999975 566899998  44678999999999999999999999999    9999999999999999999999999


Q ss_pred             CCcc---CC---CCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCcc
Q 048439          421 LSKF---GP---TSVSKTHLDPEYYRLQQL-TEKSDVYSFGVVLFEVLCARPSIL  468 (613)
Q Consensus       421 ls~~---~~---~~~~~~~~aPE~~~~~~~-t~ksDV~SfGvvL~elltg~~p~~  468 (613)
                      -|.+   ++   ..+|..|.|||++.+.+| ...-|||++|++||.++....|++
T Consensus       716 saa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  716 SAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             chhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            8854   22   246788999999999888 455799999999999999888875

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-27  Score=232.96  Aligned_cols=191  Identities=26%  Similarity=0.337  Sum_probs=157.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeec------CCc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND------DRE  343 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~------~~~  343 (613)
                      .+|.....+|.|.- .|-.+.+.-.+++||+|++...  .....+.-.+|..++..+.|+||++++.++.-      ..+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            34555556788877 5666666656688999987543  34445567899999999999999999999853      346


Q ss_pred             eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCc
Q 048439          344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK  423 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~  423 (613)
                      .|+|||||.. +|.+.+.    -.++-.+...|..|+++|+.|||+.+    |+||||||+||++..++.+||.|||+|+
T Consensus        96 ~y~v~e~m~~-nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~----IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVIL----MELDHETISYILYQMLCGIKHLHSAG----IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhhhh-HHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc----eeecccCcccceecchhheeeccchhhc
Confidence            7999999975 8988875    34777889999999999999999999    9999999999999999999999999997


Q ss_pred             cCCCC-------CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhh
Q 048439          424 FGPTS-------VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAA  472 (613)
Q Consensus       424 ~~~~~-------~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~  472 (613)
                      .....       .+..|.|||+..+..+.+.+||||.||++.||+.|+--|.+...
T Consensus       167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~  222 (369)
T KOG0665|consen  167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH  222 (369)
T ss_pred             ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH
Confidence            53322       35568999999998899999999999999999999877765443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=1.9e-26  Score=269.35  Aligned_cols=189  Identities=19%  Similarity=0.196  Sum_probs=137.6

Q ss_pred             ccCc-cceeeEEEEe-------ecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcE
Q 048439          325 QLRH-LHLVSLIGFC-------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI  396 (613)
Q Consensus       325 ~l~H-~niv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~i  396 (613)
                      .++| .||++++++|       .+...+++++||+ .++|.++|.. ....+++.+++.++.||++||.|||+++    |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~g----I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQG----I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhCC----e
Confidence            4556 6888888887       3345678889988 4599999953 2456999999999999999999999998    9


Q ss_pred             EeccCCCCceeeCC-------------------CCcEEEEecCCCccCC------------------------CCCCccc
Q 048439          397 IHRDVKTTNILLDE-------------------KWVAKVSDFGLSKFGP------------------------TSVSKTH  433 (613)
Q Consensus       397 iHrDlk~~NILl~~-------------------~~~~kl~DFGls~~~~------------------------~~~~~~~  433 (613)
                      +||||||+||||+.                   ++.+||+|||+++...                        ..++..|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   5567777888775311                        1235569


Q ss_pred             CChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHHHhcccccCCCCCC
Q 048439          434 LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRP  513 (613)
Q Consensus       434 ~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~Cl~~~p~~RP  513 (613)
                      +|||++.+..++.++|||||||+||||++|.+|+.....    ..........................+||+.+|.+||
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rp  257 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRP  257 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCc
Confidence            999999999999999999999999999999988643211    1111111111111111122222223479999999999


Q ss_pred             CHHHHHHHHH
Q 048439          514 SMSDVVWGLE  523 (613)
Q Consensus       514 s~~evl~~Le  523 (613)
                      +|.||+++..
T Consensus       258 s~~eil~h~~  267 (793)
T PLN00181        258 SMSELLQSEF  267 (793)
T ss_pred             ChHHHhhchh
Confidence            9999997654

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.93  E-value=3.8e-26  Score=215.02  Aligned_cols=186  Identities=22%  Similarity=0.409  Sum_probs=157.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC-ccceeeEEEEeecC--CceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDD--REMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~  348 (613)
                      .+|+..+.+|+|.|+.||.|....+...++||.+++..   .+.+.+|+.+|..|+ ||||++|++...+.  ....||+
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            45677778999999999999987777889999998754   446789999999998 99999999998764  4567999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC-CcEEEEecCCCccCCC
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK-WVAKVSDFGLSKFGPT  427 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGls~~~~~  427 (613)
                      ||..+-+...+.     +.|+...+.....++++||.|+|+.|    |+|||+||.|+++|.. -..+|+|+|||.+..+
T Consensus       115 E~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~G----ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  115 EYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMG----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcC----cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            999998876654     45777888999999999999999999    9999999999999965 5799999999976332


Q ss_pred             C-------CCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccc
Q 048439          428 S-------VSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILR  469 (613)
Q Consensus       428 ~-------~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~  469 (613)
                      .       .+..|-.||.+-. +.+...-|+|||||+|..|+..+.||..
T Consensus       186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh  235 (338)
T KOG0668|consen  186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  235 (338)
T ss_pred             CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence            2       2444678998744 5678899999999999999999999854

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.7e-25  Score=230.62  Aligned_cols=132  Identities=27%  Similarity=0.422  Sum_probs=113.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC--------ccceeeEEEEeec---
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR--------HLHLVSLIGFCND---  340 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~--------H~niv~l~g~~~~---  340 (613)
                      ++|...++||-|-|.+||++.+..+.+.||+|+.+... .-.+.-+.||++|++++        ..+||+|+++|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            57888889999999999999998888999999987543 22345688999999985        2579999999864   


Q ss_pred             -CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee
Q 048439          341 -DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL  408 (613)
Q Consensus       341 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl  408 (613)
                       +.+.|||+|++.. +|..+|....-+.++...+.+||.||+.||.|||.++.   |||-||||+||||
T Consensus       157 NG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg---IIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG---IIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC---ccccCCCcceeee
Confidence             5689999999954 88888877777789999999999999999999999875   9999999999996

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.91  E-value=1.4e-25  Score=232.22  Aligned_cols=203  Identities=21%  Similarity=0.283  Sum_probs=167.2

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC------ccceeeEEEEeecCCc
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR------HLHLVSLIGFCNDDRE  343 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~------H~niv~l~g~~~~~~~  343 (613)
                      .-.+|......|+|-|++|-+|....-+..||||++...... .+.=+.|+++|.+|.      -.|+++|+-.|...++
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            345677777789999999999999877788999999765221 223368999999995      4588999999999999


Q ss_pred             eEEEEEcCCCCChhHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC-CcEEEEecCC
Q 048439          344 MILVYDFMARGTLPDHLYH-SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK-WVAKVSDFGL  421 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGl  421 (613)
                      +|||+|-+.- +|++.|.. ..+..|....+..++.|+.-||..|-..+    |+|.||||.|||+++. ..+||||||-
T Consensus       509 LClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~----vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  509 LCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG----VLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             eEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC----eeecccCccceEeccCcceeeeccCcc
Confidence            9999998754 99999954 24567889999999999999999999888    9999999999999876 4689999999


Q ss_pred             CccCCCC------CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhH
Q 048439          422 SKFGPTS------VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSL  478 (613)
Q Consensus       422 s~~~~~~------~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l  478 (613)
                      |......      .+..|.|||.+.+-.|....|+||.||+||||.||+--|.+........+
T Consensus       584 A~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl  646 (752)
T KOG0670|consen  584 ASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL  646 (752)
T ss_pred             ccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence            8653322      23458999999999999999999999999999999988866554444333

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=1.2e-23  Score=200.10  Aligned_cols=158  Identities=24%  Similarity=0.299  Sum_probs=118.5

Q ss_pred             CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---CCCCC
Q 048439          354 GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---PTSVS  430 (613)
Q Consensus       354 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---~~~~~  430 (613)
                      |+|.+++... ...++|.+++.|+.|+++||.|||+.+          ||+|||++.++.+|+  ||+++..   ...++
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~----------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g~   67 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA----------KSGNILLTWDGLLKL--DGSVAFKTPEQSRVD   67 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC----------CcccEeEcCccceee--ccceEeeccccCCCc
Confidence            7899999542 456999999999999999999999864          999999999999999  9998753   23467


Q ss_pred             cccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccC-----Ccccccc--HHHH-Hh
Q 048439          431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG-----TIDQIVD--PFLK-AM  502 (613)
Q Consensus       431 ~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-----~~~~~~d--~~~~-~~  502 (613)
                      ..|+|||++.+..++.|+|||||||++|||++|++||........ .+..+........     ....+.+  .... ..
T Consensus        68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  146 (176)
T smart00750       68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMPADDPRDRSNLESVSAARSFADFMR  146 (176)
T ss_pred             ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence            789999999999999999999999999999999999864432211 1111111111110     1111111  1111 23


Q ss_pred             cccccCCCCCCCHHHHHHHHHHh
Q 048439          503 SCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       503 ~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      +||..+|.+||++.++++++...
T Consensus       147 ~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      147 VCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHhcccccccCHHHHHHHHHHH
Confidence            79999999999999999988754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=2.2e-24  Score=219.96  Aligned_cols=192  Identities=24%  Similarity=0.333  Sum_probs=163.2

Q ss_pred             HHHHhcCCCCcceeeeeCcEEEEEEEEcC---CceeEEEEEeCCCChhcHHHHHHHHHHHhccC-ccceeeEEEEeecCC
Q 048439          267 IQAATNNFDNDLVIGVGGFGDVYKGFING---STTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDR  342 (613)
Q Consensus       267 l~~at~~f~~~~~iG~G~fG~Vy~g~~~~---~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~  342 (613)
                      +....+.|...+.||+|.|++||++.+..   ....||+|.+...+.-  ....+|+++|..+. +.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            33455678888999999999999999866   6688999999776433  35789999999995 999999999999999


Q ss_pred             ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC-CCcEEEEecCC
Q 048439          343 EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE-KWVAKVSDFGL  421 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGl  421 (613)
                      ..++|+||+++-...+++..     ++..++..+...+..||.++|..+    ||||||||+|+|.+. .+.-.|.||||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G----IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG----IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC----ccccCCCccccccccccCCceEEechh
Confidence            99999999999999888743     668888999999999999999999    999999999999975 45678999999


Q ss_pred             Ccc----------------------------------------------------CCCCCCcccCChhhhhc-CCCCchh
Q 048439          422 SKF----------------------------------------------------GPTSVSKTHLDPEYYRL-QQLTEKS  448 (613)
Q Consensus       422 s~~----------------------------------------------------~~~~~~~~~~aPE~~~~-~~~t~ks  448 (613)
                      |..                                                    ....||++|.|||++.. +.-|++.
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            730                                                    01234667899999755 5678999


Q ss_pred             HHHHHHHHHHHHHhCCCCccc
Q 048439          449 DVYSFGVVLFEVLCARPSILR  469 (613)
Q Consensus       449 DV~SfGvvL~elltg~~p~~~  469 (613)
                      ||||-||+++.+++++.||..
T Consensus       260 Diws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             ceeeccceeehhhcccccccc
Confidence            999999999999999999854

>PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan []

Probab=99.90  E-value=9.1e-24  Score=222.08  Aligned_cols=120  Identities=45%  Similarity=0.760  Sum_probs=103.0

Q ss_pred             ccCCCCchHHHHHHhhcCCCcccCCceeeEEEEeeCCCCceeeeeeeeeeeecccCCCceEEEEEEcceeecccchhhh-
Q 048439           25 IRNYSAPDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIA-  103 (613)
Q Consensus        25 ~~~~~aP~~vy~Tar~~~~~~~~~~~~nltw~~~vd~~~~Y~vrlHFcei~~~~~~~~~r~F~iyi~~~~~~~~~dv~~-  103 (613)
                      .+.|.||..||+||++|++.+   .++||||.| +|+++.|+||||||||+......++|+|+|||||+++.+  |+.. 
T Consensus       227 ~~~~~~P~~V~~TA~~~~~~s---~~~nltw~~-~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~--~~~~~  300 (347)
T PF12819_consen  227 NNPYDAPSAVYQTARTPSNSS---DPLNLTWSF-VDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYS--DVSPP  300 (347)
T ss_pred             CccCcChHHHHHhhhcccccc---cceEEEecc-CCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccC--ccCcc
Confidence            679999999999999999766   238999999 999999999999999996445667999999999999986  6555 


Q ss_pred             hhCCCceeEEEEEEeeccCCCCcccccceEEEEeecCCCCCCcccccccccceEEee
Q 048439          104 WTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKV  160 (613)
Q Consensus       104 ~~~~~~~p~y~dy~v~~~~~~~~~~~~~~l~v~l~p~~~~~~~~~~~ilnglEi~~~  160 (613)
                      +.++.++|+|+||++.+   +.+    ..++|+|+|+..+  .+ +|||||+|||+|
T Consensus       301 ~~~~~~~~~~~d~~~~~---~~~----~~~~isL~~t~~S--~l-ppiLNalEIy~v  347 (347)
T PF12819_consen  301 YLGADTVPYYSDYVVNV---PDS----GFLNISLGPTPDS--TL-PPILNALEIYKV  347 (347)
T ss_pred             cccCcceEeecceEEEe---cCC----CEEEEEEEeCCCC--Cc-CceeEeeeeEeC
Confidence            55677899999999988   433    2699999999876  33 999999999985

This entry represents a malectin-like domain found in a number of plant receptor kinases.

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=8.5e-23  Score=214.54  Aligned_cols=161  Identities=24%  Similarity=0.231  Sum_probs=124.8

Q ss_pred             HHHHhcCCCCcceeeeeCcEEEEEEEEcC-CceeEEEEEeCCC-----ChhcHHHHHHHHHHHhccCccceeeEEEEeec
Q 048439          267 IQAATNNFDNDLVIGVGGFGDVYKGFING-STTPVAIKRLEPE-----SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND  340 (613)
Q Consensus       267 l~~at~~f~~~~~iG~G~fG~Vy~g~~~~-~~~~vAVK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~  340 (613)
                      +.....+|....+||+|+||+||+|++.. ++..||||++...     .......|.+|+++|++++|+|+++.+..+  
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence            34455779999999999999999998864 5577899987533     122345689999999999999999533322  


Q ss_pred             CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccC-CCCceeeCCCCcEEEEec
Q 048439          341 DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDV-KTTNILLDEKWVAKVSDF  419 (613)
Q Consensus       341 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDl-k~~NILl~~~~~~kl~DF  419 (613)
                       +..+|||||+++++|.. + .. ..      ...++.++++||.|||+.+    |+|||| ||+|||++.++.+||+||
T Consensus        91 -~~~~LVmE~~~G~~L~~-~-~~-~~------~~~~~~~i~~aL~~lH~~g----IiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHL-A-RP-HG------DPAWFRSAHRALRDLHRAG----ITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             -CCcEEEEEccCCCCHHH-h-Cc-cc------hHHHHHHHHHHHHHHHHCC----CeeCCCCCcceEEEcCCCCEEEEEC
Confidence             45799999999999963 2 11 11      1467889999999999998    999999 999999999999999999


Q ss_pred             CCCccCCC----------------CCCcccCChhhhhcCC
Q 048439          420 GLSKFGPT----------------SVSKTHLDPEYYRLQQ  443 (613)
Q Consensus       420 Gls~~~~~----------------~~~~~~~aPE~~~~~~  443 (613)
                      |+|+....                .++..|++||++...+
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~  196 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE  196 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence            99974221                1234578999886543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=6.5e-23  Score=197.53  Aligned_cols=238  Identities=19%  Similarity=0.370  Sum_probs=182.0

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCCh
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTL  356 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  356 (613)
                      +|.+.-.|..|+|++.+..  +++|+++..  +..-..+|.+|.-.|+-..||||+.++|.|.....+.++..||+.|+|
T Consensus       197 kl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl  274 (448)
T KOG0195|consen  197 KLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL  274 (448)
T ss_pred             hhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence            6788889999999998864  667777543  344456799999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEE--e--cCCCccCCCCCCcc
Q 048439          357 PDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVS--D--FGLSKFGPTSVSKT  432 (613)
Q Consensus       357 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~--D--FGls~~~~~~~~~~  432 (613)
                      ...|+......++-.+..+++.++|+|++|||+... . |.---|.+..+++|++.+++|+  |  |.+-..+ ....+.
T Consensus       275 ynvlhe~t~vvvd~sqav~faldiargmaflhslep-~-ipr~~lns~hvmidedltarismad~kfsfqe~g-r~y~pa  351 (448)
T KOG0195|consen  275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-M-IPRFYLNSKHVMIDEDLTARISMADTKFSFQEVG-RAYSPA  351 (448)
T ss_pred             HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-h-hhhhhcccceEEecchhhhheecccceeeeeccc-cccCcc
Confidence            999988777778889999999999999999999752 1 3344699999999999999885  3  2222222 223568


Q ss_pred             cCChhhhhcCCC---CchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHH-HH-HHhhccCCccccccHHHHHhccccc
Q 048439          433 HLDPEYYRLQQL---TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAV-WA-QQCYQNGTIDQIVDPFLKAMSCLND  507 (613)
Q Consensus       433 ~~aPE~~~~~~~---t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~-~~-~~~~~~~~~~~~~d~~~~~~~Cl~~  507 (613)
                      |++||.++..+-   -.++|+|||.++||||.|...||..-.+.+....+. -. +.....+....+ ..++.  -|+..
T Consensus       352 wmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm-~klm~--icmne  428 (448)
T KOG0195|consen  352 WMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHM-NKLMN--ICMNE  428 (448)
T ss_pred             cCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHH-HHHHH--HHhcC
Confidence            999999987654   347999999999999999999997665544322211 11 111222222222 12222  49999


Q ss_pred             CCCCCCCHHHHHHHHHH
Q 048439          508 EGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       508 ~p~~RPs~~evl~~Le~  524 (613)
                      ||.+||.+..|+-.||.
T Consensus       429 dpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  429 DPGKRPKFDMIVPILEK  445 (448)
T ss_pred             CCCcCCCcceehhhHHH
Confidence            99999999999988874

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=8.8e-21  Score=198.67  Aligned_cols=249  Identities=19%  Similarity=0.190  Sum_probs=184.0

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCc-eeEEEEEeCCCChhcHHHHHHHHHHHhccCc----cceeeEEEEe-ecCCceEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGST-TPVAIKRLEPESQQGALEFQTEIGMLSQLRH----LHLVSLIGFC-NDDREMIL  346 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~-~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H----~niv~l~g~~-~~~~~~~l  346 (613)
                      +|.....||+|+||.||++...... ..+|+|............+..|+.++..+.+    +++..++... ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7889999999999999999987653 5689998766543333367889999988873    6888888888 47778899


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC-----CcEEEEecCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK-----WVAKVSDFGL  421 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~-----~~~kl~DFGl  421 (613)
                      ||+.+ +.+|.++........++..+.+.|+.|++.+|++||+.+    ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G----~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG----FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC----cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99977 669999775444678999999999999999999999999    9999999999999755     4699999999


Q ss_pred             Cc--c----------CC------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhh-hHHHHH
Q 048439          422 SK--F----------GP------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV-SLAVWA  482 (613)
Q Consensus       422 s~--~----------~~------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~-~l~~~~  482 (613)
                      ++  .          .+      ..+|..|.++....+...+.+.|+||++.++.|++.|..||......... ......
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            97  2          01      11567899999999999999999999999999999999998554432221 111111


Q ss_pred             HHhhccCCccccccHHHHHhccc-ccCCCCCCCHHHHHHHHHHhh
Q 048439          483 QQCYQNGTIDQIVDPFLKAMSCL-NDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       483 ~~~~~~~~~~~~~d~~~~~~~Cl-~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ...............+...+.++ ..+-..+|....+...|+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~  298 (322)
T KOG1164|consen  254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF  298 (322)
T ss_pred             hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence            11111110111112222222233 357788999888887765433

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=1.9e-20  Score=191.90  Aligned_cols=241  Identities=28%  Similarity=0.363  Sum_probs=182.9

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh---cHHHHHHHHHHHhccCcc-ceeeEEEEeecCCceEEEEE
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ---GALEFQTEIGMLSQLRHL-HLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~---~~~~f~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~E  349 (613)
                      |.....||.|+||.||++...   ..+++|.+......   ....|.+|+.+++.+.|+ +++++..++......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            455668999999999999987   56899998765333   367799999999999988 79999999977777899999


Q ss_pred             cCCCCChhHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC-cEEEEecCCCccC--
Q 048439          350 FMARGTLPDHLYHSDN-PPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW-VAKVSDFGLSKFG--  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGls~~~--  425 (613)
                      |+.+++|.+++..... ..+.......+..+++.++.|+|+.+    ++|||+||+||+++... .+|++|||+++..  
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~----~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~  154 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG----IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD  154 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC----eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence            9999999976643221 26889999999999999999999998    99999999999999988 7999999988521  


Q ss_pred             ------------CCCCCcccCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCccchhh---hhhhhHHHHHHHhh-
Q 048439          426 ------------PTSVSKTHLDPEYYRL---QQLTEKSDVYSFGVVLFEVLCARPSILRTAA---KKQVSLAVWAQQCY-  486 (613)
Q Consensus       426 ------------~~~~~~~~~aPE~~~~---~~~t~ksDV~SfGvvL~elltg~~p~~~~~~---~~~~~l~~~~~~~~-  486 (613)
                                  ...++..|++||.+..   ...+...|+||+|++++++++|..|+.....   ........+..... 
T Consensus       155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (384)
T COG0515         155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS  234 (384)
T ss_pred             CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence                        2234567999999988   5789999999999999999999999654432   11111111111100 


Q ss_pred             ccCCccccc------cHHHHHhcccccCCCCCCCHHHHHHH
Q 048439          487 QNGTIDQIV------DPFLKAMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       487 ~~~~~~~~~------d~~~~~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      .........      ........|+..+|..|.++.+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            011111110      01111226888899999999887755

>PLN03150 hypothetical protein; Provisional

Probab=99.86  E-value=1.2e-21  Score=221.57  Aligned_cols=127  Identities=24%  Similarity=0.410  Sum_probs=109.0

Q ss_pred             CCcccee--ccCCCCchHHHHHHhhcCCCcccCCceeeEEEEeeCCCCceeeeeeeeeeeecccCCCceEEEEEEcceee
Q 048439           18 QSIHLTW--IRNYSAPDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTA   95 (613)
Q Consensus        18 ~~~~~~~--~~~~~aP~~vy~Tar~~~~~~~~~~~~nltw~~~vd~~~~Y~vrlHFcei~~~~~~~~~r~F~iyi~~~~~   95 (613)
                      ....|+|  .+.|.||..||+|||+|..+     ..|+||.|+||+++.|+||||||||+......++|+|||||||+++
T Consensus       236 t~~~I~~~~~~~~~~P~~VyqTA~~~~~~-----~~~lty~~~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~  310 (623)
T PLN03150        236 TENVIKKASNAPNFYPESLYQSALVSTDT-----QPDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTA  310 (623)
T ss_pred             cccccccccCCCccChHHHhhhhccccCC-----CCceEEEeecCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEe
Confidence            4556776  56899999999999997752     2689999999999999999999999754556789999999999999


Q ss_pred             cccchhhhhhCCCceeEEEEEEeeccCCCCcccccceEEEEeecCCCCCCcccccccccceEEeecC
Q 048439           96 EVQADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDN  162 (613)
Q Consensus        96 ~~~~dv~~~~~~~~~p~y~dy~v~~~~~~~~~~~~~~l~v~l~p~~~~~~~~~~~ilnglEi~~~~~  162 (613)
                      .+++||..++|+...|+|+||++.+   ..     ..|+|+++|...+     +|||||+|||++..
T Consensus       311 ~~~~di~~~~g~~~~~~~~~~~v~~---~~-----g~l~isl~p~~~s-----~pilNaiEI~~~~~  364 (623)
T PLN03150        311 FKDVDIVKMSGERYTALVLNKTVAV---SG-----RTLTIVLQPKKGT-----HAIINAIEVFEIIT  364 (623)
T ss_pred             ecccChhhhcCCcccceEEEeEEee---cC-----CeEEEEEeeCCCC-----cceeeeeeeeeccc
Confidence            9999999999888899999999987   32     2699999997532     69999999999865

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=4.1e-21  Score=185.39  Aligned_cols=138  Identities=17%  Similarity=0.199  Sum_probs=107.6

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh--c-------HHHH-----------------HHHHHHHhccCccce
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--G-------ALEF-----------------QTEIGMLSQLRHLHL  331 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~--~-------~~~f-----------------~~Ei~~l~~l~H~ni  331 (613)
                      ..||+|+||.||+|... ++..||||+++.....  .       ...|                 ..|++.|.++.|+++
T Consensus         3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            47999999999999987 5688999999764211  1       1122                 349999999988776


Q ss_pred             eeEEEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCcEEeccCCCCceeeCC
Q 048439          332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL-HTGANHAVIIHRDVKTTNILLDE  410 (613)
Q Consensus       332 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~iiHrDlk~~NILl~~  410 (613)
                      .....+..  ...+|||||+++++|...+.  ....+++.+.+.++.|++.+|.|| |+.+    |+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~g----iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDCR----LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhCC----cccCCCCHHHEEEE-
Confidence            44333222  22389999999987765532  235689999999999999999999 6877    99999999999998 


Q ss_pred             CCcEEEEecCCCccC
Q 048439          411 KWVAKVSDFGLSKFG  425 (613)
Q Consensus       411 ~~~~kl~DFGls~~~  425 (613)
                      ++.++|+|||+|...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=3.4e-21  Score=188.90  Aligned_cols=171  Identities=13%  Similarity=0.110  Sum_probs=133.9

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHH---H------HHHHHHHHhccCccceeeEEEEeec
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL---E------FQTEIGMLSQLRHLHLVSLIGFCND  340 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~---~------f~~Ei~~l~~l~H~niv~l~g~~~~  340 (613)
                      ..++|...++||.|+||.||.....  ...+|||.+++.......   .      |.+|+..+.+++|++|..+..++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~~--~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDTD--YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEecC--CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            4678999999999999999996553  356999999865322222   2      6899999999999999999888553


Q ss_pred             C--------CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC
Q 048439          341 D--------REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW  412 (613)
Q Consensus       341 ~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~  412 (613)
                      .        ...+|||||++|.+|.+...      ++.    ....+++.+|..||..+    ++|||+||+||+++.++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g----i~H~Dikp~Nili~~~g  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG----MVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC----CccCCCChHHEEEeCCC
Confidence            2        35789999999999988641      222    34569999999999998    99999999999999988


Q ss_pred             cEEEEecCCCccCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHH
Q 048439          413 VAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL  461 (613)
Q Consensus       413 ~~kl~DFGls~~~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ell  461 (613)
                       ++|+|||..+.......    -..++....+..++|+|||||.+.-+.
T Consensus       173 -i~liDfg~~~~~~e~~a----~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKA----KDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhh----HHHHHHHhHhcccccccceeEeehHHH
Confidence             99999998765432211    122555566778999999999987653

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=8.4e-20  Score=176.52  Aligned_cols=139  Identities=17%  Similarity=0.149  Sum_probs=109.9

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh---------------------c-----HHHHHHHHHHHhccCccce
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ---------------------G-----ALEFQTEIGMLSQLRHLHL  331 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~---------------------~-----~~~f~~Ei~~l~~l~H~ni  331 (613)
                      ..||+|+||.||+|... +++.||||+++.....                     .     ...+..|.+.+.+++|+++
T Consensus         3 ~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           3 GCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             ceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            47999999999999987 5688999998765211                     0     1124578999999999987


Q ss_pred             eeEEEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEeccCCCCceeeCC
Q 048439          332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT-GANHAVIIHRDVKTTNILLDE  410 (613)
Q Consensus       332 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~iiHrDlk~~NILl~~  410 (613)
                      .....+....  .+|||||++++++...+.  ....++..+...++.+++.+|.+||+ .+    |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~g----ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEAG----LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhCC----EecCCCChhhEEEE-
Confidence            5444443332  489999999886544321  23457888999999999999999999 88    99999999999999 


Q ss_pred             CCcEEEEecCCCccCC
Q 048439          411 KWVAKVSDFGLSKFGP  426 (613)
Q Consensus       411 ~~~~kl~DFGls~~~~  426 (613)
                      ++.++|+|||+++...
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8899999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=5.1e-21  Score=213.71  Aligned_cols=241  Identities=18%  Similarity=0.218  Sum_probs=175.1

Q ss_pred             CcceeeeeCcEEEEEEEEcCCceeEEEEEeC----CC-ChhcHH-HHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          276 NDLVIGVGGFGDVYKGFINGSTTPVAIKRLE----PE-SQQGAL-EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       276 ~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~----~~-~~~~~~-~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ...++|.|++|.|+...........+.|...    +. +..... .+..|..+-..++|+|++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            5568999999988877765443444444332    11 111111 25677788888999999988888887777777799


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc-----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF-----  424 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~-----  424 (613)
                      ||+. +|..++..  ...+...++-.+..|+..|+.|||+.+    |.|||||++|+++..+|.+||+|||.+..     
T Consensus       402 ~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~G----iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  402 YCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSMG----LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             cccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhcC----ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            9999 99999843  346888899999999999999999999    99999999999999999999999998753     


Q ss_pred             -------CCCCCCcccCChhhhhcCCCCc-hhHHHHHHHHHHHHHhCCCCccchhhhhhhh-HHHHHHHhhccC---Ccc
Q 048439          425 -------GPTSVSKTHLDPEYYRLQQLTE-KSDVYSFGVVLFEVLCARPSILRTAAKKQVS-LAVWAQQCYQNG---TID  492 (613)
Q Consensus       425 -------~~~~~~~~~~aPE~~~~~~~t~-ksDV~SfGvvL~elltg~~p~~~~~~~~~~~-l~~~~~~~~~~~---~~~  492 (613)
                             ....++..|+|||.+.+.+|.+ ..||||.||++..|++|+.||......++.. ............   .+.
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~  554 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL  554 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence                   2234567899999999999976 5899999999999999999996554443321 000000000000   000


Q ss_pred             -ccccHHHHHh-cccccCCCCCCCHHHHHHHHH
Q 048439          493 -QIVDPFLKAM-SCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       493 -~~~d~~~~~~-~Cl~~~p~~RPs~~evl~~Le  523 (613)
                       .+......++ ++|+.+|.+|.+|++|++.-+
T Consensus       555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W  587 (601)
T KOG0590|consen  555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEW  587 (601)
T ss_pred             HhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence             1111111122 789999999999999986555

>PRK10345 hypothetical protein; Provisional

Probab=99.80  E-value=5e-19  Score=172.86  Aligned_cols=136  Identities=18%  Similarity=0.187  Sum_probs=107.9

Q ss_pred             CCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-----CccceeeEEEEeecCC---c-eE
Q 048439          275 DNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-----RHLHLVSLIGFCNDDR---E-MI  345 (613)
Q Consensus       275 ~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-----~H~niv~l~g~~~~~~---~-~~  345 (613)
                      ....+||+|+||.||.  +..... .+||++........+.+.+|+.++..+     .||||++++|++.++.   . +.
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            3456899999999996  544444 479988776555567899999999999     5799999999998863   3 33


Q ss_pred             EEEEc--CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCcEEeccCCCCceeeCC----CCcEEEEe
Q 048439          346 LVYDF--MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGL-HYLHTGANHAVIIHRDVKTTNILLDE----KWVAKVSD  418 (613)
Q Consensus       346 lV~Ey--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~~iiHrDlk~~NILl~~----~~~~kl~D  418 (613)
                      +|+||  +.+|+|.+++..   ..+++.  ..++.+++.++ +|||+++    |+||||||+|||++.    ++.++|+|
T Consensus        82 ~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~----IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNR----IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCC----EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            78999  568999999943   235555  35678888887 9999998    999999999999974    34899999


Q ss_pred             cCCC
Q 048439          419 FGLS  422 (613)
Q Consensus       419 FGls  422 (613)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5544

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=2.7e-19  Score=191.60  Aligned_cols=202  Identities=27%  Similarity=0.436  Sum_probs=154.4

Q ss_pred             HhccCccceeeEEEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCC
Q 048439          323 LSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVK  402 (613)
Q Consensus       323 l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk  402 (613)
                      |+.+.|.|+.+++|.|.++..++.|.+||..|+|.|.+.. ....++|.-...+..+++.||.|||...  . ..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i-~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP--I-GYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc--c-eeeeeec
Confidence            4578999999999999999999999999999999999965 4567999999999999999999999755  1 3899999


Q ss_pred             CCceeeCCCCcEEEEecCCCccCCC-----CC-----CcccCChhhhhcC-------CCCchhHHHHHHHHHHHHHhCCC
Q 048439          403 TTNILLDEKWVAKVSDFGLSKFGPT-----SV-----SKTHLDPEYYRLQ-------QLTEKSDVYSFGVVLFEVLCARP  465 (613)
Q Consensus       403 ~~NILl~~~~~~kl~DFGls~~~~~-----~~-----~~~~~aPE~~~~~-------~~t~ksDV~SfGvvL~elltg~~  465 (613)
                      ++|+++|..+.+||+|||+......     ..     ..-|.|||.++..       ..+.+.||||||++++|+++...
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            9999999999999999999876531     11     1237899999773       24778999999999999999999


Q ss_pred             Cccchhhhhh-hhHHHHHHHhhc---cCCc---ccccc-HHHHHhcccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          466 SILRTAAKKQ-VSLAVWAQQCYQ---NGTI---DQIVD-PFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       466 p~~~~~~~~~-~~l~~~~~~~~~---~~~~---~~~~d-~~~~~~~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                      ||........ ..++.+......   .+.+   .+..+ .......||..+|++||++..|-..++.....
T Consensus       157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            9976432221 222333222011   1111   12222 22223489999999999999999887765543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=1.4e-18  Score=167.07  Aligned_cols=177  Identities=18%  Similarity=0.148  Sum_probs=132.0

Q ss_pred             CCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh----cHHHHHHHHHHHhccC-ccceeeEEEEeecCCceEEEEE
Q 048439          275 DNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ----GALEFQTEIGMLSQLR-HLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       275 ~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~----~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      .....|++|+||+||.+..  .+.+++.+.+.....-    ....|.+|+++|++|. |+++.+++++    +..+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3455899999999997655  3466887777654321    1225789999999995 5889999887    45699999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccC-CCCceeeCCCCcEEEEecCCCccCCCC
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDV-KTTNILLDEKWVAKVSDFGLSKFGPTS  428 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDl-k~~NILl~~~~~~kl~DFGls~~~~~~  428 (613)
                      |+.+.+|.+.+..         ....++.+++++|.++|+.+    |+|||| ||.|||+++++.++|+|||++......
T Consensus        79 yI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G----IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         79 YLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG----VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             eecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc----CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            9999998654311         12457789999999999999    999999 799999999999999999999753322


Q ss_pred             C---------------------CcccCChhhhhcC-CCC-chhHHHHHHHHHHHHHhCCCCccch
Q 048439          429 V---------------------SKTHLDPEYYRLQ-QLT-EKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       429 ~---------------------~~~~~aPE~~~~~-~~t-~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                      +                     ++.+++|+--..- ..+ ...+.++-|.-+|.++|++.+....
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            2                     2223444432211 122 4679999999999999999887544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.77  E-value=1.2e-18  Score=165.91  Aligned_cols=207  Identities=21%  Similarity=0.225  Sum_probs=160.0

Q ss_pred             CHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCc-cceeeEEEEeecC
Q 048439          263 SLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRH-LHLVSLIGFCNDD  341 (613)
Q Consensus       263 ~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H-~niv~l~g~~~~~  341 (613)
                      +++++..+ +.|...+.||.|+||.+|.|.....+..||||.-....  ....+..|..+...|+| ..|..+..|..+.
T Consensus         7 s~~~~iv~-gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~   83 (341)
T KOG1163|consen    7 SLEELIVG-GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEK   83 (341)
T ss_pred             chhhheec-cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence            34444333 46888889999999999999998888999999865432  22356788888888875 5677777788888


Q ss_pred             CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC---CcEEEEe
Q 048439          342 REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK---WVAKVSD  418 (613)
Q Consensus       342 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~---~~~kl~D  418 (613)
                      ..-.||||.+ +-+|.++..- ....++.++.+-++-|++.-++|+|.++    +|||||||+|+|..-+   ..+-++|
T Consensus        84 ~ynvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~----fiHRDIKPdNFLMGlgrh~~kl~LID  157 (341)
T KOG1163|consen   84 DYNVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRN----FIHRDIKPDNFLMGLGRHCNKLYLID  157 (341)
T ss_pred             ccceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhc----cccccCCccceeeccccccceEEEEe
Confidence            8889999988 5699887643 3567999999999999999999999999    9999999999998633   4678999


Q ss_pred             cCCCccCCC---------------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhH
Q 048439          419 FGLSKFGPT---------------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSL  478 (613)
Q Consensus       419 FGls~~~~~---------------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l  478 (613)
                      ||||+....               .+|.+|.+-....+..-+.+-|+=|+|.||..+.-|..||.+-....+.+.
T Consensus       158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK  232 (341)
T KOG1163|consen  158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK  232 (341)
T ss_pred             ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence            999974221               233445444444444556788999999999999999999987665544433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.76  E-value=8e-18  Score=170.02  Aligned_cols=193  Identities=21%  Similarity=0.304  Sum_probs=130.8

Q ss_pred             CCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccC----------ccceeeEEEEe---
Q 048439          275 DNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLR----------HLHLVSLIGFC---  338 (613)
Q Consensus       275 ~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~----------H~niv~l~g~~---  338 (613)
                      .....||.|+++.||.+++.++++.+|||.....   .....+++.+|......+.          |-.++-.+...   
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            3445899999999999999999999999986432   3445667777776665533          22222222211   


Q ss_pred             ------ecC---C-----ceEEEEEcCCCCChhHHhh---cC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEec
Q 048439          339 ------NDD---R-----EMILVYDFMARGTLPDHLY---HS--DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR  399 (613)
Q Consensus       339 ------~~~---~-----~~~lV~Ey~~~gsL~~~l~---~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHr  399 (613)
                            ...   .     ..+++|+-+ .++|.+++.   ..  ....+....++.+..|+++.+++||+.+    ++|+
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G----lVHg  169 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG----LVHG  169 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT----EEES
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc----eEec
Confidence                  111   1     336788877 458888753   21  1234566778888899999999999999    9999


Q ss_pred             cCCCCceeeCCCCcEEEEecCCCccC-----CCCCCcccCChhhhhcC--------CCCchhHHHHHHHHHHHHHhCCCC
Q 048439          400 DVKTTNILLDEKWVAKVSDFGLSKFG-----PTSVSKTHLDPEYYRLQ--------QLTEKSDVYSFGVVLFEVLCARPS  466 (613)
Q Consensus       400 Dlk~~NILl~~~~~~kl~DFGls~~~-----~~~~~~~~~aPE~~~~~--------~~t~ksDV~SfGvvL~elltg~~p  466 (613)
                      ||||+|+|++++|.++|+||+.....     ....+..|.+||.....        .+|.+.|.|++|++||.|.|++.|
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP  249 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP  249 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence            99999999999999999999865321     12334568899987553        468999999999999999999999


Q ss_pred             ccchhh
Q 048439          467 ILRTAA  472 (613)
Q Consensus       467 ~~~~~~  472 (613)
                      |.....
T Consensus       250 f~~~~~  255 (288)
T PF14531_consen  250 FGLSSP  255 (288)
T ss_dssp             TCCCGG
T ss_pred             CCCCCc
Confidence            975543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.76  E-value=3.3e-18  Score=169.71  Aligned_cols=191  Identities=21%  Similarity=0.241  Sum_probs=155.2

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEEEcC
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      +|...+.||+|.||.++.|+..-++.+||||.-...+  ..-++..|.+..+.| ..++|...+-|-.++..-.||+|.+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            6888899999999999999987777999999754332  233456677777776 4688888887777777789999988


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC-----CcEEEEecCCCccC-
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK-----WVAKVSDFGLSKFG-  425 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~-----~~~kl~DFGls~~~-  425 (613)
                       +-+|.|+. ......++.++.+.||.|++.-++|+|++.    +|.|||||+|+||..-     ..+.|+|||+|+.. 
T Consensus       107 -GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH~k~----LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  107 -GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVHEKD----LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             -CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHHhcc----eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence             55888865 345677999999999999999999999998    9999999999999643     46899999999742 


Q ss_pred             --------------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          426 --------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       426 --------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                                    ...+|.+||+-.-..+.+-+.+-|+=|+|-|.++.|-|..||.+-.
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence                          2245566777666667777889999999999999999999997643

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=1.2e-17  Score=163.86  Aligned_cols=134  Identities=25%  Similarity=0.357  Sum_probs=113.2

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh--------cHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--------GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~--------~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      +.||+|++|.||+|...+  ..|+||........        ....+.+|++++..++|++|.....++.+.+..++|||
T Consensus         2 ~~l~~G~~~~vy~~~~~~--~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLG--IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEeeCC--CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            479999999999998844  56899986643211        12357899999999999999888888777788899999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      |+++++|.+.+...     .+ .+..++.+++.+|.+||+.+    ++|||++|.|||++ ++.++|+|||+++.
T Consensus        80 ~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~----i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAG----IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCC----cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999988432     22 88899999999999999998    99999999999999 78999999999864

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.75  E-value=4.1e-19  Score=198.52  Aligned_cols=235  Identities=20%  Similarity=0.233  Sum_probs=174.2

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHH--HhccCccceeeEEEEeecCCceEEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGM--LSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~--l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++...+.||.+.|=+|.+|+++.|-  |+||++-... .-....|.++++-  ...++|||.+++.-+-..+...|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~--vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL--VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce--EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5666778999999999999998763  8899875433 3445555444333  445689999999888777788899999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc--CCC
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT  427 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~--~~~  427 (613)
                      |..+ +|.|.|  .-++-|...+..-|+-|++.||..+|..+    |+|||||++|||++.-.-+.|+||.-=+.  .+.
T Consensus       102 yvkh-nLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH~~g----VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRL--STRPFLVLIEKKWIAFQLLKALSQCHKLG----VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHHHcC----ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            9877 899988  44566788888999999999999999999    99999999999999888899999975431  111


Q ss_pred             -------------CCCcccCChhhhhcC-----------CCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHH
Q 048439          428 -------------SVSKTHLDPEYYRLQ-----------QLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWA  482 (613)
Q Consensus       428 -------------~~~~~~~aPE~~~~~-----------~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~  482 (613)
                                   ..-.+|+|||.|-..           .++++-||||+|||+.||++ |+|+|.-..      +..+.
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~aYr  248 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLAYR  248 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHhHh
Confidence                         112368999988542           26889999999999999987 588885432      11111


Q ss_pred             HH--hhccCCccccccHHHH--HhcccccCCCCCCCHHHHHHHH
Q 048439          483 QQ--CYQNGTIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGL  522 (613)
Q Consensus       483 ~~--~~~~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~L  522 (613)
                      ..  ...+..++++.|..++  .+.+++.||++|-+++|.++.-
T Consensus       249 ~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  249 SGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             ccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence            11  0111123334443333  3479999999999999999773

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.73  E-value=3.3e-19  Score=190.87  Aligned_cols=183  Identities=26%  Similarity=0.252  Sum_probs=153.5

Q ss_pred             eeeeeCcEEEEEEEE---cCCceeEEEEEeCCCChhc--HHHHHHHHHHHhccC-ccceeeEEEEeecCCceEEEEEcCC
Q 048439          279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQG--ALEFQTEIGMLSQLR-HLHLVSLIGFCNDDREMILVYDFMA  352 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~---~~~~~~vAVK~~~~~~~~~--~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~  352 (613)
                      ++|+|.||.|+.++-   .+.+..+|.|.++..+...  ......|..++..++ |+.+|++.-.++.+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            479999999997643   2334678888887653211  114567888888887 9999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----CCC
Q 048439          353 RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----PTS  428 (613)
Q Consensus       353 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----~~~  428 (613)
                      +|.|..++.  ....+.+.........+|-+++++|+.+    |+|||+|++||+++.+|.+|+.|||+++..    ..+
T Consensus        81 gg~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l~----iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~c  154 (612)
T KOG0603|consen   81 GGDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKLG----IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIAC  154 (612)
T ss_pred             cchhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchhH----HHHhcccccceeecccCccccCCchhhhHhHhhhhcc
Confidence            999998884  3455777777788889999999999999    999999999999999999999999999742    226


Q ss_pred             CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccc
Q 048439          429 VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILR  469 (613)
Q Consensus       429 ~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~  469 (613)
                      ++..|||||...  .....+|.||||++++||++|..||..
T Consensus       155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            688899999998  567789999999999999999999965

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=2.7e-17  Score=159.85  Aligned_cols=131  Identities=24%  Similarity=0.332  Sum_probs=107.0

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh--------hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ--------QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~--------~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +||+|+||.||+|...+  ..|++|.......        .....+.+|++++..++|+++.....++...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~~~--~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLG--LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeecCC--ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            48999999999999654  5699998654321        1134577899999999998876666666667778999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +++++|.+.+....  .       .++.+++.+|.+||+.+    ++|||++|.||+++ ++.++++|||+++..
T Consensus        79 ~~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH~~g----i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGN--D-------ELLREIGRLVGKLHKAG----IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcH--H-------HHHHHHHHHHHHHHHCC----eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999999874321  0       78999999999999998    99999999999999 889999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.73  E-value=1.3e-17  Score=186.38  Aligned_cols=141  Identities=24%  Similarity=0.321  Sum_probs=115.2

Q ss_pred             HHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--C------hhcHHHHHHHHHHHhccCccceeeEEEEee
Q 048439          268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--S------QQGALEFQTEIGMLSQLRHLHLVSLIGFCN  339 (613)
Q Consensus       268 ~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~------~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~  339 (613)
                      ......|...++||+|+||.||+|.+.+..  +++|+....  .      ......+.+|++++.+++|++++....++.
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~  406 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV  406 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence            334455567789999999999999987653  444432111  1      112346889999999999999999888888


Q ss_pred             cCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEec
Q 048439          340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDF  419 (613)
Q Consensus       340 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DF  419 (613)
                      +....++||||+++++|.+++.          .+..++.+++++|.|||+.+    ++||||||+|||+ +++.++|+||
T Consensus       407 ~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g----iiHrDlkp~NILl-~~~~~~liDF  471 (535)
T PRK09605        407 DPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG----IVHGDLTTSNFIV-RDDRLYLIDF  471 (535)
T ss_pred             eCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC----CccCCCChHHEEE-ECCcEEEEeC
Confidence            8888899999999999999883          45789999999999999998    9999999999999 5789999999


Q ss_pred             CCCccC
Q 048439          420 GLSKFG  425 (613)
Q Consensus       420 Gls~~~  425 (613)
                      |+++..
T Consensus       472 Gla~~~  477 (535)
T PRK09605        472 GLGKYS  477 (535)
T ss_pred             cccccC
Confidence            999753

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=3.3e-17  Score=163.66  Aligned_cols=142  Identities=20%  Similarity=0.215  Sum_probs=110.0

Q ss_pred             CCCcceeeeeCcEEEEEEE-EcCCceeEEEEEeCCCChh------------------------cHHHHHHHHHHHhccCc
Q 048439          274 FDNDLVIGVGGFGDVYKGF-INGSTTPVAIKRLEPESQQ------------------------GALEFQTEIGMLSQLRH  328 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~-~~~~~~~vAVK~~~~~~~~------------------------~~~~f~~Ei~~l~~l~H  328 (613)
                      |.....||+|+||.||+|. ...+++.||||.++.....                        ....+..|+..+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            5667799999999999998 5555688999998754210                        01235689999999976


Q ss_pred             cc--eeeEEEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCce
Q 048439          329 LH--LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNI  406 (613)
Q Consensus       329 ~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NI  406 (613)
                      .+  +.+++++    ...+|||||+++++|...+..  ...+...+...++.|++.+|++||+.+.   |+||||||+||
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~---iiH~Dikp~NI  180 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGE---LVHGDLSEYNI  180 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCC---EEeCCCChhhE
Confidence            33  4455543    235899999999888765422  3345666778999999999999998763   99999999999


Q ss_pred             eeCCCCcEEEEecCCCccC
Q 048439          407 LLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       407 Ll~~~~~~kl~DFGls~~~  425 (613)
                      +++ ++.++|+|||++...
T Consensus       181 li~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEE-CCCEEEEEChhhhcc
Confidence            999 889999999998743

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=4.3e-17  Score=158.58  Aligned_cols=143  Identities=20%  Similarity=0.150  Sum_probs=110.8

Q ss_pred             HHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh----------------------cHHHHHHHHHH
Q 048439          265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ----------------------GALEFQTEIGM  322 (613)
Q Consensus       265 ~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~----------------------~~~~f~~Ei~~  322 (613)
                      .++...-..|...+.||+|+||.||+|... ++..||||+++.....                      ....+..|+.+
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   86 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA   86 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence            344444444777789999999999999886 4578999987643210                      11236788999


Q ss_pred             HhccCcc--ceeeEEEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEecc
Q 048439          323 LSQLRHL--HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRD  400 (613)
Q Consensus       323 l~~l~H~--niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrD  400 (613)
                      +.++.|+  .+.+.++.    ...++||||+++++|.+....        .....++.+++.++.++|..+    |+|||
T Consensus        87 l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g----i~H~D  150 (198)
T cd05144          87 LKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG----IIHGD  150 (198)
T ss_pred             HHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC----CCcCC
Confidence            9999887  44555543    345899999999999765420        345678899999999999988    99999


Q ss_pred             CCCCceeeCCCCcEEEEecCCCcc
Q 048439          401 VKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       401 lk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      |||+||++++++.++|+|||++..
T Consensus       151 l~p~Nill~~~~~~~liDfg~~~~  174 (198)
T cd05144         151 LSEFNILVDDDEKIYIIDWPQMVS  174 (198)
T ss_pred             CCcccEEEcCCCcEEEEECCcccc
Confidence            999999999999999999999853

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=1.2e-17  Score=190.60  Aligned_cols=190  Identities=22%  Similarity=0.230  Sum_probs=149.3

Q ss_pred             HHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC---ccceeeEEEEeecCC
Q 048439          266 EIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR---HLHLVSLIGFCNDDR  342 (613)
Q Consensus       266 el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~---H~niv~l~g~~~~~~  342 (613)
                      +++..-..|.+.+.||+|+||+||+|...+ ++.||+|.-++.+.-   +|.--.+++.+|+   -+-|+++..++.-.+
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~  767 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQN  767 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence            334444567888899999999999999988 688999998776532   3333334455555   233444444555677


Q ss_pred             ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC-------CCCcEE
Q 048439          343 EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD-------EKWVAK  415 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~-------~~~~~k  415 (613)
                      ..+||+||.+.|+|.+++.  ....++|.....+..++++-+.+||..+    |||+||||+|+||.       +...++
T Consensus       768 ~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~----IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG----IIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             cceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc----eecccCCcceeEeecccCCCCcccceE
Confidence            8899999999999999994  5677999999999999999999999998    99999999999993       244689


Q ss_pred             EEecCCCcc---CC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCC
Q 048439          416 VSDFGLSKF---GP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP  465 (613)
Q Consensus       416 l~DFGls~~---~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~  465 (613)
                      |+|||-|-.   .+       ...+..+--+|...+...+...|.|.|.-+++-||.|+.
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            999998742   11       112334566899999999999999999999999999873

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.69  E-value=2.3e-16  Score=159.83  Aligned_cols=187  Identities=21%  Similarity=0.251  Sum_probs=133.0

Q ss_pred             CccceeeEEEEeec---------------------------CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHH
Q 048439          327 RHLHLVSLIGFCND---------------------------DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG  379 (613)
Q Consensus       327 ~H~niv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~  379 (613)
                      +|||||++.++|.+                           ...+||||.-.+. +|+++|..   ...+...+.-|+.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~---~~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT---RHRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc---CCCchHHHHHHHHH
Confidence            59999999987643                           2367899988876 99999843   23556667778899


Q ss_pred             HHHHHHHHhcCCCCCcEEeccCCCCceee--CCCC--cEEEEecCCCccC--------------CCCCCcccCChhhhhc
Q 048439          380 AARGLHYLHTGANHAVIIHRDVKTTNILL--DEKW--VAKVSDFGLSKFG--------------PTSVSKTHLDPEYYRL  441 (613)
Q Consensus       380 ia~gL~yLH~~~~~~~iiHrDlk~~NILl--~~~~--~~kl~DFGls~~~--------------~~~~~~~~~aPE~~~~  441 (613)
                      +++|..|||.++    |.|||+|++|||+  |+|+  ...|+|||.+-..              ...+...-||||++..
T Consensus       350 lLEav~hL~~hg----vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  350 LLEAVTHLHKHG----VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHcc----chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            999999999999    9999999999998  4444  5678999976321              1223445699999865


Q ss_pred             CC--C----CchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHHH--hcccccCCCCCC
Q 048439          442 QQ--L----TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKA--MSCLNDEGIRRP  513 (613)
Q Consensus       442 ~~--~----t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~--~~Cl~~~p~~RP  513 (613)
                      .+  .    -.|+|.|+.|.+.||++..+.||+...+. ......  .+.-+-+.+.+-+.+..+.  ...|+.||.+|+
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~--Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRv  502 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT--YQESQLPALPSRVPPVARQLVFDLLKRDPSKRV  502 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh--hhhhhCCCCcccCChHHHHHHHHHhcCCccccC
Confidence            32  1    35999999999999999999999863221 111222  1122223344444454443  268999999999


Q ss_pred             CHHHHHHHHHH
Q 048439          514 SMSDVVWGLEF  524 (613)
Q Consensus       514 s~~evl~~Le~  524 (613)
                      +..=....|.-
T Consensus       503 sp~iAANvl~L  513 (598)
T KOG4158|consen  503 SPNIAANVLNL  513 (598)
T ss_pred             CccHHHhHHHH
Confidence            97766655543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=2.2e-15  Score=138.11  Aligned_cols=135  Identities=19%  Similarity=0.211  Sum_probs=114.5

Q ss_pred             cceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCc--cceeeEEEEeecCCceEEEEEcCCCC
Q 048439          277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRH--LHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       277 ~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      .+.||+|.++.||++...+  ..++||.......  ...+..|+..+..++|  .++.+++++....+..+++|||++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             ceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            3579999999999999865  5699999866543  5678999999999987  59999999998888999999999987


Q ss_pred             ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          355 TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       355 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      .+..+         ++.....++.+++++|.+||...... ++|+|++|.|||+++.+.++++|||+++..
T Consensus        79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~-i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLV-LCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceE-EEecCCCcceEEEECCcEEEEEecccccCC
Confidence            77543         56777889999999999999853222 999999999999999899999999998643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.63  E-value=4.4e-16  Score=174.56  Aligned_cols=200  Identities=21%  Similarity=0.308  Sum_probs=141.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      .+|...++|-.|+||.||..+++.+.++.|. ++++.+.-     .+-  ++.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li-----lRn--ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI-----LRN--ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhh-cccccchh-----hhc--cccccCCccee-------------------
Confidence            5788889999999999999999988888888 44433210     110  22222233332                   


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC------
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG------  425 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~------  425 (613)
                        |+-...+.  ..++++-..        +.+++|||+-+    |+|||+||+|.|+..-|.+|+.||||++.+      
T Consensus       136 --gDc~tllk--~~g~lPvdm--------vla~Eylh~yg----ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 --GDCATLLK--NIGPLPVDM--------VLAVEYLHSYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             --chhhhhcc--cCCCCcchh--------hHHhHhhccCC----eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence              55555552  223343222        78899999998    999999999999999999999999998531      


Q ss_pred             -----------------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc
Q 048439          426 -----------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN  488 (613)
Q Consensus       426 -----------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~  488 (613)
                                       ..++++.|+|||+...+.|....|+|++|+++||.+-|+.||.+..+++-.....-....+.+
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE  279 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  279 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence                             235678899999999999999999999999999999999999988776654443333333333


Q ss_pred             CCccccccHHHHHhcccccCCCCCCC
Q 048439          489 GTIDQIVDPFLKAMSCLNDEGIRRPS  514 (613)
Q Consensus       489 ~~~~~~~d~~~~~~~Cl~~~p~~RPs  514 (613)
                      +...-..+....+-..|+.+|..|--
T Consensus       280 ~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  280 EDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             cCcCCCHHHHHHHHHHHHhChHhhcc
Confidence            32222222222223577888888853

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.62  E-value=2e-15  Score=145.10  Aligned_cols=135  Identities=21%  Similarity=0.237  Sum_probs=97.2

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh--cHHHH----------------------HHHHHHHhccCccc--e
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEF----------------------QTEIGMLSQLRHLH--L  331 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~--~~~~f----------------------~~Ei~~l~~l~H~n--i  331 (613)
                      +.||+|+||.||+|... ++..||||+++.....  ....+                      ..|...+.++.+..  +
T Consensus         3 ~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           3 GPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             cccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            47999999999999987 4578999998754211  11111                      35666666665443  4


Q ss_pred             eeEEEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEeccCCCCceeeCC
Q 048439          332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT-GANHAVIIHRDVKTTNILLDE  410 (613)
Q Consensus       332 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~iiHrDlk~~NILl~~  410 (613)
                      .+.+++    ...++||||++++++.........  .. .+...++.+++.++.++|. .+    |+||||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~----ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG----LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC----cCcCCCChhhEEEE-
Confidence            445543    245899999999654322111100  11 5678899999999999999 77    99999999999999 


Q ss_pred             CCcEEEEecCCCccC
Q 048439          411 KWVAKVSDFGLSKFG  425 (613)
Q Consensus       411 ~~~~kl~DFGls~~~  425 (613)
                      ++.++|+|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            899999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.60  E-value=3.7e-16  Score=164.65  Aligned_cols=159  Identities=26%  Similarity=0.357  Sum_probs=119.0

Q ss_pred             ceEEEEEcCCCCChhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCC
Q 048439          343 EMILVYDFMARGTLPDHLYHS-DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL  421 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl  421 (613)
                      .+++.|++|...+|.++|.++ .....+|...+.++.|++.|+.|   ++    .+|||+||.||+...+..+||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~----~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG----LIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc----chhhhccccccccccchhhhhhhhhh
Confidence            578999999999999999643 34567889999999999999999   55    89999999999999999999999998


Q ss_pred             CccC--------------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhh
Q 048439          422 SKFG--------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCY  486 (613)
Q Consensus       422 s~~~--------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~  486 (613)
                      ....              ...++..||+||.+.++.|+.|+||||+|++|+||+. -..+++..          ....-.
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~t~~d~  472 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------ATLTDI  472 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------Hhhhhh
Confidence            6431              2235677999999999999999999999999999996 22222111          111112


Q ss_pred             ccCCcc-----ccccHHHHHhcccccCCCCCCCHHHH
Q 048439          487 QNGTID-----QIVDPFLKAMSCLNDEGIRRPSMSDV  518 (613)
Q Consensus       487 ~~~~~~-----~~~d~~~~~~~Cl~~~p~~RPs~~ev  518 (613)
                      +.+.++     +.....-...+.+.+.|.+||++.++
T Consensus       473 r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  473 RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence            223332     11112122337899999999954443

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.60  E-value=9.1e-15  Score=146.33  Aligned_cols=135  Identities=19%  Similarity=0.175  Sum_probs=105.6

Q ss_pred             ceee-eeCcEEEEEEEEcCCceeEEEEEeCCCC-------------hhcHHHHHHHHHHHhccCccce--eeEEEEeecC
Q 048439          278 LVIG-VGGFGDVYKGFINGSTTPVAIKRLEPES-------------QQGALEFQTEIGMLSQLRHLHL--VSLIGFCNDD  341 (613)
Q Consensus       278 ~~iG-~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-------------~~~~~~f~~Ei~~l~~l~H~ni--v~l~g~~~~~  341 (613)
                      .+|| .||.|+||+....+  ..++||++....             ......+.+|++++.+|+|++|  +..++++...
T Consensus        37 ~~lg~~~g~gtv~~v~~~~--~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPG--VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeCC--ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4788 89999999998864  558999885321             1223457889999999998875  6777775443


Q ss_pred             Cc----eEEEEEcCCC-CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEE
Q 048439          342 RE----MILVYDFMAR-GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKV  416 (613)
Q Consensus       342 ~~----~~lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl  416 (613)
                      ..    .++|+||+++ .+|.+++..   .+++..    .+.+++.+|.+||+.+    |+||||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~G----I~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAG----VYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCC----CCCCCCCchhEEEcCCCCEEE
Confidence            22    2599999997 699888743   335443    3568999999999999    999999999999999999999


Q ss_pred             EecCCCccC
Q 048439          417 SDFGLSKFG  425 (613)
Q Consensus       417 ~DFGls~~~  425 (613)
                      +|||.++..
T Consensus       184 IDfg~~~~~  192 (239)
T PRK01723        184 IDFDRGELR  192 (239)
T ss_pred             EECCCcccC
Confidence            999998753

>PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan

Probab=99.49  E-value=2.5e-14  Score=135.81  Aligned_cols=86  Identities=27%  Similarity=0.458  Sum_probs=58.9

Q ss_pred             CCCCchHHHHHHhhcCCCcccCCceeeEEEEeeCCCCceeeeeeeeeeeecc----cCCCceEEEEEEcceeecccchhh
Q 048439           27 NYSAPDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEV----TEDGDRVFQIFIANLTAEVQADVI  102 (613)
Q Consensus        27 ~~~aP~~vy~Tar~~~~~~~~~~~~nltw~~~vd~~~~Y~vrlHFcei~~~~----~~~~~r~F~iyi~~~~~~~~~dv~  102 (613)
                      ..+.++.+|+|+|. +.      . +++|.+++.+++.|.|+|||||+....    ...|+|+|||+|||+++.++|||.
T Consensus        51 ~~t~d~~Lyqt~R~-g~------~-~f~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~  122 (174)
T PF11721_consen   51 PGTTDDPLYQTERY-GP------S-SFSYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIY  122 (174)
T ss_dssp             S-HHHHHTTT------S------S-SEEEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HH
T ss_pred             cCCCchhhhHhhcC-CC------C-ceEEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHH
Confidence            45677899999997 21      1 589999988889999999999998422    238999999999999999999999


Q ss_pred             hhhCCCceeEEEEE-Eeec
Q 048439          103 AWTGANGVTVYRDY-AVMI  120 (613)
Q Consensus       103 ~~~~~~~~p~y~dy-~v~~  120 (613)
                      +.+|+...+.++.| .|.+
T Consensus       123 ~~~G~~~~~~~~~~~~v~v  141 (174)
T PF11721_consen  123 AEAGGFNKAAVRRFFNVTV  141 (174)
T ss_dssp             HHHSSSS---EEEEEEEEE
T ss_pred             HHcCCCceEEEEEEEEEEE
Confidence            99998887777776 7766

It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.45  E-value=4.7e-13  Score=145.40  Aligned_cols=142  Identities=20%  Similarity=0.244  Sum_probs=100.6

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcH---------------------------------------
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGA---------------------------------------  313 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~---------------------------------------  313 (613)
                      .|+. ..||.|++|.||+|++.++ +.||||+.++......                                       
T Consensus       119 ~fd~-~plasaSigQVh~A~l~~G-~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       119 EFEE-KPLAAASIAQVHRARLVDG-KEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             hCCC-cceeeeehhheEEEEecCC-CEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            3443 5799999999999999765 7899999887521110                                       


Q ss_pred             -HHHHHHHHHHhccC----ccceeeEEEEe-ecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHH-HHHH
Q 048439          314 -LEFQTEIGMLSQLR----HLHLVSLIGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR-GLHY  386 (613)
Q Consensus       314 -~~f~~Ei~~l~~l~----H~niv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~y  386 (613)
                       -+|.+|.+.+.+++    |.+-+.+-..+ .-....+|||||++|++|.+...... ..+   .+..++..+++ .+..
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~---~~~~ia~~~~~~~l~q  272 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGL---DRKALAENLARSFLNQ  272 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCC---CHHHHHHHHHHHHHHH
Confidence             02555666666553    33333332232 22445799999999999988764221 112   34567777766 4788


Q ss_pred             HhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       387 LH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      +|..+    ++|+|++|.||++++++.++++|||++..
T Consensus       273 l~~~g----~~H~D~hPgNilv~~~g~i~liDfG~~~~  306 (437)
T TIGR01982       273 VLRDG----FFHADLHPGNIFVLKDGKIIALDFGIVGR  306 (437)
T ss_pred             HHhCC----ceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence            99888    99999999999999999999999999864

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=9.3e-15  Score=163.65  Aligned_cols=243  Identities=22%  Similarity=0.273  Sum_probs=178.5

Q ss_pred             CCCcceeeeeCcEEEEEEEEc-CCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccC-ccceeeEEEEeecCCceEEEEE
Q 048439          274 FDNDLVIGVGGFGDVYKGFIN-GSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~-~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      |....-||+|.|+.|-..... +....+|+|.+....  .........|..+-..+. |+|++++++...+.+..++..|
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~  101 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS  101 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence            444456999999999888763 334557777765543  222233445777777776 9999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCcEEeccCCCCceeeCCCC-cEEEEecCCCccC--
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH-TGANHAVIIHRDVKTTNILLDEKW-VAKVSDFGLSKFG--  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGls~~~--  425 (613)
                      |..+|++.+.+........+....-.+..|+..++.|+| ..+    +.|||+||+|.+++..+ ..|++|||+|...  
T Consensus       102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~----~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG----VTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc----cccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999999998884333335566677788999999999999 766    99999999999999999 9999999998532  


Q ss_pred             ---------CCCC-CcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc--cCCcc
Q 048439          426 ---------PTSV-SKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ--NGTID  492 (613)
Q Consensus       426 ---------~~~~-~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~  492 (613)
                               ...+ +..|.|||.+.+. ...+..|+||.|+++.-+++|..|+....... .....|......  .....
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~  256 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNKGRFTQLPWN  256 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccccccccCccc
Confidence                     2234 7789999999885 44678999999999999999999986554433 222333333211  22223


Q ss_pred             ccccHHHH-HhcccccCCCCCCCHHHHHHH
Q 048439          493 QIVDPFLK-AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       493 ~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      .+.+.... ..+++..+|..|.+.+++...
T Consensus       257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  257 SISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             cCChhhhhcccccccCCchhcccccccccc
Confidence            33333322 226777899999999988533

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.42  E-value=2.8e-13  Score=134.88  Aligned_cols=193  Identities=21%  Similarity=0.308  Sum_probs=135.8

Q ss_pred             HHHHhccCccceeeEEEEeecC-----CceEEEEEcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 048439          320 IGMLSQLRHLHLVSLIGFCNDD-----REMILVYDFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTGAN  392 (613)
Q Consensus       320 i~~l~~l~H~niv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~  392 (613)
                      ..-|-++-|.|||++..|+.+.     .+..++.|||..|+|..+|.+  .....+......++|.||..||.|||+.. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence            3445567899999999998653     457899999999999999964  34566788888899999999999999975 


Q ss_pred             CCcEEeccCCCCceeeCCCCcEEEEecCCCcc------------CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHH
Q 048439          393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEV  460 (613)
Q Consensus       393 ~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~------------~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~el  460 (613)
                       ++|+|+++..+-|++..+|-+|+.--.-...            ....+.++|.+||+-.....+.++|||+||...+||
T Consensus       197 -PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 -PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             -CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence             3499999999999999999888853221110            011224568899988888888999999999999999


Q ss_pred             HhCCCCccchhh--hhhhhHHHHHHHhhccCCccccccHHHHHhcccccCCCCCCCHHHHHHH
Q 048439          461 LCARPSILRTAA--KKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       461 ltg~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      ..+.--......  ..+..... +.....++.-.+.      .-+|++..|..||+|.+++.+
T Consensus       276 ailEiq~tnseS~~~~ee~ia~-~i~~len~lqr~~------i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIAN-VIIGLENGLQRGS------ITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HHheeccCCCcceeehhhhhhh-heeeccCccccCc------CcccccCCCCCCcchhhhhcC
Confidence            877643211110  01111110 1111111111111      126999999999999999854

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.31  E-value=8.9e-12  Score=117.51  Aligned_cols=131  Identities=16%  Similarity=0.100  Sum_probs=97.2

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCcccee-eEEEEeecCCceEEEEEcCCCCCh
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV-SLIGFCNDDREMILVYDFMARGTL  356 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gsL  356 (613)
                      +.|+.|.++.||++...+  ..+++|....... ....+..|+.++..+.+.+++ +++++..  ...++||||+++.++
T Consensus         4 ~~l~~G~~~~vy~~~~~~--~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEVAN--KKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEECC--eEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            367889999999998763  5699998765432 223568899999998766655 4554433  335899999999887


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          357 PDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN-HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       357 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      .+..       .   ....+..+++++|+.||.... +..++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5430       1   113456789999999998762 23369999999999999 66899999999764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.26  E-value=2.3e-11  Score=133.98  Aligned_cols=144  Identities=17%  Similarity=0.167  Sum_probs=93.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhc------------------------------H--------
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQG------------------------------A--------  313 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~------------------------------~--------  313 (613)
                      .+|+. .-||.|++|.||+|++.++++.||||+.++.-...                              .        
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 67999999999999998866889999998652110                              0        


Q ss_pred             --HHHHHHHHHHhccC----ccceeeEEEEeec-CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHH-HHH
Q 048439          314 --LEFQTEIGMLSQLR----HLHLVSLIGFCND-DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR-GLH  385 (613)
Q Consensus       314 --~~f~~Ei~~l~~l~----H~niv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~  385 (613)
                        -+|.+|+..+.+++    +.+.+.+-.++.+ ....+|||||++|+.|.+.-.-. ....+..   .++...+. -+.
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~~g~d~~---~la~~~v~~~~~  274 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-AAGTDMK---LLAERGVEVFFT  274 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-hcCCCHH---HHHHHHHHHHHH
Confidence              12455555555553    3333433333322 44678999999999998742111 1111111   22222221 233


Q ss_pred             HHhcCCCCCcEEeccCCCCceeeCCCC----cEEEEecCCCcc
Q 048439          386 YLHTGANHAVIIHRDVKTTNILLDEKW----VAKVSDFGLSKF  424 (613)
Q Consensus       386 yLH~~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFGls~~  424 (613)
                      -++..+    ++|+|+||.||+++.++    .++++|||++..
T Consensus       275 Qif~~G----ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~  313 (537)
T PRK04750        275 QVFRDG----FFHADMHPGNIFVSYDPPENPRYIALDFGIVGS  313 (537)
T ss_pred             HHHhCC----eeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence            344566    99999999999999988    999999999753

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.23  E-value=6.9e-12  Score=135.02  Aligned_cols=232  Identities=18%  Similarity=0.128  Sum_probs=166.2

Q ss_pred             CCCcceeee--eCcEEEEEEEE--cCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccC-ccceeeEEEEeecCCceEE
Q 048439          274 FDNDLVIGV--GGFGDVYKGFI--NGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       274 f~~~~~iG~--G~fG~Vy~g~~--~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~l  346 (613)
                      |.....+|.  |.+|.||.+.+  ......+|+|+-+..  ..+....=.+|+....+++ |+|.++....+.+.+..++
T Consensus       116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi  195 (524)
T KOG0601|consen  116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI  195 (524)
T ss_pred             cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence            445557899  99999999998  667788999984322  2233333467777777774 9999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCcEEeccCCCCceeeCCC-CcEEEEecCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR----GLHYLHTGANHAVIIHRDVKTTNILLDEK-WVAKVSDFGL  421 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGl  421 (613)
                      -.|+|. .+|.++.+.. ...++....+.+..+...    ||.++|+..    ++|-|+||.||++.++ ..+++.|||+
T Consensus       196 qtE~~~-~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~----~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  196 QTELCG-ESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN----IVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eecccc-chhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCc----ccccccchhheecccccceeecCCcce
Confidence            999986 5888877543 334666777777777777    999999988    9999999999999999 8899999998


Q ss_pred             CccC-------------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc
Q 048439          422 SKFG-------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN  488 (613)
Q Consensus       422 s~~~-------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~  488 (613)
                      ....             ...+...|++||...+ .++.++|+|++|.+..|..++..........      .|.......
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~~r~~~  342 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQLRQGY  342 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC------Ccccccccc
Confidence            6421             1134457999998754 6788999999999999999886554322111      111110000


Q ss_pred             CCccccc-----cHHHHHhcccccCCCCCCCHHHHH
Q 048439          489 GTIDQIV-----DPFLKAMSCLNDEGIRRPSMSDVV  519 (613)
Q Consensus       489 ~~~~~~~-----d~~~~~~~Cl~~~p~~RPs~~evl  519 (613)
                       ...+.+     ........+++.+|..|++...+.
T Consensus       343 -ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  343 -IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             -CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence             011111     111123468888998998887775

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.20  E-value=1.7e-10  Score=113.46  Aligned_cols=145  Identities=21%  Similarity=0.304  Sum_probs=113.3

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh-hcHHHHHHHHHHHhccCcc--ceeeEEEEeecCC---ceEEEEEcC
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ-QGALEFQTEIGMLSQLRHL--HLVSLIGFCNDDR---EMILVYDFM  351 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~--niv~l~g~~~~~~---~~~lV~Ey~  351 (613)
                      ..|+.|..+.||++...+ +..+++|....... .....+..|++++..+++.  ++.+++.++.+..   ..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            368999999999998865 35699998765432 2355789999999999764  4577888877643   568999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA----------------------------------------  391 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------  391 (613)
                      ++++|.+.+..   ..++..++..++.+++++|.+||+..                                        
T Consensus        83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            99988776521   45788888899999999999999531                                        


Q ss_pred             ------------CCCcEEeccCCCCceeeCC--CCcEEEEecCCCccCC
Q 048439          392 ------------NHAVIIHRDVKTTNILLDE--KWVAKVSDFGLSKFGP  426 (613)
Q Consensus       392 ------------~~~~iiHrDlk~~NILl~~--~~~~kl~DFGls~~~~  426 (613)
                                  .+..++|+|+++.|||++.  ++.+.|+||+.+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g~  208 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLGD  208 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccCC
Confidence                        1244899999999999998  6778999999886543

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.18  E-value=1.9e-10  Score=110.71  Aligned_cols=137  Identities=15%  Similarity=0.142  Sum_probs=98.6

Q ss_pred             ceeeeeCcEEEEEEEEcC------CceeEEEEEeCCCC------------h---------hc-HHHHH----HHHHHHhc
Q 048439          278 LVIGVGGFGDVYKGFING------STTPVAIKRLEPES------------Q---------QG-ALEFQ----TEIGMLSQ  325 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~------~~~~vAVK~~~~~~------------~---------~~-~~~f~----~Ei~~l~~  325 (613)
                      ..||.|--+.||.|...+      .+..+|||+.+...            .         .. ...+.    +|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            378999999999998653      23679999875310            0         00 11233    89999999


Q ss_pred             cCc--cceeeEEEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCcEEeccCC
Q 048439          326 LRH--LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL-HTGANHAVIIHRDVK  402 (613)
Q Consensus       326 l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~iiHrDlk  402 (613)
                      +..  -++..++++    ..-+|||||+.++.+..-..  ....++..+...+..+++.+|..| |..+    |+|+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L--kd~~~~~~~~~~i~~~i~~~l~~l~H~~g----lVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL--KDAKLNDEEMKNAYYQVLSMMKQLYKECN----LVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh--hccccCHHHHHHHHHHHHHHHHHHHHhCC----eecCCCC
Confidence            863  455666654    45689999998754432211  122345556677889999999999 7777    9999999


Q ss_pred             CCceeeCCCCcEEEEecCCCccC
Q 048439          403 TTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       403 ~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +.|||++ ++.+.|+|||.+...
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeC
Confidence            9999997 468999999988644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.11  E-value=1.4e-09  Score=118.52  Aligned_cols=162  Identities=17%  Similarity=0.210  Sum_probs=122.9

Q ss_pred             EEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCC
Q 048439          290 KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLP  369 (613)
Q Consensus       290 ~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~  369 (613)
                      .|..+..+.+|.|+..+..+........+-++.|+.||||||++++.....+..+|||+|-+.  -|..++..     +.
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LG  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hH
Confidence            456666668899998877665333446778899999999999999999999999999999874  45566632     23


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCCCCC--------cccCChhhhhc
Q 048439          370 WNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS--------KTHLDPEYYRL  441 (613)
Q Consensus       370 ~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~--------~~~~aPE~~~~  441 (613)
                      .......+.||+.||.+||..+.   ++|++|...-|++++.|..||++|-++........        ..|..|+....
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~~---lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDCN---LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccCC---eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence            44556677899999999997664   99999999999999999999999988754322221        12345543322


Q ss_pred             CCCCchhHHHHHHHHHHHHHhC
Q 048439          442 QQLTEKSDVYSFGVVLFEVLCA  463 (613)
Q Consensus       442 ~~~t~ksDV~SfGvvL~elltg  463 (613)
                      ..  -..|.|-|||+++|++.|
T Consensus       180 s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 SE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cc--cchhhhhHHHHHHHHhCc
Confidence            21  346999999999999999

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.08  E-value=1.4e-09  Score=101.18  Aligned_cols=143  Identities=22%  Similarity=0.230  Sum_probs=107.1

Q ss_pred             CcceeeeeCcEEEEEEEEcCCceeEEEEEe-CCC-------ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          276 NDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPE-------SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       276 ~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~-~~~-------~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ...+|-+|+-+.|+++.+.+  +.+.||.- .+.       ..-......+|++.|.+++--.|.--.-++.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~~G--e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSG--EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccCC--ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            44588999999999999876  44666642 221       122345678999999999766665555566666677899


Q ss_pred             EEcCCC-CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC---cEEEEecCCCc
Q 048439          348 YDFMAR-GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW---VAKVSDFGLSK  423 (613)
Q Consensus       348 ~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~---~~kl~DFGls~  423 (613)
                      |||.++ -++.+++...............++..+-+.+.-||...    |||+||.++||+|..++   .+-++||||+.
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd----iiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND----IIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC----eecccccccceEEecCCCcCceEEEeecchh
Confidence            999976 47888886544444444444788999999999999998    99999999999996654   46899999986


Q ss_pred             c
Q 048439          424 F  424 (613)
Q Consensus       424 ~  424 (613)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            4

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.06  E-value=1.7e-09  Score=101.10  Aligned_cols=131  Identities=24%  Similarity=0.318  Sum_probs=102.3

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEe-CCC--Ch-----hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRL-EPE--SQ-----QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~-~~~--~~-----~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      .+++|+-..+|.+.+.+.  ++.+|.= .+.  .+     -....-.+|+++|++++--.|..-+=+..+.+...|+|||
T Consensus         3 ~i~~GAEa~i~~~~~~g~--~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGL--PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             hhhCCcceeEEeeeccCc--ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            678999999999977653  3666642 221  11     1123457899999999876766666677788889999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      .++-.|.+.+...         +..++..+-+-+.-||..+    |+|+||.++||++..+. +.++||||+...
T Consensus        81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g----ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG----IVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC----eecCCCccceEEEeCCc-EEEEECCccccc
Confidence            9999999988432         3667888888889999999    99999999999998664 899999998743

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.05  E-value=6e-11  Score=127.85  Aligned_cols=242  Identities=20%  Similarity=0.199  Sum_probs=169.4

Q ss_pred             HHHHhcCCCCcceeeeeCcEEEEEEEEc-CCceeEEEEEeCCCChhcHHH--HHHHHHHHhcc-CccceeeEEEEeecCC
Q 048439          267 IQAATNNFDNDLVIGVGGFGDVYKGFIN-GSTTPVAIKRLEPESQQGALE--FQTEIGMLSQL-RHLHLVSLIGFCNDDR  342 (613)
Q Consensus       267 l~~at~~f~~~~~iG~G~fG~Vy~g~~~-~~~~~vAVK~~~~~~~~~~~~--f~~Ei~~l~~l-~H~niv~l~g~~~~~~  342 (613)
                      ...-+.+|.....||.|.|+.|++...+ .++..+++|.+.........+  =..|+.+...+ .|.|++.+...+...+
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            3344567888889999999999998765 566789999886653332222  24666666666 5888998887777777


Q ss_pred             ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC-CcEEEEecCC
Q 048439          343 EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK-WVAKVSDFGL  421 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGl  421 (613)
                      ..++--|||+++++...+  .-...++...++++..+++.++.++|+..    ++|+|+||+||++..+ +..++.|||.
T Consensus       340 ~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~----~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL----FVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             cccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh----hhcccccccceeeccchhhhhcccccc
Confidence            888999999999987766  23345778889999999999999999988    9999999999999876 8889999998


Q ss_pred             CccC------CCCCCccc-CChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCc---
Q 048439          422 SKFG------PTSVSKTH-LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTI---  491 (613)
Q Consensus       422 s~~~------~~~~~~~~-~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~---  491 (613)
                      ....      .......| .+++......+..+.|+||||.-..|.+++.+-.....        .|..  ...+..   
T Consensus       414 ~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~--i~~~~~p~~  483 (524)
T KOG0601|consen  414 WTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLT--IRSGDTPNL  483 (524)
T ss_pred             ccccceecccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------ccee--eecccccCC
Confidence            7521      11223233 35555666778899999999999999998875432111        1111  011111   


Q ss_pred             cccccHHH-HHhcccccCCCCCCCHHHHHHHHHH
Q 048439          492 DQIVDPFL-KAMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       492 ~~~~d~~~-~~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ....+... .+......++..||.+.++..+.++
T Consensus       484 ~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  484 PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             CchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            11111111 1124667788888888887765553

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.92  E-value=5.5e-08  Score=103.13  Aligned_cols=169  Identities=18%  Similarity=0.244  Sum_probs=130.6

Q ss_pred             cEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEee----cCCceEEEEEcCCC-CChhHH
Q 048439          285 FGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN----DDREMILVYDFMAR-GTLPDH  359 (613)
Q Consensus       285 fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~----~~~~~~lV~Ey~~~-gsL~~~  359 (613)
                      -.+.||+...-++..+++||++....+.......-+++++++.|.|+|++..++.    .+..++|||+|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3578999887777889999996544444434456788999999999999988775    35678999999985 678776


Q ss_pred             hhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          360 LYHS-------------DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       360 l~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      -+..             .+..+++...|.++.|+..||.++|+.|    +.-+-|.+++||++.+.+++|+..|......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG----LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG----LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC----ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            5431             2345788899999999999999999998    7889999999999999999999888765433


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 048439          427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPS  466 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p  466 (613)
                      ...    .  |-+..   -.+-|.=.||.+++-|.||+..
T Consensus       445 ~d~----~--~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDP----T--EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----C--cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            221    0  11211   2356888999999999999754

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.88  E-value=3e-08  Score=100.68  Aligned_cols=140  Identities=16%  Similarity=0.115  Sum_probs=101.7

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh-----------cHHHHHHHHHHHhccCccce--eeEEEEeec-----
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ-----------GALEFQTEIGMLSQLRHLHL--VSLIGFCND-----  340 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~-----------~~~~f~~Ei~~l~~l~H~ni--v~l~g~~~~-----  340 (613)
                      ++-+.....|.+..+.+  +.+.||+.......           ....+.+|.+.+.+|...+|  ..++++...     
T Consensus        29 ~v~~~~~rrvvr~~~~g--~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         29 VFRELEGRRTLRFELAG--KSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             EEecCCCceEEEEEECC--EEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            44444445577776644  57999987543311           11147899999998854433  455666543     


Q ss_pred             CCceEEEEEcCCCC-ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC-------CC
Q 048439          341 DREMILVYDFMARG-TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE-------KW  412 (613)
Q Consensus       341 ~~~~~lV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~-------~~  412 (613)
                      ....+||+|++++- +|.+++......+.+...+..++.+++..+.-||..+    |+|+|++++|||++.       ++
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G----i~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG----INHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc----CccCCCChhhEEEeccccCCCCCc
Confidence            23578999999986 7988874322344566777899999999999999999    999999999999975       57


Q ss_pred             cEEEEecCCCcc
Q 048439          413 VAKVSDFGLSKF  424 (613)
Q Consensus       413 ~~kl~DFGls~~  424 (613)
                      .+.|+||+.++.
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            899999998864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.88  E-value=3.6e-10  Score=127.78  Aligned_cols=197  Identities=21%  Similarity=0.225  Sum_probs=137.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh---hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ---QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ..|...+-+-+|.|+.++.+.-...+...++|.......   ...+....+-.++-..+||-++...--+.......||+
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            445555567789999999877665554445554332211   11112222222222234565555444445567889999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCC-cc---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS-KF---  424 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls-~~---  424 (613)
                      +|..+|+|...|+...  +.+..-.......+..++.|||...    +.|||++|.|+|...++..+++|||+. +.   
T Consensus       884 ~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~----r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL----RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             HHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch----hhcccccccchhhcccCCcccCccccccccccc
Confidence            9999999999986533  3444444445566788899999976    899999999999999999999999832 11   


Q ss_pred             -----------------------------------CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccc
Q 048439          425 -----------------------------------GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILR  469 (613)
Q Consensus       425 -----------------------------------~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~  469 (613)
                                                         ....++..|++||...+......+|+|++|++++|.++|.+||..
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                                               011235568999999999999999999999999999999999976


Q ss_pred             hhhhh
Q 048439          470 TAAKK  474 (613)
Q Consensus       470 ~~~~~  474 (613)
                      .....
T Consensus      1038 ~tpq~ 1042 (1205)
T KOG0606|consen 1038 ETPQQ 1042 (1205)
T ss_pred             cchhh
Confidence            55433

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.71  E-value=8.7e-08  Score=91.93  Aligned_cols=124  Identities=21%  Similarity=0.254  Sum_probs=81.1

Q ss_pred             EEEEEEEcCCceeEEEEEeCCCC-------------h--------hc-----HHHHHHHHHHHhccCcc--ceeeEEEEe
Q 048439          287 DVYKGFINGSTTPVAIKRLEPES-------------Q--------QG-----ALEFQTEIGMLSQLRHL--HLVSLIGFC  338 (613)
Q Consensus       287 ~Vy~g~~~~~~~~vAVK~~~~~~-------------~--------~~-----~~~f~~Ei~~l~~l~H~--niv~l~g~~  338 (613)
                      .||.|...++ ..+|||..+...             .        ..     .....+|.+.|.++..-  ++.+++.+.
T Consensus         1 ~Vy~~~~~~~-~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDPDG-EEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEECTT-EEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECCCC-CEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4899988665 679999876420             0        00     12356899999999765  455666552


Q ss_pred             ecCCceEEEEEcCC--CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCcEEeccCCCCceeeCCCCcEE
Q 048439          339 NDDREMILVYDFMA--RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY-LHTGANHAVIIHRDVKTTNILLDEKWVAK  415 (613)
Q Consensus       339 ~~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~~iiHrDlk~~NILl~~~~~~k  415 (613)
                          .-+|||||++  +..+..+. ..   .++......++.+++..+.. +|..+    |+|+||.+.|||++++ .+.
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~-~~---~~~~~~~~~~~~~il~~~~~~~~~~g----ivHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLK-DV---DLSPEEPKELLEEILEEIIKMLHKAG----IVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHH-HC---GGGGSTHHHHHHHHHHHHHHHHHCTT----EEESS-STTSEEEETT-CEE
T ss_pred             ----CCEEEEEecCCCccchhhHH-hc---cccchhHHHHHHHHHHHHHHHHHhcC----ceecCCChhhEEeecc-eEE
Confidence                3479999998  54554433 11   12245567788888886666 46877    9999999999999987 999


Q ss_pred             EEecCCCcc
Q 048439          416 VSDFGLSKF  424 (613)
Q Consensus       416 l~DFGls~~  424 (613)
                      |+|||.+..
T Consensus       147 iIDf~qav~  155 (188)
T PF01163_consen  147 IIDFGQAVD  155 (188)
T ss_dssp             E--GTTEEE
T ss_pred             EEecCccee
Confidence            999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK09902 hypothetical protein; Provisional

Probab=98.52  E-value=1.8e-06  Score=83.57  Aligned_cols=139  Identities=17%  Similarity=0.124  Sum_probs=105.3

Q ss_pred             eeeeCcEEEEEEEEcCCceeEEEEEeCCC---C---hhcHHHHHHHHHHHhccCcc--ceeeEEEEeec----CCceEEE
Q 048439          280 IGVGGFGDVYKGFINGSTTPVAIKRLEPE---S---QQGALEFQTEIGMLSQLRHL--HLVSLIGFCND----DREMILV  347 (613)
Q Consensus       280 iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~---~~~~~~f~~Ei~~l~~l~H~--niv~l~g~~~~----~~~~~lV  347 (613)
                      -|+||-+.|++-.+.+.  .+-+|+-...   +   +-+...|.+|+..|.+|...  .+.+.+.+...    .-.-+||
T Consensus        26 ~~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            37789999999877664  5889986521   1   44677899999999999643  34444422222    2236899


Q ss_pred             EEcCC-CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc--EEEEecCCCcc
Q 048439          348 YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV--AKVSDFGLSKF  424 (613)
Q Consensus       348 ~Ey~~-~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~--~kl~DFGls~~  424 (613)
                      +|-++ --+|.+++......+.+...+..+..+++..+.-||+.+    +.|+|+.+.|||++.++.  ++++||--++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G----v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN----RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC----CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            99776 358888875544456788888999999999999999999    999999999999986666  99999987653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.46  E-value=1.3e-06  Score=85.44  Aligned_cols=107  Identities=23%  Similarity=0.268  Sum_probs=84.8

Q ss_pred             HHHHHHHHHHHhccCc--cceeeEEEEeecCC----ceEEEEEcCCC-CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 048439          313 ALEFQTEIGMLSQLRH--LHLVSLIGFCNDDR----EMILVYDFMAR-GTLPDHLYHSDNPPLPWNQRLEICIGAARGLH  385 (613)
Q Consensus       313 ~~~f~~Ei~~l~~l~H--~niv~l~g~~~~~~----~~~lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~  385 (613)
                      .....+|...+.+|+.  -...+.+++.....    ..+||+|++++ -+|.+++....  .++...+..++.++++.+.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence            4467888888888853  34456777765532    45899999987 47999885422  2666778899999999999


Q ss_pred             HHhcCCCCCcEEeccCCCCceeeCCCC---cEEEEecCCCccC
Q 048439          386 YLHTGANHAVIIHRDVKTTNILLDEKW---VAKVSDFGLSKFG  425 (613)
Q Consensus       386 yLH~~~~~~~iiHrDlk~~NILl~~~~---~~kl~DFGls~~~  425 (613)
                      -||..+    |+|+|+++.|||++.+.   .+.++||+.++..
T Consensus       133 ~lH~~g----i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDAG----IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHCc----CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999    99999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.43  E-value=5e-08  Score=106.96  Aligned_cols=137  Identities=22%  Similarity=0.330  Sum_probs=90.8

Q ss_pred             HHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC-----------------CCCcccCChhhh
Q 048439          377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-----------------SVSKTHLDPEYY  439 (613)
Q Consensus       377 ~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~-----------------~~~~~~~aPE~~  439 (613)
                      +.+++.||.|+|....   +||++|.|++|.++.++..||+.|+.+.....                 .....|.|||++
T Consensus       105 l~~v~dgl~flh~sAk---~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAK---VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hhcccchhhhhccCcc---eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence            3456699999997664   99999999999999999999999987642111                 012348999999


Q ss_pred             hcCCCCchhHHHHHHHHHHHHHhCCCCc-cchhhhhhh----hHHHHHHHhhccCCccccccHHHHHhcccccCCCCCCC
Q 048439          440 RLQQLTEKSDVYSFGVVLFEVLCARPSI-LRTAAKKQV----SLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPS  514 (613)
Q Consensus       440 ~~~~~t~ksDV~SfGvvL~elltg~~p~-~~~~~~~~~----~l~~~~~~~~~~~~~~~~~d~~~~~~~Cl~~~p~~RPs  514 (613)
                      .....+.++|+||+||++|-+..|..+. .........    .+..............++.+.+.   +.+..++..||+
T Consensus       182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~---k~l~~~~~~rp~  258 (700)
T KOG2137|consen  182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLK---KLLNGDSAVRPT  258 (700)
T ss_pred             ccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHH---HHhcCCcccCcc
Confidence            9988899999999999999999555443 221111100    01111111112122222222222   478888999998


Q ss_pred             HHHHH
Q 048439          515 MSDVV  519 (613)
Q Consensus       515 ~~evl  519 (613)
                      +.++.
T Consensus       259 ~~~l~  263 (700)
T KOG2137|consen  259 LDLLL  263 (700)
T ss_pred             hhhhh
Confidence            77776

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.35  E-value=4.5e-06  Score=82.85  Aligned_cols=145  Identities=21%  Similarity=0.128  Sum_probs=98.9

Q ss_pred             CcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--------------------h--hcHHHHHHHHHHHhccCcc--ce
Q 048439          276 NDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--------------------Q--QGALEFQTEIGMLSQLRHL--HL  331 (613)
Q Consensus       276 ~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--------------------~--~~~~~f~~Ei~~l~~l~H~--ni  331 (613)
                      ....||.|--+.||.|....+ .++|||.-+...                    .  -.....++|.+.|.+|...  .+
T Consensus        95 iG~~IGvGKEsdVY~~~~~~g-~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          95 IGTKIGVGKESDVYVAIDPKG-RKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hccccccCccceEEEEECCCC-CEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            345899999999999998765 679999643210                    0  0122356899999998755  56


Q ss_pred             eeEEEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC
Q 048439          332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK  411 (613)
Q Consensus       332 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~  411 (613)
                      .+.+++    +...+||||.++--|...-       ++-...-.|+..|++-+.-+-..+    |+|+|+..-|||++++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G----iVHGDlSefNIlV~~d  238 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG----IVHGDLSEFNILVTED  238 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC----ccccCCchheEEEecC
Confidence            666654    4568999999985554321       223334445555555555555566    9999999999999999


Q ss_pred             CcEEEEecCCCccCCCCCCcccCChhhhhc
Q 048439          412 WVAKVSDFGLSKFGPTSVSKTHLDPEYYRL  441 (613)
Q Consensus       412 ~~~kl~DFGls~~~~~~~~~~~~aPE~~~~  441 (613)
                      |.+.++||-.+......     -|+|++.+
T Consensus       239 g~~~vIDwPQ~v~~~hp-----~a~e~l~R  263 (304)
T COG0478         239 GDIVVIDWPQAVPISHP-----DAEELLER  263 (304)
T ss_pred             CCEEEEeCcccccCCCC-----CHHHHHHh
Confidence            99999999655432211     24666654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.33  E-value=8.6e-06  Score=80.87  Aligned_cols=135  Identities=16%  Similarity=0.206  Sum_probs=86.8

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccce--eeEEEEeecCCceEEEEEcCCCCC-
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL--VSLIGFCNDDREMILVYDFMARGT-  355 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~ni--v~l~g~~~~~~~~~lV~Ey~~~gs-  355 (613)
                      .||+|..+.||+.  . + ..+++|......  ......+|.+++..+..-.+  .+.++++...+...+|||+++|.+ 
T Consensus         8 ~i~~G~t~~~y~~--~-~-~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         8 QTGEGGNGESYTH--K-T-GKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eecCCCCcceeEe--c-C-CCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            7899999999984  2 2 347788876533  23446889999998865444  677888877778889999999864 


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHhcCCCCCcE
Q 048439          356 LPDHLYHSDNPPLPWNQRLEICIGAARG---------------------------------------LHYLHTGANHAVI  396 (613)
Q Consensus       356 L~~~l~~~~~~~l~~~~~~~i~~~ia~g---------------------------------------L~yLH~~~~~~~i  396 (613)
                      +...+.      .+......++..+|+.                                       ..+|........+
T Consensus        82 ~~~~~~------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~  155 (226)
T TIGR02172        82 FSRIIS------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC  155 (226)
T ss_pred             hhhhhc------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence            211110      0001111111111111                                       2222222223347


Q ss_pred             EeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       397 iHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      +|+|+.|.||++++++ +.|+||+.+..++
T Consensus       156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~~Gd  184 (226)
T TIGR02172       156 LHGDFQIGNLITSGKG-TYWIDLGDFGYGN  184 (226)
T ss_pred             EecCCCCCcEEEcCCC-cEEEechhcCcCC
Confidence            8999999999999888 9999999886543

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.25  E-value=7.7e-06  Score=85.11  Aligned_cols=239  Identities=15%  Similarity=0.164  Sum_probs=144.1

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEe------ecCC-ceEEEEE
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFC------NDDR-EMILVYD  349 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~------~~~~-~~~lV~E  349 (613)
                      .-||+|+-+.+|-----.+   .+-|+..........+   -+..|... .||-+-.-+.|=      -++. ..-++|.
T Consensus        17 r~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          17 RPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             ccccCCccceeeecchhhc---hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            4689999999995432222   3446654433222222   23334443 455333212221      1122 2556777


Q ss_pred             cCCCCC-hhHHhh----cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEe---cCC
Q 048439          350 FMARGT-LPDHLY----HSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSD---FGL  421 (613)
Q Consensus       350 y~~~gs-L~~~l~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~D---FGl  421 (613)
                      .+++.. ..+++.    +...+...|.-.++.++.+|.+.+-||..+    ..-+|+.++|+|+.+++.+.|.|   |-+
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G----h~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG----HVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC----CcccccCccceeeecCceEEEEcccceee
Confidence            766542 222221    123467899999999999999999999998    77899999999999999999886   443


Q ss_pred             Ccc----CCCCCCcccCChhhhhcC-----CCCchhHHHHHHHHHHHHHhC-CCCccchhhh-----hhh-hHHH----H
Q 048439          422 SKF----GPTSVSKTHLDPEYYRLQ-----QLTEKSDVYSFGVVLFEVLCA-RPSILRTAAK-----KQV-SLAV----W  481 (613)
Q Consensus       422 s~~----~~~~~~~~~~aPE~~~~~-----~~t~ksDV~SfGvvL~elltg-~~p~~~~~~~-----~~~-~l~~----~  481 (613)
                      .-.    .-+.+...|.+||.-.-+     .-+...|-|.+||++++||.| +.||.+-...     ... .+..    .
T Consensus       167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y  246 (637)
T COG4248         167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY  246 (637)
T ss_pred             ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence            321    122345679999976533     346789999999999999987 8888643211     000 0100    0


Q ss_pred             HHH--hh----ccCCccccccHHHHHh--cccccC--CCCCCCHHHHHHHHHHhh
Q 048439          482 AQQ--CY----QNGTIDQIVDPFLKAM--SCLNDE--GIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       482 ~~~--~~----~~~~~~~~~d~~~~~~--~Cl~~~--p~~RPs~~evl~~Le~~l  526 (613)
                      +..  .-    .....-.++.+...++  +|+...  +.-||+++.-+..|....
T Consensus       247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            000  00    0111223444555555  787653  568999999888776543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.21  E-value=1.6e-05  Score=79.80  Aligned_cols=140  Identities=19%  Similarity=0.178  Sum_probs=85.6

Q ss_pred             eeeeCc-EEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC-ccceeeEEEEeecCCceEEEEEcCCCCChh
Q 048439          280 IGVGGF-GDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDREMILVYDFMARGTLP  357 (613)
Q Consensus       280 iG~G~f-G~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~  357 (613)
                      |-.|.. ..||+....+  ..+.||+.....   ..+..+|++++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus         6 ~~~g~~~~~v~~~~~~~--~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGKN--PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCCC--CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            444555 7899987643  468888876543   335678999988884 444557788877766789999999998776


Q ss_pred             HHh-------------------hcCC--CCCCC--HHHHHHHHHH--------------------HHHHHHHHhc---CC
Q 048439          358 DHL-------------------YHSD--NPPLP--WNQRLEICIG--------------------AARGLHYLHT---GA  391 (613)
Q Consensus       358 ~~l-------------------~~~~--~~~l~--~~~~~~i~~~--------------------ia~gL~yLH~---~~  391 (613)
                      +..                   +...  ..++.  +..++..+..                    +...+..|-.   ..
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            432                   1110  00111  0011110000                    1111222211   11


Q ss_pred             CCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       392 ~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      .++.++|+|+.|.|||++++....|+||+.+..
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            234589999999999999988889999998754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.18  E-value=5.1e-06  Score=91.39  Aligned_cols=142  Identities=16%  Similarity=0.211  Sum_probs=93.5

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhc------------------------------HH--------
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQG------------------------------AL--------  314 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~------------------------------~~--------  314 (613)
                      +|+. .-|+.++-|.||+|++.++ +.||||+.++.-...                              .+        
T Consensus       127 eF~~-~PiAsASIaQVH~A~L~sG-~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         127 EFEP-EPIASASIAQVHRAVLKSG-EEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             HcCC-CchhhhhHhhheeEEecCC-CEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            3443 3689999999999999875 789999998742110                              01        


Q ss_pred             --HHHHHHHHHhccC-----ccceeeEEEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHH-HHH
Q 048439          315 --EFQTEIGMLSQLR-----HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARG-LHY  386 (613)
Q Consensus       315 --~f~~Ei~~l~~l~-----H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g-L~y  386 (613)
                        ++.+|..-+.+++     .+++.---=|++-.....|+|||++|-.+.+...... ..++-   ..|+..++++ +..
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~---k~ia~~~~~~f~~q  280 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDR---KELAELLVRAFLRQ  280 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCH---HHHHHHHHHHHHHH
Confidence              1345655555553     2333222222233566799999999998888753222 33443   3344444433 333


Q ss_pred             HhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       387 LH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      +-..+    ++|.|..|.||+++.+|.+-+.|||+...
T Consensus       281 ~~~dg----ffHaDpHpGNi~v~~~g~i~~lDfGi~g~  314 (517)
T COG0661         281 LLRDG----FFHADPHPGNILVRSDGRIVLLDFGIVGR  314 (517)
T ss_pred             HHhcC----ccccCCCccceEEecCCcEEEEcCcceec
Confidence            33345    99999999999999999999999999753

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.15  E-value=2e-05  Score=77.76  Aligned_cols=143  Identities=20%  Similarity=0.199  Sum_probs=85.1

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccc--eeeEEEEeec---CCceEEEEEcCC
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH--LVSLIGFCND---DREMILVYDFMA  352 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--iv~l~g~~~~---~~~~~lV~Ey~~  352 (613)
                      +.|+.|..+.||+....++  .+++|.....  .....+..|..++..|....  +.++++++..   ....+++|++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~~--~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDDG--RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETTS--EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECCc--EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4689999999999998773  6999997655  44566788999988886443  4567765433   334689999999


Q ss_pred             CCChhH----------------Hh---hcC--CCCCCCHHHH---------HHH------------HHHHHH-HHHHHhc
Q 048439          353 RGTLPD----------------HL---YHS--DNPPLPWNQR---------LEI------------CIGAAR-GLHYLHT  389 (613)
Q Consensus       353 ~gsL~~----------------~l---~~~--~~~~l~~~~~---------~~i------------~~~ia~-gL~yLH~  389 (613)
                      +..+..                .+   +..  ...++.+...         ...            ...+.. .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                11   111  1111111110         000            111222 2333332


Q ss_pred             C---CCCCcEEeccCCCCceeeC-CCCcEEEEecCCCcc
Q 048439          390 G---ANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKF  424 (613)
Q Consensus       390 ~---~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGls~~  424 (613)
                      .   ..+..++|+|+.+.|||++ +++.+-|+||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            1   2234499999999999999 666668999988753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=98.09  E-value=4.2e-05  Score=90.23  Aligned_cols=149  Identities=17%  Similarity=0.247  Sum_probs=92.7

Q ss_pred             ceeeeeCcEEEEEEEEcCCc--eeEEEEEeCCCC-hhcHHHHHHHHHHHhccC-ccce--eeEEEEeecC---CceEEEE
Q 048439          278 LVIGVGGFGDVYKGFINGST--TPVAIKRLEPES-QQGALEFQTEIGMLSQLR-HLHL--VSLIGFCNDD---REMILVY  348 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~--~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV~  348 (613)
                      ..++.|.++.+|+....+++  ..+++|+..... ......+.+|+++|+.|. |.++  .+++++|.+.   +..++||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            36788999999998776542  357788765432 223456889999999995 6665  7888988764   4678999


Q ss_pred             EcCCCCChhHH-----------------------hhcCCC---------CCCCHH--HHHHHH---------------HH
Q 048439          349 DFMARGTLPDH-----------------------LYHSDN---------PPLPWN--QRLEIC---------------IG  379 (613)
Q Consensus       349 Ey~~~gsL~~~-----------------------l~~~~~---------~~l~~~--~~~~i~---------------~~  379 (613)
                      ||+++..+.+.                       ||....         .+..+.  +...+.               -.
T Consensus       124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~  203 (822)
T PLN02876        124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK  203 (822)
T ss_pred             EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence            99998653221                       111100         011111  111110               11


Q ss_pred             HHHHHHHHhcCCC-------CCcEEeccCCCCceeeCCC--CcEEEEecCCCccCC
Q 048439          380 AARGLHYLHTGAN-------HAVIIHRDVKTTNILLDEK--WVAKVSDFGLSKFGP  426 (613)
Q Consensus       380 ia~gL~yLH~~~~-------~~~iiHrDlk~~NILl~~~--~~~kl~DFGls~~~~  426 (613)
                      +.+.+.+|..+..       ++.++|+|+++.|||++.+  ..+-|.||.++..+.
T Consensus       204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence            2334556643322       1349999999999999853  346799999987543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.04  E-value=2e-05  Score=75.90  Aligned_cols=101  Identities=23%  Similarity=0.278  Sum_probs=81.1

Q ss_pred             HHHHHHHhccCc-cceeeEEEEeecCCceEEEEEcCCCCChhHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 048439          317 QTEIGMLSQLRH-LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYH-SDNPPLPWNQRLEICIGAARGLHYLHTGANHA  394 (613)
Q Consensus       317 ~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  394 (613)
                      ..|.-+|..+++ +++.+++|+|-+    ++|.||...+++...-.. ..-..-+|..|.+||.++++.+++|+..-...
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            468888888876 699999999943    679999998766432000 11234689999999999999999999865444


Q ss_pred             cEEeccCCCCceeeCCCCcEEEEecCCC
Q 048439          395 VIIHRDVKTTNILLDEKWVAKVSDFGLS  422 (613)
Q Consensus       395 ~iiHrDlk~~NILl~~~~~~kl~DFGls  422 (613)
                       +.-.|++++|+-+++++++|+.|....
T Consensus        83 -~~lcDv~~~nfgv~~~~~lk~iDld~v  109 (188)
T PF12260_consen   83 -FYLCDVSPDNFGVNDDGRLKLIDLDDV  109 (188)
T ss_pred             -EEEeecchHHeEEeCCCcEEEEechhc
Confidence             888999999999999999999998765

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.00  E-value=5.1e-05  Score=73.92  Aligned_cols=138  Identities=14%  Similarity=0.130  Sum_probs=90.8

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHH---------HHHHHHHHhccCc---cceeeEEEE
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---------FQTEIGMLSQLRH---LHLVSLIGF  337 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~---------f~~Ei~~l~~l~H---~niv~l~g~  337 (613)
                      ..++|...+++-......|.+-..++  ..+.+|..++......+.         ..+++..+.+++.   ...+.++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~~--~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEIDG--KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEECC--cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            34667776677766666676666554  568999887654332222         2344444444432   222333333


Q ss_pred             ee-----cCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC
Q 048439          338 CN-----DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW  412 (613)
Q Consensus       338 ~~-----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~  412 (613)
                      +.     -....+|||||++|..|.+...      ++.    .++..++.+|.-||..|    +.|+|..|.|+++++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G----~~HGD~hpgNFlv~~~~  172 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG----FYHGDPHPGNFLVSNNG  172 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC----CccCCCCcCcEEEECCc
Confidence            22     2345679999999988876541      222    35566788899999999    99999999999999655


Q ss_pred             cEEEEecCCCcc
Q 048439          413 VAKVSDFGLSKF  424 (613)
Q Consensus       413 ~~kl~DFGls~~  424 (613)
                       ++++||+..+.
T Consensus       173 -i~iID~~~k~~  183 (229)
T PF06176_consen  173 -IRIIDTQGKRM  183 (229)
T ss_pred             -EEEEECccccc
Confidence             89999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.93  E-value=5.2e-05  Score=83.37  Aligned_cols=156  Identities=15%  Similarity=0.178  Sum_probs=97.9

Q ss_pred             cccccCHHHHHHHh------------cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhc-------------
Q 048439          258 LCTQFSLSEIQAAT------------NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQG-------------  312 (613)
Q Consensus       258 ~~~~f~~~el~~at------------~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~-------------  312 (613)
                      .|..|+++|+...-            ..|+. .-||.-+.|.||+|+++++ +.||||+-++.-...             
T Consensus       136 ~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~-~piaaASlaQVhrA~L~~G-~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~  213 (538)
T KOG1235|consen  136 QAPPFPWEEAFKIFEEELGAPIEDIFSEFDE-EPIAAASLAQVHRARLKNG-EDVAVKVQHPGLEKLIMLDLRNLRLLAK  213 (538)
T ss_pred             cCCCCCHHHHHHHHHHHhCCCHHHHHHhcCc-chhhhcchhheEEEEecCC-CEEEEEecCcChHHHHHHHHHHHHHHHH
Confidence            45567777765433            23443 3689999999999999985 779999987642111             


Q ss_pred             ------------------------HHHHHHHHHHHhcc----Cccc------eeeEEEEeecCCceEEEEEcCCCCChhH
Q 048439          313 ------------------------ALEFQTEIGMLSQL----RHLH------LVSLIGFCNDDREMILVYDFMARGTLPD  358 (613)
Q Consensus       313 ------------------------~~~f~~Ei~~l~~l----~H~n------iv~l~g~~~~~~~~~lV~Ey~~~gsL~~  358 (613)
                                              .-+|.+|.+-..+.    +|-+      |.+++-  .-.....|+||||+|..+.|
T Consensus       214 ~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~D  291 (538)
T KOG1235|consen  214 VLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKIND  291 (538)
T ss_pred             HHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCC
Confidence                                    01244555444333    3544      222222  22346799999999998877


Q ss_pred             HhhcCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCcEEeccCCCCceeeCC----CCcEEEEecCCCccC
Q 048439          359 HLYHSDNPPLPWNQRLEICIGAARGL-HYLHTGANHAVIIHRDVKTTNILLDE----KWVAKVSDFGLSKFG  425 (613)
Q Consensus       359 ~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~~iiHrDlk~~NILl~~----~~~~kl~DFGls~~~  425 (613)
                      .-.-. ...++-..   |+..+.++. .-+-..|    ++|+|-.|.||+++.    ++.+.+-|||+....
T Consensus       292 l~~i~-~~gi~~~~---i~~~l~~~~~~qIf~~G----ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  292 LDAID-KRGISPHD---ILNKLVEAYLEQIFKTG----FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             HHHHH-HcCCCHHH---HHHHHHHHHHHHHHhcC----CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            65322 22344443   333333331 1222334    899999999999984    678999999997643

>PLN03150 hypothetical protein; Provisional

Probab=97.89  E-value=3.5e-05  Score=87.91  Aligned_cols=108  Identities=16%  Similarity=0.198  Sum_probs=74.6

Q ss_pred             chHHHHHHhhcCCCcccCCceeeEEEEeeCCCCceeeeeeeeeeeecccCCCceEEEEEEcc---eeecccchhhhhhCC
Q 048439           31 PDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIAN---LTAEVQADVIAWTGA  107 (613)
Q Consensus        31 P~~vy~Tar~~~~~~~~~~~~nltw~~~vd~~~~Y~vrlHFcei~~~~~~~~~r~F~iyi~~---~~~~~~~dv~~~~~~  107 (613)
                      +...|.|||.-......    .-.|.|++.+++.|+||+||....+. .......|||++++   -++..+++.     .
T Consensus        65 ~~~~~~t~R~F~~~~g~----~~cY~~~~~~~g~ylVRl~F~~~~y~-~~~~~~~Fdv~~~~~~~~tv~~~~~~-----~  134 (623)
T PLN03150         65 IAPPLKTLRYFPLSDGP----ENCYNINRVPKGHYSVRVFFGLVAEP-NFDSEPLFDVSVEGTQISSLKSGWSS-----H  134 (623)
T ss_pred             ccchhhccccCCccccc----ccceEeeecCCCcEEEEEEeecCCcC-CCCCCCceEEEECcEEEEEEecCccc-----C
Confidence            34559999985532111    23667889999999999999988642 22346799999999   333322221     1


Q ss_pred             CceeEEEEEEeeccCCCCcccccceEEEEeecCCCCCCcccccccccceEEeecC
Q 048439          108 NGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDN  162 (613)
Q Consensus       108 ~~~p~y~dy~v~~~~~~~~~~~~~~l~v~l~p~~~~~~~~~~~ilnglEi~~~~~  162 (613)
                       ..+++++|++.+   +.+     .+.|-+.|...     ..|++|+|||..+.+
T Consensus       135 -~~~v~~E~i~~~---~~~-----~l~vcf~~~~~-----~~pFIs~iEv~~l~~  175 (623)
T PLN03150        135 -DEQVFAEALVFL---TDG-----SASICFHSTGH-----GDPAILSIEILQVDD  175 (623)
T ss_pred             -CCcEEEEEEEEe---cCC-----cEEEEEecCCC-----CCCceeEEEEEEcCc
Confidence             346889998877   433     48888888643     268999999988765

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.87  E-value=0.00016  Score=71.30  Aligned_cols=154  Identities=18%  Similarity=0.182  Sum_probs=101.1

Q ss_pred             ccCHHHHHHHhcCCCCcceee---eeCcEEEEEEEEcCCceeEEEEEeCCCChhc-------------------HH----
Q 048439          261 QFSLSEIQAATNNFDNDLVIG---VGGFGDVYKGFINGSTTPVAIKRLEPESQQG-------------------AL----  314 (613)
Q Consensus       261 ~f~~~el~~at~~f~~~~~iG---~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~-------------------~~----  314 (613)
                      ..+++.|....++.....+.|   .|--..||+|...++ ..+|||+.+......                   ..    
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~-~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDG-RYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCC-ceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            456777777777776666655   566677999987544 779999987532111                   11    


Q ss_pred             -HHHHHHHHHhccC--ccceeeEEEEeecCCceEEEEEcCCCCCh-hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 048439          315 -EFQTEIGMLSQLR--HLHLVSLIGFCNDDREMILVYDFMARGTL-PDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG  390 (613)
Q Consensus       315 -~f~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~  390 (613)
                       --.+|..-|.++.  +-.+.+-+++.    .-.|||||+...-+ .-.|   ...++...+...+..++++.+.-|-..
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~  185 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKE  185 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHh
Confidence             1245777777763  34444455543    34799999965311 1111   112233335667778888888888774


Q ss_pred             CCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       391 ~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      +.   ++|+||..=|||+. ++.+.|+|||-|....
T Consensus       186 a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         186 AG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence            32   99999999999999 8899999999886443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.85  E-value=2.6e-06  Score=92.73  Aligned_cols=173  Identities=17%  Similarity=0.128  Sum_probs=129.0

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccc-eeeEEEEeecCCceEEEEEcCCCC-Ch
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH-LVSLIGFCNDDREMILVYDFMARG-TL  356 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~~~g-sL  356 (613)
                      -.++|++++++|.+-..+.. ...+.+...     ....-++++|.+++||| .+..++-++.+...+++++++..| +-
T Consensus       249 ~fvK~altknpKkRptaekl-L~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~  322 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKL-LQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS  322 (829)
T ss_pred             HHHHHHhcCCCccCCChhhh-eeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence            46899999999987655533 335554332     34567899999999999 777777788888899999999887 32


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-------CCCC
Q 048439          357 PDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-------PTSV  429 (613)
Q Consensus       357 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-------~~~~  429 (613)
                      .... ....-.+...+...+++.-+++|+|||+..    =+|||    |||..+ ...|..||+.....       ...+
T Consensus       323 ~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~~~----~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~  392 (829)
T KOG0576|consen  323 ALEM-TVSEIALEQYQFAYPLRKETRPLAELHSSY----KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIG  392 (829)
T ss_pred             cccC-ChhhHhhhhhhhhhhhhhhccccccccccc----ccCcc----cccccc-cccccccccCCcccCcccccccCCC
Confidence            2211 111223555667788888999999999864    38999    887775 67899999976432       2345


Q ss_pred             CcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCc
Q 048439          430 SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSI  467 (613)
Q Consensus       430 ~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~  467 (613)
                      +..+++||+...+.+..+.|+|+.|+-.-++--|-+|-
T Consensus       393 ~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  393 TPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             CCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            66789999999999999999999998777777666654

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.81  E-value=0.00029  Score=68.21  Aligned_cols=129  Identities=22%  Similarity=0.281  Sum_probs=90.5

Q ss_pred             CcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC----------------hhcHHHHHHHHHHHhccC------ccceee
Q 048439          276 NDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES----------------QQGALEFQTEIGMLSQLR------HLHLVS  333 (613)
Q Consensus       276 ~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~----------------~~~~~~f~~Ei~~l~~l~------H~niv~  333 (613)
                      ....||+|+.-.||.-  ..+ ....||+..+..                .....++.+|+.....+.      +.+|.+
T Consensus         5 ~~~~i~~G~~R~cy~H--P~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQH--PDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCcccccCCCceEEEC--CCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            3458999999999964  333 347899887765                223456677776666655      899999


Q ss_pred             EEEEeecCCceEEEEEcCCC------CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCcee
Q 048439          334 LIGFCNDDREMILVYDFMAR------GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNIL  407 (613)
Q Consensus       334 l~g~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NIL  407 (613)
                      ++|+.+++...-+|+|.+.+      -+|.+++..   ..++. ...+.+.   +-..||-+..    |+.+||+|.||+
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~~L~---~f~~~l~~~~----Iv~~dl~~~NIv  150 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQALD---EFKRYLLDHH----IVIRDLNPHNIV  150 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHHHHH---HHHHHHHHcC----CeecCCCcccEE
Confidence            99999999999999998743      257777732   33554 3333333   3445666655    999999999999


Q ss_pred             eCCC---C-cEEEEe
Q 048439          408 LDEK---W-VAKVSD  418 (613)
Q Consensus       408 l~~~---~-~~kl~D  418 (613)
                      +...   . .+.|+|
T Consensus       151 ~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  151 VQRRDSGEFRLVLID  165 (199)
T ss_pred             EEecCCCceEEEEEe
Confidence            9532   2 577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.80  E-value=0.00018  Score=71.80  Aligned_cols=140  Identities=21%  Similarity=0.259  Sum_probs=77.0

Q ss_pred             eeeeeCcE-EEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCcc---ceeeEEEEeecC---CceEEEEEcC
Q 048439          279 VIGVGGFG-DVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL---HLVSLIGFCNDD---REMILVYDFM  351 (613)
Q Consensus       279 ~iG~G~fG-~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~---niv~l~g~~~~~---~~~~lV~Ey~  351 (613)
                      .|+.||.. .||+.   +  ..+++|.....  .....+.+|.++|..|...   .+.++++.+...   ...++|||++
T Consensus         4 ~~~~gG~~n~vy~~---~--~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           4 PVDSGGTDNATFRL---G--DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eccCCCcccceEEc---C--CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            56777766 48975   1  23677765432  2344788999999887532   334445544332   2347899999


Q ss_pred             CCCChhHH------------------hhcCCCC--CC-------------CHHHHH--HHH-------HHHHHHH-H-HH
Q 048439          352 ARGTLPDH------------------LYHSDNP--PL-------------PWNQRL--EIC-------IGAARGL-H-YL  387 (613)
Q Consensus       352 ~~gsL~~~------------------l~~~~~~--~l-------------~~~~~~--~i~-------~~ia~gL-~-yL  387 (613)
                      +|.++.+.                  |+.-...  +.             .|....  .+.       .+.+..+ . ++
T Consensus        77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  156 (235)
T cd05155          77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL  156 (235)
T ss_pred             cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence            98776422                  1110000  00             111110  000       0111111 1 11


Q ss_pred             hcC-CCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          388 HTG-ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       388 H~~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +.. ..+..++|+|+.+.|||++++...-|+||+.+..+
T Consensus       157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g  195 (235)
T cd05155         157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG  195 (235)
T ss_pred             cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence            111 12344899999999999997766779999987543

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.77  E-value=0.00047  Score=71.42  Aligned_cols=75  Identities=12%  Similarity=0.048  Sum_probs=55.7

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCc---cceeeEEEEeec---CCceEEEEEcC
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRH---LHLVSLIGFCND---DREMILVYDFM  351 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H---~niv~l~g~~~~---~~~~~lV~Ey~  351 (613)
                      .-||.|..+.||+....++  .+.+|..+...  ....|..|.+.|+.|.-   ..+.+++++|..   .+..+||||++
T Consensus        20 ~~i~~G~~~~vy~~~~~~~--~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         20 ECISEQPYAALWALYDSQG--NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eecCCccceeEEEEEcCCC--CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            3699999999999866544  36777743311  23478899999998853   467888988864   36689999999


Q ss_pred             CCCCh
Q 048439          352 ARGTL  356 (613)
Q Consensus       352 ~~gsL  356 (613)
                      +++++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98765

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.65  E-value=0.0005  Score=66.30  Aligned_cols=125  Identities=28%  Similarity=0.317  Sum_probs=89.4

Q ss_pred             cCCCCcceeeeeCc-EEEEEEEEcCCceeEEEEEeCC---CCh------------------hcHHHHHHHHHHHhccC--
Q 048439          272 NNFDNDLVIGVGGF-GDVYKGFINGSTTPVAIKRLEP---ESQ------------------QGALEFQTEIGMLSQLR--  327 (613)
Q Consensus       272 ~~f~~~~~iG~G~f-G~Vy~g~~~~~~~~vAVK~~~~---~~~------------------~~~~~f~~Ei~~l~~l~--  327 (613)
                      .+++..+.||.|.- |.|||+++.+  ..+|+|.+..   ...                  .-..-|..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g--~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDG--RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECC--eEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            67777889999999 9999999976  5799999321   100                  11224888999888885  


Q ss_pred             -ccce--eeEEEEeecC------------------CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 048439          328 -HLHL--VSLIGFCNDD------------------REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY  386 (613)
Q Consensus       328 -H~ni--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y  386 (613)
                       +.++  |+++||..-.                  ....+|.||.+...           .+.    .+-+.++.+-|..
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHH
Confidence             4466  9999996211                  12356777776533           122    2334567788889


Q ss_pred             HhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCC
Q 048439          387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS  422 (613)
Q Consensus       387 LH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls  422 (613)
                      +|..+    |+-+|+|+.|..     .-||+|||.+
T Consensus       180 ~~k~g----I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG----IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC----eeeccCcccccc-----CCEEEecccC
Confidence            99998    999999999986     3489999864

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.63  E-value=0.00084  Score=71.92  Aligned_cols=75  Identities=15%  Similarity=0.080  Sum_probs=53.9

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCC------C-hhcHHHHHHHHHHHhccC---ccceeeEEEEeecCCceEEEE
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE------S-QQGALEFQTEIGMLSQLR---HLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~------~-~~~~~~f~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~  348 (613)
                      .||.|.+..||+....++++.|+||.-.+.      + ......+..|.+.|..+.   ..++.+++.+.  .+..++||
T Consensus        33 elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lVM  110 (401)
T PRK09550         33 EIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTVM  110 (401)
T ss_pred             EcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEEE
Confidence            689999999999998766457999985432      1 223456777888888763   34567777773  35578999


Q ss_pred             EcCCCCC
Q 048439          349 DFMARGT  355 (613)
Q Consensus       349 Ey~~~gs  355 (613)
                      ||+++..
T Consensus       111 E~L~~~~  117 (401)
T PRK09550        111 EDLSDHK  117 (401)
T ss_pred             ecCCCcc
Confidence            9998744

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.61  E-value=0.00019  Score=83.46  Aligned_cols=191  Identities=17%  Similarity=0.195  Sum_probs=128.2

Q ss_pred             HHHHHHHHHhccCccceeeEEEEeecCCce----EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 048439          315 EFQTEIGMLSQLRHLHLVSLIGFCNDDREM----ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG  390 (613)
Q Consensus       315 ~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~----~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~  390 (613)
                      ....|...+.++.|+|++.+++|-.++...    .+..|++..-++..++..  -..++..+.+.++.++.+||.|+|+.
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS--VGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh--ccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            345677788899999999999997664332    345688888888888854  35577888889999999999999997


Q ss_pred             CCCCcEEeccCCCC---ceeeCCCCcEEEE--ecCCCccCCCCC-------CcccCChhhhhcCCCCc--hhHHHHHHHH
Q 048439          391 ANHAVIIHRDVKTT---NILLDEKWVAKVS--DFGLSKFGPTSV-------SKTHLDPEYYRLQQLTE--KSDVYSFGVV  456 (613)
Q Consensus       391 ~~~~~iiHrDlk~~---NILl~~~~~~kl~--DFGls~~~~~~~-------~~~~~aPE~~~~~~~t~--ksDV~SfGvv  456 (613)
                      .    ..|.-+..+   +...+..+...++  ||+.++..+...       ...+.++|.........  +.|+|.+|..
T Consensus       306 ~----l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  306 S----LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             c----cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence            5    566666555   5556677777777  888776433211       23456666665555444  4799999999


Q ss_pred             HHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHHHhcccccCCCCCCCHHHHHHHHH
Q 048439          457 LFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       457 L~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      +..+..|..+........         ............|.   ..+|+..++++|++..+++.+..
T Consensus       382 ~~~~~~~~~i~~~~~~~~---------~~l~~~~~~~~~d~---~~~~~~~~~~~Rl~~~~ll~~~f  436 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKSAVPV---------SLLDVLSTSELLDA---LPKCLDEDSEERLSALELLTHPF  436 (1351)
T ss_pred             HhhhhhcCcccccccchh---------hhhccccchhhhhh---hhhhcchhhhhccchhhhhhchh
Confidence            999998876542211000         00000000112222   22699999999999999987654

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.60  E-value=0.00039  Score=70.31  Aligned_cols=139  Identities=16%  Similarity=0.160  Sum_probs=79.4

Q ss_pred             eeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCcccee-eEEEEeecCCceEEEEEcCCCCChhH
Q 048439          280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV-SLIGFCNDDREMILVYDFMARGTLPD  358 (613)
Q Consensus       280 iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gsL~~  358 (613)
                      +..|-.+.+|+....  +..+++|........-.....+|.++++.+....++ ++++.+.    -.+||||++|..+..
T Consensus         4 ~~~G~tn~~y~~~~~--~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         4 LSGGLTNRSWRIEHP--GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             CCCcCcCCeEEEEeC--CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            455777889988743  356888876543322212457899999988654443 4455442    368999999876542


Q ss_pred             H-----------------hhcCC--CCCCCHHHHH-HHHHH---------HHHHHHHHhcC----CCCCcEEeccCCCCc
Q 048439          359 H-----------------LYHSD--NPPLPWNQRL-EICIG---------AARGLHYLHTG----ANHAVIIHRDVKTTN  405 (613)
Q Consensus       359 ~-----------------l~~~~--~~~l~~~~~~-~i~~~---------ia~gL~yLH~~----~~~~~iiHrDlk~~N  405 (613)
                      .                 ||...  ..+++...++ ....+         +.+-+..+-..    ..+..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11111  1122222111 11101         11112222111    113348999999999


Q ss_pred             eeeCCCCcEEEEecCCCccC
Q 048439          406 ILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       406 ILl~~~~~~kl~DFGls~~~  425 (613)
                      |++++++ +.|+||..+..+
T Consensus       158 il~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             EEEeCCC-CEEEeccccCcC
Confidence            9999877 789999987643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.60  E-value=0.00068  Score=67.42  Aligned_cols=142  Identities=18%  Similarity=0.198  Sum_probs=81.6

Q ss_pred             eeeeeCcEEEEEEEEcC-CceeEEEEEeCCCChhcHHHHHHHHHHHhccCccce-eeEEEEeecCCceEEEEEcCCCCCh
Q 048439          279 VIGVGGFGDVYKGFING-STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL-VSLIGFCNDDREMILVYDFMARGTL  356 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~-~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL  356 (613)
                      .|..|-...+|+....+ .+..+++|........ .....+|+.++..+...++ .++++.+. .   .+||||+++.++
T Consensus         5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~l   79 (235)
T cd05157           5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRTL   79 (235)
T ss_pred             EcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCcC
Confidence            56677788999987653 2356888876544222 2233578888888854444 34554433 2   379999998776


Q ss_pred             hHH-------h----------hcCC-C--------CCC-CHHHHHHHHH----------------------HHH---HHH
Q 048439          357 PDH-------L----------YHSD-N--------PPL-PWNQRLEICI----------------------GAA---RGL  384 (613)
Q Consensus       357 ~~~-------l----------~~~~-~--------~~l-~~~~~~~i~~----------------------~ia---~gL  384 (613)
                      ...       +          +... .        ... -|..+..+..                      .+.   ..|
T Consensus        80 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l  159 (235)
T cd05157          80 EPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWL  159 (235)
T ss_pred             CHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHH
Confidence            321       0          1111 0        011 1222111111                      111   111


Q ss_pred             -HHHhcCCCCCcEEeccCCCCceeeCC-CCcEEEEecCCCccC
Q 048439          385 -HYLHTGANHAVIIHRDVKTTNILLDE-KWVAKVSDFGLSKFG  425 (613)
Q Consensus       385 -~yLH~~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGls~~~  425 (613)
                       ..+-....+..++|+|+.+.|||+++ +..+.|+||..|..+
T Consensus       160 ~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~  202 (235)
T cd05157         160 KELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN  202 (235)
T ss_pred             HHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence             11222223345999999999999998 578999999887643

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.48  E-value=0.00065  Score=70.15  Aligned_cols=142  Identities=19%  Similarity=0.109  Sum_probs=85.5

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccc--eeeEEEEe------ecCCceEEEEE
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH--LVSLIGFC------NDDREMILVYD  349 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~E  349 (613)
                      ..|..|....+|+....++  .+++|+....   .......|++++..|++.+  +.+++...      ...+..++|++
T Consensus        20 ~~i~~G~~n~~y~v~~~~~--~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          20 EGISAGIENTNYFVTTDSG--RYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             ecccCccccceEEEEeCCC--cEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            3566777789999876543  5888987652   2345667888888875433  44544421      22345689999


Q ss_pred             cCCCCChhH----Hh----------hcC--C-------CCCCCHHHHHH----------HHHHHHHHHHHHhcC---CCC
Q 048439          350 FMARGTLPD----HL----------YHS--D-------NPPLPWNQRLE----------ICIGAARGLHYLHTG---ANH  393 (613)
Q Consensus       350 y~~~gsL~~----~l----------~~~--~-------~~~l~~~~~~~----------i~~~ia~gL~yLH~~---~~~  393 (613)
                      |++|..+..    .+          +..  .       .....|.....          ....+...+.++...   ..+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876532    11          110  0       01123332211          112233445555431   122


Q ss_pred             CcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       394 ~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ..++|+|+.|.|||++++..+.|.||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            3389999999999999988789999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.28  E-value=0.0024  Score=66.19  Aligned_cols=141  Identities=21%  Similarity=0.257  Sum_probs=83.6

Q ss_pred             eeeeeCcEEEEEEEEcCC------ceeEEEEEeCCCChhcHHHHHHHHHHHhccCcccee-eEEEEeecCCceEEEEEcC
Q 048439          279 VIGVGGFGDVYKGFINGS------TTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV-SLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~------~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~  351 (613)
                      .|..|--..+|+....++      +..+++|+..... .......+|.+++..+....+. ++++++..    .+|+||+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            455566678998876542      3568899876543 2234557888888888644443 55666542    3589999


Q ss_pred             CCCChhHHh-----------------hcCCCC---------CCCHHHHHH--------------------------HHHH
Q 048439          352 ARGTLPDHL-----------------YHSDNP---------PLPWNQRLE--------------------------ICIG  379 (613)
Q Consensus       352 ~~gsL~~~l-----------------~~~~~~---------~l~~~~~~~--------------------------i~~~  379 (613)
                      +|..+....                 |.....         +.-|.....                          +...
T Consensus        80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (302)
T cd05156          80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED  159 (302)
T ss_pred             CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence            987764311                 111100         011111111                          1112


Q ss_pred             HHHHHHHHhc-----CCCCCcEEeccCCCCceeeCCC----CcEEEEecCCCcc
Q 048439          380 AARGLHYLHT-----GANHAVIIHRDVKTTNILLDEK----WVAKVSDFGLSKF  424 (613)
Q Consensus       380 ia~gL~yLH~-----~~~~~~iiHrDlk~~NILl~~~----~~~kl~DFGls~~  424 (613)
                      +..-+..|-.     ...+..++|+|+.+.|||++++    +.++++||..|..
T Consensus       160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            2233344432     1234458999999999999985    8899999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan []

Probab=97.21  E-value=0.001  Score=70.44  Aligned_cols=113  Identities=17%  Similarity=0.266  Sum_probs=76.2

Q ss_pred             CCchHHHHHHhhcCCCcccCCceeeEEEEeeC--CCCceeeeeeeeeeeeccc--C--CCceEEEEEEcceeecccchhh
Q 048439           29 SAPDLVYETARTMGQDREINEKYNLTWEFEVD--SGFTYFLRLHFCEFQIEVT--E--DGDRVFQIFIANLTAEVQADVI  102 (613)
Q Consensus        29 ~aP~~vy~Tar~~~~~~~~~~~~nltw~~~vd--~~~~Y~vrlHFcei~~~~~--~--~~~r~F~iyi~~~~~~~~~dv~  102 (613)
                      ..+...|.|||..-...      .-.|.|++.  .|..|+|||||-=..+...  +  ...-.|+++++...- ..+++.
T Consensus        45 ~~~~~~y~taR~F~~g~------r~cY~l~~~~~~~~~yliRl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~-~tV~~~  117 (347)
T PF12819_consen   45 SDSSPPYQTARIFPEGS------RNCYTLPVTPPGGGKYLIRLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFW-STVNLS  117 (347)
T ss_pred             CccccccceEEEcCCCC------ccEEEeeccCCCCceEEEEEEeccccccccccccccCCcceEEEECCcee-EEEEec
Confidence            45678999999854211      246788888  5679999999987653211  1  123469999887653 222222


Q ss_pred             hhhCCCceeEEEEEEeeccCCCCcccccceEEEEeecCCCCCCcccccccccceEEeecC
Q 048439          103 AWTGANGVTVYRDYAVMIGSKPNEENIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDN  162 (613)
Q Consensus       103 ~~~~~~~~p~y~dy~v~~~~~~~~~~~~~~l~v~l~p~~~~~~~~~~~ilnglEi~~~~~  162 (613)
                      .   ....+++++|++.+   +..    ..|.|-|.|.....    -|++||||+..+.+
T Consensus       118 ~---~~~~~~~~E~ii~v---~~~----~~l~vclv~~~~g~----~pFIsaiEl~~lp~  163 (347)
T PF12819_consen  118 N---SPSSPVVKEFIINV---TWS----DTLSVCLVPTGSGT----FPFISAIELRPLPD  163 (347)
T ss_pred             C---CCcceEEEEEEEEE---cCC----CcEEEEEEeCCCCC----CCceeEEEEEECCc
Confidence            2   12368999999998   321    36899999987521    28999999998744

This entry represents a malectin-like domain found in a number of plant receptor kinases.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.10  E-value=0.0039  Score=58.52  Aligned_cols=126  Identities=16%  Similarity=0.143  Sum_probs=85.0

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceee-EEEEeecCCceEEEEEcCCCCCh
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS-LIGFCNDDREMILVYDFMARGTL  356 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~-l~g~~~~~~~~~lV~Ey~~~gsL  356 (613)
                      ..||+|.+|.||+|.+.+.  .+|+|.-+.++.  ...+..|+++|..+.--++.+ ++.|-.    -.+.|||..|-.|
T Consensus        28 ~~L~KG~~s~Vyl~~~~~~--~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L   99 (201)
T COG2112          28 KELAKGTTSVVYLGEWRGG--EVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhcccccEEEEeeccCc--eEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcch
Confidence            4799999999999999874  589998766543  456889999999998776653 444432    2355999999888


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCC-CCceeeCCCCcEEEEecCCCcc
Q 048439          357 PDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVK-TTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       357 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk-~~NILl~~~~~~kl~DFGls~~  424 (613)
                      .+.-...     +-.+.    ..++..-.-|-..+    |-|+.|. |...+|-.+..+-|+||.-|+.
T Consensus       100 ~~~~~~~-----~rk~l----~~vlE~a~~LD~~G----I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         100 GKLEIGG-----DRKHL----LRVLEKAYKLDRLG----IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhcc-----cHHHH----HHHHHHHHHHHHhc----cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            7654211     22233    33444433344444    7777775 4444444455999999998864

>PRK05231 homoserine kinase; Provisional

Probab=96.96  E-value=0.021  Score=59.62  Aligned_cols=159  Identities=16%  Similarity=0.114  Sum_probs=85.3

Q ss_pred             ccCHHHHHHHhcCCCC-----cceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccc--eee
Q 048439          261 QFSLSEIQAATNNFDN-----DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH--LVS  333 (613)
Q Consensus       261 ~f~~~el~~at~~f~~-----~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--iv~  333 (613)
                      ..+.+++......|..     .+.|+.|....+|+....++  .+++|+.....   ......|+.++..|...+  +.+
T Consensus         6 ~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g--~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~   80 (319)
T PRK05231          6 DVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG--EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPA   80 (319)
T ss_pred             cCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC--cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCc
Confidence            3556666665566654     23456677778999876554  48899876222   223334555555553222  233


Q ss_pred             EEEE------eecCCceEEEEEcCCCCChh-----------HHh---hcCC---------CCCCCH-HHHHHHH------
Q 048439          334 LIGF------CNDDREMILVYDFMARGTLP-----------DHL---YHSD---------NPPLPW-NQRLEIC------  377 (613)
Q Consensus       334 l~g~------~~~~~~~~lV~Ey~~~gsL~-----------~~l---~~~~---------~~~l~~-~~~~~i~------  377 (613)
                      .+..      ....+..++++||++|..+.           +.|   +...         ...+.| ...+.-.      
T Consensus        81 ~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (319)
T PRK05231         81 PVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLAD  160 (319)
T ss_pred             ceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccCh
Confidence            3321      12245678999999987541           111   1100         011222 2211111      


Q ss_pred             -------HHHHHHHHHHhcC---CCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          378 -------IGAARGLHYLHTG---ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       378 -------~~ia~gL~yLH~~---~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                             ..+...+..+...   .-+..++|+|+.+.|||++++...-|+||+.+..
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        161 EQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             hHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence                   1111122333211   0123399999999999999776668999998764

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.89  E-value=0.015  Score=60.48  Aligned_cols=159  Identities=17%  Similarity=0.131  Sum_probs=89.5

Q ss_pred             cCHHHHHHHhcCCCCc-----ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccc--eeeE
Q 048439          262 FSLSEIQAATNNFDND-----LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH--LVSL  334 (613)
Q Consensus       262 f~~~el~~at~~f~~~-----~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--iv~l  334 (613)
                      .+.++|......|...     ..++.|--..+|+....++  .+++|+.+...  ...+...|++++..|....  +.++
T Consensus         7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~--~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~   82 (307)
T TIGR00938         7 VSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG--RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKP   82 (307)
T ss_pred             CCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC--cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            3445565555556443     3456666688998875443  47888875532  1234456677777774322  3444


Q ss_pred             EEEe------ecCCceEEEEEcCCCCChhH----H----------hhcC-CC--C-------CCCHHHHHH---------
Q 048439          335 IGFC------NDDREMILVYDFMARGTLPD----H----------LYHS-DN--P-------PLPWNQRLE---------  375 (613)
Q Consensus       335 ~g~~------~~~~~~~lV~Ey~~~gsL~~----~----------l~~~-~~--~-------~l~~~~~~~---------  375 (613)
                      +...      ...+..++|+||++|..+..    .          ++.. ..  .       .-.|.....         
T Consensus        83 i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l  162 (307)
T TIGR00938        83 VKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQL  162 (307)
T ss_pred             ccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhccccc
Confidence            4422      12456789999998855321    0          1110 00  0       011221111         


Q ss_pred             ---HHHHHHHHHHHHhcC---CCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          376 ---ICIGAARGLHYLHTG---ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       376 ---i~~~ia~gL~yLH~~---~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                         ....+.+.+.+|...   ..+..++|+|+.+.||++++++...|+||+.+..
T Consensus       163 ~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       163 EAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             CHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence               111233455555421   1123399999999999999988778999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02236 choline kinase

Probab=96.67  E-value=0.021  Score=60.53  Aligned_cols=140  Identities=16%  Similarity=0.189  Sum_probs=81.4

Q ss_pred             eeeeCcEEEEEEEEcC----CceeEEEEEeCCCChhcHHHHHHHHHHHhccCcccee-eEEEEeecCCceEEEEEcCCCC
Q 048439          280 IGVGGFGDVYKGFING----STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV-SLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       280 iG~G~fG~Vy~g~~~~----~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      |-.|--..+|+....+    ....|++|+........ -...+|..++..+...++. ++++.+...    .|+||+++.
T Consensus        44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~  118 (344)
T PLN02236         44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR  118 (344)
T ss_pred             cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence            3345567788876532    22568888876654332 2347799999888655554 566665332    589999877


Q ss_pred             ChhHH-----------------hhcCC----CCCCCHHHHHHHHHHH-----------------HHHHHH----HhcCCC
Q 048439          355 TLPDH-----------------LYHSD----NPPLPWNQRLEICIGA-----------------ARGLHY----LHTGAN  392 (613)
Q Consensus       355 sL~~~-----------------l~~~~----~~~l~~~~~~~i~~~i-----------------a~gL~y----LH~~~~  392 (613)
                      +|...                 +|...    .....|.+..++..++                 ...+..    +.....
T Consensus       119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~  198 (344)
T PLN02236        119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ  198 (344)
T ss_pred             CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence            76421                 11111    0112233332322111                 111222    222233


Q ss_pred             CCcEEeccCCCCceeeCC-CCcEEEEecCCCcc
Q 048439          393 HAVIIHRDVKTTNILLDE-KWVAKVSDFGLSKF  424 (613)
Q Consensus       393 ~~~iiHrDlk~~NILl~~-~~~~kl~DFGls~~  424 (613)
                      +..++|+|+++.|||+++ ++.+.++||..+..
T Consensus       199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            345899999999999986 47899999988754

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.64  E-value=0.024  Score=58.86  Aligned_cols=124  Identities=17%  Similarity=0.280  Sum_probs=77.0

Q ss_pred             ceeEEEEEeCC--CChhcHHHHHHHHHHHhccCc--cceeeEEEEeecCC--ceEEEEEcCCCCChhHHhhcCCCCCCCH
Q 048439          297 TTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRH--LHLVSLIGFCNDDR--EMILVYDFMARGTLPDHLYHSDNPPLPW  370 (613)
Q Consensus       297 ~~~vAVK~~~~--~~~~~~~~f~~Ei~~l~~l~H--~niv~l~g~~~~~~--~~~lV~Ey~~~gsL~~~l~~~~~~~l~~  370 (613)
                      ++.+++. ...  ..........+|.++|+.+.-  --+...+++|.++.  ..+.||+|+++..+.+.+...     +-
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~-----~~  121 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPE-----SL  121 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcc-----cc
Confidence            3557777 221  122234455678888877642  33456688887766  679999999985444333110     00


Q ss_pred             HHHHHHH-HHHHHHHHHHhc--------------------------------------------------CC----CCCc
Q 048439          371 NQRLEIC-IGAARGLHYLHT--------------------------------------------------GA----NHAV  395 (613)
Q Consensus       371 ~~~~~i~-~~ia~gL~yLH~--------------------------------------------------~~----~~~~  395 (613)
                      .  ..++ ..+++.|.-||+                                                  ..    .+++
T Consensus       122 ~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~  199 (321)
T COG3173         122 G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPV  199 (321)
T ss_pred             h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCce
Confidence            0  0111 244444444443                                                  21    1345


Q ss_pred             EEeccCCCCceeeCCCCcEEEEecCCCccCCCC
Q 048439          396 IIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS  428 (613)
Q Consensus       396 iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~  428 (613)
                      ++|+|+.+.|++++.+.-+=|.||+++..+.+.
T Consensus       200 lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~  232 (321)
T COG3173         200 LVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL  232 (321)
T ss_pred             eeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence            999999999999999888999999999876543

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.62  E-value=0.023  Score=58.15  Aligned_cols=32  Identities=31%  Similarity=0.533  Sum_probs=26.4

Q ss_pred             CcEEeccCCCCceeeCCCCc-EEEEecCCCccC
Q 048439          394 AVIIHRDVKTTNILLDEKWV-AKVSDFGLSKFG  425 (613)
Q Consensus       394 ~~iiHrDlk~~NILl~~~~~-~kl~DFGls~~~  425 (613)
                      +.++|+|+.+.|||+++++. .-|.||+.+..+
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            44899999999999997554 569999988654

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.47  E-value=0.011  Score=60.69  Aligned_cols=138  Identities=19%  Similarity=0.247  Sum_probs=72.3

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC---ccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR---HLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      ..|+.|....+|+..  .++..+.||.-.   ......|..|.+-|+.|.   --.+.+.+++....+.-+||+||++.+
T Consensus        23 ~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            368888899999876  444679999865   233456888998888884   445678888887777779999999876


Q ss_pred             C--------hhH---Hhhc-CCCC-------------------CCCHHH-----HHHHHH--------------HHHHHH
Q 048439          355 T--------LPD---HLYH-SDNP-------------------PLPWNQ-----RLEICI--------------GAARGL  384 (613)
Q Consensus       355 s--------L~~---~l~~-~~~~-------------------~l~~~~-----~~~i~~--------------~ia~gL  384 (613)
                      .        |..   .||. ....                   .=+|..     |+.-..              .+...+
T Consensus        98 ~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~~  177 (288)
T PF03881_consen   98 SPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVERL  177 (288)
T ss_dssp             ---CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHHH
Confidence            1        111   1222 1110                   123332     111111              112211


Q ss_pred             -HHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecC
Q 048439          385 -HYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG  420 (613)
Q Consensus       385 -~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG  420 (613)
                       ..|+....++.++|+||-+.|++.+.+|.+.|.|=.
T Consensus       178 ~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa  214 (288)
T PF03881_consen  178 PSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA  214 (288)
T ss_dssp             HHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred             HHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence             223433445669999999999999999989998843

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.36  E-value=0.038  Score=58.29  Aligned_cols=80  Identities=15%  Similarity=0.143  Sum_probs=49.6

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCC------C-hhcHHHHHHHHHHHhccC--cc-ceeeEEEEeecCCceEEEE
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE------S-QQGALEFQTEIGMLSQLR--HL-HLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~------~-~~~~~~f~~Ei~~l~~l~--H~-niv~l~g~~~~~~~~~lV~  348 (613)
                      .||.|...-||++...+++..|+||.-.+.      + +-......-|.+.|....  -| .+.+++.|  ++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            579999999999998655457999975321      1 223334455666665542  34 34445544  344567999


Q ss_pred             EcCCC-CChhHHh
Q 048439          349 DFMAR-GTLPDHL  360 (613)
Q Consensus       349 Ey~~~-gsL~~~l  360 (613)
                      |+++. ..|++.|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            99964 3344544

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.27  E-value=0.0017  Score=77.52  Aligned_cols=151  Identities=13%  Similarity=0.044  Sum_probs=106.4

Q ss_pred             HHHHHHHhccCccceeeEEEEee--cCCceEEEEEcCCCCChhHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcC--
Q 048439          317 QTEIGMLSQLRHLHLVSLIGFCN--DDREMILVYDFMARGTLPDHLYHS--DNPPLPWNQRLEICIGAARGLHYLHTG--  390 (613)
Q Consensus       317 ~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~--  390 (613)
                      ..|...++...|+++.....-..  +..+.+.+++|+..|.+.+.|.+.  +.+.++..-....-.+...+..-+|+.  
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            34444555668888876655443  345678999999999999998653  233344333333333334444454432  


Q ss_pred             CCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh
Q 048439          391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC  462 (613)
Q Consensus       391 ~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt  462 (613)
                      .+.. -+|++||+.|.+|..+.++|+.++||.+..        ...+++.|+.|+....-+++.++|+|..|+-+|+..-
T Consensus      1357 lg~T-~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNT-NVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             CCcc-chhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence            2334 689999999999999999999999999832        2233445778888888889999999999999999887


Q ss_pred             CCCCcc
Q 048439          463 ARPSIL  468 (613)
Q Consensus       463 g~~p~~  468 (613)
                      |.+++.
T Consensus      1436 ~n~~fi 1441 (2724)
T KOG1826|consen 1436 GNAYFI 1441 (2724)
T ss_pred             ccHHHH
Confidence            776653

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.26  E-value=0.064  Score=57.59  Aligned_cols=78  Identities=17%  Similarity=0.135  Sum_probs=50.6

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCC----Ch---hcHHHHHHHHHHHhccC---ccceeeEEEEeecCCceEEEE
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE----SQ---QGALEFQTEIGMLSQLR---HLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~----~~---~~~~~f~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~  348 (613)
                      .||.|....||+....+  ..++||+-.+.    +.   .....-..|.+.|..+.   ..++.+++++|.+  ..+++|
T Consensus        39 eiggGn~N~VyrV~~~~--~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM  114 (418)
T PLN02756         39 EVGDGNLNFVYIVVSSS--GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM  114 (418)
T ss_pred             EcCCCceeeEEEEEcCC--ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence            68999999999987643  45999986522    11   12223334456665543   3578889999884  457889


Q ss_pred             EcCCC--CChhHHh
Q 048439          349 DFMAR--GTLPDHL  360 (613)
Q Consensus       349 Ey~~~--gsL~~~l  360 (613)
                      ||+++  ..+++.+
T Consensus       115 E~L~~~~~ilr~~L  128 (418)
T PLN02756        115 RYLEPPHIILRKGL  128 (418)
T ss_pred             eecCCcceehhhhh
Confidence            99976  3454444

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.76  E-value=0.052  Score=57.95  Aligned_cols=80  Identities=16%  Similarity=0.143  Sum_probs=49.9

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCC------ChhcHHHHHHHHHHHhccC--cc-ceeeEEEEeecCCceEEEEE
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE------SQQGALEFQTEIGMLSQLR--HL-HLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~------~~~~~~~f~~Ei~~l~~l~--H~-niv~l~g~~~~~~~~~lV~E  349 (613)
                      .||.|.-.-||++....++..|+||.-.+.      -+-......-|.+.|+.+.  -| ++.+++.+  ++....+|||
T Consensus        36 eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vME  113 (409)
T PRK12396         36 EIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVME  113 (409)
T ss_pred             EcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHHH
Confidence            689999999999998533356999964321      1233445556666666553  34 34455554  3445678999


Q ss_pred             cCCC-CChhHHh
Q 048439          350 FMAR-GTLPDHL  360 (613)
Q Consensus       350 y~~~-gsL~~~l  360 (613)
                      +++. ..|++.|
T Consensus       114 dL~~~~ilR~~L  125 (409)
T PRK12396        114 DLSDHTILRTAL  125 (409)
T ss_pred             hCcccHHHHHHH
Confidence            9854 3344444

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.58  E-value=0.049  Score=56.84  Aligned_cols=99  Identities=16%  Similarity=0.138  Sum_probs=69.9

Q ss_pred             CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCC
Q 048439          342 REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL  421 (613)
Q Consensus       342 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl  421 (613)
                      ...+++|++. ++.|.      ....-.|.+.+.|+.+.++-|+-|..+-.   .-|||+.-.||||+ +|++-|+||-+
T Consensus       299 ~y~yl~~kdh-gt~is------~ik~~~~~e~lsff~s~~sil~~lekkf~---fehrnlt~~niLId-~GnvtLIDfkl  367 (488)
T COG5072         299 LYLYLHFKDH-GTPIS------IIKADRSEEELSFFWSCISILDILEKKFP---FEHRNLTLDNILID-EGNVTLIDFKL  367 (488)
T ss_pred             eEEEEEEecC-Cceee------eeecccHHHHHHHHHHHHHHHhhhhhcCC---cccccccccceeee-cCceEEEEeee
Confidence            3446666654 33442      12335789999999999998888876542   78999999999999 99999999999


Q ss_pred             CccCCCCCCccc---CChhhhhcCCCCchhHHHH
Q 048439          422 SKFGPTSVSKTH---LDPEYYRLQQLTEKSDVYS  452 (613)
Q Consensus       422 s~~~~~~~~~~~---~aPE~~~~~~~t~ksDV~S  452 (613)
                      +|.....+-..|   -.|-.|.+ .-+..-|||-
T Consensus       368 sRl~~~q~~isy~rldhp~lF~G-~dd~QFeIYr  400 (488)
T COG5072         368 SRLSYSQGIISYNRLDHPDLFNG-VDDYQFEIYR  400 (488)
T ss_pred             eecccCCceeeccccCchhhhcC-ccceeeeHHH
Confidence            996554443333   34666653 3355666665

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.55  E-value=0.16  Score=52.58  Aligned_cols=30  Identities=30%  Similarity=0.341  Sum_probs=25.5

Q ss_pred             CcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       394 ~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ..++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            34899999999999997 5678999997654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.51  E-value=0.05  Score=53.16  Aligned_cols=122  Identities=19%  Similarity=0.229  Sum_probs=61.4

Q ss_pred             eeEEEEEeCCCChhcHHHHHHHHHHHhccCcccee-eEEEEeecCCceEEEEEcCCCCChhHH-------h---------
Q 048439          298 TPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV-SLIGFCNDDREMILVYDFMARGTLPDH-------L---------  360 (613)
Q Consensus       298 ~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gsL~~~-------l---------  360 (613)
                      ..|.||+....+ ........|..+++.+...++. ++++++.+    .+|+||+++.+|..-       +         
T Consensus         3 ~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~   77 (211)
T PF01633_consen    3 EKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLAK   77 (211)
T ss_dssp             SEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred             CEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHHH
Confidence            457888776553 3445667899999988765554 55665433    267899977664221       0         


Q ss_pred             -hc-----CCCCCCCHHHHHHH--------------------------HHHHHHHHHHHhcCCCCCcEEeccCCCCceee
Q 048439          361 -YH-----SDNPPLPWNQRLEI--------------------------CIGAARGLHYLHTGANHAVIIHRDVKTTNILL  408 (613)
Q Consensus       361 -~~-----~~~~~l~~~~~~~i--------------------------~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl  408 (613)
                       |.     .....--|.....+                          ...+......|-....+..+.|.|+.+.|||+
T Consensus        78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~  157 (211)
T PF01633_consen   78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI  157 (211)
T ss_dssp             HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred             HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence             00     00111112222222                          11111112222122233448899999999999


Q ss_pred             -CCCCcEEEEecCCCcc
Q 048439          409 -DEKWVAKVSDFGLSKF  424 (613)
Q Consensus       409 -~~~~~~kl~DFGls~~  424 (613)
                       +.++.++++||..|..
T Consensus       158 ~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  158 NNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             TSSSSCEEE--GTT-EE
T ss_pred             ccCCCeEEEecHHHHhh
Confidence             8899999999988754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.49  E-value=0.014  Score=59.79  Aligned_cols=131  Identities=18%  Similarity=0.126  Sum_probs=87.7

Q ss_pred             CCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--------------------Chh--cHHHHHHHHHHHhccCc-c-c
Q 048439          275 DNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--------------------SQQ--GALEFQTEIGMLSQLRH-L-H  330 (613)
Q Consensus       275 ~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--------------------~~~--~~~~f~~Ei~~l~~l~H-~-n  330 (613)
                      +..+.||-|--+.||.+-...+ .+.++|.-+..                    ++.  ..-...+|...|+.|.. - -
T Consensus        95 svGnqIGVGKESDIY~v~d~~G-~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   95 SVGNQIGVGKESDIYVVADEEG-NPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhccccccccccceEEEecCCC-CchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            4556899999999999988765 56777743211                    111  11234578888888853 1 2


Q ss_pred             eeeEEEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC
Q 048439          331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE  410 (613)
Q Consensus       331 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~  410 (613)
                      +.+.+.    .+..++|||++.+-.|...-+..     +..   .++..+..-+--|..+|    +||+|..-=||++++
T Consensus       174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~-----d~~---~ly~~lm~~Iv~la~~G----lIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  174 VPKPID----HNRHCVVMELVDGYPLRQVRHVE-----DPP---TLYDDLMGLIVRLANHG----LIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCccc----ccceeeHHHhhcccceeeeeecC-----ChH---HHHHHHHHHHHHHHHcC----ceecccchheeEEec
Confidence            333333    35678999999998886643221     122   23344444455666677    999999999999999


Q ss_pred             CCcEEEEecCCC
Q 048439          411 KWVAKVSDFGLS  422 (613)
Q Consensus       411 ~~~~kl~DFGls  422 (613)
                      ++.++++||--.
T Consensus       238 d~~i~vIDFPQm  249 (465)
T KOG2268|consen  238 DDKIVVIDFPQM  249 (465)
T ss_pred             CCCEEEeechHh
Confidence            999999999643

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.40  E-value=0.14  Score=49.97  Aligned_cols=137  Identities=15%  Similarity=0.177  Sum_probs=88.8

Q ss_pred             EEEEEeCCCChh-cHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHH
Q 048439          300 VAIKRLEPESQQ-GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICI  378 (613)
Q Consensus       300 vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~  378 (613)
                      ..+|++..-... ...-|..+.+++++++  .|++|..  .....+-++.|+|-.-..           +.   .-.|..
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i-----------~~---~N~i~a  149 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI-----------NF---SNFITA  149 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc-----------ch---hHHHHH
Confidence            667777654433 4456788899998876  5777762  234456688888843111           00   111222


Q ss_pred             HHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHH
Q 048439          379 GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLF  458 (613)
Q Consensus       379 ~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~  458 (613)
                      + .+.|.-.|+...+  .+|+|..|+||+-|..|.+||.|-+.--.    .+..|..-||   ...|.++.+-+|=.-++
T Consensus       150 g-i~~L~~fH~~~~~--~lHGD~np~NiM~D~~G~lKlVDP~~Ll~----~~V~~vN~~Y---~~lT~~aE~~~fv~s~l  219 (308)
T PF07387_consen  150 G-IKDLMDFHSENQH--CLHGDCNPDNIMCDKFGYLKLVDPVCLLE----NQVNMVNIEY---ESLTQEAEVKVFVKSCL  219 (308)
T ss_pred             h-HHHHHHhhccCCC--eecCCCChhheeecCCCCEEecChhhhhh----heeeEEeeec---cccChHHHHHHHHHHHH
Confidence            2 4667888965433  89999999999999999999999763211    1223444222   24688899989888888


Q ss_pred             HHHhCC
Q 048439          459 EVLCAR  464 (613)
Q Consensus       459 elltg~  464 (613)
                      +++...
T Consensus       220 ~~v~~~  225 (308)
T PF07387_consen  220 KLVEKQ  225 (308)
T ss_pred             HHHHHH
Confidence            887543

The function of this family is unknown.

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.38  E-value=0.18  Score=51.90  Aligned_cols=72  Identities=15%  Similarity=0.157  Sum_probs=45.2

Q ss_pred             eeeCcEEEEEEEEcC--------CceeEEEEEeCCCCh-----hcHHHHHHHHHHHhccC-------------ccceeeE
Q 048439          281 GVGGFGDVYKGFING--------STTPVAIKRLEPESQ-----QGALEFQTEIGMLSQLR-------------HLHLVSL  334 (613)
Q Consensus       281 G~G~fG~Vy~g~~~~--------~~~~vAVK~~~~~~~-----~~~~~f~~Ei~~l~~l~-------------H~niv~l  334 (613)
                      |.|-.|.+|+.....        ....+.||.......     .....|.+|+.+.+.+-             .....++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            677889999887733        124589998762211     12235788887766541             1234556


Q ss_pred             EEEeecCCceEEEEEcCC
Q 048439          335 IGFCNDDREMILVYDFMA  352 (613)
Q Consensus       335 ~g~~~~~~~~~lV~Ey~~  352 (613)
                      ++...+....+||||-+.
T Consensus        82 ~~~~~~~~~~~lvlEDL~   99 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDLS   99 (294)
T ss_pred             EEeccCCCceeeehhhhh
Confidence            666655557899998874

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.36  E-value=0.091  Score=54.96  Aligned_cols=140  Identities=18%  Similarity=0.193  Sum_probs=93.1

Q ss_pred             cceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC------------------------hhcH--HHHHHHHHHHhccCccc
Q 048439          277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES------------------------QQGA--LEFQTEIGMLSQLRHLH  330 (613)
Q Consensus       277 ~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~------------------------~~~~--~~f~~Ei~~l~~l~H~n  330 (613)
                      ...|.-|--..||.+.-.++ ..+|||+.+..-                        +...  --...|++-|.+|+.-.
T Consensus       149 nGCiSTGKEANVYHat~~dG-~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDG-SEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccccCccceeEeeecCCC-ceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            34677889999999988776 459999876310                        0000  01246777788776544


Q ss_pred             eeeEEEEeecCCceEEEEEcCCCCChh-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC
Q 048439          331 LVSLIGFCNDDREMILVYDFMARGTLP-DHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD  409 (613)
Q Consensus       331 iv~l~g~~~~~~~~~lV~Ey~~~gsL~-~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~  409 (613)
                      |...--...  ..-.|||+|+....-. -.|   ....|+......+-.+++.-|.-|.+.+.   +||.||.-=|+|+.
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~---LVHADLSEfN~Lyh  299 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKCR---LVHADLSEFNLLYH  299 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHhc---eeccchhhhhheEE
Confidence            321111111  2347999999632211 111   24557777778888889999999987774   99999999999987


Q ss_pred             CCCcEEEEecCCCccCC
Q 048439          410 EKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       410 ~~~~~kl~DFGls~~~~  426 (613)
                       +|.+-|+|-+-|.-..
T Consensus       300 -dG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  300 -DGKLYIIDVSQSVEHD  315 (520)
T ss_pred             -CCEEEEEEccccccCC
Confidence             5788999998875433

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.35  E-value=0.21  Score=52.52  Aligned_cols=140  Identities=18%  Similarity=0.285  Sum_probs=81.6

Q ss_pred             eeeeCcEEEEEEEEcCC---ceeEEEEEeCCCChhcHHHHHHHHHHHhccCcccee-eEEEEeecCCceEEEEEcCCCCC
Q 048439          280 IGVGGFGDVYKGFINGS---TTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV-SLIGFCNDDREMILVYDFMARGT  355 (613)
Q Consensus       280 iG~G~fG~Vy~g~~~~~---~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gs  355 (613)
                      |..|=-..+|+....+.   ...|.+|........ .-...+|..++..+...++. ++++++. .+   +|.+|+++.+
T Consensus        22 l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~~   96 (330)
T PLN02421         22 ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINART   96 (330)
T ss_pred             eCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCCC
Confidence            33455677888876542   236888887654432 33447899999988766664 5666653 22   5899998766


Q ss_pred             hhHH-------h----------hcCC----CCCCCHHHHHHHHHHH----------------------HH---HH-HHHh
Q 048439          356 LPDH-------L----------YHSD----NPPLPWNQRLEICIGA----------------------AR---GL-HYLH  388 (613)
Q Consensus       356 L~~~-------l----------~~~~----~~~l~~~~~~~i~~~i----------------------a~---gL-~yLH  388 (613)
                      |...       +          |...    ..+--|....++..++                      ..   .+ .++.
T Consensus        97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~  176 (330)
T PLN02421         97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD  176 (330)
T ss_pred             CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence            5321       1          1111    0111233332222221                      11   11 1222


Q ss_pred             cCCCCCcEEeccCCCCceeeCC-CCcEEEEecCCCcc
Q 048439          389 TGANHAVIIHRDVKTTNILLDE-KWVAKVSDFGLSKF  424 (613)
Q Consensus       389 ~~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGls~~  424 (613)
                      ..+.+..++|.|+.+.|||+++ ++.++++||..|..
T Consensus       177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            2233445889999999999975 57899999998754

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.31  E-value=0.061  Score=58.38  Aligned_cols=48  Identities=21%  Similarity=0.369  Sum_probs=37.5

Q ss_pred             HHHHHHHHHHhccCccceeeEEEEeecC-CceEEEEEcCCCCChhHHhhc
Q 048439          314 LEFQTEIGMLSQLRHLHLVSLIGFCNDD-REMILVYDFMARGTLPDHLYH  362 (613)
Q Consensus       314 ~~f~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~~~gsL~~~l~~  362 (613)
                      ..+.....+++.+.|+|+...+.+.... ....+|+|++.. +|.+.+..
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~   75 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKT   75 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHh
Confidence            4566778889999999999999887653 346788999854 89888743

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.27  E-value=0.17  Score=52.69  Aligned_cols=33  Identities=21%  Similarity=0.400  Sum_probs=28.5

Q ss_pred             CCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       393 ~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +..++|+|+.+.|||+++++.+-++||..+...
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d  227 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASFA  227 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence            344999999999999999999999999887643

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	613
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-75
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-75
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-46
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-45
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-38
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-38
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-38
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-35
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-23
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-21
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-20
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-20
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-19
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		9e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-18
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-18
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-17
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		9e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		9e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		8e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		7e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		8e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		9e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		9e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		8e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		8e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		9e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		9e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		8e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		9e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		9e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		9e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		9e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-06
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-06
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-06
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-06
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-06
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-06
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-06
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-06
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-06
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-06
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-06
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-06
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-06
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-06
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-06
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-06
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-06
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-06
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		9e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-05
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-05
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-04
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-04
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-04
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		5e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-04
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-04
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		7e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-04
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-04

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  279 bits (714), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 159/297 (53%), Positives = 197/297 (66%), Gaps = 33/297 (11%)
Query: 264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGML 323
           L +++ ATNNFD+  +IG G FG VYKG +      VA+KR  PES QG  EF+TEI  L
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK-VALKRRTPESSQGIEEFETEIETL 89
Query: 324 SQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNP--PLPWNQRLEICIGAA 381
           S  RH HLVSLIGFC++  EMIL+Y +M  G L  HLY SD P   + W QRLEICIGAA
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHL------- 434
           RGLHYLHT A    IIHRDVK+ NILLDE +V K++DFG+SK G T + +THL       
Sbjct: 150 RGLHYLHTRA----IIHRDVKSINILLDENFVPKITDFGISKKG-TELGQTHLXXVVKGT 204
Query: 435 ----DPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT 490
               DPEY+   +LTEKSDVYSFGVVLFEVLCAR +I+++  ++ V+LA WA + + NG 
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 491 IDQIVDPFLK--------------AMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSI 533
           ++QIVDP L               A+ CL      RPSM DV+W LE++L+LQES I
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESVI 321

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  279 bits (714), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 159/297 (53%), Positives = 197/297 (66%), Gaps = 33/297 (11%)
Query: 264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGML 323
           L +++ ATNNFD+  +IG G FG VYKG +      VA+KR  PES QG  EF+TEI  L
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK-VALKRRTPESSQGIEEFETEIETL 89
Query: 324 SQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNP--PLPWNQRLEICIGAA 381
           S  RH HLVSLIGFC++  EMIL+Y +M  G L  HLY SD P   + W QRLEICIGAA
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHL------- 434
           RGLHYLHT A    IIHRDVK+ NILLDE +V K++DFG+SK G T + +THL       
Sbjct: 150 RGLHYLHTRA----IIHRDVKSINILLDENFVPKITDFGISKKG-TELDQTHLXXVVKGT 204
Query: 435 ----DPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT 490
               DPEY+   +LTEKSDVYSFGVVLFEVLCAR +I+++  ++ V+LA WA + + NG 
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 491 IDQIVDPFLK--------------AMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSI 533
           ++QIVDP L               A+ CL      RPSM DV+W LE++L+LQES I
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESVI 321

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  181 bits (460), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 114/291 (39%), Positives = 161/291 (55%), Gaps = 30/291 (10%)
Query: 261 QFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGA-LEFQTE 319
           +FSL E+Q A++NF N  ++G GGFG VYKG +   T  VA+KRL+ E  QG  L+FQTE
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL-VAVKRLKEERXQGGELQFQTE 85
Query: 320 IGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYH--SDNPPLPWNQRLEIC 377
           + M+S   H +L+ L GFC    E +LVY +MA G++   L       PPL W +R  I 
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 378 IGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-------PTSVS 430
           +G+ARGL YLH   +   IIHRDVK  NILLDE++ A V DFGL+K           +V 
Sbjct: 146 LGSARGLAYLHDHCD-PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 204
Query: 431 KT--HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPS--ILRTAAKKQVSLAVWAQQCY 486
            T  H+ PEY    + +EK+DV+ +GV+L E++  + +  + R A    V L  W +   
Sbjct: 205 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 264
Query: 487 QNGTIDQIVDPFLK--------------AMSCLNDEGIRRPSMSDVVWGLE 523
           +   ++ +VD  L+              A+ C     + RP MS+VV  LE
Sbjct: 265 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  178 bits (451), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 112/291 (38%), Positives = 159/291 (54%), Gaps = 30/291 (10%)
Query: 261 QFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGA-LEFQTE 319
           +FSL E+Q A++NF N  ++G GGFG VYKG +      VA+KRL+ E  QG  L+FQTE
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXL-VAVKRLKEERTQGGELQFQTE 77
Query: 320 IGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYH--SDNPPLPWNQRLEIC 377
           + M+S   H +L+ L GFC    E +LVY +MA G++   L       PPL W +R  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 378 IGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK---FGPTSVSKT-- 432
           +G+ARGL YLH   +   IIHRDVK  NILLDE++ A V DFGL+K   +    V     
Sbjct: 138 LGSARGLAYLHDHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 196
Query: 433 ----HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPS--ILRTAAKKQVSLAVWAQQCY 486
               H+ PEY    + +EK+DV+ +GV+L E++  + +  + R A    V L  W +   
Sbjct: 197 GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 487 QNGTIDQIVDPFLK--------------AMSCLNDEGIRRPSMSDVVWGLE 523
           +   ++ +VD  L+              A+ C     + RP MS+VV  LE
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  157 bits (398), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 93/227 (40%), Positives = 140/227 (61%), Gaps = 28/227 (12%)
Query: 262 FSLSEIQAATNNFDNDLV------IGVGGFGDVYKGFINGSTTPVAIKRL----EPESQQ 311
           FS  E++  TNNFD   +      +G GGFG VYKG++N +T  VA+K+L    +  +++
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEE 72
Query: 312 GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSD-NPPLPW 370
              +F  EI ++++ +H +LV L+GF +D  ++ LVY +M  G+L D L   D  PPL W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 371 NQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----KFGP 426
           + R +I  GAA G+++LH   NH   IHRD+K+ NILLDE + AK+SDFGL+    KF  
Sbjct: 133 HMRCKIAQGAANGINFLHE--NHH--IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 427 TSV------SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSI 467
           T +      +  ++ PE  R  ++T KSD+YSFGVVL E++   P++
Sbjct: 189 TVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAV 234

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  157 bits (398), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 93/227 (40%), Positives = 140/227 (61%), Gaps = 28/227 (12%)
Query: 262 FSLSEIQAATNNFDNDLV------IGVGGFGDVYKGFINGSTTPVAIKRL----EPESQQ 311
           FS  E++  TNNFD   +      +G GGFG VYKG++N +T  VA+K+L    +  +++
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEE 72
Query: 312 GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSD-NPPLPW 370
              +F  EI ++++ +H +LV L+GF +D  ++ LVY +M  G+L D L   D  PPL W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 371 NQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----KFGP 426
           + R +I  GAA G+++LH   NH   IHRD+K+ NILLDE + AK+SDFGL+    KF  
Sbjct: 133 HMRCKIAQGAANGINFLHE--NHH--IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 427 TSV------SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSI 467
           T +      +  ++ PE  R  ++T KSD+YSFGVVL E++   P++
Sbjct: 189 TVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAV 234

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  155 bits (392), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 92/227 (40%), Positives = 139/227 (61%), Gaps = 28/227 (12%)
Query: 262 FSLSEIQAATNNFDNDLV------IGVGGFGDVYKGFINGSTTPVAIKRL----EPESQQ 311
           FS  E++  TNNFD   +      +G GGFG VYKG++N +T  VA+K+L    +  +++
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEE 66
Query: 312 GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSD-NPPLPW 370
              +F  EI ++++ +H +LV L+GF +D  ++ LVY +M  G+L D L   D  PPL W
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 126
Query: 371 NQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----KFGP 426
           + R +I  GAA G+++LH   NH   IHRD+K+ NILLDE + AK+SDFGL+    KF  
Sbjct: 127 HMRCKIAQGAANGINFLHE--NHH--IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 427 TSV------SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSI 467
             +      +  ++ PE  R  ++T KSD+YSFGVVL E++   P++
Sbjct: 183 XVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAV 228

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 91/227 (40%), Positives = 134/227 (59%), Gaps = 28/227 (12%)
Query: 262 FSLSEIQAATNNFDNDLV------IGVGGFGDVYKGFINGSTTPVAIKRL----EPESQQ 311
           FS  E++  TNNFD   +       G GGFG VYKG++N +T  VA+K+L    +  +++
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEE 63
Query: 312 GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSD-NPPLPW 370
              +F  EI + ++ +H +LV L+GF +D  ++ LVY +   G+L D L   D  PPL W
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSW 123
Query: 371 NQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----KFGP 426
           + R +I  GAA G+++LH   NH   IHRD+K+ NILLDE + AK+SDFGL+    KF  
Sbjct: 124 HXRCKIAQGAANGINFLHE--NHH--IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 427 TSV------SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSI 467
                    +  +  PE  R  ++T KSD+YSFGVVL E++   P++
Sbjct: 180 XVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAV 225

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 77/251 (30%), Positives = 129/251 (51%), Gaps = 16/251 (6%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG V++   +GS   V I   +    +   EF  E+ ++ +LRH ++V  +G   
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 340 DDREMILVYDFMARGTLPDHLYHSD-NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
               + +V ++++RG+L   L+ S     L   +RL +    A+G++YLH    +  I+H
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN--RNPPIVH 162
Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLTEKSDV 450
           RD+K+ N+L+D+K+  KV DFGLS+   +    +         + PE  R +   EKSDV
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDV 222
Query: 451 YSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAM--SCLNDE 508
           YSFGV+L+E L             QV  AV   +C +   I + ++P + A+   C  +E
Sbjct: 223 YSFGVILWE-LATLQQPWGNLNPAQVVAAV-GFKC-KRLEIPRNLNPQVAAIIEGCWTNE 279
Query: 509 GIRRPSMSDVV 519
             +RPS + ++
Sbjct: 280 PWKRPSFATIM 290

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 130/251 (51%), Gaps = 16/251 (6%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG V++   +GS   V I   +    +   EF  E+ ++ +LRH ++V  +G   
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 340 DDREMILVYDFMARGTLPDHLYHSD-NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
               + +V ++++RG+L   L+ S     L   +RL +    A+G++YLH    +  I+H
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN--RNPPIVH 162
Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLTEKSDV 450
           R++K+ N+L+D+K+  KV DFGLS+   ++   +         + PE  R +   EKSDV
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDV 222
Query: 451 YSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAM--SCLNDE 508
           YSFGV+L+E L             QV  AV   +C +   I + ++P + A+   C  +E
Sbjct: 223 YSFGVILWE-LATLQQPWGNLNPAQVVAAV-GFKC-KRLEIPRNLNPQVAAIIEGCWTNE 279
Query: 509 GIRRPSMSDVV 519
             +RPS + ++
Sbjct: 280 PWKRPSFATIM 290

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 124/258 (48%), Gaps = 24/258 (9%)
Query: 279 VIGVGGFGDVYKGFINGST----TPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVS 333
           VIG G FG+VYKG +  S+     PVAIK L+   +++  ++F  E G++ Q  H +++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L G  +  + M+++ ++M  G L   L   D       Q + +  G A G+ YL    N+
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYL-ANMNY 168
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD-----------PEYYRLQ 442
              +HRD+   NIL++   V KVSDFGLS+        T+             PE    +
Sbjct: 169 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 443 QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT-IDQIVDPFLKA 501
           + T  SDV+SFG+V++EV+          +  +V  A+     ++  T +D     +   
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI--NDGFRLPTPMDCPSAIYQLM 283
Query: 502 MSCLNDEGIRRPSMSDVV 519
           M C   E  RRP  +D+V
Sbjct: 284 MQCWQQERARRPKFADIV 301

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/187 (34%), Positives = 105/187 (56%), Gaps = 14/187 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FGDV  G   G+   VA+K ++ ++   A  F  E  +++QLRH +LV L+G   
Sbjct: 14  IGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 340 DDRE-MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
           +++  + +V ++MA+G+L D+L       L  +  L+  +     + YL  G N    +H
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-GNN---FVH 125
Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHL-----DPEYYRLQQLTEKSDVYSF 453
           RD+   N+L+ E  VAKVSDFGL+K   ++     L      PE  R ++ + KSDV+SF
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSF 185
Query: 454 GVVLFEV 460
           G++L+E+
Sbjct: 186 GILLWEI 192

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/187 (34%), Positives = 105/187 (56%), Gaps = 14/187 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FGDV  G   G+   VA+K ++ ++   A  F  E  +++QLRH +LV L+G   
Sbjct: 29  IGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQLLGVIV 84
Query: 340 DDRE-MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
           +++  + +V ++MA+G+L D+L       L  +  L+  +     + YL  G N    +H
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-GNN---FVH 140
Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHL-----DPEYYRLQQLTEKSDVYSF 453
           RD+   N+L+ E  VAKVSDFGL+K   ++     L      PE  R ++ + KSDV+SF
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSF 200
Query: 454 GVVLFEV 460
           G++L+E+
Sbjct: 201 GILLWEI 207

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 124/258 (48%), Gaps = 23/258 (8%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIG 336
           +IG+GGFG VY+ F  G    V   R +P+    Q     + E  + + L+H ++++L G
Sbjct: 14  IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
            C  +  + LV +F   G L   L     PP   +  +   +  ARG++YLH  A    I
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPP---DILVNWAVQIARGMNYLHDEA-IVPI 129
Query: 397 IHRDVKTTNILLDEKW--------VAKVSDFGLSK--FGPTSVSKTH----LDPEYYRLQ 442
           IHRD+K++NIL+ +K         + K++DFGL++     T +S       + PE  R  
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRAS 189
Query: 443 QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAM 502
             ++ SDV+S+GV+L+E+L       R      V+  V A             +PF K M
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVP-FRGIDGLAVAYGV-AMNKLALPIPSTCPEPFAKLM 247
Query: 503 S-CLNDEGIRRPSMSDVV 519
             C N +   RPS ++++
Sbjct: 248 EDCWNPDPHSRPSFTNIL 265

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/187 (34%), Positives = 105/187 (56%), Gaps = 14/187 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FGDV  G   G+   VA+K ++ ++   A  F  E  +++QLRH +LV L+G   
Sbjct: 201 IGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQLLGVIV 256
Query: 340 DDRE-MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
           +++  + +V ++MA+G+L D+L       L  +  L+  +     + YL  G N    +H
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-GNN---FVH 312
Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHL-----DPEYYRLQQLTEKSDVYSF 453
           RD+   N+L+ E  VAKVSDFGL+K   ++     L      PE  R ++ + KSDV+SF
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSF 372
Query: 454 GVVLFEV 460
           G++L+E+
Sbjct: 373 GILLWEI 379

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG VYKG  +G      +    P  QQ    F+ E+G+L + RH++++  +G+  
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYST 78
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              ++ +V  +    +L  HL H+        + ++I    ARG+ YLH  +    IIHR
Sbjct: 79  KP-QLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHAKS----IIHR 132
Query: 400 DVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLDPEYYRLQQ---LTE 446
           D+K+ NI L E    K+ DFGL+          +F   S S   + PE  R+Q     + 
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 447 KSDVYSFGVVLFEVLCAR 464
           +SDVY+FG+VL+E++  +
Sbjct: 193 QSDVYAFGIVLYELMTGQ 210

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG VYKG  +G      +    P  QQ    F+ E+G+L + RH++++  +G+  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              ++ +V  +    +L  HL H+        + ++I    ARG+ YLH  +    IIHR
Sbjct: 91  KP-QLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHAKS----IIHR 144
Query: 400 DVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLDPEYYRLQQ---LTE 446
           D+K+ NI L E    K+ DFGL+          +F   S S   + PE  R+Q     + 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 447 KSDVYSFGVVLFEVLCAR 464
           +SDVY+FG+VL+E++  +
Sbjct: 205 QSDVYAFGIVLYELMTGQ 222

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG VYKG  +G      +    P  QQ    F+ E+G+L + RH++++  +G+  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              ++ +V  +    +L  HL H+        + ++I    ARG+ YLH  +    IIHR
Sbjct: 91  AP-QLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHAKS----IIHR 144
Query: 400 DVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLDPEYYRLQQ---LTE 446
           D+K+ NI L E    K+ DFGL+          +F   S S   + PE  R+Q     + 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 447 KSDVYSFGVVLFEVLCAR 464
           +SDVY+FG+VL+E++  +
Sbjct: 205 QSDVYAFGIVLYELMTGQ 222

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/187 (34%), Positives = 103/187 (55%), Gaps = 14/187 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FGDV  G   G+   VA+K ++ ++   A  F  E  +++QLRH +LV L+G   
Sbjct: 20  IGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQLLGVIV 75
Query: 340 DDRE-MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
           +++  + +V ++MA+G+L D+L       L  +  L+  +     + YL  G N    +H
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-GNN---FVH 131
Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHL-----DPEYYRLQQLTEKSDVYSF 453
           RD+   N+L+ E  VAKVSDFGL+K   ++     L      PE  R    + KSDV+SF
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREAAFSTKSDVWSF 191
Query: 454 GVVLFEV 460
           G++L+E+
Sbjct: 192 GILLWEI 198

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 101/195 (51%), Gaps = 24/195 (12%)
Query: 280 IGVGGFGDVYKGF-INGSTTPVAIKRLEPESQQGAL---EFQTEIGMLSQLRHLHLVSLI 335
           IG G FG V+ G+ +N     VAIK +    ++GA+   +F  E  ++ +L H  LV L 
Sbjct: 18  IGSGQFGLVHLGYWLN--KDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQLY 71
Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
           G C +   + LV++FM  G L D+L  +          L +C+    G+ YL      A 
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL----EEAC 126
Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKF----GPTSVSKTHL-----DPEYYRLQQLTE 446
           +IHRD+   N L+ E  V KVSDFG+++F      TS + T        PE +   + + 
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 186
Query: 447 KSDVYSFGVVLFEVL 461
           KSDV+SFGV+++EV 
Sbjct: 187 KSDVWSFGVLMWEVF 201

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 101/195 (51%), Gaps = 24/195 (12%)
Query: 280 IGVGGFGDVYKGF-INGSTTPVAIKRLEPESQQGAL---EFQTEIGMLSQLRHLHLVSLI 335
           IG G FG V+ G+ +N     VAIK +    ++GA+   +F  E  ++ +L H  LV L 
Sbjct: 15  IGSGQFGLVHLGYWLN--KDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
           G C +   + LV++FM  G L D+L  +          L +C+    G+ YL      A 
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL----EEAC 123
Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKF----GPTSVSKTHL-----DPEYYRLQQLTE 446
           +IHRD+   N L+ E  V KVSDFG+++F      TS + T        PE +   + + 
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 447 KSDVYSFGVVLFEVL 461
           KSDV+SFGV+++EV 
Sbjct: 184 KSDVWSFGVLMWEVF 198

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 101/195 (51%), Gaps = 24/195 (12%)
Query: 280 IGVGGFGDVYKGF-INGSTTPVAIKRLEPESQQGAL---EFQTEIGMLSQLRHLHLVSLI 335
           IG G FG V+ G+ +N     VAIK +    ++GA+   +F  E  ++ +L H  LV L 
Sbjct: 13  IGSGQFGLVHLGYWLN--KDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
           G C +   + LV++FM  G L D+L  +          L +C+    G+ YL      A 
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL----EEAC 121
Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKF----GPTSVSKTHL-----DPEYYRLQQLTE 446
           +IHRD+   N L+ E  V KVSDFG+++F      TS + T        PE +   + + 
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 447 KSDVYSFGVVLFEVL 461
           KSDV+SFGV+++EV 
Sbjct: 182 KSDVWSFGVLMWEVF 196

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 98/192 (51%), Gaps = 18/192 (9%)
Query: 280 IGVGGFGDVYKGF-INGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G FG V+ G+ +N     VAIK ++ E      +F  E  ++ +L H  LV L G C
Sbjct: 35  IGSGQFGLVHLGYWLN--KDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
            +   + LV++FM  G L D+L  +          L +C+    G+ YL      A +IH
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL----EEACVIH 146
Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKF----GPTSVSKTHL-----DPEYYRLQQLTEKSD 449
           RD+   N L+ E  V KVSDFG+++F      TS + T        PE +   + + KSD
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 450 VYSFGVVLFEVL 461
           V+SFGV+++EV 
Sbjct: 207 VWSFGVLMWEVF 218

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 101/195 (51%), Gaps = 24/195 (12%)
Query: 280 IGVGGFGDVYKGF-INGSTTPVAIKRLEPESQQGAL---EFQTEIGMLSQLRHLHLVSLI 335
           IG G FG V+ G+ +N     VAIK +    ++GA+   +F  E  ++ +L H  LV L 
Sbjct: 15  IGSGQFGLVHLGYWLN--KDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
           G C +   + LV++FM  G L D+L  +          L +C+    G+ YL      A 
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL----EEAS 123
Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKF----GPTSVSKTHL-----DPEYYRLQQLTE 446
           +IHRD+   N L+ E  V KVSDFG+++F      TS + T        PE +   + + 
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 447 KSDVYSFGVVLFEVL 461
           KSDV+SFGV+++EV 
Sbjct: 184 KSDVWSFGVLMWEVF 198

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 24/195 (12%)
Query: 280 IGVGGFGDVYKGF-INGSTTPVAIKRLEPESQQGAL---EFQTEIGMLSQLRHLHLVSLI 335
           IG G FG V+ G+ +N     VAIK +    ++GA+   +F  E  ++ +L H  LV L 
Sbjct: 16  IGSGQFGLVHLGYWLN--KDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
           G C +   + LV +FM  G L D+L  +          L +C+    G+ YL      A 
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL----EEAC 124
Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKF----GPTSVSKTHL-----DPEYYRLQQLTE 446
           +IHRD+   N L+ E  V KVSDFG+++F      TS + T        PE +   + + 
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 447 KSDVYSFGVVLFEVL 461
           KSDV+SFGV+++EV 
Sbjct: 185 KSDVWSFGVLMWEVF 199

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 27/263 (10%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG VYKG  +G      +    P  QQ    F+ E+G+L + RH++++  +G+  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              ++ +V  +    +L  HL H         + ++I    A+G+ YLH  +    IIHR
Sbjct: 75  KP-QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHAKS----IIHR 128
Query: 400 DVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLDPEYYRLQQ---LTE 446
           D+K+ NI L E    K+ DFGL+          +F   S S   + PE  R+Q     + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 447 KSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS--- 503
           +SDVY+FG+VL+E++  +        + Q+   V   + Y +  + ++     KAM    
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKVRSNCPKAMKRLM 246
Query: 504 --CLNDEGIRRPSMSDVVWGLEF 524
             CL  +   RP    ++  +E 
Sbjct: 247 AECLKKKRDERPLFPQILASIEL 269

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 27/263 (10%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG VYKG  +G      +    P  QQ    F+ E+G+L + RH++++  +G+  
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYST 94
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              ++ +V  +    +L  HL H         + ++I    A+G+ YLH  +    IIHR
Sbjct: 95  KP-QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHAKS----IIHR 148
Query: 400 DVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLDPEYYRLQQ---LTE 446
           D+K+ NI L E    K+ DFGL+          +F   S S   + PE  R+Q     + 
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 208
Query: 447 KSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS--- 503
           +SDVY+FG+VL+E++  +        + Q+   V   + Y +  + ++     KAM    
Sbjct: 209 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKVRSNCPKAMKRLM 266
Query: 504 --CLNDEGIRRPSMSDVVWGLEF 524
             CL  +   RP    ++  +E 
Sbjct: 267 AECLKKKRDERPLFPQILASIEL 289

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 27/263 (10%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG VYKG  +G      +    P  QQ    F+ E+G+L + RH++++  +G+  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              ++ +V  +    +L  HL H         + ++I    A+G+ YLH  +    IIHR
Sbjct: 75  KP-QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHAKS----IIHR 128
Query: 400 DVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLDPEYYRLQQ---LTE 446
           D+K+ NI L E    K+ DFGL+          +F   S S   + PE  R+Q     + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 447 KSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS--- 503
           +SDVY+FG+VL+E++  +        + Q+   V   + Y +  + ++     KAM    
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKVRSNCPKAMKRLM 246
Query: 504 --CLNDEGIRRPSMSDVVWGLEF 524
             CL  +   RP    ++  +E 
Sbjct: 247 AECLKKKRDERPLFPQILASIEL 269

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 27/263 (10%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG VYKG  +G      +    P  QQ    F+ E+G+L + RH++++  +G+  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYST 102
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              ++ +V  +    +L  HL H         + ++I    A+G+ YLH  +    IIHR
Sbjct: 103 KP-QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHAKS----IIHR 156
Query: 400 DVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLDPEYYRLQQ---LTE 446
           D+K+ NI L E    K+ DFGL+          +F   S S   + PE  R+Q     + 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 447 KSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS--- 503
           +SDVY+FG+VL+E++  +        + Q+   V   + Y +  + ++     KAM    
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKVRSNCPKAMKRLM 274
Query: 504 --CLNDEGIRRPSMSDVVWGLEF 524
             CL  +   RP    ++  +E 
Sbjct: 275 AECLKKKRDERPLFPQILASIEL 297

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 27/263 (10%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG VYKG  +G      +    P  QQ    F+ E+G+L + RH++++  +G+  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYST 102
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              ++ +V  +    +L  HL H         + ++I    A+G+ YLH  +    IIHR
Sbjct: 103 KP-QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHAKS----IIHR 156
Query: 400 DVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLDPEYYRLQQ---LTE 446
           D+K+ NI L E    K+ DFGL+          +F   S S   + PE  R+Q     + 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 447 KSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS--- 503
           +SDVY+FG+VL+E++  +        + Q+   V   + Y +  + ++     KAM    
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKVRSNCPKAMKRLM 274
Query: 504 --CLNDEGIRRPSMSDVVWGLEF 524
             CL  +   RP    ++  +E 
Sbjct: 275 AECLKKKRDERPLFPQILASIEL 297

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 27/263 (10%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG VYKG  +G      +    P  QQ    F+ E+G+L + RH++++  +G+  
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYST 79
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              ++ +V  +    +L  HL H         + ++I    A+G+ YLH  +    IIHR
Sbjct: 80  KP-QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHAKS----IIHR 133
Query: 400 DVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLDPEYYRLQQ---LTE 446
           D+K+ NI L E    K+ DFGL+          +F   S S   + PE  R+Q     + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 447 KSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS--- 503
           +SDVY+FG+VL+E++  +        + Q+   V   + Y +  + ++     KAM    
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKVRSNCPKAMKRLM 251
Query: 504 --CLNDEGIRRPSMSDVVWGLEF 524
             CL  +   RP    ++  +E 
Sbjct: 252 AECLKKKRDERPLFPQILASIEL 274

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 27/263 (10%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG VYKG  +G      +    P  QQ    F+ E+G+L + RH++++  +G+  
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYST 79
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              ++ +V  +    +L  HL H         + ++I    A+G+ YLH  +    IIHR
Sbjct: 80  KP-QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHAKS----IIHR 133
Query: 400 DVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLDPEYYRLQQ---LTE 446
           D+K+ NI L E    K+ DFGL+          +F   S S   + PE  R+Q     + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 447 KSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS--- 503
           +SDVY+FG+VL+E++  +        + Q+   V   + Y +  + ++     KAM    
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKVRSNCPKAMKRLM 251
Query: 504 --CLNDEGIRRPSMSDVVWGLEF 524
             CL  +   RP    ++  +E 
Sbjct: 252 AECLKKKRDERPLFPQILASIEL 274

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 27/263 (10%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG VYKG  +G      +    P  QQ    F+ E+G+L + RH++++  +G+  
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYST 76
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              ++ +V  +    +L  HL H         + ++I    A+G+ YLH  +    IIHR
Sbjct: 77  KP-QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHAKS----IIHR 130
Query: 400 DVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLDPEYYRLQQ---LTE 446
           D+K+ NI L E    K+ DFGL+          +F   S S   + PE  R+Q     + 
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 447 KSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS--- 503
           +SDVY+FG+VL+E++  +        + Q+   V   + Y +  + ++     KAM    
Sbjct: 191 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKVRSNCPKAMKRLM 248
Query: 504 --CLNDEGIRRPSMSDVVWGLEF 524
             CL  +   RP    ++  +E 
Sbjct: 249 AECLKKKRDERPLFPQILASIEL 271

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 27/263 (10%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG VYKG  +G      +    P  QQ    F+ E+G+L + RH++++  +G+  
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYST 101
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              ++ +V  +    +L  HL H         + ++I    A+G+ YLH  +    IIHR
Sbjct: 102 KP-QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHAKS----IIHR 155
Query: 400 DVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLDPEYYRLQQ---LTE 446
           D+K+ NI L E    K+ DFGL+          +F   S S   + PE  R+Q     + 
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 447 KSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS--- 503
           +SDVY+FG+VL+E++  +        + Q+   V   + Y +  + ++     KAM    
Sbjct: 216 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKVRSNCPKAMKRLM 273
Query: 504 --CLNDEGIRRPSMSDVVWGLEF 524
             CL  +   RP    ++  +E 
Sbjct: 274 AECLKKKRDERPLFPQILASIEL 296

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 22/198 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG VYKG  +G      +K ++P  +Q    F+ E+ +L + RH++++  +G+  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQ-AFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            D  + +V  +    +L  HL H         Q ++I    A+G+ YLH       IIHR
Sbjct: 103 KD-NLAIVTQWCEGSSLYKHL-HVQETKFQMFQLIDIARQTAQGMDYLHAKN----IIHR 156
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFG-----------PTSVSKTHLDPEYYRLQQ---LT 445
           D+K+ NI L E    K+ DFGL+              PT  S   + PE  R+Q     +
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTG-SVLWMAPEVIRMQDNNPFS 215
Query: 446 EKSDVYSFGVVLFEVLCA 463
            +SDVYS+G+VL+E++  
Sbjct: 216 FQSDVYSYGIVLYELMTG 233

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 27/263 (10%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG VYKG  +G      +    P  QQ    F+ E+G+L + RH++++  +G+  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              ++ +V  +    +L  HL H         + ++I    A+G+ YLH  +    IIHR
Sbjct: 75  AP-QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHAKS----IIHR 128
Query: 400 DVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLDPEYYRLQQ---LTE 446
           D+K+ NI L E    K+ DFGL+          +F   S S   + PE  R+Q     + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 447 KSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS--- 503
           +SDVY+FG+VL+E++  +        + Q+   V   + Y +  + ++     KAM    
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKVRSNCPKAMKRLM 246
Query: 504 --CLNDEGIRRPSMSDVVWGLEF 524
             CL  +   RP    ++  +E 
Sbjct: 247 AECLKKKRDERPLFPQILASIEL 269

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 120/247 (48%), Gaps = 22/247 (8%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG+V+ G+ N ST  VA+K L+P +      F  E  ++  L+H  LV L     
Sbjct: 21  LGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +  + ++ ++MA+G+L D L   +   +   + ++     A G+ Y+    N+   IHR
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER-KNY---IHR 134
Query: 400 DVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEKSDV 450
           D++  N+L+ E  + K++DFGL++      +     +K  +    PE       T KSDV
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 451 YSFGVVLFEVLC--ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS-CLND 507
           +SFG++L+E++     P   RT A    +L+    Q Y+   ++   D     M  C  +
Sbjct: 195 WSFGILLYEIVTYGKIPYPGRTNADVMTALS----QGYRMPRVENCPDELYDIMKMCWKE 250
Query: 508 EGIRRPS 514
           +   RP+
Sbjct: 251 KAEERPT 257

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 128/255 (50%), Gaps = 28/255 (10%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           V+G G FG V K         VAIK++E ES++ A  F  E+  LS++ H ++V L G C
Sbjct: 15  VVGRGAFGVVCKA--KWRAKDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGAC 70
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPW---NQRLEICIGAARGLHYLHTGANHAV 395
            +   + LV ++   G+L + L+ ++  PLP+      +  C+  ++G+ YLH+    A 
Sbjct: 71  LNP--VCLVMEYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA- 125
Query: 396 IIHRDVKTTNILLDEKW-VAKVSDFGLSKFGPTSV-----SKTHLDPEYYRLQQLTEKSD 449
           +IHRD+K  N+LL     V K+ DFG +    T +     S   + PE +     +EK D
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 450 VYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT----IDQIVDPFLKAMS-C 504
           V+S+G++L+EV+  R               +WA     NGT    I  +  P    M+ C
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGP--AFRIMWA---VHNGTRPPLIKNLPKPIESLMTRC 240
Query: 505 LNDEGIRRPSMSDVV 519
            + +  +RPSM ++V
Sbjct: 241 WSKDPSQRPSMEEIV 255

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 128/255 (50%), Gaps = 28/255 (10%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           V+G G FG V K         VAIK++E ES++ A  F  E+  LS++ H ++V L G C
Sbjct: 16  VVGRGAFGVVCKA--KWRAKDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGAC 71
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPW---NQRLEICIGAARGLHYLHTGANHAV 395
            +   + LV ++   G+L + L+ ++  PLP+      +  C+  ++G+ YLH+    A 
Sbjct: 72  LNP--VCLVMEYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA- 126
Query: 396 IIHRDVKTTNILLDEKW-VAKVSDFGLSKFGPTSV-----SKTHLDPEYYRLQQLTEKSD 449
           +IHRD+K  N+LL     V K+ DFG +    T +     S   + PE +     +EK D
Sbjct: 127 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 186
Query: 450 VYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT----IDQIVDPFLKAMS-C 504
           V+S+G++L+EV+  R               +WA     NGT    I  +  P    M+ C
Sbjct: 187 VFSWGIILWEVITRRKPFDEIGGP--AFRIMWA---VHNGTRPPLIKNLPKPIESLMTRC 241
Query: 505 LNDEGIRRPSMSDVV 519
            + +  +RPSM ++V
Sbjct: 242 WSKDPSQRPSMEEIV 256

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 34/211 (16%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           +G G FG V+    +          VA+K L+  S+    +FQ E  +L+ L+H H+V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNP--------------PLPWNQRLEICIGA 380
            G C + R +++V+++M  G L +    S  P              PL   Q L +    
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVS 430
           A G+ YL  G +    +HRD+ T N L+ +  V K+ DFG+S+           G T + 
Sbjct: 168 AAGMVYL-AGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              + PE    ++ T +SDV+SFGVVL+E+ 
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIF 254

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 34/211 (16%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           +G G FG V+    +          VA+K L+  S+    +FQ E  +L+ L+H H+V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNP--------------PLPWNQRLEICIGA 380
            G C + R +++V+++M  G L +    S  P              PL   Q L +    
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVS 430
           A G+ YL  G +    +HRD+ T N L+ +  V K+ DFG+S+           G T + 
Sbjct: 139 AAGMVYL-AGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 194
Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              + PE    ++ T +SDV+SFGVVL+E+ 
Sbjct: 195 IRWMPPESILYRKFTTESDVWSFGVVLWEIF 225

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 34/211 (16%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           +G G FG V+    +          VA+K L+  S+    +FQ E  +L+ L+H H+V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNP--------------PLPWNQRLEICIGA 380
            G C + R +++V+++M  G L +    S  P              PL   Q L +    
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVS 430
           A G+ YL  G +    +HRD+ T N L+ +  V K+ DFG+S+           G T + 
Sbjct: 145 AAGMVYL-AGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 200
Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              + PE    ++ T +SDV+SFGVVL+E+ 
Sbjct: 201 IRWMPPESILYRKFTTESDVWSFGVVLWEIF 231

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 110/211 (52%), Gaps = 24/211 (11%)
Query: 270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-------EPESQQGALEFQTEIGM 322
           A N  + +  IG GGFG V+KG +    + VAIK L       E E  +   EFQ E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 323 LSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR 382
           +S L H ++V L G  ++   M++  +F+  G L   L    + P+ W+ +L + +  A 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIAL 133
Query: 383 GLHYLHTGANHAVIIHRDVKTTNIL---LDEKW--VAKVSDFGLSKFGPTSVSK-----T 432
           G+ Y+     +  I+HRD+++ NI    LDE     AKV+DFGLS+    SVS       
Sbjct: 134 GIEYMQN--QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQ 191
Query: 433 HLDPEYYRLQQ--LTEKSDVYSFGVVLFEVL 461
            + PE    ++   TEK+D YSF ++L+ +L
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTIL 222

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 120/247 (48%), Gaps = 22/247 (8%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG+V+ G+ N ST  VA+K L+P +      F  E  ++  L+H  LV L     
Sbjct: 20  LGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +  + ++ +FMA+G+L D L   +   +   + ++     A G+ Y+    N+   IHR
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER-KNY---IHR 133
Query: 400 DVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEKSDV 450
           D++  N+L+ E  + K++DFGL++      +     +K  +    PE       T KS+V
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 451 YSFGVVLFEVLC--ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS-CLND 507
           +SFG++L+E++     P   RT A    +L+    Q Y+   ++   D     M  C  +
Sbjct: 194 WSFGILLYEIVTYGKIPYPGRTNADVMSALS----QGYRMPRMENCPDELYDIMKMCWKE 249
Query: 508 EGIRRPS 514
           +   RP+
Sbjct: 250 KAEERPT 256

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHR 133
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 194 WAFGVLLWEI 203

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHR 133
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 194 WAFGVLLWEI 203

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 33/211 (15%)
Query: 280 IGVGGFGDVYKG-FINGSTTP----VAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           +G G FG V+     N S T     VA+K L+  +     +FQ E  +L+ L+H H+V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 335 IGFCNDDREMILVYDFMARGTL--------PDHLYHSDNPP------LPWNQRLEICIGA 380
            G C D   +I+V+++M  G L        PD +   D  P      L  +Q L I    
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVS 430
           A G+ YL   + H   +HRD+ T N L+    + K+ DFG+S+           G T + 
Sbjct: 143 ASGMVYL--ASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              + PE    ++ T +SDV+SFGV+L+E+ 
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEIF 229

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 108/228 (47%), Gaps = 42/228 (18%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPE-SQQGALEFQTEIGMLSQ 325
           NN +    IG G FG V++    G       T VA+K L+ E S     +FQ E  ++++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-----------HSD---------- 364
             + ++V L+G C   + M L++++MA G L + L            HSD          
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 365 -NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
             PPL   ++L I    A G+ YL    +    +HRD+ T N L+ E  V K++DFGLS+
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL----SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 424 F----------GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
                      G  ++    + PE     + T +SDV+++GVVL+E+ 
Sbjct: 223 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHR 135
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 196 WAFGVLLWEI 205

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 109/211 (51%), Gaps = 24/211 (11%)
Query: 270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-------EPESQQGALEFQTEIGM 322
           A N  + +  IG GGFG V+KG +    + VAIK L       E E  +   EFQ E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 323 LSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR 382
           +S L H ++V L G  ++   M++  +F+  G L   L    + P+ W+ +L + +  A 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIAL 133
Query: 383 GLHYLHTGANHAVIIHRDVKTTNIL---LDEKW--VAKVSDFGLSKFGPTSVSK-----T 432
           G+ Y+     +  I+HRD+++ NI    LDE     AKV+DFG S+    SVS       
Sbjct: 134 GIEYMQN--QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLGNFQ 191
Query: 433 HLDPEYYRLQQ--LTEKSDVYSFGVVLFEVL 461
            + PE    ++   TEK+D YSF ++L+ +L
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTIL 222

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 136
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 137 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 197 WAFGVLLWEI 206

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHR 135
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 196 WAFGVLLWEI 205

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHR 135
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 196 WAFGVLLWEI 205

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHR 140
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 201 WAFGVLLWEI 210

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHR 135
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 196 WAFGVLLWEI 205

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 140
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 201 WAFGVLLWEI 210

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 109/211 (51%), Gaps = 24/211 (11%)
Query: 270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-------EPESQQGALEFQTEIGM 322
           A N  + +  IG GGFG V+KG +    + VAIK L       E E  +   EFQ E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 323 LSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR 382
           +S L H ++V L G  ++   M++  +F+  G L   L    + P+ W+ +L + +  A 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIAL 133
Query: 383 GLHYLHTGANHAVIIHRDVKTTNIL---LDEKW--VAKVSDFGLSKFGPTSVSK-----T 432
           G+ Y+     +  I+HRD+++ NI    LDE     AKV+DF LS+    SVS       
Sbjct: 134 GIEYMQN--QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLLGNFQ 191
Query: 433 HLDPEYYRLQQ--LTEKSDVYSFGVVLFEVL 461
            + PE    ++   TEK+D YSF ++L+ +L
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTIL 222

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHR 133
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 194 WAFGVLLWEI 203

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 140
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 201 WAFGVLLWEI 210

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 140
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 201 WAFGVLLWEI 210

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 137
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 198 WAFGVLLWEI 207

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 148
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 149 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 208
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 209 WAFGVLLWEI 218

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 135
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 196 WAFGVLLWEI 205

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 140
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 201 WAFGVLLWEI 210

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 135
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 196 WAFGVLLWEI 205

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 139
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 140 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 199
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 200 WAFGVLLWEI 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 137
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 198 WAFGVLLWEI 207

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 30/208 (14%)
Query: 280 IGVGGFGDV-----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           +G G FG V     Y          VA+K L+  S     +F  E  +L+ L+H H+V  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 335 IGFCNDDREMILVYDFMARGTL--------PDHLYHSD-NPP--LPWNQRLEICIGAARG 383
            G C +   +I+V+++M  G L        PD +  ++ NPP  L  +Q L I    A G
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTH 433
           + YL   + H   +HRD+ T N L+ E  + K+ DFG+S+           G T +    
Sbjct: 141 MVYL--ASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           + PE    ++ T +SDV+S GVVL+E+ 
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIF 224

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHR 342
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           ++   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 403 WAFGVLLWEI 412

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 95/190 (50%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 136
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKF--GPTSVSKTHLD-------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+   G T  +            PE     + + KSDV
Sbjct: 137 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 197 WAFGVLLWEI 206

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 95/190 (50%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 137
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKF--GPTSVSKTHLD-------PEYYRLQQLTEKSDV 450
           D+   N L+ E  + KV+DFGLS+   G T  +            PE     + + KSDV
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 198 WAFGVLLWEI 207

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 93/190 (48%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    ++ +FM  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHR 381
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           ++   N L+ E  + KV+DFGLS+         H           PE     + + KSDV
Sbjct: 382 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 441
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 442 WAFGVLLWEI 451

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 22/200 (11%)
Query: 279 VIGVGGFGDVYKGFING---STTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSL 334
           VIG G FG+V +G +       + VAIK L+   +++   EF +E  ++ Q  H +++ L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
            G   +   ++++ +FM  G L   L  +D       Q + +  G A G+ YL       
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQ-FTVIQLVGMLRGIASGMRYLA----EM 137
Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKF------GPTSVSKTH-------LDPEYYRL 441
             +HRD+   NIL++   V KVSDFGLS+F       PT  S            PE    
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
           ++ T  SD +S+G+V++EV+
Sbjct: 198 RKFTSASDAWSYGIVMWEVM 217

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 102/193 (52%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L  
Sbjct: 189 EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 246
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M++G+L D L       L   Q +++    A G+ Y+         
Sbjct: 247 VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNY 301
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           +HRD++  NIL+ E  V KV+DFGL++      +     +K  +    PE     + T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 362 SDVWSFGILLTEL 374

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 102/193 (52%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L  
Sbjct: 272 EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA 329
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M++G+L D L       L   Q +++    A G+ Y+         
Sbjct: 330 VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNY 384
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           +HRD++  NIL+ E  V KV+DFGL++      +     +K  +    PE     + T K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 445 SDVWSFGILLTEL 457

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 129/282 (45%), Gaps = 34/282 (12%)
Query: 279 VIGVGGFGDVYKGFI--NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL-RHLHLVSL 334
           VIG G FG V K  I  +G     AIKR+ E  S+    +F  E+ +L +L  H ++++L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHS---DNPP-----------LPWNQRLEICIGA 380
           +G C     + L  ++   G L D L  S   +  P           L   Q L      
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--HLDPEY 438
           ARG+ YL    +    IHRD+   NIL+ E +VAK++DFGLS+     V KT   L   +
Sbjct: 152 ARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 207
Query: 439 YRLQQL-----TEKSDVYSFGVVLFEV--LCARPSILRTAAKKQVSLAVWAQQCYQNGTI 491
             ++ L     T  SDV+S+GV+L+E+  L   P    T A+    L    +        
Sbjct: 208 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 267
Query: 492 DQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSI 533
           D++ D   +   C  ++   RPS + ++  L   L+ +++ +
Sbjct: 268 DEVYDLMRQ---CWREKPYERPSFAQILVSLNRMLEERKTYV 306

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 102/193 (52%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L  
Sbjct: 189 EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 246
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M++G+L D L       L   Q +++    A G+ Y+         
Sbjct: 247 VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNY 301
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           +HRD++  NIL+ E  V KV+DFGL++      +     +K  +    PE     + T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 362 SDVWSFGILLTEL 374

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 129/282 (45%), Gaps = 34/282 (12%)
Query: 279 VIGVGGFGDVYKGFI--NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL-RHLHLVSL 334
           VIG G FG V K  I  +G     AIKR+ E  S+    +F  E+ +L +L  H ++++L
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHS---DNPP-----------LPWNQRLEICIGA 380
           +G C     + L  ++   G L D L  S   +  P           L   Q L      
Sbjct: 82  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 141
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--HLDPEY 438
           ARG+ YL    +    IHRD+   NIL+ E +VAK++DFGLS+     V KT   L   +
Sbjct: 142 ARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 197
Query: 439 YRLQQL-----TEKSDVYSFGVVLFEV--LCARPSILRTAAKKQVSLAVWAQQCYQNGTI 491
             ++ L     T  SDV+S+GV+L+E+  L   P    T A+    L    +        
Sbjct: 198 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 257
Query: 492 DQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSI 533
           D++ D   +   C  ++   RPS + ++  L   L+ +++ +
Sbjct: 258 DEVYDLMRQ---CWREKPYERPSFAQILVSLNRMLEERKTYV 296

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 104/193 (53%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L  
Sbjct: 16  EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 73
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M++G+L D L       L   Q +++    A G+ Y+    N+   
Sbjct: 74  VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MNY--- 128
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           +HRD++  NIL+ E  V KV+DFGL++      +     +K  +    PE     + T K
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 188
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 189 SDVWSFGILLTEL 201

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 93/182 (51%), Gaps = 8/182 (4%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG+V+    N  T  VA+K ++P S      F  E  ++  L+H  LV L     
Sbjct: 190 LGAGQFGEVWMATYNKHTK-VAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +  + ++ +FMA+G+L D L   +    P  + ++     A G+ ++    N+   IHR
Sbjct: 248 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-RNY---IHR 302
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFE 459
           D++  NIL+    V K++DFGL++ G     K    PE       T KSDV+SFG++L E
Sbjct: 303 DLRAANILVSASLVCKIADFGLARVGAKFPIK-WTAPEAINFGSFTIKSDVWSFGILLME 361
Query: 460 VL 461
           ++
Sbjct: 362 IV 363

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L  
Sbjct: 13  EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 70
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M++G+L D L       L   Q +++    A G+ Y+    N+   
Sbjct: 71  VVSEE-PIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MNY--- 125
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------LDPEYYRLQQLTEK 447
           +HRD++  NIL+ E  V KV+DFGL++    +                PE     + T K
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 185
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 186 SDVWSFGILLTEL 198

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 27/201 (13%)
Query: 279 VIGVGGFGDVYKGFI--NGSTT--PVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           V+G G FG VYKG     G T   PVAIK L E    +  +EF  E  +++ + H HLV 
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           L+G C     + LV   M  G L ++++ H DN  +     L  C+  A+G+ YL     
Sbjct: 105 LLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWCVQIAKGMMYL----E 157
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTHLDPEYYR 440
              ++HRD+   N+L+      K++DFGL++             G   +    L+  +YR
Sbjct: 158 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 217
Query: 441 LQQLTEKSDVYSFGVVLFEVL 461
             + T +SDV+S+GV ++E++
Sbjct: 218 --KFTHQSDVWSYGVTIWELM 236

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 102/193 (52%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L  
Sbjct: 189 EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 246
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M++G+L D L       L   Q +++    A G+ Y+         
Sbjct: 247 VVSEE-PIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNY 301
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           +HRD++  NIL+ E  V KV+DFGL++      +     +K  +    PE     + T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 362 SDVWSFGILLTEL 374

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 91/190 (47%), Gaps = 14/190 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+VY G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +    +V ++M  G L D+L   +   +     L +    +  + YL         IHR
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKN----FIHR 154
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L+ E  V KV+DFGLS+         H           PE       + KSDV
Sbjct: 155 DLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDV 214
Query: 451 YSFGVVLFEV 460
           ++FGV+L+E+
Sbjct: 215 WAFGVLLWEI 224

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 22/200 (11%)
Query: 279 VIGVGGFGDVYKGFING---STTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSL 334
           VIG G FG+V +G +       + VAIK L+   +++   EF +E  ++ Q  H +++ L
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
            G   +   ++++ +FM  G L   L  +D       Q + +  G A G+ YL       
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQ-FTVIQLVGMLRGIASGMRYLA----EM 135
Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKF------GPTSVSKTH-------LDPEYYRL 441
             +HRD+   NIL++   V KVSDFGLS+F       PT  S            PE    
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
           ++ T  SD +S+G+V++EV+
Sbjct: 196 RKFTSASDAWSYGIVMWEVM 215

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 27/201 (13%)
Query: 279 VIGVGGFGDVYKGFI--NGSTT--PVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           V+G G FG VYKG     G T   PVAIK L E    +  +EF  E  +++ + H HLV 
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           L+G C     + LV   M  G L ++++ H DN  +     L  C+  A+G+ YL     
Sbjct: 82  LLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWCVQIAKGMMYL----E 134
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTHLDPEYYR 440
              ++HRD+   N+L+      K++DFGL++             G   +    L+  +YR
Sbjct: 135 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 194
Query: 441 LQQLTEKSDVYSFGVVLFEVL 461
             + T +SDV+S+GV ++E++
Sbjct: 195 --KFTHQSDVWSYGVTIWELM 213

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG V  G   G    VAIK ++ E      EF  E  ++  L H  LV L G C 
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
             R + ++ ++MA G L ++L    +      Q LE+C      + YL +       +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ----FLHR 144
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L++++ V KVSDFGLS++       + +          PE     + + KSD+
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 451 YSFGVVLFEV 460
           ++FGV+++E+
Sbjct: 205 WAFGVLMWEI 214

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 104/193 (53%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L  
Sbjct: 14  EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 71
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M++G+L D L       L   Q +++    A G+ Y+    N+   
Sbjct: 72  VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-MNY--- 126
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           +HRD++  NIL+ E  V KV+DFGL++      +     +K  +    PE     + T K
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 187 SDVWSFGILLTEL 199

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 104/193 (53%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L  
Sbjct: 12  EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 69
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M++G+L D L       L   Q +++    A G+ Y+    N+   
Sbjct: 70  VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-MNY--- 124
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           +HRD++  NIL+ E  V KV+DFGL++      +     +K  +    PE     + T K
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 185 SDVWSFGILLTEL 197

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 104/193 (53%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L  
Sbjct: 23  EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 80
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M++G+L D L       L   Q +++    A G+ Y+    N+   
Sbjct: 81  VVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-MNY--- 135
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           +HRD++  NIL+ E  V KV+DFGL++      +     +K  +    PE     + T K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 104/193 (53%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L  
Sbjct: 23  EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 80
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M++G+L D L       L   Q +++    A G+ Y+    N+   
Sbjct: 81  VVSEE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-MNY--- 135
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           +HRD++  NIL+ E  V KV+DFGL++      +     +K  +    PE     + T K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 104/193 (53%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L  
Sbjct: 23  EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 80
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M++G+L D L       L   Q +++    A G+ Y+    N+   
Sbjct: 81  VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-MNY--- 135
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           +HRD++  NIL+ E  V KV+DFGL++      +     +K  +    PE     + T K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L  
Sbjct: 23  EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 80
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M++G+L D L       L   Q +++    A G+ Y+    N+   
Sbjct: 81  VVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-MNY--- 135
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------LDPEYYRLQQLTEK 447
           +HRD++  NIL+ E  V KV+DFGL++    +                PE     + T K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 103/193 (53%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L  
Sbjct: 23  EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 80
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M++G L D L       L   Q +++    A G+ Y+    N+   
Sbjct: 81  VVSEE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-MNY--- 135
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           +HRD++  NIL+ E  V KV+DFGL++      +     +K  +    PE     + T K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 100/193 (51%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P        F  E  ++ +LRH  LV L  
Sbjct: 190 EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKP-GNMSPEAFLQEAQVMKKLRHEKLVQLYA 247
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M++G+L D L       L   Q +++    A G+ Y+         
Sbjct: 248 VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE----RMNY 302
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           +HRD++  NIL+ E  V KV+DFGL +      +     +K  +    PE     + T K
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 362
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 363 SDVWSFGILLTEL 375

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG V  G   G    VAIK ++ E      EF  E  ++  L H  LV L G C 
Sbjct: 16  LGTGQFGVVKYGKWRGQY-DVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
             R + ++ ++MA G L ++L    +      Q LE+C      + YL +       +HR
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ----FLHR 128
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L++++ V KVSDFGLS++       + +          PE     + + KSD+
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 188
Query: 451 YSFGVVLFEV 460
           ++FGV+++E+
Sbjct: 189 WAFGVLMWEI 198

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 93/190 (48%), Gaps = 16/190 (8%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG V  G   G    VAIK ++ E      EF  E  ++  L H  LV L G C 
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
             R + ++ ++MA G L ++L    +      Q LE+C      + YL +       +HR
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ----FLHR 129
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKF----GPTSVSKTHL-----DPEYYRLQQLTEKSDV 450
           D+   N L++++ V KVSDFGLS++      TS   +        PE     + + KSD+
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 451 YSFGVVLFEV 460
           ++FGV+++E+
Sbjct: 190 WAFGVLMWEI 199

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG V  G   G    VAIK ++ E      EF  E  ++  L H  LV L G C 
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
             R + ++ ++MA G L ++L    +      Q LE+C      + YL +       +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ----FLHR 144
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L++++ V KVSDFGLS++       + +          PE     + + KSD+
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 451 YSFGVVLFEV 460
           ++FGV+++E+
Sbjct: 205 WAFGVLMWEI 214

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 103/193 (53%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L  
Sbjct: 20  EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 77
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M +G+L D L       L   Q +++    A G+ Y+    N+   
Sbjct: 78  VVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER-MNY--- 132
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           +HRD++  NIL+ E  V KV+DFGL++      +     +K  +    PE     + T K
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 193 SDVWSFGILLTEL 205

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG V  G   G    VAIK ++ E      EF  E  ++  L H  LV L G C 
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
             R + ++ ++MA G L ++L    +      Q LE+C      + YL +       +HR
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ----FLHR 124
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L++++ V KVSDFGLS++       + +          PE     + + KSD+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 451 YSFGVVLFEV 460
           ++FGV+++E+
Sbjct: 185 WAFGVLMWEI 194

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 103/193 (53%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L  
Sbjct: 23  EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 80
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M++G L D L       L   Q +++    A G+ Y+    N+   
Sbjct: 81  VVSEE-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-MNY--- 135
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           +HRD++  NIL+ E  V KV+DFGL++      +     +K  +    PE     + T K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 128/282 (45%), Gaps = 34/282 (12%)
Query: 279 VIGVGGFGDVYKGFI--NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL-RHLHLVSL 334
           VIG G FG V K  I  +G     AIKR+ E  S+    +F  E+ +L +L  H ++++L
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLY--------------HSDNPPLPWNQRLEICIGA 380
           +G C     + L  ++   G L D L               +S    L   Q L      
Sbjct: 89  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 148
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--HLDPEY 438
           ARG+ YL    +    IHR++   NIL+ E +VAK++DFGLS+     V KT   L   +
Sbjct: 149 ARGMDYL----SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 204
Query: 439 YRLQQL-----TEKSDVYSFGVVLFEV--LCARPSILRTAAKKQVSLAVWAQQCYQNGTI 491
             ++ L     T  SDV+S+GV+L+E+  L   P    T A+    L    +        
Sbjct: 205 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 264
Query: 492 DQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSI 533
           D++ D   +   C  ++   RPS + ++  L   L+ +++ +
Sbjct: 265 DEVYDLMRQ---CWREKPYERPSFAQILVSLNRMLEERKTYV 303

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG V  G   G    VAIK ++ E      EF  E  ++  L H  LV L G C 
Sbjct: 17  LGTGQFGVVKYGKWRGQY-DVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
             R + ++ ++MA G L ++L    +      Q LE+C      + YL +       +HR
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ----FLHR 129
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L++++ V KVSDFGLS++       + +          PE     + + KSD+
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 451 YSFGVVLFEV 460
           ++FGV+++E+
Sbjct: 190 WAFGVLMWEI 199

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG V  G   G    VAIK ++ E      EF  E  ++  L H  LV L G C 
Sbjct: 23  LGTGQFGVVKYGKWRGQY-DVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
             R + ++ ++MA G L ++L    +      Q LE+C      + YL +       +HR
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ----FLHR 135
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSDV 450
           D+   N L++++ V KVSDFGLS++       + +          PE     + + KSD+
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 195
Query: 451 YSFGVVLFEV 460
           ++FGV+++E+
Sbjct: 196 WAFGVLMWEI 205

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 104/193 (53%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ ++RH  LV L  
Sbjct: 23  EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKIRHEKLVQLYA 80
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M++G+L D L       L   Q +++    A G+ Y+    N+   
Sbjct: 81  VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-MNY--- 135
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           +HRD++  NIL+ E  V KV+DFGL++      +     +K  +    PE     + T K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 99/193 (51%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L  
Sbjct: 20  EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 77
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M +G+L D L       L   Q +++    A G+ Y+    N+   
Sbjct: 78  VVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER-MNY--- 132
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKF---------GPTSVSKTHLDPEYYRLQQLTEK 447
           +HRD++  NIL+ E  V KV+DFGL++                     PE     + T K
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 193 SDVWSFGILLTEL 205

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 103/193 (53%), Gaps = 16/193 (8%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L  
Sbjct: 23  EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 80
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +++  + +V ++M++G+L D L       L   Q +++    A G+ Y+    N+   
Sbjct: 81  VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-MNY--- 135
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           +HRD+   NIL+ E  V KV+DFGL++      +     +K  +    PE     + T K
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 448 SDVYSFGVVLFEV 460
           SDV+SFG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 273 NFDNDLVIGVGGFGDVYKGFI---NGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRH 328
           N   D V+G G FG+V  G +   +     VAIK L+   +++   +F  E  ++ Q  H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
            +++ L G     + +++V ++M  G+L D      +      Q + +  G A G+ YL 
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL- 151
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTH--------LDPE 437
              +    +HRD+   NIL++   V KVSDFGLS+     P +   T           PE
Sbjct: 152 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 208
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVL 461
               ++ T  SDV+S+G+VL+EV+
Sbjct: 209 AIAYRKFTSASDVWSYGIVLWEVM 232

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 273 NFDNDLVIGVGGFGDVYKGFI---NGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRH 328
           N   D V+G G FG+V  G +   +     VAIK L+   +++   +F  E  ++ Q  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
            +++ L G     + +++V ++M  G+L D      +      Q + +  G A G+ YL 
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 135
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTH--------LDPE 437
                   +HRD+   NIL++   V KVSDFGLS+     P +   T           PE
Sbjct: 136 DMG----YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVL 461
               ++ T  SDV+S+G+VL+EV+
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 22/194 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---FQTEIGMLSQLRHLHLVSLIG 336
           +G G FG+V+ G+ NG T  VA+K L    +QG++    F  E  ++ QL+H  LV L  
Sbjct: 27  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +  + ++ ++M  G+L D L       L  N+ L++    A G+ ++    N+   
Sbjct: 82  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNY--- 136
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------LDPEYYRLQQLTEK 447
           IHRD++  NIL+ +    K++DFGL++    +                PE       T K
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 448 SDVYSFGVVLFEVL 461
           SDV+SFG++L E++
Sbjct: 197 SDVWSFGILLTEIV 210

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 100/194 (51%), Gaps = 22/194 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---FQTEIGMLSQLRHLHLVSLIG 336
           +G G FG+V+ G+ NG T  VA+K L    +QG++    F  E  ++ QL+H  LV L  
Sbjct: 27  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +  + ++ ++M  G+L D L       L  N+ L++    A G+ ++    N+   
Sbjct: 82  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNY--- 136
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           IHRD++  NIL+ +    K++DFGL++      +     +K  +    PE       T K
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 448 SDVYSFGVVLFEVL 461
           SDV+SFG++L E++
Sbjct: 197 SDVWSFGILLTEIV 210

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 100/194 (51%), Gaps = 22/194 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---FQTEIGMLSQLRHLHLVSLIG 336
           +G G FG+V+ G+ NG T  VA+K L    +QG++    F  E  ++ QL+H  LV L  
Sbjct: 16  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 70
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +  + ++ ++M  G+L D L       L  N+ L++    A G+ ++    N+   
Sbjct: 71  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNY--- 125
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           IHRD++  NIL+ +    K++DFGL++      +     +K  +    PE       T K
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 185
Query: 448 SDVYSFGVVLFEVL 461
           SDV+SFG++L E++
Sbjct: 186 SDVWSFGILLTEIV 199

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 100/194 (51%), Gaps = 22/194 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---FQTEIGMLSQLRHLHLVSLIG 336
           +G G FG+V+ G+ NG T  VA+K L    +QG++    F  E  ++ QL+H  LV L  
Sbjct: 26  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 80
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +  + ++ ++M  G+L D L       L  N+ L++    A G+ ++    N+   
Sbjct: 81  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNY--- 135
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           IHRD++  NIL+ +    K++DFGL++      +     +K  +    PE       T K
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 195
Query: 448 SDVYSFGVVLFEVL 461
           SDV+SFG++L E++
Sbjct: 196 SDVWSFGILLTEIV 209

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 22/194 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---FQTEIGMLSQLRHLHLVSLIG 336
           +G G FG+V+ G+ NG T  VA+K L    +QG++    F  E  ++ QL+H  LV L  
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +  + ++ ++M  G+L D L       L  N+ L++    A G+ ++    N+   
Sbjct: 76  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNY--- 130
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------LDPEYYRLQQLTEK 447
           IHRD++  NIL+ +    K++DFGL++    +                PE       T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 448 SDVYSFGVVLFEVL 461
           SDV+SFG++L E++
Sbjct: 191 SDVWSFGILLTEIV 204

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 22/194 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---FQTEIGMLSQLRHLHLVSLIG 336
           +G G FG+V+ G+ NG T  VA+K L    +QG++    F  E  ++ QL+H  LV L  
Sbjct: 22  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 76
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +  + ++ ++M  G+L D L       L  N+ L++    A G+ ++    N+   
Sbjct: 77  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNY--- 131
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------LDPEYYRLQQLTEK 447
           IHRD++  NIL+ +    K++DFGL++    +                PE       T K
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 191
Query: 448 SDVYSFGVVLFEVL 461
           SDV+SFG++L E++
Sbjct: 192 SDVWSFGILLTEIV 205

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 22/194 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---FQTEIGMLSQLRHLHLVSLIG 336
           +G G FG+V+ G+ NG T  VA+K L    +QG++    F  E  ++ QL+H  LV L  
Sbjct: 23  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 77
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +  + ++ ++M  G+L D L       L  N+ L++    A G+ ++    N+   
Sbjct: 78  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNY--- 132
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------LDPEYYRLQQLTEK 447
           IHRD++  NIL+ +    K++DFGL++    +                PE       T K
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 192
Query: 448 SDVYSFGVVLFEVL 461
           SDV+SFG++L E++
Sbjct: 193 SDVWSFGILLTEIV 206

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 22/194 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---FQTEIGMLSQLRHLHLVSLIG 336
           +G G FG+V+ G+ NG T  VA+K L    +QG++    F  E  ++ QL+H  LV L  
Sbjct: 29  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 83
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +  + ++ ++M  G+L D L       L  N+ L++    A G+ ++    N+   
Sbjct: 84  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNY--- 138
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------LDPEYYRLQQLTEK 447
           IHRD++  NIL+ +    K++DFGL++    +                PE       T K
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 198
Query: 448 SDVYSFGVVLFEVL 461
           SDV+SFG++L E++
Sbjct: 199 SDVWSFGILLTEIV 212

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 100/194 (51%), Gaps = 22/194 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---FQTEIGMLSQLRHLHLVSLIG 336
           +G G FG+V+ G+ NG T  VA+K L    +QG++    F  E  ++ QL+H  LV L  
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +  + ++ ++M  G+L D L       L  N+ L++    A G+ ++    N+   
Sbjct: 76  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNY--- 130
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           IHRD++  NIL+ +    K++DFGL++      +     +K  +    PE       T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 448 SDVYSFGVVLFEVL 461
           SDV+SFG++L E++
Sbjct: 191 SDVWSFGILLTEIV 204

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 22/194 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---FQTEIGMLSQLRHLHLVSLIG 336
           +G G FG+V+ G+ NG T  VA+K L    +QG++    F  E  ++ QL+H  LV L  
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +  + ++ ++M  G+L D L       L  N+ L++    A G+ ++    N+   
Sbjct: 76  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNY--- 130
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------LDPEYYRLQQLTEK 447
           IHRD++  NIL+ +    K++DFGL++    +                PE       T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 448 SDVYSFGVVLFEVL 461
           SDV+SFG++L E++
Sbjct: 191 SDVWSFGILLTEIV 204

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 273 NFDNDLVIGVGGFGDVYKGFI---NGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRH 328
           N   D V+G G FG+V  G +   +     VAIK L+   +++   +F  E  ++ Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
            +++ L G     + +++V ++M  G+L D      +      Q + +  G A G+ YL 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL- 163
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTH--------LDPE 437
              +    +HRD+   NIL++   V KVSDFGLS+     P +   T           PE
Sbjct: 164 ---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVL 461
               ++ T  SDV+S+G+VL+EV+
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 22/194 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---FQTEIGMLSQLRHLHLVSLIG 336
           +G G FG+V+ G+ NG T  VA+K L    +QG++    F  E  ++ QL+H  LV L  
Sbjct: 30  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 84
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +  + ++ ++M  G+L D L       L  N+ L++    A G+ ++    N+   
Sbjct: 85  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNY--- 139
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------LDPEYYRLQQLTEK 447
           IHRD++  NIL+ +    K++DFGL++    +                PE       T K
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 199
Query: 448 SDVYSFGVVLFEVL 461
           SDV+SFG++L E++
Sbjct: 200 SDVWSFGILLTEIV 213

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 100/194 (51%), Gaps = 22/194 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---FQTEIGMLSQLRHLHLVSLIG 336
           +G G FG+V+ G+ NG T  VA+K L    +QG++    F  E  ++ QL+H  LV L  
Sbjct: 31  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 85
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +  + ++ ++M  G+L D L       L  N+ L++    A G+ ++    N+   
Sbjct: 86  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNY--- 140
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           IHRD++  NIL+ +    K++DFGL++      +     +K  +    PE       T K
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 200
Query: 448 SDVYSFGVVLFEVL 461
           SDV+SFG++L E++
Sbjct: 201 SDVWSFGILLTEIV 214

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 273 NFDNDLVIGVGGFGDVYKGFI---NGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRH 328
           N   D V+G G FG+V  G +   +     VAIK L+   +++   +F  E  ++ Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
            +++ L G     + +++V ++M  G+L D      +      Q + +  G A G+ YL 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL- 163
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTH--------LDPE 437
              +    +HRD+   NIL++   V KVSDFGLS+     P +   T           PE
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVL 461
               ++ T  SDV+S+G+VL+EV+
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 273 NFDNDLVIGVGGFGDVYKGFI---NGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRH 328
           N   D V+G G FG+V  G +   +     VAIK L+   +++   +F  E  ++ Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
            +++ L G     + +++V ++M  G+L D      +      Q + +  G A G+ YL 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL- 163
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTH--------LDPE 437
              +    +HRD+   NIL++   V KVSDFGLS+     P +   T           PE
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVL 461
               ++ T  SDV+S+G+VL+EV+
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 273 NFDNDLVIGVGGFGDVYKGFI---NGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRH 328
           N   D V+G G FG+V  G +   +     VAIK L+   +++   +F  E  ++ Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
            +++ L G     + +++V ++M  G+L D      +      Q + +  G A G+ YL 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL- 163
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTH--------LDPE 437
              +    +HRD+   NIL++   V KVSDFGLS+     P +   T           PE
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVL 461
               ++ T  SDV+S+G+VL+EV+
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 273 NFDNDLVIGVGGFGDVYKGFI---NGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRH 328
           N   D V+G G FG+V  G +   +     VAIK L+   +++   +F  E  ++ Q  H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
            +++ L G     + +++V ++M  G+L D      +      Q + +  G A G+ YL 
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 162
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTH--------LDPE 437
                   +HRD+   NIL++   V KVSDFGLS+     P +   T           PE
Sbjct: 163 DMG----YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 218
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVL 461
               ++ T  SDV+S+G+VL+EV+
Sbjct: 219 AIAYRKFTSASDVWSYGIVLWEVM 242

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 273 NFDNDLVIGVGGFGDVYKGFI---NGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRH 328
           N   D V+G G FG+V  G +   +     VAIK L+   +++   +F  E  ++ Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
            +++ L G     + +++V ++M  G+L D      +      Q + +  G A G+ YL 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL- 163
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTH--------LDPE 437
              +    +HRD+   NIL++   V KVSDFGLS+     P +   T           PE
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVL 461
               ++ T  SDV+S+G+VL+EV+
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 22/200 (11%)
Query: 279 VIGVGGFGDVYKGFIN---GSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSL 334
           VIG G FG+V  G +         VAIK L+   +++   +F +E  ++ Q  H +++ L
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 99
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
            G       ++++ +FM  G+L   L  +D       Q + +  G A G+ YL    N+ 
Sbjct: 100 EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIAAGMKYL-ADMNY- 156
Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKF------GPTSVSKTH-------LDPEYYRL 441
             +HRD+   NIL++   V KVSDFGLS+F       PT  S            PE  + 
Sbjct: 157 --VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
           ++ T  SDV+S+G+V++EV+
Sbjct: 215 RKFTSASDVWSYGIVMWEVM 234

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 23/222 (10%)
Query: 255 PSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFIN---GSTTPVAIKRLE-PESQ 310
           P+    +F+  EI+A+    +   VIG G FG+V  G +        PVAIK L+   ++
Sbjct: 8   PNQAVHEFA-KEIEASCITIER--VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTE 64
Query: 311 QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPW 370
           +   +F  E  ++ Q  H +++ L G     + +++V ++M  G+L   L  +D      
Sbjct: 65  KQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQ-FTV 123
Query: 371 NQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPT 427
            Q + +  G + G+ YL         +HRD+   NIL++   V KVSDFGLS+     P 
Sbjct: 124 IQLVGMLRGISAGMKYLSDMG----YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 179
Query: 428 SVSKTH--------LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           +   T           PE    ++ T  SDV+S+G+V++EV+
Sbjct: 180 AAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVV 221

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 118/269 (43%), Gaps = 49/269 (18%)
Query: 251 GSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGST-----TPVAIKRL 305
           GSF  +D+   +   E + A         +G G FG VY+G   G       T VAIK +
Sbjct: 1   GSFSAADV---YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV 57
Query: 306 -EPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYH-- 362
            E  S +  +EF  E  ++ +    H+V L+G  +  +  +++ + M RG L  +L    
Sbjct: 58  NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 117
Query: 363 ---SDNP---PLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKV 416
               +NP   P   ++ +++    A G+ YL    N    +HRD+   N ++ E +  K+
Sbjct: 118 PEMENNPVLAPPSLSKMIQMAGEIADGMAYL----NANKFVHRDLAARNCMVAEDFTVKI 173
Query: 417 SDFGLS----------KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPS 466
            DFG++          K G   +    + PE  +    T  SDV+SFGVVL+E+      
Sbjct: 174 GDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI------ 227
Query: 467 ILRTAAKKQVSLAVWAQQCYQNGTIDQIV 495
                       A  A+Q YQ  + +Q++
Sbjct: 228 ------------ATLAEQPYQGLSNEQVL 244

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 118/269 (43%), Gaps = 49/269 (18%)
Query: 251 GSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGST-----TPVAIKRL 305
           GSF  +D+   +   E + A         +G G FG VY+G   G       T VAIK +
Sbjct: 1   GSFSAADV---YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV 57
Query: 306 -EPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYH-- 362
            E  S +  +EF  E  ++ +    H+V L+G  +  +  +++ + M RG L  +L    
Sbjct: 58  NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 117
Query: 363 ---SDNP---PLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKV 416
               +NP   P   ++ +++    A G+ YL    N    +HRD+   N ++ E +  K+
Sbjct: 118 PEMENNPVLAPPSLSKMIQMAGEIADGMAYL----NANKFVHRDLAARNCMVAEDFTVKI 173
Query: 417 SDFGLS----------KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPS 466
            DFG++          K G   +    + PE  +    T  SDV+SFGVVL+E+      
Sbjct: 174 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI------ 227
Query: 467 ILRTAAKKQVSLAVWAQQCYQNGTIDQIV 495
                       A  A+Q YQ  + +Q++
Sbjct: 228 ------------ATLAEQPYQGLSNEQVL 244

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 273 NFDNDLVIGVGGFGDVYKGFI---NGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRH 328
           N   D V+G G FG+V  G +   +     VAIK L+   +++   +F  E  ++ Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
            +++ L G     + +++V + M  G+L D      +      Q + +  G A G+ YL 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 389 -TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTH--------LDP 436
             GA     +HRD+   NIL++   V KVSDFGLS+     P +   T           P
Sbjct: 165 DMGA-----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVL 461
           E    ++ T  SDV+S+G+VL+EV+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 273 NFDNDLVIGVGGFGDVYKGFI---NGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRH 328
           N   D V+G G FG+V  G +   +     VAIK L+   +++   +F  E  ++ Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
            +++ L G     + +++V ++M  G+L D      +      Q + +  G A G+ YL 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTH--------LDPE 437
                   +HRD+   NIL++   V KVSDFGL++     P +   T           PE
Sbjct: 165 DMG----YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVL 461
               ++ T  SDV+S+G+VL+EV+
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 273 NFDNDLVIGVGGFGDVYKGFI---NGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRH 328
           N   D V+G G FG+V  G +   +     VAIK L+   +++   +F  E  ++ Q  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
            +++ L G     + +++V + M  G+L D      +      Q + +  G A G+ YL 
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 135
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTH--------LDPE 437
                   +HRD+   NIL++   V KVSDFGLS+     P +   T           PE
Sbjct: 136 DMG----YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVL 461
               ++ T  SDV+S+G+VL+EV+
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 100/194 (51%), Gaps = 22/194 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---FQTEIGMLSQLRHLHLVSLIG 336
           +G G FG+V+ G+ NG T  VA+K L    +QG++    F  E  ++ QL+H  LV L  
Sbjct: 17  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 71
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +  + ++ ++M  G+L D L       L  N+ L++    A G+ ++    N+   
Sbjct: 72  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNY--- 126
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEK 447
           IHR+++  NIL+ +    K++DFGL++      +     +K  +    PE       T K
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 186
Query: 448 SDVYSFGVVLFEVL 461
           SDV+SFG++L E++
Sbjct: 187 SDVWSFGILLTEIV 200

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 36/206 (17%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+  +++   +F+ EI +L  L+H ++V   
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 336 GFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G C     R + L+ +++  G+L D+L       +   + L+      +G+ YL T    
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKR-- 135
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ---------- 443
              IHR++ T NIL++ +   K+ DFGL+K  P        D EYY++++          
Sbjct: 136 --YIHRNLATRNILVENENRVKIGDFGLTKVLPQ-------DKEYYKVKEPGESPIFWYA 186
Query: 444 ---LTEK-----SDVYSFGVVLFEVL 461
              LTE      SDV+SFGVVL+E+ 
Sbjct: 187 PESLTESKFSVASDVWSFGVVLYELF 212

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 23/222 (10%)
Query: 255 PSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFIN---GSTTPVAIKRLE-PESQ 310
           P+    QF+  E+ A+    +   VIG G FG+V  G +         VAIK L+   ++
Sbjct: 29  PNRAVHQFA-KELDASCIKIER--VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTE 85
Query: 311 QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPW 370
           +   +F  E  ++ Q  H ++V L G     + +++V +FM  G L   L   D      
Sbjct: 86  KQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQ-FTV 144
Query: 371 NQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPT 427
            Q + +  G A G+ YL         +HRD+   NIL++   V KVSDFGLS+     P 
Sbjct: 145 IQLVGMLRGIAAGMRYLADMG----YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPE 200
Query: 428 SVSKTH--------LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           +V  T           PE  + ++ T  SDV+S+G+V++EV+
Sbjct: 201 AVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 242

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 273 NFDNDLVIGVGGFGDVYKGFI---NGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRH 328
           N   D V+G G FG+V  G +   +     VAIK L+   +++   +F  E  ++ Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
            +++ L G     + +++V ++M  G+L D      +      Q + +  G A G+ YL 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL- 163
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTH--------LDPE 437
              +    +HRD+   NIL++   V KVSDFGL +     P +   T           PE
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVL 461
               ++ T  SDV+S+G+VL+EV+
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 273 NFDNDLVIGVGGFGDVYKGFI---NGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRH 328
           N   D V+G G FG+V  G +   +     VAIK L+   +++   +F  E  ++ Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
            +++ L G     + +++V + M  G+L D      +      Q + +  G A G+ YL 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL- 163
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTH--------LDPE 437
              +    +HRD+   NIL++   V KVSDFGLS+     P +   T           PE
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVL 461
               ++ T  SDV+S+G+VL+EV+
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGST-----TPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G   G       T VAIK + E  S +  +EF  E  ++ +    H+V 
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYH-----SDNP---PLPWNQRLEICIGAARGLH 385
           L+G  +  +  +++ + M RG L  +L       ++NP   P   ++ +++    A G+ 
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HRD+   N ++ E +  K+ DFG++          K G   +    + 
Sbjct: 143 YL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 198
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEV 460
           PE  +    T  SDV+SFGVVL+E+
Sbjct: 199 PESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 109/240 (45%), Gaps = 46/240 (19%)
Query: 280 IGVGGFGDVYKGFINGST-----TPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G   G       T VAIK + E  S +  +EF  E  ++ +    H+V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYH-----SDNP---PLPWNQRLEICIGAARGLH 385
           L+G  +  +  +++ + M RG L  +L       ++NP   P   ++ +++    A G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HRD+   N ++ E +  K+ DFG++          K G   +    + 
Sbjct: 153 YL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV 495
           PE  +    T  SDV+SFGVVL+E+                  A  A+Q YQ  + +Q++
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWEI------------------ATLAEQPYQGLSNEQVL 250

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 22/196 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKR----LEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           IG G FG+V+ G +    T VA+K     L P+ +    +F  E  +L Q  H ++V LI
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA---KFLQEARILKQYSHPNIVRLI 178
Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
           G C   + + +V + +  G     L  ++   L     L++   AA G+ YL +      
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLES----KC 233
Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRLQQLT 445
            IHRD+   N L+ EK V K+SDFG+S+           G   V      PE     + +
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 446 EKSDVYSFGVVLFEVL 461
            +SDV+SFG++L+E  
Sbjct: 294 SESDVWSFGILLWETF 309

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 49/271 (18%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G +   +G     A+K L   +  G + +F TE  ++    H +++SL
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 335 IGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C   +   ++V  +M  G L + + +  + P      +   +  A+G+ YL +    
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKK-- 145
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRL------------ 441
              +HRD+   N +LDEK+  KV+DFGL        ++   D EYY +            
Sbjct: 146 --FVHRDLAARNCMLDEKFTVKVADFGL--------ARDMYDKEYYSVHNKTGAKLPVKW 195
Query: 442 --------QQLTEKSDVYSFGVVLFEVLC----ARPSILRTAAKKQVSLAVWAQQCYQNG 489
                   Q+ T KSDV+SFGV+L+E++       P +          + V+  Q  +  
Sbjct: 196 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLLQGRRLL 249
Query: 490 TIDQIVDPFLKAM-SCLNDEGIRRPSMSDVV 519
             +   DP  + M  C + +   RPS S++V
Sbjct: 250 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 280

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 22/196 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKR----LEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           IG G FG+V+ G +    T VA+K     L P+ +    +F  E  +L Q  H ++V LI
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA---KFLQEARILKQYSHPNIVRLI 178
Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
           G C   + + +V + +  G     L  ++   L     L++   AA G+ YL +      
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLES----KC 233
Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRLQQLT 445
            IHRD+   N L+ EK V K+SDFG+S+           G   V      PE     + +
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 446 EKSDVYSFGVVLFEVL 461
            +SDV+SFG++L+E  
Sbjct: 294 SESDVWSFGILLWETF 309

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 49/271 (18%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G +   +G     A+K L   +  G + +F TE  ++    H +++SL
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 335 IGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C   +   ++V  +M  G L + + +  + P      +   +  A+G+ YL +    
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKK-- 171
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRL------------ 441
              +HRD+   N +LDEK+  KV+DFGL        ++   D EYY +            
Sbjct: 172 --FVHRDLAARNCMLDEKFTVKVADFGL--------ARDMYDKEYYSVHNKTGAKLPVKW 221
Query: 442 --------QQLTEKSDVYSFGVVLFEVLC----ARPSILRTAAKKQVSLAVWAQQCYQNG 489
                   Q+ T KSDV+SFGV+L+E++       P +          + V+  Q  +  
Sbjct: 222 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLLQGRRLL 275
Query: 490 TIDQIVDPFLKAM-SCLNDEGIRRPSMSDVV 519
             +   DP  + M  C + +   RPS S++V
Sbjct: 276 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 306

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 49/271 (18%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G +   +G     A+K L   +  G + +F TE  ++    H +++SL
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 335 IGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C   +   ++V  +M  G L + + +  + P      +   +  A+G+ YL +    
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKK-- 153
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRL------------ 441
              +HRD+   N +LDEK+  KV+DFGL        ++   D EYY +            
Sbjct: 154 --FVHRDLAARNCMLDEKFTVKVADFGL--------ARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 442 --------QQLTEKSDVYSFGVVLFEVLC----ARPSILRTAAKKQVSLAVWAQQCYQNG 489
                   Q+ T KSDV+SFGV+L+E++       P +          + V+  Q  +  
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLLQGRRLL 257
Query: 490 TIDQIVDPFLKAM-SCLNDEGIRRPSMSDVV 519
             +   DP  + M  C + +   RPS S++V
Sbjct: 258 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 22/199 (11%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+  +++   +F+ EI +L  L+H ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 336 GFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G C     R + L+ +++  G+L D+L       +   + L+      +G+ YL T    
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKR-- 137
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE------YYRLQQLTEK 447
              IHRD+ T NIL++ +   K+ DFGL+K  P       +         +Y  + LTE 
Sbjct: 138 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 448 -----SDVYSFGVVLFEVL 461
                SDV+SFGVVL+E+ 
Sbjct: 196 KFSVASDVWSFGVVLYELF 214

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 49/271 (18%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G +   +G     A+K L   +  G + +F TE  ++    H +++SL
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 335 IGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C   +   ++V  +M  G L + + +  + P      +   +  A+G+ YL +    
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKK-- 172
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRL------------ 441
              +HRD+   N +LDEK+  KV+DFGL        ++   D EYY +            
Sbjct: 173 --FVHRDLAARNCMLDEKFTVKVADFGL--------ARDMYDKEYYSVHNKTGAKLPVKW 222
Query: 442 --------QQLTEKSDVYSFGVVLFEVLC----ARPSILRTAAKKQVSLAVWAQQCYQNG 489
                   Q+ T KSDV+SFGV+L+E++       P +          + V+  Q  +  
Sbjct: 223 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLLQGRRLL 276
Query: 490 TIDQIVDPFLKAM-SCLNDEGIRRPSMSDVV 519
             +   DP  + M  C + +   RPS S++V
Sbjct: 277 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 307

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 49/271 (18%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G +   +G     A+K L   +  G + +F TE  ++    H +++SL
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 335 IGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C   +   ++V  +M  G L + + +  + P      +   +  A+G+ YL +    
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKK-- 152
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRL------------ 441
              +HRD+   N +LDEK+  KV+DFGL        ++   D EYY +            
Sbjct: 153 --FVHRDLAARNCMLDEKFTVKVADFGL--------ARDMYDKEYYSVHNKTGAKLPVKW 202
Query: 442 --------QQLTEKSDVYSFGVVLFEVLC----ARPSILRTAAKKQVSLAVWAQQCYQNG 489
                   Q+ T KSDV+SFGV+L+E++       P +          + V+  Q  +  
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLLQGRRLL 256
Query: 490 TIDQIVDPFLKAM-SCLNDEGIRRPSMSDVV 519
             +   DP  + M  C + +   RPS S++V
Sbjct: 257 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 46/240 (19%)
Query: 280 IGVGGFGDVYKGFINGST-----TPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G   G       T VAIK + E  S +  +EF  E  ++ +    H+V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYH-----SDNP---PLPWNQRLEICIGAARGLH 385
           L+G  +  +  +++ + M RG L  +L        +NP   P   ++ +++    A G+ 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HRD+   N ++ E +  K+ DFG++          K G   +    + 
Sbjct: 146 YL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 201
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV 495
           PE  +    T  SDV+SFGVVL+E+                  A  A+Q YQ  + +Q++
Sbjct: 202 PESLKDGVFTTYSDVWSFGVVLWEI------------------ATLAEQPYQGLSNEQVL 243

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 112/258 (43%), Gaps = 46/258 (17%)
Query: 262 FSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGST-----TPVAIKRL-EPESQQGALE 315
           F   E + A         +G G FG VY+G   G       T VAIK + E  S +  +E
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 65
Query: 316 FQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYH-----SDNP---P 367
           F  E  ++ +    H+V L+G  +  +  +++ + M RG L  +L        +NP   P
Sbjct: 66  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 125
Query: 368 LPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----- 422
              ++ +++    A G+ YL    N    +HRD+   N ++ E +  K+ DFG++     
Sbjct: 126 PSLSKMIQMAGEIADGMAYL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 181
Query: 423 -----KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVS 477
                K G   +    + PE  +    T  SDV+SFGVVL+E+                 
Sbjct: 182 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI----------------- 224
Query: 478 LAVWAQQCYQNGTIDQIV 495
            A  A+Q YQ  + +Q++
Sbjct: 225 -ATLAEQPYQGLSNEQVL 241

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 49/271 (18%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G +   +G     A+K L   +  G + +F TE  ++    H +++SL
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 335 IGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C   +   ++V  +M  G L + + +  + P      +   +  A+G+ YL +    
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKK-- 151
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRL------------ 441
              +HRD+   N +LDEK+  KV+DFGL        ++   D EYY +            
Sbjct: 152 --FVHRDLAARNCMLDEKFTVKVADFGL--------ARDMYDKEYYSVHNKTGAKLPVKW 201
Query: 442 --------QQLTEKSDVYSFGVVLFEVLC----ARPSILRTAAKKQVSLAVWAQQCYQNG 489
                   Q+ T KSDV+SFGV+L+E++       P +          + V+  Q  +  
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLLQGRRLL 255
Query: 490 TIDQIVDPFLKAM-SCLNDEGIRRPSMSDVV 519
             +   DP  + M  C + +   RPS S++V
Sbjct: 256 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 286

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 49/271 (18%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G +   +G     A+K L   +  G + +F TE  ++    H +++SL
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 335 IGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C   +   ++V  +M  G L + + +  + P      +   +  A+G+ YL +    
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKYLASKK-- 148
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRL------------ 441
              +HRD+   N +LDEK+  KV+DFGL        ++   D EYY +            
Sbjct: 149 --FVHRDLAARNCMLDEKFTVKVADFGL--------ARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 442 --------QQLTEKSDVYSFGVVLFEVLC----ARPSILRTAAKKQVSLAVWAQQCYQNG 489
                   Q+ T KSDV+SFGV+L+E++       P +          + V+  Q  +  
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLLQGRRLL 252
Query: 490 TIDQIVDPFLKAM-SCLNDEGIRRPSMSDVV 519
             +   DP  + M  C + +   RPS S++V
Sbjct: 253 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 283

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 46/240 (19%)
Query: 280 IGVGGFGDVYKGFINGST-----TPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G   G       T VAIK + E  S +  +EF  E  ++ +    H+V 
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYH-----SDNP---PLPWNQRLEICIGAARGLH 385
           L+G  +  +  +++ + M RG L  +L        +NP   P   ++ +++    A G+ 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HRD+   N ++ E +  K+ DFG++          K G   +    + 
Sbjct: 138 YL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 193
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV 495
           PE  +    T  SDV+SFGVVL+E+                  A  A+Q YQ  + +Q++
Sbjct: 194 PESLKDGVFTTYSDVWSFGVVLWEI------------------ATLAEQPYQGLSNEQVL 235

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 49/271 (18%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G +   +G     A+K L   +  G + +F TE  ++    H +++SL
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 335 IGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C   +   ++V  +M  G L + + +  + P      +   +  A+G+ YL +    
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKK-- 153
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRL------------ 441
              +HRD+   N +LDEK+  KV+DFGL        ++   D EYY +            
Sbjct: 154 --FVHRDLAARNCMLDEKFTVKVADFGL--------ARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 442 --------QQLTEKSDVYSFGVVLFEVLC----ARPSILRTAAKKQVSLAVWAQQCYQNG 489
                   Q+ T KSDV+SFGV+L+E++       P +          + V+  Q  +  
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLLQGRRLL 257
Query: 490 TIDQIVDPFLKAM-SCLNDEGIRRPSMSDVV 519
             +   DP  + M  C + +   RPS S++V
Sbjct: 258 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 49/271 (18%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G +   +G     A+K L   +  G + +F TE  ++    H +++SL
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 335 IGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C   +   ++V  +M  G L + + +  + P      +   +  A+G+ YL +    
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKK-- 150
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRL------------ 441
              +HRD+   N +LDEK+  KV+DFGL        ++   D EYY +            
Sbjct: 151 --FVHRDLAARNCMLDEKFTVKVADFGL--------ARDMYDKEYYSVHNKTGAKLPVKW 200
Query: 442 --------QQLTEKSDVYSFGVVLFEVLC----ARPSILRTAAKKQVSLAVWAQQCYQNG 489
                   Q+ T KSDV+SFGV+L+E++       P +          + V+  Q  +  
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLLQGRRLL 254
Query: 490 TIDQIVDPFLKAM-SCLNDEGIRRPSMSDVV 519
             +   DP  + M  C + +   RPS S++V
Sbjct: 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 285

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 22/199 (11%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+  +++   +F+ EI +L  L+H ++V   
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 336 GFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G C     R + L+ +++  G+L D+L       +   + L+      +G+ YL T    
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKR-- 139
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE------YYRLQQLTEK 447
              IHRD+ T NIL++ +   K+ DFGL+K  P       +         +Y  + LTE 
Sbjct: 140 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 197
Query: 448 -----SDVYSFGVVLFEVL 461
                SDV+SFGVVL+E+ 
Sbjct: 198 KFSVASDVWSFGVVLYELF 216

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 96/194 (49%), Gaps = 22/194 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---FQTEIGMLSQLRHLHLVSLIG 336
           +G G  G+V+ G+ NG T  VA+K L    +QG++    F  E  ++ QL+H  LV L  
Sbjct: 21  LGAGQAGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +  + ++ ++M  G+L D L       L  N+ L++    A G+ ++    N+   
Sbjct: 76  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNY--- 130
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------LDPEYYRLQQLTEK 447
           IHRD++  NIL+ +    K++DFGL++    +                PE       T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 448 SDVYSFGVVLFEVL 461
           SDV+SFG++L E++
Sbjct: 191 SDVWSFGILLTEIV 204

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 22/199 (11%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+  +++   +F+ EI +L  L+H ++V   
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 336 GFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G C     R + L+ +++  G+L D+L       +   + L+      +G+ YL T    
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKR-- 138
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE------YYRLQQLTEK 447
              IHRD+ T NIL++ +   K+ DFGL+K  P       +         +Y  + LTE 
Sbjct: 139 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 196
Query: 448 -----SDVYSFGVVLFEVL 461
                SDV+SFGVVL+E+ 
Sbjct: 197 KFSVASDVWSFGVVLYELF 215

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 95/191 (49%), Gaps = 16/191 (8%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG+V+    N  T  VA+K ++P S      F  E  ++  L+H  LV L     
Sbjct: 23  LGAGQFGEVWMATYNKHTK-VAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +  + ++ +FMA+G+L D L   +    P  + ++     A G+ ++    N+   IHR
Sbjct: 81  KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-RNY---IHR 135
Query: 400 DVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEKSDV 450
           D++  NIL+    V K++DFGL++      +     +K  +    PE       T KSDV
Sbjct: 136 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 195
Query: 451 YSFGVVLFEVL 461
           +SFG++L E++
Sbjct: 196 WSFGILLMEIV 206

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 22/199 (11%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+  +++   +F+ EI +L  L+H ++V   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 336 GFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G C     R + L+ +++  G+L D+L       +   + L+      +G+ YL T    
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKR-- 165
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE------YYRLQQLTEK 447
              IHRD+ T NIL++ +   K+ DFGL+K  P       +         +Y  + LTE 
Sbjct: 166 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 223
Query: 448 -----SDVYSFGVVLFEVL 461
                SDV+SFGVVL+E+ 
Sbjct: 224 KFSVASDVWSFGVVLYELF 242

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 22/199 (11%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+  +++   +F+ EI +L  L+H ++V   
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 336 GFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G C     R + L+ +++  G+L D+L       +   + L+      +G+ YL T    
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKR-- 141
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE------YYRLQQLTEK 447
              IHRD+ T NIL++ +   K+ DFGL+K  P       +         +Y  + LTE 
Sbjct: 142 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 199
Query: 448 -----SDVYSFGVVLFEVL 461
                SDV+SFGVVL+E+ 
Sbjct: 200 KFSVASDVWSFGVVLYELF 218

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 46/240 (19%)
Query: 280 IGVGGFGDVYKGFINGST-----TPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G   G       T VAIK + E  S +  +EF  E  ++ +    H+V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYH-----SDNP---PLPWNQRLEICIGAARGLH 385
           L+G  +  +  +++ + M RG L  +L        +NP   P   ++ +++    A G+ 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HRD+   N ++ E +  K+ DFG++          K G   +    + 
Sbjct: 140 YL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 195
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV 495
           PE  +    T  SDV+SFGVVL+E+                  A  A+Q YQ  + +Q++
Sbjct: 196 PESLKDGVFTTYSDVWSFGVVLWEI------------------ATLAEQPYQGLSNEQVL 237

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 22/199 (11%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+  +++   +F+ EI +L  L+H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 336 GFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G C     R + L+ +++  G+L D+L       +   + L+      +G+ YL T    
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKR-- 134
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE------YYRLQQLTEK 447
              IHRD+ T NIL++ +   K+ DFGL+K  P       +         +Y  + LTE 
Sbjct: 135 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 448 -----SDVYSFGVVLFEVL 461
                SDV+SFGVVL+E+ 
Sbjct: 193 KFSVASDVWSFGVVLYELF 211

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 22/199 (11%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+  +++   +F+ EI +L  L+H ++V   
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 336 GFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G C     R + L+ +++  G+L D+L       +   + L+      +G+ YL T    
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKR-- 133
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE------YYRLQQLTEK 447
              IHRD+ T NIL++ +   K+ DFGL+K  P       +         +Y  + LTE 
Sbjct: 134 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 191
Query: 448 -----SDVYSFGVVLFEVL 461
                SDV+SFGVVL+E+ 
Sbjct: 192 KFSVASDVWSFGVVLYELF 210

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 22/199 (11%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+  +++   +F+ EI +L  L+H ++V   
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 336 GFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G C     R + L+ +++  G+L D+L       +   + L+      +G+ YL T    
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKR-- 132
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE------YYRLQQLTEK 447
              IHRD+ T NIL++ +   K+ DFGL+K  P       +         +Y  + LTE 
Sbjct: 133 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 190
Query: 448 -----SDVYSFGVVLFEVL 461
                SDV+SFGVVL+E+ 
Sbjct: 191 KFSVASDVWSFGVVLYELF 209

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 22/199 (11%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+  +++   +F+ EI +L  L+H ++V   
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 336 GFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G C     R + L+ +++  G+L D+L       +   + L+      +G+ YL T    
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKR-- 140
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE------YYRLQQLTEK 447
              IHRD+ T NIL++ +   K+ DFGL+K  P       +         +Y  + LTE 
Sbjct: 141 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 198
Query: 448 -----SDVYSFGVVLFEVL 461
                SDV+SFGVVL+E+ 
Sbjct: 199 KFSVASDVWSFGVVLYELF 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 22/199 (11%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+  +++   +F+ EI +L  L+H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 336 GFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G C     R + L+ +++  G+L D+L       +   + L+      +G+ YL T    
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKR-- 134
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE------YYRLQQLTEK 447
              IHRD+ T NIL++ +   K+ DFGL+K  P       +         +Y  + LTE 
Sbjct: 135 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 448 -----SDVYSFGVVLFEVL 461
                SDV+SFGVVL+E+ 
Sbjct: 193 KFSVASDVWSFGVVLYELF 211

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGST-----TPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G   G       T VAIK + E  S +  +EF  E  ++ +    H+V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYH-----SDNP---PLPWNQRLEICIGAARGLH 385
           L+G  +  +  +++ + M RG L  +L        +NP   P   ++ +++    A G+ 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HRD+   N ++ E +  K+ DFG++          K G   +    + 
Sbjct: 146 YL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 201
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEV 460
           PE  +    T  SDV+SFGVVL+E+
Sbjct: 202 PESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 22/200 (11%)
Query: 279 VIGVGGFGDVYKGFIN---GSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSL 334
           VIG G FG+V  G +         VAIK L+   +++   +F +E  ++ Q  H +++ L
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
            G       ++++ +FM  G+L   L  +D       Q + +  G A G+ YL    N+ 
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIAAGMKYL-ADMNY- 130
Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKF------GPTSVSKTH-------LDPEYYRL 441
             +HR +   NIL++   V KVSDFGLS+F       PT  S            PE  + 
Sbjct: 131 --VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
           ++ T  SDV+S+G+V++EV+
Sbjct: 189 RKFTSASDVWSYGIVMWEVM 208

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 22/199 (11%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+  +++   +F+ EI +L  L+H ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 336 GFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G C     R + L+ +++  G+L D+L  +    +   + L+      +G+ YL T    
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QAHAERIDHIKLLQYTSQICKGMEYLGTKR-- 137
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE------YYRLQQLTEK 447
              IHRD+ T NIL++ +   K+ DFGL+K  P       +         +Y  + LTE 
Sbjct: 138 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 448 -----SDVYSFGVVLFEVL 461
                SDV+SFGVVL+E+ 
Sbjct: 196 KFSVASDVWSFGVVLYELF 214

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 46/240 (19%)
Query: 280 IGVGGFGDVYKGFINGST-----TPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G   G       T VAIK + E  S +  +EF  E  ++ +    H+V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYH-----SDNP---PLPWNQRLEICIGAARGLH 385
           L+G  +  +  +++ + M RG L  +L        +NP   P   ++ +++    A G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HRD+   N ++ E +  K+ DFG++          K G   +    + 
Sbjct: 153 YL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV 495
           PE  +    T  SDV+SFGVVL+E+                  A  A+Q YQ  + +Q++
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWEI------------------ATLAEQPYQGLSNEQVL 250

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 22/199 (11%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+  +++   +F+ EI +L  L+H ++V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 336 GFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G C     R + L+ +++  G+L D+L       +   + L+      +G+ YL T    
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKR-- 152
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE------YYRLQQLTEK 447
              IHRD+ T NIL++ +   K+ DFGL+K  P       +         +Y  + LTE 
Sbjct: 153 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 448 -----SDVYSFGVVLFEVL 461
                SDV+SFGVVL+E+ 
Sbjct: 211 KFSVASDVWSFGVVLYELF 229

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 36/206 (17%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+  +++   +F+ EI +L  L+H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 336 GFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G C     R + L+ +++  G+L D+L       +   + L+      +G+ YL T    
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKR-- 134
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ---------- 443
              IHRD+ T NIL++ +   K+ DFGL+K  P        D E++++++          
Sbjct: 135 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEFFKVKEPGESPIFWYA 185
Query: 444 ---LTEK-----SDVYSFGVVLFEVL 461
              LTE      SDV+SFGVVL+E+ 
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELF 211

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 266 EIQAATNNFDNDLVIGVGGFGDVYKGFIN---GSTTPVAIKRLEPE-SQQGALEFQTEIG 321
           EI+A+  + +   +IG G  G+V  G +        PVAIK L+   +++   +F +E  
Sbjct: 45  EIEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           ++ Q  H +++ L G     R  ++V ++M  G+L D    + +      Q + +  G  
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLRGVG 161
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTH----- 433
            G+ YL    +    +HRD+   N+L+D   V KVSDFGLS+     P +   T      
Sbjct: 162 AGMRYL----SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIP 217
Query: 434 ---LDPEYYRLQQLTEKSDVYSFGVVLFEVLC 462
                PE    +  +  SDV+SFGVV++EVL 
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 99/191 (51%), Gaps = 16/191 (8%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG+V+ G  NG+T  VAIK L+P +      F  E  ++ +L+H  LV L    +
Sbjct: 17  LGNGQFGEVWMGTWNGNTK-VAIKTLKPGTMSPE-SFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
           ++  + +V ++M +G+L D L   +   L     +++    A G+ Y+    N+   IHR
Sbjct: 75  EE-PIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER-MNY---IHR 129
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------LDPEYYRLQQLTEKSDV 450
           D+++ NIL+    + K++DFGL++    +                PE     + T KSDV
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 451 YSFGVVLFEVL 461
           +SFG++L E++
Sbjct: 190 WSFGILLTELV 200

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 46/240 (19%)
Query: 280 IGVGGFGDVYKGFINGST-----TPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G   G       T VAIK + E  S +  +EF  E  ++ +    H+V 
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYH-----SDNP---PLPWNQRLEICIGAARGLH 385
           L+G  +  +  +++ + M RG L  +L        +NP   P   ++ +++    A G+ 
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HRD+   N ++ E +  K+ DFG++          K G   +    + 
Sbjct: 175 YL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 230
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV 495
           PE  +    T  SDV+SFGVVL+E+                  A  A+Q YQ  + +Q++
Sbjct: 231 PESLKDGVFTTYSDVWSFGVVLWEI------------------ATLAEQPYQGLSNEQVL 272

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 22/199 (11%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+  +++   +F+ EI +L  L+H ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 336 GFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G C     R + L+ +F+  G+L ++L       +   + L+      +G+ YL T    
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKR-- 137
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE------YYRLQQLTEK 447
              IHRD+ T NIL++ +   K+ DFGL+K  P       +         +Y  + LTE 
Sbjct: 138 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 448 -----SDVYSFGVVLFEVL 461
                SDV+SFGVVL+E+ 
Sbjct: 196 KFSVASDVWSFGVVLYELF 214

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 22/199 (11%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+  +++   +F+ EI +L  L+H ++V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 336 GFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G C     R + L+ +++  G+L D+L       +   + L+      +G+ YL T    
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKR-- 152
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE------YYRLQQLTEK 447
              IHRD+ T NIL++ +   K+ DFGL+K  P       +         +Y  + LTE 
Sbjct: 153 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 448 -----SDVYSFGVVLFEVL 461
                SDV+SFGVVL+E+ 
Sbjct: 211 KFSVASDVWSFGVVLYELF 229

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++  RG +   L           QR    I   A  
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFD---EQRTATYITELANA 125
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S   T      +L PE
Sbjct: 126 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE 181
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 95/191 (49%), Gaps = 16/191 (8%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG+V+    N  T  VA+K ++P S      F  E  ++  L+H  LV L     
Sbjct: 196 LGAGQFGEVWMATYNKHTK-VAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +  + ++ +FMA+G+L D L   +    P  + ++     A G+ ++    N+   IHR
Sbjct: 254 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-RNY---IHR 308
Query: 400 DVKTTNILLDEKWVAKVSDFGLSK------FGPTSVSKTHLD---PEYYRLQQLTEKSDV 450
           D++  NIL+    V K++DFGL++      +     +K  +    PE       T KSDV
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 451 YSFGVVLFEVL 461
           +SFG++L E++
Sbjct: 369 WSFGILLMEIV 379

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 266 EIQAATNNFDNDLVIGVGGFGDVYKGFIN---GSTTPVAIKRLEPE-SQQGALEFQTEIG 321
           EI+A+  + +   +IG G  G+V  G +        PVAIK L+   +++   +F +E  
Sbjct: 45  EIEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           ++ Q  H +++ L G     R  ++V ++M  G+L D    + +      Q + +  G  
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLRGVG 161
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTH----- 433
            G+ YL    +    +HRD+   N+L+D   V KVSDFGLS+     P +   T      
Sbjct: 162 AGMRYL----SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217
Query: 434 ---LDPEYYRLQQLTEKSDVYSFGVVLFEVLC 462
                PE    +  +  SDV+SFGVV++EVL 
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 121/263 (46%), Gaps = 33/263 (12%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G +   +G     A+K L   +  G + +F TE  ++    H +++SL
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 335 IGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C   +   ++V  +M  G L + + +  + P      +   +  A+G+ YL +    
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKK-- 152
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-----------LDPEYYRL 441
              +HRD+   N +LDEK+  KV+DFGL++          H           +  E  + 
Sbjct: 153 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 442 QQLTEKSDVYSFGVVLFEVLC----ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP 497
           Q+ T KSDV+SFGV+L+E++       P +          + V+  Q  +    +   DP
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLLQGRRLLQPEYCPDP 264
Query: 498 FLKAM-SCLNDEGIRRPSMSDVV 519
             + M  C + +   RPS S++V
Sbjct: 265 LYEVMLKCWHPKAEMRPSFSELV 287

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 18/198 (9%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRL--EPESQQGALE-FQTEIGMLSQLRHLHLVSLIG 336
           +G GG   VY          VAIK +   P  ++  L+ F+ E+   SQL H ++VS+I 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
              +D    LV +++   TL +  Y   + PL  +  +        G+ + H       I
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSE--YIESHGPLSVDTAINFTNQILDGIKHAHDMR----I 132
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKT--------HLDPEYYRLQQLTEK 447
           +HRD+K  NIL+D     K+ DFG++K    TS+++T        +  PE  + +   E 
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 448 SDVYSFGVVLFEVLCARP 465
           +D+YS G+VL+E+L   P
Sbjct: 193 TDIYSIGIVLYEMLVGEP 210

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 23/222 (10%)
Query: 255 PSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFIN---GSTTPVAIKRLEPE-SQ 310
           P+    +F+  EI A+    +   VIGVG FG+V  G +         VAIK L+   + 
Sbjct: 15  PNQAVREFA-KEIDASCIKIEK--VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTD 71
Query: 311 QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPW 370
           +   +F +E  ++ Q  H +++ L G     + ++++ ++M  G+L D     ++     
Sbjct: 72  KQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTV 130
Query: 371 NQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPT 427
            Q + +  G   G+ YL    +    +HRD+   NIL++   V KVSDFG+S+     P 
Sbjct: 131 IQLVGMLRGIGSGMKYL----SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE 186
Query: 428 SVSKTH--------LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           +   T           PE    ++ T  SDV+S+G+V++EV+
Sbjct: 187 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 228

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 117/258 (45%), Gaps = 27/258 (10%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG V  G   G    VA+K ++ E      EF  E   + +L H  LV   G C+
Sbjct: 16  LGSGQFGVVKLGKWKGQYD-VAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +  + +V ++++ G L ++L  S    L  +Q LE+C     G+ +L +       IHR
Sbjct: 74  KEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ----FIHR 128
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKF---------GPTSVSKTHLDPEYYRLQQLTEKSDV 450
           D+   N L+D     KVSDFG++++           T        PE +   + + KSDV
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 451 YSFGVVLFEVLCARPSILRTAAKKQVSLAV-WAQQCYQ----NGTIDQIVDPFLKAMSCL 505
           ++FG++++EV              +V L V    + Y+    + TI QI+       SC 
Sbjct: 189 WAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIM------YSCW 242
Query: 506 NDEGIRRPSMSDVVWGLE 523
           ++   +RP+   ++  +E
Sbjct: 243 HELPEKRPTFQQLLSSIE 260

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 114/249 (45%), Gaps = 18/249 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G FG+V+KG  N +   VAIK ++  E++    + Q EI +LSQ    ++    G  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
             D ++ ++ +++  G+  D L   +  PL   Q   I     +GL YLH+       IH
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK----IH 142
Query: 399 RDVKTTNILLDEKWVAKVSDFGLS-KFGPTSVSKTH-------LDPEYYRLQQLTEKSDV 450
           RD+K  N+LL E    K++DFG++ +   T + +         + PE  +      K+D+
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADI 202
Query: 451 YSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGI 510
           +S G+   E+    P        K + L          G   + +  F++A  CLN E  
Sbjct: 203 WSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA--CLNKEPS 260
Query: 511 RRPSMSDVV 519
            RP+  +++
Sbjct: 261 FRPTAKELL 269

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIG 321
           S+ Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ 
Sbjct: 5   SKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 64
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA- 380
           + S LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   
Sbjct: 65  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITEL 121
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HL 434
           A  L Y H+      +IHRD+K  N+LL      K++DFG S   P+S   T      +L
Sbjct: 122 ANALSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYL 177
Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
            PE    +   EK D++S GV+ +E L  +P
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 208

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 46/240 (19%)
Query: 280 IGVGGFGDVYKGFINGST-----TPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G   G       T VAIK + E  S +  +EF  E  ++ +    H+V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYH-----SDNP---PLPWNQRLEICIGAARGLH 385
           L+G  +  +  +++ + M RG L  +L        +NP   P   ++ +++    A G+ 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HRD+   N  + E +  K+ DFG++          K G   +    + 
Sbjct: 140 YL----NANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 195
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV 495
           PE  +    T  SDV+SFGVVL+E+                  A  A+Q YQ  + +Q++
Sbjct: 196 PESLKDGVFTTYSDVWSFGVVLWEI------------------ATLAEQPYQGLSNEQVL 237

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 146
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S   T      +L PE
Sbjct: 147 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE 202
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 203 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 230

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 114/249 (45%), Gaps = 18/249 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G FG+V+KG  N +   VAIK ++  E++    + Q EI +LSQ    ++    G  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
             D ++ ++ +++  G+  D L   +  PL   Q   I     +GL YLH+       IH
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK----IH 127
Query: 399 RDVKTTNILLDEKWVAKVSDFGLS-KFGPTSVSKTH-------LDPEYYRLQQLTEKSDV 450
           RD+K  N+LL E    K++DFG++ +   T + +         + PE  +      K+D+
Sbjct: 128 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADI 187
Query: 451 YSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGI 510
           +S G+   E+    P        K + L          G   + +  F++A  CLN E  
Sbjct: 188 WSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA--CLNKEPS 245
Query: 511 RRPSMSDVV 519
            RP+  +++
Sbjct: 246 FRPTAKELL 254

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 21  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 80
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 137
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S   T      +L PE
Sbjct: 138 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE 193
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 194 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 221

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 125
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S   T      +L PE
Sbjct: 126 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE 181
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 121
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S   T      +L PE
Sbjct: 122 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPE 177
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 205

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 114/249 (45%), Gaps = 18/249 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G FG+V+KG  N +   VAIK ++  E++    + Q EI +LSQ    ++    G  
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
             D ++ ++ +++  G+  D L   +  PL   Q   I     +GL YLH+       IH
Sbjct: 95  LKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK----IH 147
Query: 399 RDVKTTNILLDEKWVAKVSDFGLS-KFGPTSVSKTH-------LDPEYYRLQQLTEKSDV 450
           RD+K  N+LL E    K++DFG++ +   T + +         + PE  +      K+D+
Sbjct: 148 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 207
Query: 451 YSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGI 510
           +S G+   E+    P        K + L          G   + +  F++A  CLN E  
Sbjct: 208 WSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA--CLNKEPS 265
Query: 511 RRPSMSDVV 519
            RP+  +++
Sbjct: 266 FRPTAKELL 274

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 120
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S   T      +L PE
Sbjct: 121 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE 176
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 123
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S   T      +L PE
Sbjct: 124 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE 179
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 121
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S   T      +L PE
Sbjct: 122 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPE 177
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 205

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 266 EIQAATNNFDNDLVIGVGGFGDVYKGFIN---GSTTPVAIKRLEPE-SQQGALEFQTEIG 321
           EI A+    +   VIGVG FG+V  G +         VAIK L+   + +   +F +E  
Sbjct: 10  EIDASCIKIEK--VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEAS 67
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           ++ Q  H +++ L G     + ++++ ++M  G+L D     ++      Q + +  G  
Sbjct: 68  IMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIG 126
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTH----- 433
            G+ YL    +    +HRD+   NIL++   V KVSDFG+S+     P +   T      
Sbjct: 127 SGMKYL----SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 182
Query: 434 ---LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
                PE    ++ T  SDV+S+G+V++EV+
Sbjct: 183 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 213

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 114/249 (45%), Gaps = 18/249 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G FG+V+KG  N +   VAIK ++  E++    + Q EI +LSQ    ++    G  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
             D ++ ++ +++  G+  D L   +  PL   Q   I     +GL YLH+       IH
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK----IH 127
Query: 399 RDVKTTNILLDEKWVAKVSDFGLS-KFGPTSVSKTH-------LDPEYYRLQQLTEKSDV 450
           RD+K  N+LL E    K++DFG++ +   T + +         + PE  +      K+D+
Sbjct: 128 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 187
Query: 451 YSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGI 510
           +S G+   E+    P        K + L          G   + +  F++A  CLN E  
Sbjct: 188 WSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA--CLNKEPS 245
Query: 511 RRPSMSDVV 519
            RP+  +++
Sbjct: 246 FRPTAKELL 254

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 266 EIQAATNNFDNDLVIGVGGFGDVYKGFIN---GSTTPVAIKRLEPE-SQQGALEFQTEIG 321
           EI A+    +   VIGVG FG+V  G +         VAIK L+   + +   +F +E  
Sbjct: 4   EIDASCIKIEK--VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEAS 61
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           ++ Q  H +++ L G     + ++++ ++M  G+L D     ++      Q + +  G  
Sbjct: 62  IMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIG 120
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSKTH----- 433
            G+ YL    +    +HRD+   NIL++   V KVSDFG+S+     P +   T      
Sbjct: 121 SGMKYL----SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 176
Query: 434 ---LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
                PE    ++ T  SDV+S+G+V++EV+
Sbjct: 177 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 207

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 121/263 (46%), Gaps = 33/263 (12%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G +   +G     A+K L   +  G + +F TE  ++    H +++SL
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 335 IGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C   +   ++V  +M  G L + + +  + P      +   +  A+G+ +L +    
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKK-- 212
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-----------LDPEYYRL 441
              +HRD+   N +LDEK+  KV+DFGL++          H           +  E  + 
Sbjct: 213 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 442 QQLTEKSDVYSFGVVLFEVLC----ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP 497
           Q+ T KSDV+SFGV+L+E++       P +          + V+  Q  +    +   DP
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLLQGRRLLQPEYCPDP 324
Query: 498 FLKAM-SCLNDEGIRRPSMSDVV 519
             + M  C + +   RPS S++V
Sbjct: 325 LYEVMLKCWHPKAEMRPSFSELV 347

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++  RG +   L           QR    I   A  
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFD---EQRTATYITELANA 125
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S          +L PE
Sbjct: 126 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPE 181
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 119
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S   T      +L PE
Sbjct: 120 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE 175
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 176 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 203

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 121/263 (46%), Gaps = 33/263 (12%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G +   +G     A+K L   +  G + +F TE  ++    H +++SL
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 335 IGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C   +   ++V  +M  G L + + +  + P      +   +  A+G+ +L +    
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKK-- 153
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-----------LDPEYYRL 441
              +HRD+   N +LDEK+  KV+DFGL++          H           +  E  + 
Sbjct: 154 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 442 QQLTEKSDVYSFGVVLFEVLC----ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP 497
           Q+ T KSDV+SFGV+L+E++       P +          + V+  Q  +    +   DP
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLLQGRRLLQPEYCPDP 265
Query: 498 FLKAM-SCLNDEGIRRPSMSDVV 519
             + M  C + +   RPS S++V
Sbjct: 266 LYEVMLKCWHPKAEMRPSFSELV 288

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 121/263 (46%), Gaps = 33/263 (12%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G +   +G     A+K L   +  G + +F TE  ++    H +++SL
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 335 IGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C   +   ++V  +M  G L + + +  + P      +   +  A+G+ +L +    
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKK-- 151
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-----------LDPEYYRL 441
              +HRD+   N +LDEK+  KV+DFGL++          H           +  E  + 
Sbjct: 152 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 442 QQLTEKSDVYSFGVVLFEVLC----ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP 497
           Q+ T KSDV+SFGV+L+E++       P +          + V+  Q  +    +   DP
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLLQGRRLLQPEYCPDP 263
Query: 498 FLKAM-SCLNDEGIRRPSMSDVV 519
             + M  C + +   RPS S++V
Sbjct: 264 LYEVMLKCWHPKAEMRPSFSELV 286

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 123
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S   T      +L PE
Sbjct: 124 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE 179
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 121/263 (46%), Gaps = 33/263 (12%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G +   +G     A+K L   +  G + +F TE  ++    H +++SL
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 335 IGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C   +   ++V  +M  G L + + +  + P      +   +  A+G+ +L +    
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKK-- 154
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-----------LDPEYYRL 441
              +HRD+   N +LDEK+  KV+DFGL++          H           +  E  + 
Sbjct: 155 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 442 QQLTEKSDVYSFGVVLFEVLC----ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP 497
           Q+ T KSDV+SFGV+L+E++       P +          + V+  Q  +    +   DP
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLLQGRRLLQPEYCPDP 266
Query: 498 FLKAM-SCLNDEGIRRPSMSDVV 519
             + M  C + +   RPS S++V
Sbjct: 267 LYEVMLKCWHPKAEMRPSFSELV 289

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 125
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S   T      +L PE
Sbjct: 126 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE 181
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 182 XIEGRXHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 121/263 (46%), Gaps = 33/263 (12%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G +   +G     A+K L   +  G + +F TE  ++    H +++SL
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 335 IGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C   +   ++V  +M  G L + + +  + P      +   +  A+G+ +L +    
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKK-- 153
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-----------LDPEYYRL 441
              +HRD+   N +LDEK+  KV+DFGL++          H           +  E  + 
Sbjct: 154 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 442 QQLTEKSDVYSFGVVLFEVLC----ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP 497
           Q+ T KSDV+SFGV+L+E++       P +          + V+  Q  +    +   DP
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLLQGRRLLQPEYCPDP 265
Query: 498 FLKAM-SCLNDEGIRRPSMSDVV 519
             + M  C + +   RPS S++V
Sbjct: 266 LYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 121/263 (46%), Gaps = 33/263 (12%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G +   +G     A+K L   +  G + +F TE  ++    H +++SL
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 335 IGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C   +   ++V  +M  G L + + +  + P      +   +  A+G+ +L +    
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKK-- 158
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-----------LDPEYYRL 441
              +HRD+   N +LDEK+  KV+DFGL++          H           +  E  + 
Sbjct: 159 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 442 QQLTEKSDVYSFGVVLFEVLC----ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP 497
           Q+ T KSDV+SFGV+L+E++       P +          + V+  Q  +    +   DP
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLLQGRRLLQPEYCPDP 270
Query: 498 FLKAM-SCLNDEGIRRPSMSDVV 519
             + M  C + +   RPS S++V
Sbjct: 271 LYEVMLKCWHPKAEMRPSFSELV 293

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 121/263 (46%), Gaps = 33/263 (12%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G +   +G     A+K L   +  G + +F TE  ++    H +++SL
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 335 IGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C   +   ++V  +M  G L + + +  + P      +   +  A+G+ +L +    
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKK-- 154
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-----------LDPEYYRL 441
              +HRD+   N +LDEK+  KV+DFGL++          H           +  E  + 
Sbjct: 155 --FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 442 QQLTEKSDVYSFGVVLFEVLC----ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP 497
           Q+ T KSDV+SFGV+L+E++       P +          + V+  Q  +    +   DP
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLLQGRRLLQPEYCPDP 266
Query: 498 FLKAM-SCLNDEGIRRPSMSDVV 519
             + M  C + +   RPS S++V
Sbjct: 267 LYEVMLKCWHPKAEMRPSFSELV 289

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 120
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S          +L PE
Sbjct: 121 LSYCHSKK----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPE 176
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLV 332
           +G G FG+VY+G ++G     S   VA+K L PE  S+Q  L+F  E  ++S+L H ++V
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKLNHQNIV 111
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP-----LPWNQRLEICIGAARGLHYL 387
             IG         ++ + MA G L   L  +   P     L     L +    A G  YL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 388 HTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLS----------KFGPTSVSKTHL 434
               NH   IHRD+   N LL       VAK+ DFG++          K G   +    +
Sbjct: 172 EE--NH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            PE +     T K+D +SFGV+L+E+ 
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLV 332
           +G G FG+VY+G ++G     S   VA+K L PE  S+Q  L+F  E  ++S+L H ++V
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKLNHQNIV 97
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP-----LPWNQRLEICIGAARGLHYL 387
             IG         ++ + MA G L   L  +   P     L     L +    A G  YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 388 HTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLS----------KFGPTSVSKTHL 434
               NH   IHRD+   N LL       VAK+ DFG++          K G   +    +
Sbjct: 158 E--ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            PE +     T K+D +SFGV+L+E+ 
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 122
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K+++FG S   P+S   T      +L PE
Sbjct: 123 LSYCHSKR----VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPE 178
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 179 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 206

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 123
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S          +L PE
Sbjct: 124 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPE 179
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 122
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S          +L PE
Sbjct: 123 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPE 178
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 179 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 206

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIG 321
           S+ Q    +FD    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ 
Sbjct: 5   SKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVE 64
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA- 380
           + S LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   
Sbjct: 65  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFD---EQRTATYITEL 121
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HL 434
           A  L Y H+      +IHRD+K  N+LL      K++DFG S   P+S   T      +L
Sbjct: 122 ANALSYCHSKR----VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYL 177
Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
            PE    +   EK D++S GV+ +E L   P
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGMP 208

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIG 321
           S+ Q    +FD    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ 
Sbjct: 5   SKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVE 64
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA- 380
           + S LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   
Sbjct: 65  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFD---EQRTATYITEL 121
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HL 434
           A  L Y H+      +IHRD+K  N+LL      K++DFG S   P+S   T      +L
Sbjct: 122 ANALSYCHSKR----VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYL 177
Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
            PE    +   EK D++S GV+ +E L   P
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGMP 208

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 120
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S          +L PE
Sbjct: 121 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPE 176
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 123
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K+++FG S   P+S   T      +L PE
Sbjct: 124 LSYCHSKR----VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPE 179
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 146
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV------SKTHLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S       +  +L PE
Sbjct: 147 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPE 202
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 203 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 230

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 112/236 (47%), Gaps = 46/236 (19%)
Query: 261 QFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGAL- 314
           Q  L EI  +   F  +L  G   FG VYKG + G      T  VAIK L+ +  +G L 
Sbjct: 17  QAKLKEISLSAVRFMEEL--GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLR 73
Query: 315 -EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY----HSD----- 364
            EF+ E  + ++L+H ++V L+G    D+ + +++ + + G L + L     HSD     
Sbjct: 74  EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 133
Query: 365 ---------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAK 415
                     PP      + +    A G+ YL   ++H  ++H+D+ T N+L+ +K   K
Sbjct: 134 DDRTVKSALEPP----DFVHLVAQIAAGMEYL--SSHH--VVHKDLATRNVLVYDKLNVK 185
Query: 416 VSDFGLSK----------FGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           +SD GL +           G + +    + PE     + +  SD++S+GVVL+EV 
Sbjct: 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 241

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 120
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S          +L PE
Sbjct: 121 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPE 176
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 20/199 (10%)
Query: 277 DLVIGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQG-ALEFQTEIGMLSQLRHLHLVS 333
           D+ +G G FG V +G   +      VAIK L+  +++    E   E  ++ QL + ++V 
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           LIG C  +  ++LV +    G L   L       +P +   E+    + G+ YL      
Sbjct: 75  LIGVCQAE-ALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLEEKN-- 130
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSK--------FGPTSVSKTHLD---PEYYRLQ 442
              +HRD+   N+LL  +  AK+SDFGLSK        +   S  K  L    PE    +
Sbjct: 131 --FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 443 QLTEKSDVYSFGVVLFEVL 461
           + + +SDV+S+GV ++E L
Sbjct: 189 KFSSRSDVWSYGVTMWEAL 207

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 123
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S          +L PE
Sbjct: 124 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPE 179
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 120
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S          +L PE
Sbjct: 121 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPE 176
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 121
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV------SKTHLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S       +  +L PE
Sbjct: 122 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPE 177
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 205

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 120
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S          +L PE
Sbjct: 121 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPE 176
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 125
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV------SKTHLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S       +  +L PE
Sbjct: 126 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPE 181
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 28/229 (12%)
Query: 251 GSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL- 305
           GS + S      +L  I   T  F    V+G G FG VYKG           PVAIK L 
Sbjct: 1   GSHMASGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR 59
Query: 306 EPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSD 364
           E  S +   E   E  +++ + + H+  L+G C     + L+   M  G L D++  H D
Sbjct: 60  EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD 118
Query: 365 NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF 424
           N  +     L  C+  A+G++YL        ++HRD+   N+L+      K++DFGL+K 
Sbjct: 119 N--IGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKL 172
Query: 425 ------------GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
                       G   +    L+   +R+   T +SDV+S+GV ++E++
Sbjct: 173 LGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELM 219

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 17/212 (8%)
Query: 264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEI 320
           L   Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+
Sbjct: 3   LGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 321 GMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA 380
            + S LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I  
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITE 119
Query: 381 -ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV------SKTH 433
            A  L Y H+      +IHRD+K  N+LL      K++DFG S   P+S       +  +
Sbjct: 120 LANALSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDY 175
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           L PE    +   EK D++S GV+ +E L  +P
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 120
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV------SKTHLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S       +  +L PE
Sbjct: 121 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPE 176
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY          +A+K L + + ++  +E Q   E+ + S
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 117
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S   T      +L PE
Sbjct: 118 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE 173
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 174 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 201

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 75  DNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 131
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 132 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 188 LESILHRI--YTHQSDVWSYGVTVWELM 213

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-EPESQQGALEFQ--TEIGMLS 324
           Q A  +F+    +G G FG+VY      S   +A+K L + + ++  +E Q   E+ + S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-ARG 383
            LRH +++ L G+ +D   + L+ ++   GT+   L           QR    I   A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA 120
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV------SKTHLDPE 437
           L Y H+      +IHRD+K  N+LL      K++DFG S   P+S       +  +L PE
Sbjct: 121 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPE 176
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +   EK D++S GV+ +E L  +P
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 76  DNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 132
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 133 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 189 LESILHRI--YTHQSDVWSYGVTVWELM 214

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 79  DNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 135
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 136 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 192 LESILHRI--YTHQSDVWSYGVTVWELM 217

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 78  DNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 134
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 135 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 191 LESILHRI--YTHQSDVWSYGVTVWELM 216

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 77  DNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 133
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 134 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 190 LESILHRI--YTHQSDVWSYGVTVWELM 215

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 76  DNPHVCRLLGICLTS-TVQLIMQLMPFGXLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 132
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 133 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 189 LESILHRI--YTHQSDVWSYGVTVWELM 214

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 85  DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 141
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 142 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 197
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 198 LESILHRI--YTHQSDVWSYGVTVWELM 223

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 75  DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 131
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 132 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 188 LESILHRI--YTHQSDVWSYGVTVWELM 213

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLV 332
           +G G FG+VY+G ++G     S   VA+K L PE  S+Q  L+F  E  ++S+  H ++V
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP-----LPWNQRLEICIGAARGLHYL 387
             IG         ++ + MA G L   L  +   P     L     L +    A G  YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 388 HTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLS----------KFGPTSVSKTHL 434
               NH   IHRD+   N LL       VAK+ DFG++          K G   +    +
Sbjct: 157 EE--NH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            PE +     T K+D +SFGV+L+E+ 
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLV 332
           +G G FG+VY+G ++G     S   VA+K L PE  S+Q  L+F  E  ++S+  H ++V
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 111
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP-----LPWNQRLEICIGAARGLHYL 387
             IG         ++ + MA G L   L  +   P     L     L +    A G  YL
Sbjct: 112 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 388 HTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLS----------KFGPTSVSKTHL 434
               NH   IHRD+   N LL       VAK+ DFG++          K G   +    +
Sbjct: 172 EE--NH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            PE +     T K+D +SFGV+L+E+ 
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 75  DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 131
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 132 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 188 LESILHRI--YTHQSDVWSYGVTVWELM 213

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 77  DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 133
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 134 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 190 LESILHRI--YTHQSDVWSYGVTVWELM 215

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG+VY+G ++G     S   VA+K L E  S+Q  L+F  E  ++S+  H ++V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP-----LPWNQRLEICIGAARGLHYLH 388
            IG         ++ + MA G L   L  +   P     L     L +    A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 389 TGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
              NH   IHRD+   N LL       VAK+ DFG++          K G   +    + 
Sbjct: 173 E--NH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVL 461
           PE +     T K+D +SFGV+L+E+ 
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLV 332
           +G G FG+VY+G ++G     S   VA+K L PE  S+Q  L+F  E  ++S+  H ++V
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP-----LPWNQRLEICIGAARGLHYL 387
             IG         ++ + MA G L   L  +   P     L     L +    A G  YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 388 HTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLS----------KFGPTSVSKTHL 434
               NH   IHRD+   N LL       VAK+ DFG++          K G   +    +
Sbjct: 198 E--ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253
Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            PE +     T K+D +SFGV+L+E+ 
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIF 280

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLV 332
           +G G FG+VY+G ++G     S   VA+K L PE  S+Q  L+F  E  ++S+  H ++V
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP-----LPWNQRLEICIGAARGLHYL 387
             IG         ++ + MA G L   L  +   P     L     L +    A G  YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 388 HTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLS----------KFGPTSVSKTHL 434
               NH   IHRD+   N LL       VAK+ DFG++          K G   +    +
Sbjct: 158 E--ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            PE +     T K+D +SFGV+L+E+ 
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 47/211 (22%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLE----PESQQGALEFQTEIGMLSQLRHLHL 331
           +G G FG V    Y    +G+   VA+K L+    P+ + G   ++ EI +L  L H H+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG---WKQEIDILRTLYHEHI 78
Query: 332 VSLIGFCND--DREMILVYDFMARGTLPDHL-YHSDNPPLPWNQRLEICIGAARGLHYLH 388
           +   G C D  ++ + LV +++  G+L D+L  HS    +   Q L        G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLH 134
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ----- 443
             A H   IHR++   N+LLD   + K+ DFGL+K    +V + H   EYYR+++     
Sbjct: 135 --AQH--YIHRNLAARNVLLDNDRLVKIGDFGLAK----AVPEGH---EYYRVREDGDSP 183
Query: 444 --------LTE-----KSDVYSFGVVLFEVL 461
                   L E      SDV+SFGV L+E+L
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 78  DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 134
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 135 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 191 LESILHRI--YTHQSDVWSYGVTVWELM 216

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLV 332
           +G G FG+VY+G ++G     S   VA+K L PE  S+Q  L+F  E  ++S+  H ++V
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP-----LPWNQRLEICIGAARGLHYL 387
             IG         ++ + MA G L   L  +   P     L     L +    A G  YL
Sbjct: 97  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 388 HTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLS----------KFGPTSVSKTHL 434
               NH   IHRD+   N LL       VAK+ DFG++          K G   +    +
Sbjct: 157 EE--NH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            PE +     T K+D +SFGV+L+E+ 
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 78  DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 134
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 135 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 191 LESILHRI--YTHQSDVWSYGVTVWELM 216

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLV 332
           +G G FG+VY+G ++G     S   VA+K L PE  S+Q  L+F  E  ++S+  H ++V
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP-----LPWNQRLEICIGAARGLHYL 387
             IG         ++ + MA G L   L  +   P     L     L +    A G  YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 388 HTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLS----------KFGPTSVSKTHL 434
               NH   IHRD+   N LL       VAK+ DFG++          K G   +    +
Sbjct: 158 E--ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWM 213
Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            PE +     T K+D +SFGV+L+E+ 
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG+VY+G ++G     S   VA+K L E  S+Q  L+F  E  ++S+  H ++V 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP-----LPWNQRLEICIGAARGLHYLH 388
            IG         ++ + MA G L   L  +   P     L     L +    A G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 389 TGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
              NH   IHRD+   N LL       VAK+ DFG++          K G   +    + 
Sbjct: 150 E--NH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 205
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVL 461
           PE +     T K+D +SFGV+L+E+ 
Sbjct: 206 PEAFMEGIFTSKTDTWSFGVLLWEIF 231

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 100 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 156
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 157 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 212
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 213 LESILHRI--YTHQSDVWSYGVTVWELM 238

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 69  DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 125
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 126 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 182 LESILHRI--YTHQSDVWSYGVTVWELM 207

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 78  DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 134
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 135 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 191 LESILHRI--YTHQSDVWSYGVTVWELM 216

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLV 332
           +G G FG+VY+G ++G     S   VA+K L PE  S+Q  L+F  E  ++S+  H ++V
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 103
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP-----LPWNQRLEICIGAARGLHYL 387
             IG         ++ + MA G L   L  +   P     L     L +    A G  YL
Sbjct: 104 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 388 HTGANHAVIIHRDVKTTNILLD---EKWVAKVSDFGLS----------KFGPTSVSKTHL 434
               NH   IHRD+   N LL       VAK+ DFG++          K G   +    +
Sbjct: 164 E--ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 219
Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            PE +     T K+D +SFGV+L+E+ 
Sbjct: 220 PPEAFMEGIFTSKTDTWSFGVLLWEIF 246

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLV 332
           +G G FG+VY+G ++G     S   VA+K L PE  S+Q  L+F  E  ++S+  H ++V
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 114
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP-----LPWNQRLEICIGAARGLHYL 387
             IG         ++ + MA G L   L  +   P     L     L +    A G  YL
Sbjct: 115 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 388 HTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLS----------KFGPTSVSKTHL 434
               NH   IHRD+   N LL       VAK+ DFG++          K G   +    +
Sbjct: 175 E--ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 230
Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            PE +     T K+D +SFGV+L+E+ 
Sbjct: 231 PPEAFMEGIFTSKTDTWSFGVLLWEIF 257

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 75  DNPHVCRLLGICLTS-TVQLITQLMPFGXLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 131
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 132 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 188 LESILHRI--YTHQSDVWSYGVTVWELM 213

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLV 332
           +G G FG+VY+G ++G     S   VA+K L PE  S+Q  L+F  E  ++S+  H ++V
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 113
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP-----LPWNQRLEICIGAARGLHYL 387
             IG         ++ + MA G L   L  +   P     L     L +    A G  YL
Sbjct: 114 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 388 HTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLS----------KFGPTSVSKTHL 434
               NH   IHRD+   N LL       VAK+ DFG++          K G   +    +
Sbjct: 174 E--ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 229
Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            PE +     T K+D +SFGV+L+E+ 
Sbjct: 230 PPEAFMEGIFTSKTDTWSFGVLLWEIF 256

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 82  DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 138
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 139 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 195 LESILHRI--YTHQSDVWSYGVTVWELM 220

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           V+G G FG   K     +   + +K L    ++    F  E+ ++  L H +++  IG  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
             D+ +  + +++  GTL   +  S +   PW+QR+      A G+ YLH+      IIH
Sbjct: 77  YKDKRLNFITEYIKGGTL-RGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS----MNIIH 131
Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKF---------GPTSVSKTH-------------LDP 436
           RD+ + N L+ E     V+DFGL++          G  S+ K               + P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVL 461
           E    +   EK DV+SFG+VL E++
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLV 332
           +G G FG+VY+G ++G     S   VA+K L PE  S+Q  L+F  E  ++S+  H ++V
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 123
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP-----LPWNQRLEICIGAARGLHYL 387
             IG         ++ + MA G L   L  +   P     L     L +    A G  YL
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 388 HTGANHAVIIHRDVKTTNILLD---EKWVAKVSDFGLS----------KFGPTSVSKTHL 434
               NH   IHRD+   N LL       VAK+ DFG++          K G   +    +
Sbjct: 184 E--ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 239
Query: 435 DPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            PE +     T K+D +SFGV+L+E+ 
Sbjct: 240 PPEAFMEGIFTSKTDTWSFGVLLWEIF 266

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 46/233 (19%)
Query: 264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGAL--EF 316
           L EI  +   F  +L  G   FG VYKG + G      T  VAIK L+ +  +G L  EF
Sbjct: 3   LKEISLSAVRFMEEL--GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEF 59
Query: 317 QTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY----HSD-------- 364
           + E  + ++L+H ++V L+G    D+ + +++ + + G L + L     HSD        
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 365 ------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSD 418
                  PP      + +    A G+ YL   ++H  ++H+D+ T N+L+ +K   K+SD
Sbjct: 120 TVKSALEPP----DFVHLVAQIAAGMEYL--SSHH--VVHKDLATRNVLVYDKLNVKISD 171
Query: 419 FGLSK----------FGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            GL +           G + +    + PE     + +  SD++S+GVVL+EV 
Sbjct: 172 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKG----FING-STTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G     I G + T VA+K + E  S +  +EF  E  ++      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY--------HSDNPPLPWNQRLEICIGAARGLH 385
           L+G  +  +  ++V + MA G L  +L         +   PP    + +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HRD+   N ++   +  K+ DFG++          K G   +    + 
Sbjct: 145 YL----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEV 460
           PE  +    T  SD++SFGVVL+E+
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKG----FING-STTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G     I G + T VA+K + E  S +  +EF  E  ++      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY--------HSDNPPLPWNQRLEICIGAARGLH 385
           L+G  +  +  ++V + MA G L  +L         +   PP    + +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HRD+   N ++   +  K+ DFG++          K G   +    + 
Sbjct: 145 YL----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEV 460
           PE  +    T  SD++SFGVVL+E+
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKG----FING-STTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G     I G + T VA+K + E  S +  +EF  E  ++      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY--------HSDNPPLPWNQRLEICIGAARGLH 385
           L+G  +  +  ++V + MA G L  +L         +   PP    + +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HRD+   N ++   +  K+ DFG++          K G   +    + 
Sbjct: 145 YL----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMA 200
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEV 460
           PE  +    T  SD++SFGVVL+E+
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKG----FING-STTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G     I G + T VA+K + E  S +  +EF  E  ++      H+V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY--------HSDNPPLPWNQRLEICIGAARGLH 385
           L+G  +  +  ++V + MA G L  +L         +   PP    + +++    A G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HRD+   N ++   +  K+ DFG++          K G   +    + 
Sbjct: 142 YL----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 197
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEV 460
           PE  +    T  SD++SFGVVL+E+
Sbjct: 198 PESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 23/200 (11%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           +G G FG V    Y    + +   VA+K L+PES    + + + EI +L  L H ++V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 335 IGFCNDD--REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            G C +D    + L+ +F+  G+L ++L  + N  +   Q+L+  +   +G+ YL  G+ 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYL--GSR 145
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD-----------PEYYRL 441
             V  HRD+   N+L++ +   K+ DFGL+K   T      +            PE    
Sbjct: 146 QYV--HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 203
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
            +    SDV+SFGV L E+L
Sbjct: 204 SKFYIASDVWSFGVTLHELL 223

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKG----FING-STTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G     I G + T VA+K + E  S +  +EF  E  ++      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY--------HSDNPPLPWNQRLEICIGAARGLH 385
           L+G  +  +  ++V + MA G L  +L         +   PP    + +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HRD+   N ++   +  K+ DFG++          K G   +    + 
Sbjct: 145 YL----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEV 460
           PE  +    T  SD++SFGVVL+E+
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKG----FING-STTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G     I G + T VA+K + E  S +  +EF  E  ++      H+V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY--------HSDNPPLPWNQRLEICIGAARGLH 385
           L+G  +  +  ++V + MA G L  +L         +   PP    + +++    A G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HRD+   N ++   +  K+ DFG++          K G   +    + 
Sbjct: 144 YL----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 199
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEV 460
           PE  +    T  SD++SFGVVL+E+
Sbjct: 200 PESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 23/200 (11%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           +G G FG V    Y    + +   VA+K L+PES    + + + EI +L  L H ++V  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 335 IGFCNDD--REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            G C +D    + L+ +F+  G+L ++L  + N  +   Q+L+  +   +G+ YL  G+ 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYL--GSR 133
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD-----------PEYYRL 441
             V  HRD+   N+L++ +   K+ DFGL+K   T      +            PE    
Sbjct: 134 QYV--HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 191
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
            +    SDV+SFGV L E+L
Sbjct: 192 SKFYIASDVWSFGVTLHELL 211

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A G++
Sbjct: 72  DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAEGMN 128
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 129 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 185 LESILHRI--YTHQSDVWSYGVTVWELM 210

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 47/211 (22%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLE----PESQQGALEFQTEIGMLSQLRHLHL 331
           +G G FG V    Y    +G+   VA+K L+    P+ + G   ++ EI +L  L H H+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG---WKQEIDILRTLYHEHI 78
Query: 332 VSLIGFCND--DREMILVYDFMARGTLPDHL-YHSDNPPLPWNQRLEICIGAARGLHYLH 388
           +   G C D  ++ + LV +++  G+L D+L  HS    +   Q L        G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLH 134
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ----- 443
           +       IHR++   N+LLD   + K+ DFGL+K    +V + H   EYYR+++     
Sbjct: 135 SQH----YIHRNLAARNVLLDNDRLVKIGDFGLAK----AVPEGH---EYYRVREDGDSP 183
Query: 444 --------LTE-----KSDVYSFGVVLFEVL 461
                   L E      SDV+SFGV L+E+L
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 96/204 (47%), Gaps = 33/204 (16%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLE----PESQQGALEFQTEIGMLSQLRHLHL 331
           +G G FG V    Y    +G+   VA+K L+    P+ + G   ++ EI +L  L H H+
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG---WKQEIDILRTLYHEHI 95
Query: 332 VSLIGFCNDD--REMILVYDFMARGTLPDHL-YHSDNPPLPWNQRLEICIGAARGLHYLH 388
           +   G C D     + LV +++  G+L D+L  HS    +   Q L        G+ YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLH 151
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD-----------PE 437
             A H   IHRD+   N+LLD   + K+ DFGL+K  P       +            PE
Sbjct: 152 --AQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPE 207
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVL 461
             +  +    SDV+SFGV L+E+L
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELL 231

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 45/210 (21%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLE----PESQQGALEFQTEIGMLSQLRHLHL 331
           +G G FG V    Y    +G+   VA+K L+    P+ + G   +Q EI +L  L H H+
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG---WQREIEILRTLYHEHI 73
Query: 332 VSLIGFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           V   G C D  ++ + LV +++  G+L D+L       +   Q L        G+ YLH 
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLH- 129
Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ------ 443
            A H   IHR +   N+LLD   + K+ DFGL+K    +V + H   EYYR+++      
Sbjct: 130 -AQH--YIHRALAARNVLLDNDRLVKIGDFGLAK----AVPEGH---EYYRVREDGDSPV 179
Query: 444 -------LTE-----KSDVYSFGVVLFEVL 461
                  L E      SDV+SFGV L+E+L
Sbjct: 180 FWYAPECLKECKFYYASDVWSFGVTLYELL 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 45/210 (21%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLE----PESQQGALEFQTEIGMLSQLRHLHL 331
           +G G FG V    Y    +G+   VA+K L+    P+ + G   +Q EI +L  L H H+
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG---WQREIEILRTLYHEHI 72
Query: 332 VSLIGFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           V   G C D  ++ + LV +++  G+L D+L       +   Q L        G+ YLH 
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLH- 128
Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ------ 443
            A H   IHR +   N+LLD   + K+ DFGL+K    +V + H   EYYR+++      
Sbjct: 129 -AQH--YIHRALAARNVLLDNDRLVKIGDFGLAK----AVPEGH---EYYRVREDGDSPV 178
Query: 444 -------LTE-----KSDVYSFGVVLFEVL 461
                  L E      SDV+SFGV L+E+L
Sbjct: 179 FWYAPECLKECKFYYASDVWSFGVTLYELL 208

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 20/199 (10%)
Query: 277 DLVIGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQG-ALEFQTEIGMLSQLRHLHLVS 333
           D+ +G G FG V +G   +      VAIK L+  +++    E   E  ++ QL + ++V 
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           LIG C  +  ++LV +    G L   L       +P +   E+    + G+ YL      
Sbjct: 401 LIGVCQAE-ALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL----EE 454
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSK--------FGPTSVSKTHLD---PEYYRLQ 442
              +HR++   N+LL  +  AK+SDFGLSK        +   S  K  L    PE    +
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 443 QLTEKSDVYSFGVVLFEVL 461
           + + +SDV+S+GV ++E L
Sbjct: 515 KFSSRSDVWSYGVTMWEAL 533

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 79  DNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 135
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFG +K             G   +    
Sbjct: 136 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 192 LESILHRI--YTHQSDVWSYGVTVWELM 217

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+  G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 82  DNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 138
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 139 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 195 LESILHRI--YTHQSDVWSYGVTVWELM 220

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 77  DNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 133
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFG +K             G   +    
Sbjct: 134 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 190 LESILHRI--YTHQSDVWSYGVTVWELM 215

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 77  DNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 133
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFG +K             G   +    
Sbjct: 134 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 190 LESILHRI--YTHQSDVWSYGVTVWELM 215

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAI  L E  S +   E   E  +++ +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 109 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 165
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 166 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 221
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 222 LESILHRI--YTHQSDVWSYGVTVWELM 247

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 121/258 (46%), Gaps = 43/258 (16%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLR-HLHLVSLIG 336
           +G G +G V+K     +   VA+K++    Q      +T  EI +L++L  H ++V+L+ 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 337 F--CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
               ++DR++ LV+D+M       H     N   P +++  +     + + YLH+G    
Sbjct: 77  VLRADNDRDVYLVFDYMETDL---HAVIRANILEPVHKQY-VVYQLIKVIKYLHSGG--- 129
Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----------PTSVSKT------------ 432
            ++HRD+K +NILL+ +   KV+DFGLS+            P S+++             
Sbjct: 130 -LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
Query: 433 -HLDPEYYRLQQL-------TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQ 484
            ++   +YR  ++       T+  D++S G +L E+LC +P    ++   Q+   +    
Sbjct: 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVID 248
Query: 485 CYQNGTIDQIVDPFLKAM 502
              N  ++ I  PF K M
Sbjct: 249 FPSNEDVESIQSPFAKTM 266

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 77  DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 133
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFG +K             G   +    
Sbjct: 134 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 190 LESILHRI--YTHQSDVWSYGVTVWELM 215

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+  G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 75  DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 131
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 132 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 188 LESILHRI--YTHQSDVWSYGVTVWELM 213

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+  G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 82  DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 138
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFGL+K             G   +    
Sbjct: 139 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 195 LESILHRI--YTHQSDVWSYGVTVWELM 220

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 75  DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 131
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFG +K             G   +    
Sbjct: 132 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 188 LESILHRI--YTHQSDVWSYGVTVWELM 213

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQL 326
             F    V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLH 385
            + H+  L+G C     + L+   M  G L D++  H DN  +     L  C+  A+G++
Sbjct: 82  DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 138
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTH 433
           YL        ++HRD+   N+L+      K++DFG +K             G   +    
Sbjct: 139 YLEDRR----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           L+   +R+   T +SDV+S+GV ++E++
Sbjct: 195 LESILHRI--YTHQSDVWSYGVTVWELM 220

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKG----FING-STTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G     I G + T VA+K + E  S +  +EF  E  ++      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY--------HSDNPPLPWNQRLEICIGAARGLH 385
           L+G  +  +  ++V + MA G L  +L         +   PP    + +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HR++   N ++   +  K+ DFG++          K G   +    + 
Sbjct: 145 YL----NAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEV 460
           PE  +    T  SD++SFGVVL+E+
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKG----FING-STTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +G G FG VY+G     I G + T VA+K + E  S +  +EF  E  ++      H+V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY--------HSDNPPLPWNQRLEICIGAARGLH 385
           L+G  +  +  ++V + MA G L  +L         +   PP    + +++    A G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVSKTHLD 435
           YL    N    +HR++   N ++   +  K+ DFG++          K G   +    + 
Sbjct: 146 YL----NAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 201
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEV 460
           PE  +    T  SD++SFGVVL+E+
Sbjct: 202 PESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 106/215 (49%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G         T VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWN-------------QRLEIC 377
           +++L+G C  D  + ++ ++ ++G L ++L   + P L ++             + L  C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 378 I-GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV 429
               ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+ 
Sbjct: 156 AYQVARGMEYLASKK----CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 430 SK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            +     + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 266 EIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLE----PESQQG----ALEFQ 317
           ++++    ++    +G G F  VYK     +   VAIK+++     E++ G    AL   
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-- 61
Query: 318 TEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEIC 377
            EI +L +L H +++ L+        + LV+DFM   T  + +   ++  L  +      
Sbjct: 62  -EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME--TDLEVIIKDNSLVLTPSHIKAYM 118
Query: 378 IGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLD 435
           +   +GL YLH       I+HRD+K  N+LLDE  V K++DFGL+K FG P       + 
Sbjct: 119 LMTLQGLEYLH----QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV 174
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCARPSIL 468
             +YR  +L   + +Y  GV ++ V C    +L
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL---EPESQQGALEFQTEIGMLSQLRH 328
           ++FD    +G G FG+VY      +   +A+K L   + E +    + + EI + S LRH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
            +++ +  + +D + + L+ +F  RG L   L    +      +        A  LHY H
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHYCH 132
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPEYYRLQ 442
                  +IHRD+K  N+L+  K   K++DFG S   P+   +       +L PE    +
Sbjct: 133 ERK----VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 443 QLTEKSDVYSFGVVLFEVLCARP 465
              EK D++  GV+ +E L   P
Sbjct: 189 THDEKVDLWCAGVLCYEFLVGMP 211

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 38/236 (16%)
Query: 250 RGSFL--PSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP 307
           RGS +  PS L  ++ L EI            +G GG  +V+          VA+K L  
Sbjct: 17  RGSHMTTPSHLSDRYELGEI------------LGFGGMSEVHLARDLRLHRDVAVKVLRA 64
Query: 308 ESQQGA---LEFQTEIGMLSQLRHLHLVSLIGFCNDDREM----ILVYDFMARGTLPDHL 360
           +  +     L F+ E    + L H  +V++      +        +V +++   TL D +
Sbjct: 65  DLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-I 123
Query: 361 YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG 420
            H++ P  P  + +E+   A + L++ H       IIHRDVK  NI++      KV DFG
Sbjct: 124 VHTEGPMTP-KRAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFG 178
Query: 421 LSKF---GPTSVSKT--------HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           +++       SV++T        +L PE  R   +  +SDVYS G VL+EVL   P
Sbjct: 179 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 234

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 36/229 (15%)
Query: 255 PSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGA- 313
           PS L  ++ L EI            +G GG  +V+          VA+K L  +  +   
Sbjct: 7   PSHLSDRYELGEI------------LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPS 54
Query: 314 --LEFQTEIGMLSQLRHLHLVSLIGFCNDDREM----ILVYDFMARGTLPDHLYHSDNPP 367
             L F+ E    + L H  +V++      +        +V +++   TL D + H++ P 
Sbjct: 55  FYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPM 113
Query: 368 LPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--- 424
            P  + +E+   A + L++ H       IIHRDVK  NI++      KV DFG+++    
Sbjct: 114 TP-KRAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIAD 168
Query: 425 GPTSVSKT--------HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
              SV++T        +L PE  R   +  +SDVYS G VL+EVL   P
Sbjct: 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 36/229 (15%)
Query: 255 PSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGA- 313
           PS L  ++ L EI            +G GG  +V+          VA+K L  +  +   
Sbjct: 7   PSHLSDRYELGEI------------LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPS 54
Query: 314 --LEFQTEIGMLSQLRHLHLVSLIGFCNDDREM----ILVYDFMARGTLPDHLYHSDNPP 367
             L F+ E    + L H  +V++      +        +V +++   TL D + H++ P 
Sbjct: 55  FYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPM 113
Query: 368 LPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--- 424
            P  + +E+   A + L++ H       IIHRDVK  NI++      KV DFG+++    
Sbjct: 114 TP-KRAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIAD 168
Query: 425 GPTSVSKT--------HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
              SV++T        +L PE  R   +  +SDVYS G VL+EVL   P
Sbjct: 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 40/231 (17%)
Query: 255 PSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGA- 313
           PS L  ++ L EI            +G GG  +V+          VA+K L  +  +   
Sbjct: 7   PSHLSDRYELGEI------------LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPS 54
Query: 314 --LEFQTEIGMLSQLRHLHLVSLIGFCNDDREM------ILVYDFMARGTLPDHLYHSDN 365
             L F+ E    + L H  +V++  +   + E        +V +++   TL D + H++ 
Sbjct: 55  FYLRFRREAQNAAALNHPAIVAV--YATGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEG 111
Query: 366 PPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF- 424
           P  P  + +E+   A + L++ H       IIHRDVK  NI++      KV DFG+++  
Sbjct: 112 PMTP-KRAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAI 166
Query: 425 --GPTSVSKT--------HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
                SV++T        +L PE  R   +  +SDVYS G VL+EVL   P
Sbjct: 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G         T VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 331 LVSLIGFCNDDREMILVYDFMARGTL--------PDHLYHSDNPP------LPWNQRLEI 376
           +++L+G C  D  + ++ ++ ++G L        P  L +S NP       L     +  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV 429
               ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+ 
Sbjct: 149 AYQVARGMEYLASKK----CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 204
Query: 430 SK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            +     + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 205 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 239

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 15/203 (7%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL---EPESQQGALEFQTEIGMLSQLRH 328
           ++FD    +G G FG+VY      +   +A+K L   + E +    + + EI + S LRH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
            +++ +  + +D + + L+ +F  RG L   L           +        A  LHY H
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCH 131
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPEYYRLQ 442
                  +IHRD+K  N+L+  K   K++DFG S   P+   +       +L PE    +
Sbjct: 132 ERK----VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGK 187
Query: 443 QLTEKSDVYSFGVVLFEVLCARP 465
              EK D++  GV+ +E L   P
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMP 210

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 255 PSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGA- 313
           PS L  ++ L EI            +G GG  +V+          VA+K L  +  +   
Sbjct: 7   PSHLSDRYELGEI------------LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPS 54
Query: 314 --LEFQTEIGMLSQLRHLHLVSLIGFCNDDREM----ILVYDFMARGTLPDHLYHSDNPP 367
             L F+ E    + L H  +V++      +        +V +++   TL D + H++ P 
Sbjct: 55  FYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPM 113
Query: 368 LPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--- 424
            P  + +E+   A + L++ H       IIHRDVK  NIL+      KV DFG+++    
Sbjct: 114 TP-KRAIEVIADACQALNFSHQNG----IIHRDVKPANILISATNAVKVVDFGIARAIAD 168
Query: 425 GPTSVSKT--------HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
              SV +T        +L PE  R   +  +SDVYS G VL+EVL   P
Sbjct: 169 SGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 105/215 (48%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G         T VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWN-------------QRLEIC 377
           +++L+G C  D  + ++ ++ ++G L ++L     P L ++             + L  C
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 378 I-GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV 429
               ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+ 
Sbjct: 145 AYQVARGMEYLASKK----CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 200
Query: 430 SK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            +     + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 201 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 235

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G         T VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 331 LVSLIGFCNDDREMILVYDFMARGTL--------PDHLYHSDNPP------LPWNQRLEI 376
           +++L+G C  D  + ++ ++ ++G L        P  L +S NP       L     +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV 429
               ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+ 
Sbjct: 156 AYQVARGMEYLASKK----CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 430 SK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            +     + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 105/215 (48%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G         T VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWN-------------QRLEIC 377
           +++L+G C  D  + ++ ++ ++G L ++L     P L ++             + L  C
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 378 I-GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV 429
               ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+ 
Sbjct: 148 AYQVARGMEYLASKK----CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 203
Query: 430 SK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            +     + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 204 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 238

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 105/215 (48%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G         T VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPW-------------NQRLEIC 377
           +++L+G C  D  + ++ ++ ++G L ++L     P L +             ++ L  C
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 378 I-GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV 429
               ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+ 
Sbjct: 141 AYQVARGMEYLASKK----CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 430 SK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            +     + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G         T VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 331 LVSLIGFCNDDREMILVYDFMARGTL--------PDHLYHSDNPP------LPWNQRLEI 376
           +++L+G C  D  + ++ ++ ++G L        P  L +S NP       L     +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV 429
               ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+ 
Sbjct: 197 AYQVARGMEYLASKK----CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 430 SK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            +     + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 105/215 (48%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G         T VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPW-------------NQRLEIC 377
           +++L+G C  D  + ++ ++ ++G L ++L     P L +             ++ L  C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 378 I-GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV 429
               ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+ 
Sbjct: 156 AYQVARGMEYLASKK----CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 430 SK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            +     + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 21/198 (10%)
Query: 279 VIGVGGFGDVYKGFI----NGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           V+G G FG VYKG           PVAIK L E  S +   E   E  +++ +   ++  
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L+G C     + LV   M  G L DH+   +   L     L  C+  A+G+ YL      
Sbjct: 84  LLGICLTS-TVQLVTQLMPYGCLLDHV-RENRGRLGSQDLLNWCMQIAKGMSYLE----D 137
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDP----------EYYRLQQ 443
             ++HRD+   N+L+      K++DFGL++      ++ H D           E    ++
Sbjct: 138 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRR 197
Query: 444 LTEKSDVYSFGVVLFEVL 461
            T +SDV+S+GV ++E++
Sbjct: 198 FTHQSDVWSYGVTVWELM 215

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 36/229 (15%)
Query: 255 PSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGA- 313
           PS L  ++ L EI            +G GG  +V+          VA+K L  +  +   
Sbjct: 7   PSHLSDRYELGEI------------LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPS 54
Query: 314 --LEFQTEIGMLSQLRHLHLVSLIGFCNDDREM----ILVYDFMARGTLPDHLYHSDNPP 367
             L F+ E    + L H  +V++      +        +V +++   TL D + H++ P 
Sbjct: 55  FYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPM 113
Query: 368 LPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--- 424
            P  + +E+   A + L++ H       IIHRDVK  NI++      KV DFG+++    
Sbjct: 114 TP-KRAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIAD 168
Query: 425 GPTSVSKT--------HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
              SV++T        +L PE  R   +  +SDVYS G VL+EVL   P
Sbjct: 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 27/201 (13%)
Query: 279 VIGVGGFGDVYKG--FINGSTT--PVAIKRLEPESQQGALEFQTE-IGMLSQLRHLHLVS 333
           V+G G FG V+KG     G +   PV IK +E +S + + +  T+ +  +  L H H+V 
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 97
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYH---SDNPPLPWNQRLEICIGAARGLHYLHTG 390
           L+G C     + LV  ++  G+L DH+     +  P L  N  ++I    A+G++YL   
Sbjct: 98  LLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI----AKGMYYLEEH 152
Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-------SVSKTHLD---PEYYR 440
                ++HR++   N+LL      +V+DFG++   P        S +KT +     E   
Sbjct: 153 G----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 208
Query: 441 LQQLTEKSDVYSFGVVLFEVL 461
             + T +SDV+S+GV ++E++
Sbjct: 209 FGKYTHQSDVWSYGVTVWELM 229

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 42/220 (19%)
Query: 280 IGVGGFGDVYKG---FINGST--TPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVS 333
           +G G FG V K     + G    T VA+K L+  +    L +  +E  +L Q+ H H++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 334 LIGFCNDDREMILVYDFMARGTL-----------PDHLY-----------HSDNPPLPWN 371
           L G C+ D  ++L+ ++   G+L           P +L            H D   L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 372 QRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-----FGP 426
             +      ++G+ YL   +    ++HRD+   NIL+ E    K+SDFGLS+        
Sbjct: 151 DLISFAWQISQGMQYLAEMS----LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 427 TSVSKTHLDPEYYRLQQL-----TEKSDVYSFGVVLFEVL 461
              S+  +  ++  ++ L     T +SDV+SFGV+L+E++
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 42/220 (19%)
Query: 280 IGVGGFGDVYKG---FINGST--TPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVS 333
           +G G FG V K     + G    T VA+K L+  +    L +  +E  +L Q+ H H++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 334 LIGFCNDDREMILVYDFMARGTL-----------PDHLY-----------HSDNPPLPWN 371
           L G C+ D  ++L+ ++   G+L           P +L            H D   L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 372 QRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-----FGP 426
             +      ++G+ YL        ++HRD+   NIL+ E    K+SDFGLS+        
Sbjct: 151 DLISFAWQISQGMQYL----AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 427 TSVSKTHLDPEYYRLQQL-----TEKSDVYSFGVVLFEVL 461
              S+  +  ++  ++ L     T +SDV+SFGV+L+E++
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 276 NDLVIGVGGFGDVYKG-FINGSTTPV--AIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           +D VIG G FG VY G +I+ +   +  AIK L   ++   +E F  E  ++  L H ++
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 332 VSLIGFCNDDREMI-LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           ++LIG       +  ++  +M  G L   +      P      +   +  ARG+ YL   
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP-TVKDLISFGLQVARGMEYLAEQ 143
Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ------- 443
                 +HRD+   N +LDE +  KV+DFGL        ++  LD EYY +QQ       
Sbjct: 144 K----FVHRDLAARNCMLDESFTVKVADFGL--------ARDILDREYYSVQQHRHARLP 191
Query: 444 -------------LTEKSDVYSFGVVLFEVL 461
                         T KSDV+SFGV+L+E+L
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 27/201 (13%)
Query: 279 VIGVGGFGDVYKGFI----NGSTTPVAIKRLEPESQQGALEFQTE-IGMLSQLRHLHLVS 333
           V+G G FG V+KG           PV IK +E +S + + +  T+ +  +  L H H+V 
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYH---SDNPPLPWNQRLEICIGAARGLHYLHTG 390
           L+G C     + LV  ++  G+L DH+     +  P L  N  ++I    A+G++YL   
Sbjct: 80  LLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI----AKGMYYLEEH 134
Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-------SVSKTHLD---PEYYR 440
                ++HR++   N+LL      +V+DFG++   P        S +KT +     E   
Sbjct: 135 G----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 441 LQQLTEKSDVYSFGVVLFEVL 461
             + T +SDV+S+GV ++E++
Sbjct: 191 FGKYTHQSDVWSYGVTVWELM 211

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G         T VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWN-------------QRLEIC 377
           +++L+G C  D  + ++ ++ ++G L ++L     P L ++             + L  C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 378 I-GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGP 426
               ARG+ YL +       IHRD+   N+L+ E  V K++DFGL+          K   
Sbjct: 156 AYQVARGMEYLASKK----CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTN 211
Query: 427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             +    + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 42/220 (19%)
Query: 280 IGVGGFGDVYKG---FINGST--TPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVS 333
           +G G FG V K     + G    T VA+K L+  +    L +  +E  +L Q+ H H++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 334 LIGFCNDDREMILVYDFMARGTL-----------PDHLY-----------HSDNPPLPWN 371
           L G C+ D  ++L+ ++   G+L           P +L            H D   L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 372 QRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-----FGP 426
             +      ++G+ YL        ++HRD+   NIL+ E    K+SDFGLS+        
Sbjct: 151 DLISFAWQISQGMQYL----AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 427 TSVSKTHLDPEYYRLQQL-----TEKSDVYSFGVVLFEVL 461
              S+  +  ++  ++ L     T +SDV+SFGV+L+E++
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 262 FSLSEIQAATNNFDNDLV------IGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGA 313
            +L EI+      D  L+      +G G FG V KG+  +      VA+K L+ E+   A
Sbjct: 1   MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60
Query: 314 L--EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWN 371
           L  E   E  ++ QL + ++V +IG C  +  M LV +    G L  +L    N  +   
Sbjct: 61  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDK 117
Query: 372 QRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS--- 428
             +E+    + G+ YL      +  +HRD+   N+LL  +  AK+SDFGLSK        
Sbjct: 118 NIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
Query: 429 -VSKTH-------LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             ++TH         PE     + + KSDV+SFGV+++E  
Sbjct: 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 214

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALE-FQTEIGMLSQ 325
           NN      +G G FG V +    G     +   VA+K L+  +     E   +E+ ++S 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 326 L-RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHS--------DNPPLPWNQRLEI 376
           L +H ++V+L+G C     ++++ ++   G L + L           D  PL     L  
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGP 426
               A+G+ +L +       IHRDV   N+LL    VAK+ DFGL++           G 
Sbjct: 158 SSQVAQGMAFLASKN----CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 213
Query: 427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             +    + PE       T +SDV+S+G++L+E+ 
Sbjct: 214 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 248

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G           VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHL---------YHSDNPPLPWNQR-----LEI 376
           +++L+G C  D  + ++ ++ ++G L ++L         Y  D   +P  Q      +  
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV 429
               ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+ 
Sbjct: 163 TYQLARGMEYLASQK----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 430 SK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            +     + PE    +  T +SDV+SFGV+++E+ 
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 92/195 (47%), Gaps = 16/195 (8%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G FG+VYKG  N +   VAIK ++  E++    + Q EI +LSQ    ++    G  
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
               ++ ++ +++  G+  D L      PL       I     +GL YLH+       IH
Sbjct: 87  LKSTKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERK----IH 139
Query: 399 RDVKTTNILLDEKWVAKVSDFGLS-KFGPTSVSKTH-------LDPEYYRLQQLTEKSDV 450
           RD+K  N+LL E+   K++DFG++ +   T + +         + PE  +      K+D+
Sbjct: 140 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADI 199
Query: 451 YSFGVVLFEVLCARP 465
           +S G+   E+    P
Sbjct: 200 WSLGITAIELAKGEP 214

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALE-FQTEIGMLSQ 325
           NN      +G G FG V +    G     +   VA+K L+  +     E   +E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 326 L-RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHS--------DNPPLPWNQRLEI 376
           L +H ++V+L+G C     ++++ ++   G L + L           D  PL     L  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGP 426
               A+G+ +L +       IHRDV   N+LL    VAK+ DFGL++           G 
Sbjct: 166 SSQVAQGMAFLASKN----CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 221
Query: 427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             +    + PE       T +SDV+S+G++L+E+ 
Sbjct: 222 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 256

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGA-LEFQTEIGMLSQLRHLHLVSLIGFC 338
           +G G +  VYKG    +   VA+K +  E ++GA      E+ +L  L+H ++V+L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
           + ++ + LV++++ +  L  +L    N     N +L       RGL Y H       ++H
Sbjct: 70  HTEKSLTLVFEYLDKD-LKQYLDDCGNIINMHNVKL-FLFQLLRGLAYCHRQK----VLH 123
Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFG--PTSVSKTHLDPEYYRLQQL-------TEKSD 449
           RD+K  N+L++E+   K++DFGL++    PT      +   +YR   +       + + D
Sbjct: 124 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQID 183
Query: 450 VYSFGVVLFEVLCARPSILRTAAKKQV 476
           ++  G + +E+   RP    +  ++Q+
Sbjct: 184 MWGVGCIFYEMATGRPLFPGSTVEEQL 210

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGML 323
           A   N+     +G G FG V   +   +   VA+K      L     QG +E   EI  L
Sbjct: 10  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYL 67
Query: 324 SQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARG 383
             LRH H++ L        E+I+V ++ A   L D++   D       +R    I +A  
Sbjct: 68  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA-- 124
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS------KFGPTSVSKTHLDPE 437
           + Y H       I+HRD+K  N+LLDE    K++DFGLS       F  TS       P 
Sbjct: 125 VEYCHRHK----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG----SPN 176
Query: 438 YYRLQQLTEK------SDVYSFGVVLFEVLCAR 464
           Y   + ++ K       DV+S GV+L+ +LC R
Sbjct: 177 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 22/200 (11%)
Query: 277 DLVIGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGAL--EFQTEIGMLSQLRHLHLV 332
           D  +G G FG V KG+  +      VA+K L+ E+   AL  E   E  ++ QL + ++V
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            +IG C  +  M LV +    G L  +L    N  +     +E+    + G+ YL     
Sbjct: 92  RMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---- 144
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTH-------LDPEYYRL 441
            +  +HRD+   N+LL  +  AK+SDFGLSK          ++TH         PE    
Sbjct: 145 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 204
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
            + + KSDV+SFGV+++E  
Sbjct: 205 YKFSSKSDVWSFGVLMWEAF 224

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 22/200 (11%)
Query: 277 DLVIGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGAL--EFQTEIGMLSQLRHLHLV 332
           D  +G G FG V KG+  +      VA+K L+ E+   AL  E   E  ++ QL + ++V
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            +IG C  +  M LV +    G L  +L    N  +     +E+    + G+ YL     
Sbjct: 92  RMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---- 144
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTH-------LDPEYYRL 441
            +  +HRD+   N+LL  +  AK+SDFGLSK          ++TH         PE    
Sbjct: 145 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 204
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
            + + KSDV+SFGV+++E  
Sbjct: 205 YKFSSKSDVWSFGVLMWEAF 224

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGML 323
           A   N+     +G G FG V   +   +   VA+K      L     QG +E   EI  L
Sbjct: 11  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYL 68
Query: 324 SQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARG 383
             LRH H++ L        E+I+V ++ A   L D++   D       +R    I +A  
Sbjct: 69  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA-- 125
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS------KFGPTSVSKTHLDPE 437
           + Y H       I+HRD+K  N+LLDE    K++DFGLS       F  TS       P 
Sbjct: 126 VEYCHRHK----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG----SPN 177
Query: 438 YYRLQQLTEK------SDVYSFGVVLFEVLCAR 464
           Y   + ++ K       DV+S GV+L+ +LC R
Sbjct: 178 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLR 327
           AT+ ++    IGVG +G VYK     S   VA+K +   + +  L   T  E+ +L +L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 328 ---HLHLVSLIGFC---NDDREM--ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG 379
              H ++V L+  C     DRE+   LV++ + +  L  +L  +  P LP     ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSVSKT 432
             RGL +LH       I+HRD+K  NIL+      K++DFGL++         P  V+  
Sbjct: 121 FLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLW 176
Query: 433 HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           +  PE           D++S G +  E+   +P
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 22/200 (11%)
Query: 277 DLVIGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGAL--EFQTEIGMLSQLRHLHLV 332
           D  +G G FG V KG+  +      VA+K L+ E+   AL  E   E  ++ QL + ++V
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            +IG C  +  M LV +    G L  +L    N  +     +E+    + G+ YL     
Sbjct: 76  RMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---- 128
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTH-------LDPEYYRL 441
            +  +HRD+   N+LL  +  AK+SDFGLSK          ++TH         PE    
Sbjct: 129 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINY 188
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
            + + KSDV+SFGV+++E  
Sbjct: 189 YKFSSKSDVWSFGVLMWEAF 208

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G           VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHL---------YHSDNPPLPWNQR-----LEI 376
           +++L+G C  D  + ++ ++ ++G L ++L         Y  D   +P  Q      +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV 429
               ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+ 
Sbjct: 163 TYQLARGMEYLASQK----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 430 SK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            +     + PE    +  T +SDV+SFGV+++E+ 
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 22/200 (11%)
Query: 277 DLVIGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGAL--EFQTEIGMLSQLRHLHLV 332
           D  +G G FG V KG+  +      VA+K L+ E+   AL  E   E  ++ QL + ++V
Sbjct: 30  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 89
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            +IG C  +  M LV +    G L  +L    N  +     +E+    + G+ YL     
Sbjct: 90  RMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---- 142
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTH-------LDPEYYRL 441
            +  +HRD+   N+LL  +  AK+SDFGLSK          ++TH         PE    
Sbjct: 143 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 202
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
            + + KSDV+SFGV+++E  
Sbjct: 203 YKFSSKSDVWSFGVLMWEAF 222

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 22/200 (11%)
Query: 277 DLVIGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGAL--EFQTEIGMLSQLRHLHLV 332
           D  +G G FG V KG+  +      VA+K L+ E+   AL  E   E  ++ QL + ++V
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            +IG C  +  M LV +    G L  +L    N  +     +E+    + G+ YL     
Sbjct: 76  RMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---- 128
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTH-------LDPEYYRL 441
            +  +HRD+   N+LL  +  AK+SDFGLSK          ++TH         PE    
Sbjct: 129 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 188
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
            + + KSDV+SFGV+++E  
Sbjct: 189 YKFSSKSDVWSFGVLMWEAF 208

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 18/199 (9%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG VYK     ++   A K ++ +S++   ++  EI +L+   H ++V L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +  + ++ +F A G + D +      PL  +Q   +C      L+YLH       IIHR
Sbjct: 105 YENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNK----IIHR 159
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLTE----- 446
           D+K  NIL       K++DFG+S     ++ +          + PE    +   +     
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 447 KSDVYSFGVVLFEVLCARP 465
           K+DV+S G+ L E+    P
Sbjct: 220 KADVWSLGITLIEMAEIEP 238

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGML 323
           A   N+     +G G FG V   +   +   VA+K      L     QG +E   EI  L
Sbjct: 1   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYL 58
Query: 324 SQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARG 383
             LRH H++ L        E+I+V ++ A   L D++   D       +R    I +A  
Sbjct: 59  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA-- 115
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS------KFGPTSVSKTHLDPE 437
           + Y H       I+HRD+K  N+LLDE    K++DFGLS       F  TS       P 
Sbjct: 116 VEYCHRHK----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG----SPN 167
Query: 438 YYRLQQLTEK------SDVYSFGVVLFEVLCAR 464
           Y   + ++ K       DV+S GV+L+ +LC R
Sbjct: 168 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLH 330
           ++++   VIG G    V   +       VAIKR+  E  Q ++ E   EI  +SQ  H +
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYH------SDNPPLPWNQRLEICIGAARGL 384
           +VS         E+ LV   ++ G++ D + H        +  L  +    I      GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 385 HYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-------SVSKTHLDPE 437
            YLH        IHRDVK  NILL E    +++DFG+S F  T        V KT +   
Sbjct: 130 EYLHKNGQ----IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 438 YYRLQQLTE-------KSDVYSFGVVLFEV 460
            +   ++ E       K+D++SFG+   E+
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIEL 215

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 28/265 (10%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP---ESQQGALEFQTEIGMLSQLRHL 329
           NF  +  IG G F +VY+        PVA+K+++       +   +   EI +L QL H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP--LP----WNQRLEICIGAARG 383
           +++       +D E+ +V +    G L   + H       +P    W   +++C      
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC----SA 148
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LD 435
           L ++H+      ++HRD+K  N+ +    V K+ D GL +F  +  +  H        + 
Sbjct: 149 LEHMHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 204
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC-YQNGTIDQI 494
           PE         KSD++S G +L+E + A  S          SL    +QC Y     D  
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYE-MAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263
Query: 495 VDPFLKAMS-CLNDEGIRRPSMSDV 518
            +   + ++ C+N +  +RP ++ V
Sbjct: 264 SEELRQLVNMCINPDPEKRPDVTYV 288

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 22/200 (11%)
Query: 277 DLVIGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGAL--EFQTEIGMLSQLRHLHLV 332
           D  +G G FG V KG+  +      VA+K L+ E+   AL  E   E  ++ QL + ++V
Sbjct: 10  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 69
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            +IG C  +  M LV +    G L  +L    N  +     +E+    + G+ YL     
Sbjct: 70  RMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---- 122
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTH-------LDPEYYRL 441
            +  +HRD+   N+LL  +  AK+SDFGLSK          ++TH         PE    
Sbjct: 123 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 182
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
            + + KSDV+SFGV+++E  
Sbjct: 183 YKFSSKSDVWSFGVLMWEAF 202

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 94/194 (48%), Gaps = 18/194 (9%)
Query: 280 IGVGGFGDVY--KGFINGSTTPVAIKRLEPESQQGALEFQT-EIGMLSQLRHLHLVSLIG 336
           +G G FG V+  +   NG    + + + E   +   +E    E  MLS + H  ++ + G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ--RLEICIGAARGLHYLHTGANHA 394
              D +++ ++ D++  G L   L  S   P P  +    E+C+     L YLH+     
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA----LEYLHSKD--- 126
Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV-----SKTHLDPEYYRLQQLTEKSD 449
            II+RD+K  NILLD+    K++DFG +K+ P        +  ++ PE    +   +  D
Sbjct: 127 -IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVVSTKPYNKSID 185
Query: 450 VYSFGVVLFEVLCA 463
            +SFG++++E+L  
Sbjct: 186 WWSFGILIYEMLAG 199

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 22/200 (11%)
Query: 277 DLVIGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGAL--EFQTEIGMLSQLRHLHLV 332
           D  +G G FG V KG+  +      VA+K L+ E+   AL  E   E  ++ QL + ++V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            +IG C  +  M LV +    G L  +L    N  +     +E+    + G+ YL     
Sbjct: 72  RMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---- 124
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTH-------LDPEYYRL 441
            +  +HRD+   N+LL  +  AK+SDFGLSK          ++TH         PE    
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
            + + KSDV+SFGV+++E  
Sbjct: 185 YKFSSKSDVWSFGVLMWEAF 204

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGML 323
           A   N+     +G G FG V   +   +   VA+K      L     QG +E   EI  L
Sbjct: 5   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYL 62
Query: 324 SQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARG 383
             LRH H++ L        E+I+V ++ A   L D++   D       +R    I +A  
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA-- 119
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS------KFGPTSVSKTHLDPE 437
           + Y H       I+HRD+K  N+LLDE    K++DFGLS       F  TS       P 
Sbjct: 120 VEYCHRHK----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG----SPN 171
Query: 438 YYRLQQLTEK------SDVYSFGVVLFEVLCAR 464
           Y   + ++ K       DV+S GV+L+ +LC R
Sbjct: 172 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLH 330
           ++++   VIG G    V   +       VAIKR+  E  Q ++ E   EI  +SQ  H +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 331 LVSL-IGFCNDDREMILVYDFMARGTLPDHLYH------SDNPPLPWNQRLEICIGAARG 383
           +VS    F   D E+ LV   ++ G++ D + H        +  L  +    I      G
Sbjct: 75  IVSYYTSFVVKD-ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT-------SVSKTHLDP 436
           L YLH        IHRDVK  NILL E    +++DFG+S F  T        V KT +  
Sbjct: 134 LEYLHKNGQ----IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 437 EYYRLQQLTE-------KSDVYSFGVVLFEV 460
             +   ++ E       K+D++SFG+   E+
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G           VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHL---------YHSDNPPLPWNQR-----LEI 376
           +++L+G C  D  + ++ ++ ++G L ++L         Y  D   +P  Q      +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV 429
               ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+ 
Sbjct: 163 TYQLARGMEYLASQK----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 430 SK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            +     + PE    +  T +SDV+SFGV+++E+ 
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 32/208 (15%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
           ++G G FG V +G +   +G++  VA+K  +L+  SQ+   EF +E   +    H +++ 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 334 LIGFCNDDREM-----ILVYDFMARGTLPDHLYHS--DNPP--LPWNQRLEICIGAARGL 384
           L+G C +         +++  FM  G L  +L +S  +  P  +P    L+  +  A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 385 HYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSVSKTHLDPE 437
            YL    ++   +HRD+   N +L +     V+DFGLSK       +    ++K  +  +
Sbjct: 161 EYL----SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV--K 214
Query: 438 YYRLQQL-----TEKSDVYSFGVVLFEV 460
           +  ++ L     T KSDV++FGV ++E+
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 16/195 (8%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G FG+V+KG  N +   VAIK ++  E++    + Q EI +LSQ    ++    G  
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
               ++ ++ +++  G+  D L      P    Q   +     +GL YLH+       IH
Sbjct: 91  LKGSKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKK----IH 143
Query: 399 RDVKTTNILLDEKWVAKVSDFGLS-KFGPTSVSKTH-------LDPEYYRLQQLTEKSDV 450
           RD+K  N+LL E+   K++DFG++ +   T + +         + PE  +      K+D+
Sbjct: 144 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 203
Query: 451 YSFGVVLFEVLCARP 465
           +S G+   E+    P
Sbjct: 204 WSLGITAIELAKGEP 218

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 103/216 (47%), Gaps = 39/216 (18%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G           VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP---------------LPWNQRLE 375
           +++L+G C  D  + ++ ++ ++G L ++L  +  PP               + +   + 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 376 ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTS 428
                ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+
Sbjct: 208 CTYQLARGMEYLASQK----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 429 VSK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             +     + PE    +  T +SDV+SFGV+++E+ 
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 103/216 (47%), Gaps = 39/216 (18%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G           VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP---------------LPWNQRLE 375
           +++L+G C  D  + ++ ++ ++G L ++L  +  PP               + +   + 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVS 153
Query: 376 ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTS 428
                ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+
Sbjct: 154 CTYQLARGMEYLASQK----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 429 VSK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             +     + PE    +  T +SDV+SFGV+++E+ 
Sbjct: 210 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 245

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 103/216 (47%), Gaps = 39/216 (18%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G           VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP---------------LPWNQRLE 375
           +++L+G C  D  + ++ ++ ++G L ++L  +  PP               + +   + 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVS 150
Query: 376 ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTS 428
                ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+
Sbjct: 151 CTYQLARGMEYLASQK----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 429 VSK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             +     + PE    +  T +SDV+SFGV+++E+ 
Sbjct: 207 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 242

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 22/200 (11%)
Query: 277 DLVIGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGAL--EFQTEIGMLSQLRHLHLV 332
           D  +G G FG V KG+  +      VA+K L+ E+   AL  E   E  ++ QL + ++V
Sbjct: 375 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 434
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            +IG C  +  M LV +    G L  +L    N  +     +E+    + G+ YL     
Sbjct: 435 RMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL----E 487
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTH-------LDPEYYRL 441
            +  +HRD+   N+LL  +  AK+SDFGLSK          ++TH         PE    
Sbjct: 488 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 547
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
            + + KSDV+SFGV+++E  
Sbjct: 548 YKFSSKSDVWSFGVLMWEAF 567

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 102/216 (47%), Gaps = 39/216 (18%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G           VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP---------------LPWNQRLE 375
           ++ L+G C  D  + ++ ++ ++G L ++L  +  PP               + +   + 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 376 ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTS 428
                ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+
Sbjct: 162 CTYQLARGMEYLASQK----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 429 VSK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             +     + PE    +  T +SDV+SFGV+++E+ 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 22/200 (11%)
Query: 277 DLVIGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGAL--EFQTEIGMLSQLRHLHLV 332
           D  +G G FG V KG+  +      VA+K L+ E+   AL  E   E  ++ QL + ++V
Sbjct: 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 433
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            +IG C  +  M LV +    G L  +L    N  +     +E+    + G+ YL     
Sbjct: 434 RMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL----E 486
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTH-------LDPEYYRL 441
            +  +HRD+   N+LL  +  AK+SDFGLSK          ++TH         PE    
Sbjct: 487 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 546
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
            + + KSDV+SFGV+++E  
Sbjct: 547 YKFSSKSDVWSFGVLMWEAF 566

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLR 327
           AT+ ++    IGVG +G VYK     S   VA+K +   + +  L   T  E+ +L +L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 328 ---HLHLVSLIGFC---NDDREM--ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG 379
              H ++V L+  C     DRE+   LV++ + +  L  +L  +  P LP     ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSVSKT 432
             RGL +LH       I+HRD+K  NIL+      K++DFGL++         P  V+  
Sbjct: 121 FLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLW 176
Query: 433 HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           +  PE           D++S G +  E+   +P
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 103/216 (47%), Gaps = 39/216 (18%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G           VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP---------------LPWNQRLE 375
           +++L+G C  D  + ++ ++ ++G L ++L  +  PP               + +   + 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVS 148
Query: 376 ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTS 428
                ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+
Sbjct: 149 CTYQLARGMEYLASQK----CIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 429 VSK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             +     + PE    +  T +SDV+SFGV+++E+ 
Sbjct: 205 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 240

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 103/216 (47%), Gaps = 39/216 (18%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G           VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP---------------LPWNQRLE 375
           +++L+G C  D  + ++ ++ ++G L ++L  +  PP               + +   + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 376 ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTS 428
                ARG+ YL +       IHRD+   N+L+ E  V +++DFGL++       +  T+
Sbjct: 162 CTYQLARGMEYLASQK----CIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 429 VSK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             +     + PE    +  T +SDV+SFGV+++E+ 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 18/199 (9%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG VYK     ++   A K ++ +S++   ++  EI +L+   H ++V L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +  + ++ +F A G + D +      PL  +Q   +C      L+YLH       IIHR
Sbjct: 105 YENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNK----IIHR 159
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLTE----- 446
           D+K  NIL       K++DFG+S      + +          + PE    +   +     
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 447 KSDVYSFGVVLFEVLCARP 465
           K+DV+S G+ L E+    P
Sbjct: 220 KADVWSLGITLIEMAEIEP 238

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G           VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHL---------YHSDNPPLPWNQR-----LEI 376
           +++L+G C  D  + ++ ++ ++G L ++L         Y  D   +P  Q      +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGP 426
               ARG+ YL +       IHRD+   N+L+ E  V K++DFGL+          K   
Sbjct: 163 TYQLARGMEYLASQK----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             +    + PE    +  T +SDV+SFGV+++E+ 
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G           VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHL---------YHSDNPPLPWNQR-----LEI 376
           +++L+G C  D  + ++  + ++G L ++L         Y  D   +P  Q      +  
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV 429
               ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+ 
Sbjct: 163 TYQLARGMEYLASQK----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 430 SK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            +     + PE    +  T +SDV+SFGV+++E+ 
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G           VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHL---------YHSDNPPLPWNQR-----LEI 376
           +++L+G C  D  + ++  + ++G L ++L         Y  D   +P  Q      +  
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV 429
               ARG+ YL +       IHRD+   N+L+ E  V K++DFGL++       +  T+ 
Sbjct: 163 TYQLARGMEYLASQK----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 430 SK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            +     + PE    +  T +SDV+SFGV+++E+ 
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 18/199 (9%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG VYK     ++   A K ++ +S++   ++  EI +L+   H ++V L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            +  + ++ +F A G + D +      PL  +Q   +C      L+YLH       IIHR
Sbjct: 105 YENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNK----IIHR 159
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLTE----- 446
           D+K  NIL       K++DFG+S      + +          + PE    +   +     
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 447 KSDVYSFGVVLFEVLCARP 465
           K+DV+S G+ L E+    P
Sbjct: 220 KADVWSLGITLIEMAEIEP 238

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 42/227 (18%)
Query: 273 NFDNDLVIGVGGFGDV-----YKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQL 326
           N +   V+G G FG V     Y     G +  VA+K L+ ++     E   +E+ M++QL
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 327 -RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL------YHSDNPPLPWNQRLE---- 375
             H ++V+L+G C     + L++++   G L ++L      +  D       +RLE    
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 376 ---------ICIG--AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK- 423
                    +C     A+G+ +L   +     +HRD+   N+L+    V K+ DFGL++ 
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKS----CVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 424 ---------FGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
                     G   +    + PE       T KSDV+S+G++L+E+ 
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKR-LEPESQQGALEF-QTEIGMLSQLR 327
           +   ++N  ++G G +G V K     +   VAIK+ LE +  +   +    EI +L QLR
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
           H +LV+L+  C   +   LV++F+    L D     +       Q+    I    G  + 
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK--FGPTSVSKTHLDPEYYRLQQLT 445
           H       IIHRD+K  NIL+ +  V K+ DFG ++    P  V    +   +YR  +L 
Sbjct: 143 HN------IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL 196
Query: 446 -------EKSDVYSFGVVLFEVLCARP 465
                  +  DV++ G ++ E+    P
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGEP 223

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 39/216 (18%)
Query: 280 IGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLH 330
           +G G FG V      G           VA+K L+ ++ +  L +  +E+ M+  + +H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPP---------------LPWNQRLE 375
           +++L+G C  D  + ++ ++ ++G L ++L  +  PP               + +   + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEXSYDINRVPEEQMTFKDLVS 161
Query: 376 ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFG 425
                ARG+ YL +       IHRD+   N+L+ E  V K++DFGL+          K  
Sbjct: 162 CTYQLARGMEYLASQK----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 426 PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              +    + PE    +  T +SDV+SFGV+++E+ 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 24/231 (10%)
Query: 244 KATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK 303
           K  ++S G+  P  L   F++       ++F+    +G G FG+VY      S   VA+K
Sbjct: 4   KVMENSSGT--PDILTRHFTI-------DDFEIGRPLGKGKFGNVYLAREKKSHFIVALK 54
Query: 304 RL---EPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL 360
            L   + E +    + + EI + + L H +++ L  +  D R + L+ ++  RG L   L
Sbjct: 55  VLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL 114
Query: 361 YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG 420
             S        +   I    A  L Y H       +IHRD+K  N+LL  K   K++DFG
Sbjct: 115 QKSCT--FDEQRTATIMEELADALMYCHGKK----VIHRDIKPENLLLGLKGELKIADFG 168
Query: 421 LSKFGPTSVSKT------HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
            S   P+   KT      +L PE    +   EK D++  GV+ +E+L   P
Sbjct: 169 WSVHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNP 219

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 111/279 (39%), Gaps = 47/279 (16%)
Query: 280 IGVGGFGDVY--KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G+V   +  +      + I R    S     +   E+ +L  L H +++ L  F
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ--RLEICIGAARGLHYLHTGANHAV 395
             D R   LV +    G L D + H     + +N+     I      G+ YLH       
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKHN---- 156
Query: 396 IIHRDVKTTNILLDEK---WVAKVSDFGLSK-FGPTSVSKTHLDPEYY-----RLQQLTE 446
           I+HRD+K  N+LL+ K    + K+ DFGLS  F      K  L   YY       ++  E
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDE 216
Query: 447 KSDVYSFGVVLFEVLCARP--------SILRTAAKKQVSLAVWAQQCYQNGTIDQIVD-- 496
           K DV+S GV+LF +L   P         ILR   K + +      +    G  D I    
Sbjct: 217 KCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQML 276
Query: 497 ----------------PFLKAMSCLNDEGIRRPSMSDVV 519
                           P++K M    + GI  PS+++ +
Sbjct: 277 QFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAI 315

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLR 327
           AT+ ++    IGVG +G VYK     S   VA+K +   + +  L   T  E+ +L +L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 328 ---HLHLVSLIGFC---NDDREM--ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG 379
              H ++V L+  C     DRE+   LV++ + +  L  +L  +  P LP     ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSVSKT 432
             RGL +LH       I+HRD+K  NIL+      K++DFGL++         P  V+  
Sbjct: 121 FLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLW 176
Query: 433 HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           +  PE           D++S G +  E+   +P
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 109/224 (48%), Gaps = 19/224 (8%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT-EIGMLSQLR 327
           ++++ F     +G G +  VYKG    +   VA+K ++ +S++G       EI ++ +L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICI----GAARG 383
           H ++V L    + + ++ LV++FM    L  ++        P    L +         +G
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRL 441
           L + H       I+HRD+K  N+L++++   K+ DFGL++ FG P +   + +   +YR 
Sbjct: 121 LAFCHENK----ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRA 176
Query: 442 QQLTEKS-------DVYSFGVVLFEVLCARPSILRTAAKKQVSL 478
             +   S       D++S G +L E++  +P    T  ++Q+ L
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL 220

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 25/199 (12%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSL 334
           ++G G FG+VY+G      G    VA+K  + +      E F +E  ++  L H H+V L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWN---QRLEICIGAARGLHYLHTGA 391
           IG   ++   I++ +    G L  +L  + N           L+IC    + + YL +  
Sbjct: 91  IGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLYSLQIC----KAMAYLES-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---------GPTSVSKTHLDPEYYRLQ 442
                +HRD+   NIL+      K+ DFGLS++           T +    + PE    +
Sbjct: 144 --INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 201
Query: 443 QLTEKSDVYSFGVVLFEVL 461
           + T  SDV+ F V ++E+L
Sbjct: 202 RFTTASDVWMFAVCMWEIL 220

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 42/228 (18%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALE-FQTEIGMLSQ 325
           NN      +G G FG V +    G     +   VA+K L+  +     E   +E+ ++S 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 326 L-RHLHLVSLIGFCNDDREMILVYDFMARGTL---------------------PDHLYHS 363
           L +H ++V+L+G C     ++++ ++   G L                     P+ L   
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 364 DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
           D  PL     L      A+G+ +L +       IHRDV   N+LL    VAK+ DFGL++
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFLASKN----CIHRDVAARNVLLTNGHVAKIGDFGLAR 206
Query: 424 ----------FGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
                      G   +    + PE       T +SDV+S+G++L+E+ 
Sbjct: 207 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 254

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 25/199 (12%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSL 334
           ++G G FG+VY+G      G    VA+K  + +      E F +E  ++  L H H+V L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWN---QRLEICIGAARGLHYLHTGA 391
           IG   ++   I++ +    G L  +L  + N           L+IC    + + YL +  
Sbjct: 75  IGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLYSLQIC----KAMAYLES-- 127
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---------GPTSVSKTHLDPEYYRLQ 442
                +HRD+   NIL+      K+ DFGLS++           T +    + PE    +
Sbjct: 128 --INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 185
Query: 443 QLTEKSDVYSFGVVLFEVL 461
           + T  SDV+ F V ++E+L
Sbjct: 186 RFTTASDVWMFAVCMWEIL 204

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 25/199 (12%)
Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSL 334
           ++G G FG+VY+G      G    VA+K  + +      E F +E  ++  L H H+V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWN---QRLEICIGAARGLHYLHTGA 391
           IG   ++   I++ +    G L  +L  + N           L+IC    + + YL +  
Sbjct: 79  IGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLYSLQIC----KAMAYLES-- 131
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---------GPTSVSKTHLDPEYYRLQ 442
                +HRD+   NIL+      K+ DFGLS++           T +    + PE    +
Sbjct: 132 --INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 189
Query: 443 QLTEKSDVYSFGVVLFEVL 461
           + T  SDV+ F V ++E+L
Sbjct: 190 RFTTASDVWMFAVCMWEIL 208

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    L  HL  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 107 -NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 162
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 163 -ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNRP 246

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 40/216 (18%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEP---ESQQGALEFQTEIGMLSQL-RHLH 330
           +G G FG V +    G     +   VA+K L+     S+  AL   +E+ +L  +  HL+
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 94
Query: 331 LVSLIGFCND-DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------------IC 377
           +V+L+G C      ++++ +F   G L  +L    N  +P+ +  E            IC
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 378 IG--AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFG 425
                A+G+ +L +       IHRD+   NILL EK V K+ DFGL+          + G
Sbjct: 155 YSFQVAKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 426 PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              +    + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 211 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 246

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
           FD    +G G +G VYK     +   VAIK++  ES     E   EI ++ Q    H+V 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
             G    + ++ +V ++   G++ D +    N  L  ++   I     +GL YLH     
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK- 146
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLT 445
              IHRD+K  NILL+ +  AK++DFG++      ++K +        + PE  +     
Sbjct: 147 ---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYN 203
Query: 446 EKSDVYSFGVVLFEVLCARP 465
             +D++S G+   E+   +P
Sbjct: 204 CVADIWSLGITAIEMAEGKP 223

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 34/218 (15%)
Query: 268 QAATNNFDNDLVIGVGGFGDVY--KGFINGSTTPVAIKR---LEPESQQGALEFQTEIGM 322
           Q  ++ +     +G G +G+V   K  + G+   + I +   +   S  GAL    E+ +
Sbjct: 17  QGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGAL--LDEVAV 74
Query: 323 LSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL-----YHSDNPPLPWNQRLEIC 377
           L QL H +++ L  F  D R   LV +    G L D +     +   +  +   Q L   
Sbjct: 75  LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS-- 132
Query: 378 IGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK---WVAKVSDFGLS-------KFGPT 427
                G  YLH       I+HRD+K  N+LL+ K    + K+ DFGLS       K    
Sbjct: 133 -----GTTYLHKHN----IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER 183
Query: 428 SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
             +  ++ PE  R ++  EK DV+S GV+L+ +LC  P
Sbjct: 184 LGTAYYIAPEVLR-KKYDEKCDVWSCGVILYILLCGYP 220

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 18/199 (9%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG VYK     +    A K +E +S++   ++  EI +L+   H ++V L+G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            D ++ ++ +F   G + D +    +  L   Q   +C      L++LH+      IIHR
Sbjct: 87  HDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR----IIHR 141
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLTE----- 446
           D+K  N+L+  +   +++DFG+S     ++ K          + PE    + + +     
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDY 201
Query: 447 KSDVYSFGVVLFEVLCARP 465
           K+D++S G+ L E+    P
Sbjct: 202 KADIWSLGITLIEMAQIEP 220

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 18/199 (9%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG VYK     +    A K +E +S++   ++  EI +L+   H ++V L+G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
            D ++ ++ +F   G + D +    +  L   Q   +C      L++LH+      IIHR
Sbjct: 79  HDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR----IIHR 133
Query: 400 DVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLTE----- 446
           D+K  N+L+  +   +++DFG+S     ++ K          + PE    + + +     
Sbjct: 134 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDY 193
Query: 447 KSDVYSFGVVLFEVLCARP 465
           K+D++S G+ L E+    P
Sbjct: 194 KADIWSLGITLIEMAQIEP 212

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 113/259 (43%), Gaps = 20/259 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQLRHLHLVSLIG 336
           IG G FG VY      ++  VAIK++    +Q   ++Q    E+  L +LRH + +   G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +    LV ++   G+  D L      PL   +   +  GA +GL YLH+      +
Sbjct: 122 CYLREHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN----M 175
Query: 397 IHRDVKTTNILLDEKWVAKVSDFG-LSKFGPTSV---SKTHLDPEYYRLQ---QLTEKSD 449
           IHRDVK  NILL E  + K+ DFG  S   P +    +   + PE        Q   K D
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVD 235
Query: 450 VYSFGVVLFEVLCARPSILRTAAKKQV-SLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDE 508
           V+S G+   E+   +P +    A   +  +A       Q+G   +    F+   SCL   
Sbjct: 236 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD--SCLQKI 293
Query: 509 GIRRPSMSDVVWGLEFSLQ 527
              RP+ S+V+    F L+
Sbjct: 294 PQDRPT-SEVLLKHRFVLR 311

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALE-FQTEIGMLSQ 325
           NN      +G G FG V +    G     +   VA+K L+  +     E   +E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 326 L-RHLHLVSLIGFCNDDREMILVYDFMARGTL--------PDHLYHSDNPP------LPW 370
           L +H ++V+L+G C     ++++ ++   G L        P  L +S NP       L  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 371 NQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK------- 423
              L      A+G+ +L +       IHRDV   N+LL    VAK+ DFGL++       
Sbjct: 166 RDLLHFSSQVAQGMAFLASKN----CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 221
Query: 424 ---FGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
               G   +    + PE       T +SDV+S+G++L+E+ 
Sbjct: 222 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 262

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 113/259 (43%), Gaps = 20/259 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQLRHLHLVSLIG 336
           IG G FG VY      ++  VAIK++    +Q   ++Q    E+  L +LRH + +   G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               +    LV ++   G+  D L      PL   +   +  GA +GL YLH+      +
Sbjct: 83  CYLREHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN----M 136
Query: 397 IHRDVKTTNILLDEKWVAKVSDFG-LSKFGPTSV---SKTHLDPEYYRLQ---QLTEKSD 449
           IHRDVK  NILL E  + K+ DFG  S   P +    +   + PE        Q   K D
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVD 196
Query: 450 VYSFGVVLFEVLCARPSILRTAAKKQV-SLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDE 508
           V+S G+   E+   +P +    A   +  +A       Q+G   +    F+   SCL   
Sbjct: 197 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD--SCLQKI 254
Query: 509 GIRRPSMSDVVWGLEFSLQ 527
              RP+ S+V+    F L+
Sbjct: 255 PQDRPT-SEVLLKHRFVLR 272

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 36/212 (16%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEP---ESQQGALEFQTEIGMLSQL-RHLH 330
           +G G FG V +    G     +   VA+K L+     S+  AL   +E+ +L  +  HL+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 92
Query: 331 LVSLIGFCND-DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE--------ICIG-- 379
           +V+L+G C      ++++ +F   G L  +L    N  +P+    +        IC    
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQ 152
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSV 429
            A+G+ +L +       IHRD+   NILL EK V K+ DFGL+          + G   +
Sbjct: 153 VAKGMEFLASRKX----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 430 SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
               + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 36/206 (17%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+        +FQ EI +L  L    +V   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 336 G--FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G  +    + + LV +++  G L D L       L  ++ L       +G+ YL  G+  
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYL--GSRR 134
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ---------- 443
            V  HRD+   NIL++ +   K++DFGL+K  P       LD +YY +++          
Sbjct: 135 CV--HRDLAARNILVESEAHVKIADFGLAKLLP-------LDKDYYVVREPGQSPIFWYA 185
Query: 444 --------LTEKSDVYSFGVVLFEVL 461
                    + +SDV+SFGVVL+E+ 
Sbjct: 186 PESLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 36/206 (17%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+        +FQ EI +L  L    +V   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 336 G--FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G  +    + + LV +++  G L D L       L  ++ L       +G+ YL  G+  
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYL--GSRR 147
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ---------- 443
            V  HRD+   NIL++ +   K++DFGL+K  P       LD +YY +++          
Sbjct: 148 CV--HRDLAARNILVESEAHVKIADFGLAKLLP-------LDKDYYVVREPGQSPIFWYA 198
Query: 444 --------LTEKSDVYSFGVVLFEVL 461
                    + +SDV+SFGVVL+E+ 
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELF 224

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 97/197 (49%), Gaps = 18/197 (9%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHLHLVSLIGF 337
           +G G +G VYK   +     VA+KR+  +++   +      EI +L +L H ++VSLI  
Sbjct: 29  VGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
            + +R + LV++FM +      +   +   L  +Q         RG+ + H       I+
Sbjct: 88  IHSERCLTLVFEFMEKDL--KKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR----IL 141
Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRL-------QQLTEKS 448
           HRD+K  N+L++     K++DFGL++ FG    S TH +   +YR        ++ +   
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSV 201
Query: 449 DVYSFGVVLFEVLCARP 465
           D++S G +  E++  +P
Sbjct: 202 DIWSIGCIFAEMITGKP 218

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 16/215 (7%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGA---LEFQTEIGMLSQLRHLHLVSLI 335
           ++G G F  VY+     +   VAIK ++ ++   A      Q E+ +  QL+H  ++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
            +  D   + LV +    G +  +L  +   P   N+          G+ YLH+      
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIITGMLYLHSHG---- 132
Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLS--------KFGPTSVSKTHLDPEYYRLQQLTEK 447
           I+HRD+  +N+LL      K++DFGL+        K      +  ++ PE         +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE 192
Query: 448 SDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWA 482
           SDV+S G + + +L  RP       K  ++  V A
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA 227

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 34/206 (16%)
Query: 280 IGVGGFGDVY--KGFINGSTTPVAIKR---LEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           +G G +G+V   K  + G+   + I +   +   S  GAL    E+ +L QL H +++ L
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGAL--LDEVAVLKQLDHPNIMKL 69
Query: 335 IGFCNDDREMILVYDFMARGTLPDHL-----YHSDNPPLPWNQRLEICIGAARGLHYLHT 389
             F  D R   LV +    G L D +     +   +  +   Q L        G  YLH 
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS-------GTTYLHK 122
Query: 390 GANHAVIIHRDVKTTNILLDEK---WVAKVSDFGLS-------KFGPTSVSKTHLDPEYY 439
                 I+HRD+K  N+LL+ K    + K+ DFGLS       K      +  ++ PE  
Sbjct: 123 HN----IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL 178
Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARP 465
           R ++  EK DV+S GV+L+ +LC  P
Sbjct: 179 R-KKYDEKCDVWSCGVILYILLCGYP 203

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 40/216 (18%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEP---ESQQGALEFQTEIGMLSQL-RHLH 330
           +G G FG V +    G     +   VA+K L+     S+  AL   +E+ +L  +  HL+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 83
Query: 331 LVSLIGFCND-DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------------IC 377
           +V+L+G C      ++++ +F   G L  +L    N  +P+    E            IC
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 378 IG--AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK---FGPTSVSKT 432
                A+G+ +L +       IHRD+   NILL EK V K+ DFGL++     P  V K 
Sbjct: 144 YSFQVAKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 433 H-------LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
                   + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 97/197 (49%), Gaps = 18/197 (9%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHLHLVSLIGF 337
           +G G +G VYK   +     VA+KR+  +++   +      EI +L +L H ++VSLI  
Sbjct: 29  VGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
            + +R + LV++FM +      +   +   L  +Q         RG+ + H       I+
Sbjct: 88  IHSERCLTLVFEFMEKDL--KKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR----IL 141
Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRL-------QQLTEKS 448
           HRD+K  N+L++     K++DFGL++ FG    S TH +   +YR        ++ +   
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSV 201
Query: 449 DVYSFGVVLFEVLCARP 465
           D++S G +  E++  +P
Sbjct: 202 DIWSIGCIFAEMITGKP 218

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 36/206 (17%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+        +FQ EI +L  L    +V   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 336 G--FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G  +    + + LV +++  G L D L       L  ++ L       +G+ YL  G+  
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYL--GSRR 135
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ---------- 443
            V  HRD+   NIL++ +   K++DFGL+K  P       LD +YY +++          
Sbjct: 136 CV--HRDLAARNILVESEAHVKIADFGLAKLLP-------LDKDYYVVREPGQSPIFWYA 186
Query: 444 --------LTEKSDVYSFGVVLFEVL 461
                    + +SDV+SFGVVL+E+ 
Sbjct: 187 PESLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 40/216 (18%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEP---ESQQGALEFQTEIGMLSQL-RHLH 330
           +G G FG V +    G     +   VA+K L+     S+  AL   +E+ +L  +  HL+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 92
Query: 331 LVSLIGFCND-DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------------IC 377
           +V+L+G C      ++++ +F   G L  +L    N  +P+    E            IC
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 378 IG--AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK---FGPTSVSKT 432
                A+G+ +L +       IHRD+   NILL EK V K+ DFGL++     P  V K 
Sbjct: 153 YSFQVAKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 433 H-------LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
                   + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 40/216 (18%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEP---ESQQGALEFQTEIGMLSQL-RHLH 330
           +G G FG V +    G     +   VA+K L+     S+  AL   +E+ +L  +  HL+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 83
Query: 331 LVSLIGFCND-DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------------IC 377
           +V+L+G C      ++++ +F   G L  +L    N  +P+    E            IC
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 378 IG--AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK---FGPTSVSKT 432
                A+G+ +L +       IHRD+   NILL EK V K+ DFGL++     P  V K 
Sbjct: 144 YSFQVAKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 433 H-------LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
                   + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 40/216 (18%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEP---ESQQGALEFQTEIGMLSQL-RHLH 330
           +G G FG V +    G     +   VA+K L+     S+  AL   +E+ +L  +  HL+
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 129
Query: 331 LVSLIGFCND-DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------------IC 377
           +V+L+G C      ++++ +F   G L  +L    N  +P+    E            IC
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 378 IG--AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFG 425
                A+G+ +L +       IHRD+   NILL EK V K+ DFGL+          + G
Sbjct: 190 YSFQVAKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 426 PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              +    + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 281

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 40/216 (18%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEP---ESQQGALEFQTEIGMLSQL-RHLH 330
           +G G FG V +    G     +   VA+K L+     S+  AL   +E+ +L  +  HL+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 83
Query: 331 LVSLIGFCND-DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------------IC 377
           +V+L+G C      ++++ +F   G L  +L    N  +P+    E            IC
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 378 IG--AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFG 425
                A+G+ +L +       IHRD+   NILL EK V K+ DFGL+          + G
Sbjct: 144 YSFQVAKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 426 PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              +    + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 40/216 (18%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEP---ESQQGALEFQTEIGMLSQL-RHLH 330
           +G G FG V +    G     +   VA+K L+     S+  AL   +E+ +L  +  HL+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 92
Query: 331 LVSLIGFCND-DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------------IC 377
           +V+L+G C      ++++ +F   G L  +L    N  +P+    E            IC
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 378 IG--AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK---FGPTSVSKT 432
                A+G+ +L +       IHRD+   NILL EK V K+ DFGL++     P  V K 
Sbjct: 153 YSFQVAKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 433 H-------LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
                   + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 40/216 (18%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEP---ESQQGALEFQTEIGMLSQL-RHLH 330
           +G G FG V +    G     +   VA+K L+     S+  AL   +E+ +L  +  HL+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 83
Query: 331 LVSLIGFCND-DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------------IC 377
           +V+L+G C      ++++ +F   G L  +L    N  +P+    E            IC
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 378 IG--AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFG 425
                A+G+ +L +       IHRD+   NILL EK V K+ DFGL+          + G
Sbjct: 144 YSFQVAKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 426 PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              +    + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 19/196 (9%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIK---RLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           +GVG FG V  G    +   VA+K   R +  S     + + EI  L   RH H++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +   ++ +V ++++ G L D++    N  L   +   +      G+ Y H      ++
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYI--CKNGRLDEKESRRLFQQILSGVDYCHR----HMV 137
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSVSKTHLDPEYY--RLQQLTEK 447
           +HRD+K  N+LLD    AK++DFGLS           +  S  +  PE    RL    E 
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPE- 196
Query: 448 SDVYSFGVVLFEVLCA 463
            D++S GV+L+ +LC 
Sbjct: 197 VDIWSSGVILYALLCG 212

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 36/214 (16%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRL-EPESQQGALEFQTEIGMLSQL-RHLHLV 332
           +G G FG V +    G     +   VA+K L E  +        +E+ +L  +  HL++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 333 SLIGFCND-DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------------ICIG 379
           +L+G C      ++++ +F   G L  +L    N  +P+    E            IC  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 380 --AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPT 427
              A+G+ +L +       IHRD+   NILL EK V K+ DFGL+          + G  
Sbjct: 155 FQVAKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 428 SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            +    + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALE-FQTEIGMLSQ 325
           NN      +G G FG V +    G     +   VA+K L+  +     E   +E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 326 L-RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL------------YHSDNPPLPWNQ 372
           L +H ++V+L+G C     ++++ ++   G L + L            +   N  L    
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 373 RLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK--------- 423
            L      A+G+ +L +       IHRDV   N+LL    VAK+ DFGL++         
Sbjct: 166 LLHFSSQVAQGMAFLASKN----CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 424 -FGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             G   +    + PE       T +SDV+S+G++L+E+ 
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 103/239 (43%), Gaps = 25/239 (10%)
Query: 249 SRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE 308
           S  S  P+    +  LS ++     F+   ++G G +G VYKG    +    AIK ++  
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 309 SQQGALEFQTEIGMLSQLRHLHLVSLI--GFCND-----DREMILVYDFMARGTLPDHLY 361
             +   E + EI ML +  H   ++     F        D ++ LV +F   G++ D + 
Sbjct: 61  GDEEE-EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 362 HSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL 421
           ++    L       IC    RGL +LH    H VI HRD+K  N+LL E    K+ DFG+
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLH---QHKVI-HRDIKGQNVLLTENAEVKLVDFGV 175
Query: 422 SKFGPTSVSK--THLDPEYYRLQQLTE-----------KSDVYSFGVVLFEVLCARPSI 467
           S     +V +  T +   Y+   ++             KSD++S G+   E+    P +
Sbjct: 176 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEP---ESQQGALEFQTEIGMLSQL-RHLH 330
           +G G FG V +    G     +   VA+K L+     S+  AL   +E+ +L  +  HL+
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 93
Query: 331 LVSLIGFCND-DREMILVYDFMARGTLPDHLYHSDNPPLPWNQ---------RLE--ICI 378
           +V+L+G C      ++++ +F   G L  +L    N  +P+            LE  IC 
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICY 153
Query: 379 G--AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK---FGPTSVSKTH 433
               A+G+ +L +       IHRD+   NILL EK V K+ DFGL++     P  V K  
Sbjct: 154 SFQVAKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 434 -------LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
                  + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 84/196 (42%), Gaps = 19/196 (9%)
Query: 279 VIGVGGFGDVYKGFINGSTTP---VAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSL 334
            IG G FGDV++G       P   VAIK  +  +     E F  E   + Q  H H+V L
Sbjct: 19  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 78
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           IG   ++  + ++ +    G L   L       L     +      +  L YL +     
Sbjct: 79  IGVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKR--- 133
Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTHL-----DPEYYRLQQLT 445
             +HRD+   N+L+      K+ DFGLS++   S     SK  L      PE    ++ T
Sbjct: 134 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 446 EKSDVYSFGVVLFEVL 461
             SDV+ FGV ++E+L
Sbjct: 193 SASDVWMFGVCMWEIL 208

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 84/196 (42%), Gaps = 19/196 (9%)
Query: 279 VIGVGGFGDVYKGFINGSTTP---VAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSL 334
            IG G FGDV++G       P   VAIK  +  +     E F  E   + Q  H H+V L
Sbjct: 45  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 104
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           IG   ++   I++ +    G L   L       L     +      +  L YL +     
Sbjct: 105 IGVITENPVWIIM-ELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKR--- 159
Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTHL-----DPEYYRLQQLT 445
             +HRD+   N+L+      K+ DFGLS++   S     SK  L      PE    ++ T
Sbjct: 160 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 446 EKSDVYSFGVVLFEVL 461
             SDV+ FGV ++E+L
Sbjct: 219 SASDVWMFGVCMWEIL 234

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 84/196 (42%), Gaps = 19/196 (9%)
Query: 279 VIGVGGFGDVYKGFINGSTTP---VAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSL 334
            IG G FGDV++G       P   VAIK  +  +     E F  E   + Q  H H+V L
Sbjct: 20  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 79
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           IG   ++  + ++ +    G L   L       L     +      +  L YL +     
Sbjct: 80  IGVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKR--- 134
Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTHL-----DPEYYRLQQLT 445
             +HRD+   N+L+      K+ DFGLS++   S     SK  L      PE    ++ T
Sbjct: 135 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 446 EKSDVYSFGVVLFEVL 461
             SDV+ FGV ++E+L
Sbjct: 194 SASDVWMFGVCMWEIL 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 84/196 (42%), Gaps = 19/196 (9%)
Query: 279 VIGVGGFGDVYKGFINGSTTP---VAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSL 334
            IG G FGDV++G       P   VAIK  +  +     E F  E   + Q  H H+V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           IG   ++   I++ +    G L   L       L     +      +  L YL +     
Sbjct: 74  IGVITENPVWIIM-ELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKR--- 128
Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTHL-----DPEYYRLQQLT 445
             +HRD+   N+L+      K+ DFGLS++   S     SK  L      PE    ++ T
Sbjct: 129 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 446 EKSDVYSFGVVLFEVL 461
             SDV+ FGV ++E+L
Sbjct: 188 SASDVWMFGVCMWEIL 203

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 28/216 (12%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK-------RLEPESQQGALEF-QTEIGML 323
             +D   VIG G    V +     +    A+K       RL PE  +   E  + E  +L
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 324 SQLR-HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR 382
            Q+  H H+++LI        M LV+D M +G L D+L  ++   L   +   I      
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL--TEKVALSEKETRSIMRSLLE 211
Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS-------KFGPTSVSKTHLD 435
            + +LH  AN+  I+HRD+K  NILLD+    ++SDFG S       K      +  +L 
Sbjct: 212 AVSFLH--ANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLA 267
Query: 436 PEYYRLQQ------LTEKSDVYSFGVVLFEVLCARP 465
           PE  +           ++ D+++ GV+LF +L   P
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 84/196 (42%), Gaps = 19/196 (9%)
Query: 279 VIGVGGFGDVYKGFINGSTTP---VAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSL 334
            IG G FGDV++G       P   VAIK  +  +     E F  E   + Q  H H+V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           IG   ++   I++ +    G L   L       L     +      +  L YL +     
Sbjct: 77  IGVITENPVWIIM-ELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKR--- 131
Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTHL-----DPEYYRLQQLT 445
             +HRD+   N+L+      K+ DFGLS++   S     SK  L      PE    ++ T
Sbjct: 132 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 446 EKSDVYSFGVVLFEVL 461
             SDV+ FGV ++E+L
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 84/196 (42%), Gaps = 19/196 (9%)
Query: 279 VIGVGGFGDVYKGFINGSTTP---VAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSL 334
            IG G FGDV++G       P   VAIK  +  +     E F  E   + Q  H H+V L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           IG   ++   I++ +    G L   L       L     +      +  L YL +     
Sbjct: 82  IGVITENPVWIIM-ELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKR--- 136
Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTHL-----DPEYYRLQQLT 445
             +HRD+   N+L+      K+ DFGLS++   S     SK  L      PE    ++ T
Sbjct: 137 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 446 EKSDVYSFGVVLFEVL 461
             SDV+ FGV ++E+L
Sbjct: 196 SASDVWMFGVCMWEIL 211

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQL 326
            +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
            H ++V L+   + + ++ LV++F++   L D +  S    +P            +GL +
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLSMD-LKDFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL 444
            H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++
Sbjct: 121 CHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 445 -------TEKSDVYSFGVVLFEVLCAR 464
                  +   D++S G +  E++  R
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            DN + IG G  G V    +  S   VA+K+++   QQ       E+ ++   +H ++V 
Sbjct: 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 212
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +        E+ +V +F+  G L D + H+    +   Q   +C+   + L  LH     
Sbjct: 213 MYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG-- 267
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLT 445
             +IHRD+K+ +ILL      K+SDFG        V +          + PE        
Sbjct: 268 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 325
Query: 446 EKSDVYSFGVVLFEVLCARP 465
            + D++S G+++ E++   P
Sbjct: 326 PEVDIWSLGIMVIEMVDGEP 345

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 84/196 (42%), Gaps = 19/196 (9%)
Query: 279 VIGVGGFGDVYKGFINGSTTP---VAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSL 334
            IG G FGDV++G       P   VAIK  +  +     E F  E   + Q  H H+V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           IG   ++   I++ +    G L   L       L     +      +  L YL +     
Sbjct: 77  IGVITENPVWIIM-ELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKR--- 131
Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTHL-----DPEYYRLQQLT 445
             +HRD+   N+L+      K+ DFGLS++   S     SK  L      PE    ++ T
Sbjct: 132 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 446 EKSDVYSFGVVLFEVL 461
             SDV+ FGV ++E+L
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLV 332
           +D   V+G G F +V       +   VAIK +  E+ +G     + EI +L +++H ++V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           +L         + L+   ++ G L D +            RL   +  A  + YLH    
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYLHDLG- 136
Query: 393 HAVIIHRDVKTTNIL---LDEKWVAKVSDFGLSKF-GPTSVSKT------HLDPEYYRLQ 442
              I+HRD+K  N+L   LDE     +SDFGLSK   P SV  T      ++ PE    +
Sbjct: 137 ---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 443 QLTEKSDVYSFGVVLFEVLCARP 465
             ++  D +S GV+ + +LC  P
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYP 216

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            DN + IG G  G V    +  S   VA+K+++   QQ       E+ ++   +H ++V 
Sbjct: 33  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 92
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +        E+ +V +F+  G L D + H+    +   Q   +C+   + L  LH     
Sbjct: 93  MYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG-- 147
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLT 445
             +IHRD+K+ +ILL      K+SDFG        V +          + PE        
Sbjct: 148 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 205
Query: 446 EKSDVYSFGVVLFEVLCARP 465
            + D++S G+++ E++   P
Sbjct: 206 PEVDIWSLGIMVIEMVDGEP 225

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQL 326
            +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
            H ++V L+   + + ++ LV++F++   L D +  S    +P            +GL +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMD-LKDFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL 444
            H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++
Sbjct: 122 CHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 445 -------TEKSDVYSFGVVLFEVLCAR 464
                  +   D++S G +  E++  R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 94
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 95  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 150
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 151 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 209
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 210 SKGYTKSIDIWSVGCILAEMLSNRP 234

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 142
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 143 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLV 332
           +D   V+G G F +V       +   VAIK +  E+ +G     + EI +L +++H ++V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           +L         + L+   ++ G L D +            RL   +  A  + YLH    
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYLHDLG- 136
Query: 393 HAVIIHRDVKTTNIL---LDEKWVAKVSDFGLSKF-GPTSVSKT------HLDPEYYRLQ 442
              I+HRD+K  N+L   LDE     +SDFGLSK   P SV  T      ++ PE    +
Sbjct: 137 ---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 443 QLTEKSDVYSFGVVLFEVLCARP 465
             ++  D +S GV+ + +LC  P
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYP 216

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 124/283 (43%), Gaps = 46/283 (16%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEP---ESQQGALEFQTEIGMLSQL-RHLH 330
           +G G FG V +    G     +   VA+K L+     S+  AL   +E+ +L  +  HL+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 92
Query: 331 LVSLIGFCND-DREMILVYDFMARGTLPDHLYHSDNPPLPWN----------QRLEICIG 379
           +V+L+G C      ++++ +F   G L  +L    N  +P+             +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQ 152
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSV 429
            A+G+ +L +       IHRD+   NILL EK V K+ DFGL+          + G   +
Sbjct: 153 VAKGMEFLASRKX----IHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 430 SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG 489
               + PE    +  T +SDV+SFGV+L+E+       L  +    V +     +  + G
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDEEFXRRLKEG 263
Query: 490 TIDQIVD-----PFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQ 527
           T  +  D      +   + C + E  +RP+ S++V  L   LQ
Sbjct: 264 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 84/196 (42%), Gaps = 19/196 (9%)
Query: 279 VIGVGGFGDVYKGFINGSTTP---VAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSL 334
            IG G FGDV++G       P   VAIK  +  +     E F  E   + Q  H H+V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           IG   ++  + ++ +    G L   L       L     +      +  L YL +     
Sbjct: 77  IGVITEN-PVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLESKR--- 131
Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTHL-----DPEYYRLQQLT 445
             +HRD+   N+L+      K+ DFGLS++   S     SK  L      PE    ++ T
Sbjct: 132 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 446 EKSDVYSFGVVLFEVL 461
             SDV+ FGV ++E+L
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            DN + IG G  G V    +  S   VA+K+++   QQ       E+ ++   +H ++V 
Sbjct: 31  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 90
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +        E+ +V +F+  G L D + H+    +   Q   +C+   + L  LH     
Sbjct: 91  MYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG-- 145
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLT 445
             +IHRD+K+ +ILL      K+SDFG        V +          + PE        
Sbjct: 146 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 203
Query: 446 EKSDVYSFGVVLFEVLCARP 465
            + D++S G+++ E++   P
Sbjct: 204 PEVDIWSLGIMVIEMVDGEP 223

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 88
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 89  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 144
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 145 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNRP 228

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 85  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 140
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 141 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNRP 224

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 142
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 143 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            DN + IG G  G V    +  S   VA+K+++   QQ       E+ ++   +H ++V 
Sbjct: 22  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +        E+ +V +F+  G L D + H+    +   Q   +C+   + L  LH     
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG-- 136
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLT 445
             +IHRD+K+ +ILL      K+SDFG        V +          + PE        
Sbjct: 137 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 194
Query: 446 EKSDVYSFGVVLFEVLCARP 465
            + D++S G+++ E++   P
Sbjct: 195 PEVDIWSLGIMVIEMVDGEP 214

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 16/206 (7%)
Query: 270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLR 327
           +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
           H ++V L+   + + ++ LV++F+ +  L D +  S    +P            +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL- 444
           H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++ 
Sbjct: 120 HSHR----VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175
Query: 445 ------TEKSDVYSFGVVLFEVLCAR 464
                 +   D++S G +  E++  R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 92  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 147
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 148 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 206
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNRP 231

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 92
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 93  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 148
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 149 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 207
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 208 SKGYTKSIDIWSVGCILAEMLSNRP 232

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 83
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 84  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 139
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 140 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 198
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 199 SKGYTKSIDIWSVGCILAEMLSNRP 223

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 146
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 147 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            DN + IG G  G V    +  S   VA+K+++   QQ       E+ ++   +H ++V 
Sbjct: 76  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 135
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +        E+ +V +F+  G L D + H+    +   Q   +C+   + L  LH     
Sbjct: 136 MYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG-- 190
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLT 445
             +IHRD+K+ +ILL      K+SDFG        V +          + PE        
Sbjct: 191 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 248
Query: 446 EKSDVYSFGVVLFEVLCARP 465
            + D++S G+++ E++   P
Sbjct: 249 PEVDIWSLGIMVIEMVDGEP 268

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 85  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 140
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 141 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNRP 224

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 35/233 (15%)
Query: 280 IGVGGFG--DVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G GGF   D+ +G  +G     A+KR+    QQ   E Q E  M     H +++ L+ +
Sbjct: 37  LGEGGFSYVDLVEGLHDGHF--YALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 338 CNDDR----EMILVYDFMARGTLPDHLYHSDNPP--LPWNQRLEICIGAARGLHYLHTGA 391
           C  +R    E  L+  F  RGTL + +    +    L  +Q L + +G  RGL  +H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFG-----------------LSKFGPTSVSKTHL 434
                 HRD+K TNILL ++    + D G                 L  +     + ++ 
Sbjct: 155 ----YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 435 DPEYYRLQQ---LTEKSDVYSFGVVLFEVLCAR-PSILRTAAKKQVSLAVWAQ 483
            PE + +Q    + E++DV+S G VL+ ++    P  +       V+LAV  Q
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            DN + IG G  G V    +  S   VA+K+++   QQ       E+ ++   +H ++V 
Sbjct: 26  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 85
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +        E+ +V +F+  G L D + H+    +   Q   +C+   + L  LH     
Sbjct: 86  MYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG-- 140
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLT 445
             +IHRD+K+ +ILL      K+SDFG        V +          + PE        
Sbjct: 141 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 198
Query: 446 EKSDVYSFGVVLFEVLCARP 465
            + D++S G+++ E++   P
Sbjct: 199 PEVDIWSLGIMVIEMVDGEP 218

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 84/196 (42%), Gaps = 19/196 (9%)
Query: 279 VIGVGGFGDVYKGFINGSTTP---VAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSL 334
            IG G FGDV++G       P   VAIK  +  +     E F  E   + Q  H H+V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           IG   ++  + ++ +    G L   L       L     +      +  L YL +     
Sbjct: 77  IGVITEN-PVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLESKR--- 131
Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTHL-----DPEYYRLQQLT 445
             +HRD+   N+L+      K+ DFGLS++   S     SK  L      PE    ++ T
Sbjct: 132 -FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 446 EKSDVYSFGVVLFEVL 461
             SDV+ FGV ++E+L
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLV 332
           +D   V+G G F +V       +   VAIK +  E+ +G     + EI +L +++H ++V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           +L         + L+   ++ G L D +            RL   +  A  + YLH    
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYLHDLG- 136
Query: 393 HAVIIHRDVKTTNIL---LDEKWVAKVSDFGLSKF-GPTSVSKT------HLDPEYYRLQ 442
              I+HRD+K  N+L   LDE     +SDFGLSK   P SV  T      ++ PE    +
Sbjct: 137 ---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 443 QLTEKSDVYSFGVVLFEVLCARP 465
             ++  D +S GV+ + +LC  P
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYP 216

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 107 -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 162
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 163 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNRP 246

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 84/196 (42%), Gaps = 19/196 (9%)
Query: 279 VIGVGGFGDVYKGFINGSTTP---VAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSL 334
            IG G FGDV++G       P   VAIK  +  +     E F  E   + Q  H H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           IG   ++  + ++ +    G L   L       L     +      +  L YL +     
Sbjct: 457 IGVITEN-PVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLESKR--- 511
Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTHL-----DPEYYRLQQLT 445
             +HRD+   N+L+      K+ DFGLS++   S     SK  L      PE    ++ T
Sbjct: 512 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 446 EKSDVYSFGVVLFEVL 461
             SDV+ FGV ++E+L
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 22/199 (11%)
Query: 280 IGVGGFGDV----YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           +G G FG V    Y    + +   VA+K+L+        +FQ EI +L  L    +V   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 336 G--FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           G  +     E+ LV +++  G L D L       L  ++ L       +G+ YL  G+  
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYL--GSRR 131
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS-----VSKTHLDPEYYRLQQ----- 443
            V  HRD+   NIL++ +   K++DFGL+K  P       V +    P ++   +     
Sbjct: 132 CV--HRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDN 189
Query: 444 -LTEKSDVYSFGVVLFEVL 461
             + +SDV+SFGVVL+E+ 
Sbjct: 190 IFSRQSDVWSFGVVLYELF 208

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 142
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 143 -ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 146
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 147 -ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 38/210 (18%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 339 N-----DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYL 387
                   +++ +V D M           +D   L   Q L    IC       RGL Y+
Sbjct: 91  RAPTIEQMKDVYIVQDLME----------TDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQ 442
           H+    A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  
Sbjct: 141 HS----ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 443 QL-------TEKSDVYSFGVVLFEVLCARP 465
           ++       T+  D++S G +L E+L  RP
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 38/214 (17%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEP---ESQQGALEFQTEIGMLSQL-RHLH 330
           +G G FG V +    G     +   VA+K L+     S+  AL   +E+ +L  +  HL+
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 94
Query: 331 LVSLIGFCND-DREMILVYDFMARGTLPDHLYHSDNPPLPWNQR--------LEICIG-- 379
           +V+L+G C      ++++ +F   G L  +L    N  +P+           LE  I   
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 380 --AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK---FGPTSVSKTH- 433
              A+G+ +L +       IHRD+   NILL EK V K+ DFGL++     P  V K   
Sbjct: 155 FQVAKGMEFLASRKX----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 434 ------LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
                 + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L   RH +++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI---- 88
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 89  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 144
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 145 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNRP 228

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 38/210 (18%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 339 N-----DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYL 387
                   +++ +V D M           +D   L   Q L    IC       RGL Y+
Sbjct: 91  RAPTIEQMKDVYIVQDLME----------TDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQ 442
           H+    A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  
Sbjct: 141 HS----ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 443 QL-------TEKSDVYSFGVVLFEVLCARP 465
           ++       T+  D++S G +L E+L  RP
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS--- 146
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 147 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 43/210 (20%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRL-----EPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           IG G +G V+K     +   VAIK+      +P  ++ AL    EI ML QL+H +LV+L
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR---EIRMLKQLKHPNLVNL 67
Query: 335 IGFCNDDREMILVYDFMARGTL----------PDHLYHSDNPPLPWNQRLEICIGAARGL 384
           +      R + LV+++     L          P+HL  S    + W           + +
Sbjct: 68  LEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKS----ITWQ--------TLQAV 115
Query: 385 HYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSVSKTHLDPEYYRLQ 442
           ++ H        IHRDVK  NIL+ +  V K+ DFG ++   GP+      +   +YR  
Sbjct: 116 NFCHKHN----CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171
Query: 443 QLT-------EKSDVYSFGVVLFEVLCARP 465
           +L           DV++ G V  E+L   P
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVP 201

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 84/196 (42%), Gaps = 19/196 (9%)
Query: 279 VIGVGGFGDVYKGFINGSTTP---VAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSL 334
            IG G FGDV++G       P   VAIK  +  +     E F  E   + Q  H H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           IG   ++  + ++ +    G L   L       L     +      +  L YL +     
Sbjct: 457 IGVITEN-PVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLESKR--- 511
Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTHL-----DPEYYRLQQLT 445
             +HRD+   N+L+      K+ DFGLS++   S     SK  L      PE    ++ T
Sbjct: 512 -FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 446 EKSDVYSFGVVLFEVL 461
             SDV+ FGV ++E+L
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 280 IGVGGFGDVY-------KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           +G GGF   Y       K    G   P ++  L+P  ++   +  TEI +   L + H+V
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSM-LLKPHQKE---KMSTEIAIHKSLDNPHVV 89
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
              GF  DD  + +V +   R +L +   H     +   +         +G+ YLH    
Sbjct: 90  GFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYLHNNR- 146
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLS---KFGPTSVSKTHLDPEYYRLQQLTEKS- 448
              +IHRD+K  N+ L++    K+ DFGL+   +F           P Y   + L +K  
Sbjct: 147 ---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGH 203
Query: 449 ----DVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSC 504
               D++S G +L+ +L  +P    T+  K+  + +   +      I+ +    ++ M  
Sbjct: 204 SFEVDIWSLGCILYTLLVGKPP-FETSCLKETYIRIKKNEYSVPRHINPVASALIRRM-- 260
Query: 505 LNDEGIRRPSMSDVV 519
           L+ +   RPS+++++
Sbjct: 261 LHADPTLRPSVAELL 275

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGI---- 90
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 146
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 147 -ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 280 IGVGGFGDVY-------KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           +G GGF   Y       K    G   P ++  L+P  ++   +  TEI +   L + H+V
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSM-LLKPHQKE---KMSTEIAIHKSLDNPHVV 105
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
              GF  DD  + +V +   R +L +   H     +   +         +G+ YLH    
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYLHNNR- 162
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLS---KFGPTSVSKTHLDPEYYRLQQLTEKS- 448
              +IHRD+K  N+ L++    K+ DFGL+   +F           P Y   + L +K  
Sbjct: 163 ---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGH 219
Query: 449 ----DVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSC 504
               D++S G +L+ +L  +P    T+  K+  + +   +      I+ +    ++ M  
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPP-FETSCLKETYIRIKKNEYSVPRHINPVASALIRRM-- 276
Query: 505 LNDEGIRRPSMSDVV 519
           L+ +   RPS+++++
Sbjct: 277 LHADPTLRPSVAELL 291

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP---ESQQGALEFQTEIGMLSQLRHLH 330
           +D   V+G G F +V       +   VAIK +     E ++G++E   EI +L +++H +
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME--NEIAVLHKIKHPN 77
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           +V+L         + L+   ++ G L D +            RL   +  A  + YLH  
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYLHDL 135
Query: 391 ANHAVIIHRDVKTTNIL---LDEKWVAKVSDFGLSKF-GPTSVSKT------HLDPEYYR 440
                I+HRD+K  N+L   LDE     +SDFGLSK   P SV  T      ++ PE   
Sbjct: 136 G----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 191
Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
            +  ++  D +S GV+ + +LC  P
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYP 216

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 280 IGVGGFGDVY-------KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           +G GGF   Y       K    G   P ++  L+P  ++   +  TEI +   L + H+V
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSM-LLKPHQKE---KMSTEIAIHKSLDNPHVV 105
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
              GF  DD  + +V +   R +L +   H     +   +         +G+ YLH    
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYLHNNR- 162
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLS---KFGPTSVSKTHLDPEYYRLQQLTEKS- 448
              +IHRD+K  N+ L++    K+ DFGL+   +F           P Y   + L +K  
Sbjct: 163 ---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGH 219
Query: 449 ----DVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSC 504
               D++S G +L+ +L  +P    T+  K+  + +   +      I+ +    ++ M  
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPP-FETSCLKETYIRIKKNEYSVPRHINPVASALIRRM-- 276
Query: 505 LNDEGIRRPSMSDVV 519
           L+ +   RPS+++++
Sbjct: 277 LHADPTLRPSVAELL 291

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAI+++ P E Q        EI +L + RH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 146
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 147 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 280 IGVGGFGDVY-------KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           +G GGF   Y       K    G   P ++  L+P  ++   +  TEI +   L + H+V
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSM-LLKPHQKE---KMSTEIAIHKSLDNPHVV 105
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
              GF  DD  + +V +   R +L +   H     +   +         +G+ YLH    
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYLHNNR- 162
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLS---KFGPTSVSKTHLDPEYYRLQQLTEKS- 448
              +IHRD+K  N+ L++    K+ DFGL+   +F           P Y   + L +K  
Sbjct: 163 ---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGH 219
Query: 449 ----DVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSC 504
               D++S G +L+ +L  +P    T+  K+  + +   +      I+ +    ++ M  
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPP-FETSCLKETYIRIKKNEYSVPRHINPVASALIRRM-- 276
Query: 505 LNDEGIRRPSMSDVV 519
           L+ +   RPS+++++
Sbjct: 277 LHADPTLRPSVAELL 291

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 33/225 (14%)
Query: 264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFI---NGSTTPVAIKRLEPE--SQQGALEFQT 318
           L ++      F    ++G G FG V +  +   +GS   VA+K L+ +  +     EF  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 319 EIGMLSQLRHLHLVSLIGFCNDDREM------ILVYDFMARGTLPDHLYHS---DNP-PL 368
           E   + +  H H+  L+G     R        +++  FM  G L   L  S   +NP  L
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 369 PWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----- 423
           P    +   +  A G+ YL +       IHRD+   N +L E     V+DFGLS+     
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRN----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG 190
Query: 424 --FGPTSVSKTHLDPEYYRLQQL-----TEKSDVYSFGVVLFEVL 461
             +     SK  L  ++  L+ L     T  SDV++FGV ++E++
Sbjct: 191 DYYRQGCASK--LPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 42/227 (18%)
Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH 330
            ++F+   V+G G FG V K      +   AIK++   +++      +E+ +L+ L H +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 331 LVSLIGFCNDDREMI-------------LVYDFMARGTLPDHLYHSDNPPLPWNQRLEIC 377
           +V       + R  +             +  ++   GTL D L HS+N     ++   + 
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD-LIHSENLNQQRDEYWRLF 122
Query: 378 IGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE 437
                 L Y+H+      IIHRD+K  NI +DE    K+ DFGL+K    S+    LD +
Sbjct: 123 RQILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 438 -----------------YYRLQQL------TEKSDVYSFGVVLFEVL 461
                            Y   + L       EK D+YS G++ FE++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 52/225 (23%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF- 337
            +G G +G+V++G  +G +  VA+K      +Q     +TEI     LRH +++  I   
Sbjct: 15  CVGKGRYGEVWRGLWHGES--VAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIASD 71
Query: 338 ---CNDDREMILV---------YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
               N   ++ L+         YDF+ R TL  HL             L + + AA GL 
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHL------------ALRLAVSAACGLA 119
Query: 386 YLHT----GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSV 429
           +LH           I HRD K+ N+L+       ++D GL+               P   
Sbjct: 120 HLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVG 179
Query: 430 SKTHLDPEYYRLQQLTEK------SDVYSFGVVLFEVLCARPSIL 468
           +K ++ PE    Q  T+       +D+++FG+VL+E+  AR +I+
Sbjct: 180 TKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTIV 222

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L   RH +++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI---- 88
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 89  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 144
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY-----YRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    EY     YR  ++   
Sbjct: 145 -ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNRP 228

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 38/210 (18%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + +   T VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 339 NDD-----REMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYL 387
                   R++ +V D M           +D   L  +Q+L    IC       RGL Y+
Sbjct: 111 RASTLEAMRDVYIVQDLM----------ETDLYKLLKSQQLSNDHICYFLYQILRGLKYI 160
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE-----YYRLQ 442
           H+    A ++HRD+K +N+L++     K+ DFGL++        T    E     +YR  
Sbjct: 161 HS----ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAP 216
Query: 443 QL-------TEKSDVYSFGVVLFEVLCARP 465
           ++       T+  D++S G +L E+L  RP
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALE-FQTEIGMLSQ 325
           NN      +G G FG V +    G     +   VA+K L+  +     E   +E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 326 L-RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL------------YHSDNPPLPWNQ 372
           L +H ++V+L+G C     ++++ ++   G L + L            +   N       
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 373 RLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK--------- 423
            L      A+G+ +L +       IHRDV   N+LL    VAK+ DFGL++         
Sbjct: 166 LLHFSSQVAQGMAFLASKN----CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 424 -FGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             G   +    + PE       T +SDV+S+G++L+E+ 
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 73/166 (43%), Gaps = 27/166 (16%)
Query: 315 EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL 374
           E   EI +L  L H +++ L     D +   LV +F   G L + + +          + 
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--------HKF 143
Query: 375 EICIGA------ARGLHYLHTGANHAVIIHRDVKTTNILLDEK---WVAKVSDFGLSKFG 425
           + C  A        G+ YLH       I+HRD+K  NILL+ K      K+ DFGLS F 
Sbjct: 144 DECDAANIMKQILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199
Query: 426 PTSVS-KTHLDPEYY-----RLQQLTEKSDVYSFGVVLFEVLCARP 465
                 +  L   YY       ++  EK DV+S GV+++ +LC  P
Sbjct: 200 SKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYP 245

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 25/200 (12%)
Query: 280 IGVGGFGDVYKGFIN---GSTTPVAIKRLEPE--SQQGALE-FQTEIGMLSQLRHLHLVS 333
           +G G FG V +G  +   G T  VA+K L+P+  SQ  A++ F  E+  +  L H +L+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           L G       M +V +    G+L D L  H  +  L    R  + +  A G+ YL +   
Sbjct: 80  LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGMGYLESKR- 135
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTH-------LDPEYYRL 441
               IHRD+   N+LL  + + K+ DFGL +  P +    V + H         PE  + 
Sbjct: 136 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
           +  +  SD + FGV L+E+ 
Sbjct: 193 RTFSHASDTWMFGVTLWEMF 212

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQL 326
            +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
            H ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL +
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQL 444
            H+      ++HRD+K  N+L++ +   K++DFGL++ FG    + TH +   +YR  ++
Sbjct: 120 CHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 175
Query: 445 -------TEKSDVYSFGVVLFEVLCAR 464
                  +   D++S G +  E++  R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 91/197 (46%), Gaps = 15/197 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G  G VY      +   VAI+++  + Q        EI ++ + ++ ++V+ +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              E+ +V +++A G+L D +  +    +   Q   +C    + L +LH+      +IHR
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ----VIHR 140
Query: 400 DVKTTNILLDEKWVAKVSDFGL-SKFGPTSVSKTH-------LDPEYYRLQQLTEKSDVY 451
           D+K+ NILL      K++DFG  ++  P    ++        + PE    +    K D++
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 452 SFGVVLFEVLCARPSIL 468
           S G++  E++   P  L
Sbjct: 201 SLGIMAIEMIEGEPPYL 217

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 19/196 (9%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIK---RLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           +GVG FG V  G    +   VA+K   R +  S     + + EI  L   RH H++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +   +  +V ++++ G L D++           +RL   I +A  + Y H      ++
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA--VDYCHR----HMV 132
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLS------KFGPTSV-SKTHLDPEYY--RLQQLTEK 447
           +HRD+K  N+LLD    AK++DFGLS      +F  TS  S  +  PE    RL    E 
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE- 191
Query: 448 SDVYSFGVVLFEVLCA 463
            D++S GV+L+ +LC 
Sbjct: 192 VDIWSCGVILYALLCG 207

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHL 329
            NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQL--- 444
                 ++HRD+K  N+L++ +   K++DFGL++ FG    + TH +   +YR  ++   
Sbjct: 122 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 445 ----TEKSDVYSFGVVLFEVLCAR 464
               +   D++S G +  E++  R
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 25/200 (12%)
Query: 280 IGVGGFGDVYKG---FINGSTTPVAIKRLEPE--SQQGALE-FQTEIGMLSQLRHLHLVS 333
           +G G FG V +G     +G T  VA+K L+P+  SQ  A++ F  E+  +  L H +L+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           L G       M +V +    G+L D L  H  +  L    R  + +  A G+ YL +   
Sbjct: 86  LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGMGYLESKR- 141
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTH-------LDPEYYRL 441
               IHRD+   N+LL  + + K+ DFGL +  P +    V + H         PE  + 
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
           +  +  SD + FGV L+E+ 
Sbjct: 199 RTFSHASDTWMFGVTLWEMF 218

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHL 329
            NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQL--- 444
                 ++HRD+K  N+L++ +   K++DFGL++ FG    + TH +   +YR  ++   
Sbjct: 122 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 445 ----TEKSDVYSFGVVLFEVLCAR 464
               +   D++S G +  E++  R
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 25/200 (12%)
Query: 280 IGVGGFGDVYKG---FINGSTTPVAIKRLEPE--SQQGALE-FQTEIGMLSQLRHLHLVS 333
           +G G FG V +G     +G T  VA+K L+P+  SQ  A++ F  E+  +  L H +L+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           L G       M +V +    G+L D L  H  +  L    R  + +  A G+ YL +   
Sbjct: 86  LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGMGYLESKR- 141
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTH-------LDPEYYRL 441
               IHRD+   N+LL  + + K+ DFGL +  P +    V + H         PE  + 
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
           +  +  SD + FGV L+E+ 
Sbjct: 199 RTFSHASDTWMFGVTLWEMF 218

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHL 329
            NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQL--- 444
                 ++HRD+K  N+L++ +   K++DFGL++ FG    + TH +   +YR  ++   
Sbjct: 121 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 445 ----TEKSDVYSFGVVLFEVLCAR 464
               +   D++S G +  E++  R
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHL 329
            NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQL--- 444
                 ++HRD+K  N+L++ +   K++DFGL++ FG    + TH +   +YR  ++   
Sbjct: 122 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 445 ----TEKSDVYSFGVVLFEVLCAR 464
               +   D++S G +  E++  R
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHL 329
            NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQL--- 444
                 ++HRD+K  N+L++ +   K++DFGL++ FG    + TH +   +YR  ++   
Sbjct: 121 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 445 ----TEKSDVYSFGVVLFEVLCAR 464
               +   D++S G +  E++  R
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHL 329
            NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQL--- 444
                 ++HRD+K  N+L++ +   K++DFGL++ FG    + TH +   +YR  ++   
Sbjct: 122 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 445 ----TEKSDVYSFGVVLFEVLCAR 464
               +   D++S G +  E++  R
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 25/200 (12%)
Query: 280 IGVGGFGDVYKGFIN---GSTTPVAIKRLEPE--SQQGALE-FQTEIGMLSQLRHLHLVS 333
           +G G FG V +G  +   G T  VA+K L+P+  SQ  A++ F  E+  +  L H +L+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           L G       M +V +    G+L D L  H  +  L    R  + +  A G+ YL +   
Sbjct: 80  LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGMGYLESKR- 135
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTH-------LDPEYYRL 441
               IHRD+   N+LL  + + K+ DFGL +  P +    V + H         PE  + 
Sbjct: 136 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
           +  +  SD + FGV L+E+ 
Sbjct: 193 RTFSHASDTWMFGVTLWEMF 212

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHL 329
            NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + H+
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQL--- 444
                 ++HRD+K  N+L++ +   K++DFGL++ FG    + TH +   +YR  ++   
Sbjct: 129 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 445 ----TEKSDVYSFGVVLFEVLCAR 464
               +   D++S G +  E++  R
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHL 329
            NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + H+
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQL--- 444
                 ++HRD+K  N+L++ +   K++DFGL++ FG    + TH +   +YR  ++   
Sbjct: 126 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 181
Query: 445 ----TEKSDVYSFGVVLFEVLCAR 464
               +   D++S G +  E++  R
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 25/200 (12%)
Query: 280 IGVGGFGDVYKGFIN---GSTTPVAIKRLEPE--SQQGALE-FQTEIGMLSQLRHLHLVS 333
           +G G FG V +G  +   G T  VA+K L+P+  SQ  A++ F  E+  +  L H +L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           L G       M +V +    G+L D L  H  +  L    R  + +  A G+ YL +   
Sbjct: 76  LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGMGYLESKR- 131
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTH-------LDPEYYRL 441
               IHRD+   N+LL  + + K+ DFGL +  P +    V + H         PE  + 
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
           +  +  SD + FGV L+E+ 
Sbjct: 189 RTFSHASDTWMFGVTLWEMF 208

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLE---PESQQGALEFQT--EIGMLS 324
           AT+ ++    IGVG +G VYK     S   VA+K +         G L   T  E+ +L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 325 QLR---HLHLVSLIGFC---NDDREM--ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEI 376
           +L    H ++V L+  C     DRE+   LV++ + +  L  +L  +  P LP     ++
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV 429
                RGL +LH       I+HRD+K  NIL+      K++DFGL++         P  V
Sbjct: 126 MRQFLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV 181
Query: 430 SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           +  +  PE           D++S G +  E+   +P
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHL 329
            NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + H+
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQL--- 444
                 ++HRD+K  N+L++ +   K++DFGL++ FG    + TH +   +YR  ++   
Sbjct: 129 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 445 ----TEKSDVYSFGVVLFEVLCAR 464
               +   D++S G +  E++  R
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 91/197 (46%), Gaps = 15/197 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G  G VY      +   VAI+++  + Q        EI ++ + ++ ++V+ +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              E+ +V +++A G+L D +  +    +   Q   +C    + L +LH+      +IHR
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ----VIHR 140
Query: 400 DVKTTNILLDEKWVAKVSDFGL-SKFGPTSVSKTH-------LDPEYYRLQQLTEKSDVY 451
           D+K+ NILL      K++DFG  ++  P    ++        + PE    +    K D++
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 452 SFGVVLFEVLCARPSIL 468
           S G++  E++   P  L
Sbjct: 201 SLGIMAIEMIEGEPPYL 217

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 25/200 (12%)
Query: 280 IGVGGFGDVYKGFIN---GSTTPVAIKRLEPE--SQQGALE-FQTEIGMLSQLRHLHLVS 333
           +G G FG V +G  +   G T  VA+K L+P+  SQ  A++ F  E+  +  L H +L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           L G       M +V +    G+L D L  H  +  L    R  + +  A G+ YL +   
Sbjct: 76  LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGMGYLESKR- 131
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTH-------LDPEYYRL 441
               IHRD+   N+LL  + + K+ DFGL +  P +    V + H         PE  + 
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
           +  +  SD + FGV L+E+ 
Sbjct: 189 RTFSHASDTWMFGVTLWEMF 208

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 146
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE-----YYRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    E     +YR  ++   
Sbjct: 147 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 205
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G V   + N +   VAIK++ P E Q        EI +L + RH +++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICI---GAARGLHYLHTGAN 392
            +D       + M    +   L  +D   L   Q L    IC       RGL Y+H+   
Sbjct: 92  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 147
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE-----YYRLQQL--- 444
            A ++HRD+K +N+LL+     K+ DFGL++        T    E     +YR  ++   
Sbjct: 148 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 206
Query: 445 ----TEKSDVYSFGVVLFEVLCARP 465
               T+  D++S G +L E+L  RP
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNRP 231

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQL 326
            +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
            H ++V L+   + + ++ LV++F++   L   +  S    +P            +GL +
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLSMD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL 444
            H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++
Sbjct: 120 CHSHR----VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 445 -------TEKSDVYSFGVVLFEVLCAR 464
                  +   D++S G +  E++  R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 25/200 (12%)
Query: 280 IGVGGFGDVYKGFIN---GSTTPVAIKRLEPE--SQQGALE-FQTEIGMLSQLRHLHLVS 333
           +G G FG V +G  +   G T  VA+K L+P+  SQ  A++ F  E+  +  L H +L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           L G       M +V +    G+L D L  H  +  L    R  + +  A G+ YL +   
Sbjct: 76  LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGMGYLESKR- 131
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS----VSKTH-------LDPEYYRL 441
               IHRD+   N+LL  + + K+ DFGL +  P +    V + H         PE  + 
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 442 QQLTEKSDVYSFGVVLFEVL 461
           +  +  SD + FGV L+E+ 
Sbjct: 189 RTFSHASDTWMFGVTLWEMF 208

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLR 327
           +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
           H ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL- 444
           H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++ 
Sbjct: 120 HSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175
Query: 445 ------TEKSDVYSFGVVLFEVLCAR 464
                 +   D++S G +  E++  R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQL 326
            +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
            H ++V L+   + + ++ LV++F++   L   +  S    +P            +GL +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL 444
            H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++
Sbjct: 122 CHSHR----VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 445 -------TEKSDVYSFGVVLFEVLCAR 464
                  +   D++S G +  E++  R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQL 326
            +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
            H ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL +
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL 444
            H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++
Sbjct: 121 CHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 445 -------TEKSDVYSFGVVLFEVLCAR 464
                  +   D++S G +  E++  R
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 91/197 (46%), Gaps = 15/197 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G  G VY      +   VAI+++  + Q        EI ++ + ++ ++V+ +    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              E+ +V +++A G+L D +  +    +   Q   +C    + L +LH+      +IHR
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ----VIHR 141
Query: 400 DVKTTNILLDEKWVAKVSDFGL-SKFGPTSVSKTH-------LDPEYYRLQQLTEKSDVY 451
           D+K+ NILL      K++DFG  ++  P    ++        + PE    +    K D++
Sbjct: 142 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 452 SFGVVLFEVLCARPSIL 468
           S G++  E++   P  L
Sbjct: 202 SLGIMAIEMIEGEPPYL 218

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 91/197 (46%), Gaps = 15/197 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G  G VY      +   VAI+++  + Q        EI ++ + ++ ++V+ +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              E+ +V +++A G+L D +  +    +   Q   +C    + L +LH+      +IHR
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ----VIHR 140
Query: 400 DVKTTNILLDEKWVAKVSDFGL-SKFGPTSVSKTH-------LDPEYYRLQQLTEKSDVY 451
           D+K+ NILL      K++DFG  ++  P    ++        + PE    +    K D++
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 452 SFGVVLFEVLCARPSIL 468
           S G++  E++   P  L
Sbjct: 201 SLGIMAIEMIEGEPPYL 217

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLR 327
           +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
           H ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL- 444
           H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++ 
Sbjct: 120 HSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175
Query: 445 ------TEKSDVYSFGVVLFEVLCAR 464
                 +   D++S G +  E++  R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLR 327
           +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
           H ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL- 444
           H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++ 
Sbjct: 120 HSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175
Query: 445 ------TEKSDVYSFGVVLFEVLCAR 464
                 +   D++S G +  E++  R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQL 326
            +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L
Sbjct: 4   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
            H ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL +
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL 444
            H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++
Sbjct: 123 CHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 178
Query: 445 -------TEKSDVYSFGVVLFEVLCAR 464
                  +   D++S G +  E++  R
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQL 326
            +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
            H ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL +
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL 444
            H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++
Sbjct: 121 CHSHR----VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 445 -------TEKSDVYSFGVVLFEVLCAR 464
                  +   D++S G +  E++  R
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQL 326
            +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
            H ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL 444
            H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++
Sbjct: 122 CHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 445 -------TEKSDVYSFGVVLFEVLCAR 464
                  +   D++S G +  E++  R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQL 326
            +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
            H ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL +
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL 444
            H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++
Sbjct: 120 CHSHR----VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 445 -------TEKSDVYSFGVVLFEVLCAR 464
                  +   D++S G +  E++  R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQL 326
            +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
            H ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL +
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL 444
            H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++
Sbjct: 121 CHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 445 -------TEKSDVYSFGVVLFEVLCAR 464
                  +   D++S G +  E++  R
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQL 326
            +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
            H ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL +
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL 444
            H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++
Sbjct: 120 CHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 445 -------TEKSDVYSFGVVLFEVLCAR 464
                  +   D++S G +  E++  R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQL 326
            +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
            H ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL 444
            H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++
Sbjct: 122 CHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 445 -------TEKSDVYSFGVVLFEVLCAR 464
                  +   D++S G +  E++  R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLR 327
           +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
           H ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL- 444
           H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++ 
Sbjct: 120 HSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175
Query: 445 ------TEKSDVYSFGVVLFEVLCAR 464
                 +   D++S G +  E++  R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 23/202 (11%)
Query: 279 VIGVGGFGDVYK------GFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           V+G GGFG+V+       G +         +  + +  QGA+    E  +L+++    +V
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIV 248
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTG 390
           SL        ++ LV   M  G +  H+Y+   DNP     + +        GL +LH  
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH-- 306
Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS---KFGPTSV-----SKTHLDPEYYRLQ 442
                II+RD+K  N+LLD+    ++SD GL+   K G T       +   + PE    +
Sbjct: 307 --QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 443 QLTEKSDVYSFGVVLFEVLCAR 464
           +     D ++ GV L+E++ AR
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 23/202 (11%)
Query: 279 VIGVGGFGDVYK------GFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           V+G GGFG+V+       G +         +  + +  QGA+    E  +L+++    +V
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIV 248
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTG 390
           SL        ++ LV   M  G +  H+Y+   DNP     + +        GL +LH  
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH-- 306
Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS---KFGPTSV-----SKTHLDPEYYRLQ 442
                II+RD+K  N+LLD+    ++SD GL+   K G T       +   + PE    +
Sbjct: 307 --QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 443 QLTEKSDVYSFGVVLFEVLCAR 464
           +     D ++ GV L+E++ AR
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 23/202 (11%)
Query: 279 VIGVGGFGDVYK------GFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           V+G GGFG+V+       G +         +  + +  QGA+    E  +L+++    +V
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIV 248
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTG 390
           SL        ++ LV   M  G +  H+Y+   DNP     + +        GL +LH  
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH-- 306
Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS---KFGPTSV-----SKTHLDPEYYRLQ 442
                II+RD+K  N+LLD+    ++SD GL+   K G T       +   + PE    +
Sbjct: 307 --QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 443 QLTEKSDVYSFGVVLFEVLCAR 464
           +     D ++ GV L+E++ AR
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHL 329
            NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL--- 444
                 ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++   
Sbjct: 121 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 445 ----TEKSDVYSFGVVLFEVLCAR 464
               +   D++S G +  E++  R
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 272 NNFDNDLVIGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL 329
            NF     IG G +G VYK    + G    +   RL+ E++        EI +L +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQL--- 444
                 ++HRD+K  N+L++ +   K++DFGL++ FG    + TH +   +YR  ++   
Sbjct: 122 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 445 ----TEKSDVYSFGVVLFEVLCAR 464
               +   D++S G +  E++  R
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 272 NNFDNDLVIGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL 329
            NF     IG G +G VYK    + G    +   RL+ E++        EI +L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQL--- 444
                 ++HRD+K  N+L++ +   K++DFGL++ FG    + TH +   +YR  ++   
Sbjct: 121 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 445 ----TEKSDVYSFGVVLFEVLCAR 464
               +   D++S G +  E++  R
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQL 326
            +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
            H ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKTFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL 444
            H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++
Sbjct: 122 CHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 445 -------TEKSDVYSFGVVLFEVLCAR 464
                  +   D++S G +  E++  R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHL 329
            NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL--- 444
                 ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++   
Sbjct: 121 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 445 ----TEKSDVYSFGVVLFEVLCAR 464
               +   D++S G +  E++  R
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 85/198 (42%), Gaps = 15/198 (7%)
Query: 276 NDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
           N + IG G  G V       +   VA+K+++   QQ       E+ ++    H ++V + 
Sbjct: 49  NFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMY 108
Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
                  E+ +V +F+  G L D + H+    +   Q   +C+   R L YLH       
Sbjct: 109 SSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQG---- 161
Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLTEK 447
           +IHRD+K+ +ILL      K+SDFG        V K          + PE         +
Sbjct: 162 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTE 221
Query: 448 SDVYSFGVVLFEVLCARP 465
            D++S G+++ E++   P
Sbjct: 222 VDIWSLGIMVIEMIDGEP 239

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 31/203 (15%)
Query: 283 GGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF----C 338
           G FG V+K  +      V I    P   + + + + E+  L  ++H +++  IG      
Sbjct: 35  GRFGCVWKAQLLNEYVAVKIF---PIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH------TGAN 392
           + D ++ L+  F  +G+L D L  +    + WN+   I    ARGL YLH         +
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLS-KF-GPTSVSKTH--LDPEYYRLQQLTE-- 446
              I HRD+K+ N+LL     A ++DFGL+ KF    S   TH  +    Y   ++ E  
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA 208
Query: 447 ---------KSDVYSFGVVLFEV 460
                    + D+Y+ G+VL+E+
Sbjct: 209 INFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 23/202 (11%)
Query: 279 VIGVGGFGDVYK------GFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           V+G GGFG+V+       G +         +  + +  QGA+    E  +L+++    +V
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIV 248
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTG 390
           SL        ++ LV   M  G +  H+Y+   DNP     + +        GL +LH  
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH-- 306
Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS---KFGPTSV-----SKTHLDPEYYRLQ 442
                II+RD+K  N+LLD+    ++SD GL+   K G T       +   + PE    +
Sbjct: 307 --QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 443 QLTEKSDVYSFGVVLFEVLCAR 464
           +     D ++ GV L+E++ AR
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 37/215 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKG--FINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH 330
           +F    +IG GGFG V+K    I+G T    IKR++  +++     + E+  L++L H++
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKT--YVIKRVKYNNEKA----EREVKALAKLDHVN 65
Query: 331 LVSLIGFC-------------NDDRE----MILVYDFMARGTLPDHLYHSDNPPLPWNQR 373
           +V   G C             N  R     + +  +F  +GTL   +       L     
Sbjct: 66  IVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 374 LEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG----LSKFGPTSV 429
           LE+     +G+ Y+H+      +I+RD+K +NI L +    K+ DFG    L   G    
Sbjct: 125 LELFEQITKGVDYIHSKK----LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXR 180
Query: 430 SK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
           SK    ++ PE    Q   ++ D+Y+ G++L E+L
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHL 329
            NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           ++V L+   + + ++ LV++F+ +  L   +  S    +P            +GL + H+
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL--- 444
                 ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++   
Sbjct: 123 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 445 ----TEKSDVYSFGVVLFEVLCAR 464
               +   D++S G +  E++  R
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 108/255 (42%), Gaps = 28/255 (10%)
Query: 280 IGVGGFGDVY-------KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           +G GGF   +       K    G   P ++  L+P  ++   +   EI +   L H H+V
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSL-LLKPHQRE---KMSMEISIHRSLAHQHVV 80
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
              GF  D+  + +V +   R +L +   H     L   +          G  YLH    
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNR- 137
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGL-SKFGPTSVSKTHL--DPEYYRLQQLTEKS- 448
              +IHRD+K  N+ L+E    K+ DFGL +K       K  L   P Y   + L++K  
Sbjct: 138 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH 194
Query: 449 ----DVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSC 504
               DV+S G +++ +L  +P    T+  K+  L +   +      I+ +    ++ M  
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM-- 251
Query: 505 LNDEGIRRPSMSDVV 519
           L  +   RP++++++
Sbjct: 252 LQTDPTARPTINELL 266

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++     QG      E+ ++ +L H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIV 76
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D++     P+ +Y          Q L +          
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS  ++  
Sbjct: 132 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICS 185
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 108/255 (42%), Gaps = 28/255 (10%)
Query: 280 IGVGGFGDVY-------KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           +G GGF   +       K    G   P ++  L+P  ++   +   EI +   L H H+V
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSL-LLKPHQRE---KMSMEISIHRSLAHQHVV 80
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
              GF  D+  + +V +   R +L +   H     L   +          G  YLH    
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNR- 137
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGL-SKFGPTSVSKTHL--DPEYYRLQQLTEKS- 448
              +IHRD+K  N+ L+E    K+ DFGL +K       K  L   P Y   + L++K  
Sbjct: 138 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH 194
Query: 449 ----DVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSC 504
               DV+S G +++ +L  +P    T+  K+  L +   +      I+ +    ++ M  
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM-- 251
Query: 505 LNDEGIRRPSMSDVV 519
           L  +   RP++++++
Sbjct: 252 LQTDPTARPTINELL 266

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 108/255 (42%), Gaps = 28/255 (10%)
Query: 280 IGVGGFGDVY-------KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           +G GGF   +       K    G   P ++  L+P  ++   +   EI +   L H H+V
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSL-LLKPHQRE---KMSMEISIHRSLAHQHVV 84
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
              GF  D+  + +V +   R +L +   H     L   +          G  YLH    
Sbjct: 85  GFHGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNR- 141
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGL-SKFGPTSVSKTHL--DPEYYRLQQLTEKS- 448
              +IHRD+K  N+ L+E    K+ DFGL +K       K  L   P Y   + L++K  
Sbjct: 142 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH 198
Query: 449 ----DVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSC 504
               DV+S G +++ +L  +P    T+  K+  L +   +      I+ +    ++ M  
Sbjct: 199 SFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM-- 255
Query: 505 LNDEGIRRPSMSDVV 519
           L  +   RP++++++
Sbjct: 256 LQTDPTARPTINELL 270

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++     QG      E+ ++ +L H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIV 76
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D++     P+ +Y          Q L +          
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS  ++  
Sbjct: 132 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICS 185
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 120/293 (40%), Gaps = 61/293 (20%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLE--------PESQQGALEFQTE 319
           +A  + +     +G G  G+V   F   +   VAIK +               AL  +TE
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 320 IGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE--IC 377
           I +L +L H  ++ +  F  D  +  +V + M  G L D +          N+RL+   C
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVG--------NKRLKEATC 116
Query: 378 ----IGAARGLHYLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSK-FGPTSV 429
                     + YLH       IIHRD+K  N+LL   +E  + K++DFG SK  G TS+
Sbjct: 117 KLYFYQMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 430 SKTHL-DPEYYRLQQLT--------EKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLA- 479
            +T    P Y   + L            D +S GV+LF  L   P    +  + QVSL  
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKD 230
Query: 480 ------------VWAQQCYQNGTIDQ---IVDPFLKAMSCLNDEGIRRPSMSD 517
                       VWA+   +   + +   +VDP  +  +   +E +R P + D
Sbjct: 231 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT---EEALRHPWLQD 280

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           +V+G G +G VY G    +   +AIK +     + +     EI +   L+H ++V  +G 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG-----AARGLHYLHTGAN 392
            +++  + +  + +  G+L   L  S   PL  N++    IG        GL YLH    
Sbjct: 88  FSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQ---TIGFYTKQILEGLKYLHDNQ- 142
Query: 393 HAVIIHRDVKTTNILLDE-KWVAKVSDFGLSK--FGPTSVSKTHLDPEYYRLQQLTEK-- 447
              I+HRD+K  N+L++    V K+SDFG SK   G    ++T      Y   ++ +K  
Sbjct: 143 ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 448 ------SDVYSFGVVLFEVLCARP 465
                 +D++S G  + E+   +P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP 223

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 120/293 (40%), Gaps = 61/293 (20%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLE--------PESQQGALEFQTE 319
           +A  + +     +G G  G+V   F   +   VAIK +               AL  +TE
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 320 IGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE--IC 377
           I +L +L H  ++ +  F  D  +  +V + M  G L D +          N+RL+   C
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVG--------NKRLKEATC 116
Query: 378 ----IGAARGLHYLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSK-FGPTSV 429
                     + YLH       IIHRD+K  N+LL   +E  + K++DFG SK  G TS+
Sbjct: 117 KLYFYQMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 430 SKTHL-DPEYYRLQQLT--------EKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLA- 479
            +T    P Y   + L            D +S GV+LF  L   P    +  + QVSL  
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKD 230
Query: 480 ------------VWAQQCYQNGTIDQ---IVDPFLKAMSCLNDEGIRRPSMSD 517
                       VWA+   +   + +   +VDP  +  +   +E +R P + D
Sbjct: 231 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT---EEALRHPWLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 120/293 (40%), Gaps = 61/293 (20%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLE--------PESQQGALEFQTE 319
           +A  + +     +G G  G+V   F   +   VAIK +               AL  +TE
Sbjct: 5   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 64
Query: 320 IGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE--IC 377
           I +L +L H  ++ +  F  D  +  +V + M  G L D +          N+RL+   C
Sbjct: 65  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVG--------NKRLKEATC 115
Query: 378 ----IGAARGLHYLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSK-FGPTSV 429
                     + YLH       IIHRD+K  N+LL   +E  + K++DFG SK  G TS+
Sbjct: 116 KLYFYQMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 171
Query: 430 SKTHL-DPEYYRLQQLT--------EKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLA- 479
            +T    P Y   + L            D +S GV+LF  L   P    +  + QVSL  
Sbjct: 172 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKD 229
Query: 480 ------------VWAQQCYQNGTIDQ---IVDPFLKAMSCLNDEGIRRPSMSD 517
                       VWA+   +   + +   +VDP  +  +   +E +R P + D
Sbjct: 230 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT---EEALRHPWLQD 279

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 120/293 (40%), Gaps = 61/293 (20%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLE--------PESQQGALEFQTE 319
           +A  + +     +G G  G+V   F   +   VAIK +               AL  +TE
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 320 IGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE--IC 377
           I +L +L H  ++ +  F  D  +  +V + M  G L D +          N+RL+   C
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVG--------NKRLKEATC 116
Query: 378 ----IGAARGLHYLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSK-FGPTSV 429
                     + YLH       IIHRD+K  N+LL   +E  + K++DFG SK  G TS+
Sbjct: 117 KLYFYQMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 430 SKTHL-DPEYYRLQQLT--------EKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLA- 479
            +T    P Y   + L            D +S GV+LF  L   P    +  + QVSL  
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKD 230
Query: 480 ------------VWAQQCYQNGTIDQ---IVDPFLKAMSCLNDEGIRRPSMSD 517
                       VWA+   +   + +   +VDP  +  +   +E +R P + D
Sbjct: 231 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT---EEALRHPWLQD 280

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 120/293 (40%), Gaps = 61/293 (20%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLE--------PESQQGALEFQTE 319
           +A  + +     +G G  G+V   F   +   VAIK +               AL  +TE
Sbjct: 12  KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 71
Query: 320 IGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE--IC 377
           I +L +L H  ++ +  F  D  +  +V + M  G L D +          N+RL+   C
Sbjct: 72  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--------GNKRLKEATC 122
Query: 378 ----IGAARGLHYLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSK-FGPTSV 429
                     + YLH       IIHRD+K  N+LL   +E  + K++DFG SK  G TS+
Sbjct: 123 KLYFYQMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 178
Query: 430 SKTHL-DPEYYRLQQLT--------EKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLA- 479
            +T    P Y   + L            D +S GV+LF  L   P    +  + QVSL  
Sbjct: 179 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKD 236
Query: 480 ------------VWAQQCYQNGTIDQ---IVDPFLKAMSCLNDEGIRRPSMSD 517
                       VWA+   +   + +   +VDP  +  +   +E +R P + D
Sbjct: 237 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT---EEALRHPWLQD 286

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 29/203 (14%)
Query: 279 VIGVGGFGDVY--KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           V+G G F +V+  K  + G    +   +  P  +  +LE   EI +L +++H ++V+L  
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE--NEIAVLKKIKHENIVTLED 73
Query: 337 FCNDDREMILVYDFMARGTLPDHL-----YHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
                    LV   ++ G L D +     Y   +  L   Q L         + YLH   
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS-------AVKYLHENG 126
Query: 392 NHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSKFGPTSVSKT------HLDPEYYRLQ 442
               I+HRD+K  N+L    +E     ++DFGLSK     +  T      ++ PE    +
Sbjct: 127 ----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQK 182
Query: 443 QLTEKSDVYSFGVVLFEVLCARP 465
             ++  D +S GV+ + +LC  P
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYP 205

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 19/196 (9%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIK---RLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           +GVG FG V  G    +   VA+K   R +  S     + + EI  L   RH H++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             +   +  +V ++++ G L D++           +RL   I +A  + Y H      ++
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA--VDYCHR----HMV 132
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGP-------TSVSKTHLDPEYY--RLQQLTEK 447
           +HRD+K  N+LLD    AK++DFGLS           +  S  +  PE    RL    E 
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPE- 191
Query: 448 SDVYSFGVVLFEVLCA 463
            D++S GV+L+ +LC 
Sbjct: 192 VDIWSCGVILYALLCG 207

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 16/168 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL 331
           +++D    +G G FG V++     +    A K +    +      + EI  +S LRH  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V+L     DD EM+++Y+FM+ G L + +    N  +  ++ +E      +GL ++H   
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN 169
Query: 392 NHAVIIHRDVKTTNILLDEKWV--AKVSDFGLSKFGPTSVSKTHLDPE 437
                +H D+K  NI+   K     K+ DFGL+          HLDP+
Sbjct: 170 ----YVHLDLKPENIMFTTKRSNELKLIDFGLT---------AHLDPK 204

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 108/255 (42%), Gaps = 28/255 (10%)
Query: 280 IGVGGFGDVY-------KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           +G GGF   +       K    G   P ++  L+P  ++   +   EI +   L H H+V
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSL-LLKPHQRE---KMSMEISIHRSLAHQHVV 104
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
              GF  D+  + +V +   R +L +   H     L   +          G  YLH    
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNR- 161
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGL-SKFGPTSVSKTHL--DPEYYRLQQLTEKS- 448
              +IHRD+K  N+ L+E    K+ DFGL +K       K  L   P Y   + L++K  
Sbjct: 162 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 449 ----DVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSC 504
               DV+S G +++ +L  +P    T+  K+  L +   +      I+ +    ++ M  
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM-- 275
Query: 505 LNDEGIRRPSMSDVV 519
           L  +   RP++++++
Sbjct: 276 LQTDPTARPTINELL 290

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 16/168 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL 331
           +++D    +G G FG V++     +    A K +    +      + EI  +S LRH  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V+L     DD EM+++Y+FM+ G L + +    N  +  ++ +E      +GL ++H   
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 392 NHAVIIHRDVKTTNILLDEKWV--AKVSDFGLSKFGPTSVSKTHLDPE 437
                +H D+K  NI+   K     K+ DFGL+          HLDP+
Sbjct: 276 ----YVHLDLKPENIMFTTKRSNELKLIDFGLT---------AHLDPK 310

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 108/255 (42%), Gaps = 28/255 (10%)
Query: 280 IGVGGFGDVY-------KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           +G GGF   +       K    G   P ++  L+P  ++   +   EI +   L H H+V
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSL-LLKPHQRE---KMSMEISIHRSLAHQHVV 102
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
              GF  D+  + +V +   R +L +   H     L   +          G  YLH    
Sbjct: 103 GFHGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNR- 159
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGL-SKFGPTSVSKTHL--DPEYYRLQQLTEKS- 448
              +IHRD+K  N+ L+E    K+ DFGL +K       K  L   P Y   + L++K  
Sbjct: 160 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 216
Query: 449 ----DVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSC 504
               DV+S G +++ +L  +P    T+  K+  L +   +      I+ +    ++ M  
Sbjct: 217 SFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM-- 273
Query: 505 LNDEGIRRPSMSDVV 519
           L  +   RP++++++
Sbjct: 274 LQTDPTARPTINELL 288

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           +V+G G +G VY G    +   +AIK +     + +     EI +   L+H ++V  +G 
Sbjct: 14  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG-----AARGLHYLHTGAN 392
            +++  + +  + +  G+L   L  S   PL  N++    IG        GL YLH    
Sbjct: 74  FSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQ---TIGFYTKQILEGLKYLHDNQ- 128
Query: 393 HAVIIHRDVKTTNILLDE-KWVAKVSDFGLSK--FGPTSVSKTHLDPEYYRLQQLTEK-- 447
              I+HRD+K  N+L++    V K+SDFG SK   G    ++T      Y   ++ +K  
Sbjct: 129 ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 185
Query: 448 ------SDVYSFGVVLFEVLCARP 465
                 +D++S G  + E+   +P
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGKP 209

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 116/281 (41%), Gaps = 61/281 (21%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPES--------QQGALEFQTEIGMLSQLRHLHL 331
           +G G  G+V   F   +   VAI+ +               AL  +TEI +L +L H  +
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE--IC----IGAARGLH 385
           + +  F  D  +  +V + M  G L D +          N+RL+   C          + 
Sbjct: 217 IKIKNFF-DAEDYYIVLELMEGGELFDKVVG--------NKRLKEATCKLYFYQMLLAVQ 267
Query: 386 YLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSK-FGPTSVSKTHL-DPEYYR 440
           YLH       IIHRD+K  N+LL   +E  + K++DFG SK  G TS+ +T    P Y  
Sbjct: 268 YLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 323
Query: 441 LQQLT--------EKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLA------------- 479
            + L            D +S GV+LF  L   P    +  + QVSL              
Sbjct: 324 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKDQITSGKYNFIPE 381
Query: 480 VWAQQCYQNGTIDQ---IVDPFLKAMSCLNDEGIRRPSMSD 517
           VWA+   +   + +   +VDP  +  +   +E +R P + D
Sbjct: 382 VWAEVSEKALDLVKKLLVVDPKARFTT---EEALRHPWLQD 419

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 108/255 (42%), Gaps = 28/255 (10%)
Query: 280 IGVGGFGDVY-------KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           +G GGF   +       K    G   P ++  L+P  ++   +   EI +   L H H+V
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSL-LLKPHQRE---KMSMEISIHRSLAHQHVV 78
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
              GF  D+  + +V +   R +L +   H     L   +          G  YLH    
Sbjct: 79  GFHGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNR- 135
Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGL-SKFGPTSVSKTHL--DPEYYRLQQLTEKS- 448
              +IHRD+K  N+ L+E    K+ DFGL +K       K  L   P Y   + L++K  
Sbjct: 136 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 449 ----DVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSC 504
               DV+S G +++ +L  +P    T+  K+  L +   +      I+ +    ++ M  
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM-- 249
Query: 505 LNDEGIRRPSMSDVV 519
           L  +   RP++++++
Sbjct: 250 LQTDPTARPTINELL 264

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 116/281 (41%), Gaps = 61/281 (21%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLE--------PESQQGALEFQTEIGMLSQLRHLHL 331
           +G G  G+V   F   +   VAI+ +               AL  +TEI +L +L H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE--IC----IGAARGLH 385
           + +  F  D  +  +V + M  G L D +          N+RL+   C          + 
Sbjct: 203 IKIKNFF-DAEDYYIVLELMEGGELFDKVVG--------NKRLKEATCKLYFYQMLLAVQ 253
Query: 386 YLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSK-FGPTSVSKTHL-DPEYYR 440
           YLH       IIHRD+K  N+LL   +E  + K++DFG SK  G TS+ +T    P Y  
Sbjct: 254 YLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309
Query: 441 LQQLT--------EKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLA------------- 479
            + L            D +S GV+LF  L   P    +  + QVSL              
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKDQITSGKYNFIPE 367
Query: 480 VWAQQCYQNGTIDQ---IVDPFLKAMSCLNDEGIRRPSMSD 517
           VWA+   +   + +   +VDP  +  +   +E +R P + D
Sbjct: 368 VWAEVSEKALDLVKKLLVVDPKARFTT---EEALRHPWLQD 405

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 27/208 (12%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGA-LEFQTEIGMLSQLRHLHLV 332
           F+    +G G F +V       +    A+K +  ++ +G     + EI +L +++H ++V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHL-----YHSDNPPLPWNQRLEICIGAARGLHYL 387
           +L         + LV   ++ G L D +     Y   +      Q L+        ++YL
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD-------AVYYL 136
Query: 388 HTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSKF-GPTSVSKT------HLDPE 437
           H       I+HRD+K  N+L    DE+    +SDFGLSK  G   V  T      ++ PE
Sbjct: 137 HRMG----IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPE 192
Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +  ++  D +S GV+ + +LC  P
Sbjct: 193 VLAQKPYSKAVDCWSIGVIAYILLCGYP 220

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 104/262 (39%), Gaps = 30/262 (11%)
Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSL 334
           D+ IG G F  VYKG    +T  VA   L+    ++     F+ E   L  L+H ++V  
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
Query: 335 I----GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLP----WNQRLEICIGAARGLHY 386
                      + ++LV +    GTL  +L       +     W      C    +GL +
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW------CRQILKGLQF 144
Query: 387 LHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSVSKTHLD------PEYY 439
           LHT      IIHRD+K  NI +       K+ D GL+     S +K  +       PE Y
Sbjct: 145 LHT--RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFXAPEXY 202
Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL 499
             ++  E  DVY+FG    E   +           Q+   V +    +  + D++  P +
Sbjct: 203 E-EKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSG--VKPASFDKVAIPEV 259
Query: 500 KAM--SCLNDEGIRRPSMSDVV 519
           K +   C+      R S+ D++
Sbjct: 260 KEIIEGCIRQNKDERYSIKDLL 281

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +    E Q    ++ +L H ++V
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 104
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D++     P+ +Y          Q L +          
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQL 159
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS  ++  
Sbjct: 160 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICS 213
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 214 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 249

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 42/227 (18%)
Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH 330
            ++F+   V+G G FG V K      +   AIK++   +++      +E+ +L+ L H +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 331 LVSLIGFCNDDREMI-------------LVYDFMARGTLPDHLYHSDNPPLPWNQRLEIC 377
           +V       + R  +             +  ++    TL D L HS+N     ++   + 
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYD-LIHSENLNQQRDEYWRLF 122
Query: 378 IGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE 437
                 L Y+H+      IIHRD+K  NI +DE    K+ DFGL+K    S+    LD +
Sbjct: 123 RQILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 438 -----------------YYRLQQL------TEKSDVYSFGVVLFEVL 461
                            Y   + L       EK D+YS G++ FE++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +    E Q    ++ +L H ++V
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 114
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D++     P+ +Y          Q L +          
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQL 169
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS  ++  
Sbjct: 170 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICS 223
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 224 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 259

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +    E Q    ++ +L H ++V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 110
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D+     +P+ +Y          Q L +          
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS  ++  
Sbjct: 166 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICS 219
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +    E Q    ++ +L H ++V
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 81
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D++     P+ +Y          Q L +          
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQL 136
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS  ++  
Sbjct: 137 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICS 190
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 191 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 226

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 110/232 (47%), Gaps = 25/232 (10%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTP-----VAIKRLEPESQQGALEFQTEI-- 320
           +A  ++F+   V+G G FG V+   +   T P      A+K L+  + +     +T++  
Sbjct: 24  KADPSHFELLKVLGQGSFGKVF--LVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMER 81
Query: 321 GMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA 380
            +L+ + H  +V L      + ++ L+ DF+  G L   L       +   + ++  +  
Sbjct: 82  DILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAE 138
Query: 381 -ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------- 432
            A GL +LH+      II+RD+K  NILLDE+   K++DFGLSK       K        
Sbjct: 139 LALGLDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTV 194
Query: 433 -HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQ 483
            ++ PE    Q  +  +D +S+GV++FE+L           K+ ++L + A+
Sbjct: 195 EYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAK 246

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +    E Q    ++ +L H ++V
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 112
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D+     +P+ +Y          Q L +          
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMYQL 167
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS  ++  
Sbjct: 168 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICS 221
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 222 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 257

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 91/197 (46%), Gaps = 15/197 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G  G VY      +   VAI+++  + Q        EI ++ + ++ ++V+ +    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
              E+ +V +++A G+L D +  +    +   Q   +C    + L +LH+      +IHR
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ----VIHR 141
Query: 400 DVKTTNILLDEKWVAKVSDFGL-SKFGPTSVSKTH-------LDPEYYRLQQLTEKSDVY 451
           ++K+ NILL      K++DFG  ++  P    ++        + PE    +    K D++
Sbjct: 142 NIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 452 SFGVVLFEVLCARPSIL 468
           S G++  E++   P  L
Sbjct: 202 SLGIMAIEMIEGEPPYL 218

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +    E Q    ++ +L H ++V
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 155
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D+     +P+ +Y          Q L +          
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMYQL 210
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS  ++  
Sbjct: 211 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICS 264
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 265 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 300

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 48/221 (21%)
Query: 279 VIGVGGFGDVYKG--FINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           +IG GGFG V+K    I+G T    I+R++  +++     + E+  L++L H+++V   G
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKT--YVIRRVKYNNEKA----EREVKALAKLDHVNIVHYNG 72
Query: 337 F---------CNDD--------------------REMILVYDFMARGTLPDHLYHSDNPP 367
                      +DD                    + + +  +F  +GTL   +       
Sbjct: 73  CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 132
Query: 368 LPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG----LSK 423
           L     LE+     +G+ Y+H+      +IHRD+K +NI L +    K+ DFG    L  
Sbjct: 133 LDKVLALELFEQITKGVDYIHSKK----LIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 188
Query: 424 FGPTSVSK---THLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
            G  + SK    ++ PE    Q   ++ D+Y+ G++L E+L
Sbjct: 189 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +    E Q    ++ +L H ++V
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 89
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D++     P+ +Y          Q L +          
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQL 144
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS  ++  
Sbjct: 145 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICS 198
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 199 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 234

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 16/192 (8%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHLHLVSLIGF 337
           +G G +G+VYK     +   VAIKR+  E ++  +      E+ +L +L+H +++ L   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
            + +  + L++++ A   L    Y   NP +              G+++ H+       +
Sbjct: 102 IHHNHRLHLIFEY-AENDLKK--YMDKNPDVSMRVIKSFLYQLINGVNFCHSRR----CL 154
Query: 398 HRDVKTTNILL-----DEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQLTEKSDV 450
           HRD+K  N+LL      E  V K+ DFGL++ FG      TH +   +YR  ++   S  
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRH 214
Query: 451 YSFGVVLFEVLC 462
           YS  V ++ + C
Sbjct: 215 YSTSVDIWSIAC 226

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 268 QAATNNF---DNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLS 324
           Q A N+F       ++G G FG V+K     +   +A K ++    +   E + EI +++
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICIGAA 381
           QL H +L+ L        +++LV +++  G L D +          +  L   +IC G  
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG-I 200
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLS-KFGPTSVSKTH---- 433
           R +H ++       I+H D+K  NIL    D K + K+ DFGL+ ++ P    K +    
Sbjct: 201 RHMHQMY-------ILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNFGTP 252
Query: 434 --LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             L PE      ++  +D++S GV+ + +L
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 280 IGVGGFGDVYKG--FINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLR---HLHLV 332
           IG G +G V+K     NG    VA+KR+  ++ +  +   T  E+ +L  L    H ++V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRF-VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 333 SLIGFCN---DDRE--MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
            L   C     DRE  + LV++ + +  L  +L     P +P     ++     RGL +L
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-----FGPTSVSKT--HLDPEYYR 440
           H+      ++HRD+K  NIL+      K++DFGL++        TSV  T  +  PE   
Sbjct: 137 HSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
                   D++S G +  E+   +P
Sbjct: 193 QSSYATPVDLWSVGCIFAEMFRRKP 217

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++     QG      E+ ++ +L H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIV 76
Query: 333 SLIGFC------NDDREMILVYDFMARGT--LPDHLYHSDNPPLPWNQRLEICIGAARGL 384
            L  F        D+  + LV D++      +  H Y      LP            R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 385 HYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDPEYYR 440
            Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS   +   YYR
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYR 189
Query: 441 LQQL-------TEKSDVYSFGVVLFEVLCARP 465
             +L       T   DV+S G VL E+L  +P
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +    E Q    ++ +L H ++V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 110
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D+     +P+ +Y          Q L +          
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS   +  
Sbjct: 166 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICS 219
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +    E Q    ++ +L H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 76
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D++     P+ +Y          Q L +          
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS  ++  
Sbjct: 132 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICS 185
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 261 QFSLSEIQAATNN-FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ---GALEF 316
           Q+   E Q  T N F    V+G GGFG+V    +  +    A K+LE +  +   G    
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 317 QTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL-- 374
             E  +L ++    +VSL         + LV   M  G L  H+YH      P  + +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 375 --EICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT 432
             EIC G    L  LH       I++RD+K  NILLD+    ++SD GL+   P   +  
Sbjct: 292 AAEICCG----LEDLH----RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 343
Query: 433 -------HLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
                  ++ PE  + ++ T   D ++ G +L+E++
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 261 QFSLSEIQAATNN-FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ---GALEF 316
           Q+   E Q  T N F    V+G GGFG+V    +  +    A K+LE +  +   G    
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 317 QTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL-- 374
             E  +L ++    +VSL         + LV   M  G L  H+YH      P  + +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 375 --EICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT 432
             EIC G    L  LH       I++RD+K  NILLD+    ++SD GL+   P   +  
Sbjct: 292 AAEICCG----LEDLH----RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 343
Query: 433 -------HLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
                  ++ PE  + ++ T   D ++ G +L+E++
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 280 IGVGGFGDVYKG--FINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLR---HLHLV 332
           IG G +G V+K     NG    VA+KR+  ++ +  +   T  E+ +L  L    H ++V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRF-VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 333 SLIGFCN---DDRE--MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
            L   C     DRE  + LV++ + +  L  +L     P +P     ++     RGL +L
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-----FGPTSVSKT--HLDPEYYR 440
           H+      ++HRD+K  NIL+      K++DFGL++        TSV  T  +  PE   
Sbjct: 137 HSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
                   D++S G +  E+   +P
Sbjct: 193 QSSYATPVDLWSVGCIFAEMFRRKP 217

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG+V++G   G    VA+K      ++     + EI     LRH +++  I   N
Sbjct: 17  IGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADN 73
Query: 340 DDR----EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT----GA 391
            D     ++ LV D+   G+L D+L   +   +     +++ +  A GL +LH       
Sbjct: 74  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV------------SKTHLDPEY- 438
               I HRD+K+ NIL+ +     ++D GL+    ++             +K ++ PE  
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 190
Query: 439 -----YRLQQLTEKSDVYSFGVVLFEV 460
                 +  +  +++D+Y+ G+V +E+
Sbjct: 191 DDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG+V++G   G    VA+K      ++     + EI     LRH +++  I   N
Sbjct: 12  IGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADN 68
Query: 340 DDR----EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT----GA 391
            D     ++ LV D+   G+L D+L   +   +     +++ +  A GL +LH       
Sbjct: 69  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV------------SKTHLDPEY- 438
               I HRD+K+ NIL+ +     ++D GL+    ++             +K ++ PE  
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 185
Query: 439 -----YRLQQLTEKSDVYSFGVVLFEV 460
                 +  +  +++D+Y+ G+V +E+
Sbjct: 186 DDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHL 329
            NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           ++V L+   + + ++ LV++ + +  L   +  S    +P            +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQD-LKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQL--- 444
                 ++HRD+K  N+L++ +   K++DFGL++ FG    + TH +   +YR  ++   
Sbjct: 121 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 445 ----TEKSDVYSFGVVLFEVLCAR 464
               +   D++S G +  E++  R
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 18/207 (8%)
Query: 271 TNNFDNDLVIGVGGFGDVY--KGFINGSTTPV-AIKRLEPESQQGALEFQTEIGMLSQLR 327
           ++ +    V+G G FG+V   K  I G    V  I + + + +        E+ +L QL 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
           H +++ L  F  D     LV +    G L D +            R  I      G+ Y+
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYM 142
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWV---AKVSDFGLS-KFGPTSVSKTHLDPEYYRLQQ 443
           H       I+HRD+K  N+LL+ K      ++ DFGLS  F  +   K  +   YY   +
Sbjct: 143 HKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198
Query: 444 L-----TEKSDVYSFGVVLFEVLCARP 465
           +      EK DV+S GV+L+ +L   P
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCP 225

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 18/207 (8%)
Query: 271 TNNFDNDLVIGVGGFGDVY--KGFINGSTTPV-AIKRLEPESQQGALEFQTEIGMLSQLR 327
           ++ +    V+G G FG+V   K  I G    V  I + + + +        E+ +L QL 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
           H +++ L  F  D     LV +    G L D +            R  I      G+ Y+
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYM 148
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWV---AKVSDFGLS-KFGPTSVSKTHLDPEYYRLQQ 443
           H       I+HRD+K  N+LL+ K      ++ DFGLS  F  +   K  +   YY   +
Sbjct: 149 HKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 204
Query: 444 LT-----EKSDVYSFGVVLFEVLCARP 465
           +      EK DV+S GV+L+ +L   P
Sbjct: 205 VLHGTYDEKCDVWSTGVILYILLSGCP 231

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG+V++G   G    VA+K      ++     + EI     LRH +++  I   N
Sbjct: 37  IGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADN 93
Query: 340 DDR----EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT----GA 391
            D     ++ LV D+   G+L D+L   +   +     +++ +  A GL +LH       
Sbjct: 94  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV------------SKTHLDPEY- 438
               I HRD+K+ NIL+ +     ++D GL+    ++             +K ++ PE  
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 210
Query: 439 -----YRLQQLTEKSDVYSFGVVLFEV 460
                 +  +  +++D+Y+ G+V +E+
Sbjct: 211 DDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 18/207 (8%)
Query: 271 TNNFDNDLVIGVGGFGDVY--KGFINGSTTPV-AIKRLEPESQQGALEFQTEIGMLSQLR 327
           ++ +    V+G G FG+V   K  I G    V  I + + + +        E+ +L QL 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
           H +++ L  F  D     LV +    G L D +            R  I      G+ Y+
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYM 165
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWV---AKVSDFGLS-KFGPTSVSKTHLDPEYYRLQQ 443
           H       I+HRD+K  N+LL+ K      ++ DFGLS  F  +   K  +   YY   +
Sbjct: 166 HKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 221
Query: 444 L-----TEKSDVYSFGVVLFEVLCARP 465
           +      EK DV+S GV+L+ +L   P
Sbjct: 222 VLHGTYDEKCDVWSTGVILYILLSGCP 248

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 18/207 (8%)
Query: 271 TNNFDNDLVIGVGGFGDVY--KGFINGSTTPV-AIKRLEPESQQGALEFQTEIGMLSQLR 327
           ++ +    V+G G FG+V   K  I G    V  I + + + +        E+ +L QL 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
           H +++ L  F  D     LV +    G L D +            R  I      G+ Y+
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYM 166
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWV---AKVSDFGLS-KFGPTSVSKTHLDPEYYRLQQ 443
           H       I+HRD+K  N+LL+ K      ++ DFGLS  F  +   K  +   YY   +
Sbjct: 167 HKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 222
Query: 444 L-----TEKSDVYSFGVVLFEVLCARP 465
           +      EK DV+S GV+L+ +L   P
Sbjct: 223 VLHGTYDEKCDVWSTGVILYILLSGCP 249

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 106/241 (43%), Gaps = 40/241 (16%)
Query: 246 TKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL 305
           T S  GS LP  L  Q +++       +      IG G FG+V++G   G    VA+K  
Sbjct: 24  TTSGSGSGLP--LLVQRTIARTIVLQES------IGKGRFGEVWRGKWRGE--EVAVKIF 73
Query: 306 EPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR----EMILVYDFMARGTLPDHLY 361
               ++     + EI     LRH +++  I   N D     ++ LV D+   G+L D+L 
Sbjct: 74  SSREERSWFR-EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL- 131
Query: 362 HSDNPPLPWNQRLEICIGAARGLHYLHT----GANHAVIIHRDVKTTNILLDEKWVAKVS 417
             +   +     +++ +  A GL +LH           I HRD+K+ NIL+ +     ++
Sbjct: 132 --NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189
Query: 418 DFGLSKFGPTSV------------SKTHLDPEY------YRLQQLTEKSDVYSFGVVLFE 459
           D GL+    ++             +K ++ PE        +  +  +++D+Y+ G+V +E
Sbjct: 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 249
Query: 460 V 460
           +
Sbjct: 250 I 250

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 88/191 (46%), Gaps = 14/191 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G FG V++     +      K +           + EI +++QL H  L++L     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR 399
           D  EM+L+ +F++ G L D +   D   +   + +     A  GL ++H  +    I+H 
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEHS----IVHL 173
Query: 400 DVKTTNILLDEKWVA--KVSDFGLS-KFGP------TSVSKTHLDPEYYRLQQLTEKSDV 450
           D+K  NI+ + K  +  K+ DFGL+ K  P      T+ +     PE    + +   +D+
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDM 233
Query: 451 YSFGVVLFEVL 461
           ++ GV+ + +L
Sbjct: 234 WAIGVLGYVLL 244

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 22/202 (10%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP---ESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           IG G +G V K     S   +A+KR+     E +Q  L    ++ M S     ++V   G
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS-DCPYIVQFYG 88
Query: 337 FCNDDREMILVYDFMARG--TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
               + +  +  + M+        ++Y   +  +P     +I +   + L++L       
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-- 146
Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------------HLDPEYYRLQ 442
            IIHRD+K +NILLD     K+ DFG+S     S++KT             +DP   R Q
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASR-Q 204
Query: 443 QLTEKSDVYSFGVVLFEVLCAR 464
               +SDV+S G+ L+E+   R
Sbjct: 205 GYDVRSDVWSLGITLYELATGR 226

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG+V++G   G    VA+K      ++     + EI     LRH +++  I   N
Sbjct: 14  IGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADN 70
Query: 340 DDR----EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT----GA 391
            D     ++ LV D+   G+L D+L   +   +     +++ +  A GL +LH       
Sbjct: 71  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV------------SKTHLDPEY- 438
               I HRD+K+ NIL+ +     ++D GL+    ++             +K ++ PE  
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 187
Query: 439 -----YRLQQLTEKSDVYSFGVVLFEV 460
                 +  +  +++D+Y+ G+V +E+
Sbjct: 188 DDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 102 FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 155
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 156 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 212
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 213 NQTVDIWSVGCIMAELLTGR 232

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 280 IGVGGFGDVYKG--FINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLR---HLHLV 332
           IG G +G V+K     NG    VA+KR+  ++ +  +   T  E+ +L  L    H ++V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRF-VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 333 SLIGFCN---DDRE--MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
            L   C     DRE  + LV++ + +  L  +L     P +P     ++     RGL +L
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-----FGPTSVSKT--HLDPEYYR 440
           H+      ++HRD+K  NIL+      K++DFGL++        TSV  T  +  PE   
Sbjct: 137 HSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
                   D++S G +  E+   +P
Sbjct: 193 QSSYATPVDLWSVGCIFAEMFRRKP 217

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 97  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 150
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 151 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-GYVATRWYRAPEIMLNWMHY 207
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +    E Q    ++ +L H ++V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 88
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D++     P+ +Y          Q L +          
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQL 143
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS   +  
Sbjct: 144 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICS 197
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 233

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 22/157 (14%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKR--LEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G FG+V+K     +   VA+K+  +E E +   +    EI +L  L+H ++V+LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 338 CNDDRE--------MILVYDFMAR---GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
           C             + LV+DF      G L + L          ++   +      GL+Y
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIKRVMQMLLNGLYY 140
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
           +H       I+HRD+K  N+L+    V K++DFGL++
Sbjct: 141 IHRNK----ILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 97  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 150
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 151 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-GYVATRWYRAPEIMLNWMHY 207
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG+V++G   G    VA+K      ++     + EI     LRH +++  I   N
Sbjct: 11  IGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADN 67
Query: 340 DDR----EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT----GA 391
            D     ++ LV D+   G+L D+L   +   +     +++ +  A GL +LH       
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV------------SKTHLDPEY- 438
               I HRD+K+ NIL+ +     ++D GL+    ++             +K ++ PE  
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 439 -----YRLQQLTEKSDVYSFGVVLFEV 460
                 +  +  +++D+Y+ G+V +E+
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 97  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 150
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 151 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-GYVATRWYRAPEIMLNWMHY 207
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 95  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 148
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 149 --ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 205
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 206 NQTVDIWSVGCIMAELLTGR 225

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +    E Q    ++ +L H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 76
Query: 333 SL-IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA------RGLH 385
            L   F +   +  +VY  +    +P+ +Y          Q L +           R L 
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 386 YLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDPEYYRL 441
           Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS   +   YYR 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 190
Query: 442 QQL-------TEKSDVYSFGVVLFEVLCARP 465
            +L       T   DV+S G VL E+L  +P
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +    E Q    ++ +L H ++V
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 95
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D++     P+ +Y          Q L +          
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQL 150
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS   +  
Sbjct: 151 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICS 204
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 205 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 240

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +    E Q    ++ +L H ++V
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 84
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D++     P+ +Y          Q L +          
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQL 139
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS   +  
Sbjct: 140 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICS 193
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 194 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 229

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 125
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 126 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 442 QQL-TEKSDVYSFGVVLFEVLCA 463
           ++   E  DV+S G+VL  +L  
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 124
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 125 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 442 QQL-TEKSDVYSFGVVLFEVLCA 463
           ++   E  DV+S G+VL  +L  
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +    E Q    ++ +L H ++V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 88
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D++     P+ +Y          Q L +          
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQL 143
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS   +  
Sbjct: 144 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICS 197
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 233

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 18/196 (9%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGA---LEFQTEIGMLSQLRHLHLVSLIG 336
           +G G FG V       +   VA+K +  +  + +   +  + EI  L  LRH H++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
                 ++++V ++ A G L D++           +R    I  A  + Y H       I
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICA--IEYCHRHK----I 129
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLS------KFGPTSV-SKTHLDPEYYRLQQLT-EKS 448
           +HRD+K  N+LLD+    K++DFGLS       F  TS  S  +  PE    +     + 
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEV 189
Query: 449 DVYSFGVVLFEVLCAR 464
           DV+S G+VL+ +L  R
Sbjct: 190 DVWSCGIVLYVMLVGR 205

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 119/282 (42%), Gaps = 32/282 (11%)
Query: 273 NFDNDLV---IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT---EIGMLSQL 326
           NFD+  +   IG G FG V     N +    A+K +  +      E +    E+ ++  L
Sbjct: 13  NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
            H  LV+L     D+ +M +V D +  G L  HL  + +       +L IC      L Y
Sbjct: 73  EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK-EETVKLFIC-ELVMALDY 130
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV-------SKTHLDPEYY 439
           L        IIHRD+K  NILLDE     ++DF ++   P          +K ++ PE +
Sbjct: 131 LQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMF 186
Query: 440 RLQQLTEKS---DVYSFGVVLFEVLCA-RPSILR--TAAKKQVSLAVWAQQCYQNGTIDQ 493
             ++    S   D +S GV  +E+L   RP  +R  T++K+ V         Y +    +
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQE 246
Query: 494 IVDPFLKAMSCLNDEGIRR-------PSMSDVVWGLEFSLQL 528
           +V    K +    D+   +       P M+D+ W   F  +L
Sbjct: 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRL 288

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQL 326
            +  NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 327 RHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
            H ++V L+   + + ++ LV++ + +  L   +  S    +P            +GL +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQL 444
            H+      ++HRD+K  N+L++ +   K++DFGL++ FG P       +   +YR  ++
Sbjct: 122 CHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 445 -------TEKSDVYSFGVVLFEVLCAR 464
                  +   D++S G +  E++  R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 101 FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 154
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 155 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 211
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 212 NQTVDIWSVGCIMAELLTGR 231

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI + + L H ++
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENV 67
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 125
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 126 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 442 QQL-TEKSDVYSFGVVLFEVL 461
           ++   E  DV+S G+VL  +L
Sbjct: 182 REFHAEPVDVWSCGIVLTAML 202

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 102 FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 155
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 156 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-YVATRWYRAPEIMLNWMHY 212
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 213 NQTVDIWSVGCIMAELLTGR 232

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 124
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 125 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 442 QQL-TEKSDVYSFGVVLFEVLCA 463
           ++   E  DV+S G+VL  +L  
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 102 FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 155
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 156 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-YVATRWYRAPEIMLNWMHY 212
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 213 NQTVDIWSVGCIMAELLTGR 232

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-YVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 23/211 (10%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLS 324
           +   N+FD   ++G G FG V       +    A+K L  E   ++       TE  +L 
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 325 QLRHLHLVSL-IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA--A 381
             RH  L +L   F   DR +  V ++   G L    +H     +   +R     GA   
Sbjct: 64  NTRHPFLTALKYAFQTHDR-LCFVMEYANGGEL---FFHLSRERVFTEERARF-YGAEIV 118
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT--SVSKT------H 433
             L YLH+      +++RD+K  N++LD+    K++DFGL K G +  +  KT      +
Sbjct: 119 SALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 174
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           L PE           D +  GVV++E++C R
Sbjct: 175 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 125
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 126 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 442 QQL-TEKSDVYSFGVVLFEVLCA 463
           ++   E  DV+S G+VL  +L  
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 125
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 126 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 442 QQL-TEKSDVYSFGVVLFEVLCA 463
           ++   E  DV+S G+VL  +L  
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 125
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 126 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 442 QQL-TEKSDVYSFGVVLFEVLCA 463
           ++   E  DV+S G+VL  +L  
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 95/217 (43%), Gaps = 27/217 (12%)
Query: 280 IGVGGFGDVYKGFINGST--------TPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL 331
           IG G FG   K  +  ST          + I R+  + ++   E + E+ +L+ ++H ++
Sbjct: 32  IGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKERE---ESRREVAVLANMKHPNI 85
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V       ++  + +V D+   G L   +          +Q L+  +     L ++H   
Sbjct: 86  VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV--------SKTHLDPEYYRLQQ 443
               I+HRD+K+ NI L +    ++ DFG+++   ++V        +  +L PE    + 
Sbjct: 146 ----ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 444 LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAV 480
              KSD+++ G VL+E LC         + K + L +
Sbjct: 202 YNNKSDIWALGCVLYE-LCTLKHAFEAGSMKNLVLKI 237

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 92  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 145
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 146 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-YVATRWYRAPEIMLNWMHY 202
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 203 NQTVDIWSVGCIMAELLTGR 222

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +    E Q    ++ +L H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 76
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D++     P+ +Y          Q L +          
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS   +  
Sbjct: 132 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICS 185
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 124
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 125 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 442 QQL-TEKSDVYSFGVVLFEVLCA 463
           ++   E  DV+S G+VL  +L  
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 110 FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 163
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 164 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 220
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 221 NQTVDIWSVGCIMAELLTGR 240

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 97  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 150
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 151 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 207
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 22/157 (14%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKR--LEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G FG+V+K     +   VA+K+  +E E +   +    EI +L  L+H ++V+LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 338 CNDDRE--------MILVYDFMAR---GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
           C             + LV+DF      G L + L          ++   +      GL+Y
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIKRVMQMLLNGLYY 140
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
           +H       I+HRD+K  N+L+    V K++DFGL++
Sbjct: 141 IHRNK----ILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNAMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-YVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +    E Q    ++ +L H ++V
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 80
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D++     P+ +Y          Q L +          
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQL 135
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS   +  
Sbjct: 136 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICS 189
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 190 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 225

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +    E Q    ++ +L H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 76
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D++     P+ +Y          Q L +          
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS   +  
Sbjct: 132 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICS 185
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 124
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 125 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 442 QQL-TEKSDVYSFGVVLFEVL 461
           ++   E  DV+S G+VL  +L
Sbjct: 181 REFHAEPVDVWSCGIVLTAML 201

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 88  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 141
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 142 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-YVATRWYRAPEIMLNWMHY 198
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 199 NQTVDIWSVGCIMAELLTGR 218

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 23/211 (10%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLS 324
           +   N+FD   ++G G FG V       +    A+K L  E   ++       TE  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 325 QLRHLHLVSL-IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA--A 381
             RH  L +L   F   DR +  V ++   G L    +H     +   +R     GA   
Sbjct: 61  NTRHPFLTALKYAFQTHDR-LCFVMEYANGGEL---FFHLSRERVFTEERARF-YGAEIV 115
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT--SVSKT------H 433
             L YLH+      +++RD+K  N++LD+    K++DFGL K G +  +  KT      +
Sbjct: 116 SALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 171
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           L PE           D +  GVV++E++C R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 23/211 (10%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLS 324
           +   N+FD   ++G G FG V       +    A+K L  E   ++       TE  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 325 QLRHLHLVSL-IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA--A 381
             RH  L +L   F   DR +  V ++   G L    +H     +   +R     GA   
Sbjct: 61  NTRHPFLTALKYAFQTHDR-LCFVMEYANGGEL---FFHLSRERVFTEERARF-YGAEIV 115
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT--SVSKT------H 433
             L YLH+      +++RD+K  N++LD+    K++DFGL K G +  +  KT      +
Sbjct: 116 SALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 171
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           L PE           D +  GVV++E++C R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 22/157 (14%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKR--LEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G FG+V+K     +   VA+K+  +E E +   +    EI +L  L+H ++V+LI  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 338 CNDDRE--------MILVYDFMAR---GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
           C             + LV+DF      G L + L          ++   +      GL+Y
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIKRVMQMLLNGLYY 139
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
           +H       I+HRD+K  N+L+    V K++DFGL++
Sbjct: 140 IHRNK----ILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 95  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 148
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 149 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 205
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 206 NQTVDIWSVGCIMAELLTGR 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 89  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 142
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 143 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 199
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 200 NQTVDIWSVGCIMAELLTGR 219

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +  +Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL +     ++  ++   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMT-GYVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 113 FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 166
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 167 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 223
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 224 NQTVDIWSVGCIMAELLTGR 243

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 92  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 145
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 146 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 202
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 203 NQTVDIWSVGCIMAELLTGR 222

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 86  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 139
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-YVATRWYRAPEIMLNWMHY 196
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +    E Q    ++ +L H ++V
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 77
Query: 333 SLIGFC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA----- 381
            L  F        D+  + LV D++     P+ +Y          Q L +          
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQL 132
Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK---FGPTSVSKTHLDP 436
            R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K    G  +VS   +  
Sbjct: 133 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICS 186
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
            YYR  +L       T   DV+S G VL E+L  +P
Sbjct: 187 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 222

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 92  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 145
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 146 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 202
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 203 NQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 87  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 140
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 141 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 197
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 198 NQTVDIWSVGCIMAELLTGR 217

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 101 FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 154
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 155 --ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 211
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 212 NQTVDIWSVGCIMAELLTGR 231

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 22/157 (14%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKR--LEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G FG+V+K     +   VA+K+  +E E +   +    EI +L  L+H ++V+LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 338 CNDDRE--------MILVYDFMAR---GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
           C             + LV+DF      G L + L          ++   +      GL+Y
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIKRVMQMLLNGLYY 140
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
           +H       I+HRD+K  N+L+    V K++DFGL++
Sbjct: 141 IHRNK----ILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 109 FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 162
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 163 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 219
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 220 NQTVDIWSVGCIMAELLTGR 239

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 124
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 125 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 442 QQL-TEKSDVYSFGVVLFEVLCA 463
           ++   E  DV+S G+VL  +L  
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 124
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 125 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 442 QQL-TEKSDVYSFGVVLFEVLCA 463
           ++   E  DV+S G+VL  +L  
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 123
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 124 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 442 QQL-TEKSDVYSFGVVLFEVL 461
           ++   E  DV+S G+VL  +L
Sbjct: 180 REFHAEPVDVWSCGIVLTAML 200

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 124
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 125 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 442 QQL-TEKSDVYSFGVVLFEVL 461
           ++   E  DV+S G+VL  +L
Sbjct: 181 REFHAEPVDVWSCGIVLTAML 201

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 95  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 148
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 149 --ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 205
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 206 NQTVDIWSVGCIMAELLTGR 225

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 95  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 148
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 149 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-YVATRWYRAPEIMLNWMHY 205
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 206 NQTVDIWSVGCIMAELLTGR 225

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 96  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 149
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 150 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 206
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 207 NQTVDIWSVGCIMAELLTGR 226

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 125
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 126 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 442 QQL-TEKSDVYSFGVVLFEVL 461
           ++   E  DV+S G+VL  +L
Sbjct: 182 REFHAEPVDVWSCGIVLTAML 202

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 87  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 140
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 141 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 197
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 198 NQTVDIWSVGCIMAELLTGR 217

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHL 331
           + N   +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H ++
Sbjct: 34  YQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 93
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLH 385
           + L+      R +    D      L  HL  +D   +   Q+L       +     RGL 
Sbjct: 94  IGLLDVFTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 149
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL- 444
           Y+H+    A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++ 
Sbjct: 150 YIHS----ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 204
Query: 445 ------TEKSDVYSFGVVLFEVLCAR 464
                  +  D++S G ++ E+L  R
Sbjct: 205 LNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 124
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 125 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 442 QQL-TEKSDVYSFGVVLFEVL 461
           ++   E  DV+S G+VL  +L
Sbjct: 181 REFHAEPVDVWSCGIVLTAML 201

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 34/206 (16%)
Query: 283 GGFGDVYKGFINGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRHLHLVSLIGF---- 337
           G FG V+K  +      V I  L+  +S Q   E  +  GM    +H +L+  I      
Sbjct: 26  GRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGM----KHENLLQFIAAEKRG 81
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT------GA 391
            N + E+ L+  F  +G+L D+L       + WN+   +    +RGL YLH       G 
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 392 NHA-VIIHRDVKTTNILLDEKWVAKVSDFGLS-KFGPTSV---------SKTHLDPEYYR 440
            H   I HRD K+ N+LL     A ++DFGL+ +F P            ++ ++ PE   
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLE 198
Query: 441 -----LQQLTEKSDVYSFGVVLFEVL 461
                 +    + D+Y+ G+VL+E++
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 125
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 126 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 442 QQL-TEKSDVYSFGVVLFEVL 461
           ++   E  DV+S G+VL  +L
Sbjct: 182 REFHAEPVDVWSCGIVLTAML 202

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 67
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 125
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 126 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 181
Query: 442 QQL-TEKSDVYSFGVVLFEVLCA 463
           ++   E  DV+S G+VL  +L  
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 92  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 145
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 146 --ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 202
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 203 NQTVDIWSVGCIMAELLTGR 222

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRH 328
           A ++ F+ +  +G G    VY+    G+  P A+K L+    +  +  +TEIG+L +L H
Sbjct: 50  ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV--RTEIGVLLRLSH 107
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHL-----YHSDNPPLPWNQRLEICIGAARG 383
            +++ L        E+ LV + +  G L D +     Y   +      Q LE        
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE-------A 160
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDE---KWVAKVSDFGLSKFGPTSV-------SKTH 433
           + YLH       I+HRD+K  N+L          K++DFGLSK     V       +  +
Sbjct: 161 VAYLHENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGY 216
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVLCA 463
             PE  R      + D++S G++ + +LC 
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 124
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 125 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 442 QQL-TEKSDVYSFGVVLFEVL 461
           ++   E  DV+S G+VL  +L
Sbjct: 181 REFHAEPVDVWSCGIVLTAML 201

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 124
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 125 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 442 QQL-TEKSDVYSFGVVLFEVLCA 463
           ++   E  DV+S G+VL  +L  
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 124
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 125 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 442 QQL-TEKSDVYSFGVVLFEVL 461
           ++   E  DV+S G+VL  +L
Sbjct: 181 REFHAEPVDVWSCGIVLTAML 201

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 86  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 139
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 196
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 109 FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 162
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 163 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 219
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 220 NQTVDIWSVGCIMAELLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 110 FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 163
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 164 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 220
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 221 NQTVDIWSVGCIMAELLTGR 240

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 113 FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 166
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     +   ++   +YR  ++       
Sbjct: 167 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXG-YVATRWYRAPEIMLNWMHY 223
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 224 NQTVDIWSVGCIMAELLTGR 243

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 96  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 149
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 150 --ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 206
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 207 NQTVDIWSVGCIMAELLTGR 226

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLH 330
           ++F+    +G G  G V+K     S   +A K +  E +     +   E+ +L +    +
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           +V   G    D E+ +  + M  G+L   L  +    +P     ++ I   +GL YL   
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK 185
Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS------KTHLDPEYYRLQQL 444
                I+HRDVK +NIL++ +   K+ DFG+S     S++      ++++ PE  +    
Sbjct: 186 HK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 242
Query: 445 TEKSDVYSFGVVLFEVLCARPSILRTAAKK 474
           + +SD++S G+ L E+   R  I    AK+
Sbjct: 243 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 272

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLS 324
           +   N+FD   ++G G FG V       +    A+K L  E   ++       TE  +L 
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 325 QLRHLHLVSL-IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA--A 381
             RH  L +L   F   DR +  V ++   G L    +H     +   +R     GA   
Sbjct: 66  NTRHPFLTALKYAFQTHDR-LCFVMEYANGGEL---FFHLSRERVFTEERARF-YGAEIV 120
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------H 433
             L YLH+      +++RD+K  N++LD+    K++DFGL K G +  +          +
Sbjct: 121 SALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEY 176
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           L PE           D +  GVV++E++C R
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 96  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 149
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 150 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 206
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 207 NQTVDIWSVGCIMAELLTGR 226

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLS 324
           +   N+FD   ++G G FG V       +    A+K L  E   ++       TE  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 325 QLRHLHLVSL-IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA--A 381
             RH  L +L   F   DR +  V ++   G L    +H     +   +R     GA   
Sbjct: 61  NTRHPFLTALKYAFQTHDR-LCFVMEYANGGEL---FFHLSRERVFTEERARF-YGAEIV 115
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------H 433
             L YLH+      +++RD+K  N++LD+    K++DFGL K G +  +          +
Sbjct: 116 SALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEY 171
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           L PE           D +  GVV++E++C R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 268 QAATNNFDNDLVIGVGGFGDVY-KGFINGSTTP--VAIKRLEPESQQGALEFQTEI--GM 322
           +A  + F+   V+G G FG V+    I+GS      A+K L+  + +     +T++   +
Sbjct: 21  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 323 LSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-A 381
           L ++ H  +V L      + ++ L+ DF+  G L   L       +   + ++  +   A
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELA 137
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------H 433
             L +LH+      II+RD+K  NILLDE+   K++DFGLSK       K         +
Sbjct: 138 LALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 193
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVLCA 463
           + PE    +  T+ +D +SFGV++FE+L  
Sbjct: 194 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 17/198 (8%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQG--ALEFQTEIGMLSQLRHLHLVSLIG 336
           ++G G FG+V K     +    A+K +   S +         E+ +L +L H +++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
              D     +V +    G L D +          +    I      G+ Y+H       I
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHN----I 142
Query: 397 IHRDVKTTNILLDEKWV---AKVSDFGLSK-FGPTSVSKTHLDPEYYRLQQLT-----EK 447
           +HRD+K  NILL+ K      K+ DFGLS  F   +  K  +   YY   ++      EK
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEK 202
Query: 448 SDVYSFGVVLFEVLCARP 465
            DV+S GV+L+ +L   P
Sbjct: 203 CDVWSAGVILYILLSGTP 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++   +   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGX-VATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 268 QAATNNFDNDLVIGVGGFGDVY-KGFINGSTTP--VAIKRLEPESQQGALEFQTEI--GM 322
           +A  + F+   V+G G FG V+    I+GS      A+K L+  + +     +T++   +
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 323 LSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-A 381
           L ++ H  +V L      + ++ L+ DF+  G L   L       +   + ++  +   A
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELA 136
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------H 433
             L +LH+      II+RD+K  NILLDE+   K++DFGLSK       K         +
Sbjct: 137 LALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVLCA 463
           + PE    +  T+ +D +SFGV++FE+L  
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGM----- 322
           QA  N+ +N   +G G  G V+K     +   +A+K++    + G  E    I M     
Sbjct: 21  QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKEENKRILMDLDVV 77
Query: 323 LSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR 382
           L      ++V   G    + ++ +  + M  GT  + L      P+P     ++ +   +
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSK-------THLD 435
            L+YL     H VI HRDVK +NILLDE+   K+ DFG+S       +K        ++ 
Sbjct: 136 ALYYLK--EKHGVI-HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMA 192
Query: 436 PEYYRLQQLTE-----KSDVYSFGVVLFEV 460
           PE       T+     ++DV+S G+ L E+
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLS 324
           +   N+FD   ++G G FG V       +    A+K L  E   ++       TE  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 325 QLRHLHLVSL-IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA--A 381
             RH  L +L   F   DR +  V ++   G L    +H     +   +R     GA   
Sbjct: 61  NTRHPFLTALKYAFQTHDR-LCFVMEYANGGEL---FFHLSRERVFTEERARF-YGAEIV 115
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------H 433
             L YLH+      +++RD+K  N++LD+    K++DFGL K G +  +          +
Sbjct: 116 SALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEY 171
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           L PE           D +  GVV++E++C R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 87/187 (46%), Gaps = 10/187 (5%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHLHLVSLIGF 337
           IG G +G V+K     +   VA+KR+  +     +      EI +L +L+H ++V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
            + D+++ LV++F  +       + S N  L             +GL + H+      ++
Sbjct: 70  LHSDKKLTLVFEFCDQDL--KKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN----VL 123
Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQLTEKSDVYSFGV 455
           HRD+K  N+L++     K++DFGL++ FG P       +   +YR   +   + +YS  +
Sbjct: 124 HRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 456 VLFEVLC 462
            ++   C
Sbjct: 184 DMWSAGC 190

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 86/207 (41%), Gaps = 18/207 (8%)
Query: 271 TNNFDNDLVIGVGGFGDVY--KGFINGSTTPV-AIKRLEPESQQGALEFQTEIGMLSQLR 327
           ++ +    V+G G FG+V   K  I G    V  I + + + +        E+ +L QL 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
           H ++  L  F  D     LV +    G L D +               I      G+ Y 
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEII--SRKRFSEVDAARIIRQVLSGITYX 142
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWV---AKVSDFGLS-KFGPTSVSKTHLDPEYYRLQQ 443
           H       I+HRD+K  N+LL+ K      ++ DFGLS  F  +   K  +   YY   +
Sbjct: 143 HKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPE 198
Query: 444 L-----TEKSDVYSFGVVLFEVLCARP 465
           +      EK DV+S GV+L+ +L   P
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCP 225

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 96  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 149
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 150 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 206
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 207 NQTVDIWSVGCIMAELLTGR 226

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 268 QAATNNFDNDLVIGVGGFGDVY-KGFINGSTTP--VAIKRLEPESQQGALEFQTEI--GM 322
           +A  + F+   V+G G FG V+    I+GS      A+K L+  + +     +T++   +
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 323 LSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA-A 381
           L ++ H  +V L      + ++ L+ DF+  G L   L       +   + ++  +   A
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELA 136
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------H 433
             L +LH+      II+RD+K  NILLDE+   K++DFGLSK       K         +
Sbjct: 137 LALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVLCA 463
           + PE    +  T+ +D +SFGV++FE+L  
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 12/215 (5%)
Query: 267 IQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQ 325
           ++   ++F+    +G G  G V+K     S   +A K +  E +     +   E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
               ++V   G    D E+ +  + M  G+L   L  +    +P     ++ I   +GL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLT 118
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS------KTHLDPEYY 439
           YL        I+HRDVK +NIL++ +   K+ DFG+S     S++      ++++ PE  
Sbjct: 119 YLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 175
Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK 474
           +    + +SD++S G+ L E+   R  I    AK+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLS 324
           +   N+FD   ++G G FG V       +    A+K L  E   ++       TE  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 325 QLRHLHLVSL-IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA--A 381
             RH  L +L   F   DR +  V ++   G L    +H     +   +R     GA   
Sbjct: 61  NTRHPFLTALKYAFQTHDR-LCFVMEYANGGEL---FFHLSRERVFTEERARF-YGAEIV 115
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------H 433
             L YLH+      +++RD+K  N++LD+    K++DFGL K G +  +          +
Sbjct: 116 SALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEY 171
Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           L PE           D +  GVV++E++C R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 42/227 (18%)
Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH 330
            ++F+   V+G G FG V K      +   AIK++   +++      +E+ +L+ L H +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNHQY 63
Query: 331 LVSLIGFCNDDREMI-------------LVYDFMARGTLPDHLYHSDNPPLPWNQRLEIC 377
           +V       + R  +             +  ++    TL D L HS+N     ++   + 
Sbjct: 64  VVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYD-LIHSENLNQQRDEYWRLF 122
Query: 378 IGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE 437
                 L Y+H+      IIHR++K  NI +DE    K+ DFGL+K    S+    LD +
Sbjct: 123 RQILEALSYIHSQG----IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 438 -----------------YYRLQQL------TEKSDVYSFGVVLFEVL 461
                            Y   + L       EK D YS G++ FE +
Sbjct: 179 NLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 35/199 (17%)
Query: 280 IGVGGFGDVYKGFIN-GSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G VYK   N G T  +   RLE E +        EI +L +L+H ++V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR-------------GLH 385
           +  + ++LV++ + +                  + L++C G                G+ 
Sbjct: 70  HTKKRLVLVFEHLDQDL---------------KKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQ 443
           Y H       ++HRD+K  N+L++ +   K++DFGL++ FG      TH +   +YR   
Sbjct: 115 YCHDRR----VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170
Query: 444 LTEKSDVYSFGVVLFEVLC 462
           +   S  YS  + ++ V C
Sbjct: 171 VLMGSKKYSTTIDIWSVGC 189

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 78/162 (48%), Gaps = 11/162 (6%)
Query: 319 EIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICI 378
           E+ +L +    ++V   G    D E+ +  + M  G+L   L  +    +P     ++ I
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSI 121
Query: 379 GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS------KT 432
              RGL YL        I+HRDVK +NIL++ +   K+ DFG+S     S++      ++
Sbjct: 122 AVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 178
Query: 433 HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK 474
           ++ PE  +    + +SD++S G+ L E+   R  I    AK+
Sbjct: 179 YMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKE 220

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ D+GL++     ++  ++   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 12/215 (5%)
Query: 267 IQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQ 325
           ++   ++F+    +G G  G V+K     S   +A K +  E +     +   E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
               ++V   G    D E+ +  + M  G+L   L  +    +P     ++ I   +GL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLT 118
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS------KTHLDPEYY 439
           YL        I+HRDVK +NIL++ +   K+ DFG+S     S++      ++++ PE  
Sbjct: 119 YLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 175
Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK 474
           +    + +SD++S G+ L E+   R  I    AK+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 12/215 (5%)
Query: 267 IQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQ 325
           ++   ++F+    +G G  G V+K     S   +A K +  E +     +   E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
               ++V   G    D E+ +  + M  G+L   L  +    +P     ++ I   +GL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLT 118
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS------KTHLDPEYY 439
           YL        I+HRDVK +NIL++ +   K+ DFG+S     S++      ++++ PE  
Sbjct: 119 YLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 175
Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK 474
           +    + +SD++S G+ L E+   R  I    AK+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 35/199 (17%)
Query: 280 IGVGGFGDVYKGFIN-GSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G VYK   N G T  +   RLE E +        EI +L +L+H ++V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR-------------GLH 385
           +  + ++LV++ + +                  + L++C G                G+ 
Sbjct: 70  HTKKRLVLVFEHLDQDL---------------KKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQ 443
           Y H       ++HRD+K  N+L++ +   K++DFGL++ FG      TH +   +YR   
Sbjct: 115 YCHDRR----VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPD 170
Query: 444 LTEKSDVYSFGVVLFEVLC 462
           +   S  YS  + ++ V C
Sbjct: 171 VLMGSKKYSTTIDIWSVGC 189

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 35/199 (17%)
Query: 280 IGVGGFGDVYKGFIN-GSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           IG G +G VYK   N G T  +   RLE E +        EI +L +L+H ++V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR-------------GLH 385
           +  + ++LV++ + +                  + L++C G                G+ 
Sbjct: 70  HTKKRLVLVFEHLDQDL---------------KKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-LDPEYYRLQQ 443
           Y H       ++HRD+K  N+L++ +   K++DFGL++ FG      TH +   +YR   
Sbjct: 115 YCHDRR----VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPD 170
Query: 444 LTEKSDVYSFGVVLFEVLC 462
           +   S  YS  + ++ V C
Sbjct: 171 VLMGSKKYSTTIDIWSVGC 189

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLS 324
           +   N F+   ++G G FG V       +    A+K L+ E   ++       TE  +L 
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 325 QLRHLHLVSL-IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARG 383
             RH  L +L   F   DR +  V ++   G L  HL  S       ++           
Sbjct: 204 NSRHPFLTALKYSFQTHDR-LCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSA 260
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT--SVSKT------HLD 435
           L YLH+  N   +++RD+K  N++LD+    K++DFGL K G    +  KT      +L 
Sbjct: 261 LDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 317
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           PE           D +  GVV++E++C R
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLS 324
           +   N F+   ++G G FG V       +    A+K L+ E   ++       TE  +L 
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 206
Query: 325 QLRHLHLVSL-IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARG 383
             RH  L +L   F   DR +  V ++   G L  HL  S       ++           
Sbjct: 207 NSRHPFLTALKYSFQTHDR-LCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSA 263
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT--SVSKT------HLD 435
           L YLH+  N   +++RD+K  N++LD+    K++DFGL K G    +  KT      +L 
Sbjct: 264 LDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 320
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           PE           D +  GVV++E++C R
Sbjct: 321 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 17/198 (8%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQG--ALEFQTEIGMLSQLRHLHLVSLIG 336
           ++G G FG+V K     +    A+K +   S +         E+ +L +L H +++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
              D     +V +    G L D +          +    I      G+ Y+H       I
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHN----I 142
Query: 397 IHRDVKTTNILLDEK---WVAKVSDFGLSK-FGPTSVSKTHLDPEYYRLQQLT-----EK 447
           +HRD+K  NILL+ K      K+ DFGLS  F   +  K  +   YY   ++      EK
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEK 202
Query: 448 SDVYSFGVVLFEVLCARP 465
            DV+S GV+L+ +L   P
Sbjct: 203 CDVWSAGVILYILLSGTP 220

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALE-FQTEIGMLSQL-RHLHLV 332
           +G G FG V +    G     +   VA+K L+P +     E   +E+ +LS L  H+++V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG------------- 379
           +L+G C      +++ ++   G L + L    +  +       I                
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 380 ---AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF----------GP 426
               A+G+ +L +       IHRD+   NILL    + K+ DFGL++           G 
Sbjct: 174 SYQVAKGMAFLASKN----CIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGN 229
Query: 427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             +    + PE       T +SDV+S+G+ L+E+ 
Sbjct: 230 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 12/215 (5%)
Query: 267 IQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQ 325
           ++   ++F+    +G G  G V+K     S   +A K +  E +     +   E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
               ++V   G    D E+ +  + M  G+L   L  +    +P     ++ I   +GL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLT 118
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS------KTHLDPEYY 439
           YL        I+HRDVK +NIL++ +   K+ DFG+S     S++      ++++ PE  
Sbjct: 119 YLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 175
Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK 474
           +    + +SD++S G+ L E+   R  I    AK+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 12/215 (5%)
Query: 267 IQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQ 325
           ++   ++F+    +G G  G V+K     S   +A K +  E +     +   E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
               ++V   G    D E+ +  + M  G+L   L  +    +P     ++ I   +GL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLT 118
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS------KTHLDPEYY 439
           YL        I+HRDVK +NIL++ +   K+ DFG+S     S++      ++++ PE  
Sbjct: 119 YLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 175
Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK 474
           +    + +SD++S G+ L E+   R  I    AK+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 86  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 139
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++   +   +YR  ++       
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-GFVATRWYRAPEIMLNWMHY 196
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLH 330
           ++F+    +G G  G V+K     S   +A K +  E +     +   E+ +L +    +
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           +V   G    D E+ +  + M  G+L   L  +    +P     ++ I   +GL YL   
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK 150
Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS------KTHLDPEYYRLQQL 444
                I+HRDVK +NIL++ +   K+ DFG+S     S++      ++++ PE  +    
Sbjct: 151 HK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 207
Query: 445 TEKSDVYSFGVVLFEVLCARPSILRTAAKK 474
           + +SD++S G+ L E+   R  I    AK+
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 17/198 (8%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQG--ALEFQTEIGMLSQLRHLHLVSLIG 336
           ++G G FG+V K     +    A+K +   S +         E+ +L +L H +++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
              D     +V +    G L D +          +    I      G+ Y+H       I
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHN----I 142
Query: 397 IHRDVKTTNILLDEK---WVAKVSDFGLSK-FGPTSVSKTHLDPEYYRLQQLT-----EK 447
           +HRD+K  NILL+ K      K+ DFGLS  F   +  K  +   YY   ++      EK
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEK 202
Query: 448 SDVYSFGVVLFEVLCARP 465
            DV+S GV+L+ +L   P
Sbjct: 203 CDVWSAGVILYILLSGTP 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++   +   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-GFVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++   +   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-GFVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALE-FQTEIGMLSQL-RHLHLV 332
           +G G FG V +    G     +   VA+K L+P +     E   +E+ +LS L  H+++V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG------------- 379
           +L+G C      +++ ++   G L + L    +  +       I                
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 380 ---AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGP 426
               A+G+ +L +       IHRD+   NILL    + K+ DFGL++           G 
Sbjct: 167 SYQVAKGMAFLASKN----CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 222
Query: 427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             +    + PE       T +SDV+S+G+ L+E+ 
Sbjct: 223 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 257

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 83/200 (41%), Gaps = 15/200 (7%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            D+ + IG G  G V       S   VA+K ++   QQ       E+ ++   +H ++V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +        E+ ++ +F+  G L D +       L   Q   +C    + L YLH     
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQG-- 161
Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLT 445
             +IHRD+K+ +ILL      K+SDFG        V K          + PE        
Sbjct: 162 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYA 219
Query: 446 EKSDVYSFGVVLFEVLCARP 465
            + D++S G+++ E++   P
Sbjct: 220 TEVDIWSLGIMVIEMVDGEP 239

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 110 FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 163
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     +    +   +YR  ++       
Sbjct: 164 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGX-VATRWYRAPEIMLNWMHY 220
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 221 NQTVDIWSVGCIMAELLTGR 240

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 20/201 (9%)
Query: 275 DNDLV--IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHL 331
           D DLV  +G G  G+V       +   VA+K ++ +      E  + EI +   L H ++
Sbjct: 7   DWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G   +     L  ++ + G L D +      P P  QR    + A  G+ YLH   
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG 124
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGPTSVSKTHLDPEYYRL 441
               I HRD+K  N+LLDE+   K+SDFGL+                 +  ++ PE  + 
Sbjct: 125 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 442 QQL-TEKSDVYSFGVVLFEVL 461
           ++   E  DV+S G+VL  +L
Sbjct: 181 REFHAEPVDVWSCGIVLTAML 201

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALE-FQTEIGMLSQL-RHLHLV 332
           +G G FG V +    G     +   VA+K L+P +     E   +E+ +LS L  H+++V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG------------- 379
           +L+G C      +++ ++   G L + L    +  +       I                
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 380 ---AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGP 426
               A+G+ +L +       IHRD+   NILL    + K+ DFGL++           G 
Sbjct: 151 SYQVAKGMAFLASKN----CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             +    + PE       T +SDV+S+G+ L+E+ 
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALE-FQTEIGMLSQL-RHLHLV 332
           +G G FG V +    G     +   VA+K L+P +     E   +E+ +LS L  H+++V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG------------- 379
           +L+G C      +++ ++   G L + L    +  +       I                
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 380 ---AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGP 426
               A+G+ +L +       IHRD+   NILL    + K+ DFGL++           G 
Sbjct: 169 SYQVAKGMAFLASKN----CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 224
Query: 427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             +    + PE       T +SDV+S+G+ L+E+ 
Sbjct: 225 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 259

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 37/215 (17%)
Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALE-FQTEIGMLSQL-RHLHLV 332
           +G G FG V +    G     +   VA+K L+P +     E   +E+ +LS L  H+++V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG------------- 379
           +L+G C      +++ ++   G L + L    +  +       I                
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 380 ---AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----------FGP 426
               A+G+ +L +       IHRD+   NILL    + K+ DFGL++           G 
Sbjct: 174 SYQVAKGMAFLASKN----CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 229
Query: 427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
             +    + PE       T +SDV+S+G+ L+E+ 
Sbjct: 230 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 44/213 (20%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G +G+V+ G   G    V   ++   +++ +   +TEI     +RH    +++GF  
Sbjct: 45  IGKGRYGEVWMGKWRGEKVAV---KVFFTTEEASWFRETEIYQTVLMRH---ENILGFIA 98
Query: 340 DD-------REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT--- 389
            D        ++ L+ D+   G+L D+L    +  L     L++   +  GL +LHT   
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 390 -GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS---------------------KFGPT 427
                  I HRD+K+ NIL+ +     ++D GL+                     ++ P 
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 428 SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEV 460
            V    L+  ++   Q    +D+YSFG++L+EV
Sbjct: 216 EVLDESLNRNHF---QSYIMADMYSFGLILWEV 245

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/250 (22%), Positives = 114/250 (45%), Gaps = 19/250 (7%)
Query: 286 GDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR--E 343
           G+++KG   G+   V + ++   S + + +F  E   L    H +++ ++G C       
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKT 403
             L+  +M  G+L + L+   N  +  +Q ++  +  ARG+ +LHT     +I    + +
Sbjct: 84  PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL--EPLIPRHALNS 141
Query: 404 TNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTEK--------SDVYSFGV 455
            ++++DE   A++S     KF   S  + +  P +   + L +K        +D++SF V
Sbjct: 142 RSVMIDEDMTARIS-MADVKFSFQSPGRMYA-PAWVAPEALQKKPEDTNRRSADMWSFAV 199
Query: 456 VLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS--CLNDEGIRRP 513
           +L+E L  R       +  ++ + V  +      TI   + P +  +   C+N++  +RP
Sbjct: 200 LLWE-LVTREVPFADLSNMEIGMKVALEGL--RPTIPPGISPHVSKLMKICMNEDPAKRP 256
Query: 514 SMSDVVWGLE 523
               +V  LE
Sbjct: 257 KFDMIVPILE 266

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 28/202 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRL-EP-ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V       +   VAIK+L  P +S+  A     E+ +L  +RH +++ L+  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 338 CNDDR------EMILVYDFMAR--GTLPDHLYHSDNPPLPWNQRLEICI-GAARGLHYLH 388
              D       +  LV  FM    G L  H    ++       R++  +    +GL Y+H
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED-------RIQFLVYQMLKGLRYIH 145
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS-----VSKTHLDPEY-YRLQ 442
                A IIHRD+K  N+ ++E    K+ DFGL++   +      V++ +  PE      
Sbjct: 146 A----AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTRWYRAPEVILNWM 201
Query: 443 QLTEKSDVYSFGVVLFEVLCAR 464
           + T+  D++S G ++ E++  +
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGK 223

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 33/206 (16%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           +IG G FG VY G  +G    + +  +E +++     F+ E+    Q RH ++V  +G C
Sbjct: 40  LIGKGRFGQVYHGRWHGEVA-IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
                + ++   + +G     +       L  N+  +I     +G+ YLH       I+H
Sbjct: 99  MSPPHLAIITS-LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG----ILH 153
Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT---------------HLDPEYYRLQQ 443
           +D+K+ N+  D   V  ++DFGL  F  + V +                HL PE  R   
Sbjct: 154 KDLKSKNVFYDNGKVV-ITDFGL--FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 444 ---------LTEKSDVYSFGVVLFEV 460
                     ++ SDV++ G + +E+
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 266 EIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQ 325
           +I+    +F+   ++G G FG V+      +    AIK L+ +     ++   E  M+ +
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEK 69
Query: 326 ------LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY--HSDNPPLPWNQRLEIC 377
                   H  L  +         +  V +++  G L  H+   H  +         EI 
Sbjct: 70  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 129
Query: 378 IGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT----- 432
           +G    L +LH+      I++RD+K  NILLD+    K++DFG+ K      +KT     
Sbjct: 130 LG----LQFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCG 181
Query: 433 ---HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
              ++ PE    Q+     D +SFGV+L+E+L  +
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 110/256 (42%), Gaps = 24/256 (9%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSLIGFC 338
           +G G FGDV+      S     IK +  +  Q  +E  + EI +L  L H +++ +    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 339 NDDREMILVYDFMARGTLPDHLY--HSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
            D   M +V +    G L + +    +    L      E+       L Y H+   H  +
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--QH--V 145
Query: 397 IHRDVKTTNILLDE---KWVAKVSDFGLSKFGPTSVSKT-------HLDPEYYRLQQLTE 446
           +H+D+K  NIL  +       K+ DFGL++   +    T       ++ PE ++ + +T 
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTF 204
Query: 447 KSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ---NGTIDQIVDPFLKAMS 503
           K D++S GVV++ +L        T+ ++    A + +  Y         Q VD  LK M 
Sbjct: 205 KCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVD-LLKQM- 262
Query: 504 CLNDEGIRRPSMSDVV 519
            L  +  RRPS + V+
Sbjct: 263 -LTKDPERRPSAAQVL 277

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 303 KRLEPESQQGAL--EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL 360
           KR    S++G    + + E+ +L +++H ++++L     +  ++IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 361 YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV----AKV 416
             ++   L   +  E       G++YLH+      I H D+K  NI+L ++ V     K+
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHS----LQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 417 SDFGLS-------KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILR 469
            DFGL+       +F     +   + PE    + L  ++D++S GV+ + +L      L 
Sbjct: 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL- 218
Query: 470 TAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSD 517
               KQ +LA  +   Y      +  D +    S L  + IRR  + D
Sbjct: 219 -GDTKQETLANVSAVNY------EFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/187 (24%), Positives = 87/187 (46%), Gaps = 10/187 (5%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHLHLVSLIGF 337
           IG G +G V+K     +   VA+KR+  +     +      EI +L +L+H ++V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
            + D+++ LV++F  +       + S N  L             +GL + H+      ++
Sbjct: 70  LHSDKKLTLVFEFCDQDL--KKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN----VL 123
Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSK-FG-PTSVSKTHLDPEYYRLQQLTEKSDVYSFGV 455
           HRD+K  N+L++     K+++FGL++ FG P       +   +YR   +   + +YS  +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 456 VLFEVLC 462
            ++   C
Sbjct: 184 DMWSAGC 190

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLH 330
           ++F+    +G G  G V+K     S   +A K +  E +     +   E+ +L +    +
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           +V   G    D E+ +  + M  G+L   L  +    +P     ++ I   +GL YL   
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK 142
Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS------KTHLDPEYYRLQQL 444
                I+HRDVK +NIL++ +   K+ DFG+S     S++      ++++ PE  +    
Sbjct: 143 HK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 199
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
           + +SD++S G+ L E+   R
Sbjct: 200 SVQSDIWSMGLSLVEMAVGR 219

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 22/157 (14%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           +IG G +G VYKG ++    PVA+K     ++Q  +  +  I  +  + H ++   I   
Sbjct: 20  LIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNFIN-EKNIYRVPLMEHDNIARFI--V 74
Query: 339 NDDR-------EMILVYDFMARGTLPDHL-YHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
            D+R       E +LV ++   G+L  +L  H+ +    W     +     RGL YLHT 
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD----WVSSCRLAHSVTRGLAYLHTE 130
Query: 391 ---ANH--AVIIHRDVKTTNILLDEKWVAKVSDFGLS 422
               +H    I HRD+ + N+L+       +SDFGLS
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 88/198 (44%), Gaps = 21/198 (10%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G +G+V      G+    A K++     +    F+ EI ++  L H +++ L     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV---I 396
           D+ ++ LV +    G L + + H         +R+     AAR +  + +   +     +
Sbjct: 77  DNTDIYLVMELCTGGELFERVVH---------KRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 397 IHRDVKTTNILL---DEKWVAKVSDFGLS-KFGPTSVSKTHLDPEYYRLQQLTE-----K 447
            HRD+K  N L          K+ DFGL+ +F P  + +T +   YY   Q+ E     +
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPE 187
Query: 448 SDVYSFGVVLFEVLCARP 465
            D +S GV+++ +LC  P
Sbjct: 188 CDEWSAGVMMYVLLCGYP 205

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +    +L       +     RGL Y+H+  
Sbjct: 86  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHS-- 139
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 196
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 95/201 (47%), Gaps = 23/201 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIK----RLEPESQQGAL--EFQTEIGMLSQLRHLHLVS 333
           +G G F  V K    G+    A K    R    S++G    E + E+ +L ++RH ++++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L     +  +++L+ + ++ G L D L  ++   L  ++  +       G+HYLH+    
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLHSKR-- 128
Query: 394 AVIIHRDVKTTNILLDEKWV----AKVSDFGLS-------KFGPTSVSKTHLDPEYYRLQ 442
             I H D+K  NI+L +K V     K+ DFG++       +F     +   + PE    +
Sbjct: 129 --IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186
Query: 443 QLTEKSDVYSFGVVLFEVLCA 463
            L  ++D++S GV+ + +L  
Sbjct: 187 PLGLEADMWSIGVITYILLSG 207

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 88/198 (44%), Gaps = 21/198 (10%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G +G+V      G+    A K++     +    F+ EI ++  L H +++ L     
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 93
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV---I 396
           D+ ++ LV +    G L + + H         +R+     AAR +  + +   +     +
Sbjct: 94  DNTDIYLVMELCTGGELFERVVH---------KRVFRESDAARIMKDVLSAVAYCHKLNV 144
Query: 397 IHRDVKTTNILL---DEKWVAKVSDFGLS-KFGPTSVSKTHLDPEYYRLQQLTE-----K 447
            HRD+K  N L          K+ DFGL+ +F P  + +T +   YY   Q+ E     +
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPE 204
Query: 448 SDVYSFGVVLFEVLCARP 465
            D +S GV+++ +LC  P
Sbjct: 205 CDEWSAGVMMYVLLCGYP 222

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 303 KRLEPESQQGAL--EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL 360
           KR    S++G    + + E+ +L +++H ++++L     +  ++IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 361 YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV----AKV 416
             ++   L   +  E       G++YLH+      I H D+K  NI+L ++ V     K+
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHS----LQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 417 SDFGLS-------KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILR 469
            DFGL+       +F     +   + PE    + L  ++D++S GV+ + +L      L 
Sbjct: 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL- 218
Query: 470 TAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSD 517
               KQ +LA  +   Y      +  D +    S L  + IRR  + D
Sbjct: 219 -GDTKQETLANVSAVNY------EFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+  FGL++     ++  ++   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTG-YVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 18/209 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLS 324
           +   N F+   ++G G FG V       +    A+K L+ E   ++       TE  +L 
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 64
Query: 325 QLRHLHLVSL-IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARG 383
             RH  L +L   F   DR +  V ++   G L  HL  S       ++           
Sbjct: 65  NSRHPFLTALKYSFQTHDR-LCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSA 121
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------HLD 435
           L YLH+  N   +++RD+K  N++LD+    K++DFGL K G    +          +L 
Sbjct: 122 LDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLA 178
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           PE           D +  GVV++E++C R
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 18/209 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLS 324
           +   N F+   ++G G FG V       +    A+K L+ E   ++       TE  +L 
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 325 QLRHLHLVSL-IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARG 383
             RH  L +L   F   DR +  V ++   G L  HL  S       ++           
Sbjct: 66  NSRHPFLTALKYSFQTHDR-LCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSA 122
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------HLD 435
           L YLH+  N   +++RD+K  N++LD+    K++DFGL K G    +          +L 
Sbjct: 123 LDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLA 179
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           PE           D +  GVV++E++C R
Sbjct: 180 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 303 KRLEPESQQGAL--EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL 360
           KR    S++G    + + E+ +L +++H ++++L     +  ++IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 361 YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV----AKV 416
             ++   L   +  E       G++YLH+      I H D+K  NI+L ++ V     K+
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHS----LQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 417 SDFGLS-------KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILR 469
            DFGL+       +F     +   + PE    + L  ++D++S GV+ + +L      L 
Sbjct: 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL- 218
Query: 470 TAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSD 517
               KQ +LA  +   Y      +  D +    S L  + IRR  + D
Sbjct: 219 -GDTKQETLANVSAVNY------EFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 303 KRLEPESQQGAL--EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL 360
           KR    S++G    + + E+ +L +++H ++++L     +  ++IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 361 YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV----AKV 416
             ++   L   +  E       G++YLH+      I H D+K  NI+L ++ V     K+
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHS----LQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 417 SDFGLS-------KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILR 469
            DFGL+       +F     +   + PE    + L  ++D++S GV+ + +L      L 
Sbjct: 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL- 218
Query: 470 TAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSD 517
               KQ +LA  +   Y      +  D +    S L  + IRR  + D
Sbjct: 219 -GDTKQETLANVSAVNY------EFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 18/209 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLS 324
           +   N F+   ++G G FG V       +    A+K L+ E   ++       TE  +L 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 325 QLRHLHLVSL-IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARG 383
             RH  L +L   F   DR +  V ++   G L  HL  S       ++           
Sbjct: 64  NSRHPFLTALKYSFQTHDR-LCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSA 120
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------HLD 435
           L YLH+  N   +++RD+K  N++LD+    K++DFGL K G    +          +L 
Sbjct: 121 LDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLA 177
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           PE           D +  GVV++E++C R
Sbjct: 178 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 303 KRLEPESQQGAL--EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL 360
           KR    S++G    + + E+ +L +++H ++++L     +  ++IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 361 YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV----AKV 416
             ++   L   +  E       G++YLH+      I H D+K  NI+L ++ V     K+
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHS----LQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 417 SDFGLS-------KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILR 469
            DFGL+       +F     +   + PE    + L  ++D++S GV+ + +L      L 
Sbjct: 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL- 218
Query: 470 TAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSD 517
               KQ +LA  +   Y      +  D +    S L  + IRR  + D
Sbjct: 219 -GDTKQETLANVSAVNY------EFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 114/261 (43%), Gaps = 31/261 (11%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIK----RLEPESQQGAL--EFQTEIGMLSQLR 327
           +D    +G G F  V K     +    A K    R    S++G    + + E+ +L +++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
           H ++++L     +  ++IL+ + +A G L D L  ++   L   +  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWV----AKVSDFGLS-------KFGPTSVSKTHLDP 436
           H+      I H D+K  NI+L ++ V     K+ DFGL+       +F     +   + P
Sbjct: 131 HS----LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVD 496
           E    + L  ++D++S GV+ + +L      L     KQ +LA  +   Y      +  D
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETLANVSAVNY------EFED 238
Query: 497 PFLKAMSCLNDEGIRRPSMSD 517
            +    S L  + IRR  + D
Sbjct: 239 EYFSNTSALAKDFIRRLLVKD 259

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 303 KRLEPESQQGAL--EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL 360
           KR    S++G    + + E+ +L +++H ++++L     +  ++IL+ + +A G L D L
Sbjct: 45  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 104
Query: 361 YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV----AKV 416
             ++   L   +  E       G++YLH+      I H D+K  NI+L ++ V     K+
Sbjct: 105 --AEKESLTEEEATEFLKQILNGVYYLHS----LQIAHFDLKPENIMLLDRNVPKPRIKI 158
Query: 417 SDFGLS-------KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILR 469
            DFGL+       +F     +   + PE    + L  ++D++S GV+ + +L      L 
Sbjct: 159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL- 217
Query: 470 TAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSD 517
               KQ +LA  +   Y      +  D +    S L  + IRR  + D
Sbjct: 218 -GDTKQETLANVSAVNY------EFEDEYFSNTSALAKDFIRRLLVKD 258

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIK----RLEPESQQGAL--EFQTEIGMLSQLRHLHLVS 333
           +G G F  V K    G+    A K    R    S++G    E + E+ +L ++RH ++++
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L     +  +++L+ + ++ G L D L  ++   L  ++  +       G+HYLH+    
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLHSKR-- 135
Query: 394 AVIIHRDVKTTNILLDEKWV----AKVSDFGLS-------KFGPTSVSKTHLDPEYYRLQ 442
             I H D+K  NI+L +K V     K+ DFG++       +F     +   + PE    +
Sbjct: 136 --IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 193
Query: 443 QLTEKSDVYSFGVVLFEVLCARPSIL 468
            L  ++D++S GV+ + +L      L
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFL 219

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 303 KRLEPESQQGAL--EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL 360
           KR    S++G    + + E+ +L +++H ++++L     +  ++IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 361 YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV----AKV 416
             ++   L   +  E       G++YLH+      I H D+K  NI+L ++ V     K+
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHS----LQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 417 SDFGLS-------KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILR 469
            DFGL+       +F     +   + PE    + L  ++D++S GV+ + +L      L 
Sbjct: 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL- 218
Query: 470 TAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSD 517
               KQ +LA  +   Y      +  D +    S L  + IRR  + D
Sbjct: 219 -GDTKQETLANVSAVNY------EFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ D GL++     ++  ++   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 303 KRLEPESQQGAL--EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL 360
           KR    S++G    + + E+ +L +++H ++++L     +  ++IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 361 YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV----AKV 416
             ++   L   +  E       G++YLH+      I H D+K  NI+L ++ V     K+
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHS----LQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 417 SDFGLS-------KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILR 469
            DFGL+       +F     +   + PE    + L  ++D++S GV+ + +L      L 
Sbjct: 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL- 218
Query: 470 TAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSD 517
               KQ +LA  +   Y      +  D +    S L  + IRR  + D
Sbjct: 219 -GDTKQETLANVSAVNY------EFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 303 KRLEPESQQGAL--EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL 360
           KR    S++G    + + E+ +L +++H ++++L     +  ++IL+ + +A G L D L
Sbjct: 45  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 104
Query: 361 YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV----AKV 416
             ++   L   +  E       G++YLH+      I H D+K  NI+L ++ V     K+
Sbjct: 105 --AEKESLTEEEATEFLKQILNGVYYLHS----LQIAHFDLKPENIMLLDRNVPKPRIKI 158
Query: 417 SDFGLS-------KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILR 469
            DFGL+       +F     +   + PE    + L  ++D++S GV+ + +L      L 
Sbjct: 159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL- 217
Query: 470 TAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSD 517
               KQ +LA  +   Y      +  D +    S L  + IRR  + D
Sbjct: 218 -GDTKQETLANVSAVNY------EFEDEYFSNTSALAKDFIRRLLVKD 258

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLH 330
           ++F+    +G G  G V+K     S   +A K +  E +     +   E+ +L +    +
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           +V   G    D E+ +  + M  G+L   L  +    +P     ++ I   +GL YL   
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK 126
Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS-----KFGPTSV-SKTHLDPEYYRLQQL 444
                I+HRDVK +NIL++ +   K+ DFG+S     +     V +++++ PE  +    
Sbjct: 127 HK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGTHY 183
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
           + +SD++S G+ L E+   R
Sbjct: 184 SVQSDIWSMGLSLVEMAVGR 203

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 303 KRLEPESQQGAL--EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL 360
           KR    S++G    + + E+ +L +++H ++++L     +  ++IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 361 YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV----AKV 416
             ++   L   +  E       G++YLH+      I H D+K  NI+L ++ V     K+
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHS----LQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 417 SDFGLS-------KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILR 469
            DFGL+       +F     +   + PE    + L  ++D++S GV+ + +L      L 
Sbjct: 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL- 218
Query: 470 TAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSD 517
               KQ +LA  +   Y      +  D +    S L  + IRR  + D
Sbjct: 219 -GDTKQETLANVSAVNY------EFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPE----SQQGAL--EFQTEIGMLSQLRHLHLVS 333
           +G G F  V K    G+    A K ++      S++G    E + E+ +L ++RH ++++
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L     +  +++L+ + ++ G L D L  ++   L  ++  +       G+HYLH+    
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLHSKR-- 149
Query: 394 AVIIHRDVKTTNILLDEKWV----AKVSDFGLS-------KFGPTSVSKTHLDPEYYRLQ 442
             I H D+K  NI+L +K V     K+ DFG++       +F     +   + PE    +
Sbjct: 150 --IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 207
Query: 443 QLTEKSDVYSFGVVLFEVLCARPSIL 468
            L  ++D++S GV+ + +L      L
Sbjct: 208 PLGLEADMWSIGVITYILLSGASPFL 233

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ D GL++     ++  ++   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 24/215 (11%)
Query: 263 SLSEIQAATNNFDNDLVIGVGGFGDVY--KGFINGSTTPVAI---KRLEPESQQGALEFQ 317
           S ++ Q    N+     IG G F  V   +  + G    V I    +L P S Q      
Sbjct: 6   SATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-- 63
Query: 318 TEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEI 376
            E+ ++  L H ++V L      ++ + LV ++ + G + D+L  H          +   
Sbjct: 64  -EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 122
Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS-------KFGPTSV 429
            + A +  H          I+HRD+K  N+LLD     K++DFG S       K      
Sbjct: 123 IVSAVQYCH-------QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCG 175
Query: 430 SKTHLDPEYYRLQQLT-EKSDVYSFGVVLFEVLCA 463
           S  +  PE ++ ++    + DV+S GV+L+ ++  
Sbjct: 176 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 114/261 (43%), Gaps = 31/261 (11%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIK----RLEPESQQGAL--EFQTEIGMLSQLR 327
           +D    +G G F  V K     +    A K    R    S++G    + + E+ +L +++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
           H ++++L     +  ++IL+ + +A G L D L  ++   L   +  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWV----AKVSDFGLS-------KFGPTSVSKTHLDP 436
           H+      I H D+K  NI+L ++ V     K+ DFGL+       +F     +   + P
Sbjct: 131 HS----LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAP 186
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVD 496
           E    + L  ++D++S GV+ + +L      L     KQ +LA  +   Y      +  D
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETLANVSAVNY------EFED 238
Query: 497 PFLKAMSCLNDEGIRRPSMSD 517
            +    S L  + IRR  + D
Sbjct: 239 EYFSNTSALAKDFIRRLLVKD 259

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DF L++     ++  ++   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMT-GYVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 26/215 (12%)
Query: 266 EIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQ 325
           +I+    +F    ++G G FG V+      +    AIK L+ +     ++   E  M+ +
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEK 68
Query: 326 ------LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY--HSDNPPLPWNQRLEIC 377
                   H  L  +         +  V +++  G L  H+   H  +         EI 
Sbjct: 69  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128
Query: 378 IGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT----- 432
           +G    L +LH+      I++RD+K  NILLD+    K++DFG+ K      +KT     
Sbjct: 129 LG----LQFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCG 180
Query: 433 ---HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
              ++ PE    Q+     D +SFGV+L+E+L  +
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   F   +   VA+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
               R +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ D GL++     ++  ++   +YR  ++       
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTG-YVATRWYRAPEIMLNWMHY 200
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  R
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 92/217 (42%), Gaps = 26/217 (11%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLS 324
           S   A  ++F    VIG G FG V            A+K L+   ++  L+ + E  ++S
Sbjct: 31  SNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ---KKAILKKKEEKHIMS 87
Query: 325 Q-------LRHLHLVSL-IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEI 376
           +       ++H  LV L   F   D+ +  V D++  G L  HL        P  +    
Sbjct: 88  ERNVLLKNVKHPFLVGLHFSFQTADK-LYFVLDYINGGELFYHLQRERCFLEPRARFYAA 146
Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT---- 432
            I +A G  YLH+      I++RD+K  NILLD +    ++DFGL K      S T    
Sbjct: 147 EIASALG--YLHS----LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC 200
Query: 433 ----HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +L PE    Q      D +  G VL+E+L   P
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 303 KRLEPESQQGAL--EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL 360
           KR    S++G    + + E+ +L +++H ++++L     +  ++IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL 105
Query: 361 YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV----AKV 416
             ++   L   +  E       G++YLH+      I H D+K  NI+L ++ V     K+
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLHS----LQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 417 SDFGLS-------KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILR 469
            DFGL+       +F     +   + PE    + L  ++D++S GV+ + +L      L 
Sbjct: 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL- 218
Query: 470 TAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSD 517
               KQ +LA  +   Y      +  D +    S L  + IRR  + D
Sbjct: 219 -GDTKQETLANVSAVNY------EFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/76 (39%), Positives = 44/76 (57%), Gaps = 9/76 (11%)
Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSVSKT------HLDPEYYRLQQLTEK 447
           ++HRD+K  N+ LD K   K+ DFGL++     TS +KT      ++ PE        EK
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK 196
Query: 448 SDVYSFGVVLFEVLCA 463
           SD++S G +L+E LCA
Sbjct: 197 SDIWSLGCLLYE-LCA 211

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 114/261 (43%), Gaps = 31/261 (11%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIK----RLEPESQQGAL--EFQTEIGMLSQLR 327
           +D    +G G F  V K     +    A K    R    S++G    + + E+ +L +++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
           H ++++L     +  ++IL+ + +A G L D L  ++   L   +  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWV----AKVSDFGLS-------KFGPTSVSKTHLDP 436
           H+      I H D+K  NI+L ++ V     K+ DFGL+       +F     +   + P
Sbjct: 131 HS----LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVD 496
           E    + L  ++D++S GV+ + +L      L     KQ +LA  +   Y      +  D
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETLANVSAVNY------EFED 238
Query: 497 PFLKAMSCLNDEGIRRPSMSD 517
            +    S L  + IRR  + D
Sbjct: 239 EYFSNTSALAKDFIRRLLVKD 259

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 27/202 (13%)
Query: 280 IGVGGFGDVYKG-------FINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           +G G F  ++KG       +     T V +K L+   +  +  F     M+S+L H HLV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNP-PLPWNQRLEICIGAARGLHYLHTGA 391
              G C    E ILV +F+  G+L  +L  + N   + W  +LE+    A  +H+L    
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEENT 133
Query: 392 NHAVIIHRDVKTTNILL----DEKW----VAKVSDFGLS-KFGPTSVSKTHL---DPEYY 439
               +IH +V   NILL    D K       K+SD G+S    P  + +  +    PE  
Sbjct: 134 ----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECI 189
Query: 440 R-LQQLTEKSDVYSFGVVLFEV 460
              + L   +D +SFG  L+E+
Sbjct: 190 ENPKNLNLATDKWSFGTTLWEI 211

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 103/237 (43%), Gaps = 25/237 (10%)
Query: 246 TKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL 305
           T S+    L S  C        +   ++ +  + +G G +G V K     S   +A+KR+
Sbjct: 25  TSSTPPRDLDSKACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI 84
Query: 306 EP---ESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYH 362
                  +Q  L    +I M + +     V+  G    + ++ +  + M   T  D  Y 
Sbjct: 85  RATVNSQEQKRLLMDLDISMRT-VDCPFTVTFYGALFREGDVWICMELM--DTSLDKFYK 141
Query: 363 S---DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDF 419
                   +P +   +I +   + L +LH+  +   +IHRDVK +N+L++     K+ DF
Sbjct: 142 QVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDF 198
Query: 420 GLSKFGPTSVSKT------------HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           G+S +   SV+KT             ++PE  + +  + KSD++S G+ + E+   R
Sbjct: 199 GISGYLVDSVAKTIDAGCKPYMAPERINPELNQ-KGYSVKSDIWSLGITMIELAILR 254

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEF-QTEIGMLS 324
           +   +NF+   V+G G FG V    +  +    A+K L+ +   Q   +E   TE  +LS
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 325 QLR-HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARG 383
             R H  L  L         +  V +F+  G L  H+  S        +     I +A  
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA-- 136
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------HLD 435
           L +LH       II+RD+K  N+LLD +   K++DFG+ K G  +   T        ++ 
Sbjct: 137 LMFLHDKG----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIA 192
Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCA 463
           PE  +        D ++ GV+L+E+LC 
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 36/209 (17%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+V++G   G    VA+K      ++     +TE+     LRH +++  I    
Sbjct: 16  VGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDM 72
Query: 340 DDR----EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT----GA 391
             R    ++ L+  +   G+L D+L  +    L     L I +  A GL +LH       
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTHLDPEYY 439
               I HRD+K+ NIL+ +     ++D GL+               P   +K ++ PE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV- 188
Query: 440 RLQQLTE--------KSDVYSFGVVLFEV 460
            L +  +        + D+++FG+VL+EV
Sbjct: 189 -LDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHL 329
           +++F    ++G G +G V       +   VAIK++EP +    AL    EI +L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICI-GAARGLHYLH 388
           +++++      D        ++ +  +   L+   +  +  +  ++  I    R +  LH
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTHLDP 436
            G+N   +IHRD+K +N+L++     KV DFGL++             G  S    ++  
Sbjct: 130 -GSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVAT 185
Query: 437 EYYRLQQLTEKS-------DVYSFGVVLFEVLCARP 465
            +YR  ++   S       DV+S G +L E+   RP
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 27/202 (13%)
Query: 280 IGVGGFGDVYKG-------FINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           +G G F  ++KG       +     T V +K L+   +  +  F     M+S+L H HLV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNP-PLPWNQRLEICIGAARGLHYLHTGA 391
              G C    E ILV +F+  G+L  +L  + N   + W  +LE+    A  +H+L    
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEENT 133
Query: 392 NHAVIIHRDVKTTNILL----DEKW----VAKVSDFGLS-KFGPTSVSKTHL---DPEYY 439
               +IH +V   NILL    D K       K+SD G+S    P  + +  +    PE  
Sbjct: 134 ----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECI 189
Query: 440 R-LQQLTEKSDVYSFGVVLFEV 460
              + L   +D +SFG  L+E+
Sbjct: 190 ENPKNLNLATDKWSFGTTLWEI 211

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 24/228 (10%)
Query: 252 SFLPSDLCTQFSLSE-----IQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLE 306
            F+ SD  T+F   +     I    N+F    +IG GGFG+VY      +    A+K L+
Sbjct: 163 KFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD 222
Query: 307 PES---QQG---ALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL 360
            +    +QG   AL  +  + ++S      +V +    +   ++  + D M  G L  HL
Sbjct: 223 KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL 282
Query: 361 YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG 420
             S +                 GL ++H    +  +++RD+K  NILLDE    ++SD G
Sbjct: 283 --SQHGVFSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLG 336
Query: 421 L----SKFGPTSVSKTH--LDPEYYRLQQLTEKS-DVYSFGVVLFEVL 461
           L    SK  P +   TH  + PE  +     + S D +S G +LF++L
Sbjct: 337 LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 24/228 (10%)
Query: 252 SFLPSDLCTQFSLSE-----IQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLE 306
            F+ SD  T+F   +     I    N+F    +IG GGFG+VY      +    A+K L+
Sbjct: 164 KFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD 223
Query: 307 PES---QQG---ALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL 360
            +    +QG   AL  +  + ++S      +V +    +   ++  + D M  G L  HL
Sbjct: 224 KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL 283
Query: 361 YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG 420
             S +                 GL ++H    +  +++RD+K  NILLDE    ++SD G
Sbjct: 284 --SQHGVFSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 421 L----SKFGPTSVSKTH--LDPEYYRLQQLTEKS-DVYSFGVVLFEVL 461
           L    SK  P +   TH  + PE  +     + S D +S G +LF++L
Sbjct: 338 LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 36/210 (17%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            +G G +G+V++G   G    VA+K      ++     +TE+     LRH +++  I   
Sbjct: 44  CVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASD 100
Query: 339 NDDR----EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT----G 390
              R    ++ L+  +   G+L D+L  +    L     L I +  A GL +LH      
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGT 157
Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTHLDPEY 438
                I HRD+K+ NIL+ +     ++D GL+               P   +K ++ PE 
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 217
Query: 439 YRLQQLTE--------KSDVYSFGVVLFEV 460
             L +  +        + D+++FG+VL+EV
Sbjct: 218 --LDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 116/277 (41%), Gaps = 39/277 (14%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGF 337
           V+  GGF  VY+    GS    A+KRL    ++       E+  + +L  H ++V     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 338 CNDDREM-------ILVYDFMARGTLPDHLYHSDNP-PLPWNQRLEICIGAARGLHYLHT 389
            +  +E         L+   + +G L + L   ++  PL  +  L+I     R + ++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFG----LSKFGPTS----------------V 429
                 IIHRD+K  N+LL  +   K+ DFG    +S +   S                 
Sbjct: 155 --QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 430 SKTHLDPEYYRLQQ---LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCY 486
           +  +  PE   L     + EK D+++ G +L+ +LC R       AK ++    ++    
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILY-LLCFRQHPFEDGAKLRIVNGKYS--IP 269
Query: 487 QNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLE 523
            + T   +    ++AM  +N E   R S+++VV  L+
Sbjct: 270 PHDTQYTVFHSLIRAMLQVNPE--ERLSIAEVVHQLQ 304

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 36/209 (17%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           +G G +G+V++G   G    VA+K      ++     +TE+     LRH +++  I    
Sbjct: 16  VGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDM 72
Query: 340 DDR----EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT----GA 391
             R    ++ L+  +   G+L D+L  +    L     L I +  A GL +LH       
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTHLDPEYY 439
               I HRD+K+ NIL+ +     ++D GL+               P   +K ++ PE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV- 188
Query: 440 RLQQLTE--------KSDVYSFGVVLFEV 460
            L +  +        + D+++FG+VL+EV
Sbjct: 189 -LDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 24/228 (10%)
Query: 252 SFLPSDLCTQFSLSE-----IQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLE 306
            F+ SD  T+F   +     I    N+F    +IG GGFG+VY      +    A+K L+
Sbjct: 164 KFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD 223
Query: 307 PES---QQG---ALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL 360
            +    +QG   AL  +  + ++S      +V +    +   ++  + D M  G L  HL
Sbjct: 224 KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL 283
Query: 361 YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG 420
             S +                 GL ++H    +  +++RD+K  NILLDE    ++SD G
Sbjct: 284 --SQHGVFSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 421 L----SKFGPTSVSKTH--LDPEYYRLQQLTEKS-DVYSFGVVLFEVL 461
           L    SK  P +   TH  + PE  +     + S D +S G +LF++L
Sbjct: 338 LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 24/228 (10%)
Query: 252 SFLPSDLCTQFSLSE-----IQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLE 306
            F+ SD  T+F   +     I    N+F    +IG GGFG+VY      +    A+K L+
Sbjct: 164 KFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD 223
Query: 307 PES---QQG---ALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL 360
            +    +QG   AL  +  + ++S      +V +    +   ++  + D M  G L  HL
Sbjct: 224 KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL 283
Query: 361 YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG 420
             S +                 GL ++H    +  +++RD+K  NILLDE    ++SD G
Sbjct: 284 --SQHGVFSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 421 L----SKFGPTSVSKTH--LDPEYYRLQQLTEKS-DVYSFGVVLFEVL 461
           L    SK  P +   TH  + PE  +     + S D +S G +LF++L
Sbjct: 338 LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 41/215 (19%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRL---EPESQQGALEFQTEIGMLSQLRHLHLVSL-- 334
           +G GG G V+    N     VAIK++   +P+S + AL    EI ++ +L H ++V +  
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR---EIKIIRRLDHDNIVKVFE 75
Query: 335 ------------IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR 382
                       +G   +   + +V ++M    L + L     P L  + RL       R
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVL--EQGPLLEEHARL-FMYQLLR 131
Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK-FGPTSVSKTHLDP---- 436
           GL Y+H+    A ++HRD+K  N+ ++ E  V K+ DFGL++   P    K HL      
Sbjct: 132 GLKYIHS----ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 437 EYYRLQQL-------TEKSDVYSFGVVLFEVLCAR 464
           ++YR  +L       T+  D+++ G +  E+L  +
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSL--IGF 337
           +G G +G VYK               + E    ++    EI +L +L+H +++SL  +  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 338 CNDDREMILVYDFMARGTLPDHLYH----SDNPP--LPWNQRLEICIGAARGLHYLHTGA 391
            + DR++ L++D+          +H    ++  P  LP      +      G+HYLH   
Sbjct: 89  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 148
Query: 392 NHAVIIHRDVKTTNILL----DEKWVAKVSDFGLSK-FGPTSVSKTHLDPE----YYRLQ 442
               ++HRD+K  NIL+     E+   K++D G ++ F         LDP     +YR  
Sbjct: 149 ----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 443 QL-------TEKSDVYSFGVVLFEVLCARP 465
           +L       T+  D+++ G +  E+L + P
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEP 234

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQL-RH 328
           +FD   VIG G +  V    +  +    A++ ++ E     +     QTE  +  Q   H
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
             LV L      +  +  V +++  G L  H+      P    +     I  A  L+YLH
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLH 170
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--PTSVSKT------HLDPEYYR 440
                  II+RD+K  N+LLD +   K++D+G+ K G  P   + T      ++ PE  R
Sbjct: 171 ERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 226
Query: 441 LQQLTEKSDVYSFGVVLFEVLCAR 464
            +      D ++ GV++FE++  R
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 20/153 (13%)
Query: 319 EIGMLSQLRHLHLVSLIGFCNDDRE--MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEI 376
           EI +L +L H ++V L+   +D  E  + +V++ + +G +   +      PL  +Q    
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSEDQARFY 142
Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS---KFGPTSVSKTH 433
                +G+ YLH    +  IIHRD+K +N+L+ E    K++DFG+S   K     +S T 
Sbjct: 143 FQDLIKGIEYLH----YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV 198
Query: 434 LDPEYYRLQQLTEKS--------DVYSFGVVLF 458
             P +   + L+E          DV++ GV L+
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 43/227 (18%)
Query: 264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIG 321
           + E +   + +    ++G GGFG VY G       PVAIK +E +  S  G L   T + 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 322 M-LSQLRHLH-----LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSD 364
           M +  L+ +      ++ L+ +       +L+          +DF+  RG L + L  S 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS- 119
Query: 365 NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK 423
                W Q LE    A R  H       +  ++HRD+K  NIL+D  +   K+ DFG   
Sbjct: 120 ---FFW-QVLE----AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGA 164
Query: 424 FGPTSV------SKTHLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
               +V      ++ +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 165 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 95/241 (39%), Gaps = 56/241 (23%)
Query: 250 RGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE- 308
           R   LP+  C  + + E             +G GGFG V +     +   VAIK+   E 
Sbjct: 5   RSPSLPTQTCGPWEMKE------------RLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL 52
Query: 309 SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREM------ILVYDFMARGTLPDHLYH 362
           S +    +  EI ++ +L H ++VS     +  +++      +L  ++   G L  +L  
Sbjct: 53  SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ 112
Query: 363 SDNPPLPWNQRLEICIGAARG------------LHYLHTGANHAVIIHRDVKTTNILLD- 409
            +N           C G   G            L YLH       IIHRD+K  NI+L  
Sbjct: 113 FEN-----------CCGLKEGPIRTLLSDISSALRYLHENR----IIHRDLKPENIVLQP 157
Query: 410 --EKWVAKVSDFGLSKFGPTSVSKT-------HLDPEYYRLQQLTEKSDVYSFGVVLFEV 460
             ++ + K+ D G +K        T       +L PE    ++ T   D +SFG + FE 
Sbjct: 158 GPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFEC 217
Query: 461 L 461
           +
Sbjct: 218 I 218

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 95/241 (39%), Gaps = 56/241 (23%)
Query: 250 RGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE- 308
           R   LP+  C  + + E             +G GGFG V +     +   VAIK+   E 
Sbjct: 4   RSPSLPTQTCGPWEMKE------------RLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL 51
Query: 309 SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREM------ILVYDFMARGTLPDHLYH 362
           S +    +  EI ++ +L H ++VS     +  +++      +L  ++   G L  +L  
Sbjct: 52  SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ 111
Query: 363 SDNPPLPWNQRLEICIGAARG------------LHYLHTGANHAVIIHRDVKTTNILLD- 409
            +N           C G   G            L YLH       IIHRD+K  NI+L  
Sbjct: 112 FEN-----------CCGLKEGPIRTLLSDISSALRYLHENR----IIHRDLKPENIVLQP 156
Query: 410 --EKWVAKVSDFGLSKFGPTSVSKT-------HLDPEYYRLQQLTEKSDVYSFGVVLFEV 460
             ++ + K+ D G +K        T       +L PE    ++ T   D +SFG + FE 
Sbjct: 157 GPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFEC 216
Query: 461 L 461
           +
Sbjct: 217 I 217

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 267 IQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK---RLEPESQQGALEFQTEIGML 323
           +Q    ++D   VIG G FG+V       S    A+K   + E   +  +  F  E  ++
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 324 SQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARG 383
           +      +V L     DD+ + +V ++M  G L + + + D P   W +     +  A  
Sbjct: 130 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAKFYTAEVVLA-- 186
Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS-KFGPTSV--------SKTHL 434
           L  +H+      +IHRDVK  N+LLD+    K++DFG   K   T +        +  ++
Sbjct: 187 LDAIHSMG----LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYI 242
Query: 435 DPEYYRLQ----QLTEKSDVYSFGVVLFEVLCA 463
            PE  + Q        + D +S GV LFE+L  
Sbjct: 243 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 43/227 (18%)
Query: 264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIG 321
           + E +   + +    ++G GGFG VY G       PVAIK +E +  S  G L   T + 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 322 M-LSQLRHLH-----LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSD 364
           M +  L+ +      ++ L+ +       +L+          +DF+  RG L + L  S 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS- 119
Query: 365 NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK 423
                W Q LE    A R  H       +  ++HRD+K  NIL+D  +   K+ DFG   
Sbjct: 120 ---FFW-QVLE----AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGA 164
Query: 424 FGPTSV------SKTHLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
               +V      ++ +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 165 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 28/206 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G +G V       +   VAIK++    +    A     E+ +L   +H +++++   
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 338 CN------DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
                   + + + +V D M        + HS  P L             RGL Y+H+  
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMESDL--HQIIHSSQP-LTLEHVRYFLYQLLRGLKYMHS-- 177
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSK------THLDPEYYR----- 440
             A +IHRD+K +N+L++E    K+ DFG+++   TS ++       ++   +YR     
Sbjct: 178 --AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 235
Query: 441 --LQQLTEKSDVYSFGVVLFEVLCAR 464
             L + T+  D++S G +  E+L  R
Sbjct: 236 LSLHEYTQAIDLWSVGCIFGEMLARR 261

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 43/227 (18%)
Query: 264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIG 321
           + E +   + +    ++G GGFG VY G       PVAIK +E +  S  G L   T + 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 322 M-LSQLRHLH-----LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSD 364
           M +  L+ +      ++ L+ +       +L+          +DF+  RG L + L  S 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS- 119
Query: 365 NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK 423
                W Q LE    A R  H       +  ++HRD+K  NIL+D  +   K+ DFG   
Sbjct: 120 ---FFW-QVLE----AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGA 164
Query: 424 FGPTSV------SKTHLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
               +V      ++ +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 165 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   +   S   +A+K+L    Q    A     E+ +L  ++H +++ L+  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLHYLHTGA 391
                 +    D      L  HL  +D   +   Q+L       +     RGL Y+H+  
Sbjct: 119 FTPATSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 172
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    K+ DFGL++     ++  ++   +YR  ++       
Sbjct: 173 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-YVATRWYRAPEIMLNWMHY 229
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
               D++S G ++ E+L  R
Sbjct: 230 NMTVDIWSVGCIMAELLTGR 249

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 140
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 141 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 193
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 194 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 141
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 142 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 194
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 153
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 154 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 206
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 140
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 141 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 193
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 194 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 43/76 (56%), Gaps = 9/76 (11%)
Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSVSKT------HLDPEYYRLQQLTEK 447
           ++HRD+K  N+ LD K   K+ DFGL++     TS +K       ++ PE        EK
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK 196
Query: 448 SDVYSFGVVLFEVLCA 463
           SD++S G +L+E LCA
Sbjct: 197 SDIWSLGCLLYE-LCA 211

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 154
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 155 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 207
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 28/206 (13%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G +G V       +   VAIK++    +    A     E+ +L   +H +++++   
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 338 CN------DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
                   + + + +V D M        + HS  P L             RGL Y+H+  
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESDL--HQIIHSSQP-LTLEHVRYFLYQLLRGLKYMHS-- 176
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSK------THLDPEYYR----- 440
             A +IHRD+K +N+L++E    K+ DFG+++   TS ++       ++   +YR     
Sbjct: 177 --AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 234
Query: 441 --LQQLTEKSDVYSFGVVLFEVLCAR 464
             L + T+  D++S G +  E+L  R
Sbjct: 235 LSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 141
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 142 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 194
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 154
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 155 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 207
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 24/213 (11%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVY--KGFINGSTTPVAI---KRLEPESQQGALEFQTE 319
           S+ Q    N+     IG G F  V   +  + G    + I    +L P S Q       E
Sbjct: 5   SDEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR---E 61
Query: 320 IGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICI 378
           + ++  L H ++V L      ++ + L+ ++ + G + D+L  H          +    +
Sbjct: 62  VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 121
Query: 379 GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS-------KFGPTSVSK 431
            A +  H          I+HRD+K  N+LLD     K++DFG S       K      S 
Sbjct: 122 SAVQYCH-------QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSP 174
Query: 432 THLDPEYYRLQQLT-EKSDVYSFGVVLFEVLCA 463
            +  PE ++ ++    + DV+S GV+L+ ++  
Sbjct: 175 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 141
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 142 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 194
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 154
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 155 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 207
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 153
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 154 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 206
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 168
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 169 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 221
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 75  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 125
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 126 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 178
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 153
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 154 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 206
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 154
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 155 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 207
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 153
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 154 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 206
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQL-RH 328
           +FD   VIG G +  V    +  +    A+K ++ E     +     QTE  +  Q   H
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 80
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
             LV L      +  +  V +++  G L  H+      P    +     I  A  L+YLH
Sbjct: 81  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLH 138
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------HLDPEYYR 440
                  II+RD+K  N+LLD +   K++D+G+ K G      T        ++ PE  R
Sbjct: 139 ERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 194
Query: 441 LQQLTEKSDVYSFGVVLFEVLCAR 464
            +      D ++ GV++FE++  R
Sbjct: 195 GEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 125
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 126 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 178
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 25/216 (11%)
Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHL 329
           +++F    ++G G +G V       +   VAIK++EP +    AL    EI +L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICI-GAARGLHYLH 388
           +++++      D        ++ +  +   L+   +  +  +  ++  I    R +  LH
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTHLDP 436
            G+N   +IHRD+K +N+L++     KV DFGL++             G  S     +  
Sbjct: 130 -GSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVAT 185
Query: 437 EYYRLQQLTEKS-------DVYSFGVVLFEVLCARP 465
            +YR  ++   S       DV+S G +L E+   RP
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 168
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 169 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 221
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 43/227 (18%)
Query: 264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIG 321
           + E +   + +    ++G GGFG VY G       PVAIK +E +  S  G L   T + 
Sbjct: 23  MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 82
Query: 322 M-LSQLRHLH-----LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSD 364
           M +  L+ +      ++ L+ +       +L+          +DF+  RG L + L  S 
Sbjct: 83  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS- 141
Query: 365 NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK 423
                W Q LE    A R  H       +  ++HRD+K  NIL+D  +   K+ DFG   
Sbjct: 142 ---FFW-QVLE----AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGA 186
Query: 424 FGPTSV------SKTHLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
               +V      ++ +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 187 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 160
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 161 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 213
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 14/105 (13%)
Query: 367 PLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS---- 422
           P+     +      ARG+ +L +       IHRD+   NILL E  V K+ DFGL+    
Sbjct: 195 PITMEDLISYSFQVARGMEFLSSRK----CIHRDLAARNILLSENNVVKICDFGLARDIY 250
Query: 423 ------KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
                 + G T +    + PE    +  + KSDV+S+GV+L+E+ 
Sbjct: 251 KNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIF 295

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 150 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 205
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +  ++ SD+++ G ++++++   P
Sbjct: 206 LTEKSASKSSDLWALGCIIYQLVAGLP 232

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 20/225 (8%)
Query: 254 LPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQ 311
           +PS+   Q S +  +    +F+  +V+G G FG V      G+    AIK L+ +   Q 
Sbjct: 1   MPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQD 60
Query: 312 GALEF-QTEIGMLSQLRHLHLVSLIGFCND--DREMILVYDFMARGTLPDHLYHSDNPPL 368
             +E    E  +L+ L     ++ +  C    DR +  V +++  G L  H+        
Sbjct: 61  DDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDR-LYFVMEYVNGGDLMYHIQQVGKFKE 119
Query: 369 PWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---- 424
           P  Q +      + GL +LH       II+RD+K  N++LD +   K++DFG+ K     
Sbjct: 120 P--QAVFYAAEISIGLFFLHKRG----IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMD 173
Query: 425 GPTSV----SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           G T+     +  ++ PE    Q   +  D +++GV+L+E+L  +P
Sbjct: 174 GVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 218

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 123 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 173
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 174 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 226
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 227 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 121
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 122 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 174
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 74  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 124
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 125 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 177
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 178 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 121
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 122 AVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 174
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQL-R 327
            +FD   VIG G +  V    +  +    A+K ++ E     +     QTE  +  Q   
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
           H  LV L      +  +  V +++  G L  H+      P    +     I  A  L+YL
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYL 122
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------HLDPEYY 439
           H       II+RD+K  N+LLD +   K++D+G+ K G      T        ++ PE  
Sbjct: 123 HERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL 178
Query: 440 RLQQLTEKSDVYSFGVVLFEVLCAR 464
           R +      D ++ GV++FE++  R
Sbjct: 179 RGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 89/197 (45%), Gaps = 24/197 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G  G V   F       VA+K+L    ++Q  A     E+ +L  + H +++SL+  
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 338 ------CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
                   + +++ LV + M            D+  + +     +C     G+ +LH+  
Sbjct: 90  FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHSAG 144
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-HLDPEYYRLQQLT----- 445
               IIHRD+K +NI++      K+ DFGL++   T+   T ++   YYR  ++      
Sbjct: 145 ----IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGY 200
Query: 446 -EKSDVYSFGVVLFEVL 461
            E  D++S G ++ E++
Sbjct: 201 KENVDIWSVGCIMGELV 217

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 30/203 (14%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G  G V   +       VAIK+L    ++Q  A     E+ ++  + H +++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 338 ------CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
                   + +++ +V + M            D+  + +     +C     G+ +LH+  
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG 146
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE----YYRLQQLT-- 445
               IIHRD+K +NI++      K+ DFGL++   TS     ++PE    YYR  ++   
Sbjct: 147 ----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MEPEVVTRYYRAPEVILG 199
Query: 446 ----EKSDVYSFGVVLFEVLCAR 464
               E  D++S G ++ E++C +
Sbjct: 200 MGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQL-RH 328
           +FD   VIG G +  V    +  +    A+K ++ E     +     QTE  +  Q   H
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
             LV L      +  +  V +++  G L  H+      P    +     I  A  L+YLH
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLH 127
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--------HLDPEYYR 440
                  II+RD+K  N+LLD +   K++D+G+ K G      T        ++ PE  R
Sbjct: 128 ERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 183
Query: 441 LQQLTEKSDVYSFGVVLFEVLCAR 464
            +      D ++ GV++FE++  R
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 18/220 (8%)
Query: 256 SDLCTQFSLSEIQAAT----NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ES 309
           S +  QF   E+  +T      + N   IG G  G V   +       VAIK+L    ++
Sbjct: 4   SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 63
Query: 310 QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD-FMARGTLPDHLYHSDNPPL 368
           Q  A     E+ ++  + H +++SL+      + +    D ++    +  +L       L
Sbjct: 64  QTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMEL 123
Query: 369 PWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS 428
              +   +      G+ +LH+      IIHRD+K +NI++      K+ DFGL++   TS
Sbjct: 124 DHERMSYLLYQMLXGIKHLHSAG----IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 179
Query: 429 VSKT-HLDPEYYRLQQLT------EKSDVYSFGVVLFEVL 461
              T ++   YYR  ++       E  D++S G ++ E++
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 99/225 (44%), Gaps = 28/225 (12%)
Query: 256 SDLCTQFSLSEIQAAT----NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ES 309
           S +  QF   E+  +T      + N   IG G  G V   +       VAIK+L    ++
Sbjct: 4   SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 63
Query: 310 QQGALEFQTEIGMLSQLRHLHLVSLIGF------CNDDREMILVYDFMARGTLPDHLYHS 363
           Q  A     E+ ++  + H +++SL+          + +++ LV + M            
Sbjct: 64  QTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 123
Query: 364 DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
           D+  + +     +C     G+ +LH+      IIHRD+K +NI++      K+ DFGL++
Sbjct: 124 DHERMSYLLYQMLC-----GIKHLHSAG----IIHRDLKPSNIVVKSDXTLKILDFGLAR 174
Query: 424 FGPTSVSKT-HLDPEYYRLQQLT------EKSDVYSFGVVLFEVL 461
              TS   T ++   YYR  ++       E  D++S G ++ E++
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 86/195 (44%), Gaps = 14/195 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G  G V   +       VAIK+L    ++Q  A     E+ ++  + H +++ L+  
Sbjct: 26  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 85
Query: 338 CNDDREMILVYDFMARGTLPD-HLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               + +    D      L D +L       L   +   +      G+ +LH+      I
Sbjct: 86  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG----I 141
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-HLDPEYYRLQQLT------EKSD 449
           IHRD+K +NI++      K+ DFGL++   TS   T ++   YYR  ++       E  D
Sbjct: 142 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 201
Query: 450 VYSFGVVLFEVLCAR 464
           ++S G ++ E++C +
Sbjct: 202 LWSVGCIMGEMVCHK 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 14/201 (6%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHL 331
           + N   IG G  G V   +       VAIK+L    ++Q  A     E+ ++  + H ++
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 90
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPD-HLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           + L+      + +    D      L D +L       L   +   +      G+ +LH+ 
Sbjct: 91  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 150
Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-HLDPEYYRLQQLT---- 445
                IIHRD+K +NI++      K+ DFGL++   TS   T ++   YYR  ++     
Sbjct: 151 G----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 206
Query: 446 --EKSDVYSFGVVLFEVLCAR 464
             E  D++S G ++ E++C +
Sbjct: 207 YKENVDLWSVGCIMGEMVCHK 227

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 24/213 (11%)
Query: 263 SLSEIQAATNNFDNDLVIGVGGFGDVY--KGFINGSTTPVAI---KRLEPESQQGALEFQ 317
           S ++ Q    N+     IG G F  V   +  + G    + I    +L P S Q      
Sbjct: 6   SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-- 63
Query: 318 TEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEI 376
            E+ ++  L H ++V L      ++ + L+ ++ + G + D+L  H          +   
Sbjct: 64  -EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ 122
Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS-------KFGPTSV 429
            + A +  H          I+HRD+K  N+LLD     K++DFG S       K      
Sbjct: 123 IVSAVQYCH-------QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCG 175
Query: 430 SKTHLDPEYYRLQQLT-EKSDVYSFGVVLFEVL 461
           +  +  PE ++ ++    + DV+S GV+L+ ++
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 208

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 25/216 (11%)
Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHL 329
           +++F    ++G G +G V       +   VAIK++EP +    AL    EI +L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICI-GAARGLHYLH 388
           +++++      D        ++ +  +   L+   +  +  +  ++  I    R +  LH
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------------GPTSVSKTHLDP 436
            G+N   +IHRD+K +N+L++     KV DFGL++             G  S     +  
Sbjct: 130 -GSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 437 EYYRLQQLTEKS-------DVYSFGVVLFEVLCARP 465
            +YR  ++   S       DV+S G +L E+   RP
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 99/225 (44%), Gaps = 28/225 (12%)
Query: 256 SDLCTQFSLSEIQAAT----NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ES 309
           S +  QF   E+  +T      + N   IG G  G V   +       VAIK+L    ++
Sbjct: 4   SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 63
Query: 310 QQGALEFQTEIGMLSQLRHLHLVSLIGF------CNDDREMILVYDFMARGTLPDHLYHS 363
           Q  A     E+ ++  + H +++SL+          + +++ LV + M            
Sbjct: 64  QTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMEL 123
Query: 364 DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
           D+  + +     +C     G+ +LH+      IIHRD+K +NI++      K+ DFGL++
Sbjct: 124 DHERMSYLLYQMLC-----GIKHLHSAG----IIHRDLKPSNIVVKSDXTLKILDFGLAR 174
Query: 424 FGPTSVSKT-HLDPEYYRLQQLT------EKSDVYSFGVVLFEVL 461
              TS   T ++   YYR  ++       E  D++S G ++ E++
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 88/197 (44%), Gaps = 24/197 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G  G V   +       VAIK+L    ++Q  A     E+ ++  + H +++SL+  
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 338 CNDDR------EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
               +      ++ LV + M            D+  + +     +C     G+ +LH+  
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG 184
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-HLDPEYYRLQQL------ 444
               IIHRD+K +NI++      K+ DFGL++   TS   T ++   YYR  ++      
Sbjct: 185 ----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 240
Query: 445 TEKSDVYSFGVVLFEVL 461
            E  D++S G ++ E++
Sbjct: 241 KENVDIWSVGCIMGEMV 257

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGM-LSQLRHLH----- 330
           ++G GGFG VY G       PVAIK +E +  S  G L   T + M +  L+ +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L  S      W Q LE    
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 121
Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSV------SKT 432
           A R  H       +  ++HRD+K  NIL+D  +   K+ DFG       +V      ++ 
Sbjct: 122 AVRHCH-------NXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 174
Query: 433 HLDPEYYRLQQLTEKS-DVYSFGVVLFEVLCA 463
           +  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 154
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 155 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 210
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 211 LTEKSACKSSDLWALGCIIYQLVAGLP 237

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 147
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 148 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPEL 203
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 125
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 126 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 181
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLP 208

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 124
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 125 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 180
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 181 LTEKSACKSSDLWALGCIIYQLVAGLP 207

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 150
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 151 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 206
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLP 233

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 150 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 81/195 (41%), Gaps = 18/195 (9%)
Query: 280 IGVGGFGDVY--KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G F  V   +  + G    V I      +     +   E+ ++  L H ++V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 338 CNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
              ++ + LV ++ + G + D+L  H          +    + A +  H          I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-------QKFI 134
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLS-------KFGPTSVSKTHLDPEYYRLQQLT-EKS 448
           +HRD+K  N+LLD     K++DFG S       K      S  +  PE ++ ++    + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEV 194
Query: 449 DVYSFGVVLFEVLCA 463
           DV+S GV+L+ ++  
Sbjct: 195 DVWSLGVILYTLVSG 209

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 150
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 151 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 206
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLP 233

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 147
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 148 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 150 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 152
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 153 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 208
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 209 LTEKSACKSSDLWALGCIIYQLVAGLP 235

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 127
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 128 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 183
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 184 LTEKSACKSSDLWALGCIIYQLVAGLP 210

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 150 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 147
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 148 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 81/195 (41%), Gaps = 18/195 (9%)
Query: 280 IGVGGFGDVY--KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G F  V   +  + G    V I      +     +   E+ ++  L H ++V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 338 CNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
              ++ + LV ++ + G + D+L  H          +    + A +  H          I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-------QKFI 134
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLS-------KFGPTSVSKTHLDPEYYRLQQLT-EKS 448
           +HRD+K  N+LLD     K++DFG S       K      S  +  PE ++ ++    + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEV 194
Query: 449 DVYSFGVVLFEVLCA 463
           DV+S GV+L+ ++  
Sbjct: 195 DVWSLGVILYTLVSG 209

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 126
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 127 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 182
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 183 LTEKSACKSSDLWALGCIIYQLVAGLP 209

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 28/225 (12%)
Query: 256 SDLCTQFSLSEIQAAT----NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ES 309
           S +  QF   E+  +T      + N   IG G  G V   +       VAIK+L    ++
Sbjct: 4   SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 63
Query: 310 QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR------EMILVYDFMARGTLPDHLYHS 363
           Q  A     E+ ++  + H +++SL+      +      ++ LV + M            
Sbjct: 64  QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 123
Query: 364 DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
           D+  + +     +C     G+ +LH+      IIHRD+K +NI++      K+ DFGL++
Sbjct: 124 DHERMSYLLYQMLC-----GIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 424 FGPTSVSKT-HLDPEYYRLQQLT------EKSDVYSFGVVLFEVL 461
              TS   T ++   YYR  ++       E  D++S G ++ E++
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 28/225 (12%)
Query: 256 SDLCTQFSLSEIQAAT----NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ES 309
           S +  QF   E+  +T      + N   IG G  G V   +       VAIK+L    ++
Sbjct: 3   SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 62
Query: 310 QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR------EMILVYDFMARGTLPDHLYHS 363
           Q  A     E+ ++  + H +++SL+      +      ++ LV + M            
Sbjct: 63  QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 122
Query: 364 DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
           D+  + +     +C     G+ +LH+      IIHRD+K +NI++      K+ DFGL++
Sbjct: 123 DHERMSYLLYQMLC-----GIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLAR 173
Query: 424 FGPTSVSKT-HLDPEYYRLQQLT------EKSDVYSFGVVLFEVL 461
              TS   T ++   YYR  ++       E  D++S G ++ E++
Sbjct: 174 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 28/225 (12%)
Query: 256 SDLCTQFSLSEIQAAT----NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ES 309
           S +  QF   E+  +T      + N   IG G  G V   +       VAIK+L    ++
Sbjct: 5   SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 64
Query: 310 QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR------EMILVYDFMARGTLPDHLYHS 363
           Q  A     E+ ++  + H +++SL+      +      ++ LV + M            
Sbjct: 65  QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 124
Query: 364 DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
           D+  + +     +C     G+ +LH+      IIHRD+K +NI++      K+ DFGL++
Sbjct: 125 DHERMSYLLYQMLC-----GIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLAR 175
Query: 424 FGPTSVSKT-HLDPEYYRLQQLT------EKSDVYSFGVVLFEVL 461
              TS   T ++   YYR  ++       E  D++S G ++ E++
Sbjct: 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 150 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 28/225 (12%)
Query: 256 SDLCTQFSLSEIQAAT----NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ES 309
           S +  QF   E+  +T      + N   IG G  G V   +       VAIK+L    ++
Sbjct: 42  SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 101
Query: 310 QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR------EMILVYDFMARGTLPDHLYHS 363
           Q  A     E+ ++  + H +++SL+      +      ++ LV + M            
Sbjct: 102 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 161
Query: 364 DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
           D+  + +     +C     G+ +LH+      IIHRD+K +NI++      K+ DFGL++
Sbjct: 162 DHERMSYLLYQMLC-----GIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLAR 212
Query: 424 FGPTSVSKT-HLDPEYYRLQQLT------EKSDVYSFGVVLFEVL 461
              TS   T ++   YYR  ++       E  D++S G ++ E++
Sbjct: 213 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 150 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 206 LTEKSAXKSSDLWALGCIIYQLVAGLP 232

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 28/225 (12%)
Query: 256 SDLCTQFSLSEIQAAT----NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ES 309
           S +  QF   E+  +T      + N   IG G  G V   +       VAIK+L    ++
Sbjct: 5   SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 64
Query: 310 QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR------EMILVYDFMARGTLPDHLYHS 363
           Q  A     E+ ++  + H +++SL+      +      ++ LV + M            
Sbjct: 65  QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 124
Query: 364 DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
           D+  + +     +C     G+ +LH+      IIHRD+K +NI++      K+ DFGL++
Sbjct: 125 DHERMSYLLYQMLC-----GIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLAR 175
Query: 424 FGPTSVSKT-HLDPEYYRLQQLT------EKSDVYSFGVVLFEVL 461
              TS   T ++   YYR  ++       E  D++S G ++ E++
Sbjct: 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/195 (22%), Positives = 87/195 (44%), Gaps = 15/195 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V       S   VAIK+L    +S+  A     E+ +L  ++H +++ L+  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 338 CNDDREMILVYDF-MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
                 +   YDF +    +   L           +   +     +GL Y+H+    A +
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS----AGV 165
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL-------TEKSD 449
           +HRD+K  N+ ++E    K+ DFGL++     ++  ++   +YR  ++        +  D
Sbjct: 166 VHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-GYVVTRWYRAPEVILSWMHYNQTVD 224
Query: 450 VYSFGVVLFEVLCAR 464
           ++S G ++ E+L  +
Sbjct: 225 IWSVGCIMAEMLTGK 239

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 28/225 (12%)
Query: 256 SDLCTQFSLSEIQAAT----NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ES 309
           S +  QF   E+  +T      + N   IG G  G V   +       VAIK+L    ++
Sbjct: 4   SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 63
Query: 310 QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR------EMILVYDFMARGTLPDHLYHS 363
           Q  A     E+ ++  + H +++SL+      +      ++ LV + M            
Sbjct: 64  QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 123
Query: 364 DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
           D+  + +     +C     G+ +LH+      IIHRD+K +NI++      K+ DFGL++
Sbjct: 124 DHERMSYLLYQMLC-----GIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 424 FGPTSVSKT-HLDPEYYRLQQLT------EKSDVYSFGVVLFEVL 461
              TS   T ++   YYR  ++       E  D++S G ++ E++
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 81/195 (41%), Gaps = 18/195 (9%)
Query: 280 IGVGGFGDVY--KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G F  V   +  + G    V I      +     +   E+ ++  L H ++V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 338 CNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
              ++ + LV ++ + G + D+L  H          +    + A +  H          I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-------QKFI 134
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLS-------KFGPTSVSKTHLDPEYYRLQQLT-EKS 448
           +HRD+K  N+LLD     K++DFG S       K      S  +  PE ++ ++    + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEV 194
Query: 449 DVYSFGVVLFEVLCA 463
           DV+S GV+L+ ++  
Sbjct: 195 DVWSLGVILYTLVSG 209

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 261 QFSLSEIQAAT----NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGAL 314
           QF   E+  +T      + N   IG G  G V   +       VAIK+L    ++Q  A 
Sbjct: 3   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 62
Query: 315 EFQTEIGMLSQLRHLHLVSLIGFCNDDR------EMILVYDFMARGTLPDHLYHSDNPPL 368
               E+ ++  + H +++SL+      +      ++ LV + M            D+  +
Sbjct: 63  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 122
Query: 369 PWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS 428
            +     +C     G+ +LH+      IIHRD+K +NI++      K+ DFGL++   TS
Sbjct: 123 SYLLYQMLC-----GIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 173
Query: 429 VSKT-HLDPEYYRLQQLT------EKSDVYSFGVVLFEVL 461
              T ++   YYR  ++       E  D++S G ++ E++
Sbjct: 174 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 81/195 (41%), Gaps = 18/195 (9%)
Query: 280 IGVGGFGDVY--KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G F  V   +  + G    V I      +     +   E+ ++  L H ++V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 338 CNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
              ++ + LV ++ + G + D+L  H          +    + A +  H          I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-------QKFI 134
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLS-------KFGPTSVSKTHLDPEYYRLQQLT-EKS 448
           +HRD+K  N+LLD     K++DFG S       K      S  +  PE ++ ++    + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEV 194
Query: 449 DVYSFGVVLFEVLCA 463
           DV+S GV+L+ ++  
Sbjct: 195 DVWSLGVILYTLVSG 209

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 30/203 (14%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G  G V   +       VAIK+L    ++Q  A     E+ ++  + H +++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 338 ------CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
                   + +++ +V + M            D+  + +     +C     G+ +LH+  
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG 146
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE----YYRLQQLT-- 445
               IIHRD+K +NI++      K+ DFGL++   TS     ++PE    YYR  ++   
Sbjct: 147 ----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MEPEVVTRYYRAPEVILG 199
Query: 446 ----EKSDVYSFGVVLFEVLCAR 464
               E  D++S G ++ E++C +
Sbjct: 200 MGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 146
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 147 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 202
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAGLP 229

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/195 (21%), Positives = 86/195 (44%), Gaps = 15/195 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V       S   VAIK+L    +S+  A     E+ +L  ++H +++ L+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 338 CNDDREMILVYDF-MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
                 +   YDF +    +   L           +   +     +GL Y+H+      +
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG----V 147
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL-------TEKSD 449
           +HRD+K  N+ ++E    K+ DFGL++     ++  ++   +YR  ++        +  D
Sbjct: 148 VHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-GYVVTRWYRAPEVILSWMHYNQTVD 206
Query: 450 VYSFGVVLFEVLCAR 464
           ++S G ++ E+L  +
Sbjct: 207 IWSVGCIMAEMLTGK 221

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 261 QFSLSEIQAAT----NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGAL 314
           QF   E+  +T      + N   IG G  G V   +       VAIK+L    ++Q  A 
Sbjct: 3   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 62
Query: 315 EFQTEIGMLSQLRHLHLVSLIGFCNDDR------EMILVYDFMARGTLPDHLYHSDNPPL 368
               E+ ++  + H +++SL+      +      ++ LV + M            D+  +
Sbjct: 63  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 122
Query: 369 PWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS 428
            +     +C     G+ +LH+      IIHRD+K +NI++      K+ DFGL++   TS
Sbjct: 123 SYLLYQMLC-----GIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 173
Query: 429 VSKT-HLDPEYYRLQQLT------EKSDVYSFGVVLFEVL 461
              T ++   YYR  ++       E  D++S G ++ E++
Sbjct: 174 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 18/220 (8%)
Query: 256 SDLCTQFSLSEIQAAT----NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ES 309
           S +  QF   E+  +T      + N   IG G  G V   +       VAIK+L    ++
Sbjct: 4   SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 63
Query: 310 QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD-FMARGTLPDHLYHSDNPPL 368
           Q  A     E+ ++  + H +++SL+      + +    D ++    +  +L       L
Sbjct: 64  QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMEL 123
Query: 369 PWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS 428
              +   +      G+ +LH+      IIHRD+K +NI++      K+ DFGL++   TS
Sbjct: 124 DHERMSYLLYQMLXGIKHLHSAG----IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 179
Query: 429 VSKT-HLDPEYYRLQQLT------EKSDVYSFGVVLFEVL 461
              T ++   YYR  ++       E  D++S G ++ E++
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 261 QFSLSEIQAAT----NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGAL 314
           QF   E+  +T      + N   IG G  G V   +       VAIK+L    ++Q  A 
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 315 EFQTEIGMLSQLRHLHLVSLIGFCNDDR------EMILVYDFMARGTLPDHLYHSDNPPL 368
               E+ ++  + H +++SL+      +      ++ LV + M            D+  +
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 121
Query: 369 PWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS 428
            +     +C     G+ +LH+      IIHRD+K +NI++      K+ DFGL++   TS
Sbjct: 122 SYLLYQMLC-----GIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
Query: 429 VSKT-HLDPEYYRLQQLT------EKSDVYSFGVVLFEVL 461
              T ++   YYR  ++       E  D++S G ++ E++
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 14/91 (15%)
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVS 430
           A+G+ +L +       IHRD+   NILL EK V K+ DFGL+          + G   + 
Sbjct: 210 AKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 296

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 146
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 147 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 202
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAGLP 229

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 131
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 132 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 187
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 188 LTEKSACKSSDLWALGCIIYQLVAGLP 214

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 14/91 (15%)
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVS 430
           A+G+ +L +       IHRD+   NILL EK V K+ DFGL+          + G   + 
Sbjct: 208 AKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 294

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 14/91 (15%)
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVS 430
           A+G+ +L +       IHRD+   NILL EK V K+ DFGL+          + G   + 
Sbjct: 201 AKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 287

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 14/91 (15%)
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS----------KFGPTSVS 430
           A+G+ +L +       IHRD+   NILL EK V K+ DFGL+          + G   + 
Sbjct: 203 AKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 39/215 (18%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
           + N  VIG G FG V++  +  S   VAIK++  + +    E Q    ++  ++H ++V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQ----IMRIVKHPNVVD 96
Query: 334 LIGF--CNDDRE----MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICI------GAA 381
           L  F   N D++    + LV ++     +P+ +Y +        Q + + +         
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEY-----VPETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKF---GPTSVSKTHLDPE 437
           R L Y+H+      I HRD+K  N+LLD    V K+ DFG +K    G  +VS   +   
Sbjct: 152 RSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX--ICSR 205
Query: 438 YYRLQQL-------TEKSDVYSFGVVLFEVLCARP 465
           YYR  +L       T   D++S G V+ E++  +P
Sbjct: 206 YYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 94/215 (43%), Gaps = 18/215 (8%)
Query: 261 QFSLSEIQAAT----NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGAL 314
           QF   E+  +T      + N   IG G  G V   +       VAIK+L    ++Q  A 
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 315 EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD-FMARGTLPDHLYHSDNPPLPWNQR 373
               E+ ++  + H +++SL+      + +    D ++    +  +L       L   + 
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERM 121
Query: 374 LEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT- 432
             +      G+ +LH+      IIHRD+K +NI++      K+ DFGL++   TS   T 
Sbjct: 122 SYLLYQMLXGIKHLHSAG----IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTP 177
Query: 433 HLDPEYYRLQQLT------EKSDVYSFGVVLFEVL 461
           ++   YYR  ++       E  D++S G ++ E++
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/195 (22%), Positives = 81/195 (41%), Gaps = 18/195 (9%)
Query: 280 IGVGGFGDVY--KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G F  V   +  + G    V I      +     +   E+ ++  L H ++V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 338 CNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
              ++ + LV ++ + G + D+L  H          +    + A +  H          I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-------QKFI 134
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLS-------KFGPTSVSKTHLDPEYYRLQQLT-EKS 448
           +HRD+K  N+LLD     K++DFG S       K      +  +  PE ++ ++    + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEV 194
Query: 449 DVYSFGVVLFEVLCA 463
           DV+S GV+L+ ++  
Sbjct: 195 DVWSLGVILYTLVSG 209

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 42/76 (55%), Gaps = 9/76 (11%)
Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSK-------FGPTSV-SKTHLDPEYYRLQQLTEK 447
           ++HRD+K  N+ LD K   K+ DFGL++       F    V +  ++ PE        EK
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMSYNEK 196
Query: 448 SDVYSFGVVLFEVLCA 463
           SD++S G +L+E LCA
Sbjct: 197 SDIWSLGCLLYE-LCA 211

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/250 (21%), Positives = 109/250 (43%), Gaps = 19/250 (7%)
Query: 286 GDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR--E 343
           G+++KG   G+   V + ++   S + + +F  E   L    H +++ ++G C       
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKT 403
             L+  +   G+L + L+   N  +  +Q ++  +  ARG  +LHT     +I    + +
Sbjct: 84  PTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTL--EPLIPRHALNS 141
Query: 404 TNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTEK--------SDVYSFGV 455
            ++ +DE   A++S   + KF   S  + +  P +   + L +K        +D +SF V
Sbjct: 142 RSVXIDEDXTARISXADV-KFSFQSPGRXYA-PAWVAPEALQKKPEDTNRRSADXWSFAV 199
Query: 456 VLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS--CLNDEGIRRP 513
           +L+E L  R       +  ++   V  +      TI   + P +  +   C N++  +RP
Sbjct: 200 LLWE-LVTREVPFADLSNXEIGXKVALEGL--RPTIPPGISPHVSKLXKICXNEDPAKRP 256
Query: 514 SMSDVVWGLE 523
               +V  LE
Sbjct: 257 KFDXIVPILE 266

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 85/192 (44%), Gaps = 14/192 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G  G V   +       VAIK+L    ++Q  A     E+ ++  + H +++ L+  
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 338 CNDDREMILVYDFMARGTLPD-HLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               + +    D      L D +L       L   +   +      G+ +LH+      I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG----I 147
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-HLDPEYYRLQQLT------EKSD 449
           IHRD+K +NI++      K+ DFGL++   TS   T ++   YYR  ++       E  D
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 450 VYSFGVVLFEVL 461
           ++S GV++ E++
Sbjct: 208 IWSVGVIMGEMI 219

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 21  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 80
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 81  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--V 138
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSV---SKTHLDP 436
               YLH+      +I+RD+K  N+L+DE+   +V+DFG +K   G T     +  +L P
Sbjct: 139 LTFEYLHS----LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAP 194
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +   +  D ++ GV+++E+    P
Sbjct: 195 EIILSKGYNKAVDWWALGVLIYEMAAGYP 223

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IGVG + +  +     +    A+K ++   +  + E +    +L   +H ++++L    +
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI---LLRYGQHPNIITLKDVYD 91
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE--ICIGAARGLHYLHTGANHAVII 397
           D + + LV + M  G L D +         +++R    +     + + YLH+      ++
Sbjct: 92  DGKHVYLVTELMRGGELLDKILRQKF----FSEREASFVLHTIGKTVEYLHSQG----VV 143
Query: 398 HRDVKTTNIL-LDEKW---VAKVSDFGLSK--------FGPTSVSKTHLDPEYYRLQQLT 445
           HRD+K +NIL +DE       ++ DFG +K              +   + PE  + Q   
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYD 203
Query: 446 EKSDVYSFGVVLFEVLCA 463
           E  D++S G++L+ +L  
Sbjct: 204 EGCDIWSLGILLYTMLAG 221

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IGVG + +  +     +    A+K ++   +  + E +    +L   +H ++++L    +
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI---LLRYGQHPNIITLKDVYD 91
Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE--ICIGAARGLHYLHTGANHAVII 397
           D + + LV + M  G L D +         +++R    +     + + YLH+      ++
Sbjct: 92  DGKHVYLVTELMRGGELLDKILRQKF----FSEREASFVLHTIGKTVEYLHSQG----VV 143
Query: 398 HRDVKTTNIL-LDEKW---VAKVSDFGLSK--------FGPTSVSKTHLDPEYYRLQQLT 445
           HRD+K +NIL +DE       ++ DFG +K              +   + PE  + Q   
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYD 203
Query: 446 EKSDVYSFGVVLFEVLCA 463
           E  D++S G++L+ +L  
Sbjct: 204 EGCDIWSLGILLYTMLAG 221

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 88/197 (44%), Gaps = 24/197 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G  G V   F       VA+K+L    ++Q  A     E+ +L  + H +++SL+  
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 338 ------CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
                   + +++ LV + M            D+  + +     +C     G+ +LH+  
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHSAG 146
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-HLDPEYYRLQQL------ 444
               IIHRD+K +NI++      K+ DFGL++   T+   T ++   YYR  ++      
Sbjct: 147 ----IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGY 202
Query: 445 TEKSDVYSFGVVLFEVL 461
               D++S G ++ E++
Sbjct: 203 AANVDIWSVGCIMGELV 219

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--V 151
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDP 436
               YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T   + +  +L P
Sbjct: 152 LTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPEYLAP 207
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +   +  D ++ GV+++E+    P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 38/219 (17%)
Query: 269 AATNNFD-NDLVIGVGGFGDVYKGFINGSTTPVAIKRL--EPESQQGA-LEFQTEIGMLS 324
           A T+++  +  V+G+G  G V + F   +    A+K L   P+++Q     +Q   G   
Sbjct: 6   AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGP-- 63
Query: 325 QLRHLHLVSLI----GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA 380
                H+V ++       +  R ++++ + M  G L   +    +      +  EI    
Sbjct: 64  -----HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 118
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEK---WVAKVSDFGLSK-----------FGP 426
              + +LH+      I HRDVK  N+L   K    V K++DFG +K           + P
Sbjct: 119 GTAIQFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTP 174
Query: 427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
             V+   L PE Y      +  D++S GV+++ +LC  P
Sbjct: 175 YYVAPEVLGPEKY-----DKSCDMWSLGVIMYILLCGFP 208

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 38/219 (17%)
Query: 269 AATNNFD-NDLVIGVGGFGDVYKGFINGSTTPVAIKRL--EPESQQGA-LEFQTEIGMLS 324
           A T+++  +  V+G+G  G V + F   +    A+K L   P+++Q     +Q   G   
Sbjct: 25  AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGP-- 82
Query: 325 QLRHLHLVSLI----GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA 380
                H+V ++       +  R ++++ + M  G L   +    +      +  EI    
Sbjct: 83  -----HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEK---WVAKVSDFGLSK-----------FGP 426
              + +LH+      I HRDVK  N+L   K    V K++DFG +K           + P
Sbjct: 138 GTAIQFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTP 193
Query: 427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
             V+   L PE Y      +  D++S GV+++ +LC  P
Sbjct: 194 YYVAPEVLGPEKY-----DKSCDMWSLGVIMYILLCGFP 227

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 19/207 (9%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQT-EIGMLSQLRH 328
            +F    ++G G F          ++   AIK LE     ++  + + T E  ++S+L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
              V L     DD ++     +   G L  ++    +      +     I +A  L YLH
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 147
Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSV---------SKTHLDPEY 438
                  IIHRD+K  NILL+E    +++DFG +K   P S          +  ++ PE 
Sbjct: 148 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +   + SD+++ G ++++++   P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 55  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 114
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 115 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--V 172
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSV---SKTHLDP 436
               YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L P
Sbjct: 173 LTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPEYLAP 228
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +   +  D ++ GV+++E+    P
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 85/192 (44%), Gaps = 14/192 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G  G V   +       VAIK+L    ++Q  A     E+ ++  + H +++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 338 CNDDREMILVYDFMARGTLPD-HLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               + +    D      L D +L       L   +   +      G+ +LH+      I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG----I 147
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-HLDPEYYRLQQLT------EKSD 449
           IHRD+K +NI++      K+ DFGL++   TS   T ++   YYR  ++       E  D
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 450 VYSFGVVLFEVL 461
           ++S GV++ E++
Sbjct: 208 IWSVGVIMGEMI 219

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   +       VA+K+L    Q    A     E+ +L  L+H +++ L+  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 338 ------CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
                   D  E+ LV   M  G   +++  S    L       +     RGL Y+H+  
Sbjct: 96  FTPATSIEDFSEVYLVTTLM--GADLNNIVKSQ--ALSDEHVQFLVYQLLRGLKYIHS-- 149
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
             A IIHRD+K +N+ ++E    ++ DFGL++     ++  ++   +YR  ++       
Sbjct: 150 --AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT-GYVATRWYRAPEIMLNWMHY 206
Query: 445 TEKSDVYSFGVVLFEVLCAR 464
            +  D++S G ++ E+L  +
Sbjct: 207 NQTVDIWSVGCIMAELLQGK 226

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 87/209 (41%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--V 151
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRL 441
               YLH+      +I+RD+K  N+L+D++   +V+DFG +K            PEY   
Sbjct: 152 LTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTPEYLAP 207
Query: 442 QQLTEKS-----DVYSFGVVLFEVLCARP 465
           + +  K      D ++ GV+++E+    P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 81/195 (41%), Gaps = 18/195 (9%)
Query: 280 IGVGGFGDVY--KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G F  V   +  + G    V I      +     +   E+ ++  L H ++V L   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 338 CNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
              ++ + LV ++ + G + D+L  H          +    + A +  H          I
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCH-------QKFI 127
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLS-------KFGPTSVSKTHLDPEYYRLQQLT-EKS 448
           +HRD+K  N+LLD     K++DFG S       K      S  +  PE ++ ++    + 
Sbjct: 128 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEV 187
Query: 449 DVYSFGVVLFEVLCA 463
           DV+S GV+L+ ++  
Sbjct: 188 DVWSLGVILYTLVSG 202

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 23/216 (10%)
Query: 264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK---RLEPESQQGALEFQTEI 320
           + +++    +++   VIG G FG+V       +    A+K   + E   +  +  F  E 
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 321 GMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA 380
            +++      +V L     DDR + +V ++M  G L + + + D P   W +     +  
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVL 179
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG----LSKFGPTSVSKTHLDP 436
           A  L  +H+       IHRDVK  N+LLD+    K++DFG    ++K G          P
Sbjct: 180 A--LDAIHSMG----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233
Query: 437 EYYRLQQLT---------EKSDVYSFGVVLFEVLCA 463
           +Y   + L           + D +S GV L+E+L  
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 23/216 (10%)
Query: 264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK---RLEPESQQGALEFQTEI 320
           + +++    +++   VIG G FG+V       +    A+K   + E   +  +  F  E 
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 321 GMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA 380
            +++      +V L     DDR + +V ++M  G L + + + D P   W +     +  
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVL 184
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG----LSKFGPTSVSKTHLDP 436
           A  L  +H+       IHRDVK  N+LLD+    K++DFG    ++K G          P
Sbjct: 185 A--LDAIHSMG----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 238
Query: 437 EYYRLQQLT---------EKSDVYSFGVVLFEVLCA 463
           +Y   + L           + D +S GV L+E+L  
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/195 (22%), Positives = 80/195 (41%), Gaps = 18/195 (9%)
Query: 280 IGVGGFGDVY--KGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G F  V   +  + G    V I      +     +   E+ +   L H ++V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 338 CNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
              ++ + LV ++ + G + D+L  H          +    + A +  H          I
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCH-------QKFI 134
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLS-------KFGPTSVSKTHLDPEYYRLQQLT-EKS 448
           +HRD+K  N+LLD     K++DFG S       K      +  +  PE ++ ++    + 
Sbjct: 135 VHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEV 194
Query: 449 DVYSFGVVLFEVLCA 463
           DV+S GV+L+ ++  
Sbjct: 195 DVWSLGVILYTLVSG 209

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 23/216 (10%)
Query: 264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK---RLEPESQQGALEFQTEI 320
           + +++    +++   VIG G FG+V       +    A+K   + E   +  +  F  E 
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 321 GMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA 380
            +++      +V L     DDR + +V ++M  G L + + + D P   W +     +  
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVL 184
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG----LSKFGPTSVSKTHLDP 436
           A  L  +H+       IHRDVK  N+LLD+    K++DFG    ++K G          P
Sbjct: 185 A--LDAIHSMG----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 238
Query: 437 EYYRLQQLTEK---------SDVYSFGVVLFEVLCA 463
           +Y   + L  +          D +S GV L+E+L  
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--V 151
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSV---SKTHLDP 436
               YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L P
Sbjct: 152 LTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAP 207
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +   +  D ++ GV+++E+    P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQI--V 151
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSV---SKTHLDP 436
               YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L P
Sbjct: 152 LTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAP 207
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +   +  D ++ GV+++E+    P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--V 151
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSV---SKTHLDP 436
               YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L P
Sbjct: 152 LTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAP 207
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +   +  D ++ GV+++E+    P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 315 EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTL---PDHLYHSDNPP---L 368
           +F+ E+ +++ +++ + ++  G   +  E+ ++Y++M   ++    ++ +  D      +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 369 PWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS 428
           P      I         Y+H   N   I HRDVK +NIL+D+    K+SDFG S++    
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 429 VSK------THLDPEYYRLQQLTE--KSDVYSFGVVLF 458
             K        + PE++  +      K D++S G+ L+
Sbjct: 206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--V 151
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSV---SKTHLDP 436
               YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L P
Sbjct: 152 LTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAP 207
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +   +  D ++ GV+++E+    P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--V 151
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDP 436
               YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L P
Sbjct: 152 LTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAP 207
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +   +  D ++ GV+++E+    P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 35  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--V 152
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDP 436
               YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L P
Sbjct: 153 LTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAP 208
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +   +  D ++ GV+++E+    P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--V 151
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDP 436
               YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L P
Sbjct: 152 LTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAP 207
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +   +  D ++ GV+++E+    P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 47/108 (43%), Gaps = 24/108 (22%)
Query: 374 LEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL-----------S 422
           L I I  A  + +LH+      ++HRD+K +NI      V KV DFGL           +
Sbjct: 167 LHIFIQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 423 KFGPTSVSKTH---------LDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
              P     TH         + PE       + K D++S G++LFE+L
Sbjct: 223 VLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI--V 151
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSV---SKTHLDP 436
               YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L P
Sbjct: 152 LTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAP 207
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +   +  D ++ GV+++E+    P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   +       VA+K+L    Q    A     E+ +L  L+H +++ L+  
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 338 ------CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLH 385
                   D  E+ LV   M           +D   +   Q L       +     RGL 
Sbjct: 88  FTPATSIEDFSEVYLVTTLMG----------ADLNNIVKCQALSDEHVQFLVYQLLRGLK 137
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL- 444
           Y+H+      IIHRD+K +N+ ++E    ++ DFGL++     ++  ++   +YR  ++ 
Sbjct: 138 YIHSAG----IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMT-GYVATRWYRAPEIM 192
Query: 445 ------TEKSDVYSFGVVLFEVL 461
                  +  D++S G ++ E+L
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELL 215

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI--V 151
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSV---SKTHLDP 436
               YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L P
Sbjct: 152 LTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAP 207
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +   +  D ++ GV+++E+    P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 55  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 114
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 115 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI--V 172
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDP 436
               YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L P
Sbjct: 173 LTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAP 228
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +   +  D ++ GV+++E+    P
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 21/159 (13%)
Query: 345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTT 404
            LV+D M +G L D+L  ++   L   +  +I     R L  +    +   I+HRD+K  
Sbjct: 87  FLVFDLMKKGELFDYL--TEKVTLSEKETRKI----MRALLEVICALHKLNIVHRDLKPE 140
Query: 405 NILLDEKWVAKVSDFGLS-------KFGPTSVSKTHLDPEYYRLQQ------LTEKSDVY 451
           NILLD+    K++DFG S       K      + ++L PE              ++ D++
Sbjct: 141 NILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 200
Query: 452 SFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT 490
           S GV+++ +L   P       K+ + L +     YQ G+
Sbjct: 201 STGVIMYTLLAGSPPFWH--RKQMLMLRMIMSGNYQFGS 237

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 29  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 88
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 89  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI--V 146
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSV---SKTHLDP 436
               YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L P
Sbjct: 147 LTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAP 202
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +   +  D ++ GV+++E+    P
Sbjct: 203 EIILSKGYNKAVDWWALGVLIYEMAAGYP 231

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 88/197 (44%), Gaps = 24/197 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G  G V   +       VAIK+L    ++Q  A     E+ ++  + H +++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 338 ------CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
                   + +++ +V + M            D+  + +     +C     G+ +LH+  
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG 146
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-HLDPEYYRLQQLT----- 445
               IIHRD+K +NI++      K+ DFGL++   TS   T ++   YYR  ++      
Sbjct: 147 ----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 446 -EKSDVYSFGVVLFEVL 461
            E  D++S G ++ E++
Sbjct: 203 KENVDIWSVGCIMGEMI 219

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI--V 151
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDP 436
               YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L P
Sbjct: 152 LTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAP 207
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +   +  D ++ GV+++E+    P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 89/203 (43%), Gaps = 24/203 (11%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHL 331
           + N   IG G  G V   +       VAIK+L    ++Q  A     E+ ++  + H ++
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 332 VSLIGFCNDDR------EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           + L+      +      ++ +V + M            D+  + +     +C     G+ 
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIK 141
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-HLDPEYYRLQQL 444
           +LH+      IIHRD+K +NI++      K+ DFGL++   TS   T ++   YYR  ++
Sbjct: 142 HLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 445 T------EKSDVYSFGVVLFEVL 461
                  E  D++S G ++ E++
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMI 220

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 25/229 (10%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK----RLEPESQQGAL--EFQTEIG 321
           Q   + +D    +G G F  V K     +    A K    R    S++G    E + E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L Q+ H ++++L     +  +++L+ + ++ G L D L   ++  L   +         
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQIL 125
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWV----AKVSDFGLS-------KFGPTSVS 430
            G++YLHT      I H D+K  NI+L +K +     K+ DFGL+       +F     +
Sbjct: 126 DGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLA 479
              + PE    + L  ++D++S GV+ + +L      L     KQ +LA
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETLA 228

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 88/197 (44%), Gaps = 24/197 (12%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G  G V   +       VAIK+L    ++Q  A     E+ ++  + H +++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 338 ------CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
                   + +++ +V + M            D+  + +     +C     G+ +LH+  
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG 146
Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-HLDPEYYRLQQLT----- 445
               IIHRD+K +NI++      K+ DFGL++   TS   T ++   YYR  ++      
Sbjct: 147 ----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 446 -EKSDVYSFGVVLFEVL 461
            E  D++S G ++ E++
Sbjct: 203 KENVDIWSVGCIMGEMI 219

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 21/160 (13%)
Query: 344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKT 403
             LV+D M +G L D+L  ++   L   +  +I     R L  +    +   I+HRD+K 
Sbjct: 99  FFLVFDLMKKGELFDYL--TEKVTLSEKETRKI----MRALLEVICALHKLNIVHRDLKP 152
Query: 404 TNILLDEKWVAKVSDFGLS-------KFGPTSVSKTHLDPEYYRLQQ------LTEKSDV 450
            NILLD+    K++DFG S       K      + ++L PE              ++ D+
Sbjct: 153 ENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 212
Query: 451 YSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT 490
           +S GV+++ +L   P       K+ + L +     YQ G+
Sbjct: 213 WSTGVIMYTLLAGSPPFWH--RKQMLMLRMIMSGNYQFGS 250

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 21/160 (13%)
Query: 344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKT 403
             LV+D M +G L D+L  ++   L   +  +I     R L  +    +   I+HRD+K 
Sbjct: 99  FFLVFDLMKKGELFDYL--TEKVTLSEKETRKI----MRALLEVICALHKLNIVHRDLKP 152
Query: 404 TNILLDEKWVAKVSDFGLS-------KFGPTSVSKTHLDPEYYRLQQ------LTEKSDV 450
            NILLD+    K++DFG S       K      + ++L PE              ++ D+
Sbjct: 153 ENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 212
Query: 451 YSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT 490
           +S GV+++ +L   P       K+ + L +     YQ G+
Sbjct: 213 WSTGVIMYTLLAGSPPFWH--RKQMLMLRMIMSGNYQFGS 250

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 36/232 (15%)
Query: 264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQG--------ALE 315
           ++E+ A  + +     I  G +G V  G ++    PVAIKR+      G        +  
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 316 FQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD--FMARGTLPDHLYHSDNPPLPWNQR 373
            +  +  +  L H H  +++G     R++ + ++   M +  L   L  +D   +  +QR
Sbjct: 73  CKRVLREIRLLNHFHHPNILGL----RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR 128
Query: 374 LEICIGAAR--------GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG 425
           + I     +        GLH LH       ++HRD+   NILL +     + DF L++  
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAG----VVHRDLHPGNILLADNNDITICDFNLARED 184
Query: 426 PTSVSKTH-LDPEYYRLQQL-------TEKSDVYSFGVVLFEVLCARPSILR 469
               +KTH +   +YR  +L       T+  D++S G V+ E+   R ++ R
Sbjct: 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFR 235

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 93/217 (42%), Gaps = 29/217 (13%)
Query: 279 VIGVGGFGDVYK-GFINGSTT------PVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL 331
           V+G GG+G V++   + G+ T       V  K +   + +     + E  +L +++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHS----DNPPLPWNQRLEICIGAARGLHYL 387
           V LI       ++ L+ ++++ G L   L       ++    +   + + +G      +L
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG------HL 137
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYY 439
           H       II+RD+K  NI+L+ +   K++DFGL K      + TH        + PE  
Sbjct: 138 HQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEIL 193
Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV 476
                    D +S G +++++L   P       KK +
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 14/192 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G  G V   +       VAIK+L    ++Q  A     E+ ++  + H +++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 338 CNDDREMILVYDFMARGTLPD-HLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               + +    D      L D +L       L   +   +      G+ +LH+      I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG----I 147
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-HLDPEYYRLQQL------TEKSD 449
           IHRD+K +NI++      K+ DFGL++   TS   T ++   YYR  ++       E  D
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 450 VYSFGVVLFEVL 461
           ++S G ++ E++
Sbjct: 208 IWSVGCIMGEMI 219

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 36/232 (15%)
Query: 264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQG--------ALE 315
           ++E+ A  + +     I  G +G V  G ++    PVAIKR+      G        +  
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 316 FQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD--FMARGTLPDHLYHSDNPPLPWNQR 373
            +  +  +  L H H  +++G     R++ + ++   M +  L   L  +D   +  +QR
Sbjct: 73  CKRVLREIRLLNHFHHPNILGL----RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR 128
Query: 374 LEICIGAAR--------GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG 425
           + I     +        GLH LH       ++HRD+   NILL +     + DF L++  
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAG----VVHRDLHPGNILLADNNDITICDFNLARED 184
Query: 426 PTSVSKTH-LDPEYYRLQQL-------TEKSDVYSFGVVLFEVLCARPSILR 469
               +KTH +   +YR  +L       T+  D++S G V+ E+   R ++ R
Sbjct: 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFR 235

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ--GALEFQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G V   +       VA+K+L    Q    A     E+ +L  L+H +++ L+  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 338 ------CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARGLH 385
                   D  E+ LV   M           +D   +   Q L       +     RGL 
Sbjct: 96  FTPATSIEDFSEVYLVTTLMG----------ADLNNIVKCQALSDEHVQFLVYQLLRGLK 145
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL- 444
           Y+H+    A IIHRD+K +N+ ++E    ++ DFGL++     ++  ++   +YR  ++ 
Sbjct: 146 YIHS----AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT-GYVATRWYRAPEIM 200
Query: 445 ------TEKSDVYSFGVVLFEVL 461
                  +  D++S G ++ E+L
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELL 223

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 89/190 (46%), Gaps = 21/190 (11%)
Query: 303 KRLEPESQQGAL--EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL 360
           KR    S++G    E + E+ +L Q+ H ++++L     +  +++L+ + ++ G L D L
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 361 YHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV----AKV 416
              ++  L   +          G++YLHT      I H D+K  NI+L +K +     K+
Sbjct: 107 AQKES--LSEEEATSFIKQILDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 417 SDFGLS-------KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILR 469
            DFGL+       +F     +   + PE    + L  ++D++S GV+ + +L      L 
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL- 219
Query: 470 TAAKKQVSLA 479
               KQ +LA
Sbjct: 220 -GDTKQETLA 228

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--V 151
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRL 441
               YLH+      +I+RD+K  N+++D++   +V+DFG +K            PEY   
Sbjct: 152 LTFEYLHS----LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAP 207
Query: 442 QQLTEKS-----DVYSFGVVLFEVLCARP 465
           + +  K      D ++ GV+++E+    P
Sbjct: 208 EIIISKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 93/217 (42%), Gaps = 29/217 (13%)
Query: 279 VIGVGGFGDVYK-GFINGSTT------PVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL 331
           V+G GG+G V++   + G+ T       V  K +   + +     + E  +L +++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHS----DNPPLPWNQRLEICIGAARGLHYL 387
           V LI       ++ L+ ++++ G L   L       ++    +   + + +G      +L
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG------HL 137
Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYY 439
           H       II+RD+K  NI+L+ +   K++DFGL K      + TH        + PE  
Sbjct: 138 HQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEIL 193
Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV 476
                    D +S G +++++L   P       KK +
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 100/229 (43%), Gaps = 25/229 (10%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL------EFQTEIG 321
           Q   + +D    +G G F  V K     +    A K ++    + +       E + E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L Q+ H ++++L     +  +++L+ + ++ G L D L   ++  L   +         
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQIL 125
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWV----AKVSDFGLS-------KFGPTSVS 430
            G++YLHT      I H D+K  NI+L +K +     K+ DFGL+       +F     +
Sbjct: 126 DGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLA 479
              + PE    + L  ++D++S GV+ + +L      L     KQ +LA
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETLA 228

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 86/223 (38%), Gaps = 38/223 (17%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRHLHL 331
           +F+    +G GGFG V++          AIKR+  P  +    +   E+  L++L H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 332 VSLIG--FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQR-----------LEICI 378
           V         +  E +          +   L   +N     N R           L I +
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 379 GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL-----------SKFGPT 427
             A  + +LH+      ++HRD+K +NI      V KV DFGL           +   P 
Sbjct: 126 QIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 428 SV---------SKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVL 461
                      +K ++ PE       + K D++S G++LFE+L
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 14/192 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G  G V   +       VAIK+L    ++Q  A     E+ ++  + H +++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 338 CNDDREMILVYDFMARGTLPD-HLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               + +    D      L D +L       L   +   +      G+ +LH+      I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG----I 147
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-HLDPEYYRLQQL------TEKSD 449
           IHRD+K +NI++      K+ DFGL++   TS   T ++   YYR  ++       E  D
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 450 VYSFGVVLFEVL 461
           ++S G ++ E++
Sbjct: 208 IWSVGCIMGEMI 219

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 100/229 (43%), Gaps = 25/229 (10%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL------EFQTEIG 321
           Q   + +D    +G G F  V K     +    A K ++    + +       E + E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L Q+ H ++++L     +  +++L+ + ++ G L D L   ++  L   +         
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQIL 125
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWV----AKVSDFGLS-------KFGPTSVS 430
            G++YLHT      I H D+K  NI+L +K +     K+ DFGL+       +F     +
Sbjct: 126 DGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLA 479
              + PE    + L  ++D++S GV+ + +L      L     KQ +LA
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETLA 228

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 100/229 (43%), Gaps = 25/229 (10%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL------EFQTEIG 321
           Q   + +D    +G G F  V K     +    A K ++    + +       E + E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L Q+ H ++++L     +  +++L+ + ++ G L D L   ++  L   +         
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQIL 125
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWV----AKVSDFGLS-------KFGPTSVS 430
            G++YLHT      I H D+K  NI+L +K +     K+ DFGL+       +F     +
Sbjct: 126 DGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLA 479
              + PE    + L  ++D++S GV+ + +L      L     KQ +LA
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETLA 228

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 14/192 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G  G V   +       VAIK+L    ++Q  A     E+ ++  + H +++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 338 CNDDREMILVYDFMARGTLPD-HLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               + +    D      L D +L       L   +   +      G+ +LH+      I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG----I 147
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-HLDPEYYRLQQL------TEKSD 449
           IHRD+K +NI++      K+ DFGL++   TS   T ++   YYR  ++       E  D
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 450 VYSFGVVLFEVL 461
           ++S G ++ E++
Sbjct: 208 IWSVGCIMGEMI 219

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 24/203 (11%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHL 331
           + N   IG G  G V   +       VAIK+L    ++Q  A     E+ ++  + H ++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 332 VSLIGFCNDDR------EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           + L+      +      ++ +V + M            D+  + +     +C     G+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIK 140
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-HLDPEYYRLQQL 444
           +LH+      IIHRD+K +NI++      K+ DFGL++   TS   T  +   YYR  ++
Sbjct: 141 HLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEV 196
Query: 445 ------TEKSDVYSFGVVLFEVL 461
                  E  D++S G ++ E++
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--V 151
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRL 441
               YLH+      +I+RD+K  N+L+D++   +V+DFG +K            PEY   
Sbjct: 152 LTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAP 207
Query: 442 QQLTEKS-----DVYSFGVVLFEVLCARP 465
             +  K      D ++ GV+++E+    P
Sbjct: 208 AIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 34/207 (16%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL-HLVSLIGF 337
           V+G+G  G V + F   +    A+K L     Q   + + E+ +  +     H+V ++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 338 CND----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
             +     + +++V + +  G L   +    +      +  EI       + YLH+    
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---- 179
Query: 394 AVIIHRDVKTTNILLDEKW---VAKVSDFGLSK------------FGPTSVSKTHLDPEY 438
             I HRDVK  N+L   K    + K++DFG +K            + P  V+   L PE 
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 239
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
           Y      +  D++S GV+++ +LC  P
Sbjct: 240 Y-----DKSCDMWSLGVIMYILLCGYP 261

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 14/192 (7%)
Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G  G V   +       VAIK+L    ++Q  A     E+ ++  + H +++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 338 CNDDREMILVYDFMARGTLPD-HLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
               + +    D      L D +L       L   +   +      G+ +LH+      I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG----I 147
Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-HLDPEYYRLQQL------TEKSD 449
           IHRD+K +NI++      K+ DFGL++   TS   T ++   YYR  ++       E  D
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 450 VYSFGVVLFEVL 461
           ++S G ++ E++
Sbjct: 208 IWSVGCIMGEMI 219

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--V 151
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDP 436
               YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L P
Sbjct: 152 LTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAP 207
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +   +  D ++ GV+++++    P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYQMAAGYP 236

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 100/229 (43%), Gaps = 25/229 (10%)
Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL------EFQTEIG 321
           Q   + +D    +G G F  V K     +    A K ++    + +       E + E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L Q+ H ++++L     +  +++L+ + ++ G L D L   ++  L   +         
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQIL 125
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWV----AKVSDFGLS-------KFGPTSVS 430
            G++YLHT      I H D+K  NI+L +K +     K+ DFGL+       +F     +
Sbjct: 126 DGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLA 479
              + PE    + L  ++D++S GV+ + +L      L     KQ +LA
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETLA 228

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 34/207 (16%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL-HLVSLIGF 337
           V+G+G  G V + F   +    A+K L     Q   + + E+ +  +     H+V ++  
Sbjct: 23  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 338 CND----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
             +     + +++V + +  G L   +    +      +  EI       + YLH+    
Sbjct: 78  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---- 133
Query: 394 AVIIHRDVKTTNILLDEK---WVAKVSDFGLSK------------FGPTSVSKTHLDPEY 438
             I HRDVK  N+L   K    + K++DFG +K            + P  V+   L PE 
Sbjct: 134 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEK 193
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
           Y      +  D++S GV+++ +LC  P
Sbjct: 194 Y-----DKSCDMWSLGVIMYILLCGYP 215

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 53/102 (51%), Gaps = 16/102 (15%)
Query: 375 EICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSK--- 431
           +I +   + L +LH+  +   +IHRDVK +N+L++     K+ DFG+S +    V+K   
Sbjct: 113 KIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID 169
Query: 432 ---------THLDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
                      ++PE  + +  + KSD++S G+ + E+   R
Sbjct: 170 AGCKPYMAPERINPELNQ-KGYSVKSDIWSLGITMIELAILR 210

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 14/209 (6%)
Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIG 321
           S+  A  + FD    +G G FG V       S    A+K L+ +      + +    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L  +    LV L     D+  + +V +++A G +  HL        P  +     I   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--V 151
Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDP 436
               YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +   L P
Sbjct: 152 LTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEALAP 207
Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +   +  D ++ GV+++E+    P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 34/207 (16%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL-HLVSLIGF 337
           V+G+G  G V + F   +    A+K L     Q   + + E+ +  +     H+V ++  
Sbjct: 29  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 83
Query: 338 CND----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
             +     + +++V + +  G L   +    +      +  EI       + YLH+    
Sbjct: 84  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---- 139
Query: 394 AVIIHRDVKTTNILLDEKW---VAKVSDFGLSK------------FGPTSVSKTHLDPEY 438
             I HRDVK  N+L   K    + K++DFG +K            + P  V+   L PE 
Sbjct: 140 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 199
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
           Y      +  D++S GV+++ +LC  P
Sbjct: 200 Y-----DKSCDMWSLGVIMYILLCGYP 221

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 34/207 (16%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL-HLVSLIGF 337
           V+G+G  G V + F   +    A+K L     Q   + + E+ +  +     H+V ++  
Sbjct: 39  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 93
Query: 338 CND----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
             +     + +++V + +  G L   +    +      +  EI       + YLH+    
Sbjct: 94  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---- 149
Query: 394 AVIIHRDVKTTNILLDEK---WVAKVSDFGLSK------------FGPTSVSKTHLDPEY 438
             I HRDVK  N+L   K    + K++DFG +K            + P  V+   L PE 
Sbjct: 150 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 209
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
           Y      +  D++S GV+++ +LC  P
Sbjct: 210 Y-----DKSCDMWSLGVIMYILLCGYP 231

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 34/207 (16%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL-HLVSLIGF 337
           V+G+G  G V + F   +    A+K L     Q   + + E+ +  +     H+V ++  
Sbjct: 31  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 85
Query: 338 CND----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
             +     + +++V + +  G L   +    +      +  EI       + YLH+    
Sbjct: 86  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---- 141
Query: 394 AVIIHRDVKTTNILLDEK---WVAKVSDFGLSK------------FGPTSVSKTHLDPEY 438
             I HRDVK  N+L   K    + K++DFG +K            + P  V+   L PE 
Sbjct: 142 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 201
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
           Y      +  D++S GV+++ +LC  P
Sbjct: 202 Y-----DKSCDMWSLGVIMYILLCGYP 223

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 34/207 (16%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL-HLVSLIGF 337
           V+G+G  G V + F   +    A+K L     Q   + + E+ +  +     H+V ++  
Sbjct: 75  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 129
Query: 338 CND----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
             +     + +++V + +  G L   +    +      +  EI       + YLH+    
Sbjct: 130 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---- 185
Query: 394 AVIIHRDVKTTNILLDEKW---VAKVSDFGLSK------------FGPTSVSKTHLDPEY 438
             I HRDVK  N+L   K    + K++DFG +K            + P  V+   L PE 
Sbjct: 186 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 245
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
           Y      +  D++S GV+++ +LC  P
Sbjct: 246 Y-----DKSCDMWSLGVIMYILLCGYP 267

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 34/207 (16%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL-HLVSLIGF 337
           V+G+G  G V + F   +    A+K L     Q   + + E+ +  +     H+V ++  
Sbjct: 24  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 78
Query: 338 CND----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
             +     + +++V + +  G L   +    +      +  EI       + YLH+    
Sbjct: 79  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---- 134
Query: 394 AVIIHRDVKTTNILLDEK---WVAKVSDFGLSK------------FGPTSVSKTHLDPEY 438
             I HRDVK  N+L   K    + K++DFG +K            + P  V+   L PE 
Sbjct: 135 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 194
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
           Y      +  D++S GV+++ +LC  P
Sbjct: 195 Y-----DKSCDMWSLGVIMYILLCGYP 216

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 34/207 (16%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL-HLVSLIGF 337
           V+G+G  G V + F   +    A+K L     Q   + + E+ +  +     H+V ++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 338 CND----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
             +     + +++V + +  G L   +    +      +  EI       + YLH+    
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---- 135
Query: 394 AVIIHRDVKTTNILLDEKW---VAKVSDFGLSK------------FGPTSVSKTHLDPEY 438
             I HRDVK  N+L   K    + K++DFG +K            + P  V+   L PE 
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 195
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
           Y      +  D++S GV+++ +LC  P
Sbjct: 196 Y-----DKSCDMWSLGVIMYILLCGYP 217

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 34/207 (16%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL-HLVSLIGF 337
           V+G+G  G V + F   +    A+K L     Q   + + E+ +  +     H+V ++  
Sbjct: 23  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 338 CND----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
             +     + +++V + +  G L   +    +      +  EI       + YLH+    
Sbjct: 78  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---- 133
Query: 394 AVIIHRDVKTTNILLDEK---WVAKVSDFGLSK------------FGPTSVSKTHLDPEY 438
             I HRDVK  N+L   K    + K++DFG +K            + P  V+   L PE 
Sbjct: 134 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 193
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
           Y      +  D++S GV+++ +LC  P
Sbjct: 194 Y-----DKSCDMWSLGVIMYILLCGYP 215

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 34/207 (16%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL-HLVSLIGF 337
           V+G+G  G V + F   +    A+K L     Q   + + E+ +  +     H+V ++  
Sbjct: 30  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 84
Query: 338 CND----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
             +     + +++V + +  G L   +    +      +  EI       + YLH+    
Sbjct: 85  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---- 140
Query: 394 AVIIHRDVKTTNILLDEKW---VAKVSDFGLSK------------FGPTSVSKTHLDPEY 438
             I HRDVK  N+L   K    + K++DFG +K            + P  V+   L PE 
Sbjct: 141 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 200
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
           Y      +  D++S GV+++ +LC  P
Sbjct: 201 Y-----DKSCDMWSLGVIMYILLCGYP 222

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 87/203 (42%), Gaps = 24/203 (11%)
Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHL 331
           + N   IG G  G V   +       VAIK+L    ++Q  A     E+ ++  + H ++
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 87
Query: 332 VSLIGFCNDDR------EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           + L+      +      ++ +V + M            D+  + +     +C     G+ 
Sbjct: 88  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIK 142
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS-------VSKTHLDPEY 438
           +LH+      IIHRD+K +NI++      K+ DFGL++   TS       V++ +  PE 
Sbjct: 143 HLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEV 198
Query: 439 YRLQQLTEKSDVYSFGVVLFEVL 461
                  E  D++S G ++ E++
Sbjct: 199 ILGMGYKENVDIWSVGCIMGEMI 221

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 34/207 (16%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL-HLVSLIGF 337
           V+G+G  G V + F   +    A+K L     Q   + + E+ +  +     H+V ++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 338 CND----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
             +     + +++V + +  G L   +    +      +  EI       + YLH+    
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---- 135
Query: 394 AVIIHRDVKTTNILLDEKW---VAKVSDFGLSK------------FGPTSVSKTHLDPEY 438
             I HRDVK  N+L   K    + K++DFG +K            + P  V+   L PE 
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 195
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
           Y      +  D++S GV+++ +LC  P
Sbjct: 196 Y-----DKSCDMWSLGVIMYILLCGYP 217

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 100/234 (42%), Gaps = 38/234 (16%)
Query: 250 RGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES 309
           RGS    +  T+FS        +N+D    +G G F  V +     +    A K +  + 
Sbjct: 15  RGSEFMMNASTKFS--------DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK- 65
Query: 310 QQGALEFQT---EIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL-----Y 361
           +  A +FQ    E  +  +L+H ++V L     ++    LV+D +  G L + +     Y
Sbjct: 66  KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY 125
Query: 362 HSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW---VAKVSD 418
              +      Q LE        + Y H+      I+HR++K  N+LL  K      K++D
Sbjct: 126 SEADASHCIQQILE-------SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLAD 174
Query: 419 FGLS-------KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           FGL+        +   + +  +L PE  +    ++  D+++ GV+L+ +L   P
Sbjct: 175 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 22/212 (10%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL--EPESQQGALEFQTEIGMLSQLRHL 329
           + F  + + G G FG V  G    +   VAIK++  +P  +   L+   ++ +L     +
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIV 82
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHL-------YHSDNPPLPWNQRLEICIGAAR 382
            L S   +   +R+   +Y  +    +PD L       Y     P P   ++       R
Sbjct: 83  QLQSYF-YTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-FLFQLIR 140
Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEK-WVAKVSDFG-LSKFGPTSVSKTHLDPEYYR 440
            +  LH  + +  + HRD+K  N+L++E     K+ DFG   K  P+  +  ++   YYR
Sbjct: 141 SIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYR 198
Query: 441 L-------QQLTEKSDVYSFGVVLFEVLCARP 465
                   Q  T   D++S G +  E++   P
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQ 325
           A  + F+    IG G FG V       +    A+K L+ +      + +    E  +L  
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           +    LV L     D+  + +V ++M  G +  HL        P  +     I       
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQI--VLTFE 155
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDPEYYR 440
           YLH+      +I+RD+K  N+L+D++   KV+DFG +K   G T     +  +L PE   
Sbjct: 156 YLHS----LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
            +   +  D ++ GV+++E+    P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQ 325
           A  + F+    IG G FG V       +    A+K L+ +      + +    E  +L  
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           +    LV L     D+  + +V ++M  G +  HL        P  +     I       
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQI--VLTFE 155
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDPEYYR 440
           YLH+      +I+RD+K  N+L+D++   KV+DFG +K   G T     +  +L PE   
Sbjct: 156 YLHS----LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
            +   +  D ++ GV+++E+    P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 22/201 (10%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
           VIG G F  V +     +    A+K     +          + + E  +   L+H H+V 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL--EICIGAARGLHYLHTGA 391
           L+   + D  + +V++FM    L   +    +    +++ +           L Y H   
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 392 NHAVIIHRDVKTTNILLDEK---WVAKVSDFGLS-KFGPTS------VSKTH-LDPEYYR 440
               IIHRDVK  N+LL  K      K+ DFG++ + G +       V   H + PE  +
Sbjct: 151 ----IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206
Query: 441 LQQLTEKSDVYSFGVVLFEVL 461
            +   +  DV+  GV+LF +L
Sbjct: 207 REPYGKPVDVWGCGVILFILL 227

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 39/234 (16%)
Query: 257 DLCTQFSLSEIQAATNNFDNDLVI----GVGGFGDVYKGFINGSTTPVAIKRLEPE--SQ 310
           DL T+    +  A    F +D  +    G G F  V +      T   A K +  +  S 
Sbjct: 12  DLGTENLYFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSA 71
Query: 311 QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHL----YHSDNP 366
           +   + + E  +   L+H ++V L    +++    LV+D +  G L + +    Y+S+  
Sbjct: 72  RDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE-- 129
Query: 367 PLPWNQRLEICIGAARGLHYLHTGANHAV---IIHRDVKTTNILLDEKW---VAKVSDFG 420
                        A+  +H +    NH     I+HRD+K  N+LL  K      K++DFG
Sbjct: 130 -----------ADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFG 178
Query: 421 LSK---------FGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           L+          FG    +  +L PE  R     +  D+++ GV+L+ +L   P
Sbjct: 179 LAIEVQGEQQAWFGFAG-TPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYP 231

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 34/207 (16%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL-HLVSLIGF 337
           V+G+G  G V + F   +    A+K L     Q   + + E+ +  +     H+V ++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKXL-----QDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 338 CND----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
             +     + +++V + +  G L   +    +      +  EI       + YLH+    
Sbjct: 124 YENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHS---- 179
Query: 394 AVIIHRDVKTTNILLDEKW---VAKVSDFGLSK------------FGPTSVSKTHLDPEY 438
             I HRDVK  N+L   K    + K++DFG +K            + P  V+   L PE 
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 239
Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
           Y      +  D +S GV+ + +LC  P
Sbjct: 240 Y-----DKSCDXWSLGVIXYILLCGYP 261

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 24/157 (15%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
           +IG G +G V + +       VAIK++    E          EI +L++L H H+V ++ 
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 337 FC--NDDREMILVY--------DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHY 386
                D  +   +Y        DF      P +L       L +N  +        G+ Y
Sbjct: 120 IVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLV--------GVKY 171
Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
           +H+      I+HRD+K  N L+++    KV DFGL++
Sbjct: 172 VHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLAR 204

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES------------QQGALEFQTEI 320
           +F+  +V+G G FG V      G+    A+K L+ +             ++  L    + 
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 321 GMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA 380
             L+QL          F   DR +  V +++  G L  H+        P    +      
Sbjct: 81  PFLTQLHSC-------FQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEP--HAVFYAAEI 130
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF----GPTSV----SKT 432
           A GL +L +      II+RD+K  N++LD +   K++DFG+ K     G T+     +  
Sbjct: 131 AIGLFFLQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPD 186
Query: 433 HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           ++ PE    Q   +  D ++FGV+L+E+L  +
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT---EIGMLSQLR 327
           ++N+D    +G G F  V +     +    A K +  + +  A +FQ    E  +  +L+
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK-KLSARDFQKLEREARICRKLQ 62
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHL-----YHSDNPPLPWNQRLEICIGAAR 382
           H ++V L     ++    LV+D +  G L + +     Y   +      Q LE       
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE------- 115
Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKW---VAKVSDFGLS-------KFGPTSVSKT 432
            + Y H+      I+HR++K  N+LL  K      K++DFGL+        +   + +  
Sbjct: 116 SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG 171
Query: 433 HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           +L PE  +    ++  D+++ GV+L+ +L   P
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 204

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQ 325
           A  + F+    +G G FG V       +    A+K L+ +      E +    E  +L  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA 97
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           +    LV L     D+  + +V ++   G +  HL        P  +     I       
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFE 155
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDPEYYR 440
           YLH+      +I+RD+K  N+++D++   KV+DFGL+K   G T     +  +L PE   
Sbjct: 156 YLHS----LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
            +   +  D ++ GV+++E+    P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES------------QQGALEFQTEI 320
           +F+  +V+G G FG V      G+    A+K L+ +             ++  L    + 
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 321 GMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA 380
             L+QL          F   DR +  V +++  G L  H+        P    +      
Sbjct: 402 PFLTQLHSC-------FQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEP--HAVFYAAEI 451
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF----GPTSV----SKT 432
           A GL +L +      II+RD+K  N++LD +   K++DFG+ K     G T+     +  
Sbjct: 452 AIGLFFLQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPD 507
Query: 433 HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           ++ PE    Q   +  D ++FGV+L+E+L  +
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT---EIGMLSQLR 327
           ++N+D    +G G F  V +     +    A K +  + +  A +FQ    E  +  +L+
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK-KLSARDFQKLEREARICRKLQ 63
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHL-----YHSDNPPLPWNQRLEICIGAAR 382
           H ++V L     ++    LV+D +  G L + +     Y   +      Q LE       
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE------- 116
Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKW---VAKVSDFGLS-------KFGPTSVSKT 432
            + Y H+      I+HR++K  N+LL  K      K++DFGL+        +   + +  
Sbjct: 117 SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG 172
Query: 433 HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           +L PE  +    ++  D+++ GV+L+ +L   P
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT---EIGMLSQLR 327
           ++N+D    +G G F  V +     +    A K +  + +  A +FQ    E  +  +L+
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK-KLSARDFQKLEREARICRKLQ 63
Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHL-----YHSDNPPLPWNQRLEICIGAAR 382
           H ++V L     ++    LV+D +  G L + +     Y   +      Q LE       
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE------- 116
Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKW---VAKVSDFGLS-------KFGPTSVSKT 432
            + Y H+      I+HR++K  N+LL  K      K++DFGL+        +   + +  
Sbjct: 117 SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG 172
Query: 433 HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           +L PE  +    ++  D+++ GV+L+ +L   P
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 51/102 (50%), Gaps = 16/102 (15%)
Query: 375 EICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSK--- 431
           +I +   + L +LH+  +   +IHRDVK +N+L++     K  DFG+S +    V+K   
Sbjct: 140 KIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID 196
Query: 432 ---------THLDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
                      ++PE  + +  + KSD++S G+   E+   R
Sbjct: 197 AGCKPYXAPERINPELNQ-KGYSVKSDIWSLGITXIELAILR 237

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQ 325
           A  + F+    IG G FG V       +    A+K L+ +      + +    E  +L  
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           +    LV L     D+  + +V +++  G +  HL        P  +     I       
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFE 155
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDPEYYR 440
           YLH+      +I+RD+K  N+L+D++   KV+DFG +K   G T     +  +L PE   
Sbjct: 156 YLHS----LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
            +   +  D ++ GV+++E+    P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 110/271 (40%), Gaps = 37/271 (13%)
Query: 268 QAATNNFDNDLVIGVGGFGDVY-----KGFINGSTTPVAIKRLEPESQQGAL--EFQTEI 320
           +    NF+   V+G G +G V+      G   G    + + +     Q+       +TE 
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 321 GMLSQLRHL-HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG 379
            +L  +R    LV+L      + ++ L+ D++  G L  HL   +         ++I +G
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT---EHEVQIYVG 166
Query: 380 A-ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKT----- 432
                L +LH       II+RD+K  NILLD      ++DFGLSK F      +      
Sbjct: 167 EIVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 433 ---HLDPEYYRLQQLTEKSDV--YSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCY 486
              ++ P+  R         V  +S GV+++E+L  A P  +      Q  ++       
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS------- 275
Query: 487 QNGTIDQIVDPFLKAMSCLNDEGIRRPSMSD 517
               I +   P+ + MS L  + I+R  M D
Sbjct: 276 --RRILKSEPPYPQEMSALAKDLIQRLLMKD 304

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 42/279 (15%)
Query: 279 VIGVGGFGD-VYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           V+G G  G  VY+G  +     VA+KR+ PE    A     E+ +L +    H   +  F
Sbjct: 31  VLGHGAEGTIVYRGMFDNRD--VAVKRILPECFSFA---DREVQLLRESDE-HPNVIRYF 84
Query: 338 CND-DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
           C + DR+   +   +   TL +++   D   L   + + +      GL +LH+      I
Sbjct: 85  CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGL-EPITLLQQTTSGLAHLHS----LNI 139
Query: 397 IHRDVKTTNILLDE-----KWVAKVSDFGLSK---FGPTSVSKTH--------LDPEYYR 440
           +HRD+K  NIL+       K  A +SDFGL K    G  S S+          + PE   
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 441 ---LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQ--VSLAVWAQQC-YQNGTIDQI 494
               +  T   D++S G V + V+         + ++Q  + L   +  C +     D I
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVI 259
Query: 495 VDPFLKAMSCLNDEGIRRPSMSDVV-----WGLEFSLQL 528
               ++ M  ++ +  +RPS   V+     W LE  LQ 
Sbjct: 260 ARELIEKMIAMDPQ--KRPSAKHVLKHPFFWSLEKQLQF 296

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 22/163 (13%)
Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRHL 329
           +N++   +IG G +G VY  +   +   VAIK++    E          EI +L++L+  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDN--------PPLPWNQRLE-ICIGA 380
           +++ L        ++I+  D +    L   L  +D+        P     Q ++ I    
Sbjct: 88  YIIRL-------HDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNL 140
Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
             G  ++H       IIHRD+K  N LL++    K+ DFGL++
Sbjct: 141 LLGEKFIHESG----IIHRDLKPANCLLNQDCSVKICDFGLAR 179

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/203 (20%), Positives = 84/203 (41%), Gaps = 21/203 (10%)
Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH 330
           T+ ++    IGVG +    +     +    A+K ++   +    E +    +L   +H +
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQHPN 77
Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           +++L    +D + + +V + M  G L D +           +   +     + + YLH  
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHAQ 135
Query: 391 ANHAVIIHRDVKTTNIL-LDEKW---VAKVSDFGLSK--------FGPTSVSKTHLDPEY 438
                ++HRD+K +NIL +DE       ++ DFG +K              +   + PE 
Sbjct: 136 G----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEV 191
Query: 439 YRLQQLTEKSDVYSFGVVLFEVL 461
              Q      D++S GV+L+ +L
Sbjct: 192 LERQGYDAACDIWSLGVLLYTML 214

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 14/205 (6%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQ 325
           A  + F+    +G G FG V       +    A+K L+ +      + +    E  +L  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           +    LV L     D+  + +V +++A G +  HL        P  +     I       
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFE 155
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDPEYYR 440
           YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L PE   
Sbjct: 156 YLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
            +   +  D ++ GV+++E+    P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 34/213 (15%)
Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGF 337
           ++G G +  V       +    A+K +E ++         E+  L Q + + +++ LI F
Sbjct: 20  LLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEF 79
Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQR--LEICIGAARGLHYLHTGANHAV 395
             DD    LV++ +  G++  H+    +    +N+R    +    A  L +LHT      
Sbjct: 80  FEDDTRFYLVFEKLQGGSILAHIQKQKH----FNEREASRVVRDVAAALDFLHTKG---- 131
Query: 396 IIHRDVKTTNILLD--EKWV-AKVSDFGLS---------------KFGPTSVSKTHLDPE 437
           I HRD+K  NIL +  EK    K+ DF L                +      S  ++ PE
Sbjct: 132 IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPE 191
Query: 438 YYRL--QQLT---EKSDVYSFGVVLFEVLCARP 465
              +   Q T   ++ D++S GVVL+ +L   P
Sbjct: 192 VVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYP 224

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 9/77 (11%)
Query: 398 HRDVKTTNILLDEKWVAKVSDFG---------LSKFGPTSVSKTHLDPEYYRLQQLTEKS 448
           HRDVK  NIL+     A + DFG         L++ G T  +  +  PE +     T ++
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 449 DVYSFGVVLFEVLCARP 465
           D+Y+   VL+E L   P
Sbjct: 217 DIYALTCVLYECLTGSP 233

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/163 (22%), Positives = 71/163 (43%), Gaps = 19/163 (11%)
Query: 312 GALEFQTEIGMLSQLRHLHLVSLIG--FCNDDREMILVYDFMARGTLPDHLYHSDNPPLP 369
           G    + EI +L +LRH +++ L+   +  + ++M +V ++   G + + L        P
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFP 107
Query: 370 WNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----FG 425
             Q          GL YLH+      I+H+D+K  N+LL      K+S  G+++    F 
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQG----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163
Query: 426 PTSVSKTHLDPEYYRLQQLTE--------KSDVYSFGVVLFEV 460
                +T      ++  ++          K D++S GV L+ +
Sbjct: 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNI 206

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQ 325
           A  + F+    +G G FG V       +    A+K L+ +      E +    E  +L  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA 97
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           +    LV L     D+  + +V ++   G +  HL        P  +     I       
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFE 155
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDPEYYR 440
           YLH+      +I+RD+K  N+++D++   +V+DFGL+K   G T     +  +L PE   
Sbjct: 156 YLHS----LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
            +   +  D ++ GV+++E+    P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 87/204 (42%), Gaps = 29/204 (14%)
Query: 280 IGVGGFGDVYK--GFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
           IG G F  V +      G      I   +  S +   + + E  +   L+H ++V L   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 338 CNDDREMILVYDFMARGTLPDHL----YHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
            +++    LV+D +  G L + +    Y+S+       Q++   +     LH    G   
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-----LHCHQMG--- 123
Query: 394 AVIIHRDVKTTNILLDEKW---VAKVSDFGLSK---------FGPTSVSKTHLDPEYYRL 441
             ++HRD+K  N+LL  K      K++DFGL+          FG    +  +L PE  R 
Sbjct: 124 --VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAG-TPGYLSPEVLRK 180
Query: 442 QQLTEKSDVYSFGVVLFEVLCARP 465
           +   +  D+++ GV+L+ +L   P
Sbjct: 181 EAYGKPVDIWACGVILYILLVGYP 204

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQ 325
           A  + F+    +G G FG V       +    A+K L+ +      + +    E  +L  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           +    LV L     D+  + +V +++  G +  HL        P  +     I       
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFE 155
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDPEYYR 440
           YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L PE   
Sbjct: 156 YLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
            +   +  D ++ GV+++E+    P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQ 325
           A  + F+    +G G FG V       +    A+K L+ +      + +    E  +L  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           +    LV L     D+  + +V +++  G +  HL        P  +     I       
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFE 155
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDPEYYR 440
           YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L PE   
Sbjct: 156 YLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
            +   +  D ++ GV+++E+    P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 87/208 (41%), Gaps = 14/208 (6%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQ 325
           A  + F+    +G G FG V       +    A+K L+ +      + +    E  +L  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           +    LV L     D+  + +V +++  G +  HL        P  +     I       
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFE 155
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDPEYYR 440
           YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L PE   
Sbjct: 156 YLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 441 LQQLTEKSDVYSFGVVLFEVLCARPSIL 468
            +   +  D ++ GV+++E+    P   
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 86/205 (41%), Gaps = 14/205 (6%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQ 325
           A  + F+    +G G FG V       +    A+K L+ +      + +    E  +L  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           +    LV L     D+  + +V ++   G +  HL        P  +     I       
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFE 156
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDPEYYR 440
           YLH+      +I+RD+K  N+++D++   KV+DFG +K   G T     +  +L PE   
Sbjct: 157 YLHS----LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
            +   +  D ++ GV+++E+    P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQ 325
           A  + F+    +G G FG V       +    A+K L+ +      + +    E  +L  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           +    LV L     D+  + +V +++  G +  HL        P  +     I       
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFE 156
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSV---SKTHLDPEYYR 440
           YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L PE   
Sbjct: 157 YLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
            +   +  D ++ GV+++E+    P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQ 325
           A  + F+    +G G FG V       +    A+K L+ +      + +    E  +L  
Sbjct: 59  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           +    LV L     D+  + +V +++  G +  HL        P  +     I       
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFE 176
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDPEYYR 440
           YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L PE   
Sbjct: 177 YLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL 232
Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
            +   +  D ++ GV+++E+    P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQ 325
           A  + F+    +G G FG V       +    A+K L+ +      + +    E  +L  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           +    LV L     D+  + +V +++  G +  HL        P  +     I       
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFE 156
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSV---SKTHLDPEYYR 440
           YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L PE   
Sbjct: 157 YLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
            +   +  D ++ GV+++E+    P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQ---TEIGMLSQ 325
           A  + F+    +G G FG V       +    A+K L+ +      + +    E  +L  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           +    LV L     D+  + +V +++  G +  HL        P  +     I       
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFE 156
Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPT---SVSKTHLDPEYYR 440
           YLH+      +I+RD+K  N+L+D++   +V+DFG +K   G T     +  +L PE   
Sbjct: 157 YLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
            +   +  D ++ GV+++E+    P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	613
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-166
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-115
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-107
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-69
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-59
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-57
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-57
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-55
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-55
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-49
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-48
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-48
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-46
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-43
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-39
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-39
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-39
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-38
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-38
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-38
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-37
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-37
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-37
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-37
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-37
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-37
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-36
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-36
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-36
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-36
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-36
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-36
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-35
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-34
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-34
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-34
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-33
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-33
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-31
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-31
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-30
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-29
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-29
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-28
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-28
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-27
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-26
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-25
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-25
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-25
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-25
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-24
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-24
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-24
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-24
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-24
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-24
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-24
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-23
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-23
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-22
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-22
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-22
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-22
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-21
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-21
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	4e-21
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-21
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-20
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-19
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-19
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-19
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-19
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-18
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-18
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-18
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-18
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-18
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-18
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-18
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-17
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-17
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-17
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-17
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-17
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-17
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-17
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-17
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-16
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-16
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-16
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-15
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-15
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-15
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-15
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-15
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-15
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-14
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-14
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-14
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-10
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-14
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-13
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-13
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-13
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-12
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-12
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-12
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-12
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-12
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-05

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  474 bits (1223), Expect = e-166
 Identities = 160/321 (49%), Positives = 201/321 (62%), Gaps = 33/321 (10%)

Query: 240 SKTIKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTP 299
             T     +   S+L      +  L +++ ATNNFD+  +IG G FG VYKG +      
Sbjct: 7   KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA-K 65

Query: 300 VAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDH 359
           VA+KR  PES QG  EF+TEI  LS  RH HLVSLIGFC++  EMIL+Y +M  G L  H
Sbjct: 66  VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125

Query: 360 LYHSDNP--PLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVS 417
           LY SD P   + W QRLEICIGAARGLHYLHT A    IIHRDVK+ NILLDE +V K++
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA----IIHRDVKSINILLDENFVPKIT 181

Query: 418 DFGLSKFGPTSVSKTH-----------LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPS 466
           DFG+SK G     +TH           +DPEY+   +LTEKSDVYSFGVVLFEVLCAR +
Sbjct: 182 DFGISKKGTEL-DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

Query: 467 ILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--------------AMSCLNDEGIRR 512
           I+++  ++ V+LA WA + + NG ++QIVDP L               A+ CL      R
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDR 300

Query: 513 PSMSDVVWGLEFSLQLQESSI 533
           PSM DV+W LE++L+LQES I
Sbjct: 301 PSMGDVLWKLEYALRLQESVI 321

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  346 bits (889), Expect = e-115
 Identities = 100/299 (33%), Positives = 157/299 (52%), Gaps = 46/299 (15%)

Query: 262 FSLSEIQAATNNFDNDL------VIGVGGFGDVYKGFINGSTTPVAIKRLE----PESQQ 311
           FS  E++  TNNFD          +G GGFG VYKG++N   T VA+K+L       +++
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVAVKKLAAMVDITTEE 72

Query: 312 GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDN-PPLPW 370
              +F  EI ++++ +H +LV L+GF +D  ++ LVY +M  G+L D L   D  PPL W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132

Query: 371 NQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS 430
           + R +I  GAA G+++LH        IHRD+K+ NILLDE + AK+SDFGL++      +
Sbjct: 133 HMRCKIAQGAANGINFLHENH----HIHRDIKSANILLDEAFTAKISDFGLARASEKF-A 187

Query: 431 KTH-----------LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLA 479
           +T            + PE  R  ++T KSD+YSFGVVL E++   P++     ++   L 
Sbjct: 188 QTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH--REPQLLL 244

Query: 480 VWAQQCYQN-GTIDQIVDPFLK-------------AMSCLNDEGIRRPSMSDVVWGLEF 524
              ++      TI+  +D  +              A  CL+++  +RP +  V   L+ 
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  324 bits (834), Expect = e-107
 Identities = 116/291 (39%), Positives = 161/291 (55%), Gaps = 32/291 (10%)

Query: 262 FSLSEIQAATNNFDNDLVIGVGGFGDVYKGFI-NGSTTPVAIKRLEPESQQGA-LEFQTE 319
           FSL E+Q A++NF N  ++G GGFG VYKG + +G  T VA+KRL+ E  QG  L+FQTE
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG--TLVAVKRLKEERTQGGELQFQTE 77

Query: 320 IGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY--HSDNPPLPWNQRLEIC 377
           + M+S   H +L+ L GFC    E +LVY +MA G++   L       PPL W +R  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137

Query: 378 IGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-------TSVS 430
           +G+ARGL YLH       IIHRDVK  NILLDE++ A V DFGL+K          T+V 
Sbjct: 138 LGSARGLAYLHDHC-DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196

Query: 431 KT--HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSI--LRTAAKKQVSLAVWAQQCY 486
            T  H+ PEY    + +EK+DV+ +GV+L E++  + +    R A    V L  W +   
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256

Query: 487 QNGTIDQIVDPFLK--------------AMSCLNDEGIRRPSMSDVVWGLE 523
           +   ++ +VD  L+              A+ C     + RP MS+VV  LE
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  227 bits (580), Expect = 1e-69
 Identities = 62/317 (19%), Positives = 115/317 (36%), Gaps = 54/317 (17%)

Query: 261 QFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEI 320
                 +   +       V   G FG V+K  +      VA+K    + +Q   + + E+
Sbjct: 13  DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFPIQDKQS-WQNEYEV 69

Query: 321 GMLSQLRHLHLVSLIGFC----NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEI 376
             L  ++H +++  IG      + D ++ L+  F  +G+L D L       + WN+   I
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHI 126

Query: 377 CIGAARGLHYLHT------GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPT 427
               ARGL YLH         +   I HRD+K+ N+LL     A ++DFGL+     G +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 428 SVSKTH-------LDPEYYR-----LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQ 475
           +            + PE         +    + D+Y+ G+VL+E+     +      +  
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 476 VSLAVWAQQCYQNGTIDQIV---------------DPFLKAMS-----CLNDEGIRRPSM 515
           +       Q      + ++V                  +  +      C + +   R S 
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

Query: 516 SDVVWGLEFSLQLQESS 532
             V   +    Q+Q  +
Sbjct: 307 GCVGERIT---QMQRLT 320

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  208 bits (532), Expect = 1e-62
 Identities = 78/277 (28%), Positives = 138/277 (49%), Gaps = 41/277 (14%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL--EFQTEIGMLSQLRHLHLVSLIG 336
            IG G FG V++   +G  + VA+K L  +        EF  E+ ++ +LRH ++V  +G
Sbjct: 44  KIGAGSFGTVHRAEWHG--SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 337 FCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
                  + +V ++++RG+L   L+       L   +RL +    A+G++YLH    +  
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH--NRNPP 159

Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD--------PEYYRLQQLTEK 447
           I+HR++K+ N+L+D+K+  KV DFGLS+   ++   +           PE  R +   EK
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219

Query: 448 SDVYSFGVVLFEVLCAR-------PSILRTAAKKQVSLAVWAQQCYQNG--TIDQIVDPF 498
           SDVYSFGV+L+E+   +       P+        QV  AV     ++     I + ++P 
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPA--------QVVAAV----GFKCKRLEIPRNLNPQ 267

Query: 499 LKAM--SCLNDEGIRRPSMSDVVWGLEFSLQLQESSI 533
           + A+   C  +E  +RPS + ++  L     L +S++
Sbjct: 268 VAAIIEGCWTNEPWKRPSFATIMDLLR---PLIKSAV 301

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  200 bits (511), Expect = 1e-59
 Identities = 72/258 (27%), Positives = 128/258 (49%), Gaps = 26/258 (10%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           V+G G FG V K         VAIK++E ES++    F  E+  LS++ H ++V L G C
Sbjct: 15  VVGRGAFGVVCKAKWRA--KDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGAC 70

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPP-LPWNQRLEICIGAARGLHYLHTGANHAVII 397
            +   + LV ++   G+L + L+ ++  P       +  C+  ++G+ YLH+    A +I
Sbjct: 71  LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA-LI 127

Query: 398 HRDVKTTNILLDEKW-VAKVSDFGLSKFGPTSVSKTH-----LDPEYYRLQQLTEKSDVY 451
           HRD+K  N+LL     V K+ DFG +    T ++        + PE +     +EK DV+
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVF 187

Query: 452 SFGVVLFEVLCAR-PSILRTAAKKQVSLAVWAQQCYQNG---TIDQIVDPFLKAM--SCL 505
           S+G++L+EV+  R P         ++  AV       NG    + + +   ++++   C 
Sbjct: 188 SWGIILWEVITRRKPFDEIGGPAFRIMWAV------HNGTRPPLIKNLPKPIESLMTRCW 241

Query: 506 NDEGIRRPSMSDVVWGLE 523
           + +  +RPSM ++V  + 
Sbjct: 242 SKDPSQRPSMEEIVKIMT 259

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  194 bits (496), Expect = 6e-58
 Identities = 69/268 (25%), Positives = 117/268 (43%), Gaps = 35/268 (13%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL----EFQTEIGMLSQLRHLHLVSL 334
           +IG+GGFG VY+ F  G    VA+K    +  +         + E  + + L+H ++++L
Sbjct: 14  IIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
            G C  +  + LV +F   G L   L       +P +  +   +  ARG++YLH      
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHD-EAIV 127

Query: 395 VIIHRDVKTTNILLDEK--------WVAKVSDFGLSKFGPTSVSKTHLD------PEYYR 440
            IIHRD+K++NIL+ +K         + K++DFGL++    +   +         PE  R
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIR 187

Query: 441 LQQLTEKSDVYSFGVVLFEVLCAR-PSILRTAAKKQVSLAVWAQQCYQNG--TIDQIVDP 497
               ++ SDV+S+GV+L+E+L    P          V+  V            I      
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--AVAYGV----AMNKLALPIPSTCPE 241

Query: 498 FLKA--MSCLNDEGIRRPSMSDVVWGLE 523
                   C N +   RPS ++++  L 
Sbjct: 242 PFAKLMEDCWNPDPHSRPSFTNILDQLT 269

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  192 bits (491), Expect = 3e-57
 Identities = 50/266 (18%), Positives = 109/266 (40%), Gaps = 37/266 (13%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIG 336
            +     G+++KG   G    + +K L+    S + + +F  E   L    H +++ ++G
Sbjct: 17  KLNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 337 FCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
            C         L+  +M  G+L + L+   N  +  +Q ++  +  ARG+ +LHT     
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP-- 132

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---PEYYRLQQL---TEKS 448
           +I    + + ++++DE   A++S   +     +           PE  + +        +
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSA 192

Query: 449 DVYSFGVVLFEVLCAR-------PSILRTAAKKQVSLAVWAQQCYQNG--TIDQIVDPFL 499
           D++SF V+L+E++                    ++ + V      +    TI   + P +
Sbjct: 193 DMWSFAVLLWELVTREVPFADLSNM--------EIGMKV----ALEGLRPTIPPGISPHV 240

Query: 500 KAM--SCLNDEGIRRPSMSDVVWGLE 523
             +   C+N++  +RP    +V  LE
Sbjct: 241 SKLMKICMNEDPAKRPKFDMIVPILE 266

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  193 bits (492), Expect = 6e-57
 Identities = 64/292 (21%), Positives = 116/292 (39%), Gaps = 35/292 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           V+G G FG   K     +   + +K L    ++    F  E+ ++  L H +++  IG  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
             D+ +  + +++  GTL   +  S +   PW+QR+      A G+ YLH+  N   IIH
Sbjct: 77  YKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLHS-MN---IIH 131

Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD----------------------P 436
           RD+ + N L+ E     V+DFGL++      ++                          P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191

Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLC---ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ 493
           E    +   EK DV+SFG+VL E++    A P  L     + +   +  +          
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL----PRTMDFGLNVRGFLDRYCPPN 247

Query: 494 IVDPFLKAM-SCLNDEGIRRPSMSDVVWGLEFSLQLQESSIAIAKEIDENEE 544
               F      C + +  +RPS   +   LE         + +  ++++ + 
Sbjct: 248 CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDR 299

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  192 bits (489), Expect = 9e-57
 Identities = 78/270 (28%), Positives = 125/270 (46%), Gaps = 35/270 (12%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL-------EFQTEIGMLSQLRHLHL 331
            IG GGFG V+KG +    + VAIK L     +G         EFQ E+ ++S L H ++
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85

Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V L G  ++     +V +F+  G L   L      P+ W+ +L + +  A G+ Y+    
Sbjct: 86  VKLYGLMHN--PPRMVMEFVPCGDLYHRL-LDKAHPIKWSVKLRLMLDIALGIEYMQ--N 140

Query: 392 NHAVIIHRDVKTTNILLDEKW-----VAKVSDFGLSKFGPTSVSKTH-----LDPEYYRL 441
            +  I+HRD+++ NI L          AKV+DFGLS+    SVS        + PE    
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGA 200

Query: 442 QQL--TEKSDVYSFGVVLFEVL-CARPSILRTAAKKQVSLAVWAQQCYQNG---TIDQIV 495
           ++   TEK+D YSF ++L+ +L    P    +  K +    +      + G   TI +  
Sbjct: 201 EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI-----REEGLRPTIPEDC 255

Query: 496 DPFLKAM--SCLNDEGIRRPSMSDVVWGLE 523
            P L+ +   C + +  +RP  S +V  L 
Sbjct: 256 PPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  189 bits (482), Expect = 2e-55
 Identities = 57/274 (20%), Positives = 100/274 (36%), Gaps = 44/274 (16%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL--EFQTEIGMLSQLRHLHLVSLIG 336
           +IG G FG VY G  +G    VAI+ ++ E         F+ E+    Q RH ++V  +G
Sbjct: 40  LIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
            C     + ++       TL   +       L  N+  +I     +G+ YLH       I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLHAKG----I 151

Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD-------------PEYYRLQQ 443
           +H+D+K+ N+  D      ++DFGL        +    D             PE  R   
Sbjct: 152 LHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 444 L---------TEKSDVYSFGVVLFEVLCAR---PSILRTAAKKQVSLAVWAQQCYQNGTI 491
                     ++ SDV++ G + +E+        +    A   Q+          +    
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM------GTGMKPNLS 264

Query: 492 DQIVDPFLKA--MSCLNDEGIRRPSMSDVVWGLE 523
              +   +    + C   E   RP+ + ++  LE
Sbjct: 265 QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  188 bits (479), Expect = 3e-55
 Identities = 73/265 (27%), Positives = 118/265 (44%), Gaps = 33/265 (12%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL--EFQTEIGMLSQLRHLHLVSLIGF 337
           IG G FG VYKG  +G    VA+K L   +        F+ E+G+L + RH++++  +G+
Sbjct: 32  IGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
               +  I V  +    +L  HL H+        + ++I    ARG+ YLH  A    II
Sbjct: 89  STAPQLAI-VTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLH--AKS--II 142

Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD----------PEYYRLQQL--- 444
           HRD+K+ NI L E    K+ DFGL+            +          PE  R+Q     
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202

Query: 445 TEKSDVYSFGVVLFEVLCAR---PSILRTAAKKQVSLAVWAQQCYQNG-TIDQIVDPFLK 500
           + +SDVY+FG+VL+E++  +    +I     + Q+   V       +   +       +K
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNI---NNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259

Query: 501 A--MSCLNDEGIRRPSMSDVVWGLE 523
                CL  +   RPS   ++  +E
Sbjct: 260 RLMAECLKKKRDERPSFPRILAEIE 284

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  183 bits (467), Expect = 4e-53
 Identities = 58/318 (18%), Positives = 108/318 (33%), Gaps = 68/318 (21%)

Query: 261 QFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTE- 319
           + + SE     +N     +IG G +G VYKG ++    PVA+K     ++Q    F  E 
Sbjct: 2   EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFANRQ---NFINEK 56

Query: 320 -IGMLSQLRHLHLVSLIGFC-----NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQR 373
            I  +  + H ++   I        +   E +LV ++   G+L  +L         W   
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSS 113

Query: 374 LEICIGAARGLHYLHTGANHA-----VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS 428
             +     RGL YLHT           I HRD+ + N+L+       +SDFGLS     +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 429 VSKTHLD----------------PEYYR-------LQQLTEKSDVYSFGVVLFEVLCARP 465
                 +                PE           +   ++ D+Y+ G++ +E +  R 
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE-IFMRC 232

Query: 466 SILRTAAKKQVSLAVWAQQCYQNGTIDQIVD-------------------PFLKAMS--- 503
           + L            +  +   + T + +                       ++++    
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 504 --CLNDEGIRRPSMSDVV 519
             C + +   R +     
Sbjct: 293 EDCWDQDAEARLTAQXAE 310

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  171 bits (435), Expect = 2e-48
 Identities = 61/298 (20%), Positives = 107/298 (35%), Gaps = 54/298 (18%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            IG G +G+V+ G   G    VA+K      +  +   +TEI     +RH +++  I   
Sbjct: 44  QIGKGRYGEVWMGKWRG--EKVAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAAD 100

Query: 339 NDDR----EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
                   ++ L+ D+   G+L D+L    +  L     L++   +  GL +LHT     
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFST 157

Query: 395 ----VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD------------PE- 437
                I HRD+K+ NIL+ +     ++D GL+    +  ++  +             PE 
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217

Query: 438 -----YYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID 492
                     Q    +D+YSFG++L+EV     S       +     +           +
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277

Query: 493 QIV--------------DPFLKAMS-----CLNDEGIRRPSMSDVVWGLEFSLQLQES 531
            +               D  L+ M      C       R +   V   L    ++ ES
Sbjct: 278 IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA---KMSES 332

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  169 bits (430), Expect = 4e-48
 Identities = 56/290 (19%), Positives = 105/290 (36%), Gaps = 59/290 (20%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            +G G +G+V++G   G    VA+K      ++     +TE+     LRH +++  I   
Sbjct: 15  CVGKGRYGEVWRGSWQG--ENVAVKIFSSRDEKSWF-RETELYNTVMLRHENILGFIASD 71

Query: 339 NDDR----EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
              R    ++ L+  +   G+L D+L       L     L I +  A GL +LH      
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 395 ----VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD------------PE- 437
                I HRD+K+ NIL+ +     ++D GL+     S ++  +             PE 
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188

Query: 438 -----YYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID 492
                        ++ D+++FG+VL+EV   R          +     +      + + +
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKP---PFYDVVPNDPSFE 244

Query: 493 QIV------------------DPFLKAMS-----CLNDEGIRRPSMSDVV 519
            +                   DP L +++     C       R +   + 
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  166 bits (421), Expect = 2e-46
 Identities = 58/290 (20%), Positives = 112/290 (38%), Gaps = 59/290 (20%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            IG G FG+V++G   G    VA+K      ++     + EI     LRH +++  I   
Sbjct: 49  SIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 105

Query: 339 NDDR----EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           N D     ++ LV D+   G+L D+L   +   +     +++ +  A GL +LH      
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162

Query: 395 ----VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD------------PE- 437
                I HRD+K+ NIL+ +     ++D GL+    ++     +             PE 
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222

Query: 438 -----YYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID 492
                  +  +  +++D+Y+ G+V +E+   R SI       Q+    +      + +++
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQL---PYYDLVPSDPSVE 278

Query: 493 QIV------------------DPFLKAMS-----CLNDEGIRRPSMSDVV 519
           ++                      L+ M+     C    G  R +   + 
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  158 bits (401), Expect = 4e-43
 Identities = 57/194 (29%), Positives = 88/194 (45%), Gaps = 16/194 (8%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
            IG G FG+V+ G +    T VA+K            +F  E  +L Q  H ++V LIG 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
           C   + + +V + +  G     L  ++   L     L++   AA G+ YL   +     I
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE--SKC--CI 235

Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD----------PEYYRLQQLTEK 447
           HRD+   N L+ EK V K+SDFG+S+     V                PE     + + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295

Query: 448 SDVYSFGVVLFEVL 461
           SDV+SFG++L+E  
Sbjct: 296 SDVWSFGILLWETF 309

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  151 bits (382), Expect = 1e-39
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 14/192 (7%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 285

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
             +    ++ +FM  G L D+L   +   +     L +    +  + YL     +   IH
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN--FIH 341

Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSD 449
           R++   N L+ E  + KV+DFGLS+         H           PE     + + KSD
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401

Query: 450 VYSFGVVLFEVL 461
           V++FGV+L+E+ 
Sbjct: 402 VWAFGVLLWEIA 413

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  144 bits (366), Expect = 3e-39
 Identities = 53/211 (25%), Positives = 84/211 (39%), Gaps = 41/211 (19%)

Query: 279 VIGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL 331
            +G G F  ++KG             T V +K L+   +  +  F     M+S+L H HL
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V   G C    E ILV +F+  G+L  +L   +   +    +LE+    A  +H+L    
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLE--E 131

Query: 392 NHAVIIHRDVKTTNILLDEKW--------VAKVSDFGLSKFGPTSVSKTHLDPEYYRL-- 441
           N   +IH +V   NILL  +           K+SD G+S           L  +  +   
Sbjct: 132 NT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--------VLPKDILQERI 181

Query: 442 -----------QQLTEKSDVYSFGVVLFEVL 461
                      + L   +D +SFG  L+E+ 
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEIC 212

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  147 bits (374), Expect = 7e-39
 Identities = 63/189 (33%), Positives = 103/189 (54%), Gaps = 14/189 (7%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            IG G FGDV  G   G    VA+K ++ ++      F  E  +++QLRH +LV L+G  
Sbjct: 200 TIGKGEFGDVMLGDYRG--NKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVI 255

Query: 339 NDDREMI-LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
            +++  + +V ++MA+G+L D+L       L  +  L+  +     + YL    N+   +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNN--FV 311

Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHL-----DPEYYRLQQLTEKSDVYS 452
           HRD+   N+L+ E  VAKVSDFGL+K   ++     L      PE  R ++ + KSDV+S
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 371

Query: 453 FGVVLFEVL 461
           FG++L+E+ 
Sbjct: 372 FGILLWEIY 380

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  142 bits (361), Expect = 1e-38
 Identities = 54/192 (28%), Positives = 94/192 (48%), Gaps = 14/192 (7%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +LV L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
             +    ++ +FM  G L D+L   +   +     L +    +  + YL     +   IH
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKN--FIH 134

Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSD 449
           RD+   N L+ E  + KV+DFGLS+         H           PE     + + KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194

Query: 450 VYSFGVVLFEVL 461
           V++FGV+L+E+ 
Sbjct: 195 VWAFGVLLWEIA 206

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  142 bits (361), Expect = 2e-38
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 36/205 (17%)

Query: 279 VIGVGGFGDVYKGFINGS--TTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSL 334
            +G G FG V KG+         VA+K L+ E        E   E  ++ QL + ++V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           IG C  +  M+ V +    G L  +L    N  +     +E+    + G+ YL    ++ 
Sbjct: 84  IGICEAESWML-VMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL--EESN- 137

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ----------- 443
             +HRD+   N+LL  +  AK+SDFGLSK           D  YY+ Q            
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-------LRADENYYKAQTHGKWPVKWYAP 189

Query: 444 -------LTEKSDVYSFGVVLFEVL 461
                   + KSDV+SFGV+++E  
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAF 214

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  146 bits (369), Expect = 3e-38
 Identities = 62/192 (32%), Positives = 97/192 (50%), Gaps = 16/192 (8%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L    
Sbjct: 191 KLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
           +++   I V ++M++G+L D L       L   Q +++    A G+ Y+     +   +H
Sbjct: 249 SEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN--YVH 303

Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSD 449
           RD++  NIL+ E  V KV+DFGL++    +                PE     + T KSD
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363

Query: 450 VYSFGVVLFEVL 461
           V+SFG++L E+ 
Sbjct: 364 VWSFGILLTELT 375

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  142 bits (361), Expect = 4e-38
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 38/213 (17%)

Query: 279 VIGVGGFGDVYKGFING----STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
            +G G FG V     +     +   VA+K+L+        +FQ EI +L  L    +V  
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89

Query: 335 IGFCNDDRE--MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            G         + LV +++  G L D L       L  ++ L       +G+ YL   + 
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLG--SR 146

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL-------- 444
               +HRD+   NIL++ +   K++DFGL+K          LD +YY +++         
Sbjct: 147 R--CVHRDLAARNILVESEAHVKIADFGLAKL-------LPLDKDYYVVREPGQSPIFWY 197

Query: 445 ----------TEKSDVYSFGVVLFEV--LCARP 465
                     + +SDV+SFGVVL+E+   C + 
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  141 bits (357), Expect = 7e-38
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 36/207 (17%)

Query: 279 VIGVGGFGDVYKG----FINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
            +G G FG V         + +   VA+K+L+  +++   +F+ EI +L  L+H ++V  
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76

Query: 335 IGFCNDDRE--MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            G C       + L+ +++  G+L D+L       +   + L+      +G+ YL     
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLG--TK 133

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ--------- 443
               IHRD+ T NIL++ +   K+ DFGL+K  P        D E++++++         
Sbjct: 134 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEFFKVKEPGESPIFWY 184

Query: 444 ---------LTEKSDVYSFGVVLFEVL 461
                     +  SDV+SFGVVL+E+ 
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELF 211

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  144 bits (366), Expect = 8e-38
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 16/192 (8%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            +G G FG+V+    N   T VA+K ++P S      F  E  ++  L+H  LV L    
Sbjct: 195 KLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVV 252

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
             +   I + +FMA+G+L D L   +    P  + ++     A G+ ++     +   IH
Sbjct: 253 TKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRN--YIH 307

Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGP----TSVSKTHL-----DPEYYRLQQLTEKSD 449
           RD++  NIL+    V K++DFGL++       T+            PE       T KSD
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367

Query: 450 VYSFGVVLFEVL 461
           V+SFG++L E++
Sbjct: 368 VWSFGILLMEIV 379

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  140 bits (354), Expect = 1e-37
 Identities = 60/192 (31%), Positives = 90/192 (46%), Gaps = 16/192 (8%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            IG G FG V+ G+       VAIK +   +     +F  E  ++ +L H  LV L G C
Sbjct: 15  EIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
            +   + LV +FM  G L D+L  +          L +C+    G+ YL        +IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL--EEAC--VIH 127

Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSD 449
           RD+   N L+ E  V KVSDFG+++F       +            PE +   + + KSD
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187

Query: 450 VYSFGVVLFEVL 461
           V+SFGV+++EV 
Sbjct: 188 VWSFGVLMWEVF 199

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  140 bits (354), Expect = 1e-37
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 16/192 (8%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            +G G FG+V+ G+ NG  T VA+K L+  S      F  E  ++ QL+H  LV L    
Sbjct: 20  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVV 77

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
             +   I + ++M  G+L D L       L  N+ L++    A G+ ++     +   IH
Sbjct: 78  TQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN--YIH 132

Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSD 449
           RD++  NIL+ +    K++DFGL++    +                PE       T KSD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192

Query: 450 VYSFGVVLFEVL 461
           V+SFG++L E++
Sbjct: 193 VWSFGILLTEIV 204

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  140 bits (354), Expect = 1e-37
 Identities = 64/189 (33%), Positives = 104/189 (55%), Gaps = 14/189 (7%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            IG G FGDV  G   G    VA+K ++ ++   A  F  E  +++QLRH +LV L+G  
Sbjct: 28  TIGKGEFGDVMLGDYRG--NKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 339 NDDREMI-LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
            +++  + +V ++MA+G+L D+L       L  +  L+  +     + YL    N+   +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNN--FV 139

Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHL-----DPEYYRLQQLTEKSDVYS 452
           HRD+   N+L+ E  VAKVSDFGL+K   ++     L      PE  R ++ + KSDV+S
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 199

Query: 453 FGVVLFEVL 461
           FG++L+E+ 
Sbjct: 200 FGILLWEIY 208

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  141 bits (357), Expect = 1e-37
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 36/207 (17%)

Query: 279 VIGVGGFGDVYKGFING----STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
            +G G FG V     +     +   VA+K+L+  +++   +F+ EI +L  L+H ++V  
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107

Query: 335 IGFCNDDRE--MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            G C       + L+ +++  G+L D+L       +   + L+      +G+ YL     
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLG--TK 164

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL-------- 444
               IHRD+ T NIL++ +   K+ DFGL+K  P        D EYY++++         
Sbjct: 165 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEYYKVKEPGESPIFWY 215

Query: 445 ----------TEKSDVYSFGVVLFEVL 461
                     +  SDV+SFGVVL+E+ 
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELF 242

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  140 bits (355), Expect = 2e-37
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 37/208 (17%)

Query: 279 VIGVGGFGDVYKG----FINGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVS 333
            +G G FG V         + +   VA+K L+PES    + + + EI +L  L H ++V 
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87

Query: 334 LIGFCNDDRE--MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
             G C +D    + L+ +F+  G+L ++L   +   +   Q+L+  +   +G+ YL   +
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLG--S 144

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
                +HRD+   N+L++ +   K+ DFGL+K           D EYY ++         
Sbjct: 145 RQ--YVHRDLAARNVLVESEHQVKIGDFGLTKA-------IETDKEYYTVKDDRDSPVFW 195

Query: 445 -----------TEKSDVYSFGVVLFEVL 461
                         SDV+SFGV L E+L
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELL 223

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  145 bits (367), Expect = 2e-37
 Identities = 62/192 (32%), Positives = 97/192 (50%), Gaps = 16/192 (8%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  LV L    
Sbjct: 274 KLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
           +++   I V ++M++G+L D L       L   Q +++    A G+ Y+     +   +H
Sbjct: 332 SEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN--YVH 386

Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---------PEYYRLQQLTEKSD 449
           RD++  NIL+ E  V KV+DFGL++    +                PE     + T KSD
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446

Query: 450 VYSFGVVLFEVL 461
           V+SFG++L E+ 
Sbjct: 447 VWSFGILLTELT 458

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  138 bits (351), Expect = 2e-37
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 32/200 (16%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            +G G FG V  G   G    VA+K ++  S     EF  E   + +L H  LV   G C
Sbjct: 15  ELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
           + +  + +V ++++ G L ++L  S    L  +Q LE+C     G+ +L   ++    IH
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFL--ESHQ--FIH 127

Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQ---------------- 442
           RD+   N L+D     KVSDFG++++         LD +Y                    
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYV--------LDDQYVSSVGTKFPVKWSAPEVFHY 179

Query: 443 -QLTEKSDVYSFGVVLFEVL 461
            + + KSDV++FG++++EV 
Sbjct: 180 FKYSSKSDVWAFGILMWEVF 199

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  139 bits (353), Expect = 3e-37
 Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 38/208 (18%)

Query: 279 VIGVGGFGDVYKGF---INGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G     +G     A+K L          +F TE  ++    H +++SL
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91

Query: 335 IGFCNDDRE-MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C       ++V  +M  G L + +  ++         +   +  A+G+ YL   +  
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLA--SKK 148

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL--------- 444
              +HRD+   N +LDEK+  KV+DFGL++           D EYY +            
Sbjct: 149 --FVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEYYSVHNKTGAKLPVKW 198

Query: 445 -----------TEKSDVYSFGVVLFEVL 461
                      T KSDV+SFGV+L+E++
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELM 226

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  138 bits (351), Expect = 4e-37
 Identities = 59/192 (30%), Positives = 92/192 (47%), Gaps = 16/192 (8%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            +G G FG V  G   G    VAIK ++  S     EF  E  ++  L H  LV L G C
Sbjct: 31  ELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
              R + ++ ++MA G L ++L           Q LE+C      + YL   +     +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYL--ESKQ--FLH 143

Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGP----TSVSKTHL-----DPEYYRLQQLTEKSD 449
           RD+   N L++++ V KVSDFGLS++      TS   +        PE     + + KSD
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 203

Query: 450 VYSFGVVLFEVL 461
           +++FGV+++E+ 
Sbjct: 204 IWAFGVLMWEIY 215

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  139 bits (353), Expect = 6e-37
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 51/218 (23%)

Query: 279 VIGVGGFGDVYKGFIN--GSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSL 334
           VIG G FG V K  I   G     AIKR++   S+    +F  E+ +L +L  H ++++L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91

Query: 335 IGFCNDDREMILVYDFMARGTLPDHL--------------YHSDNPPLPWNQRLEICIGA 380
           +G C     + L  ++   G L D L               +S    L   Q L      
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYR 440
           ARG+ YL         IHRD+   NIL+ E +VAK++DFGLS+             E Y 
Sbjct: 152 ARGMDYL--SQKQ--FIHRDLAARNILVGENYVAKIADFGLSR-----------GQEVYV 196

Query: 441 LQQL------------------TEKSDVYSFGVVLFEV 460
            + +                  T  SDV+S+GV+L+E+
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  138 bits (349), Expect = 7e-37
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 34/206 (16%)

Query: 277 DLVIGVGGFGDVYKGFIN--GSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVS 333
           D+ +G G FG V +G          VAIK L+  +++    E   E  ++ QL + ++V 
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           LIG C  +  M+ V +    G L   L       +P +   E+    + G+ YL     +
Sbjct: 75  LIGVCQAEALML-VMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYL--EEKN 130

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ---------- 443
              +HRD+   N+LL  +  AK+SDFGLSK           D  YY  +           
Sbjct: 131 --FVHRDLAARNVLLVNRHYAKISDFGLSKA-------LGADDSYYTARSAGKWPLKWYA 181

Query: 444 --------LTEKSDVYSFGVVLFEVL 461
                    + +SDV+S+GV ++E L
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEAL 207

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  138 bits (351), Expect = 1e-36
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 21/198 (10%)

Query: 279 VIGVGGFGDVYKGF----INGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVS 333
           V+G G FG VYKG           PVAIK L   +   A  E   E  +++ + + H+  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L+G C      + +   M  G L D++       +     L  C+  A+G++YL      
Sbjct: 82  LLGICLTSTVQL-ITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE--DRR 137

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD----------PEYYRLQQ 443
             ++HRD+   N+L+      K++DFGL+K       + H +           E    + 
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 444 LTEKSDVYSFGVVLFEVL 461
            T +SDV+S+GV ++E++
Sbjct: 196 YTHQSDVWSYGVTVWELM 213

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  138 bits (350), Expect = 1e-36
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 34/205 (16%)

Query: 279 VIGVGGFGDVYKG---FINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSL 334
           +IG G  G+V  G          PVAIK L+   +++   +F +E  ++ Q  H +++ L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
            G     R  ++V ++M  G+L   L  + +      Q + +  G   G+ YL       
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYL--SDLG- 171

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ----------- 443
             +HRD+   N+L+D   V KVSDFGLS+           DP+                 
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGLSRV-------LEDDPDAAYTTTGGKIPIRWTAP 223

Query: 444 -------LTEKSDVYSFGVVLFEVL 461
                   +  SDV+SFGVV++EVL
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVL 248

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  136 bits (346), Expect = 2e-36
 Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 37/207 (17%)

Query: 279 VIGVGGFGDVYKGFIN---GSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLV 332
            +G G FG V +G  +   G T  VA+K L+P+     +   +F  E+  +  L H +L+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            L G        + V +    G+L D L                 +  A G+ YL   + 
Sbjct: 85  RLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLE--SK 140

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ--------- 443
               IHRD+   N+LL  + + K+ DFGL +  P        + ++Y +Q+         
Sbjct: 141 R--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ-------NDDHYVMQEHRKVPFAWC 191

Query: 444 ---------LTEKSDVYSFGVVLFEVL 461
                     +  SD + FGV L+E+ 
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMF 218

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  137 bits (347), Expect = 2e-36
 Identities = 62/208 (29%), Positives = 93/208 (44%), Gaps = 39/208 (18%)

Query: 279 VIGVGGFGDVYKGFIN----GSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVS 333
            +G G FG V     +    G+   VA+K L+ ++       ++ EI +L  L H H++ 
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97

Query: 334 LIGFCNDDRE--MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
             G C D     + LV +++  G+L D+L       +   Q L        G+ YLH  A
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH--A 152

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL------- 444
            H   IHRD+   N+LLD   + K+ DFGL+K  P          EYYR+++        
Sbjct: 153 QH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-------GHEYYRVREDGDSPVFW 203

Query: 445 -----------TEKSDVYSFGVVLFEVL 461
                         SDV+SFGV L+E+L
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELL 231

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  137 bits (348), Expect = 3e-36
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 35/206 (16%)

Query: 279 VIGVGGFGDVYKGFINGST----TPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVS 333
           VIG G FG+VYKG +  S+     PVAIK L+   +++  ++F  E G++ Q  H +++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L G  +  + M+++ ++M  G L   L    +      Q + +  G A G+ YL     +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYLA--NMN 167

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ---------- 443
              +HRD+   NIL++   V KVSDFGLS+           DPE                
Sbjct: 168 --YVHRDLAARNILVNSNLVCKVSDFGLSRV-------LEDDPEATYTTSGGKIPIRWTA 218

Query: 444 --------LTEKSDVYSFGVVLFEVL 461
                    T  SDV+SFG+V++EV+
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVM 244

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  137 bits (347), Expect = 3e-36
 Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 50/225 (22%)

Query: 279 VIGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            +G G FG V+    +          VA+K L+  S+    +FQ E  +L+ L+H H+V 
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHL-------------YHSDNPPLPWNQRLEICIGA 380
             G C + R +++V+++M  G L   L                   PL   Q L +    
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYR 440
           A G+ YL     H   +HRD+ T N L+ +  V K+ DFG+S+   ++        +YYR
Sbjct: 168 AAGMVYL--AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST--------DYYR 215

Query: 441 LQQL------------------TEKSDVYSFGVVLFEV--LCARP 465
           +                     T +SDV+SFGVVL+E+     +P
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  138 bits (350), Expect = 3e-36
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 34/205 (16%)

Query: 279 VIGVGGFGDVYKGFIN---GSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSL 334
           V+G G FG+V  G +         VAIK L+   +++   +F  E  ++ Q  H +++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
            G     + +++V ++M  G+L   L    +      Q + +  G A G+ YL       
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYL--SDMG- 167

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ----------- 443
             +HRD+   NIL++   V KVSDFGL +           DPE     +           
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLGRV-------LEDDPEAAYTTRGGKIPIRWTSP 219

Query: 444 -------LTEKSDVYSFGVVLFEVL 461
                   T  SDV+S+G+VL+EV+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVM 244

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  135 bits (342), Expect = 5e-36
 Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 35/204 (17%)

Query: 279 VIGVGGFGDVYKGF---INGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVSL 334
           ++G G FG+VY+G      G    VA+K  + +       +F +E  ++  L H H+V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           IG   ++   I + +    G L  +L   +   L     +   +   + + YL   + + 
Sbjct: 79  IGIIEEEPTWI-IMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLE--SIN- 133

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQ------------ 442
             +HRD+   NIL+      K+ DFGLS++          D +YY+              
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLSRY--------IEDEDYYKASVTRLPIKWMSPE 184

Query: 443 -----QLTEKSDVYSFGVVLFEVL 461
                + T  SDV+ F V ++E+L
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEIL 208

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  135 bits (343), Expect = 6e-36
 Identities = 62/208 (29%), Positives = 88/208 (42%), Gaps = 38/208 (18%)

Query: 279 VIGVGGFGDVYKGF---INGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G       +    AIK L      Q    F  E  ++  L H ++++L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 335 IGFCNDDREMIL-VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           IG       +   +  +M  G L   +  S          +   +  ARG+ YL      
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYLA--EQK 144

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL--------- 444
              +HRD+   N +LDE +  KV+DFGL++          LD EYY +QQ          
Sbjct: 145 --FVHRDLAARNCMLDESFTVKVADFGLARD--------ILDREYYSVQQHRHARLPVKW 194

Query: 445 -----------TEKSDVYSFGVVLFEVL 461
                      T KSDV+SFGV+L+E+L
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELL 222

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  136 bits (344), Expect = 8e-36
 Identities = 73/320 (22%), Positives = 129/320 (40%), Gaps = 83/320 (25%)

Query: 279 VIGVGGFGDVYKGFING-----STTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLV 332
            +G G FG VY+G   G       T VAIK +    S +  +EF  E  ++ +    H+V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 333 SLIGFCNDDREMILVYDFMARGTL--------PDHLYHSDNPPLPWNQRLEICIGAARGL 384
            L+G  +  +  +++ + M RG L        P    +    P   ++ +++    A G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 385 HYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL 444
            YL+  AN    +HRD+   N ++ E +  K+ DFG+++         + + +YYR    
Sbjct: 152 AYLN--ANK--FVHRDLAARNCMVAEDFTVKIGDFGMTR-------DIY-ETDYYRKGGK 199

Query: 445 ------------------TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCY 486
                             T  SDV+SFGVVL+E+                +L   A+Q Y
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATL---AEQPY 241

Query: 487 QNGTIDQIVDPFLKA------------------MSCLNDEGIRRPSMSDVVWGLEFSLQ- 527
           Q  + +Q++  F+                      C       RPS  +++  ++  ++ 
Sbjct: 242 QGLSNEQVLR-FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300

Query: 528 -LQESSIAIAKEIDENEEEE 546
             +E S   ++E    E EE
Sbjct: 301 GFREVSFYYSEENKLPEPEE 320

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  135 bits (342), Expect = 9e-36
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 51/225 (22%)

Query: 280 IGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           +G G FG V+               VA+K L+  +     +FQ E  +L+ L+H H+V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 335 IGFCNDDREMILVYDFMARGTLPDHL--------------YHSDNPPLPWNQRLEICIGA 380
            G C D   +I+V+++M  G L   L                     L  +Q L I    
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYR 440
           A G+ YL   + H   +HRD+ T N L+    + K+ DFG+S+     V  T    +YYR
Sbjct: 143 ASGMVYL--ASQH--FVHRDLATRNCLVGANLLVKIGDFGMSR----DVYST----DYYR 190

Query: 441 LQQL------------------TEKSDVYSFGVVLFEV--LCARP 465
           +                     T +SDV+SFGV+L+E+     +P
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  136 bits (345), Expect = 1e-35
 Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 22/200 (11%)

Query: 279 VIGVGGFGDVYKGF---INGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           VIG G FG VY G     +G     A+K L          +F TE  ++    H +++SL
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155

Query: 335 IGFCNDDRE-MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +G C       ++V  +M  G L + +  ++         +   +  A+G+ +L   +  
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLA--SKK 212

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKF----GPTSVSKTHLD--------PEYYRL 441
              +HRD+   N +LDEK+  KV+DFGL++        SV               E  + 
Sbjct: 213 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270

Query: 442 QQLTEKSDVYSFGVVLFEVL 461
           Q+ T KSDV+SFGV+L+E++
Sbjct: 271 QKFTTKSDVWSFGVLLWELM 290

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  134 bits (340), Expect = 2e-35
 Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 46/216 (21%)

Query: 279 VIGVGGFGDVYKGF---INGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVS 333
           ++G G FG V +G     +G++  VA+K ++ +  SQ+   EF +E   +    H +++ 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100

Query: 334 LIGFCNDD------REMILVYDFMARGTLPDHL----YHSDNPPLPWNQRLEICIGAARG 383
           L+G C +       + M+++  FM  G L  +L      +    +P    L+  +  A G
Sbjct: 101 LLGVCIEMSSQGIPKPMVIL-PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ 443
           + YL     +   +HRD+   N +L +     V+DFGLSK       K +   +YYR  +
Sbjct: 160 MEYL--SNRN--FLHRDLAARNCMLRDDMTVCVADFGLSK-------KIY-SGDYYRQGR 207

Query: 444 L------------------TEKSDVYSFGVVLFEVL 461
           +                  T KSDV++FGV ++E+ 
Sbjct: 208 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  133 bits (337), Expect = 3e-35
 Identities = 53/204 (25%), Positives = 79/204 (38%), Gaps = 35/204 (17%)

Query: 279 VIGVGGFGDVYKG---FINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSL 334
            IG G FGDV++G           VAIK  +   S     +F  E   + Q  H H+V L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           IG   ++   I + +    G L   L       L     +      +  L YL   +   
Sbjct: 82  IGVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKR- 136

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQ------------ 442
             +HRD+   N+L+      K+ DFGLS++          D  YY+              
Sbjct: 137 -FVHRDIAARNVLVSSNDCVKLGDFGLSRY--------MEDSTYYKASKGKLPIKWMAPE 187

Query: 443 -----QLTEKSDVYSFGVVLFEVL 461
                + T  SDV+ FGV ++E+L
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEIL 211

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  133 bits (337), Expect = 3e-35
 Identities = 63/251 (25%), Positives = 100/251 (39%), Gaps = 22/251 (8%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
            IG G F  VYKG    +T  VA    +    ++     F+ E  ML  L+H ++V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 337 ----FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
                    + ++LV + M  GTL  +L       +        C    +GL +LHT   
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHT--R 148

Query: 393 HAVIIHRDVKTTNILLDEK-WVAKVSDFGLSKFGPTSVSKTHLD------PEYYRLQQLT 445
              IIHRD+K  NI +       K+ D GL+     S +K  +       PE Y  ++  
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-EKYD 207

Query: 446 EKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKA--MS 503
           E  DVY+FG+ + E+  +           Q+   V +    +  + D++  P +K     
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--KPASFDKVAIPEVKEIIEG 265

Query: 504 CLNDEGIRRPS 514
           C+      R S
Sbjct: 266 CIRQNKDERYS 276

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  133 bits (337), Expect = 4e-35
 Identities = 56/227 (24%), Positives = 99/227 (43%), Gaps = 52/227 (22%)

Query: 279 VIGVGGFGDVYKGFING-----STTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLV 332
            +G   FG VYKG + G      T  VAIK L +        EF+ E  + ++L+H ++V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHL--------------YHSDNPPLPWNQRLEICI 378
            L+G    D+ + +++ + + G L + L                +    L     + +  
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135

Query: 379 GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY 438
             A G+ YL   ++H  ++H+D+ T N+L+ +K   K+SD GL +    +        +Y
Sbjct: 136 QIAAGMEYL--SSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAA--------DY 183

Query: 439 YRLQQL------------------TEKSDVYSFGVVLFEV--LCARP 465
           Y+L                     +  SD++S+GVVL+EV     +P
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  132 bits (335), Expect = 1e-34
 Identities = 64/221 (28%), Positives = 92/221 (41%), Gaps = 46/221 (20%)

Query: 279 VIGVGGFGDVYKGFING-----STTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLV 332
            +G G FG+VY+G ++G     S   VA+K L    S+Q  L+F  E  ++S+  H ++V
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHL-----YHSDNPPLPWNQRLEICIGAARGLHYL 387
             IG         ++ + MA G L   L       S    L     L +    A G  YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

Query: 388 HTGANHAVIIHRDVKTTNILLDEKW---VAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL 444
               NH   IHRD+   N LL       VAK+ DFG+++    +         YYR    
Sbjct: 157 --EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA--------SYYRKGGC 204

Query: 445 ------------------TEKSDVYSFGVVLFEV--LCARP 465
                             T K+D +SFGV+L+E+  L   P
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  132 bits (334), Expect = 2e-34
 Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 21/198 (10%)

Query: 279 VIGVGGFGDVYKGF----INGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVS 333
           V+G G FG VYKG           PVAIK L   +   A  E   E  +++ + + H+  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L+G C      + +   M  G L D++       +     L  C+  A+G++YL    + 
Sbjct: 82  LLGICLTSTVQL-ITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL---EDR 136

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD----------PEYYRLQQ 443
             ++HRD+   N+L+      K++DFGL+K       + H +           E    + 
Sbjct: 137 R-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 444 LTEKSDVYSFGVVLFEVL 461
            T +SDV+S+GV ++E++
Sbjct: 196 YTHQSDVWSYGVTVWELM 213

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  132 bits (333), Expect = 2e-34
 Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 45/216 (20%)

Query: 279 VIGVGGFGDVYKGFIN---GSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVS 333
           ++G G FG V +  +    GS   VA+K L+ +  +     EF  E   + +  H H+  
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89

Query: 334 LIGFCNDDR------EMILVYDFMARGTLPDHL----YHSDNPPLPWNQRLEICIGAARG 383
           L+G     R        +++  FM  G L   L       +   LP    +   +  A G
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ 443
           + YL   + +   IHRD+   N +L E     V+DFGLS+       K +   +YYR   
Sbjct: 150 MEYL--SSRN--FIHRDLAARNCMLAEDMTVCVADFGLSR-------KIY-SGDYYRQGC 197

Query: 444 L------------------TEKSDVYSFGVVLFEVL 461
                              T  SDV++FGV ++E++
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  132 bits (334), Expect = 2e-34
 Identities = 62/328 (18%), Positives = 125/328 (38%), Gaps = 94/328 (28%)

Query: 279 VIGVGGFGDVYKGFING-------STTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHL 329
            +G G FG V      G           VA+K L+ + +++   +  +E+ M+  + +H 
Sbjct: 42  PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101

Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHL--------------YHSDNPPLPWNQRLE 375
           ++++L+G C  D  + ++ ++ ++G L ++L                     + +   + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161

Query: 376 ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD 435
                ARG+ YL   +     IHRD+   N+L+ E  V K++DFGL++         +  
Sbjct: 162 CTYQLARGMEYL--ASQK--CIHRDLAARNVLVTENNVMKIADFGLAR-------DINNI 210

Query: 436 PEYYRLQQL------------------TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVS 477
            +YY+                      T +SDV+SFGV+++E+                +
Sbjct: 211 -DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI---------------FT 254

Query: 478 LAVWAQQCYQNGTIDQIVDPFLKA------------------MSCLNDEGIRRPSMSDVV 519
           L       Y    ++++    LK                     C +    +RP+   +V
Sbjct: 255 L---GGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

Query: 520 WGLEFSLQLQESSIAIAKEIDENEEEEK 547
             L+  L L  +       +D ++  E+
Sbjct: 311 EDLDRILTLTTNEE----YLDLSQPLEQ 334

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  136 bits (344), Expect = 4e-34
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 34/206 (16%)

Query: 277 DLVIGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGAL-EFQTEIGMLSQLRHLHLVS 333
           D+ +G G FG V +G   +      VAIK L+  +++    E   E  ++ QL + ++V 
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           LIG C  +  M+ V +    G L   L       +P +   E+    + G+ YL     +
Sbjct: 401 LIGVCQAEALML-VMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYL--EEKN 456

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQ---------- 443
              +HR++   N+LL  +  AK+SDFGLSK           D  YY  +           
Sbjct: 457 --FVHRNLAARNVLLVNRHYAKISDFGLSKA-------LGADDSYYTARSAGKWPLKWYA 507

Query: 444 --------LTEKSDVYSFGVVLFEVL 461
                    + +SDV+S+GV ++E L
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEAL 533

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  132 bits (333), Expect = 5e-34
 Identities = 64/221 (28%), Positives = 92/221 (41%), Gaps = 46/221 (20%)

Query: 279 VIGVGGFGDVYKGFING-----STTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLV 332
            +G G FG+VY+G ++G     S   VA+K L    S+Q  L+F  E  ++S+  H ++V
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHL-----YHSDNPPLPWNQRLEICIGAARGLHYL 387
             IG         ++ + MA G L   L       S    L     L +    A G  YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 388 HTGANHAVIIHRDVKTTNILLDEKW---VAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL 444
               NH   IHRD+   N LL       VAK+ DFG+++    +         YYR    
Sbjct: 198 --EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA--------GYYRKGGC 245

Query: 445 ------------------TEKSDVYSFGVVLFEV--LCARP 465
                             T K+D +SFGV+L+E+  L   P
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  132 bits (333), Expect = 5e-34
 Identities = 58/304 (19%), Positives = 116/304 (38%), Gaps = 90/304 (29%)

Query: 279 VIGVGGFGDVYKGFING-------STTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHL 329
            +G G FG V      G           VA+K L+ + +++   +  +E+ M+  + +H 
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147

Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHL--------------YHSDNPPLPWNQRLE 375
           ++++L+G C  D  + ++ ++ ++G L ++L                     + +   + 
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207

Query: 376 ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD 435
                ARG+ YL   +     IHRD+   N+L+ E  V K++DFGL++         +  
Sbjct: 208 CTYQLARGMEYL--ASQK--CIHRDLAARNVLVTENNVMKIADFGLAR-------DINNI 256

Query: 436 PEYYRLQQL------------------TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVS 477
            +YY+                      T +SDV+SFGV+++E+                +
Sbjct: 257 -DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI---------------FT 300

Query: 478 LAVWAQQCYQNGTIDQIVDPFLKA------------------MSCLNDEGIRRPSMSDVV 519
           L       Y    ++++    LK                     C +    +RP+   +V
Sbjct: 301 L---GGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356

Query: 520 WGLE 523
             L+
Sbjct: 357 EDLD 360

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  130 bits (330), Expect = 6e-34
 Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 21/198 (10%)

Query: 279 VIGVGGFGDVYKGF----INGSTTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLVS 333
           V+G G FG V+KG           PV IK + +   +Q        +  +  L H H+V 
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L+G C      + V  ++  G+L DH+       L     L   +  A+G++YL     H
Sbjct: 80  LLGLCPGSSLQL-VTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYL---EEH 134

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD----------PEYYRLQQ 443
             ++HR++   N+LL      +V+DFG++   P    +               E     +
Sbjct: 135 G-MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193

Query: 444 LTEKSDVYSFGVVLFEVL 461
            T +SDV+S+GV ++E++
Sbjct: 194 YTHQSDVWSYGVTVWELM 211

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  135 bits (342), Expect = 1e-33
 Identities = 55/196 (28%), Positives = 81/196 (41%), Gaps = 19/196 (9%)

Query: 279 VIGVGGFGDVYKGF---INGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSL 334
            IG G FGDV++G           VAIK  +   S     +F  E   + Q  H H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           IG   ++   I + +    G L   L       L     +      +  L YL   +   
Sbjct: 457 IGVITENPVWI-IMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLE--SKR- 511

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKF----GPTSVSKTHL-----DPEYYRLQQLT 445
             +HRD+   N+L+      K+ DFGLS++         SK  L      PE    ++ T
Sbjct: 512 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570

Query: 446 EKSDVYSFGVVLFEVL 461
             SDV+ FGV ++E+L
Sbjct: 571 SASDVWMFGVCMWEIL 586

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  129 bits (326), Expect = 2e-33
 Identities = 57/228 (25%), Positives = 91/228 (39%), Gaps = 58/228 (25%)

Query: 279 VIGVGGFGDVYKGFING-----STTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLV 332
            +G G FG V K            T VA+K L E  S     +  +E  +L Q+ H H++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHL----------------------YHSDNPPLPW 370
            L G C+ D  ++L+ ++   G+L   L                       H D   L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 371 NQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS 430
              +      ++G+ YL        ++HRD+   NIL+ E    K+SDFGLS+       
Sbjct: 150 GDLISFAWQISQGMQYL--AEMK--LVHRDLAARNILVAEGRKMKISDFGLSR------- 198

Query: 431 KTHLDPEYYRLQQL------------------TEKSDVYSFGVVLFEV 460
             + + + Y  +                    T +SDV+SFGV+L+E+
Sbjct: 199 DVYEE-DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  129 bits (327), Expect = 2e-33
 Identities = 71/321 (22%), Positives = 122/321 (38%), Gaps = 95/321 (29%)

Query: 279 VIGVGGFGDVYKGFING-----STTPVAIKRL-EPESQQGALEFQTEIGMLSQLRHLHLV 332
            IG G FG V++    G       T VA+K L E  S     +FQ E  ++++  + ++V
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHL----------------------YHSDNPPLPW 370
            L+G C   + M L++++MA G L + L                           PPL  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173

Query: 371 NQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS 430
            ++L I    A G+ YL         +HRD+ T N L+ E  V K++DFGLS+    ++ 
Sbjct: 174 AEQLCIARQVAAGMAYL--SERK--FVHRDLATRNCLVGENMVVKIADFGLSR----NIY 225

Query: 431 KTHLDPEYYRLQQL------------------TEKSDVYSFGVVLFEVLCARPSILRTAA 472
                 +YY+                      T +SDV+++GVVL+E+            
Sbjct: 226 SA----DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI------------ 269

Query: 473 KKQVSLAVWAQQCYQNGTIDQIVDPFLKA------------------MSCLNDEGIRRPS 514
               S      Q Y     ++++  +++                     C +     RPS
Sbjct: 270 ---FSY---GLQPYYGMAHEEVIY-YVRDGNILACPENCPLELYNLMRLCWSKLPADRPS 322

Query: 515 MSDVVWGLEFSLQLQESSIAI 535
              +   L+   +  E ++ +
Sbjct: 323 FCSIHRILQRMCERAEGTVGV 343

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  127 bits (322), Expect = 6e-33
 Identities = 52/223 (23%), Positives = 89/223 (39%), Gaps = 53/223 (23%)

Query: 279 VIGVGGFGDVYKGFING-----STTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHL 331
            +G G FG V +    G     +   VA+K L+P           +E+ +LS L  H+++
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHL----------------YHSDNPPLPWNQRLE 375
           V+L+G C      +++ ++   G L + L                   D   L     L 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 376 ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD 435
                A+G+ +L   + +   IHRD+   NILL    + K+ DFGL++           D
Sbjct: 150 FSYQVAKGMAFLA--SKN--CIHRDLAARNILLTHGRITKICDFGLAR-------DIKND 198

Query: 436 PEYYRLQQ------------------LTEKSDVYSFGVVLFEV 460
              Y ++                    T +SDV+S+G+ L+E+
Sbjct: 199 -SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  127 bits (322), Expect = 9e-33
 Identities = 51/219 (23%), Positives = 91/219 (41%), Gaps = 49/219 (22%)

Query: 279 VIGVGGFGDVYKGFING-----STTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHL 331
            +G G FG V +    G     +   VA+K L+            +E+ ++S L +H ++
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHL------------YHSDNPPLPWNQRLEICIG 379
           V+L+G C     ++++ ++   G L + L            +   N        L     
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172

Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYY 439
            A+G+ +L   + +   IHRDV   N+LL    VAK+ DFGL++           D   Y
Sbjct: 173 VAQGMAFL--ASKN--CIHRDVAARNVLLTNGHVAKIGDFGLAR-------DIMND-SNY 220

Query: 440 RLQQL------------------TEKSDVYSFGVVLFEV 460
            ++                    T +SDV+S+G++L+E+
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  127 bits (322), Expect = 2e-32
 Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 53/223 (23%)

Query: 279 VIGVGGFGDVYKGFING-------STTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHL 329
            +G G FG V      G         T VA+K L+ + +++   +  +E+ M+  + +H 
Sbjct: 76  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135

Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHL--------------YHSDNPPLPWNQRLE 375
           ++++L+G C  D  + ++ ++ ++G L ++L               H+    L     + 
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195

Query: 376 ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD 435
                ARG+ YL   +     IHRD+   N+L+ E  V K++DFGL++         H  
Sbjct: 196 CAYQVARGMEYL--ASKK--CIHRDLAARNVLVTEDNVMKIADFGLAR-------DIHHI 244

Query: 436 PEYYRLQQL------------------TEKSDVYSFGVVLFEV 460
            +YY+                      T +SDV+SFGV+L+E+
Sbjct: 245 -DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  125 bits (316), Expect = 5e-32
 Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 52/222 (23%)

Query: 279 VIGVGGFGDVYKGFING-----STTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHL 331
            +G G FG V +    G     +   VA+K L+   +        +E+ +L  +  HL++
Sbjct: 34  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93

Query: 332 VSLIGFCND-DREMILVYDFMARGTLPDHL--------------YHSDNPPLPWNQRLEI 376
           V+L+G C      ++++ +F   G L  +L                     L     +  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153

Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDP 436
               A+G+ +L   +     IHRD+   NILL EK V K+ DFGL++         + D 
Sbjct: 154 SFQVAKGMEFL--ASRK--CIHRDLAARNILLSEKNVVKICDFGLAR-------DIYKD- 201

Query: 437 EYYRLQQ------------------LTEKSDVYSFGVVLFEV 460
             Y  +                    T +SDV+SFGV+L+E+
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  124 bits (313), Expect = 2e-31
 Identities = 52/228 (22%), Positives = 91/228 (39%), Gaps = 58/228 (25%)

Query: 279 VIGVGGFGDVYKGFING-----STTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHL 331
           V+G G FG V      G      +  VA+K L+ +          +E+ M++QL  H ++
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111

Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHL---------------------YHSDNPPLPW 370
           V+L+G C     + L++++   G L ++L                        D   L +
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171

Query: 371 NQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS 430
              L      A+G+ +L         +HRD+   N+L+    V K+ DFGL++       
Sbjct: 172 EDLLCFAYQVAKGMEFL--EFKS--CVHRDLAARNVLVTHGKVVKICDFGLAR------- 220

Query: 431 KTHLDPEYYRLQQ------------------LTEKSDVYSFGVVLFEV 460
               D   Y ++                    T KSDV+S+G++L+E+
Sbjct: 221 DIMSD-SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  122 bits (307), Expect = 7e-31
 Identities = 53/213 (24%), Positives = 82/213 (38%), Gaps = 30/213 (14%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            +G GGF  V            A+KR+    QQ   E Q E  M     H +++ L+ +C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 339 NDDR----EMILVYDFMARGTLPDHL--YHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
             +R    E  L+  F  RGTL + +         L  +Q L + +G  RGL  +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---- 151

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSK---FGPTSVSKTHLDPE--------YYR- 440
                HRD+K TNILL ++    + D G             +     +         YR 
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211

Query: 441 --------LQQLTEKSDVYSFGVVLFEVLCARP 465
                      + E++DV+S G VL+ ++    
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  118 bits (297), Expect = 8e-30
 Identities = 59/272 (21%), Positives = 108/272 (39%), Gaps = 42/272 (15%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL 331
            +F    +IG GGFG V+K           IKR++  ++    + + E+  L++L H+++
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66

Query: 332 VSLIGFCNDDREMI----------------LVYDFMARGTLPDHLYHSDNPPLPWNQRLE 375
           V   G  +                      +  +F  +GTL   +       L     LE
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 376 ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH- 433
           +     +G+ Y+H+      +I+RD+K +NI L +    K+ DFGL              
Sbjct: 127 LFEQITKGVDYIHS--KK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK 182

Query: 434 -----LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN 488
                + PE    Q   ++ D+Y+ G++L E+L    +   T+               ++
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD---------LRD 233

Query: 489 GTIDQIVDPFLKAM--SCLNDEGIRRPSMSDV 518
           G I  I D   K +    L+ +   RP+ S++
Sbjct: 234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  117 bits (295), Expect = 2e-29
 Identities = 45/200 (22%), Positives = 85/200 (42%), Gaps = 17/200 (8%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRL---EPESQQGALEFQTEIGMLSQLRHLHLVSLI 335
            IG G F +VY+        PVA+K++   +    +   +   EI +L QL H +++   
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 336 GFCNDDREMILVYDFMARGTLPDHL--YHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
               +D E+ +V +    G L   +  +      +P     +  +     L ++H  +  
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--SRR 156

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLT 445
             ++HRD+K  N+ +    V K+ D GL +F  +  +  H        + PE        
Sbjct: 157 --VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 214

Query: 446 EKSDVYSFGVVLFEVLCARP 465
            KSD++S G +L+E+   + 
Sbjct: 215 FKSDIWSLGCLLYEMAALQS 234

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  118 bits (297), Expect = 3e-29
 Identities = 43/197 (21%), Positives = 82/197 (41%), Gaps = 14/197 (7%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
            IG G FG               IK   +   S +   E + E+ +L+ ++H ++V    
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
              ++  + +V D+   G L   +          +Q L+  +     L ++H       I
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD--RK--I 146

Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLTEKS 448
           +HRD+K+ NI L +    ++ DFG+++   ++V            L PE    +    KS
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKS 206

Query: 449 DVYSFGVVLFEVLCARP 465
           D+++ G VL+E+   + 
Sbjct: 207 DIWALGCVLYELCTLKH 223

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  114 bits (287), Expect = 2e-28
 Identities = 59/263 (22%), Positives = 101/263 (38%), Gaps = 33/263 (12%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            IG G +G   K         +  K      +    +Q  +   +E+ +L +L+H ++V 
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVNLLRELKHPNIVR 69

Query: 334 LIG--FCNDDREMILVYDFMARGTLPDHL--YHSDNPPLPWNQRLEICIGAARGLHYLHT 389
                    +  + +V ++   G L   +     +   L     L +       L   H 
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129

Query: 390 -GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSVSKTH------LDPEYYR 440
                  ++HRD+K  N+ LD K   K+ DFGL++     TS +KT       + PE   
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMN 189

Query: 441 LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF-- 498
                EKSD++S G +L+E+    P      A  Q  LA       + G   +I   +  
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPF---TAFSQKELA----GKIREGKFRRIPYRYSD 242

Query: 499 -LKAM--SCLNDEGIRRPSMSDV 518
            L  +    LN +   RPS+ ++
Sbjct: 243 ELNEIITRMLNLKDYHRPSVEEI 265

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  113 bits (284), Expect = 7e-28
 Identities = 46/207 (22%), Positives = 72/207 (34%), Gaps = 25/207 (12%)

Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQL-RHL 329
           +F     +G G +G+V+K          A+K         +       E+G   ++ +H 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
             V L     +   + L  +     +L  H        LP  Q           L +LH+
Sbjct: 118 CCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLHS 175

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTHL-DPEY--------- 438
                 ++H DVK  NI L  +   K+ DFGL    G     +    DP Y         
Sbjct: 176 --QG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS 231

Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
           Y        +DV+S G+ + EV C   
Sbjct: 232 Y-----GTAADVFSLGLTILEVACNME 253

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  112 bits (283), Expect = 8e-28
 Identities = 61/295 (20%), Positives = 109/295 (36%), Gaps = 65/295 (22%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH 330
            ++F+   V+G G FG V K      +   AIK++    ++ +    +E+ +L+ L H +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQY 63

Query: 331 LVSLIGFCNDDREMI-------------LVYDFMARGTLPDHLYHSDNPPLPWNQRLEIC 377
           +V       + R  +             +  ++   GTL D + HS+N     ++   + 
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYWRLF 122

Query: 378 IGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD-- 435
                 L Y+H  +    IIHRD+K  NI +DE    K+ DFGL+K    S+    LD  
Sbjct: 123 RQILEALSYIH--SQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 436 --------------------PE------YYRLQQLTEKSDVYSFGVVLFEVLCA------ 463
                                E      +Y      EK D+YS G++ FE++        
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIYPFSTGME 233

Query: 464 RPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDV 518
           R +IL+      +                      ++ +   +    +RP    +
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKK-----IIRLLIDHDPN--KRPGARTL 281

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  112 bits (282), Expect = 1e-27
 Identities = 39/149 (26%), Positives = 74/149 (49%), Gaps = 5/149 (3%)

Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
           ++    +G G FG VYK     +    A K +E +S++   ++  EI +L+   H ++V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L+G    D ++ ++ +F   G +   +    +  L   Q   +C      L++LH  +  
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLH--SKR 137

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLS 422
             IIHRD+K  N+L+  +   +++DFG+S
Sbjct: 138 --IIHRDLKAGNVLMTLEGDIRLADFGVS 164

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  111 bits (279), Expect = 2e-27
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 18/198 (9%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALE-FQTEIGMLSQLRHLHLVSLIG 336
           +G GG   VY          VAIK +      ++  L+ F+ E+   SQL H ++VS+I 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
              +D    LV +++   TL +++    + PL  +  +        G+ + H       I
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAH----DMRI 132

Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH--------LDPEYYRLQQLTEK 447
           +HRD+K  NIL+D     K+ DFG++K    TS+++T+          PE  + +   E 
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192

Query: 448 SDVYSFGVVLFEVLCARP 465
           +D+YS G+VL+E+L   P
Sbjct: 193 TDIYSIGIVLYEMLVGEP 210

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  110 bits (277), Expect = 4e-27
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 27/202 (13%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLE-PESQQGALEFQT--EIGMLSQLRHLHLVSLI 335
            +G G FG+VY      +   +A+K L   + ++  +E Q   EI + S LRH +++ + 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA------ARGLHYLHT 389
            + +D + + L+ +F  RG L   L          + R +    A      A  LHY H 
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQK--------HGRFDEQRSATFMEELADALHYCH- 131

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPEYYRLQQ 443
                 +IHRD+K  N+L+  K   K++DFG S   P+   +T      +L PE    + 
Sbjct: 132 -ERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKT 188

Query: 444 LTEKSDVYSFGVVLFEVLCARP 465
             EK D++  GV+ +E L   P
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMP 210

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  109 bits (276), Expect = 5e-27
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 27/202 (13%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQT--EIGMLSQLRHLHLVSLI 335
            +G G FG+VY      S   +A+K L     ++  +E Q   E+ + S LRH +++ L 
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA------ARGLHYLHT 389
           G+ +D   + L+ ++   GT+   L            + +    A      A  L Y H 
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKL--------SKFDEQRTATYITELANALSYCH- 126

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPEYYRLQQ 443
            +    +IHRD+K  N+LL      K++DFG S   P+S          +L PE    + 
Sbjct: 127 -SKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRM 183

Query: 444 LTEKSDVYSFGVVLFEVLCARP 465
             EK D++S GV+ +E L  +P
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKP 205

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  111 bits (279), Expect = 6e-27
 Identities = 41/230 (17%), Positives = 86/230 (37%), Gaps = 46/230 (20%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK----------------RLEPESQQGALE 315
           N++     +  G F  +     +      A+K                  +  S +   +
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEKDNKF--YALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 316 -FQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL 374
            F+ E+ +++ +++ + ++  G   +  E+ ++Y++M   ++     +       +   +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 375 EICIGA------ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS 428
            I +             Y+H   N   I HRDVK +NIL+D+    K+SDFG S++    
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205

Query: 429 VSKT------HLDPE-------YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
             K        + PE       Y        K D++S G+ L+ +     
Sbjct: 206 KIKGSRGTYEFMPPEFFSNESSYN-----GAKVDIWSLGICLYVMFYNVV 250

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  109 bits (275), Expect = 1e-26
 Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 15/197 (7%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH 330
              FD    +G G +G VYK     +   VAIK++  ES     E   EI ++ Q    H
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ--EIIKEISIMQQCDSPH 85

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           +V   G    + ++ +V ++   G++ D +    N  L  ++   I     +GL YLH  
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144

Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQ 442
                 IHRD+K  NILL+ +  AK++DFG++     +++K +        + PE  +  
Sbjct: 145 R----KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200

Query: 443 QLTEKSDVYSFGVVLFE 459
                +D++S G+   E
Sbjct: 201 GYNCVADIWSLGITAIE 217

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  108 bits (271), Expect = 3e-26
 Identities = 46/194 (23%), Positives = 84/194 (43%), Gaps = 15/194 (7%)

Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
           +     IG G  G VY      +   VAI+++  + Q        EI ++ + ++ ++V+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
            +       E+ +V +++A G+L D +       +   Q   +C    + L +LH+    
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ-- 136

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLT 445
             +IHRD+K+ NILL      K++DFG         SK          + PE    +   
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194

Query: 446 EKSDVYSFGVVLFE 459
            K D++S G++  E
Sbjct: 195 PKVDIWSLGIMAIE 208

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  108 bits (271), Expect = 5e-26
 Identities = 62/323 (19%), Positives = 107/323 (33%), Gaps = 62/323 (19%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGF 337
           V+  GGF  VY+    GS    A+KRL    ++       E+  + +L  H ++V     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 338 C--------NDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLH 388
                        E +L+ +   +G L + L       PL  +  L+I     R + ++H
Sbjct: 95  ASIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153

Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF--GPTSVSKTHLD----------- 435
                  IIHRD+K  N+LL  +   K+ DFG +         S +              
Sbjct: 154 --RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 436 -------PE---YYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC 485
                  PE    Y    + EK D+++ G +L+ +        +   +    L +     
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF-----RQHPFEDGAKLRI----- 261

Query: 486 YQNGTIDQIVDPFLKAMS---------CLNDEGIRRPSMSDVVWGLEFSLQLQESSIAIA 536
             NG   +   P                L      R S+++V   +    ++  +     
Sbjct: 262 -VNG---KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEV---VHQLQEIAAARNVNP 314

Query: 537 KEIDENEEEEKLLDNYETDGSGP 559
           K       E+       T   GP
Sbjct: 315 KSPITELLEQNGGYGSATLSRGP 337

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  107 bits (270), Expect = 6e-26
 Identities = 48/194 (24%), Positives = 80/194 (41%), Gaps = 15/194 (7%)

Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            D+ + IG G  G V       S   VA+K ++   QQ       E+ ++   +H ++V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           +        E+ ++ +F+  G L D +       L   Q   +C    + L YLH     
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQG-- 161

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLT 445
             +IHRD+K+ +ILL      K+SDFG        V K          + PE        
Sbjct: 162 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYA 219

Query: 446 EKSDVYSFGVVLFE 459
            + D++S G+++ E
Sbjct: 220 TEVDIWSLGIMVIE 233

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  107 bits (269), Expect = 6e-26
 Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 16/195 (8%)

Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLV 332
           F     IG G FG+V+KG  N +   VAIK ++ E  +  +E  Q EI +LSQ    ++ 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
              G    D ++ ++ +++  G+  D L      PL   Q   I     +GL YLH+   
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATILREILKGLDYLHSEK- 139

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQL 444
               IHRD+K  N+LL E    K++DFG++     +  K +        + PE  +    
Sbjct: 140 ---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 196

Query: 445 TEKSDVYSFGVVLFE 459
             K+D++S G+   E
Sbjct: 197 DSKADIWSLGITAIE 211

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  111 bits (279), Expect = 9e-26
 Identities = 44/198 (22%), Positives = 71/198 (35%), Gaps = 21/198 (10%)

Query: 279 VIGVGGFGDVYKGF-INGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSLIG 336
            I  GG G +Y     N +  PV +K L       A      E   L+++ H  +V +  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 337 FCNDDREMILVYDFMA----RG-TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           F            ++      G +L           LP  + +   +     L YLH   
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH--- 199

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK----FGPTSVSKTHLDPEYYRLQQLTEK 447
               +++ D+K  NI+L E+ + K+ D G       FG    +     PE  R    T  
Sbjct: 200 -SIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSFGYLYGTPGFQAPEIVR-TGPTVA 256

Query: 448 SDVYSFGVVLFEVLCARP 465
           +D+Y+ G  L  +    P
Sbjct: 257 TDIYTVGRTLAALTLDLP 274

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  106 bits (268), Expect = 1e-25
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 24/204 (11%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALE-FQTEIGMLSQLRHLHLVSL-- 334
           +G GG  +V+          VA+K L  +          F+ E    + L H  +V++  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79

Query: 335 IGFCNDDREMI--LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            G        +  +V +++   TL D +      P+   + +E+   A + L++ H    
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSH---- 133

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH----------LDPEYYRL 441
              IIHRDVK  NI++      KV DFG+++    +  S T           L PE  R 
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 442 QQLTEKSDVYSFGVVLFEVLCARP 465
             +  +SDVYS G VL+EVL   P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEP 217

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  106 bits (267), Expect = 1e-25
 Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 31/212 (14%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLH 330
           ++++   VIG G    V   +       VAIKR+  E  Q +++    EI  +SQ  H +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 331 LVSLIG-FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE------ICIGAARG 383
           +VS    F   D E+ LV   ++ G++ D + H        +  L+      I      G
Sbjct: 75  IVSYYTSFVVKD-ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD-------- 435
           L YLH   N    IHRDVK  NILL E    +++DFG+S F  T    T           
Sbjct: 134 LEYLH--KNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 436 -----PEYYRLQQLT---EKSDVYSFGVVLFE 459
                PE   ++Q+     K+D++SFG+   E
Sbjct: 190 PCWMAPEV--MEQVRGYDFKADIWSFGITAIE 219

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  105 bits (265), Expect = 2e-25
 Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 32/207 (15%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           V+G G +G VY G    +   +AIK +     + +     EI +   L+H ++V  +G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWN---------QRLEICIGAARGLHYLHT 389
           +++  + +  + +  G+L   L  S   PL  N         Q LE       GL YLH 
Sbjct: 89  SENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQILE-------GLKYLHD 140

Query: 390 GANHAVIIHRDVKTTNILLDEKW-VAKVSDFGLSKFGPTSVSKTH--------LDPEYYR 440
                 I+HRD+K  N+L++    V K+SDFG SK        T         + PE   
Sbjct: 141 NQ----IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID 196

Query: 441 LQQL--TEKSDVYSFGVVLFEVLCARP 465
                  + +D++S G  + E+   +P
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKP 223

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  105 bits (264), Expect = 3e-25
 Identities = 47/210 (22%), Positives = 85/210 (40%), Gaps = 27/210 (12%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSLIGF 337
           ++G G   +V++G    +    AIK     S    ++    E  +L +L H ++V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 338 --CNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
                 R  +L+ +F   G+L   L   S+   LP ++ L +      G+++L    N  
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--ENG- 132

Query: 395 VIIHRDVKTTNILL----DEKWVAKVSDFGLSK-FGPTSVSKT------HLDPEYYRLQQ 443
            I+HR++K  NI+     D + V K++DFG ++         +      +L P+ Y    
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191

Query: 444 L--------TEKSDVYSFGVVLFEVLCARP 465
           L            D++S GV  +       
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  105 bits (264), Expect = 3e-25
 Identities = 48/199 (24%), Positives = 77/199 (38%), Gaps = 18/199 (9%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALE-FQTEIGMLSQLRHLHLVSLI 335
           ++G GG GDVY+         VA+K +     S        Q E     +L+  H+V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
            F   D ++ +    +    L   L      PL   + + I       L   H     A 
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAH----AAG 154

Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH--------LDPEYYRLQQLTE 446
             HRDVK  NIL+     A + DFG++       +++          + PE +     T 
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATY 214

Query: 447 KSDVYSFGVVLFEVLCARP 465
           ++D+Y+   VL+E L   P
Sbjct: 215 RADIYALTCVLYECLTGSP 233

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  107 bits (268), Expect = 3e-25
 Identities = 43/198 (21%), Positives = 67/198 (33%), Gaps = 23/198 (11%)

Query: 281 GVGGFGDVYKGFINGSTTPVAIKR--LEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           G      V       +   V ++R  LE  S +     Q E+ +     H ++V      
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
             D E+ +V  FMA G+  D +       +       I  G  + L Y+H        +H
Sbjct: 96  IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH--MG--YVH 151

Query: 399 RDVKTTNILLDEKWVAKVSDFGLSK--FGPTSVSKTHLDPEYYR-----------LQQL- 444
           R VK ++IL+       +S    +          +   D   Y            LQQ  
Sbjct: 152 RSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL 211

Query: 445 ---TEKSDVYSFGVVLFE 459
                KSD+YS G+   E
Sbjct: 212 QGYDAKSDIYSVGITACE 229

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  105 bits (264), Expect = 6e-25
 Identities = 51/194 (26%), Positives = 87/194 (44%), Gaps = 12/194 (6%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEF-QTEIGMLSQLRHLHLVSLIGF 337
            +G G  G V+K     S   +A K +  E +         E+ +L +    ++V   G 
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
              D E+ +  + M  G+L D +       +P     ++ I   +GL YL        I+
Sbjct: 100 FYSDGEISICMEHMDGGSL-DQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHK---IM 154

Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYY----RLQQL--TEKSDVY 451
           HRDVK +NIL++ +   K+ DFG+S     S++ + +    Y    RLQ    + +SD++
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 214

Query: 452 SFGVVLFEVLCARP 465
           S G+ L E+   R 
Sbjct: 215 SMGLSLVEMAVGRY 228

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  107 bits (269), Expect = 1e-24
 Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 24/206 (11%)

Query: 279 VIGVGGFGDVYKGFINGST-TPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSLI- 335
            +G GGFG V +  I+  T   VAIK+   E      E +  EI ++ +L H ++VS   
Sbjct: 21  RLGTGGFGYVLRW-IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79

Query: 336 -----GFCNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHT 389
                     +   +L  ++   G L  +L    +   L       +    +  L YLH 
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH- 138

Query: 390 GANHAVIIHRDVKTTNILLD---EKWVAKVSDFGLSK-FGPTSVSKTH------LDPEYY 439
             N   IIHRD+K  NI+L    ++ + K+ D G +K      +          L PE  
Sbjct: 139 -ENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL 195

Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARP 465
             ++ T   D +SFG + FE +    
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFR 221

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  103 bits (260), Expect = 1e-24
 Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 12/168 (7%)

Query: 262 FSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIG 321
             LS ++     F+   ++G G +G VYKG    +    AIK ++    +   E + EI 
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEIN 72

Query: 322 MLSQL-RHLHLVSLIG------FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL 374
           ML +   H ++ +  G          D ++ LV +F   G++ D + ++    L      
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132

Query: 375 EICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS 422
            IC    RGL +LH   +   +IHRD+K  N+LL E    K+ DFG+S
Sbjct: 133 YICREILRGLSHLH--QHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 176

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  103 bits (259), Expect = 1e-24
 Identities = 45/212 (21%), Positives = 80/212 (37%), Gaps = 34/212 (16%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKR--LEPESQQGALEFQTEIGMLSQLRH--LHLVSL 334
            IG GG   V++   N      AIK   LE    Q    ++ EI  L++L+     ++ L
Sbjct: 35  QIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
             +   D+ + +V +      L   L       +   +R          +H +H    H 
Sbjct: 94  YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIH---QHG 147

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD----------PE------- 437
            I+H D+K  N L+ +  + K+ DFG++       +    D          PE       
Sbjct: 148 -IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205

Query: 438 ----YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
                    +++ KSDV+S G +L+ +   + 
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  103 bits (258), Expect = 2e-24
 Identities = 46/226 (20%), Positives = 79/226 (34%), Gaps = 38/226 (16%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLE-PESQQGALEFQTEIGMLSQLRHLH 330
            +F+    +G GGFG V++          AIKR+  P  +    +   E+  L++L H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 331 LVSLIGFCNDDREMI------------LVYDFMARGTLPDHL-YHSDNPPLPWNQRLEIC 377
           +V       +                 +      +  L D +           +  L I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 378 IGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPE 437
           +  A  + +LH  +    ++HRD+K +NI      V KV DFGL         +  +   
Sbjct: 125 LQIAEAVEFLH--SKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 438 YYRLQQLT--------------------EKSDVYSFGVVLFEVLCA 463
                + T                     K D++S G++LFE+L  
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP 226

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  103 bits (259), Expect = 2e-24
 Identities = 54/262 (20%), Positives = 97/262 (37%), Gaps = 27/262 (10%)

Query: 218 RGRKVKDSSSGTGTSLLGTFLWSKTIKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDND 277
              +    +S   T   G+    +    T+ + G  L   L  +    E +   +   + 
Sbjct: 6   SSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKL--KPVDYEYREEVHWMTHQ 63

Query: 278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF 337
             +G G FG+V++     +    A+K++  E  +       E+   + L    +V L G 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
             +   + +  + +  G+L   +       LP ++ L     A  GL YLHT      I+
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR----IL 172

Query: 398 HRDVKTTNILLDEK-WVAKVSDFGLSK-FGPTSVSKTHLD------------PEYYRLQQ 443
           H DVK  N+LL      A + DFG +    P  + K+ L             PE    + 
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232

Query: 444 LTEKSDVYSFGVVLFEVLCARP 465
              K D++S   ++  +L    
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCH 254

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  104 bits (260), Expect = 2e-24
 Identities = 48/152 (31%), Positives = 72/152 (47%), Gaps = 9/152 (5%)

Query: 274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEF---QTEIGMLSQLRHLH 330
           F +   IG G FG VY      ++  VAIK++    +Q   ++     E+  L +LRH +
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
            +   G    +    LV ++   G+  D L      PL   +   +  GA +GL YLH+ 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173

Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS 422
                +IHRDVK  NILL E  + K+ DFG +
Sbjct: 174 N----MIHRDVKAGNILLSEPGLVKLGDFGSA 201

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  104 bits (262), Expect = 2e-24
 Identities = 47/210 (22%), Positives = 84/210 (40%), Gaps = 27/210 (12%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSLIGF 337
           ++G G   +V++G    +    AIK     S    ++    E  +L +L H ++V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 338 --CNDDREMILVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
                 R  +L+ +F   G+L   L   S+   LP ++ L +      G+++L    N  
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--ENG- 132

Query: 395 VIIHRDVKTTNILL----DEKWVAKVSDFGLSK-FGPTSVSKTH------LDPEYYRLQQ 443
            I+HR++K  NI+     D + V K++DFG ++         +       L P+ Y    
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191

Query: 444 L--------TEKSDVYSFGVVLFEVLCARP 465
           L            D++S GV  +       
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  103 bits (259), Expect = 2e-24
 Identities = 45/212 (21%), Positives = 80/212 (37%), Gaps = 34/212 (16%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKR--LEPESQQGALEFQTEIGMLSQLRH--LHLVSL 334
            IG GG   V++   N      AIK   LE    Q    ++ EI  L++L+     ++ L
Sbjct: 16  QIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
             +   D+ + +V +      L   L       +   +R          +H +H    H 
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIH---QHG 128

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD----------PE------- 437
            I+H D+K  N L+ +  + K+ DFG++       +    D          PE       
Sbjct: 129 -IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 438 ----YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
                    +++ KSDV+S G +L+ +   + 
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  104 bits (260), Expect = 3e-24
 Identities = 47/219 (21%), Positives = 81/219 (36%), Gaps = 48/219 (21%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKR--LEPESQQGALEFQTEIGMLSQLRH--LHLVSL 334
            IG GG   V++   N      AIK   LE    Q    ++ EI  L++L+     ++ L
Sbjct: 63  QIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLP-------WNQRLEICIGAARGLHYL 387
             +   D+ + +V +      L   L       +        W   LE        +H +
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNMLE-------AVHTI 171

Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD----------PE 437
           H    H  I+H D+K  N L+ +  + K+ DFG++       +    D          PE
Sbjct: 172 H---QHG-IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226

Query: 438 -----------YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
                           +++ KSDV+S G +L+ +   + 
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  102 bits (255), Expect = 9e-24
 Identities = 26/263 (9%), Positives = 53/263 (20%), Gaps = 47/263 (17%)

Query: 244 KATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK 303
              ++   +  P +  T    S +            + VG    V+           A+K
Sbjct: 35  AMVEAVTATVWPQNAETTVD-SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALK 93

Query: 304 RLEPESQQGALE---FQTEIGMLSQLRHLHLVSLIGFCN--------------------- 339
                ++    E           ++L                                  
Sbjct: 94  VFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSP 153

Query: 340 --DDREMILVYDFM--ARGTLPD-----HLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
             DD  +      M  A   L          +             +     R    L   
Sbjct: 154 GQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ-- 211

Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYY--------RLQ 442
           +    ++H      N+ +       + D         +       P  Y           
Sbjct: 212 SKG--LVHGHFTPDNLFIMPDGRLMLGDVSALW-KVGTRGPASSVPVTYAPREFLNASTA 268

Query: 443 QLTEKSDVYSFGVVLFEVLCARP 465
             T   + +  G+ ++ V C   
Sbjct: 269 TFTHALNAWQLGLSIYRVWCLFL 291

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  102 bits (256), Expect = 2e-23
 Identities = 50/211 (23%), Positives = 80/211 (37%), Gaps = 32/211 (15%)

Query: 273 NFDNDLVIGVGGFGD-VYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLH 330
           +F    V+G G  G  VY+G  +     VA+KR+ PE    A     E+ +L +   H +
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDN--RDVAVKRILPECFSFA---DREVQLLRESDEHPN 79

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           ++       D +   +  +  A  TL        +      + + +      GL +LH  
Sbjct: 80  VIRYFCTEKDRQFQYIAIELCA-ATL-QEYVEQKDFAHLGLEPITLLQQTTSGLAHLH-- 135

Query: 391 ANHAVIIHRDVKTTNILLDEK-----WVAKVSDFGLSK-FGPTSVSKTHLD--------- 435
                I+HRD+K  NIL+          A +SDFGL K       S +            
Sbjct: 136 --SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 436 -PEYYR---LQQLTEKSDVYSFGVVLFEVLC 462
            PE       +  T   D++S G V + V+ 
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  100 bits (251), Expect = 3e-23
 Identities = 32/230 (13%), Positives = 65/230 (28%), Gaps = 33/230 (14%)

Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTP-----VAIKRLEPESQQGALEFQTE 319
           +E Q  +       ++G G F  VY+                +K  +P +          
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 320 IGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNP---PLPWNQRLEI 376
           +  L        +            +LV +  + GTL + +    N     +P    +  
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVA-----------KVSDFGLSK-- 423
            +     +  +H       IIH D+K  N +L   ++             + D G S   
Sbjct: 178 AMRMLYMIEQVHDCE----IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233

Query: 424 --FGPTSVSKT------HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
             F   ++             E    +    + D +     ++ +L    
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 98.6 bits (246), Expect = 5e-23
 Identities = 46/229 (20%), Positives = 82/229 (35%), Gaps = 43/229 (18%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKR--LEPESQQGALEFQTEIGMLSQL-R 327
           T  F     IG G FG V+K          AIKR                E+   + L +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHL--YHSDNPPLPWNQRLEICIGAARGLH 385
           H H+V       +D  M++  ++   G+L D +   +         +  ++ +   RGL 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 386 YLHTGANHAVIIHRDVKTTNILLDE-------------------KWVAKVSDFGLSKFGP 426
           Y+H  +    ++H D+K +NI +                     K + K+ D G      
Sbjct: 130 YIH--SMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---- 181

Query: 427 TSVSKTHL---DPEYY----RLQQL---TEKSDVYSFGVVLFEVLCARP 465
           T +S   +   D   +     LQ+      K+D+++  + +     A P
Sbjct: 182 TRISSPQVEEGDS-RFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  100 bits (250), Expect = 7e-23
 Identities = 36/235 (15%), Positives = 77/235 (32%), Gaps = 52/235 (22%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGA---LEFQTEIGMLSQLR-------- 327
           V+G        +     +     +       +  +    + + E+  L  LR        
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 328 --------------HLHLVSLIGFCNDDREMILVYDFM----ARGTLPDHL-----YHSD 364
                               +I    D+R+M ++  F      +  L         + S 
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 365 NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK- 423
           +  L  + RL++ +   R L  LH    H  ++H  ++  +I+LD++    ++ F     
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH----HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 424 FGPTSVSKTH---LDPEY----------YRLQQLTEKSDVYSFGVVLFEVLCARP 465
            G ++VS        PE           +    +T   D ++ G+ ++ + CA  
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 46/217 (21%), Positives = 88/217 (40%), Gaps = 19/217 (8%)

Query: 263 SLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIG 321
                QA  N+ +N   +G G  G V+K     +   +A+K++     +   +    ++ 
Sbjct: 16  GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD 75

Query: 322 ML-SQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGA 380
           ++       ++V   G    + ++ +  + M      + L      P+P     ++ +  
Sbjct: 76  VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCA--EKLKKRMQGPIPERILGKMTVAI 133

Query: 381 ARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH------- 433
            + L+YL        +IHRDVK +NILLDE+   K+ DFG+S       +K         
Sbjct: 134 VKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAY 190

Query: 434 -----LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
                +DP          ++DV+S G+ L E+   + 
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 99.3 bits (247), Expect = 1e-22
 Identities = 32/236 (13%), Positives = 72/236 (30%), Gaps = 53/236 (22%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLE----------------------------PESQ 310
           V+G        +     +     +                                 +  
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 311 QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMA----RGTLPDHLYH--SD 364
           +  L F     ++   +   ++ +     D   +   + +        T  + L    S 
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 365 NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK- 423
           +  L  + RL++ +   R L  LH       ++H  ++  +I+LD++    ++ F     
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH--HYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 424 ---FGPTSVSKTHLDPEY-----------YRLQQLTEKSDVYSFGVVLFEVLCARP 465
                 +SVS+    PE             R   +T   D ++ G+V++ + CA  
Sbjct: 256 DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 49/206 (23%), Positives = 81/206 (39%), Gaps = 35/206 (16%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALE-FQTEIGMLSQLRHLHLVSLIG 336
           +G GGF   ++     +    A K +      +    E    EI +   L H H+V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL-EICIGAAR--------GLHYL 387
           F  D+  + +V +   R +L +             + L E     AR        G  YL
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKR--------RKALTEP---EARYYLRQIVLGCQYL 131

Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYY 439
           H   N   +IHRD+K  N+ L+E    K+ DFGL+        +          + PE  
Sbjct: 132 H--RNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL 187

Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARP 465
             +  + + DV+S G +++ +L  +P
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKP 213

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 95.7 bits (239), Expect = 4e-22
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 16/197 (8%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQ--TEIGMLSQLRHLHLVSLIG 336
           +G G F  VY+     +   VAIK ++ ++  +  +  +   E+ +  QL+H  ++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
           +  D   + LV +    G +  +L  +   P   N+          G+ YLH  ++   I
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIITGMLYLH--SHG--I 133

Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLTEKS 448
           +HRD+  +N+LL      K++DFGL+        K +        + PE         +S
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLES 193

Query: 449 DVYSFGVVLFEVLCARP 465
           DV+S G + + +L  RP
Sbjct: 194 DVWSLGCMFYTLLIGRP 210

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 49/206 (23%), Positives = 81/206 (39%), Gaps = 35/206 (16%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALE-FQTEIGMLSQLRHLHLVSLIG 336
           +G GGF   ++     +    A K +      +    E    EI +   L H H+V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL-EICIGAAR--------GLHYL 387
           F  D+  + +V +   R +L +             + L E     AR        G  YL
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKR--------RKALTEP---EARYYLRQIVLGCQYL 157

Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYY 439
           H   N   +IHRD+K  N+ L+E    K+ DFGL+        +          + PE  
Sbjct: 158 H--RNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL 213

Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARP 465
             +  + + DV+S G +++ +L  +P
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKP 239

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 28/207 (13%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGM-----LSQLRHLHLVS 333
            IG G +G V K     S   +A+KR+     +   + Q ++ M     +      ++V 
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE---KEQKQLLMDLDVVMRSSDCPYIVQ 85

Query: 334 LIGFCNDDREMILVYDFMARG--TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
             G    + +  +  + M+        ++Y   +  +P     +I +   + L++L    
Sbjct: 86  FYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH-------LDPEYYRLQQL 444
               IIHRD+K +NILLD     K+ DFG+S     S++KT        + PE  R+   
Sbjct: 146 K---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE--RIDPS 200

Query: 445 ------TEKSDVYSFGVVLFEVLCARP 465
                   +SDV+S G+ L+E+   R 
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRF 227

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174

 Score = 90.0 bits (223), Expect = 4e-21
 Identities = 20/147 (13%), Positives = 47/147 (31%), Gaps = 23/147 (15%)

Query: 19  SIHLTWIRNYSAPDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEV 78
            + L  +R+     ++Y+T R          + +  ++  +     Y L L F E     
Sbjct: 41  GMKLPILRSNPEDQVLYQTERYN--------EDSFGYDIPIKEEGEYVLVLKFAEVYF-- 90

Query: 79  TEDGDRVFQIFIANLTAEVQADVIAWTGANGV------TVYRDYAVMIGSKPNEENIKQN 132
            +   +VF + +   T     D+    G +           +   + +  + +    K +
Sbjct: 91  AQSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLS 150

Query: 133 LSIQLHPAPRWRTKYSDAILNGLEIFK 159
           +          +  Y +  +  L I K
Sbjct: 151 VEF-------VKGYYDNPKVCALFIMK 170

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 94.5 bits (235), Expect = 9e-21
 Identities = 51/230 (22%), Positives = 89/230 (38%), Gaps = 49/230 (21%)

Query: 272 NNFDNDLVIGVGGFGDV-YKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHL 329
           N   ++ ++G G  G V ++G   G   PVA+KR+  +    A     EI +L++   H 
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQG--RPVAVKRMLIDFCDIA---LMEIKLLTESDDHP 69

Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPD-----HLYHSDNPPLPWNQRLEICIGAARGL 384
           +++        DR + +  +      L D     ++   +         + +    A G+
Sbjct: 70  NVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128

Query: 385 HYLHTGANHAVIIHRDVKTTNILLDEKWV-------------AKVSDFGLSKF---GPTS 428
            +LH  +    IIHRD+K  NIL+                    +SDFGL K    G +S
Sbjct: 129 AHLH--SLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184

Query: 429 VSKTHLDP---EYYR-------------LQQLTEKSDVYSFGVVLFEVLC 462
                 +P     +R              ++LT   D++S G V + +L 
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 46/206 (22%), Positives = 87/206 (42%), Gaps = 27/206 (13%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGM-----LSQLRHLHLVS 333
            +G G +G V K     S   +A+KR+         + Q  + M     +  +     V+
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS---QEQKRLLMDLDISMRTVDCPFTVT 70

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLY---HSDNPPLPWNQRLEICIGAARGLHYLHTG 390
             G    + ++ +  + M   +L D  Y         +P +   +I +   + L +LH+ 
Sbjct: 71  FYGALFREGDVWICMELMD-TSL-DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128

Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH-------LDPE----YY 439
            +   +IHRDVK +N+L++     K+ DFG+S +    V+K         + PE      
Sbjct: 129 LS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPEL 185

Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARP 465
             +  + KSD++S G+ + E+   R 
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRF 211

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 89.9 bits (223), Expect = 1e-19
 Identities = 48/246 (19%), Positives = 80/246 (32%), Gaps = 63/246 (25%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            IG G +G V     N +    AIK     ++   + +     +TE+ ++ +L H ++  
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG-------------- 379
           L     D++ + LV +    G L D L    +          +                 
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152

Query: 380 -----------------AAR-------GLHYLHTGANHAVIIHRDVKTTNILL--DEKWV 413
                             +         LHYLH       I HRD+K  N L   ++ + 
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLH--NQG--ICHRDIKPENFLFSTNKSFE 208

Query: 414 AKVSDFGLSKFGPTSVSKTHLD-------PEY-------YRLQQLTEKSDVYSFGVVLFE 459
            K+ DFGLSK      +  +         P +          +    K D +S GV+L  
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268

Query: 460 VLCARP 465
           +L    
Sbjct: 269 LLMGAV 274

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 91.3 bits (227), Expect = 1e-19
 Identities = 57/201 (28%), Positives = 83/201 (41%), Gaps = 23/201 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            +G G +G+V       +    AIK      +   S     +   E+ +L  L H +++ 
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNS---KLLEEVAVLKLLDHPNIMK 100

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L  F  D R   LV +    G L D + H             I      G+ YLH     
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLH----K 154

Query: 394 AVIIHRDVKTTNILL---DEKWVAKVSDFGLSK-FGPTSVSKTHLDPEYYR-----LQQL 444
             I+HRD+K  N+LL   ++  + K+ DFGLS  F      K  L   YY       ++ 
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKY 214

Query: 445 TEKSDVYSFGVVLFEVLCARP 465
            EK DV+S GV+LF +L   P
Sbjct: 215 DEKCDVWSIGVILFILLAGYP 235

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 49/200 (24%), Positives = 86/200 (43%), Gaps = 18/200 (9%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSLIGF 337
            +G G FGDV+      S     IK +  +  Q  +E  + EI +L  L H +++ +   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQR--LEICIGAARGLHYLHTGANHAV 395
             D   M +V +    G L + +  +       ++    E+       L Y H  + H  
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH--SQH-- 144

Query: 396 IIHRDVKTTNILL---DEKWVAKVSDFGLSK-FGPTSVSKTH------LDPEYYRLQQLT 445
           ++H+D+K  NIL          K+ DFGL++ F     S         + PE ++ + +T
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVT 203

Query: 446 EKSDVYSFGVVLFEVLCARP 465
            K D++S GVV++ +L    
Sbjct: 204 FKCDIWSAGVVMYFLLTGCL 223

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 90.1 bits (224), Expect = 2e-19
 Identities = 66/250 (26%), Positives = 99/250 (39%), Gaps = 40/250 (16%)

Query: 243 IKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAI 302
           I  + S    F+  DL         +A  + +     +G G  G+V   F   +   VAI
Sbjct: 106 IALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAI 165

Query: 303 KRL--------EPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARG 354
           + +               AL  +TEI +L +L H  ++ +  F  D  +  +V + M  G
Sbjct: 166 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG 224

Query: 355 TLPDHLYHSDNPPLPWNQRL------EICIGAARGLHYLHTGANHAVIIHRDVKTTNILL 408
            L D +          N+RL               + YLH       IIHRD+K  N+LL
Sbjct: 225 ELFDKVVG--------NKRLKEATCKLYFYQMLLAVQYLHENG----IIHRDLKPENVLL 272

Query: 409 ---DEKWVAKVSDFGLSKF-GPTSVSKT------HLDPE---YYRLQQLTEKSDVYSFGV 455
              +E  + K++DFG SK  G TS+ +T      +L PE              D +S GV
Sbjct: 273 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332

Query: 456 VLFEVLCARP 465
           +LF  L   P
Sbjct: 333 ILFICLSGYP 342

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 86.3 bits (214), Expect = 7e-19
 Identities = 22/205 (10%), Positives = 58/205 (28%), Gaps = 30/205 (14%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLI 335
             G       ++         VA+  ++P+         E  +    LS++    +  ++
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
              +     ++V +++  G+L +     D  P P    +      A      H     A 
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPV-GAIRAMQSLAAAADAAH----RAG 149

Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGV 455
           +       + + +       ++                       +     + D+   G 
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPAT-------------------MPDANPQDDIRGIGA 190

Query: 456 VLFEVLCARPSILRTAAKKQVSLAV 480
            L+ +L  R  +     +  ++ A 
Sbjct: 191 SLYALLVNRWPLPEAGVRSGLAPAE 215

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 89.0 bits (221), Expect = 7e-19
 Identities = 52/199 (26%), Positives = 80/199 (40%), Gaps = 18/199 (9%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE---FQTEIGMLSQLRHLHLVSLI 335
           V+G G FG+V       +    A+K +     +   +      E+ +L QL H +++ L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
            F  D     LV +    G L D +               I      G+ Y+H       
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMH----KNK 146

Query: 396 IIHRDVKTTNILL---DEKWVAKVSDFGLSK-FGPTSVSKTHLDPEYYR-----LQQLTE 446
           I+HRD+K  N+LL    +    ++ DFGLS  F  +   K  +   YY           E
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 206

Query: 447 KSDVYSFGVVLFEVLCARP 465
           K DV+S GV+L+ +L   P
Sbjct: 207 KCDVWSTGVILYILLSGCP 225

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 88.2 bits (219), Expect = 1e-18
 Identities = 54/209 (25%), Positives = 83/209 (39%), Gaps = 28/209 (13%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRL-------------EPESQQGALEFQTEIGMLSQ 325
            +G G +G+V         +  AIK +                 ++   E   EI +L  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102

Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           L H +++ L     D +   LV +F   G L + + +             I      G+ 
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGIC 160

Query: 386 YLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSK-FGPTSVSKTHLDPEYYR- 440
           YLH       I+HRD+K  NILL   +     K+ DFGLS  F      +  L   YY  
Sbjct: 161 YLH----KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIA 216

Query: 441 ----LQQLTEKSDVYSFGVVLFEVLCARP 465
                ++  EK DV+S GV+++ +LC  P
Sbjct: 217 PEVLKKKYNEKCDVWSCGVIMYILLCGYP 245

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 48/209 (22%), Positives = 83/209 (39%), Gaps = 41/209 (19%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
           V+G G F +V+      +    A+K ++          + EI +L +++H ++V+L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 339 NDDREMILVYDFMARGTLPD------HLYHSDNPPLPWNQRLEICIGAAR-------GLH 385
                  LV   ++ G L D           D               A+         + 
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYTEKD---------------ASLVIQQVLSAVK 120

Query: 386 YLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSKFGPTSVSKT------HLDP 436
           YLH   N   I+HRD+K  N+L    +E     ++DFGLSK     +  T      ++ P
Sbjct: 121 YLH--ENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAP 176

Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    +  ++  D +S GV+ + +LC  P
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCGYP 205

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 87.6 bits (217), Expect = 3e-18
 Identities = 57/241 (23%), Positives = 102/241 (42%), Gaps = 30/241 (12%)

Query: 244 KATKSSRGSFLPSDLCTQFSLSEIQAATNNFDN--DL--VIGVGGFGDVYKGFINGSTTP 299
           K T SS       D+  Q+    ++   ++  +  D+   +G G FG V++     +   
Sbjct: 125 KGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNN 184

Query: 300 VAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDH 359
            A K +    +      + EI  +S LRH  LV+L     DD EM+++Y+FM+ G L + 
Sbjct: 185 FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK 244

Query: 360 LYHSDNPPLPWNQRL--EICIGAAR----GLHYLHTGANHAVIIHRDVKTTNILLDEKWV 413
           +    N       ++  +  +   R    GL ++H   N+   +H D+K  NI+   K  
Sbjct: 245 VADEHN-------KMSEDEAVEYMRQVCKGLCHMHE--NN--YVHLDLKPENIMFTTKRS 293

Query: 414 A--KVSDFGLS-KFGPTSVSKTHLD-PEYY-----RLQQLTEKSDVYSFGVVLFEVLCAR 464
              K+ DFGL+    P    K      E+        + +   +D++S GV+ + +L   
Sbjct: 294 NELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 353

Query: 465 P 465
            
Sbjct: 354 S 354

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 86.8 bits (215), Expect = 4e-18
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 25/221 (11%)

Query: 261 QFSLSEIQAAT-NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEF 316
           Q+   E Q  T N F    V+G GGFG+V    +  +    A K+LE +    ++G    
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231

Query: 317 QTEIGMLSQLRHLHLVSLI-GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL- 374
             E  +L ++    +VSL   +   D  + LV   M  G L  H+YH      P  + + 
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDA-LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290

Query: 375 ---EICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVS 430
              EIC G    L  LH       I++RD+K  NILLD+    ++SD GL+         
Sbjct: 291 YAAEICCG----LEDLHRER----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 342

Query: 431 KT------HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           K       ++ PE  + ++ T   D ++ G +L+E++  + 
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 83.8 bits (208), Expect = 5e-18
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 36/204 (17%)

Query: 280 IGVGGFGDVYKGFINGST-TPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G+V    +N  T   VA+K ++ +      E  + EI +   L H ++V   G 
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR--------GLHYLHT 389
             +     L  ++ + G L D +          +  +      A+        G+ YLH 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP--------DIGMPE--PDAQRFFHQLMAGVVYLHG 123

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD----------PEYY 439
                 I HRD+K  N+LLDE+   K+SDFGL+     +  +  L+          PE  
Sbjct: 124 IG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 440 RLQQLT-EKSDVYSFGVVLFEVLC 462
           + ++   E  DV+S G+VL  +L 
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLA 203

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 85.5 bits (212), Expect = 5e-18
 Identities = 47/199 (23%), Positives = 84/199 (42%), Gaps = 26/199 (13%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            +G G FG V++     +      K +           + EI +++QL H  L++L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117

Query: 339 NDDREMILVYDFMARGTLPD------HLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            D  EM+L+ +F++ G L D      +            Q  E       GL ++H   +
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE-------GLKHMH--EH 168

Query: 393 HAVIIHRDVKTTNILLDEKWVA--KVSDFGLS-KFGPTSVSKTH------LDPEYYRLQQ 443
              I+H D+K  NI+ + K  +  K+ DFGL+ K  P  + K          PE    + 
Sbjct: 169 S--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 226

Query: 444 LTEKSDVYSFGVVLFEVLC 462
           +   +D+++ GV+ + +L 
Sbjct: 227 VGFYTDMWAIGVLGYVLLS 245

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 84.3 bits (209), Expect = 6e-18
 Identities = 59/221 (26%), Positives = 86/221 (38%), Gaps = 54/221 (24%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRL--------EPESQQGALEFQTEIGMLSQLRHLH 330
            +G G  G+V   F   +   VAIK +               AL  +TEI +L +L H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPD------HLYHSDNPPLPWNQRLEICIGAAR-- 382
           ++ +  F  D  +  +V + M  G L D       L  +                     
Sbjct: 77  IIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEAT---------------CKLYF 120

Query: 383 -----GLHYLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSKF-GPTSVSKT- 432
                 + YLH    +  IIHRD+K  N+LL   +E  + K++DFG SK  G TS+ +T 
Sbjct: 121 YQMLLAVQYLH---ENG-IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176

Query: 433 -----HLDPE---YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
                +L PE              D +S GV+LF  L   P
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 84.2 bits (209), Expect = 6e-18
 Identities = 43/173 (24%), Positives = 86/173 (49%), Gaps = 15/173 (8%)

Query: 269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQG----ALEFQTEIGMLS 324
           ++++ F     +G G +  VYKG    +   VA+K ++ +S++G    A+    EI ++ 
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---EISLMK 58

Query: 325 QLRHLHLVSLIGFCNDDREMILVYDFMA---RGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +L+H ++V L    + + ++ LV++FM    +  +      +    L  N          
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH 433
           +GL + H   N   I+HRD+K  N+L++++   K+ DFGL++ FG    + + 
Sbjct: 119 QGLAFCH--ENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 85.9 bits (213), Expect = 6e-18
 Identities = 51/201 (25%), Positives = 81/201 (40%), Gaps = 23/201 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
           ++G G FG+V K     +    A+K       + +          E+ +L +L H +++ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS---TILREVELLKKLDHPNIMK 85

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L     D     +V +    G L D +          +    I      G+ Y+H     
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMH----K 139

Query: 394 AVIIHRDVKTTNILL---DEKWVAKVSDFGLSK-FGPTSVSKTHLDPEYYR-----LQQL 444
             I+HRD+K  NILL   ++    K+ DFGLS  F   +  K  +   YY          
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199

Query: 445 TEKSDVYSFGVVLFEVLCARP 465
            EK DV+S GV+L+ +L   P
Sbjct: 200 DEKCDVWSAGVILYILLSGTP 220

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 86.0 bits (213), Expect = 7e-18
 Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 28/224 (12%)

Query: 261 QFSLSEIQAAT-NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEF 316
           Q+   E Q    + F +  V+G GGFG+V+   +  +    A K+L  +    ++G    
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232

Query: 317 QTEIGMLSQLRHLHLVSLI-GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL- 374
             E  +L+++    +VSL   F      + LV   M  G +  H+Y+ D     + +   
Sbjct: 233 MVEKKILAKVHSRFIVSLAYAFETKTD-LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291

Query: 375 -----EICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV 429
                +I  G    L +LH       II+RD+K  N+LLD+    ++SD GL+       
Sbjct: 292 IFYTAQIVSG----LEHLHQRN----IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343

Query: 430 SKTH--------LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           +KT         + PE    ++     D ++ GV L+E++ AR 
Sbjct: 344 TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 84.3 bits (209), Expect = 8e-18
 Identities = 45/205 (21%), Positives = 80/205 (39%), Gaps = 22/205 (10%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
           VIG G F  V +     +    A+K     +          + + E  +   L+H H+V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL--EICIGAARGLHYLHTGA 391
           L+   + D  + +V++FM    L   +    +    +++ +           L Y H   
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH--D 148

Query: 392 NHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSK--FGPTSVSKT------HLDPEYYR 440
           N+  IIHRDVK   +LL   +     K+  FG++        V+         + PE  +
Sbjct: 149 NN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206

Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
            +   +  DV+  GV+LF +L    
Sbjct: 207 REPYGKPVDVWGCGVILFILLSGCL 231

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 36/204 (17%)

Query: 280 IGVGGFGDVYKGFINGST-TPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSLIGF 337
           +G G +G+V    +N  T   VA+K ++ +      E  + EI +   L H ++V   G 
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR--------GLHYLHT 389
             +     L  ++ + G L D +          +  +      A+        G+ YLH 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP--------DIGMPE--PDAQRFFHQLMAGVVYLHG 123

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD----------PEYY 439
                 I HRD+K  N+LLDE+   K+SDFGL+     +  +  L+          PE  
Sbjct: 124 IG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 440 RLQQLT-EKSDVYSFGVVLFEVLC 462
           + ++   E  DV+S G+VL  +L 
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLA 203

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 45/199 (22%), Positives = 90/199 (45%), Gaps = 14/199 (7%)

Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
                 ++G G FG V+K     +   +A K ++    +   E + EI +++QL H +L+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            L        +++LV +++  G L D +   ++  L     +        G+ ++H    
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRII-DESYNLTELDTILFMKQICEGIRHMHQ--M 206

Query: 393 HAVIIHRDVKTTNILLDEKWVA--KVSDFGLSK-FGPTSVSKTHL-DPEYY-----RLQQ 443
           +  I+H D+K  NIL   +     K+ DFGL++ + P    K +   PE+          
Sbjct: 207 Y--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDF 264

Query: 444 LTEKSDVYSFGVVLFEVLC 462
           ++  +D++S GV+ + +L 
Sbjct: 265 VSFPTDMWSVGVIAYMLLS 283

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 46/223 (20%), Positives = 81/223 (36%), Gaps = 55/223 (24%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK---------RLEPESQQGALEFQTEIGMLSQL-RH 328
           ++G G    V +     +    A+K             E Q+       E+ +L ++  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPD------HLYHSDNPPLPWNQRLEICIGAAR 382
            +++ L      +    LV+D M +G L D       L   +                 +
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE---------------TRK 128

Query: 383 -------GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKT-- 432
                   +  LH    +  I+HRD+K  NILLD+    K++DFG S    P    +   
Sbjct: 129 IMRALLEVICALH--KLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184

Query: 433 ----HLDPE------YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +L PE              ++ D++S GV+++ +L   P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 52/204 (25%), Positives = 85/204 (41%), Gaps = 29/204 (14%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
           ++G G FG+V K     +    A+K       + +          E+ +L +L H +++ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS---TILREVELLKKLDHPNIMK 85

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQR--LEICIGAARGLHYLHT-G 390
           L     D     +V +    G L D +         +++     I      G+ Y+H   
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMHKHN 141

Query: 391 ANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSK-FGPTSVSKTHLDPEYYR----LQ 442
                I+HRD+K  NILL   ++    K+ DFGLS  F   +  K  +   YY     L+
Sbjct: 142 -----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR 196

Query: 443 QL-TEKSDVYSFGVVLFEVLCARP 465
               EK DV+S GV+L+ +L   P
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTP 220

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 38/171 (22%), Positives = 77/171 (45%), Gaps = 22/171 (12%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQG----ALEFQTEIGMLSQLR 327
             +     +G G +  VYKG    +   VA+K +  E ++G    A+    E+ +L  L+
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLK 58

Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDH----LYHSDNPPLPWNQRLEICIGAARG 383
           H ++V+L    + ++ + LV++++      D             +  +          RG
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYL------DKDLKQYLDDCGNIINMHNVKLFLFQLLRG 112

Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH 433
           L Y H       ++HRD+K  N+L++E+   K++DFGL++     + +  +
Sbjct: 113 LAYCH--RQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 48/196 (24%), Positives = 83/196 (42%), Gaps = 15/196 (7%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            IG G +G+V      G+    A K++     +    F+ EI ++  L H +++ L    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
            D+ ++ LV +    G L + + H        +    I       + Y H    +  + H
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCH--KLN--VAH 129

Query: 399 RDVKTTNILL---DEKWVAKVSDFGLSK-FGPTSVSKTHLDPEYYR----LQQL-TEKSD 449
           RD+K  N L          K+ DFGL+  F P  + +T +   YY     L+ L   + D
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECD 189

Query: 450 VYSFGVVLFEVLCARP 465
            +S GV+++ +LC  P
Sbjct: 190 EWSAGVMMYVLLCGYP 205

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 82.5 bits (204), Expect = 4e-17
 Identities = 58/222 (26%), Positives = 88/222 (39%), Gaps = 54/222 (24%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK-------RLEPESQQGALE-FQTEIGMLSQLR-HL 329
           VIG G    V +     +    A+K       RL PE  +   E  + E  +L Q+  H 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPD------HLYHSDNPPLPWNQRLEICIGAAR- 382
           H+++LI        M LV+D M +G L D       L   +                   
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKE---------------TRSI 205

Query: 383 ------GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKT--- 432
                  + +LH  AN+  I+HRD+K  NILLD+    ++SDFG S    P    +    
Sbjct: 206 MRSLLEAVSFLH--ANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCG 261

Query: 433 ---HLDPE------YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
              +L PE              ++ D+++ GV+LF +L   P
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 81.9 bits (203), Expect = 4e-17
 Identities = 45/168 (26%), Positives = 76/168 (45%), Gaps = 15/168 (8%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHL 329
             ++N  ++G G +G V K     +   VAIK+         ++     EI +L QLRH 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQR---LEICIGAARGLHY 386
           +LV+L+  C   +   LV++F+   T+ D L    N       +    +I      G+ +
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII----NGIGF 139

Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH 433
            H  +++  IIHRD+K  NIL+ +  V K+ DFG ++           
Sbjct: 140 CH--SHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 80.3 bits (199), Expect = 6e-17
 Identities = 49/214 (22%), Positives = 90/214 (42%), Gaps = 49/214 (22%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALE-FQTEIGMLSQLRHLHLV 332
            +G G F  V K    G+    A K     RL    +  + E  + E+ +L ++RH +++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 333 SLIGFCNDDREMILVYDFMARGTLPD------HLYHSDNPPLPWNQRLEICIGAAR---- 382
           +L     +  +++L+ + ++ G L D       L   +               A +    
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDE---------------ATQFLKQ 116

Query: 383 ---GLHYLHTGANHAVIIHRDVKTTNILLDEKWVA----KVSDFGLSK-FGPTSVSKT-- 432
              G+HYLH+      I H D+K  NI+L +K V     K+ DFG++      +  K   
Sbjct: 117 ILDGVHYLHS--KR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 172

Query: 433 ----HLDPEYYRLQQLTEKSDVYSFGVVLFEVLC 462
                + PE    + L  ++D++S GV+ + +L 
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 46/213 (21%), Positives = 87/213 (40%), Gaps = 45/213 (21%)

Query: 279 VIGVGGFGDVYKGFINGST-TPVAIKRLEPE--SQQGALEFQ--TEIGMLSQLRHLHLVS 333
           ++G G +G V +  ++  T    A+K L+ +   +    E     EI +L +LRH +++ 
Sbjct: 12  LLGEGSYGKVKEV-LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 334 L--IGFCNDDREMILVYDFMARGT--LPDHLYHSDNPPLPWNQRLEICIGAAR------- 382
           L  + +  + ++M +V ++   G   + D +           +R  +C   A        
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE---------KRFPVC--QAHGYFCQLI 119

Query: 383 -GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD------ 435
            GL YLH  +    I+H+D+K  N+LL      K+S  G+++      +           
Sbjct: 120 DGLEYLH--SQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 436 ----PEYYRLQQLTE--KSDVYSFGVVLFEVLC 462
               PE           K D++S GV L+ +  
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 81.2 bits (201), Expect = 7e-17
 Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 38/204 (18%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           IG G F  V       +   VAIK     +L P S Q   +   E+ ++  L H ++V L
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ---KLFREVRIMKILNHPNIVKL 79

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR--------GLHY 386
                 ++ + L+ ++ + G + D+L          + R++     AR         + Y
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVA--------HGRMKE--KEARSKFRQIVSAVQY 129

Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS-KFGPTSVSKTHLD------PEYY 439
            H       I+HRD+K  N+LLD     K++DFG S +F                 PE +
Sbjct: 130 CH--QKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELF 185

Query: 440 RLQQLT-EKSDVYSFGVVLFEVLC 462
           + ++    + DV+S GV+L+ ++ 
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVS 209

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 80.8 bits (200), Expect = 8e-17
 Identities = 48/219 (21%), Positives = 84/219 (38%), Gaps = 59/219 (26%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALE-FQTEIGMLSQLRHL--H 330
           ++G GGFG VY G       PVAIK     R+    +         E+ +L ++      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 331 LVSLIGFCNDDREMILV----------YDFMA-RGTLPDHLYHSDNPPLPWNQRLEICIG 379
           ++ L+ +       +L+          +DF+  RG L + L                   
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL------------------- 150

Query: 380 AAR--------GLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSVS 430
            AR         + + H       ++HRD+K  NIL+D  +   K+ DFG       +V 
Sbjct: 151 -ARSFFWQVLEAVRHCHNCG----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 205

Query: 431 KTH------LDPEYYRLQQLT-EKSDVYSFGVVLFEVLC 462
                      PE+ R  +     + V+S G++L++++C
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 80.8 bits (200), Expect = 8e-17
 Identities = 44/211 (20%), Positives = 85/211 (40%), Gaps = 43/211 (20%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALE-FQTEIGMLSQLRHLHLV 332
            +G G F  V K     +    A K     +     +  + E  + E+ +L Q+ H +++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 333 SLIGFCNDDREMILVYDFMARGTLPD------HLYHSDNPPLPWNQRLEICIGAAR---- 382
           +L     +  +++L+ + ++ G L D       L   +                 +    
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE------------ATSFIKQILD 126

Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKWVA----KVSDFGLS-KFGPTSVSKTH---- 433
           G++YLH       I H D+K  NI+L +K +     K+ DFGL+ +       K      
Sbjct: 127 GVNYLH--TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182

Query: 434 --LDPEYYRLQQLTEKSDVYSFGVVLFEVLC 462
             + PE    + L  ++D++S GV+ + +L 
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 79.9 bits (198), Expect = 9e-17
 Identities = 45/215 (20%), Positives = 83/215 (38%), Gaps = 50/215 (23%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            +G G F  V +     +    A K     +L     Q   + + E  +  +L+H ++V 
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRKLQHPNIVR 69

Query: 334 LIGFCNDDREMILVYDFMARGTLPD------HLYHSDNPPLPWNQRLEICIGAAR----- 382
           L     ++    LV+D +  G L +          +D               A+      
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---------------ASHCIQQI 114

Query: 383 --GLHYLHTGANHAVIIHRDVKTTNILLDEKW---VAKVSDFGLSK-FGPTSVSKT---- 432
              + Y H  +N   I+HR++K  N+LL  K      K++DFGL+     +         
Sbjct: 115 LESIAYCH--SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 170

Query: 433 --HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
             +L PE  +    ++  D+++ GV+L+ +L   P
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 44/200 (22%), Positives = 81/200 (40%), Gaps = 23/200 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGMLSQLRHL-HLV 332
            +G G F  V +     +    A K     R   + +    E   EI +L   +    ++
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA---EILHEIAVLELAKSCPRVI 92

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           +L     +  E+IL+ ++ A G +           +  N  + +      G++YLH   N
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ--N 150

Query: 393 HAVIIHRDVKTTNILL---DEKWVAKVSDFGLSK-FGPTSVSKTH------LDPEYYRLQ 442
           +  I+H D+K  NILL         K+ DFG+S+  G     +        L PE     
Sbjct: 151 N--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD 208

Query: 443 QLTEKSDVYSFGVVLFEVLC 462
            +T  +D+++ G++ + +L 
Sbjct: 209 PITTATDMWNIGIIAYMLLT 228

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 47/214 (21%), Positives = 89/214 (41%), Gaps = 43/214 (20%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALE-FQTEIGMLSQLRHLHLV 332
            +G G F  V K     +    A K     R +   +  + E  + E+ +L +++H +++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 333 SLIGFCNDDREMILVYDFMARGTLPD------HLYHSDNPPLPWNQRLEICIGAAR---- 382
           +L     +  ++IL+ + +A G L D       L   +                 +    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE------------ATEFLKQILN 125

Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKWVA----KVSDFGLS-KFGPTSVSKT----- 432
           G++YLH+      I H D+K  NI+L ++ V     K+ DFGL+ K    +  K      
Sbjct: 126 GVYYLHS--LQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181

Query: 433 -HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
             + PE    + L  ++D++S GV+ + +L    
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 30/179 (16%), Positives = 56/179 (31%), Gaps = 33/179 (18%)

Query: 309 SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPL 368
           S         +I  +      + V  +   +    + +      +  L D +    +   
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160

Query: 369 P-----WNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
                  +  ++I       + +LH       ++HRD+K +NI      V KV DFGL  
Sbjct: 161 REHGVCLHIFIQIA----EAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT 212

Query: 424 FGPTSVSKTHLDPEYYRLQQLT--------------------EKSDVYSFGVVLFEVLC 462
                  +  +          T                     K D++S G++LFE+L 
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 40/155 (25%), Positives = 66/155 (42%), Gaps = 14/155 (9%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHL 329
             ++    IG G +G V+K     +   VAIK+         ++     EI ML QL+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQR---LEICIGAARGLHY 386
           +LV+L+      R + LV+++    T+   L            +    +      + +++
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL----QAVNF 117

Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL 421
            H        IHRDVK  NIL+ +  V K+ DFG 
Sbjct: 118 CH----KHNCIHRDVKPENILITKHSVIKLCDFGF 148

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 45/211 (21%), Positives = 82/211 (38%), Gaps = 43/211 (20%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK------RLEPESQQGALEFQTEIGMLSQLRHLHLV 332
            +G G F  V K     +    A K                 E + E+ +L Q+ H +++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 333 SLIGFCNDDREMILVYDFMARGTLPD------HLYHSDNPPLPWNQRLEICIGAAR---- 382
           +L     +  +++L+ + ++ G L D       L   +                 +    
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE------------ATSFIKQILD 126

Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKWVA----KVSDFGLSK-FGPTSVSKTH---- 433
           G++YLHT      I H D+K  NI+L +K +     K+ DFGL+         K      
Sbjct: 127 GVNYLHT--KK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182

Query: 434 --LDPEYYRLQQLTEKSDVYSFGVVLFEVLC 462
             + PE    + L  ++D++S GV+ + +L 
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 50/230 (21%), Positives = 81/230 (35%), Gaps = 53/230 (23%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE--FQT---------E 319
            + +     I  G +G V  G ++    PVAIKR+      G                 E
Sbjct: 21  QSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79

Query: 320 IGMLSQLRHLHLVSLI-----GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWN--- 371
           I +L+   H +++ L             ++ LV + M   T    + H     +      
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQHIQ 137

Query: 372 ----QRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT 427
                 L        GLH LH     A ++HRD+   NILL +     + DF L++    
Sbjct: 138 YFMYHIL-------LGLHVLHE----AGVVHRDLHPGNILLADNNDITICDFNLAREDTA 186

Query: 428 SVSKTHLDPEY-----YR-------LQQLTEKSDVYSFGVVLFEVLCARP 465
             +KT     Y     YR        +  T+  D++S G V+ E+   + 
Sbjct: 187 DANKT----HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 79.5 bits (197), Expect = 2e-16
 Identities = 41/157 (26%), Positives = 81/157 (51%), Gaps = 8/157 (5%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHLHLVSLIGF 337
           IG G +G VYK     +   VA+K++  +++   +      EI +L +L H ++V L+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
            + + ++ LV++F+ +  L   +  S    +P            +GL + H  ++   ++
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--SHR--VL 125

Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH 433
           HRD+K  N+L++ +   K++DFGL++ FG    + TH
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 79.1 bits (196), Expect = 2e-16
 Identities = 40/161 (24%), Positives = 75/161 (46%), Gaps = 17/161 (10%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHLHLVSLIGF 337
           IG G +G V+K     +   VA+KR+  +     +      EI +L +L+H ++V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 338 CNDDREMILVYDFMARGTLPDH----LYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
            + D+++ LV++F       D      + S N  L             +GL + H  + +
Sbjct: 70  LHSDKKLTLVFEFC------DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH--SRN 121

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH 433
             ++HRD+K  N+L++     K+++FGL++ FG      + 
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           +GVG FG V  G    +   VA+K     ++      G ++   EI  L   RH H++ L
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKL 76

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR--------GLHY 386
               +   +  +V ++++ G L D++          + R+E     AR         + Y
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICK--------HGRVEE--MEARRLFQQILSAVDY 126

Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS-KFGPTSVSKT------HLDPEYY 439
            H       ++HRD+K  N+LLD    AK++DFGLS         +T      +  PE  
Sbjct: 127 CHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 182

Query: 440 RLQQLT-EKSDVYSFGVVLFEVLC 462
             +     + D++S GV+L+ +LC
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLC 206

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 18/173 (10%)

Query: 268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQ 325
           Q     +     +G G +G VYK   +     VA+KR+  +++   +      EI +L +
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE 75

Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDH----LYHSDNPPLPWNQRLEICIGAA 381
           L H ++VSLI   + +R + LV++FM      +     +   +   L  +Q         
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFM------EKDLKKVLDENKTGLQDSQIKIYLYQLL 129

Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH 433
           RG+ + H   +   I+HRD+K  N+L++     K++DFGL++ FG    S TH
Sbjct: 130 RGVAHCH--QHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 79.6 bits (197), Expect = 4e-16
 Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 52/226 (23%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHL 329
              + N   IG G +G V   + N +   VAIK++ P E Q        EI +L + RH 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85

Query: 330 HLVSLI-----GFCNDDREMILVYDFM---------ARGTLPDH----LYHSDNPPLPWN 371
           +++ +            +++ +V D M          +    DH    LY          
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY---------- 135

Query: 372 QRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSK 431
           Q L       RGL Y+H+ AN   ++HRD+K +N+LL+     K+ DFGL++        
Sbjct: 136 QIL-------RGLKYIHS-AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184

Query: 432 THLDPEY-----YR-------LQQLTEKSDVYSFGVVLFEVLCARP 465
           T    EY     YR        +  T+  D++S G +L E+L  RP
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 77.9 bits (193), Expect = 4e-16
 Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 18/161 (11%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT--EIGMLSQLRHLHLVSLIGF 337
           IG G +G VYK   N      A+K++  E +   +   T  EI +L +L+H ++V L   
Sbjct: 10  IGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 338 CNDDREMILVYDFMARGTLPDH----LYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
            +  + ++LV++ +      D     L       L         +    G+ Y H     
Sbjct: 69  IHTKKRLVLVFEHL------DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--DRR 120

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH 433
             ++HRD+K  N+L++ +   K++DFGL++ FG      TH
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 78.5 bits (194), Expect = 6e-16
 Identities = 45/215 (20%), Positives = 83/215 (38%), Gaps = 50/215 (23%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            +G G F  V +     +    A K     +L     Q   + + E  +  +L+H ++V 
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRKLQHPNIVR 92

Query: 334 LIGFCNDDREMILVYDFMARGTLPD------HLYHSDNPPLPWNQRLEICIGAAR----- 382
           L     ++    LV+D +  G L +          +D               A+      
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---------------ASHCIQQI 137

Query: 383 --GLHYLHTGANHAVIIHRDVKTTNILLDEKW---VAKVSDFGLSK-FGPTSVSKT---- 432
              + Y H  +N   I+HR++K  N+LL  K      K++DFGL+     +         
Sbjct: 138 LESIAYCH--SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 193

Query: 433 --HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
             +L PE  +    ++  D+++ GV+L+ +L   P
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 78.7 bits (194), Expect = 9e-16
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 44/221 (19%)

Query: 277 DLVIGVGGFGDVYKGFINGSTT--PVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
              +G G +G VYK            A+K++E      ++    EI +L +L+H +++SL
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISL 83

Query: 335 IGFCND--DREMILVYDFMARGTLPDH-LYH-SDNPPLPWNQRLEICIGAA--------- 381
                   DR++ L++D+       +H L+H           +  + +            
Sbjct: 84  QKVFLSHADRKVWLLFDYA------EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137

Query: 382 -RGLHYLHTGANHAVIIHRDVKTTNILL----DEKWVAKVSDFGLS-KFGPTSVSKTHLD 435
             G+HYLH  AN   ++HRD+K  NIL+     E+   K++D G +  F         LD
Sbjct: 138 LDGIHYLH--ANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193

Query: 436 PE----YYR----L---QQLTEKSDVYSFGVVLFEVLCARP 465
           P     +YR    L   +  T+  D+++ G +  E+L + P
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 234

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 44/210 (20%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            +G G    VY+    G+  P A+K L+    +  +   TEIG+L +L H +++ L    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPNIIKLKEIF 117

Query: 339 NDDREMILVYDFMARGTLPD------HLYHSDNPPLPWNQRLEICIGAAR-------GLH 385
               E+ LV + +  G L D      +    D               AA         + 
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERD---------------AADAVKQILEAVA 162

Query: 386 YLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSKF-GPTSVSKT------HLD 435
           YLH   N   I+HRD+K  N+L          K++DFGLSK      + KT      +  
Sbjct: 163 YLH--ENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218

Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           PE  R      + D++S G++ + +LC   
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFE 248

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 42/215 (19%), Positives = 77/215 (35%), Gaps = 53/215 (24%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQT---EIGMLSQLRHLHL 331
           +G G FG V+          V +K     ++  +      +      EI +LS++ H ++
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 332 VSLIGFCNDDREMILVYDFMARGT-LPDHLYHSDNPPLPWNQRLEICIGAAR-------- 382
           + ++    +     LV +    G  L   +          + RL+     A         
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR--------HPRLDE--PLASYIFRQLVS 141

Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD-----PE 437
            + YL        IIHRD+K  NI++ E +  K+ DFG + +                 E
Sbjct: 142 AVGYLRLKD----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLE---RGKLFYTFCGTIE 194

Query: 438 Y----------YRLQQLTEKSDVYSFGVVLFEVLC 462
           Y          YR      + +++S GV L+ ++ 
Sbjct: 195 YCAPEVLMGNPYR----GPELEMWSLGVTLYTLVF 225

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 43/221 (19%), Positives = 81/221 (36%), Gaps = 61/221 (27%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRL------EPESQQGALEFQTEIGMLSQLR----H 328
           ++G GGFG V+ G        VAIK +             ++    E+ +L ++     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 329 LHLVSLIGFCNDDREMILV----------YDF-MARGTLPDHLYHSDNPPLPWNQRLEIC 377
             ++ L+ +       +LV          +D+   +G L +                   
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP----------------- 140

Query: 378 IGAAR--------GLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTS 428
              +R         + + H+      ++HRD+K  NIL+D  +  AK+ DFG        
Sbjct: 141 ---SRCFFGQVVAAIQHCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE 193

Query: 429 VSKTH------LDPEYYRLQQLT-EKSDVYSFGVVLFEVLC 462
                        PE+    Q     + V+S G++L++++C
Sbjct: 194 PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 44/213 (20%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT-EIGMLSQLRHLHLVSLIGF 337
           VIG G FG VY+  +  S   VAIK++  +       F+  E+ ++ +L H ++V L  F
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYF 115

Query: 338 ------CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE----------ICIGAA 381
                   D+  + LV D++     P+ +Y          Q L           +     
Sbjct: 116 FYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQLF---- 166

Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK-FGPTSVSKTHLDPEYY 439
           R L Y+H+      I HRD+K  N+LLD +  V K+ DFG +K       + +++   YY
Sbjct: 167 RSLAYIHS----FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 222

Query: 440 R-------LQQLTEKSDVYSFGVVLFEVLCARP 465
           R           T   DV+S G VL E+L  +P
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 36/196 (18%), Positives = 85/196 (43%), Gaps = 15/196 (7%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            +G G FG V++     S      K +        +  + EI +L+  RH +++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
               E++++++F++   + + +  +    L   + +         L +LH  +++  I H
Sbjct: 71  ESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLH--SHN--IGH 125

Query: 399 RDVKTTNILLDEKWVA--KVSDFGLSKF-GPTSVSKTHL-DPEYY-----RLQQLTEKSD 449
            D++  NI+   +  +  K+ +FG ++   P    +     PEYY     +   ++  +D
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATD 185

Query: 450 VYSFGVVLFEVLCARP 465
           ++S G +++ +L    
Sbjct: 186 MWSLGTLVYVLLSGIN 201

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 79.5 bits (196), Expect = 1e-15
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 25/210 (11%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRH 328
           N+F    +IG GGFG+VY      +    A+K L+ +    +QG      E  MLS +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 329 LH---LVSLIGFCNDDREMI-LVYDFMARGTLPDHLYHSDNPPLPWNQ--RLEICIGAAR 382
                +V +  +     + +  + D M  G L  HL           +    EI +G   
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG--- 304

Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDP 436
            L ++H       +++RD+K  NILLDE    ++SD GL+                ++ P
Sbjct: 305 -LEHMHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAP 359

Query: 437 EYYRLQQLTEKS-DVYSFGVVLFEVLCARP 465
           E  +     + S D +S G +LF++L    
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 38/206 (18%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           +G G FG V       +   VA+K      L+       +E   EI  L  LRH H++ L
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKL 74

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR--------GLHY 386
                   ++++V ++ A G L D++           +R+       R         + Y
Sbjct: 75  YDVITTPTDIVMVIEY-AGGELFDYIVE--------KKRMTE--DEGRRFFQQIICAIEY 123

Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS-KFGPTSVSKT------HLDPEYY 439
            H       I+HRD+K  N+LLD+    K++DFGLS      +  KT      +  PE  
Sbjct: 124 CH----RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179

Query: 440 RLQQLT-EKSDVYSFGVVLFEVLCAR 464
             +     + DV+S G+VL+ +L  R
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGR 205

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 57/267 (21%), Positives = 98/267 (36%), Gaps = 69/267 (25%)

Query: 240 SKTIKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDL------VIGVGGFGDVYKGFI 293
           S T+     +     P D   +               ++      VIG G FG V++   
Sbjct: 2   SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQA-K 60

Query: 294 NGSTTPVAIKRLEPESQQGALEFQT-EIGMLSQLRHLHLVSLIGF------CNDDREMIL 346
              +  VAIK++  +       F+  E+ ++  ++H ++V L  F        D+  + L
Sbjct: 61  LVESDEVAIKKVLQDK-----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115

Query: 347 VYDFMARGTLPDHLYHSDNPPLPWNQRLE----------ICIGAARGLHYLHTGANHAVI 396
           V +++     P+ +Y +        Q +           +     R L Y+H+      I
Sbjct: 116 VLEYV-----PETVYRASRHYAKLKQTMPMLLIKLYMYQLL----RSLAYIHS----IGI 162

Query: 397 IHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSVSKTHLDPE----------YYR----- 440
            HRD+K  N+LLD    V K+ DFG +K          L             YYR     
Sbjct: 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAK---------ILIAGEPNVSYICSRYYRAPELI 213

Query: 441 --LQQLTEKSDVYSFGVVLFEVLCARP 465
                 T   D++S G V+ E++  +P
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQP 240

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 48/227 (21%), Positives = 86/227 (37%), Gaps = 59/227 (25%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRH 328
              + +   +G G +G V       S   VAIK+L    +S+  A     E+ +L  ++H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 329 LHLVSLI------GFCNDDREMILVYDFMA-------RGTL-PDH----LYHSDNPPLPW 370
            +++ L+          +  +  LV  FM              +     +Y         
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY--------- 133

Query: 371 NQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS 430
            Q L       +GL Y+H+    A ++HRD+K  N+ ++E    K+ DFGL++       
Sbjct: 134 -QML-------KGLKYIHS----AGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAE 179

Query: 431 KTHLDPEY-----YR-------LQQLTEKSDVYSFGVVLFEVLCARP 465
            T     Y     YR            +  D++S G ++ E+L  + 
Sbjct: 180 MT----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 77.0 bits (190), Expect = 3e-15
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 21/208 (10%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEF-QTEIGMLSQLRH 328
           ++F+    IG G FG V     N +    A+K +  +   ++  +     E+ ++  L H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEIC-IGAARGLHYL 387
             LV+L     D+ +M +V D +  G L  HL  + +       +L IC +  A  L YL
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET-VKLFICELVMA--LDYL 131

Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----TSVSKTH--LDPEYYR 440
                   IIHRD+K  NILLDE     ++DF ++   P     T+++ T   + PE + 
Sbjct: 132 Q--NQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFS 187

Query: 441 LQQLTEKS---DVYSFGVVLFEVLCARP 465
            ++    S   D +S GV  +E+L  R 
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 76.5 bits (189), Expect = 3e-15
 Identities = 50/159 (31%), Positives = 76/159 (47%), Gaps = 26/159 (16%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQG------ALEFQTEIGMLSQLRHLHL 331
           +G G F  VYK     +   VAIK  +L   S+        AL    EI +L +L H ++
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR---EIKLLQELSHPNI 74

Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDH----LYHSDNPPLPWNQRLEICIGAARGLHYL 387
           + L+        + LV+DFM      +     +   ++  L  +      +   +GL YL
Sbjct: 75  IGLLDAFGHKSNISLVFDFM------ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128

Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FG 425
           H   +   I+HRD+K  N+LLDE  V K++DFGL+K FG
Sbjct: 129 H--QHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 77.1 bits (190), Expect = 4e-15
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 37/204 (18%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGMLSQLRHLHLVSL 334
           +GVG FG V  G    +   VA+K     ++      G +    EI  L   RH H++ L
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKL 81

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR--------GLHY 386
               +   ++ +V ++++ G L D++          N RL+     +R        G+ Y
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICK--------NGRLDE--KESRRLFQQILSGVDY 131

Query: 387 LHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS------KFGPTSV-SKTHLDPEYY 439
            H      +++HRD+K  N+LLD    AK++DFGLS      +F  TS  S  +  PE  
Sbjct: 132 CH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 187

Query: 440 RLQQLT-EKSDVYSFGVVLFEVLC 462
             +     + D++S GV+L+ +LC
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLC 211

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 75.3 bits (186), Expect = 4e-15
 Identities = 47/217 (21%), Positives = 86/217 (39%), Gaps = 39/217 (17%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEF-QTEIGMLSQLRH 328
            +F    ++G G F  V       ++   AIK LE     ++  + +   E  ++S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL----------EICI 378
              V L     DD ++     +   G L  ++                        EI  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--------GSFDETCTRFYTAEIVS 141

Query: 379 GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--TSVSKTH--- 433
                L YLH       IIHRD+K  NILL+E    +++DFG +K     +  ++ +   
Sbjct: 142 A----LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 193

Query: 434 -----LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
                + PE    +   + SD+++ G ++++++   P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 76.2 bits (188), Expect = 4e-15
 Identities = 50/227 (22%), Positives = 86/227 (37%), Gaps = 50/227 (22%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH 330
            + F  + + G G FG V  G    +   VAIK++  + +    E Q  +  L+ L H +
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPN 80

Query: 331 LVSLIGF-------CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLE-------- 375
           +V L  +          D  + +V +++     PD L+                      
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 376 --ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK-WVAKVSDFGLSK-FGP----T 427
             +     R +  LH  +    + HRD+K  N+L++E     K+ DFG +K   P     
Sbjct: 136 FQLI----RSIGCLHLPS--VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189

Query: 428 S--VSKTHLDPEYYR-------LQQLTEKSDVYSFGVVLFEVLCARP 465
           +   S+      YYR        Q  T   D++S G +  E++   P
Sbjct: 190 AYICSR------YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 76.1 bits (188), Expect = 5e-15
 Identities = 54/233 (23%), Positives = 94/233 (40%), Gaps = 59/233 (25%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP-ESQQGALEFQTEIGMLSQLRHL 329
           +++F    ++G G +G V       +   VAIK++EP +    AL    EI +L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69

Query: 330 HLVSLI-----GFCNDDREMILVYDFM--------ARGTL-PDH----LYHSDNPPLPWN 371
           +++++          +  E+ ++ + M        +   L  DH    +Y          
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY---------- 119

Query: 372 QRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL----SKFGPT 427
           Q L       R +  LH  +N   +IHRD+K +N+L++     KV DFGL     +    
Sbjct: 120 QTL-------RAVKVLHG-SN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168

Query: 428 SVSKTHLDP---EY-----YR-------LQQLTEKSDVYSFGVVLFEVLCARP 465
           +   T       E+     YR         + +   DV+S G +L E+   RP
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 76.0 bits (187), Expect = 1e-14
 Identities = 50/214 (23%), Positives = 88/214 (41%), Gaps = 32/214 (14%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRH 328
              + N   IG G  G V   +       VAIK+L    ++Q  A     E+ ++  + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 329 LHLVSLI------GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR 382
            +++SL+          + +++ LV + M       +L       L   +   +      
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQMLC 175

Query: 383 GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEY---- 438
           G+ +LH+    A IIHRD+K +NI++      K+ DFGL++   TS   T     Y    
Sbjct: 176 GIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT----PYVVTR 227

Query: 439 -YR------LQQLTEKSDVYSFGVVLFEVLCARP 465
            YR           E  D++S G ++ E++  + 
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 47/190 (24%), Positives = 86/190 (45%), Gaps = 31/190 (16%)

Query: 261 QFSLSEIQAATN--NFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQG---- 312
             S+S   +AT+   +     +G G +G+VYK     +   VAIK  RLE E ++G    
Sbjct: 21  SMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGT 79

Query: 313 ALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDH---LYHSDNPPLP 369
           A+    E+ +L +L+H +++ L    + +  + L++++       ++    Y   NP + 
Sbjct: 80  AIR---EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA------ENDLKKYMDKNPDVS 130

Query: 370 WNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVA-----KVSDFGLSK- 423
                        G+++ H+       +HRD+K  N+LL     +     K+ DFGL++ 
Sbjct: 131 MRVIKSFLYQLINGVNFCHS--RR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186

Query: 424 FGPTSVSKTH 433
           FG      TH
Sbjct: 187 FGIPIRQFTH 196

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 42/217 (19%), Positives = 81/217 (37%), Gaps = 53/217 (24%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK-----RLEPESQQGALEFQTEIGMLSQLRHLHLVS 333
            +G G F  V +     +    A       +L     Q   + + E  +   L+H ++V 
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ---KLEREARICRLLKHPNIVR 74

Query: 334 LIGFCNDDREMILVYDFMARGTLPD------HLYHSDNPPLPWNQRLEICIGAAR----- 382
           L    +++    L++D +  G L +      +   +D               A+      
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD---------------ASHCIQQI 119

Query: 383 --GLHYLHT-GANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSKF--GPTSVSKT-- 432
              + + H  G     ++HR++K  N+LL    +    K++DFGL+    G         
Sbjct: 120 LEAVLHCHQMG-----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174

Query: 433 ----HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
               +L PE  R     +  D+++ GV+L+ +L   P
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 211

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 51/226 (22%), Positives = 88/226 (38%), Gaps = 56/226 (24%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRH 328
              + N   IG G  G V   +       VAIK+L    ++Q  A     E+ ++  + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 329 LHLVSLI------GFCNDDREMILVYDFMA-------RGTL-PDH----LYHSDNPPLPW 370
            +++ L+          + +++ +V + M        +  L  +     LY         
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY--------- 134

Query: 371 NQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVS 430
            Q L        G+ +LH+    A IIHRD+K +NI++      K+ DFGL++   TS  
Sbjct: 135 -QML-------CGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 182

Query: 431 KTHLDPEY-----YR------LQQLTEKSDVYSFGVVLFEVLCARP 465
            T     Y     YR           E  D++S G ++ E++    
Sbjct: 183 MT----PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.2 bits (185), Expect = 2e-14
 Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 22/208 (10%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEF-QTEIGMLSQLRH 328
           N F+   ++G G FG V       +    A+K L+ E    +  +    TE  +L   RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 329 LHLVSLIG-FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ--RLEICIGAARGLH 385
             L +L   F   DR +  V ++   G L  HL           +    EI       L 
Sbjct: 208 PFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA----LD 262

Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPE 437
           YLH+  N   +++RD+K  N++LD+    K++DFGL K G    +           L PE
Sbjct: 263 YLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 319

Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
                      D +  GVV++E++C R 
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 347

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 53/233 (22%), Positives = 89/233 (38%), Gaps = 64/233 (27%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIK---------------RLEPESQQGALEFQT------ 318
           IG G +G V   +     T  A+K               R  P   + A           
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 319 -----EIGMLSQLRHLHLVSL---IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPW 370
                EI +L +L H ++V L   +   N+D  + +V++ + +G + +        PL  
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTLK---PLSE 136

Query: 371 NQRLEICIGAAR--------GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS 422
           +Q        AR        G+ YLH       IIHRD+K +N+L+ E    K++DFG+S
Sbjct: 137 DQ--------ARFYFQDLIKGIEYLH--YQK--IIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 423 KFGPTSVSKTH--------LDPEYYRLQQLT---EKSDVYSFGVVLFEVLCAR 464
                S +           + PE     +     +  DV++ GV L+  +  +
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 53/235 (22%), Positives = 92/235 (39%), Gaps = 61/235 (25%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH 330
            + + +   +G GG G V+    N     VAIK++     Q       EI ++ +L H +
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 331 LVSLI--------------GFCNDDREMILVYDFM--------ARGTL-PDH----LYHS 363
           +V +               G   +   + +V ++M         +G L  +H    +Y  
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY-- 127

Query: 364 DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLS 422
                   Q L       RGL Y+H+ AN   ++HRD+K  N+ ++ E  V K+ DFGL+
Sbjct: 128 --------QLL-------RGLKYIHS-AN---VLHRDLKPANLFINTEDLVLKIGDFGLA 168

Query: 423 KFGPTSVSKTHLDPEY-----YR-------LQQLTEKSDVYSFGVVLFEVLCARP 465
           +      S      E      YR           T+  D+++ G +  E+L  + 
Sbjct: 169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 72.6 bits (179), Expect = 3e-14
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 21/162 (12%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEF-QT---EIGMLSQLR---HLH 330
           IGVG +G VYK     S   VA+K  R+      G      +   E+ +L +L    H +
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNG-GGGGGGLPISTVREVALLRRLEAFEHPN 75

Query: 331 LVSLI-----GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
           +V L+        + + ++ LV++ + +  L  +L  +  P LP     ++     RGL 
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134

Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGP 426
           +LH  AN   I+HRD+K  NIL+      K++DFGL++ +  
Sbjct: 135 FLH--ANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSY 172

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 73.0 bits (180), Expect = 4e-14
 Identities = 49/166 (29%), Positives = 76/166 (45%), Gaps = 33/166 (19%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQG----ALEFQTEIGMLSQLRHLHLVS 333
           IG G FG+V+K     +   VA+K   +E E ++G    AL    EI +L  L+H ++V+
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALR---EIKILQLLKHENVVN 80

Query: 334 LIGFCNDDREMI--------LVYDFMARGTLPDH----LYHSDNPPLPWNQRLEICIGAA 381
           LI  C               LV+DF       +H    L  +       ++   +     
Sbjct: 81  LIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKRVMQMLL 134

Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS-KFGP 426
            GL+Y+H   N   I+HRD+K  N+L+    V K++DFGL+  F  
Sbjct: 135 NGLYYIH--RNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSL 176

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 72.8 bits (179), Expect = 6e-14
 Identities = 54/228 (23%), Positives = 91/228 (39%), Gaps = 60/228 (26%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRH 328
              + N   +G G +G V   F   +   VA+K+L    +S   A     E+ +L  ++H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 329 LHLVSLI------GFCNDDREMILVYDFM---------ARGTLPDH----LYHSDNPPLP 369
            +++ L+          +  ++ LV   M          +    DH    +Y        
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY-------- 139

Query: 370 WNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV 429
             Q L       RGL Y+H+    A IIHRD+K +N+ ++E    K+ DFGL++   T+ 
Sbjct: 140 --QIL-------RGLKYIHS----ADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTAD 184

Query: 430 SKTHLDPEY-----YR-------LQQLTEKSDVYSFGVVLFEVLCARP 465
             T     Y     YR            +  D++S G ++ E+L  R 
Sbjct: 185 EMT----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 71.9 bits (177), Expect = 6e-14
 Identities = 47/214 (21%), Positives = 83/214 (38%), Gaps = 36/214 (16%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGF 337
           V+G G    V       ++   A+K +E +          E+ ML Q + H +++ LI F
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQR--LEICIGAARGLHYLHT-GANHA 394
             ++    LV++ M  G++  H++   +    +N+     +    A  L +LH  G    
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRH----FNELEASVVVQDVASALDFLHNKG---- 131

Query: 395 VIIHRDVKTTNILL---DEKWVAKVSDFGLSKFGPTSVSKTHLD---------------P 436
            I HRD+K  NIL    ++    K+ DF L      +   + +                P
Sbjct: 132 -IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

Query: 437 EYYRLQQLTEKS-----DVYSFGVVLFEVLCARP 465
           E                D++S GV+L+ +L   P
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 72.8 bits (179), Expect = 6e-14
 Identities = 41/253 (16%), Positives = 88/253 (34%), Gaps = 92/253 (36%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGF- 337
            +G G FG V + F   S    A+K++  + +    E      ++  L H++++ L+ + 
Sbjct: 14  TLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDHVNIIKLVDYF 69

Query: 338 -------------------------------------CNDDREMILVYDFMARGTLPDHL 360
                                                 + ++ + ++ +++     PD L
Sbjct: 70  YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-----PDTL 124

Query: 361 YHSDNPPLPWNQRLE----------ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD- 409
           +      +   + +           +     R + ++H+      I HRD+K  N+L++ 
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHS----LGICHRDIKPQNLLVNS 176

Query: 410 EKWVAKVSDFGLSKFGPTSVSKTHLDPE----------YYR-------LQQLTEKSDVYS 452
           +    K+ DFG +K          L P           +YR         + T   D++S
Sbjct: 177 KDNTLKLCDFGSAK---------KLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWS 227

Query: 453 FGVVLFEVLCARP 465
            G V  E++  +P
Sbjct: 228 IGCVFGELILGKP 240

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 72.7 bits (178), Expect = 6e-14
 Identities = 54/246 (21%), Positives = 88/246 (35%), Gaps = 52/246 (21%)

Query: 315 EFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL 374
           + +  +G +       L S+    +      +    ++     +         L     +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLI 196

Query: 375 EICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---GPTSVSK 431
                 A+G+ +L         IHRD+   NILL EK V K+ DFGL++     P  V K
Sbjct: 197 CYSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252

Query: 432 TH-------LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQ 484
                    + PE    +  T +SDV+SFGV+L+E+                SL      
Sbjct: 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI---------------FSL---GAS 294

Query: 485 CYQNGTIDQIVDPFLKA------------------MSCLNDEGIRRPSMSDVVWGLEFSL 526
            Y    ID+     LK                   + C + E  +RP+ S++V  L    
Sbjct: 295 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN-- 352

Query: 527 QLQESS 532
            LQ ++
Sbjct: 353 LLQANA 358

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 37/184 (20%), Positives = 70/184 (38%), Gaps = 21/184 (11%)

Query: 279 VIGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGAL-EFQTEIGMLSQL-RHLHL 331
            +G G FG V +    G     +   VA+K L+  +         +E+ +L  +  HL++
Sbjct: 29  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88

Query: 332 VSLIGFCND-DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           V+L+G C      ++++ +F   G L  +L          ++R E      +G  +   G
Sbjct: 89  VNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPYKTKGARF-RQG 138

Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTEKSDV 450
            ++   I  D+K     +     +  S F   K    S  +    PE      LT +  +
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK--SLSDVEEEEAPEDLYKDFLTLE-HL 195

Query: 451 YSFG 454
             + 
Sbjct: 196 ICYS 199

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 72.4 bits (178), Expect = 8e-14
 Identities = 53/228 (23%), Positives = 89/228 (39%), Gaps = 60/228 (26%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRH 328
              + +   +G G +G V       +   VAIK+L    +S+  A     E+ +L  +RH
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83

Query: 329 LHLVSLI------GFCNDDREMILVYDFM--------ARGTL-PDH----LYHSDNPPLP 369
            +++ L+         +D  +  LV  FM            L  D     +Y        
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY-------- 135

Query: 370 WNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSV 429
             Q L       +GL Y+H     A IIHRD+K  N+ ++E    K+ DFGL++      
Sbjct: 136 --QML-------KGLRYIHA----AGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADS 180

Query: 430 SKTHLDPEY-----YR-------LQQLTEKSDVYSFGVVLFEVLCARP 465
             T     Y     YR         + T+  D++S G ++ E++  + 
Sbjct: 181 EMT----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 71.9 bits (177), Expect = 9e-14
 Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 20/205 (9%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALE-FQTEIGMLSQLRH 328
           + FD    +G G FG V       S    A+K L+ +   +   +E    E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
             LV L     D+  + +V +++A G +  HL        P  +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLH 158

Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYR 440
           +      +I+RD+K  N+L+D++   +V+DFG +K       +T         L PE   
Sbjct: 159 SLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIIL 211

Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
            +   +  D ++ GV+++E+    P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 50/203 (24%), Positives = 79/203 (38%), Gaps = 33/203 (16%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN 339
           IG G FG         +   VA+K +E          Q EI     LRH ++V       
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86

Query: 340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAAR--------GLHYLHTGA 391
               + ++ ++ + G L + + +          R       AR        G+ Y H  +
Sbjct: 87  TPTHLAIIMEYASGGELYERICN--------AGRFSE--DEARFFFQQLLSGVSYCH--S 134

Query: 392 NHAVIIHRDVKTTNILLDEKWVA--KVSDFGLSKFGP------TSV-SKTHLDPEYYRLQ 442
               I HRD+K  N LLD       K+ DFG SK         ++V +  ++ PE    Q
Sbjct: 135 MQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQ 192

Query: 443 QLT-EKSDVYSFGVVLFEVLCAR 464
           +   + +DV+S GV L+ +L   
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGA 215

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 48/228 (21%), Positives = 87/228 (38%), Gaps = 62/228 (27%)

Query: 223 KDSSSGTGTSLLGTFLWSKTIKATKSSRGSFLPSDLCTQFSLSEIQAATNNFDNDLVIGV 282
           +  +SGT  ++ G+    +  K   SS+ +       + + + +       ++   +IG 
Sbjct: 10  QQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPD------RYEIRHLIGT 63

Query: 283 GGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQT---------EIGMLSQLRHLHLVS 333
           G +G V + +       VAIK++          F+          EI +L++L H H+V 
Sbjct: 64  GSYGHVCEAYDKLEKRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNHDHVVK 116

Query: 334 LI-----GFCNDDREMILVYDFM---------ARGTL-PDH----LYHSDNPPLPWNQRL 374
           ++            E+ +V +               L   H    LY            L
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY----------NLL 166

Query: 375 EICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS 422
                   G+ Y+H+ A    I+HRD+K  N L+++    KV DFGL+
Sbjct: 167 -------VGVKYVHS-AG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 46/207 (22%), Positives = 82/207 (39%), Gaps = 35/207 (16%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGF 337
           V+G+G  G V + F   +    A+K L         + + E+    Q     H+V ++  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDV 90

Query: 338 CNDDREMI----LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT-GAN 392
             +         ++ + M  G L   +    +      +  EI       + +LH+    
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN-- 148

Query: 393 HAVIIHRDVKTTNILL---DEKWVAKVSDFGLSKFGPTSVSKTH-----------LDPEY 438
              I HRDVK  N+L    ++  V K++DFG +K    +  +T            L PE 
Sbjct: 149 ---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEK 205

Query: 439 YRLQQLTEKSDVYSFGVVLFEVLCARP 465
           Y      +  D++S GV+++ +LC  P
Sbjct: 206 Y-----DKSCDMWSLGVIMYILLCGFP 227

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 23/208 (11%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEF-QTEIGMLSQLRH 328
           N+FD   ++G G FG V       +    A+K L  E    +  +    TE  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 329 LHLVSLIG-FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ--RLEICIGAARGLH 385
             L +L   F   DR +  V ++   G L  HL           +    EI       L 
Sbjct: 65  PFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA----LE 119

Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPE 437
           YLH+      +++RD+K  N++LD+    K++DFGL K G +  +           L PE
Sbjct: 120 YLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
                      D +  GVV++E++C R 
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 71.0 bits (175), Expect = 2e-13
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 27/204 (13%)

Query: 279 VIGVGGFGDVY---KGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVS 333
           V+G G FG V+   K   + +    A+K L+  +   +  +  + E  +L ++ H  +V 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 334 LI-GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICIGAARGLHYLHT 389
           L   F  + + + L+ DF+  G L   L            +    E+ +     L +LH+
Sbjct: 91  LHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEED-VKFYLAELALA----LDHLHS 144

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRL 441
                 II+RD+K  NILLDE+   K++DFGLSK       K +        + PE    
Sbjct: 145 LG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200

Query: 442 QQLTEKSDVYSFGVVLFEVLCARP 465
           +  T+ +D +SFGV++FE+L    
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTL 224

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 46/223 (20%), Positives = 86/223 (38%), Gaps = 28/223 (12%)

Query: 263 SLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALE-FQTE 319
            + +++    +F+   VIG G FG+V    +  +    A+K L      ++     F+ E
Sbjct: 65  KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124

Query: 320 IGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNP-PLPWNQ--RLEI 376
             +L       + +L     DD  + LV D+   G L   L   ++  P    +    E+
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184

Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTH-- 433
            I     +  +H        +HRD+K  NIL+D     +++DFG           ++   
Sbjct: 185 VIA----IDSVHQLH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236

Query: 434 ------LDPEYYRLQQLTEKS-----DVYSFGVVLFEVLCARP 465
                 + PE  +  +  +       D +S GV ++E+L    
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 41/206 (19%), Positives = 78/206 (37%), Gaps = 48/206 (23%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGFC 338
           +G G + +V++     +   V +K L+P  ++       EI +L  LR   ++++L    
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK---REIKILENLRGGPNIITLADIV 100

Query: 339 NDDREMILVYDFMARGTLPDHLYHSD----NPPLPWN-------QRLEICIGAARGLHYL 387
            D         F        H+ ++D       L          + L       + L Y 
Sbjct: 101 KDPVSRTPALVFE-------HVNNTDFKQLYQTLTDYDIRFYMYEIL-------KALDYC 146

Query: 388 HTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSVSKTHLDPE----YYR-- 440
           H+      I+HRDVK  N+++D E    ++ D+GL++F                 Y++  
Sbjct: 147 HS----MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV---RVASRYFKGP 199

Query: 441 -----LQQLTEKSDVYSFGVVLFEVL 461
                 Q      D++S G +L  ++
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMI 225

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 70.4 bits (172), Expect = 7e-13
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 24/209 (11%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEF-QTEIGMLSQ-LR 327
            +F+  +V+G G FG V      G+    A+K L+ +   Q   +E    E  +L+   +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 328 HLHLVSLIG-FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ--RLEICIGAARGL 384
              L  L   F   DR +  V +++  G L  H+        P       EI IG    L
Sbjct: 401 PPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----L 455

Query: 385 HYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDP 436
            +L +      II+RD+K  N++LD +   K++DFG+ K        T         + P
Sbjct: 456 FFLQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAP 511

Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E    Q   +  D ++FGV+L+E+L  + 
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 44/232 (18%), Positives = 80/232 (34%), Gaps = 44/232 (18%)

Query: 263 SLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALE-FQTE 319
            L E++   ++F+   VIG G F +V    +  +    A+K +      ++G +  F+ E
Sbjct: 52  RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE 111

Query: 320 IGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG 379
             +L       +  L     D+  + LV ++   G L   L            +    I 
Sbjct: 112 RDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL-----------SKFGERIP 160

Query: 380 AAR----------GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTS 428
           A             +  +H        +HRD+K  NILLD     +++DFG         
Sbjct: 161 AEMARFYLAEIVMAIDSVHRLG----YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216

Query: 429 VSKTH--------LDPEYYRLQQLTEKSDVY-------SFGVVLFEVLCARP 465
             ++         L PE  +       +  Y       + GV  +E+   + 
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 40/169 (23%), Positives = 75/169 (44%), Gaps = 37/169 (21%)

Query: 280 IGVGGFGDVYKGFINGSTT--PVAIK--RLEPESQQG----ALEFQTEIGMLSQLR---H 328
           IG G +G V+K   +       VA+K  R++   ++G     +    E+ +L  L    H
Sbjct: 19  IGEGAYGKVFKA-RDLKNGGRFVALKRVRVQTG-EEGMPLSTIR---EVAVLRHLETFEH 73

Query: 329 LHLVSLI-----GFCNDDREMILVYDFMARGTLPDH-----LYHSDNPPLPWNQRLEICI 378
            ++V L         + + ++ LV++ +      D      L     P +P     ++  
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHV------DQDLTTYLDKVPEPGVPTETIKDMMF 127

Query: 379 GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGP 426
              RGL +LH  ++   ++HRD+K  NIL+      K++DFGL++ +  
Sbjct: 128 QLLRGLDFLH--SHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 44/207 (21%), Positives = 74/207 (35%), Gaps = 52/207 (25%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLRH 328
            +N+    +IG G +G VY  +   +   VAIK++    E          EI +L++L+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84

Query: 329 LHLVSLI-----GFCNDDREMILVYDFM---------ARGTL-PDH----LYHSDNPPLP 369
            +++ L             E+ +V +               L  +H    LY        
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY-------- 136

Query: 370 WNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS------- 422
               L        G +++H  +    IIHRD+K  N LL++    KV DFGL+       
Sbjct: 137 --NLL-------LGENFIHE-SG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183

Query: 423 ---KFGPTSVSKTHLDPEYYRLQQLTE 446
                     ++          +QLT 
Sbjct: 184 DTNIVNDLEENEEPGPHNKNLKKQLTS 210

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 67.9 bits (167), Expect = 1e-12
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 40/215 (18%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALE-FQTEIGMLSQLRH 328
            +F     +G G FG V+      +    A+K L+ E   +   +E    E  MLS + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL----------EICI 378
             ++ + G   D +++ ++ D++  G L   L  S        QR           E+C+
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--------QRFPNPVAKFYAAEVCL 117

Query: 379 GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH----- 433
                L YLH  +    II+RD+K  NILLD+    K++DFG +K+ P     T+     
Sbjct: 118 A----LEYLH--SKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGT 166

Query: 434 ---LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
              + PE    +   +  D +SFG++++E+L    
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 43/202 (21%), Positives = 77/202 (38%), Gaps = 27/202 (13%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGF 337
            +G G F    K     S    A+K +    +      Q EI  L     H ++V L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEITALKLCEGHPNIVKLHEV 74

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQR--LEICIGAARGLHYLHT-GANHA 394
            +D     LV + +  G L + +    +    +++     I       + ++H  G    
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKH----FSETEASYIMRKLVSAVSHMHDVG---- 126

Query: 395 VIIHRDVKTTNILL---DEKWVAKVSDFGLSKF--GPTSVSKT------HLDPEYYRLQQ 443
            ++HRD+K  N+L    ++    K+ DFG ++         KT      +  PE      
Sbjct: 127 -VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG 185

Query: 444 LTEKSDVYSFGVVLFEVLCARP 465
             E  D++S GV+L+ +L  + 
Sbjct: 186 YDESCDLWSLGVILYTMLSGQV 207

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 67.2 bits (165), Expect = 3e-12
 Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 29/206 (14%)

Query: 279 VIGVGGFGDVY---KGFINGSTTPVAIKRLEPES---QQGALEF-QTEIGMLSQLRHLHL 331
           V+G GG+G V+   K     +    A+K L+              + E  +L +++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 332 VSLI-GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICIGAARGLHYL 387
           V LI  F    + + L+ ++++ G L   L                 EI +     L +L
Sbjct: 84  VDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFMEDT-ACFYLAEISMA----LGHL 137

Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYY 439
           H       II+RD+K  NI+L+ +   K++DFGL K      + TH        + PE  
Sbjct: 138 HQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEIL 193

Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARP 465
                    D +S G +++++L   P
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAP 219

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 43/214 (20%), Positives = 81/214 (37%), Gaps = 51/214 (23%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIG-MLSQLRHLHLVSLIGF 337
            IGVG +    +     +    A+K ++    +   +   EI  +L   +H ++++L   
Sbjct: 29  DIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEIEILLRYGQHPNIITLKDV 84

Query: 338 CNDDREMILVYDFMARGTLPD------HLYHSDNPPLPWNQRLEICIGAAR-------GL 384
            +D + + +V + M  G L D           +               A+         +
Sbjct: 85  YDDGKYVYVVTELMKGGELLDKILRQKFFSERE---------------ASAVLFTITKTV 129

Query: 385 HYLHT-GANHAVIIHRDVKTTNILLDEK----WVAKVSDFGLSKF--GPTSVSKT----- 432
            YLH  G     ++HRD+K +NIL  ++       ++ DFG +K       +  T     
Sbjct: 130 EYLHAQG-----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA 184

Query: 433 -HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
             + PE    Q      D++S GV+L+ +L    
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYT 218

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 49/227 (21%), Positives = 86/227 (37%), Gaps = 39/227 (17%)

Query: 263 SLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALE-FQTE 319
            + +++    +++   VIG G FG+V       +    A+K L      ++     F  E
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119

Query: 320 IGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG 379
             +++      +V L     DDR + +V ++M  G L + +              ++   
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-----------SNYDVPEK 168

Query: 380 AAR--------GLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVS 430
            AR         L  +H+       IHRDVK  N+LLD+    K++DFG         + 
Sbjct: 169 WARFYTAEVVLALDAIHSMG----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224

Query: 431 KTH--------LDPEYYRLQQLTEK----SDVYSFGVVLFEVLCARP 465
           +          + PE  + Q          D +S GV L+E+L    
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 66.1 bits (162), Expect = 8e-12
 Identities = 57/202 (28%), Positives = 86/202 (42%), Gaps = 24/202 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEF-QTEIGMLSQ-LRHLHLVSL 334
           V+G G FG V    +  +    A+K L+ +   Q   +E   TE  +LS    H  L  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89

Query: 335 IG-FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ--RLEICIGAARGLHYLHTGA 391
              F   DR +  V +F+  G L  H+  S        +    EI       L +LH   
Sbjct: 90  FCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA----LMFLHDKG 144

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQ 443
               II+RD+K  N+LLD +   K++DFG+ K G  +   T         + PE  +   
Sbjct: 145 ----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML 200

Query: 444 LTEKSDVYSFGVVLFEVLCARP 465
                D ++ GV+L+E+LC   
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHA 222

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 66.3 bits (162), Expect = 9e-12
 Identities = 45/208 (21%), Positives = 85/208 (40%), Gaps = 36/208 (17%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGF 337
           V+G+G  G V + F   +    A+K L+        + + E+ +  +  +  H+V ++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDV 123

Query: 338 CND----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT-GAN 392
             +     + +++V + +  G L   +    +      +  EI       + YLH+    
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 181

Query: 393 HAVIIHRDVKTTNILL---DEKWVAKVSDFGLSK-FGPTSVSKTH-----------LDPE 437
              I HRDVK  N+L        + K++DFG +K     +   T            L PE
Sbjct: 182 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 238

Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARP 465
            Y      +  D++S GV+++ +LC  P
Sbjct: 239 KY-----DKSCDMWSLGVIMYILLCGYP 261

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 65.3 bits (160), Expect = 1e-11
 Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 24/202 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALE-FQTEIGMLSQ-LRHLHLVSL 334
           ++G G FG V+      +    AIK L+ +       +E    E  +LS    H  L  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 335 IG-FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ--RLEICIGAARGLHYLHTGA 391
              F   +  +  V +++  G L  H+       L        EI +G    L +LH+  
Sbjct: 84  FCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG----LQFLHSKG 138

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQ 443
               I++RD+K  NILLD+    K++DFG+ K      +KT+        + PE    Q+
Sbjct: 139 ----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 194

Query: 444 LTEKSDVYSFGVVLFEVLCARP 465
                D +SFGV+L+E+L  + 
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQS 216

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.3 bits (158), Expect = 1e-11
 Identities = 38/214 (17%), Positives = 57/214 (26%), Gaps = 53/214 (24%)

Query: 257 DLCTQ---FSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRL-------- 305
             C+Q      S     T        IG G FG+V++   +   TPVAIK +        
Sbjct: 3   GECSQKGPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIADH--TPVAIKIIAIEGPDLV 59

Query: 306 EPESQQGALEFQTEIGMLSQLRHLHLVSLI---GFCN----------DDREMILVYDFMA 352
               Q+   E   EI +  +L  L         GF                ++  +D   
Sbjct: 60  NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119

Query: 353 --RGTLPDH---------------------LYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
             +G+  D                      L               I       L     
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA 179

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK 423
                   HRD+   N+LL +  + K+      K
Sbjct: 180 SLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 64.9 bits (159), Expect = 2e-11
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 24/209 (11%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEF-QTEIGMLSQ-LR 327
            +FD   VIG G +  V    +  +    A+K ++ E       +++ QTE  +  Q   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 328 HLHLVSLIG-FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ--RLEICIGAARGL 384
           H  LV L   F  + R +  V +++  G L  H+      P    +    EI +     L
Sbjct: 69  HPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----L 123

Query: 385 HYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDP 436
           +YLH       II+RD+K  N+LLD +   K++D+G+ K G      T         + P
Sbjct: 124 NYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 179

Query: 437 EYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
           E  R +      D ++ GV++FE++  R 
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRS 208

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 24/202 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEF-QTEIGMLSQ-LRHLHLVSL 334
           V+G G FG V      G+    A+K L+ +   Q   +E    E  +L+   +   L  L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86

Query: 335 IG-FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ--RLEICIGAARGLHYLHTGA 391
              F   DR +  V +++  G L  H+        P       EI IG    L +L +  
Sbjct: 87  HSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQSKG 141

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQ 443
               II+RD+K  N++LD +   K++DFG+ K        T         + PE    Q 
Sbjct: 142 ----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP 197

Query: 444 LTEKSDVYSFGVVLFEVLCARP 465
             +  D ++FGV+L+E+L  + 
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQA 219

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 24/202 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEF-QTEIGMLSQ-LRHLHLVSL 334
           VIG G +  V    +  +    A++ ++ E       +++ QTE  +  Q   H  LV L
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118

Query: 335 IG-FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQ--RLEICIGAARGLHYLHTGA 391
              F  + R +  V +++  G L  H+      P    +    EI +     L+YLH   
Sbjct: 119 HSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLHERG 173

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQ 443
               II+RD+K  N+LLD +   K++D+G+ K G      T         + PE  R + 
Sbjct: 174 ----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 229

Query: 444 LTEKSDVYSFGVVLFEVLCARP 465
                D ++ GV++FE++  R 
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRS 251

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 59/243 (24%), Positives = 106/243 (43%), Gaps = 69/243 (28%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP--ESQQGALEFQTEIGMLSQLR- 327
              ++    +G G +G V+K     +   VA+K++    ++   A     EI +L++L  
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67

Query: 328 HLHLVSL--IGFCNDDREMILVYDFMA-------RGTL--PDH----LYHSDNPPLPWNQ 372
           H ++V+L  +   ++DR++ LV+D+M        R  +  P H    +Y          Q
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY----------Q 117

Query: 373 RLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT 432
            +       + + YLH+      ++HRD+K +NILL+ +   KV+DFGLS+        T
Sbjct: 118 LI-------KVIKYLHS-GG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166

Query: 433 HLDP------------------EY-----YR-------LQQLTEKSDVYSFGVVLFEVLC 462
           +  P                  +Y     YR         + T+  D++S G +L E+LC
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226

Query: 463 ARP 465
            +P
Sbjct: 227 GKP 229

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 59/203 (29%), Positives = 85/203 (41%), Gaps = 26/203 (12%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEF-QTEIGMLSQ-LRHLHLVSL 334
           VIG G FG V            A+K L+ ++  ++   +   +E  +L + ++H  LV L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 335 IG-FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICIGAARGLHYLHTG 390
              F   D+ +  V D++  G L  HL        P   R    EI       L YLH+ 
Sbjct: 105 HFSFQTADK-LYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAEIASA----LGYLHSL 158

Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQ 442
                I++RD+K  NILLD +    ++DFGL K      S T         L PE    Q
Sbjct: 159 N----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ 214

Query: 443 QLTEKSDVYSFGVVLFEVLCARP 465
                 D +  G VL+E+L   P
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLP 237

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 39/216 (18%), Positives = 82/216 (37%), Gaps = 37/216 (17%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHL------- 329
            +G G F  V+      + T VA+K  R +    + A +   EI +L ++          
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKEDS 82

Query: 330 ----HLVSLIG---FCNDDRE-MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
               H++ L+        +   +++V++ +    L   +   ++  +P     +I     
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLL 141

Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDE------KWVAKVSDFGLSKFGPTSVSKTHLD 435
            GL Y+H       IIH D+K  N+L++           K++D G + +     +   + 
Sbjct: 142 LGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT-NSIQ 197

Query: 436 PEYYRL------QQLTEKSDVYSFGVVLFEVLCARP 465
              YR             +D++S   ++FE++    
Sbjct: 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 41/196 (20%), Positives = 80/196 (40%), Gaps = 33/196 (16%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGF 337
           V+G+G  G V + F   +    A+K L+        + + E+ +  +  +  H+V ++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDV 79

Query: 338 CND----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT-GAN 392
             +     + +++V + +  G L   +    +      +  EI       + YLH+    
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 137

Query: 393 HAVIIHRDVKTTNILL---DEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTEKSD 449
              I HRDVK  N+L        + K++DFG +K      +    D             D
Sbjct: 138 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTGEKYDKS----------CD 180

Query: 450 VYSFGVVLFEVLCARP 465
           ++S GV+++ +LC  P
Sbjct: 181 MWSLGVIMYILLCGYP 196

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 33/217 (15%)

Query: 272 NNFDNDLVIGVGGFGDVY---KGFINGSTTPVAIKRLEPESQQGALEF----QTEIGMLS 324
            NF+   V+G G +G V+   K   + +    A+K L+  +     +     +TE  +L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 325 QLRHLH-LVSLIG-FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRL---EICIG 379
            +R    LV+L   F  + + + L+ D++  G L  HL   +        ++   EI + 
Sbjct: 114 HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHE-VQIYVGEIVLA 171

Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------- 432
               L +LH       II+RD+K  NILLD      ++DFGLSK      ++        
Sbjct: 172 ----LEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 223

Query: 433 --HLDPEYYRLQQL--TEKSDVYSFGVVLFEVLCARP 465
             ++ P+  R       +  D +S GV+++E+L    
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 27/166 (16%), Positives = 58/166 (34%), Gaps = 28/166 (16%)

Query: 280 IGVGGFGDVYKGFINGSTT--------PVAIKRLEPESQQGALEF-----QTEIGMLSQL 326
                 G +Y+     + T          ++K L+ +  +   E        +   +++ 
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108

Query: 327 RHLHLVSLIGF-------CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG 379
           + L+   L+          + D+   LV   + R +L   L  S    L     L++   
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACR 167

Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKV--SDFGLSK 423
               L +LH        +H +V   NI +D +  ++V  + +G + 
Sbjct: 168 LLDALEFLHENE----YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.9 bits (139), Expect = 8e-09
 Identities = 77/514 (14%), Positives = 138/514 (26%), Gaps = 149/514 (28%)

Query: 24  WI--------RNYSAPDLVYETART-MGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEF 74
           ++        R  S    +Y   R  +  D ++  KYN++            LR    E 
Sbjct: 93  FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLK-----LRQALLEL 147

Query: 75  QIE--VTEDGDRVF--QIFIANLTAEVQADV---------IAWTGANGVTVYRDYAVMIG 121
           +    V  DG            +  +V             I W     + +         
Sbjct: 148 RPAKNVLIDGVLGSGKTW----VALDVCLSYKVQCKMDFKIFW-----LNLKNC------ 192

Query: 122 SKPNEE-NIKQNLSIQLHPAPRWRTKYSDAILNGLEIFKVDNTGNLGGPNPEPRTI---- 176
           + P     + Q L  Q+ P    R+ +S  I   +   +      L    P    +    
Sbjct: 193 NSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ-AELRRLLKSKPYENCLLVLL 251

Query: 177 ----PPNLDA----SPTIEPTKKNNVTGMVAGAISGSSVLSLLLLLIFWRGRKVKDSSSG 228
                   +A       +  T+   VT  ++ A +    L    + +        D    
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL------TPDEV-- 303

Query: 229 TGTSLLGTFLWSKTIKATKSSRGSFLPSDLCTQ--FSLSEIQAATNNFDNDLVIGVGGFG 286
              SLL  +L  +            LP ++ T     LS I  +  +             
Sbjct: 304 --KSLLLKYLDCRPQD---------LPREVLTTNPRRLSIIAESIRDGLATW-------- 344

Query: 287 DVYKGFINGSTTPVAIKR----LEPESQQGALE----FQ--TEI--GMLSQL-------- 326
           D +K  +N       I+     LEP   +   +    F     I   +LS +        
Sbjct: 345 DNWK-HVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSD 403

Query: 327 -----RHLHLVSLIGFCNDDREMILVYD--FMARGTLPD----H-----------LYHSD 364
                  LH  SL+         I +       +  L +    H            + SD
Sbjct: 404 VMVVVNKLHKYSLV-EKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD 462

Query: 365 NPPLPWNQRLEICIGAARGLHYLHTG-----ANHAVIIHRDVKTTNILLDEKWV-AKVSD 418
           +   P+               Y H G       H     R      + LD +++  K+  
Sbjct: 463 DLIPPYL----------DQYFYSHIGHHLKNIEHP---ERMTLFRMVFLDFRFLEQKIRH 509

Query: 419 FGLSKFGPTSVSKTHLDPEYYRLQQLTEKSDVYS 452
              +     S+  T    ++Y+   + +    Y 
Sbjct: 510 DSTAWNASGSILNTLQQLKFYK-PYICDNDPKYE 542

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 47/203 (23%), Positives = 81/203 (39%), Gaps = 23/203 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHL------H 330
           +IG G FG V K +       VAIK  + +      A     E+ +L  +         +
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ---IEVRLLELMNKHDTEMKYY 117

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           +V L         + LV++ ++   L D L +++   +  N   +        L +L T 
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT- 175

Query: 391 ANHAVIIHRDVKTTNILL--DEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQL---- 444
                IIH D+K  NILL   ++   K+ DFG S      +   ++   +YR  ++    
Sbjct: 176 -PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY-QYIQSRFYRSPEVLLGM 233

Query: 445 --TEKSDVYSFGVVLFEVLCARP 465
                 D++S G +L E+    P
Sbjct: 234 PYDLAIDMWSLGCILVEMHTGEP 256

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 47/197 (23%), Positives = 79/197 (40%), Gaps = 25/197 (12%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHL------H 330
           VIG G FG V K + +     VA+K  R E    + A     EI +L  LR        +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA---EEIRILEHLRKQDKDNTMN 160

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           ++ ++        + + ++ ++   L + +  +           +      + L  LH  
Sbjct: 161 VIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH-- 217

Query: 391 ANHAVIIHRDVKTTNILLDE--KWVAKVSDFGLSKFGPTSVSKTHLDPEYYR----LQQL 444
                IIH D+K  NILL +  +   KV DFG S +    V  T++   +YR    +   
Sbjct: 218 --KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY-TYIQSRFYRAPEVILGA 274

Query: 445 --TEKSDVYSFGVVLFE 459
                 D++S G +L E
Sbjct: 275 RYGMPIDMWSLGCILAE 291

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 34/158 (21%), Positives = 63/158 (39%), Gaps = 12/158 (7%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRH-LHLVSLIGFC 338
           IG G FGD+Y G    +   VAIK    +++   L    E  +   ++  + + ++    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWCG 74

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
            +    ++V + +  G   + L++  +        L +       + Y+H        IH
Sbjct: 75  AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIH 128

Query: 399 RDVKTTNILLDEKWVAK---VSDFGLSKFGPTSVSKTH 433
           RDVK  N L+          + DFGL+K    + +  H
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 35/148 (23%), Positives = 64/148 (43%), Gaps = 12/148 (8%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGFC 338
           IG G FG++Y G    +   VAIK    +++   L +  E  +   L+    + ++  F 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWFG 72

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
            +    +LV D +  G   + L++  +  L     L +       + ++H+       +H
Sbjct: 73  VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS----KSFLH 126

Query: 399 RDVKTTNILLDEKWVAK---VSDFGLSK 423
           RD+K  N L+     A    + DFGL+K
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 35/160 (21%), Positives = 55/160 (34%), Gaps = 14/160 (8%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRH-LHLVSLIGFC 338
           IG G FG +++G    +   VAIK     S    L    E      L     + ++  F 
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYYFG 75

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
            +    +LV D +  G   + L                       +  +H       +++
Sbjct: 76  QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE----KSLVY 129

Query: 399 RDVKTTNILLDEKWVAK-----VSDFGLSKFGPTSVSKTH 433
           RD+K  N L+            V DFG+ KF    V+K H
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 169

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 38/161 (23%), Positives = 63/161 (39%), Gaps = 16/161 (9%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRH-LHLVSLIGFC 338
           IG G FG++  G    +   VAIK LEP   +       E     QL     +  +  F 
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHL-EYRFYKQLGSGDGIPQVYYFG 74

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
              +   +V + +  G   + L+   +        L I I     + Y+H+      +I+
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS----KNLIY 128

Query: 399 RDVKTTNILL------DEKWVAKVSDFGLSKFGPTSVSKTH 433
           RDVK  N L+       ++ +  + DF L+K      +K H
Sbjct: 129 RDVKPENFLIGRPGNKTQQVI-HIIDFALAKEYIDPETKKH 168

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 44/215 (20%), Positives = 69/215 (32%), Gaps = 43/215 (20%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLR--------HL 329
           +G G F  V+  +       VA+K  +      + AL+   EI +L  +R          
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVRNSDPNDPNRE 101

Query: 330 HLVSLIG-----------FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICI 378
            +V L+             C       +V++ +    L   +  S+   LP     +I  
Sbjct: 102 MVVQLLDDFKISGVNGTHIC-------MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ 153

Query: 379 GAARGLHYLHTGANHAVIIHRDVKTTNILL--------DEKWVAKVSDFGLSKFGPTSVS 430
              +GL YLHT      IIH D+K  NILL             A       +     S  
Sbjct: 154 QVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210

Query: 431 KTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
            T        L    E  +     V + ++  A  
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW 245

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 32/166 (19%), Positives = 61/166 (36%), Gaps = 28/166 (16%)

Query: 280 IGVGGFGDVYKGFINGST-----TPVAIKRLEPESQQGALEFQT-----EIGMLSQLRHL 329
           IG GGFG +Y   +N S       P  +K    ++     E +      +   + +    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 330 HLVSLIGFC----------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG 379
             +  +G            N      ++ D    G+    +Y ++         L++ + 
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLR 160

Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKV--SDFGLSK 423
               L Y+H        +H D+K +N+LL+ K   +V   D+GL+ 
Sbjct: 161 ILDILEYIH----EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 44.7 bits (106), Expect = 5e-05
 Identities = 34/164 (20%), Positives = 57/164 (34%), Gaps = 27/164 (16%)

Query: 280 IGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ-GALEFQTEI-------GMLSQLRHLHL 331
           IG GGFG +Y  F        A   ++ E Q+ G L  + +          + +      
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 332 VSLIGF----------CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           +  +G                   +V + +    L        N     +  L++ I   
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQK--ISGQNGTFKKSTVLQLGIRML 161

Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKV--SDFGLSK 423
             L Y+H        +H D+K  N+LL  K   +V  +D+GLS 
Sbjct: 162 DVLEYIH----ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	613
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.8
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.63
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.18
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.09
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.0
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.74
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.64
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.56
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.53
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.41
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.33
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.21
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.9
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.84
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.83
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.72
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.37
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.32
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.3
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.28
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.21
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.01
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.99
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.89
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.13
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.92
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.85
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.04
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.38
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	91.07
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	90.24
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	90.17
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	89.28
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	87.51
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.27
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	85.66
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	84.88
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	83.98

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.1e-54  Score=451.65  Aligned_cols=250  Identities=28%  Similarity=0.437  Sum_probs=203.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ++|...++||+|+||+||+|++.+     ++..||||+++..+....++|.+|+++|++|+|||||+++|+|.+.+.++|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            456667789999999999999753     457899999998887788899999999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc
Q 048439          347 VYDFMARGTLPDHLYHSD-------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV  413 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~  413 (613)
                      |||||++|+|.++|....             ..+|+|.+++.|+.|||+||+|||+.+    ||||||||+||||+++++
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~----iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH----FVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEEETTTE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC----eecccccHhhEEECCCCc
Confidence            999999999999996532             246999999999999999999999988    999999999999999999


Q ss_pred             EEEEecCCCccC----------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHH
Q 048439          414 AKVSDFGLSKFG----------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWA  482 (613)
Q Consensus       414 ~kl~DFGls~~~----------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~  482 (613)
                      +||+|||+|+..          ...++..|||||++....++.|+|||||||+||||+| |++||......+....+   
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i---  273 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI---  273 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH---
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH---
Confidence            999999999742          2345778999999999999999999999999999999 89999765443322222   


Q ss_pred             HHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          483 QQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       483 ~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                      ...........+.+.... +.+||+.||++||||.||+++|+...+.
T Consensus       274 ~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          274 TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            111111222222222222 3389999999999999999999876554

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1e-54  Score=447.94  Aligned_cols=248  Identities=26%  Similarity=0.410  Sum_probs=202.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ++|...+.||+|+||+||+|++.+     ++..||||+++..+....++|.+|+++|++|+|||||+++|+|.+++.++|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            456777899999999999999753     457899999998877778899999999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEE
Q 048439          347 VYDFMARGTLPDHLYHS-----------DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAK  415 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~k  415 (613)
                      |||||++|+|.++|...           ....|+|.+++.|+.|||+||+|||+++    |+||||||+||||++++++|
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~----iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH----FVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECGGGCEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCccCHhhEEECCCCcEE
Confidence            99999999999999643           2357999999999999999999999988    99999999999999999999


Q ss_pred             EEecCCCccC----------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHH
Q 048439          416 VSDFGLSKFG----------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQ  484 (613)
Q Consensus       416 l~DFGls~~~----------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~  484 (613)
                      |+|||+|+..          ...++..|||||++..+.++.|+|||||||+||||+| |++||......+....   ...
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~---i~~  245 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC---ITQ  245 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH---HHH
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HHc
Confidence            9999999632          1235678999999999999999999999999999998 8999976544332222   221


Q ss_pred             hhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          485 CYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       485 ~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      .........+.+.... ..+||+.||++||||.||++.|+...
T Consensus       246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          246 GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            1111122222222222 33899999999999999998887543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.6e-54  Score=445.00  Aligned_cols=244  Identities=25%  Similarity=0.385  Sum_probs=198.3

Q ss_pred             CCCcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          274 FDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      +...+.||+|+||+||+|++.+     .++.||||+++... ....++|.+|+.++++|+|||||+++|+|.+++.++||
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV  107 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI  107 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence            3445689999999999999743     44789999997653 34567899999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc
Q 048439          348 YDFMARGTLPDHLYHSD--------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV  413 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~  413 (613)
                      ||||++|+|.++|....              ...|+|.+++.|+.|||+||+|||+.+    ||||||||+||||+++++
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~----iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH----VVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECGGGC
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC----CCCCCccccceEECCCCC
Confidence            99999999999996432              246999999999999999999999998    999999999999999999


Q ss_pred             EEEEecCCCccC----------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHH
Q 048439          414 AKVSDFGLSKFG----------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWA  482 (613)
Q Consensus       414 ~kl~DFGls~~~----------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~  482 (613)
                      +||+|||+|+..          ...++..|||||++..+.++.|+|||||||+||||+| |++||......+.   ....
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~---~~~i  260 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---VEMI  260 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH---HHHH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH---HHHH
Confidence            999999999742          2345678999999999999999999999999999998 8999976544332   2222


Q ss_pred             HHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          483 QQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       483 ~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .........+.+.+.... +.+||+.||++||||.||++.|+.
T Consensus       261 ~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          261 RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            222222222333333222 338999999999999999999984

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=9.9e-53  Score=433.78  Aligned_cols=242  Identities=27%  Similarity=0.497  Sum_probs=194.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      +++...+.||+|+||+||+|++.+   .||||+++..  +.+..++|.+|+.+|++++|||||+++|+|.+ +.++||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            456667789999999999998764   3999998754  44556789999999999999999999999875 56899999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----  425 (613)
                      ||++|+|.++|+.. ...++|.+++.|+.|||+||+|||+.+    ||||||||+||||++++++||+|||+|+..    
T Consensus       112 y~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~----IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKN----IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTT----CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC----ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            99999999999653 456999999999999999999999988    999999999999999999999999999742    


Q ss_pred             ------CCCCCcccCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCc----c
Q 048439          426 ------PTSVSKTHLDPEYYRL---QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTI----D  492 (613)
Q Consensus       426 ------~~~~~~~~~aPE~~~~---~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~----~  492 (613)
                            ...+|+.|||||++..   +.++.|+|||||||+||||+||++||............  .......+.+    .
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~--~~~~~~~p~~~~~~~  264 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM--VGRGYASPDLSKLYK  264 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHTTCCCCCSTTSCT
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH--HhcCCCCCCcccccc
Confidence                  2356889999999974   46899999999999999999999999754433222211  1111111111    1


Q ss_pred             ccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          493 QIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       493 ~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .+.+.+.. +.+||+.||++||||.||++.|+.
T Consensus       265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~  297 (307)
T 3omv_A          265 NCPKAMKRLVADCVKKVKEERPLFPQILSSIEL  297 (307)
T ss_dssp             TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            22222222 338999999999999999999874

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.3e-52  Score=436.21  Aligned_cols=248  Identities=19%  Similarity=0.258  Sum_probs=201.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|...+.||+|+||+||+|+...+++.||||+++..  .....+.|.+|+++|++|+|||||++++++.+++.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5788999999999999999999888899999999754  34456789999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---  426 (613)
                      ||++|+|.++|.......+++.+.+.|+.||+.||+|||+++    |+||||||+||||++++.+||+|||+|+...   
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~----IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK----ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT----CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            999999999997666677899999999999999999999998    9999999999999999999999999998532   


Q ss_pred             -----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          427 -----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                           ..||+.|+|||++.+..++.++|||||||+||||+||++||......+....+.   ..........+.+.... 
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~---~~~~~~~~~~~s~~~~~l  256 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII---SGSFPPVSLHYSYDLRSL  256 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HTCCCCCCTTSCHHHHHH
T ss_pred             ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH---cCCCCCCCccCCHHHHHH
Confidence                 247889999999999999999999999999999999999997654433222211   11111111122222211 


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ..+||+.||.+|||+.|++++.+..-
T Consensus       257 i~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          257 VSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             HHHHccCChhHCcCHHHHhcCHHhhc
Confidence            22799999999999999998766543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.9e-51  Score=431.44  Aligned_cols=258  Identities=25%  Similarity=0.386  Sum_probs=204.8

Q ss_pred             HHHHHHhcCCCCcceeeeeCcEEEEEEEEcCC-----ceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCc-cceeeEEEE
Q 048439          265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGS-----TTPVAIKRLEPES-QQGALEFQTEIGMLSQLRH-LHLVSLIGF  337 (613)
Q Consensus       265 ~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~-----~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H-~niv~l~g~  337 (613)
                      ++-+...++|...+.||+|+||+||+|++.+.     .+.||||+++... ....++|.+|+++|.+++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            33344557888889999999999999998653     3579999997654 3446679999999999965 899999999


Q ss_pred             eecC-CceEEEEEcCCCCChhHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCC
Q 048439          338 CNDD-REMILVYDFMARGTLPDHLYHSD--------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVK  402 (613)
Q Consensus       338 ~~~~-~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk  402 (613)
                      |.+. +.++||||||++|+|.++|....              ...|+|.+++.|+.|||+||+|||+++    |||||||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~----iiHRDLK  212 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK----CIHRDLA  212 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCS
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC----eecCccC
Confidence            9764 57899999999999999996432              345899999999999999999999998    9999999


Q ss_pred             CCceeeCCCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchh
Q 048439          403 TTNILLDEKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTA  471 (613)
Q Consensus       403 ~~NILl~~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~  471 (613)
                      |+||||++++++||+|||+|+...          ..++..|||||++..+.++.|+|||||||+||||+| |++||....
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999997532          124567999999999999999999999999999998 899997543


Q ss_pred             hhhhhhHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          472 AKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       472 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                      ..+..  .............+...+.... ..+||+.||++|||+.||+++|+..++.
T Consensus       293 ~~~~~--~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          293 IDEEF--CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CSHHH--HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHH--HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            32221  1111111111112222222222 3379999999999999999999977653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.1e-51  Score=429.53  Aligned_cols=244  Identities=21%  Similarity=0.323  Sum_probs=203.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ..|+..+.||+|+||+||+|+...+++.||||+++.......+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            45777789999999999999999888999999997665556667899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC------
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG------  425 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~------  425 (613)
                      ++|+|.+++.+   ..+++.+...|+.||+.||+|||+++    ||||||||+||||++++.+||+|||+|+..      
T Consensus       154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~----IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG----VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC----cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            99999999854   45999999999999999999999998    999999999999999999999999999642      


Q ss_pred             --CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc-CCccccccHHHH-H
Q 048439          426 --PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN-GTIDQIVDPFLK-A  501 (613)
Q Consensus       426 --~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~d~~~~-~  501 (613)
                        ...+|+.|+|||++.+..|+.++|||||||+||||++|++||......+....+.  ...... .....+.+.... .
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~--~~~~~~~~~~~~~s~~~~dli  304 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR--DNLPPRLKNLHKVSPSLKGFL  304 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--HSSCCCCSCGGGSCHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH--cCCCCCCCccccCCHHHHHHH
Confidence              2357889999999999999999999999999999999999997654433322221  111111 111222222222 2


Q ss_pred             hcccccCCCCCCCHHHHHHHHHH
Q 048439          502 MSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .+||+.||++|||+.|++++.++
T Consensus       305 ~~~L~~dP~~R~ta~e~l~Hp~~  327 (346)
T 4fih_A          305 DRLLVRDPAQRATAAELLKHPFL  327 (346)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCGGG
T ss_pred             HHHcCCChhHCcCHHHHhcCHhh
Confidence            27999999999999999877664

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.7e-51  Score=425.54  Aligned_cols=243  Identities=22%  Similarity=0.238  Sum_probs=199.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      +.|...+.||+|+||.||+|+...+++.||||+++....     +.+|+.+|++|+|||||++++++.+++.++||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            457777789999999999999998889999999976432     257999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC-cEEEEecCCCccCC----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW-VAKVSDFGLSKFGP----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGls~~~~----  426 (613)
                      ++|+|.++|..  ...|++.+.+.|+.||+.||+|||+++    ||||||||+||||+.++ .+||+|||+|+...    
T Consensus       133 ~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~----IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          133 EGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTRR----ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             TTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTT----EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            99999999954  356999999999999999999999998    99999999999999988 59999999997421    


Q ss_pred             ---------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccH
Q 048439          427 ---------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP  497 (613)
Q Consensus       427 ---------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  497 (613)
                               ..||+.|||||++.+..++.++|||||||+||||++|++||......+....+.  ........+..-+.+
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~s~  284 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA--SEPPPIREIPPSCAP  284 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH--HSCCGGGGSCTTSCH
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH--cCCCCchhcCccCCH
Confidence                     247889999999999999999999999999999999999997654333222111  111110111111222


Q ss_pred             HHH--HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          498 FLK--AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       498 ~~~--~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      .+.  ..+||+.||.+|||+.|++++|..+++
T Consensus       285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            222  227999999999999999999886654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.3e-51  Score=416.76  Aligned_cols=242  Identities=26%  Similarity=0.397  Sum_probs=193.2

Q ss_pred             CCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeec----CCceEEEE
Q 048439          275 DNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND----DREMILVY  348 (613)
Q Consensus       275 ~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~  348 (613)
                      ....+||+|+||+||+|++..++..||||++...  .....+.|.+|+++|++|+|||||+++++|.+    ++.++|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            3445799999999999999988899999998654  34456779999999999999999999999865    35589999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC-CCCcEEEEecCCCccCC-
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGP-  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGls~~~~-  426 (613)
                      |||++|+|.++|..  ...+++..+..|+.||++||+|||+++.  +|+||||||+||||+ +++.+||+|||+|+... 
T Consensus       109 Ey~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~~~--~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTP--PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSS--CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCC--CEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999954  4579999999999999999999998752  299999999999998 47999999999997532 


Q ss_pred             -----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          427 -----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                           ..||+.|||||++.+ +++.++|||||||+||||+||++||........  +............+.....+.+. 
T Consensus       185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~  261 (290)
T 3fpq_A          185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVKPASFDKVAIPEVKE  261 (290)
T ss_dssp             TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred             CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHHHHHcCCCCCCCCccCCHHHHH
Confidence                 347889999999865 699999999999999999999999965432221  11111111111122222333232 


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHH
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                       ..+||+.||++|||+.|++++.+
T Consensus       262 li~~~L~~dP~~R~s~~e~l~Hp~  285 (290)
T 3fpq_A          262 IIEGCIRQNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCcc
Confidence             23799999999999999987655

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.1e-51  Score=418.59  Aligned_cols=238  Identities=20%  Similarity=0.270  Sum_probs=200.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...++||+|+||+||+|+...+++.||||+++..   .....+.+.+|+++|++|+|||||++++++.+++.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4689999999999999999999988899999999754   2344567999999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      |||++|+|.++|..  ...+++.+...++.||+.||+|||+++    |+||||||+||||++++.+||+|||+|+..   
T Consensus       112 Ey~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~~----IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999954  456999999999999999999999998    999999999999999999999999999742   


Q ss_pred             -------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          426 -------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       426 -------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                             ...||+.|+|||++.+..++.++||||+||+||||+||++||......+....+.  .   ....+.+-+.+.
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~--~---~~~~~p~~~s~~  260 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII--K---LEYDFPEKFFPK  260 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--H---TCCCCCTTCCHH
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--c---CCCCCCcccCHH
Confidence                   2357889999999999999999999999999999999999997654433222211  1   111222223333


Q ss_pred             HH--HhcccccCCCCCCCHHHHHH
Q 048439          499 LK--AMSCLNDEGIRRPSMSDVVW  520 (613)
Q Consensus       499 ~~--~~~Cl~~~p~~RPs~~evl~  520 (613)
                      ..  ..+||+.||++|||+.|++.
T Consensus       261 ~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          261 ARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             HHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             HHHHHHHHccCCHhHCcChHHHcC
Confidence            22  22799999999999998753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.8e-50  Score=431.13  Aligned_cols=244  Identities=21%  Similarity=0.320  Sum_probs=203.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      +.|...+.||+|+||.||+|+...+++.||||+++.......+.+.+|+.+|++|+|||||++++++.+++.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56888889999999999999999888999999998766666677999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC------
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG------  425 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~------  425 (613)
                      ++|+|.+++..   ..+++.++..|+.||+.||+|||+++    ||||||||+||||+.+|.+||+|||+|+..      
T Consensus       231 ~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~----IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~  303 (423)
T 4fie_A          231 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG----VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  303 (423)
T ss_dssp             TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred             CCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC----eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence            99999999854   35999999999999999999999998    999999999999999999999999999642      


Q ss_pred             --CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhh-ccCCccccccHHHH-H
Q 048439          426 --PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCY-QNGTIDQIVDPFLK-A  501 (613)
Q Consensus       426 --~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~d~~~~-~  501 (613)
                        ...||+.|||||++.+..|+.++|||||||+||||++|++||......+....+.  .... .......+.+.... .
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~--~~~~~~~~~~~~~s~~~~dli  381 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR--DNLPPRLKNLHKVSPSLKGFL  381 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--HSCCCCCSCTTSSCHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH--cCCCCCCcccccCCHHHHHHH
Confidence              2346888999999999999999999999999999999999997654433322221  1111 11111122222221 2


Q ss_pred             hcccccCCCCCCCHHHHHHHHHH
Q 048439          502 MSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .+||..||++|||+.|++++-++
T Consensus       382 ~~~L~~dP~~R~ta~ell~Hp~~  404 (423)
T 4fie_A          382 DRLLVRDPAQRATAAELLKHPFL  404 (423)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCGGG
T ss_pred             HHHcCCChhHCcCHHHHhcCHHh
Confidence            27999999999999999877654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.8e-50  Score=409.00  Aligned_cols=242  Identities=24%  Similarity=0.341  Sum_probs=192.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||+||+|+...+++.||||+++...   ......+.+|+++|++++|||||++++++.+++.+++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999998888999999997542   334567899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||| +|+|.+++..  ...+++.+...++.|++.||+|||+++    |+||||||+||||++++.+||+|||+|+..   
T Consensus        93 Ey~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~----IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHK----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 6899999854  456999999999999999999999998    999999999999999999999999999742   


Q ss_pred             ----CCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          426 ----PTSVSKTHLDPEYYRLQQL-TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~~~~-t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                          ...+|+.|+|||++.+..+ +.++||||+||+||||+||++||.............   .  ....++..+++...
T Consensus       166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~---~--~~~~~p~~~s~~~~  240 (275)
T 3hyh_A          166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS---N--GVYTLPKFLSPGAA  240 (275)
T ss_dssp             ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H--TCCCCCTTSCHHHH
T ss_pred             CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---c--CCCCCCCCCCHHHH
Confidence                2357889999999998876 579999999999999999999997654332211111   1  11122233333333


Q ss_pred             H--hcccccCCCCCCCHHHHHHHHHHh
Q 048439          501 A--MSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       501 ~--~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      .  .+||+.||++|||+.|++++.++.
T Consensus       241 ~li~~~L~~dP~~R~s~~eil~hpw~k  267 (275)
T 3hyh_A          241 GLIKRMLIVNPLNRISIHEIMQDDWFK  267 (275)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHHcCcccc
Confidence            2  279999999999999999887754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.8e-50  Score=412.82  Aligned_cols=249  Identities=22%  Similarity=0.300  Sum_probs=186.1

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCC----ceEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR----EMILVY  348 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~  348 (613)
                      ++...+.||+|+||+||+|++.  ++.||||+++..... ...+..|+..+.+++|||||+++|+|.+++    .++|||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4566679999999999999985  377999999754322 223456677778899999999999998754    579999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA----NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      |||++|+|.++|..   ..++|..+++|+.|+|+||+|||++.    ..++|+||||||+||||++++++||+|||+|+.
T Consensus        81 Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             cCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            99999999999954   45999999999999999999999862    112299999999999999999999999999864


Q ss_pred             C------------CCCCCcccCChhhhhcC------CCCchhHHHHHHHHHHHHHhCCCCccchhhhh---------hhh
Q 048439          425 G------------PTSVSKTHLDPEYYRLQ------QLTEKSDVYSFGVVLFEVLCARPSILRTAAKK---------QVS  477 (613)
Q Consensus       425 ~------------~~~~~~~~~aPE~~~~~------~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~---------~~~  477 (613)
                      .            ...+|..|+|||++.+.      .++.|+|||||||+||||+||++|+.......         ...
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            2            12468889999999764      46789999999999999999988764221100         001


Q ss_pred             HHHHHHHhhccC---Cccc------cccHHH-HHhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          478 LAVWAQQCYQNG---TIDQ------IVDPFL-KAMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       478 l~~~~~~~~~~~---~~~~------~~d~~~-~~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      ............   .++.      ..+.+. .+.+||+.||++||||.||++.|+...+
T Consensus       238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            111111111111   1111      111121 2348999999999999999999985443

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.7e-50  Score=414.77  Aligned_cols=241  Identities=24%  Similarity=0.304  Sum_probs=193.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEc---CCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFIN---GSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~---~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ++|...+.||+|+||+||+|+..   .+++.||||+++...  ......+.+|+++|++++|||||++++++.+++.++|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            46888899999999999999873   345789999997642  2334468899999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-  425 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-  425 (613)
                      |||||++|+|.++|..  ...+++.+...++.|++.||+|||+++    |+||||||+|||+++++.+||+|||+|+.. 
T Consensus       104 vmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~----IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999954  457999999999999999999999998    999999999999999999999999999742 


Q ss_pred             -------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          426 -------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       426 -------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                             ...+|+.|+|||.+.+..++.++|||||||+||||+||++||......+....+.   .  ....+...+.+.
T Consensus       178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~---~--~~~~~p~~~s~~  252 (304)
T 3ubd_A          178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL---K--AKLGMPQFLSPE  252 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H--CCCCCCTTSCHH
T ss_pred             CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH---c--CCCCCCCcCCHH
Confidence                   2357889999999999999999999999999999999999997655443322221   1  111222233333


Q ss_pred             HHH--hcccccCCCCCCC-----HHHHHHHHH
Q 048439          499 LKA--MSCLNDEGIRRPS-----MSDVVWGLE  523 (613)
Q Consensus       499 ~~~--~~Cl~~~p~~RPs-----~~evl~~Le  523 (613)
                      ...  .+||+.||++|||     ++|++++.+
T Consensus       253 ~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~  284 (304)
T 3ubd_A          253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF  284 (304)
T ss_dssp             HHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred             HHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence            332  2799999999998     467776554

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.8e-48  Score=401.84  Aligned_cols=239  Identities=22%  Similarity=0.317  Sum_probs=186.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCC--------
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR--------  342 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~--------  342 (613)
                      ++|+..+.||+|+||+||+|+...+++.||||+++... ....+.+.+|+.+|++|+|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46888899999999999999998888999999987543 344567999999999999999999999987544        


Q ss_pred             ----ceEEEEEcCCCCChhHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEE
Q 048439          343 ----EMILVYDFMARGTLPDHLYHSDN-PPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVS  417 (613)
Q Consensus       343 ----~~~lV~Ey~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~  417 (613)
                          .+++|||||++|+|.+++..... ...++...+.|+.|++.||+|||+++    |+||||||+||||+.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~----IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc----CccccCcHHHeEECCCCcEEEc
Confidence                36899999999999999965432 34667778999999999999999998    9999999999999999999999


Q ss_pred             ecCCCccCC--------------------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhh
Q 048439          418 DFGLSKFGP--------------------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVS  477 (613)
Q Consensus       418 DFGls~~~~--------------------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~  477 (613)
                      |||+|+...                    ..||+.|||||++.+..++.++|||||||+||||++   ||.....  ...
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~~  235 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RVR  235 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HHH
Confidence            999997421                    247889999999999999999999999999999996   6643321  111


Q ss_pred             HHHHHHHhhccCCccccc----cHHH-HHhcccccCCCCCCCHHHHHHHHH
Q 048439          478 LAVWAQQCYQNGTIDQIV----DPFL-KAMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       478 l~~~~~~~~~~~~~~~~~----d~~~-~~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .....    .....+...    .... ...+||+.||.+|||+.|++++..
T Consensus       236 ~~~~~----~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~  282 (299)
T 4g31_A          236 TLTDV----RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAV  282 (299)
T ss_dssp             HHHHH----HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHH----hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence            11111    111111111    1111 123799999999999999986543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-46  Score=398.19  Aligned_cols=247  Identities=21%  Similarity=0.266  Sum_probs=199.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeec------CCc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND------DRE  343 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~------~~~  343 (613)
                      ++|...+.||+|+||+||+|+...+++.||||+++..  .....+.+.+|+++|++|+|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            4688889999999999999999988899999999754  33445678999999999999999999998753      467


Q ss_pred             eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCc
Q 048439          344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK  423 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~  423 (613)
                      +|||||||+ |+|.+++..  ...+++.++..|+.||+.||+|||+.+    ||||||||+|||++.++.+||+|||+|+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~----iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQ----VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCc----CcCCCcCccccccCCCCCEEEeecceee
Confidence            899999996 689999943  567999999999999999999999998    9999999999999999999999999997


Q ss_pred             cC------------CCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccC-
Q 048439          424 FG------------PTSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG-  489 (613)
Q Consensus       424 ~~------------~~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-  489 (613)
                      ..            ...+|+.|+|||++.+. .++.++||||+||+||||++|++||.+....++...+.......... 
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            42            23578889999998875 56999999999999999999999998766555544433221111000 


Q ss_pred             ----------------------Cccc---cccHHHH--HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          490 ----------------------TIDQ---IVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       490 ----------------------~~~~---~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                                            .+..   -+++...  ..+||..||.+|||+.|++++..+.
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  349 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA  349 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence                                  0000   0111111  2279999999999999999887653

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.3e-46  Score=385.89  Aligned_cols=266  Identities=57%  Similarity=0.954  Sum_probs=224.0

Q ss_pred             cccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEee
Q 048439          260 TQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN  339 (613)
Q Consensus       260 ~~f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~  339 (613)
                      ..+++.++..++++|...+.||+|+||.||+|++.+ +..||||++........+.|.+|+.++++++||||++++++|.
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTT-CCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEECC-CCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            456777888899999999999999999999999764 4789999998877777788999999999999999999999999


Q ss_pred             cCCceEEEEEcCCCCChhHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEE
Q 048439          340 DDREMILVYDFMARGTLPDHLYHSD--NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVS  417 (613)
Q Consensus       340 ~~~~~~lV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~  417 (613)
                      +.+..++||||+++|+|.+++....  ...++|.+++.++.|+++||.|||+.+    |+||||||+|||++.++.+||+
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~----ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA----IIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCSTTEEECTTCCEEEC
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC----eecCCCCHHHEEECCCCCEEEe
Confidence            9999999999999999999996543  246999999999999999999999998    9999999999999999999999


Q ss_pred             ecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc
Q 048439          418 DFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ  487 (613)
Q Consensus       418 DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~  487 (613)
                      |||+++...          ..++..|+|||.+....++.++|||||||+||||++|+.||......+......|......
T Consensus       182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  261 (321)
T 2qkw_B          182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN  261 (321)
T ss_dssp             CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred             ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence            999986422          1246679999999999999999999999999999999999987666665666666554444


Q ss_pred             cCCccccccH-------------HH-HHhcccccCCCCCCCHHHHHHHHHHhhhhhh
Q 048439          488 NGTIDQIVDP-------------FL-KAMSCLNDEGIRRPSMSDVVWGLEFSLQLQE  530 (613)
Q Consensus       488 ~~~~~~~~d~-------------~~-~~~~Cl~~~p~~RPs~~evl~~Le~~l~~~~  530 (613)
                      .+.+..++++             +. ...+||+.||++||++.||+++|+..+++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~  318 (321)
T 2qkw_B          262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE  318 (321)
T ss_dssp             TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred             cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence            3333322211             11 1338999999999999999999998887665

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.6e-45  Score=407.97  Aligned_cols=248  Identities=21%  Similarity=0.278  Sum_probs=205.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||.||+|+...++..||||++........+.+.+|+.+|++|+|||||++++++.+++.++||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            67888999999999999999999888999999998776666778999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC--CcEEEEecCCCccCC---
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK--WVAKVSDFGLSKFGP---  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~--~~~kl~DFGls~~~~---  426 (613)
                      ++|+|.++|.. ....|++.+...++.||+.||+|||+++    |+||||||+|||++.+  +.+||+|||+|+...   
T Consensus       237 ~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~----iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          237 SGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENN----YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             CCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            99999999854 3456999999999999999999999998    9999999999999854  899999999997532   


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-H
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-A  501 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~  501 (613)
                          ..+|+.|+|||++.+..++.++|||||||+||||++|++||......+....+..............+.+.... .
T Consensus       312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli  391 (573)
T 3uto_A          312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI  391 (573)
T ss_dssp             EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHH
T ss_pred             ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence                24688899999999999999999999999999999999999766544432222111101111111222222222 2


Q ss_pred             hcccccCCCCCCCHHHHHHHHHH
Q 048439          502 MSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .+||+.||.+||++.|++++-++
T Consensus       392 ~~~L~~dp~~R~t~~e~l~Hpw~  414 (573)
T 3uto_A          392 RKLLLADPNTRMTIHQALEHPWL  414 (573)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSTTT
T ss_pred             HHHccCChhHCcCHHHHhcCcCc
Confidence            27999999999999999987654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.5e-44  Score=380.55  Aligned_cols=191  Identities=23%  Similarity=0.375  Sum_probs=168.5

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEc---CCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCce
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFIN---GSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~---~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~  344 (613)
                      ...+.|...+.||+|+||+||+|+.+   .+++.||||++....  ....+.+|+++|.++ +|||||++++++.+.+.+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            34578999999999999999999874   346789999987653  345678999999998 699999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC-CcEEEEecCCCc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK-WVAKVSDFGLSK  423 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGls~  423 (613)
                      +||||||++|+|.+++.     .+++.+...++.|++.||+|||+.+    |+||||||+|||++.+ +.+||+|||+|+
T Consensus        96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g----IiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG----IVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC----eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            99999999999999982     4899999999999999999999999    9999999999999877 799999999996


Q ss_pred             cC------------------------------------CCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCC
Q 048439          424 FG------------------------------------PTSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPS  466 (613)
Q Consensus       424 ~~------------------------------------~~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p  466 (613)
                      ..                                    ...+|+.|+|||++.+. .++.++||||+||+||||++|++|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            32                                    12478889999999775 589999999999999999999999


Q ss_pred             ccch
Q 048439          467 ILRT  470 (613)
Q Consensus       467 ~~~~  470 (613)
                      |...
T Consensus       247 f~~~  250 (361)
T 4f9c_A          247 FYKA  250 (361)
T ss_dssp             SSCC
T ss_pred             CCCC
Confidence            9543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.6e-44  Score=400.79  Aligned_cols=245  Identities=22%  Similarity=0.297  Sum_probs=197.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHH---HHHHHHHhccCccceeeEEEEeecCCceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEF---QTEIGMLSQLRHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f---~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  345 (613)
                      ++|...++||+|+||+||+|+...++..||||+++...   ......+   ..++.+++.++|||||++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57899999999999999999999999999999996531   1222223   34467777889999999999999999999


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc-
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF-  424 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~-  424 (613)
                      ||||||+||+|.++|..  ...+++.....++.||+.||+|||+++    ||||||||+||||+++|.+||+|||+|+. 
T Consensus       269 lVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~g----IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTTT----EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999954  456999999999999999999999998    99999999999999999999999999964 


Q ss_pred             -----CCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          425 -----GPTSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       425 -----~~~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                           ....||+.|||||++.. ..|+.++|||||||+||||++|++||......+...+......  ....+..-+.+.
T Consensus       343 ~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~--~~~~~p~~~S~~  420 (689)
T 3v5w_A          343 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPE  420 (689)
T ss_dssp             SSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--CCCCCCTTSCHH
T ss_pred             CCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--CCCCCCccCCHH
Confidence                 23467889999999965 5799999999999999999999999976544332222221111  111222223333


Q ss_pred             HHH--hcccccCCCCCCC-----HHHHHHHHHH
Q 048439          499 LKA--MSCLNDEGIRRPS-----MSDVVWGLEF  524 (613)
Q Consensus       499 ~~~--~~Cl~~~p~~RPs-----~~evl~~Le~  524 (613)
                      ...  .+||..||.+|++     +.||+++..+
T Consensus       421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF  453 (689)
T 3v5w_A          421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF  453 (689)
T ss_dssp             HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGG
T ss_pred             HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccc
Confidence            322  2799999999998     7899876654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.6e-43  Score=363.52  Aligned_cols=247  Identities=23%  Similarity=0.385  Sum_probs=206.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...++||+|+||.||+|+...++..||+|++........+.|.+|++++++++||||++++++|.+++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            46777889999999999999998888999999998777777888999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC------
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG------  425 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~------  425 (613)
                      ++|+|.+++... ...++|.+++.++.|+++||+|||+.+    |+||||||+|||+++++.+||+|||+++..      
T Consensus        90 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           90 KGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN----IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             TTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC----ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            999999999653 456999999999999999999999998    999999999999999999999999998642      


Q ss_pred             ----------------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhh---hhHHHHHHHhh
Q 048439          426 ----------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQ---VSLAVWAQQCY  486 (613)
Q Consensus       426 ----------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~---~~l~~~~~~~~  486 (613)
                                      ...++..|+|||.+.+..++.++|||||||+||||++|..|+........   ...........
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC  244 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTC
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccC
Confidence                            22456779999999999999999999999999999999998865332211   12222222222


Q ss_pred             ccCCccccccHHHHHhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          487 QNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       487 ~~~~~~~~~d~~~~~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ......++.+ +  ..+||+.||++||++.++++.|+...
T Consensus       245 ~~~~~~~l~~-l--i~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          245 PPNCPPSFFP-I--TVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             CTTCCTTHHH-H--HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCHHHHH-H--HHHHccCChhhCcCHHHHHHHHHHHH
Confidence            2222222222 2  22699999999999999999888654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.7e-43  Score=366.95  Aligned_cols=261  Identities=41%  Similarity=0.713  Sum_probs=216.4

Q ss_pred             ccccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh-hcHHHHHHHHHHHhccCccceeeEEEE
Q 048439          259 CTQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ-QGALEFQTEIGMLSQLRHLHLVSLIGF  337 (613)
Q Consensus       259 ~~~f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~g~  337 (613)
                      ...|++.++..++++|...+.||+|+||.||+|+..+ +..||||++..... .....|.+|+.++++++||||++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSS-SCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecC-CCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            3579999999999999999999999999999998654 47899999976532 233468999999999999999999999


Q ss_pred             eecCCceEEEEEcCCCCChhHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CCCCcEEeccCCCCceeeCCCC
Q 048439          338 CNDDREMILVYDFMARGTLPDHLYHSD--NPPLPWNQRLEICIGAARGLHYLHTG---ANHAVIIHRDVKTTNILLDEKW  412 (613)
Q Consensus       338 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~---~~~~~iiHrDlk~~NILl~~~~  412 (613)
                      |.+.+..++||||+++|+|.+++....  ...++|..++.|+.|++.||.|||+.   +    |+||||||+|||+++++
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~----ivH~Dlkp~Nil~~~~~  171 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK----IIHRDVKAANILLDEEF  171 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC----EECCCCSGGGEEECTTC
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC----eEeCCCchhhEEECCCC
Confidence            999999999999999999999997542  44699999999999999999999998   6    99999999999999999


Q ss_pred             cEEEEecCCCccCC---------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhh--hhhhhHHHH
Q 048439          413 VAKVSDFGLSKFGP---------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAA--KKQVSLAVW  481 (613)
Q Consensus       413 ~~kl~DFGls~~~~---------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~--~~~~~l~~~  481 (613)
                      .+||+|||+++...         ..++..|+|||++....++.++|||||||++|||++|++||.....  ........|
T Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  251 (326)
T 3uim_A          172 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW  251 (326)
T ss_dssp             CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred             CEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence            99999999996422         2367789999999999999999999999999999999999964322  223345555


Q ss_pred             HHHhhccCCcccccc-------------HHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          482 AQQCYQNGTIDQIVD-------------PFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       482 ~~~~~~~~~~~~~~d-------------~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ............+.+             .+.. +.+||+.+|.+|||+.||+++|+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            555444443333322             1111 337999999999999999999985

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7.3e-43  Score=363.87  Aligned_cols=255  Identities=21%  Similarity=0.292  Sum_probs=210.1

Q ss_pred             cccCHHHHHHHhcC----------CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCcc
Q 048439          260 TQFSLSEIQAATNN----------FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL  329 (613)
Q Consensus       260 ~~f~~~el~~at~~----------f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~  329 (613)
                      ..|++++++.+++.          |.....||+|+||.||+|+...+++.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            35899999999976          55667899999999999999877789999999877767778899999999999999


Q ss_pred             ceeeEEEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC
Q 048439          330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD  409 (613)
Q Consensus       330 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~  409 (613)
                      ||++++++|...+..++||||+++|+|.+++.   ...+++..++.++.|++.||.|||+.+    |+||||||+|||++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~~~----ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQG----VIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHEEEC
Confidence            99999999999999999999999999999984   346999999999999999999999998    99999999999999


Q ss_pred             CCCcEEEEecCCCccC--------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHH
Q 048439          410 EKWVAKVSDFGLSKFG--------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVW  481 (613)
Q Consensus       410 ~~~~~kl~DFGls~~~--------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~  481 (613)
                      .++.+||+|||+++..        ...++..|+|||++....++.++|||||||+||||++|++||.........   ..
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~---~~  252 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KR  252 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HH
T ss_pred             CCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HH
Confidence            9999999999998642        224577899999999999999999999999999999999999754433221   11


Q ss_pred             HHHhhc-cCCccccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          482 AQQCYQ-NGTIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       482 ~~~~~~-~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ...... ........++.+.  ..+||+.||.+||++.|++++...
T Consensus       253 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~  298 (321)
T 2c30_A          253 LRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL  298 (321)
T ss_dssp             HHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             HhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence            111111 1011111222222  227999999999999999987664

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.4e-43  Score=359.30  Aligned_cols=246  Identities=21%  Similarity=0.319  Sum_probs=203.6

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      .++|...+.||+|+||.||+|....++..||||++..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            36788889999999999999999888899999999776666677899999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-----  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-----  425 (613)
                      +++|+|.+++..   ..+++.+++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..     
T Consensus        99 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC----ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            999999999854   35899999999999999999999998    999999999999999999999999998642     


Q ss_pred             ---CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--
Q 048439          426 ---PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--  500 (613)
Q Consensus       426 ---~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--  500 (613)
                         ...++..|+|||.+.+..++.++|||||||+||||++|+.||.............  ............+...+.  
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l  249 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--TNGTPELQNPEKLSAIFRDF  249 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--HHCSCCCSCGGGSCHHHHHH
T ss_pred             ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCccccCHHHHHH
Confidence               2346778999999999999999999999999999999999997654433222211  111111111222222222  


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ..+||+.||++||++.|++++....
T Consensus       250 i~~~l~~dp~~Rps~~ell~h~~~~  274 (297)
T 3fxz_A          250 LNRCLEMDVEKRGSAKELLQHQFLK  274 (297)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             HHHHccCChhHCcCHHHHhhChhhc
Confidence            2279999999999999999876653

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8.2e-43  Score=370.87  Aligned_cols=251  Identities=22%  Similarity=0.400  Sum_probs=202.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEc-------CCceeEEEEEeCCC-ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFIN-------GSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDR  342 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~-------~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~  342 (613)
                      ++|...+.||+|+||.||+|+..       ..+..||||+++.. .......+.+|+.+++++ +||||++++++|.+.+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            57888889999999999999874       23467999999765 344566799999999999 8999999999999999


Q ss_pred             ceEEEEEcCCCCChhHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee
Q 048439          343 EMILVYDFMARGTLPDHLYHSD--------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL  408 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl  408 (613)
                      .+++||||+++|+|.+++....              ...+++.+++.++.|+++||.|||+.+    |+||||||+|||+
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivHrDlkp~NIll  236 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK----CIHRDLAARNVLV  236 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEE
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC----eeccccchhhEEE
Confidence            9999999999999999996532              235899999999999999999999998    9999999999999


Q ss_pred             CCCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhh
Q 048439          409 DEKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVS  477 (613)
Q Consensus       409 ~~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~  477 (613)
                      +.++.+||+|||+++...          ..++..|+|||++.+..++.++|||||||+||||++ |++||......+.. 
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~-  315 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-  315 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-
Confidence            999999999999987321          123456999999999999999999999999999999 99999765433322 


Q ss_pred             HHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhhhh
Q 048439          478 LAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQLQ  529 (613)
Q Consensus       478 l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~~  529 (613)
                        ..............+.+.+.. ..+||+.+|.+||++.|+++.|+..+++.
T Consensus       316 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          316 --KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             --HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence              111111111111222222222 23799999999999999999999877543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=8.6e-43  Score=364.00  Aligned_cols=250  Identities=26%  Similarity=0.449  Sum_probs=201.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCc---eeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGST---TPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~---~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|...++||+|+||.||+|++..++   ..||||+++.. .......|.+|+.++++++||||++++++|.+.+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            45777789999999999999996433   45999999865 445567899999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT  427 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~  427 (613)
                      |||+++|+|.+++... ...+++.+++.|+.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++....
T Consensus       129 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          129 TEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLG----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             eeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC----eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            9999999999999543 456999999999999999999999998    99999999999999999999999999974321


Q ss_pred             -----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          428 -----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       428 -----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                                 .++..|+|||++....++.++|||||||+||||++ |+.||......+....   ............+.
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~  280 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS---VEEGYRLPAPMGCP  280 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH---HHTTCCCCCCTTCC
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH---HHcCCCCCCCCCcC
Confidence                       12346999999999999999999999999999999 9999965543332211   11111111112222


Q ss_pred             cHHHH-HhcccccCCCCCCCHHHHHHHHHHhhhhh
Q 048439          496 DPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQLQ  529 (613)
Q Consensus       496 d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~~  529 (613)
                      +.+.. ..+||+.+|.+||++.+|++.|+..++..
T Consensus       281 ~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            22222 23799999999999999999999766543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.7e-43  Score=364.62  Aligned_cols=243  Identities=20%  Similarity=0.269  Sum_probs=201.2

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      .++|...+.||+|+||.||+|+...+++.||||++...  .....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            45788889999999999999999888899999998654  3445667899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+++|+|.+++..  ...+++..++.++.|+++||+|||+.+    |+||||||+|||++.++.+||+|||+++..   
T Consensus        94 e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~----ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQKR----IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            99999999999854  356999999999999999999999998    999999999999999999999999998642   


Q ss_pred             ----CCCCCcccCChhhhhcCCCC-chhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          426 ----PTSVSKTHLDPEYYRLQQLT-EKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~~~~t-~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                          ...++..|+|||.+.+..++ .++|||||||+||||++|++||......+......   .  .....+....+...
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~--~~~~~p~~~s~~~~  242 (328)
T 3fe3_A          168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL---R--GKYRIPFYMSTDCE  242 (328)
T ss_dssp             CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H--CCCCCCTTSCHHHH
T ss_pred             CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH---h--CCCCCCCCCCHHHH
Confidence                23467789999999988875 79999999999999999999997654433222111   1  11112222222222


Q ss_pred             --HhcccccCCCCCCCHHHHHHHHHH
Q 048439          501 --AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       501 --~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                        ..+||..||.+|||+.|++++...
T Consensus       243 ~li~~~L~~dP~~R~t~~eil~h~~~  268 (328)
T 3fe3_A          243 NLLKRFLVLNPIKRGTLEQIMKDRWI  268 (328)
T ss_dssp             HHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred             HHHHHHCCCChhHCcCHHHHhcCHhh
Confidence              227999999999999999977654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.2e-43  Score=373.23  Aligned_cols=247  Identities=26%  Similarity=0.405  Sum_probs=200.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ++|...+.||+|+||.||+|++..++..||||.++... .....+|.+|+++|++++||||++++|+|.+.+..++||||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            56777889999999999999998777899999997653 33445789999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC---
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT---  427 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~---  427 (613)
                      |++|+|.+++... ...+++.+++.++.|+++||+|||+.+    |+||||||+|||+++++.+||+|||+++....   
T Consensus       194 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~----ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          194 VQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKC----CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             CTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC----cCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            9999999999642 346899999999999999999999998    99999999999999999999999999874221   


Q ss_pred             -------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH
Q 048439          428 -------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       428 -------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                             ..+..|+|||.+..+.++.++|||||||+||||++ |+.||......+..   ................+...
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~  345 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR---EFVEKGGRLPCPELCPDAVF  345 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH---HHHHTTCCCCCCTTCCHHHH
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCCCCCCCCCCCHHHH
Confidence                   12345999999999999999999999999999998 99998654433221   11211111111122222222


Q ss_pred             H-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          500 K-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       500 ~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      . ..+||+.||++|||+.+|++.|+...
T Consensus       346 ~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          346 RLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            2 23799999999999999999998654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-42  Score=358.52  Aligned_cols=250  Identities=16%  Similarity=0.234  Sum_probs=202.1

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      .++|...+.||+|+||.||+|+...++..||+|.+.... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            367888889999999999999999888999999997543 3455689999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC--CCcEEEEecCCCccCCC-
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE--KWVAKVSDFGLSKFGPT-  427 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~--~~~~kl~DFGls~~~~~-  427 (613)
                      |++|+|.+++.. ....+++.+++.++.|++.||.|||+.+    |+||||||+|||++.  ++.+||+|||+++.... 
T Consensus        83 ~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~g----ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC----CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999853 3356999999999999999999999998    999999999999987  78999999999975322 


Q ss_pred             ------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          428 ------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       428 ------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                            .+++.|+|||++.+..++.++|||||||+||||++|++||......+...................+.+.... 
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  237 (321)
T 1tki_A          158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF  237 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred             CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence                  2467799999999988999999999999999999999999765443322111110000000001122222222 


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ..+||..||.+|||+.|++++.....
T Consensus       238 i~~~L~~dp~~Rpt~~e~l~hp~~~~  263 (321)
T 1tki_A          238 VDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             HHHHcCCChhHCcCHHHHhcChhhcc
Confidence            23899999999999999998887643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.9e-42  Score=368.54  Aligned_cols=248  Identities=25%  Similarity=0.457  Sum_probs=195.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEc---CCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFIN---GSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~---~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|...++||+|+||.||+|++.   ..+..||||+++.. .....++|.+|+.++++++||||++++++|.+.+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57888899999999999999886   34577999999765 344567899999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT  427 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~  427 (613)
                      |||+++|+|.+++.. ....+++.+++.|+.|+++||+|||+.+    |+||||||+|||++.++.+||+|||+++....
T Consensus       125 ~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          125 TEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMG----YVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            999999999999964 3456999999999999999999999998    99999999999999999999999999874321


Q ss_pred             -----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          428 -----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       428 -----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                                 .++..|+|||++....++.++|||||||+||||++ |+.||......+..   ................
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~---~~i~~~~~~~~~~~~~  276 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI---KAVDEGYRLPPPMDCP  276 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH---HHHHTTEECCCCTTCB
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCCCCCCCcccc
Confidence                       12346999999999999999999999999999998 99999655433221   1111111212122222


Q ss_pred             cHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          496 DPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       496 d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      ..+.. ..+||+.+|.+||++.+|++.|+..++
T Consensus       277 ~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence            22222 337999999999999999999987654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1e-42  Score=384.23  Aligned_cols=250  Identities=24%  Similarity=0.410  Sum_probs=206.7

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ..+|...+.||+|+||.||+|++...+..||||.++... ...++|.+|+.+|++++|||||+++++|.+.+..+|||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            456778889999999999999998877899999997654 3467899999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      |++|+|.+++.......+++..++.|+.|+++||+|||+.+    |+||||||+|||+++++.+||+|||+++...    
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~----ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            99999999997666677999999999999999999999998    9999999999999999999999999987532    


Q ss_pred             -----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          427 -----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                           ..++..|+|||.+....++.++|||||||+||||++ |++||......+.   ...............+.+.+..
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~  450 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLEKDYRMERPEGCPEKVYE  450 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHHTTCCCCCCTTCCHHHHH
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCCCCCCCCCCHHHHH
Confidence                 122456999999999999999999999999999999 9999865543322   2222222222222222222222


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                       ..+||+.+|.+||++.+|++.|+..++.
T Consensus       451 li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          451 LMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             HHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence             2379999999999999999999976543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.8e-42  Score=363.92  Aligned_cols=259  Identities=25%  Similarity=0.399  Sum_probs=206.5

Q ss_pred             cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEE-----cCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhcc-CccceeeE
Q 048439          262 FSLSEIQAATNNFDNDLVIGVGGFGDVYKGFI-----NGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQL-RHLHLVSL  334 (613)
Q Consensus       262 f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~-----~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l  334 (613)
                      +...+.....++|...+.||+|+||.||+|++     ..+++.||||+++... ....+.|.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            45566666778999999999999999999984     3455889999997653 34456799999999999 79999999


Q ss_pred             EEEeecCCc-eEEEEEcCCCCChhHHhhcCCC------------------------------------------------
Q 048439          335 IGFCNDDRE-MILVYDFMARGTLPDHLYHSDN------------------------------------------------  365 (613)
Q Consensus       335 ~g~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------  365 (613)
                      +++|.+.+. .++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999987654 8999999999999999965422                                                


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---
Q 048439          366 ----------------PPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       366 ----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---  426 (613)
                                      ..+++..++.++.|+++||+|||+.+    |+||||||+|||++.++.+||+|||+++...   
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~----ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC----cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                            12899999999999999999999998    9999999999999999999999999997421   


Q ss_pred             -------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          427 -------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       427 -------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                             ..++..|+|||++.+..++.++|||||||++|||++ |++||......+..  ......... ........+.
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~  324 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKEGTR-MRAPDYTTPE  324 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHHHHHTCC-CCCCTTCCHH
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHHHHcCCC-CCCCCCCCHH
Confidence                   223456999999999999999999999999999998 99999654433221  111111111 1112222222


Q ss_pred             HH--HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          499 LK--AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       499 ~~--~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      +.  ..+||+.+|.+||++.||+++|+..++
T Consensus       325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            22  237999999999999999999997664

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.2e-42  Score=351.04  Aligned_cols=250  Identities=26%  Similarity=0.397  Sum_probs=198.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEE----cCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeec--CCceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCND--DREMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~----~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~  345 (613)
                      ++|...+.||+|+||.||+|++    ..++..||||++........+.|.+|+.++++++||||++++++|..  ....+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            5677888999999999999984    44668899999988777777889999999999999999999999865  45689


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +||||+++|+|.+++... ...+++.+++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..
T Consensus        90 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKR----YIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             EEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             EEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCC----cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            999999999999999653 345999999999999999999999998    999999999999999999999999999743


Q ss_pred             C-----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhh---------hhHHHHHHHh
Q 048439          426 P-----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQ---------VSLAVWAQQC  485 (613)
Q Consensus       426 ~-----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~---------~~l~~~~~~~  485 (613)
                      .           ..++..|+|||.+....++.++|||||||++|||++|..|+........         ..........
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  244 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence            2           1233459999999999999999999999999999999998864332110         0000011111


Q ss_pred             h----ccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          486 Y----QNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       486 ~----~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      .    .......+.+.+.. ..+||+.+|.+||++.|+++.|+...
T Consensus       245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            1    11111222222222 23799999999999999999998654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.6e-42  Score=365.52  Aligned_cols=243  Identities=21%  Similarity=0.287  Sum_probs=194.5

Q ss_pred             CcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCC
Q 048439          276 NDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGT  355 (613)
Q Consensus       276 ~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs  355 (613)
                      ..++||+|+||.||+|+...++..||||+++.......++|.+|+.+|++++||||++++++|.+.+..+|||||+++|+
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            34579999999999999988888999999988776677889999999999999999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee--CCCCcEEEEecCCCccCC-------
Q 048439          356 LPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL--DEKWVAKVSDFGLSKFGP-------  426 (613)
Q Consensus       356 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl--~~~~~~kl~DFGls~~~~-------  426 (613)
                      |.+++... ...+++..++.++.|+++||.|||+.+    |+||||||+|||+  ++++.+||+|||+++...       
T Consensus       173 L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~  247 (373)
T 2x4f_A          173 LFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMY----ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV  247 (373)
T ss_dssp             EHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred             HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC----cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence            99988643 346999999999999999999999998    9999999999999  677899999999987422       


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc--cCCccccccHHHH-Hhc
Q 048439          427 TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ--NGTIDQIVDPFLK-AMS  503 (613)
Q Consensus       427 ~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~d~~~~-~~~  503 (613)
                      ..++..|+|||++....++.++|||||||+||||++|++||......+...  ........  ......+.+.... ..+
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~li~~  325 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN--NILACRWDLEDEEFQDISEEAKEFISK  325 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--HHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhccCCCChhhhccCCHHHHHHHHH
Confidence            236778999999999999999999999999999999999997654433221  11111111  1111122222222 238


Q ss_pred             ccccCCCCCCCHHHHHHHHHHh
Q 048439          504 CLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       504 Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ||+.||.+||++.|++++..+.
T Consensus       326 ~L~~dp~~Rps~~e~l~hp~~~  347 (373)
T 2x4f_A          326 LLIKEKSWRISASEALKHPWLS  347 (373)
T ss_dssp             TSCSSGGGSCCHHHHHHSHHHH
T ss_pred             HcCCChhhCCCHHHHhcCcCcC
Confidence            9999999999999999877653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.1e-41  Score=353.22  Aligned_cols=256  Identities=28%  Similarity=0.461  Sum_probs=200.4

Q ss_pred             HHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCC
Q 048439          265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR  342 (613)
Q Consensus       265 ~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~  342 (613)
                      .++....++|...+.||+|+||.||+|+..  +..||||++....  .....+|.+|+.++++++||||+++++++.+.+
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            333444567888899999999999999875  3679999987653  444567999999999999999999999999999


Q ss_pred             ceEEEEEcCCCCChhHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCC
Q 048439          343 EMILVYDFMARGTLPDHLYHSD-NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL  421 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl  421 (613)
                      ..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+.  +|+||||||+|||+++++.+||+|||+
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~--~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP--PIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS--CCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC--CEECCCCChhhEEEeCCCcEEECCCCC
Confidence            9999999999999999996532 2349999999999999999999998762  289999999999999999999999999


Q ss_pred             CccC--------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccc
Q 048439          422 SKFG--------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ  493 (613)
Q Consensus       422 s~~~--------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  493 (613)
                      ++..        ...++..|+|||.+.+..++.++|||||||+||||++|+.||......+....   ............
T Consensus       186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~---~~~~~~~~~~~~  262 (309)
T 3p86_A          186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA---VGFKCKRLEIPR  262 (309)
T ss_dssp             ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH---HHHSCCCCCCCT
T ss_pred             CccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCCCCCCCc
Confidence            8642        23457789999999999999999999999999999999999976543332211   111111222222


Q ss_pred             cccHHHH--HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          494 IVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       494 ~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      .+++.+.  ..+||+.+|.+||++.++++.|+..++
T Consensus       263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            2333322  227999999999999999999986654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.7e-42  Score=357.38  Aligned_cols=247  Identities=20%  Similarity=0.286  Sum_probs=199.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh------hcHHHHHHHHHHHhccCccceeeEEEEeecCCceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ------QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~------~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  345 (613)
                      ++|...+.||+|+||.||+|+...++..||||.+.....      .....+.+|+.+|++++||||+++++++.+.+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            468888899999999999999988889999999865422      23567999999999999999999999999999999


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC----cEEEEecCC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW----VAKVSDFGL  421 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFGl  421 (613)
                      +||||+++|+|.+++.  ....+++.+++.++.|++.||.|||+.+    |+||||||+|||++.++    .+||+|||+
T Consensus        91 lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~~----ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           91 LILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHCC----eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            9999999999999994  3467999999999999999999999998    99999999999999887    899999999


Q ss_pred             CccC-------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccc
Q 048439          422 SKFG-------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQI  494 (613)
Q Consensus       422 s~~~-------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  494 (613)
                      ++..       ...++..|+|||++....++.++|||||||+||||++|++||......+...................+
T Consensus       165 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (326)
T 2y0a_A          165 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT  244 (326)
T ss_dssp             CEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred             CeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccC
Confidence            8643       234677899999999999999999999999999999999999765433322111100000000000111


Q ss_pred             ccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          495 VDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       495 ~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ...... ..+||+.||.+|||+.|++++...
T Consensus       245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  275 (326)
T 2y0a_A          245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI  275 (326)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence            111111 227999999999999999987764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7e-42  Score=346.40  Aligned_cols=245  Identities=27%  Similarity=0.460  Sum_probs=200.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||.||+|+...+ ..||||++.... ...+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhceeeheecCCCccEEEEEEecCC-CeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            4677788999999999999998765 679999997653 23467999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC------
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG------  425 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~------  425 (613)
                      ++|+|.+++.. ....+++..++.++.|+++||+|||+.+    |+||||||+|||++.++.+||+|||+++..      
T Consensus        88 ~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~----i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           88 EHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             TTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhCC----eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence            99999999854 3456999999999999999999999998    999999999999999999999999998642      


Q ss_pred             ---CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          426 ---PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       426 ---~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                         ...++..|+|||.+....++.++|||||||++|||++ |++||......+....   ...... .......++.+. 
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~  238 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED---ISTGFR-LYKPRLASTHVYQ  238 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---HHTTCC-CCCCTTSCHHHHH
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH---HhcCcc-CCCCCcCCHHHHH
Confidence               2233456999999999999999999999999999999 9999965443322111   111111 111222222222 


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                       ..+||+.+|.+||++.+++++|+...+
T Consensus       239 li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          239 IMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence             237999999999999999999986543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.5e-41  Score=346.27  Aligned_cols=259  Identities=37%  Similarity=0.640  Sum_probs=207.6

Q ss_pred             cccCHHHHHHHhcCCCCc------ceeeeeCcEEEEEEEEcCCceeEEEEEeCCC----ChhcHHHHHHHHHHHhccCcc
Q 048439          260 TQFSLSEIQAATNNFDND------LVIGVGGFGDVYKGFINGSTTPVAIKRLEPE----SQQGALEFQTEIGMLSQLRHL  329 (613)
Q Consensus       260 ~~f~~~el~~at~~f~~~------~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~----~~~~~~~f~~Ei~~l~~l~H~  329 (613)
                      ..|++.++..++++|...      +.||+|+||.||+|...  +..||||++...    .....+.|.+|+.++++++||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            569999999999999988      89999999999999874  367999998653    233456799999999999999


Q ss_pred             ceeeEEEEeecCCceEEEEEcCCCCChhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee
Q 048439          330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHS-DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL  408 (613)
Q Consensus       330 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl  408 (613)
                      ||+++++++.+.+..++||||+++|+|.+++... ....++|..++.++.|++.||.|||+.+    |+||||||+|||+
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~----i~H~dlkp~Nili  166 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH----HIHRDIKSANILL  166 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC----eecCCCCHHHEEE
Confidence            9999999999999999999999999999998643 3457999999999999999999999998    9999999999999


Q ss_pred             CCCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhH
Q 048439          409 DEKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSL  478 (613)
Q Consensus       409 ~~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l  478 (613)
                      ++++.+||+|||+++...          ..++..|+|||.+.+ .++.++|||||||++|||++|++||...........
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            999999999999986422          245678999998865 589999999999999999999999975443221111


Q ss_pred             HHHHHHh-------hccCCcccc----ccHHH-HHhcccccCCCCCCCHHHHHHHHHHh
Q 048439          479 AVWAQQC-------YQNGTIDQI----VDPFL-KAMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       479 ~~~~~~~-------~~~~~~~~~----~d~~~-~~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      .......       .....+...    .+.+. ...+||+.+|.+||++.+|++.|+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            1100000       000111111    11111 13379999999999999999999853

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.1e-42  Score=361.92  Aligned_cols=248  Identities=21%  Similarity=0.278  Sum_probs=199.7

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh------cHHHHHHHHHHHhccCccceeeEEEEeecCCce
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ------GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~------~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~  344 (613)
                      .++|...+.||+|+||.||+|+...++..||||.++.....      ....+.+|+.+|.+++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            35688888999999999999999988899999998764321      356799999999999999999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC----cEEEEecC
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW----VAKVSDFG  420 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFG  420 (613)
                      ++||||+++|+|.+++.  ....+++..++.++.|++.||.|||+.+    |+||||||+|||+++++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g----ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            99999999999999994  3457999999999999999999999998    99999999999998877    79999999


Q ss_pred             CCccC-------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccc
Q 048439          421 LSKFG-------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ  493 (613)
Q Consensus       421 ls~~~-------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  493 (613)
                      +++..       ...++..|+|||++....++.++|||||||++|||++|++||......+...................
T Consensus       165 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (361)
T 2yab_A          165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ  244 (361)
T ss_dssp             SCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             CceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccC
Confidence            98642       23467789999999999999999999999999999999999976543332111110000000000011


Q ss_pred             cccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          494 IVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       494 ~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      +.+.... ..+||..||.+||++.|++++.+.
T Consensus       245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~  276 (361)
T 2yab_A          245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI  276 (361)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCcCc
Confidence            1111111 227999999999999999987664

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=369.74  Aligned_cols=251  Identities=25%  Similarity=0.392  Sum_probs=200.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEc-----CCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFIN-----GSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~-----~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  345 (613)
                      ++|...+.||+|+||.||+|++.     .++..||||+++.. .......+.+|+.++++++||||+++++++.+....+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            56788889999999999999953     34578999999754 4455667999999999999999999999999999999


Q ss_pred             EEEEcCCCCChhHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC---cEEEE
Q 048439          346 LVYDFMARGTLPDHLYHSD-----NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW---VAKVS  417 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~---~~kl~  417 (613)
                      +||||+++|+|.+++....     ...+++.+++.++.|+++||.|||+.+    |+||||||+|||++.++   .+||+
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC----eeCCCCChhhEEEecCCCCceEEEC
Confidence            9999999999999996432     246999999999999999999999998    99999999999999554   59999


Q ss_pred             ecCCCccC----------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhh
Q 048439          418 DFGLSKFG----------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCY  486 (613)
Q Consensus       418 DFGls~~~----------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~  486 (613)
                      |||+++..          ...++..|+|||.+....++.++|||||||+||||++ |++||......+..   .......
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~---~~i~~~~  303 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---EFVTSGG  303 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHHHTTC
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCC
Confidence            99998621          1223567999999999999999999999999999998 99999665433321   1111111


Q ss_pred             ccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhhhh
Q 048439          487 QNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQLQ  529 (613)
Q Consensus       487 ~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~~  529 (613)
                      .......+.+.+.. ..+||+.+|.+||++.+|+++|+...+..
T Consensus       304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            11112222222222 23799999999999999999999766543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.2e-41  Score=371.19  Aligned_cols=245  Identities=30%  Similarity=0.473  Sum_probs=199.9

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCC-ceEEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR-EMILVYD  349 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~E  349 (613)
                      .++|...+.||+|+||.||+|.+.+  ..||||+++...  ..+.|.+|+.+|++++|||||+++++|.+.+ ..++|||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~~--~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT--EEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEecC--CeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            4567788899999999999999864  679999998654  4568999999999999999999999987765 7999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---  426 (613)
                      ||++|+|.+++.......+++..++.++.|+++||+|||+.+    |+||||||+|||+++++.+||+|||+++...   
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~----ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  343 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  343 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence            999999999997655556899999999999999999999998    9999999999999999999999999987432   


Q ss_pred             --CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-Hh
Q 048439          427 --TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AM  502 (613)
Q Consensus       427 --~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~  502 (613)
                        ...+..|+|||.+....++.++|||||||+||||++ |+.||......+...   .............+.+.+.. ..
T Consensus       344 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~---~i~~~~~~~~p~~~~~~l~~li~  420 (450)
T 1k9a_A          344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---RVEKGYKMDAPDGCPPAVYDVMK  420 (450)
T ss_dssp             ---CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH---HHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHcCCCCCCCCcCCHHHHHHHH
Confidence              233567999999999999999999999999999998 999997554333221   11111111112222222222 23


Q ss_pred             cccccCCCCCCCHHHHHHHHHHhh
Q 048439          503 SCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       503 ~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      +||+.+|.+||++.++++.|+...
T Consensus       421 ~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          421 NCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcCCChhHCcCHHHHHHHHHHHH
Confidence            799999999999999999998544

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.7e-42  Score=361.22  Aligned_cols=242  Identities=24%  Similarity=0.327  Sum_probs=200.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...++||+|+||+||+|+...+++.||||+++..   .......+.+|+.+|++++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            5788889999999999999999888899999999754   2344567899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+++|+|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..   
T Consensus        85 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~----ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           85 EYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            99999999999854  356899999999999999999999998    999999999999999999999999998742   


Q ss_pred             -----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          426 -----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       426 -----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                           ...++..|+|||++.+..++.++|||||||+||||++|++||.............     .....+...+++.+.
T Consensus       159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~-----~~~~~~p~~~s~~~~  233 (337)
T 1o6l_A          159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-----MEEIRFPRTLSPEAK  233 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HCCCCCCTTSCHHHH
T ss_pred             CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCHHHH
Confidence                 1235678999999999999999999999999999999999997654332221111     111122222232222


Q ss_pred             --HhcccccCCCCCC-----CHHHHHHHHHH
Q 048439          501 --AMSCLNDEGIRRP-----SMSDVVWGLEF  524 (613)
Q Consensus       501 --~~~Cl~~~p~~RP-----s~~evl~~Le~  524 (613)
                        ..+||+.||.+||     ++.|++++..+
T Consensus       234 ~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f  264 (337)
T 1o6l_A          234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF  264 (337)
T ss_dssp             HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             HHHHHHhhcCHHHhcCCCCCCHHHHHcCCCc
Confidence              2279999999999     89999877654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.9e-42  Score=358.38  Aligned_cols=247  Identities=24%  Similarity=0.384  Sum_probs=193.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCce----eEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTT----PVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~----~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ++|...++||+|+||.||+|++..++.    .||+|.+... ......+|.+|+.++++++||||++++++|.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            467888899999999999999865544    3688888654 3455678999999999999999999999998764 789


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      |+||+++|+|.+++... ...+++..++.|+.|+++||.|||+.+    |+||||||+|||++.++.+||+|||+++...
T Consensus        94 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~----ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCC----eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            99999999999999653 456999999999999999999999998    9999999999999999999999999986321


Q ss_pred             ----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          427 ----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       427 ----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                                ..++..|+|||++.+..++.++|||||||+||||++ |+.||......+....   ..............
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~  245 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERLPQPPICT  245 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---HHTTCCCCCCTTBC
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH---HHcCCCCCCCccCC
Confidence                      123457999999999999999999999999999999 9999976544332221   11111111111222


Q ss_pred             cHHH-HHhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          496 DPFL-KAMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       496 d~~~-~~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      .... ...+||+.+|.+||++.+++++|+...+
T Consensus       246 ~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          246 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            2222 2338999999999999999999986543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.9e-42  Score=374.80  Aligned_cols=248  Identities=25%  Similarity=0.436  Sum_probs=202.2

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ...++|...+.||+|+||.||+|.+..+ ..||||+++... ...++|.+|+.+|++++|||||++++++. .+..++||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~  261 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKH-TKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT  261 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTT-EEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCc-cEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence            3456788888999999999999999765 679999998654 45678999999999999999999999987 56789999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      |||++|+|.+++.......+++..++.++.|+++||+|||+.+    |+||||||+|||++.++.+||+|||+++...  
T Consensus       262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~----ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT----CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC----ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            9999999999996544446899999999999999999999998    9999999999999999999999999997532  


Q ss_pred             -------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          427 -------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       427 -------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                             ..++..|+|||.+..+.++.++|||||||+||||++ |+.||......+....   ............+.+.+
T Consensus       338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~---i~~~~~~~~~~~~~~~l  414 (454)
T 1qcf_A          338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA---LERGYRMPRPENCPEEL  414 (454)
T ss_dssp             HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH---HHHTCCCCCCTTSCHHH
T ss_pred             ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHcCCCCCCCCCCCHHH
Confidence                   123456999999999999999999999999999999 9999975543332221   12222222222222332


Q ss_pred             HH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          499 LK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       499 ~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      .. ..+||+.||++||++.+|++.|+...
T Consensus       415 ~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          415 YNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             HHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            22 23799999999999999999998544

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-42  Score=359.81  Aligned_cols=253  Identities=28%  Similarity=0.444  Sum_probs=204.4

Q ss_pred             HHHHhcCCCCcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeec
Q 048439          267 IQAATNNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCND  340 (613)
Q Consensus       267 l~~at~~f~~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~  340 (613)
                      +....++|...+.||+|+||.||+|+..+     ++..||||+++... ......|.+|+.++++++||||++++++|.+
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            34456789999999999999999999863     34789999998653 3445679999999999999999999999999


Q ss_pred             CCceEEEEEcCCCCChhHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEe
Q 048439          341 DREMILVYDFMARGTLPDHLYHSD----------------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH  398 (613)
Q Consensus       341 ~~~~~lV~Ey~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiH  398 (613)
                      .+..++||||+++|+|.+++....                      ...+++.+++.|+.|+++||+|||+.+    |+|
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----ivH  197 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK----FVH  197 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT----CCC
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC----eec
Confidence            999999999999999999996532                      257999999999999999999999998    999


Q ss_pred             ccCCCCceeeCCCCcEEEEecCCCccC----------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCc
Q 048439          399 RDVKTTNILLDEKWVAKVSDFGLSKFG----------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSI  467 (613)
Q Consensus       399 rDlk~~NILl~~~~~~kl~DFGls~~~----------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~  467 (613)
                      |||||+|||+++++.+||+|||+++..          ...++..|+|||.+....++.++|||||||++|||++ |+.||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            999999999999999999999998531          2234567999999999999999999999999999999 99999


Q ss_pred             cchhhhhhhhHHHHHHHhhccCCccccccHHHH--HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          468 LRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       468 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      ......+..   ......... .......+.+.  ..+||+.+|.+||++.+|++.|+...+
T Consensus       278 ~~~~~~~~~---~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          278 YGMAHEEVI---YYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             TTSCHHHHH---HHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCChHHHH---HHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            654433221   111111111 11112222222  237999999999999999999986554

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-41  Score=352.41  Aligned_cols=250  Identities=26%  Similarity=0.398  Sum_probs=202.2

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEc-----CCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCce
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFIN-----GSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~-----~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~  344 (613)
                      .++|...+.||+|+||.||+|...     .++..||||++... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            467888889999999999999873     34478999999765 344567799999999999999999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCC
Q 048439          345 ILVYDFMARGTLPDHLYHSDN----------------------PPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVK  402 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk  402 (613)
                      ++||||+++|+|.+++.....                      ..+++.+++.++.|+++||+|||+.+    |+|||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----ivH~dik  177 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK----LVHRDLA  177 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT----EECCCCS
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC----Ccccccc
Confidence            999999999999999965322                      34899999999999999999999998    9999999


Q ss_pred             CCceeeCCCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchh
Q 048439          403 TTNILLDEKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTA  471 (613)
Q Consensus       403 ~~NILl~~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~  471 (613)
                      |+|||+++++.+||+|||+++...          ..++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999986421          123456999999999999999999999999999999 999997654


Q ss_pred             hhhhhhHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          472 AKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       472 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      .....   ..............+.+.+.. ..+||+.||.+||++.|+++.|+..++
T Consensus       258 ~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          258 PERLF---NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             GGGHH---HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHH---HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            43322   111111111111222222222 237999999999999999999997654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.4e-41  Score=360.22  Aligned_cols=249  Identities=19%  Similarity=0.257  Sum_probs=200.9

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ..++|...+.||+|+||.||+|....++..||||++...  .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            356789999999999999999999888899999999754  334556789999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC---CcEEEEecCCCcc
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK---WVAKVSDFGLSKF  424 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGls~~  424 (613)
                      |||+++|+|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.+   +.+||+|||+++.
T Consensus       107 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~----ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            999999999999853  456999999999999999999999998    9999999999999865   4599999999864


Q ss_pred             CC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccH
Q 048439          425 GP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP  497 (613)
Q Consensus       425 ~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  497 (613)
                      ..       ..++..|+|||++.+..++.++|||||||++|||++|++||......+...................+.+.
T Consensus       181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  260 (362)
T 2bdw_A          181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  260 (362)
T ss_dssp             CTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred             ecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            32       34677899999999999999999999999999999999999765433221111100000011111122222


Q ss_pred             HHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          498 FLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       498 ~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ... ..+||+.||.+||++.|++++.+.
T Consensus       261 ~~~li~~~L~~dP~~R~t~~e~l~hp~~  288 (362)
T 2bdw_A          261 AKSLIDSMLTVNPKKRITADQALKVPWI  288 (362)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence            222 227999999999999999987654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=362.11  Aligned_cols=250  Identities=23%  Similarity=0.403  Sum_probs=202.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcC-------CceeEEEEEeCCC-ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFING-------STTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDR  342 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~-------~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~  342 (613)
                      ++|...+.||+|+||.||+|+..+       .+..||||+++.. .......+.+|+++++++ +||||++++++|.+.+
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            577788899999999999999743       2357999999765 344557799999999999 9999999999999999


Q ss_pred             ceEEEEEcCCCCChhHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee
Q 048439          343 EMILVYDFMARGTLPDHLYHSD--------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL  408 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl  408 (613)
                      ..++||||+++|+|.+++....              ...+++.+++.|+.|+++||.|||+.+    |+||||||+|||+
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dlkp~NIll  224 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK----CIHRDLAARNVLV  224 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEE
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC----EecCCCCcceEEE
Confidence            9999999999999999996543              246999999999999999999999998    9999999999999


Q ss_pred             CCCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhh
Q 048439          409 DEKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVS  477 (613)
Q Consensus       409 ~~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~  477 (613)
                      ++++.+||+|||+++...          ..++..|+|||++.+..++.++|||||||+||||++ |+.||......+.  
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~--  302 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--  302 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence            999999999999987422          123456999999999999999999999999999999 9999965543322  


Q ss_pred             HHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          478 LAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       478 l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                       ...............+.+.+.. ..+||+.+|.+||++.||++.|+..+..
T Consensus       303 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  353 (382)
T 3tt0_A          303 -FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  353 (382)
T ss_dssp             -HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence             1112111111112222222222 2379999999999999999999976643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.2e-42  Score=351.27  Aligned_cols=247  Identities=24%  Similarity=0.319  Sum_probs=199.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|+...++..||||.+...   .....+.|.+|+.++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            5688888999999999999999888889999998543   3344567899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+++|+|.+++..  ..++++..++.++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++...  
T Consensus        91 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           91 EYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDMR----IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             ECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            99999999999854  346999999999999999999999998    9999999999999999999999999986422  


Q ss_pred             -------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc---cCCcccccc
Q 048439          427 -------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ---NGTIDQIVD  496 (613)
Q Consensus       427 -------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d  496 (613)
                             ..++..|+|||.+.+..++.++|||||||++|||++|++||........... . ......   ......+.+
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~  242 (294)
T 4eqm_A          165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK-H-IQDSVPNVTTDVRKDIPQ  242 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH-H-HSSCCCCHHHHSCTTSCH
T ss_pred             cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-H-hhccCCCcchhcccCCCH
Confidence                   2357789999999999999999999999999999999999976543221110 0 000000   000111222


Q ss_pred             HHHH-HhcccccCCCCCC-CHHHHHHHHHHhh
Q 048439          497 PFLK-AMSCLNDEGIRRP-SMSDVVWGLEFSL  526 (613)
Q Consensus       497 ~~~~-~~~Cl~~~p~~RP-s~~evl~~Le~~l  526 (613)
                      .+.. ..+||+.||.+|| ++.++.+.|+..+
T Consensus       243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          243 SLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             HHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            2222 2379999999999 8999988887544

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-41  Score=361.51  Aligned_cols=249  Identities=19%  Similarity=0.279  Sum_probs=202.7

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      .++|...+.||+|+||.||+|....++..||+|.+..........+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            35788889999999999999999888899999999877666667899999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC--CCcEEEEecCCCccCC--
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE--KWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~--~~~~kl~DFGls~~~~--  426 (613)
                      |++|+|.+++.. ....+++.+++.++.|++.||.|||+.+    |+||||||+|||++.  ++.+||+|||+++...  
T Consensus       130 ~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g----ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCC----eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999999854 3356999999999999999999999998    999999999999974  5789999999997532  


Q ss_pred             -----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          427 -----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                           ..++..|+|||++.+..++.++|||||||+||||++|++||......+...................+.+.... 
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  284 (387)
T 1kob_A          205 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF  284 (387)
T ss_dssp             SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred             cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence                 23577899999999999999999999999999999999999765433222111100000111111222222222 


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ..+||+.||.+||++.|++++...
T Consensus       285 i~~~L~~dP~~Rpt~~ell~hp~~  308 (387)
T 1kob_A          285 IKNLLQKEPRKRLTVHDALEHPWL  308 (387)
T ss_dssp             HHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred             HHHHcCCChhHCcCHHHHhhCccc
Confidence            238999999999999999987654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=8.4e-42  Score=349.06  Aligned_cols=247  Identities=25%  Similarity=0.352  Sum_probs=197.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCc-------eeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGST-------TPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~-------~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~  344 (613)
                      ++|...+.||+|+||.||+|+...++       ..||+|.+........+.|.+|+.++++++||||++++++|.+.+..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            56778889999999999999987644       46999999877767778899999999999999999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc--------EEE
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV--------AKV  416 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~--------~kl  416 (613)
                      ++||||+++|+|.+++... ...+++..++.++.|+++||.|||+.+    |+||||||+|||++.++.        +||
T Consensus        88 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~----ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENT----LIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             EEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCC----eECCCcCcceEEEecCCcccccccceeee
Confidence            9999999999999999653 344899999999999999999999998    999999999999998887        999


Q ss_pred             EecCCCccCCC----CCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHh-hccCC
Q 048439          417 SDFGLSKFGPT----SVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC-YQNGT  490 (613)
Q Consensus       417 ~DFGls~~~~~----~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~-~~~~~  490 (613)
                      +|||+++....    .++..|+|||.+.. ..++.++|||||||++|||++|..|+......... ...+.... .....
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~  241 (289)
T 4fvq_A          163 SDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYEDRHQLPAPK  241 (289)
T ss_dssp             CCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTTCCCCCCS
T ss_pred             ccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhhccCCCCCCC
Confidence            99999865332    24567999999987 77999999999999999999965544332222111 11111111 11111


Q ss_pred             ccccccHHHHHhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          491 IDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       491 ~~~~~d~~~~~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      ..++.+ +  ..+||+.||.+||++.|++++|+..+.
T Consensus       242 ~~~l~~-l--i~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          242 AAELAN-L--INNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             SCTTHH-H--HHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             CHHHHH-H--HHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            122222 2  226999999999999999999996554

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.4e-41  Score=343.77  Aligned_cols=245  Identities=25%  Similarity=0.402  Sum_probs=198.9

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      .++|...+.||+|+||.||+|...++ ..||||+++... ....++.+|+.++.+++||||++++++|.+.+..++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTT-EEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCc-eeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            35678888999999999999988765 679999997653 2346799999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      +++|+|.+++... ...+++.+++.++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++...    
T Consensus        85 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           85 ISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQ----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             CTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT----EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             cCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            9999999998542 345999999999999999999999998    9999999999999999999999999986422    


Q ss_pred             -----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          427 -----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                           ..++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.....   .... .........+.+.
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~l~  235 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV---SQGH-RLYRPHLASDTIY  235 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---HTTC-CCCCCTTSCHHHH
T ss_pred             hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH---HcCC-CCCCCCcChHHHH
Confidence                 223446999999999999999999999999999999 99999654433321111   1111 1111222222222


Q ss_pred             --HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          501 --AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       501 --~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                        ..+||+.+|.+||++.|+++.|+...
T Consensus       236 ~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          236 QIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence              22799999999999999999998543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-41  Score=347.94  Aligned_cols=253  Identities=24%  Similarity=0.407  Sum_probs=208.0

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ..++|...+.||+|+||.||+|....++..||||.+.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            3567888889999999999999998888899999997643 346679999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCCC-
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS-  428 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~-  428 (613)
                      |+++|+|.+++.......+++..++.++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++..... 
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~----i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT----CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC----ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            999999999997766677999999999999999999999998    999999999999999999999999998753321 


Q ss_pred             --------CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH
Q 048439          429 --------VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       429 --------~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                              ++..|+|||.+....++.++||||||+++|||++ |++||........   ...............+.+.+.
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~  242 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLEKDYRMERPEGCPEKVY  242 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHHTTCCCCCCTTCCHHHH
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHhccCCCCCCCCCCHHHH
Confidence                    2346999999999999999999999999999999 9999865443322   121222212111222222222


Q ss_pred             H-HhcccccCCCCCCCHHHHHHHHHHhhhhhh
Q 048439          500 K-AMSCLNDEGIRRPSMSDVVWGLEFSLQLQE  530 (613)
Q Consensus       500 ~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~~~  530 (613)
                      . ..+||+.||.+||++.++++.|+..++...
T Consensus       243 ~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          243 ELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            2 227999999999999999999997665433

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.4e-42  Score=357.29  Aligned_cols=254  Identities=24%  Similarity=0.362  Sum_probs=191.3

Q ss_pred             HHHhcCCCCcceeeeeCcEEEEEEEEcCCce---eEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCC
Q 048439          268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTT---PVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR  342 (613)
Q Consensus       268 ~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~---~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~  342 (613)
                      ....++|...+.||+|+||.||+|++..++.   .||||+++..  .....+.|.+|+.++++++||||+++++++....
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            3445689999999999999999999866543   7999999765  3445678999999999999999999999998876


Q ss_pred             ce------EEEEEcCCCCChhHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC
Q 048439          343 EM------ILVYDFMARGTLPDHLYHS----DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW  412 (613)
Q Consensus       343 ~~------~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~  412 (613)
                      ..      ++||||+++|+|.+++...    ....+++.+++.|+.|+++||.|||+.+    |+||||||+|||+++++
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~----ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN----FIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECTTS
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC----cccCCCCcceEEEcCCC
Confidence            55      9999999999999998542    2236999999999999999999999998    99999999999999999


Q ss_pred             cEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHH
Q 048439          413 VAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVW  481 (613)
Q Consensus       413 ~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~  481 (613)
                      .+||+|||+++...          ..++..|+|||.+.+..++.++|||||||++|||++ |++||......+....   
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~---  251 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY---  251 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH---
Confidence            99999999986421          123456999999999999999999999999999999 8999975543332211   


Q ss_pred             HHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          482 AQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       482 ~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                      ............+.+.+.. ..+||+.||.+||++.++++.|+..++.
T Consensus       252 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          252 LIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            1111111112222222222 2379999999999999999999977653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.1e-41  Score=345.23  Aligned_cols=245  Identities=26%  Similarity=0.420  Sum_probs=197.7

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      .++|...+.||+|+||.||+|...++ ..||||++.... ...+++.+|++++.+++|+||++++++|.+.+..++||||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTT-EEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCC-CeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            45778888999999999999998754 679999998653 2346799999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-----  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-----  425 (613)
                      +++|+|.+++... ...+++.+++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++..     
T Consensus       101 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          101 MANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             CTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             cCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCC----ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            9999999999542 356999999999999999999999998    999999999999999999999999998642     


Q ss_pred             ----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          426 ----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                          ...++..|+|||.+....++.++|||||||++|||++ |+.||......+.....   ..... .......++.+.
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~l~  251 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---AQGLR-LYRPHLASEKVY  251 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---HTTCC-CCCCTTCCHHHH
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH---hcccC-CCCCCcCCHHHH
Confidence                2233456999999999999999999999999999998 99999755433222111   11111 112222222222


Q ss_pred             --HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          501 --AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       501 --~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                        ..+||+.+|.+||++.+++++|+..+
T Consensus       252 ~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          252 TIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence              23799999999999999999998655

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.4e-41  Score=354.61  Aligned_cols=246  Identities=23%  Similarity=0.311  Sum_probs=198.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ++|...+.||+|+||.||+|+...++..||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            57888899999999999999998888999999986543 23345688999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-----  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-----  425 (613)
                      +++|+|.+++.  ....+++.+++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..     
T Consensus        87 ~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~g----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           87 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC----ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            99999999984  3456999999999999999999999998    999999999999999999999999998631     


Q ss_pred             -----CCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH
Q 048439          426 -----PTSVSKTHLDPEYYRLQQL-TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       426 -----~~~~~~~~~aPE~~~~~~~-t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                           ...++..|+|||++.+..+ +.++|||||||+||||++|+.||........ ....|............+.+...
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  239 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTYLNPWKKIDSAPL  239 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhcccccCCccccCCHHHH
Confidence                 2346778999999988776 7899999999999999999999965433221 22222222222121222222222


Q ss_pred             H-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          500 K-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       500 ~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      . ..+||+.||.+||++.|++++.++
T Consensus       240 ~li~~~L~~dP~~R~t~~eil~h~~~  265 (323)
T 3tki_A          240 ALLHKILVENPSARITIPDIKKDRWY  265 (323)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             HHHHHHccCChhhCcCHHHHhhChhh
Confidence            2 237999999999999999876654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.5e-42  Score=369.97  Aligned_cols=258  Identities=19%  Similarity=0.223  Sum_probs=206.4

Q ss_pred             cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEe
Q 048439          262 FSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFC  338 (613)
Q Consensus       262 f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~  338 (613)
                      +.+.++...+++|...++||+|+||+||+|+...+++.||||+++...   ......+.+|+.++..++||||++++++|
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            456677778899999999999999999999999888999999997532   12233488999999999999999999999


Q ss_pred             ecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEe
Q 048439          339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSD  418 (613)
Q Consensus       339 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~D  418 (613)
                      .+.+.++||||||++|+|.+++... ...+++..+..++.|++.||.|||+.+    |+||||||+||||+.++.+||+|
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~g----iiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLH----YVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCC----eEecccCHHHeeEcCCCCEEEcc
Confidence            9999999999999999999999642 456999999999999999999999998    99999999999999999999999


Q ss_pred             cCCCccC---------CCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHH-HHH
Q 048439          419 FGLSKFG---------PTSVSKTHLDPEYYR-----LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAV-WAQ  483 (613)
Q Consensus       419 FGls~~~---------~~~~~~~~~aPE~~~-----~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~-~~~  483 (613)
                      ||+|+..         ...++..|+|||++.     .+.++.++|||||||+||||++|++||......+....+. +..
T Consensus       219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  298 (437)
T 4aw2_A          219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE  298 (437)
T ss_dssp             CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred             hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence            9998632         135688899999997     4678999999999999999999999997665444333222 111


Q ss_pred             HhhccCCccccccHHHHH-hcccccCCCC--CCCHHHHHHHHHH
Q 048439          484 QCYQNGTIDQIVDPFLKA-MSCLNDEGIR--RPSMSDVVWGLEF  524 (613)
Q Consensus       484 ~~~~~~~~~~~~d~~~~~-~~Cl~~~p~~--RPs~~evl~~Le~  524 (613)
                      ..........+.+..... .+||..+|++  ||++.|++++..+
T Consensus       299 ~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff  342 (437)
T 4aw2_A          299 RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF  342 (437)
T ss_dssp             HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred             cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence            111111111222222221 1566666666  9999999987765

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.1e-42  Score=368.61  Aligned_cols=254  Identities=22%  Similarity=0.283  Sum_probs=205.1

Q ss_pred             HHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeec
Q 048439          264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCND  340 (613)
Q Consensus       264 ~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~  340 (613)
                      +.++....++|...++||+|+||.||+|+...++..||+|+++...   ......+.+|+.+++.++|||||+++++|.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            4556667789999999999999999999999888999999986531   2233458899999999999999999999999


Q ss_pred             CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecC
Q 048439          341 DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG  420 (613)
Q Consensus       341 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG  420 (613)
                      .+.++||||||++|+|.+++..   ..+++..+..++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~g----ivHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG----FIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC----eEeccCCHHHeeECCCCCEEEeccc
Confidence            9999999999999999999854   35899999999999999999999998    9999999999999999999999999


Q ss_pred             CCccC---------CCCCCcccCChhhhhcCC----CCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc
Q 048439          421 LSKFG---------PTSVSKTHLDPEYYRLQQ----LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ  487 (613)
Q Consensus       421 ls~~~---------~~~~~~~~~aPE~~~~~~----~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~  487 (613)
                      +++..         ...++..|+|||++....    ++.++|||||||+||||++|++||......+....+........
T Consensus       214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~  293 (410)
T 3v8s_A          214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT  293 (410)
T ss_dssp             TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred             eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc
Confidence            99642         334788899999998765    78999999999999999999999976554443322221111111


Q ss_pred             cCCccccccHHHH-HhcccccCCCC--CCCHHHHHHHHHH
Q 048439          488 NGTIDQIVDPFLK-AMSCLNDEGIR--RPSMSDVVWGLEF  524 (613)
Q Consensus       488 ~~~~~~~~d~~~~-~~~Cl~~~p~~--RPs~~evl~~Le~  524 (613)
                      ......+...... ..+||..+|.+  ||++.||+++..+
T Consensus       294 ~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f  333 (410)
T 3v8s_A          294 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  333 (410)
T ss_dssp             CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred             CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence            1111122222211 22688888888  9999999988775

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.9e-41  Score=351.34  Aligned_cols=243  Identities=22%  Similarity=0.301  Sum_probs=190.6

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCc------
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDRE------  343 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~------  343 (613)
                      .++|...+.||+|+||.||+|+...++..||||+++... ....+.+.+|+.+|++++||||++++++|.+...      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            457888889999999999999998788899999997543 3455779999999999999999999999865442      


Q ss_pred             ---------------------------------------------------eEEEEEcCCCCChhHHhhcCC-CCCCCHH
Q 048439          344 ---------------------------------------------------MILVYDFMARGTLPDHLYHSD-NPPLPWN  371 (613)
Q Consensus       344 ---------------------------------------------------~~lV~Ey~~~gsL~~~l~~~~-~~~l~~~  371 (613)
                                                                         .++|||||++|+|.+++.... ....++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                               799999999999999996542 3456777


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC--------------------CCCc
Q 048439          372 QRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT--------------------SVSK  431 (613)
Q Consensus       372 ~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~--------------------~~~~  431 (613)
                      .++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++....                    .++.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~----ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHhCC----eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            89999999999999999998    99999999999999999999999999864322                    3677


Q ss_pred             ccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH-HHhcccccCCC
Q 048439          432 THLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL-KAMSCLNDEGI  510 (613)
Q Consensus       432 ~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~-~~~~Cl~~~p~  510 (613)
                      .|+|||.+.+..++.++|||||||++|||++|..|+.....     ..................+... ...+||+.||.
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  315 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-----IITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPT  315 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH-----HHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGG
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH-----HHHHhhccCCCcccccCChhHHHHHHHHccCCCC
Confidence            89999999999999999999999999999999887632211     1111110000000011111111 12379999999


Q ss_pred             CCCCHHHHHHHH
Q 048439          511 RRPSMSDVVWGL  522 (613)
Q Consensus       511 ~RPs~~evl~~L  522 (613)
                      +||++.|++++.
T Consensus       316 ~Rps~~~~l~~~  327 (332)
T 3qd2_B          316 ERPEATDIIENA  327 (332)
T ss_dssp             GSCCHHHHHHST
T ss_pred             cCCCHHHHhhch
Confidence            999999998654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.4e-42  Score=362.94  Aligned_cols=243  Identities=22%  Similarity=0.285  Sum_probs=199.3

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l  346 (613)
                      .++|...++||+|+||.||+|+...++..||||+++..   .......+.+|..++..+ +||||+++++++.+.+.++|
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            46899999999999999999999988899999999754   233456688999999988 69999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-  425 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-  425 (613)
                      |||||++|+|.+++..  ...+++.+++.++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++.. 
T Consensus       102 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g----ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDKG----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            9999999999999954  356999999999999999999999998    999999999999999999999999998742 


Q ss_pred             -------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          426 -------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       426 -------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                             ...++..|+|||++.+..++.++|||||||+||||++|++||......+....+.     .........+.+.
T Consensus       176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~-----~~~~~~p~~~~~~  250 (353)
T 3txo_A          176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL-----NDEVVYPTWLHED  250 (353)
T ss_dssp             C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HCCCCCCTTSCHH
T ss_pred             cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCHH
Confidence                   2346778999999999999999999999999999999999997655443222211     1111122222222


Q ss_pred             HH--HhcccccCCCCCCCH------HHHHHHHHH
Q 048439          499 LK--AMSCLNDEGIRRPSM------SDVVWGLEF  524 (613)
Q Consensus       499 ~~--~~~Cl~~~p~~RPs~------~evl~~Le~  524 (613)
                      ..  ..+||..||.+||++      .|++++..+
T Consensus       251 ~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f  284 (353)
T 3txo_A          251 ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF  284 (353)
T ss_dssp             HHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGG
T ss_pred             HHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcc
Confidence            22  227999999999998      778766553

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=346.22  Aligned_cols=250  Identities=18%  Similarity=0.249  Sum_probs=197.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCC--ceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR--EMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~  348 (613)
                      ++|...++||+|+||.||+|+...++..||||+++... ....+.+.+|++++++++||||+++++++.+..  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            46778889999999999999999888899999997643 344667889999999999999999999988755  789999


Q ss_pred             EcCCCCChhHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee----CCCCcEEEEecCCCc
Q 048439          349 DFMARGTLPDHLYHSD-NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL----DEKWVAKVSDFGLSK  423 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGls~  423 (613)
                      ||+++|+|.+++.... ...+++.+++.++.|++.||.|||+.+    |+||||||+|||+    +.++.+||+|||+++
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~----ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC----EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            9999999999996532 334999999999999999999999998    9999999999999    888899999999996


Q ss_pred             cC-------CCCCCcccCChhhhh--------cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhh-hHHHHHHHhhc
Q 048439          424 FG-------PTSVSKTHLDPEYYR--------LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV-SLAVWAQQCYQ  487 (613)
Q Consensus       424 ~~-------~~~~~~~~~aPE~~~--------~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~-~l~~~~~~~~~  487 (613)
                      ..       ...++..|+|||++.        ...++.++|||||||+||||++|+.||......... ...........
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            42       223577899999987        477899999999999999999999999654322211 11111111111


Q ss_pred             cC-----------------------CccccccHHHH--HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          488 NG-----------------------TIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       488 ~~-----------------------~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ..                       .+.......+.  ..+||+.||++||++.|+++++...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            00                       01111111221  2279999999999999999888743

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.4e-41  Score=352.43  Aligned_cols=247  Identities=23%  Similarity=0.324  Sum_probs=192.6

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCC----ceEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR----EMIL  346 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~l  346 (613)
                      .++|...++||+|+||.||+|+..+  ..||||++.... .....+..|+.++++++|||||++++++.+..    .+++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEETT--EEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEECC--CEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            3578888899999999999998873  789999997543 23445677999999999999999999998754    3799


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------CCCCcEEeccCCCCceeeCCCCcEEE
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG----------ANHAVIIHRDVKTTNILLDEKWVAKV  416 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~~iiHrDlk~~NILl~~~~~~kl  416 (613)
                      ||||+++|+|.+++..   ..++|..++.++.|+++||.|||+.          +    |+||||||+|||++.++.+||
T Consensus       100 v~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~----ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA----ISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             EEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE----EECSCCSGGGEEECTTCCEEE
T ss_pred             EEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC----EEeCCCChHhEEECCCCeEEE
Confidence            9999999999999954   3499999999999999999999998          6    999999999999999999999


Q ss_pred             EecCCCccC----------CCCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhh-----
Q 048439          417 SDFGLSKFG----------PTSVSKTHLDPEYYRL-----QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV-----  476 (613)
Q Consensus       417 ~DFGls~~~----------~~~~~~~~~aPE~~~~-----~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~-----  476 (613)
                      +|||+++..          ...++..|+|||++.+     ..++.++|||||||+||||++|++||.........     
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            999999531          1245778999999987     35567899999999999999999998653221111     


Q ss_pred             -----hHHHHHHHhhccC---Ccccccc------HHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          477 -----SLAVWAQQCYQNG---TIDQIVD------PFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       477 -----~l~~~~~~~~~~~---~~~~~~d------~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                           ....+........   .+.....      .+.. ..+||+.||++|||+.||++.|+...+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                 1112222211111   1111110      0111 237999999999999999999986544

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-41  Score=353.12  Aligned_cols=242  Identities=23%  Similarity=0.301  Sum_probs=200.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|+...+++.||+|+++...   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56888889999999999999998888999999997542   234567889999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+++|+|.+++..  ...+++..+..++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..   
T Consensus        86 e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~----ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           86 DYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTT----EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            99999999999954  356899999999999999999999998    999999999999999999999999999643   


Q ss_pred             --CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--H
Q 048439          426 --PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--A  501 (613)
Q Consensus       426 --~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~  501 (613)
                        ...++..|+|||.+.+..++.++|||||||+||||++|++||.............     .....+....++.+.  .
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-----~~~~~~p~~~~~~~~~li  234 (318)
T 1fot_A          160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL-----NAELRFPPFFNEDVKDLL  234 (318)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----HCCCCCCTTSCHHHHHHH
T ss_pred             cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hCCCCCCCCCCHHHHHHH
Confidence              2356788999999999999999999999999999999999997654332211111     111112222222222  2


Q ss_pred             hcccccCCCCCC-----CHHHHHHHHHH
Q 048439          502 MSCLNDEGIRRP-----SMSDVVWGLEF  524 (613)
Q Consensus       502 ~~Cl~~~p~~RP-----s~~evl~~Le~  524 (613)
                      .+||..||.+||     ++.|++++..+
T Consensus       235 ~~lL~~dp~~R~~~~~~~~~~i~~hp~f  262 (318)
T 1fot_A          235 SRLITRDLSQRLGNLQNGTEDVKNHPWF  262 (318)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             HHHhccCHHHcCCCcCCCHHHHhcCccc
Confidence            279999999999     89999876654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-41  Score=352.37  Aligned_cols=252  Identities=24%  Similarity=0.388  Sum_probs=198.6

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEc-----CCceeEEEEEeCCC-ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCC
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFIN-----GSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDR  342 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~-----~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~  342 (613)
                      ..++|...+.||+|+||.||+|+..     +.+..||||++... .......+.+|+.++.++ +||||+++++++.+.+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            4577888899999999999999972     34568999999764 334556799999999999 8999999999999999


Q ss_pred             ceEEEEEcCCCCChhHHhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccC
Q 048439          343 EMILVYDFMARGTLPDHLYHSDN---------------------PPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDV  401 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDl  401 (613)
                      ..++||||+++|+|.+++.....                     ..+++..++.++.|++.||.|||+.+    |+||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----ivH~Di  198 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS----CVHRDL  198 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT----EEETTC
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC----cccCCC
Confidence            99999999999999999965432                     34899999999999999999999998    999999


Q ss_pred             CCCceeeCCCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccch
Q 048439          402 KTTNILLDEKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRT  470 (613)
Q Consensus       402 k~~NILl~~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~  470 (613)
                      ||+|||++.++.+||+|||+++...          ..++..|+|||.+....++.++|||||||+||||++ |+.||...
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            9999999999999999999986421          122446999999999999999999999999999998 99999654


Q ss_pred             hhhhhhhHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          471 AAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       471 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      .....  ..................+.+.. ..+||+.||.+||++.+|+++|+..+.
T Consensus       279 ~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          279 PVDAN--FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             CCSHH--HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CcHHH--HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            33221  11111111111111122222222 237999999999999999999996554

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.6e-41  Score=354.11  Aligned_cols=246  Identities=23%  Similarity=0.361  Sum_probs=195.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCcee----EEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTP----VAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~----vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ++|...++||+|+||.||+|++..++..    ||+|.+.... ......+.+|+.++++++||||++++++|. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            4677788999999999999998766554    8888875442 334456789999999999999999999986 456899


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++...
T Consensus        92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG----MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT----CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC----CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999999643 457999999999999999999999998    9999999999999999999999999997532


Q ss_pred             ----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCc-ccc
Q 048439          427 ----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTI-DQI  494 (613)
Q Consensus       427 ----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~-~~~  494 (613)
                                ..++..|+|||.+..+.++.++|||||||+||||++ |+.||......+................. .++
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV  246 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTT
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHH
Confidence                      123457999999999999999999999999999999 99999765433322222111111111111 122


Q ss_pred             ccHHHHHhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          495 VDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       495 ~d~~~~~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      .+ +  ..+||+.+|.+||++.+++++|+...
T Consensus       247 ~~-l--i~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          247 YM-V--MVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             TH-H--HHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             HH-H--HHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            22 2  23699999999999999999998654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-41  Score=355.52  Aligned_cols=255  Identities=22%  Similarity=0.263  Sum_probs=199.2

Q ss_pred             HHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC-----ChhcHHHHHHHHHHHhccCccceeeEEEEeec
Q 048439          266 EIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE-----SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND  340 (613)
Q Consensus       266 el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~  340 (613)
                      ++....++|...+.||+|+||.||+|+...++..||||++...     .....+.+.+|+.++++++||||++++++|.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            3566778899999999999999999999888889999998643     33456789999999999999999999999999


Q ss_pred             CCceEEEEEcCCCCChhHHhhcC--------------------------------------CCCCCCHHHHHHHHHHHHH
Q 048439          341 DREMILVYDFMARGTLPDHLYHS--------------------------------------DNPPLPWNQRLEICIGAAR  382 (613)
Q Consensus       341 ~~~~~lV~Ey~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~  382 (613)
                      .+..++||||+++|+|.+++...                                      ....+++..++.|+.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999998420                                      0122467788899999999


Q ss_pred             HHHHHhcCCCCCcEEeccCCCCceeeCCCC--cEEEEecCCCcc------------CCCCCCcccCChhhhhc--CCCCc
Q 048439          383 GLHYLHTGANHAVIIHRDVKTTNILLDEKW--VAKVSDFGLSKF------------GPTSVSKTHLDPEYYRL--QQLTE  446 (613)
Q Consensus       383 gL~yLH~~~~~~~iiHrDlk~~NILl~~~~--~~kl~DFGls~~------------~~~~~~~~~~aPE~~~~--~~~t~  446 (613)
                      ||+|||+.+    |+||||||+|||++.++  .+||+|||+++.            ....++..|+|||.+..  ..++.
T Consensus       180 ~l~~LH~~~----ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          180 ALHYLHNQG----ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHHHTT----EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHHHCC----ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence            999999998    99999999999998776  899999999863            12345778999999975  67899


Q ss_pred             hhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          447 KSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       447 ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ++|||||||+||||++|+.||......+...................+.+.... ..+||+.+|.+||++.|++++...
T Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~  334 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI  334 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHH
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhh
Confidence            999999999999999999999765443322211111101111111111122222 227999999999999999987654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.6e-41  Score=344.58  Aligned_cols=248  Identities=23%  Similarity=0.354  Sum_probs=192.2

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCC---ceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGS---TTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~---~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      .++|...+.||+|+||.||+|.+..+   +..||||.+... .....+.|.+|+.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            35778888999999999999998543   356999998764 3445567999999999999999999999985 467899


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++...
T Consensus        93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC----eecccccHHHEEECCCCCEEECccccccccC
Confidence            99999999999999643 456999999999999999999999998    9999999999999999999999999986432


Q ss_pred             ---------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCcccccc
Q 048439          427 ---------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVD  496 (613)
Q Consensus       427 ---------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  496 (613)
                               ..++..|+|||.+....++.++|||||||++|||++ |++||......+..   ..............+.+
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~  244 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENGERLPMPPNCPP  244 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHTTCCCCCCTTCCH
T ss_pred             cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---HHHHcCCCCCCCCCCCH
Confidence                     123456999999999999999999999999999996 99999755433322   11111111111122222


Q ss_pred             HHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          497 PFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       497 ~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      .+.. ..+||+.+|.+||++.|+++.|+..++
T Consensus       245 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          245 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            2222 237999999999999999999997654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3e-41  Score=367.06  Aligned_cols=249  Identities=16%  Similarity=0.195  Sum_probs=199.9

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ..++|...+.||+|+||.||+|....++..+|+|++....  ....+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            3567888899999999999999998888999999987643  34456789999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC---CCCcEEEEecCCCcc
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD---EKWVAKVSDFGLSKF  424 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGls~~  424 (613)
                      ||||++|+|.+.+..  ...+++..+..++.|++.||.|||+.+    |+||||||+|||++   +++.+||+|||+++.
T Consensus        89 ~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~g----ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999999865  356999999999999999999999998    99999999999998   568899999999964


Q ss_pred             CC--------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccccc
Q 048439          425 GP--------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVD  496 (613)
Q Consensus       425 ~~--------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  496 (613)
                      ..        ..++..|+|||++....++.++|||||||+||||++|++||......+...................+.+
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  242 (444)
T 3soa_A          163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP  242 (444)
T ss_dssp             CCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             ecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence            22        2467789999999999999999999999999999999999976543332221111111111111122222


Q ss_pred             HHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          497 PFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       497 ~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .... ..+||+.||.+||++.|++++...
T Consensus       243 ~~~~li~~~L~~dP~~Rpta~e~L~hp~~  271 (444)
T 3soa_A          243 EAKDLINKMLTINPSKRITAAEALKHPWI  271 (444)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHHSCTT
T ss_pred             HHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence            2222 227999999999999999976543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.3e-41  Score=346.89  Aligned_cols=251  Identities=22%  Similarity=0.404  Sum_probs=201.5

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEE-----cCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFI-----NGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDRE  343 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~-----~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~  343 (613)
                      .++|...+.||+|+||.||+|+.     ..++..||||+++... ....+.+.+|+.+++++ +||||++++++|.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            35788888999999999999986     3456789999998654 34456799999999999 99999999999999999


Q ss_pred             eEEEEEcCCCCChhHHhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCcee
Q 048439          344 MILVYDFMARGTLPDHLYHSDN----------------PPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNIL  407 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NIL  407 (613)
                      .++||||+++|+|.+++.....                ..+++.+++.++.|+++||.|||+.+    |+||||||+|||
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dlkp~Nil  177 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN----CIHRDLAARNIL  177 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCccceEE
Confidence            9999999999999999965432                25999999999999999999999998    999999999999


Q ss_pred             eCCCCcEEEEecCCCccCCC----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhh
Q 048439          408 LDEKWVAKVSDFGLSKFGPT----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQV  476 (613)
Q Consensus       408 l~~~~~~kl~DFGls~~~~~----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~  476 (613)
                      ++.++.+||+|||+++....          .++..|+|||.+....++.++|||||||+||||++ |++||.........
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            99999999999999874321          12346999999999999999999999999999999 99998654332221


Q ss_pred             hHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          477 SLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       477 ~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                        .................+.+.. ..+||+.||.+||++.|+++.|+..++
T Consensus       258 --~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          258 --YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             --HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence              1111111111111222222222 227999999999999999999986654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.8e-41  Score=345.02  Aligned_cols=243  Identities=22%  Similarity=0.304  Sum_probs=190.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh--------------------------hcHHHHHHHHHHHhc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ--------------------------QGALEFQTEIGMLSQ  325 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~--------------------------~~~~~f~~Ei~~l~~  325 (613)
                      ++|...+.||+|+||.||+|+...++..||||++.....                          ...+.+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            578888899999999999999988889999999865421                          123468999999999


Q ss_pred             cCccceeeEEEEeec--CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCC
Q 048439          326 LRHLHLVSLIGFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKT  403 (613)
Q Consensus       326 l~H~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~  403 (613)
                      ++||||+++++++.+  .+..++||||+++|+|.+++   ....+++.+++.++.|+++||+|||+.+    |+||||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~Dlkp  165 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHYQK----IIHRDIKP  165 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC----eeccCCCH
Confidence            999999999999986  56789999999999998865   3457999999999999999999999998    99999999


Q ss_pred             CceeeCCCCcEEEEecCCCccC--------CCCCCcccCChhhhhcCC---CCchhHHHHHHHHHHHHHhCCCCccchhh
Q 048439          404 TNILLDEKWVAKVSDFGLSKFG--------PTSVSKTHLDPEYYRLQQ---LTEKSDVYSFGVVLFEVLCARPSILRTAA  472 (613)
Q Consensus       404 ~NILl~~~~~~kl~DFGls~~~--------~~~~~~~~~aPE~~~~~~---~t~ksDV~SfGvvL~elltg~~p~~~~~~  472 (613)
                      +|||++.++.+||+|||+++..        ...++..|+|||.+....   .+.++|||||||+||||++|+.||.....
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            9999999999999999998642        234677899999998765   37899999999999999999999975433


Q ss_pred             hhhhhHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          473 KKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       473 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ......  .............+.+.+.. ..+||+.||.+||++.|++++..
T Consensus       246 ~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~  295 (298)
T 2zv2_A          246 MCLHSK--IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW  295 (298)
T ss_dssp             HHHHHH--HHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred             HHHHHH--HhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence            221111  11111111111122222222 23799999999999999987654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.3e-41  Score=343.89  Aligned_cols=247  Identities=18%  Similarity=0.249  Sum_probs=200.4

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      .++|...+.||+|+||.||+|....++..||+|++........+.+.+|++++++++||||++++++|.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            45688888999999999999999988889999999876666678899999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee---CCCCcEEEEecCCCccC--
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSKFG--  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGls~~~--  425 (613)
                      +++++|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||+   +.++.+||+|||++...  
T Consensus        88 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           88 CTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            999999998854  356899999999999999999999998    9999999999999   88899999999998642  


Q ss_pred             -----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCC--ccccccHH
Q 048439          426 -----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT--IDQIVDPF  498 (613)
Q Consensus       426 -----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~d~~  498 (613)
                           ...++..|+|||.+.+ .++.++|||||||++|||++|+.||......+.....  .........  ...+.+..
T Consensus       162 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  238 (277)
T 3f3z_A          162 GKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPEKDWLNVSPQA  238 (277)
T ss_dssp             TSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCCCCCCHHHHTTSCHHH
T ss_pred             ccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH--HhCCCCCCchhhhcCCHHH
Confidence                 2345778999999865 4899999999999999999999999765433221111  111000000  00111111


Q ss_pred             HH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          499 LK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       499 ~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      .. ..+||+.+|.+||++.+++++..+.-
T Consensus       239 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          239 ESLIRRLLTKSPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence            11 22799999999999999997766533

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.8e-41  Score=350.43  Aligned_cols=248  Identities=17%  Similarity=0.138  Sum_probs=198.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ++|...+.||+|+||.||+|+...++..||||.+.....  ...+.+|+.+++++ +|+||+++++++.+.+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            578888899999999999999988889999999875432  23588999999999 999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc-----EEEEecCCCccC
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV-----AKVSDFGLSKFG  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~-----~kl~DFGls~~~  425 (613)
                      + +|+|.+++... ...+++..++.|+.|++.||+|||+.+    |+||||||+|||++.++.     +||+|||+++..
T Consensus        87 ~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~----iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           87 L-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN----LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC----eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            9 99999998653 457999999999999999999999998    999999999999999887     999999999631


Q ss_pred             ---------------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCC
Q 048439          426 ---------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT  490 (613)
Q Consensus       426 ---------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~  490 (613)
                                     ...++..|+|||++.+..++.++|||||||+||||++|+.||.......................
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  240 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP  240 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence                           23457789999999999999999999999999999999999976433222211111111110000


Q ss_pred             c----cccccHHHHHhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          491 I----DQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       491 ~----~~~~d~~~~~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      .    ....+.......||+.+|.+||++.+|++.|+..++
T Consensus       241 ~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          241 IEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             HHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence            0    011111111237999999999999999998885543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.2e-41  Score=355.28  Aligned_cols=250  Identities=16%  Similarity=0.184  Sum_probs=193.9

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCC-----ceeEEEEEeCCCChhcH-----------HHHHHHHHHHhccCccceee
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGS-----TTPVAIKRLEPESQQGA-----------LEFQTEIGMLSQLRHLHLVS  333 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~-----~~~vAVK~~~~~~~~~~-----------~~f~~Ei~~l~~l~H~niv~  333 (613)
                      ..++|...+.||+|+||.||+|.+..+     +..||||++........           ..+..|+..+..++|+||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            346788889999999999999998664     47799999876542211           22445667778889999999


Q ss_pred             EEEEeecC----CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC
Q 048439          334 LIGFCNDD----REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD  409 (613)
Q Consensus       334 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~  409 (613)
                      +++++...    ...+|||||+ +|+|.+++.. ....+++.+++.|+.|++.||+|||+.+    |+||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~----iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEHE----YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC----eEEecCCHHHEEEe
Confidence            99998764    4489999999 9999999865 3467999999999999999999999998    99999999999999


Q ss_pred             --CCCcEEEEecCCCccC---------------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhh
Q 048439          410 --EKWVAKVSDFGLSKFG---------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAA  472 (613)
Q Consensus       410 --~~~~~kl~DFGls~~~---------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~  472 (613)
                        .++.+||+|||+++..               ...++..|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999531               11267789999999999999999999999999999999999975432


Q ss_pred             hhhhh----------HHHHHHHhhccCCccccccHHHHHhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          473 KKQVS----------LAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       473 ~~~~~----------l~~~~~~~~~~~~~~~~~d~~~~~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      .....          +..+...+.........+..+  ...||+.+|.+||++.+|++.|+..++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l--i~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          267 DPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKY--METVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             CHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHH--HHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHH--HHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            22111          111111111111111111111  227999999999999999999987665

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.4e-40  Score=335.97  Aligned_cols=247  Identities=20%  Similarity=0.305  Sum_probs=197.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecC--CceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD--REMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV  347 (613)
                      ++|...+.||+|+||.||+|++.  +..||||++...  .....+.|.+|+.++++++||||++++++|.+.  +..++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            46778889999999999999986  367999999765  344566799999999999999999999999887  788999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc---
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF---  424 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~---  424 (613)
                      |||+++|+|.+++.......+++.+++.++.|++.||.|||+.+.  +|+||||||+|||+++++.+||+|||++..   
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP--LIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSS--CCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--ceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            999999999999976655679999999999999999999998652  389999999999999999999998887643   


Q ss_pred             CCCCCCcccCChhhhhcCCCCc---hhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          425 GPTSVSKTHLDPEYYRLQQLTE---KSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       425 ~~~~~~~~~~aPE~~~~~~~t~---ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                      ....++..|+|||.+.+...+.   ++|||||||++|||++|+.||..........  ........ .......++.+. 
T Consensus       166 ~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~  242 (271)
T 3kmu_A          166 PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM--KVALEGLR-PTIPPGISPHVSK  242 (271)
T ss_dssp             TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH--HHHHSCCC-CCCCTTCCHHHHH
T ss_pred             cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH--HHHhcCCC-CCCCCCCCHHHHH
Confidence            2334577899999998765544   8999999999999999999996544332211  11111111 112222222222 


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                       ..+||+.||.+||++.|+++.|+..
T Consensus       243 li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          243 LMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHHHh
Confidence             2279999999999999999998854

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.9e-41  Score=358.07  Aligned_cols=209  Identities=22%  Similarity=0.253  Sum_probs=184.1

Q ss_pred             cccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC-----ccceeeE
Q 048439          260 TQFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-----HLHLVSL  334 (613)
Q Consensus       260 ~~f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-----H~niv~l  334 (613)
                      ..|++.+.....++|...+.||+|+||.||+|+...++..||||+++.. ......+..|+.++.+++     |+||+++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            3466666666778999999999999999999999888889999999753 344556788999999986     9999999


Q ss_pred             EEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC----
Q 048439          335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE----  410 (613)
Q Consensus       335 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~----  410 (613)
                      ++++...+..++||||+ +++|.+++.......+++..++.++.|++.||+|||+.+    |+||||||+|||++.    
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS----LTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEESCTTCC
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeeCCCCcccEEEcccccc
Confidence            99999999999999999 899999997766667999999999999999999999998    999999999999986    


Q ss_pred             ---------------------CCcEEEEecCCCccC-----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCC
Q 048439          411 ---------------------KWVAKVSDFGLSKFG-----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR  464 (613)
Q Consensus       411 ---------------------~~~~kl~DFGls~~~-----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~  464 (613)
                                           ++.+||+|||+++..     ...++..|+|||++.+..++.++|||||||+||||++|+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  256 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS  256 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence                                 789999999999742     234577899999999999999999999999999999999


Q ss_pred             CCccchhhhh
Q 048439          465 PSILRTAAKK  474 (613)
Q Consensus       465 ~p~~~~~~~~  474 (613)
                      +||......+
T Consensus       257 ~pf~~~~~~~  266 (360)
T 3llt_A          257 LLFRTHEHME  266 (360)
T ss_dssp             CSCCCSSHHH
T ss_pred             CCCCCCcHHH
Confidence            9997654433

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.6e-41  Score=370.60  Aligned_cols=246  Identities=28%  Similarity=0.439  Sum_probs=198.2

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      .++|...+.||+|+||.||+|.+.++ ..||||+++... ...++|.+|+.+|++++||||++++++|.+ +..++||||
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            45677888999999999999999875 569999998654 345689999999999999999999999976 678999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      |++|+|.+++.......+++.+++.++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+++...    
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            99999999996433456999999999999999999999998    9999999999999999999999999997532    


Q ss_pred             -----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          427 -----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                           ..++..|+|||.+..+.++.++|||||||+||||++ |+.||......+....   ............+.+.+..
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~---i~~~~~~~~~~~~~~~l~~  412 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VERGYRMPCPPECPESLHD  412 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---HHTTCCCCCCTTSCHHHHH
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHcCCCCCCCCCCCHHHHH
Confidence                 123456999999999999999999999999999999 9999965543332211   1111111112222222222


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                       ..+||+.+|++||++.+|++.|+...
T Consensus       413 li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          413 LMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHh
Confidence             23799999999999999999998544

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.9e-41  Score=349.98  Aligned_cols=252  Identities=22%  Similarity=0.399  Sum_probs=201.6

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEc-------CCceeEEEEEeCCC-ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecC
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFIN-------GSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDD  341 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~-------~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~  341 (613)
                      .++|...+.||+|+||.||+|+..       .++..||||+++.. .......+.+|+.+++++ +||||++++++|.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            367888889999999999999985       24467999999765 344567799999999999 899999999999999


Q ss_pred             CceEEEEEcCCCCChhHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCcee
Q 048439          342 REMILVYDFMARGTLPDHLYHSDN--------------PPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNIL  407 (613)
Q Consensus       342 ~~~~lV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NIL  407 (613)
                      +..++||||+++|+|.+++.....              ..+++.+++.++.|++.||.|||+.+    |+||||||+|||
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dlkp~NIl  189 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK----CIHRDLAARNVL  189 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC----eeCCCCccceEE
Confidence            999999999999999999965331              34899999999999999999999998    999999999999


Q ss_pred             eCCCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhh
Q 048439          408 LDEKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQV  476 (613)
Q Consensus       408 l~~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~  476 (613)
                      ++.++.+||+|||+++...          ..++..|+|||++.+..++.++|||||||+||||++ |+.||......+..
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  269 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  269 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence            9999999999999986422          123456999999999999999999999999999999 99999655433221


Q ss_pred             hHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhhhh
Q 048439          477 SLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQLQ  529 (613)
Q Consensus       477 ~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~~  529 (613)
                         ..............+.+.+.. ..+||+.+|.+||++.|+++.|+..++..
T Consensus       270 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          270 ---KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             ---HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence               111111111111222222222 23799999999999999999999876643

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.7e-41  Score=353.81  Aligned_cols=247  Identities=21%  Similarity=0.282  Sum_probs=188.8

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ..++|...+.||+|+||.||+|+...++..||||+++...  ..+.+.+|+.++++++||||++++++|.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3567888899999999999999998888899999997643  34568899999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC---CCcEEEEecCCCccCC
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE---KWVAKVSDFGLSKFGP  426 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGls~~~~  426 (613)
                      |+++|+|.+++..  ...+++.+++.++.|++.||.|||+.+    |+||||||+|||++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~----ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999999843  456999999999999999999999998    999999999999975   8999999999987422


Q ss_pred             -------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhh--ccCCccccccH
Q 048439          427 -------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCY--QNGTIDQIVDP  497 (613)
Q Consensus       427 -------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~--~~~~~~~~~d~  497 (613)
                             ..++..|+|||++.+..++.++|||||||+||||++|+.||......... .........  .......+...
T Consensus       203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~  281 (349)
T 2w4o_A          203 HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM-FRRILNCEYYFISPWWDEVSLN  281 (349)
T ss_dssp             ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH-HHHHHTTCCCCCTTTTTTSCHH
T ss_pred             cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH-HHHHHhCCCccCCchhhhCCHH
Confidence                   23577899999999999999999999999999999999999654432211 111111000  01111222222


Q ss_pred             HHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          498 FLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       498 ~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ... ..+||+.||++||++.|++++....
T Consensus       282 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  310 (349)
T 2w4o_A          282 AKDLVRKLIVLDPKKRLTTFQALQHPWVT  310 (349)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence            222 2389999999999999999876543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=364.66  Aligned_cols=257  Identities=19%  Similarity=0.199  Sum_probs=205.2

Q ss_pred             cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEe
Q 048439          262 FSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFC  338 (613)
Q Consensus       262 f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~  338 (613)
                      +.+.++....++|...++||+|+||+||+|+...+++.||||+++...   ......+.+|+.++.+++|+||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            456677777899999999999999999999998888999999997532   22334588999999999999999999999


Q ss_pred             ecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEe
Q 048439          339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSD  418 (613)
Q Consensus       339 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~D  418 (613)
                      .+.+.++||||||++|+|.+++... ...+++..+..++.|++.||+|||+.+    |+||||||+|||++.++.+||+|
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g----iiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLG----YVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC----eeecccCHHHeeecCCCCEEEee
Confidence            9999999999999999999999642 346999999999999999999999998    99999999999999999999999


Q ss_pred             cCCCccC---------CCCCCcccCChhhhh-------cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHH
Q 048439          419 FGLSKFG---------PTSVSKTHLDPEYYR-------LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWA  482 (613)
Q Consensus       419 FGls~~~---------~~~~~~~~~aPE~~~-------~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~  482 (613)
                      ||+++..         ...++..|+|||++.       ...++.++|||||||+||||++|++||......+....+...
T Consensus       206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  285 (412)
T 2vd5_A          206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY  285 (412)
T ss_dssp             CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred             chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            9998642         135678899999997       357899999999999999999999999765544432222211


Q ss_pred             HHhhccCCccccccHHHH--HhcccccCCCCC---CCHHHHHHHHHH
Q 048439          483 QQCYQNGTIDQIVDPFLK--AMSCLNDEGIRR---PSMSDVVWGLEF  524 (613)
Q Consensus       483 ~~~~~~~~~~~~~d~~~~--~~~Cl~~~p~~R---Ps~~evl~~Le~  524 (613)
                      ............+.+...  ..+||. +|.+|   |++.|++++..+
T Consensus       286 ~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff  331 (412)
T 2vd5_A          286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF  331 (412)
T ss_dssp             HHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred             ccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence            111111111112222222  227888 89888   699999877664

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.8e-41  Score=358.70  Aligned_cols=248  Identities=23%  Similarity=0.291  Sum_probs=196.1

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l  346 (613)
                      .++|...++||+|+||+||+|+...++..||||+++...   ......+.+|..+|.++ +|||||++++++.+.+.++|
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            357888899999999999999999888999999997542   23344688999999887 89999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-  425 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-  425 (613)
                      |||||++|+|.+++..  ...+++..+..++.||+.||.|||+.+    |+||||||+||||+.++.+||+|||+++.. 
T Consensus       131 V~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g----ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            9999999999999854  356999999999999999999999998    999999999999999999999999999742 


Q ss_pred             -------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhh---hhHH-HHHHHhhccCCcccc
Q 048439          426 -------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQ---VSLA-VWAQQCYQNGTIDQI  494 (613)
Q Consensus       426 -------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~---~~l~-~~~~~~~~~~~~~~~  494 (613)
                             ...++..|+|||++.+..++.++|||||||+||||++|++||......+.   .... ...........+...
T Consensus       205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~  284 (396)
T 4dc2_A          205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS  284 (396)
T ss_dssp             CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred             cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence                   23467789999999999999999999999999999999999964321110   0000 111111111122222


Q ss_pred             ccHHHH--HhcccccCCCCCCCH------HHHHHHHHH
Q 048439          495 VDPFLK--AMSCLNDEGIRRPSM------SDVVWGLEF  524 (613)
Q Consensus       495 ~d~~~~--~~~Cl~~~p~~RPs~------~evl~~Le~  524 (613)
                      +++...  ..+||+.||.+||++      .||+++..+
T Consensus       285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff  322 (396)
T 4dc2_A          285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF  322 (396)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred             CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence            332222  227999999999985      677665543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-40  Score=340.57  Aligned_cols=247  Identities=30%  Similarity=0.451  Sum_probs=195.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhc-------HHHHHHHHHHHhccCccceeeEEEEeecCCce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQG-------ALEFQTEIGMLSQLRHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~-------~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~  344 (613)
                      ++|...+.||+|+||.||+|++..++..||||++.......       .+.|.+|+.++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            57888889999999999999998888999999986543221       267899999999999999999999997665  


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc-----EEEEec
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV-----AKVSDF  419 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~-----~kl~DF  419 (613)
                      ++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+.  +|+||||||+|||++.++.     +||+||
T Consensus        97 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNP--PIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTSSS--CCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhCCC--CeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            799999999999998865 34579999999999999999999998762  2899999999999988776     999999


Q ss_pred             CCCccCC-----CCCCcccCChhhhh--cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcc
Q 048439          420 GLSKFGP-----TSVSKTHLDPEYYR--LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID  492 (613)
Q Consensus       420 Gls~~~~-----~~~~~~~~aPE~~~--~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  492 (613)
                      |+++...     ..++..|+|||.+.  ...++.++|||||||++|||++|+.||............. ...........
T Consensus       174 g~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~  252 (287)
T 4f0f_A          174 GLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM-IREEGLRPTIP  252 (287)
T ss_dssp             TTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH-HHHSCCCCCCC
T ss_pred             CccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH-HhccCCCCCCC
Confidence            9997432     34567899999984  4567899999999999999999999996544332221222 11111111222


Q ss_pred             ccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          493 QIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       493 ~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ....+.+.  ..+||+.||.+||++.|+++.|+.
T Consensus       253 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          253 EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            22222222  227999999999999999998873

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=8e-42  Score=359.75  Aligned_cols=245  Identities=22%  Similarity=0.289  Sum_probs=200.0

Q ss_pred             HHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCc
Q 048439          268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDRE  343 (613)
Q Consensus       268 ~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~  343 (613)
                      ....++|...++||+|+||.||+|+...+++.||||+++...   ......+..|..++.++ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678999999999999999999999888999999997542   33456688999999887 89999999999999999


Q ss_pred             eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCc
Q 048439          344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK  423 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~  423 (613)
                      +++||||+++|+|.+++..  ...+++.++..++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++
T Consensus        93 ~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~----ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            9999999999999999954  346999999999999999999999998    9999999999999999999999999987


Q ss_pred             cC--------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          424 FG--------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       424 ~~--------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                      ..        ...++..|+|||++.+..++.++|||||||++|||++|++||......+......     .....+...+
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~-----~~~~~~p~~~  241 (345)
T 1xjd_A          167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-----MDNPFYPRWL  241 (345)
T ss_dssp             CCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HCCCCCCTTS
T ss_pred             hcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-----hCCCCCCccc
Confidence            42        2346778999999999999999999999999999999999997654433222111     1112222223


Q ss_pred             cHHHH--HhcccccCCCCCCCHH-HHHHHHH
Q 048439          496 DPFLK--AMSCLNDEGIRRPSMS-DVVWGLE  523 (613)
Q Consensus       496 d~~~~--~~~Cl~~~p~~RPs~~-evl~~Le  523 (613)
                      ++.+.  ..+||..||.+||++. |++++..
T Consensus       242 s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~  272 (345)
T 1xjd_A          242 EKEAKDLLVKLFVREPEKRLGVRGDIRQHPL  272 (345)
T ss_dssp             CHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred             CHHHHHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence            33222  2279999999999997 7765544

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1e-40  Score=340.08  Aligned_cols=248  Identities=19%  Similarity=0.258  Sum_probs=199.6

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      .++|...+.||+|+||.||+|....++..||+|++...  .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            46788889999999999999999888889999998654  3445567899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc---EEEEecCCCccC
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV---AKVSDFGLSKFG  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFGls~~~  425 (613)
                      ||+++|+|.+.+..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999998854  356999999999999999999999998    999999999999986655   999999998542


Q ss_pred             -------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          426 -------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       426 -------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                             ...++..|+|||.+.+..++.++||||||+++|||++|+.||..........................+.+..
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             CSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             ccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence                   2345678999999999999999999999999999999999997654333221111111001111111222222


Q ss_pred             HH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          499 LK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       499 ~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .. ..+||+.+|++||++.|++++...
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~  265 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRITADQALKVPWI  265 (284)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred             HHHHHHHcccChhhCCCHHHHhcCccc
Confidence            22 227999999999999999977654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.8e-41  Score=356.42  Aligned_cols=242  Identities=21%  Similarity=0.263  Sum_probs=199.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|+...++..||||+++...   ......+.+|+.+|++++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            56888889999999999999998888999999986542   234567899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+++|+|.+++..  ...+++..++.++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++..   
T Consensus       121 e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~----ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----cccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999999954  346999999999999999999999998    999999999999999999999999999743   


Q ss_pred             --CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--H
Q 048439          426 --PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--A  501 (613)
Q Consensus       426 --~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~  501 (613)
                        ...++..|+|||++.+..++.++|||||||+||||++|++||......+......  .   ....+...+++.+.  .
T Consensus       195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--~---~~~~~p~~~~~~~~~li  269 (350)
T 1rdq_E          195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV--S---GKVRFPSHFSSDLKDLL  269 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--H---CCCCCCTTCCHHHHHHH
T ss_pred             cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH--c---CCCCCCCCCCHHHHHHH
Confidence              2345778999999999999999999999999999999999997654332211111  1   11112222222222  2


Q ss_pred             hcccccCCCCCCC-----HHHHHHHHHH
Q 048439          502 MSCLNDEGIRRPS-----MSDVVWGLEF  524 (613)
Q Consensus       502 ~~Cl~~~p~~RPs-----~~evl~~Le~  524 (613)
                      .+||+.||.+||+     +.||+++..+
T Consensus       270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f  297 (350)
T 1rdq_E          270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF  297 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             HHHhhcCHHhccCCccCCHHHHHhCcCc
Confidence            2799999999998     8888876654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.9e-41  Score=349.34  Aligned_cols=253  Identities=24%  Similarity=0.372  Sum_probs=201.4

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCCc-----eeEEEEEeCCCC-hhcHHHHHHHHHHHhcc-CccceeeEEEEeecC
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGST-----TPVAIKRLEPES-QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDD  341 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~~-----~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~  341 (613)
                      ...++|...+.||+|+||.||+|.....+     ..||||.+.... ......+.+|+.+++++ +||||++++++|.+.
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            34578888899999999999999986544     369999997653 34566799999999999 899999999999999


Q ss_pred             CceEEEEEcCCCCChhHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC
Q 048439          342 REMILVYDFMARGTLPDHLYHSD------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD  409 (613)
Q Consensus       342 ~~~~lV~Ey~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~  409 (613)
                      +..++||||+++|+|.+++....            ...+++..++.++.|++.||.|||+.+    |+||||||+|||++
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN----CIHRDVAARNVLLT  198 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGCEEE
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC----cccCCcccceEEEC
Confidence            99999999999999999985421            346899999999999999999999998    99999999999999


Q ss_pred             CCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhH
Q 048439          410 EKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSL  478 (613)
Q Consensus       410 ~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l  478 (613)
                      .++.+||+|||+++...          ..++..|+|||.+.+..++.++|||||||++|||++ |++||.........  
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--  276 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF--  276 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH--
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH--
Confidence            99999999999986421          122456999999999999999999999999999998 99998654332211  


Q ss_pred             HHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          479 AVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       479 ~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      .................+.+.. ..+||+.+|.+||++.||++.|+...+
T Consensus       277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence            1112211111111111122222 237999999999999999999986553

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.3e-41  Score=353.39  Aligned_cols=259  Identities=23%  Similarity=0.399  Sum_probs=206.2

Q ss_pred             cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEc-----CCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEE
Q 048439          262 FSLSEIQAATNNFDNDLVIGVGGFGDVYKGFIN-----GSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLI  335 (613)
Q Consensus       262 f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~-----~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~  335 (613)
                      +..++.+...++|...+.||+|+||.||+|+..     ..+..||||.+.... ......|.+|+.++++++|+||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            444455566788999999999999999999876     245779999997653 34556799999999999999999999


Q ss_pred             EEeecCCceEEEEEcCCCCChhHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCcee
Q 048439          336 GFCNDDREMILVYDFMARGTLPDHLYHS--------DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNIL  407 (613)
Q Consensus       336 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NIL  407 (613)
                      +++.+.+..++||||+++|+|.+++...        ....+++..++.++.|++.||.|||+.+    |+||||||+|||
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dikp~NIl  170 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK----FVHRDLAARNCM  170 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT----CBCSCCSGGGEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC----CccCCCccceEE
Confidence            9999999999999999999999998542        1256799999999999999999999998    999999999999


Q ss_pred             eCCCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhh
Q 048439          408 LDEKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQV  476 (613)
Q Consensus       408 l~~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~  476 (613)
                      ++.++.+||+|||+++...          ..++..|+|||.+.+..++.++|||||||+||||++ |++||.........
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  250 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL  250 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred             EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence            9999999999999986421          122456999999999999999999999999999999 88888654332211


Q ss_pred             hHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          477 SLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       477 ~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                         ..............+.+.... ..+||+.+|.+||++.|+++.|+..+.
T Consensus       251 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          251 ---RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             ---HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ---HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence               111111111111222222222 227999999999999999999986554

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.8e-41  Score=342.89  Aligned_cols=243  Identities=24%  Similarity=0.332  Sum_probs=200.3

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      .++|...+.||+|+||.||+|....++..||||++....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467888889999999999999999888899999986532   23356789999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--  425 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--  425 (613)
                      |||+++|+|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||++...  
T Consensus        88 ~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~----i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTT----CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            999999999999854  356899999999999999999999988    999999999999999999999999988542  


Q ss_pred             ----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          426 ----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                          ...++..|+|||.+.+..++.++||||||+++|||++|+.||......+......     .............+. 
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  236 (279)
T 3fdn_A          162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-----RVEFTFPDFVTEGARD  236 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----HTCCCCCTTSCHHHHH
T ss_pred             ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH-----hCCCCCCCcCCHHHHH
Confidence                2345678999999999999999999999999999999999997654433222111     111112222222222 


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHHH
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                       ..+||+.+|.+||++.|++++...
T Consensus       237 li~~~l~~~p~~Rps~~e~l~h~~~  261 (279)
T 3fdn_A          237 LISRLLKHNPSQRPMLREVLEHPWI  261 (279)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHHCHHH
T ss_pred             HHHHHhccChhhCCCHHHHhhCccc
Confidence             227999999999999999988764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.9e-40  Score=338.93  Aligned_cols=248  Identities=18%  Similarity=0.152  Sum_probs=198.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ++|...+.||+|+||.||+|+...++..||||++....  ....+.+|+.++.++ +|+|++++++++.+....++||||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   87 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   87 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence            56888889999999999999998888999999986543  233578999999999 799999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc-----EEEEecCCCccC
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV-----AKVSDFGLSKFG  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~-----~kl~DFGls~~~  425 (613)
                      + +|+|.+++... ...+++.+++.++.|++.||+|||+.+    |+||||||+|||++.++.     +||+|||+++..
T Consensus        88 ~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~----ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           88 L-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS----LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT----EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             c-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCC----EecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            9 99999999653 346999999999999999999999998    999999999999987776     999999998642


Q ss_pred             ---------------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCC
Q 048439          426 ---------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT  490 (613)
Q Consensus       426 ---------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~  490 (613)
                                     ...++..|+|||.+.+..++.++|||||||+||||++|+.||.......................
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  241 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence                           12356789999999999999999999999999999999999976432221111111111111011


Q ss_pred             c----cccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          491 I----DQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       491 ~----~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      .    ..+.+.+.. ..+||+.+|.+||++.+|++.|+..++
T Consensus       242 ~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          242 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            0    111222222 227999999999999999999986553

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-40  Score=348.67  Aligned_cols=248  Identities=29%  Similarity=0.502  Sum_probs=195.8

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCC----ceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGS----TTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~----~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      +|...++||+|+||.||+|+...+    +..||||+++.. .......|.+|+.++++++||||+++++++.+.+..++|
T Consensus        45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  124 (333)
T 1mqb_A           45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII  124 (333)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence            455567999999999999998643    245999999765 334456799999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT  427 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~  427 (613)
                      |||+++|+|.+++... ...+++.+++.++.|+++||.|||+.+    |+||||||+|||+++++.+||+|||+++....
T Consensus       125 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          125 TEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN----YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC----eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            9999999999998643 456999999999999999999999998    99999999999999999999999999864221


Q ss_pred             -----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          428 -----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       428 -----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                                 .++..|+|||.+....++.++|||||||+||||++ |+.||......+..   ..............+.
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~  276 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM---KAINDGFRLPTPMDCP  276 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHHTTCCCCCCTTCB
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH---HHHHCCCcCCCcccCC
Confidence                       12446999999999999999999999999999999 99999654432221   1111111111112222


Q ss_pred             cHHHH-HhcccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          496 DPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       496 d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                      +.+.. ..+||+.+|.+||++.++++.|+..++.
T Consensus       277 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          277 SAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            22222 2379999999999999999999876543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.2e-40  Score=346.26  Aligned_cols=249  Identities=22%  Similarity=0.311  Sum_probs=185.1

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      .++|...+.||+|+||.||+|....++..||||+++... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            457888889999999999999998888999999987653 3345678999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          350 FMARGTLPDHLYHS----DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      |++ |+|.+++...    ....+++..+..++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~----ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK----ILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC----eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            998 5999988532    2346999999999999999999999998    999999999999999999999999998642


Q ss_pred             --------CCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccC-------
Q 048439          426 --------PTSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG-------  489 (613)
Q Consensus       426 --------~~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-------  489 (613)
                              ...++..|+|||.+.+ ..++.++|||||||++|||++|++||......+...............       
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK  238 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred             CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence                    2245678999999976 468999999999999999999999997665444332221111000000       


Q ss_pred             ----------------------CccccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          490 ----------------------TIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       490 ----------------------~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                                            ......+..+.  ..+||+.||.+|||+.|++++..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f  297 (317)
T 2pmi_A          239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF  297 (317)
T ss_dssp             CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred             hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhh
Confidence                                  00001122222  227999999999999999876553

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2e-40  Score=341.01  Aligned_cols=250  Identities=26%  Similarity=0.389  Sum_probs=194.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEE----cCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecC--Cce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD--REM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~----~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~--~~~  344 (613)
                      ++|...+.||+|+||.||+|++    ..++..||||++.... ......+.+|+.++++++||||+++++++.+.  +..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            3477778999999999999994    4466889999998653 34557899999999999999999999999876  678


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQ----YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCC----cccCCCchheEEEcCCCCEEECccccccc
Confidence            9999999999999998543 356999999999999999999999998    99999999999999999999999999864


Q ss_pred             CC-----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhh---------hhhhHHHHHHH
Q 048439          425 GP-----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAK---------KQVSLAVWAQQ  484 (613)
Q Consensus       425 ~~-----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~---------~~~~l~~~~~~  484 (613)
                      ..           ..++..|+|||.+.+..++.++|||||||++|||++|+.|+......         ...........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            22           23345599999999999999999999999999999999986433211         01111111111


Q ss_pred             hh---ccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          485 CY---QNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       485 ~~---~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ..   .......+.+.+.. ..+||+.||.+||++.++++.|+..+
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            11   11111122222222 22799999999999999999998655

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-40  Score=336.15  Aligned_cols=244  Identities=27%  Similarity=0.445  Sum_probs=199.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||.||+|...++ ..||||++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTT-EEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEecCC-CeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            4677788999999999999998754 6799999986542 3467999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC------
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG------  425 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~------  425 (613)
                      ++|+|.+++... ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..      
T Consensus        86 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           86 EHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             TTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            999999999643 356899999999999999999999998    999999999999999999999999998642      


Q ss_pred             ---CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          426 ---PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       426 ---~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                         ...++..|+|||.+....++.++||||||+++|||++ |++||......+..   ........ .......+..+. 
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~i~~~~~-~~~~~~~~~~l~~  236 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---EDISTGFR-LYKPRLASTHVYQ  236 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHHTTCC-CCCCTTSCHHHHH
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH---HHHhcCCc-CCCCccCcHHHHH
Confidence               2233457999999999999999999999999999999 89998654332211   11111111 111222222222 


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                       ..+||+.+|.+||++.++++.|+...
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          237 IMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             23799999999999999999998654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.3e-41  Score=354.27  Aligned_cols=246  Identities=20%  Similarity=0.242  Sum_probs=197.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-----hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-----QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ++|...+.||+|+||.||+|+...+++.||||++....     ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            46888889999999999999998888999999986421     2245679999999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc---EEEEecCC
Q 048439          347 VYDFMARGTLPDHLYHS--DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV---AKVSDFGL  421 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFGl  421 (613)
                      |||||++|+|.+.+...  ....+++..++.++.|++.||+|||+.+    |+||||||+|||++.++.   +||+|||+
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~----ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC----ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            99999999999887542  3456899999999999999999999998    999999999999987654   99999999


Q ss_pred             CccC--------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccC--Cc
Q 048439          422 SKFG--------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG--TI  491 (613)
Q Consensus       422 s~~~--------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--~~  491 (613)
                      ++..        ...++..|+|||++....++.++|||||||+||||++|++||.......   ............  ..
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~i~~~~~~~~~~~~  256 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL---FEGIIKGKYKMNPRQW  256 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHH---HHHHHHTCCCCCHHHH
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHH---HHHHHcCCCCCCcccc
Confidence            8642        2246778999999999999999999999999999999999997643211   111111100000  00


Q ss_pred             cccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          492 DQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       492 ~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ..+.+.... ..+||+.||.+||++.|++++...
T Consensus       257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~  290 (351)
T 3c0i_A          257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWL  290 (351)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhh
Confidence            111111211 227999999999999999987664

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.1e-40  Score=339.82  Aligned_cols=248  Identities=23%  Similarity=0.420  Sum_probs=199.1

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcC---CceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFING---STTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~---~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      .++|...+.||+|+||.||+|+...   .+..||||.+... .....+.|.+|+.++++++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4678888899999999999998754   3356999999765 344567799999999999999999999998754 5689


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ||||+++|+|.+++... ...+++..++.++.|+++||.|||+.+    |+||||||+|||++.++.+||+|||+++...
T Consensus        90 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESIN----CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            99999999999999542 356899999999999999999999998    9999999999999999999999999986422


Q ss_pred             ---------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCcccccc
Q 048439          427 ---------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVD  496 (613)
Q Consensus       427 ---------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  496 (613)
                               ..++..|+|||.+....++.++|||||||++|||++ |+.||......+.....   ...... ......+
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~---~~~~~~-~~~~~~~  240 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL---EKGDRL-PKPDLCP  240 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH---HHTCCC-CCCTTCC
T ss_pred             cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH---hcCCCC-CCCCCCC
Confidence                     223456999999999999999999999999999998 99999654433322111   111111 1122222


Q ss_pred             HHHH--HhcccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          497 PFLK--AMSCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       497 ~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                      +.+.  ..+||+.+|.+||++.|+++.|+..++.
T Consensus       241 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          241 PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            2222  2379999999999999999999976654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1e-40  Score=356.61  Aligned_cols=195  Identities=23%  Similarity=0.239  Sum_probs=174.7

Q ss_pred             cCCCCcceeeee--CcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVG--GFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G--~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|...++||+|  +||.||+|+...++..||||+++..  .......+.+|+.++++++|||||++++++.+.+..++|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            568888899999  9999999999988899999999754  244456788999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--  425 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--  425 (613)
                      ||||++|+|.+++.......+++..++.|+.|++.||+|||+.+    |+||||||+|||++.++.+||+|||++...  
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~----ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG----YVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999997665577999999999999999999999998    999999999999999999999999987421  


Q ss_pred             -------------CCCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          426 -------------PTSVSKTHLDPEYYRL--QQLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       426 -------------~~~~~~~~~aPE~~~~--~~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                                   ...++..|+|||++.+  ..++.++|||||||+||||++|++||...
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  240 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  240 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence                         1245667999999987  67899999999999999999999999654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.5e-41  Score=369.96  Aligned_cols=243  Identities=23%  Similarity=0.319  Sum_probs=193.0

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      .++|...++||+|+||.||+|+...++..||||+++..   .......+.+|+.++++++||||++++++|.+.+.++||
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46788899999999999999999888899999999753   334456688999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT-GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-  425 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-  425 (613)
                      ||||++|+|.+++..  ...+++..+..++.|+++||+|||+ .+    |+||||||+||||+.++.+||+|||+++.. 
T Consensus       227 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~g----iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKN----VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHTC----CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCC----EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999999854  3569999999999999999999998 77    999999999999999999999999998742 


Q ss_pred             -------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          426 -------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       426 -------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                             ...++..|+|||++.+..++.++|||||||+||||++|++||.............     .....+...+++.
T Consensus       301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~-----~~~~~~p~~~~~~  375 (446)
T 4ejn_A          301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-----MEEIRFPRTLGPE  375 (446)
T ss_dssp             C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HCCCCCCTTSCHH
T ss_pred             CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH-----hCCCCCCccCCHH
Confidence                   2346778999999999999999999999999999999999997654433222211     1111222223332


Q ss_pred             HH--HhcccccCCCCCC-----CHHHHHHHHHH
Q 048439          499 LK--AMSCLNDEGIRRP-----SMSDVVWGLEF  524 (613)
Q Consensus       499 ~~--~~~Cl~~~p~~RP-----s~~evl~~Le~  524 (613)
                      +.  ..+||+.||.+||     ++.|++++..+
T Consensus       376 ~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f  408 (446)
T 4ejn_A          376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF  408 (446)
T ss_dssp             HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             HHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence            22  2279999999999     99999877664

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.1e-40  Score=346.97  Aligned_cols=246  Identities=21%  Similarity=0.291  Sum_probs=199.3

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh------hcHHHHHHHHHHHhccCccceeeEEEEeecCCce
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ------QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~------~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~  344 (613)
                      .++|...+.||+|+||.||+|+...++..||||.+.....      ....++.+|+.++.+++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            3568888899999999999999988888999999875432      1356799999999999999999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC----cEEEEecC
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW----VAKVSDFG  420 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFG  420 (613)
                      ++||||+++|+|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~----ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999954  456899999999999999999999998    99999999999999888    79999999


Q ss_pred             CCccC-------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccC-Ccc
Q 048439          421 LSKFG-------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG-TID  492 (613)
Q Consensus       421 ls~~~-------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~  492 (613)
                      +++..       ...++..|+|||.+....++.++|||||||+||||++|+.||......+.....  ........ ...
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~  242 (321)
T 2a2a_A          165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--TSVSYDFDEEFF  242 (321)
T ss_dssp             TCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--HTTCCCCCHHHH
T ss_pred             cceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--HhcccccChhhh
Confidence            98642       223577899999999999999999999999999999999999765433221111  11000000 000


Q ss_pred             ccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          493 QIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       493 ~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ...+..+.  ..+||+.||.+||++.|++++...
T Consensus       243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~  276 (321)
T 2a2a_A          243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI  276 (321)
T ss_dssp             TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred             cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence            11112221  238999999999999999987664

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=350.22  Aligned_cols=240  Identities=20%  Similarity=0.217  Sum_probs=188.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...++||+|+||+||+|+...++..||||++...  .......+..|+..+.++ +|+||++++++|.+.+..+|||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            5788999999999999999999887899999998654  233444566677666665 8999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+ +|+|.+++... ...++|..++.|+.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..   
T Consensus       137 e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQG----LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             ECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             ecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC----EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            999 67999988653 456999999999999999999999998    999999999999999999999999998642   


Q ss_pred             ----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          426 ----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                          ...++..|+|||++.+ .++.++|||||||+||||++|+.++..........     ...........+.+.+.. 
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~l  284 (311)
T 3p1a_A          211 GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLR-----QGYLPPEFTAGLSSELRSV  284 (311)
T ss_dssp             ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHT-----TTCCCHHHHTTSCHHHHHH
T ss_pred             CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHh-----ccCCCcccccCCCHHHHHH
Confidence                2235778999999876 79999999999999999999977765432211110     000000000111111111 


Q ss_pred             HhcccccCCCCCCCHHHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ..+||+.||++||++.|++++..
T Consensus       285 i~~~L~~dP~~Rpt~~ell~hp~  307 (311)
T 3p1a_A          285 LVMMLEPDPKLRATAEALLALPV  307 (311)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             HHHHcCCChhhCcCHHHHHhCcc
Confidence            22799999999999999987654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1e-40  Score=348.42  Aligned_cols=254  Identities=20%  Similarity=0.245  Sum_probs=202.5

Q ss_pred             HHHHHhcCCCCc-ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccC-ccceeeEEEEeecC
Q 048439          266 EIQAATNNFDND-LVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDD  341 (613)
Q Consensus       266 el~~at~~f~~~-~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~  341 (613)
                      ......+.|... +.||+|+||.||+|+...++..||||++....  .....++.+|+.++.+++ ||||+++++++.+.
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~  101 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT  101 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence            334455666665 78999999999999998888999999987642  334678999999999995 69999999999999


Q ss_pred             CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC---CCcEEEEe
Q 048439          342 REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE---KWVAKVSD  418 (613)
Q Consensus       342 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~---~~~~kl~D  418 (613)
                      +..++||||+++|+|.+++.......+++.+++.++.|++.||+|||+.+    |+||||||+|||++.   ++.+||+|
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g----ivH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN----IVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC----eecCcCChHHEEEecCCCCCcEEEee
Confidence            99999999999999999986655678999999999999999999999998    999999999999998   78999999


Q ss_pred             cCCCccCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCc
Q 048439          419 FGLSKFGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTI  491 (613)
Q Consensus       419 FGls~~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~  491 (613)
                      ||+++...       ..++..|+|||++....++.++|||||||+||||++|+.||......+.................
T Consensus       178 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  257 (327)
T 3lm5_A          178 FGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF  257 (327)
T ss_dssp             GGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred             CccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhh
Confidence            99996422       24677899999999999999999999999999999999999765443322211111111111111


Q ss_pred             cccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          492 DQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       492 ~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ..+.+.... ..+||+.||.+||++.+++++..
T Consensus       258 ~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~  290 (327)
T 3lm5_A          258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW  290 (327)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred             cccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence            222222222 23799999999999999986655

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.2e-40  Score=335.25  Aligned_cols=244  Identities=28%  Similarity=0.470  Sum_probs=188.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC----hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES----QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~----~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|...+.||+|+||.||+|.+.  +..||||+++...    ....+.+.+|++++++++||||++++++|.+.+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            56788889999999999999986  3679999987543    23356789999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC--------CCcEEEEec
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE--------KWVAKVSDF  419 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~--------~~~~kl~DF  419 (613)
                      |||+++|+|.+++.   ...+++..++.++.|++.||.|||+.+..+ |+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~-i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVP-IIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSC-CCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCc-eeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999983   356999999999999999999999986332 789999999999986        778999999


Q ss_pred             CCCccC------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccc
Q 048439          420 GLSKFG------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ  493 (613)
Q Consensus       420 Gls~~~------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  493 (613)
                      |+++..      ...++..|+|||.+.+..++.++||||||+++|||++|+.||............  ............
T Consensus       161 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~  238 (271)
T 3dtc_A          161 GLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV--AMNKLALPIPST  238 (271)
T ss_dssp             CC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH--HTSCCCCCCCTT
T ss_pred             CcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh--hcCCCCCCCCcc
Confidence            998642      234577899999999999999999999999999999999999754332211111  111111111122


Q ss_pred             cccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          494 IVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       494 ~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      +.+.+.. ..+||+.+|.+||++.|++++|+
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~  269 (271)
T 3dtc_A          239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQLT  269 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence            2222222 23799999999999999999987

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.5e-40  Score=343.12  Aligned_cols=246  Identities=23%  Similarity=0.290  Sum_probs=192.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|...+.||+|+||.||+|+... +..||||++....  ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             hhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            678888899999999999999865 5789999997543  2234678999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---  426 (613)
                      |+++ +|.+.+.. ....+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++...   
T Consensus       100 ~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~----ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQHR----ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CCSE-EHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCCC-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            9985 88888754 3456999999999999999999999998    9999999999999999999999999986421   


Q ss_pred             -----CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCc---------
Q 048439          427 -----TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTI---------  491 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~---------  491 (613)
                           ..++..|+|||.+.+ ..++.++|||||||++|||++|++||......+.................         
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  253 (311)
T 3niz_A          174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW  253 (311)
T ss_dssp             C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred             ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence                 235677999999976 56899999999999999999999999765544332222111100000000         


Q ss_pred             -----------------cccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          492 -----------------DQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       492 -----------------~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                                       ..+...... ..+||+.||.+|||+.|++++..+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  304 (311)
T 3niz_A          254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF  304 (311)
T ss_dssp             HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred             hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence                             001111111 227999999999999999876553

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.9e-41  Score=351.07  Aligned_cols=246  Identities=23%  Similarity=0.316  Sum_probs=191.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCc----e
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDRE----M  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~----~  344 (613)
                      ++|...+.||+|+||.||+|+...+++.||||+++...   ......|.+|+.++.+++||||+++++++.....    .
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            57888889999999999999998888999999997653   3345578999999999999999999999876554    3


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++||||+++|+|.+++..  ...+++.+++.++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++.
T Consensus        92 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             EEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            999999999999999954  346999999999999999999999998    99999999999999999999999999864


Q ss_pred             CC-----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccc
Q 048439          425 GP-----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ  493 (613)
Q Consensus       425 ~~-----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  493 (613)
                      ..           ..++..|+|||.+.+..++.++|||||||+||||++|+.||......+...................
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG  245 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence            21           2257789999999999999999999999999999999999976544332111100000000000011


Q ss_pred             cccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          494 IVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       494 ~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      +.+.+.. ..+||+.||.+||+..+++.+..
T Consensus       246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l  276 (311)
T 3ork_A          246 LSADLDAVVLKALAKNPENRYQTAAEMRADL  276 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             CCHHHHHHHHHHHhcCHhhChhhHHHHHHHH
Confidence            1111111 23799999999998887765443

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.4e-41  Score=355.20  Aligned_cols=244  Identities=20%  Similarity=0.272  Sum_probs=199.2

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceE
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~  345 (613)
                      ..++|...++||+|+||.||+|+...+++.||||+++..   .......+..|..+|..+ +||||+++++++.+.+.++
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            346788999999999999999999988899999999754   233456788999999988 8999999999999999999


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +||||+++|+|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..
T Consensus        98 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g----ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            99999999999999954  346999999999999999999999998    999999999999999999999999998742


Q ss_pred             --------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccH
Q 048439          426 --------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP  497 (613)
Q Consensus       426 --------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  497 (613)
                              ...++..|+|||++....++.++|||||||+||||++|++||......+......  .   ....+...+++
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~---~~~~~p~~~s~  246 (353)
T 2i0e_A          172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--E---HNVAYPKSMSK  246 (353)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--H---CCCCCCTTSCH
T ss_pred             ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH--h---CCCCCCCCCCH
Confidence                    2346778999999999999999999999999999999999997654433221111  1   11112222222


Q ss_pred             HHH--HhcccccCCCCCCC-----HHHHHHHHHH
Q 048439          498 FLK--AMSCLNDEGIRRPS-----MSDVVWGLEF  524 (613)
Q Consensus       498 ~~~--~~~Cl~~~p~~RPs-----~~evl~~Le~  524 (613)
                      .+.  ..+||..+|.+||+     +.|++++..+
T Consensus       247 ~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f  280 (353)
T 2i0e_A          247 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF  280 (353)
T ss_dssp             HHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred             HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence            222  22799999999995     5777766543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.4e-40  Score=350.39  Aligned_cols=247  Identities=23%  Similarity=0.298  Sum_probs=196.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|...++||+|+||.||+|+...+++.||||+++..   .......+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            5688888999999999999999988899999999754   233456688999999988 899999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--  425 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--  425 (613)
                      |||+++|+|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..  
T Consensus        89 ~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~----ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            999999999999854  346999999999999999999999998    999999999999999999999999999742  


Q ss_pred             ------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhh---hhHH-HHHHHhhccCCccccc
Q 048439          426 ------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQ---VSLA-VWAQQCYQNGTIDQIV  495 (613)
Q Consensus       426 ------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~---~~l~-~~~~~~~~~~~~~~~~  495 (613)
                            ...++..|+|||++.+..++.++|||||||+||||++|++||........   .... ...........+....
T Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~  242 (345)
T 3a8x_A          163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL  242 (345)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred             CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence                  22467789999999999999999999999999999999999964211100   0000 0111111111222223


Q ss_pred             cHHHH--HhcccccCCCCCCCH------HHHHHHHHH
Q 048439          496 DPFLK--AMSCLNDEGIRRPSM------SDVVWGLEF  524 (613)
Q Consensus       496 d~~~~--~~~Cl~~~p~~RPs~------~evl~~Le~  524 (613)
                      ++.+.  ..+||+.||.+||++      .|++.+..+
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f  279 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF  279 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred             CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence            32222  227999999999995      677655543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2e-40  Score=340.03  Aligned_cols=247  Identities=20%  Similarity=0.271  Sum_probs=192.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|...+.||+|+||.||+|+...++..||||++....  ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888889999999999999998888999999987543  3334678999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----  425 (613)
                      |+++ +|.+.+.. ....+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..    
T Consensus        82 ~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~----ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9986 66665543 3456999999999999999999999998    999999999999999999999999999642    


Q ss_pred             ----CCCCCcccCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCccchh-hhhhhhHHHHHHHhhccCCcc-------
Q 048439          426 ----PTSVSKTHLDPEYYRLQQ-LTEKSDVYSFGVVLFEVLCARPSILRTA-AKKQVSLAVWAQQCYQNGTID-------  492 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~~~-~t~ksDV~SfGvvL~elltg~~p~~~~~-~~~~~~l~~~~~~~~~~~~~~-------  492 (613)
                          ...++..|+|||.+.+.. ++.++|||||||++|||++|..|+.... ..+..................       
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence                223466799999998766 7999999999999999998887754332 222211111111000000000       


Q ss_pred             -----------------ccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          493 -----------------QIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       493 -----------------~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                                       .-.++...  ..+||+.||++|||+.|++++..+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  286 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF  286 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence                             00111111  237999999999999999876553

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.3e-40  Score=338.70  Aligned_cols=246  Identities=26%  Similarity=0.429  Sum_probs=196.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||.||+|...++ ..||||.+.... ...+.|.+|++++++++||||+++++++.+ +..++||||+
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   89 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTT-EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCC-cEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence            5677888999999999999998754 679999997653 345689999999999999999999999874 5689999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++|+|.+++.......+++.+++.++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+++...     
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            9999999995433346999999999999999999999998    9999999999999999999999999986422     


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                          ..++..|+|||.+....++.++|||||||++|||++ |+.||......+..   ..............+.+.+.. 
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~l  242 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---QNLERGYRMVRPDNCPEELYQL  242 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH---HHHhcccCCCCcccccHHHHHH
Confidence                123456999999999999999999999999999999 89998654433211   111111111111122222222 


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      ..+||+.+|++||++.++++.|+..+.
T Consensus       243 i~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          243 MRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhccChhhCCCHHHHHHHHHHHHH
Confidence            237999999999999999999986654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.8e-40  Score=349.87  Aligned_cols=246  Identities=26%  Similarity=0.338  Sum_probs=197.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      +.|...+.||+|+||.||+|+...++..||||++....   ....+.|.+|++++++++||||++++++|.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45778889999999999999998888999999987542   334467899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+. |+|.+++.. ....+++..++.++.|+++||.|||+.+    |+||||||+|||+++++.+||+|||+++..   
T Consensus       134 e~~~-g~l~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             ECCS-EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC----eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            9997 688888753 2457999999999999999999999998    999999999999999999999999998753   


Q ss_pred             -CCCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          426 -PTSVSKTHLDPEYYR---LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       426 -~~~~~~~~~aPE~~~---~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                       ...++..|+|||++.   .+.++.++|||||||+||||++|++||..........  ....... ........+..+. 
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~l~~  284 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQNES-PALQSGHWSEYFRN  284 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHHSCC-CCCCCTTSCHHHHH
T ss_pred             CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHhcCC-CCCCCCCCCHHHHH
Confidence             234677899999985   5678999999999999999999999996544332211  1111111 1111111222222 


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                       ..+||+.+|.+||++.+++++.....
T Consensus       285 li~~~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          285 FVDSCLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             HHHHHcccChhhCcCHHHHhhChhhhc
Confidence             22799999999999999998877543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=356.10  Aligned_cols=244  Identities=24%  Similarity=0.276  Sum_probs=197.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...++||+|+||.||+|+...++..||||++....   ......+.+|+.+|++++|||||+++++|.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56888889999999999999999888999999986532   334567899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+++|+|.+++..  ...+++..+..++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..   
T Consensus        95 e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g----ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            99999999999954  456999999999999999999999998    999999999999999999999999999642   


Q ss_pred             ----CCCCCcccCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          426 ----PTSVSKTHLDPEYYRL---QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~---~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                          ...++..|+|||++..   ..++.++|||||||+||||++|++||..........+.......  ...........
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~p~~~s~~  246 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT--VVTYPSAWSQE  246 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--CCCCCTTSCHH
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--ccCCCCcCCHH
Confidence                3356778999999974   45899999999999999999999999754333322222222111  11112222222


Q ss_pred             HH--HhcccccCCCCCCC-HHHHHHHHH
Q 048439          499 LK--AMSCLNDEGIRRPS-MSDVVWGLE  523 (613)
Q Consensus       499 ~~--~~~Cl~~~p~~RPs-~~evl~~Le  523 (613)
                      +.  ..+||+.||.+||+ +.+|+.+..
T Consensus       247 ~~~li~~lL~~dP~~R~s~~~~l~~hp~  274 (384)
T 4fr4_A          247 MVSLLKKLLEPNPDQRFSQLSDVQNFPY  274 (384)
T ss_dssp             HHHHHHHHSCSSGGGSCCSHHHHHTSGG
T ss_pred             HHHHHHHHhcCCHhHhcccHHHHHcChh
Confidence            22  22799999999998 777775444

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.3e-41  Score=349.66  Aligned_cols=247  Identities=24%  Similarity=0.369  Sum_probs=195.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCcee----EEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTP----VAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~----vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ++|...++||+|+||.||+|++..++..    ||+|.+... .......+.+|+.++++++||||++++++|.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            5688888999999999999998665544    578877654 4455678999999999999999999999998764 889


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      |+||+++|+|.+++... ...+++..++.|+.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++...
T Consensus        94 v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCC----CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            99999999999998653 456999999999999999999999998    9999999999999999999999999996421


Q ss_pred             ----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          427 ----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       427 ----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                                ..++..|+|||.+.+..++.++|||||||+||||++ |++||......+....   ..............
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~  245 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERLPQPPICT  245 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---HHTTCCCCCCTTBC
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH---HHcCCCCCCCccCC
Confidence                      123456999999999999999999999999999999 9999976544332221   11111111112222


Q ss_pred             cHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          496 DPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       496 d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      ..+.. ..+||+.+|.+||++.|+++.|+...+
T Consensus       246 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          246 IDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            22222 237999999999999999999986553

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.5e-40  Score=339.94  Aligned_cols=241  Identities=23%  Similarity=0.328  Sum_probs=185.9

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhc--cCccceeeEEEEeec----CCce
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQ--LRHLHLVSLIGFCND----DREM  344 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~--l~H~niv~l~g~~~~----~~~~  344 (613)
                      .++|...+.||+|+||.||+|+..  +..||||++...   ....+..|.+++..  ++||||+++++++.+    ....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEEC--CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            467888899999999999999984  477999998654   23455666666665  899999999999754    3458


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCcEEeccCCCCceeeCCCCcEEE
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH--------TGANHAVIIHRDVKTTNILLDEKWVAKV  416 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~~iiHrDlk~~NILl~~~~~~kl  416 (613)
                      ++||||+++|+|.+++.   ...+++..++.|+.|++.||+|||        +.+    |+||||||+|||++.++.+||
T Consensus        82 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~----ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA----IAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE----EECSCCCGGGEEECTTSCEEE
T ss_pred             EEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC----eecCCCChHhEEEcCCCCEEE
Confidence            99999999999999993   346999999999999999999999        666    999999999999999999999


Q ss_pred             EecCCCccC------------CCCCCcccCChhhhhcC------CCCchhHHHHHHHHHHHHHhC----------CCCcc
Q 048439          417 SDFGLSKFG------------PTSVSKTHLDPEYYRLQ------QLTEKSDVYSFGVVLFEVLCA----------RPSIL  468 (613)
Q Consensus       417 ~DFGls~~~------------~~~~~~~~~aPE~~~~~------~~t~ksDV~SfGvvL~elltg----------~~p~~  468 (613)
                      +|||+++..            ...++..|+|||.+...      .++.++|||||||++|||++|          ++||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            999998531            12467789999999877      455799999999999999999          88885


Q ss_pred             chhhhhhhhHHHHHHHhhccCCccccc---------cHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          469 RTAAKKQVSLAVWAQQCYQNGTIDQIV---------DPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       469 ~~~~~~~~~l~~~~~~~~~~~~~~~~~---------d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .......... ..............+.         +.+.. ..+||+.||.+|||+.||++.|+.
T Consensus       235 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          235 DVVPNDPSFE-DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TTSCSSCCHH-HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccCCCCcchh-hhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            5433222111 1111111111111111         11111 337999999999999999999884

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.4e-40  Score=357.31  Aligned_cols=245  Identities=19%  Similarity=0.334  Sum_probs=190.3

Q ss_pred             cCCCCc-ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhc-cCccceeeEEEEeec----CCceE
Q 048439          272 NNFDND-LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQ-LRHLHLVSLIGFCND----DREMI  345 (613)
Q Consensus       272 ~~f~~~-~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~-l~H~niv~l~g~~~~----~~~~~  345 (613)
                      ++|... ++||+|+||+||+|+...++..||||+++..     ..+.+|+.++.+ ++||||+++++++..    ...++
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            455554 5899999999999999888899999998632     356788888754 589999999998865    56789


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC---CCcEEEEecCCC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE---KWVAKVSDFGLS  422 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGls  422 (613)
                      ||||||++|+|.+++.......+++.+++.|+.|++.||.|||+.+    |+||||||+|||++.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC----ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            9999999999999997655567999999999999999999999998    999999999999998   789999999999


Q ss_pred             ccCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhh-hHHHHHH-Hhh--ccCCc
Q 048439          423 KFGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV-SLAVWAQ-QCY--QNGTI  491 (613)
Q Consensus       423 ~~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~-~l~~~~~-~~~--~~~~~  491 (613)
                      +...       ..++..|+|||++....++.++|||||||+||||++|++||......... ....... ...  .....
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~  291 (400)
T 1nxk_A          212 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW  291 (400)
T ss_dssp             EECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTT
T ss_pred             cccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccc
Confidence            7432       23577899999999999999999999999999999999999765432211 0111111 111  11111


Q ss_pred             cccccHHHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          492 DQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       492 ~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ..+.+.... ..+||+.||.+||++.|++++.+..
T Consensus       292 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  326 (400)
T 1nxk_A          292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  326 (400)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence            222222222 2389999999999999999887764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=9.4e-42  Score=357.93  Aligned_cols=244  Identities=21%  Similarity=0.309  Sum_probs=198.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|+...++..||||++....   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57888889999999999999998888999999986532   223457899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+ +|+|.+++..  ...+++.+++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++..   
T Consensus        89 E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g----ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRHK----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHT----CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 6899998854  356999999999999999999999998    999999999999999999999999998642   


Q ss_pred             ----CCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          426 ----PTSVSKTHLDPEYYRLQQL-TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~~~~-t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                          ...++..|+|||.+.+..+ +.++|||||||+||||++|+.||.............     ...........+.+.
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~-----~~~~~~p~~~s~~~~  236 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN-----SCVYVMPDFLSPGAQ  236 (336)
T ss_dssp             BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC-----SSCCCCCTTSCHHHH
T ss_pred             cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH-----cCCCCCcccCCHHHH
Confidence                2346778999999988776 789999999999999999999997543322111000     000111222233222


Q ss_pred             --HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          501 --AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       501 --~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                        ..+||+.||.+|||+.|++++.++...
T Consensus       237 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          237 SLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence              238999999999999999988876543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=343.15  Aligned_cols=249  Identities=24%  Similarity=0.325  Sum_probs=195.1

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-----hhcHHHHHHHHHHHhccC---ccceeeEEEEeecC
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-----QQGALEFQTEIGMLSQLR---HLHLVSLIGFCNDD  341 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-----~~~~~~f~~Ei~~l~~l~---H~niv~l~g~~~~~  341 (613)
                      .+++|...+.||+|+||.||+|+...+++.||||++....     ......+.+|+.++++++   ||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4678999999999999999999998888899999986432     122346677888777765   99999999999876


Q ss_pred             C-----ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEE
Q 048439          342 R-----EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKV  416 (613)
Q Consensus       342 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl  416 (613)
                      .     ..++||||+. |+|.+++.......+++.+++.++.|++.||+|||+.+    |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~----ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC----IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEEcCCCCEEE
Confidence            5     4799999997 59999997666666999999999999999999999998    999999999999999999999


Q ss_pred             EecCCCccCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccC
Q 048439          417 SDFGLSKFGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG  489 (613)
Q Consensus       417 ~DFGls~~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~  489 (613)
                      +|||+++...       ..++..|+|||.+....++.++|||||||++|||++|++||......+...............
T Consensus       162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9999997432       234677999999999999999999999999999999999997665544333222111111111


Q ss_pred             Cc-----------------------cccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          490 TI-----------------------DQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       490 ~~-----------------------~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ..                       .++.+.... ..+||+.||.+|||+.|++++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~  299 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY  299 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence            00                       011111111 23799999999999999987654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=9.2e-41  Score=365.55  Aligned_cols=196  Identities=24%  Similarity=0.316  Sum_probs=169.2

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecC------C
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD------R  342 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~------~  342 (613)
                      .++|...+.||+|+||.||+|+...+++.||||++...  .......+.+|+.+|+.++|||||++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46788889999999999999999888899999999754  344566789999999999999999999999654      4


Q ss_pred             ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCC
Q 048439          343 EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS  422 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls  422 (613)
                      ..+||||||++ +|.+.+.    ..+++.++..++.|+++||+|||+.+    |+||||||+|||++.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~----iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            57999999986 5666663    24899999999999999999999998    999999999999999999999999999


Q ss_pred             ccCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhh
Q 048439          423 KFGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQ  475 (613)
Q Consensus       423 ~~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~  475 (613)
                      +...       ..++..|+|||++.+..++.++|||||||+||||++|++||.+....++
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~  271 (464)
T 3ttj_A          212 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ  271 (464)
T ss_dssp             -----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             eecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            7532       3457789999999999999999999999999999999999977654443

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.3e-40  Score=345.29  Aligned_cols=251  Identities=24%  Similarity=0.329  Sum_probs=199.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEE----cCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEee--cCCceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN--DDREMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~----~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~  345 (613)
                      ++|...+.||+|+||.||+|++    ..++..||||++........+.+.+|++++++++|+||+++++++.  +.+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            4677888999999999999995    4566889999998877777778999999999999999999999886  456689


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +||||+++|+|.+++... ...+++.+++.|+.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++..
T Consensus       103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~----ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRR----CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC----ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            999999999999998542 345999999999999999999999998    999999999999999999999999998642


Q ss_pred             C-----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhh------------hHHHHH
Q 048439          426 P-----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV------------SLAVWA  482 (613)
Q Consensus       426 ~-----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~------------~l~~~~  482 (613)
                      .           ..++..|+|||.+.+..++.++|||||||++|||++|+.||.........            .+....
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL  257 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence            2           22345599999999999999999999999999999999998654332110            011111


Q ss_pred             HHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          483 QQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       483 ~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      ...........+.+.+.. ..+||+.||.+||++.|++++|+....
T Consensus       258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            111111111122222222 237999999999999999999986543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1e-40  Score=348.58  Aligned_cols=242  Identities=21%  Similarity=0.276  Sum_probs=190.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEc---CCceeEEEEEeCCCC----hhcHHHHHHHHHHHhccCccceeeEEEEeecCCce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFIN---GSTTPVAIKRLEPES----QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~---~~~~~vAVK~~~~~~----~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~  344 (613)
                      ++|...++||+|+||.||+++..   .++..||||+++...    ......+.+|+.+|++++||||+++++++.+.+..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            57888889999999999999984   456889999997642    23445688999999999999999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++||||+++|+|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++.
T Consensus        97 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~----ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           97 YLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC----EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            999999999999999854  346899999999999999999999998    99999999999999999999999999864


Q ss_pred             C--------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccccc
Q 048439          425 G--------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVD  496 (613)
Q Consensus       425 ~--------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  496 (613)
                      .        ...++..|+|||.+....++.++|||||||+||||++|++||.............   .  ....+...++
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~---~--~~~~~p~~~~  245 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL---K--CKLNLPPYLT  245 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---H--TCCCCCTTSC
T ss_pred             cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH---h--CCCCCCCCCC
Confidence            2        2346778999999999999999999999999999999999997654433221111   1  1111222222


Q ss_pred             HHHH--HhcccccCCCCCC-----CHHHHHHHHHH
Q 048439          497 PFLK--AMSCLNDEGIRRP-----SMSDVVWGLEF  524 (613)
Q Consensus       497 ~~~~--~~~Cl~~~p~~RP-----s~~evl~~Le~  524 (613)
                      ..+.  ..+||..||.+||     ++.|++++..+
T Consensus       246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f  280 (327)
T 3a62_A          246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF  280 (327)
T ss_dssp             HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred             HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence            2222  2279999999999     78888877664

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-40  Score=338.88  Aligned_cols=246  Identities=26%  Similarity=0.369  Sum_probs=193.8

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCc---eeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCce-EEEE
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGST---TPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREM-ILVY  348 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~---~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~lV~  348 (613)
                      |...++||+|+||.||+|++..+.   ..||+|.+.... ....+.|.+|+.++++++||||+++++++.+.+.. ++||
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            445578999999999999975443   379999997643 34567899999999999999999999999876665 9999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+.+|+|.+++.. ....+++.+++.++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+++..   
T Consensus       103 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~----i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          103 PYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQK----FVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             CCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             ecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            99999999999965 3467899999999999999999999998    999999999999999999999999998632   


Q ss_pred             ---------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCC-ccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          426 ---------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPS-ILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       426 ---------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                               ...++..|+|||.+.+..++.++|||||||++|||++|..| +......+   ................+.
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  254 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHFLAQGRRLPQPEYCP  254 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHHHHTTCCCCCCTTCC
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHHhhcCCCCCCCccch
Confidence                     12235579999999999999999999999999999995554 43332222   222222221111122222


Q ss_pred             cHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          496 DPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       496 d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      +.+.. ..+||+.+|.+||++.++++.|+..++
T Consensus       255 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          255 DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            22222 227999999999999999999986553

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2e-40  Score=337.51  Aligned_cols=239  Identities=25%  Similarity=0.394  Sum_probs=198.0

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeec----------
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCND----------  340 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~----------  340 (613)
                      .++|...+.||+|+||.||+|+...++..||||++....    ..+.+|++++++++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            456888889999999999999998777899999997654    246789999999999999999998854          


Q ss_pred             ------CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcE
Q 048439          341 ------DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVA  414 (613)
Q Consensus       341 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~  414 (613)
                            ....++||||+++|+|.+++.......+++..++.++.|++.||.|||+.+    |+||||||+|||+++++.+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK----LINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEEETTEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC----eeeccCCHHHEEEcCCCCE
Confidence                  445899999999999999997655567999999999999999999999998    9999999999999999999


Q ss_pred             EEEecCCCccC-------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc
Q 048439          415 KVSDFGLSKFG-------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ  487 (613)
Q Consensus       415 kl~DFGls~~~-------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~  487 (613)
                      ||+|||+++..       ...++..|+|||.+.+..++.++|||||||++|||++|..|+.....     ...    ...
T Consensus       162 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~~~----~~~  232 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----FFT----DLR  232 (284)
T ss_dssp             EECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-----HHH----HHH
T ss_pred             EECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-----HHH----Hhh
Confidence            99999998642       22356789999999999999999999999999999999998753211     111    111


Q ss_pred             cCCccccccHHHH--HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          488 NGTIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       488 ~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      .+.+....+..+.  ..+||+.||.+||++.|++++|+...
T Consensus       233 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          233 DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            2223333333333  23799999999999999999998544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.2e-40  Score=338.00  Aligned_cols=245  Identities=20%  Similarity=0.256  Sum_probs=192.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|...+.||+|+||.||+|+.. ++..||||++....  ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcC-CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            46778889999999999999984 45789999987653  2334678999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----  425 (613)
                      |+++ +|.+++... ...+++..++.++.|+++||+|||+.+    |+||||||+|||++.++.+||+|||+++..    
T Consensus        81 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRR----VLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            9986 999888543 456999999999999999999999998    999999999999999999999999998532    


Q ss_pred             ----CCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCC----------
Q 048439          426 ----PTSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT----------  490 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~----------  490 (613)
                          ...++..|+|||.+.+. .++.++|||||||++|||++|++||......+................          
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence                22457789999999764 589999999999999999999999976544333222111110000000          


Q ss_pred             --------------ccccccHHHH--HhcccccCCCCCCCHHHHHHHHH
Q 048439          491 --------------IDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       491 --------------~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                                    ...-+++.+.  ..+||+.||.+||++.|++++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  283 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY  283 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence                          0001122211  22799999999999999987654

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.5e-41  Score=373.79  Aligned_cols=247  Identities=28%  Similarity=0.438  Sum_probs=200.3

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ..++|...+.||+|+||.||+|.+.++ ..||||+++... ...++|.+|+++|++++|+|||+++++|.+ +..+||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            345677888999999999999999876 569999998654 345689999999999999999999999976 67899999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---  426 (613)
                      ||++|+|.++|.......+++.+++.|+.||++||+|||+.+    |+||||||+|||+++++.+||+|||+++...   
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            999999999996433456999999999999999999999998    9999999999999999999999999997532   


Q ss_pred             ------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH
Q 048439          427 ------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       427 ------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                            ..++..|+|||.+..+.++.++|||||||+||||++ |+.||......+....   ............+.+.+.
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~---i~~~~~~~~~~~~~~~l~  494 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VERGYRMPCPPECPESLH  494 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH---HHTTCCCCCCTTCCHHHH
T ss_pred             eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHcCCCCCCCCCCCHHHH
Confidence                  223457999999999999999999999999999999 8999965543332211   111111111222222222


Q ss_pred             H-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          500 K-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       500 ~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      . ..+||+.+|++||++.+|++.|+..+
T Consensus       495 ~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          495 DLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             HHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            2 23799999999999999999998544

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.4e-40  Score=352.47  Aligned_cols=248  Identities=21%  Similarity=0.223  Sum_probs=192.8

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      .++|...+.||+|+||.||+++...++..||||++.... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            357888899999999999999999888999999997543 2345688999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc--EEEEecCCCccC---
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV--AKVSDFGLSKFG---  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~--~kl~DFGls~~~---  425 (613)
                      +++|+|.+++..  ...+++..++.++.|+++||.|||+.+    |+||||||+|||++.++.  +||+|||+++..   
T Consensus        98 ~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~----ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSMQ----ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999999854  346999999999999999999999998    999999999999987765  999999998631   


Q ss_pred             ----CCCCCcccCChhhhhcCCCCch-hHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc--CCccccccHH
Q 048439          426 ----PTSVSKTHLDPEYYRLQQLTEK-SDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN--GTIDQIVDPF  498 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~~~~t~k-sDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~d~~  498 (613)
                          ...++..|+|||++.+..++.+ +|||||||+||||++|++||.....................  .....+.+..
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  251 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC  251 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHH
T ss_pred             CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHH
Confidence                2346778999999998888766 89999999999999999999754432221111111111110  1111111222


Q ss_pred             HH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          499 LK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       499 ~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      .. ..+||+.+|.+|||+.|++++..+.
T Consensus       252 ~~li~~~L~~dP~~Rps~~ell~hp~f~  279 (361)
T 3uc3_A          252 CHLISRIFVADPATRISIPEIKTHSWFL  279 (361)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred             HHHHHHHccCChhHCcCHHHHHhCcchh
Confidence            11 2279999999999999999887764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.1e-40  Score=341.24  Aligned_cols=247  Identities=25%  Similarity=0.313  Sum_probs=196.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|...+.||+|+||.||+|+...++..||||++....  ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57888889999999999999998888899999986543  2335668899999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---  426 (613)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++...   
T Consensus        83 ~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHN----CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCC----CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            9999999988743  456999999999999999999999998    9999999999999999999999999986422   


Q ss_pred             -----CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHh--------h------
Q 048439          427 -----TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC--------Y------  486 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~--------~------  486 (613)
                           ..++..|+|||.+.+ ..++.++|||||||++|||++|++||......+...........        .      
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence                 235667999999976 67899999999999999999999999766554433322211100        0      


Q ss_pred             ccCCc-------------cccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          487 QNGTI-------------DQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       487 ~~~~~-------------~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .....             ..+.+.... ..+||+.||.+|||+.|++++..+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  288 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF  288 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGG
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHH
Confidence            00000             011111111 237999999999999999977553

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.5e-40  Score=343.95  Aligned_cols=259  Identities=25%  Similarity=0.394  Sum_probs=204.4

Q ss_pred             cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEc-----CCceeEEEEEeCCCC-hhcHHHHHHHHHHHhcc-CccceeeE
Q 048439          262 FSLSEIQAATNNFDNDLVIGVGGFGDVYKGFIN-----GSTTPVAIKRLEPES-QQGALEFQTEIGMLSQL-RHLHLVSL  334 (613)
Q Consensus       262 f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~-----~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l  334 (613)
                      +...+.....++|...+.||+|+||.||+|+..     .++..||||+++... ......+.+|+.++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            444555556788999999999999999999863     355789999997653 34456799999999999 79999999


Q ss_pred             EEEeecCC-ceEEEEEcCCCCChhHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEec
Q 048439          335 IGFCNDDR-EMILVYDFMARGTLPDHLYHSDN--------------PPLPWNQRLEICIGAARGLHYLHTGANHAVIIHR  399 (613)
Q Consensus       335 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHr  399 (613)
                      +++|.+.+ ..++||||+++|+|.+++.....              ..+++..++.++.|+++||.|||+.+    |+||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~----i~H~  172 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK----CIHR  172 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT----CCCS
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC----cccc
Confidence            99988754 58999999999999999965432              23899999999999999999999998    9999


Q ss_pred             cCCCCceeeCCCCcEEEEecCCCccCCC----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCcc
Q 048439          400 DVKTTNILLDEKWVAKVSDFGLSKFGPT----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSIL  468 (613)
Q Consensus       400 Dlk~~NILl~~~~~~kl~DFGls~~~~~----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~  468 (613)
                      ||||+|||++.++.+||+|||+++....          .++..|+|||.+.+..++.++|||||||++|||++ |+.||.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            9999999999999999999999874321          22446999999999999999999999999999998 999996


Q ss_pred             chhhhhhhhHHHHHHHhhccCCccccccHHHH--HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          469 RTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       469 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      ........  ......... ........+.+.  ..+||+.+|.+||++.|++++|+..++
T Consensus       253 ~~~~~~~~--~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          253 GVKIDEEF--CRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             TCCCSHHH--HHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccchhHHH--HHHhccCcc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            54332211  111111111 111222222222  237999999999999999999997764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-41  Score=356.03  Aligned_cols=246  Identities=26%  Similarity=0.430  Sum_probs=189.1

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCC---ceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeec-CCceEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGS---TTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND-DREMILV  347 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~---~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV  347 (613)
                      .|...++||+|+||.||+|++...   ...||||.++.. .......|.+|+.++++++||||++++++|.+ ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            355667899999999999987432   346899998754 34456789999999999999999999999765 5678999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-  426 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-  426 (613)
                      |||+++|+|.+++.. ....+++.+++.++.|+++||.|||+.+    |+||||||+|||+++++.+||+|||+++... 
T Consensus       170 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK----FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC----EecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999954 3456899999999999999999999998    9999999999999999999999999996321 


Q ss_pred             -----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCcccc
Q 048439          427 -----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQI  494 (613)
Q Consensus       427 -----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  494 (613)
                                 ..++..|+|||.+....++.++|||||||+||||++ |.+||......+.   ...............+
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~~~~~~~~~~p~~~  321 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLLQGRRLLQPEYC  321 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHHHHTTCCCCCCTTC
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHHHHcCCCCCCCCCC
Confidence                       123456999999999999999999999999999999 6777754433221   1111111111111222


Q ss_pred             ccHHHH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          495 VDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       495 ~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      .+.+.. ..+||+.+|.+||++.|+++.|+..+
T Consensus       322 ~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~  354 (373)
T 3c1x_A          322 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  354 (373)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            222222 23799999999999999999998654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.5e-40  Score=340.12  Aligned_cols=251  Identities=22%  Similarity=0.341  Sum_probs=194.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|....++..||||++...   .......+.+|+.++++++|+||+++++++.+.+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            5688888999999999999999877789999999753   3445667899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          349 DFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ||+++|+|.+++..  .....+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++...
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC----eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999999853  23567999999999999999999999998    9999999999999999999999999986422


Q ss_pred             --------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccH-
Q 048439          427 --------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP-  497 (613)
Q Consensus       427 --------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~-  497 (613)
                              ..++..|+|||.+....++.++|||||||++|||++|+.||....... ..+................... 
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  266 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEQCDYPPLPSDHYSEE  266 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHHHHHTTCSCCCCTTTSCHH
T ss_pred             CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHHHhhcccCCCCcccccCHH
Confidence                    235667999999999999999999999999999999999996543221 1111111111111111111222 


Q ss_pred             HHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          498 FLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       498 ~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      +.. ..+||+.||.+||++.+|++.|+....
T Consensus       267 l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          267 LRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            222 227999999999999999999985443

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.1e-40  Score=347.65  Aligned_cols=249  Identities=29%  Similarity=0.451  Sum_probs=197.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCcee--EEEEEeCCC-ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTP--VAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~--vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|...+.||+|+||.||+|+...++..  ||||++... .......+.+|++++.++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            5788888999999999999998766664  499998754 334456789999999999 899999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc
Q 048439          348 YDFMARGTLPDHLYHSD--------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV  413 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~  413 (613)
                      |||+++|+|.+++....              ...+++.+++.++.|++.||.|||+.+    |+||||||+|||++.++.
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ----FIHRDLAARNILVGENYV  180 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECGGGC
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC----ccCCCCccceEEEcCCCe
Confidence            99999999999996532              347999999999999999999999998    999999999999999999


Q ss_pred             EEEEecCCCccC-------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHh
Q 048439          414 AKVSDFGLSKFG-------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQC  485 (613)
Q Consensus       414 ~kl~DFGls~~~-------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~  485 (613)
                      +||+|||+++..       ...++..|+|||.+....++.++|||||||++|||++ |+.||......+..   ......
T Consensus       181 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~---~~~~~~  257 (327)
T 1fvr_A          181 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---EKLPQG  257 (327)
T ss_dssp             EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHGGGT
T ss_pred             EEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH---HHhhcC
Confidence            999999998632       1223557999999999999999999999999999998 99999655432211   111111


Q ss_pred             hccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          486 YQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       486 ~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      ........+.+.+.. ..+||+.+|.+||++.++++.|+..++
T Consensus       258 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  300 (327)
T 1fvr_A          258 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  300 (327)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            111111122222222 237999999999999999999986554

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-40  Score=364.57  Aligned_cols=243  Identities=24%  Similarity=0.337  Sum_probs=199.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|+...++..||||+++...   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56788889999999999999998888999999997542   233567899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+++|+|.+++.  ....+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..   
T Consensus        96 E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g----ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTTT----EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC----CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            9999999999994  3457999999999999999999999998    999999999999999999999999998642   


Q ss_pred             ----CCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          426 ----PTSVSKTHLDPEYYRLQQL-TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~~~~-t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                          ...++..|+|||.+.+..+ +.++|||||||+||||++|+.||...........   ...  ........+++.+.
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~---i~~--~~~~~p~~~s~~~~  244 (476)
T 2y94_A          170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK---ICD--GIFYTPQYLNPSVI  244 (476)
T ss_dssp             CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH---HHT--TCCCCCTTCCHHHH
T ss_pred             ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH---Hhc--CCcCCCccCCHHHH
Confidence                2346778999999988765 6899999999999999999999976543221111   111  11111222222222


Q ss_pred             --HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          501 --AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       501 --~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                        ..+||+.||.+|||+.|++++....
T Consensus       245 ~Li~~~L~~dP~~Rpt~~eil~hp~~~  271 (476)
T 2y94_A          245 SLLKHMLQVDPMKRATIKDIREHEWFK  271 (476)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred             HHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence              2279999999999999999876654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-40  Score=339.31  Aligned_cols=246  Identities=23%  Similarity=0.326  Sum_probs=195.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ++|...+.||+|+||.||+|....++..||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            46788889999999999999998888899999987653 34567899999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee---CCCCcEEEEecCCCccC
Q 048439          351 MARGTLPDHLYHS--DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGls~~~  425 (613)
                      +++|+|.+++...  ....+++..++.|+.|+++||.|||+.+    |+||||||+|||+   +.++.+||+|||+++..
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~----ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC----EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            9999999988542  2467999999999999999999999998    9999999999999   55688999999999642


Q ss_pred             -------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          426 -------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       426 -------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                             ...++..|+|||.+. +.++.++|||||||+||||++|+.||......+......+...... .....+.+..
T Consensus       178 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  255 (285)
T 3is5_A          178 KSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA-VECRPLTPQA  255 (285)
T ss_dssp             ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-C--CCCCHHH
T ss_pred             CCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc-cccCcCCHHH
Confidence                   234567899999986 5789999999999999999999999976544332221111110000 0001111222


Q ss_pred             HH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          499 LK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       499 ~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .. ..+||+.||.+||++.|++++..
T Consensus       256 ~~li~~~L~~dP~~Rps~~e~l~hp~  281 (285)
T 3is5_A          256 VDLLKQMLTKDPERRPSAAQVLHHEW  281 (285)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCHH
Confidence            21 23799999999999999986544

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-40  Score=337.37  Aligned_cols=247  Identities=25%  Similarity=0.382  Sum_probs=196.0

Q ss_pred             cCCCCcc-eeeeeCcEEEEEEEEc--CCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDL-VIGVGGFGDVYKGFIN--GSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~-~iG~G~fG~Vy~g~~~--~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|.... .||+|+||.||+|.+.  .++..||||+++.. .....+.+.+|++++++++||||+++++++ +.+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            3444444 8999999999999864  34578999999875 344567799999999999999999999999 45679999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-  426 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-  426 (613)
                      |||+++|+|.+++.. ....+++.+++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++... 
T Consensus        88 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN----FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCC----EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999999999999853 3456999999999999999999999998    9999999999999999999999999986421 


Q ss_pred             ----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          427 ----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       427 ----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                                ..++..|+|||.+....++.++|||||||++|||++ |+.||......+..   ..............+.
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~i~~~~~~~~~~~~~  239 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQGKRMECPPECP  239 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---HHHHTTCCCCCCTTCC
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH---HHHhcCCcCCCCCCcC
Confidence                      122456999999999999999999999999999998 99999654433221   1111111111112222


Q ss_pred             cHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          496 DPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       496 d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      +.+.. ..+||+.+|.+||++.++++.|+..+.
T Consensus       240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            22222 227999999999999999999996653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.7e-40  Score=338.84  Aligned_cols=248  Identities=25%  Similarity=0.364  Sum_probs=196.0

Q ss_pred             hcCCCCcc-eeeeeCcEEEEEEEE--cCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceE
Q 048439          271 TNNFDNDL-VIGVGGFGDVYKGFI--NGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       271 t~~f~~~~-~iG~G~fG~Vy~g~~--~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  345 (613)
                      .++|.... .||+|+||.||+|.+  ...+..||||+++...  ....++|.+|+.++++++||||+++++++ +.+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            34566666 899999999999965  4556889999997653  33356799999999999999999999999 567789


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +||||+++|+|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..
T Consensus        94 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~----i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCC----eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            99999999999999964  356999999999999999999999998    999999999999999999999999998643


Q ss_pred             CC-----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccc
Q 048439          426 PT-----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ  493 (613)
Q Consensus       426 ~~-----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  493 (613)
                      ..           .++..|+|||.+....++.++||||||+++|||++ |+.||......+..   ..............
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~  244 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT---AMLEKGERMGCPAG  244 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHHTTCCCCCCTT
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHHcCCCCCCCCC
Confidence            21           12356999999999999999999999999999999 99999765433221   11111111111112


Q ss_pred             cccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          494 IVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       494 ~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                      +.+.+.. ..+||+.||.+||++.+|++.|+..+..
T Consensus       245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          245 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            2222222 2279999999999999999999976543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.7e-40  Score=342.55  Aligned_cols=246  Identities=21%  Similarity=0.315  Sum_probs=197.6

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      .++|...+.||+|+||.||+|+...+++.||||+++.........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            35688888999999999999999877889999999876555556789999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee---CCCCcEEEEecCCCccCCC
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSKFGPT  427 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGls~~~~~  427 (613)
                      +++|+|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||+   ++++.+||+|||+++....
T Consensus        88 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           88 VSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            999999999854  346899999999999999999999998    9999999999999   7889999999999875432


Q ss_pred             ------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhh--ccCCccccccHHH
Q 048439          428 ------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCY--QNGTIDQIVDPFL  499 (613)
Q Consensus       428 ------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~--~~~~~~~~~d~~~  499 (613)
                            .++..|+|||.+.+..++.++|||||||++|||++|++||..........  .......  .......+.+...
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~  239 (304)
T 2jam_A          162 GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE--KIKEGYYEFESPFWDDISESAK  239 (304)
T ss_dssp             BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHHCCCCCCTTTTTTSCHHHH
T ss_pred             CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHcCCCCCCccccccCCHHHH
Confidence                  25678999999999999999999999999999999999996544332211  1111111  1111112222222


Q ss_pred             H-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          500 K-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       500 ~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      . ..+||+.||.+||++.|++++...
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~  265 (304)
T 2jam_A          240 DFICHLLEKDPNERYTCEKALSHPWI  265 (304)
T ss_dssp             HHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCccc
Confidence            2 227999999999999999987664

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.9e-40  Score=334.46  Aligned_cols=246  Identities=21%  Similarity=0.311  Sum_probs=196.0

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCC
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMA  352 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  352 (613)
                      +|....+||+|+||.||+|....++..||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            45556699999999999999988888999999987766667789999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC-CCcEEEEecCCCccC-----
Q 048439          353 RGTLPDHLYHS-DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE-KWVAKVSDFGLSKFG-----  425 (613)
Q Consensus       353 ~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGls~~~-----  425 (613)
                      +|+|.+++... ....+++..++.++.|++.||.|||+.+    |+||||||+|||++. ++.+||+|||+++..     
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ----IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC----EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            99999999654 2346789999999999999999999998    999999999999987 899999999998642     


Q ss_pred             ---CCCCCcccCChhhhhcCC--CCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          426 ---PTSVSKTHLDPEYYRLQQ--LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       426 ---~~~~~~~~~aPE~~~~~~--~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                         ...++..|+|||.+....  ++.++|||||||++|||++|+.||......... ...... ......+.....+.+.
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~  256 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFKVGM-FKVHPEIPESMSAEAK  256 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHHHHH-HCCCCCCCTTSCHHHH
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHhhcc-ccccccccccCCHHHH
Confidence               224567899999997754  899999999999999999999999654322211 111111 1111122222222222


Q ss_pred             --HhcccccCCCCCCCHHHHHHHHHH
Q 048439          501 --AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       501 --~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                        ..+||+.||++||++.|++++...
T Consensus       257 ~li~~~l~~dp~~Rps~~~ll~~~~~  282 (295)
T 2clq_A          257 AFILKCFEPDPDKRACANDLLVDEFL  282 (295)
T ss_dssp             HHHHHTTCSSTTTSCCHHHHHTSGGG
T ss_pred             HHHHHHccCChhhCCCHHHHhcChhh
Confidence              237999999999999999866543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.2e-40  Score=339.39  Aligned_cols=243  Identities=28%  Similarity=0.473  Sum_probs=190.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||.||+|+..+  ..||||++...  ...+.|.+|++++++++||||+++++++.+  ..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWRA--KDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETT--EEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEECC--eeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            467778899999999999999864  67999998654  345679999999999999999999999874  489999999


Q ss_pred             CCCChhHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhc---CCCCCcEEeccCCCCceeeCCCCc-EEEEecCCCccC-
Q 048439          352 ARGTLPDHLYHSDN-PPLPWNQRLEICIGAARGLHYLHT---GANHAVIIHRDVKTTNILLDEKWV-AKVSDFGLSKFG-  425 (613)
Q Consensus       352 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~---~~~~~~iiHrDlk~~NILl~~~~~-~kl~DFGls~~~-  425 (613)
                      ++|+|.+++..... ..+++..++.++.|+++||.|||+   .+    |+||||||+|||++.++. +||+|||+++.. 
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~----ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA----LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC----CCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC----eecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            99999999965432 358899999999999999999999   55    999999999999998886 799999998642 


Q ss_pred             ----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc-CCccccccHHHH
Q 048439          426 ----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN-GTIDQIVDPFLK  500 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~d~~~~  500 (613)
                          ...++..|+|||.+.+..++.++|||||||++|||++|+.||........  ...|....... .....+.+.+..
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~  235 (307)
T 2eva_A          158 THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNGTRPPLIKNLPKPIES  235 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHHTTCCCCCBTTCCHHHHH
T ss_pred             cccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHhcCCCCCcccccCHHHHH
Confidence                23467789999999999999999999999999999999999964322211  11222211111 112222222222


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                       ..+||+.+|.+||++.++++.|+...
T Consensus       236 li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          236 LMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             HHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence             23799999999999999999998544

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2e-40  Score=369.02  Aligned_cols=248  Identities=24%  Similarity=0.331  Sum_probs=203.1

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      .++|...++||+|+||.||+|+...++..||||++...   .......+.+|+.+|.+++|||||++++++.+.+.+++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            46688889999999999999999888899999999653   233456689999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--  425 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--  425 (613)
                      ||||++|+|.+++.......+++..++.++.||+.||.|||+.+    |+||||||+||||+.++.+||+|||+++..  
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g----IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER----IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC----EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999997665667999999999999999999999998    999999999999999999999999999643  


Q ss_pred             -----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhh-hHHHHHHHhhccCCccccccHHH
Q 048439          426 -----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV-SLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       426 -----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                           ...++..|+|||++.+..++.++|||||||+||||++|++||......... .+......  ....+...+.+.+
T Consensus       339 ~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~~~~~p~~~s~~~  416 (576)
T 2acx_A          339 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSERFSPQA  416 (576)
T ss_dssp             TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--CCCCCCTTSCHHH
T ss_pred             CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc--ccccCCccCCHHH
Confidence                 234677899999999999999999999999999999999999764322111 11111111  1111222223222


Q ss_pred             H--HhcccccCCCCCC-----CHHHHHHHHHH
Q 048439          500 K--AMSCLNDEGIRRP-----SMSDVVWGLEF  524 (613)
Q Consensus       500 ~--~~~Cl~~~p~~RP-----s~~evl~~Le~  524 (613)
                      .  ..+||..||.+||     ++.||+++..+
T Consensus       417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF  448 (576)
T 2acx_A          417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLF  448 (576)
T ss_dssp             HHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGG
T ss_pred             HHHHHHhccCCHHHcCCCCCCCHHHHHhChhh
Confidence            2  2279999999999     78999877554

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=348.34  Aligned_cols=246  Identities=20%  Similarity=0.276  Sum_probs=194.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCc--cceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRH--LHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|...+.||+|+||.||++.... +..||||++...  ..+....|.+|+.+|.+++|  +||+++++++.+.+..++|
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTT-SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCC-CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            468888899999999999998865 578999998654  34456789999999999986  9999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--  425 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--  425 (613)
                      || +.+|+|.+++..  ...+++.+++.++.|++.||+|||+.+    |+||||||+|||++ ++.+||+|||+++..  
T Consensus        88 ~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~----iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 567899999964  457999999999999999999999998    99999999999997 678999999999642  


Q ss_pred             --------CCCCCcccCChhhhhc-----------CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhh
Q 048439          426 --------PTSVSKTHLDPEYYRL-----------QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCY  486 (613)
Q Consensus       426 --------~~~~~~~~~aPE~~~~-----------~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~  486 (613)
                              ...++..|+|||++..           ..++.++|||||||+||||++|++||........ .+.... ...
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~-~~~  237 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-KLHAII-DPN  237 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHHHH-CTT
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-HHHHHh-cCC
Confidence                    2246788999999975           6789999999999999999999999964322111 111111 111


Q ss_pred             ccCCccccccHHHH--HhcccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          487 QNGTIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       487 ~~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                      .........+..+.  ..+||+.||.+||++.|++++.+...+.
T Consensus       238 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence            11122232322222  2379999999999999999998876543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.7e-40  Score=372.69  Aligned_cols=239  Identities=25%  Similarity=0.402  Sum_probs=193.5

Q ss_pred             eeeeeCcEEEEEEEEc--CCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCCCC
Q 048439          279 VIGVGGFGDVYKGFIN--GSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGT  355 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~--~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs  355 (613)
                      .||+|+||.||+|.+.  +++..||||+++... ....++|.+|+++|++++|||||+++++|.+ +..++|||||++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999875  345679999998753 3456789999999999999999999999986 56999999999999


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC--------
Q 048439          356 LPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT--------  427 (613)
Q Consensus       356 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~--------  427 (613)
                      |.+++.. ....+++.+++.|+.||++||+|||+.+    |+||||||+|||+++++.+||+|||+++....        
T Consensus       422 L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~----iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  496 (613)
T 2ozo_A          422 LHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN----FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  496 (613)
T ss_dssp             HHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             HHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC----EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence            9999954 3456999999999999999999999998    99999999999999999999999999975321        


Q ss_pred             ---CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-Hh
Q 048439          428 ---SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AM  502 (613)
Q Consensus       428 ---~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~  502 (613)
                         .++..|+|||++..+.++.++|||||||+||||++ |+.||......+..   ..............+.+.+.. ..
T Consensus       497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~---~~i~~~~~~~~p~~~~~~l~~li~  573 (613)
T 2ozo_A          497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQGKRMECPPECPPELYALMS  573 (613)
T ss_dssp             -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH---HHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHcCCCCCCCCcCCHHHHHHHH
Confidence               12356999999999999999999999999999998 99999765443322   111111111112222222222 23


Q ss_pred             cccccCCCCCCCHHHHHHHHHHhh
Q 048439          503 SCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       503 ~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      +||+.+|++||++.+|++.|+...
T Consensus       574 ~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          574 DCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             HTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHcCCChhHCcCHHHHHHHHHHHH
Confidence            799999999999999999998544

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.1e-40  Score=341.81  Aligned_cols=255  Identities=24%  Similarity=0.390  Sum_probs=196.4

Q ss_pred             HHHHHhcCCCCcceeeeeCcEEEEEEEEcC---CceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeec
Q 048439          266 EIQAATNNFDNDLVIGVGGFGDVYKGFING---STTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND  340 (613)
Q Consensus       266 el~~at~~f~~~~~iG~G~fG~Vy~g~~~~---~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~  340 (613)
                      ++....++|...+.||+|+||.||+|....   ++..||||+++..  .......|.+|+.++++++||||+++++++.+
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            334455678888899999999999998754   4457999998754  34455779999999999999999999999987


Q ss_pred             CC-----ceEEEEEcCCCCChhHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC
Q 048439          341 DR-----EMILVYDFMARGTLPDHLYH----SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK  411 (613)
Q Consensus       341 ~~-----~~~lV~Ey~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~  411 (613)
                      .+     ..++||||+++|+|.+++..    .....+++..++.++.|+++||.|||+.+    |+||||||+|||++++
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~dikp~NIli~~~  183 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN----FLHRDLAARNCMLRDD  183 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT----CCCCCCSGGGEEECTT
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCCcceEEEcCC
Confidence            65     35999999999999999843    23467999999999999999999999998    9999999999999999


Q ss_pred             CcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHH
Q 048439          412 WVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAV  480 (613)
Q Consensus       412 ~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~  480 (613)
                      +.+||+|||+++...          ..++..|+|||.+....++.++|||||||+||||++ |++||.........   .
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~  260 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY---D  260 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---H
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---H
Confidence            999999999986421          123456999999999999999999999999999999 88888654433221   1


Q ss_pred             HHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          481 WAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       481 ~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      .............+.+.+.. ..+||+.+|.+||++.+++++|+..++
T Consensus       261 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          261 YLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             HHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            11111111122222222222 237999999999999999999997654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.6e-40  Score=336.91  Aligned_cols=244  Identities=20%  Similarity=0.310  Sum_probs=196.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh------hcHHHHHHHHHHHhccCccceeeEEEEeecCCceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ------QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~------~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  345 (613)
                      ++|...+.||+|+||.||+|+...++..||||.++....      ...+.|.+|+.++++++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            467888899999999999999988788999999865421      23678999999999999999999999999999999


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC----cEEEEecCC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW----VAKVSDFGL  421 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFGl  421 (613)
                      +||||+++++|.+++..  ...+++.+++.++.|++.||.|||+.+    |+||||||+|||++.++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            99999999999999854  356999999999999999999999998    99999999999999877    899999999


Q ss_pred             CccCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc--CCcc
Q 048439          422 SKFGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN--GTID  492 (613)
Q Consensus       422 s~~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~  492 (613)
                      ++...       ..++..|+|||.+....++.++||||||+++|||++|+.||......+.....  .......  ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~  236 (283)
T 3bhy_A          159 AHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI--SAVNYDFDEEYFS  236 (283)
T ss_dssp             CEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HTTCCCCCHHHHT
T ss_pred             ceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh--HhcccCCcchhcc
Confidence            86422       23567899999999999999999999999999999999999765433221111  1000000  0001


Q ss_pred             ccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          493 QIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       493 ~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ...+.... ..+||..||.+||++.|++++..
T Consensus       237 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  268 (283)
T 3bhy_A          237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW  268 (283)
T ss_dssp             TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHH
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHH
Confidence            11111111 23899999999999999997655

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.2e-40  Score=338.52  Aligned_cols=243  Identities=27%  Similarity=0.370  Sum_probs=200.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +.|...+.||+|+||.||+|+...++..||||++.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            45788889999999999999998888899999997653 34567899999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-----  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-----  425 (613)
                      +++++|.+++.   ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..     
T Consensus       102 ~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          102 LGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEK----KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             CTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             CCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC----CccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            99999999984   356999999999999999999999998    999999999999999999999999998532     


Q ss_pred             ---CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--
Q 048439          426 ---PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--  500 (613)
Q Consensus       426 ---~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--  500 (613)
                         ...++..|+|||.+....++.++|||||||+||||++|++||..........   ..... .........+..+.  
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~l~~l  250 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF---LIPKN-NPPTLEGNYSKPLKEF  250 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHS-CCCCCCSSCCHHHHHH
T ss_pred             ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH---HhhcC-CCCCCccccCHHHHHH
Confidence               2235677999999999999999999999999999999999996543322211   11111 11112222222222  


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ..+||+.+|.+||++.|++++....
T Consensus       251 i~~~l~~dp~~Rps~~~ll~~~~~~  275 (303)
T 3a7i_A          251 VEACLNKEPSFRPTAKELLKHKFIL  275 (303)
T ss_dssp             HHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred             HHHHcCCChhhCcCHHHHhhChhhh
Confidence            2279999999999999999877654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.3e-40  Score=338.94  Aligned_cols=248  Identities=27%  Similarity=0.428  Sum_probs=194.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCC---ceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEee-cCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGS---TTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCN-DDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~---~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~l  346 (613)
                      .+|...++||+|+||.||+|++..+   ...||||.++.. .....+.|.+|+.++++++||||++++++|. .++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            4577778999999999999997433   345899998764 3445677999999999999999999999865 4567899


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+++...
T Consensus       105 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~----i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKK----FVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC----ccCCCCchheEEECCCCCEEECccccccccc
Confidence            9999999999999964 3466899999999999999999999998    9999999999999999999999999986421


Q ss_pred             ------------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccc
Q 048439          427 ------------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ  493 (613)
Q Consensus       427 ------------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  493 (613)
                                  ..++..|+|||.+.+..++.++|||||||++|||++ |.+|+......+.   ...............
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  256 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLLQGRRLLQPEY  256 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHHHHTTCCCCCCTT
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHHHhcCCCCCCCcc
Confidence                        123456999999999999999999999999999999 5566544332221   111111111111122


Q ss_pred             cccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          494 IVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       494 ~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      ..+.+.. ..+||+.+|.+||++.|+++.|+..+.
T Consensus       257 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            2222222 237999999999999999999986554

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.7e-40  Score=342.63  Aligned_cols=250  Identities=25%  Similarity=0.300  Sum_probs=197.9

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEee----cCCceEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN----DDREMIL  346 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~----~~~~~~l  346 (613)
                      .++|...+.||+|+||.||+++...++..||||++..........+.+|+.++++++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            467888899999999999999998788999999997776677788999999999999999999999987    3457899


Q ss_pred             EEEcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          347 VYDFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ||||+++|+|.+++..  .....+++.+++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++.
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~----ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG----YAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            9999999999999854  23567999999999999999999999998    99999999999999999999999998864


Q ss_pred             CCC-----------------CCCcccCChhhhhcCC---CCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHH
Q 048439          425 GPT-----------------SVSKTHLDPEYYRLQQ---LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQ  484 (613)
Q Consensus       425 ~~~-----------------~~~~~~~aPE~~~~~~---~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~  484 (613)
                      ...                 .++..|+|||.+....   ++.++|||||||++|||++|+.||........ ........
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~  262 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAVQN  262 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHHHC
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHhhc
Confidence            321                 1366799999987654   68999999999999999999999964322211 11111111


Q ss_pred             hhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          485 CYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       485 ~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      .........+...+.. ..+||+.||.+||++.++++.|+..
T Consensus       263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  304 (317)
T 2buj_A          263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL  304 (317)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence            1111111122222222 2379999999999999999999853

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=348.28  Aligned_cols=246  Identities=17%  Similarity=0.145  Sum_probs=187.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcC---CceeEEEEEeCCCChh-----------cHHHHHHHHHHHhccCccceeeEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFING---STTPVAIKRLEPESQQ-----------GALEFQTEIGMLSQLRHLHLVSLIGF  337 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~---~~~~vAVK~~~~~~~~-----------~~~~f~~Ei~~l~~l~H~niv~l~g~  337 (613)
                      ++|...+.||+|+||.||+|+...   .+..||||++......           ....+.+|+..+..++|+||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            568888899999999999999976   6688999998765321           22346788999999999999999999


Q ss_pred             eec----CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC-
Q 048439          338 CND----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW-  412 (613)
Q Consensus       338 ~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~-  412 (613)
                      +.+    ....++||||+ +++|.+++...  ..+++.+++.|+.|++.||.|||+.+    |+||||||+|||++.++ 
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENE----YVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEESSST
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC----eeCCCcCHHHEEEccCCC
Confidence            987    77899999999 99999998543  37999999999999999999999998    99999999999999887 


Q ss_pred             -cEEEEecCCCccC---------------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhh
Q 048439          413 -VAKVSDFGLSKFG---------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV  476 (613)
Q Consensus       413 -~~kl~DFGls~~~---------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~  476 (613)
                       .+||+|||+++..               ...++..|+|||++.+..++.++|||||||+||||++|+.||.........
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             9999999999532               224677899999999999999999999999999999999999653222211


Q ss_pred             hHHHHHH--HhhccC-----CccccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          477 SLAVWAQ--QCYQNG-----TIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       477 ~l~~~~~--~~~~~~-----~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .......  ......     ....+.+.+.. ..+||..+|.+||++.+|++.|+.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  325 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP  325 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred             HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            1111111  000000     00011112222 227999999999999999998884

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.7e-40  Score=353.37  Aligned_cols=198  Identities=27%  Similarity=0.428  Sum_probs=165.7

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccC-ccceeeEEEEeecCC--ce
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDR--EM  344 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~--~~  344 (613)
                      ..++|...+.||+|+||.||+|....++..||||++...  .......+.+|+.+|.+++ |+||+++++++...+  .+
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            457899999999999999999999888899999998653  3445667889999999997 999999999997544  78


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++|||||+ |+|.+++..   ..+++..+..++.|+++||+|||+.+    |+||||||+|||++.++.+||+|||+|+.
T Consensus        87 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~----ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG----LLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC----EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            99999998 599998854   46899999999999999999999998    99999999999999999999999999964


Q ss_pred             CC-----------------------------CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhh
Q 048439          425 GP-----------------------------TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK  474 (613)
Q Consensus       425 ~~-----------------------------~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~  474 (613)
                      ..                             ..++..|+|||++.+ ..++.++|||||||+||||++|++||......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            21                             245677999999986 678999999999999999999999997665544


Q ss_pred             h
Q 048439          475 Q  475 (613)
Q Consensus       475 ~  475 (613)
                      +
T Consensus       239 ~  239 (388)
T 3oz6_A          239 Q  239 (388)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3e-40  Score=348.30  Aligned_cols=245  Identities=16%  Similarity=0.156  Sum_probs=194.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcC--------CceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceee----------
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFING--------STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVS----------  333 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~--------~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~----------  333 (613)
                      ++|...+.||+|+||.||+|+...        .+..||||++...     ..+.+|+.++.+++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            578888899999999999999976        3678999998754     35789999999999999998          


Q ss_pred             -----EEEEeec-CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCcee
Q 048439          334 -----LIGFCND-DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNIL  407 (613)
Q Consensus       334 -----l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NIL  407 (613)
                           +++++.. .+..++||||+ +|+|.+++.......+++.+++.|+.|++.||.|||+.+    |+||||||+|||
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----ivH~Dikp~NIl  191 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE----YVHGNVTAENIF  191 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT----CBCSCCCGGGEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC----ccCCCCCHHHEE
Confidence                 6777765 77889999999 999999997654567999999999999999999999998    999999999999


Q ss_pred             eCCCC--cEEEEecCCCccC---------------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          408 LDEKW--VAKVSDFGLSKFG---------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       408 l~~~~--~~kl~DFGls~~~---------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                      ++.++  .+||+|||+++..               ...++..|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  9999999999532               124677899999999999999999999999999999999999765


Q ss_pred             hhhhhhhHHHHHHHhh-ccCCcc-------ccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          471 AAKKQVSLAVWAQQCY-QNGTID-------QIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       471 ~~~~~~~l~~~~~~~~-~~~~~~-------~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      ...... ......... ....+.       .+...+.. ..+||+.||.+||++.+|++.|+..++
T Consensus       272 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  336 (352)
T 2jii_A          272 LPNTED-IMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ  336 (352)
T ss_dssp             TTCHHH-HHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CcCHHH-HHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence            422211 111111111 111110       11122222 227999999999999999999986554

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.5e-40  Score=339.41  Aligned_cols=242  Identities=21%  Similarity=0.327  Sum_probs=199.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|....++..||+|.+...   .....+.+.+|+.++++++|+||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            5677888999999999999999988889999998654   2345567899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+++++|.+++..  ...+++.+++.++.|+++||.|||+.+    |+||||||+|||++.++.+||+|||+++...  
T Consensus        95 e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           95 ELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNR----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             ECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            99999999998853  356999999999999999999999998    9999999999999999999999999986422  


Q ss_pred             ------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          427 ------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       427 ------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                            ..++..|+|||.+....++.++||||||+++|||++|+.||......+.....     ...........++.+.
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  243 (294)
T 2rku_A          169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-----KKNEYSIPKHINPVAA  243 (294)
T ss_dssp             TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-----HTTCCCCCTTSCHHHH
T ss_pred             ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----hhccCCCccccCHHHH
Confidence                  23566799999999999999999999999999999999999765433321111     1111122222333222


Q ss_pred             --HhcccccCCCCCCCHHHHHHHHHH
Q 048439          501 --AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       501 --~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                        ..+||+.||.+||++.|++++..+
T Consensus       244 ~li~~~l~~~p~~Rps~~~ll~~~~~  269 (294)
T 2rku_A          244 SLIQKMLQTDPTARPTINELLNDEFF  269 (294)
T ss_dssp             HHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             HHHHHHcccChhhCcCHHHHhhChhe
Confidence              227999999999999999876653

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5e-40  Score=336.67  Aligned_cols=245  Identities=29%  Similarity=0.481  Sum_probs=189.0

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      .++|...+.||+|+||.||+|+..+   .||||+++..  .....+.|.+|+.++++++|+||+++++++. ....++||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~   98 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT   98 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence            3568888899999999999998654   3999998754  3445677999999999999999999999764 55689999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+++++|.+++... ...+++.+++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++...  
T Consensus        99 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~----i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           99 QWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKS----IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC----cccccCccceEEECCCCCEEEccceeccccccc
Confidence            999999999998543 466999999999999999999999998    9999999999999999999999999986321  


Q ss_pred             --------CCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcc---
Q 048439          427 --------TSVSKTHLDPEYYR---LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID---  492 (613)
Q Consensus       427 --------~~~~~~~~aPE~~~---~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---  492 (613)
                              ..++..|+|||.+.   ...++.++|||||||++|||++|+.||......+.  +..............   
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~  251 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRGSLSPDLSKVR  251 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHHTSCCCCTTSSC
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhcccccCcchhhcc
Confidence                    23577899999997   56788999999999999999999999976443332  122222211111111   


Q ss_pred             -ccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          493 -QIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       493 -~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                       .+.+.+.. ..+||+.+|.+||++.++++.|+...
T Consensus       252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence             12222222 23799999999999999999998654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3e-40  Score=344.82  Aligned_cols=239  Identities=21%  Similarity=0.293  Sum_probs=176.3

Q ss_pred             cceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC-ccceeeEEEEeecCCceEEEEEcCCCCC
Q 048439          277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDREMILVYDFMARGT  355 (613)
Q Consensus       277 ~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gs  355 (613)
                      .+.||+|+||.||+|+...++..||||++...   ....+.+|+.++.+++ ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            36899999999999999888899999998643   3456789999999997 9999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC---cEEEEecCCCccCC------
Q 048439          356 LPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW---VAKVSDFGLSKFGP------  426 (613)
Q Consensus       356 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~---~~kl~DFGls~~~~------  426 (613)
                      |.+++..  ...+++.+++.|+.|++.||+|||+.+    |+||||||+|||++.++   .+||+|||+++...      
T Consensus        93 L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~----ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~  166 (325)
T 3kn6_A           93 LFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVG----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL  166 (325)
T ss_dssp             HHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence            9999965  457999999999999999999999998    99999999999997665   89999999997422      


Q ss_pred             --CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcc-------ccccH
Q 048439          427 --TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID-------QIVDP  497 (613)
Q Consensus       427 --~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-------~~~d~  497 (613)
                        ..++..|+|||++....++.++|||||||++|||++|++||.....................+...       .+.+.
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  246 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQE  246 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHH
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHH
Confidence              234677999999999999999999999999999999999997543321111111111112222111       11111


Q ss_pred             HHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          498 FLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       498 ~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ... ..+||+.||.+||++.|++++.+.
T Consensus       247 ~~~li~~~L~~dP~~Rpt~~ell~h~w~  274 (325)
T 3kn6_A          247 AKDLIQGLLTVDPNKRLKMSGLRYNEWL  274 (325)
T ss_dssp             HHHHHHHHHCCCTTTCCCTTTSTTCGGG
T ss_pred             HHHHHHHHCCCChhHCCCHHHHhcChhh
Confidence            211 227999999999999999866553

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.8e-40  Score=346.02  Aligned_cols=251  Identities=25%  Similarity=0.392  Sum_probs=196.4

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEE-----cCCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCce
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFI-----NGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~-----~~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~  344 (613)
                      .++|...+.||+|+||.||+|++     ..++..||||++... ......++.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            36788888999999999999984     345578999999754 445566799999999999999999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC---CCcEEE
Q 048439          345 ILVYDFMARGTLPDHLYHSD-----NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE---KWVAKV  416 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~---~~~~kl  416 (613)
                      ++||||+++|+|.+++....     ...+++.+++.++.|++.||.|||+.+    |+||||||+|||++.   +..+||
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~----i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH----FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC----eecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999996542     245999999999999999999999998    999999999999984   456999


Q ss_pred             EecCCCccC----------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHh
Q 048439          417 SDFGLSKFG----------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQC  485 (613)
Q Consensus       417 ~DFGls~~~----------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~  485 (613)
                      +|||+++..          ...++..|+|||.+....++.++|||||||+||||++ |+.||......+.   .......
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~~~~  261 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEFVTSG  261 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHHHTT
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---HHHHhcC
Confidence            999998521          1223567999999999999999999999999999998 9999865433221   1111111


Q ss_pred             hccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          486 YQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       486 ~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                      ........+.+.+.. ..+||+.+|.+||++.+++++|+...+.
T Consensus       262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            111111122222222 2379999999999999999999976543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=344.44  Aligned_cols=258  Identities=25%  Similarity=0.345  Sum_probs=200.9

Q ss_pred             ccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEee
Q 048439          261 QFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCN  339 (613)
Q Consensus       261 ~f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~  339 (613)
                      .+.+.++....++|...+.||+|+||.||+|+...++..||||++.... .....+.+|+.++.++ +||||+++++++.
T Consensus        13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            3555566667889999999999999999999998777899999987543 3456789999999999 7999999999997


Q ss_pred             c------CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc
Q 048439          340 D------DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV  413 (613)
Q Consensus       340 ~------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~  413 (613)
                      .      .+..++||||+++|+|.+++.......+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK----VIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCSGGGEEECTTCC
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC----ccccCCcHHHEEEcCCCC
Confidence            6      467899999999999999997655567999999999999999999999998    999999999999999999


Q ss_pred             EEEEecCCCccCC--------CCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHH
Q 048439          414 AKVSDFGLSKFGP--------TSVSKTHLDPEYYR-----LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAV  480 (613)
Q Consensus       414 ~kl~DFGls~~~~--------~~~~~~~~aPE~~~-----~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~  480 (613)
                      +||+|||++....        ..++..|+|||.+.     ...++.++|||||||+||||++|++||...........  
T Consensus       168 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--  245 (326)
T 2x7f_A          168 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL--  245 (326)
T ss_dssp             EEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--
T ss_pred             EEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH--
Confidence            9999999986422        23567799999997     56789999999999999999999999965443322111  


Q ss_pred             HHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          481 WAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       481 ~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      .............+.+.+.. ..+||..||.+||++.+++++....
T Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~  291 (326)
T 2x7f_A          246 IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR  291 (326)
T ss_dssp             HHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred             hhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence            11111111111111122222 2279999999999999999876543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=345.22  Aligned_cols=247  Identities=22%  Similarity=0.335  Sum_probs=194.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh-cHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ-GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ++|...+.||+|+||.||+|+...++..||||++...... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            4678888999999999999999888889999999765322 222456899999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      ++ |+|.+++... ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++...    
T Consensus        82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~----ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQK----VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT----EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC----ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            98 5999988653 456999999999999999999999998    9999999999999999999999999986422    


Q ss_pred             ----CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccc-------
Q 048439          427 ----TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQI-------  494 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~-------  494 (613)
                          ..++..|+|||.+.+ ..++.++|||||||++|||++|++||......+....................       
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence                234677999999976 56899999999999999999999999776555443333222111111111100       


Q ss_pred             ------------------ccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          495 ------------------VDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       495 ------------------~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                                        +++.+.  ..+||+.||.+|||+.|++++..+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  285 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF  285 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhh
Confidence                              111111  227999999999999999977664

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.2e-40  Score=333.90  Aligned_cols=247  Identities=23%  Similarity=0.310  Sum_probs=199.4

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      .++|...+.||+|+||.||+|+...++..||||++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            357888889999999999999998778899999986543 3445678999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----  425 (613)
                      |+++|+|.+++.  ....+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||++...    
T Consensus        86 ~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC----eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            999999999984  3456999999999999999999999998    999999999999999999999999998631    


Q ss_pred             ------CCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          426 ------PTSVSKTHLDPEYYRLQQL-TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       426 ------~~~~~~~~~aPE~~~~~~~-t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                            ...++..|+|||.+....+ +.++|||||||++|||++|+.||........ ....|............+.+..
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  238 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTYLNPWKKIDSAP  238 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTTCTTSTTGGGSCHHH
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhcccccCchhhcCHHH
Confidence                  2345678999999988765 7899999999999999999999975443221 2222322211111112222222


Q ss_pred             HH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          499 LK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       499 ~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .. ..+||+.||.+||++.|++++..+
T Consensus       239 ~~li~~~l~~~p~~Rps~~~il~~~~~  265 (276)
T 2yex_A          239 LALLHKILVENPSARITIPDIKKDRWY  265 (276)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             HHHHHHHCCCCchhCCCHHHHhcCccc
Confidence            22 237999999999999999876543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.1e-40  Score=347.32  Aligned_cols=194  Identities=26%  Similarity=0.358  Sum_probs=173.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ++|...+.||+|+||.||+|....++..||+|++... .......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            5688888999999999999999988899999999765 344456799999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc-----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG-ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF-----  424 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~-----  424 (613)
                      +++|+|.+++..  ...+++..+..++.+++.||.|||+. +    |+||||||+|||++.++.+||+|||+++.     
T Consensus       113 ~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  186 (360)
T 3eqc_A          113 MDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  186 (360)
T ss_dssp             CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHC----CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred             CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHhCC----EEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence            999999999954  34689999999999999999999985 7    99999999999999999999999999852     


Q ss_pred             -CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          425 -GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       425 -~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                       ....++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  234 (360)
T 3eqc_A          187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  234 (360)
T ss_dssp             ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred             ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence             23356778999999999999999999999999999999999996543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.9e-40  Score=346.16  Aligned_cols=242  Identities=21%  Similarity=0.329  Sum_probs=200.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+++...++..||+|++...   .....+.+.+|+.++++++|+||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            5678888999999999999999988889999998654   3345567899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+++++|.+++..  ...+++.+++.++.|+++||.|||+.+    |+||||||+|||++.++.+||+|||+++...  
T Consensus       121 e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~----ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          121 ELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNR----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             CCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC----CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            99999999998854  356999999999999999999999998    9999999999999999999999999986422  


Q ss_pred             ------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          427 ------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       427 ------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                            ..++..|+|||.+....++.++|||||||+||||++|+.||......+......     .....+....++.+.
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  269 (335)
T 2owb_A          195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-----KNEYSIPKHINPVAA  269 (335)
T ss_dssp             TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----HTCCCCCTTSCHHHH
T ss_pred             cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh-----cCCCCCCccCCHHHH
Confidence                  235667999999999999999999999999999999999997654333211111     111122222333222


Q ss_pred             --HhcccccCCCCCCCHHHHHHHHHH
Q 048439          501 --AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       501 --~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                        ..+||+.||.+||++.|++++..+
T Consensus       270 ~li~~~l~~dp~~Rps~~ell~~~~~  295 (335)
T 2owb_A          270 SLIQKMLQTDPTARPTINELLNDEFF  295 (335)
T ss_dssp             HHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             HHHHHHccCChhHCcCHHHHhcCccc
Confidence              227999999999999999876554

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.1e-40  Score=341.15  Aligned_cols=247  Identities=22%  Similarity=0.259  Sum_probs=193.3

Q ss_pred             cCCCC-cceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDN-DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~-~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      +.|.. .++||+|+||.||+|+...++..||||++..........+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            34555 36799999999999998877889999999876666677899999999985 79999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc---EEEEecCCCccCC
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV---AKVSDFGLSKFGP  426 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFGls~~~~  426 (613)
                      |+++|+|.+++..  ...+++..++.++.|++.||+|||+.+    |+||||||+|||++.++.   +||+|||+++...
T Consensus        92 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~----ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNKG----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC----ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            9999999999954  356899999999999999999999998    999999999999998776   9999999986421


Q ss_pred             ---------------CCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCccchhhhh------------
Q 048439          427 ---------------TSVSKTHLDPEYYRL-----QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK------------  474 (613)
Q Consensus       427 ---------------~~~~~~~~aPE~~~~-----~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~------------  474 (613)
                                     ..++..|+|||.+..     ..++.++|||||||++|||++|++||......+            
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence                           226778999999975     568899999999999999999999996543211            


Q ss_pred             hhhHHHHHHHhhccCC---ccccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          475 QVSLAVWAQQCYQNGT---IDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       475 ~~~l~~~~~~~~~~~~---~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ...+............   ...+...... ..+||+.||.+||++.|++++...
T Consensus       246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~  299 (316)
T 2ac3_A          246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV  299 (316)
T ss_dssp             HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred             HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence            0111111111000000   0111111111 227999999999999999977653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.3e-39  Score=331.92  Aligned_cols=249  Identities=18%  Similarity=0.189  Sum_probs=195.4

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEe-ecCCceEEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC-NDDREMILVYD  349 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~E  349 (613)
                      .++|...+.||+|+||.||+|+...+++.||||++.....  ..++.+|+.++.+++|++++..++++ .+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            4678888999999999999999988889999999865432  23688999999999998877766665 55677899999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee---CCCCcEEEEecCCCccC-
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSKFG-  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGls~~~-  425 (613)
                      |+ +|+|.+++... ...+++.+++.++.|++.||+|||+.+    |+||||||+|||+   ++++.+||+|||+++.. 
T Consensus        86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~----ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC----eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 89999998642 456999999999999999999999998    9999999999999   48899999999998631 


Q ss_pred             --------------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHH-HHHHHhhccC-
Q 048439          426 --------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLA-VWAQQCYQNG-  489 (613)
Q Consensus       426 --------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~-~~~~~~~~~~-  489 (613)
                                    ...++..|+|||.+.+..++.++|||||||+||||++|+.||............ .......... 
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence                          224567799999999999999999999999999999999999754322211111 1111111110 


Q ss_pred             --CccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          490 --TIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       490 --~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                        ....+.+.+.. ..+||+.+|.+||++.+|++.|+...+
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  280 (296)
T 3uzp_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence              00111111211 227999999999999999999986554

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.1e-40  Score=351.85  Aligned_cols=253  Identities=19%  Similarity=0.249  Sum_probs=199.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCC--ceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR--EMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~  348 (613)
                      ++|...++||+|+||.||+|+...++..||||+++... ......+.+|++++++++||||+++++++.+.+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            46778889999999999999999888999999997643 344567889999999999999999999998755  789999


Q ss_pred             EcCCCCChhHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee----CCCCcEEEEecCCCc
Q 048439          349 DFMARGTLPDHLYHSD-NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL----DEKWVAKVSDFGLSK  423 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGls~  423 (613)
                      ||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+    |+||||||+|||+    +.++.+||+|||+++
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC----EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            9999999999996432 334999999999999999999999998    9999999999999    888899999999996


Q ss_pred             cC-------CCCCCcccCChhhhhc--------CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhh-hHHHHHHHhhc
Q 048439          424 FG-------PTSVSKTHLDPEYYRL--------QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV-SLAVWAQQCYQ  487 (613)
Q Consensus       424 ~~-------~~~~~~~~~aPE~~~~--------~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~-~l~~~~~~~~~  487 (613)
                      ..       ...++..|+|||++..        ..++.++|||||||++|||++|+.||......... ...........
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p  244 (396)
T 4eut_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (396)
T ss_dssp             ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred             EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence            42       2345778999999875        56788999999999999999999999754322211 11111111110


Q ss_pred             cC-----------------------CccccccHHHH--HhcccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          488 NG-----------------------TIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       488 ~~-----------------------~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                      ..                       .+....+..+.  ..+||+.||++||++.++++.++..++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            00                       00111111221  2279999999999999999999887764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.2e-40  Score=336.92  Aligned_cols=242  Identities=24%  Similarity=0.321  Sum_probs=198.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|+...++..||||++....   ......+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56888889999999999999998888899999986532   223467899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+++|+|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||++...   
T Consensus        94 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           94 EFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHERK----VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTT----EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            99999999999854  346899999999999999999999998    999999999999999999999999998542   


Q ss_pred             ---CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--
Q 048439          426 ---PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--  500 (613)
Q Consensus       426 ---~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--  500 (613)
                         ...++..|+|||.+.+..++.++||||||+++|||++|+.||......+......     ..........+..+.  
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l  242 (284)
T 2vgo_A          168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV-----NVDLKFPPFLSDGSKDL  242 (284)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----TTCCCCCTTSCHHHHHH
T ss_pred             ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh-----ccccCCCCcCCHHHHHH
Confidence               2345678999999999999999999999999999999999997544332211111     111112222222222  


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ..+||+.+|.+||++.+++++...
T Consensus       243 i~~~l~~~p~~Rps~~~ll~h~~~  266 (284)
T 2vgo_A          243 ISKLLRYHPPQRLPLKGVMEHPWV  266 (284)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred             HHHHhhcCHhhCCCHHHHhhCHHH
Confidence            227999999999999999877654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.8e-40  Score=337.60  Aligned_cols=245  Identities=30%  Similarity=0.454  Sum_probs=191.9

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecC-CceEEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD-REMILVYD  349 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~E  349 (613)
                      .++|...+.||+|+||.||+|...  +..||||+++...  ..+.|.+|+.++++++||||+++++++.+. +..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            357888889999999999999886  3679999997543  456789999999999999999999997654 57899999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---  426 (613)
                      |+++|+|.+++.......+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++...   
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  171 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  171 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC----ccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence            999999999996543344899999999999999999999998    9999999999999999999999999986422   


Q ss_pred             --CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-Hh
Q 048439          427 --TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AM  502 (613)
Q Consensus       427 --~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~  502 (613)
                        ..++..|+|||.+....++.++||||||+++|||++ |++||......+..   ................+.+.. ..
T Consensus       172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~  248 (278)
T 1byg_A          172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRVEKGYKMDAPDGCPPAVYEVMK  248 (278)
T ss_dssp             ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---HHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred             cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHhcCCCCCCcccCCHHHHHHHH
Confidence              234567999999999999999999999999999998 99999654433221   111111111111122222222 22


Q ss_pred             cccccCCCCCCCHHHHHHHHHHhh
Q 048439          503 SCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       503 ~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      +||+.||.+||++.|+++.|+...
T Consensus       249 ~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          249 NCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhcCChhhCCCHHHHHHHHHHHH
Confidence            799999999999999999998643

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=339.06  Aligned_cols=250  Identities=26%  Similarity=0.395  Sum_probs=197.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEE----cCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCC--ceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFI----NGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR--EMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~----~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~  345 (613)
                      ++|...+.||+|+||.||+|++    ..++..||||++........+.|.+|++++++++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            4577788999999999999985    4456889999998877777788999999999999999999999987654  789


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +||||+++|+|.+++... ...+++.+++.++.|+++||.|||+.+    |+||||||+|||++.++.+||+|||+++..
T Consensus       121 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKR----YIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             EEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC----EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            999999999999999653 356999999999999999999999998    999999999999999999999999998643


Q ss_pred             C-----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhh----------hh---hHHHH
Q 048439          426 P-----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK----------QV---SLAVW  481 (613)
Q Consensus       426 ~-----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~----------~~---~l~~~  481 (613)
                      .           ..++..|+|||.+.+..++.++|||||||+||||++|+.|+......-          ..   .+...
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  275 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence            2           123445999999999999999999999999999999999886432110          00   01111


Q ss_pred             HHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          482 AQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       482 ~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ............+.+.+.. ..+||+.+|.+||++.||++.|+...
T Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1111111111222222222 23799999999999999999998654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.5e-40  Score=344.63  Aligned_cols=249  Identities=20%  Similarity=0.296  Sum_probs=191.5

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh--hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ--QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ...++|...+.||+|+||.||+|+...++..||||+++....  .....+.+|+.++++++||||+++++++.+.+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            345689999999999999999999988889999999976532  234567899999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee-----CCCCcEEEEecCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL-----DEKWVAKVSDFGL  421 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl-----~~~~~~kl~DFGl  421 (613)
                      ||||+++ +|.+++..  ...+++..++.|+.|++.||.|||+.+    |+||||||+|||+     ++++.+||+|||+
T Consensus       111 v~e~~~~-~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~----ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSRR----CLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEECCSE-EHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEecCCC-CHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            9999984 99999854  346999999999999999999999998    9999999999999     5566799999999


Q ss_pred             CccC--------CCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCc-
Q 048439          422 SKFG--------PTSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTI-  491 (613)
Q Consensus       422 s~~~--------~~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~-  491 (613)
                      ++..        ...++..|+|||++.+. .++.++|||||||++|||++|++||......+................. 
T Consensus       184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  263 (329)
T 3gbz_A          184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP  263 (329)
T ss_dssp             HHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence            8532        22346789999999874 4899999999999999999999999765544332222211111100000 


Q ss_pred             ------------------------cccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          492 ------------------------DQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       492 ------------------------~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                                              ....+..+.  ..+||+.||.+|||+.|++++..+
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  322 (329)
T 3gbz_A          264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF  322 (329)
T ss_dssp             TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence                                    001122221  237999999999999999876553

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.7e-39  Score=332.67  Aligned_cols=251  Identities=18%  Similarity=0.186  Sum_probs=193.7

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEe-ecCCceEEEE
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC-NDDREMILVY  348 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~  348 (613)
                      ..++|...+.||+|+||.||+|+...++..||||++.....  ...+.+|+.++.+++|++++..+++| .+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            45789999999999999999999988889999998755432  23578999999999988887777766 5677789999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee---CCCCcEEEEecCCCccC
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGls~~~  425 (613)
                      ||+ +|+|.+++... ...+++..++.++.|++.||+|||+.+    |+||||||+|||+   ++++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~----ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 99999998643 456999999999999999999999998    9999999999999   78999999999998632


Q ss_pred             ---------------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCC
Q 048439          426 ---------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT  490 (613)
Q Consensus       426 ---------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~  490 (613)
                                     ...++..|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence                           22456789999999999999999999999999999999999975433222222111111111111


Q ss_pred             c----cccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          491 I----DQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       491 ~----~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                      .    ..+.+.+.. ..+||+.+|++||++.+|++.|+..++.
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence            0    111122221 2279999999999999999999876643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.4e-40  Score=354.02  Aligned_cols=236  Identities=24%  Similarity=0.298  Sum_probs=184.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHH-HhccCccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGM-LSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|...++||+|+||.||+|+...++..||||+++...   ......+..|..+ ++.++||||+++++++.+.+.+++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            57888899999999999999999888999999997643   2334456777776 5778999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--  425 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--  425 (613)
                      |||+++|+|.+++..  ...+++..++.++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++..  
T Consensus       118 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g----ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          118 LDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLN----IVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            999999999999854  346899999999999999999999998    999999999999999999999999998741  


Q ss_pred             ------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH
Q 048439          426 ------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       426 ------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                            ...++..|+|||++.+..++.++|||||||+||||++|++||......+......  .   ....+..-+...+
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~---~~~~~~~~~~~~~  266 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--N---KPLQLKPNITNSA  266 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH--H---SCCCCCSSSCHHH
T ss_pred             CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--h---cccCCCCCCCHHH
Confidence                  2246778999999999999999999999999999999999997654433222111  1   1111111222222


Q ss_pred             H--HhcccccCCCCCCCHHHH
Q 048439          500 K--AMSCLNDEGIRRPSMSDV  518 (613)
Q Consensus       500 ~--~~~Cl~~~p~~RPs~~ev  518 (613)
                      .  ..+||+.||.+||++.+.
T Consensus       267 ~~li~~lL~~dp~~R~~~~~~  287 (373)
T 2r5t_A          267 RHLLEGLLQKDRTKRLGAKDD  287 (373)
T ss_dssp             HHHHHHHTCSSGGGSTTTTTT
T ss_pred             HHHHHHHcccCHHhCCCCCCC
Confidence            2  227999999999998543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.3e-40  Score=337.84  Aligned_cols=247  Identities=22%  Similarity=0.283  Sum_probs=195.9

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      .++|...+.||+|+||.||+|+...++..||+|.+..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            35788888999999999999999888889999999877777778899999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc------
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------  424 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~------  424 (613)
                      +++|+|.+++... ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||++..      
T Consensus        98 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (302)
T 2j7t_A           98 CPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKR----IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ  172 (302)
T ss_dssp             CTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred             CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCC----cccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence            9999999988542 356999999999999999999999998    99999999999999999999999998742      


Q ss_pred             --CCCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccH
Q 048439          425 --GPTSVSKTHLDPEYYR-----LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP  497 (613)
Q Consensus       425 --~~~~~~~~~~aPE~~~-----~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  497 (613)
                        ....++..|+|||++.     ...++.++|||||||++|||++|++||........  ..................+.
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  250 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSDPPTLLTPSKWSV  250 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSCCCCCSSGGGSCH
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHHHhccCCcccCCccccCH
Confidence              2334677899999984     56789999999999999999999999975443221  11111111111111122222


Q ss_pred             HHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          498 FLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       498 ~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .+.  ..+||+.||.+||++.+++++...
T Consensus       251 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~  279 (302)
T 2j7t_A          251 EFRDFLKIALDKNPETRPSAAQLLEHPFV  279 (302)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHTTSTTT
T ss_pred             HHHHHHHHHcccChhhCCCHHHHhcChHH
Confidence            222  227999999999999999976554

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-39  Score=331.93  Aligned_cols=243  Identities=21%  Similarity=0.265  Sum_probs=194.8

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEE
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l  346 (613)
                      ..++|...+.||+|+||.||+|+...++..||||++...  ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            346788889999999999999999877889999998764  334456789999999999 99999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC--------------
Q 048439          347 VYDFMARGTLPDHLYHSD--NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE--------------  410 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~--------------  410 (613)
                      ||||+++|+|.+++....  ...+++..++.|+.|++.||.|||+.+    |+||||||+|||++.              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~----ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS----LVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEC---------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC----EeecCCCHHHEEEcCCCCCcccccccccc
Confidence            999999999999996432  266999999999999999999999998    999999999999984              


Q ss_pred             -----CCcEEEEecCCCccCC----CCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHH
Q 048439          411 -----KWVAKVSDFGLSKFGP----TSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAV  480 (613)
Q Consensus       411 -----~~~~kl~DFGls~~~~----~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~  480 (613)
                           ...+||+|||+++...    ..++..|+|||.+... .++.++|||||||++|||++|++++.......     .
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-----~  239 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH-----E  239 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH-----H
T ss_pred             cccCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH-----H
Confidence                 4489999999986432    3467789999999876 56789999999999999999998774332111     1


Q ss_pred             HHHHhhccCCccccccHHHH--HhcccccCCCCCCCHHHHHHHHH
Q 048439          481 WAQQCYQNGTIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       481 ~~~~~~~~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ... . ....+....++.+.  ..+||+.||.+||++.|++++..
T Consensus       240 ~~~-~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  282 (289)
T 1x8b_A          240 IRQ-G-RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV  282 (289)
T ss_dssp             HHT-T-CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred             HHc-C-CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence            111 1 11112222222222  22799999999999999987654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7e-40  Score=347.16  Aligned_cols=246  Identities=15%  Similarity=0.178  Sum_probs=194.6

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEE-----EcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC---ccceeeEEEEeec
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGF-----INGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR---HLHLVSLIGFCND  340 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~-----~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~---H~niv~l~g~~~~  340 (613)
                      ...++|...++||+|+||.||+|.     ....+..||||+++...   ..++..|++++.+++   |+||+++++++..
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            345778888999999999999994     45556889999997654   446777888887776   9999999999999


Q ss_pred             CCceEEEEEcCCCCChhHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC-------
Q 048439          341 DREMILVYDFMARGTLPDHLYHS---DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE-------  410 (613)
Q Consensus       341 ~~~~~lV~Ey~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~-------  410 (613)
                      .+..+||||||++|+|.+++...   ....++|..++.|+.|+++||+|||+.+    |+||||||+||||+.       
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~----ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE----IIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT----EECCCCSGGGEEECGGGTCC--
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC----eecCCCCHHHEEecccccCccc
Confidence            99999999999999999999531   3467999999999999999999999988    999999999999998       


Q ss_pred             ----CCcEEEEecCCCcc----------CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhh
Q 048439          411 ----KWVAKVSDFGLSKF----------GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV  476 (613)
Q Consensus       411 ----~~~~kl~DFGls~~----------~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~  476 (613)
                          ++.+||+|||+|+.          ....++..|+|||++.+..++.++|||||||+||||++|+.||.........
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  294 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK  294 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence                89999999999952          2234678899999999999999999999999999999999998654332110


Q ss_pred             hHHHHHHHhhccCCccccccHHHHHhcccccCCCCC-CCHHHHHHHHHHhhhh
Q 048439          477 SLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRR-PSMSDVVWGLEFSLQL  528 (613)
Q Consensus       477 ~l~~~~~~~~~~~~~~~~~d~~~~~~~Cl~~~p~~R-Ps~~evl~~Le~~l~~  528 (613)
                       +    ..........+....++.  .||+.+|.+| |++.++.+.|+..++.
T Consensus       295 -~----~~~~~~~~~~~~~~~~~~--~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          295 -P----EGLFRRLPHLDMWNEFFH--VMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             -E----CSCCTTCSSHHHHHHHHH--HHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -e----chhccccCcHHHHHHHHH--HHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence             0    000000011111122222  6999999888 6788888888876653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7.4e-40  Score=350.56  Aligned_cols=245  Identities=20%  Similarity=0.275  Sum_probs=193.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccC--ccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLR--HLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|...+.||+|+||.||+|.... +..||||++...  .......|.+|+.+|.+++  |+||+++++++...+.++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            458888899999999999999876 578999998654  3455678999999999996  59999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--  425 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--  425 (613)
                      || +.+|+|.+++...  ..+++.+++.|+.||+.||+|||+.+    |+||||||+|||++ ++.+||+|||+++..  
T Consensus       135 ~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~----ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTT----CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC----eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 6788999999653  47899999999999999999999998    99999999999996 589999999999742  


Q ss_pred             --------CCCCCcccCChhhhhc-----------CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhh
Q 048439          426 --------PTSVSKTHLDPEYYRL-----------QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCY  486 (613)
Q Consensus       426 --------~~~~~~~~~aPE~~~~-----------~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~  486 (613)
                              ...++..|+|||++..           ..++.++|||||||+||||++|++||........ .+.. .....
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~~~~-~~~~~  284 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-KLHA-IIDPN  284 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHH-HHCTT
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-HHHH-HhCcc
Confidence                    2246778999999975           4689999999999999999999999964322111 1111 11111


Q ss_pred             ccCCccccccHHHH--HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          487 QNGTIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       487 ~~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      .........+..+.  ..+||+.||.+||++.|++++.....+
T Consensus       285 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            11112222222222  237999999999999999988876543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.2e-40  Score=361.43  Aligned_cols=247  Identities=24%  Similarity=0.328  Sum_probs=193.8

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      .++|...+.||+|+||.||+|+...++..||||++....  ......+.+|+.++++++|||||+++++|.+.+..++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            356888889999999999999998888899999987642  334667899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC---CCcEEEEecCCCccC
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE---KWVAKVSDFGLSKFG  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGls~~~  425 (613)
                      |||++|+|.+++..  ...+++..++.|+.|++.||.|||+.+    |+||||||+|||++.   ++.+||+|||+++..
T Consensus       116 e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~----ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKHN----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            99999999998854  356899999999999999999999998    999999999999976   455999999998642


Q ss_pred             -------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          426 -------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       426 -------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                             ...++..|+|||++. +.++.++|||||||++|||++|++||......+...................+.+..
T Consensus       190 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  268 (494)
T 3lij_A          190 ENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA  268 (494)
T ss_dssp             BTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred             CCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence                   234677899999986 569999999999999999999999997655443222221111111111111222222


Q ss_pred             HH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          499 LK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       499 ~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .. ..+||+.+|.+|||+.|++++.+.
T Consensus       269 ~~li~~~L~~dp~~R~s~~e~l~hp~~  295 (494)
T 3lij_A          269 KDLIKQMLQFDSQRRISAQQALEHPWI  295 (494)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred             HHHHHHHCCCChhhCccHHHHhcCccc
Confidence            22 227999999999999999976543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=334.41  Aligned_cols=245  Identities=21%  Similarity=0.287  Sum_probs=194.0

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC----hhcHHHHHHHHHHHhccCccceeeEEEEe--ecCCce
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES----QQGALEFQTEIGMLSQLRHLHLVSLIGFC--NDDREM  344 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~----~~~~~~f~~Ei~~l~~l~H~niv~l~g~~--~~~~~~  344 (613)
                      .++|...+.||+|+||.||+|....++..||||+++...    ......+.+|+.++++++|+||+++++++  .+.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999998888899999997542    23456799999999999999999999998  445688


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++||||+++| |.+++.......+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~----i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG----IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC----eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999986 778776655678999999999999999999999998    99999999999999999999999999864


Q ss_pred             C----------CCCCCcccCChhhhhcCCC--CchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcc
Q 048439          425 G----------PTSVSKTHLDPEYYRLQQL--TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID  492 (613)
Q Consensus       425 ~----------~~~~~~~~~aPE~~~~~~~--t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  492 (613)
                      .          ...++..|+|||.+.+...  +.++|||||||++|||++|+.||......+.....   ... ......
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i---~~~-~~~~~~  234 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI---GKG-SYAIPG  234 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHC-CCCCCS
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH---hcC-CCCCCC
Confidence            2          2235678999999986543  78999999999999999999999765433221111   110 011111


Q ss_pred             ccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          493 QIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       493 ~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ...+.+.. ..+||+.||.+||++.|++++...
T Consensus       235 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~  267 (305)
T 2wtk_C          235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF  267 (305)
T ss_dssp             SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence            12222222 227999999999999999977664

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.3e-40  Score=347.02  Aligned_cols=251  Identities=24%  Similarity=0.314  Sum_probs=198.6

Q ss_pred             HHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh--------hcHHHHHHHHHHHhcc-CccceeeEE
Q 048439          265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ--------QGALEFQTEIGMLSQL-RHLHLVSLI  335 (613)
Q Consensus       265 ~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~--------~~~~~f~~Ei~~l~~l-~H~niv~l~  335 (613)
                      .......++|.....||+|+||.||+|++..++..||||+++....        .....+.+|+.++.++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            3344556789999999999999999999987778999999876431        1234678999999999 799999999


Q ss_pred             EEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEE
Q 048439          336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAK  415 (613)
Q Consensus       336 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~k  415 (613)
                      +++......++||||+++|+|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||+++++.+|
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~g----i~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTCCEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEECCCCCEE
Confidence            999999999999999999999999854  356999999999999999999999998    99999999999999999999


Q ss_pred             EEecCCCccC-------CCCCCcccCChhhhhcC------CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHH
Q 048439          416 VSDFGLSKFG-------PTSVSKTHLDPEYYRLQ------QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWA  482 (613)
Q Consensus       416 l~DFGls~~~-------~~~~~~~~~aPE~~~~~------~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~  482 (613)
                      |+|||++...       ...++..|+|||++.+.      .++.++|||||||+||||++|++||............  .
T Consensus       241 l~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i--~  318 (365)
T 2y7j_A          241 LSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--M  318 (365)
T ss_dssp             ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--H
T ss_pred             EEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH--H
Confidence            9999998642       23467789999999743      5789999999999999999999999654332221111  1


Q ss_pred             HHhhccC--CccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          483 QQCYQNG--TIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       483 ~~~~~~~--~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .......  ........... ..+||+.||.+||++.|++++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~  362 (365)
T 2y7j_A          319 EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPF  362 (365)
T ss_dssp             HTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             hCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence            1000000  00111111111 22799999999999999987654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.4e-40  Score=335.34  Aligned_cols=250  Identities=21%  Similarity=0.295  Sum_probs=196.4

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEee--cCCceEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCN--DDREMIL  346 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~l  346 (613)
                      .++|.....||+|+||.||+|+...++..||+|++...  .....+.+.+|+.++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            35788888999999999999999888899999999754  3445667999999999999999999999874  4678899


Q ss_pred             EEEcCCCCChhHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEeccCCCCceeeCCCCcEEEEecCCCc
Q 048439          347 VYDFMARGTLPDHLYHS--DNPPLPWNQRLEICIGAARGLHYLHTGAN-HAVIIHRDVKTTNILLDEKWVAKVSDFGLSK  423 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~~iiHrDlk~~NILl~~~~~~kl~DFGls~  423 (613)
                      ||||+++|+|.+++...  ....+++..++.++.|++.||.|||+.+. ..+|+||||||+|||+++++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999998642  34569999999999999999999998651 1228999999999999999999999999986


Q ss_pred             cCCC--------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          424 FGPT--------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       424 ~~~~--------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                      ....        .++..|+|||.+....++.++||||||+++|||++|++||......+.   .......... .+....
T Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~i~~~~~~-~~~~~~  240 (279)
T 2w5a_A          165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AGKIREGKFR-RIPYRY  240 (279)
T ss_dssp             HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHTCCC-CCCTTS
T ss_pred             eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HHHHhhcccc-cCCccc
Confidence            4322        246679999999999999999999999999999999999976543221   1111111111 111122


Q ss_pred             cHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          496 DPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       496 d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ...+.  ..+||+.+|.+||++.||+++++.
T Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          241 SDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            22222  237999999999999999987763

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=337.60  Aligned_cols=243  Identities=23%  Similarity=0.338  Sum_probs=180.9

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      .++|...+.||+|+||.||+|+...++..||||.+....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            357888889999999999999998777899999986542   22346789999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-  426 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-  426 (613)
                      |||+++++|.+++.. ....+++.+++.++.|+++||.|||+.+    |+||||||+|||++.++.+||+|||+++... 
T Consensus        90 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSHG----ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHTT----EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999864 3457999999999999999999999998    9999999999999999999999999986432 


Q ss_pred             -------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH
Q 048439          427 -------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       427 -------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                             ..++..|+|||.+....++.++|||||||++|||++|++||..........     ................+
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  239 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-----KVVLADYEMPSFLSIEA  239 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CCSSCCCCCTTSCHHH
T ss_pred             CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-----HHhhcccCCccccCHHH
Confidence                   235667999999999999999999999999999999999996543322111     00011111122222222


Q ss_pred             H--HhcccccCCCCCCCHHHHHHHHH
Q 048439          500 K--AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       500 ~--~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .  ..+||+.||.+||++.+++++..
T Consensus       240 ~~li~~~l~~dp~~Rps~~~~l~h~~  265 (278)
T 3cok_A          240 KDLIHQLLRRNPADRLSLSSVLDHPF  265 (278)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred             HHHHHHHcccCHhhCCCHHHHhcCcc
Confidence            2  23799999999999999986654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.7e-40  Score=339.83  Aligned_cols=249  Identities=21%  Similarity=0.252  Sum_probs=195.6

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      .++|...+.||+|+||.||+|+...++..||||++....   ......+.+|+.++.+++||||+++++++.+++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478899999999999999999998888999999997643   23346789999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--  425 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--  425 (613)
                      |||+++++|.+++..  ...+++.+++.++.|+++||.|||+.+    |+||||||+|||++.++.+||+|||+++..  
T Consensus       113 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAAG----ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCc----CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            999999999999854  356999999999999999999999998    999999999999999999999999998642  


Q ss_pred             -------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc-c-CCcccccc
Q 048439          426 -------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ-N-GTIDQIVD  496 (613)
Q Consensus       426 -------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~-~-~~~~~~~d  496 (613)
                             ...++..|+|||.+....++.++||||||++||||++|+.||.......   +......... . .....+.+
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  263 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---MGAHINQAIPRPSTVRPGIPV  263 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---HHHHHHSCCCCGGGTSTTCCT
T ss_pred             cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---HHHHhccCCCCccccCCCCCH
Confidence                   2235677999999999999999999999999999999999997654321   1111111100 0 00111222


Q ss_pred             HHHH-HhcccccCCCCCC-CHHHHHHHHHHhhhh
Q 048439          497 PFLK-AMSCLNDEGIRRP-SMSDVVWGLEFSLQL  528 (613)
Q Consensus       497 ~~~~-~~~Cl~~~p~~RP-s~~evl~~Le~~l~~  528 (613)
                      .+.. ..+||+.||++|| ++.++++.|+..+..
T Consensus       264 ~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          264 AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence            2222 2379999999999 999999999976543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.7e-39  Score=337.65  Aligned_cols=247  Identities=28%  Similarity=0.406  Sum_probs=194.7

Q ss_pred             CCCcceeeeeCcEEEEEEEEc----CCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeec--CCceEE
Q 048439          274 FDNDLVIGVGGFGDVYKGFIN----GSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCND--DREMIL  346 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~----~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l  346 (613)
                      |...+.||+|+||.||++.+.    .+++.||||+++... ......|.+|++++++++||||+++++++.+  ...+++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            377789999999999988753    356889999998653 4456679999999999999999999999987  467899


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ||||+++|+|.+++..   ..+++.+++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++...
T Consensus       113 v~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~----ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQH----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCC----ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999954   34999999999999999999999998    9999999999999999999999999986432


Q ss_pred             -----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhh---------hhhHHHHHHH--
Q 048439          427 -----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK---------QVSLAVWAQQ--  484 (613)
Q Consensus       427 -----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~---------~~~l~~~~~~--  484 (613)
                                 ..++..|+|||.+.+..++.++|||||||++|||++|+.||.......         ..........  
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence                       123445999999999999999999999999999999999986543221         0111111111  


Q ss_pred             -hhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          485 -CYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       485 -~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                       .........+.+.+.. ..+||+.+|.+||++.|+++.|+...+
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence             1111111222222222 227999999999999999999986543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.9e-40  Score=346.51  Aligned_cols=244  Identities=19%  Similarity=0.327  Sum_probs=194.0

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      .++|...+.||+|+||.||+|+...++..||||++.....    .+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            4678888999999999999999998889999999976532    235688888888 79999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC----CcEEEEecCCCccC
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK----WVAKVSDFGLSKFG  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~----~~~kl~DFGls~~~  425 (613)
                      ||++|+|.+++..  ...+++..++.++.|++.||+|||+.+    |+||||||+|||+.++    +.+||+|||+++..
T Consensus        97 ~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~g----ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           97 LMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            9999999999854  456999999999999999999999998    9999999999998433    35999999998642


Q ss_pred             --------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHh-hc--cCCcccc
Q 048439          426 --------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC-YQ--NGTIDQI  494 (613)
Q Consensus       426 --------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~-~~--~~~~~~~  494 (613)
                              ...++..|+|||++.+..++.++|||||||+||||++|++||..........+....... ..  ......+
T Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             BCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             cCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence                    234577899999999888999999999999999999999999754322222222111111 10  1111122


Q ss_pred             ccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          495 VDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       495 ~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .+.... ..+||..||++||++.|++++...
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  281 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWI  281 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence            222222 227999999999999999987765

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.1e-39  Score=353.63  Aligned_cols=199  Identities=23%  Similarity=0.306  Sum_probs=174.9

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc------CccceeeEEEEeecCCce
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL------RHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l------~H~niv~l~g~~~~~~~~  344 (613)
                      ..+|...++||+|+||.||+|+...++..||||+++.. ......+.+|++++..+      .|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            35688888999999999999999888899999999754 33345678888888877      467999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc--EEEEecCCC
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV--AKVSDFGLS  422 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~--~kl~DFGls  422 (613)
                      ++||||+. |+|.+++.......+++..++.|+.|++.||+|||+.+    |+||||||+|||++.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR----IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT----EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 69999997766667999999999999999999999998    999999999999999987  999999998


Q ss_pred             ccC-----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhh
Q 048439          423 KFG-----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQ  475 (613)
Q Consensus       423 ~~~-----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~  475 (613)
                      +..     ...++..|+|||++.+..++.++|||||||+||||++|++||......+.
T Consensus       250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~  307 (429)
T 3kvw_A          250 CYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ  307 (429)
T ss_dssp             EETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             eecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            642     23457789999999999999999999999999999999999976654443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.9e-40  Score=372.82  Aligned_cols=239  Identities=26%  Similarity=0.393  Sum_probs=192.2

Q ss_pred             ceeeeeCcEEEEEEEEc--CCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCC
Q 048439          278 LVIGVGGFGDVYKGFIN--GSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMAR  353 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~--~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  353 (613)
                      +.||+|+||.||+|.+.  ..+..||||+++...  ....++|.+|+.+|.+++|||||+++++|.+ +..++|||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999663  455789999997653  3346789999999999999999999999975 468999999999


Q ss_pred             CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC------
Q 048439          354 GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT------  427 (613)
Q Consensus       354 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~------  427 (613)
                      |+|.+++..  ...+++.+++.|+.||+.||+|||+.+    |+||||||+||||++++.+||+|||+++....      
T Consensus       454 g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~----iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCC----EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            999999954  456999999999999999999999998    99999999999999999999999999864211      


Q ss_pred             -----CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          428 -----SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       428 -----~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                           .++..|+|||++....++.++|||||||+||||++ |+.||......+....   ............+.+.+.. 
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~---i~~~~~~~~p~~~~~~l~~l  604 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM---LEKGERMGCPAGCPREMYDL  604 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---HHTTCCCCCCTTCCHHHHHH
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHcCCCCCCCCCCCHHHHHH
Confidence                 12356999999999999999999999999999998 9999976544332211   1111111112222222222 


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ..+||+.||++||++.+|++.|+...
T Consensus       605 i~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          605 MNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            23799999999999999999998543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.5e-40  Score=345.83  Aligned_cols=238  Identities=20%  Similarity=0.263  Sum_probs=196.7

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh--------hcHHHHHHHHHHHhccCccceeeEEEEeecC
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ--------QGALEFQTEIGMLSQLRHLHLVSLIGFCNDD  341 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~--------~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~  341 (613)
                      ..++|...+.||+|+||.||+|+...++..||||+++....        .....+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            35678888999999999999999988889999999876421        1334578899999999999999999999999


Q ss_pred             CceEEEEEcCCCC-ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecC
Q 048439          342 REMILVYDFMARG-TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG  420 (613)
Q Consensus       342 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG  420 (613)
                      +..++||||+.+| +|.+++..  ...+++..++.|+.|++.||.|||+.+    |+||||||+|||+++++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~----ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKD----IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999877 99999853  456999999999999999999999998    9999999999999999999999999


Q ss_pred             CCccCCC-------CCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcc
Q 048439          421 LSKFGPT-------SVSKTHLDPEYYRLQQL-TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID  492 (613)
Q Consensus       421 ls~~~~~-------~~~~~~~aPE~~~~~~~-t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  492 (613)
                      +++....       .++..|+|||++.+..+ +.++|||||||++|||++|+.||........           ......
T Consensus       176 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----------~~~~~~  244 (335)
T 3dls_A          176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-----------AAIHPP  244 (335)
T ss_dssp             TCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT-----------TCCCCS
T ss_pred             cceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh-----------hccCCC
Confidence            9974322       35778999999988877 8899999999999999999999965322110           001111


Q ss_pred             ccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          493 QIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       493 ~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ..+++.+.  ..+||+.||.+||++.+++++...
T Consensus       245 ~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~  278 (335)
T 3dls_A          245 YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV  278 (335)
T ss_dssp             SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence            11222222  227999999999999999987664

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1e-40  Score=355.43  Aligned_cols=240  Identities=15%  Similarity=0.164  Sum_probs=184.8

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHH---HHHhccCccceeeEE-------EE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEI---GMLSQLRHLHLVSLI-------GF  337 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei---~~l~~l~H~niv~l~-------g~  337 (613)
                      .++|...+.||+|+||.||+|+...++..||||++...   .....+.|.+|+   ++|++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46778888999999999999998777789999998743   334567789999   556666899999998       66


Q ss_pred             eecCC-----------------ceEEEEEcCCCCChhHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 048439          338 CNDDR-----------------EMILVYDFMARGTLPDHLYHSD-----NPPLPWNQRLEICIGAARGLHYLHTGANHAV  395 (613)
Q Consensus       338 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~  395 (613)
                      +.+.+                 ..+|||||+ +|+|.+++....     ...++|..++.|+.|+++||+|||+.+    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----  226 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----  226 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT----
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC----
Confidence            55543                 278999999 689999996421     234556899999999999999999998    


Q ss_pred             EEeccCCCCceeeCCCCcEEEEecCCCccC-----CCCCCcccCChhhhhcC-----------CCCchhHHHHHHHHHHH
Q 048439          396 IIHRDVKTTNILLDEKWVAKVSDFGLSKFG-----PTSVSKTHLDPEYYRLQ-----------QLTEKSDVYSFGVVLFE  459 (613)
Q Consensus       396 iiHrDlk~~NILl~~~~~~kl~DFGls~~~-----~~~~~~~~~aPE~~~~~-----------~~t~ksDV~SfGvvL~e  459 (613)
                      |+||||||+|||++.++.+||+|||+++..     ...+ ..|+|||++...           .++.++|||||||+|||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            999999999999999999999999999742     2234 789999999988           89999999999999999


Q ss_pred             HHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          460 VLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       460 lltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      |++|+.||............       .. ....+.+.... ..+||+.||.+||++.|++++..+
T Consensus       306 lltg~~Pf~~~~~~~~~~~~-------~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f  363 (377)
T 3byv_A          306 IWCADLPITKDAALGGSEWI-------FR-SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY  363 (377)
T ss_dssp             HHHSSCCC------CCSGGG-------GS-SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred             HHHCCCCCcccccccchhhh-------hh-hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence            99999999654332211110       00 11122222222 237999999999999999976553

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.1e-39  Score=361.85  Aligned_cols=246  Identities=24%  Similarity=0.318  Sum_probs=198.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...++||+|+||.||+|+...+++.||||++....   ......+.+|+.+|++++||||+++++++.+.+.+++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56788889999999999999998888999999996542   234567899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-
Q 048439          349 DFMARGTLPDHLYHSD--NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-  425 (613)
                      ||+++|+|.+++....  ...+++..++.++.||+.||.|||+.+    |+||||||+|||++.++.+||+|||+++.. 
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g----IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN----IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC----CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999986533  457999999999999999999999998    999999999999999999999999999642 


Q ss_pred             -------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhh-hhHHHHHHHhhccCCccccccH
Q 048439          426 -------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQ-VSLAVWAQQCYQNGTIDQIVDP  497 (613)
Q Consensus       426 -------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~  497 (613)
                             ...++..|+|||++.+..++.++|||||||+||||++|++||........ ..+.....  .........+.+
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~--~~~~~~p~~~s~  418 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL--EQAVTYPDKFSP  418 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH--HCCCCCCTTSCH
T ss_pred             CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh--hcccCCCcccCH
Confidence                   12567889999999999999999999999999999999999976432111 11111111  111112222222


Q ss_pred             HHH--HhcccccCCCCCCCH-----HHHHHHHH
Q 048439          498 FLK--AMSCLNDEGIRRPSM-----SDVVWGLE  523 (613)
Q Consensus       498 ~~~--~~~Cl~~~p~~RPs~-----~evl~~Le  523 (613)
                      .+.  ..+||+.||.+||++     .+|+.+..
T Consensus       419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpf  451 (543)
T 3c4z_A          419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL  451 (543)
T ss_dssp             HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGG
T ss_pred             HHHHHHHHhccCCHhHCCCCcccCHHHHHcCcc
Confidence            222  227999999999975     66665544

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.6e-39  Score=333.64  Aligned_cols=247  Identities=21%  Similarity=0.275  Sum_probs=196.7

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---------hhcHHHHHHHHHHHhccC-ccceeeEEEEeec
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---------QQGALEFQTEIGMLSQLR-HLHLVSLIGFCND  340 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---------~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~  340 (613)
                      .++|...+.||+|+||.||+|....++..||||+++...         ......+.+|+.++.+++ ||||+++++++.+
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            467888899999999999999998888999999987543         122456889999999996 9999999999999


Q ss_pred             CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecC
Q 048439          341 DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG  420 (613)
Q Consensus       341 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG  420 (613)
                      .+..++||||+++|+|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCcceEEEcCCCcEEEeccc
Confidence            9999999999999999999954  356999999999999999999999998    9999999999999999999999999


Q ss_pred             CCccC-------CCCCCcccCChhhhh------cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc
Q 048439          421 LSKFG-------PTSVSKTHLDPEYYR------LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ  487 (613)
Q Consensus       421 ls~~~-------~~~~~~~~~aPE~~~------~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~  487 (613)
                      +++..       ...++..|+|||.+.      ...++.++||||||++||||++|+.||....................
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  249 (298)
T 1phk_A          170 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG  249 (298)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             chhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC
Confidence            98642       224567899999986      45688999999999999999999999965443322111110000001


Q ss_pred             cCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          488 NGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       488 ~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ......+.+.+.. ..+||+.||.+||++.|++++..
T Consensus       250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~  286 (298)
T 1phk_A          250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF  286 (298)
T ss_dssp             TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred             cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence            1111122222222 23799999999999999986554

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.8e-40  Score=360.59  Aligned_cols=247  Identities=22%  Similarity=0.285  Sum_probs=198.9

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      .++|...++||+|+||.||+|+...++..||||++....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            356888889999999999999998888999999986542   34567799999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee---CCCCcEEEEecCCCcc
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSKF  424 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGls~~  424 (613)
                      |||+.+|+|.+++..  ...+++..++.|+.|++.||.|||+.+    |+||||||+|||+   +.++.+||+|||+++.
T Consensus       105 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~----ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            999999999999854  456999999999999999999999998    9999999999999   5678999999999864


Q ss_pred             CC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccH
Q 048439          425 GP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP  497 (613)
Q Consensus       425 ~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  497 (613)
                      ..       ..++..|+|||.+.+ .++.++|||||||++|||++|++||......+...................+.+.
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  257 (484)
T 3nyv_A          179 FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES  257 (484)
T ss_dssp             BCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred             cccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence            32       235778999999876 6999999999999999999999999765443322211111000011111122222


Q ss_pred             HHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          498 FLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       498 ~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ... ..+||+.+|.+|||+.|++++.+.
T Consensus       258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~  285 (484)
T 3nyv_A          258 AKDLIRKMLTYVPSMRISARDALDHEWI  285 (484)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence            222 227999999999999999977654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-39  Score=335.48  Aligned_cols=252  Identities=22%  Similarity=0.278  Sum_probs=191.6

Q ss_pred             HHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhc--cCccceeeEEEEeecC-
Q 048439          265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQ--LRHLHLVSLIGFCNDD-  341 (613)
Q Consensus       265 ~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~--l~H~niv~l~g~~~~~-  341 (613)
                      ..-....++|...+.||+|+||.||+|+..  +..||||++....   ...+..|.+++..  ++||||+++++++.+. 
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            333445578999999999999999999986  4789999986432   2344555555554  4899999999999877 


Q ss_pred             ---CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CCCCcEEeccCCCCceeeCC
Q 048439          342 ---REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG--------ANHAVIIHRDVKTTNILLDE  410 (613)
Q Consensus       342 ---~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------~~~~~iiHrDlk~~NILl~~  410 (613)
                         ...++||||+++|+|.+++..   ..+++..++.++.|++.||+|||+.        +    |+||||||+|||++.
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~----ivH~Dikp~Nill~~  177 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA----IAHRDLKSKNILVKK  177 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC----EECSCCCGGGEEECT
T ss_pred             CCCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC----EEecccchHHEEECC
Confidence               789999999999999999954   3599999999999999999999987        6    999999999999999


Q ss_pred             CCcEEEEecCCCccC------------CCCCCcccCChhhhhcCCCCch------hHHHHHHHHHHHHHhC---------
Q 048439          411 KWVAKVSDFGLSKFG------------PTSVSKTHLDPEYYRLQQLTEK------SDVYSFGVVLFEVLCA---------  463 (613)
Q Consensus       411 ~~~~kl~DFGls~~~------------~~~~~~~~~aPE~~~~~~~t~k------sDV~SfGvvL~elltg---------  463 (613)
                      ++.+||+|||+++..            ...++..|+|||.+.....+.+      +|||||||+||||++|         
T Consensus       178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~  257 (337)
T 3mdy_A          178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE  257 (337)
T ss_dssp             TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence            999999999998531            2246778999999988776654      9999999999999999         


Q ss_pred             -CCCccchhhhhhhhHHHHHHHhhc---cCCcc------ccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhhhh
Q 048439          464 -RPSILRTAAKKQVSLAVWAQQCYQ---NGTID------QIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQLQ  529 (613)
Q Consensus       464 -~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~------~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~~  529 (613)
                       +.||......... ..........   .....      ...+.+.. ..+||+.||.+||++.||+++|+...+.+
T Consensus       258 ~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          258 YQLPYHDLVPSDPS-YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CCCTTTTTSCSSCC-HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ccccHhhhcCCCCc-hhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence             6666443222211 1111111111   11111      11111111 23899999999999999999999766543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=9e-40  Score=340.72  Aligned_cols=250  Identities=22%  Similarity=0.306  Sum_probs=185.3

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC-ccceeeEEEEee--------c
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGFCN--------D  340 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~--------~  340 (613)
                      ...+|...++||+|+||.||+|+...++..||||++..........+.+|+.++.++. ||||+++++++.        .
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            3457888899999999999999998888899999997776666778999999999996 999999999983        3


Q ss_pred             CCceEEEEEcCCCCChhHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEec
Q 048439          341 DREMILVYDFMARGTLPDHLYH-SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDF  419 (613)
Q Consensus       341 ~~~~~lV~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DF  419 (613)
                      ...+++||||+. |+|.+++.. .....+++.+++.|+.|++.||.|||+.+.  +|+||||||+|||++.++.+||+||
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP--PIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSS--CCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC--CEEEccCCcccEEECCCCCEEEecC
Confidence            445899999996 799998854 234569999999999999999999998752  2899999999999999999999999


Q ss_pred             CCCccCC--------------------CCCCcccCChhhh---hcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhh
Q 048439          420 GLSKFGP--------------------TSVSKTHLDPEYY---RLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV  476 (613)
Q Consensus       420 Gls~~~~--------------------~~~~~~~~aPE~~---~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~  476 (613)
                      |+++...                    ..++..|+|||.+   ....++.++|||||||+||||++|+.||.......  
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--  260 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--  260 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence            9987532                    1256679999998   56778999999999999999999999996433211  


Q ss_pred             hHHHHHHHhhccCCccccccHHHHHhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          477 SLAVWAQQCYQNGTIDQIVDPFLKAMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       477 ~l~~~~~~~~~~~~~~~~~d~~~~~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                       .................+..+  ..+||+.+|.+||++.|++++|+...+
T Consensus       261 -~~~~~~~~~~~~~~~~~~~~l--i~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          261 -IVNGKYSIPPHDTQYTVFHSL--IRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             ------CCCCTTCCSSGGGHHH--HHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -hhcCcccCCcccccchHHHHH--HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             111000001111111112222  227999999999999999999986543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.3e-39  Score=360.40  Aligned_cols=247  Identities=23%  Similarity=0.337  Sum_probs=195.6

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh-------------hcHHHHHHHHHHHhccCccceeeEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ-------------QGALEFQTEIGMLSQLRHLHLVSLIGF  337 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~-------------~~~~~f~~Ei~~l~~l~H~niv~l~g~  337 (613)
                      .++|...+.||+|+||.||+|+...++..||||++.....             ...+.+.+|+.+|++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            4678888999999999999999988889999999875421             235678999999999999999999999


Q ss_pred             eecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC---cE
Q 048439          338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW---VA  414 (613)
Q Consensus       338 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~---~~  414 (613)
                      |.+....++|||||++|+|.+++..  ...+++..++.|+.|++.||.|||+.+    |+||||||+|||++.++   .+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~----ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKHN----IVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEESSTTCCSSE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEeCCCcHHHEEEecCCCCccE
Confidence            9999999999999999999999854  356999999999999999999999998    99999999999998776   69


Q ss_pred             EEEecCCCccC-------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc
Q 048439          415 KVSDFGLSKFG-------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ  487 (613)
Q Consensus       415 kl~DFGls~~~-------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~  487 (613)
                      ||+|||+++..       ...++..|+|||++. +.++.++|||||||++|||++|++||......+.............
T Consensus       189 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  267 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD  267 (504)
T ss_dssp             EECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             EEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99999999642       234677899999987 5699999999999999999999999976554432222211100000


Q ss_pred             cCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          488 NGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       488 ~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ......+.+.... ..+||+.||.+|||+.|++++.+.
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~  305 (504)
T 3q5i_A          268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI  305 (504)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence            0000111222221 227999999999999999977654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-39  Score=341.51  Aligned_cols=251  Identities=24%  Similarity=0.285  Sum_probs=191.2

Q ss_pred             HHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh-----cHHHHHHHHHHHhccCccceeeEEEEeecCC
Q 048439          268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ-----GALEFQTEIGMLSQLRHLHLVSLIGFCNDDR  342 (613)
Q Consensus       268 ~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~-----~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~  342 (613)
                      ....++|...+.||+|+||.||+|+...++..||||++......     ....+.+|+.++++++||||+++++++.+.+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            34457899999999999999999999887889999998754221     1346889999999999999999999999999


Q ss_pred             ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCC
Q 048439          343 EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS  422 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls  422 (613)
                      ..++||||+++ +|.+++.. ....+++..++.++.|+++||+|||+.+    |+||||||+|||++.++.+||+|||++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ceEEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCC----EECCCCCHHHEEEcCCCCEEEEecccc
Confidence            99999999986 88888854 3456999999999999999999999998    999999999999999999999999998


Q ss_pred             ccC--------CCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCc--
Q 048439          423 KFG--------PTSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTI--  491 (613)
Q Consensus       423 ~~~--------~~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~--  491 (613)
                      +..        ...++..|+|||.+.+. .++.++|||||||+||||++|.+||......+.................  
T Consensus       160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred             eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence            642        12356779999999764 5899999999999999999999999765544332221111111000000  


Q ss_pred             ----------------------cccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          492 ----------------------DQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       492 ----------------------~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                                            ....+.... ..+||+.||.+|||+.|++++..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f  295 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF  295 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence                                  011111111 227999999999999999977664

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.3e-39  Score=332.67  Aligned_cols=250  Identities=21%  Similarity=0.296  Sum_probs=186.7

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhc-HHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQG-ALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~-~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      .++|...+.||+|+||.||+|+...+++.||||+++... ... ...+.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            467888889999999999999998888999999997652 222 333455566688899999999999999999999999


Q ss_pred             EcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          349 DFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTG-ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      ||++ |+|.+++..  .....+++..++.|+.|++.||.|||+. +    |+||||||+|||++.++.+||+|||+++..
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS----VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC----CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC----eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            9998 588887743  2456799999999999999999999997 7    999999999999999999999999998642


Q ss_pred             -------CCCCCcccCChhhh----hcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccc
Q 048439          426 -------PTSVSKTHLDPEYY----RLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQI  494 (613)
Q Consensus       426 -------~~~~~~~~~aPE~~----~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  494 (613)
                             ...++..|+|||.+    ....++.++|||||||++|||++|+.||........ .+...............+
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~  239 (290)
T 3fme_A          161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQVVEEPSPQLPADKF  239 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHHHHHSCCCCCCTTTS
T ss_pred             cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHHHhccCCCCcccccC
Confidence                   12467789999996    566789999999999999999999999964322211 111111111111111122


Q ss_pred             ccHHHH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          495 VDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       495 ~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      .+.... ..+||+.+|.+|||+.|++++..+..
T Consensus       240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             CHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            222222 23799999999999999998776543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.8e-40  Score=359.60  Aligned_cols=247  Identities=22%  Similarity=0.298  Sum_probs=198.4

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      .++|...++||+|+||.||+|+...++..||||++...  .......+.+|+.+|++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            35788889999999999999999888899999998643  2334667899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC---CCCcEEEEecCCCccC
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD---EKWVAKVSDFGLSKFG  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGls~~~  425 (613)
                      |||++|+|.+.+..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||++   .++.+||+|||+++..
T Consensus       101 e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~----ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          101 ELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            99999999998854  356999999999999999999999998    99999999999995   5668999999998642


Q ss_pred             -------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          426 -------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       426 -------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                             ...++..|+|||++.+ .++.++|||||||+||||++|++||......+...................+.+..
T Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  253 (486)
T 3mwu_A          175 QQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA  253 (486)
T ss_dssp             CCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred             CCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence                   2346778999999875 59999999999999999999999997654433222211110001111111222222


Q ss_pred             HH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          499 LK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       499 ~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .. ..+||+.+|.+|||+.+++++.+.
T Consensus       254 ~~li~~~L~~dp~~R~t~~~~l~hp~~  280 (486)
T 3mwu_A          254 KDLIRKMLTFHPSLRITATQCLEHPWI  280 (486)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence            22 227999999999999999987654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.4e-39  Score=335.72  Aligned_cols=245  Identities=24%  Similarity=0.315  Sum_probs=190.5

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--------hhcHHHHHHHHHHHhccCccceeeEEEEeecCC
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--------QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR  342 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--------~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~  342 (613)
                      .++|...+.||+|+||.||+|+...++..||||.+....        ......+.+|++++++++||||+++++++..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            467888899999999999999998888999999987542        122345889999999999999999999987665


Q ss_pred             ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc---EEEEec
Q 048439          343 EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV---AKVSDF  419 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~---~kl~DF  419 (613)
                       .++||||+++|+|.+++.  ....+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.   +||+||
T Consensus        89 -~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             -EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             -eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC----eeccCCCHHHEEEecCCCCCeEEEccC
Confidence             899999999999999984  3467999999999999999999999998    999999999999987654   999999


Q ss_pred             CCCccCCC-------CCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccC
Q 048439          420 GLSKFGPT-------SVSKTHLDPEYYR---LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG  489 (613)
Q Consensus       420 Gls~~~~~-------~~~~~~~aPE~~~---~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~  489 (613)
                      |+++....       .++..|+|||++.   ...++.++|||||||+||||++|++||........  +...........
T Consensus       162 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~  239 (322)
T 2ycf_A          162 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITSGKYNF  239 (322)
T ss_dssp             TTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHHTCCCC
T ss_pred             ccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHhCcccc
Confidence            99975432       2567899999974   46789999999999999999999999965432211  111111110000


Q ss_pred             ---CccccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          490 ---TIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       490 ---~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                         ....+.+.... ..+||+.||.+||++.+++++...
T Consensus       240 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~  278 (322)
T 2ycf_A          240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL  278 (322)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCc
Confidence               00111111111 227999999999999999876553

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7.8e-40  Score=332.19  Aligned_cols=242  Identities=23%  Similarity=0.327  Sum_probs=193.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|+...+++.||||++....   ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            56888889999999999999998777899999986542   234567899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      ||+++++|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||++....  
T Consensus        91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           91 EYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             ECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHC----SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC----CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            99999999999854  346899999999999999999999998    9999999999999999999999999987532  


Q ss_pred             -----CCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          427 -----TSVSKTHLDPEYYRLQQL-TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~~~~-t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                           ..++..|+|||.+.+..+ +.++||||||+++|||++|+.||...........   ...  .........+..+.
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~--~~~~~~~~~~~~l~  239 (276)
T 2h6d_A          165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK---IRG--GVFYIPEYLNRSVA  239 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHH--CCCCCCTTSCHHHH
T ss_pred             cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH---hhc--CcccCchhcCHHHH
Confidence                 234667999999988765 6899999999999999999999975433221111   111  11112222222222


Q ss_pred             --HhcccccCCCCCCCHHHHHHHHHH
Q 048439          501 --AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       501 --~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                        ..+||+.||.+||++.|++++..+
T Consensus       240 ~li~~~l~~~p~~Rps~~~~l~h~~~  265 (276)
T 2h6d_A          240 TLLMHMLQVDPLKRATIKDIREHEWF  265 (276)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred             HHHHHHccCChhhCCCHHHHHhChhh
Confidence              237999999999999999987664

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.2e-40  Score=355.10  Aligned_cols=247  Identities=24%  Similarity=0.321  Sum_probs=190.0

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--------hhcHHHHHHHHHHHhccCccceeeEEEEeec
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--------QQGALEFQTEIGMLSQLRHLHLVSLIGFCND  340 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--------~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~  340 (613)
                      ...++|...+.||+|+||.||+|....++..||||++....        ......+.+|+.+|++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34678999999999999999999999888999999986532        1122348899999999999999999999865


Q ss_pred             CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC---CcEEEE
Q 048439          341 DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK---WVAKVS  417 (613)
Q Consensus       341 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~---~~~kl~  417 (613)
                       +..++|||||++|+|.+++.  ....+++.+++.++.|++.||+|||+.+    |+||||||+|||++.+   +.+||+
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~----ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             -CceEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC----ccccCCChHhEEEecCCCcceEEEe
Confidence             45899999999999999884  3467999999999999999999999998    9999999999999654   469999


Q ss_pred             ecCCCccCC-------CCCCcccCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc
Q 048439          418 DFGLSKFGP-------TSVSKTHLDPEYYRL---QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ  487 (613)
Q Consensus       418 DFGls~~~~-------~~~~~~~~aPE~~~~---~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~  487 (613)
                      |||+++...       ..++..|+|||++..   ..++.++|||||||+||||++|++||........  +.........
T Consensus       285 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i~~~~~  362 (419)
T 3i6u_A          285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITSGKY  362 (419)
T ss_dssp             CSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHHHTTCC
T ss_pred             ecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHHhcCCC
Confidence            999997532       235778999999853   6788999999999999999999999965432211  1111111100


Q ss_pred             cC---CccccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          488 NG---TIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       488 ~~---~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ..   ....+.+.... ..+||+.||.+||++.|++++.++
T Consensus       363 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~  403 (419)
T 3i6u_A          363 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL  403 (419)
T ss_dssp             CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence            00   00111222221 227999999999999999987764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.7e-39  Score=332.59  Aligned_cols=243  Identities=26%  Similarity=0.405  Sum_probs=191.9

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeec----CCceEEE
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND----DREMILV  347 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV  347 (613)
                      |.....||+|+||.||+|....++..||+|.+...  .....+.+.+|+.++++++||||+++++++..    ...+++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            55666899999999999999888899999998654  34456779999999999999999999998865    4568999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC-CCCcEEEEecCCCccCC
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGls~~~~  426 (613)
                      |||+++|+|.+++..  ...+++..++.++.|++.||.|||+.+.  +|+||||||+|||++ +++.+||+|||+++...
T Consensus       108 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~~--~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          108 TELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTP--PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSS--CCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcCCC--CEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            999999999999954  3568999999999999999999998752  289999999999998 78999999999986432


Q ss_pred             ------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          427 ------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       427 ------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                            ..++..|+|||.+. +.++.++|||||||++|||++|+.||.........  ..................+.+.
T Consensus       184 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~  260 (290)
T 1t4h_A          184 ASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRVTSGVKPASFDKVAIPEVK  260 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHHHTTTCCCGGGGGCCCHHHH
T ss_pred             ccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--HHHHhccCCccccCCCCCHHHH
Confidence                  23567899999887 46999999999999999999999999654332221  1111111111112222222222


Q ss_pred             --HhcccccCCCCCCCHHHHHHHHH
Q 048439          501 --AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       501 --~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                        ..+||+.+|.+||++.|++++..
T Consensus       261 ~li~~~l~~dp~~Rps~~ell~h~~  285 (290)
T 1t4h_A          261 EIIEGCIRQNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHccCChhhCCCHHHHhhCcc
Confidence              23799999999999999987654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.7e-39  Score=340.56  Aligned_cols=247  Identities=23%  Similarity=0.329  Sum_probs=195.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeec--------C
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCND--------D  341 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~--------~  341 (613)
                      ++|...+.||+|+||.||+|+...++..||||++....  ......+.+|+.++++++||||+++++++.+        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            57888899999999999999998888899999986543  3335678899999999999999999999977        4


Q ss_pred             CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCC
Q 048439          342 REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL  421 (613)
Q Consensus       342 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl  421 (613)
                      +..++||||+++ +|.+.+.. ....+++.+++.|+.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~----ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC----eeCCCCCHHHEEEcCCCCEEEccchh
Confidence            468999999985 78777754 3356999999999999999999999998    99999999999999999999999999


Q ss_pred             CccCC------------CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc
Q 048439          422 SKFGP------------TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN  488 (613)
Q Consensus       422 s~~~~------------~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~  488 (613)
                      ++...            ..++..|+|||.+.+ ..++.++|||||||++|||++|++||.....................
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            86321            234667999999976 45799999999999999999999999876555443333322211111


Q ss_pred             CCcccc---------------------------ccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          489 GTIDQI---------------------------VDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       489 ~~~~~~---------------------------~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ......                           .++.+.  ..+||+.||.+|||+.|++++..+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  315 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF  315 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence            111110                           012121  227999999999999999987664

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-39  Score=353.30  Aligned_cols=184  Identities=25%  Similarity=0.385  Sum_probs=152.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeec-----CCce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND-----DREM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~-----~~~~  344 (613)
                      ++|...++||+|+||.||+|+...++..||||++...  .....+.+.+|+.+|++++|+|||+++++|..     ...+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            6788899999999999999999888899999998654  34455678999999999999999999999943     3578


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++||||+. |+|.+++..  ...+++..+..++.||++||+|||+.+    |+||||||+||||+.++.+||+|||+++.
T Consensus       133 ~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~----iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEECCCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEeccc-cchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCC----cCCCCCChhhEEECCCCCEeecccccchh
Confidence            99999985 699998853  456999999999999999999999998    99999999999999999999999999975


Q ss_pred             CC-----------------------------------CCCCcccCChhhh-hcCCCCchhHHHHHHHHHHHHHh
Q 048439          425 GP-----------------------------------TSVSKTHLDPEYY-RLQQLTEKSDVYSFGVVLFEVLC  462 (613)
Q Consensus       425 ~~-----------------------------------~~~~~~~~aPE~~-~~~~~t~ksDV~SfGvvL~ellt  462 (613)
                      ..                                   ..++..|+|||++ ....++.++|||||||+||||++
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            32                                   1236679999986 55679999999999999999999

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.3e-39  Score=340.31  Aligned_cols=248  Identities=23%  Similarity=0.353  Sum_probs=196.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|....+||+|+||.||+|+...++..||||++....  ......+.+|+.++++++||||++++++|.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            56888889999999999999998888999999986543  3334568899999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----  425 (613)
                      |+++++|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..    
T Consensus       105 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          105 FVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             CCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             cCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC----EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            9999999887643  346999999999999999999999998    999999999999999999999999998642    


Q ss_pred             ----CCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHH-------------HHhh-
Q 048439          426 ----PTSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWA-------------QQCY-  486 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~-------------~~~~-  486 (613)
                          ...++..|+|||++.+. .++.++|||||||++|||++|++||......+........             .... 
T Consensus       179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence                23456779999999875 7899999999999999999999999765443322211110             0000 


Q ss_pred             ccCCcc-------------ccccHHHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          487 QNGTID-------------QIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       487 ~~~~~~-------------~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ......             .+.+.... ..+||+.||.+||++.|++++..+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~  311 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ  311 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhc
Confidence            000000             11111111 2379999999999999999877653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-39  Score=342.28  Aligned_cols=246  Identities=22%  Similarity=0.317  Sum_probs=190.7

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecC------C
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD------R  342 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~------~  342 (613)
                      .++|...+.||+|+||.||+|....++..||||++...  .....+.+.+|+.+|++++||||+++++++...      .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            35788888999999999999999888899999998653  334456789999999999999999999999765      3


Q ss_pred             ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCC
Q 048439          343 EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS  422 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls  422 (613)
                      .+++||||+ +++|.+++..   ..+++..+..++.|+++||.|||+.+    |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~----ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG----IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC----ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            469999999 7899999854   46899999999999999999999998    999999999999999999999999999


Q ss_pred             ccCC-----CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHH------------
Q 048439          423 KFGP-----TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQ------------  484 (613)
Q Consensus       423 ~~~~-----~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~------------  484 (613)
                      +...     ..++..|+|||.+.+ ..++.++|||||||++|||++|++||......++.........            
T Consensus       176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          176 RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             EECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            7532     245677999999987 7899999999999999999999999976654443322211100            


Q ss_pred             ---------hh--ccCCcccc---ccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          485 ---------CY--QNGTIDQI---VDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       485 ---------~~--~~~~~~~~---~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                               ..  ....+..+   ..+...  ..+||..||.+|||+.|++++..+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f  311 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF  311 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHH
Confidence                     00  00011111   111111  227999999999999999987664

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-40  Score=346.25  Aligned_cols=245  Identities=23%  Similarity=0.263  Sum_probs=193.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEc---CCceeEEEEEeCCCC----hhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFIN---GSTTPVAIKRLEPES----QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDRE  343 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~---~~~~~vAVK~~~~~~----~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~  343 (613)
                      ++|...+.||+|+||.||+|+..   .++..||||+++...    ......+.+|+++|.++ +|+||+++++++.+.+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            57888899999999999999983   356889999987542    23345678899999999 69999999999999999


Q ss_pred             eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCc
Q 048439          344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK  423 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~  423 (613)
                      .+|||||+++|+|.+++..  ...+++..++.++.|+++||.|||+.+    |+||||||+|||++.++.+||+|||+++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~----ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            9999999999999999954  346999999999999999999999998    9999999999999999999999999986


Q ss_pred             cC---------CCCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhh-hHHHHHHHhhccCCc
Q 048439          424 FG---------PTSVSKTHLDPEYYRL--QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV-SLAVWAQQCYQNGTI  491 (613)
Q Consensus       424 ~~---------~~~~~~~~~aPE~~~~--~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~-~l~~~~~~~~~~~~~  491 (613)
                      ..         ...++..|+|||++.+  ..++.++|||||||+||||++|+.||......... .+.....  ......
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~  285 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL--KSEPPY  285 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH--HCCCCC
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh--ccCCCC
Confidence            42         1245778999999986  34789999999999999999999999654322211 1111111  111112


Q ss_pred             cccccHHHH--HhcccccCCCCCC-----CHHHHHHHHHH
Q 048439          492 DQIVDPFLK--AMSCLNDEGIRRP-----SMSDVVWGLEF  524 (613)
Q Consensus       492 ~~~~d~~~~--~~~Cl~~~p~~RP-----s~~evl~~Le~  524 (613)
                      ...+...+.  ..+||..||.+||     ++.|+++++.+
T Consensus       286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f  325 (355)
T 1vzo_A          286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  325 (355)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence            222222222  2379999999999     99999987764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.8e-39  Score=343.20  Aligned_cols=249  Identities=19%  Similarity=0.279  Sum_probs=189.7

Q ss_pred             HHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeec------
Q 048439          267 IQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCND------  340 (613)
Q Consensus       267 l~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~------  340 (613)
                      +....++|...+.||+|+||.||+|+...++..||||++......    +.+|+.+++.++|+|||++++++..      
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            345667899999999999999999999888899999998654322    3479999999999999999999844      


Q ss_pred             --------------------------------CCceEEEEEcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHH
Q 048439          341 --------------------------------DREMILVYDFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHY  386 (613)
Q Consensus       341 --------------------------------~~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~y  386 (613)
                                                      ...+++||||++ |+|.+.+..  .....+++..+..++.|+++||+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            334889999998 588877753  345679999999999999999999


Q ss_pred             HhcCCCCCcEEeccCCCCceeeC-CCCcEEEEecCCCccC-------CCCCCcccCChhhhhcC-CCCchhHHHHHHHHH
Q 048439          387 LHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFG-------PTSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVL  457 (613)
Q Consensus       387 LH~~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGls~~~-------~~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL  457 (613)
                      ||+.+    |+||||||+|||++ +++.+||+|||+++..       ...++..|+|||.+.+. .++.++|||||||++
T Consensus       157 LH~~g----i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          157 IHSLG----ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             HHTTT----EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HHHCc----CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            99998    99999999999998 6899999999999742       22346679999998775 489999999999999


Q ss_pred             HHHHhCCCCccchhhhhhhhHHHHHHHh------------hccCC------------ccccccHHH-H-HhcccccCCCC
Q 048439          458 FEVLCARPSILRTAAKKQVSLAVWAQQC------------YQNGT------------IDQIVDPFL-K-AMSCLNDEGIR  511 (613)
Q Consensus       458 ~elltg~~p~~~~~~~~~~~l~~~~~~~------------~~~~~------------~~~~~d~~~-~-~~~Cl~~~p~~  511 (613)
                      |||++|++||......++..........            .....            +..-.++.+ . ..+||+.||.+
T Consensus       233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  312 (383)
T 3eb0_A          233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL  312 (383)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence            9999999999776544433222111000            00000            000011111 1 22799999999


Q ss_pred             CCCHHHHHHHHHH
Q 048439          512 RPSMSDVVWGLEF  524 (613)
Q Consensus       512 RPs~~evl~~Le~  524 (613)
                      |||+.|++++..+
T Consensus       313 R~t~~e~l~hp~f  325 (383)
T 3eb0_A          313 RINPYEAMAHPFF  325 (383)
T ss_dssp             SCCHHHHHTSGGG
T ss_pred             CCCHHHHhcCHHH
Confidence            9999999977654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.3e-39  Score=346.65  Aligned_cols=188  Identities=26%  Similarity=0.372  Sum_probs=165.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecC-----Cce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD-----REM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~  344 (613)
                      ++|...++||+|+||.||+|+...++..||||++...  .....+.+.+|+.+|++++|+||+++++++...     +..
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            5788889999999999999999988899999999764  344556789999999999999999999999776     579


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++||||++ |+|.+++..  ...+++..++.++.||++||.|||+.+    |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~g----ivHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESG----IIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC----CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            99999997 599999853  456999999999999999999999998    99999999999999999999999999974


Q ss_pred             C------------------------------CCCCCcccCChhhh-hcCCCCchhHHHHHHHHHHHHHhCCCC
Q 048439          425 G------------------------------PTSVSKTHLDPEYY-RLQQLTEKSDVYSFGVVLFEVLCARPS  466 (613)
Q Consensus       425 ~------------------------------~~~~~~~~~aPE~~-~~~~~t~ksDV~SfGvvL~elltg~~p  466 (613)
                      .                              ...++..|+|||++ ....++.++|||||||+||||++|..|
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  251 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS  251 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence            2                              12346779999986 566799999999999999999985433

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.2e-39  Score=337.41  Aligned_cols=244  Identities=21%  Similarity=0.337  Sum_probs=182.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHH--HHHhccCccceeeEEEEee-----cCCce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEI--GMLSQLRHLHLVSLIGFCN-----DDREM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei--~~l~~l~H~niv~l~g~~~-----~~~~~  344 (613)
                      ++|...+.||+|+||.||+|+..  +..||||++....   ...+..|.  ..+..++|+||+++++++.     ....+
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             HHhheeeecccCCCeEEEEEEEC--CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            57888889999999999999874  4789999997543   23444444  4455689999999998553     23467


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------CCCCcEEeccCCCCceeeCCCCcEE
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG---------ANHAVIIHRDVKTTNILLDEKWVAK  415 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------~~~~~iiHrDlk~~NILl~~~~~~k  415 (613)
                      ++||||+++|+|.+++..   ..++|..++.|+.|+++||.|||+.         +    |+||||||+|||++.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~----ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA----ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC----EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccc----eeecccccceEEEcCCCcEE
Confidence            899999999999999954   3358999999999999999999998         6    99999999999999999999


Q ss_pred             EEecCCCccC----------------CCCCCcccCChhhhhc-------CCCCchhHHHHHHHHHHHHHhCCCCccchhh
Q 048439          416 VSDFGLSKFG----------------PTSVSKTHLDPEYYRL-------QQLTEKSDVYSFGVVLFEVLCARPSILRTAA  472 (613)
Q Consensus       416 l~DFGls~~~----------------~~~~~~~~~aPE~~~~-------~~~t~ksDV~SfGvvL~elltg~~p~~~~~~  472 (613)
                      |+|||+++..                ...++..|+|||.+.+       ..++.++|||||||+||||++|+.|+.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            9999999642                1236778999999987       4567899999999999999999777643221


Q ss_pred             hhh------------hhHHHHHHHhhc---cCCcccc------c-cHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          473 KKQ------------VSLAVWAQQCYQ---NGTIDQI------V-DPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       473 ~~~------------~~l~~~~~~~~~---~~~~~~~------~-d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      ...            .....+......   ...+...      . +.+.. ..+||+.||++|||+.|+++.|+..+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            110            001111111111   1111111      0 01111 337999999999999999999986654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=329.41  Aligned_cols=247  Identities=23%  Similarity=0.315  Sum_probs=195.3

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ..++|...+.||+|+||.||+|....++..||||.+....  ...++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            3467888899999999999999998878899999997643  35678999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----  425 (613)
                      |+++|+|.+++.. ....+++..++.++.+++.||.|||+.+    |+||||||+|||++.++.+||+|||+++..    
T Consensus       105 ~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          105 YCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMR----KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             CCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             cCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC----CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            9999999999853 2456999999999999999999999998    999999999999999999999999998532    


Q ss_pred             ----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          426 ----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                          ...++..|+|||.+....++.++|||||||++|||++|+.||............  ..............+..+. 
T Consensus       180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~  257 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI--PTNPPPTFRKPELWSDNFTD  257 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HHSCCCCCSSGGGSCHHHHH
T ss_pred             cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--hcCCCcccCCcccCCHHHHH
Confidence                224566799999999999999999999999999999999999654332221111  1111111111122222222 


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                       ..+||+.||.+||++.+++++....
T Consensus       258 li~~~l~~dp~~Rpt~~~ll~~~~~~  283 (314)
T 3com_A          258 FVKQCLVKSPEQRATATQLLQHPFVR  283 (314)
T ss_dssp             HHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHhCHHHh
Confidence             2279999999999999999876643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7e-39  Score=341.91  Aligned_cols=194  Identities=22%  Similarity=0.276  Sum_probs=170.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC--------ccceeeEEEEee----
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR--------HLHLVSLIGFCN----  339 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~--------H~niv~l~g~~~----  339 (613)
                      ++|...++||+|+||.||+|+...+++.||||+++.. ......+.+|+.++++++        |+||+++++++.    
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            6788899999999999999999888899999999754 344567899999999996        788999999987    


Q ss_pred             cCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcEEeccCCCCceeeCCCC------
Q 048439          340 DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG-ANHAVIIHRDVKTTNILLDEKW------  412 (613)
Q Consensus       340 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~iiHrDlk~~NILl~~~~------  412 (613)
                      +....+|||||+ +|+|.+.+.......+++..++.|+.|++.||.|||++ +    |+||||||+|||++.++      
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g----ivHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR----IIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC----EECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC----EecCCCCHHHeeEeccchhhhhh
Confidence            566899999999 56777777665556799999999999999999999998 7    99999999999999775      


Q ss_pred             -------------------------------------------cEEEEecCCCccC-----CCCCCcccCChhhhhcCCC
Q 048439          413 -------------------------------------------VAKVSDFGLSKFG-----PTSVSKTHLDPEYYRLQQL  444 (613)
Q Consensus       413 -------------------------------------------~~kl~DFGls~~~-----~~~~~~~~~aPE~~~~~~~  444 (613)
                                                                 .+||+|||+++..     ...++..|+|||++.+..+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~  270 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGY  270 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCC
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCC
Confidence                                                       7999999998642     2346778999999999999


Q ss_pred             CchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          445 TEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       445 t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                      +.++|||||||+||||++|++||....
T Consensus       271 ~~~~DiwslG~il~elltg~~pf~~~~  297 (397)
T 1wak_A          271 NTPADIWSTACMAFELATGDYLFEPHS  297 (397)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             CcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            999999999999999999999996543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.7e-39  Score=331.68  Aligned_cols=245  Identities=21%  Similarity=0.311  Sum_probs=189.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEee------------
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN------------  339 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~------------  339 (613)
                      ++|...+.||+|+||.||+|+...+++.||||++........+.+.+|+.++++++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            56788889999999999999999888999999998777777788999999999999999999999874            


Q ss_pred             --cCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC-CCCcEEE
Q 048439          340 --DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKV  416 (613)
Q Consensus       340 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~-~~~~~kl  416 (613)
                        +.+..++||||++ |+|.+++.   ...+++..++.++.|++.||+|||+.+    |+||||||+|||++ +++.+||
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSAN----VLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCSGGGEEEETTTTEEEE
T ss_pred             ccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhCC----EecCCCCHHHEEEcCCCCeEEE
Confidence              4467899999998 69999984   356899999999999999999999998    99999999999997 5779999


Q ss_pred             EecCCCccCC-----------CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHH-
Q 048439          417 SDFGLSKFGP-----------TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQ-  483 (613)
Q Consensus       417 ~DFGls~~~~-----------~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~-  483 (613)
                      +|||+++...           ..++..|+|||.+.. ..++.++|||||||+||||++|+.||......+......... 
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  242 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP  242 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999987432           123556999999876 678999999999999999999999997654433222111000 


Q ss_pred             -------------------HhhccC--C----ccccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          484 -------------------QCYQNG--T----IDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       484 -------------------~~~~~~--~----~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                                         ......  .    ...+...... ..+||+.||.+||++.|++++...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  309 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM  309 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence                               000000  0    0111111221 228999999999999999977664

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8.2e-39  Score=333.47  Aligned_cols=197  Identities=19%  Similarity=0.316  Sum_probs=173.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEE-cCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccc------eeeEEEEeecCCce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFI-NGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH------LVSLIGFCNDDREM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~-~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~n------iv~l~g~~~~~~~~  344 (613)
                      ++|...+.||+|+||.||+|.. ..++..||||+++.. ......+.+|+.++..++|+|      ++++++++.+.+..
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            5788888999999999999998 556688999999754 344567899999999998765      99999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC--------------
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE--------------  410 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~--------------  410 (613)
                      ++||||+ +++|.+++.......+++..++.++.|++.||+|||+.+    |+||||||+|||++.              
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK----LTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC----CcCCCCCHHHEEEeccccccccCCccccc
Confidence            9999999 889999997666667999999999999999999999998    999999999999987              


Q ss_pred             -----CCcEEEEecCCCccCC-----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhh
Q 048439          411 -----KWVAKVSDFGLSKFGP-----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK  474 (613)
Q Consensus       411 -----~~~~kl~DFGls~~~~-----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~  474 (613)
                           ++.+||+|||+++...     ..++..|+|||.+.+..++.++|||||||+||||++|++||......+
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             cccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                 6789999999987532     245778999999999999999999999999999999999997654443

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-38  Score=331.99  Aligned_cols=186  Identities=22%  Similarity=0.373  Sum_probs=166.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC-ccceeeEEEEeec--CCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGFCND--DREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|+...++..||||+++...   ...+.+|+.++.+++ |+||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            56888889999999999999998888999999997543   457899999999997 9999999999987  67789999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC-cEEEEecCCCccC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW-VAKVSDFGLSKFG--  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGls~~~--  425 (613)
                      ||+++++|.+++.     .+++.+++.++.|++.||.|||+.+    |+||||||+|||++.++ .+||+|||+++..  
T Consensus       113 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             ECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCC----eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            9999999999883     3899999999999999999999998    99999999999999776 8999999999642  


Q ss_pred             -----CCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccc
Q 048439          426 -----PTSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILR  469 (613)
Q Consensus       426 -----~~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~  469 (613)
                           ...++..|+|||.+.. ..++.++|||||||+||||++|+.||..
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~  233 (330)
T 3nsz_A          184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  233 (330)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence                 2235667999999987 6789999999999999999999999854

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.4e-38  Score=331.41  Aligned_cols=252  Identities=23%  Similarity=0.328  Sum_probs=195.1

Q ss_pred             CHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhc--cCccceeeEEEEeec
Q 048439          263 SLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQ--LRHLHLVSLIGFCND  340 (613)
Q Consensus       263 ~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~--l~H~niv~l~g~~~~  340 (613)
                      ++..-....++|...+.||+|+||.||+|+..  ++.||||++...   ....+.+|++++..  ++||||+++++++..
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            33334455678999999999999999999985  478999999653   34567888888887  799999999999988


Q ss_pred             CC----ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCcEEeccCCCCceee
Q 048439          341 DR----EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH--------TGANHAVIIHRDVKTTNILL  408 (613)
Q Consensus       341 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~~iiHrDlk~~NILl  408 (613)
                      ..    ..++||||+++|+|.+++..   ..+++.+++.++.|++.||.|||        +.+    |+||||||+|||+
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~----ivH~Dlkp~NIll  180 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA----IAHRDLKSKNILV  180 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE----EECSCCSGGGEEE
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC----eeeCCCCHHHEEE
Confidence            76    78999999999999999954   35899999999999999999999        666    9999999999999


Q ss_pred             CCCCcEEEEecCCCccC------------CCCCCcccCChhhhhcCC------CCchhHHHHHHHHHHHHHhC-------
Q 048439          409 DEKWVAKVSDFGLSKFG------------PTSVSKTHLDPEYYRLQQ------LTEKSDVYSFGVVLFEVLCA-------  463 (613)
Q Consensus       409 ~~~~~~kl~DFGls~~~------------~~~~~~~~~aPE~~~~~~------~t~ksDV~SfGvvL~elltg-------  463 (613)
                      +.++.+||+|||+++..            ...++..|+|||.+....      ++.++|||||||+||||++|       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            99999999999998531            224577899999998763      34789999999999999999       


Q ss_pred             ---CCCccchhhhhhhhHHHHHHHhhcc---CCcc------ccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          464 ---RPSILRTAAKKQVSLAVWAQQCYQN---GTID------QIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       464 ---~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~------~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                         +.||........ ....+.......   ..+.      ...+.+.. ..+||+.||.+||++.+|+++|+...+
T Consensus       261 ~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~  336 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDP-SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  336 (342)
T ss_dssp             CCCCCTTTTTSCSSC-CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccccCccccCcCcc-cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence               677754322111 111222211111   1111      11112222 238999999999999999999996554

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.4e-39  Score=338.97  Aligned_cols=257  Identities=21%  Similarity=0.254  Sum_probs=197.5

Q ss_pred             ccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh-----------hcHHHHHHHHHHHhccCcc
Q 048439          261 QFSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ-----------QGALEFQTEIGMLSQLRHL  329 (613)
Q Consensus       261 ~f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~-----------~~~~~f~~Ei~~l~~l~H~  329 (613)
                      ...+.++....++|...+.||+|+||.||+|.... +..||||++.....           ...+.+.+|+.++++++||
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   89 (362)
T 3pg1_A           11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP   89 (362)
T ss_dssp             HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCT
T ss_pred             HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCc
Confidence            34577889999999999999999999999999876 57899999865321           1236799999999999999


Q ss_pred             ceeeEEEEeec-----CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCC
Q 048439          330 HLVSLIGFCND-----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTT  404 (613)
Q Consensus       330 niv~l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~  404 (613)
                      ||+++++++..     ...+++||||++ |+|.+++.. ....+++..++.++.|++.||.|||+.+    |+||||||+
T Consensus        90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~----ivH~Dlkp~  163 (362)
T 3pg1_A           90 NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAG----VVHRDLHPG  163 (362)
T ss_dssp             TBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGG
T ss_pred             CccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCc----CEecCCChH
Confidence            99999999843     346899999998 688888864 3457999999999999999999999998    999999999


Q ss_pred             ceeeCCCCcEEEEecCCCccC-------CCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhh
Q 048439          405 NILLDEKWVAKVSDFGLSKFG-------PTSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV  476 (613)
Q Consensus       405 NILl~~~~~~kl~DFGls~~~-------~~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~  476 (613)
                      |||++.++.+||+|||+++..       ...++..|+|||.+.+ ..++.++|||||||++|||++|++||......+..
T Consensus       164 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  243 (362)
T 3pg1_A          164 NILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL  243 (362)
T ss_dssp             GEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             HEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999999999999999642       1234667999999987 67899999999999999999999999765443322


Q ss_pred             hHHHHHH-----------------HhhccCC---c-------cccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          477 SLAVWAQ-----------------QCYQNGT---I-------DQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       477 ~l~~~~~-----------------~~~~~~~---~-------~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .......                 .......   .       ....++.+.  ..+||+.||.+|||+.|++++..+
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  320 (362)
T 3pg1_A          244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF  320 (362)
T ss_dssp             HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchh
Confidence            2111000                 0000000   0       000111111  237999999999999999977664

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.3e-38  Score=335.01  Aligned_cols=246  Identities=21%  Similarity=0.294  Sum_probs=194.5

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecC-----Cce
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD-----REM  344 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~  344 (613)
                      .++|...+.||+|+||.||+|+...++..||||++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            367888899999999999999998888999999997543 34456788999999999999999999998764     678


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++||||+. |+|.+++..   ..+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~----ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSN----VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999998 599998854   46999999999999999999999998    99999999999999999999999999864


Q ss_pred             CC------------------CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHh
Q 048439          425 GP------------------TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC  485 (613)
Q Consensus       425 ~~------------------~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~  485 (613)
                      ..                  ..++..|+|||.+.. ..++.++|||||||+||||++|++||......+...........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            22                  134667999998865 77899999999999999999999999765543332211110000


Q ss_pred             hc------------------------cCCc----cccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          486 YQ------------------------NGTI----DQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       486 ~~------------------------~~~~----~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ..                        ....    ..+.+.... ..+||+.||.+||++.|++++...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  309 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL  309 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence            00                        0000    011111111 237999999999999999876653

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.4e-39  Score=334.41  Aligned_cols=248  Identities=27%  Similarity=0.359  Sum_probs=180.7

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ..++|...+.||+|+||.||+|....++..||||++.... .....++.+|+.++.+++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            3468888999999999999999987777889999987543 344567899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCC
Q 048439          349 DFMARGTLPDHLYH------SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS  422 (613)
Q Consensus       349 Ey~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls  422 (613)
                      ||+++|+|.+++..      .....+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||++
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG----QIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC----CCCCCCChhhEEEcCCCCEEEEeccch
Confidence            99999999999853      13456999999999999999999999998    999999999999999999999999987


Q ss_pred             ccCC-------------CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc-
Q 048439          423 KFGP-------------TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ-  487 (613)
Q Consensus       423 ~~~~-------------~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~-  487 (613)
                      +...             ..++..|+|||.+.. ..++.++|||||||+||||++|+.||............  ...... 
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~  246 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT--LQNDPPS  246 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--HTSSCCC
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH--hccCCCc
Confidence            5321             235667999999976 57899999999999999999999999764433221111  000000 


Q ss_pred             -------cCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          488 -------NGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       488 -------~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                             ..........+.. ..+||+.||.+||++.|++++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  290 (303)
T 2vwi_A          247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF  290 (303)
T ss_dssp             TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred             cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence                   0001111112221 23799999999999999986644

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.6e-39  Score=371.10  Aligned_cols=244  Identities=20%  Similarity=0.268  Sum_probs=200.2

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceE
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~  345 (613)
                      ..++|...++||+|+||.||+|+...+++.||||+++..   .......+..|..+|..+ +|+||+++++++.+.+.++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            456788999999999999999999988899999999753   233456788999999988 7999999999999999999


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      |||||+++|+|.+++..  ...+++..++.++.||+.||.|||+.+    |+||||||+||||+.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g----IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTS----EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            99999999999999964  346999999999999999999999998    999999999999999999999999998742


Q ss_pred             --------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccH
Q 048439          426 --------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP  497 (613)
Q Consensus       426 --------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  497 (613)
                              ...++..|+|||++....++.++|||||||+||||++|++||......+....+.     .....+..-+.+
T Consensus       493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~-----~~~~~~p~~~s~  567 (674)
T 3pfq_A          493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-----EHNVAYPKSMSK  567 (674)
T ss_dssp             CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----SSCCCCCTTSCH
T ss_pred             ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH-----hCCCCCCccCCH
Confidence                    2346788999999999999999999999999999999999997654433222111     111122222233


Q ss_pred             HHH--HhcccccCCCCCCCH-----HHHHHHHHH
Q 048439          498 FLK--AMSCLNDEGIRRPSM-----SDVVWGLEF  524 (613)
Q Consensus       498 ~~~--~~~Cl~~~p~~RPs~-----~evl~~Le~  524 (613)
                      .+.  ..+||+.||.+||++     .||+++..+
T Consensus       568 ~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff  601 (674)
T 3pfq_A          568 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF  601 (674)
T ss_dssp             HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGG
T ss_pred             HHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccc
Confidence            222  227999999999997     777755543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.2e-38  Score=331.38  Aligned_cols=250  Identities=23%  Similarity=0.345  Sum_probs=195.4

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEc-CCceeEEEEEeCCCC--hhcHHHHHHHHHHHhcc---CccceeeEEEEee---
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFIN-GSTTPVAIKRLEPES--QQGALEFQTEIGMLSQL---RHLHLVSLIGFCN---  339 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~-~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l---~H~niv~l~g~~~---  339 (613)
                      .+.++|...+.||+|+||.||+|+.. .++..||||+++...  ......+.+|+.+++++   +||||++++++|.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            35578999999999999999999984 566889999986432  22233567788777766   8999999999987   


Q ss_pred             --cCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEE
Q 048439          340 --DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVS  417 (613)
Q Consensus       340 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~  417 (613)
                        .....++||||++ |+|.+++.......+++..++.++.|++.||.|||+.+    |+||||||+|||++.++.+||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g----i~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC----ceeccCCHHHeEEcCCCCEEEe
Confidence              5677899999998 69999997665667999999999999999999999998    9999999999999999999999


Q ss_pred             ecCCCccC-------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc--
Q 048439          418 DFGLSKFG-------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN--  488 (613)
Q Consensus       418 DFGls~~~-------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--  488 (613)
                      |||+++..       ...++..|+|||.+....++.++|||||||++|||++|++||......+..............  
T Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (326)
T 1blx_A          163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  242 (326)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence            99998642       234567899999999999999999999999999999999999765544332222111100000  


Q ss_pred             -----------------CCc---cccccHHHH--HhcccccCCCCCCCHHHHHHHHH
Q 048439          489 -----------------GTI---DQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       489 -----------------~~~---~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                                       ...   ..-++..+.  ..+||+.||.+||++.|++++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  299 (326)
T 1blx_A          243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  299 (326)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence                             000   011122221  23799999999999999986554

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.5e-38  Score=337.04  Aligned_cols=247  Identities=23%  Similarity=0.306  Sum_probs=195.3

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecC-----Cce
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD-----REM  344 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~  344 (613)
                      .++|...+.||+|+||.||+|+...++..||||++.... ......+.+|++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457888899999999999999998888999999997643 34456789999999999999999999998654     468


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++||||++ |+|.+++..   ..+++.+++.|+.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC----eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999998 599998854   45999999999999999999999998    99999999999999999999999999864


Q ss_pred             CC-----------CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHH---------
Q 048439          425 GP-----------TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQ---------  483 (613)
Q Consensus       425 ~~-----------~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~---------  483 (613)
                      ..           ..++..|+|||++.. ..++.++|||||||+||||++|++||......+.........         
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            21           245778999998765 458999999999999999999999997655444332221100         


Q ss_pred             ------------HhhccCCc------cccccHHHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          484 ------------QCYQNGTI------DQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       484 ------------~~~~~~~~------~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                                  ........      ..+...... ..+||+.||.+|||+.|++++....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  318 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE  318 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence                        00000000      011111111 2279999999999999999877643

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.4e-39  Score=329.81  Aligned_cols=246  Identities=23%  Similarity=0.349  Sum_probs=188.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcC-C--ceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFING-S--TTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~-~--~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  345 (613)
                      ++|...+.||+|+||.||+|++.. +  ...||||+++..   .....+.|.+|+.++++++||||+++++++.+.. .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            568888899999999999998643 2  236999998764   2345678999999999999999999999998765 89


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +||||+++|+|.+++... ...+++..++.++.|+++||.|||+.+    |+||||||+|||++.++.+||+|||+++..
T Consensus        97 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~----i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKR----FIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCC----cccCCCchheEEEcCCCCEEEccccccccc
Confidence            999999999999998643 356899999999999999999999998    999999999999999999999999998643


Q ss_pred             CC-----------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHh-hccCCcc
Q 048439          426 PT-----------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQC-YQNGTID  492 (613)
Q Consensus       426 ~~-----------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~-~~~~~~~  492 (613)
                      ..           .++..|+|||.+....++.++|||||||++|||++ |+.||......+..   ...... .......
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~  248 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---HKIDKEGERLPRPE  248 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHHTSCCCCCCCT
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH---HHHHccCCCCCCCc
Confidence            21           23446999999999999999999999999999999 99999655433211   111111 1111112


Q ss_pred             ccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          493 QIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       493 ~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      .+.+.+.. ..+||+.+|.+||++.++++.|+...
T Consensus       249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence            22222222 23799999999999999999988543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2e-39  Score=340.52  Aligned_cols=246  Identities=18%  Similarity=0.250  Sum_probs=195.8

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhc-----------------HHHHHHHHHHHhccCccceee
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQG-----------------ALEFQTEIGMLSQLRHLHLVS  333 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~-----------------~~~f~~Ei~~l~~l~H~niv~  333 (613)
                      .++|...+.||+|+||.||+|..  ++..||||++.......                 ...|.+|+.++++++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            36788889999999999999999  55889999986542111                 178999999999999999999


Q ss_pred             EEEEeecCCceEEEEEcCCCCChhHH------hhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEeccCCCCce
Q 048439          334 LIGFCNDDREMILVYDFMARGTLPDH------LYHSDNPPLPWNQRLEICIGAARGLHYLHT-GANHAVIIHRDVKTTNI  406 (613)
Q Consensus       334 l~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~iiHrDlk~~NI  406 (613)
                      +++++.+.+..++||||+++|+|.++      +.......+++..++.++.|++.||.|||+ .+    |+||||||+||
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~----i~H~dl~p~Ni  183 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN----ICHRDVKPSNI  183 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC----EECCCCCGGGE
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC----EeecCCChHhE
Confidence            99999999999999999999999998      644346789999999999999999999998 87    99999999999


Q ss_pred             eeCCCCcEEEEecCCCccC------CCCCCcccCChhhhhcC-CCCc-hhHHHHHHHHHHHHHhCCCCccchhhhhhhhH
Q 048439          407 LLDEKWVAKVSDFGLSKFG------PTSVSKTHLDPEYYRLQ-QLTE-KSDVYSFGVVLFEVLCARPSILRTAAKKQVSL  478 (613)
Q Consensus       407 Ll~~~~~~kl~DFGls~~~------~~~~~~~~~aPE~~~~~-~~t~-ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l  478 (613)
                      |++.++.+||+|||+++..      ...++..|+|||.+.+. .++. ++|||||||++|||++|++||.......  ..
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~  261 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--EL  261 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--HH
T ss_pred             EEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HH
Confidence            9999999999999998642      23467789999999887 6666 9999999999999999999997544311  11


Q ss_pred             HHHHHHhhccCCc-----------------cccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          479 AVWAQQCYQNGTI-----------------DQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       479 ~~~~~~~~~~~~~-----------------~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .............                 ....+..+.  ..+||+.||.+||++.|++++..+
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f  326 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL  326 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence            1111110000000                 011222222  227999999999999999987654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.9e-39  Score=327.87  Aligned_cols=244  Identities=22%  Similarity=0.316  Sum_probs=188.8

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeec----------
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCND----------  340 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~----------  340 (613)
                      .++|...+.||+|+||.||+|+...++..||||++... ......+.+|+.++++++||||++++++|.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            46788889999999999999999877889999998643 3445678999999999999999999998865          


Q ss_pred             ---CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEE
Q 048439          341 ---DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVS  417 (613)
Q Consensus       341 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~  417 (613)
                         .+..++||||+++|+|.+++.. ....+++..++.++.|+++||.|||+.+    |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~----i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhCC----eecccCCHHhEEEcCCCCEEEe
Confidence               3567999999999999999964 3456888999999999999999999998    9999999999999999999999


Q ss_pred             ecCCCccCC----------------------CCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhh
Q 048439          418 DFGLSKFGP----------------------TSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKK  474 (613)
Q Consensus       418 DFGls~~~~----------------------~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~  474 (613)
                      |||+++...                      ..++..|+|||.+.+. .++.++|||||||++|||++   |+.......
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~  235 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV  235 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence            999986432                      1245679999999864 78999999999999999998   443221111


Q ss_pred             hhhHHHHHHHhhc--cCCcc-ccccHHHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          475 QVSLAVWAQQCYQ--NGTID-QIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       475 ~~~l~~~~~~~~~--~~~~~-~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                        ...........  ..... ...+.... ..+||+.||.+||++.+++++....
T Consensus       236 --~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (303)
T 1zy4_A          236 --NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP  288 (303)
T ss_dssp             --HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSC
T ss_pred             --HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcC
Confidence              11111111100  11111 11111121 2379999999999999999876643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.6e-39  Score=342.46  Aligned_cols=246  Identities=22%  Similarity=0.331  Sum_probs=182.8

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecC------C
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD------R  342 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~------~  342 (613)
                      .++|...+.||+|+||.||+|....++..||||++...  .......+.+|+.+|++++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            36788888999999999999999888899999999754  334556789999999999999999999998654      5


Q ss_pred             ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCC
Q 048439          343 EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS  422 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls  422 (613)
                      ..++|+||+ +++|.+++..   ..+++..++.++.|+++||.|||+.+    |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g----ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC----eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            689999999 6899988843   56999999999999999999999998    999999999999999999999999999


Q ss_pred             ccCC-----CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHh-----------
Q 048439          423 KFGP-----TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC-----------  485 (613)
Q Consensus       423 ~~~~-----~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~-----------  485 (613)
                      +...     ..++..|+|||.+.+ ..++.++|||||||++|||++|++||......++..........           
T Consensus       180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          180 RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             ccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            7532     245778999999987 67899999999999999999999999766554433322211000           


Q ss_pred             ----------hc--cCCcccc---ccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          486 ----------YQ--NGTIDQI---VDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       486 ----------~~--~~~~~~~---~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                                ..  ...+..+   .++...  ..+||..||.+|||+.|++.+..+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~  315 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF  315 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhh
Confidence                      00  0000000   111111  227999999999999999987664

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7e-39  Score=340.55  Aligned_cols=192  Identities=23%  Similarity=0.322  Sum_probs=165.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCC------c
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR------E  343 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~------~  343 (613)
                      ++|...+.||+|+||.||+|+...++..||||++...  .......+.+|+.+++.++||||+++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            6788889999999999999999888899999998753  3344567899999999999999999999997665      6


Q ss_pred             eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCc
Q 048439          344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK  423 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~  423 (613)
                      .++||||+++ +|.+.+.    ..+++..+..++.|++.||.|||+.+    |+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~----ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             eEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCC----eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            8999999985 7888884    34899999999999999999999998    9999999999999999999999999987


Q ss_pred             cCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhh
Q 048439          424 FGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAA  472 (613)
Q Consensus       424 ~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~  472 (613)
                      ...       ..++..|+|||++.+..++.++|||||||+||||++|++||.....
T Consensus       176 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  231 (371)
T 2xrw_A          176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH  231 (371)
T ss_dssp             --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            432       2456779999999999999999999999999999999999976544

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.7e-38  Score=338.80  Aligned_cols=201  Identities=25%  Similarity=0.283  Sum_probs=173.5

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC-cc-----ceeeEEEEeecCC
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HL-----HLVSLIGFCNDDR  342 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~-----niv~l~g~~~~~~  342 (613)
                      ...++|...+.||+|+||.||+|+...++..||||+++.. .....++..|+.++..++ |+     +|+++++++...+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            3457899999999999999999999888899999999754 334566788999988885 44     4999999999999


Q ss_pred             ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc--CCCCCcEEeccCCCCceeeC--CCCcEEEEe
Q 048439          343 EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT--GANHAVIIHRDVKTTNILLD--EKWVAKVSD  418 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~--~~~~~~iiHrDlk~~NILl~--~~~~~kl~D  418 (613)
                      ..+|||||++ |+|.+++.......+++..++.++.|++.||.|||+  .+    |+||||||+|||++  .++.+||+|
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~----ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS----IIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC----EECCCCSGGGEEESSTTSCCEEECC
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC----EEcCCCCcccEEEecCCCCcEEEEe
Confidence            9999999996 599999977655679999999999999999999995  34    99999999999994  578899999


Q ss_pred             cCCCccC-----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhh
Q 048439          419 FGLSKFG-----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQ  475 (613)
Q Consensus       419 FGls~~~-----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~  475 (613)
                      ||+++..     ...++..|+|||++.+..++.++|||||||+||||++|++||......+.
T Consensus       205 FG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~  266 (382)
T 2vx3_A          205 FGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ  266 (382)
T ss_dssp             CTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999643     23457789999999999999999999999999999999999976554443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.5e-39  Score=345.50  Aligned_cols=248  Identities=12%  Similarity=0.021  Sum_probs=177.2

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh---hcHHHHHHHHHHHhcc--CccceeeEE-------EEe
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ---QGALEFQTEIGMLSQL--RHLHLVSLI-------GFC  338 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l--~H~niv~l~-------g~~  338 (613)
                      ..+|...+.||+|+||.||+|++..++..||||++.....   .....+.+|+.++..|  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            3457788899999999999999988889999999987542   3445677885544444  699988855       343


Q ss_pred             ecC-----------------CceEEEEEcCCCCChhHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCc
Q 048439          339 NDD-----------------REMILVYDFMARGTLPDHLYHSDNPPLPWNQR------LEICIGAARGLHYLHTGANHAV  395 (613)
Q Consensus       339 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~~  395 (613)
                      ...                 ...+||||||+ |+|.+++... ...+.+..+      +.++.|+++||+|||+.+    
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~----  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQSKG----  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT----
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC----
Confidence            322                 33799999999 8999999653 234577777      889999999999999998    


Q ss_pred             EEeccCCCCceeeCCCCcEEEEecCCCccCC-----CCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCcc
Q 048439          396 IIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----TSVSKTHLDPEYYRL--QQLTEKSDVYSFGVVLFEVLCARPSIL  468 (613)
Q Consensus       396 iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----~~~~~~~~aPE~~~~--~~~t~ksDV~SfGvvL~elltg~~p~~  468 (613)
                      |+||||||+|||++.++.+||+|||+++...     ..++..|+|||++..  ..++.++|||||||+||||++|++||.
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999999987532     234578999999987  789999999999999999999999997


Q ss_pred             chhhhhhhhHHHH--HH---HhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          469 RTAAKKQVSLAVW--AQ---QCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       469 ~~~~~~~~~l~~~--~~---~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .............  ..   ..........+.+.... ..+||+.||++||++.|++++..+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  356 (371)
T 3q60_A          295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF  356 (371)
T ss_dssp             BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred             CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence            6533211100000  00   00000001122222222 227999999999999999976664

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.1e-38  Score=344.75  Aligned_cols=249  Identities=19%  Similarity=0.178  Sum_probs=196.4

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCc-cceeeEEEEeecCCceEEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRH-LHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E  349 (613)
                      .++|...++||+|+||.||+|+...++..||||++......  .++..|++++..|+| +++..+..++.+.+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            36788899999999999999999887889999988654322  357899999999986 556666667778888999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee---CCCCcEEEEecCCCccC-
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL---DEKWVAKVSDFGLSKFG-  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGls~~~-  425 (613)
                      |+ +++|.+++... ...+++.+++.|+.||+.||.|||+.+    |+||||||+||||   +.++.+||+|||+++.. 
T Consensus        84 ~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g----IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS----FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC----EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 89999998643 456999999999999999999999998    9999999999999   68899999999998632 


Q ss_pred             --------------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCc
Q 048439          426 --------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTI  491 (613)
Q Consensus       426 --------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~  491 (613)
                                    ...++..|+|||++.+..++.++|||||||+||||++|+.||.......................+
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence                          234567899999999999999999999999999999999999764432222222111111111111


Q ss_pred             ----cccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          492 ----DQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       492 ----~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                          ..+.+.+.. ...||+.+|++||++.+|++.|+..++
T Consensus       238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence                111112222 227999999999999999999987755

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1e-38  Score=326.45  Aligned_cols=247  Identities=23%  Similarity=0.302  Sum_probs=196.3

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ...++|...+.||+|+||.||+|+...+++.||||++...  .......+.+|+.++++++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            3446788999999999999999999877789999998654  23456789999999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC---CcEEEEecCCCc
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK---WVAKVSDFGLSK  423 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGls~  423 (613)
                      ||||+++++|.+.+..  ...+++.+++.++.|++.||.|||+.+    |+||||||+|||++.+   +.+||+|||+++
T Consensus        99 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~----i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           99 VGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            9999999999998854  346899999999999999999999998    9999999999999754   479999999987


Q ss_pred             cCCC-------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc--CCcccc
Q 048439          424 FGPT-------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN--GTIDQI  494 (613)
Q Consensus       424 ~~~~-------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~~  494 (613)
                      ....       .++..|+|||.+.+ .++.++||||||+++|||++|++||......+.....  .......  .....+
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  249 (287)
T 2wei_A          173 CFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDLPQWRTI  249 (287)
T ss_dssp             TBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCCCCCCSGGGTTS
T ss_pred             eecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH--HcCCCCCCchhhhhc
Confidence            5322       13456999999875 5899999999999999999999999765433221111  1111100  001112


Q ss_pred             ccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          495 VDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       495 ~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .+.... ..+||+.+|.+||++.|++++...
T Consensus       250 ~~~~~~li~~~l~~dp~~Rps~~ell~hp~~  280 (287)
T 2wei_A          250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWI  280 (287)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHhcCHHH
Confidence            222222 227999999999999999976553

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.7e-38  Score=343.35  Aligned_cols=244  Identities=26%  Similarity=0.271  Sum_probs=186.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecC------CceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD------REMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~  345 (613)
                      .+|...++||+|+||.||+|++..++..||||++.....    .+.+|+++|++++|+|||+++++|...      ..++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            357778899999999999999988788999999865432    234799999999999999999998542      2367


Q ss_pred             EEEEcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC-CcEEEEecCCC
Q 048439          346 LVYDFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK-WVAKVSDFGLS  422 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGls  422 (613)
                      +||||+++ +|.+.+..  .....+++..++.++.|+++||.|||+.+    |+||||||+|||++.+ +.+||+|||++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~----ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT----EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC----ccccCCChhhEEEeCCCCeEEeccchhh
Confidence            99999986 66666532  24567999999999999999999999998    9999999999999955 67899999999


Q ss_pred             ccC-------CCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHH----------HH
Q 048439          423 KFG-------PTSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWA----------QQ  484 (613)
Q Consensus       423 ~~~-------~~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~----------~~  484 (613)
                      +..       ...++..|+|||++.+. .++.++|||||||+||||++|++||......++.......          ..
T Consensus       205 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~  284 (420)
T 1j1b_A          205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  284 (420)
T ss_dssp             EECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             hhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            742       22356779999999764 7899999999999999999999999766544433222111          00


Q ss_pred             hh--ccCCcc------------ccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          485 CY--QNGTID------------QIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       485 ~~--~~~~~~------------~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ..  ....+.            ...++...  ..+||..||.+||++.|++++..+
T Consensus       285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f  340 (420)
T 1j1b_A          285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  340 (420)
T ss_dssp             CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence            00  000000            01111121  227999999999999999987765

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.2e-38  Score=335.45  Aligned_cols=245  Identities=20%  Similarity=0.287  Sum_probs=193.5

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCce----
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREM----  344 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~----  344 (613)
                      .++|...+.||+|+||.||+|....++..||||++...  .......+.+|+.++++++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            36788888999999999999999888899999999764  334456789999999999999999999999887655    


Q ss_pred             --EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCC
Q 048439          345 --ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLS  422 (613)
Q Consensus       345 --~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls  422 (613)
                        ++||||+. |+|.+.+    ...+++..++.++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHSAG----VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCC----CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999998 5888877    234999999999999999999999998    999999999999999999999999999


Q ss_pred             ccC-----CCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHH--------------
Q 048439          423 KFG-----PTSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWA--------------  482 (613)
Q Consensus       423 ~~~-----~~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~--------------  482 (613)
                      +..     ...++..|+|||++.+ ..++.++|||||||+||||++|++||......+........              
T Consensus       192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  271 (371)
T 4exu_A          192 RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  271 (371)
T ss_dssp             --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred             cccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence            742     2345778999999987 78899999999999999999999999765443322211110              


Q ss_pred             -------HHhhccC--Cc----cccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          483 -------QQCYQNG--TI----DQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       483 -------~~~~~~~--~~----~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                             .......  ..    ....+.... ..+||+.||.+||++.|++++..+
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  327 (371)
T 4exu_A          272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF  327 (371)
T ss_dssp             HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred             hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence                   0000000  00    011111111 227999999999999999977664

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.4e-38  Score=362.18  Aligned_cols=250  Identities=23%  Similarity=0.357  Sum_probs=199.3

Q ss_pred             HHhcCCCCcceeeeeCcEEEEEEEEcCC---ceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCce
Q 048439          269 AATNNFDNDLVIGVGGFGDVYKGFINGS---TTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       269 ~at~~f~~~~~iG~G~fG~Vy~g~~~~~---~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~  344 (613)
                      ...++|...+.||+|+||.||+|++..+   +..||||.++.. .....+.|.+|+.++++++||||++++|++. ++..
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            3456788888999999999999998542   457999998764 3444567999999999999999999999985 4568


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ++||||+++|+|.+++... ...+++..++.++.|+++||.|||+.+    |+||||||+|||++.++.+||+|||+++.
T Consensus       466 ~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g----ivHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             EEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC----ccccccchHhEEEeCCCCEEEEecCCCee
Confidence            9999999999999999643 456999999999999999999999998    99999999999999999999999999975


Q ss_pred             CCC---------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCcccc
Q 048439          425 GPT---------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQI  494 (613)
Q Consensus       425 ~~~---------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  494 (613)
                      ...         .++..|+|||.+....++.++|||||||+||||++ |++||......+...   .............+
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~---~i~~~~~~~~~~~~  617 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RIENGERLPMPPNC  617 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---HHHHTCCCCCCTTC
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHcCCCCCCCccc
Confidence            321         22457999999999999999999999999999997 999997554333221   11111111111222


Q ss_pred             ccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          495 VDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       495 ~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      .+.+.. ..+||+.||.+||++.+|++.|+..++
T Consensus       618 ~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            222222 237999999999999999999997653

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.1e-38  Score=331.53  Aligned_cols=197  Identities=20%  Similarity=0.321  Sum_probs=172.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCc-eeEEEEEeCCCChhcHHHHHHHHHHHhccCccc------eeeEEEEeecCCce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGST-TPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH------LVSLIGFCNDDREM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~-~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~n------iv~l~g~~~~~~~~  344 (613)
                      ++|...+.||+|+||.||+|+....+ ..||||+++.. ......+.+|+.++++++|++      ++.+++++...+..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            57888899999999999999986554 78999999754 344567889999999998877      99999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee----------------
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL----------------  408 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl----------------  408 (613)
                      ++||||+ +|+|.+++.......+++.+++.++.|++.||+|||+.+    |+||||||+|||+                
T Consensus        98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~----ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ----LTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT----EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEEEeccccccccccccccc
Confidence            9999999 667878876655567999999999999999999999998    9999999999999                


Q ss_pred             ---CCCCcEEEEecCCCccC-----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhh
Q 048439          409 ---DEKWVAKVSDFGLSKFG-----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKK  474 (613)
Q Consensus       409 ---~~~~~~kl~DFGls~~~-----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~  474 (613)
                         +.++.+||+|||+++..     ...++..|+|||.+.+..++.++|||||||+||||++|++||......+
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence               66889999999999742     2345778999999999999999999999999999999999997655443

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.6e-38  Score=333.22  Aligned_cols=247  Identities=19%  Similarity=0.311  Sum_probs=172.6

Q ss_pred             hcCCCCc-ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeec----CCceE
Q 048439          271 TNNFDND-LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCND----DREMI  345 (613)
Q Consensus       271 t~~f~~~-~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~  345 (613)
                      .++|... ++||+|+||.||+|+...+++.||||++.... .   ...+....+..++|+||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            3577774 47999999999999999888999999986532 1   12223334566799999999999876    44589


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC---CCcEEEEecCCC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE---KWVAKVSDFGLS  422 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGls  422 (613)
                      +||||+++|+|.+++.......+++.+++.++.|++.||.|||+.+    |+||||||+|||++.   ++.+||+|||++
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~----ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            9999999999999997665668999999999999999999999998    999999999999976   456999999998


Q ss_pred             ccCC------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhH----HHHHHHhhccCCcc
Q 048439          423 KFGP------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSL----AVWAQQCYQNGTID  492 (613)
Q Consensus       423 ~~~~------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l----~~~~~~~~~~~~~~  492 (613)
                      +...      ..++..|+|||++....++.++|||||||+||||++|++||...........    ..............
T Consensus       179 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (336)
T 3fhr_A          179 KETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS  258 (336)
T ss_dssp             EEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTST
T ss_pred             eeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhc
Confidence            6422      2346779999999888899999999999999999999999965443221110    00011111111112


Q ss_pred             ccccHHHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          493 QIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       493 ~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      .+.+.... ..+||+.||.+||++.|++++....
T Consensus       259 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  292 (336)
T 3fhr_A          259 EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN  292 (336)
T ss_dssp             TCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence            22222222 2279999999999999999887764

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.6e-38  Score=332.56  Aligned_cols=254  Identities=20%  Similarity=0.211  Sum_probs=185.1

Q ss_pred             HHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCc-
Q 048439          265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDRE-  343 (613)
Q Consensus       265 ~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~-  343 (613)
                      .+.....++|...+.||+|+||.||+|+...++..||||++.... .....+.+|++.+..++||||++++++|...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            456677889999999999999999999998888899999986543 233456788899999999999999999866443 


Q ss_pred             ------eEEEEEcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCcEEeccCCCCceeeCC-CC
Q 048439          344 ------MILVYDFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLH--TGANHAVIIHRDVKTTNILLDE-KW  412 (613)
Q Consensus       344 ------~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~~iiHrDlk~~NILl~~-~~  412 (613)
                            .++||||+++ +|.+.+..  .....+++..+..++.|++.||.|||  +.+    |+||||||+|||++. ++
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~----ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN----VCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC----CBCSCCCGGGEEEETTTT
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC----eecCcCCHHHEEEeCCCC
Confidence                  7899999987 55444432  34567899999999999999999999  777    999999999999997 89


Q ss_pred             cEEEEecCCCccCC-------CCCCcccCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHH
Q 048439          413 VAKVSDFGLSKFGP-------TSVSKTHLDPEYYRLQQ-LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQ  484 (613)
Q Consensus       413 ~~kl~DFGls~~~~-------~~~~~~~~aPE~~~~~~-~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~  484 (613)
                      .+||+|||+++...       ..++..|+|||++.+.. ++.++|||||||+||||++|++||.................
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  249 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG  249 (360)
T ss_dssp             EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence            99999999997432       23467799999986654 89999999999999999999999976554433222211100


Q ss_pred             hh---------c-cCC------------------ccccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          485 CY---------Q-NGT------------------IDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       485 ~~---------~-~~~------------------~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ..         . ...                  .....+.... ..+||+.||.+|||+.|++++..+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  318 (360)
T 3e3p_A          250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF  318 (360)
T ss_dssp             CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred             CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence            00         0 000                  0000111111 237999999999999999987665

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6e-38  Score=330.65  Aligned_cols=244  Identities=21%  Similarity=0.294  Sum_probs=192.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCc------
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDRE------  343 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~------  343 (613)
                      ++|.....||+|+||.||+|+...++..||||++...  .......+.+|+.++++++||||+++++++...+.      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            5678888999999999999999888899999999764  33345678999999999999999999999987654      


Q ss_pred             eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCc
Q 048439          344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK  423 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~  423 (613)
                      .++||||+. |+|.+++.    ..+++.+++.++.|++.||.|||+.+    |+||||||+|||+++++.+||+|||+++
T Consensus       104 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~----ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG----VVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             EEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC----cccCCCCHHHEeECCCCcEEEeeccccc
Confidence            499999998 58888772    34999999999999999999999998    9999999999999999999999999997


Q ss_pred             cCC-----CCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHH---------------
Q 048439          424 FGP-----TSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWA---------------  482 (613)
Q Consensus       424 ~~~-----~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~---------------  482 (613)
                      ...     ..++..|+|||.+.+ ..++.++|||||||++|||++|++||......+........               
T Consensus       175 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  254 (353)
T 3coi_A          175 HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  254 (353)
T ss_dssp             C--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred             CCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence            532     245678999999987 67899999999999999999999999765443322211110               


Q ss_pred             ------HHhhc--cCCccc---cccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          483 ------QQCYQ--NGTIDQ---IVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       483 ------~~~~~--~~~~~~---~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                            .....  ...+..   ...+.+.  ..+||+.||.+||++.+++++..+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f  309 (353)
T 3coi_A          255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF  309 (353)
T ss_dssp             HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred             HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence                  00000  000010   1112222  227999999999999999877654

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.7e-38  Score=333.10  Aligned_cols=194  Identities=20%  Similarity=0.283  Sum_probs=168.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC-----------ccceeeEEEEeec
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-----------HLHLVSLIGFCND  340 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-----------H~niv~l~g~~~~  340 (613)
                      ++|...+.||+|+||.||+|+...+++.||||++... ......+.+|+.++.+++           |+||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            5788888999999999999999888899999999754 334567889999999886           8999999999876


Q ss_pred             CC----ceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcEEeccCCCCceeeC------
Q 048439          341 DR----EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG-ANHAVIIHRDVKTTNILLD------  409 (613)
Q Consensus       341 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~iiHrDlk~~NILl~------  409 (613)
                      .+    ..++||||+ +++|.+++.......+++..++.++.|++.||+|||+. +    |+||||||+|||++      
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~----ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG----IIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC----EECSCCSGGGEEEEEEETTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC----EEecCCChHHeEEeccCCCc
Confidence            54    789999999 88999999765566799999999999999999999998 8    99999999999994      


Q ss_pred             CCCcEEEEecCCCccC-----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          410 EKWVAKVSDFGLSKFG-----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       410 ~~~~~kl~DFGls~~~-----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                      ..+.+||+|||+++..     ...++..|+|||++.+..++.++|||||||+||||++|++||....
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             TEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             CcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence            4558999999998642     2346778999999999999999999999999999999999997543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2e-38  Score=330.37  Aligned_cols=243  Identities=21%  Similarity=0.306  Sum_probs=176.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHH-HHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIG-MLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|...+.||+|+||.||+|....++..||||+++... .....++..|+. +++.++||||+++++++.+.+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            57888889999999999999998888999999997653 334455666666 7778899999999999999999999999


Q ss_pred             cCCCCChhHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          350 FMARGTLPDHLYH---SDNPPLPWNQRLEICIGAARGLHYLHTG-ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       350 y~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      |+++ +|.+++..   .....+++..+..++.|++.||.|||+. +    |+||||||+|||++.++.+||+|||+++..
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~----ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK----IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS----CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC----EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            9985 88777642   2356799999999999999999999998 7    999999999999999999999999998642


Q ss_pred             C-------CCCCcccCChhhh----hcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc--CCc-
Q 048439          426 P-------TSVSKTHLDPEYY----RLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN--GTI-  491 (613)
Q Consensus       426 ~-------~~~~~~~~aPE~~----~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--~~~-  491 (613)
                      .       ..++..|+|||.+    ....++.++|||||||+||||++|+.||........     ........  ..+ 
T Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~  251 (327)
T 3aln_A          177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVVKGDPPQLS  251 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCCSCCCCCC
T ss_pred             ccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHhcCCCCCCC
Confidence            2       2456779999998    566789999999999999999999999965322110     00000000  000 


Q ss_pred             ----cccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          492 ----DQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       492 ----~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                          ..+...+.. ..+||+.||.+||++.|++++...
T Consensus       252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~  289 (327)
T 3aln_A          252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI  289 (327)
T ss_dssp             CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred             CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence                111122222 237999999999999999977664

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.8e-38  Score=337.99  Aligned_cols=190  Identities=26%  Similarity=0.419  Sum_probs=152.6

Q ss_pred             CCC-cceeeeeCcEEEEEEEEc--CCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEee--cCCceEEEE
Q 048439          274 FDN-DLVIGVGGFGDVYKGFIN--GSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCN--DDREMILVY  348 (613)
Q Consensus       274 f~~-~~~iG~G~fG~Vy~g~~~--~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~lV~  348 (613)
                      |.. .++||+|+||.||+|+..  .++..||||++....  ....+.+|+.+|++++|||||++++++.  .....+|||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            443 458999999999999976  345789999997543  2346889999999999999999999994  467899999


Q ss_pred             EcCCCCChhHHhhc-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee----CCCCcEEEE
Q 048439          349 DFMARGTLPDHLYH-------SDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL----DEKWVAKVS  417 (613)
Q Consensus       349 Ey~~~gsL~~~l~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl----~~~~~~kl~  417 (613)
                      ||+++ +|.+++..       .....+++..++.|+.|++.||+|||+.+    |+||||||+||||    +.++.+||+
T Consensus       100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~----ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A          100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC----EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99975 88887742       12235999999999999999999999998    9999999999999    778999999


Q ss_pred             ecCCCccCC-----------CCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          418 DFGLSKFGP-----------TSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       418 DFGls~~~~-----------~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                      |||+++...           ..++..|+|||++.+. .++.++|||||||+||||++|++||...
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            999996421           2346779999999874 5899999999999999999999999643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.4e-38  Score=336.55  Aligned_cols=244  Identities=23%  Similarity=0.280  Sum_probs=184.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCc------eE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDRE------MI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~------~~  345 (613)
                      .+|...++||+|+||.||+|+...++. ||+|++......    ..+|++++++++||||++++++|...+.      ++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            457888899999999999999987755 888887544322    2469999999999999999999865433      78


Q ss_pred             EEEEcCCCCChhHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC-CCCcEEEEecCCCc
Q 048439          346 LVYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSK  423 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGls~  423 (613)
                      +||||++++.+..... ......+++..++.++.|+++||+|||+.+    |+||||||+|||++ .++.+||+|||+++
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~----ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC----ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            9999998754433322 123567999999999999999999999998    99999999999999 79999999999996


Q ss_pred             cC-------CCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHH----------H-
Q 048439          424 FG-------PTSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQ----------Q-  484 (613)
Q Consensus       424 ~~-------~~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~----------~-  484 (613)
                      ..       ...++..|+|||.+.+. .++.++|||||||+||||++|++||......++........          . 
T Consensus       191 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  270 (394)
T 4e7w_A          191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN  270 (394)
T ss_dssp             ECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            42       12346679999998764 58999999999999999999999997765444332221110          0 


Q ss_pred             -hhccCCccc------------cccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          485 -CYQNGTIDQ------------IVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       485 -~~~~~~~~~------------~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                       ......+..            -.++.+.  ..+||+.||.+||++.|++++..+
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  325 (394)
T 4e7w_A          271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF  325 (394)
T ss_dssp             GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred             hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhh
Confidence             000000000            0111111  227999999999999999987664

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.7e-38  Score=325.53  Aligned_cols=247  Identities=20%  Similarity=0.241  Sum_probs=176.6

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh-hc-HHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ-QG-ALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~-~~-~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      .++|...+.||+|+||.||+|+...++..||||++..... .. ...+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            3578888899999999999999987778999999976532 22 233455566788889999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG-ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--  425 (613)
                      ||+ ++.+..++ ......+++..++.++.|++.||.|||+. +    |+||||||+|||++.++.+||+|||+++..  
T Consensus       104 e~~-~~~~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~----i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLK-KRMQGPIPERILGKMTVAIVKALYYLKEKHG----VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC----CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHHhhCC----EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 44454443 33356799999999999999999999985 7    999999999999999999999999998642  


Q ss_pred             -----CCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          426 -----PTSVSKTHLDPEYYR-----LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       426 -----~~~~~~~~~aPE~~~-----~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                           ...++..|+|||.+.     ...++.++|||||||+||||++|+.||........ .+...............-.
T Consensus       178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  256 (318)
T 2dyl_A          178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VLTKVLQEEPPLLPGHMGF  256 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHHHHHSCCCCCCSSSCC
T ss_pred             CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-HHHHHhccCCCCCCccCCC
Confidence                 224567899999994     56789999999999999999999999965322111 1111111100000000111


Q ss_pred             cHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          496 DPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       496 d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ++.+.  ..+||+.||.+||++.+++++...
T Consensus       257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (318)
T 2dyl_A          257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI  287 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence            22222  237999999999999999976553

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=8.9e-38  Score=323.50  Aligned_cols=254  Identities=19%  Similarity=0.270  Sum_probs=196.1

Q ss_pred             cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccC--ccceeeEEEE
Q 048439          262 FSLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLR--HLHLVSLIGF  337 (613)
Q Consensus       262 f~~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~--H~niv~l~g~  337 (613)
                      +.++.+....++|...+.||+|+||.||++.... +..||||++...  .......+.+|+.++.+++  |+||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            3444444556778888999999999999999865 577999998654  3445678999999999997  4999999999


Q ss_pred             eecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEE
Q 048439          338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVS  417 (613)
Q Consensus       338 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~  417 (613)
                      +.+.+..++||| +.+++|.+++..  ...+++.+++.++.|+++||.|||+.+    |+||||||+|||+++ +.+||+
T Consensus        97 ~~~~~~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivH~dlkp~NIl~~~-~~~kL~  168 (313)
T 3cek_A           97 EITDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIVD-GMLKLI  168 (313)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEEET-TEEEEC
T ss_pred             eecCCEEEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----ceecCCCcccEEEEC-CeEEEe
Confidence            999999999999 668899999964  357899999999999999999999998    999999999999974 899999


Q ss_pred             ecCCCccCC----------CCCCcccCChhhhhc-----------CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhh
Q 048439          418 DFGLSKFGP----------TSVSKTHLDPEYYRL-----------QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQV  476 (613)
Q Consensus       418 DFGls~~~~----------~~~~~~~~aPE~~~~-----------~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~  476 (613)
                      |||+++...          ..++..|+|||.+..           ..++.++|||||||+||||++|+.||........ 
T Consensus       169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-  247 (313)
T 3cek_A          169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-  247 (313)
T ss_dssp             CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-
T ss_pred             eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-
Confidence            999986421          235778999999976           4788999999999999999999999964322111 


Q ss_pred             hHHHHHHHhhccCCccccccHHHH--HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          477 SLAVWAQQCYQNGTIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       477 ~l~~~~~~~~~~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      .+..... ...........+..+.  ..+||+.||.+||++.|++++.....
T Consensus       248 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~  298 (313)
T 3cek_A          248 KLHAIID-PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  298 (313)
T ss_dssp             HHHHHHC-TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred             HHHHHHh-cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence            1111111 1111112222222222  23799999999999999998877543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=329.82  Aligned_cols=248  Identities=23%  Similarity=0.347  Sum_probs=192.5

Q ss_pred             HHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceE
Q 048439          268 QAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       268 ~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  345 (613)
                      ....++|...+.||+|+||.||+|...+   .+|||.++...  ....+.|.+|+.++++++|+||+++++++.+.+..+
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA  105 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence            3345778888999999999999999864   39999987542  333456889999999999999999999999999999


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +||||+++++|.+++.. ....+++.+++.++.|++.||.|||+.+    |+||||||+|||++ ++.+||+|||+++..
T Consensus       106 iv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~----i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKG----ILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             EECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHTT----CCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             EEeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC----ccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            99999999999999854 3456999999999999999999999998    99999999999998 679999999987532


Q ss_pred             -------------CCCCCcccCChhhhhc---------CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHH
Q 048439          426 -------------PTSVSKTHLDPEYYRL---------QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQ  483 (613)
Q Consensus       426 -------------~~~~~~~~~aPE~~~~---------~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~  483 (613)
                                   ...++..|+|||.+..         ..++.++|||||||++|||++|+.||...........   ..
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~  256 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ---MG  256 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH---HH
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---hc
Confidence                         1235567999999975         4578999999999999999999999975543322111   11


Q ss_pred             HhhccCCc-cccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          484 QCYQNGTI-DQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       484 ~~~~~~~~-~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      ........ ..+.+.+.. ..+||+.+|.+||++.++++.|+...+
T Consensus       257 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             TTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             cCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            11111111 111112221 237999999999999999999986543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6e-38  Score=324.48  Aligned_cols=240  Identities=22%  Similarity=0.345  Sum_probs=185.6

Q ss_pred             HHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh------cHHHHHHHHHHHhcc----CccceeeEEE
Q 048439          267 IQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ------GALEFQTEIGMLSQL----RHLHLVSLIG  336 (613)
Q Consensus       267 l~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~------~~~~f~~Ei~~l~~l----~H~niv~l~g  336 (613)
                      .....++|...+.||+|+||.||+|+...++..||||++......      ....+.+|+.++.++    +|+||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            344567899999999999999999999888889999999765321      223466799999998    8999999999


Q ss_pred             EeecCCceEEEEEc-CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC-CCCcE
Q 048439          337 FCNDDREMILVYDF-MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVA  414 (613)
Q Consensus       337 ~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~-~~~~~  414 (613)
                      ++.+.+..++|||| +.+++|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||++ +++.+
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSRG----VVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHT----EECCCCSGGGEEEETTTTEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeecCCChhhEEEeCCCCeE
Confidence            99999999999999 789999999954  346999999999999999999999998    99999999999999 89999


Q ss_pred             EEEecCCCccC------CCCCCcccCChhhhhcCCCC-chhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhc
Q 048439          415 KVSDFGLSKFG------PTSVSKTHLDPEYYRLQQLT-EKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ  487 (613)
Q Consensus       415 kl~DFGls~~~------~~~~~~~~~aPE~~~~~~~t-~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~  487 (613)
                      ||+|||+++..      ...++..|+|||++....+. .++|||||||++|||++|+.||.......        .   .
T Consensus       180 kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~---~  248 (312)
T 2iwi_A          180 KLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL--------E---A  248 (312)
T ss_dssp             EECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------H---T
T ss_pred             EEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh--------h---h
Confidence            99999998642      23456779999999887775 59999999999999999999996532110        0   0


Q ss_pred             cCCccccccHHHH--HhcccccCCCCCCCHHHHHHHHH
Q 048439          488 NGTIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       488 ~~~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ...+....+..+.  ..+||+.+|++||++.|++++..
T Consensus       249 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~  286 (312)
T 2iwi_A          249 ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW  286 (312)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred             ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence            1111111222222  23799999999999999987655

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.7e-38  Score=326.58  Aligned_cols=241  Identities=20%  Similarity=0.334  Sum_probs=193.9

Q ss_pred             HHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh------cHHHHHHHHHHHhccC--ccceeeEEEEe
Q 048439          267 IQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ------GALEFQTEIGMLSQLR--HLHLVSLIGFC  338 (613)
Q Consensus       267 l~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~------~~~~f~~Ei~~l~~l~--H~niv~l~g~~  338 (613)
                      .....++|...+.||+|+||.||+|+...++..||||++......      ....+.+|+.++.+++  |+||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            334457788899999999999999999888899999998754221      2245678999999996  59999999999


Q ss_pred             ecCCceEEEEEcCCC-CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC-CCCcEEE
Q 048439          339 NDDREMILVYDFMAR-GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKV  416 (613)
Q Consensus       339 ~~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~-~~~~~kl  416 (613)
                      .+.+..++||||+.+ ++|.+++..  ...+++..++.++.|++.||.|||+.+    |+||||||+|||++ +++.+||
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~----ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCG----VLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEEETTTTEEEE
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC----cEeCCCCHHHEEEeCCCCCEEE
Confidence            999999999999986 899999854  356899999999999999999999998    99999999999999 7899999


Q ss_pred             EecCCCccC------CCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccC
Q 048439          417 SDFGLSKFG------PTSVSKTHLDPEYYRLQQL-TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG  489 (613)
Q Consensus       417 ~DFGls~~~------~~~~~~~~~aPE~~~~~~~-t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~  489 (613)
                      +|||+++..      ...++..|+|||++....+ +.++|||||||+||||++|+.||.......        .   ...
T Consensus       192 ~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--------~---~~~  260 (320)
T 3a99_A          192 IDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------R---GQV  260 (320)
T ss_dssp             CCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------H---CCC
T ss_pred             eeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh--------c---ccc
Confidence            999998642      2345778999999988776 688999999999999999999996532110        0   001


Q ss_pred             CccccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          490 TIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       490 ~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .....+.+.+.  ..+||+.||.+||++.|++++...
T Consensus       261 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~  297 (320)
T 3a99_A          261 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM  297 (320)
T ss_dssp             CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence            11111222221  227999999999999999876653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.1e-37  Score=314.92  Aligned_cols=228  Identities=19%  Similarity=0.337  Sum_probs=177.2

Q ss_pred             cCCCCc-ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHH-hccCccceeeEEEEeec----CCceE
Q 048439          272 NNFDND-LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGML-SQLRHLHLVSLIGFCND----DREMI  345 (613)
Q Consensus       272 ~~f~~~-~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l-~~l~H~niv~l~g~~~~----~~~~~  345 (613)
                      ++|... ++||+|+||.||+|....++..||||+++..     ..+.+|+.++ +.++||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456555 6799999999999999888889999998642     3567888888 55689999999999876    67789


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC---CCcEEEEecCCC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE---KWVAKVSDFGLS  422 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGls  422 (613)
                      +||||+++|+|.+++.......+++..++.++.|++.||+|||+.+    |+||||||+|||++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            9999999999999997766667999999999999999999999998    999999999999998   789999999998


Q ss_pred             ccCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCc-------cccc
Q 048439          423 KFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTI-------DQIV  495 (613)
Q Consensus       423 ~~~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~-------~~~~  495 (613)
                      +...              ...++.++|||||||+||||++|++||...........   .......+..       ..+.
T Consensus       168 ~~~~--------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (299)
T 3m2w_A          168 KETT--------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQYEFPNPEWSEVS  230 (299)
T ss_dssp             EECT--------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC---SCCSSCTTCCSSCHHHHTTSC
T ss_pred             cccc--------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH---HHHHHhhccccCCchhcccCC
Confidence            6432              24577899999999999999999999965432211000   0000000000       1111


Q ss_pred             cHHHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          496 DPFLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       496 d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      +.... ..+||+.||.+||++.|++++....
T Consensus       231 ~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~  261 (299)
T 3m2w_A          231 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  261 (299)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhcChhhc
Confidence            11111 2279999999999999999877653

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.6e-37  Score=334.33  Aligned_cols=238  Identities=21%  Similarity=0.262  Sum_probs=177.7

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEEEcCC
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYDFMA  352 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~  352 (613)
                      |...++||+|+||+||.+.... ++.||||++....   .+.+.+|+.+|.++ +|||||++++++.+.+..++|||||.
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~~-g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEESS-SSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeccCeEeeCCCeEEEEEEEEC-CeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            3445789999999998765443 5789999986532   34678999999986 89999999999999999999999996


Q ss_pred             CCChhHHhhcCCCC-----CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC-------------CcE
Q 048439          353 RGTLPDHLYHSDNP-----PLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK-------------WVA  414 (613)
Q Consensus       353 ~gsL~~~l~~~~~~-----~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~-------------~~~  414 (613)
                       |+|.+++......     ..++..++.|+.|++.||+|||+.+    |+||||||+|||++.+             +.+
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK----IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC----ccccCCChHhEEEecCcccccccccCCCceEE
Confidence             6999999653221     1244566889999999999999998    9999999999999654             589


Q ss_pred             EEEecCCCccCC------------CCCCcccCChhhhhc-------CCCCchhHHHHHHHHHHHHHh-CCCCccchhhhh
Q 048439          415 KVSDFGLSKFGP------------TSVSKTHLDPEYYRL-------QQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKK  474 (613)
Q Consensus       415 kl~DFGls~~~~------------~~~~~~~~aPE~~~~-------~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~  474 (613)
                      ||+|||+++...            ..++..|+|||++.+       ..++.++|||||||+||||++ |++||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            999999986422            246778999999976       678999999999999999999 899996543322


Q ss_pred             hhhHHHHHHHhhccCCccccc-----cHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          475 QVSLAVWAQQCYQNGTIDQIV-----DPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       475 ~~~l~~~~~~~~~~~~~~~~~-----d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .    ................     +.... ..+||+.||.+||++.||+++..+
T Consensus       248 ~----~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f  299 (434)
T 2rio_A          248 S----NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF  299 (434)
T ss_dssp             H----HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             H----HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence            1    1111111111111111     11111 238999999999999999976654

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.1e-36  Score=312.16  Aligned_cols=226  Identities=11%  Similarity=0.083  Sum_probs=178.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|+...+++.||||++....   ......|.+|+.++.+++|+||+++++++.+.+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            56888889999999999999998878999999997653   334567999999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCCC
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS  428 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~  428 (613)
                      ||+++++|.+++..   . ....+.++|+.|++.||.|||+.+    |+||||||+|||+++++.+||+++|.       
T Consensus       111 e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~g----ivH~Dikp~NIll~~~g~~kl~~~~~-------  175 (286)
T 3uqc_A          111 EWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAG----VALSIDHPSRVRVSIDGDVVLAYPAT-------  175 (286)
T ss_dssp             ECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCSGGGEEEETTSCEEECSCCC-------
T ss_pred             EecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCC----CccCCCCcccEEEcCCCCEEEEeccc-------
Confidence            99999999999832   2 355678899999999999999998    99999999999999999999986543       


Q ss_pred             CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHH-HHHHH-----hhccCCccccccHHHHHh
Q 048439          429 VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLA-VWAQQ-----CYQNGTIDQIVDPFLKAM  502 (613)
Q Consensus       429 ~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~-~~~~~-----~~~~~~~~~~~d~~~~~~  502 (613)
                           ++       .++.++|||||||+||||++|+.||......+..... .....     ......+...+..+  ..
T Consensus       176 -----~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l--i~  241 (286)
T 3uqc_A          176 -----MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV--AA  241 (286)
T ss_dssp             -----CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHH--HH
T ss_pred             -----cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHH--HH
Confidence                 33       3789999999999999999999999764432211000 00000     00001111111111  22


Q ss_pred             cccccCCCCCCCHHHHHHHHHHhhh
Q 048439          503 SCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       503 ~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      +||+.||.+| |+.|+++.|+....
T Consensus       242 ~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          242 RSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             HHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             HHcccCCccC-CHHHHHHHHHHHhc
Confidence            7999999999 99999999986543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.8e-37  Score=331.85  Aligned_cols=241  Identities=22%  Similarity=0.269  Sum_probs=180.2

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEE
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ...+|...++||+|+||+||..... +++.||||++......   .+.+|+.+|+++ +|||||++++++.+.+..+|||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~-~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEES-SSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEe-CCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            3456888889999999996543333 3477999999765432   356899999999 7999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC-----CCCcEEEEecCCCc
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD-----EKWVAKVSDFGLSK  423 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~-----~~~~~kl~DFGls~  423 (613)
                      |||. |+|.+++... ...+.+..++.++.|+++||+|||+.+    |+||||||+|||++     ....+||+|||+++
T Consensus        98 E~~~-g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~----ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           98 ELCA-ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSLN----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             ECCS-EEHHHHHHSS-SCCCCSSCHHHHHHHHHHHHHHHHHTT----CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             ECCC-CCHHHHHHhc-CCCccchhHHHHHHHHHHHHHHHHHCc----CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            9997 5999998654 334566677899999999999999998    99999999999994     33468899999986


Q ss_pred             cCC-----------CCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhcc
Q 048439          424 FGP-----------TSVSKTHLDPEYYR---LQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQN  488 (613)
Q Consensus       424 ~~~-----------~~~~~~~~aPE~~~---~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~  488 (613)
                      ...           ..++..|+|||++.   ...++.++|||||||+||||++ |++||........ ..   .......
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~---~~~~~~~  247 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NI---LLGACSL  247 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HH---HTTCCCC
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HH---HhccCCc
Confidence            432           23678899999997   4677889999999999999999 8888854332211 11   0000000


Q ss_pred             C--CccccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          489 G--TIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       489 ~--~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .  ......+....  ..+||+.||.+||++.||+++..+
T Consensus       248 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f  287 (432)
T 3p23_A          248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF  287 (432)
T ss_dssp             TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTT
T ss_pred             cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccc
Confidence            0  01111122121  237999999999999999966543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.6e-36  Score=345.71  Aligned_cols=234  Identities=18%  Similarity=0.238  Sum_probs=184.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcC-CceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCc-----e
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFING-STTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDRE-----M  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~-~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~-----~  344 (613)
                      ++|.....||+|+||.||+|++.. +++.||||++... .......|.+|++++.+++||||++++++|.+.+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            689999999999999999999965 5688999998654 34455678999999999999999999999987665     7


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      +|||||+++++|.+++..    .++|.+++.|+.|+++||.|||+.+    |+||||||+|||++++ .+||+|||+++.
T Consensus       160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g----iiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG----LVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC----CeecccChHHeEEeCC-cEEEEecccchh
Confidence            999999999999987732    6999999999999999999999998    9999999999999986 899999999875


Q ss_pred             C----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH-
Q 048439          425 G----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL-  499 (613)
Q Consensus       425 ~----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~-  499 (613)
                      .    ...++..|+|||++.++. +.++|||||||+||||++|.+|+...........          .......+.+. 
T Consensus       231 ~~~~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~----------~~~~~~~~~l~~  299 (681)
T 2pzi_A          231 INSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPED----------DPVLKTYDSYGR  299 (681)
T ss_dssp             TTCCSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTT----------CHHHHHCHHHHH
T ss_pred             cccCCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccccc----------ccccccCHHHHH
Confidence            3    234678899999998764 8999999999999999999998864321110000          00000001111 


Q ss_pred             HHhcccccCCCCCCC-HHHHHHHHHHh
Q 048439          500 KAMSCLNDEGIRRPS-MSDVVWGLEFS  525 (613)
Q Consensus       500 ~~~~Cl~~~p~~RPs-~~evl~~Le~~  525 (613)
                      ...+||+.||.+||+ +.++...|...
T Consensus       300 li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          300 LLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             HHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            123799999999996 55555555543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-36  Score=325.92  Aligned_cols=240  Identities=16%  Similarity=0.127  Sum_probs=178.2

Q ss_pred             HhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCc-cce----------e---
Q 048439          270 ATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRH-LHL----------V---  332 (613)
Q Consensus       270 at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H-~ni----------v---  332 (613)
                      .+.+|...++||+|+||.||+|++..+++.||||+++...   ....+.|.+|+.++..++| +|.          +   
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            3455777789999999999999998888899999988443   2336789999999999987 211          1   


Q ss_pred             --eE------EEEeec-----CCceEEEEEcCCCCChhHHhh-----cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 048439          333 --SL------IGFCND-----DREMILVYDFMARGTLPDHLY-----HSDNPPLPWNQRLEICIGAARGLHYLHTGANHA  394 (613)
Q Consensus       333 --~l------~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  394 (613)
                        .+      +.++..     ....+++|+++ +++|.+++.     ......++|..++.|+.|+++||+|||+.+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence              11      111111     23457777765 579999884     233556899999999999999999999998   


Q ss_pred             cEEeccCCCCceeeCCCCcEEEEecCCCccC-----CCCCCcccCChhhh----------hcCCCCchhHHHHHHHHHHH
Q 048439          395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-----PTSVSKTHLDPEYY----------RLQQLTEKSDVYSFGVVLFE  459 (613)
Q Consensus       395 ~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-----~~~~~~~~~aPE~~----------~~~~~t~ksDV~SfGvvL~e  459 (613)
                       |+||||||+||||+.++.+||+|||+++..     ...+ ..|+|||++          ....++.++|||||||+|||
T Consensus       232 -iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             -EECSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             -cccCCcccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence             999999999999999999999999998642     2345 789999999          55568899999999999999


Q ss_pred             HHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          460 VLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       460 lltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      |++|+.||............      ..  ....+.+.... ..+||+.||++||++.+++++..
T Consensus       310 lltg~~Pf~~~~~~~~~~~~------~~--~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~  366 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEWI------FR--SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE  366 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGGG------GS--SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred             HHHCCCCCCCcchhhhHHHH------Hh--hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence            99999999765433221111      11  01122222222 22799999999999999987644

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.3e-36  Score=342.04  Aligned_cols=195  Identities=26%  Similarity=0.345  Sum_probs=170.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeec------CCce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND------DREM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~------~~~~  344 (613)
                      ++|...+.||+|+||.||+|....++..||||+++.. .......|.+|++++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            6799999999999999999999888889999998765 44556779999999999999999999999765      6778


Q ss_pred             EEEEEcCCCCChhHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc---EEEEecC
Q 048439          345 ILVYDFMARGTLPDHLYHSD-NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV---AKVSDFG  420 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFG  420 (613)
                      ++|||||++|+|.+++.... ...+++..++.|+.+++.||+|||+.+    |+||||||+|||++.++.   +||+|||
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g----IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR----IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT----BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC----CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            99999999999999996532 346999999999999999999999998    999999999999997664   9999999


Q ss_pred             CCccCC-------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          421 LSKFGP-------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       421 ls~~~~-------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                      +++...       ..++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~  226 (676)
T 3qa8_A          170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN  226 (676)
T ss_dssp             CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence            997532       24567899999999999999999999999999999999999653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4e-35  Score=306.93  Aligned_cols=189  Identities=21%  Similarity=0.243  Sum_probs=158.1

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--------hhcHHHHHHHHHHHhccC---------ccceee
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--------QQGALEFQTEIGMLSQLR---------HLHLVS  333 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--------~~~~~~f~~Ei~~l~~l~---------H~niv~  333 (613)
                      .++|...+.||+|+||.||+|+..  ++.||||++....        ....+.+.+|+.++++++         |+|||+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEET--TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEeC--CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            356778889999999999999983  4889999997542        223477899999999886         777777


Q ss_pred             EEEEe-----------------e-------------cCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHH
Q 048439          334 LIGFC-----------------N-------------DDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARG  383 (613)
Q Consensus       334 l~g~~-----------------~-------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g  383 (613)
                      +.+.+                 .             +.+..+||||||++|+|.+.+..   ..+++.+++.|+.|++.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence            76653                 2             26789999999999987777732   568999999999999999


Q ss_pred             HHHHh-cCCCCCcEEeccCCCCceeeCCCC--------------------cEEEEecCCCccCC---CCCCcccCChhhh
Q 048439          384 LHYLH-TGANHAVIIHRDVKTTNILLDEKW--------------------VAKVSDFGLSKFGP---TSVSKTHLDPEYY  439 (613)
Q Consensus       384 L~yLH-~~~~~~~iiHrDlk~~NILl~~~~--------------------~~kl~DFGls~~~~---~~~~~~~~aPE~~  439 (613)
                      |+||| +.+    |+||||||+|||++.++                    .+||+|||+|+...   ..++..|+|||.+
T Consensus       174 L~~lH~~~~----ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~  249 (336)
T 2vuw_A          174 LAVAEASLR----FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLF  249 (336)
T ss_dssp             HHHHHHHHC----CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGG
T ss_pred             HHHHHHhCC----EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhh
Confidence            99999 888    99999999999999887                    99999999997532   2467789999999


Q ss_pred             hcCCCCchhHHHHHHHH-HHHHHhCCCCccc
Q 048439          440 RLQQLTEKSDVYSFGVV-LFEVLCARPSILR  469 (613)
Q Consensus       440 ~~~~~t~ksDV~SfGvv-L~elltg~~p~~~  469 (613)
                      .+.. +.++||||||++ .+++++|..||..
T Consensus       250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             cCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence            8766 899999998777 7788999999853

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=1.5e-29  Score=282.89  Aligned_cols=178  Identities=19%  Similarity=0.107  Sum_probs=125.7

Q ss_pred             eeeeCcEEEEEEEEcCCceeEEEEEeCCC----------ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEEE
Q 048439          280 IGVGGFGDVYKGFINGSTTPVAIKRLEPE----------SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       280 iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~----------~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      .+.|++|.+..++..-.+..+|||.+...          .....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            46677776666554333467999998653          133456799999999999 7999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCCC
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS  428 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~  428 (613)
                      ||++||+|.++|..  ..+++..   +|+.||+.||+|||+++    ||||||||+||||++++.+||+|||+|+.....
T Consensus       322 Eyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~G----IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQG----FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTT----CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCC----ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999954  4556654   58899999999999999    999999999999999999999999999764332


Q ss_pred             --------CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCc
Q 048439          429 --------VSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSI  467 (613)
Q Consensus       429 --------~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~  467 (613)
                              +|+.|++||.+.+ ++..++|+||+|+++++|.++..++
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence                    4567999999875 5677899999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=3.7e-26  Score=254.10  Aligned_cols=175  Identities=18%  Similarity=0.191  Sum_probs=140.6

Q ss_pred             CCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh--------hcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          275 DNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ--------QGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       275 ~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~--------~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ...++||+|+||.||+|...+  ..+++|+......        ...+.|.+|+++|++++||||+++..++...+..+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLD--FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEECSS--CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEECC--CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            345689999999999995544  5689998654321        123458999999999999999977777777788899


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      |||||++|+|.+++..          ++.++.|+++||.|||+.+    |+||||||+|||+++  .+||+|||+++...
T Consensus       417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g----IiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND----VIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT----EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc----CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            9999999999999843          5689999999999999998    999999999999998  99999999998643


Q ss_pred             C---------------CCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCc
Q 048439          427 T---------------SVSKTHLDPEYYRL--QQLTEKSDVYSFGVVLFEVLCARPSI  467 (613)
Q Consensus       427 ~---------------~~~~~~~aPE~~~~--~~~t~ksDV~SfGvvL~elltg~~p~  467 (613)
                      .               .++..|+|||++..  ..|+.++|+||..+-.++.+.++.++
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            3               24667999999987  66888999999999999988887765

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A*

Probab=99.91  E-value=5.2e-25  Score=208.10  Aligned_cols=116  Identities=18%  Similarity=0.307  Sum_probs=98.6

Q ss_pred             ccCCCCchHHHHHHhhcCCCcccCCceeeEEEEeeCCCCceeeeeeeeeeeecccCCCceEEEEEEcceeecccchhhhh
Q 048439           25 IRNYSAPDLVYETARTMGQDREINEKYNLTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAW  104 (613)
Q Consensus        25 ~~~~~aP~~vy~Tar~~~~~~~~~~~~nltw~~~vd~~~~Y~vrlHFcei~~~~~~~~~r~F~iyi~~~~~~~~~dv~~~  104 (613)
                      ...+++|..||+|||.+.        .++||.|+|+++++|+||||||||.  .++.++|+|||||||+++.++|||..+
T Consensus        47 ~~~~~~~~~lY~TaR~~~--------~~~tY~f~v~~~G~Y~VrLhF~ei~--~~~~~~rvFdV~ing~~~l~~fdi~~~  116 (174)
T 2jwp_A           47 LRSNPEDQVLYQTERYNE--------DSFGYDIPIKEEGEYVLVLKFAEVY--FAQSQQKVFDVRVNGHTVVKDLDIFDR  116 (174)
T ss_dssp             SSSCHHHHHTTTCCCCCC--------SCEEEEEECCSCEEEEEEEEEECCS--CCCSSSSCEEEEETTEEEEEEECHHHH
T ss_pred             cccCCCCchhhhhhccCC--------CCeEEEEEeCCCeEEEEEEEEeccc--cCCCCCeEeEEEECCEEeecCcCHHHh
Confidence            335788999999999844        2799999999999999999999998  578999999999999999999999999


Q ss_pred             hCCCceeEEEEEEeeccCCCCcc--------cccceEEEEeecCCCCCCcccccccccceEEe
Q 048439          105 TGANGVTVYRDYAVMIGSKPNEE--------NIKQNLSIQLHPAPRWRTKYSDAILNGLEIFK  159 (613)
Q Consensus       105 ~~~~~~p~y~dy~v~~~~~~~~~--------~~~~~l~v~l~p~~~~~~~~~~~ilnglEi~~  159 (613)
                      +|+ +.|++++|.+.+   .++.        .....|+|+++|..     .++|++|||||++
T Consensus       117 ag~-~~~~~~~~~~~v---~~~~l~i~~~~~~~~g~L~I~f~p~~-----~~~a~inaIEI~~  170 (174)
T 2jwp_A          117 VGH-STAHDEIIPISI---KKGKLSVQGEVSTFTGKLSVEFVKGY-----YDNPKVCALFIMK  170 (174)
T ss_dssp             HSS-SSCEEEEEEEEE---ETTEEEETTEEEECCSEEEEEEECSS-----SCSSSEEEEEEES
T ss_pred             hCC-CeeEEEEEEEEE---ecCceeeeeeecccCCeEEEEEeccC-----CCCcEEEEEEEEe
Confidence            987 789999998876   3321        11346999999853     3589999999997

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=4.7e-24  Score=217.78  Aligned_cols=154  Identities=12%  Similarity=0.044  Sum_probs=122.9

Q ss_pred             HHHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh------------------hcHHHHHHHHHHHhc
Q 048439          264 LSEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ------------------QGALEFQTEIGMLSQ  325 (613)
Q Consensus       264 ~~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~------------------~~~~~f~~Ei~~l~~  325 (613)
                      +..+......|...+.||+|+||.||+|.. .++..||||.++....                  .....+.+|+.++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~  160 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK  160 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence            334444555566778999999999999999 6668899999975321                  134568999999999


Q ss_pred             cCccceeeEEEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCc
Q 048439          326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTN  405 (613)
Q Consensus       326 l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~N  405 (613)
                      ++  | +++.+++.. +..++||||+++|+|.+ +.        ......++.|+++||.|||+.+    |+||||||+|
T Consensus       161 l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH~~g----iiHrDlkp~N  223 (282)
T 1zar_A          161 LQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFYHRG----IVHGDLSQYN  223 (282)
T ss_dssp             TT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHHHTT----EECSCCSTTS
T ss_pred             cc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHHHCC----CEeCCCCHHH
Confidence            99  5 666665543 56799999999999988 51        1234579999999999999998    9999999999


Q ss_pred             eeeCCCCcEEEEecCCCccCCCCCCcccCChhhhhc
Q 048439          406 ILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRL  441 (613)
Q Consensus       406 ILl~~~~~~kl~DFGls~~~~~~~~~~~~aPE~~~~  441 (613)
                      ||++ ++.+||+|||+|+..     ..+.|||++.+
T Consensus       224 ILl~-~~~vkl~DFG~a~~~-----~~~~a~e~l~r  253 (282)
T 1zar_A          224 VLVS-EEGIWIIDFPQSVEV-----GEEGWREILER  253 (282)
T ss_dssp             EEEE-TTEEEECCCTTCEET-----TSTTHHHHHHH
T ss_pred             EEEE-CCcEEEEECCCCeEC-----CCCCHHHHHHH
Confidence            9999 999999999999743     35688998864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.80  E-value=6.4e-20  Score=184.61  Aligned_cols=137  Identities=17%  Similarity=0.127  Sum_probs=106.9

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCcee--EEEEEeCCCChh------------------------cHHHHHHHHHHHhccC
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTP--VAIKRLEPESQQ------------------------GALEFQTEIGMLSQLR  327 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~--vAVK~~~~~~~~------------------------~~~~f~~Ei~~l~~l~  327 (613)
                      |.....||+|+||.||+|....++..  ||||+++.....                        ....+.+|+.+|.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45667899999999999998445577  999987643211                        1135789999999999


Q ss_pred             ccce--eeEEEEeecCCceEEEEEcCCC-C----ChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCcEEec
Q 048439          328 HLHL--VSLIGFCNDDREMILVYDFMAR-G----TLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH-TGANHAVIIHR  399 (613)
Q Consensus       328 H~ni--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~~iiHr  399 (613)
                      |+++  ..++++    +..+|||||+.+ |    +|.++...     +++.....++.|++.||.||| +.+    |+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g----ivHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE----LVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC----EECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC----EEeC
Confidence            8864  344443    356899999942 4    67666422     345678899999999999999 888    9999


Q ss_pred             cCCCCceeeCCCCcEEEEecCCCccC
Q 048439          400 DVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       400 Dlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      ||||+|||+++  .++|+|||+|...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.63  E-value=1.5e-16  Score=167.61  Aligned_cols=136  Identities=13%  Similarity=0.057  Sum_probs=97.6

Q ss_pred             CCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh--------------hcHHH--------HHHHHHHHhccCccce
Q 048439          274 FDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ--------------QGALE--------FQTEIGMLSQLRHLHL  331 (613)
Q Consensus       274 f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~--------------~~~~~--------f~~Ei~~l~~l~H~ni  331 (613)
                      |.....||+|+||.||+|.... ++.||||+++....              .....        ...|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~-G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEK-GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTT-CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECCC-CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            7888899999999999999865 47899998764210              01111        1345666666654443


Q ss_pred             eeEEEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCC
Q 048439          332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEK  411 (613)
Q Consensus       332 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~  411 (613)
                      ....-+..  ...+|||||+++++|.++..        ......++.|++.+|.|||..+    ||||||||.|||++++
T Consensus       176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~g----IVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKHG----LIHGDFNEFNILIREE  241 (397)
T ss_dssp             SCCCEEEE--ETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHTT----EECSCCSTTSEEEEEE
T ss_pred             CCCeeeec--cCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHCC----CcCCCCCHHHEEEeCC
Confidence            22111111  12379999999999876541        1234568899999999999988    9999999999999887


Q ss_pred             C----------cEEEEecCCCcc
Q 048439          412 W----------VAKVSDFGLSKF  424 (613)
Q Consensus       412 ~----------~~kl~DFGls~~  424 (613)
                      +          .+.|+||+-+..
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCcccccccccceEEEEeCCccc
Confidence            6          489999997753

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.33  E-value=2.5e-12  Score=128.72  Aligned_cols=149  Identities=15%  Similarity=0.101  Sum_probs=115.5

Q ss_pred             HHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC-ccceeeEEEEeecCCceE
Q 048439          267 IQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       267 l~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~  345 (613)
                      +.....+|.....++.|+.+.||+....  +..+++|+...........+.+|+++++.|. |.++.++++++.+.+..+
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            4445567877777888889999998754  3579999987532223345889999999985 677889999999888999


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA----------------------------------  391 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------  391 (613)
                      +||||++|.+|.+.+.       +......++.+++++|..||+..                                  
T Consensus        87 lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            9999999999987641       12334578899999999999811                                  


Q ss_pred             ---------------------CCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          392 ---------------------NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       392 ---------------------~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                                           .+..++|+|+++.|||++++..+.|+||+.+..
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                 114489999999999998766678999998743

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.18  E-value=2.5e-11  Score=120.61  Aligned_cols=130  Identities=19%  Similarity=0.133  Sum_probs=97.6

Q ss_pred             eeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccce--eeEEEEeecCCceEEEEEcCCCCChhH
Q 048439          281 GVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL--VSLIGFCNDDREMILVYDFMARGTLPD  358 (613)
Q Consensus       281 G~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~ni--v~l~g~~~~~~~~~lV~Ey~~~gsL~~  358 (613)
                      +.|..+.||+....+ +..++||.....   ....+..|+.+++.+++.++  .++++++.+.+..++||||+++.+|. 
T Consensus        29 ~gg~~~~v~~~~~~~-g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQG-RPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             CTTSSCEEEEEECTT-SCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred             cCCCCceEEEEecCC-CCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence            355569999997643 356999997654   22457889999999865554  56899888888899999999998884 


Q ss_pred             HhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------------
Q 048439          359 HLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA-----------------------------------------------  391 (613)
Q Consensus       359 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----------------------------------------------  391 (613)
                       +..     .   ....++.++++.|..||+..                                               
T Consensus       104 -~~~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (264)
T 1nd4_A          104 -SSH-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL  174 (264)
T ss_dssp             -TSC-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred             -cCc-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence             211     1   12367788888888888643                                               


Q ss_pred             -------CCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          392 -------NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       392 -------~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                             .+..++|+|++|.|||++++..++|+|||.+..
T Consensus       175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                   123399999999999998877778999999754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.09  E-value=2.5e-10  Score=119.77  Aligned_cols=143  Identities=19%  Similarity=0.279  Sum_probs=107.6

Q ss_pred             cceeeeeCcEEEEEEEEcCCceeEEEEEeC--CCC-hhcHHHHHHHHHHHhccC--ccceeeEEEEeecC---CceEEEE
Q 048439          277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLE--PES-QQGALEFQTEIGMLSQLR--HLHLVSLIGFCNDD---REMILVY  348 (613)
Q Consensus       277 ~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~--~~~-~~~~~~f~~Ei~~l~~l~--H~niv~l~g~~~~~---~~~~lV~  348 (613)
                      ...|+.|.++.||+....+  ..+++|+..  ... ......+.+|+.+++.|+  +..+.+++++|.+.   +..++||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~--~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG--QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS--CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             EEEcCCcccceEEEEEECC--ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3468899999999987654  458888876  332 122346788999999997  45678999999876   4589999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA-------------------------------------  391 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------  391 (613)
                      ||+++..+.+..    ...++..++..++.++++.|..||+..                                     
T Consensus       121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            999998875422    234788899999999999999999731                                     


Q ss_pred             -----------------CCCcEEeccCCCCceeeCCCC--cEEEEecCCCccC
Q 048439          392 -----------------NHAVIIHRDVKTTNILLDEKW--VAKVSDFGLSKFG  425 (613)
Q Consensus       392 -----------------~~~~iiHrDlk~~NILl~~~~--~~kl~DFGls~~~  425 (613)
                                       .+..++|+|+++.|||++.++  .+.|+||+.+..+
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                             024599999999999999775  3689999998654

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.00  E-value=8.9e-10  Score=112.83  Aligned_cols=180  Identities=17%  Similarity=0.179  Sum_probs=126.1

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC-ccc--eeeEEEEeecCC---ceEEEEEcC
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLH--LVSLIGFCNDDR---EMILVYDFM  351 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~Ey~  351 (613)
                      ..++.|....||+..     ..+++|+....  .....+.+|+++|+.+. +..  +.++++.+...+   ..++|||++
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            468999999999863     34889986533  34567889999998884 332  345565554433   347899999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA----------------------------------------  391 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------  391 (613)
                      +|.+|.+...    ..++..++..++.++++.|..||+..                                        
T Consensus        99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            9988876442    34677888889999999999998621                                        


Q ss_pred             --------------CCCcEEeccCCCCceeeCC--CCcEEEEecCCCccCCCCC----Cccc---CChhhhhc-----CC
Q 048439          392 --------------NHAVIIHRDVKTTNILLDE--KWVAKVSDFGLSKFGPTSV----SKTH---LDPEYYRL-----QQ  443 (613)
Q Consensus       392 --------------~~~~iiHrDlk~~NILl~~--~~~~kl~DFGls~~~~~~~----~~~~---~aPE~~~~-----~~  443 (613)
                                    .+..++|+|+++.|||+++  +..+.|+||+.+..+....    ....   ..|+....     +.
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                          1234899999999999998  5668999999987654321    1111   33432211     11


Q ss_pred             CC---------chhHHHHHHHHHHHHHhCCCCcc
Q 048439          444 LT---------EKSDVYSFGVVLFEVLCARPSIL  468 (613)
Q Consensus       444 ~t---------~ksDV~SfGvvL~elltg~~p~~  468 (613)
                      .+         ...+.|++|.++|++.+|++++.
T Consensus       255 ~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          255 KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            11         23689999999999999998774

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.56  E-value=5.8e-07  Score=92.01  Aligned_cols=138  Identities=19%  Similarity=0.164  Sum_probs=97.9

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCcc---ceeeEEEEee-cCCceEEEEEcCCC
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL---HLVSLIGFCN-DDREMILVYDFMAR  353 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~---niv~l~g~~~-~~~~~~lV~Ey~~~  353 (613)
                      ..++.|....||+.   +  ..++||+..  .......+..|.++|..|.+.   .+.+.++++. ..+..++||||++|
T Consensus        25 ~~l~~G~~n~v~~v---g--~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           25 ESLGEGFRNYAILV---N--GDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEECSSEEEEEE---T--TTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eecCCCcceeEEEE---C--CEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            36788888999987   2  458888853  233456789999999999753   3556777774 45567899999999


Q ss_pred             CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 048439          354 GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA------------------------------------------  391 (613)
Q Consensus       354 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------  391 (613)
                      .+|.+...    ..++..++..++.++++.|..||+..                                          
T Consensus        98 ~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           98 QILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             EECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             eECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            88876431    12455566666666666666666432                                          


Q ss_pred             --------------CCCcEEeccCCCCceeeCC---CCc-EEEEecCCCccCC
Q 048439          392 --------------NHAVIIHRDVKTTNILLDE---KWV-AKVSDFGLSKFGP  426 (613)
Q Consensus       392 --------------~~~~iiHrDlk~~NILl~~---~~~-~kl~DFGls~~~~  426 (613)
                                    .+..++|+|+++.|||++.   ++. +.|+||+.+..++
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                          2234899999999999997   344 5899999886543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.53  E-value=3.6e-07  Score=91.33  Aligned_cols=137  Identities=20%  Similarity=0.167  Sum_probs=101.8

Q ss_pred             eeeeeCcE-EEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC-ccceeeEEEEeecCCceEEEEEcCCCCCh
Q 048439          279 VIGVGGFG-DVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDREMILVYDFMARGTL  356 (613)
Q Consensus       279 ~iG~G~fG-~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  356 (613)
                      .+..|..| .||+.....++..+.||+-...   ...++..|...|+.|. +--+.++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34556555 6998877666677999986543   3456788999998884 44466889999999999999999999888


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------------
Q 048439          357 PDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA---------------------------------------------  391 (613)
Q Consensus       357 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------------  391 (613)
                      .+....      ....+..++.+++..|.-||...                                             
T Consensus       108 ~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          108 FQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            776522      12344567777777777777531                                             


Q ss_pred             ---------CCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          392 ---------NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       392 ---------~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                               .+..++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                     122389999999999999887778999998754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.33  E-value=1.5e-06  Score=90.65  Aligned_cols=146  Identities=10%  Similarity=0.092  Sum_probs=91.2

Q ss_pred             ee-eeeCcEEEEEEEEc---C---CceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCc---cceeeEEEEeecC---C
Q 048439          279 VI-GVGGFGDVYKGFIN---G---STTPVAIKRLEPES---QQGALEFQTEIGMLSQLRH---LHLVSLIGFCNDD---R  342 (613)
Q Consensus       279 ~i-G~G~fG~Vy~g~~~---~---~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H---~niv~l~g~~~~~---~  342 (613)
                      .| +.|....+|+....   +   ++..+++|+.....   ......+.+|+.+++.|..   -.+.++++++.+.   +
T Consensus        27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g  106 (357)
T 3ats_A           27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG  106 (357)
T ss_dssp             EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred             ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence            56 77888999988764   1   13568888865432   1112457889999988853   3567888888765   3


Q ss_pred             ceEEEEEcCCCCChhHHhh---c-CCCCCCCHHHHHHHHHHHHHHHHHHh------------------------------
Q 048439          343 EMILVYDFMARGTLPDHLY---H-SDNPPLPWNQRLEICIGAARGLHYLH------------------------------  388 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~---~-~~~~~l~~~~~~~i~~~ia~gL~yLH------------------------------  388 (613)
                      ..++||||+++..|.+.+.   . .....++..++..++.++++.|.-||                              
T Consensus       107 ~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  186 (357)
T 3ats_A          107 TPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNWVR  186 (357)
T ss_dssp             SCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHHHH
T ss_pred             CceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHHHH
Confidence            5689999999877654210   0 00001222333333333333333333                              


Q ss_pred             ------------------------cCCC------CCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          389 ------------------------TGAN------HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       389 ------------------------~~~~------~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                                              ....      +..++|+|+.+.|||++++..+.|+||+.+..
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          187 SWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             HHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             HHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence                                    2111      34599999999999999655678999998754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.21  E-value=4.6e-06  Score=88.32  Aligned_cols=75  Identities=15%  Similarity=0.102  Sum_probs=49.2

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh-------hcHHHHHHHHHHHhccCc--cc-eeeEEEEeecCCceEEE
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ-------QGALEFQTEIGMLSQLRH--LH-LVSLIGFCNDDREMILV  347 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~-------~~~~~f~~Ei~~l~~l~H--~n-iv~l~g~~~~~~~~~lV  347 (613)
                      ..||.|.++.||++....++..++||...+...       .....+..|.++|..+..  +. +.+++.+.  .+..++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEEE
Confidence            468999999999997654456799998654321       123456788888887742  33 44566553  3456899


Q ss_pred             EEcCCCC
Q 048439          348 YDFMARG  354 (613)
Q Consensus       348 ~Ey~~~g  354 (613)
                      |||+++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999864

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.90  E-value=3.8e-05  Score=78.92  Aligned_cols=140  Identities=18%  Similarity=0.194  Sum_probs=79.6

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCcc--ceeeEEE------EeecCCceEEEEEc
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL--HLVSLIG------FCNDDREMILVYDF  350 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~--niv~l~g------~~~~~~~~~lV~Ey  350 (613)
                      .|+.|..+.||+....++  .+++|+....    ..++..|..++..|...  .+.+++.      +....+..++||||
T Consensus        39 ~l~gG~~n~~~~v~~~~~--~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG--AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             ECC----CEEEEEEETTE--EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eccccccCcEEEEEeCCC--CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            455567899999887543  4899998752    22334555666555321  2333443      11235667899999


Q ss_pred             CCCCChh--------------HHhhc--CC---C-------CCCCHHHHH------------------------------
Q 048439          351 MARGTLP--------------DHLYH--SD---N-------PPLPWNQRL------------------------------  374 (613)
Q Consensus       351 ~~~gsL~--------------~~l~~--~~---~-------~~l~~~~~~------------------------------  374 (613)
                      ++|.++.              ..++.  ..   .       ..-.|...+                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              11111  10   0       012343211                              


Q ss_pred             -HHHHHHHHHHHHHhc--------C-CCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          375 -EICIGAARGLHYLHT--------G-ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       375 -~i~~~ia~gL~yLH~--------~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                       .+...+.+++.+|+.        . ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             011123446667763        1 0123399999999999998888999999998754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.84  E-value=7.2e-05  Score=76.57  Aligned_cols=137  Identities=13%  Similarity=0.130  Sum_probs=91.3

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC---ccceeeEEEEeecCCceEEEEEcCCCC
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR---HLHLVSLIGFCNDDREMILVYDFMARG  354 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~~g  354 (613)
                      ..|+.|....+|+....  +..++||+....   ....|..|.+.|+.|.   ...+.++++++...+..++||||+++.
T Consensus        42 ~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           42 EKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             EEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            46889999999998753  356889986543   3556889999998884   356788999988888899999999987


Q ss_pred             ChhH-----------HhhcCCC-C-------------------CCCHHHHH-----HHHHH--------------HHHH-
Q 048439          355 TLPD-----------HLYHSDN-P-------------------PLPWNQRL-----EICIG--------------AARG-  383 (613)
Q Consensus       355 sL~~-----------~l~~~~~-~-------------------~l~~~~~~-----~i~~~--------------ia~g-  383 (613)
                      .+..           .|+.... .                   .-+|....     .-..+              ++.- 
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6521           1222111 1                   12454322     11111              1111 


Q ss_pred             HHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecC
Q 048439          384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFG  420 (613)
Q Consensus       384 L~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG  420 (613)
                      ...|.....++.++|+|+.+.|++++.++ +.|.||.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            23343223345699999999999999887 8899973

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.83  E-value=0.00011  Score=73.90  Aligned_cols=77  Identities=16%  Similarity=0.128  Sum_probs=55.8

Q ss_pred             CCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCc---cceeeEEEEeecCCceEEEEEcC
Q 048439          275 DNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRH---LHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       275 ~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H---~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      .....+|.|..+.||+.++.++ +.|.||+...........|..|.+.|+.|.-   -.+.+++++.    .-++||||+
T Consensus        18 ~~v~~~g~G~~~~vyrv~l~DG-~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l   92 (288)
T 3f7w_A           18 AAVAERGHSHRWHLYRVELADG-TPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTS-CEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred             EEEEecCCCCCeEEEEEEECCC-CEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence            3445689999999999998776 6799998765544444568899999988842   2345556553    237899999


Q ss_pred             CCCCh
Q 048439          352 ARGTL  356 (613)
Q Consensus       352 ~~gsL  356 (613)
                      +.+..
T Consensus        93 ~~~~~   97 (288)
T 3f7w_A           93 DERPP   97 (288)
T ss_dssp             CCCCC
T ss_pred             cccCC
Confidence            87654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.72  E-value=0.00013  Score=77.75  Aligned_cols=72  Identities=15%  Similarity=0.153  Sum_probs=45.2

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCC----Ch-----hcHHHHHHHHHHHhc-cCccceeeEEEEeecCCceEEE
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPE----SQ-----QGALEFQTEIGMLSQ-LRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~----~~-----~~~~~f~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ..||.|..+.||+...  ++..++||...+.    ..     .....+..|+..+.. ..+..+.+++++.  .+..++|
T Consensus        40 ~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           40 KEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            4688999999999864  3356999953321    11     123344455443332 2345667777776  4567999


Q ss_pred             EEcC-CC
Q 048439          348 YDFM-AR  353 (613)
Q Consensus       348 ~Ey~-~~  353 (613)
                      |||+ ++
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.37  E-value=0.00025  Score=71.84  Aligned_cols=138  Identities=12%  Similarity=0.035  Sum_probs=77.6

Q ss_pred             cceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccce-eeEEEEeecCCceEEEEEcC-CCC
Q 048439          277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL-VSLIGFCNDDREMILVYDFM-ARG  354 (613)
Q Consensus       277 ~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~-~~g  354 (613)
                      ...|+.|....+|+.      ..+++|+....... .....+|+.++..+...++ .++++++.+  .-++|+||+ ++.
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCc
Confidence            457888999999998      34889987654222 1223568888887754344 366665433  347899999 654


Q ss_pred             ChhHH------------------hhcCCCCCC----CH-HHHHHH------------------HHHHHHHHHHHhcCCCC
Q 048439          355 TLPDH------------------LYHSDNPPL----PW-NQRLEI------------------CIGAARGLHYLHTGANH  393 (613)
Q Consensus       355 sL~~~------------------l~~~~~~~l----~~-~~~~~i------------------~~~ia~gL~yLH~~~~~  393 (613)
                      +|...                  ||.. ...+    .. .....+                  ...+..-...|.....+
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~La~lH~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~  172 (301)
T 3dxq_A           94 TMSPEKFKTRPGSPARAGEAFRKLHGS-GAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP  172 (301)
T ss_dssp             ECCHHHHHHSTTHHHHHHHHHHHHHTS-CCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             cCCHhhHhhhHHHHHHHHHHHHHHhCC-CCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence            44310                  1111 1111    11 111111                  11111111222222334


Q ss_pred             CcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       394 ~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      ..++|+|+.+.||+ .+++.+.|+||..+..+
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            55899999999999 55667899999887643

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.32  E-value=0.0017  Score=66.09  Aligned_cols=160  Identities=13%  Similarity=0.099  Sum_probs=91.8

Q ss_pred             ccCHHHHHHHhcCCCCcc-----eeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccce--ee
Q 048439          261 QFSLSEIQAATNNFDNDL-----VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL--VS  333 (613)
Q Consensus       261 ~f~~~el~~at~~f~~~~-----~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~ni--v~  333 (613)
                      .++.+++......|....     .|+.|....+|+....++  .+++|......  ...++..|+.++..|+...+  .+
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g--~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~   81 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD--PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL   81 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC--CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc--cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCc
Confidence            467778887777776532     355677889999887654  48899887631  12345667777777753232  33


Q ss_pred             EEEEe------ecCCceEEEEEcCCCCChhH--------------HhhcC--C--CC---C---CCHHHHHHH-------
Q 048439          334 LIGFC------NDDREMILVYDFMARGTLPD--------------HLYHS--D--NP---P---LPWNQRLEI-------  376 (613)
Q Consensus       334 l~g~~------~~~~~~~lV~Ey~~~gsL~~--------------~l~~~--~--~~---~---l~~~~~~~i-------  376 (613)
                      ++...      ...+..++|++|++|..+..              .++..  .  ..   .   ..|...+.-       
T Consensus        82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~  161 (322)
T 2ppq_A           82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  161 (322)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence            33221      12355689999999865421              01110  0  00   0   123331110       


Q ss_pred             -----HHHHHHHHHHHhcC---CCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          377 -----CIGAARGLHYLHTG---ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       377 -----~~~ia~gL~yLH~~---~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                           ...+...+..|+..   ..+..++|+|+.+.|||++++..+.|+||+.+..
T Consensus       162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                 11234455555532   2234599999999999999876668999998753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.30  E-value=0.00059  Score=73.00  Aligned_cols=72  Identities=14%  Similarity=0.128  Sum_probs=49.6

Q ss_pred             eeeeeCcEEEEEEEEcC-------CceeEEEEEeCCCChhcHHHHHHHHHHHhccCccce-eeEEEEeecCCceEEEEEc
Q 048439          279 VIGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL-VSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~-------~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey  350 (613)
                      .|+.|-...+|+....+       .+..+.+|+.....  ....+..|..++..|...++ .++++.+.+    .+|+||
T Consensus        80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            57778889999998753       13568898874321  11456689999988864444 567776643    389999


Q ss_pred             CCCCCh
Q 048439          351 MARGTL  356 (613)
Q Consensus       351 ~~~gsL  356 (613)
                      +++.+|
T Consensus       154 l~G~~l  159 (429)
T 1nw1_A          154 IPSRPL  159 (429)
T ss_dssp             CCEEEC
T ss_pred             eCCccc
Confidence            986444

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.28  E-value=0.0015  Score=67.05  Aligned_cols=142  Identities=13%  Similarity=0.099  Sum_probs=72.8

Q ss_pred             eeeeeCcEE-EEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCc--cceeeEEEEeecCCceEEEEEcCCCCC
Q 048439          279 VIGVGGFGD-VYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRH--LHLVSLIGFCNDDREMILVYDFMARGT  355 (613)
Q Consensus       279 ~iG~G~fG~-Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gs  355 (613)
                      .|+.|+... +|+....++ ..+++|...+...   .++..|+.++..|..  -.+.+++.++.+.+  ++|||++.+.+
T Consensus        25 ~l~gg~s~~~~~r~~~~~~-~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTG-AKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             C--------CCEEEECTTC-CEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             ECCCCCCCceEEEEEcCCC-CeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            355554444 667654323 4577776544321   233456777766643  23456777754443  78999998766


Q ss_pred             hhHHhhc---------------------CCC---CCCCHHHHH-------H-------------HHHHHHHHHHHHhc--
Q 048439          356 LPDHLYH---------------------SDN---PPLPWNQRL-------E-------------ICIGAARGLHYLHT--  389 (613)
Q Consensus       356 L~~~l~~---------------------~~~---~~l~~~~~~-------~-------------i~~~ia~gL~yLH~--  389 (613)
                      +.+.+..                     ...   +.++.....       .             ....+...+..|..  
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            6443311                     100   112111100       0             00011122222211  


Q ss_pred             CCCCCcEEeccCCCCceeeCCC----CcEEEEecCCCccCC
Q 048439          390 GANHAVIIHRDVKTTNILLDEK----WVAKVSDFGLSKFGP  426 (613)
Q Consensus       390 ~~~~~~iiHrDlk~~NILl~~~----~~~kl~DFGls~~~~  426 (613)
                      ...+..++|+|+.+.|||++.+    ..+.|+||+.+..++
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            1123459999999999999875    689999999987654

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.21  E-value=0.0023  Score=65.31  Aligned_cols=161  Identities=16%  Similarity=0.128  Sum_probs=90.4

Q ss_pred             ccCHHHHHHHhcCCCC-----cceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccc--eee
Q 048439          261 QFSLSEIQAATNNFDN-----DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLH--LVS  333 (613)
Q Consensus       261 ~f~~~el~~at~~f~~-----~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--iv~  333 (613)
                      ..+.+++..+...|..     ...|+ |....||+....++ ..+++|..++.. .....+..|..++..|....  +.+
T Consensus        10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g-~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~   86 (328)
T 1zyl_A           10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDR-RRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAA   86 (328)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTC-CCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred             CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCC-CEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecc
Confidence            3555666655555532     22466 88889998766543 469999987542 13445677888888775322  344


Q ss_pred             EEEE-----eecCCceEEEEEcCCCCChh----HH----------hhc--C-----CCCCCCHHHH--------------
Q 048439          334 LIGF-----CNDDREMILVYDFMARGTLP----DH----------LYH--S-----DNPPLPWNQR--------------  373 (613)
Q Consensus       334 l~g~-----~~~~~~~~lV~Ey~~~gsL~----~~----------l~~--~-----~~~~l~~~~~--------------  373 (613)
                      ++..     ....+..++||||+++..+.    +.          ++.  .     ....+++...              
T Consensus        87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  166 (328)
T 1zyl_A           87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI  166 (328)
T ss_dssp             CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred             eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence            4443     11234567899999875432    11          111  0     0112232211              


Q ss_pred             --------HHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          374 --------LEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       374 --------~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                              ...+..++..+.-+.....+..++|+|+++.|||++ + .+.|+||+.+..++
T Consensus       167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~  225 (328)
T 1zyl_A          167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNGP  225 (328)
T ss_dssp             CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEEC
T ss_pred             CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcCc
Confidence                    011112222222221111234489999999999999 4 89999999876543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.01  E-value=0.0029  Score=66.35  Aligned_cols=141  Identities=16%  Similarity=0.150  Sum_probs=84.1

Q ss_pred             eeeeeCcEEEEEEEEcC-------CceeEEEEEeCCCChhcHHHHHHHHHHHhccCccce-eeEEEEeecCCceEEEEEc
Q 048439          279 VIGVGGFGDVYKGFING-------STTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL-VSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~-------~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey  350 (613)
                      .|..|-...+|+....+       ++..+.+|+.... ......+.+|.++++.|.-.++ .++++++.+    .+||||
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            45667778889887642       2356888885332 2345667799999988853333 467777654    299999


Q ss_pred             CCCCChhHH-----------------hhcCC---CCCC--CHHHHHHHHHHHHH-------------------HHHH---
Q 048439          351 MARGTLPDH-----------------LYHSD---NPPL--PWNQRLEICIGAAR-------------------GLHY---  386 (613)
Q Consensus       351 ~~~gsL~~~-----------------l~~~~---~~~l--~~~~~~~i~~~ia~-------------------gL~y---  386 (613)
                      +++.+|...                 |+...   ....  -|.+..++..++..                   .+..   
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            998665311                 11111   1112  24455544443321                   2233   


Q ss_pred             -HhcCCCCCcEEeccCCCCceeeCCC----CcEEEEecCCCcc
Q 048439          387 -LHTGANHAVIIHRDVKTTNILLDEK----WVAKVSDFGLSKF  424 (613)
Q Consensus       387 -LH~~~~~~~iiHrDlk~~NILl~~~----~~~kl~DFGls~~  424 (613)
                       |.....+..++|+|+.+.|||++++    +.+.|+||..+..
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence             3333444569999999999999876    7899999988753

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.99  E-value=0.0023  Score=66.71  Aligned_cols=73  Identities=11%  Similarity=0.093  Sum_probs=44.4

Q ss_pred             eeeeeCcEEEEEEEEcCC--------ceeEEEEEeCCCChhcHHHHHHHHHHHhccCccce-eeEEEEeecCCceEEEEE
Q 048439          279 VIGVGGFGDVYKGFINGS--------TTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL-VSLIGFCNDDREMILVYD  349 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~--------~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E  349 (613)
                      .|+.|....+|+....++        +..+++|+...... ...+...|..++..|...++ .++++...    -++|||
T Consensus        40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~e  114 (369)
T 3c5i_A           40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIEE  114 (369)
T ss_dssp             EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEEE
Confidence            567777889999887541        14688887654322 22234678888888864444 36666542    268999


Q ss_pred             cCCCCCh
Q 048439          350 FMARGTL  356 (613)
Q Consensus       350 y~~~gsL  356 (613)
                      |+++.+|
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987544

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.89  E-value=0.0057  Score=65.80  Aligned_cols=73  Identities=15%  Similarity=0.111  Sum_probs=48.0

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccce-eeEEEEeecCCceEEEEEcCCCCCh
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL-VSLIGFCNDDREMILVYDFMARGTL  356 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL  356 (613)
                      .|+.|-...+|+....+++..+++|+....... .....+|..++..|...++ .++++++.  +  .+||||+++.+|
T Consensus       115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            577788899999988653466888887543221 1123588889988865555 46777773  2  359999987554

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.13  E-value=0.014  Score=55.68  Aligned_cols=102  Identities=15%  Similarity=0.133  Sum_probs=67.1

Q ss_pred             CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCCCCCccc
Q 048439          354 GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH  433 (613)
Q Consensus       354 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  433 (613)
                      -+|.+.|.. .+.+|++.+.|.+|.|.+++|.-+-.+..+   ..+=+-|..|+|..+|.+.+.+ +.+.    .....+
T Consensus        33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~---~~~i~~~~~i~l~~dG~V~f~~-~~s~----~~~~~~  103 (229)
T 2yle_A           33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRRQP---RHRVRSAAQIRVWRDGAVTLAP-AADD----AGEPPP  103 (229)
T ss_dssp             EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC---CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcccC---CceecCCcceEEecCCceeccc-cccc----ccccCC
Confidence            378888854 467899999999999999998887322111   1233457899999999988764 2221    112346


Q ss_pred             CChhhhhcCCCCchhHHHHHHHHHHHHHhCCC
Q 048439          434 LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP  465 (613)
Q Consensus       434 ~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~  465 (613)
                      .+||... ...+++.=|||+|++||.-+-=..
T Consensus       104 ~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A          104 VAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             ---CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             CChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence            6787763 355789999999999999885433

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.85  E-value=0.026  Score=58.03  Aligned_cols=34  Identities=21%  Similarity=0.392  Sum_probs=28.9

Q ss_pred             CCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       393 ~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      +..++|+|+.+.||++++++.+.|+||+.+..++
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            3459999999999999988889999998876543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.04  E-value=0.09  Score=55.77  Aligned_cols=140  Identities=15%  Similarity=0.174  Sum_probs=83.7

Q ss_pred             eeeeeCcEEEEEEEEcCC-------ceeEEEEEeCCCChhcHHHHHHHHHHHhccCccce-eeEEEEeecCCceEEEEEc
Q 048439          279 VIGVGGFGDVYKGFINGS-------TTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL-VSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~-------~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey  350 (613)
                      .|..|--..+|+....++       +..+++|+..... .......+|.++++.|...++ .++++.+.    -++||||
T Consensus        77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef  151 (424)
T 3mes_A           77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF  151 (424)
T ss_dssp             EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred             EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence            466677888999887531       3568888865433 222234678888888854344 45665442    2789999


Q ss_pred             CCCCChhHH-----------------hhc----C-------CCCCCCHHHHHHHHHHH-------------------HHH
Q 048439          351 MARGTLPDH-----------------LYH----S-------DNPPLPWNQRLEICIGA-------------------ARG  383 (613)
Q Consensus       351 ~~~gsL~~~-----------------l~~----~-------~~~~l~~~~~~~i~~~i-------------------a~g  383 (613)
                      +++.+|...                 ||.    .       ...+.-|.+..++..++                   ...
T Consensus       152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e  231 (424)
T 3mes_A          152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE  231 (424)
T ss_dssp             CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred             eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence            998664210                 011    0       11122344444433222                   222


Q ss_pred             HHHHh--------------------cCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          384 LHYLH--------------------TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       384 L~yLH--------------------~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      +..|.                    ....+..++|+|+.+.||+ ++++.+.|+||..+..
T Consensus       232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            33332                    1223445899999999999 7888999999988753

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.38  E-value=0.97  Score=47.26  Aligned_cols=32  Identities=38%  Similarity=0.501  Sum_probs=26.4

Q ss_pred             CCcEEeccCCCCceee------CCCCcEEEEecCCCcc
Q 048439          393 HAVIIHRDVKTTNILL------DEKWVAKVSDFGLSKF  424 (613)
Q Consensus       393 ~~~iiHrDlk~~NILl------~~~~~~kl~DFGls~~  424 (613)
                      +..++|+|+.+.|||+      +++..+.++||-.|..
T Consensus       243 ~~vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          243 PVVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             CEEEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             CeeeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            3447899999999999      4567899999998764

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=91.07  E-value=0.23  Score=34.37  Aligned_cols=26  Identities=19%  Similarity=0.365  Sum_probs=12.1

Q ss_pred             eeehHHHHHHHHHHHH--HHHHHhhccc
Q 048439          196 GMVAGAISGSSVLSLL--LLLIFWRGRK  221 (613)
Q Consensus       196 ~ii~g~v~~~~~l~~~--~~~~~~~~rr  221 (613)
                      .|.+|+++|+++++++  ++++++|||+
T Consensus        12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~   39 (44)
T 2ks1_B           12 SIATGMVGALLLLLVVALGIGLFMRRRH   39 (44)
T ss_dssp             SSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             eEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence            4455555555443333  2334455544

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=90.24  E-value=0.12  Score=34.73  Aligned_cols=8  Identities=25%  Similarity=0.401  Sum_probs=3.4

Q ss_pred             eehHHHHH
Q 048439          197 MVAGAISG  204 (613)
Q Consensus       197 ii~g~v~~  204 (613)
                      .++|+++|
T Consensus        12 aIAGiVvG   19 (38)
T 2k1k_A           12 EIVAVIFG   19 (38)
T ss_dssp             HHHHHHHH
T ss_pred             ceeeeehH
Confidence            34444443

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=90.17  E-value=0.28  Score=33.99  Aligned_cols=28  Identities=21%  Similarity=0.149  Sum_probs=17.6

Q ss_pred             cceeehHHHH-HHHHHHHHHHHHHhhccc
Q 048439          194 VTGMVAGAIS-GSSVLSLLLLLIFWRGRK  221 (613)
Q Consensus       194 ~~~ii~g~v~-~~~~l~~~~~~~~~~~rr  221 (613)
                      ..+++.|+++ +++++++.+++-.++.++
T Consensus        14 A~gVVgGv~~~~ii~~~~~~~~RRr~~~~   42 (44)
T 2ks1_B           14 ATGMVGALLLLLVVALGIGLFMRRRHIVR   42 (44)
T ss_dssp             THHHHHHHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             EeehhHHHHHHHHHHHHHHHHhhhhHhhc
Confidence            3555555544 456677777777766665

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=89.28  E-value=0.31  Score=33.67  Aligned_cols=27  Identities=22%  Similarity=0.480  Sum_probs=12.4

Q ss_pred             eeehHHHHHHHHHHHH--HHHHHhhcccc
Q 048439          196 GMVAGAISGSSVLSLL--LLLIFWRGRKV  222 (613)
Q Consensus       196 ~ii~g~v~~~~~l~~~--~~~~~~~~rr~  222 (613)
                      .|.+|+++|+++++++  ++++++|||+.
T Consensus        11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr~   39 (44)
T 2l2t_A           11 LIAAGVIGGLFILVIVGLTFAVYVRRKSI   39 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             eEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence            3455555555443333  23344555443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=87.51  E-value=0.32  Score=33.60  Aligned_cols=29  Identities=14%  Similarity=0.124  Sum_probs=14.2

Q ss_pred             ceeehHHHH-HHHHHHHHHHHHHhhccccc
Q 048439          195 TGMVAGAIS-GSSVLSLLLLLIFWRGRKVK  223 (613)
Q Consensus       195 ~~ii~g~v~-~~~~l~~~~~~~~~~~rr~~  223 (613)
                      .+++.|+++ +++++++.+++=.++++++|
T Consensus        14 ~gVVgGv~~v~ii~~~~~~~~RRRr~~~kr   43 (44)
T 2l2t_A           14 AGVIGGLFILVIVGLTFAVYVRRKSIKKKR   43 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTTCSSCCC
T ss_pred             EeehHHHHHHHHHHHHHHHHhhhhhhhhcc
Confidence            344443433 34555666666555554443

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.27  E-value=0.054  Score=58.24  Aligned_cols=58  Identities=9%  Similarity=0.077  Sum_probs=16.2

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEE------EEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEee
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAI------KRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCN  339 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAV------K~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~  339 (613)
                      .||   ||.||+|.+.....+|||      |..+..  +.+....|.+|..++..++|+|+++.+++..
T Consensus       149 ~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          149 HVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            455   999999999765567999      776543  2344557889999999999999999988754

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=85.66  E-value=0.33  Score=33.09  Aligned_cols=15  Identities=20%  Similarity=0.392  Sum_probs=8.2

Q ss_pred             ceeehHHHHHHHHHH
Q 048439          195 TGMVAGAISGSSVLS  209 (613)
Q Consensus       195 ~~ii~g~v~~~~~l~  209 (613)
                      ..+++++++|+++++
T Consensus        13 ~~I~~~vv~Gv~ll~   27 (41)
T 2k9y_A           13 LAVIGGVAVGVVLLL   27 (41)
T ss_dssp             THHHHHHHHHHHHHH
T ss_pred             EEEEeehhHHHHHHH
Confidence            445555555665544

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=84.88  E-value=0.57  Score=32.30  Aligned_cols=7  Identities=29%  Similarity=0.577  Sum_probs=2.9

Q ss_pred             HHhhccc
Q 048439          215 IFWRGRK  221 (613)
Q Consensus       215 ~~~~~rr  221 (613)
                      +++||||
T Consensus        33 ~~~RRR~   39 (44)
T 2jwa_A           33 ILIKRRQ   39 (44)
T ss_dssp             HHHHHHC
T ss_pred             hheehhh
Confidence            3344443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=83.98  E-value=3.2  Score=39.32  Aligned_cols=118  Identities=10%  Similarity=0.086  Sum_probs=80.7

Q ss_pred             cCccceeeEEEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCc
Q 048439          326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTN  405 (613)
Q Consensus       326 l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~N  405 (613)
                      ..||+.+.. .+-.+++.+.+.|+.-+++.=...+     ..++...+++++..|+.--.++++      =+|--|.|+|
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~~------r~tf~L~P~N  109 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNRT------RYTFVLAPDE  109 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGGS------SEECCCSGGG
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhcC------ceEEEEecce
Confidence            368888876 4556666666667654432212223     347789999999999998866664      2677899999


Q ss_pred             eeeCCCCcEEEEecCCCccCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccc
Q 048439          406 ILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILR  469 (613)
Q Consensus       406 ILl~~~~~~kl~DFGls~~~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~  469 (613)
                      ++++.++.+++.-.|+....+         |.     ..++..=.-.+=+++..+++++..|..
T Consensus       110 L~f~~~~~p~i~~RGik~~l~---------P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVVD---------PL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             EEECTTSCEEESCCEETTTBS---------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             EEEcCCCCEEEEEccCccCCC---------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            999999999999888743222         21     122222334577888999999988853

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	613
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-58
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-57
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-57
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-56
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-54
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-53
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-53
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-52
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-52
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-52
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-51
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-51
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-51
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-50
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-50
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-48
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-47
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-47
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-47
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-47
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-46
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-46
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-46
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-44
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-43
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-43
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-42
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-40
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-40
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-39
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-37
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-37
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-36
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-36
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-35
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-33
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-32
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-31
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-27
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-27
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-19

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 8e-58
 Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 34/273 (12%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIG 336
            IG G FG VYKG  +G    VA+K L     + Q    F+ E+G+L + RH++++  +G
Sbjct: 15  RIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
           +    + + +V  +    +L  HL H         + ++I    A+G+ YLH       I
Sbjct: 72  YSTAPQ-LAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLH----AKSI 125

Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT----------HLDPEYYRLQQ--- 443
           IHRD+K+ NI L E    K+ DFGL+                     + PE  R+Q    
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185

Query: 444 LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAM- 502
            + +SDVY+FG+VL+E++  +        + Q+   V   + Y +  + ++     KAM 
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--RGYLSPDLSKVRSNCPKAMK 243

Query: 503 ----SCLNDEGIRRPSMSDVVWGLEFSLQLQES 531
                CL  +   RP    ++  +E    L  S
Sbjct: 244 RLMAECLKKKRDERPLFPQILASIE---LLARS 273

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  193 bits (490), Expect = 2e-57
 Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 34/289 (11%)

Query: 262 FSLSEIQAATNNFDNDL---------VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPE- 308
           F+  +   A   F  ++         VIG G FG+V  G +         VAIK L+   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 309 SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPL 368
           +++   +F +E  ++ Q  H +++ L G       ++++ +FM  G+L D     ++   
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQF 125

Query: 369 PWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS 428
              Q + +  G A G+ YL         +HRD+   NIL++   V KVSDFGLS+F    
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA----DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 429 VSKTH-------------LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQ 475
            S                  PE  + ++ T  SDV+S+G+V++EV+            + 
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241

Query: 476 VSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE 523
           V  A+  +Q Y+            +  + C   +   RP    +V  L+
Sbjct: 242 VINAI--EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 5e-57
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 12/206 (5%)

Query: 267 IQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQ 325
           ++   ++F+    +G G  G V+K     S   +A K +  E +         E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
               ++V   G    D E+ +  + M  G+L   L       +P     ++ I   +GL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLT 118

Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH------LDPEYY 439
           YL        I+HRDVK +NIL++ +   K+ DFG+S     S++ +       + PE  
Sbjct: 119 YLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 175

Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARP 465
           +    + +SD++S G+ L E+   R 
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRY 201

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 7e-57
 Identities = 64/255 (25%), Positives = 110/255 (43%), Gaps = 19/255 (7%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            +G G FG+V+ G+ NG  T VA+K L+  S      F  E  ++ QL+H  LV L    
Sbjct: 20  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVV 77

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
             +  + ++ ++M  G+L D L       L  N+ L++    A G+ ++         IH
Sbjct: 78  TQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE----ERNYIH 132

Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------LDPEYYRLQQLTEKSD 449
           RD++  NIL+ +    K++DFGL++    +                PE       T KSD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192

Query: 450 VYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDE 508
           V+SFG++L E++             +V   +  ++ Y+    D   +   +    C  + 
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--ERGYRMVRPDNCPEELYQLMRLCWKER 250

Query: 509 GIRRPSMSDVVWGLE 523
              RP+   +   LE
Sbjct: 251 PEDRPTFDYLRSVLE 265

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  189 bits (480), Expect = 5e-56
 Identities = 72/284 (25%), Positives = 125/284 (44%), Gaps = 24/284 (8%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL 331
            +      +G G +G+VY+G     +  VA+K L+ ++ +   EF  E  ++ +++H +L
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 75

Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V L+G C  +    ++ +FM  G L D+L   +   +     L +    +  + YL    
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------LDPEYYRLQ 442
                IHRD+   N L+ E  + KV+DFGLS+         H           PE     
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191

Query: 443 QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-A 501
           + + KSDV++FGV+L+E+     S        QV   +  ++ Y+    +   +   +  
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--EKDYRMERPEGCPEKVYELM 249

Query: 502 MSCLNDEGIRRPSMSDVVWGLEFSLQLQESSIAIAKEIDENEEE 545
            +C       RPS +++    E     QESSI+     DE E+E
Sbjct: 250 RACWQWNPSDRPSFAEIHQAFE--TMFQESSIS-----DEVEKE 286

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 7e-56
 Identities = 72/252 (28%), Positives = 119/252 (47%), Gaps = 17/252 (6%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            IG G FGDV  G   G    VA+K ++ ++      F  E  +++QLRH +LV L+G  
Sbjct: 14  TIGKGEFGDVMLGDYRG--NKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVI 69

Query: 339 NDDREMI-LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
            +++  + +V ++MA+G+L D+L       L  +  L+  +     + YL         +
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFV 125

Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH-----LDPEYYRLQQLTEKSDVYS 452
           HRD+   N+L+ E  VAKVSDFGL+K   ++            PE  R ++ + KSDV+S
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 185

Query: 453 FGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIR 511
           FG++L+E+             K V   V  ++ Y+    D       +   +C + +   
Sbjct: 186 FGILLWEIYSFGRVPYPRIPLKDVVPRV--EKGYKMDAPDGCPPAVYEVMKNCWHLDAAM 243

Query: 512 RPSMSDVVWGLE 523
           RPS   +   LE
Sbjct: 244 RPSFLQLREQLE 255

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 5e-54
 Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 22/258 (8%)

Query: 277 DLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSL 334
           D+ IG G F  VYKG    +T  VA   L+    ++     F+ E  ML  L+H ++V  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 335 IGFC----NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
                      + ++LV + M  GTL  +L       +        C    +GL +LH  
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLH-- 129

Query: 391 ANHAVIIHRDVKTTNILL-DEKWVAKVSDFGLSKFGPTSVSKT------HLDPEYYRLQQ 443
                IIHRD+K  NI +       K+ D GL+     S +K        + PE Y  ++
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-EK 188

Query: 444 LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--A 501
             E  DVY+FG+ + E+  +           Q+   V      +  + D++  P +K   
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV--TSGVKPASFDKVAIPEVKEII 246

Query: 502 MSCLNDEGIRRPSMSDVV 519
             C+      R S+ D++
Sbjct: 247 EGCIRQNKDERYSIKDLL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 5e-53
 Identities = 68/264 (25%), Positives = 109/264 (41%), Gaps = 24/264 (9%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            IG G FG V+ G    +   VAIK +   +     +F  E  ++ +L H  LV L G C
Sbjct: 12  EIGSGQFGLVHLG-YWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
            +   + LV++FM  G L      +          L +C+    G+ YL      A +IH
Sbjct: 70  LEQAPICLVFEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIH 124

Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT---------HLDPEYYRLQQLTEKSD 449
           RD+   N L+ E  V KVSDFG+++F       +            PE +   + + KSD
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184

Query: 450 VYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--AMSCLND 507
           V+SFGV+++EV           +  +V   V            ++    +      C  +
Sbjct: 185 VWSFGVLMWEVFSEGKIPYENRSNSEV---VEDISTGFRLYKPRLASTHVYQIMNHCWKE 241

Query: 508 EGIRRPSMSDVVWGLEFSLQLQES 531
               RP+ S ++  L    ++ ES
Sbjct: 242 RPEDRPAFSRLLRQLA---EIAES 262

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 6e-53
 Identities = 78/289 (26%), Positives = 132/289 (45%), Gaps = 26/289 (8%)

Query: 265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGST----TPVAIKRLEPE-SQQGALEFQTE 319
           +EI    +      VIG G FG+VYKG +  S+     PVAIK L+   +++  ++F  E
Sbjct: 2   TEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59

Query: 320 IGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIG 379
            G++ Q  H +++ L G  +  + M+++ ++M  G   D      +      Q + +  G
Sbjct: 60  AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRG 118

Query: 380 AARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH------ 433
            A G+ YL     +   +HRD+   NIL++   V KVSDFGLS+        T+      
Sbjct: 119 IAAGMKYLA----NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174

Query: 434 -----LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN 488
                  PE    ++ T  SDV+SFG+V++EV+          +  +V  A+     ++ 
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI--NDGFRL 232

Query: 489 GTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSIAIA 536
            T         +  M C   E  RRP  +D+V  L+  ++  +S   +A
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 281

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 8e-53
 Identities = 58/298 (19%), Positives = 110/298 (36%), Gaps = 52/298 (17%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            IG G FG+V++G   G    VA+K      ++     + EI     LRH +++  I   
Sbjct: 10  SIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 66

Query: 339 NDDR----EMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           N D     ++ LV D+   G+L D+L   +   +     +++ +  A GL +LH      
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 395 V----IIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH------------LDPEY 438
                I HRD+K+ NIL+ +     ++D GL+    ++                 + PE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 439 YRLQ------QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQ----VSLAVWAQQCYQN 488
                     +  +++D+Y+ G+V +E+             +     +  +  + +  + 
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 489 GTIDQIVDPFLK---------------AMSCLNDEGIRRPSMSDVVWGLEFSLQLQES 531
              +Q + P +                   C    G  R +   +   L   L  QE 
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS-QLSQQEG 300

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-52
 Identities = 66/294 (22%), Positives = 117/294 (39%), Gaps = 32/294 (10%)

Query: 266 EIQAATNNFD-NDLVIGVGGFGDVYKGF--INGSTTPVAIKRLEPESQQGALE-FQTEIG 321
           ++    +N    D+ +G G FG V +G   +      VAIK L+  +++   E    E  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 322 MLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           ++ QL + ++V LIG C     ++LV +    G L   L       +P +   E+    +
Sbjct: 62  IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVS 119

Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH-------- 433
            G+ YL         +HRD+   N+LL  +  AK+SDFGLSK      S           
Sbjct: 120 MGMKYLE----EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

Query: 434 ---LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT 490
                PE    ++ + +SDV+S+GV ++E L       +     +V   +      +   
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KRME 232

Query: 491 IDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSIAIAKEIDEN 542
                 P L      C   +   RP    V        +++    ++A +++ +
Sbjct: 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQ------RMRACYYSLASKVEGH 280

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 3e-52
 Identities = 67/269 (24%), Positives = 119/269 (44%), Gaps = 27/269 (10%)

Query: 273 NFDNDLVIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRH 328
           +F+   VIG G FG VY G +   +G     A+K L   +  G +  F TE  ++    H
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 329 LHLVSLIGFC-NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYL 387
            +++SL+G C   +   ++V  +M  G L  +   ++         +   +  A+G+ +L
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKFL 146

Query: 388 HTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------------HLD 435
                    +HRD+   N +LDEK+  KV+DFGL++        +             + 
Sbjct: 147 A----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202

Query: 436 PEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV 495
            E  + Q+ T KSDV+SFGV+L+E++                + V+  Q  +    +   
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNTFDITVYLLQGRRLLQPEYCP 260

Query: 496 DPFLK-AMSCLNDEGIRRPSMSDVVWGLE 523
           DP  +  + C + +   RPS S++V  + 
Sbjct: 261 DPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 5e-52
 Identities = 61/252 (24%), Positives = 103/252 (40%), Gaps = 22/252 (8%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEP---ESQQGALEFQTEIGMLSQLRHLHLVSLI 335
            +G G FG+VY      S   +A+K L     E      + + E+ + S LRH +++ L 
Sbjct: 13  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
           G+ +D   + L+ ++   GT+   L           +        A  L Y H+      
Sbjct: 73  GYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKR---- 126

Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------HLDPEYYRLQQLTEKSD 449
           +IHRD+K  N+LL      K++DFG S   P+S   T      +L PE    +   EK D
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 186

Query: 450 VYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAM--SCLND 507
           ++S GV+ +E L  +P       +       + +      T    V    + +    L  
Sbjct: 187 LWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241

Query: 508 EGIRRPSMSDVV 519
              +RP + +V+
Sbjct: 242 NPSQRPMLREVL 253

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 5e-52
 Identities = 70/262 (26%), Positives = 118/262 (45%), Gaps = 19/262 (7%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL 331
            +   ++ +G G FG+V+ G  NG TT VAIK L+P +      F  E  ++ +LRH  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKL 74

Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V L    +++  + +V ++M++G+L D L       L   Q +++    A G+ Y+    
Sbjct: 75  VQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--- 130

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT---------HLDPEYYRLQ 442
                +HRD++  NIL+ E  V KV+DFGL++    +                PE     
Sbjct: 131 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189

Query: 443 QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-A 501
           + T KSDV+SFG++L E+             ++V   V  ++ Y+     +  +      
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--ERGYRMPCPPECPESLHDLM 247

Query: 502 MSCLNDEGIRRPSMSDVVWGLE 523
             C   E   RP+   +   LE
Sbjct: 248 CQCWRKEPEERPTFEYLQAFLE 269

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 9e-52
 Identities = 64/262 (24%), Positives = 110/262 (41%), Gaps = 19/262 (7%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL 331
            +      +G G FG V  G   G    VAIK ++  S     EF  E  ++  L H  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKL 61

Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V L G C   R + ++ ++MA G L ++L           Q LE+C      + YL    
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE--- 117

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------LDPEYYRLQ 442
                +HRD+   N L++++ V KVSDFGLS++       +            PE     
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 443 QLTEKSDVYSFGVVLFEVL-CARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKA 501
           + + KSD+++FGV+++E+    +    R    +         + Y+     + V   +  
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY- 235

Query: 502 MSCLNDEGIRRPSMSDVVWGLE 523
            SC +++   RP+   ++  + 
Sbjct: 236 -SCWHEKADERPTFKILLSNIL 256

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 3e-51
 Identities = 59/255 (23%), Positives = 101/255 (39%), Gaps = 22/255 (8%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            +G G FG VYK     ++   A K ++ +S++   ++  EI +L+   H ++V L+   
Sbjct: 19  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
             +  + ++ +F A G + D +      PL  +Q   +C      L+YLH       IIH
Sbjct: 79  YYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLH----DNKIIH 133

Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQL-----T 445
           RD+K  NIL       K++DFG+S     ++ +          + PE    +        
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 193

Query: 446 EKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKA--MS 503
            K+DV+S G+ L E+    P        +   L   A+                K     
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHELNPMRV--LLKIAKSEPPTLAQPSRWSSNFKDFLKK 251

Query: 504 CLNDEGIRRPSMSDV 518
           CL      R + S +
Sbjct: 252 CLEKNVDARWTTSQL 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 6e-51
 Identities = 67/263 (25%), Positives = 108/263 (41%), Gaps = 25/263 (9%)

Query: 277 DLVIGVGGFGDVYKGFINGSTT--PVAIKRLEPESQQGAL--EFQTEIGMLSQLRHLHLV 332
           D  +G G FG V KG+         VA+K L+ E+   AL  E   E  ++ QL + ++V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            +IG C  +   +LV +    G L  +L    N  +     +E+    + G+ YL     
Sbjct: 72  RMIGICEAE-SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLE---- 124

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH-----------LDPEYYRL 441
            +  +HRD+   N+LL  +  AK+SDFGLSK      +                PE    
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 442 QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK- 500
            + + KSDV+SFGV+++E         R     +V+  +  ++  + G            
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML--EKGERMGCPAGCPREMYDL 242

Query: 501 AMSCLNDEGIRRPSMSDVVWGLE 523
              C   +   RP  + V   L 
Sbjct: 243 MNLCWTYDVENRPGFAAVELRLR 265

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 8e-51
 Identities = 76/288 (26%), Positives = 123/288 (42%), Gaps = 32/288 (11%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFI--NGSTTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-R 327
           N+     VIG G FG V K  I  +G     AIKR++   S+    +F  E+ +L +L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLY--------------HSDNPPLPWNQR 373
           H ++++L+G C     + L  ++   G L D L               +S    L   Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 374 LEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH 433
           L      ARG+ YL         IHRD+   NIL+ E +VAK++DFGLS+     V KT 
Sbjct: 130 LHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 185

Query: 434 -------LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCY 486
                  +  E       T  SDV+S+GV+L+E++    +        ++   +   Q Y
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--QGY 243

Query: 487 QNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQLQESSI 533
           +        D        C  ++   RPS + ++  L   L+ +++ +
Sbjct: 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  174 bits (442), Expect = 2e-50
 Identities = 73/300 (24%), Positives = 122/300 (40%), Gaps = 45/300 (15%)

Query: 263 SLSEIQAATNNFDNDLVIGVGGFGDVYKGFINGST-----TPVAIKRLEPESQQGAL-EF 316
            L  ++   NN +    IG G FG V++    G       T VA+K L+ E+      +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 317 QTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSD------------ 364
           Q E  ++++  + ++V L+G C   + M L++++MA G L + L                
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 365 ----------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVA 414
                      PPL   ++L I    A G+ YL         +HRD+ T N L+ E  V 
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS----ERKFVHRDLATRNCLVGENMVV 179

Query: 415 KVSDFGLSKF----------GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR 464
           K++DFGLS+           G  ++    + PE     + T +SDV+++GVVL+E+    
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

Query: 465 PSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE 523
                  A ++V   V  +        +            C +     RPS   +   L+
Sbjct: 240 LQPYYGMAHEEVIYYV--RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 3e-50
 Identities = 53/256 (20%), Positives = 95/256 (37%), Gaps = 17/256 (6%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL--EFQTEIGMLSQLRHLHLVSLIG 336
            IG G +G   K         +  K L+  S   A      +E+ +L +L+H ++V    
Sbjct: 11  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70

Query: 337 FCND--DREMILVYDFMARGTLPDHLYHS--DNPPLPWNQRLEICIGAARGLHYLHT-GA 391
              D  +  + +V ++   G L   +     +   L     L +       L   H    
Sbjct: 71  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130

Query: 392 NHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQ 443
               ++HRD+K  N+ LD K   K+ DFGL++      S           + PE      
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS 190

Query: 444 LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS 503
             EKSD++S G +L+E+    P     + K+        +           ++  +    
Sbjct: 191 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIIT--R 248

Query: 504 CLNDEGIRRPSMSDVV 519
            LN +   RPS+ +++
Sbjct: 249 MLNLKDYHRPSVEEIL 264

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  169 bits (430), Expect = 2e-48
 Identities = 72/285 (25%), Positives = 113/285 (39%), Gaps = 23/285 (8%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQG---ALEFQTEIGMLSQLRHLHLVSLI 335
            IG G FG VY      ++  VAIK++    +Q      +   E+  L +LRH + +   
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
           G    +    LV ++           H    PL   +   +  GA +GL YLH       
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLH----SHN 135

Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT----HLDPEYYRLQ---QLTEKS 448
           +IHRDVK  NILL E  + K+ DFG +     + S       + PE        Q   K 
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKV 195

Query: 449 DVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQ-CYQNGTIDQIVDPFLKAMSCLND 507
           DV+S G+   E+   +P +    A   +      +    Q+G   +    F+   SCL  
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD--SCLQK 253

Query: 508 EGIRRPSMSDVVWGLEFSLQLQESSIAIAKE-IDENEEEEKLLDN 551
               RP+   +   L+    L+E    +  + I   ++  + LDN
Sbjct: 254 IPQDRPTSEVL---LKHRFVLRERPPTVIMDLIQRTKDAVRELDN 295

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 1e-47
 Identities = 53/250 (21%), Positives = 102/250 (40%), Gaps = 19/250 (7%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            IG G  G VY      +   VAI+++  + Q        EI ++ + ++ ++V+ +   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
               E+ +V +++A G+L D +  +    +   Q   +C    + L +LH       +IH
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH----SNQVIH 139

Query: 399 RDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLTEKSDV 450
           RD+K+ NILL      K++DFG         SK          + PE    +    K D+
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199

Query: 451 YSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKA--MSCLNDE 508
           +S G++  E++   P           +L + A          + +    +     CL+ +
Sbjct: 200 WSLGIMAIEMIEGEP--PYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257

Query: 509 GIRRPSMSDV 518
             +R S  ++
Sbjct: 258 VEKRGSAKEL 267

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 1e-47
 Identities = 62/288 (21%), Positives = 114/288 (39%), Gaps = 41/288 (14%)

Query: 279 VIGVGGFGDVYKGFING-----STTPVAIKRLEPESQQGALE-FQTEIGMLSQL-RHLHL 331
            +G G FG V +    G     +   VA+K L+P +     E   +E+ +LS L  H+++
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHS----------------DNPPLPWNQRLE 375
           V+L+G C      +++ ++   G L + L                   D   L     L 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 376 ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT--- 432
                A+G+ +L         IHRD+   NILL    + K+ DFGL++      +     
Sbjct: 150 FSYQVAKGMAFLA----SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 433 -------HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC 485
                   + PE       T +SDV+S+G+ L+E+     S                ++ 
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-YPGMPVDSKFYKMIKEG 264

Query: 486 YQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQLQESS 532
           ++  + +           +C + + ++RP+   +V  +E   Q+ ES+
Sbjct: 265 FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK--QISEST 310

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 2e-47
 Identities = 64/322 (19%), Positives = 119/322 (36%), Gaps = 52/322 (16%)

Query: 241 KTIKATKSSRGSFLPSDLCTQFSLS---EIQAATNNFDNDLVIGVGGFGDVYKGFI---- 293
           + ++ T SS   +   D   ++      E      N +   V+G G FG V         
Sbjct: 6   QMVQVTGSSDNEYFYVDF-REYEYDLKWEFPR--ENLEFGKVLGSGAFGKVMNATAYGIS 62

Query: 294 -NGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQL-RHLHLVSLIGFCNDDREMILVYDF 350
             G +  VA+K L+ ++     E   +E+ M++QL  H ++V+L+G C     + L++++
Sbjct: 63  KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEY 122

Query: 351 MARGTLPDHLY---------------------HSDNPPLPWNQRLEICIGAARGLHYLHT 389
              G L ++L                        D   L +   L      A+G+ +L  
Sbjct: 123 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE- 181

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT----------HLDPEYY 439
                  +HRD+   N+L+    V K+ DFGL++   +  +             + PE  
Sbjct: 182 ---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238

Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL 499
                T KSDV+S+G++L+E+     +             +                  +
Sbjct: 239 FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG--FKMDQPFYATEEI 296

Query: 500 K--AMSCLNDEGIRRPSMSDVV 519
                SC   +  +RPS  ++ 
Sbjct: 297 YIIMQSCWAFDSRKRPSFPNLT 318

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-47
 Identities = 57/267 (21%), Positives = 98/267 (36%), Gaps = 22/267 (8%)

Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSL 334
            IG G FGDV++G           VAIK  +  +     E F  E   + Q  H H+V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
           IG   ++  + ++ +    G L           L     +      +  L YL       
Sbjct: 74  IGVITENP-VWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLE----SK 127

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------LDPEYYRLQQLT 445
             +HRD+   N+L+      K+ DFGLS++   S              + PE    ++ T
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187

Query: 446 EKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMSC 504
             SDV+ FGV ++E+L               +      ++          +   +    C
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT--KC 245

Query: 505 LNDEGIRRPSMSDVVWGLEFSLQLQES 531
              +  RRP  +++   L   L+ +++
Sbjct: 246 WAYDPSRRPRFTELKAQLSTILEEEKA 272

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 3e-46
 Identities = 60/274 (21%), Positives = 107/274 (39%), Gaps = 26/274 (9%)

Query: 279 VIGVGGFGDVYKGFINGS----TTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVS 333
           V+G G FG VYKG           PVAIK L    S +   E   E  +++ + + H+  
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L+G C       L+   M  G L D+        +     L  C+  A+G++YL      
Sbjct: 76  LLGICLTSTVQ-LITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLE----D 129

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH----------LDPEYYRLQQ 443
             ++HRD+   N+L+      K++DFGL+K       + H          +  E    + 
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189

Query: 444 LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--A 501
            T +SDV+S+GV ++E++             ++S  +      +      I    +    
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---ERLPQPPICTIDVYMIM 246

Query: 502 MSCLNDEGIRRPSMSDVVWGLEFSLQLQESSIAI 535
           + C   +   RP   +++       +  +  + I
Sbjct: 247 VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 280

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 3e-46
 Identities = 58/269 (21%), Positives = 99/269 (36%), Gaps = 28/269 (10%)

Query: 279 VIGVGGFGDVYKGFI---NGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLV 332
            +G G FG V +G     +G T  VA+K L+P+     +   +F  E+  +  L H +L+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
            L G       M +V +    G+L D                   +  A G+ YL     
Sbjct: 75  RLYGVVLTP-PMKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLE---- 128

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH-----------LDPEYYRL 441
               IHRD+   N+LL  + + K+ DFGL +  P +                  PE  + 
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188

Query: 442 QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK- 500
           +  +  SD + FGV L+E+              Q+   +  +   +    +         
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG-ERLPRPEDCPQDIYNV 247

Query: 501 AMSCLNDEGIRRPSMSDVVWGLEFSLQLQ 529
            + C   +   RP+   +    +F L+ Q
Sbjct: 248 MVQCWAHKPEDRPTFVALR---DFLLEAQ 273

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 4e-46
 Identities = 57/254 (22%), Positives = 101/254 (39%), Gaps = 22/254 (8%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSLIGF 337
            +G G +G+V       +   VA+K ++ +      E  + EI +   L H ++V   G 
Sbjct: 12  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
             +     L  ++ + G L D +    +  +P             G+ YLH       I 
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH----GIGIT 125

Query: 398 HRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH----------LDPEYYRLQQL-TE 446
           HRD+K  N+LLDE+   K+SDFGL+     +  +            + PE  + ++   E
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185

Query: 447 KSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKA--MSC 504
             DV+S G+VL  +L       + +   Q       ++ Y N    + +D    A     
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN--PWKKIDSAPLALLHKI 243

Query: 505 LNDEGIRRPSMSDV 518
           L +    R ++ D+
Sbjct: 244 LVENPSARITIPDI 257

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  163 bits (413), Expect = 8e-46
 Identities = 57/295 (19%), Positives = 113/295 (38%), Gaps = 18/295 (6%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHL 331
           +++D    +G G FG V++     +    A K +    +      + EI  +S LRH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 332 VSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGA 391
           V+L     DD EM+++Y+FM+ G L + +    N  +  ++ +E      +GL ++H   
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH--- 141

Query: 392 NHAVIIHRDVKTTNILLDEKW--VAKVSDFGLSKFGPTSVSKTH-------LDPEYYRLQ 442
                +H D+K  NI+   K     K+ DFGL+       S            PE    +
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 200

Query: 443 QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAM 502
            +   +D++S GV+ + +L            + +           +     I +     +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260

Query: 503 S-CLNDEGIRRPSMSDVV---WGLEFSLQLQESSIAIAKEIDENEEEEKLLDNYE 553
              L  +   R ++   +   W    +   ++S I  ++     +  +   D + 
Sbjct: 261 RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWP 315

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  158 bits (400), Expect = 6e-44
 Identities = 48/250 (19%), Positives = 98/250 (39%), Gaps = 15/250 (6%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            +G G FG V++     +      K +           + EI +++QL H  L++L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
            D  EM+L+ +F++ G L D +  +++  +   + +     A  GL ++H       I+H
Sbjct: 96  EDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVH 150

Query: 399 RDVKTTNILLDEK--WVAKVSDFGLSKF-------GPTSVSKTHLDPEYYRLQQLTEKSD 449
            D+K  NI+ + K     K+ DFGL+           T+ +     PE    + +   +D
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTD 210

Query: 450 VYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS-CLNDE 508
           +++ GV+ + +L            + +         +       +       +   L  E
Sbjct: 211 MWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKE 270

Query: 509 GIRRPSMSDV 518
             +R ++ D 
Sbjct: 271 PRKRLTVHDA 280

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 7e-43
 Identities = 48/255 (18%), Positives = 92/255 (36%), Gaps = 26/255 (10%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLI 335
           ++G G F  V       ++   AIK LE      +        E  ++S+L H   V L 
Sbjct: 15  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74

Query: 336 GFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAV 395
               DD ++     +   G L  ++                       L YLH       
Sbjct: 75  FTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH----GKG 128

Query: 396 IIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH----------LDPEYYRLQQLT 445
           IIHRD+K  NILL+E    +++DFG +K       +            + PE    +   
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188

Query: 446 EKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAM--S 503
           + SD+++ G ++++++   P     A  + +   ++ +         +   P  + +   
Sbjct: 189 KSSDLWALGCIIYQLVAGLP--PFRAGNEYL---IFQKIIKLEYDFPEKFFPKARDLVEK 243

Query: 504 CLNDEGIRRPSMSDV 518
            L  +  +R    ++
Sbjct: 244 LLVLDATKRLGCEEM 258

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 8e-43
 Identities = 62/281 (22%), Positives = 113/281 (40%), Gaps = 31/281 (11%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPE-SQQGALEFQTEIGMLSQ 325
                   +G G FG VY+G   G       T VAIK +    S +  +EF  E  ++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDN--------PPLPWNQRLEIC 377
               H+V L+G  +  +  +++ + M RG L  +L              P   ++ +++ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 378 IGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT----- 432
              A G+ YL+        +HRD+   N ++ E +  K+ DFG+++    +         
Sbjct: 140 GEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 433 -----HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQ 487
                 + PE  +    T  SDV+SFGVVL+E+        +  + +QV   V   +   
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV--MEGGL 253

Query: 488 NGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ 527
               D   D   +    C       RPS  +++  ++  ++
Sbjct: 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 6e-42
 Identities = 60/284 (21%), Positives = 119/284 (41%), Gaps = 40/284 (14%)

Query: 279 VIGVGGFGDVYKGFING-------STTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHL 329
            +G G FG V      G         T VA+K L+ + +++   +  +E+ M+  + +H 
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLY--------------HSDNPPLPWNQRLE 375
           ++++L+G C  D  + ++ ++ ++G L ++L               H+    L     + 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 376 ICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH-- 433
                ARG+ YL         IHRD+   N+L+ E  V K++DFGL++            
Sbjct: 140 CAYQVARGMEYLA----SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 434 --------LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC 485
                   + PE    +  T +SDV+SFGV+L+E+     S       +++   +  ++ 
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--KEG 253

Query: 486 YQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQL 528
           ++        +        C +    +RP+   +V  L+  + L
Sbjct: 254 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 7e-42
 Identities = 41/250 (16%), Positives = 101/250 (40%), Gaps = 16/250 (6%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            +G G FG V++     S      K ++ +     L  + EI +L+  RH +++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESF 70

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
               E++++++F++   + + + ++    L   + +         L +LH       I H
Sbjct: 71  ESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLH----SHNIGH 125

Query: 399 RDVKTTNILLDEK--WVAKVSDFGLSKF-------GPTSVSKTHLDPEYYRLQQLTEKSD 449
            D++  NI+   +     K+ +FG ++             +  +  PE ++   ++  +D
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATD 185

Query: 450 VYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS-CLNDE 508
           ++S G +++ +L      L    ++ +   + A+  +      +I    +  +   L  E
Sbjct: 186 MWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKE 245

Query: 509 GIRRPSMSDV 518
              R + S+ 
Sbjct: 246 RKSRMTASEA 255

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (377), Expect = 4e-41
 Identities = 62/285 (21%), Positives = 116/285 (40%), Gaps = 21/285 (7%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHLHLVSLIGF 337
           V+G G F +V       +   VAIK +  ++ +G     + EI +L +++H ++V+L   
Sbjct: 16  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
                 + L+   ++ G L D +               +       + YLH       I+
Sbjct: 76  YESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLH----DLGIV 129

Query: 398 HRDVKTTNILL---DEKWVAKVSDFGLSKF-GPTSVSKT------HLDPEYYRLQQLTEK 447
           HRD+K  N+L    DE     +SDFGLSK   P SV  T      ++ PE    +  ++ 
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189

Query: 448 SDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS-CLN 506
            D +S GV+ + +LC  P        K     + A+  + +   D I D     +   + 
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLME 249

Query: 507 DEGIRRPSMSDVV---WGLEFSLQLQESSIAIAKEIDENEEEEKL 548
            +  +R +    +   W    +   +    +++++I +N  + K 
Sbjct: 250 KDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKW 294

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  150 bits (379), Expect = 8e-41
 Identities = 55/259 (21%), Positives = 99/259 (38%), Gaps = 23/259 (8%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEP------ESQQGALEFQTEIGMLSQ 325
           N+F    +IG GGFG+VY      +    A+K L+       + +  AL  +  + ++S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 326 LRHLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLH 385
                +V +    +   ++  + D M  G L  HL  S +                 GL 
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLE 121

Query: 386 YLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK-FGPTSVSKTHLDPEYYRLQQL 444
           ++H    +  +++RD+K  NILLDE    ++SD GL+  F       +     Y   + L
Sbjct: 122 HMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL 177

Query: 445 ------TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF 498
                    +D +S G +LF++L       +   K +    +          +     P 
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMAVELPDSFSPE 235

Query: 499 LKAM--SCLNDEGIRRPSM 515
           L+++    L  +  RR   
Sbjct: 236 LRSLLEGLLQRDVNRRLGC 254

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  147 bits (372), Expect = 1e-40
 Identities = 52/264 (19%), Positives = 100/264 (37%), Gaps = 30/264 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEP---------ESQQGALEFQTEIGMLSQLR-H 328
           ++G G    V +     +    A+K ++          E Q+       E+ +L ++  H
Sbjct: 10  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69

Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
            +++ L      +    LV+D M +G L D+L  ++   L   +  +I       +  LH
Sbjct: 70  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICALH 127

Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-------HLDPEYYRL 441
                  I+HRD+K  NILLD+    K++DFG S                 +L PE    
Sbjct: 128 ----KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 183

Query: 442 QQL------TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV 495
                     ++ D++S GV+++ +L   P          + + +     + +   D   
Sbjct: 184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 243

Query: 496 DPFLKAMS-CLNDEGIRRPSMSDV 518
           D     +S  L  +  +R +  + 
Sbjct: 244 DTVKDLVSRFLVVQPQKRYTAEEA 267

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  146 bits (368), Expect = 8e-40
 Identities = 64/318 (20%), Positives = 118/318 (37%), Gaps = 34/318 (10%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRH 328
            +F     +G G FG V+      +    A+K L+ E     +       E  MLS + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
             ++ + G   D +++ ++ D++  G L   L    +   P              L YLH
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLH 121

Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT-----HLDPEYYRLQQ 443
                  II+RD+K  NILLD+    K++DFG +K+ P           ++ PE    + 
Sbjct: 122 ----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKP 177

Query: 444 LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS 503
             +  D +SFG++++E+L        +   K     + A+  +     + + D  L  + 
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD-LLSRLI 236

Query: 504 CLN------------DEGIRRPSMSDVVWGLEFSLQLQ-------ESSIAIAKEIDENEE 544
             +            ++    P   +VVW    S  ++       +       + D+  E
Sbjct: 237 TRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPE 296

Query: 545 EEKLLDNYETDGSGPVFS 562
           E+        D    +F 
Sbjct: 297 EDINYGVQGEDPYADLFR 314

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-39
 Identities = 67/286 (23%), Positives = 109/286 (38%), Gaps = 46/286 (16%)

Query: 279 VIGVGGFGDVYKGFINGST-----TPVAIKRLEPESQQGALE--FQTEIGMLSQLRHLHL 331
            +G G FG V +    G         VA+K L+  +              ++    HL++
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 332 VSLIGFC-NDDREMILVYDFMARGTLPDHLYHSDNP--------------PLPWNQRLEI 376
           V+L+G C      ++++ +F   G L  +L    N                L     +  
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 377 CIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--- 433
               A+G+ +L         IHRD+   NILL EK V K+ DFGL++             
Sbjct: 140 SFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 434 -------LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCY 486
                  + PE    +  T +SDV+SFGV+L+E+     S         V +     +  
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKIDEEFCRRL 250

Query: 487 QNGTIDQIVDPFLK-----AMSCLNDEGIRRPSMSDVVWGLEFSLQ 527
           + GT  +  D          + C + E  +RP+ S++V  L   LQ
Sbjct: 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  141 bits (356), Expect = 1e-38
 Identities = 60/274 (21%), Positives = 108/274 (39%), Gaps = 28/274 (10%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLR 327
           ++ ++   ++G GG  +V+          VA+K L  +        L F+ E    + L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 328 HLHLVSLIGFCNDDRE----MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARG 383
           H  +V++      +        +V +++   TL D ++     P+   + +E+   A + 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQA 123

Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------- 433
           L++ H       IIHRDVK  NI++      KV DFG+++    S +             
Sbjct: 124 LNFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 434 -LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID 492
            L PE  R   +  +SDVYS G VL+EVL   P      +   V+     +         
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP-PFTGDSPVSVAYQHVREDPIPPSARH 238

Query: 493 QIVDPFLKA--MSCLNDEGIRRP-SMSDVVWGLE 523
           + +   L A  +  L      R  + +++   L 
Sbjct: 239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-37
 Identities = 47/204 (23%), Positives = 88/204 (43%), Gaps = 16/204 (7%)

Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHLH 330
           NF     IG G +G VYK     +   VA+K  RL+ E++        EI +L +L H +
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           +V L+   + + ++ LV++F+ +      +  S    +P            +GL + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHL---------DPEYYRL 441
                ++HRD+K  N+L++ +   K++DFGL++     V                     
Sbjct: 120 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 442 QQLTEKSDVYSFGVVLFEVLCARP 465
           +  +   D++S G +  E++  R 
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA 201

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 4e-37
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 20/201 (9%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-----FQTEIGMLSQLRHLHLVS 333
            +G G F  VYK     +   VAIK+++   +  A +        EI +L +L H +++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 334 LIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
           L+        + LV+DFM        +   ++  L  +      +   +GL YLH     
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH----Q 118

Query: 394 AVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTS--------VSKTHLDPEYYRLQQL- 444
             I+HRD+K  N+LLDE  V K++DFGL+K   +         V++ +  PE     ++ 
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 445 TEKSDVYSFGVVLFEVLCARP 465
               D+++ G +L E+L   P
Sbjct: 179 GVGVDMWAVGCILAELLLRVP 199

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 7e-37
 Identities = 54/253 (21%), Positives = 94/253 (37%), Gaps = 25/253 (9%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLS-QLRHLHLVSL 334
           ++G G FG V+      +    AIK L+ +             E  +LS    H  L  +
Sbjct: 9   MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68

Query: 335 IGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
                    +  V +++  G L  H+          ++          GL +LH      
Sbjct: 69  FCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLH----SK 122

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH--------LDPEYYRLQQLTE 446
            I++RD+K  NILLD+    K++DFG+ K      +KT+        + PE    Q+   
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNH 182

Query: 447 KSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKA--MSC 504
             D +SFGV+L+E+L  +          Q    ++      N    + ++   K   +  
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPF-----HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237

Query: 505 LNDEGIRRPSMSD 517
              E  +R  +  
Sbjct: 238 FVREPEKRLGVRG 250

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  136 bits (342), Expect = 2e-36
 Identities = 44/268 (16%), Positives = 89/268 (33%), Gaps = 30/268 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFC 338
            IG G FGD+Y G    +   VAIK    +++    +   E  +   ++    +  I +C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGVGIPTIRWC 71

Query: 339 NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIH 398
             + +  ++   +   +L + L++  +        L +       + Y+H        IH
Sbjct: 72  GAEGDYNVMVMELLGPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIH 126

Query: 399 RDVKTTNIL---LDEKWVAKVSDFGLSKFGPTSVSKTHLD---------------PEYYR 440
           RDVK  N L     +  +  + DFGL+K    + +  H+                   + 
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 441 LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK 500
             + + + D+ S G VL              A  +        +   +  I+ +   +  
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPS 246

Query: 501 AM-----SCLNDEGIRRPSMSDVVWGLE 523
                   C +     +P  S +     
Sbjct: 247 EFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 6e-36
 Identities = 55/302 (18%), Positives = 127/302 (42%), Gaps = 37/302 (12%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGF 337
           V+G+G  G V + F   +    A+K L+   +      + E+ +  +  +  H+V ++  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73

Query: 338 CND----DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANH 393
             +     + +++V + +  G L   +    +      +  EI       + YLH     
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----S 129

Query: 394 AVIIHRDVKTTNILLDEKW---VAKVSDFGLSKFGPTSVSKTHLD-------PEYYRLQQ 443
             I HRDVK  N+L   K    + K++DFG +K   +  S T          PE    ++
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 189

Query: 444 LTEKSDVYSFGVVLFEVLCARP-------SILRTAAKKQVSLAVWAQQCYQNGTIDQIVD 496
             +  D++S GV+++ +LC  P         +    K ++ +  +     +   + + V 
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK 249

Query: 497 PFLKAMSCLNDEGIRRPSMSDVV---WGLEFSLQLQESSIAIAKEIDENEEEEKLLDNYE 553
             ++  + L  E  +R ++++ +   W ++ S ++ ++ +  ++ + E++E  + +    
Sbjct: 250 MLIR--NLLKTEPTQRMTITEFMNHPWIMQ-STKVPQTPLHTSRVLKEDKERWEDVKEEM 306

Query: 554 TD 555
           T 
Sbjct: 307 TS 308

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  134 bits (338), Expect = 6e-36
 Identities = 43/271 (15%), Positives = 80/271 (29%), Gaps = 34/271 (12%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL-HLVSLIGF 337
            IG G FG +++G    +   VAIK     S     + + E      L     + ++  F
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--QLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVII 397
             +    +LV D +  G   + L                       +  +H       ++
Sbjct: 70  GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLV 123

Query: 398 HRDVKTTNILLDEKWV-----AKVSDFGLSKFGPTSVSKTHLD---------------PE 437
           +RD+K  N L+            V DFG+ KF    V+K H+                  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 438 YYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP 497
            +  ++ + + D+ + G V    L          A           +  Q+  + ++   
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243

Query: 498 FLKAM-----SCLNDEGIRRPSMSDVVWGLE 523
           F +          N      P    +     
Sbjct: 244 FPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 2e-35
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 23/214 (10%)

Query: 270 ATNNFDNDLVIGVGGFGDVYKGF-INGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQL 326
           A   ++    IG G +G V+K   +      VA+KR+  ++  +   L    E+ +L  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 327 ---RHLHLVSLIGFCNDDRE-----MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICI 378
               H ++V L   C   R      + LV++ + +     +L     P +P     ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMF 123

Query: 379 GAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKT------ 432
              RGL +LH       ++HRD+K  NIL+      K++DFGL++     ++ T      
Sbjct: 124 QLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 179

Query: 433 -HLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
            +  PE           D++S G +  E+   +P
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 2e-35
 Identities = 50/209 (23%), Positives = 84/209 (40%), Gaps = 18/209 (8%)

Query: 271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALE-FQTEIGMLSQLRHL 329
              + N   IG G +G V   + N +   VAIK++ P   Q   +    EI +L + RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLP-DHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
           +++ +           +   ++    +  D         L  +          RGL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD-----------PE 437
                A ++HRD+K +N+LL+     K+ DFGL++        T              PE
Sbjct: 127 ----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 438 YYRLQQL-TEKSDVYSFGVVLFEVLCARP 465
                +  T+  D++S G +L E+L  RP
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRP 211

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  132 bits (332), Expect = 3e-35
 Identities = 46/205 (22%), Positives = 84/205 (40%), Gaps = 18/205 (8%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHL 329
             +     IG G +G VYK   N      A+K  RLE E +        EI +L +L+H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 330 HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT 389
           ++V L    +  + ++LV++ + +      L       L         +    G+ Y H 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLK--KLLDVCEGGLESVTAKSFLLQLLNGIAYCH- 117

Query: 390 GANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------LDPEYYR 440
                 ++HRD+K  N+L++ +   K++DFGL++     V K                  
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
            ++ +   D++S G +  E++   P
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTP 199

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 4e-35
 Identities = 48/258 (18%), Positives = 104/258 (40%), Gaps = 24/258 (9%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL------EFQTEIGMLSQLRHLHLV 332
            +G G F  V K     +    A K ++    + +       + + E+ +L +++H +++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 333 SLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
           +L     +  ++IL+ + +A G L D    ++   L   +  E       G++YLH    
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDF--LAEKESLTEEEATEFLKQILNGVYYLH---- 130

Query: 393 HAVIIHRDVKTTNILLDEKWVA----KVSDFGLSKFGPTSVSKTH-------LDPEYYRL 441
              I H D+K  NI+L ++ V     K+ DFGL+          +       + PE    
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 190

Query: 442 QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKA 501
           + L  ++D++S GV+ + +L      L    ++ ++        +++             
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250

Query: 502 MS-CLNDEGIRRPSMSDV 518
           +   L  +  +R ++ D 
Sbjct: 251 IRRLLVKDPKKRMTIQDS 268

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 4e-35
 Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 24/209 (11%)

Query: 273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV 332
           ++ +  VIG G FG VY+  +  S   VAIK++  + +        E+ ++ +L H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76

Query: 333 SLIGFCNDDRE------MILVYDFMARGTLPDHLYHS-DNPPLPWNQRLEICIGAARGLH 385
            L  F     E      + LV D++         ++S     LP            R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 386 YLHTGANHAVIIHRDVKTTNILLDEK-WVAKVSDFGLSK-FGPTSVSKTHLDPEYY---- 439
           Y+H+      I HRD+K  N+LLD    V K+ DFG +K       + +++   YY    
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192

Query: 440 ---RLQQLTEKSDVYSFGVVLFEVLCARP 465
                   T   DV+S G VL E+L  +P
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 5e-35
 Identities = 48/256 (18%), Positives = 96/256 (37%), Gaps = 30/256 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES------QQGALEFQTEIGMLSQLRHLH-- 330
           ++G GGFG VY G       PVAIK +E +                E+ +L ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 331 LVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
           ++ L+ +       +L+ +           + ++   L               + + H  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQD-LFDFITERGALQEELARSFFWQVLEAVRHCH-- 127

Query: 391 ANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSVSKT------HLDPEYYRLQQ 443
             +  ++HRD+K  NIL+D  +   K+ DFG       +V         +  PE+ R  +
Sbjct: 128 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 185

Query: 444 L-TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAM 502
                + V+S G++L++++C          ++ +   V+ +Q   +     I        
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDI--PFEHDEEIIRGQVFFRQRVSSECQHLI-------R 236

Query: 503 SCLNDEGIRRPSMSDV 518
            CL      RP+  ++
Sbjct: 237 WCLALRPSDRPTFEEI 252

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 7e-34
 Identities = 51/205 (24%), Positives = 80/205 (39%), Gaps = 17/205 (8%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRH 328
           N+FD   ++G G FG V       +    A+K L  E   ++       TE  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
             L +L         +  V ++   G L  HL           +           L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLH 122

Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD---PEY-----YR 440
                  +++RD+K  N++LD+    K++DFGL K G +  +        PEY       
Sbjct: 123 ----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 441 LQQLTEKSDVYSFGVVLFEVLCARP 465
                   D +  GVV++E++C R 
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRL 203

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (326), Expect = 1e-33
 Identities = 49/258 (18%), Positives = 95/258 (36%), Gaps = 18/258 (6%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRH 328
           + FD    +G G FG V       S    A+K L+ +     +       E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
             LV L     D+  + +V +++A G +  HL                         YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLH 158

Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH-----LDPEYYRLQQ 443
                  +I+RD+K  N+L+D++   +V+DFG +K               L PE    + 
Sbjct: 159 ----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKG 214

Query: 444 LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLKAMS 503
             +  D ++ GV+++E+    P         Q+   + + +          +   L+ + 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYP-PFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273

Query: 504 CLNDE---GIRRPSMSDV 518
            ++     G  +  ++D+
Sbjct: 274 QVDLTKRFGNLKNGVNDI 291

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 4e-33
 Identities = 43/198 (21%), Positives = 82/198 (41%), Gaps = 17/198 (8%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIK--RLEPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
            IG G +G V+K     +   VA+K  RL+ + +        EI +L +L+H ++V L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVI 396
             + D+++ LV++F  +           N  L             +GL + H       +
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCH----SRNV 122

Query: 397 IHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTH---------LDPEYYRLQQLTEK 447
           +HRD+K  N+L++     K+++FGL++     V                  +  +  +  
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182

Query: 448 SDVYSFGVVLFEVLCARP 465
            D++S G +  E+  A  
Sbjct: 183 IDMWSAGCIFAELANAGR 200

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 3e-32
 Identities = 44/197 (22%), Positives = 83/197 (42%), Gaps = 14/197 (7%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIG 336
            +G G +G V       +   VAIK+L     S+  A     E+ +L  +RH +++ L+ 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 337 FCNDDREMILVYDFMARGTLPDHLYHS--DNPPLPWNQRLEICIGAARGLHYLHTGANHA 394
               D  +    DF                +  L  ++   +     +GL Y+H     A
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH----AA 140

Query: 395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYY------RLQQLTEKS 448
            IIHRD+K  N+ ++E    K+ DFGL++   + ++   +   Y          + T+  
Sbjct: 141 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTV 200

Query: 449 DVYSFGVVLFEVLCARP 465
           D++S G ++ E++  + 
Sbjct: 201 DIWSVGCIMAEMITGKT 217

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 2e-31
 Identities = 48/217 (22%), Positives = 89/217 (41%), Gaps = 29/217 (13%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGAL--EFQTEIGMLSQLRHL 329
           + ++    IG G FG+V+K     +   VA+K++  E+++         EI +L  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 330 HLVSLIGFCND--------DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAA 381
           ++V+LI  C             + LV+DF         L  +       ++   +     
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA--GLLSNVLVKFTLSEIKRVMQMLL 127

Query: 382 RGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLD------ 435
            GL+Y+H       I+HRD+K  N+L+    V K++DFGL++    + +           
Sbjct: 128 NGLYYIH----RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 436 -PEYYRLQQL------TEKSDVYSFGVVLFEVLCARP 465
              Y   + L          D++  G ++ E+    P
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 6e-28
 Identities = 55/266 (20%), Positives = 95/266 (35%), Gaps = 28/266 (10%)

Query: 272 NNFDNDLVIGVGGFGDVYKG---FINGSTTPVAIKRLEP----ESQQGALEFQTEIGMLS 324
            NF+   V+G G +G V+       + +    A+K L+     +  +     +TE  +L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 325 QLRHL-HLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARG 383
            +R    LV+L      + ++ L+ D++  G L  HL          ++           
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLA 141

Query: 384 LHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF----GPTSVSKTHLDPEYY 439
           L +LH       II+RD+K  NILLD      ++DFGLSK                 EY 
Sbjct: 142 LEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 440 RLQQL-------TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID 492
               +        +  D +S GV+++E+L           +K     +  +         
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS-PFTVDGEKNSQAEISRRILKSEPPYP 256

Query: 493 QIVDPFLKA--MSCLNDEGIRRPSMS 516
           Q +    K      L  +  +R    
Sbjct: 257 QEMSALAKDLIQRLLMKDPKKRLGCG 282

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 1e-27
 Identities = 42/199 (21%), Positives = 80/199 (40%), Gaps = 18/199 (9%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRL--EPESQQGALEFQTEIGMLSQLRHLHLVSLIG 336
            +G G +G V   F   +   VA+K+L    +S   A     E+ +L  ++H +++ L+ 
Sbjct: 25  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84

Query: 337 FCNDDREMILVYDFM----ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN 392
                R +    D        G   +++       L  +    +     RGL Y+H+   
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADI 142

Query: 393 HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDPEYY------RLQQLTE 446
                HRD+K +N+ ++E    K+ DFGL++     ++       Y             +
Sbjct: 143 I----HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 198

Query: 447 KSDVYSFGVVLFEVLCARP 465
             D++S G ++ E+L  R 
Sbjct: 199 TVDIWSVGCIMAELLTGRT 217

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  109 bits (274), Expect = 5e-27
 Identities = 38/206 (18%), Positives = 78/206 (37%), Gaps = 24/206 (11%)

Query: 272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLH 330
           +++     +G G + +V++     +   V +K L+P  ++   + + EI +L  LR   +
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91

Query: 331 LVSLIGFCND--DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
           +++L     D   R   LV++ +                L             + L Y H
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH 146

Query: 389 TGANHAVIIHRDVKTTNILLDEK-WVAKVSDFGLSKFGPTSVSKTH--------LDPEYY 439
                  I+HRDVK  N+++D +    ++ D+GL++F                       
Sbjct: 147 ----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 202

Query: 440 RLQQLTEKSDVYSFGVVLFEVLCARP 465
             Q      D++S G +L  ++  + 
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKE 228

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 6e-27
 Identities = 46/202 (22%), Positives = 80/202 (39%), Gaps = 24/202 (11%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIG 336
            IG G  G V   +       VAIK+L     +Q  A     E+ ++  + H +++SL+ 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 337 FC------NDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG 390
                    + +++ LV + M                    +   +      G+ +LH  
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLH-- 136

Query: 391 ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHL-------DPEYYRLQQ 443
              A IIHRD+K +NI++      K+ DFGL++   TS   T          PE      
Sbjct: 137 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194

Query: 444 LTEKSDVYSFGVVLFEVLCARP 465
             E  D++S G ++ E++  + 
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKI 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 99.3 bits (246), Expect = 4e-23
 Identities = 35/212 (16%), Positives = 71/212 (33%), Gaps = 29/212 (13%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHL--------- 329
            +G G F  V+      + T VA+K +  +        + EI +L ++            
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMG 78

Query: 330 --HLVSLIGFCNDDREMILVYDFMARGTLPDHLYH---SDNPPLPWNQRLEICIGAARGL 384
             H++ L+   N      +    +      + L      ++  +P     +I      GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 385 HYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGPTSVSKT----------H 433
            Y+H       IIH D+K  N+L++       +    ++  G                 +
Sbjct: 139 DYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 434 LDPEYYRLQQLTEKSDVYSFGVVLFEVLCARP 465
             PE          +D++S   ++FE++    
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDF 227

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 84.4 bits (208), Expect = 2e-19
 Identities = 28/190 (14%), Positives = 58/190 (30%), Gaps = 28/190 (14%)

Query: 279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPES----------QQGALEFQTEIGMLSQLRH 328
           ++G G    V+    +       +K  +               G L F       ++   
Sbjct: 7   LMGEGKESAVFNC-YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 329 LHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLH 388
             L  L G       +  VY +     L + +   +   +      E+       +   +
Sbjct: 66  RALQKLQGLA-----VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 389 TGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPTSVSKTHLDP------EYYRLQ 442
               H  I+H D+   N+L+ E+ +  + DF  S        +  L+        Y+  +
Sbjct: 121 ----HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITYFS-R 174

Query: 443 QLTEKSDVYS 452
               + D+ S
Sbjct: 175 TYRTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	613
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.55
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.96
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.69
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.8
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.61
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.18
d2o14a1	146	Hypothetical protein YxiM {Bacillus subtilis [TaxI	90.0

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-52  Score=428.32  Aligned_cols=260  Identities=26%  Similarity=0.457  Sum_probs=203.4

Q ss_pred             ccCHHHHHHHhcCCC---------CcceeeeeCcEEEEEEEEcCCc---eeEEEEEeCCC-ChhcHHHHHHHHHHHhccC
Q 048439          261 QFSLSEIQAATNNFD---------NDLVIGVGGFGDVYKGFINGST---TPVAIKRLEPE-SQQGALEFQTEIGMLSQLR  327 (613)
Q Consensus       261 ~f~~~el~~at~~f~---------~~~~iG~G~fG~Vy~g~~~~~~---~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~  327 (613)
                      .|+++++..|+.+|.         ..++||+|+||+||+|++..++   ..||||++... .....++|.+|+++|++++
T Consensus         6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~   85 (299)
T d1jpaa_           6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD   85 (299)
T ss_dssp             GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence            356677777776664         3468999999999999986543   35899998765 4455678999999999999


Q ss_pred             ccceeeEEEEeecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCcee
Q 048439          328 HLHLVSLIGFCNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNIL  407 (613)
Q Consensus       328 H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NIL  407 (613)
                      |||||+++|+|.+++.+++|||||++|+|.+++.. ....++|.+++.|+.|||+||+|||+.+    |+||||||+|||
T Consensus        86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~~----iiHrDlKp~NIL  160 (299)
T d1jpaa_          86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMN----YVHRDLAARNIL  160 (299)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEE
T ss_pred             CCCCccEEEEEeeCCEEEEEEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhCC----CccCccccceEE
Confidence            99999999999999999999999999999998854 3456999999999999999999999988    999999999999


Q ss_pred             eCCCCcEEEEecCCCccCC-------------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhh
Q 048439          408 LDEKWVAKVSDFGLSKFGP-------------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAK  473 (613)
Q Consensus       408 l~~~~~~kl~DFGls~~~~-------------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~  473 (613)
                      |++++++||+|||+|+...             ..++..|+|||.+..+.++.++|||||||+||||+| |++||......
T Consensus       161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~  240 (299)
T d1jpaa_         161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ  240 (299)
T ss_dssp             ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999997421             123567999999999999999999999999999998 89999765443


Q ss_pred             hhhhHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          474 KQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       474 ~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                      +..   ..............+.+.+.. +.+||+.||++||||.||++.|+..++.
T Consensus       241 ~~~---~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         241 DVI---NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             HHH---HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHH---HHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            322   222222222222222222222 3389999999999999999999876653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.3e-51  Score=416.98  Aligned_cols=250  Identities=25%  Similarity=0.415  Sum_probs=205.3

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      .++|...+.||+|+||+||+|++..+++.||||+++... ...++|.+|+++|++++|||||+++|+|.+++.+++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            356777789999999999999998888899999997653 4467899999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCCC---
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGPT---  427 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~---  427 (613)
                      |++|+|.+++.......++|..++.|+.|+|+||+|||+.+    |+||||||+||||++++++||+|||+|+....   
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~----iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC----cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            99999999998777788999999999999999999999998    99999999999999999999999999985322   


Q ss_pred             ------CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          428 ------SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       428 ------~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                            .++..|+|||++..+.++.|+|||||||+||||++|..|+........  +...............+.+.+.. 
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~l~~l  248 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDYRMERPEGCPEKVYEL  248 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHHHHhcCCCCCCCccchHHHHHH
Confidence                  134569999999999999999999999999999997766644332222  11212222222222222222222 


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      ..+||+.||++||||.||++.|+..++
T Consensus       249 i~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         249 MRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             HHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            338999999999999999999886554

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-51  Score=411.98  Aligned_cols=244  Identities=27%  Similarity=0.449  Sum_probs=194.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||.||+|++.++ ..||||+++... ...++|.+|++++++++|||||+++|+|.+++..++|||||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~-~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTT-EEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCC-CEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            4677778999999999999999765 679999997643 44578999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++|+|.+++.. ....++|..++.|+.|+|+||+|||+.+    |+||||||+|||+++++++||+|||+|+...     
T Consensus        83 ~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~~----iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          83 EHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             TTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT----CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             CCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhccc----eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            99999999864 3467999999999999999999999998    9999999999999999999999999997421     


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhC-CCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCA-RPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                          ..++..|+|||++..+.++.|+|||||||+||||+|+ ++|+......+.   ........... .+...++.+. 
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~---~~~i~~~~~~~-~p~~~~~~l~~  233 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VEDISTGFRLY-KPRLASTHVYQ  233 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH---HHHHHHTCCCC-CCTTSCHHHHH
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH---HHHHHhcCCCC-CccccCHHHHH
Confidence                2346679999999999999999999999999999995 555543332222   12122221111 2222233322 


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                       +.+||+.||++||||.||+++|+...
T Consensus       234 li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         234 IMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence             23799999999999999999998654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=410.22  Aligned_cols=244  Identities=28%  Similarity=0.507  Sum_probs=196.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|...+.||+|+||+||+|++.+   .||||+++..  +.+..+.|.+|+.+|++++|||||+++|+|.+ +.++||||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            567888899999999999998653   4999998754  45566789999999999999999999999865 56899999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----  425 (613)
                      ||++|+|.+++... ...++|.+++.|+.|||+||+|||+.+    |+||||||+||||++++.+||+|||+|+..    
T Consensus        84 y~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~----ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKS----IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCC----EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            99999999999643 456999999999999999999999988    999999999999999999999999999642    


Q ss_pred             ------CCCCCcccCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcc----
Q 048439          426 ------PTSVSKTHLDPEYYRL---QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID----  492 (613)
Q Consensus       426 ------~~~~~~~~~aPE~~~~---~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~----  492 (613)
                            ...++..|+|||++..   ..++.|+|||||||+||||+||+.||............  .......+...    
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~--~~~~~~~p~~~~~~~  236 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM--VGRGYLSPDLSKVRS  236 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHHTSCCCCGGGSCT
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH--HhcCCCCCcchhccc
Confidence                  2245778999999965   35899999999999999999999999765433322222  12222221111    


Q ss_pred             ccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          493 QIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       493 ~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      .+.+.+.. ..+||+.||.+||||.||+++|+...
T Consensus       237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         237 NCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            12222222 33899999999999999999998544

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=409.94  Aligned_cols=244  Identities=26%  Similarity=0.416  Sum_probs=196.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||.||+|+++++ ..||||+++... ...++|.+|+++|++++|||||+++|+|.+ +..++|||||
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~-~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTT-EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCC-CEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            4677778999999999999998754 679999997643 445689999999999999999999999865 5679999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++|+|.+++.......++|.+++.|+.|||+||+|||+.+    |+||||||+||||++++.+||+|||+|+...     
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~----ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----cccCccchhheeeecccceeeccccceEEccCCccc
Confidence            9999999886554557999999999999999999999988    9999999999999999999999999997432     


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCc-cchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSI-LRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                          ..++..|+|||++..+.++.|+|||||||+||||+||..|+ ......+   +...............+.+.+.. 
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~---~~~~i~~~~~~~~p~~~~~~l~~l  242 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNLERGYRMVRPDNCPEELYQL  242 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH---HHHHHHhcCCCCCcccChHHHHHH
Confidence                23456799999999999999999999999999999965544 3332222   11222221121122222222222 


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      +.+||+.||++||||.+|++.|+..
T Consensus       243 i~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         243 MRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            3389999999999999999998853

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-50  Score=406.71  Aligned_cols=250  Identities=29%  Similarity=0.494  Sum_probs=197.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCc----eeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGST----TPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~----~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      ..|...++||+|+||.||+|.+..++    ..||||+++.. ......+|.+|+.+|++++|||||+++|+|.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            45777889999999999999986543    46999999765 34445679999999999999999999999999999999


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      |||||.+|+|.+++.. ....++|.+++.++.|+|.||+|||+.+    |+||||||+||||+.++++||+|||+|+...
T Consensus        87 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~~----iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMN----YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhccccc----cccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999988754 3467999999999999999999999988    9999999999999999999999999997421


Q ss_pred             -----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          427 -----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       427 -----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                                 ..++..|+|||++..+.++.|+|||||||+||||+++..|+.......+  +...............+.
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~~i~~~~~~~~~~~~~  239 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAINDGFRLPTPMDCP  239 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTCCCCCCTTCB
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HHHHHhccCCCCCchhhH
Confidence                       2346679999999999999999999999999999997655543322221  122222222222222333


Q ss_pred             cHHHH-HhcccccCCCCCCCHHHHHHHHHHhhhh
Q 048439          496 DPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQL  528 (613)
Q Consensus       496 d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~~  528 (613)
                      +.+.. ..+||+.+|++||+|.||++.|+..++.
T Consensus       240 ~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         240 SAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            32222 3389999999999999999999866554

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=409.83  Aligned_cols=246  Identities=23%  Similarity=0.316  Sum_probs=198.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ++|+..+.||+|+||+||+|+...+++.||||+++... .+..+.|.+|+.+|++++|||||++++++.+++..+|||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            46888889999999999999998888999999987653 33445689999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc------
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF------  424 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~------  424 (613)
                      |++|+|.++|.  ....+++.+++.++.|+++||+|||+.+    |+||||||+|||+++++.+||+|||+|+.      
T Consensus        85 ~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~~----IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC----CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            99999999984  3457999999999999999999999998    99999999999999999999999999964      


Q ss_pred             ----CCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH
Q 048439          425 ----GPTSVSKTHLDPEYYRLQQL-TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       425 ----~~~~~~~~~~aPE~~~~~~~-t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                          ....+|+.|+|||++.+..+ +.++|||||||+||||++|++||......... ...+............+.+...
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~  237 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTYLNPWKKIDSAPL  237 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHHHTTCTTSTTGGGSCHHHH
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHHhcCCCCCCccccCCHHHH
Confidence                22346889999999998876 57899999999999999999999654432221 1122211111111222222222


Q ss_pred             H-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          500 K-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       500 ~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      . ..+||+.||++|||+.|++++.++
T Consensus       238 ~li~~~L~~dP~~R~t~~eil~hpwf  263 (271)
T d1nvra_         238 ALLHKILVENPSARITIPDIKKDRWY  263 (271)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCHhh
Confidence            2 227999999999999999876554

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=408.28  Aligned_cols=242  Identities=24%  Similarity=0.346  Sum_probs=202.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||+||+|+...+++.||||++...   .......+.+|+.++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            3688888999999999999999988899999998653   2334567899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      |||++|+|.+++..  ...+++.+++.++.|+++||+|||+++    |+||||||+|||+++++.+||+|||+|+...  
T Consensus        86 Ey~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~~----ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC----eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999954  356999999999999999999999998    9999999999999999999999999997533  


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--  500 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--  500 (613)
                          ..+|..|+|||++.+..++.++|||||||+||||++|++||......+......     .....+++.+++.+.  
T Consensus       160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~-----~~~~~~p~~~s~~~~~l  234 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-----RVEFTFPDFVTEGARDL  234 (263)
T ss_dssp             CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----TTCCCCCTTSCHHHHHH
T ss_pred             cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH-----cCCCCCCccCCHHHHHH
Confidence                245778999999999999999999999999999999999997654433222111     112223333333333  


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ..+||+.||++|||+.|++++...
T Consensus       235 i~~~L~~dp~~R~t~~eil~hp~~  258 (263)
T d2j4za1         235 ISRLLKHNPSQRPMLREVLEHPWI  258 (263)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTCHHH
T ss_pred             HHHHccCCHhHCcCHHHHHcCcCc
Confidence            228999999999999999976553

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-50  Score=406.49  Aligned_cols=244  Identities=25%  Similarity=0.383  Sum_probs=194.9

Q ss_pred             CCCCcc-eeeeeCcEEEEEEEEcC--CceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          273 NFDNDL-VIGVGGFGDVYKGFING--STTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       273 ~f~~~~-~iG~G~fG~Vy~g~~~~--~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      +|.... .||+|+||.||+|.+..  ++..||||+++... ....++|.+|+++|++++|||||+++|+|.+ +.++|||
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm   87 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM   87 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence            444444 49999999999998753  34579999997653 4456789999999999999999999999975 4689999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC--
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP--  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~--  426 (613)
                      |||++|+|.+++.. .+..+++.+++.|+.|+|+||+|||+++    |+||||||+||||++++.+||+|||+|+...  
T Consensus        88 E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~----iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          88 EMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN----FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             ECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC----eecCcCchhheeeccCCceeeccchhhhccccc
Confidence            99999999998743 3457999999999999999999999998    9999999999999999999999999997421  


Q ss_pred             ---------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCcccccc
Q 048439          427 ---------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVD  496 (613)
Q Consensus       427 ---------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  496 (613)
                               ..++..|+|||++..+.++.|+|||||||+||||+| |++||......+....   ............+.+
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~---i~~~~~~~~p~~~~~  239 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---IEQGKRMECPPECPP  239 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH---HHTTCCCCCCTTCCH
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH---HHcCCCCCCCCcCCH
Confidence                     234567999999999999999999999999999998 8999976543322211   111111112222222


Q ss_pred             HHHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          497 PFLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       497 ~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      .+.. ..+||+.+|++||+|.+|++.|+..
T Consensus       240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         240 ELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            2222 3389999999999999999988754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=404.83  Aligned_cols=246  Identities=23%  Similarity=0.299  Sum_probs=202.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      +.|+..+.||+|+||+||+|+...++..||||+++.......+.|.+|+++|++++|||||++++++.+++.++||||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            35777789999999999999999888999999998777777788999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc-------
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF-------  424 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~-------  424 (613)
                      ++|+|.+++... ...+++.++..++.|+++||+|||+++    |+||||||+|||++.++.+||+|||+|+.       
T Consensus        92 ~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~----ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~  166 (288)
T d2jfla1          92 AGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNK----IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  166 (288)
T ss_dssp             TTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred             CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC----EEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence            999999987542 356999999999999999999999998    99999999999999999999999999863       


Q ss_pred             -CCCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          425 -GPTSVSKTHLDPEYYR-----LQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       425 -~~~~~~~~~~aPE~~~-----~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                       ....+++.|+|||++.     ...++.|+|||||||+||||++|++||......+...  ..............-+.+.
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~--~i~~~~~~~~~~~~~~s~~  244 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL--KIAKSEPPTLAQPSRWSSN  244 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH--HHHHSCCCCCSSGGGSCHH
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH--HHHcCCCCCCCccccCCHH
Confidence             3456788999999984     4568999999999999999999999997654433221  1111111111111122222


Q ss_pred             HH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          499 LK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       499 ~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      +.  ..+||+.||.+|||+.|++++...
T Consensus       245 ~~~li~~~L~~dp~~R~t~~ell~hp~~  272 (288)
T d2jfla1         245 FKDFLKKCLEKNVDARWTTSQLLQHPFV  272 (288)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            22  227999999999999999876553

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=405.10  Aligned_cols=244  Identities=21%  Similarity=0.327  Sum_probs=203.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||+||+|+...+++.||||+++.......+.+.+|+.+|++++|||||++++++.+++.++||||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            46888899999999999999998888999999998766556778999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC------
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG------  425 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~------  425 (613)
                      ++|+|.+++.+   ..+++.+++.++.|++.||+|||+.+    |+||||||+|||++.++++||+|||+|+..      
T Consensus       100 ~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~----iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (293)
T ss_dssp             TTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC----CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence            99999998754   35999999999999999999999998    999999999999999999999999999642      


Q ss_pred             --CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--H
Q 048439          426 --PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--A  501 (613)
Q Consensus       426 --~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~  501 (613)
                        ...+|+.|+|||++.++.++.++|||||||+||||++|++||......+.....  ............-+++.+.  .
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~--~~~~~~~~~~~~~~s~~~~~li  250 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--ATNGTPELQNPEKLSAIFRDFL  250 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HHHCSCCCSSGGGSCHHHHHHH
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH--HhCCCCCCCCcccCCHHHHHHH
Confidence              234678899999999999999999999999999999999999765443322221  1111111111222222222  2


Q ss_pred             hcccccCCCCCCCHHHHHHHHHH
Q 048439          502 MSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .+||+.||.+|||+.|++++...
T Consensus       251 ~~~L~~dP~~R~s~~eil~Hp~~  273 (293)
T d1yhwa1         251 NRCLDMDVEKRGSAKELLQHQFL  273 (293)
T ss_dssp             HHHTCSSTTTSCCHHHHTTCGGG
T ss_pred             HHHccCChhHCcCHHHHhcCHhh
Confidence            28999999999999999876554

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=404.66  Aligned_cols=237  Identities=26%  Similarity=0.393  Sum_probs=189.8

Q ss_pred             ceeeeeCcEEEEEEEEcC--CceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCCC
Q 048439          278 LVIGVGGFGDVYKGFING--STTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMAR  353 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~--~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  353 (613)
                      +.||+|+||+||+|.+..  .++.||||+++..  +....++|.+|+++|++++|||||+++|+|.+ +..+||||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999998754  3467999999754  23345679999999999999999999999965 467899999999


Q ss_pred             CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-------
Q 048439          354 GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-------  426 (613)
Q Consensus       354 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-------  426 (613)
                      |+|.+++..  ...++|.+++.|+.|||+||+|||+.+    |+||||||+||||+.++.+||+|||+|+...       
T Consensus        92 g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~----iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCC----cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999999854  456999999999999999999999988    9999999999999999999999999997421       


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                          ..++..|+|||.+..+.++.++|||||||+||||+| |++||......+....   ............+.+.+.. 
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~---i~~~~~~~~p~~~~~~~~~l  242 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM---LEKGERMGCPAGCPREMYDL  242 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---HHTTCCCCCCTTCCHHHHHH
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH---HHcCCCCCCCcccCHHHHHH
Confidence                235667999999999999999999999999999998 8999976543332211   1111111111222222222 


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHH
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ..+||+.||++|||+.+|+..|+.
T Consensus       243 i~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         243 MNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhC
Confidence            338999999999999999988874

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-49  Score=397.00  Aligned_cols=241  Identities=26%  Similarity=0.429  Sum_probs=200.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||+||+|++++ +..||||.++... ...++|++|+.++++++|||||+++|+|.+++.+++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETT-TEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECC-CCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            578888999999999999999974 4789999998654 34568999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++|+|.+++.. ....+++..+++|+.|+|+||.|||+.+    |+||||||+|||+++++.+||+|||+++...     
T Consensus        82 ~~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~~----iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          82 ANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQ----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             TTEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT----BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             CCCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhcC----cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            99999998754 3456899999999999999999999988    9999999999999999999999999996421     


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                          ..++..|+|||.+..+.++.|+|||||||++|||+| |+.||......+.....   ...... ..+....+.+. 
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i---~~~~~~-~~p~~~~~~l~~  232 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---AQGLRL-YRPHLASEKVYT  232 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH---HTTCCC-CCCTTCCHHHHH
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH---HhCCCC-CCcccccHHHHH
Confidence                234567999999999999999999999999999998 79999765543322221   111111 22223333222 


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHH
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                       ..+||+.||++|||+.+|+++|.
T Consensus       233 li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         233 IMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHccCCHhHCcCHHHHHHHhh
Confidence             23899999999999999999885

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-49  Score=411.01  Aligned_cols=248  Identities=24%  Similarity=0.383  Sum_probs=196.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCc-----eeEEEEEeCCC-ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGST-----TPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~-----~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~  344 (613)
                      ++|...++||+|+||+||+|+..+.+     ..||||.+... .......|.+|+.+|.++ +|||||+++|+|.+.+.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            56888889999999999999986543     36999998754 344556799999999998 899999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCC
Q 048439          345 ILVYDFMARGTLPDHLYHSD---------------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKT  403 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~  403 (613)
                      +||||||++|+|.++|....                     ...++|..++.|+.|+++||+|||+.+    |+||||||
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~----IiHRDlKp  192 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS----CVHRDLAA  192 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT----EEETTCSG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC----eeeccCch
Confidence            99999999999999996532                     235899999999999999999999998    99999999


Q ss_pred             CceeeCCCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhh
Q 048439          404 TNILLDEKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAA  472 (613)
Q Consensus       404 ~NILl~~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~  472 (613)
                      +|||++.++++||+|||+|+...          ..++..|+|||++..+.++.++|||||||+||||+| |++||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999997421          223667999999999999999999999999999997 8999965443


Q ss_pred             hhhhhHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          473 KKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       473 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ...  +...............+.+.+.. ..+||+.||++||||.||+++|...
T Consensus       273 ~~~--~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~~  324 (325)
T d1rjba_         273 DAN--FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ  324 (325)
T ss_dssp             SHH--HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH--HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhCC
Confidence            322  12222222221222222222222 2389999999999999999999743

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-50  Score=403.17  Aligned_cols=247  Identities=21%  Similarity=0.310  Sum_probs=191.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeec--CCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND--DREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV  347 (613)
                      ++|+..+.||+|+||+||+|+...+++.||||.++..  .....+.|.+|+++|++++|||||++++++.+  .+.+++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5788889999999999999999888899999999765  34455679999999999999999999999865  4568999


Q ss_pred             EEcCCCCChhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          348 YDFMARGTLPDHLYH--SDNPPLPWNQRLEICIGAARGLHYLHTGAN-HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ||||++|+|.+++..  .....+++..++.++.|++.||+|||+.+. ..+|+||||||+||||++++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999854  235679999999999999999999998641 12299999999999999999999999999864


Q ss_pred             C--------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccccc
Q 048439          425 G--------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVD  496 (613)
Q Consensus       425 ~--------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  496 (613)
                      .        ...+|+.|+|||++.+..++.|+|||||||+||||++|++||......+....   ............+.+
T Consensus       164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~---i~~~~~~~~~~~~s~  240 (269)
T d2java1         164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK---IREGKFRRIPYRYSD  240 (269)
T ss_dssp             C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHTCCCCCCTTSCH
T ss_pred             cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHH---HHcCCCCCCCcccCH
Confidence            2        23467889999999999999999999999999999999999976544332111   111111111122222


Q ss_pred             HHHH-HhcccccCCCCCCCHHHHHHH
Q 048439          497 PFLK-AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       497 ~~~~-~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      .... ..+||+.||.+|||+.|++++
T Consensus       241 ~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         241 ELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            2222 228999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-49  Score=408.83  Aligned_cols=195  Identities=26%  Similarity=0.353  Sum_probs=175.9

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      .++|...+.||+|+||+||+|+...++..||||+++... ......+.+|+.+|++++|||||+++++|.+++.++||||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            567888899999999999999998888999999997653 3445678999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG-ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF----  424 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~----  424 (613)
                      ||++|+|.+++.+  ...+++..+..++.|+++||.|||+. +    |+||||||+||||++++++||+|||+|+.    
T Consensus        85 y~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~~----IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             CCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHC----CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             cCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCC----EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            9999999999964  34699999999999999999999974 6    99999999999999999999999999963    


Q ss_pred             --CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchh
Q 048439          425 --GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTA  471 (613)
Q Consensus       425 --~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~  471 (613)
                        ....+|..|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus       159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence              23467889999999999999999999999999999999999996543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.3e-49  Score=405.05  Aligned_cols=255  Identities=27%  Similarity=0.452  Sum_probs=204.9

Q ss_pred             HHHHHHhcCCCCcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEe
Q 048439          265 SEIQAATNNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFC  338 (613)
Q Consensus       265 ~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~  338 (613)
                      .+++...++|+..+.||+|+||+||+|+..+     ++..||||+++... .+..++|.+|+++|++++||||++++++|
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            3455566789999999999999999999853     44789999997654 34456799999999999999999999999


Q ss_pred             ecCCceEEEEEcCCCCChhHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcE
Q 048439          339 NDDREMILVYDFMARGTLPDHLYHSD----------------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVI  396 (613)
Q Consensus       339 ~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~i  396 (613)
                      .+.+..++||||+++|+|.++|....                      ...++|.+++.|+.|+|.||+|||+.+    |
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~----i  161 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK----F  161 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT----C
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC----e
Confidence            99999999999999999999986421                      235899999999999999999999998    9


Q ss_pred             EeccCCCCceeeCCCCcEEEEecCCCcc----------CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCC-C
Q 048439          397 IHRDVKTTNILLDEKWVAKVSDFGLSKF----------GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR-P  465 (613)
Q Consensus       397 iHrDlk~~NILl~~~~~~kl~DFGls~~----------~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~-~  465 (613)
                      +||||||+|||||.++++||+|||+|+.          ....++..|+|||++....++.|+|||||||+||||++|. +
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            9999999999999999999999999863          1234556799999999999999999999999999999996 5


Q ss_pred             CccchhhhhhhhHHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          466 SILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       466 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ||......+...   .............+...+.. ..+||+.+|++||||.||++.|+..+
T Consensus       242 p~~~~~~~e~~~---~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         242 PYYGMAHEEVIY---YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTTTSCHHHHHH---HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCHHHHHH---HHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            665544333222   12211111112222222222 33899999999999999999998654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=395.02  Aligned_cols=242  Identities=26%  Similarity=0.397  Sum_probs=191.5

Q ss_pred             CCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeec----CCceEEEE
Q 048439          275 DNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND----DREMILVY  348 (613)
Q Consensus       275 ~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~  348 (613)
                      .....||+|+||+||+|++..++..||||.+...  .....+.|.+|+++|++++|||||++++++.+    +..+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            3445799999999999999988889999998654  34456679999999999999999999999864    45689999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC-CCCcEEEEecCCCccCC-
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD-EKWVAKVSDFGLSKFGP-  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGls~~~~-  426 (613)
                      |||++|+|.+++..  ...+++..++.++.||++||+|||+++.  +|+||||||+||||+ +++.+||+|||+|+... 
T Consensus        92 E~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~~~--~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTP--PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSS--CCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHHCCC--CEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999954  3569999999999999999999998752  299999999999996 58999999999997532 


Q ss_pred             -----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-
Q 048439          427 -----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-  500 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  500 (613)
                           ..+|+.|+|||++.+ +++.++|||||||+||||++|++||........  +............+.....+.+. 
T Consensus       168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~  244 (270)
T d1t4ha_         168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVKPASFDKVAIPEVKE  244 (270)
T ss_dssp             TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred             CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHHHHHcCCCCcccCccCCHHHHH
Confidence                 246788999999875 699999999999999999999999965432221  11111111111122222333222 


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHH
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                       ..+||+.||++|||+.|++++..
T Consensus       245 li~~~l~~dp~~R~s~~ell~Hp~  268 (270)
T d1t4ha_         245 IIEGCIRQNKDERYSIKDLLNHAF  268 (270)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHccCCHhHCcCHHHHhCCcc
Confidence             23899999999999999987543

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-49  Score=399.28  Aligned_cols=245  Identities=27%  Similarity=0.425  Sum_probs=195.7

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||+||+|++.++ ..||||+++... ...+.|.+|+.++++++|+|||+++|+|.+ +.+++|||||
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            4688888999999999999999877 569999997543 445789999999999999999999999965 5689999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++|+|.+++.......++|.+++.|+.|||.||+|||+.+    |+||||||+|||||+++++||+|||+|+...     
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~----ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh----eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence            9999999986655567999999999999999999999998    9999999999999999999999999997421     


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-H
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-A  501 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~  501 (613)
                          ..++..|+|||++..+.++.++|||||||+||||+||..|+........  ...+............+...+.. +
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~l~~li  247 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYRMPCPPECPESLHDLM  247 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHHhcCCCCCCcccCHHHHHHH
Confidence                2346679999999999999999999999999999997655543322221  12222212121222222222222 3


Q ss_pred             hcccccCCCCCCCHHHHHHHHHHh
Q 048439          502 MSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      .+||+.||++||+|.+|++.|+..
T Consensus       248 ~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         248 CQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             HHHcccCHhHCcCHHHHHHHHhhh
Confidence            389999999999999999888743

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.9e-48  Score=405.46  Aligned_cols=248  Identities=21%  Similarity=0.271  Sum_probs=204.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||.||+|+...++..||||++........+.+.+|+.+|++++|||||++++++.+++.++||||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57888899999999999999998888999999998777666778999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC--CCCcEEEEecCCCccCC---
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD--EKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~--~~~~~kl~DFGls~~~~---  426 (613)
                      ++|+|.+++... ...+++..++.|+.||+.||.|||+.+    |+||||||+|||++  .++.+||+|||+|+...   
T Consensus       106 ~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~----iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         106 SGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN----YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcC----CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            999999998543 456999999999999999999999998    99999999999995  46889999999997532   


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-H
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-A  501 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~  501 (613)
                          ..+|..|+|||++.+..++.++|||||||+||||++|++||......+...................+.+.... .
T Consensus       181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  260 (350)
T d1koaa2         181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI  260 (350)
T ss_dssp             CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHH
T ss_pred             ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence                24578899999999999999999999999999999999999765443322221111100111111122222222 2


Q ss_pred             hcccccCCCCCCCHHHHHHHHHH
Q 048439          502 MSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .+||..||++|||+.|++++...
T Consensus       261 ~~~L~~dP~~R~t~~eil~hp~~  283 (350)
T d1koaa2         261 RKLLLADPNTRMTIHQALEHPWL  283 (350)
T ss_dssp             HHHCCSSGGGSCCHHHHHHSTTT
T ss_pred             HHHccCChhHCcCHHHHhcCccc
Confidence            37999999999999999987543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.2e-49  Score=403.64  Aligned_cols=247  Identities=21%  Similarity=0.319  Sum_probs=189.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      +.|...++||+|+||+||+|+...+++.||||++.... ......+.+|+.+|++++|||||++++++.+++.++|||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            56888889999999999999998888999999997653 23345688999999999999999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC---CCCcEEEEecCCCccC--
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD---EKWVAKVSDFGLSKFG--  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGls~~~--  425 (613)
                      |++|+|.++|..  ...+++.++..++.|++.||+|||+.+    |+||||||+|||+.   +++.+||+|||+|+..  
T Consensus        89 ~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~----iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          89 VSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLG----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             cCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhce----eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            999999999954  457999999999999999999999998    99999999999994   5789999999999742  


Q ss_pred             -----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH
Q 048439          426 -----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK  500 (613)
Q Consensus       426 -----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  500 (613)
                           ...+|+.|+|||++.++.++.++|||||||+||||++|++||......+...................+.+....
T Consensus       163 ~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  242 (307)
T d1a06a_         163 GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD  242 (307)
T ss_dssp             ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred             CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHH
Confidence                 234678899999999999999999999999999999999999765443322111111101111111222222222


Q ss_pred             -HhcccccCCCCCCCHHHHHHHHHH
Q 048439          501 -AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       501 -~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                       ..+||+.||.+|||+.|++++...
T Consensus       243 li~~~L~~dP~~R~s~~eil~hp~~  267 (307)
T d1a06a_         243 FIRHLMEKDPEKRFTCEQALQHPWI  267 (307)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred             HHHHHccCCHhHCcCHHHHhcCHhh
Confidence             227999999999999999987554

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-48  Score=399.72  Aligned_cols=244  Identities=26%  Similarity=0.327  Sum_probs=198.3

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      .|...+.||+|+||+||+|+...++..||||+++...   ....+.|.+|+.+|++++|||||++++++.+++.++||||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4788889999999999999998888999999987653   3344678999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----  425 (613)
                      ||++|+|..++..  ...+++.+++.++.||+.||.|||+.+    |+||||||+||||++++.+||+|||+|+..    
T Consensus        96 ~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~----iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (309)
T d1u5ra_          96 YCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN  169 (309)
T ss_dssp             CCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC
T ss_pred             ecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC----EeccCCCcceEEECCCCCEEEeecccccccCCCC
Confidence            9999999776643  457999999999999999999999998    999999999999999999999999999753    


Q ss_pred             CCCCCcccCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--
Q 048439          426 PTSVSKTHLDPEYYRL---QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--  500 (613)
Q Consensus       426 ~~~~~~~~~aPE~~~~---~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--  500 (613)
                      ...+|+.|+|||++.+   +.++.++|||||||+||||++|++||......+.....  ... ...........+.+.  
T Consensus       170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i--~~~-~~~~~~~~~~s~~~~~l  246 (309)
T d1u5ra_         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQN-ESPALQSGHWSEYFRNF  246 (309)
T ss_dssp             CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HHS-CCCCCSCTTSCHHHHHH
T ss_pred             ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH--HhC-CCCCCCCCCCCHHHHHH
Confidence            3457888999999864   46899999999999999999999999755433321111  111 111111111222222  


Q ss_pred             HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          501 AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       501 ~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ..+||+.||.+|||+.|++++....
T Consensus       247 i~~~L~~dP~~Rpt~~ell~Hp~~~  271 (309)
T d1u5ra_         247 VDSCLQKIPQDRPTSEVLLKHRFVL  271 (309)
T ss_dssp             HHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             HHHHCcCChhHCcCHHHHHhCHHhc
Confidence            2279999999999999999876543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-49  Score=402.08  Aligned_cols=239  Identities=20%  Similarity=0.255  Sum_probs=199.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...++||+|+||+||+|+...+++.||||+++..   .....+.+.+|+++|++++|||||++++++.+++.+++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            4688889999999999999999888889999998653   2334567999999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      |||++|+|.+++..  ...+++..++.++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+|+..   
T Consensus        88 Ey~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~----iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhcccc----EEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999998854  356999999999999999999999998    999999999999999999999999999742   


Q ss_pred             -------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          426 -------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       426 -------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                             ...+|..|+|||++.+..++.++|||||||+||||++|++||......+......     .....+..-+.+.
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~-----~~~~~~p~~~s~~  236 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-----KLEYDFPEKFFPK  236 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----TTCCCCCTTCCHH
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH-----cCCCCCCccCCHH
Confidence                   1246888999999999999999999999999999999999997654333221111     1111222223333


Q ss_pred             HH--HhcccccCCCCCCCHHHHHHH
Q 048439          499 LK--AMSCLNDEGIRRPSMSDVVWG  521 (613)
Q Consensus       499 ~~--~~~Cl~~~p~~RPs~~evl~~  521 (613)
                      ..  ..+||+.||.+|||+.|++..
T Consensus       237 ~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         237 ARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             HHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHcCC
Confidence            32  238999999999999998654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.2e-48  Score=402.96  Aligned_cols=247  Identities=19%  Similarity=0.283  Sum_probs=203.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||.||+|+...+++.||||+++.........+.+|+.+|++|+|||||++++++.+++.++||||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            46888899999999999999998888999999998776666678899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC--CCCcEEEEecCCCccCC---
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD--EKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~--~~~~~kl~DFGls~~~~---  426 (613)
                      ++|+|.+++.. ...+|++.+.+.|+.||+.||.|||+.+    |+||||||+||||+  .++.+||+|||+|+...   
T Consensus       109 ~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~----iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC----eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            99999988743 3456999999999999999999999998    99999999999998  67899999999997532   


Q ss_pred             ----CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-H
Q 048439          427 ----TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-A  501 (613)
Q Consensus       427 ----~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~  501 (613)
                          ..++..|+|||++.+..++.++|||||||+||||+||++||......+...................+.+.... .
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  263 (352)
T d1koba_         184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI  263 (352)
T ss_dssp             CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred             ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence                24577899999999999999999999999999999999999765544332221111111111111222222222 2


Q ss_pred             hcccccCCCCCCCHHHHHHHHH
Q 048439          502 MSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .+||+.||.+|||+.|++++..
T Consensus       264 ~~~L~~dp~~R~s~~eil~Hp~  285 (352)
T d1koba_         264 KNLLQKEPRKRLTVHDALEHPW  285 (352)
T ss_dssp             HTTSCSSGGGSCCHHHHHTSTT
T ss_pred             HHHccCChhHCcCHHHHhcCHh
Confidence            3899999999999999987654

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=393.30  Aligned_cols=243  Identities=30%  Similarity=0.467  Sum_probs=191.6

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeec-CCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCND-DREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey  350 (613)
                      ++|...+.||+|+||.||+|++.+  ..||||+++..  ...+.|.+|++++++++|||||+++|+|.+ .+.+++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~--~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT--EEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEECC--eEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            456677789999999999999964  67999999754  345679999999999999999999999865 4678999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC----
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP----  426 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~----  426 (613)
                      +++|+|.++|.......++|..+++|+.|||.||.|||+.+    |+||||||+|||++.++.+||+|||+++...    
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~----ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~  158 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD  158 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc----eeccccchHhheecCCCCEeecccccceecCCCCc
Confidence            99999999997654456999999999999999999999988    9999999999999999999999999997532    


Q ss_pred             -CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-Hhc
Q 048439          427 -TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-AMS  503 (613)
Q Consensus       427 -~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~  503 (613)
                       ..++..|+|||++.++.++.++|||||||++|||+| |++|+......+   +..+..............+.... ..+
T Consensus       159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~li~~  235 (262)
T d1byga_         159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGYKMDAPDGCPPAVYEVMKN  235 (262)
T ss_dssp             ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTTTCCCCCCTTCCHHHHHHHHH
T ss_pred             cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence             234567999999999999999999999999999998 688776543332   22322222222222222222222 238


Q ss_pred             ccccCCCCCCCHHHHHHHHHHh
Q 048439          504 CLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       504 Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      ||+.||.+||||.||+++|+..
T Consensus       236 cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         236 CWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcccCHhHCcCHHHHHHHHHHH
Confidence            9999999999999999998753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-48  Score=395.77  Aligned_cols=246  Identities=20%  Similarity=0.281  Sum_probs=198.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC------hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES------QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~------~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  345 (613)
                      ++|...+.||+|+||+||+|+...+++.||||+++...      ....+.|.+|+.+|++++|||||++++++.+++.++
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            56888899999999999999998888999999986432      223577999999999999999999999999999999


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC----cEEEEecCC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW----VAKVSDFGL  421 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFGl  421 (613)
                      ||||||++|+|.+++..  ...+++..++.++.|++.||+|||+.+    |+||||||+|||++.++    .+||+|||+
T Consensus        90 iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~~----ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          90 LILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhcc----eeecccccceEEEecCCCcccceEecchhh
Confidence            99999999999999954  356999999999999999999999998    99999999999998876    599999999


Q ss_pred             CccC-------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccc
Q 048439          422 SKFG-------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQI  494 (613)
Q Consensus       422 s~~~-------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  494 (613)
                      |+..       ...++..|+|||++.+..++.++|||||||+||||++|++||......+...................+
T Consensus       164 a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (293)
T d1jksa_         164 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT  243 (293)
T ss_dssp             CEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             hhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence            8642       234567899999999999999999999999999999999999765443322111100000000000111


Q ss_pred             ccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          495 VDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       495 ~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      ...... ..+||+.||.+|||+.|++++..
T Consensus       244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~  273 (293)
T d1jksa_         244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPW  273 (293)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            111111 22899999999999999987654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-48  Score=399.02  Aligned_cols=245  Identities=24%  Similarity=0.388  Sum_probs=194.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCce----eEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTT----PVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~----~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  346 (613)
                      .+|+..++||+|+||+||+|++..+++    .||||+++.. +.+..++|.+|+.+|++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            358888999999999999999865543    5999998754 445677899999999999999999999999875 5778


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      ++||+.+|+|.+++.. ....++|..++.|+.|||+||+|||+++    |+||||||+||||+.++.+||+|||+|+...
T Consensus        88 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~----iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHcC----cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8999999999998865 3567999999999999999999999998    9999999999999999999999999986421


Q ss_pred             ----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccc
Q 048439          427 ----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIV  495 (613)
Q Consensus       427 ----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  495 (613)
                                ..++..|+|||++.++.++.++|||||||+||||+| |++||......+.....   ...........+.
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i---~~~~~~~~p~~~~  239 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---EKGERLPQPPICT  239 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH---HHTCCCCCCTTBC
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH---HcCCCCCCCcccC
Confidence                      134678999999999999999999999999999998 78888655433322222   1111111122222


Q ss_pred             cHHHH-HhcccccCCCCCCCHHHHHHHHHHh
Q 048439          496 DPFLK-AMSCLNDEGIRRPSMSDVVWGLEFS  525 (613)
Q Consensus       496 d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~  525 (613)
                      +.... ..+||+.||.+|||+.||+++|+..
T Consensus       240 ~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            22222 3389999999999999999998754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-48  Score=391.05  Aligned_cols=247  Identities=23%  Similarity=0.361  Sum_probs=193.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCC---ceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGS---TTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~---~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|...+.||+|+||.||+|++...   ...||||.++.. .....+.|.+|+.+|++++|||||+++|+|. ++.+++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            4677888999999999999998543   356999998765 3444567999999999999999999999996 4678999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-  426 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-  426 (613)
                      ||||++|+|.+++.. ....+++.+++.++.|+++||+|||+.+    |+||||||+|||+++++.+||+|||+|+... 
T Consensus        86 ~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~----iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          86 MELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhcccC----eeccccchhheeecCCCcEEEccchhheeccC
Confidence            999999999998754 3457999999999999999999999998    9999999999999999999999999997421 


Q ss_pred             --------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHhhccCCccccccH
Q 048439          427 --------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDP  497 (613)
Q Consensus       427 --------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  497 (613)
                              ..++..|+|||++..+.++.++|||||||+||||++ |++||......+...   .............+.+.
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~---~i~~~~~~~~~~~~~~~  237 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RIENGERLPMPPNCPPT  237 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---HHHTTCCCCCCTTCCHH
T ss_pred             CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH---HHHcCCCCCCCCCCCHH
Confidence                    234667999999999999999999999999999998 899987654433221   12221111222222222


Q ss_pred             HHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          498 FLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       498 ~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      +.. ..+||+.||++|||+.||++.|+..++
T Consensus       238 ~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         238 LYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            222 238999999999999999999986554

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-47  Score=391.10  Aligned_cols=243  Identities=26%  Similarity=0.436  Sum_probs=192.8

Q ss_pred             cceeeeeCcEEEEEEEEcCC---ceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeec-CCceEEEEEcC
Q 048439          277 DLVIGVGGFGDVYKGFINGS---TTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND-DREMILVYDFM  351 (613)
Q Consensus       277 ~~~iG~G~fG~Vy~g~~~~~---~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~  351 (613)
                      .++||+|+||+||+|++..+   ...||||+++.. +.....+|.+|+++|++++|||||+++|+|.+ ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            35899999999999998553   246999999754 55566789999999999999999999999875 56889999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-----
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-----  426 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-----  426 (613)
                      ++|+|.+++.. ....+++..+++++.|+|+||.|||+.+    |+||||||+||||++++.+||+|||+++...     
T Consensus       112 ~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~----iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccC----cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999998864 4556889999999999999999999998    9999999999999999999999999997421     


Q ss_pred             -------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH
Q 048439          427 -------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       427 -------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                             ..++..|+|||++..+.++.|+|||||||+||||+||+.||.......  ....+............+.+.+.
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~~g~~~~~p~~~~~~l~  264 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGRRLLQPEYCPDPLY  264 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCCCCCcccCcHHHH
Confidence                   224567999999999999999999999999999999877775433222  12222222222222222223332


Q ss_pred             H-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          500 K-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       500 ~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      . +.+||+.||++||+|.||+++|+..+
T Consensus       265 ~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         265 EVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            2 33899999999999999999998654

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=394.64  Aligned_cols=248  Identities=29%  Similarity=0.455  Sum_probs=196.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCce--eEEEEEeCCC-ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTT--PVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~--~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|...++||+|+||.||+|++.+++.  .||||+++.. .....++|.+|+++|+++ +|||||+++|+|.+++.+++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            567778899999999999999976654  5788888654 444566899999999999 799999999999999999999


Q ss_pred             EEcCCCCChhHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCc
Q 048439          348 YDFMARGTLPDHLYHS--------------DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWV  413 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~  413 (613)
                      |||+++|+|.++|+..              ....|+|.+++.++.|||+||.|||+.+    |+||||||+|||++.++.
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~----iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ----FIHRDLAARNILVGENYV  165 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECGGGC
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC----ccccccccceEEEcCCCc
Confidence            9999999999999643              2467999999999999999999999998    999999999999999999


Q ss_pred             EEEEecCCCccC-------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCC-CCccchhhhhhhhHHHHHHHh
Q 048439          414 AKVSDFGLSKFG-------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR-PSILRTAAKKQVSLAVWAQQC  485 (613)
Q Consensus       414 ~kl~DFGls~~~-------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~-~p~~~~~~~~~~~l~~~~~~~  485 (613)
                      +||+|||+|+..       ...++..|+|||.+..+.++.++|||||||+||||++|. +||......+   +.......
T Consensus       166 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~~i~~~  242 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLPQG  242 (309)
T ss_dssp             EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHGGGT
T ss_pred             eEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHHHHHhc
Confidence            999999998642       223567899999999999999999999999999999976 4564433222   11211111


Q ss_pred             hccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          486 YQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       486 ~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ........+.+.+.. ..+||+.||++||||.||+++|+..+
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            111112222222222 23899999999999999999988654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.8e-47  Score=395.09  Aligned_cols=241  Identities=22%  Similarity=0.292  Sum_probs=201.1

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||+||+|+...+++.||||+++..   .....+.+.+|+.+|++++|||||++++++.+++.+++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4688889999999999999999888899999999753   2344667999999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      |||++|+|.+++..  ...+++.....++.|++.||+|||+++    |+||||||+||||++++.+||+|||+|+..   
T Consensus        84 E~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~----iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTT----EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCc----EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999998854  456889999999999999999999998    999999999999999999999999999753   


Q ss_pred             --CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH--H
Q 048439          426 --PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK--A  501 (613)
Q Consensus       426 --~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~  501 (613)
                        ...+++.|+|||++.+..++.++|||||||+||||++|++||......+.......     ........+++.+.  .
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-----~~~~~p~~~s~~~~~li  232 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-----AELRFPPFFNEDVKDLL  232 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-----CCCCCCTTSCHHHHHHH
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc-----CCCCCCCCCCHHHHHHH
Confidence              34578889999999999999999999999999999999999976544332222111     11122222333222  2


Q ss_pred             hcccccCCCCCC-----CHHHHHHHHH
Q 048439          502 MSCLNDEGIRRP-----SMSDVVWGLE  523 (613)
Q Consensus       502 ~~Cl~~~p~~RP-----s~~evl~~Le  523 (613)
                      .+||..||.+||     ++.|++++..
T Consensus       233 ~~~L~~dp~~R~~~~r~t~~~il~Hp~  259 (316)
T d1fota_         233 SRLITRDLSQRLGNLQNGTEDVKNHPW  259 (316)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             HHHhhhCHHhccccchhhHHHHHcCcc
Confidence            279999999996     8999987655

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-47  Score=388.99  Aligned_cols=250  Identities=26%  Similarity=0.408  Sum_probs=188.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCC-ChhcHHHHHHHHHHHhcc-CccceeeEEEEeecC-Cc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPE-SQQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDD-RE  343 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~-~~  343 (613)
                      ++|...++||+|+||.||+|++..     +++.||||+++.. .....+.|.+|+.++.++ +|+|||.+++++.+. +.
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            568888899999999999999754     2367999999764 344456788898888887 689999999998764 56


Q ss_pred             eEEEEEcCCCCChhHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC
Q 048439          344 MILVYDFMARGTLPDHLYHSD--------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD  409 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~  409 (613)
                      +++|||||++|+|.++|....              ...++|.+++.++.|||+||+|||+.+    |+||||||+||||+
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~----ivHrDlKp~NILl~  168 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK----CIHRDLAARNILLS  168 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEEC
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC----CcCCcCCccceeEC
Confidence            899999999999999996432              245899999999999999999999998    99999999999999


Q ss_pred             CCCcEEEEecCCCccC----------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCC-CCccchhhhhhhhH
Q 048439          410 EKWVAKVSDFGLSKFG----------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR-PSILRTAAKKQVSL  478 (613)
Q Consensus       410 ~~~~~kl~DFGls~~~----------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~-~p~~~~~~~~~~~l  478 (613)
                      +++++||+|||+|+..          ...++..|+|||++.++.++.++|||||||+||||++|. +||......+.  +
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--~  246 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F  246 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--H
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH--H
Confidence            9999999999999642          123567899999999999999999999999999999875 56644332221  1


Q ss_pred             HHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          479 AVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       479 ~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                      .............+.+.+.+.. ..+||+.||.+|||+.||+++|+..+|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1111111111112222222222 337999999999999999999997664

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-47  Score=388.92  Aligned_cols=249  Identities=23%  Similarity=0.396  Sum_probs=196.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCc-------eeEEEEEeCCCC-hhcHHHHHHHHHHHhcc-CccceeeEEEEeecCC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGST-------TPVAIKRLEPES-QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDR  342 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~-------~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~  342 (613)
                      ++|...+.||+|+||.||+|+....+       ..||||+++... .....++.+|...+.++ +|||||+++|+|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            46777789999999999999875432       469999997764 44567899999999998 8999999999999999


Q ss_pred             ceEEEEEcCCCCChhHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee
Q 048439          343 EMILVYDFMARGTLPDHLYHSD--------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL  408 (613)
Q Consensus       343 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl  408 (613)
                      ..++|||||++|+|.++|....              ...+++.+++.++.|+|.||+|||+.+    |+||||||+|||+
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~----ivHrDiKp~NiLl  168 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK----CIHRDLAARNVLV  168 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEE
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC----EEeeeecccceee
Confidence            9999999999999999996432              246999999999999999999999998    9999999999999


Q ss_pred             CCCCcEEEEecCCCccC----------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhh
Q 048439          409 DEKWVAKVSDFGLSKFG----------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVS  477 (613)
Q Consensus       409 ~~~~~~kl~DFGls~~~----------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~  477 (613)
                      +.++.+||+|||+++..          ...++..|+|||++..+.++.|+|||||||+||||++ |++||........  
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~--  246 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--  246 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH--
Confidence            99999999999998742          1234667999999999999999999999999999998 6888865443322  


Q ss_pred             HHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhhh
Q 048439          478 LAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSLQ  527 (613)
Q Consensus       478 l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l~  527 (613)
                       ...............+.+.+.. ..+||+.||.+|||+.||++.|+..+.
T Consensus       247 -~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         247 -FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             -HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence             1222222222222222222222 338999999999999999999987654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9e-47  Score=382.99  Aligned_cols=247  Identities=23%  Similarity=0.318  Sum_probs=195.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHHHHHHHhccCccceeeEEEEeecCC----ce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR----EM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~----~~  344 (613)
                      ++|...+.||+|+||.||+|+...+++.||||+++...   ......|.+|+++|++++|||||++++++...+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            56888899999999999999998888999999997643   334567999999999999999999999987654    37


Q ss_pred             EEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          345 ILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      +||||||++|+|.+++..  ...+++.+++.|+.|++.||+|||+.+    |+||||||+|||++.++..+|+|||+++.
T Consensus        87 ~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~----iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC----ccCccccCcccccCccccceeehhhhhhh
Confidence            899999999999998854  356999999999999999999999998    99999999999999999999999998753


Q ss_pred             C-----------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccc
Q 048439          425 G-----------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ  493 (613)
Q Consensus       425 ~-----------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  493 (613)
                      .           ...++..|+|||++.+..++.++|||||||+||||+||++||......+...................
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG  240 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence            1           22467889999999999999999999999999999999999976544332211111100001111112


Q ss_pred             cccHHHH-HhcccccCCCCCC-CHHHHHHHHHH
Q 048439          494 IVDPFLK-AMSCLNDEGIRRP-SMSDVVWGLEF  524 (613)
Q Consensus       494 ~~d~~~~-~~~Cl~~~p~~RP-s~~evl~~Le~  524 (613)
                      +.+.+.. ..+||+.||.+|| ++.+++..|..
T Consensus       241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            2222222 2389999999999 89999877764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=388.38  Aligned_cols=247  Identities=16%  Similarity=0.241  Sum_probs=199.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFM  351 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  351 (613)
                      ++|...+.||+|+||+||+|+...+++.||||.++.... ....+.+|+++|++++|||||++++++.+++.++||||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            568888899999999999999998889999999976543 3456889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC--CCcEEEEecCCCccCCC--
Q 048439          352 ARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE--KWVAKVSDFGLSKFGPT--  427 (613)
Q Consensus       352 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~--~~~~kl~DFGls~~~~~--  427 (613)
                      ++|+|.+++.. ....+++.+++.|+.||+.||+|||+.+    |+||||||+|||++.  .+.+||+|||+++....  
T Consensus        84 ~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~~----iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          84 SGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             CCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcC----CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            99999999954 2346999999999999999999999998    999999999999985  45899999999975322  


Q ss_pred             -----CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHHH-H
Q 048439          428 -----SVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFLK-A  501 (613)
Q Consensus       428 -----~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~  501 (613)
                           .+++.|++||.+.+..++.++|||||||+||||++|++||......+....+..............+.+.... .
T Consensus       159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T d1tkia_         159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence                 3467899999999999999999999999999999999999765543322211110000000001112222211 2


Q ss_pred             hcccccCCCCCCCHHHHHHHHHH
Q 048439          502 MSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       502 ~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .+||..||.+|||+.|++++...
T Consensus       239 ~~~L~~dp~~R~s~~eil~hp~~  261 (321)
T d1tkia_         239 DRLLVKERKSRMTASEALQHPWL  261 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             HHHccCChhHCcCHHHHhcCHhh
Confidence            28999999999999999987654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-47  Score=395.68  Aligned_cols=243  Identities=24%  Similarity=0.324  Sum_probs=202.0

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEE
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      .++|...++||+|+||+||+|+...+++.||||+++..   .......+.+|+.+|++++|||||++++++.+++.+++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            35788999999999999999999888899999999754   233456789999999999999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC-
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP-  426 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~-  426 (613)
                      ||||++|+|.+++..  ...+++.....++.|++.||+|||+++    |+||||||+|||++++|.+||+|||+|+... 
T Consensus        84 ~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~~----iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhcC----ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            999999999999854  456899999999999999999999998    9999999999999999999999999997532 


Q ss_pred             -------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH
Q 048439          427 -------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       427 -------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                             ..+|+.|+|||++.+..++.++|||||||+||||++|++||......+......     .....+...+.+..
T Consensus       158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~-----~~~~~~p~~~s~~~  232 (337)
T d1o6la_         158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-----MEEIRFPRTLSPEA  232 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HCCCCCCTTSCHHH
T ss_pred             CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh-----cCCCCCCccCCHHH
Confidence                   235778999999999999999999999999999999999997765433222111     11122222233333


Q ss_pred             HH--hcccccCCCCCCC-----HHHHHHHHHH
Q 048439          500 KA--MSCLNDEGIRRPS-----MSDVVWGLEF  524 (613)
Q Consensus       500 ~~--~~Cl~~~p~~RPs-----~~evl~~Le~  524 (613)
                      ..  .+||+.||.+||+     +.|++++..+
T Consensus       233 ~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f  264 (337)
T d1o6la_         233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF  264 (337)
T ss_dssp             HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             HHHHHhhccCCchhhcccccccHHHHHcCccc
Confidence            32  2799999999995     8888776553

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-47  Score=384.72  Aligned_cols=244  Identities=23%  Similarity=0.350  Sum_probs=188.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCC---ceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGS---TTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~---~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  345 (613)
                      ++|+..+.||+|+||.||+|++...   ...||||+++..   ..+..++|.+|+.+|++++|||||+++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            4677788999999999999987432   346999998764   33445689999999999999999999999976 4678


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +|||||++|+|.+++... ...+++..++.++.|+|+||.|||+++    |+||||||+||||+.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~----iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKR----FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCC----EeeeeecHHHhccccccceeeccchhhhhc
Confidence            999999999999987643 456999999999999999999999988    999999999999999999999999999753


Q ss_pred             C-----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCccchhhhhhhhHHHHHHHh-hccCCcc
Q 048439          426 P-----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLC-ARPSILRTAAKKQVSLAVWAQQC-YQNGTID  492 (613)
Q Consensus       426 ~-----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~-~~~~~~~  492 (613)
                      .           ..++..|+|||++....++.++|||||||+||||+| |++||......+..   .+.... .......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~---~~i~~~~~~~~~~~  238 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---HKIDKEGERLPRPE  238 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHHTSCCCCCCCT
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH---HHHHhCCCCCCCcc
Confidence            2           123557999999999999999999999999999998 89999655443322   222111 1112222


Q ss_pred             ccccHHHH-HhcccccCCCCCCCHHHHHHHHHH
Q 048439          493 QIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       493 ~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      .+.+.... ..+||+.||++||||.||++.|+.
T Consensus       239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            33333322 338999999999999999988874

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.2e-46  Score=381.78  Aligned_cols=246  Identities=20%  Similarity=0.274  Sum_probs=197.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh---------hcHHHHHHHHHHHhccC-ccceeeEEEEeecC
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ---------QGALEFQTEIGMLSQLR-HLHLVSLIGFCNDD  341 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~---------~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~  341 (613)
                      ++|...+.||+|+||+||+|+...+++.||||+++....         ...+.+.+|+.+|++++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            578888999999999999999988889999999865421         12235889999999997 99999999999999


Q ss_pred             CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCC
Q 048439          342 REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL  421 (613)
Q Consensus       342 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl  421 (613)
                      +..+||||||++|+|.++|..  ...+++.+++.++.||+.||+|||+.+    |+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~~----ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC----CcccccccceEEEcCCCCeEEccchh
Confidence            999999999999999999954  457999999999999999999999998    99999999999999999999999999


Q ss_pred             CccCC-------CCCCcccCChhhhhc------CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc
Q 048439          422 SKFGP-------TSVSKTHLDPEYYRL------QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN  488 (613)
Q Consensus       422 s~~~~-------~~~~~~~~aPE~~~~------~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~  488 (613)
                      ++...       ..++..|++||++.+      ..++.++||||+||+||||++|++||......+..............
T Consensus       157 a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~  236 (277)
T d1phka_         157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  236 (277)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             eeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            96422       235678999999974      34688999999999999999999999866544332222111111111


Q ss_pred             CCccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          489 GTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       489 ~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      .....+...... ..+||+.+|++||++.||+++-.
T Consensus       237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~  272 (277)
T d1phka_         237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF  272 (277)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence            111122222222 22899999999999999986643

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=388.32  Aligned_cols=248  Identities=24%  Similarity=0.412  Sum_probs=198.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcC-----CceeEEEEEeCCC-ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFING-----STTPVAIKRLEPE-SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~-----~~~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  345 (613)
                      ++|...+.||+|+||.||+|++.+     .++.||||+++.. ..+....|.+|+.++++++|||||+++|+|..++..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            567777899999999999998853     2467999999764 4445567999999999999999999999999999999


Q ss_pred             EEEEcCCCCChhHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEE
Q 048439          346 LVYDFMARGTLPDHLYHS--------DNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVS  417 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~  417 (613)
                      +|||||++|+|.+++...        ....++|..+++++.|+|+||.|||+.+    |+||||||+|||+++++++||+
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~----ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK----FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT----CBCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC----eeeceEcCCceeecCCceEEEe
Confidence            999999999999988532        2346899999999999999999999988    9999999999999999999999


Q ss_pred             ecCCCccC----------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCC-CCccchhhhhhhhHHHHHHHhh
Q 048439          418 DFGLSKFG----------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCAR-PSILRTAAKKQVSLAVWAQQCY  486 (613)
Q Consensus       418 DFGls~~~----------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~-~p~~~~~~~~~~~l~~~~~~~~  486 (613)
                      |||+|+..          ...++..|+|||.+.++.++.++|||||||+||||++|+ +|+......+.....   ....
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i---~~~~  252 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV---MEGG  252 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH---HTTC
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HhCC
Confidence            99999742          123467899999999999999999999999999999985 666443332222111   1111


Q ss_pred             ccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          487 QNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       487 ~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      .......+...+.. ..+||+.+|.+||||.+|+++|+..+
T Consensus       253 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         253 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            11111222222222 23899999999999999999998554

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-46  Score=384.62  Aligned_cols=249  Identities=22%  Similarity=0.403  Sum_probs=198.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEc-----CCceeEEEEEeCCCC-hhcHHHHHHHHHHHhcc-CccceeeEEEEeecCCce
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFIN-----GSTTPVAIKRLEPES-QQGALEFQTEIGMLSQL-RHLHLVSLIGFCNDDREM  344 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~-----~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~~~~~  344 (613)
                      ++|...++||+|+||.||+|++.     ..+..||||+++... .....+|.+|+.+++++ +|||||+++|+|.+.+..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            46777889999999999999873     345789999998754 34556799999999999 699999999999999999


Q ss_pred             EEEEEcCCCCChhHHhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceee
Q 048439          345 ILVYDFMARGTLPDHLYHSD----------------NPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILL  408 (613)
Q Consensus       345 ~lV~Ey~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl  408 (613)
                      +||||||++|+|.++|....                ...+++..++.++.|||+||+|||+++    |+||||||+|||+
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~----ivHrDLKp~NIl~  178 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN----CIHRDLAARNILL  178 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCSGGGEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC----eeecccccccccc
Confidence            99999999999999986432                236999999999999999999999998    9999999999999


Q ss_pred             CCCCcEEEEecCCCccCC----------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhC-CCCccchhhhhhhh
Q 048439          409 DEKWVAKVSDFGLSKFGP----------TSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCA-RPSILRTAAKKQVS  477 (613)
Q Consensus       409 ~~~~~~kl~DFGls~~~~----------~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg-~~p~~~~~~~~~~~  477 (613)
                      +.++.+||+|||+++...          ..++..|+|||++..+.++.++|||||||+||||+|+ .+++......+.  
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--  256 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--  256 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--
Confidence            999999999999997532          2336679999999999999999999999999999995 555544333222  


Q ss_pred             HHHHHHHhhccCCccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          478 LAVWAQQCYQNGTIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       478 l~~~~~~~~~~~~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      +.................+.+.. ..+||+.||++||||.+|+++|+..+
T Consensus       257 ~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence            11222222222222222222222 33899999999999999999998654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-46  Score=393.74  Aligned_cols=242  Identities=21%  Similarity=0.264  Sum_probs=199.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  348 (613)
                      ++|...+.||+|+||.||+|+...+++.||||+++..   .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            4788889999999999999999888899999998643   2334567899999999999999999999999999999999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC---
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG---  425 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~---  425 (613)
                      ||+.+|+|.+++..  ...+++.+++.++.||+.||.|||+.+    ||||||||+||||+.++.+||+|||+|+..   
T Consensus       121 e~~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~----iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC----EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999999854  346999999999999999999999998    999999999999999999999999999753   


Q ss_pred             --CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCc-cccccHHHH-H
Q 048439          426 --PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTI-DQIVDPFLK-A  501 (613)
Q Consensus       426 --~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~d~~~~-~  501 (613)
                        ...+++.|+|||++.+..++.++|||||||+||||++|++||.............  .   ..... ..+.+.... .
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~--~---~~~~~p~~~s~~~~~li  269 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV--S---GKVRFPSHFSSDLKDLL  269 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--H---CCCCCCTTCCHHHHHHH
T ss_pred             cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh--c---CCCCCCccCCHHHHHHH
Confidence              2346778999999999999999999999999999999999997654333222111  1   11111 222222222 2


Q ss_pred             hcccccCCCCCC-----CHHHHHHHHHH
Q 048439          502 MSCLNDEGIRRP-----SMSDVVWGLEF  524 (613)
Q Consensus       502 ~~Cl~~~p~~RP-----s~~evl~~Le~  524 (613)
                      .+||+.||.+|+     ++.|++++..+
T Consensus       270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f  297 (350)
T d1rdqe_         270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF  297 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             HHHhhhCHHhccccccccHHHHHcCccc
Confidence            279999999994     89999876553

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.9e-46  Score=391.70  Aligned_cols=245  Identities=22%  Similarity=0.283  Sum_probs=195.5

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC---hhcHHHHHH---HHHHHhccCccceeeEEEEeecCCceE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES---QQGALEFQT---EIGMLSQLRHLHLVSLIGFCNDDREMI  345 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~---~~~~~~f~~---Ei~~l~~l~H~niv~l~g~~~~~~~~~  345 (613)
                      ++|...++||+|+||.||+|+...+++.||||++....   ......+.+   |+.+++.++|||||++++++.+.+.++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57889999999999999999999888999999986431   222333444   477778888999999999999999999


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG  425 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~  425 (613)
                      +|||||++|+|.++|..  ...+++..++.++.||+.||+|||+.+    |+||||||+||||++++.+||+|||+|+..
T Consensus        84 ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~----iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHCC----ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999954  456899999999999999999999998    999999999999999999999999999742


Q ss_pred             ------CCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHH
Q 048439          426 ------PTSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPF  498 (613)
Q Consensus       426 ------~~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  498 (613)
                            ...+|+.|+|||++.. ..++.++|||||||+||||++|++||......+...+...  ..........-+++.
T Consensus       158 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~  235 (364)
T d1omwa3         158 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--TLTMAVELPDSFSPE  235 (364)
T ss_dssp             SSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH--SSSCCCCCCSSSCHH
T ss_pred             CCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cccCCCCCCCCCCHH
Confidence                  2457889999999975 5689999999999999999999999976544332222111  111111222223333


Q ss_pred             HH--HhcccccCCCCCCC-----HHHHHHHHHH
Q 048439          499 LK--AMSCLNDEGIRRPS-----MSDVVWGLEF  524 (613)
Q Consensus       499 ~~--~~~Cl~~~p~~RPs-----~~evl~~Le~  524 (613)
                      +.  ..+||+.||.+||+     +.|++++..+
T Consensus       236 ~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f  268 (364)
T d1omwa3         236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF  268 (364)
T ss_dssp             HHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGG
T ss_pred             HHHHHHHHcccCHHHhCCCcccCHHHHHcCccc
Confidence            22  22799999999999     6888876553

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=388.39  Aligned_cols=241  Identities=22%  Similarity=0.300  Sum_probs=198.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC---ChhcHHHHHHHHHHHh-ccCccceeeEEEEeecCCceEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE---SQQGALEFQTEIGMLS-QLRHLHLVSLIGFCNDDREMILV  347 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~---~~~~~~~f~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV  347 (613)
                      ++|...++||+|+||+||+|+...+++.||||+++..   .......+..|+.++. .++|||||++++++.+++.++||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            4688889999999999999999988899999999753   2344556777877765 68999999999999999999999


Q ss_pred             EEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC--
Q 048439          348 YDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG--  425 (613)
Q Consensus       348 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--  425 (613)
                      ||||++|+|.+++..  ...+++.+++.++.||+.||+|||+++    |+||||||+|||+++++.+||+|||+++..  
T Consensus        82 mEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~~----iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT----CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC----eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999954  456899999999999999999999998    999999999999999999999999999742  


Q ss_pred             ------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccccccHHH
Q 048439          426 ------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQIVDPFL  499 (613)
Q Consensus       426 ------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  499 (613)
                            ...++..|+|||++.++.++.++|||||||+||||++|+.||......+......     .........+++.+
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~-----~~~~~~p~~~s~~~  230 (320)
T d1xjda_         156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-----MDNPFYPRWLEKEA  230 (320)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HCCCCCCTTSCHHH
T ss_pred             ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH-----cCCCCCCccCCHHH
Confidence                  2346778999999999999999999999999999999999997655443222221     11222233333333


Q ss_pred             HHh--cccccCCCCCCCHH-HHHHHHH
Q 048439          500 KAM--SCLNDEGIRRPSMS-DVVWGLE  523 (613)
Q Consensus       500 ~~~--~Cl~~~p~~RPs~~-evl~~Le  523 (613)
                      ..+  +||..||.+||++. |++++..
T Consensus       231 ~dli~~~L~~dP~~R~s~~~~l~~hpf  257 (320)
T d1xjda_         231 KDLLVKLFVREPEKRLGVRGDIRQHPL  257 (320)
T ss_dssp             HHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred             HHHHHHhcccCCCCCcCHHHHHHhCch
Confidence            322  79999999999995 7765543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-45  Score=375.77  Aligned_cols=240  Identities=23%  Similarity=0.248  Sum_probs=187.6

Q ss_pred             ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChh-----cHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEEcCC
Q 048439          278 LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQ-----GALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYDFMA  352 (613)
Q Consensus       278 ~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~-----~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  352 (613)
                      ++||+|+||+||+|+...+++.||||+++.....     ....+.+|+.+|++++|||||++++++.+++.++||||||.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            5899999999999999888899999998754322     13468899999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC------
Q 048439          353 RGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP------  426 (613)
Q Consensus       353 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~------  426 (613)
                      ++++..++  .....+++.++..++.||+.||+|||+.+    |+||||||+|||+++++.+||+|||+|+...      
T Consensus        84 ~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~~----iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          84 TDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             EEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred             chHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhccc----eecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence            98776665  34567999999999999999999999998    9999999999999999999999999996422      


Q ss_pred             --CCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCC-------------
Q 048439          427 --TSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT-------------  490 (613)
Q Consensus       427 --~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~-------------  490 (613)
                        ..++..|+|||++... .++.++|||||||+||||++|++||......++...............             
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence              2357789999998754 579999999999999999999999976655444332221111000000             


Q ss_pred             --c-----c---ccccHHHH--HhcccccCCCCCCCHHHHHHHHH
Q 048439          491 --I-----D---QIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       491 --~-----~---~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                        .     .   ...++.+.  ..+||+.||++|||+.|++++-.
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~  282 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  282 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence              0     0   00111111  22799999999999999986544

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-45  Score=376.63  Aligned_cols=248  Identities=23%  Similarity=0.292  Sum_probs=183.7

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecCC----ceEEEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR----EMILVY  348 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~  348 (613)
                      +|...+.||+|+||.||+|++.+  ..||||+++..... ...+..|+..+.+++|||||+++|+|.+.+    .+++||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~~g--~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEETT--EEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEECC--EEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            45566789999999999999853  68999999654321 222345666667889999999999998654    589999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN----HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      |||++|+|.++|..   ..++|.++++++.|+|.||+|||+...    ..+|+||||||+||||++++.+||+|||+++.
T Consensus        81 Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          81 DYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            99999999999964   359999999999999999999997411    12299999999999999999999999999863


Q ss_pred             C------------CCCCCcccCChhhhhcCC------CCchhHHHHHHHHHHHHHhCCCCccchhhhh---------hhh
Q 048439          425 G------------PTSVSKTHLDPEYYRLQQ------LTEKSDVYSFGVVLFEVLCARPSILRTAAKK---------QVS  477 (613)
Q Consensus       425 ~------------~~~~~~~~~aPE~~~~~~------~t~ksDV~SfGvvL~elltg~~p~~~~~~~~---------~~~  477 (613)
                      .            ...++..|+|||++....      ++.|+|||||||+||||+||++|+.......         ...
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            1            234678899999987643      5779999999999999999988764321110         011


Q ss_pred             HHHHHHHhhccC---Cccccc------cHHH-HHhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          478 LAVWAQQCYQNG---TIDQIV------DPFL-KAMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       478 l~~~~~~~~~~~---~~~~~~------d~~~-~~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      ............   .+....      ..+. .+.+||+.||++||||.||++.|+...
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            111111111111   111111      1112 134899999999999999999998543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-45  Score=372.42  Aligned_cols=247  Identities=21%  Similarity=0.274  Sum_probs=194.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|...+.||+|+||+||+|+...+++.||||+++...  ......+.+|+++|++++|||||++++++.+++.+++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            47888899999999999999998888899999996543  3346789999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----  425 (613)
                      |+.+ ++.+++.......+++.++..++.|++.||+|||+.+    |+||||||+|||++.++++||+|||+|+..    
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~----IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC----EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            9976 5555555555677999999999999999999999998    999999999999999999999999998532    


Q ss_pred             ----CCCCCcccCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCccc-------
Q 048439          426 ----PTSVSKTHLDPEYYRLQQ-LTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQ-------  493 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~~~-~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-------  493 (613)
                          ...++..|+|||.+.... ++.++|||||||++|||++|+.||......+.............+.....       
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence                235677899999987765 58899999999999999999999976554433222211111000000000       


Q ss_pred             -----------------cccHHHH--HhcccccCCCCCCCHHHHHHHHH
Q 048439          494 -----------------IVDPFLK--AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       494 -----------------~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                                       -.++...  ..+||..||.+|||+.|++++-.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~f  285 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF  285 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHh
Confidence                             0111111  22799999999999999987644

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-45  Score=380.69  Aligned_cols=241  Identities=20%  Similarity=0.330  Sum_probs=191.0

Q ss_pred             cCCCCc-ceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhcc-CccceeeEEEEeec----CCceE
Q 048439          272 NNFDND-LVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQL-RHLHLVSLIGFCND----DREMI  345 (613)
Q Consensus       272 ~~f~~~-~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~~  345 (613)
                      ++|... ++||+|+||+||+|+...+++.||||+++..     ..+.+|+.++.++ +|||||++++++.+    +..++
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            577765 4699999999999999888899999998642     4577899987655 89999999999865    46689


Q ss_pred             EEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC---CCcEEEEecCCC
Q 048439          346 LVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE---KWVAKVSDFGLS  422 (613)
Q Consensus       346 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGls  422 (613)
                      ||||||++|+|.++|.......|++.++..|+.|++.||+|||+.+    |+||||||+|||+++   ++.+||+|||+|
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~----iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC----Ccccccccccccccccccccccccccccee
Confidence            9999999999999997655667999999999999999999999998    999999999999985   567999999999


Q ss_pred             ccC-------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCc--c-
Q 048439          423 KFG-------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTI--D-  492 (613)
Q Consensus       423 ~~~-------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~--~-  492 (613)
                      +..       ...+++.|+|||++.+..++.++|||||||+||||+||++||...........   .......+..  . 
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         162 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQYEFPN  238 (335)
T ss_dssp             EECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSSSCCT
T ss_pred             eeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHHHHhcCCCCCCC
Confidence            642       23568889999999999999999999999999999999999976543221111   1111111111  0 


Q ss_pred             ---ccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          493 ---QIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       493 ---~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                         .-+.+.+.  ..+||+.||++|||+.|++.+...
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  275 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI  275 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHH
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHh
Confidence               01112121  227999999999999999987544

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-45  Score=367.84  Aligned_cols=235  Identities=20%  Similarity=0.340  Sum_probs=189.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh------hcHHHHHHHHHHHhccC--ccceeeEEEEeecCCc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ------QGALEFQTEIGMLSQLR--HLHLVSLIGFCNDDRE  343 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~------~~~~~f~~Ei~~l~~l~--H~niv~l~g~~~~~~~  343 (613)
                      ++|...++||+|+||.||+|+...+++.||||+++....      .....+.+|+.+|++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            568888999999999999999988889999999865321      11234678999999996  8999999999999999


Q ss_pred             eEEEEEcCCC-CChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC-CCcEEEEecCC
Q 048439          344 MILVYDFMAR-GTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE-KWVAKVSDFGL  421 (613)
Q Consensus       344 ~~lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGl  421 (613)
                      .++||||+.+ +++.+++..  ...+++.++..++.|++.||+|||+.+    |+||||||+|||++. ++.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~~----iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCG----VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC----CccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 678777743  456999999999999999999999998    999999999999985 47999999999


Q ss_pred             CccC------CCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcccc
Q 048439          422 SKFG------PTSVSKTHLDPEYYRLQQL-TEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTIDQI  494 (613)
Q Consensus       422 s~~~------~~~~~~~~~aPE~~~~~~~-t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  494 (613)
                      |+..      ...+|..|+|||++.+..+ +.++|||||||+||||++|+.||......      ..     ....+..-
T Consensus       158 a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i------~~-----~~~~~~~~  226 (273)
T d1xwsa_         158 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IR-----GQVFFRQR  226 (273)
T ss_dssp             CEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------HH-----CCCCCSSC
T ss_pred             ceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH------hh-----cccCCCCC
Confidence            9642      2346788999999988776 56799999999999999999999653211      00     01111122


Q ss_pred             ccHHHH--HhcccccCCCCCCCHHHHHHHHH
Q 048439          495 VDPFLK--AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       495 ~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                      +.+.+.  ..+||+.||++|||+.|++++..
T Consensus       227 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~  257 (273)
T d1xwsa_         227 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW  257 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence            222222  22799999999999999987654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1e-43  Score=362.04  Aligned_cols=245  Identities=19%  Similarity=0.225  Sum_probs=193.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|...+.||+|+||+||+|+...+ +.||||+++...  ....+.|.+|+.+|++++|||||++++++.+++..++++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTS-CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCC-CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            5788888999999999999998754 789999997653  3345789999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC----
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG----  425 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~----  425 (613)
                      |+.++.+..+.  .....+++.++..|+.||+.||+|||+.+    |+||||||+|||++.++.+||+|||+|...    
T Consensus        81 ~~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          81 HLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRR----VLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CCSEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             eehhhhHHHHH--hhcCCcchhhhHHHHHHHHHHHHHhccCc----EEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            99987776665  34567999999999999999999999988    999999999999999999999999998531    


Q ss_pred             ----CCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCc---------
Q 048439          426 ----PTSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTI---------  491 (613)
Q Consensus       426 ----~~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~---------  491 (613)
                          ...++..|++||.+... .++.++|||||||+||||++|++||......++................         
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence                22356679999998764 5689999999999999999999999765544433222211111000000         


Q ss_pred             ---------------cccccHHHH--HhcccccCCCCCCCHHHHHHHHH
Q 048439          492 ---------------DQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       492 ---------------~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                                     ....++...  ..+||+.||++|||+.|++++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~  283 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY  283 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence                           011112221  22799999999999999986543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=365.20  Aligned_cols=248  Identities=22%  Similarity=0.324  Sum_probs=192.4

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcC-CceeEEEEEeCCCC--hhcHHHHHHHHHHHhcc---CccceeeEEEEeec----
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFING-STTPVAIKRLEPES--QQGALEFQTEIGMLSQL---RHLHLVSLIGFCND----  340 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~-~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l---~H~niv~l~g~~~~----  340 (613)
                      .++|...+.||+|+||+||+|++.. +++.||||+++...  ......+.+|+.+|+.|   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            4689999999999999999999854 46789999986532  22233466777777665   79999999999853    


Q ss_pred             -CCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEec
Q 048439          341 -DREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDF  419 (613)
Q Consensus       341 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DF  419 (613)
                       ...++++||||.+|.+.... ......+++..+..++.|++.||+|||+.+    |+||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~----ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCC----EEecCCCccEEEEcCCCCeeecch
Confidence             35689999999987765443 345667999999999999999999999998    999999999999999999999999


Q ss_pred             CCCcc-------CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccC---
Q 048439          420 GLSKF-------GPTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNG---  489 (613)
Q Consensus       420 Gls~~-------~~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---  489 (613)
                      |+++.       ....+|+.|+|||++.+..++.++||||+||+||||++|++||......+...............   
T Consensus       161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            99864       23456889999999999999999999999999999999999998765544433322221110000   


Q ss_pred             -------------------CccccccHHHH--HhcccccCCCCCCCHHHHHHHHH
Q 048439          490 -------------------TIDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       490 -------------------~~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                                         ....-+++...  ..+||+.||++|||+.|++++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf  295 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  295 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence                               00011122222  23799999999999999987654

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-42  Score=359.05  Aligned_cols=247  Identities=23%  Similarity=0.304  Sum_probs=193.2

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeec--------C
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND--------D  341 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~--------~  341 (613)
                      ++|+..+.||+|+||+||+|+...+++.||||++...  .......+.+|+.+|++++|+||+++++++..        +
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6788889999999999999999888899999998654  33445678999999999999999999999865        3


Q ss_pred             CceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCC
Q 048439          342 REMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGL  421 (613)
Q Consensus       342 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl  421 (613)
                      +.+++|||||.++.+....  .....++...+..++.|++.||+|||+.+    |+||||||+|||+++++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~----ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCC----EEecCcCchheeecCCCcEEeeecce
Confidence            5689999999987776544  34567899999999999999999999998    99999999999999999999999999


Q ss_pred             CccC------------CCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc
Q 048439          422 SKFG------------PTSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN  488 (613)
Q Consensus       422 s~~~------------~~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~  488 (613)
                      ++..            ...+|..|+|||.+.+. .++.|+|||||||++|||++|++||......+..............
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            8531            12367789999998765 6899999999999999999999999765544443333222211111


Q ss_pred             CCcccc---------------------------ccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          489 GTIDQI---------------------------VDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       489 ~~~~~~---------------------------~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                      ......                           .++...  ..+||+.||++|||+.|++++..+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff  308 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF  308 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence            100000                           011111  237999999999999999987664

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-42  Score=362.78  Aligned_cols=243  Identities=25%  Similarity=0.252  Sum_probs=186.1

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEEEEeecC------CceEE
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDD------REMIL  346 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l  346 (613)
                      +|...++||+|+||+||+|++..+++.||||++......    +.+|+++|++++|+|||+++++|...      ..++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            567778999999999999999988899999999765422    34799999999999999999998542      34789


Q ss_pred             EEEcCCCCChhHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC-cEEEEecCCCcc
Q 048439          347 VYDFMARGTLPDHLY-HSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW-VAKVSDFGLSKF  424 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGls~~  424 (613)
                      |||||++|.+..+.. ......+++.++..++.|++.||+|||+.+    |+||||||+||||+.++ .+||+|||+++.
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~----IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT----EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC----CcccCCCcceEEEecCCCceeEecccchhh
Confidence            999998765444332 134567999999999999999999999998    99999999999999775 899999999864


Q ss_pred             C-------CCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHH----------HHhh
Q 048439          425 G-------PTSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWA----------QQCY  486 (613)
Q Consensus       425 ~-------~~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~----------~~~~  486 (613)
                      .       ...++..|+|||.+.. ..++.++|||||||++|||++|++||......++.......          ....
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  252 (350)
T d1q5ka_         173 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  252 (350)
T ss_dssp             CCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred             ccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence            2       2345678999998865 56899999999999999999999999766544433222111          0000


Q ss_pred             --ccCCc------------cccccHHHH--HhcccccCCCCCCCHHHHHHHHH
Q 048439          487 --QNGTI------------DQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       487 --~~~~~------------~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                        .....            ....++...  ..+||..||++|||+.|++++-.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  305 (350)
T d1q5ka_         253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF  305 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence              00000            001122222  22799999999999999987654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-42  Score=362.15  Aligned_cols=245  Identities=22%  Similarity=0.306  Sum_probs=187.3

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeecCC------c
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR------E  343 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~------~  343 (613)
                      ++|...+.||+|+||+||+|+...+++.||||+++..  +....+.+.+|+++|++++|||||+++++|...+      .
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            5788888999999999999999888899999999754  3344567899999999999999999999997654      5


Q ss_pred             eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCc
Q 048439          344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK  423 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~  423 (613)
                      ++|||||| +++|..++.   ...|++..++.++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+|+
T Consensus        98 ~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~----IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAAG----IIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhCC----CcccccCcchhhccccccccccccccee
Confidence            79999999 457777663   346999999999999999999999998    9999999999999999999999999997


Q ss_pred             cCC-----CCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHh------------
Q 048439          424 FGP-----TSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQC------------  485 (613)
Q Consensus       424 ~~~-----~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~------------  485 (613)
                      ...     ..++..|+|||.+.+. .++.++||||+||+||||++|++||..................            
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         170 QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             ECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             ccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence            532     3457789999998764 5689999999999999999999999765443332221111100            


Q ss_pred             --------h---ccCCccc---cccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          486 --------Y---QNGTIDQ---IVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       486 --------~---~~~~~~~---~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                              .   ....+..   -.++...  ..+||..||.+|||+.|++++..+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f  304 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF  304 (346)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence                    0   0000111   1122221  227999999999999999987553

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-42  Score=361.28  Aligned_cols=245  Identities=22%  Similarity=0.273  Sum_probs=187.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC-hhcHHHHHHHHHHHhccCccceeeEEEEeecCC----ceEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES-QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDR----EMIL  346 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~l  346 (613)
                      .+|...+.||+|+||+||+|+...+++.||||+++... ....+.+++|+.+|++|+||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            46888889999999999999998888999999997653 344567899999999999999999999987643    2345


Q ss_pred             EEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccC-
Q 048439          347 VYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFG-  425 (613)
Q Consensus       347 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~-  425 (613)
                      +++|+.+|+|.+++..   ..+++..+..++.|++.||+|||+++    |+||||||+||||++++.+||+|||+|+.. 
T Consensus        88 l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~----iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          88 LVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC----CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            5566779999999953   36999999999999999999999998    999999999999999999999999998632 


Q ss_pred             ----------CCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhh--------
Q 048439          426 ----------PTSVSKTHLDPEYYRL-QQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCY--------  486 (613)
Q Consensus       426 ----------~~~~~~~~~aPE~~~~-~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~--------  486 (613)
                                ...++..|+|||.+.. ..++.++||||+||++|||++|++||......+............        
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence                      2335678999999855 467899999999999999999999997655433332222111000        


Q ss_pred             ----------ccCC---------ccccccHHHH-HhcccccCCCCCCCHHHHHHHHH
Q 048439          487 ----------QNGT---------IDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       487 ----------~~~~---------~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                                ....         ...+.+.... ..+||..||.+|||+.|++++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf  297 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY  297 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence                      0000         0011111111 23799999999999999998754

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-42  Score=348.00  Aligned_cols=246  Identities=19%  Similarity=0.245  Sum_probs=193.9

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCC--hhcHHHHHHHHHHHhccCccceeeEEEEeecCCceEEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPES--QQGALEFQTEIGMLSQLRHLHLVSLIGFCNDDREMILVYD  349 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  349 (613)
                      ++|+..+.||+|+||+||+|+...+++.||||+++...  ......+.+|+.+|++++|||||+++++|.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            46888899999999999999998888999999986543  3345678999999999999999999999999999999999


Q ss_pred             cCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCccCC---
Q 048439          350 FMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP---  426 (613)
Q Consensus       350 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~---  426 (613)
                      ++.+++|..++.  ....+++..+..++.|++.||+|||+.+    |+||||||+|||++.++.+||+|||+|+...   
T Consensus        82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~~----IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcCC----EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999988774  3467899999999999999999999998    9999999999999999999999999997432   


Q ss_pred             -----CCCCcccCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCccchhh-hhhhhHHHHHHHhhccCC---------
Q 048439          427 -----TSVSKTHLDPEYYRLQQ-LTEKSDVYSFGVVLFEVLCARPSILRTAA-KKQVSLAVWAQQCYQNGT---------  490 (613)
Q Consensus       427 -----~~~~~~~~aPE~~~~~~-~t~ksDV~SfGvvL~elltg~~p~~~~~~-~~~~~l~~~~~~~~~~~~---------  490 (613)
                           ...+..|++||.+.... ++.++|||||||++|||++|+.||..... .+................         
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence                 12345688999987665 69999999999999999999988754322 222221111111000000         


Q ss_pred             ---------------ccccccHHHH--HhcccccCCCCCCCHHHHHHHHH
Q 048439          491 ---------------IDQIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLE  523 (613)
Q Consensus       491 ---------------~~~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le  523 (613)
                                     ...-.++...  ..+||+.||.+|||+.|++++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~  285 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY  285 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChh
Confidence                           0001111111  22799999999999999987654

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-41  Score=348.64  Aligned_cols=247  Identities=18%  Similarity=0.162  Sum_probs=187.0

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCccceeeEE-EEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLVSLI-GFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~-g~~~~~~~~~lV~Ey  350 (613)
                      ++|...+.||+|+||.||+|++..+++.||||++......  .++..|++++++++|+|++.++ ++..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            4588889999999999999999888899999998765332  3578999999999877766554 455677888999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeC---CCCcEEEEecCCCccC--
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLD---EKWVAKVSDFGLSKFG--  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGls~~~--  425 (613)
                      +. |+|.+.+.. ....+++..++.++.|++.||+|||+++    |+||||||+|||++   .+..+||+|||+|+..  
T Consensus        85 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~----iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 LG-PSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKN----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CC-CBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT----EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             cC-Cchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCC----eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            95 566666543 3456999999999999999999999998    99999999999875   4567999999999642  


Q ss_pred             -------------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHH-HHHHHhhccC--
Q 048439          426 -------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLA-VWAQQCYQNG--  489 (613)
Q Consensus       426 -------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~-~~~~~~~~~~--  489 (613)
                                   ...++..|+|||.+.+..++.++|||||||++|||++|+.||............ .+........  
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  238 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence                         124678899999999999999999999999999999999999765433322222 1111111110  


Q ss_pred             -CccccccHHHH-HhcccccCCCCCCCHHHHHHHHHHhh
Q 048439          490 -TIDQIVDPFLK-AMSCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       490 -~~~~~~d~~~~-~~~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                       ....+.+.+.. ...||+.+|++||++.++.+.|+...
T Consensus       239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence             01112222222 22799999999999999988877544

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.7e-41  Score=344.23  Aligned_cols=247  Identities=19%  Similarity=0.156  Sum_probs=194.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCc-cceeeEEEEeecCCceEEEEEc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRH-LHLVSLIGFCNDDREMILVYDF  350 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey  350 (613)
                      ++|...+.||+|+||+||+|+...+++.||||++.....  ...+.+|++.+..|+| +|++.+++++.+....++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            578888999999999999999988889999999865432  2346788999999965 8999999999999999999999


Q ss_pred             CCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCC-----CCcEEEEecCCCccC
Q 048439          351 MARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDE-----KWVAKVSDFGLSKFG  425 (613)
Q Consensus       351 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~-----~~~~kl~DFGls~~~  425 (613)
                      + +|+|.+++.. ....+++.+++.++.|++.||+|||+.+    |+||||||+|||++.     ++.+||+|||+|+..
T Consensus        83 ~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~g----iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          83 L-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKS----LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTT----EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             c-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCC----ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            9 6799998854 3456999999999999999999999999    999999999999974     578999999999642


Q ss_pred             ---------------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCC
Q 048439          426 ---------------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGT  490 (613)
Q Consensus       426 ---------------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~  490 (613)
                                     ...||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence                           12367889999999999999999999999999999999999975433222111111111111111


Q ss_pred             c----cccccHHHHHh-cccccCCCCCCCHHHHHHHHHHhh
Q 048439          491 I----DQIVDPFLKAM-SCLNDEGIRRPSMSDVVWGLEFSL  526 (613)
Q Consensus       491 ~----~~~~d~~~~~~-~Cl~~~p~~RPs~~evl~~Le~~l  526 (613)
                      .    ..+...+...+ .|+..+|++||++..+.+.|+..+
T Consensus       237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            1    11222222222 699999999999998887777544

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=358.64  Aligned_cols=247  Identities=22%  Similarity=0.240  Sum_probs=192.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEE---cCCceeEEEEEeCCCC----hhcHHHHHHHHHHHhccCc-cceeeEEEEeecCCc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFI---NGSTTPVAIKRLEPES----QQGALEFQTEIGMLSQLRH-LHLVSLIGFCNDDRE  343 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~---~~~~~~vAVK~~~~~~----~~~~~~f~~Ei~~l~~l~H-~niv~l~g~~~~~~~  343 (613)
                      ++|+..+.||+|+||+||+|+.   ..+++.||||.++...    ....+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5688899999999999999987   3356889999987542    2334568899999999977 799999999999999


Q ss_pred             eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCc
Q 048439          344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK  423 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~  423 (613)
                      +++|||||.+|+|.+++..  ...++......++.|++.||+|||+.+    |+||||||+||||+.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~--~~~~~e~~~~~~~~Qi~~al~~lH~~~----ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHh--cccccHHHHHHHHHHHHHHHHHhhcCC----EEeccCCccceeecCCCCEEEeeccchh
Confidence            9999999999999999854  345778899999999999999999998    9999999999999999999999999986


Q ss_pred             cC---------CCCCCcccCChhhhhcC--CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhccCCcc
Q 048439          424 FG---------PTSVSKTHLDPEYYRLQ--QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQNGTID  492 (613)
Q Consensus       424 ~~---------~~~~~~~~~aPE~~~~~--~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  492 (613)
                      ..         ...++..|++||.+...  .++.++|||||||+||||++|+.||......+..................
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~  257 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ  257 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence            32         23456779999999765  46889999999999999999999997654433322222111111111112


Q ss_pred             ccccHHHHH-hcccccCCCCCCC-----HHHHHHHHHH
Q 048439          493 QIVDPFLKA-MSCLNDEGIRRPS-----MSDVVWGLEF  524 (613)
Q Consensus       493 ~~~d~~~~~-~~Cl~~~p~~RPs-----~~evl~~Le~  524 (613)
                      ...+..... .+||+.||.+||+     +.|++++..+
T Consensus       258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff  295 (322)
T d1vzoa_         258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  295 (322)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence            222222222 2799999999994     7888766553

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.8e-41  Score=346.49  Aligned_cols=187  Identities=22%  Similarity=0.372  Sum_probs=163.8

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC-ccceeeEEEEeec--CCceEEEE
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGFCND--DREMILVY  348 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV~  348 (613)
                      ++|...++||+|+||+||+|+...+++.||||+++...   .+.+.+|+.+|.+++ ||||+++++++..  ...+++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57888899999999999999998888999999997643   457889999999995 9999999999874  45689999


Q ss_pred             EcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCC-cEEEEecCCCccCC-
Q 048439          349 DFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKW-VAKVSDFGLSKFGP-  426 (613)
Q Consensus       349 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGls~~~~-  426 (613)
                      |||.+|+|.+..     ..+++..+..++.||+.||.|||+.+    |+||||||+|||++.++ .+||+|||+|+... 
T Consensus       112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g----IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT----EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc----cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999997754     35999999999999999999999999    99999999999998654 69999999996432 


Q ss_pred             ------CCCCcccCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          427 ------TSVSKTHLDPEYYRLQQ-LTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       427 ------~~~~~~~~aPE~~~~~~-~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                            ..++..|+|||.+.+.. ++.++||||+||++|||++|+.||...
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~  233 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  233 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence                  23466799999987754 799999999999999999999998654

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-41  Score=353.70  Aligned_cols=247  Identities=21%  Similarity=0.290  Sum_probs=189.5

Q ss_pred             hcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeec-----CCc
Q 048439          271 TNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND-----DRE  343 (613)
Q Consensus       271 t~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~-----~~~  343 (613)
                      .++|...+.||+|+||+||+|+...+++.||||+++..  +....+.+.+|+++|++++|+|||++++++..     ...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            45788889999999999999999888899999999754  33445678999999999999999999999863     334


Q ss_pred             eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCc
Q 048439          344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK  423 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~  423 (613)
                      .++++||+.+|+|.+++..   ..+++..+..++.||+.||+|||+.+    |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~g----iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCC----CcccccCCccccccccccccccccchhc
Confidence            5667788889999999843   46999999999999999999999998    9999999999999999999999999986


Q ss_pred             cC-----CCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCccchhhhhhhhHHHHHHHhhcc---------
Q 048439          424 FG-----PTSVSKTHLDPEYYRLQ-QLTEKSDVYSFGVVLFEVLCARPSILRTAAKKQVSLAVWAQQCYQN---------  488 (613)
Q Consensus       424 ~~-----~~~~~~~~~aPE~~~~~-~~t~ksDV~SfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---------  488 (613)
                      ..     ...++..|+|||.+... .++.++|||||||+||||++|++||.....................         
T Consensus       170 ~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (348)
T d2gfsa1         170 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  249 (348)
T ss_dssp             CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred             ccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence            43     23346679999987765 4689999999999999999999999765443332222111100000         


Q ss_pred             ---------CCcc--------ccccHHHH--HhcccccCCCCCCCHHHHHHHHHH
Q 048439          489 ---------GTID--------QIVDPFLK--AMSCLNDEGIRRPSMSDVVWGLEF  524 (613)
Q Consensus       489 ---------~~~~--------~~~d~~~~--~~~Cl~~~p~~RPs~~evl~~Le~  524 (613)
                               ....        .-.++...  ..+||..||.+|||+.|++++-.+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f  304 (348)
T d2gfsa1         250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF  304 (348)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhh
Confidence                     0000        00111111  227999999999999999977654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-41  Score=354.10  Aligned_cols=192  Identities=24%  Similarity=0.322  Sum_probs=162.4

Q ss_pred             cCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCC--ChhcHHHHHHHHHHHhccCccceeeEEEEeec------CCc
Q 048439          272 NNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPE--SQQGALEFQTEIGMLSQLRHLHLVSLIGFCND------DRE  343 (613)
Q Consensus       272 ~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~g~~~~------~~~  343 (613)
                      ++|...++||+|+||+||+|++..+++.||||++...  +......+.+|+.+|++++|||||++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5788889999999999999999988899999999754  34455678999999999999999999999864      367


Q ss_pred             eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCc
Q 048439          344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSK  423 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~  423 (613)
                      +|+|||||.++.+ +.+.    ..+++..++.++.|++.||+|||+.+    |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g----iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT----CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc----cccccCCccccccccccceeeechhhhh
Confidence            8999999976544 4442    35899999999999999999999998    9999999999999999999999999986


Q ss_pred             cC-------CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccchhh
Q 048439          424 FG-------PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRTAA  472 (613)
Q Consensus       424 ~~-------~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~~~  472 (613)
                      ..       ...++..|+|||++.+..++.++||||+||++|||++|++||.....
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~  223 (355)
T d2b1pa1         168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY  223 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH
Confidence            42       22457789999999999999999999999999999999999965443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.8e-36  Score=312.79  Aligned_cols=193  Identities=20%  Similarity=0.240  Sum_probs=158.4

Q ss_pred             CCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC-----------ccceeeEEEEeec-
Q 048439          273 NFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-----------HLHLVSLIGFCND-  340 (613)
Q Consensus       273 ~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-----------H~niv~l~g~~~~-  340 (613)
                      +|...++||+|+||+||+|+...+++.||||+++... ...+.+.+|+.++++++           |+|||++++++.. 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            4888899999999999999998888999999998653 23456788999988875           5789999998764 


Q ss_pred             -CCceEEEEEcCCCCCh-hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcEEeccCCCCceeeCCCC-----
Q 048439          341 -DREMILVYDFMARGTL-PDHLYHSDNPPLPWNQRLEICIGAARGLHYLHT-GANHAVIIHRDVKTTNILLDEKW-----  412 (613)
Q Consensus       341 -~~~~~lV~Ey~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~iiHrDlk~~NILl~~~~-----  412 (613)
                       ....+++++++..+.. ...........+++..+..++.|+++||+|||+ .+    |+||||||+||||+.++     
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~----IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG----IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC----EECSCCSGGGEEEEEEETTTTE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC----cccccCChhHeeeeccCccccc
Confidence             4556777777665543 333344556788999999999999999999997 66    99999999999998665     


Q ss_pred             -cEEEEecCCCccC-----CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCccch
Q 048439          413 -VAKVSDFGLSKFG-----PTSVSKTHLDPEYYRLQQLTEKSDVYSFGVVLFEVLCARPSILRT  470 (613)
Q Consensus       413 -~~kl~DFGls~~~-----~~~~~~~~~aPE~~~~~~~t~ksDV~SfGvvL~elltg~~p~~~~  470 (613)
                       .+|++|||.|+..     ...++..|+|||.+....++.++||||+||+|+||++|+.||...
T Consensus       169 ~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             EEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             ceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence             4999999998642     234677899999999999999999999999999999999998644

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=5.1e-24  Score=202.38  Aligned_cols=162  Identities=14%  Similarity=0.129  Sum_probs=121.6

Q ss_pred             CcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCCh------------------hcHHHHHHHHHHHhccCccceeeEEEE
Q 048439          276 NDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQ------------------QGALEFQTEIGMLSQLRHLHLVSLIGF  337 (613)
Q Consensus       276 ~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~------------------~~~~~f~~Ei~~l~~l~H~niv~l~g~  337 (613)
                      ..+.||+|+||.||+|+..++ ..||||+++....                  .....+..|...+.++.|.+++..+++
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g-~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKF-GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTT-EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCC-CEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            456899999999999998754 7899998764211                  012235678899999999999998876


Q ss_pred             eecCCceEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEE
Q 048439          338 CNDDREMILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVS  417 (613)
Q Consensus       338 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~  417 (613)
                      ..    .++||||++++.+.+         +++.....++.|++++|+|||+.+    |+||||||+|||++++ .++|+
T Consensus        83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g----iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG----IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT----EECSCCSTTSEEEETT-EEEEC
T ss_pred             cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC----EEEccCChhheeeeCC-CEEEE
Confidence            42    379999999866543         344556789999999999999998    9999999999999965 58999


Q ss_pred             ecCCCccCCCCCCcccCCh------hhhhcCCCCchhHHHHHHHHH
Q 048439          418 DFGLSKFGPTSVSKTHLDP------EYYRLQQLTEKSDVYSFGVVL  457 (613)
Q Consensus       418 DFGls~~~~~~~~~~~~aP------E~~~~~~~t~ksDV~SfGvvL  457 (613)
                      |||+|+.........|+..      +++ .+.++.++||||..--+
T Consensus       145 DFG~a~~~~~~~~~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWREILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHHHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcHHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence            9999976544333333321      222 35678899999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.55  E-value=1.3e-07  Score=91.70  Aligned_cols=151  Identities=16%  Similarity=0.103  Sum_probs=105.0

Q ss_pred             HHHHHHhcCCCCcceeeeeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccC-ccceeeEEEEeecCCc
Q 048439          265 SEIQAATNNFDNDLVIGVGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLR-HLHLVSLIGFCNDDRE  343 (613)
Q Consensus       265 ~el~~at~~f~~~~~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~g~~~~~~~  343 (613)
                      .|+...-..|...+..+-++...||+....  +..+.||+...........+.+|..++..|. +--+.++++++.+++.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~--~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeC--CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            355555666665444333445789987543  3458899887655444556788888888774 4345678888888888


Q ss_pred             eEEEEEcCCCCChhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-------------------------------
Q 048439          344 MILVYDFMARGTLPDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTGAN-------------------------------  392 (613)
Q Consensus       344 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-------------------------------  392 (613)
                      .++||+++++.++.+....       ......++.++++.|..||+...                               
T Consensus        85 ~~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             eEEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            9999999999888765421       12234456677777777775311                               


Q ss_pred             ------------------------CCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          393 ------------------------HAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       393 ------------------------~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                                              +..++|+|+.+.|||++++...-|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                    12389999999999999877777999998754

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.96  E-value=1.9e-05  Score=75.47  Aligned_cols=131  Identities=19%  Similarity=0.177  Sum_probs=85.7

Q ss_pred             eeeeCc-EEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCc--cceeeEEEEeecCCceEEEEEcCCCCCh
Q 048439          280 IGVGGF-GDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRH--LHLVSLIGFCNDDREMILVYDFMARGTL  356 (613)
Q Consensus       280 iG~G~f-G~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL  356 (613)
                      +..|.. +.||+....++ ..+.+|........   .+..|+..|+.|..  -.+.++++++.+.+..++||||+++.++
T Consensus        18 ~~~G~s~~~v~r~~~~~~-~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGR-PVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTS-CCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCC-CEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            344443 67999877654 55888987655322   46678888877743  3356788888888899999999998665


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 048439          357 PDHLYHSDNPPLPWNQRLEICIGAARGLHYLHTG----------------------------------------------  390 (613)
Q Consensus       357 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------------  390 (613)
                      .+..       +.   ...++.++++.|.-||+.                                              
T Consensus        94 ~~~~-------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          94 LSSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             TTSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             cccc-------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            3311       11   112223333444444421                                              


Q ss_pred             --------CCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          391 --------ANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       391 --------~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                              ..+..++|+|+.+.|||++++..+-|+||+.+..
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                    1123389999999999999877778999998754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.69  E-value=4.6e-05  Score=78.15  Aligned_cols=75  Identities=15%  Similarity=0.067  Sum_probs=48.1

Q ss_pred             eeeeeCcEEEEEEEEcCCceeEEEEEeCCC------C-hhcHHHHHHHHHHHhccC---ccceeeEEEEeecCCceEEEE
Q 048439          279 VIGVGGFGDVYKGFINGSTTPVAIKRLEPE------S-QQGALEFQTEIGMLSQLR---HLHLVSLIGFCNDDREMILVY  348 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~~~~vAVK~~~~~------~-~~~~~~f~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~  348 (613)
                      .||.|....||+....++++.++||.-.+.      + .........|.+.|..+.   ...+.++++++  .+..++||
T Consensus        33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lvm  110 (392)
T d2pula1          33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTVM  110 (392)
T ss_dssp             ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEEE
T ss_pred             EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEEE
Confidence            689999999999988776678999975432      1 112233456777776652   24456677664  34568999


Q ss_pred             EcCCCCC
Q 048439          349 DFMARGT  355 (613)
Q Consensus       349 Ey~~~gs  355 (613)
                      |++++..
T Consensus       111 E~L~~~~  117 (392)
T d2pula1         111 EDLSHLK  117 (392)
T ss_dssp             CCCTTSE
T ss_pred             eccCCcc
Confidence            9998654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.80  E-value=0.0029  Score=62.38  Aligned_cols=138  Identities=15%  Similarity=0.157  Sum_probs=78.7

Q ss_pred             cEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCcccee--eEEE-----EeecCCceEEEEEcCCCCChh
Q 048439          285 FGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV--SLIG-----FCNDDREMILVYDFMARGTLP  357 (613)
Q Consensus       285 fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv--~l~g-----~~~~~~~~~lV~Ey~~~gsL~  357 (613)
                      --.||+....++ ..+++|..++.. ....++..|...+..|....+.  ..+.     .....+..+.++++++|..+.
T Consensus        35 EN~vy~v~~~dg-~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQDEDR-RRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECCTTC-CCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEcCCC-CEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            357999988765 679999987653 2345677888888887533321  1111     123355678899999864321


Q ss_pred             H----Hh----------hc----C---CCCCCCHH-------------------HHHHHHHHHHHHHHHHh---cCCCCC
Q 048439          358 D----HL----------YH----S---DNPPLPWN-------------------QRLEICIGAARGLHYLH---TGANHA  394 (613)
Q Consensus       358 ~----~l----------~~----~---~~~~l~~~-------------------~~~~i~~~ia~gL~yLH---~~~~~~  394 (613)
                      .    .+          +.    .   ....+++.                   .+..+...+.+.+..+.   ....+.
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence            0    00          10    0   01122221                   11122222233333332   222344


Q ss_pred             cEEeccCCCCceeeCCCCcEEEEecCCCccCC
Q 048439          395 VIIHRDVKTTNILLDEKWVAKVSDFGLSKFGP  426 (613)
Q Consensus       395 ~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~  426 (613)
                      .+||+|+.+.|||++++  ..++||+-++.++
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~g~  222 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARNGP  222 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCEEC
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhcccCc
Confidence            58999999999999754  4589999887543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.61  E-value=0.003  Score=64.07  Aligned_cols=72  Identities=14%  Similarity=0.132  Sum_probs=49.1

Q ss_pred             eeeeeCcEEEEEEEEcCC-------ceeEEEEEeCCCChhcHHHHHHHHHHHhccCcccee-eEEEEeecCCceEEEEEc
Q 048439          279 VIGVGGFGDVYKGFINGS-------TTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV-SLIGFCNDDREMILVYDF  350 (613)
Q Consensus       279 ~iG~G~fG~Vy~g~~~~~-------~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey  350 (613)
                      .|+.|---.+|+.....+       ...|.+++.. . ........+|..+++.+.-.+++ +++++|.+    .+|+||
T Consensus        49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef  122 (395)
T d1nw1a_          49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  122 (395)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence            577788889999987543       2345565544 2 22344567899999888644554 78888753    689999


Q ss_pred             CCCCCh
Q 048439          351 MARGTL  356 (613)
Q Consensus       351 ~~~gsL  356 (613)
                      +++.+|
T Consensus       123 i~g~~l  128 (395)
T d1nw1a_         123 IPSRPL  128 (395)
T ss_dssp             CCEEEC
T ss_pred             eccccC
Confidence            987554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.18  E-value=0.022  Score=55.16  Aligned_cols=160  Identities=13%  Similarity=0.053  Sum_probs=88.7

Q ss_pred             ccCHHHHHHHhcCCCCcceee-----eeCcEEEEEEEEcCCceeEEEEEeCCCChhcHHHHHHHHHHHhccCcccee--e
Q 048439          261 QFSLSEIQAATNNFDNDLVIG-----VGGFGDVYKGFINGSTTPVAIKRLEPESQQGALEFQTEIGMLSQLRHLHLV--S  333 (613)
Q Consensus       261 ~f~~~el~~at~~f~~~~~iG-----~G~fG~Vy~g~~~~~~~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv--~  333 (613)
                      ..+.+||+....+|....+..     .|---+.|+....++  .+++|+......  ..+...|+.++..|.+.++.  .
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g--~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~   77 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD--PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPL   77 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC--CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC--cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccc
Confidence            367789999999998765543     444577899887654  389999865422  23444566666666433321  1


Q ss_pred             EEE------EeecCCceEEEEEcCCCCChhHH--------------hhc--C------CCCCC-----------------
Q 048439          334 LIG------FCNDDREMILVYDFMARGTLPDH--------------LYH--S------DNPPL-----------------  368 (613)
Q Consensus       334 l~g------~~~~~~~~~lV~Ey~~~gsL~~~--------------l~~--~------~~~~l-----------------  368 (613)
                      .+-      +..-......++.+..+......              ++.  .      .....                 
T Consensus        78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (316)
T d2ppqa1          78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  157 (316)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence            111      11123445667777765433110              000  0      00000                 


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCCcEEeccCCCCceeeCCCCcEEEEecCCCcc
Q 048439          369 PWNQRLEICIGAARGLHYLHTGANHAVIIHRDVKTTNILLDEKWVAKVSDFGLSKF  424 (613)
Q Consensus       369 ~~~~~~~i~~~ia~gL~yLH~~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~  424 (613)
                      ........+..+...+.-.+...-+..+||+|+.+.||+++++...-|.||+.+..
T Consensus       158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            01111223333344444444444445599999999999999988778999998753

>d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]}

class: All beta proteins
fold: Galactose-binding domain-like
superfamily: Galactose-binding domain-like
family: YxiM N-terminal domain-like
domain: Hypothetical protein YxiM
species: Bacillus subtilis [TaxId: 1423]

Probab=90.00  E-value=0.42  Score=40.46  Aligned_cols=80  Identities=13%  Similarity=0.196  Sum_probs=50.4

Q ss_pred             eEEEEeeCCCCceeeeeeeeeeeecccCCCceEEEEEEcceeecccchhhhhhCCCceeEEEEEEeeccCCCCcccccce
Q 048439           53 LTWEFEVDSGFTYFLRLHFCEFQIEVTEDGDRVFQIFIANLTAEVQADVIAWTGANGVTVYRDYAVMIGSKPNEENIKQN  132 (613)
Q Consensus        53 ltw~~~vd~~~~Y~vrlHFcei~~~~~~~~~r~F~iyi~~~~~~~~~dv~~~~~~~~~p~y~dy~v~~~~~~~~~~~~~~  132 (613)
                      ..|.++|. ++.|.|.++|.|..         ..++.+.++.+...+     +|.   ..-+-|.|.+   .++     .
T Consensus        65 ~~f~v~vP-nG~Y~Vtv~~Gd~~---------~~~~~~eg~~~~~~~-----~g~---~~~~~~~V~V---tDG-----~  118 (146)
T d2o14a1          65 NTFNVDLP-NGLYEVKVTLGNTA---------RASVAAEGVFQVINM-----TGD---GAEDTFQIPV---TDG-----Q  118 (146)
T ss_dssp             CCEEEECC-SEEEEEEEEESSCS---------EEEEEETTEEEEEEE-----EST---TCEEEEEEEE---CSS-----E
T ss_pred             ceEEEECC-CCeEEEEEEEecCC---------CccEEEeeEEecccc-----CCc---cEEEEEEEEE---ECC-----e
Confidence            36777777 78999999999943         235666666553332     222   2235578888   554     4


Q ss_pred             EEEEeecCCCCCCcccccccccceEEeecC
Q 048439          133 LSIQLHPAPRWRTKYSDAILNGLEIFKVDN  162 (613)
Q Consensus       133 l~v~l~p~~~~~~~~~~~ilnglEi~~~~~  162 (613)
                      |++.+-.... ..   .+.||+|||-++++
T Consensus       119 L~l~ft~~~~-G~---~~~in~l~I~~~~d  144 (146)
T d2o14a1         119 LNLLVTEGKA-GT---AFTLSALKIKKLSD  144 (146)
T ss_dssp             EEEEEEESST-TS---CCEEEEEEEEEEES
T ss_pred             EEEEEecCCC-CC---ccEEEEEEEEeccc
Confidence            6666532221 01   57899999988754